PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bewick, S; Yang, RT; Zhang, MJ				Bewick, Sharon; Yang, Ruoting; Zhang, Mingjun			The Danger Is Growing! A New Paradigm for Immune System Activation and Peripheral Tolerance	PLOS ONE			English	Article							REGULATORY T-CELLS; SINGLE-STRANDED RNA; TH17; DIFFERENTIATION; RECOGNITION; T(H)17; HYPOTHESIS; INDUCTION; RECEPTOR; FAMILY	Successful immune defense is a complex balancing act. In order to protect a host against invasion by harmful pathogens, an immune response must be rapid and vigorous, and must eliminate foreign invaders before their populations grow beyond control. That same immune response, however, must be selective enough to recognize and ignore commensal bacteria, environmental antigens and host tissue itself. How the immune system makes the crucial decision whether or not to attack a particular antigen has been a long-standing question central to the study of immunology. Here we show that the structure of the signaling network between regulatory T-cells and type 17 helper T-cells allows the immune system to selectively attack pathogens based on whether or not the pathogens represent a growing, and thus dangerous population. We term this mechanism for immune system activation the 'Growth Detection Paradigm', because it offers an entirely new explanation for immune system regulation and peripheral tolerance.	[Bewick, Sharon; Yang, Ruoting; Zhang, Mingjun] Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Bewick, S (corresponding author), Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA.	mjzhang@utk.edu						Abbas AK, 2007, J AUTOIMMUN, V28, P59, DOI 10.1016/j.jaut.2007.02.002; Abbas AK., 2020, BASIC IMMUNOLOGY, V6a; ANNUNZIATO F, 2008, INT IMMUNOL; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betti M, 2006, ANN ONCOL, V17, P235; Bi YJ, 2007, J CELL PHYSIOL, V211, P273, DOI 10.1002/jcp.20973; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; HATTON RD, 2009, F1000 BIOL REPORTS, V1, P1; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Ho PP, 2008, CELL RES, V18, P605, DOI 10.1038/cr.2008.63; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8112	10.1371/journal.pone.0008112	http://dx.doi.org/10.1371/journal.pone.0008112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956616	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828800010
J	Ay, F; Xu, F; Kahveci, T				Ay, Ferhat; Xu, Fei; Kahveci, Tamer			Scalable Steady State Analysis of Boolean Biological Regulatory Networks	PLOS ONE			English	Article							GENETIC-CONTROL; P53 PATHWAY; MODEL; DIFFERENTIATION; ALGORITHM; DYNAMICS; PREDICTS	Background: Computing the long term behavior of regulatory and signaling networks is critical in understanding how biological functions take place in organisms. Steady states of these networks determine the activity levels of individual entities in the long run. Identifying all the steady states of these networks is difficult due to the state space explosion problem. Methodology: In this paper, we propose a method for identifying all the steady states of Boolean regulatory and signaling networks accurately and efficiently. We build a mathematical model that allows pruning a large portion of the state space quickly without causing any false dismissals. For the remaining state space, which is typically very small compared to the whole state space, we develop a randomized traversal method that extracts the steady states. We estimate the number of steady states, and the expected behavior of individual genes and gene pairs in steady states in an online fashion. Also, we formulate a stopping criterion that terminates the traversal as soon as user supplied percentage of the results are returned with high confidence. Conclusions: This method identifies the observed steady states of boolean biological networks computationally. Our algorithm successfully reported the G1 phases of both budding and fission yeast cell cycles. Besides, the experiments suggest that this method is useful in identifying co-expressed genes as well. By analyzing the steady state profile of Hedgehog network, we were able to find the highly co-expressed gene pair GL1-SMO together with other such pairs. Availability: Source code of this work is available at http://bioinformatics.cise.ufl.edu/palSteady.html twocolumnfalse]	[Ay, Ferhat; Xu, Fei; Kahveci, Tamer] Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Ay, F (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	fay@cise.ufl.edu	Ay, Ferhat/J-7800-2019	Ay, Ferhat/0000-0002-0708-6914	NSF [CCF-0829867, DBI-0606607, IIS-0845439]	NSF(National Science Foundation (NSF))	This work was supported partially by NSF under grants CCF-0829867, DBI-0606607 and IIS-0845439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts MJ, 2008, INT J STROKE, V3, P16, DOI 10.1111/j.1747-4949.2008.00174.x; Ay Ferhat, 2008, Comput Syst Bioinformatics Conf, V7, P237, DOI 10.1142/9781848162648_0021; Ay Ferhat, 2009, Journal of Bioinformatics and Computational Biology, V7, P389, DOI 10.1142/S0219720009004163; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; BUYLLA EA, 2008, PLOS ONE, V3, pE3626; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DEMONGEOT J, 2008, C P ADV INF NET APP, P782; Devloo V, 2003, B MATH BIOL, V65, P1025, DOI 10.1016/S0092-8240(03)00061-2; FANGTING L, 2004, P NATL ACAD SCI USA, V101, P4781; GARG A, 2007, C P IEEE ENG MED BIO, P1398; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Hachtel GD, 1996, IEEE T COMPUT AID D, V15, P1479, DOI 10.1109/43.552081; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Lane DP, 1999, BRIT J CANCER, V80, P1; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; NIELSEN J, 2006, BUDDY BINARY DECISIO; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; OSAMU H, 2005, LECT NOTES COMPUT SC, V3482, P349; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; SATORU M, 2003, C P COMP MET SYS BIO, P207; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schaub MA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-4; Segal E, 2005, J MACH LEARN RES, V6, P557; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; TATSUYA A, 1999, C P PAC S BIOC, V4, P17; TATSUYA A, 2003, THEOR COMPUT SCI, V298, P235; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442; Zotenko E, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-7	46	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7992	10.1371/journal.pone.0007992	http://dx.doi.org/10.1371/journal.pone.0007992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956604	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828700003
J	Gunn, DA; Rexbye, H; Griffiths, CEM; Murray, PG; Fereday, A; Catt, SD; Tomlin, CC; Strongitharm, BH; Perrett, DI; Catt, M; Mayes, AE; Messenger, AG; Green, MR; van der Ouderaa, F; Vaupel, JW; Christensen, K				Gunn, David A.; Rexbye, Helle; Griffiths, Christopher E. M.; Murray, Peter G.; Fereday, Amelia; Catt, Sharon D.; Tomlin, Cyrena C.; Strongitharm, Barbara H.; Perrett, Dave I.; Catt, Michael; Mayes, Andrew E.; Messenger, Andrew G.; Green, Martin R.; van der Ouderaa, Frans; Vaupel, James W.; Christensen, Kaare			Why Some Women Look Young for Their Age	PLOS ONE			English	Article							FACIAL SKIN; HAIR LOSS; GENETIC-DETERMINANTS; NASOLABIAL FOLD; ALOPECIA-AREATA; SCALP BIOPSIES; PERCEIVED AGE; PERCEPTION; MINIATURIZATION; ATTRACTIVENESS	The desire of many to look young for their age has led to the establishment of a large cosmetics industry. However, the features of appearance that primarily determine how old women look for their age and whether genetic or environmental factors predominately influence such features are largely unknown. We studied the facial appearance of 102 pairs of female Danish twins aged 59 to 81 as well as 162 British females aged 45 to 75. Skin wrinkling, hair graying and lip height were significantly and independently associated with how old the women looked for their age. The appearance of facial sun-damage was also found to be significantly correlated to how old women look for their age and was primarily due to its commonality with the appearance of skin wrinkles. There was also considerable variation in the perceived age data that was unaccounted for. Composite facial images created from women who looked young or old for their age indicated that the structure of subcutaneous tissue was partly responsible. Heritability analyses of the appearance features revealed that perceived age, pigmented age spots, skin wrinkles and the appearance of sun-damage were influenced more or less equally by genetic and environmental factors. Hair graying, recession of hair from the forehead and lip height were influenced mainly by genetic factors whereas environmental factors influenced hair thinning. These findings indicate that women who look young for their age have large lips, avoid sun-exposure and possess genetic factors that protect against the development of gray hair and skin wrinkles. The findings also demonstrate that perceived age is a better biomarker of skin, hair and facial aging than chronological age.	[Gunn, David A.; Murray, Peter G.; Fereday, Amelia; Catt, Sharon D.; Tomlin, Cyrena C.; Strongitharm, Barbara H.; Mayes, Andrew E.; Green, Martin R.] Unilever Discover, Sharnbrook, Beds, England; [Rexbye, Helle; Christensen, Kaare] Univ So Denmark, Danish Twin Registry, Odense, Denmark; [Rexbye, Helle; Christensen, Kaare] Univ So Denmark, Danish Aging Res Ctr, Inst Publ Hlth, Odense, Denmark; [Griffiths, Christopher E. M.] Univ Manchester, Salford Royal Hosp, Manchester, Lancs, England; [Perrett, Dave I.] Univ St Andrews, Percept Lab, Sch Psychol, St Andrews, Fife, Scotland; [Catt, Michael] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Messenger, Andrew G.] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England; [van der Ouderaa, Frans] Leiden Univ, Med Ctr, Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	Unilever; University of Southern Denmark; University of Southern Denmark; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; University of St Andrews; Newcastle University - UK; University of Sheffield; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Gunn, DA (corresponding author), Unilever Discover, Sharnbrook, Beds, England.	david.gunn@unilever.com	Christensen, Kaare/C-2360-2009; Messenger, Andrew/J-1240-2019; Griffiths, Christopher E.M./P-5448-2014; Van Der Ouderaa, Frans/AAA-8580-2020	Christensen, Kaare/0000-0002-5429-5292; Messenger, Andrew/0000-0003-1424-8069; Griffiths, Christopher E.M./0000-0001-5371-4427; Vaupel, James/0000-0003-0783-3905; Catt, Michael/0000-0003-0935-7973; Gunn, David/0000-0001-9866-3221; Perrett, David/0000-0002-6025-0939	Unilever PLC; MRC [G0900886] Funding Source: UKRI; Medical Research Council [G0900886] Funding Source: researchfish	Unilever PLC(Unilever); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Both studies were funded by Unilever PLC (http://www.unilever.com/). Some of the authors are employed by Unilever PLC and were involved in the design, data collection and analysis as well as the decision to publish.	BARTLETT SP, 1992, PLAST RECONSTR SURG, V90, P592, DOI 10.1097/00006534-199210000-00007; Bastiaens M, 2004, PIGM CELL RES, V17, P225, DOI 10.1111/j.1600-0749.2004.00131.x; BORKAN GA, 1980, J GERONTOL, V35, P177, DOI 10.1093/geronj/35.2.177; Bulpitt CJ, 2001, POSTGRAD MED J, V77, P578, DOI 10.1136/pmj.77.911.578; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Dixson AF, 2003, ARCH SEX BEHAV, V32, P29, DOI 10.1023/A:1021889228469; Fink B, 2008, J EUR ACAD DERMATOL, V22, P493, DOI 10.1111/j.1468-3083.2007.02512.x; Gosain AK, 1996, PLAST RECONSTR SURG, V98, P622, DOI 10.1097/00006534-199609001-00005; GRIFFITHS CEM, 1992, BRIT J DERMATOL, V127, P37, DOI 10.1111/j.1365-2133.1992.tb16986.x; GRIFFITHS CEM, 1992, ARCH DERMATOL, V128, P347, DOI 10.1001/archderm.128.3.347; Gulec AT, 2004, INT J DERMATOL, V43, P352, DOI 10.1111/j.1365-4632.2004.02028.x; Gunn DA, 2008, BIOGERONTOLOGY, V9, P357, DOI 10.1007/s10522-008-9141-y; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; HAYAKAWA K, 1992, ACTA GENET MED GEMEL, V41, P177, DOI 10.1017/S0001566000002385; Jacobi U, 2004, SKIN RES TECHNOL, V10, P207, DOI 10.1111/j.1600-0846.2004.00075.x; Kim HS, 2006, EXP DERMATOL, V15, P515, DOI 10.1111/j.1600-0625.2006.00443.x; Knize DM, 2000, PLAST RECONSTR SURG, V105, P350, DOI 10.1097/00006534-200001000-00058; Krejci-Papa NC, 2005, SKIN AGING, P133; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Leveque JL, 2004, DERMATOLOGY, V208, P307, DOI 10.1159/000077838; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Messenger AG, 2006, BRIT J DERMATOL, V155, P926, DOI 10.1111/j.1365-2133.2006.07409.x; Neale MC, 1992, METHODOLOGY GENETIC; Nkengne A, 2008, J EUR ACAD DERMATOL, V22, P982, DOI 10.1111/j.1468-3083.2008.02698.x; Nouveau-Richard S, 2005, J DERMATOL SCI, V40, P187, DOI 10.1016/j.jdermsci.2005.06.006; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Ozdemir R, 2002, PLAST RECONSTR SURG, V110, P1134, DOI 10.1097/01.PRS.0000021442.30272.0E; Patriarca MT, 2007, EUR J OBSTET GYN R B, V130, P202, DOI 10.1016/j.ejogrb.2006.05.024; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Rexbye H, 2005, J GERONTOL A-BIOL, V60, P1077, DOI 10.1093/gerona/60.8.1077; Rohrich RJ, 2007, PLAST RECONSTR SURG, V119, P2219, DOI 10.1097/01.prs.0000265403.66886.54; Sartfaktoglu N, 2004, SCAND J PLAST RECONS, V38, P244, DOI 10.1080/02844310410027257; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Shekar SN, 2005, J INVEST DERMATOL, V125, P1119, DOI 10.1111/j.0022-202X.2005.23961.x; Sinclair R, 2004, J AM ACAD DERMATOL, V51, P189, DOI 10.1016/s0190-9622(03)00045-8; SINGER RS, 1994, ARCH DERMATOL, V130, P121, DOI 10.1001/archderm.1994.01690010127031; SMITH MA, 1964, ARCH DERMATOL, V89, P95, DOI 10.1001/archderm.1964.01590250101017; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Takema Y, 1996, Exp Dermatol, V5, P145, DOI 10.1111/j.1600-0625.1996.tb00109.x; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WARREN R, 1991, J AM ACAD DERMATOL, V25, P751, DOI 10.1016/S0190-9622(08)80964-4; Whiting DA, 1999, J INVEST DERM SYMP P, V4, P282, DOI 10.1038/sj.jidsp.5640230; Wildt L, 1999, LANCET, V354, P224, DOI 10.1016/S0140-6736(99)01436-1; Wong BJF, 2008, LARYNGOSCOPE, V118, P962, DOI 10.1097/MLG.0b013e31816bf545; YOUSIF NJ, 1994, PLAST RECONSTR SURG, V93, P70, DOI 10.1097/00006534-199401000-00010	49	128	131	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8021	10.1371/journal.pone.0008021	http://dx.doi.org/10.1371/journal.pone.0008021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956599	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000272828700005
J	Aguilar, S; Scotton, CJ; McNulty, K; Nye, E; Stamp, G; Laurent, G; Bonnet, D; Janes, SM				Aguilar, Susana; Scotton, Chris J.; McNulty, Katrina; Nye, Emma; Stamp, Gordon; Laurent, Geoff; Bonnet, Dominique; Janes, Sam M.			Bone Marrow Stem Cells Expressing Keratinocyte Growth Factor via an Inducible Lentivirus Protects against Bleomycin-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							INDUCED LUNG INJURY; IN-VIVO; EPITHELIAL PROLIFERATION; MULTIPLE MECHANISMS; PROGENITOR CELLS; GENE-EXPRESSION; II CELLS; MICE; MODEL; ENGRAFTMENT	Many common diseases of the gas exchange surface of the lung have no specific treatment but cause serious morbidity and mortality. Idiopathic Pulmonary Fibrosis (IPF) is characterized by alveolar epithelial cell injury, interstitial inflammation, fibroblast proliferation and collagen accumulation within the lung parenchyma. Keratinocyte Growth Factor (KGF, also known as FGF-7) is a critical mediator of pulmonary epithelial repair through stimulation of epithelial cell proliferation. During repair, the lung not only uses resident cells after injury but also recruits circulating bone marrow-derived cells (BMDC). Several groups have used Mesenchymal Stromal Cells (MSCs) as therapeutic vectors, but little is known about the potential of Hematopoietic Stem cells (HSCs). Using an inducible lentiviral vector (Tet-On) expressing KGF, we were able to efficiently transduce both MSCs and HSCs, and demonstrated that KGF expression is induced in a regulated manner both in vitro and in vivo. We used the in vivo bleomycin-induced lung fibrosis model to assess the potential therapeutic effect of MSCs and HSCs. While both populations reduced the collagen accumulation associated with bleomycin-induced lung fibrosis, only transplantation of transduced HSCs greatly attenuated the histological damage. Using double immunohistochemistry, we show that the reduced lung damage likely occurs through endogenous type II pneumocyte proliferation induced by KGF. Taken together, our data indicates that bone marrow transplantation of lentivirus-transduced HSCs can attenuate lung damage, and shows for the first time the potential of using an inducible Tet-On system for cell based gene therapy in the lung.	[Aguilar, Susana; Scotton, Chris J.; McNulty, Katrina; Laurent, Geoff; Janes, Sam M.] UCL, Rayne Inst, Ctr Resp Res, London, England; [Aguilar, Susana; Bonnet, Dominique] Canc Res UK, London Res Inst, Hematopoiet Stem Cell Lab, London, England; [Nye, Emma; Stamp, Gordon] Canc Res UK, London Res Inst, Expt Pathol Lab, London, England; [Nye, Emma; Stamp, Gordon] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England	University of London; King's College London; University College London; Cancer Research UK; Cancer Research UK; Imperial College London	Aguilar, S (corresponding author), UCL, Rayne Inst, Ctr Resp Res, London, England.	d.bonnet@cancer.org.uk; s.janes@ucl.ac.uk		Scotton, Chris/0000-0002-9671-9057	Johnson and Johnso; Department of Health's NIHR Biomedical Research Centres funding scheme; Internal Cancer Research UK; Medical Research Council [G108/596, G0800340, G0900380] Funding Source: researchfish; MRC [G0900380, G108/596, G0800340] Funding Source: UKRI	Johnson and Johnso; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Internal Cancer Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DB is a Cancer Research UK principle Investigator. SJ was an MRC Clinician Scientist. This work was in part funded by a Johnson and Johnson "Focussed Giving Grant'' to SJ and partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme (SJ) and by internal Cancer Research UK funding (DB).	Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atzori L, 2004, THORAX, V59, P217, DOI 10.1136/thx.2003.008979; Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bigger BW, 2006, GENE THER, V13, P117, DOI 10.1038/sj.gt.3302638; BOWDEN DH, 1984, LAB INVEST, V50, P487; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bruscia EM, 2006, P NATL ACAD SCI USA, V103, P2965, DOI 10.1073/pnas.0510758103; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Emoto H, 1997, J BIOL CHEM, V272, P23191, DOI 10.1074/jbc.272.37.23191; Frank MH, 2004, LANCET, V363, P1411, DOI 10.1016/S0140-6736(04)16134-5; Grove JE, 2002, AM J RESP CELL MOL, V27, P645, DOI 10.1165/rcmb.2002-0056RC; Guo J, 1998, AM J PHYSIOL-LUNG C, V275, pL800, DOI 10.1152/ajplung.1998.275.4.L800; HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laurent Geoffrey J, 2008, Proc Am Thorac Soc, V5, P311, DOI 10.1513/pats.200710-159DR; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Liebler JM, 2008, AM J PHYSIOL-LUNG C, V295, pL285, DOI 10.1152/ajplung.00222.2007; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; Mason CM, 1996, CRIT CARE MED, V24, P925, DOI 10.1097/00003246-199606000-00009; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Morikawa O, 2000, AM J RESP CELL MOL, V23, P626, DOI 10.1165/ajrcmb.23.5.4178; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; PANOS RJ, 1993, J CLIN INVEST, V92, P969, DOI 10.1172/JCI116673; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ray P, 2003, P NATL ACAD SCI USA, V100, P6098, DOI 10.1073/pnas.1031851100; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Spees JL, 2007, AM J RESP CRIT CARE, V176, P385, DOI 10.1164/rccm.200607-1004OC; Sugahara K, 1998, J PATHOL, V186, P90; Theise ND, 2002, EXP HEMATOL, V30, P1333, DOI 10.1016/S0301-472X(02)00931-1; ULICH TR, 1994, AM J PATHOL, V144, P862; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Waters CM, 1999, J CELL PHYSIOL, V181, P424, DOI 10.1002/(SICI)1097-4652(199912)181:3<424::AID-JCP6>3.0.CO;2-Z; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146; YI ES, 1994, AM J PATHOL, V145, P80; Zhang X, 2008, CANCER GENE THER, V15, P73, DOI 10.1038/sj.cgt.7701108; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	125	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8013	10.1371/journal.pone.0008013	http://dx.doi.org/10.1371/journal.pone.0008013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956603	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500035
J	Fischer, BJ; Anderson, CH; Pena, JL				Fischer, Brian J.; Anderson, Charles H.; Pena, Jose Luis			Multiplicative Auditory Spatial Receptive Fields Created by a Hierarchy of Population Codes	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; OWLS INFERIOR COLLICULUS; SPACE-SPECIFIC NEURONS; BARN OWL; SOUND-LOCALIZATION; OPTIC TECTUM; BRAIN-STEM; NUCLEUS LAMINARIS; CROSS-CORRELATION; COCHLEAR NUCLEUS	A multiplicative combination of tuning to interaural time difference (ITD) and interaural level difference (ILD) contributes to the generation of spatially selective auditory neurons in the owl's midbrain. Previous analyses of multiplicative responses in the owl have not taken into consideration the frequency-dependence of ITD and ILD cues that occur under natural listening conditions. Here, we present a model for the responses of ITD- and ILD-sensitive neurons in the barn owl's inferior colliculus which satisfies constraints raised by experimental data on frequency convergence, multiplicative interaction of ITD and ILD, and response properties of afferent neurons. We propose that multiplication between ITD- and ILD-dependent signals occurs only within frequency channels and that frequency integration occurs using a linear-threshold mechanism. The model reproduces the experimentally observed nonlinear responses to ITD and ILD in the inferior colliculus, with greater accuracy than previous models. We show that linear-threshold frequency integration allows the system to represent multiple sound sources with natural sound localization cues, whereas multiplicative frequency integration does not. Nonlinear responses in the owl's inferior colliculus can thus be generated using a combination of cellular and network mechanisms, showing that multiple elements of previous theories can be combined in a single system.	[Fischer, Brian J.] Occidental Coll, Dept Math, Los Angeles, CA 90041 USA; [Fischer, Brian J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Fischer, Brian J.; Anderson, Charles H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Pena, Jose Luis] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Occidental College; California Institute of Technology; Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine	Fischer, BJ (corresponding author), Occidental Coll, Dept Math, Los Angeles, CA 90041 USA.	Brian.Fischer@ens.fr		Pena, Jose/0000-0001-6773-5640	NIH [DC007690]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH grant DC007690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1993, J NEUROSCI, V13, P3647; Arthur BJ, 2005, J COMP NEUROL, V492, P110, DOI 10.1002/cne.20726; ATWAL GS, 2004, SOFT MATTER, V70; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; BROZOVIC M, 2008, J COMPUT NEUROSCI; CARR CE, 1990, J NEUROSCI, V10, P3227; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Colburn HS, 1996, AUDITORY COMPUTATION, P332; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Eliasmith C, 2003, NEURAL ENG; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; EUSTON DR, 2000, THESIS U OREGON; Fischer BJ, 2008, J NEUROSCI, V28, P8107, DOI 10.1523/JNEUROSCI.1969-08.2008; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; GELFLAND JJ, 1988, 3 IEEE INT S INT CON, V3, P147; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; GRASSI E, 2001, P C INF SCI SYST, P344; Kardar M, 2002, P NATL ACAD SCI USA, V99, P15894, DOI 10.1073/pnas.252472699; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1983, J COMP NEUROL, V218, P174, DOI 10.1002/cne.902180205; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Koppl C, 1999, J NEUROSCI, V19, P9674; Koppl C, 1997, J NEUROPHYSIOL, V77, P364, DOI 10.1152/jn.1997.77.1.364; MARTIN KD, 1995, THESIS MIT; MAZER JA, 1995, THESIS CALTECH; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MEL BW, 1990, 6 CNS CALTECH; MOISEFF A, 1983, J NEUROSCI, V3, P2553; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P637, DOI 10.1007/BF00614506; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; Mori K, 1997, HEARING RES, V111, P22, DOI 10.1016/S0378-5955(97)00090-7; Murphy BK, 2003, J NEUROSCI, V23, P10040; Mysore SP, 2005, IEEE IJCNN, P2766; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; Pena JL, 1996, J NEUROSCI, V16, P7046; Pena JL, 2002, J NEUROSCI, V22, P5652; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Pena JL, 2000, P NATL ACAD SCI USA, V97, P11787, DOI 10.1073/pnas.97.22.11787; Perez ML, 2006, J NEUROPHYSIOL, V95, P783, DOI 10.1152/jn.00833.2005; Poganiatz I, 2001, JARO, V2, P1; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; POUGET A, 1995, ADV NEURAL INFORM PR, V7; ROSEN DJ, 1994, ADV NEURAL INFORM PR, V6; Rucci M, 1997, J NEUROSCI, V17, P334, DOI 10.1523/JNEUROSCI.17-01-00334.1997; Rucci M, 1999, NEURAL NETWORKS, V12, P31, DOI 10.1016/S0893-6080(98)00107-5; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SPENCE CD, 1989, ADV IN NEURAL INFORM, V1; Spezio ML, 2003, J NEUROSCI, V23, P4677; Suarez H, 1989, NEURAL COMPUT, V1, P318, DOI 10.1162/neco.1989.1.3.318; SULLIVAN WE, 1984, J NEUROSCI, V4, P1787; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; TAKAHASHI TT, 1994, J NEUROSCI, V14, P4780; TAKAHASHI TT, 1988, J COMP NEUROL, V274, P190, DOI 10.1002/cne.902740206; TAKAHASHI TT, 1989, J COMP NEUROL, V281, P545, DOI 10.1002/cne.902810405; Viete S, 1997, J NEUROSCI, V17, P1815; WAGNER H, 1992, J COMP PHYSIOL A, V170, P3; WAGNER H, 1987, J NEUROSCI, V7, P3105; WAGNER H, 1993, J NEUROSCI, V13, P371; Witten IB, 2008, J NEUROPHYSIOL, V100, P1067, DOI 10.1152/jn.00013.2008	70	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8015	10.1371/journal.pone.0008015	http://dx.doi.org/10.1371/journal.pone.0008015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956693	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000272827500037
J	Gonzalez, MJ; Plummer, EM; Rae, CS; Manchester, M				Gonzalez, Maria J.; Plummer, Emily M.; Rae, Chris S.; Manchester, Marianne			Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RESPIRATORY SYNCYTIAL VIRUS; MEMBRANE PROTEIN F; PLANT-VIRUS; T-CELLS; PSEUDOMONAS-AERUGINOSA; SUBEPITHELIAL DOME; PEYERS PATCH; BONE-MARROW; FLT3 LIGAND	Background: Plant viruses such as Cowpea mosaic virus (CPMV) are increasingly being developed for applications in nanobiotechnology including vaccine development because of their potential for producing large quantities of antigenic material in plant hosts. In order to improve efficacy of viral nanoparticles in these types of roles, an investigation of the individual cell types that interact with the particles is critical. In particular, it is important to understand the interactions of a potential vaccine with antigen presenting cells (APCs) of the immune system. CPMV was previously shown to interact with vimentin displayed on cell surfaces to mediate cell entry, but the expression of surface vimentin on APCs has not been characterized. Methodology: The binding and internalization of CPMV by several populations of APCs was investigated both in vitro and in vivo by flow cytometry and fluorescence confocal microscopy. The association of the particles with mouse gastrointestinal epithelium and Peyer's patches was also examined by confocal microscopy. The expression of surface vimentin on APCs was also measured. Conclusions: We found that CPMV is bound and internalized by subsets of several populations of APCs both in vitro and in vivo following intravenous, intraperitoneal, and oral administration, and also by cells isolated from the Peyer's patch following gastrointestinal delivery. Surface vimentin was also expressed on APC populations that could internalize CPMV. These experiments demonstrate that APCs capture CPMV particles in vivo, and that further tuning the interaction with surface vimentin may facilitate increased uptake by APCs and priming of antibody responses. These studies also indicate that CPMV particles likely access the systemic circulation following oral delivery via the Peyer's patch.	[Gonzalez, Maria J.; Plummer, Emily M.; Rae, Chris S.; Manchester, Marianne] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gonzalez, MJ (corresponding author), Anaphore Inc, La Jolla, CA USA.	mmanchester@ucsd.edu		Manchester, Marianne/0000-0002-7143-5744	 [R01CA112075]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work has been supported by grant number R01CA112075 (http://www.nih.gov/). Extra funding includes the Gustavus and Louise Pfeiffer Research Foundation Grant (http://foundationcenter.org/grantmaker/pfeiffer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Brennan FR, 1999, MICROBIOL-SGM, V145, P211, DOI 10.1099/13500872-145-1-211; Brennan FR, 1999, MICROBIOL-SGM, V145, P2061, DOI 10.1099/13500872-145-8-2061; Butz EA, 1998, J IMMUNOL, V160, P2139; Canizares MC, 2005, EXPERT REV VACCINES, V4, P687, DOI 10.1586/14760584.4.5.687; Canizares MC, 2005, IMMUNOL CELL BIOL, V83, P263, DOI 10.1111/j.1440-1711.2005.01339.x; Chatterji A, 2004, CHEM BIOL, V11, P855, DOI 10.1016/j.chembiol.2004.04.011; Christen U, 2004, J CLIN INVEST, V114, P1290, DOI 10.1172/JCI200422557; Coester C, 2006, EUR J PHARM BIOPHARM, V62, P306, DOI 10.1016/j.ejpb.2005.09.009; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dalsgaard K, 1997, NAT BIOTECHNOL, V15, P248, DOI 10.1038/nbt0397-248; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; HAHN K, 1994, VIROLOGY, V201, P330, DOI 10.1006/viro.1994.1298; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jiang LB, 2006, VACCINE, V24, P109, DOI 10.1016/j.vaccine.2005.09.060; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Koudelka KJ, 2007, J VIROL, V81, P1632, DOI 10.1128/JVI.00960-06; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Lin TW, 2003, ADV VIRUS RES, V62, P167, DOI 10.1016/S0065-3527(03)62004-X; Liu L, 2005, VACCINE, V23, P1788, DOI 10.1016/j.vaccine.2004.11.006; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; MCLAIN L, 1995, AIDS RES HUM RETROV, V11, P327, DOI 10.1089/aid.1995.11.327; McLain L, 1996, VACCINE, V14, P799, DOI 10.1016/0264-410X(95)00229-T; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nuzzaci M, 2007, ARCH VIROL, V152, P915, DOI 10.1007/s00705-006-0916-7; Piazzolla G, 2005, J CLIN IMMUNOL, V25, P142, DOI 10.1007/s10875-005-2820-4; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Porta C, 2003, VIROLOGY, V310, P50, DOI 10.1016/S0042-6822(03)00140-5; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017; Rennermalm A, 2001, VACCINE, V19, P3376, DOI 10.1016/S0264-410X(01)00080-9; Sapsford KE, 2006, BIOSENS BIOELECTRON, V21, P1668, DOI 10.1016/j.bios.2005.09.003; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Singh P., 2006, DRUG DEVELOP RES, V67, P1; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; STEINMETZ NF, 2009, CURR TOP MICROBIOL I, P23; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; Wang Q, 2002, CHEM BIOL, V9, P805, DOI 10.1016/S1074-5521(02)00165-5; Wang X, 2005, IMMUNOL LETT, V98, P123, DOI 10.1016/j.imlet.2004.10.028; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Yusibov V, 2005, VACCINE, V23, P2261, DOI 10.1016/j.vaccine.2005.01.039	58	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7981	10.1371/journal.pone.0007981	http://dx.doi.org/10.1371/journal.pone.0007981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956734	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827300023
J	Grigoryev, YA; Kurian, SM; Nakorchevskiy, AA; Burke, JP; Campbell, D; Head, SR; Deng, J; Kantor, AB; Yates, JR; Salomon, DR				Grigoryev, Yevgeniy A.; Kurian, Sunil M.; Nakorchevskiy, Aleksey A.; Burke, John P.; Campbell, Daniel; Head, Steve R.; Deng, Jun; Kantor, Aaron B.; Yates, John R., III; Salomon, Daniel R.			Genome-Wide Analysis of Immune Activation in Human T and B Cells Reveals Distinct Classes of Alternatively Spliced Genes	PLOS ONE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; PERIPHERAL-BLOOD LYMPHOCYTES; EXON EXPRESSION ARRAYS; MESSENGER-RNA DECAY; MICROARRAY ANALYSIS; AFFYMETRIX EXON; GLOBAL ANALYSIS; HUMAN TRANSCRIPTOME; SHOTGUN PROTEOMICS; DNA MICROARRAY	Alternative splicing of pre-mRNA is a mechanism that increases the protein diversity of a single gene by differential exon inclusion/exclusion during post-transcriptional processing. While alternative splicing is established to occur during lymphocyte activation, little is known about the role it plays during the immune response. Our study is among the first reports of a systematic genome-wide analysis of activated human T and B lymphocytes using whole exon DNA microarrays integrating alternative splicing and differential gene expression. Purified human CD2(+) T or CD19(+) B cells were activated using protocols to model the early events in post-transplant allograft immunity and sampled as a function of time during the process of immune activation. Here we show that 3 distinct classes of alternatively spliced and/or differentially expressed genes change in an ordered manner as a function of immune activation. We mapped our results to function-based canonical pathways and demonstrated that some are populated by only one class of genes, like integrin signaling, while other pathways, such as purine metabolism and T cell receptor signaling, are populated by all three classes of genes. Our studies augment the current view of T and B cell activation in immunity that has been based exclusively upon differential gene expression by providing evidence for a large number of molecular networks populated as a function of time and activation by alternatively spliced genes, many of which are constitutively expressed.			Grigoryev, YA (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	NIAID NIH HHS [U19 AI063603] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumgarth N, 2000, IMMUNOL REV, V176, P171; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blumerman SL, 2007, MOL IMMUNOL, V44, P2023, DOI 10.1016/j.molimm.2006.09.020; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Cheung HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-216; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Du ZY, 2003, ACTA PHARMACOL SIN, V24, P864; Erickson LM, 2002, TRANSPLANT P, V34, P1385, DOI 10.1016/S0041-1345(02)02896-8; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hansel NN, 2005, J LAB CLIN MED, V145, P263, DOI 10.1016/j.lab.2005.02.010; Hess K, 2004, INT IMMUNOL, V16, P1711, DOI 10.1093/intimm/dxh172; Holm AM, 2004, CLIN EXP IMMUNOL, V138, P278, DOI 10.1111/j.1365-2249.2004.02630.x; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2008, PHARMACOGENET GENOM, V18, P545, DOI 10.1097/FPC.0b013e3282fe1745; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; ITOH K, 1994, CELL IMMUNOL, V157, P478, DOI 10.1006/cimm.1994.1243; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joshi T, 2004, P ANN INT IEEE EMBS, V26, P2881; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kindler V, 1997, J IMMUNOL, V159, P2085; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Li XD, 2001, GENES IMMUN, V2, P88, DOI 10.1038/sj.gene.6363743; Li YF, 2006, INT J MOL MED, V18, P1127; Lin ZS, 2003, LAB INVEST, V83, P765, DOI 10.1097/01.LAB.0000073130.58435.E5; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; Mao XY, 2007, GENE CHROMOSOME CANC, V46, P675, DOI 10.1002/gcc.20452; Marrack P, 2000, CURR OPIN IMMUNOL, V12, P206, DOI 10.1016/S0952-7915(99)00075-8; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Okoniewski MJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r79; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; SCHILIZZI BM, 1997, IMMUNOLOGY; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THORSEN K, 2008, MOL CELL PROTEOMICS; Vinuesa CG, 2002, ANN NY ACAD SCI, V975, P33, DOI 10.1111/j.1749-6632.2002.tb05939.x; Wang ET, 2008, NATURE; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; XI L, 2008, NUCL ACIDS RES; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Xing Y, 2007, MOL BIOL EVOL, V24, P1283, DOI 10.1093/molbev/msm061; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yoshida Ryo, 2006, Genome Inform, V17, P88; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhang XS, 2002, LIFE SCI, V71, P3005, DOI 10.1016/S0024-3205(02)02164-1	72	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7906	10.1371/journal.pone.0007906	http://dx.doi.org/10.1371/journal.pone.0007906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936255	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004600010
J	Ke, YD; Delerue, F; Gladbach, A; Gotz, J; Ittner, LM				Ke, Yazi D.; Delerue, Fabien; Gladbach, Amadeus; Goetz, Juergen; Ittner, Lars M.			Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ANIMAL-MODELS; NEUROFIBRILLARY TANGLES; IN-VIVO; INSULIN; PHOSPHORYLATION; BRAIN; ASSOCIATION; TAUOPATHY; DEMENTIA; BEHAVIOR	Diabetes mellitus (DM) is characterized by hyperglycemia caused by a lack of insulin, insulin resistance, or both. There is increasing evidence that insulin also plays a role in Alzheimer's disease (AD) as it is involved in the metabolism of beta-amyloid (A beta) and tau, two proteins that form A beta plaques and neurofibrillary tangles (NFTs), respectively, the hallmark lesions in AD. Here, we examined the effects of experimental DM on a pre-existing tau pathology in the pR5 transgenic mouse strain that is characterized by NFTs. pR5 mice express P301L mutant human tau that is associated with dementia. Experimental DM was induced by administration of streptozotocin (STZ), which causes insulin deficiency. We determined phosphorylation of tau, using immunohistochemistry and Western blotting. Solubility of tau was determined upon extraction with sarkosyl and formic acid, and Gallyas silver staining was employed to reveal NFTs. Insulin depletion by STZ administration in six months-old non-transgenic mice causes increased tau phosphorylation, without its deposition or NFT formation. In contrast, in pR5 mice this results in massive deposition of hyperphosphorylated, insoluble tau. Furthermore, they develop a pronounced tau-histopathology, including NFTs at this early age, while the pathology in sham-treated pR5 mice is moderate. Whereas experimental DM did not result in deposition of hyperphosphorylated tau in non-transgenic mice, a predisposition to develop a tau pathology in young pR5 mice was both sufficient and necessary to exacerbate tau deposition and NFT formation. Hence, DM can accelerate onset and increase severity of disease in individuals with a predisposition to developing tau pathology.			Ke, YD (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2006, Australia.	Iittner@med.usyd.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Ittner, Lars/0000-0001-6738-3825; Delerue, Fabien/0000-0001-7944-2108				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; CLAVAGUERA F, 2009, NAT CELL BIOL; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gasparini L, 2002, TRENDS PHARMACOL SCI, V23, P288, DOI 10.1016/S0165-6147(02)02037-0; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Ittner LM, 2005, BIOCHEMISTRY-US, V44, P5749, DOI 10.1021/bi048111o; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; van Eersel J, 2009, J NEURAL TRANSM, V116, P1243, DOI 10.1007/s00702-009-0293-y; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405	40	146	151	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7917	10.1371/journal.pone.0007917	http://dx.doi.org/10.1371/journal.pone.0007917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936237	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004600019
J	Averette, KM; Pratt, MR; Yang, YA; Bassilian, S; Whitelegge, JP; Loo, JA; Muir, TW; Bradley, KA				Averette, Kathleen M.; Pratt, Matthew R.; Yang, Yanan; Bassilian, Sara; Whitelegge, Julian P.; Loo, Joseph A.; Muir, Tom W.; Bradley, Kenneth A.			Anthrax Lethal Toxin Induced Lysosomal Membrane Permeabilization and Cytosolic Cathepsin Release Is Nlrp1b/Nalp1b-Dependent	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NOD-LIKE RECEPTORS; CELL-DEATH; CASPASE-1 ACTIVATION; INDUCED APOPTOSIS; NALP3 INFLAMMASOME; TRANSCRIPTIONAL RESPONSES; MURINE MACROPHAGES; PROTEIN; PATHWAY	NOD-like receptors (NLRs) are a group of cytoplasmic molecules that recognize microbial invasion or 'danger signals'. Activation of NLRs can induce rapid caspase-1 dependent cell death termed pyroptosis, or a caspase-1 independent cell death termed pyronecrosis. Bacillus anthracis lethal toxin (LT), is recognized by a subset of alleles of the NLR protein Nlrp1b, resulting in pyroptotic cell death of macrophages and dendritic cells. Here we show that LT induces lysosomal membrane permeabilization (LMP). The presentation of LMP requires expression of an LT-responsive allele of Nlrp1b, and is blocked by proteasome inhibitors and heat shock, both of which prevent LT-mediated pyroptosis. Further the lysosomal protease cathepsin B is released into the cell cytosol and cathepsin inhibitors block LT-mediated cell death. These data reveal a role for lysosomal membrane permeabilization in the cellular response to bacterial pathogens and demonstrate a shared requirement for cytosolic relocalization of cathepsins in pyroptosis and pyronecrosis.			Averette, KM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	kbradley@microbio.ucla.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057870, P30AI028697, T32AI007323, R56AI077791, R01AI077791] Funding Source: NIH RePORTER; NCI NIH HHS [CA16042, P30 CA016042] Funding Source: Medline; NIAID NIH HHS [R01 AI077791, AI077791, AI28697, R56 AI077791, R01 AI057870, AI057870, P30 AI028697, T32 AI007323] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Banks David J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010714; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; BEALL FA, 1962, J BACTERIOL, V83, P1274, DOI 10.1128/JB.83.6.1274-1280.1962; Benchoua A, 2004, J CEREBR BLOOD F MET, V24, P1272, DOI 10.1097/01.WCB.0000140272.54583.FB; Bergman NH, 2005, INFECT IMMUN, V73, P1069, DOI 10.1128/IAI.73.2.1069-1080.2005; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Chandra H, 2005, BBA-PROTEINS PROTEOM, V1747, P151, DOI 10.1016/j.bbapap.2004.10.012; Cheung NS, 2007, NEUROPHARMACOLOGY, V53, P505, DOI 10.1016/j.neuropharm.2007.06.014; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Comer JE, 2005, INFECT IMMUN, V73, P1879, DOI 10.1128/IAI.73.3.1879-1885.2005; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Drysdale M, 2007, INFECT IMMUN, V75, P1757, DOI 10.1128/IAI.01712-06; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gehring U, 2004, EMBO REP, V5, P148, DOI 10.1038/sj.embor.7400083; Giammarioli AM, 2008, CANCER RES, V68, P5291, DOI 10.1158/0008-5472.CAN-08-0222; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gotoh T, 2001, CELL DEATH DIFFER, V8, P357, DOI 10.1038/sj.cdd.4400829; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hammond SE, 1998, INFECT IMMUN, V66, P2374, DOI 10.1128/IAI.66.5.2374-2378.1998; Hayashi MAF, 2008, TOXICON, V52, P508, DOI 10.1016/j.toxicon.2008.06.029; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jaattela M, 2004, CELL DEATH DIFFER, V11, P135, DOI 10.1038/sj.cdd.4401333; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim J, 2008, ARCH BIOCHEM BIOPHYS, V472, P58, DOI 10.1016/j.abb.2008.01.020; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuhn JF, 2006, ELECTROPHORESIS, V27, P1584, DOI 10.1002/elps.200500747; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LEVIN TC, 2008, CELL MICROBIOL; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MCINTIRE CR, 2009, INFLAMMASOMES INFECT; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sandes E, 2007, INT J MOL MED, V20, P823; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shin S, 1999, CELL BIOL TOXICOL, V15, P19, DOI 10.1023/A:1007546505528; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; WEI YQ, 1994, CANCER RES, V54, P4952; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Windelborn JA, 2008, J NEUROCHEM, V106, P56, DOI 10.1111/j.1471-4159.2008.05349.x; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zang Y, 2001, CELL DEATH DIFFER, V8, P477, DOI 10.1038/sj.cdd.4400843; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481; Zhao M, 2001, FEBS LETT, V509, P399, DOI 10.1016/S0014-5793(01)03184-2	98	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7913	10.1371/journal.pone.0007913	http://dx.doi.org/10.1371/journal.pone.0007913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924255	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700028
J	Prashar, V; Bihani, S; Das, A; Ferrer, JL; Hosur, M				Prashar, Vishal; Bihani, Subhash; Das, Amit; Ferrer, Jean-Luc; Hosur, Madhusoodan			Catalytic Water Co-Existing with a Product Peptide in the Active Site of HIV-1 Protease Revealed by X-Ray Structure Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 PROTEASE; BARRIER HYDROGEN-BOND; CRYSTAL-STRUCTURES; MECHANISM; COMPLEX; RESOLUTION; INHIBITOR; SUBSTRATE; CRYSTALLOGRAPHY; AIDS	Background: It is known that HIV-1 protease is an important target for design of antiviral compounds in the treatment of Acquired Immuno Deficiency Syndrome (AIDS). In this context, understanding the catalytic mechanism of the enzyme is of crucial importance as transition state structure directs inhibitor design. Most mechanistic proposals invoke nucleophilic attack on the scissile peptide bond by a water molecule. But such a water molecule coexisting with any ligand in the active site has not been found so far in the crystal structures. Principal Findings: We report here the first observation of the coexistence in the active site, of a water molecule WAT1, along with the carboxyl terminal product (Q product) peptide. The product peptide has been generated in situ through cleavage of the full-length substrate. The N-terminal product (P product) has diffused out and is replaced by a set of water molecules while the Q product is still held in the active site through hydrogen bonds. The position of WAT1, which hydrogen bonds to both the catalytic aspartates, is different from when there is no substrate bound in the active site. We propose WAT1 to be the position from where catalytic water attacks the scissile peptide bond. Comparison of structures of HIV-1 protease complexed with the same oligopeptide substrate, but at pH 2.0 and at pH 7.0 shows interesting changes in the conformation and hydrogen bonding interactions from the catalytic aspartates. Conclusions/Significance: The structure is suggestive of the repositioning, during substrate binding, of the catalytic water for activation and subsequent nucleophilic attack. The structure could be a snap shot of the enzyme active site primed for the next round of catalysis. This structure further suggests that to achieve the goal of designing inhibitors mimicking the transition-state, the hydrogen-bonding pattern between WAT1 and the enzyme should be replicated.			Prashar, V (corresponding author), Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India.	hosur@barc.gov.in	Bihani, Subhash Chandra/G-1255-2010	Bihani, Subhash Chandra/0000-0002-0724-4919; Hosur, Madhusoodan/0000-0003-1012-0906				Adachi M, 2009, P NATL ACAD SCI USA, V106, P4641, DOI 10.1073/pnas.0809400106; Anderson VE, 2006, CHEM REV, V106, P3236, DOI 10.1021/cr050281z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bihani S, 2009, PROTEINS, V74, P594, DOI 10.1002/prot.22174; Brunger A.T., 2001, CRYSTALLOGRAPHY NMR; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATFIELD DC, 1995, J AM CHEM SOC, V117, P5561, DOI 10.1021/ja00125a018; CHENG YSE, 1990, P NATL ACAD SCI USA, V87, P9660, DOI 10.1073/pnas.87.24.9660; Das A, 2006, P NATL ACAD SCI USA, V103, P18464, DOI 10.1073/pnas.0605809103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Hine J, 1978, ADV PHYS ORG CHEM, V15, P1; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8441, DOI 10.1021/bi00098a023; JAMES MNG, 1992, BIOCHEMISTRY-US, V31, P3872, DOI 10.1021/bi00130a019; JASKOLSKI M, 1991, BIOCHEMISTRY-US, V30, P1600, DOI 10.1021/bi00220a023; Johnson ECB, 2007, J MOL BIOL, V373, P573, DOI 10.1016/j.jmb.2007.07.054; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Kovalevsky AY, 2007, BIOCHEMISTRY-US, V46, P14854, DOI 10.1021/bi700822g; Kumar M, 2005, BIOCHEM J, V389, P365, DOI 10.1042/BJ20041804; Kumar M, 2002, BIOCHEM BIOPH RES CO, V294, P395, DOI 10.1016/S0006-291X(02)00482-5; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; Okimoto N, 1999, J AM CHEM SOC, V121, P7349, DOI 10.1021/ja9841106; Piana S, 2004, J PHYS CHEM B, V108, P11139, DOI 10.1021/jp037651c; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Rose RB, 1996, BIOCHEMISTRY-US, V35, P12933, DOI 10.1021/bi9612733; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Silva AM, 1996, J MOL BIOL, V255, P321, DOI 10.1006/jmbi.1996.0026; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Torbeev VY, 2008, BIOORG MED CHEM LETT, V18, P4554, DOI 10.1016/j.bmcl.2008.07.039; Trylska J, 2004, PROTEIN SCI, V13, P513, DOI 10.1110/ps.03372304; Tyndall JDA, 2008, BIOCHEMISTRY-US, V47, P3736, DOI 10.1021/bi7023157; YUNFENG T, 2004, J MOL BIOL, V338, P341	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7860	10.1371/journal.pone.0007860	http://dx.doi.org/10.1371/journal.pone.0007860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924250	gold, Green Published, Green Submitted			2022-12-27	WOS:000271854200008
J	Kim, K; Wang, L; Hwang, I				Kim, Kwangmi; Wang, Lin; Hwang, Inkyu			Acute Inhibition of Selected Membrane-Proximal Mouse T Cell Receptor Signaling by Mitochondrial Antagonists	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIRECT STIMULATION; ANTIGEN RECEPTOR; ATP SYNTHASE; COMPLEX-III; MECHANISMS; CA2+; PROLIFERATION; EXPRESSION; INTEGRINS	T cells absorb nanometric membrane vesicles, prepared from plasma membrane of antigen presenting cells, via dual receptor/ligand interactions of T cell receptor (TCR) with cognate peptide/major histocompatibility complex (MHC) plus lymphocyte function-associated antigen 1 (LFA-1) with intercellular adhesion molecule 1. TCR-mediated signaling for LFA-1 activation is also required for the vesicle absorption. Exploiting those findings, we had established a high throughput screening (HTS) platform and screened a library for isolation of small molecules inhibiting the vesicle absorption. Follow-up studies confirmed that treatments (1 hour) with various mitochondrial antagonists, including a class of anti-diabetic drugs (i.e., Metformin and Phenformin), resulted in ubiquitous inhibition of the vesicle absorption without compromising viability of T cells. Further studies revealed that the mitochondrial drug treatments caused impairment of specific membrane-proximal TCR signaling event(s). Thus, activation of Akt and PLC-gamma 1 and entry of extracellular Ca2+ following TCR stimulation were attenuated while polymerization of monomeric actins upon TCR triggering progressed normally after the treatments. Dynamic F-actin rearrangement concurring with the vesicle absorption was also found to be impaired by the drug treatments, implying that the inhibition by the drug treatments of downstream signaling events (and the vesicle absorption) could result from lack of directional relocation of signaling and cell surface molecules. We also assessed the potential application of mitochondrial antagonists as immune modulators by probing effects of the long-term drug treatments (24 hours) on viability of resting primary T cells and cell cycle progression of antigen-stimulated T cells. This study unveils a novel regulatory mechanism for T cell immunity in response to environmental factors having effects on mitochondrial function.			Kim, K (corresponding author), Amorepacific Corp, R&D Ctr, Yongin, Gyeonggi Do, South Korea.	inkyu@scripps.edu		Hwang, Inkyu/0000-0001-8997-6090	NIAID NIH HHS [R01 AI066146, R56 AI066146, AI066146] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI066146, R01AI066146] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Badour K, 2003, IMMUNOL REV, V192, P98, DOI 10.1034/j.1600-065X.2003.00031.x; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Childs EW, 2008, SHOCK, V29, P636, DOI 10.1097/SHK.0b013e318157f524; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fang NB, 1999, J AGR FOOD CHEM, V47, P2130, DOI 10.1021/jf981188x; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Gong YX, 2006, CANCER RES, V66, P4880, DOI 10.1158/0008-5472.CAN-05-4162; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; Kim K, 2009, J BIOL CHEM, V284, P22149, DOI 10.1074/jbc.M109.000752; Kim K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006044; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Leverve XM, 2003, DIABETES METAB, V29, pS88; Mahnke DK, 2005, BIOCHEMISTRY-US, V44, P5551, DOI 10.1021/bi048121p; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; OWEN MR, 1993, BIOCHIM BIOPHYS ACTA, V1142, P11, DOI 10.1016/0005-2728(93)90079-U; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; Schnermann MJ, 2006, J AM CHEM SOC, V128, P11799, DOI 10.1021/ja0632862; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Thomas R, 2007, MOL CELL BIOCHEM, V296, P35, DOI 10.1007/s11010-006-9295-3; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Vincenti F, 2007, ANNU REV MED, V58, P347, DOI 10.1146/annurev.med.58.080205.154004; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7738	10.1371/journal.pone.0007738	http://dx.doi.org/10.1371/journal.pone.0007738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901985	gold, Green Submitted, Green Published			2022-12-27	WOS:000271658800005
J	Boulais, N; Pennec, JP; Lebonvallet, N; Pereira, U; Rougier, N; Dorange, G; Chesne, C; Misery, L				Boulais, Nicholas; Pennec, Jean-Pierre; Lebonvallet, Nicolas; Pereira, Ulysse; Rougier, Nathalie; Dorange, Germaine; Chesne, Christophe; Misery, Laurent			Rat Merkel Cells Are Mechanoreceptors and Osmoreceptors	PLOS ONE			English	Article							DEVELOPING NERVOUS-SYSTEM; HISTAMINE H-3 RECEPTORS; PERMEANT BLOCKER; TRPV CHANNELS; SKIN; TRANSDUCTION; ACTIVATION; LOCALIZATION; HYPERPLASIA; EXOCYTOSIS	Merkel cells (MCs) associated with nerve terminals constitute MC-neurite complexes, which are involved in slowly-adapting type I mechanoreception. Although MCs are known to express voltage-gated Ca(2+) channels and hypotonic-induced membrane deformation is known to lead to Ca(2+) transients, whether MCs initiate mechanotransduction is currently unknown. To answer to this question, rat MCs were transfected with a reporter vector, which enabled their identification. Their properties were investigated through electrophysiological studies. Voltage-gated K(+), Ca(2+) and Ca(2+)-activated K(+) (K(Ca)) channels were identified, as previously described. Here, we also report the activation of Ca(2+) channels by histamine and their inhibition by acetylcholine. As a major finding, we demonstrated that direct mechanical stimulations induced strong inward Ca(2+) currents in MCs. Depolarizations were dependent on the strength and the length of the stimulation. Moreover, touch-evoked currents were inhibited by the stretch channel antagonist gadolinium. These data confirm the mechanotransduction capabilities of MCs. Furthermore, we found that activation of the osmoreceptor TRPV4 in FM1-43-labeled MCs provoked neurosecretory granule exocytosis. Since FM1-43 blocks mechanosensory channels, this suggests that hypo-osmolarity activates MCs in the absence of mechanotransduction. Thus, mechanotransduction and osmoreception are likely distinct pathways.			Boulais, N (corresponding author), CHU Brest, EA4326, Lab Nervous Factors & Tissular Struct, European Univ Brittany,Univ Brest, F-29285 Brest, France.	laurent.misery@chu-brest.fr	Misery, Laurent/I-1186-2019; Pereira, Ulysse/ABF-6922-2020	Pereira, Ulysse/0000-0001-5677-6906; Lebonvallet, Nicolas/0000-0001-7263-1408				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrang J.-M., 2007, ANNALES PHARMACEUTIQUES FRANCAISES, V65, P275, DOI 10.1016/S0003-4509(07)90047-4; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; BOULAIS N, 2008, EUR J DERMA IN PRESS, V18; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006528; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cannon KE, 2007, PAIN, V129, P76, DOI 10.1016/j.pain.2006.09.039; Cannon KE, 2007, PHARMACOL BIOCHEM BE, V88, P122, DOI 10.1016/j.pbb.2007.07.014; Chateau Y, 2007, J INVEST DERMATOL, V127, P979, DOI 10.1038/sj.jid.5700646; Corey DP, 2006, J PHYSIOL-LONDON, V576, P23, DOI 10.1113/jphysiol.2006.116582; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1903, DOI 10.1152/jn.1997.78.4.1903; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; Endoh T, 2007, NEUROREPORT, V18, P1141, DOI 10.1097/WNR.0b013e3280ba499d; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; FRYE RA, 1983, MOL PHARMACOL, V23, P547; Fukuda J, 2003, CELL TISSUE RES, V311, P325, DOI 10.1007/s00441-002-0688-7; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; GAUDILLERE A, 1994, ANN DERMATOL VENER, V121, P909; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTSCHUH W, 1984, PEPTIDES, V5, P239, DOI 10.1016/0196-9781(84)90213-4; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kanitakis J, 1998, DERMATOLOGY, V196, P208, DOI 10.1159/000017900; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; MEROT Y, 1989, DERMATOLOGICA, V178, P189, DOI 10.1159/000248425; MILLS LR, 1995, J NEUROCYTOL, V24, P117, DOI 10.1007/BF01181555; Nagano N, 1996, JPN J PHARMACOL, V71, P51, DOI 10.1254/jjp.71.51; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Pacitti E G, 1988, Prog Brain Res, V74, P37; PISKOROWSKI R, 2008, PFLUGERS ARCH; REGAZZINI R, 1995, EUR J DERMATOL, V5, P326; Righi A, 2006, INT J SURG PATHOL, V14, P206, DOI 10.1177/1066896906290053; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Senok SS, 1997, J PHYSIOL-LONDON, V500, P29, DOI 10.1113/jphysiol.1997.sp021996; Shimohira-Yamasaki M, 2006, CELL STRUCT FUNCT, V31, P39, DOI 10.1247/csf.31.39; Tachibana T, 2003, HISTOCHEM CELL BIOL, V120, P13, DOI 10.1007/s00418-003-0540-5; Talon S, 2005, J PHYSIOL-LONDON, V565, P827, DOI 10.1113/jphysiol.2005.084681; Tazaki M, 1998, NEUROSCI LETT, V243, P69, DOI 10.1016/S0304-3940(98)00066-4; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120	52	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7759	10.1371/journal.pone.0007759	http://dx.doi.org/10.1371/journal.pone.0007759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898622	Green Submitted, Green Published, gold			2022-12-27	WOS:000271658000006
J	Tatavarty, V; Kim, EJ; Rodionov, V; Yu, J				Tatavarty, Vedakumar; Kim, Eun-Ji; Rodionov, Vladimir; Yu, Ji			Investigating Sub-Spine Actin Dynamics in Rat Hippocampal Neurons with Super-Resolution Optical Imaging	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; LOCALIZATION MICROSCOPY; SYNAPTIC PLASTICITY; PROTRUSION; STABILITY; FILAMENT; TURNOVER	Morphological changes in dendritic spines represent an important mechanism for synaptic plasticity which is postulated to underlie the vital cognitive phenomena of learning and memory. These morphological changes are driven by the dynamic actin cytoskeleton that is present in dendritic spines. The study of actin dynamics in these spines traditionally has been hindered by the small size of the spine. In this study, we utilize a photo-activation localization microscopy (PALM)-based single-molecule tracking technique to analyze F-actin movements with similar to 30-nm resolution in cultured hippocampal neurons. We were able to observe the kinematic (physical motion of actin filaments, i.e., retrograde flow) and kinetic (F-actin turn-over) dynamics of F-actin at the single-filament level in dendritic spines. We found that F-actin in dendritic spines exhibits highly heterogeneous kinematic dynamics at the individual filament level, with simultaneous actin flows in both retrograde and anterograde directions. At the ensemble level, movements of filaments integrate into a net retrograde flow of similar to 138 nm/min. These results suggest a weakly polarized F-actin network that consists of mostly short filaments in dendritic spines.			Tatavarty, V (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT USA.	jyu@uchc.edu			NIGMS NIH HHS [GM62290, GM085301, R01 GM085301-01A1, R01 GM085301, R01 GM062290] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062290, R01GM085301] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chen YC, 2004, NEUROREPORT, V15, P829, DOI 10.1097/00001756-200404090-00018; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kim CH, 1999, J NEUROSCI, V19, P4314; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MONTAGUE C, 1983, J MUSCLE RES CELL M, V4, P95, DOI 10.1007/BF00711960; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	27	67	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7724	10.1371/journal.pone.0007724	http://dx.doi.org/10.1371/journal.pone.0007724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898630	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000003
J	Kim, I; Li, Y; Muniz, P; Rao, H				Kim, Ikjin; Li, Yue; Muniz, Paulina; Rao, Hai			Usa1 Protein Facilitates Substrate Ubiquitylation through Two Separate Domains	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; UBIQUITIN; COMPLEX; MEMBRANE; PATHWAY; ATPASE	Background: Defects in protein folding are recognized as the root of many neurodegenerative disorders. In the endoplasmic reticulum (ER), secretory proteins are subjected to a stringent quality control process to eliminate misfolded proteins by the ER-associated degradation (ERAD) pathway. A novel ERAD component Usa1 was recently identified. However, the specific role of Usa1 in ERAD remains obscure. Methodology/Principal Findings: Here, we demonstrate that Usa1 is important for substrate ubiquitylation. Furthermore, we defined key cis-elements of Usa1 essential for its degradation function. Interestingly, a putative proteasome-binding motif is dispensable for the functioning of Usa1 in ERAD. We identify two separate cytosolic domains critical for Usa1 activity in ERAD, one of which is involved in binding to the Ub-protein ligase Hrd1/Hrd3. Usa1 may have another novel role in substrate ubiquitylation that is separate from the Hrd1 association. Conclusions/Significance: We conclude that Usa1 has two important roles in ERAD substrate ubiquitylation.			Kim, I (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78229 USA.	kimi@uthscsa.edu; raoh@uthscsa.edu	Li, Yue/C-2835-2014	RAO, HAI/0000-0002-4235-2210	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078085, GM078085] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Awasthi S, 2001, J BIOL CHEM, V276, P31004, DOI 10.1074/jbc.M100022200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Plemper RK, 1999, J CELL SCI, V112, P4123; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	33	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7604	10.1371/journal.pone.0007604	http://dx.doi.org/10.1371/journal.pone.0007604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898607	Green Published, gold, Green Submitted			2022-12-27	WOS:000271232000002
J	Gill, KZ; Purves, D				Gill, Kamraan Z.; Purves, Dale			A Biological Rationale for Musical Scales	PLOS ONE			English	Article							CONSONANCE THEORY; EVOLUTION; PITCH	Scales are collections of tones that divide octaves into specific intervals used to create music. Since humans can distinguish about 240 different pitches over an octave in the mid-range of hearing [1], in principle a very large number of tone combinations could have been used for this purpose. Nonetheless, compositions in Western classical, folk and popular music as well as in many other musical traditions are based on a relatively small number of scales that typically comprise only five to seven tones [2-6]. Why humans employ only a few of the enormous number of possible tone combinations to create music is not known. Here we show that the component intervals of the most widely used scales throughout history and across cultures are those with the greatest overall spectral similarity to a harmonic series. These findings suggest that humans prefer tone combinations that reflect the spectral characteristics of conspecific vocalizations. The analysis also highlights the spectral similarity among the scales used by different cultures.	[Gill, Kamraan Z.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA; Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University	Gill, KZ (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	kzg2101@columbia.edu; purves@neuro.duke.edu			NSF; Duke University	NSF(National Science Foundation (NSF)); Duke University	NSF (www.nsf.gov) and Duke University (www.duke.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwell Edward, 2011, HARMONY VOICE LEADIN; AOYAGI T, 1996, P 4 INT C MUS PERC C, P65; ARNOLD B, 2002, ESSENTIALS CHORD CHA; Atcherson W, 1973, J MUSIC THEORY, V17, P204, DOI 10.2307/843342; Bagchee Sandeep, 1998, NAD UNDERSTANDING RA; BERNSTEIN L., 1976, UNANSWERED QUESTION; BROUGHTON S, 2000, WORLD MUSIC ROUGH GU; Brown S, 2000, ORIGINS OF MUSIC, P271; Burkholder James Peter, 2006, HIST W MUSIC; BURNS EM, 1982, PSYCHOL MUSIC, P215; Butterfield E. C, 1970, 3 S OR SENS PERC MOU, P313; Day-O'Connell Jeremy, 2007, PENTATONICISM 18 CEN; DEBEER A, 1969, SONORUM SPECULUM, V38, P26; Duffin Ross W., 2007, EQUAL TEMPERAMENT RU; FERGUSON J, 2000, ALL BLUES SCALE JAZZ; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; GOLD L, 2007, MUSIC BALI EXPERIENC; Gunde Richard, 2002, CULTURE CUSTOMS CHIN; HARRISON M, 2003, BLUES PIANO HAL LEON; Helmholtz H., 1877, SENSATIONS TONE; Isacoff Stuart., 2001, TEMPERAMENT; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Kostka Stefan, 2000, TONAL HARMONY; LEHRDAHL F, 1996, GEN THEORY TONAL MUS; LENTZ DA, 1961, TONE INTERVALS HINDU; MANDELBAUM MJ, 1961, THESIS INDIANA U BLO; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McPhee C., 1966, MUSIC BALI; MUKHERJEE P, 2004, SCALES INDIAN MUSIC; Parncutt R., 1989, HARMONY PSYCHOACOUST; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; PIERCE JR, 2000, SCI MUSICAL SOUND; PLOMP R, 1964, J ACOUST SOC AM, V36, P1628, DOI 10.1121/1.1919256; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Samson Jim, 1977, MUSIC TRANSITION STU; SATYANARAYANA NC, 2005, SCI INDIAN MUSIC; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Schwartz DA, 2004, HEARING RES, V194, P31, DOI 10.1016/j.heares.2004.01.019; SETHARES WA, 1993, J ACOUST SOC AM, V94, P1218, DOI 10.1121/1.408175; SETHARES WA, 1998, TIMBRE TUNING SPECTR; SNOWDON CT, 2009, AFFECTIVE RESPONSES; TERHARDT E, 1984, MUSIC PERCEPT, V1, P276; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; Touma Habib Hassan, 1996, MUSIC ARABS; von Hoerner Sebastian, 1974, PSYCHOL MUSIC, V2, P18, DOI DOI 10.1177/030573567422003; VONHOERNER S, 1976, PSYCHOL MUSIC, V4, P12; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Wright Owen, 1978, MODAL SYSTEM ARAB PE; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zwicker E., 1999, PSYCHOACOUSTICS, DOI [10.1007/978-3-662-09562-1, DOI 10.1007/978-3-662-09562-1]	51	64	66	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8144	10.1371/journal.pone.0008144	http://dx.doi.org/10.1371/journal.pone.0008144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997506	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000005
J	Das, S; Ghosh, D; Basu, A				Das, Sulagna; Ghosh, Debapriya; Basu, Anirban			Japanese Encephalitis Virus Induce Immuno-Competency in Neural Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; CLASS-I; PROGENITOR CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; COSTIMULATORY MOLECULES; INFLAMMATORY CYTOKINES; RESIST DESTRUCTION; NEURONAL DEATH; T-LYMPHOCYTES; EXPRESSION	Background: The low immunogenicity of neural stem/progenitor cells (NSPCs) coupled with negligible expression of MHC antigens has popularized their use in transplantation medicine. However, in an inflammatory environment, the NSPCs express costimulatory molecules and MHC antigens, and also exhibit certain immunomodulatory functions. Since NSPCs are the cellular targets in a number of virus infections both during postnatal and adult stages, we wanted to investigate the immunological properties of these stem cells in response to viral pathogen. Methodology/Principal Findings: We utilized both in vivo mouse model and in vitro neurosphere model of Japanese encephalitis virus (JEV) infection for the study. The NSPCs residing in the subventricular zone of the infected brains showed prominent expression of MHC-I and costimulatory molecules CD40, CD80, and CD86. Using Flow cytometry and fluorescence microscopy, we observed increased surface expression of co-stimulatory molecule and MHC class I antigen in NSPCs upon progressive JEV infection in vitro. Moreover, significant production of pro-inflammatory cyto/chemokines was detected in JEV infected NSPCs by Cytokine Bead Array analysis. Interestingly, NSPCs were capable of providing functional costimulation to allogenic T cells and JEV infection resulted in increased proliferation of allogenic T cells, as detected by Mixed Lymphocyte reaction and CFSE experiments. We also report IL-2 production by NSPCs upon JEV infection, which possibly provides mitogenic signals to T cells and trigger their proliferation. Conclusion/Significance: The in vivo and in vitro findings clearly indicate the development of immunogenicity in NSPCs following progressive JEV infection, in our case, JEV infection. Following a neurotropic virus infection, NSPCs possibly behave as immunogenic cells and contribute to both the innate and adaptive immune axes. The newly discovered immunological properties of NSPCs may have implications in assigning a new role of these cells as non-professional antigen presenting cells in the central nervous system.	[Das, Sulagna; Ghosh, Debapriya; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Das, S (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in		Das, Sulagna/0000-0002-8495-3153; Ghosh, Debapriya/0000-0002-8251-6945; Basu, Anirban/0000-0002-5200-2054	Department of Biotechnology [BT/PR8682/Med/14/1273/2007]; Senior Research Fellowship from University	Department of Biotechnology; Senior Research Fellowship from University	This work was supported by grant awarded to AB from the Department of Biotechnology, Award #BT/PR8682/Med/14/1273/2007. SD is a recipient of a Senior Research Fellowship from University Grants Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, AUTOIMMUN REV, V2, P115, DOI 10.1016/S1568-9972(03)00028-4; Abraham SA, 2006, VIRUS RES, V119, P216, DOI 10.1016/j.virusres.2006.03.006; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Foster JA, 2002, J NEUROIMMUNOL, V131, P83, DOI 10.1016/S0165-5728(02)00258-8; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Hori J, 2007, OCUL IMMUNOL INFLAMM, V15, P261, DOI 10.1080/09273940701382242; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Issazadeh S, 1998, J IMMUNOL, V161, P1104; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SY, 2009, J NEUROSCI RES, V87, P2264, DOI 10.1002/jnr.22050; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; Martino G, 2007, NAT CELL BIOL, V9, P1031, DOI 10.1038/ncb0907-1031; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miralves J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001354; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Odeberg J, 2005, J NEUROIMMUNOL, V161, P1, DOI 10.1016/j.jneuroim.2004.11.016; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Pechhold K, 1997, J IMMUNOL, V158, P4921; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sheng WS, 2005, J LEUKOCYTE BIOL, V78, P1233, DOI 10.1189/jlb.0405221; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665	43	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8134	10.1371/journal.pone.0008134	http://dx.doi.org/10.1371/journal.pone.0008134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956550	Green Submitted, gold, Green Published			2022-12-27	WOS:000272828800025
J	Kolachalama, VB; Levine, EG; Edelman, ER				Kolachalama, Vijaya B.; Levine, Evan G.; Edelman, Elazer R.			Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations	PLOS ONE			English	Article							PACLITAXEL-ELUTING STENTS; LEFT MAIN; DELIVERY; LESIONS; TRIAL; IMPLANTATION; THROMBOSIS; PROTEINS; DISEASE; UPDATE	Background: Treatment of arterial bifurcation lesions using drug-eluting stents (DES) is now common clinical practice and yet the mechanisms governing drug distribution in these complex morphologies are incompletely understood. It is still not evident how to efficiently determine the efficacy of local drug delivery and quantify zones of excessive drug that are harbingers of vascular toxicity and thrombosis, and areas of depletion that are associated with tissue overgrowth and luminal re-narrowing. Methods and Results: We constructed two-phase computational models of stent-deployed arterial bifurcations simulating blood flow and drug transport to investigate the factors modulating drug distribution when the main-branch (MB) was treated using a DES. Simulations predicted extensive flow-mediated drug delivery in bifurcated vascular beds where the drug distribution patterns are heterogeneous and sensitive to relative stent position and luminal flow. A single DES in the MB coupled with large retrograde luminal flow on the lateral wall of the side-branch (SB) can provide drug deposition on the SB lumen-wall interface, except when the MB stent is downstream of the SB flow divider. In an even more dramatic fashion, the presence of the SB affects drug distribution in the stented MB. Here fluid mechanic effects play an even greater role than in the SB especially when the DES is across and downstream to the flow divider and in a manner dependent upon the Reynolds number. Conclusions: The flow effects on drug deposition and subsequent uptake from endovascular DES are amplified in bifurcation lesions. When only one branch is stented, a complex interplay occurs - drug deposition in the stented MB is altered by the flow divider imposed by the SB and in the SB by the presence of a DES in the MB. The use of DES in arterial bifurcations requires a complex calculus that balances vascular and stent geometry as well as luminal flow.	[Kolachalama, Vijaya B.; Levine, Evan G.; Edelman, Elazer R.] MIT, Ctr Biomed Engn, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kolachalama, VB (corresponding author), MIT, Ctr Biomed Engn, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	vbk@mit.edu	Kolachalama, Vijaya B./AAH-3528-2020	Kolachalama, Vijaya B./0000-0002-5312-8644; Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM-49039]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by a grant from the NIH (R01 GM-49039) to ERE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan B, 2005, CIRCULATION, V111, P2958, DOI 10.1161/CIRCULATIONAHA.104.512475; Balakrishnan B, 2007, J CONTROL RELEASE, V123, P100, DOI 10.1016/j.jconrel.2007.06.025; Balakrishnan B, 2008, J CONTROL RELEASE, V131, P173, DOI 10.1016/j.jconrel.2008.07.027; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; Colombo A, 2007, CIRCULATION, V116, P1424, DOI 10.1161/CIRCULATIONAHA.106.621359; Creel CJ, 2000, CIRC RES, V86, P879, DOI 10.1161/01.RES.86.8.879; *FDA, 2007, KEY FDA CRIT PATH AC; Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937; Food and Drug Administration [FDA], 2008, GUID IND COR DRUG EL; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Hitt E, 2002, NAT MED, V8, P544, DOI 10.1038/nm0602-544a; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Hwang Chao-Wei, 2003, Int J Cardiovasc Intervent, V5, P7; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kolachalama VB, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-47; Kolachalama VB, 2009, J CONTROL RELEASE, V133, P24, DOI 10.1016/j.jconrel.2008.09.075; Latib A, 2009, HEART, V95, P495, DOI 10.1136/hrt.2008.150391; Lemos PA, 2003, CIRCULATION, V107, P3003, DOI 10.1161/01.CIR.0000078025.19258.28; Lovich MA, 2001, J PHARM SCI, V90, P1324, DOI 10.1002/jps.1085; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Richter Y, 2004, J CLIN INVEST, V113, P1607, DOI 10.1172/JCI200421007; Richter Y, 2006, CIRCULATION, V113, P2679, DOI 10.1161/CIRCULATIONAHA.106.632687; Serruys P., 2002, HDB CORONARY STENTS; Sheiban I, 2009, J INTERV CARDIOL, V22, P150, DOI 10.1111/j.1540-8183.2009.00444.x; Sheiban I, 2009, CATHETER CARDIO INTE, V73, P25, DOI 10.1002/ccd.21759; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tada S, 2001, ANN BIOMED ENG, V29, P456, DOI 10.1114/1.1376410; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; Tanabe K, 2004, CIRCULATION, V109, P196, DOI 10.1161/01.CIR.0000109137.51122.49; Wentzel JJ, 2001, CIRCULATION, V103, P1740, DOI 10.1161/01.CIR.103.13.1740	33	44	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8105	10.1371/journal.pone.0008105	http://dx.doi.org/10.1371/journal.pone.0008105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956555	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800009
J	Ochola, R; Sande, C; Fegan, G; Scott, PD; Medley, GF; Cane, PA; Nokes, DJ				Ochola, Rachel; Sande, Charles; Fegan, Gregory; Scott, Paul D.; Medley, Graham F.; Cane, Patricia A.; Nokes, D. James			The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; RURAL AREA; INFECTION; ANTIBODIES; AGE; EPIDEMIOLOGY; PREVALENCE; DISTRICT; MEASLES; BIRTH	Background: Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants. The rate of decay of RSV-specific maternal antibodies (RSV-matAb), the factors affecting cord blood levels, and the relationship between these levels and protection from infection are poorly defined. Methods: A birth cohort (n = 635) in rural Kenya, was studied intensively to monitor infections and describe age-related serological characteristics. RSV specific IgG antibody (Ab) in serum was measured by the enzyme linked immunosorbent assay (ELISA) in cord blood, consecutive samples taken 3 monthly, and in paired acute and convalescent samples. A linear regression model was used to calculate the rate of RSV-matAb decline. The effect of risk factors on cord blood titres was investigated. Results: The half-life of matAb in the Kenyan cohort was calculated to be 79 days (95% confidence limits (CL): 76-81 days). Ninety seven percent of infants were born with RSV-matAb. Infants who subsequently experienced an infection in early life had significantly lower cord titres of anti-RSV Ab in comparison to infants who did not have any incident infection in the first 6 months (P = 0.011). RSV infections were shown to have no effect on the rate of decay of RSV-matAb. Conclusion: Maternal-specific RSV Ab decline rapidly following birth. However, we provide evidence of protection against severe disease by RSV-matAb during the first 6-7 months. This suggests that boosting maternal-specific Ab by RSV vaccination may be a useful strategy to consider.	[Ochola, Rachel; Sande, Charles; Fegan, Gregory; Nokes, D. James] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Scott, Paul D.; Medley, Graham F.; Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Cane, Patricia A.] Hlth Protect Agcy, London, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; Health Protection Agency	Ochola, R (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.	rachel.opiyo@gmail.com	Medley, Graham/B-7289-2008; Fegan, Greg W/O-8079-2018	Medley, Graham/0000-0002-0030-7278; Fegan, Greg W/0000-0002-2663-2765; Sande, Charles/0000-0002-8364-6063	The Wellcome Trust [061584, 076278]	The Wellcome Trust(Wellcome TrustEuropean Commission)	Financial support was provided by The Wellcome Trust (http://www.wellcome.ac.uk/; 061584 and 076278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeck K D, 1996, Monaldi Arch Chest Dis, V51, P210; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Connor E, 1997, PEDIATRICS, V99, P93; Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2; Ebihara T, 2004, J MED VIROL, V72, P304, DOI 10.1002/jmv.10572; Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Hacimustafaoglu M, 2004, ARCH DIS CHILD, V89, P52, DOI 10.1136/adc.2002.017780; HALL CB, 1979, NEW ENGL J MED, V300, P393, DOI 10.1056/NEJM197902223000803; LAMPRECHT CL, 1976, J INFECT DIS, V134, P211, DOI 10.1093/infdis/134.3.211; Lee DH, 2001, ORG LETT, V3, P5, DOI 10.1021/ol006690t; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; *MIN FIN PLANN, 2002, AN REP POP PROJ, V2; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; NANDAPALAN N, 1986, J MED VIROL, V20, P79, DOI 10.1002/jmv.1890200110; NELIGAN GA, 1970, BMJ-BRIT MED J, V3, P146, DOI 10.1136/bmj.3.5715.146; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; OGILVIE MM, 1981, J MED VIROL, V7, P263, DOI 10.1002/jmv.1890070403; Roca A, 2003, J MED VIROL, V69, P579, DOI 10.1002/jmv.10348; Roca A, 2002, J MED VIROL, V67, P616, DOI 10.1002/jmv.10148; SATO H, 1979, AM J DIS CHILD, V133, P1240, DOI 10.1001/archpedi.1979.02130120032005; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; WARD KA, 1983, J GEN VIROL, V64, P1867, DOI 10.1099/0022-1317-64-9-1867; Wilson SD, 2000, J MED VIROL, V61, P81, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;81::AID-JMV13&gt;3.0.CO;2-O; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	29	108	109	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8088	10.1371/journal.pone.0008088	http://dx.doi.org/10.1371/journal.pone.0008088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956576	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000272828800008
J	Kaushik, JK; Kumar, A; Duary, RK; Mohanty, AK; Grover, S; Batish, VK				Kaushik, Jai K.; Kumar, Ashutosh; Duary, Raj K.; Mohanty, Ashok K.; Grover, Sunita; Batish, Virender K.			Functional and Probiotic Attributes of an Indigenous Isolate of Lactobacillus plantarum	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME SEQUENCE; HUMAN INTESTINAL-MUCOSA; BILE-SALT HYDROLASE; IN-VITRO; GASTROINTESTINAL-TRACT; LACTOCOCCUS-LACTIS; ADHESION; STRAINS; IDENTIFICATION	Background: Probiotic microorganisms favorably alter the intestinal microflora balance, promote intestinal integrity and mobility, inhibit the growth of harmful bacteria and increase resistance to infection. Probiotics are increasingly used in nutraceuticals, functional foods or in microbial interference treatment. However, the effectiveness of probiotic organism is considered to be population-specific due to variation in gut microflora, food habits and specific host-microbial interactions. Most of the probiotic strains available in the market are of western or European origin, and a strong need for exploring new indigenous probiotic organisms is felt. Methods and Findings: An indigenous isolate Lp9 identified as Lactobacillus plantarum by molecular-typing methods was studied extensively for its functional and probiotic attributes, viz., acid and bile salt tolerance, cell surface hydrophobicity, autoaggregation and Caco-2 cell-binding as well as antibacterial and antioxidative activities. Lp9 isolate could survive 2 h incubation at pH 1.5-2.0 and toxicity of 1.5-2.0% oxgall bile. Lp9 could deconjugate major bile salts like glycocholate and deoxytaurocholate, indicating its potential to cause hypocholesterolemia. The isolate exhibited cell-surface hydrophobicity of similar to 37% and autoaggregation of similar to 31%. Presence of putative probiotic marker genes like mucus-binding protein (mub), fibronectin-binding protein (fbp) and bile salt hydrolase (bsh) were confirmed by PCR. Presence of these genes suggested the possibility of specific interaction and colonization potential of Lp9 isolate in the gut, which was also suggested by a good adhesion ratio of 7.4 +/- 1.3% with Caco-2 cell line. The isolate demonstrated higher free radical scavenging activity than standard probiotics L. johnsonii LA1 and L. acidophilus LA7. Lp9 also exhibited antibacterial activity against E. coli, L. monocytogenes, S. typhi, S. aureus and B. cereus. Conclusion: The indigenous Lactobacillus plantarum Lp9 exhibited high resistance against low pH and bile and possessed antibacterial, antioxidative and cholesterol lowering properties with a potential for exploitation in the development of indigenous functional food or nutraceuticals.	[Kaushik, Jai K.; Mohanty, Ashok K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India; [Kumar, Ashutosh; Duary, Raj K.; Grover, Sunita; Batish, Virender K.] Natl Dairy Res Inst, Dairy Microbiol Div, Mol Biol Unit, Karnal, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India.	Jaikr1@gmail.com; vkbatish@gmail.com	DUARY, RAJ KUMAR/U-8465-2017	DUARY, RAJ KUMAR/0000-0002-1186-6999; Kaushik, Jai/0000-0002-8872-0066	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The running funds of the department were used to purchase the chemicals. AK and RKD acknowledge the Indian Council of Agricultural Research for providing Junior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 1996, APPL ENVIRON MICROB, V62, P2244, DOI 10.1128/AEM.62.7.2244-2251.1996; Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Mariutti LRB, 2008, BRAZ ARCH BIOL TECHN, V51, P1225, DOI 10.1590/S1516-89132008000600018; Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Boekhorst J, 2006, MICROBIOL-SGM, V152, P3175, DOI 10.1099/mic.0.29217-0; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Cataloluk O, 2004, FEMS MICROBIOL LETT, V236, P7, DOI 10.1016/j.femsle.2004.05.010; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Collado MC, 2007, J FOOD SCI, V72, pM89, DOI 10.1111/j.1750-3841.2007.00294.x; Collado MC, 2006, J FOOD PROTECT, V69, P1675, DOI 10.4315/0362-028X-69.7.1675; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; DESMET I, 1994, MICROB ECOL HEALTH D, V7, P315, DOI 10.3109/08910609409141371; Donnet-Hughes A, 1999, J DAIRY SCI, V82, P863, DOI 10.3168/jds.S0022-0302(99)75304-X; Draksler D, 2004, REPROD NUTR DEV, V44, P397, DOI 10.1051/rnd:2004046; du Toit M, 1998, INT J FOOD MICROBIOL, V40, P93, DOI 10.1016/S0168-1605(98)00024-5; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P657, DOI 10.1111/j.1469-0691.2007.01688.x; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; FLOCH MH, 1972, AM J CLIN NUTR, V25, P1418; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; GILLILAND SE, 2001, HLTH NUTR PROPERTIES; Hernandez-Ledesma B, 2005, J SCI FOOD AGR, V85, P1041, DOI 10.1002/jsfa.2063; Hugo AA, 2008, LETT APPL MICROBIOL, V46, P613, DOI 10.1111/j.1472-765X.2008.02363.x; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; JENCKS WP, 1969, MCGRAWHILL SERIES AD, P555; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; KAIZU H, 1993, J DAIRY SCI, V76, P2493, DOI 10.3168/jds.S0022-0302(93)77584-0; Klaenhammer T. R., 1993, BACTERIOCINS LACTIC, P151; Klaenhammer TR, 2005, FEMS MICROBIOL REV, V29, P393, DOI 10.1016/j.femsre.2005.04.007; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kmet V, 1997, FEMS IMMUNOL MED MIC, V19, P111, DOI 10.1016/S0928-8244(97)00075-8; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Lam EKY, 2007, EUR J PHARMACOL, V565, P171, DOI 10.1016/j.ejphar.2007.02.050; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lankaputhra W. E. V., 1995, Cultured Dairy Products Journal, V30, P2; Lim Hyeong-Jun, 2004, J Vet Sci, V5, P391; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149, DOI 10.1111/j.1574-6968.1990.tb04885.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; MARTEAU P, 1993, FEMS MICROBIOL REV, V12, P207, DOI [10.1016/0168-6445(93)90064-G, 10.1111/j.1574-6976.1993.tb00019.x]; Minelli EB, 2004, INT DAIRY J, V14, P723, DOI 10.1016/j.idairyj.2004.01.007; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Nollet Lode J.A., 1999, Microbial Ecology in Health and Disease, V11, P13, DOI 10.1080/089106099435871; Ocana Virginia S, 2002, Br J Biomed Sci, V59, P183; ODUNFA SA, 1996, TRADITIONAL FERMENTE, P27; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Pereira DIA, 2003, APPL ENVIRON MICROB, V69, P4743, DOI 10.1128/AEM.69.8.4743-4752.2003; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Prakash R, 1997, INDIAN J DAIRY SCI, V10, P43; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; RENZIK SR, 1993, MIKROBIOLZ, V55, P81; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255, DOI 10.1128/AEM.59.10.3255-3265.1993; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6; Schiffrin EJ, 1997, AM J CLIN NUTR, V66, P515, DOI 10.1093/ajcn/66.2.515S; Schillinger U, 2005, INT DAIRY J, V15, P1289, DOI 10.1016/j.idairyj.2004.12.008; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Tomas MSJ, 2005, J APPL MICROBIOL, V99, P1383, DOI 10.1111/j.1365-2672.2005.02726.x; Troost FJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-374; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Tuomola EM, 1998, INT J FOOD MICROBIOL, V41, P45, DOI 10.1016/S0168-1605(98)00033-6; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Vanderhoof JA, 1998, J PEDIATR GASTR NUTR, V27, P323, DOI 10.1097/00005176-199809000-00011; VANDEVOORDE L, 1992, J APPL BACTERIOL, V72, P214, DOI 10.1111/j.1365-2672.1992.tb01826.x; VELDMAN A, 1992, TIJDSCHR DIERGENEESK, V117, P345; Vitini E, 2000, BIOCELL, V24, P223; Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, DOI 10.1016/j.ijantimicag.2008.11.005; Wilson AR, 2005, J APPL MICROBIOL, V99, P1516, DOI 10.1111/j.1365-2672.2005.02725.x; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Yadav H, 2006, BIOSCI BIOTECH BIOCH, V70, P1255, DOI 10.1271/bbb.70.1255	88	197	208	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8099	10.1371/journal.pone.0008099	http://dx.doi.org/10.1371/journal.pone.0008099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956615	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828700012
J	Mito, JK; Riedel, RF; Dodd, L; Lahat, G; Lazar, AJ; Dodd, RD; Stangenberg, L; Eward, WC; Hornicek, FJ; Yoon, SS; Brigman, BE; Jacks, T; Lev, D; Mukherjee, S; Kirsch, DG				Mito, Jeffrey K.; Riedel, Richard F.; Dodd, Leslie; Lahat, Guy; Lazar, Alexander J.; Dodd, Rebecca D.; Stangenberg, Lars; Eward, William C.; Hornicek, Francis J.; Yoon, Sam S.; Brigman, Brian E.; Jacks, Tyler; Lev, Dina; Mukherjee, Sayan; Kirsch, David G.			Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; GENE-EXPRESSION; H-RAS; NORMALIZATION; MUTATIONS; INSIGHTS	Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras(G12D); Trp53(Flox/Flox) mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-Kras(G12D); p53(Flox/Flox) mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.	[Mito, Jeffrey K.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Riedel, Richard F.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; [Dodd, Leslie; Lev, Dina] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Lahat, Guy] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Dodd, Rebecca D.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Stangenberg, Lars; Hornicek, Francis J.; Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Stangenberg, Lars; Hornicek, Francis J.; Yoon, Sam S.] Harvard Univ, Sch Med, Boston, MA USA; [Eward, William C.; Brigman, Brian E.] Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, Durham, NC 27710 USA; [Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Duke University; Duke University	Mito, JK (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	david.kirsch@duke.edu	Riedel, Richard/HHM-4275-2022; Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499; Dodd, Rebecca/0000-0001-7295-1882; Stangenberg, Lars/0000-0002-9432-0683; Mukherjee, Sayan/0000-0002-6715-3920	Howard Hughes Medical Institute [KO8 CA 114176, RO1 CA 138265, T32 GM- 07171]; Maria Garcia-Estrada Foundation; NATIONAL CANCER INSTITUTE [R01CA138265, K08CA114176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Maria Garcia-Estrada Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Howard Hughes Medical Institute (TJ) and by KO8 CA 114176 and RO1 CA 138265 (DGK), T32 GM- 07171 (JM), and the Maria Garcia-Estrada Foundation (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; HOLLOWOOD K, 1995, SEMIN DIAGN PATHOL, V12, P210; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; LEACH FS, 1993, CANCER RES, V53, P2231; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; OZZELLO L, 1963, CANCER-AM CANCER SOC, V16, P331, DOI 10.1002/1097-0142(196303)16:3<331::AID-CNCR2820160307>3.0.CO;2-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Yoo J, 1999, CANCER, V86, P58, DOI 10.1002/(SICI)1097-0142(19990701)86:1<58::AID-CNCR10>3.3.CO;2-J; Yoo JY, 1999, MODERN PATHOL, V12, P775	20	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8075	10.1371/journal.pone.0008075	http://dx.doi.org/10.1371/journal.pone.0008075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956606	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400022
J	Moffitt, H; McPhail, GD; Woodman, B; Hobbs, C; Bates, GP				Moffitt, Hilary; McPhail, Graham D.; Woodman, Ben; Hobbs, Carl; Bates, Gillian P.			Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED CAG REPEAT; HD TRANSGENIC MICE; R6/2 MOUSE; SKELETAL-MUSCLE; GENE-EXPRESSION; DIABETES-MELLITUS; WEIGHT-LOSS; MUTATION; ABNORMALITIES	Background: Huntington's disease (HD) is an inherited progressive neurodegenerative disorder caused by a CAG repeat expansion in the ubiquitously expressed HD gene resulting in an abnormally long polyglutamine repeat in the huntingtin protein. Polyglutamine inclusions are a hallmark of the neuropathology of HD. We have previously shown that inclusion pathology is also present in the peripheral tissues of the R6/2 mouse model of HD which expresses a small N-terminal fragment of mutant huntingtin. To determine whether this peripheral pathology is a consequence of the aberrant expression of this N-terminal fragment, we extend this analysis to the genetically precise knock-in mouse model of HD, HdhQ150, which expresses mutant mouse huntingtin. Methodology/Principal Findings: We have previously standardized the CAG repeat size and strain background of the R6/2 and HdhQ150 knock-in mouse models and found that they develop a comparable and widespread neuropathology. To determine whether HdhQ150 knock-in mice also develop peripheral inclusion pathology, homozygous Hdh(Q150/Q150) mice were perfusion fixed at 22 months of age, and tissues were processed for histology and immunohistochemistry with the anti-huntingtin antibody S830. The peripheral inclusion pathology was almost identical to that found in R6/2 mice at 12 weeks of age with minor differences in inclusion abundance. Conclusions/Significance: The highly comparable peripheral inclusion pathology that is present in both the R6/2 and HdhQ150 knock-in models of HD indicates that the presence of peripheral inclusions in R6/2 mice is not a consequence of the aberrant expression of an N-terminal huntingtin protein. It remains to be determined whether peripheral inclusions are a pathological feature of the human disease. Both mouse models carry CAG repeats that cause childhood disease in humans, and therefore, inclusion pathology may be a feature of the childhood rather than the adult forms of HD. It is important to establish the extent to which peripheral pathology causes the peripheral symptoms of HD from the perspective of a mechanistic understanding and future treatment options.	[Moffitt, Hilary; Woodman, Ben; Bates, Gillian P.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [McPhail, Graham D.] Royal London Hosp, Barts & London NHS Trust, Div Cellular Pathol, London E1 1BB, England; [Hobbs, Carl] Kings Coll London, Sch Med, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; University of London; King's College London	Moffitt, H (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305	Medical Research Council [G9800001]; Wellcome Trust [066270]; CHDI Foundation; Huntington's Disease Society of America Coalition; MRC [G9800001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); CHDI Foundation; Huntington's Disease Society of America Coalition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Medical Research Council (G9800001), Wellcome Trust (066270), CHDI Foundation, and Huntington's Disease Society of America Coalition for the Cure to GPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Bacos K, 2008, HISTOCHEM CELL BIOL, V129, P623, DOI 10.1007/s00418-008-0393-z; Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; BATES G, 2002, HUNTINGTONS DIS; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hayat M.A., 2000, PRINCIPALS TECHNIQUE; Henley SMD, 2009, MOVEMENT DISORD, V24, P932, DOI 10.1002/mds.22485; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hunt MJ, 2005, EXP BRAIN RES, V166, P220, DOI 10.1007/s00221-005-2357-z; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Josefsen K, 2008, J NEUROENDOCRINOL, V20, P165, DOI 10.1111/j.1365-2826.2007.01629.x; Kloppel S, 2009, NEUROSCIENCE, V164, P205, DOI 10.1016/j.neuroscience.2009.01.045; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lodi R, 2000, ANN NEUROL, V48, P72; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Powley TL, 2005, AM J PHYSIOL-REG I, V289, pR563, DOI 10.1152/ajpregu.00167.2005; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; SATHASIVAM K, 2009, HUM MOL GEN IN PRESS; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 1999, HUM MOL GENET, V8, P943; SEWRY CA, 2001, DISORDERS VOLUNTARY; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Squitieri F, 2006, MECH AGEING DEV, V127, P217, DOI 10.1016/j.mad.2005.09.010; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	64	109	109	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8025	10.1371/journal.pone.0008025	http://dx.doi.org/10.1371/journal.pone.0008025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956633	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828400004
J	Wu, YJ; Wang, CX; Sun, H; LeRoith, D; Yakar, S				Wu, Yingjie; Wang, Chunxin; Sun, Hui; LeRoith, Derek; Yakar, Shoshana			High-Efficient FLPo Deleter Mice in C57BL/6J Background	PLOS ONE			English	Article							TRANSGENIC MICE; CRE RECOMBINASE; MAMMALIAN-CELLS; EXPRESSION; GENE; WIDESPREAD; MOUSE	Conditional gene manipulation in mice becomes a routine for genetic studies of mammalian gene functions. Additional site-specific recombinases such as FLP or phi 31 provide one more level of gene manipulation flexibility. The recombination activity of the currently available FLP deleter mice remains low. We generated a new FLP deleter mouse line with the mouse codon-optimized FLPo gene in C57BJ/6 background, which showed superior recombination efficacy in comparison to FLPe deleter mice. 100% complete removal of FRT-flanked Neo cassette was observed in all F1 progeny mice carrying both FLPo and Neo cassette, which can be transmitted to F2 generation independent of FLPo activity. Our new FLPo transgenic mice (on pure C57BJ/6 background) will largely facilitate the gene targeting process and is valuable for conditional gene manipulation.	[Wu, Yingjie; Sun, Hui; LeRoith, Derek; Yakar, Shoshana] Mt Sinai Sch Med, Endocrinol Diabet & Bone Dis Div, New York, NY USA; [Wang, Chunxin] NINDS, Biochem Sect, SNB, NIH, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, YJ (corresponding author), Mt Sinai Sch Med, Endocrinol Diabet & Bone Dis Div, New York, NY USA.	shoshana.yakar@mssm.edu	Wang, Chunxin/B-9312-2016	Wang, Chunxin/0000-0001-6015-6806	NIH [AR054919, AR055141]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054919, R01AR055141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is funded by the NIH grants AR054919, AR055141 to S.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kondo S, 2009, J MOL BIOL, V390, P221, DOI 10.1016/j.jmb.2009.04.057; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169	18	54	55	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8054	10.1371/journal.pone.0008054	http://dx.doi.org/10.1371/journal.pone.0008054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956655	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828100010
J	Jeong, JH; Song, HR; Ko, JH; Jeong, YM; Kwon, YE; Seol, JH; Amasino, RM; Noh, B; Noh, YS				Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Kwon, Young Eun; Seol, Jae Hong; Amasino, Richard M.; Noh, Bosl; Noh, Yoo-Sun			Repression of FLOWERING LOCUS T Chromatin by Functionally Redundant Histone H3 Lysine 4 Demethylases in Arabidopsis	PLOS ONE			English	Article							MADS DOMAIN PROTEIN; FLORAL INDUCTION; HETEROCHROMATIN PROTEIN1; EXPRESSION ANALYSIS; TARGET GENES; JMJC DOMAIN; TIME; CONSTANS; ENCODES; THALIANA	FLOWERING LOCUS T (FT) plays a key role as a mobile floral induction signal that initiates the floral transition. Therefore, precise control of FT expression is critical for the reproductive success of flowering plants. Coexistence of bivalent histone H3 lysine 27 trimethylation (H3K27me3) and H3K4me3 marks at the FT locus and the role of H3K27me3 as a strong FT repression mechanism in Arabidopsis have been reported. However, the role of an active mark, H3K4me3, in FT regulation has not been addressed, nor have the components affecting this mark been identified. Mutations in Arabidopsis thaliana Jumonji4 (AtJmj4) and EARLY FLOWERING6 (ELF6), two Arabidopsis genes encoding Jumonji (Jmj) family proteins, caused FT-dependent, additive early flowering correlated with increased expression of FT mRNA and increased H3K4me3 levels within FT chromatin. Purified recombinant AtJmj4 protein possesses specific demethylase activity for mono-, di-, and trimethylated H3K4. Tagged AtJmj4 and ELF6 proteins associate directly with the FT transcription initiation region, a region where the H3K4me3 levels were increased most significantly in the mutants. Thus, our study demonstrates the roles of AtJmj4 and ELF6 as H3K4 demethylases directly repressing FT chromatin and preventing precocious flowering in Arabidopsis.	[Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Amasino, Richard M.; Noh, Bosl; Noh, Yoo-Sun] Seoul Natl Univ, Global Res Lab Floral Regulatory Signaling, Seoul, South Korea; [Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Kwon, Young Eun; Seol, Jae Hong; Noh, Yoo-Sun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Noh, Bosl] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju, South Korea; [Jeong, Young-Min; Amasino, Richard M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Seoul National University (SNU); Seoul National University (SNU); Gyeongsang National University; University of Wisconsin System; University of Wisconsin Madison	Noh, B (corresponding author), Seoul Natl Univ, Global Res Lab Floral Regulatory Signaling, Seoul, South Korea.	bnoh2003@yahoo.co.kr; ysnoh@snu.ac.kr		Jeong, Young-Min/0000-0001-6849-0067	Ministry of Education, Science, and Technology [R15-2003-012-01001-0]; Korea Research Foundation [KRF-2007-313-C00703, KRF-2008-314-C00359]; BK21 Program	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Global Research Laboratory Program of the Ministry of Education, Science, and Technology, by the Plant Diversity Research Center, and by the Bio-Green21 Program of the Rural Development Administration. B.N. was supported by a grant from the Ministry of Education, Science, and Technology to the Environmental Biotechnology National Core Research Center (R15-2003-012-01001-0) and by grants from the Korea Research Foundation (KRF-2007-313-C00703 and KRF-2008-314-C00359). J.-H. J and H.-R. S. were supported by the BK21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Farrona S, 2008, SEMIN CELL DEV BIOL, V19, P560, DOI 10.1016/j.semcdb.2008.07.015; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Han SK, 2007, PLANT J, V49, P103, DOI 10.1111/j.1365-313X.2006.02939.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hong EH, 2009, MOL CELLS, V27, P481, DOI 10.1007/s10059-009-0054-7; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kang BH, 2001, PLANT PHYSIOL, V126, P47, DOI 10.1104/pp.126.1.47; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Larsson AS, 1998, GENETICS, V149, P597; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lee JH, 2007, BBA-GENE STRUCT EXPR, V1769, P455, DOI 10.1016/j.bbaexp.2007.05.001; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Schatlowski N, 2008, SEMIN CELL DEV BIOL, V19, P547, DOI 10.1016/j.semcdb.2008.07.019; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	63	114	123	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8033	10.1371/journal.pone.0008033	http://dx.doi.org/10.1371/journal.pone.0008033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946624	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800020
J	Guo, L; Sun, BL; Sang, F; Wang, W; Lu, ZH				Guo, Li; Sun, Beili; Sang, Fei; Wang, Wei; Lu, Zuhong			Haplotype Distribution and Evolutionary Pattern of miR-17 and miR-124 Families Based on Population Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITES; MICRORNAS; IDENTIFICATION; RNAS; NETWORKS; SEQUENCE	Background: MicroRNAs (miRNAs) are small, endogenously expressed non-coding RNAs that regulate mRNAs post-transcriptionally. Previous studies have explored miRNA evolutionary trend, but evolutionary history and pattern in the miRNA world are still not fully clear. In the paper, we intended to analyze miRNA haplotype distribution and evolutionary network by analyzing miRNA sequences of miR-17 and miR-124 families across animal species as special populations. Principal Findings: 31 haplotypes were detected in miR-17 family while only 9 haplotypes were defined in miR-124 family. The complex miR-17 family was mainly distributed in vertebrates, but miR-124 was shared by more animal species from Caenorhabditis to Homo and had a wide distribution spectrum. Some haplotypes of the two miRNA families appeared discontinuous distributions across animals. Compared with a simple phylogenetic network in miR-124 family, miR-17 family indicated a complex network with some median vectors that might be lost ancestral or potential miRNA haplotypes. By analyzing different miRNAs across 12 animal species, we found these small RNAs showed different haplotype diversities, haplotype distributions and phylogenetic networks. Conclusions: Different miRNAs had quite different haplotype distributions and evolutionary patterns. Discontinuous distributions of miRNAs and median vectors in phylogenetic networks implied more members in the miRNA world. miRNA may be an excellent phylogenetic marker to discover its evolutionary history and pattern across the animal kingdom.	[Guo, Li; Sun, Beili; Wang, Wei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Sang, Fei; Lu, Zuhong] Southeast Univ, Key Lab Child Dev, Nanjing, Peoples R China; [Sang, Fei; Lu, Zuhong] Southeast Univ, Learning Sci Minist Educ, Nanjing, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Lu, Zuhong/A-5448-2013	Sang, Fei/0000-0002-8746-5868; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the project 30871393 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fu XH, 2008, MOL BIOL EVOL, V25, P1067, DOI 10.1093/molbev/msn060; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; HE L, 2004, NATURE REV GENETICS, V5, P522; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7944	10.1371/journal.pone.0007944	http://dx.doi.org/10.1371/journal.pone.0007944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956752	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827300004
J	Li, J; Yang, TL; Wang, L; Yan, H; Zhang, YP; Guo, Y; Pan, F; Zhang, ZX; Peng, YM; Zhou, Q; He, LN; Zhu, XZ; Deng, HY; Levy, S; Papasian, CJ; Drees, BM; Hamilton, JJ; Recker, RR; Cheng, J; Deng, HW				Li, Jian; Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hongyi; Levy, Shawn; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Recker, Robert R.; Cheng, Jing; Deng, Hong-Wen			Whole Genome Distribution and Ethnic Differentiation of Copy Number Variation in Caucasian and Asian Populations	PLOS ONE			English	Article							AFFYMETRIX SNP ARRAYS; COMPREHENSIVE ANALYSIS; STRUCTURAL VARIATION; DNA; GENE; WIDE; HETEROZYGOSITY; POLYMORPHISM; NUCLEOTIDE; SUSCEPTIBILITY	Although copy number variation (CNV) has recently received much attention as a form of structure variation within the human genome, knowledge is still inadequate on fundamental CNV characteristics such as occurrence rate, genomic distribution and ethnic differentiation. In the present study, we used the Affymetrix GeneChip(R) Mapping 500K Array to discover and characterize CNVs in the human genome and to study ethnic differences of CNVs between Caucasians and Asians. Three thousand and nineteen CNVs, including 2381 CNVs in autosomes and 638 CNVs in X chromosome, from 985 Caucasian and 692 Asian individuals were identified, with a mean length of 296 kb. Among these CNVs, 190 had frequencies greater than 1% in at least one ethnic group, and 109 showed significant ethnic differences in frequencies (p<0.01). After merging overlapping CNVs, 1135 copy number variation regions (CNVRs), covering approximately 439 Mb (14.3%) of the human genome, were obtained. Our findings of ethnic differentiation of CNVs, along with the newly constructed CNV genomic map, extend our knowledge on the structural variation in the human genome and may furnish a basis for understanding the genomic differentiation of complex traits across ethnic groups.	[Li, Jian; Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Zhixin; Deng, Hongyi; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn Minist Educ, Xian 710049, Shanxi, Peoples R China; [Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shanxi, Peoples R China; [Levy, Shawn] Vanderbilt Univ, Nashville, TN USA; [Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA; [Cheng, Jing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University; Vanderbilt University; Creighton University; Hunan Normal University	Li, J (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Yang, Tie-Lin/G-8365-2014; Li, Jian/G-4445-2015; Guo, Yan/G-8742-2014	Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Levy, Shawn/0000-0002-1369-5740; Deng, Hong-Wen/0000-0002-0387-8818	NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation, Xi'an Jiaotong University; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation, Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Investigators of this work were partially supported by grants from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, and P50 AR055081). The study also benefited from grants from National Science Foundation of China, Huo Ying Dong Education Foundation, Xi'an Jiaotong University, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hegele RA, 2007, CAN MED ASSOC J, V176, P441, DOI 10.1503/cmaj.061689; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hu N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-299; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lo KC, 2008, GENE CHROMOSOME CANC, V47, P221, DOI 10.1002/gcc.20524; Madrigal I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-443; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selvarajah S, 2007, CANCER GENET CYTOGEN, V179, P52, DOI 10.1016/j.cancergencyto.2007.08.003; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	28	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7958	10.1371/journal.pone.0007958	http://dx.doi.org/10.1371/journal.pone.0007958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956714	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827300015
J	Delihas, N				Delihas, Nicholas			Stem Loop Sequences Specific to Transposable Element IS605 Are Found Linked to Lipoprotein Genes in Borrelia Plasmids	PLOS ONE			English	Article							DNA INSERTION SEQUENCES; LYME-DISEASE SPIROCHETE; FUNCTIONAL-PROPERTIES; SMALL RNA; BURGDORFERI; ORGANIZATION; REPEATS; GENOME; NEISSERIAE; ACTIVATION	Background: Plasmids of Borrelia species are dynamic structures that contain a large number of repetitive genes, gene fragments, and gene fusions. In addition, the transposable element IS605/200 family, as well as degenerate forms of this IS element, are prevalent. In Helicobacter pylori, flanking regions of the IS605 transposase gene contain sequences that fold into identical small stem loops. These function in transposition at the single-stranded DNA level. Methodology/Principal Findings: In work reported here, bioinformatics techniques were used to scan Borrelia plasmid genomes for IS605 transposable element specific stem loop sequences. Two variant stem loop motifs are found in the left and right flanking regions of the transposase gene. Both motifs appear to have dispersed in plasmid genomes and are found "free-standing'' and phylogenetically conserved without the associated IS605 transposase gene or the adjacent flanking sequence. Importantly, IS605 specific stem loop sequences are also found at the 3' ends of lipoprotein genes (PFam12 and PFam60), however the left and right sequences appear to develop their own evolutionary patterns. The lipoprotein gene-linked left stem loop sequences maintain the IS605 stem loop motif in orthologs but only at the RNA level. These show mutations whereby variants fold into phylogenetically conserved RNA-type stem loops that contain the wobble non-Watson-Crick G-U base-pairing. The right flanking sequence is associated with the family lipoprotein-1 genes. A comparison of homologs shows that the IS605 stem loop motif rapidly dissipates, but a more elaborate secondary structure appears to develop in its place. Conclusions/Significance: Stem loop sequences specific to the transposable element IS605 are present in plasmid regions devoid of a transposase gene and significantly, are found linked to lipoprotein genes in Borrelia plasmids. These sequences are evolutionarily conserved and/or structurally developed in an RNA format. The findings show that IS605 stem loop sequences are multifaceted and are selectively conserved during evolution when the transposable element dissipates.			Delihas, N (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	Nicholas.delihas@sunysb.edu		Delihas, Nicholas/0000-0002-1704-2587				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chen Y, 2008, GENETICS, V179, P2291, DOI 10.1534/genetics.108.089995; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; De Gregorio E, 2002, BBA-GENE STRUCT EXPR, V1576, P39, DOI 10.1016/S0167-4781(02)00290-7; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; Delihas N, 2007, GENE REGUL SYST BIO, V1, P191; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Delihas N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-101; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Mazzone M, 2001, GENE, V278, P211, DOI 10.1016/S0378-1119(01)00725-9; Mcmanus CJ, 2007, RNA, V13, P2252, DOI 10.1261/rna.699907; Ostberg Y, 2004, J BACTERIOL, V186, P8472, DOI 10.1128/JB.186.24.8472-8477.2004; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schmitz M, 2004, NUCLEIC ACIDS RES, V32, P6358, DOI 10.1093/nar/gkh961; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Zhou F, 2008, BIOCHEM BIOPH RES CO, V365, P790, DOI 10.1016/j.bbrc.2007.11.038; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7941	10.1371/journal.pone.0007941	http://dx.doi.org/10.1371/journal.pone.0007941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936201	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004800018
J	Lowenstein, JH; Amato, G; Kolokotronis, SO				Lowenstein, Jacob H.; Amato, George; Kolokotronis, Sergios-Orestis			The Real maccoyii: Identifying Tuna Sushi with DNA Barcodes - Contrasting Characteristic Attributes and Genetic Distances	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; FISH; TAXONOMY; DELIMITATION; SUBSTITUTION; MUSCLE; MARKET	Background: The use of DNA barcodes for the identification of described species is one of the least controversial and most promising applications of barcoding. There is no consensus, however, as to what constitutes an appropriate identification standard and most barcoding efforts simply attempt to pair a query sequence with reference sequences and deem identification successful if it falls within the bounds of some pre-established cutoffs using genetic distance. Since the Renaissance, however, most biological classification schemes have relied on the use of diagnostic characters to identify and place species. Methodology/Principal Findings: Here we developed a cytochrome c oxidase subunit 1 character-based key for the identification of all tuna species of the genus Thunnus, and compared its performance with distance-based measures for identification of 68 samples of tuna sushi purchased from 31 restaurants in Manhattan (New York City) and Denver, Colorado. Both the character-based key and GenBank BLAST successfully identified 100% of the tuna samples, while the Barcode of Life Database (BOLD) as well as genetic distance thresholds, and neighbor-joining phylogenetic tree building performed poorly in terms of species identification. A piece of tuna sushi has the potential to be an endangered species, a fraud, or a health hazard. All three of these cases were uncovered in this study. Nineteen restaurant establishments were unable to clarify or misrepresented what species they sold. Five out of nine samples sold as a variant of "white tuna'' were not albacore (T. alalunga), but escolar (Lepidocybium flavorunneum), a gempylid species banned for sale in Italy and Japan due to health concerns. Nineteen samples were northern bluefin tuna (T. thynnus) or the critically endangered southern bluefin tuna (T. maccoyii), though nine restaurants that sold these species did not state these species on their menus. Conclusions/Significance: The Convention on International Trade Endangered Species (CITES) requires that listed species must be identifiable in trade. This research fulfills this requirement for tuna, and supports the nomination of northern bluefin tuna for CITES listing in 2010.			Lowenstein, JH (corresponding author), Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA.	jlowenstein@amnh.org; koloko@amnh.org	Kolokotronis, Sergios-Orestis/GWM-5773-2022; 赵, 鹏/B-8401-2009; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amato G, 1999, ANIM CONSERV, V2, P1, DOI 10.1111/j.1469-1795.1999.tb00042.x; Atanassova V, 2008, J FOOD PROTECT, V71, P860, DOI 10.4315/0362-028X-71.4.860; Backeljau T, 1996, MOL BIOL EVOL, V13, P309, DOI 10.1093/oxfordjournals.molbev.a025590; Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOSE S, 1996, MARINE RESOURCE EC, V11, P143, DOI DOI 10.1086/MRE.11.3.42629157; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; *BUR RUR SCI, 2008, FISH STAT REP 2007 S; CATARCI C, 2005, WORLD TUNA IND ANAL, P279; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow S, 1995, J MOL EVOL, V41, P741, DOI 10.1007/BF00173154; COLLETTE BB, 1999, MACKERELS MOL MORPHO, P149; COLLETTE BB, 1979, PHYSL ECOLOGY TUNAS, P7; Collette Bruce B., 2001, Fish Physiology, V19, P1; *COMM CONS SO BLU, 2008, 13 M SCI COMM ROT NZ; *COMM CONS SO BLU, 2008, REP PERF REV; *COMM CONS SO BLUE, 2008, REP IND EXP; CORSON T, 2007, ZEN FISH STORY SUSHI; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; de Carvalho MR, 2008, EVOL BIOL, V35, P150, DOI 10.1007/s11692-008-9018-7; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2006, J BIOMED INFORM, V39, P6, DOI 10.1016/j.jbi.2005.11.002; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; DeSalle R, 1996, NATURE, V381, P197, DOI 10.1038/381197a0; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; ELLIS R, 2008, TUNA LOVE STORY; *EUR FOOD SAF AUTH, 2004, EFSA J, V92, P1; FARRIS J S, 1985, Cladistics, V1, P67, DOI 10.1111/j.1096-0031.1985.tb00411.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARWELL CJ, 2001, TUNA PHYSL ECOLOGY E, P391; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; FOX D, 2008, CONSERVATION MAGAZIN; FROESE R, 2008, FISHBASE; Godfray HCJ, 2004, PHILOS T R SOC B, V359, P559, DOI 10.1098/rstb.2003.1457; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Hamilton A, 2008, ISIS, V99, P331, DOI 10.1086/588691; HEARNSHAW JB, 1986, ANAL STARLIGHT 150 Y; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Holst-Jensen A, 2004, NEW PHYTOL, V161, P11, DOI 10.1111/j.1469-8137.2004.00961.x; Hsieh YHP, 1998, J FOOD QUALITY, V21, P1, DOI 10.1111/j.1745-4557.1998.tb00499.x; HSIEH YHP, 1995, J FOOD QUALITY, V18, P131, DOI 10.1111/j.1745-4557.1995.tb00368.x; HURRY GD, 2008, REPORT INDEPENDENT R; *INT GAM FISH ASS, 2006, WORLD REC GAM FISH; ISSENBERG S, 2007, SUSHI EC GLOBALIZATI; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitagawa T, 2007, FISH OCEANOGR, V16, P409, DOI 10.1111/j.1365-2419.2007.00441.x; Kochzius M, 2008, MAR BIOTECHNOL, V10, P207, DOI 10.1007/s10126-007-9068-3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lipp EK, 1997, REV SCI TECH OIE, V16, P620, DOI 10.20506/rst.16.2.1048; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Logan CA, 2008, BIOL CONSERV, V141, P1591, DOI 10.1016/j.biocon.2008.04.007; Majkowski J., 2007, FAO FISH TECH PAP, V483, P1; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Mayr E., 1982, GROWTH BIOL THOUGHT; MEDITERRANEAN WWF, 2008, LIFTING LID ITALYS B; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; *MONT BAY AQ, 2008, SUSH GUID; MORENO JIL, 2005, STATUS TUNA STOCKS W, P58; Nakagawa R, 1997, CHEMOSPHERE, V35, P2909, DOI 10.1016/S0045-6535(97)00351-2; OSHIMA T, 1987, PARASITOL TODAY, V3, P44, DOI 10.1016/0169-4758(87)90212-2; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Paine MA, 2007, B MAR SCI, V80, P353; POLACHECK T, 2007, IMPLICATIONS JAPANES, P16; Porch CE, 2005, B MAR SCI, V76, P363; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; PUNT A, 1996, THUNNUS MACCOYII; QUAMMEN D, 2000, BOILERPLATE RHINO NA; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; SAFINA C, 1993, CONSERV BIOL, V7, P229, DOI 10.1046/j.1523-1739.1993.07020229.x; SAFINA C, 1998, SONG BLUE OCEAN ENCO; SAFINA C, 2001, TUNA PHYSL ECOLOGY E, P413; Safina C, 2008, CONSERV BIOL, V22, P243, DOI 10.1111/j.1523-1739.2008.00901.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SCHWARTZ J, 2008, NY TIMES        0822; SHADBOLT C, 2002, COMMUNICABLE DIS INT, V26, P3; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; SOUTHERLAND B, 2008, NEWSWEEK        0707; Takezaki N, 1998, MOL BIOL EVOL, V15, P727, DOI 10.1093/oxfordjournals.molbev.a025976; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teisl MF, 2002, J ENVIRON ECON MANAG, V43, P339, DOI 10.1006/jeem.2000.1186; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; WALT V, 2008, TIME            1128; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARDLE CS, 1989, J FISH BIOL, V35, P129, DOI 10.1111/j.1095-8649.1989.tb03399.x; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; *WWF, 2008, 1000 JOIN BLUEF TUN; *WWF, 2008, TUN COMM COM DISG NO; Yancy HF, 2008, J FOOD PROTECT, V71, P210, DOI 10.4315/0362-028X-71.1.210; 2008, ECONOMIST       1127; 2008, TELEGRAPH       0926	117	124	135	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7866	10.1371/journal.pone.0007866	http://dx.doi.org/10.1371/journal.pone.0007866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924239	Green Published, gold			2022-12-27	WOS:000271936700009
J	Robert, G; Ben Sahra, I; Puissant, A; Colosetti, P; Belhacene, N; Gounon, P; Hofman, P; Bost, F; Cassuto, JP; Auberger, P				Robert, Guillaume; Ben Sahra, Issam; Puissant, Alexandre; Colosetti, Pascal; Belhacene, Nathalie; Gounon, Pierre; Hofman, Paul; Bost, Frederic; Cassuto, Jill-Patrice; Auberger, Patrick			Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ABL TYROSINE KINASE; BCR-ABL; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; MYELOID-LEUKEMIA; BLAST-CRISIS; STEM-CELLS; IN-VITRO; APOPTOSIS	CML is an hematopoietic stem cell disease characterized by the t(9;22) (q34;q11) translocation encoding the oncoprotein p210BCR-ABL. The effect of acadesine (AICAR, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) a compound with known antileukemic effect on B cell chronic lymphoblastic leukemia (B-CLL) was investigated in different CML cell lines. Acadesine triggered loss of cell metabolism in K562, LAMA-84 and JURL-MK1 and was also effective in killing imatinib-resistant K562 cells and Ba/F3 cells carrying the T315I-BCR-ABL mutation. The anti-leukemic effect of acadesine did not involve apoptosis but required rather induction of autophagic cell death. AMPK knock-down by Sh-RNA failed to prevent the effect of acadesine, indicating an AMPK-independent mechanism. The effect of acadesine was abrogated by GF109203X and Ro-32-0432, both inhibitor of classical and new PKCs and accordingly, acadesine triggered relocation and activation of several PKC isoforms in K562 cells. In addition, this compound exhibited a potent anti-leukemic effect in clonogenic assays of CML cells in methyl cellulose and in a xenograft model of K562 cells in nude mice. In conclusion, our work identifies an original and unexpected mechanism by which acadesine triggers autophagic cell death through PKC activation. Therefore, in addition to its promising effects in B-CLL, acadesine might also be beneficial for Imatinib-resistant CML patients.			Robert, G (corresponding author), Fac Med Nice, INSERM, UMR 895, Team Cell Death Differentiat & Canc 2, U210, F-06034 Nice, France.	auberger@unice.fr	Hofman, Paul/P-7654-2018; robert, guillaume/O-1935-2017; AUBERGER, Patrick/G-1491-2013; BOST, Frederic/AAN-4691-2020; Colosetti, Pascal/ABH-4585-2020; Puissant, Alexandre/AAF-3875-2021; PUISSANT, ALEXANDRE/O-9575-2016	Hofman, Paul/0000-0003-0431-9353; robert, guillaume/0000-0002-6350-2222; AUBERGER, Patrick/0000-0002-2481-8275; BOST, Frederic/0000-0003-4509-4701; Puissant, Alexandre/0000-0002-3997-9282; PUISSANT, ALEXANDRE/0000-0002-3997-9282				Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Campas C, 2005, LEUKEMIA, V19, P292, DOI 10.1038/sj.leu.2403593; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Dan S, 1998, CELL DEATH DIFFER, V5, P710, DOI 10.1038/sj.cdd.4400400; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Galluzzi L, 2008, CURR MOL MED, V8, P78; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Herrant M, 2002, ONCOGENE, V21, P4957, DOI 10.1038/sj.onc.1205689; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacquel A, 2007, ONCOGENE, V26, P2445, DOI 10.1038/sj.onc.1210034; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim YM, 2007, ANN NY ACAD SCI, V1095, P496, DOI 10.1196/annals.1397.053; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Larocca MC, 2002, CELL SIGNAL, V14, P641, DOI 10.1016/S0898-6568(02)00003-7; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mari B, 1997, FASEB J, V11, P869, DOI 10.1096/fasebj.11.11.9285485; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ren RB, 2002, ONCOGENE, V21, P8629, DOI 10.1038/sj.onc.1206090; Schaefer M, 2001, FASEB J, V15, P1634, DOI 10.1096/fj.00-0824fje; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tanimura A, 2002, J BIOL CHEM, V277, P29054, DOI 10.1074/jbc.M201130200; DRUGS R D, V9, P169	45	73	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7889	10.1371/journal.pone.0007889	http://dx.doi.org/10.1371/journal.pone.0007889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924252	Green Submitted, gold, Green Published			2022-12-27	WOS:000271936700021
J	Aranda, P; Agirre, X; Ballestar, E; Andreu, EJ; Roman-Gomez, J; Prieto, I; Martin-Subero, JI; Cigudosa, JC; Siebert, R; Esteller, M; Prosper, F				Aranda, Pablo; Agirre, Xabier; Ballestar, Esteban; Andreu, Enrique J.; Roman-Gomez, Jose; Prieto, Ines; Martin-Subero, Jose Ignacio; Cigudosa, Juan Cruz; Siebert, Reiner; Esteller, Manel; Prosper, Felipe			Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells	PLOS ONE			English	Article							ADULT PROGENITOR CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; GENE-EXPRESSION; DEVELOPMENTAL REGULATORS; ABERRANT METHYLATION; POLYCOMB; PLURIPOTENT; MICRORNA; GENOME				Aranda, P (corresponding author), Univ Navarra, Fdn Appl Med Res, Dept Hematol, Univ Navarra Clin, E-31080 Pamplona, Spain.	fprosper@unav.es	Agirre, Xabier/ABE-4110-2020; Esteller, Manel/L-5956-2014; Cigudosa, Juan C/E-4105-2016; Andreu, Enrique J/F-9813-2016; Prosper, Felipe/H-6859-2017; Ballestar, Esteban/ABG-8561-2020; Siebert, Reiner/A-8049-2010	Esteller, Manel/0000-0003-4490-6093; Andreu, Enrique J/0000-0001-5317-9989; Prosper, Felipe/0000-0001-6115-8790; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Ballestar, Esteban/0000-0002-1400-2440				Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; ROMANGOMEZ J, 2009, J CLIN ONCOL; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	62	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7809	10.1371/journal.pone.0007809	http://dx.doi.org/10.1371/journal.pone.0007809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915669	Green Published, gold			2022-12-27	WOS:000271721900003
J	Antao, EM; Ewers, C; Gurlebeck, D; Preisinger, R; Homeier, T; Li, GW; Wieler, LH				Antao, Esther-Maria; Ewers, Christa; Guerlebeck, Doreen; Preisinger, Rudolf; Homeier, Timo; Li, Ganwu; Wieler, Lothar H.			Signature-Tagged Mutagenesis in a Chicken Infection Model Leads to the Identification of a Novel Avian Pathogenic Escherichia coli Fimbrial Adhesin	PLOS ONE			English	Article							TYPE-1 FIMBRIAE; EXTRAINTESTINAL INFECTIONS; BACTERIAL VIRULENCE; GENETIC-ANALYSIS; GENOME SEQUENCE; URINARY-TRACT; P-FIMBRIAE; STRAINS; APEC; PYELONEPHRITIS	The extraintestinal pathogen, avian pathogenic E. coli (APEC), known to cause systemic infections in chickens, is responsible for large economic losses in the poultry industry worldwide. In order to identify genes involved in the early essential stages of pathogenesis, namely adhesion and colonization, Signature-tagged mutagenesis (STM) was applied to a previously established lung colonization model of infection by generating and screening a total of 1,800 mutants of an APEC strain IMT5155 (O2:K1:H5; Sequence type complex 95). The study led to the identification of new genes of interest, including two adhesins, one of which coded for a novel APEC fimbrial adhesin (Yqi) not described for its role in APEC pathogenesis to date. Its gene product has been temporarily designated ExPEC Adhesin I (EA/I) until the adhesin-specific receptor is identified. Deletion of the ExPEC adhesin I gene resulted in reduced colonization ability by APEC strain IMT5155 both in vitro and in vivo. Furthermore, complementation of the adhesin gene restored its ability to colonize epithelial cells in vitro. The ExPEC adhesin I protein was successfully expressed in vitro. Electron microscopy of an afimbriate strain E. coli AAEC189 overexpressed with the putative EA/I gene cluster revealed short fimbrial-like appendages protruding out of the bacterial outer membrane. We observed that this adhesin coding gene yqi is prevalent among extraintestinal pathogenic E. coli (ExPEC) isolates, including APEC (54.4%), uropathogenic E. coli (UPEC) (65.9%) and newborn meningitic E. coli (NMEC) (60.0%), and absent in all of the 153 intestinal pathogenic E. coli strains tested, thereby validating the designation of the adhesin as ExPEC Adhesin I. In addition, prevalence of EA/I was most frequently associated with the B2 group of the EcoR classification and ST95 complex of the multi locus sequence typing (MLST) scheme, with evidence of a positive selection within this highly pathogenic complex. This is the first report of the newly identified and functionally characterized ExPEC adhesin I and its significant role during APEC infection in chickens.			Antao, EM (corresponding author), Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-1000 Berlin, Germany.	antao.em@vetmed.fu-berlin.de	Ewers, Christa/AAL-9186-2020; Li, Ganwu/AAC-7423-2020	Wieler, Lothar H./0000-0003-4365-3717; Ewers, Christa/0000-0001-6167-1340				Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; CHANTELOUP NK, 1991, MICROB PATHOGENESIS, V10, P271, DOI 10.1016/0882-4010(91)90011-X; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chiang SL, 1999, ANNU REV MICROBIOL, V53, P129, DOI 10.1146/annurev.micro.53.1.129; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dho-Moulin M, 1999, VET RES, V30, P299; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; FANTINATTI F, 1994, VET MICROBIOL, V41, P75, DOI 10.1016/0378-1135(94)90137-6; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; HANSON MS, 1988, NATURE, V332, P265, DOI 10.1038/332265a0; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Janssen T, 2001, INT J MED MICROBIOL, V291, P371, DOI 10.1078/1438-4221-00143; Johnson J, 2003, J CLIN MICROBIOL, V41, P5798, DOI 10.1128/JCM.41.12.5798-5802.2003; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; JONES CH, 1992, INFECT IMMUN, V60, P4445, DOI 10.1128/IAI.60.11.4445-4451.1992; KAADEN OR, 1982, IN VITRO CELL DEV B, V18, P827, DOI 10.1007/BF02796323; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Li G, 2008, MICROBIOL-SGM, V154, P1082, DOI 10.1099/mic.0.2007/015784-0; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martindale J, 2000, MOL MICROBIOL, V37, P1293, DOI 10.1046/j.1365-2958.2000.02088.x; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; MORDHORST IL, 2009, ENV MICROBIOL; MURILLO J, 1994, PLASMID, V31, P275, DOI 10.1006/plas.1994.1029; PECHA B, 1989, J CLIN INVEST, V83, P2102, DOI 10.1172/JCI114123; Pourbakhsh SA, 1997, MICROB PATHOGENESIS, V22, P331, DOI 10.1006/mpat.1996.0116; ROBERTS JA, 1984, J UROLOGY, V131, P602, DOI 10.1016/S0022-5347(17)50513-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wizemann TM, 1999, EMERG INFECT DIS, V5, P395, DOI 10.3201/eid0503.990310; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75	45	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7796	10.1371/journal.pone.0007796	http://dx.doi.org/10.1371/journal.pone.0007796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907658	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721400004
J	Lund, TC; Glass, TJ; Tolar, J; Blazar, BR				Lund, Troy C.; Glass, Tiffany J.; Tolar, Jakub; Blazar, Bruce R.			Expression of Telomerase and Telomere Length Are Unaffected by either Age or Limb Regeneration in Danio rerio	PLOS ONE			English	Article							GRADUAL SENESCENCE; ZEBRAFISH; CANCER; HAPLOINSUFFICIENCY; BIOLOGY; CELLS	Background: The zebrafish is an increasingly popular model for studying many aspects of biology. Recently, ztert, the zebrafish homolog of the mammalian telomerase gene has been cloned and sequenced. In contrast to humans, it has been shown that the zebrafish maintains telomerase activity for much of its adult life and has remarkable regenerative capacity. To date, there has been no longitudinal study to assess whether this retention of telomerase activity equates to the retention of chromosome telomere length through adulthood. Methodology/Principal Findings: We have systematically analyzed individual organs of zebrafish with regard to both telomere length and telomerase activity at various time points in its adult life. Heart, gills, kidney, spleen, liver, and intestine were evaluated at 3 months, 6 months, 9 months, and 2 years of age by Southern blot analysis. We found that telomeres do not appreciably shorten throughout the lifespan of the zebrafish in any organ. In addition, there was little difference in telomere lengths between organs. Even when cells were under the highest pressure to divide after fin-clipping experiments, telomere length was unaffected. All aged ( 2 year old) tissues examined also expressed active amounts of telomerase activity as assessed by TRAP assay. Conclusions/Significance: In contrast to several other species including humans, the retention of lifelong telomerase and telomeres, as we have reported here, would be necessary in the zebrafish to maintain its tremendous regenerative capacity. The ongoing study of the zebrafish's ability to maintain telomerase activity may be helpful in unraveling the complexity involved in the maintenance ( or lack thereof) of telomeres in other species such the mouse or human.			Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Tolar, Jakub/0000-0002-0957-4380				Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2; KIPLING D, 1992, HUM MOL GENET, V1, P3, DOI 10.1093/hmg/1.1.3-a; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Lau BWM, 2008, J MOL NEUROSCI, V34, P63, DOI 10.1007/s12031-007-0072-x; Major Robert J, 2007, Drug Discov Today Dis Models, V4, P219, DOI 10.1016/j.ddmod.2007.09.002; McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349; Meyerson M, 2000, J CLIN ONCOL, V18, P2626, DOI 10.1200/JCO.2000.18.13.2626; Modino S, 2002, INT J RADIAT BIOL, V78, P757, DOI 10.1080/09553000210146563; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769	23	50	51	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7688	10.1371/journal.pone.0007688	http://dx.doi.org/10.1371/journal.pone.0007688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893630	Green Published, gold, Green Submitted			2022-12-27	WOS:000271478000001
J	Xia, YL; Yamaoka, Y; Zhu, Q; Matha, I; Gao, XL				Xia, Youlin; Yamaoka, Yoshio; Zhu, Qi; Matha, Ivan; Gao, Xiaolian			A Comprehensive Sequence and Disease Correlation Analyses for the C-Terminal Region of CagA Protein of Helicobacter pylori	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; VIRULENCE FACTOR CAGA; TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; BIOLOGICAL-ACTIVITY; DISTINCT DIVERSITY; GENE; STRAINS; ANTIGEN; CANCER	Chronic Helicobacter pylori infection is known to be associated with the development of peptic ulcer, gastric cancer and gastric lymphoma. Currently, the bacterial factors of H. pylori are reported to be important in the development of gastroduodenal diseases. CagA protein, encoded by the cagA, is the best studied virulence factor of H. pylori. The pathogenic CagA protein contains a highly polymorphic Glu-Pro-Ile-Tyr-Ala (EPIYA) repeat region in the C-terminal. This repeat region is reported to be involved in the pathogenesis of gastroduodenal diseases. The segments containing EPIYA motifs have been designated as segments A, B, C, and D; however the classification and disease relation are still unclear. This study used 560 unique CagA sequences containing 1,796 EPIYA motifs collected from public resources, including 274 Western and 286 East Asian strains with clinical data obtained from 433 entries. Fifteen types of EPIYA or EPIYA-like sequences are defined. In addition to four previously reported major segment types, several minor segment types ( e. g., segment B', B '') and more than 30 sequence types (e.g., ABC, ABD) were defined using our classification method. We confirm that the sequences from Western and East Asian strains contain segment C and D, respectively. We also confirm that strains with two EPIYA segment C have a greater chance of developing gastric cancer than those with one segment C. Our results shed light on the relationships between the types of CagAs, the country of origin of each sequence type, and the frequency of gastric disease.			Xia, YL (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	yyamaoka@bcm.tmc.edu; xgao@uh.edu		Yamaoka, Yoshio/0000-0002-1222-5819	NIDDK NIH HHS [R01 DK062813-05, R01 DK62813, R01 DK062813] Funding Source: Medline; NIGMS NIH HHS [R42 GM067364] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R42GM067364] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Argent RH, 2008, J MED MICROBIOL, V57, P1062, DOI 10.1099/jmm.0.2008/001818-0; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Azuma T, 2004, J CLIN MICROBIOL, V42, P2508, DOI 10.1128/JCM.42.6.2508-2517.2004; Azuma T, 2002, J INFECT DIS, V186, P1621, DOI 10.1086/345374; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Ferreira AC, 2008, HELICOBACTER, V13, P28, DOI 10.1111/j.1523-5378.2008.00633.x; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hoshino FB, 2000, J GASTROENTEROL, V35, P890, DOI 10.1007/s005350070002; Jenks PJ, 1998, GUT, V43, P752, DOI 10.1136/gut.43.6.752; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Rota CA, 2001, J CLIN MICROBIOL, V39, P606, DOI 10.1128/JCM.39.2.606-612.2001; Satomi S, 2006, J GASTROENTEROL, V41, P668, DOI 10.1007/s00535-006-1838-6; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Snider Jared L, 2009, J Carcinog, V8, P7, DOI 10.4103/1477-3163.50892; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; UMEDA M, 2009, J BIOL CHEM     0622; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Zhou JC, 2004, J MED MICROBIOL, V53, P231, DOI 10.1099/jmm.0.05366-0	55	82	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7736	10.1371/journal.pone.0007736	http://dx.doi.org/10.1371/journal.pone.0007736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893742	Green Published, Green Submitted, gold			2022-12-27	WOS:000271478000011
J	Bischoff, K; Ballew, AC; Simon, MA; O'Reilly, AM				Bischoff, Kara; Ballew, Anna C.; Simon, Michael A.; O'Reilly, Alana M.			Wing Defects in Drosophila xenicid Mutant Clones Are Caused by C-Terminal Deletion of Additional Sex Combs (Asx)	PLOS ONE			English	Article							POLYCOMB GROUP GENES; BITHORAX COMPLEX; ENGRAILED EXPRESSION; PS INTEGRINS; CONTRABITHORAX MUTATIONS; SIGNALING PATHWAY; GENOME PROJECT; HOMEOTIC LOCI; MELANOGASTER; MORPHOGENESIS	Background: The coordinated action of genes that control patterning, cell fate determination, cell size, and cell adhesion is required for proper wing formation in Drosophila. Defects in any of these basic processes can lead to wing aberrations, including blisters. The xenicid mutation was originally identified in a screen designed to uncover regulators of adhesion between wing surfaces [1]. Principal Findings: Here, we demonstrate that expression of the beta PS integrin or the patterning protein Engrailed are not affected in developing wing imaginal discs in xenicid mutants. Instead, expression of the homeotic protein Ultrabithorax (Ubx) is strongly increased in xenicid mutant cells. Conclusion: Our results suggest that upregulation of Ubx transforms cells from a wing blade fate to a haltere fate, and that the presence of haltere cells within the wing blade is the primary defect leading to the adult wing phenotypes observed.	[Bischoff, Kara; Ballew, Anna C.; Simon, Michael A.; O'Reilly, Alana M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [O'Reilly, Alana M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Stanford University; Fox Chase Cancer Center	Bischoff, K (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	Alana.OReilly@fccc.edu			NIH R01; Ruth L. Kirschstein NRSA; Stanford University Undergraduate Research	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University Undergraduate Research(Stanford University)	This study was supported by an NIH R01 (MAS), a Ruth L. Kirschstein NRSA (AOR) and a Stanford University Undergraduate Research Programs (URO) grant (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Brabant MC, 1996, DEVELOPMENT, V122, P3307; BREEN TR, 1995, MECH DEVELOP, V52, P89, DOI 10.1016/0925-4773(95)00393-F; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; BUNCH TA, 1992, DEVELOPMENT, V116, P239; BUSTURIA A, 1988, DEVELOPMENT, V104, P713; CASANOVA J, 1985, CELL, V42, P663, DOI 10.1016/0092-8674(85)90123-0; Casares F, 2000, DEVELOPMENT, V127, P1499; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; FRISTROM D, 1993, DEVELOPMENT, V117, P509; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Fristrom DF, 1993, METAMORPHIC DEV ADUL; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; GONZALEZGAITAN MA, 1990, GENETICS, V126, P139; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; KERRIDGE S, 1982, J EMBRYOL EXP MORPH, V68, P211; Lewis E B, 1982, Prog Clin Biol Res, V85 Pt A, P269; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; LEWIS EB, 1963, AM ZOOL, V3, P33; MCKEON J, 1994, MOL GEN GENET, V244, P474, DOI 10.1007/BF00583898; MCKEON J, 1991, ROUX ARCH DEV BIOL, V199, P387, DOI 10.1007/BF01705848; MICOL JL, 1988, P NATL ACAD SCI USA, V85, P1146, DOI 10.1073/pnas.85.4.1146; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; MOAZED D, 1992, DEVELOPMENT, V116, P805; Montagne J, 1996, DEVELOPMENT, V122, P2589; MORATA G, 1981, NATURE, V290, P778, DOI 10.1038/290778a0; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Muller M, 1999, GENETICS, V153, P1333; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Petruk S, 2008, DEVELOPMENT, V135, P2383, DOI 10.1242/dev.023275; Prout M, 1997, GENETICS, V146, P275; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Roch F, 2000, DEVELOPMENT, V127, P97; SIMON J, 1992, DEVELOPMENT, V114, P493; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; Steinberg AG, 1944, P NATL ACAD SCI USA, V30, P5, DOI 10.1073/pnas.30.1.5; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Walsh EP, 1998, GENETICS, V150, P791; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WILCOX M, 1989, DEVELOPMENT, V107, P891; Wolpert L., 1998, PRINCIPLES DEV; ZIMM GG, 1951, J EXP ZOOL, V116, P289, DOI 10.1002/jez.1401160205; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	58	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8106	10.1371/journal.pone.0008106	http://dx.doi.org/10.1371/journal.pone.0008106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956620	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700017
J	Leite, NR; Krogh, R; Xu, W; Ishida, Y; Iulek, J; Leal, WS; Oliva, G				Leite, Ney Ribeiro; Krogh, Renata; Xu, Wei; Ishida, Yuko; Iulek, Jorge; Leal, Walter S.; Oliva, Glaucius			Structure of an Odorant-Binding Protein from the Mosquito Aedes aegypti Suggests a Binding Pocket Covered by a pH-Sensitive "Lid"	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; APIS-MELLIFERA L; PHEROMONE-BINDING; BOMBYX-MORI; NMR STRUCTURE; OLFACTORY PROTEINS; ANOPHELES-GAMBIAE; CRYSTAL-STRUCTURE; LIGAND RELEASE; MOTH	Background: The yellow fever mosquito, Aedes aegypti, is the primary vector for the viruses that cause yellow fever, mostly in tropical regions of Africa and in parts of South America, and human dengue, which infects 100 million people yearly in the tropics and subtropics. A better understanding of the structural biology of olfactory proteins may pave the way for the development of environmentally-friendly mosquito attractants and repellents, which may ultimately contribute to reduction of mosquito biting and disease transmission. Methodology: Previously, we isolated and cloned a major, female-enriched odorant-binding protein (OBP) from the yellow fever mosquito, AaegOBP1, which was later inadvertently renamed AaegOBP39. We prepared recombinant samples of AaegOBP1 by using an expression system that allows proper formation of disulfide bridges and generates functional OBPs, which are indistinguishable from native OBPs. We crystallized AaegOBP1 and determined its three-dimensional structure at 1.85 angstrom resolution by molecular replacement based on the structure of the malaria mosquito OBP, AgamOBP1, the only mosquito OBP structure known to date. Conclusion: The structure of AaegOBP1 (= AaegOBP39) shares the common fold of insect OBPs with six alpha-helices knitted by three disulfide bonds. A long molecule of polyethylene glycol (PEG) was built into the electron-density maps identified in a long tunnel formed by a crystallographic dimer of AaegOBP1. Circular dichroism analysis indicated that delipidated AaegOBP1 undergoes a pH-dependent conformational change, which may lead to release of odorant at low pH (as in the environment in the vicinity of odorant receptors). A C-terminal loop covers the binding cavity and this "lid" may be opened by disruption of an array of acid-labile hydrogen bonds thus explaining reduced or no binding affinity at low pH.	[Leite, Ney Ribeiro; Krogh, Renata; Oliva, Glaucius] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil; [Xu, Wei; Ishida, Yuko; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Iulek, Jorge] Univ Estadual Ponta Grossa, Dept Quim, Ponta Grossa, Parana, Brazil	Universidade de Sao Paulo; University of California System; University of California Davis; Universidade Estadual de Ponta Grossa	Leite, NR (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil.	wsleal@ucdavis.edu	4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Iulek, Jorge/G-4356-2019; Xu, Wei/G-4709-2010; Leal, Walter/ABC-6940-2021; Oliva, Glaucius/B-9059-2012	Iulek, Jorge/0000-0002-2293-4950; Oliva, Glaucius/0000-0003-2719-0302; Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	National Science Foundation [0918177]; National Institutes of Health NIAID; Brazilian National Institutes of Science and Technology;  [573607/2008-7];  [08/57910-0]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian National Institutes of Science and Technology; ; 	This work was supported in part by the National Science Foundation (0918177 to W. S. L), the National Institutes of Health NIAID (to W. S. L.), and by the Brazilian National Institutes of Science and Technology (INCT, a consortium of CNPq, FAPESP, and the Ministry of Health, 573607/2008-7 and 08/57910-0 to G. O.), but the funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEIL TA, 1987, ANN NY ACAD SCI, V510, P403; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; KRISSINEL E, 2007, PISA SERVER; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, ACTA CRYSTALLOGR D, V59, P919, DOI 10.1107/S090744490300413X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Leal WS, 2007, INSECT REPELLENTS PR, P229; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mohanty S, 2004, J MOL BIOL, V338, P1037, DOI 10.1016/j.jmb.2004.03.052; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2008, INSECT MOL BIOL, V17, P445	43	91	97	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8006	10.1371/journal.pone.0008006	http://dx.doi.org/10.1371/journal.pone.0008006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956631	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100003
J	Stefflova, K; Dulik, MC; Pai, AA; Walker, AH; Zeigler-Johnson, CM; Gueye, SM; Schurr, TG; Rebbeck, TR				Stefflova, Klara; Dulik, Matthew C.; Pai, Athma A.; Walker, Amy H.; Zeigler-Johnson, Charnita M.; Gueye, Serigne M.; Schurr, Theodore G.; Rebbeck, Timothy R.			Evaluation of Group Genetic Ancestry of Populations from Philadelphia and Dakar in the Context of Sex-Biased Admixture in the Americas	PLOS ONE			English	Article							SUB-SAHARAN POPULATIONS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; BRAZILIAN POPULATIONS; PARENTAL POPULATIONS; HUMAN MIGRATIONS; CONTROL REGION; UNITED-STATES; MALE LINEAGES; NEAR-EASTERN	Background: Population history can be reflected in group genetic ancestry, where genomic variation captured by the mitochondrial DNA (mtDNA) and non-recombining portion of the Y chromosome (NRY) can separate female-and male-specific admixture processes. Genetic ancestry may influence genetic association studies due to differences in individual admixture within recently admixed populations like African Americans. Principal Findings: We evaluated the genetic ancestry of Senegalese as well as European Americans and African Americans from Philadelphia. Senegalese mtDNA consisted of similar to 12% U haplotypes (U6 and U5b1b haplotypes, common in North Africa) while the NRY haplotypes belonged solely to haplogroup E. In Philadelphia, we observed varying degrees of admixture. While African Americans have 9-10% mtDNAs and similar to 31% NRYs of European origin, these results are not mirrored in the mtDNA/NRY pools of European Americans: they have less than 7% mtDNAs and less than 2% NRYs from non-European sources. Additionally, there is < 2% Native American contribution to Philadelphian African American ancestry and the admixture from combined mtDNA/NRY estimates is consistent with the admixture derived from autosomal genetic data. To further dissect these estimates, we have analyzed our samples in the context of different demographic groups in the Americas. Conclusions: We found that sex-biased admixture in African-derived populations is present throughout the Americas, with continual influence of European males, while Native American females contribute mainly to populations of the Caribbean and South America. The high non-European female contribution to the pool of European-derived populations is consistently characteristic of Iberian colonization. These data suggest that genomic data correlate well with historical records of colonization in the Americas.	[Stefflova, Klara; Walker, Amy H.; Zeigler-Johnson, Charnita M.; Rebbeck, Timothy R.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Dulik, Matthew C.; Pai, Athma A.; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Gueye, Serigne M.] Hop Gen Grand Yoff, Dakar, Senegal; [Gueye, Serigne M.] Univ Cheikh Anta Diop, Dakar, Senegal; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University Cheikh Anta Diop Dakar; University of Pennsylvania; Pennsylvania Medicine	Stefflova, K (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	Klara.Stefflova@cancer.org.uk	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900; Pai, Athma/0000-0002-7995-9948; Zeigler-Johnson, Charnita/0000-0003-2641-7755; Barsi, Klara/0000-0001-9338-0468	Public Health Service [R29-ES08031, R01-CA85074, P50-CA105641]; Penn; NATIONAL CANCER INSTITUTE [R01CA085074, P50CA105641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Penn; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from the Public Health Service (R29-ES08031, R01-CA85074, and P50-CA105641) to TRR and Faculty Research Funds from Penn to TGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Allard MW, 2005, FORENSIC SCI INT, V148, P169, DOI 10.1016/j.forsciint.2004.06.001; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Bortolini MC, 1997, HUM BIOL, V69, P141; Brion M, 2005, ELECTROPHORESIS, V26, P4411, DOI 10.1002/elps.200500293; Ribeiro-dos-Santos AKC, 2007, FORENSIC SCI INT, V167, P77, DOI 10.1016/j.forsciint.2005.12.033; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Goncalves VF, 2007, GENET MOL RES, V6, P256; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hammer MF, 2006, FORENSIC SCI INT, V164, P45, DOI 10.1016/j.forsciint.2005.11.013; Hunemeier T, 2007, AM J PHYS ANTHROPOL, V133, P854, DOI 10.1002/ajpa.20604; Jackson BA, 2005, AM J PHYS ANTHROPOL, V128, P156, DOI 10.1002/ajpa.20040; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rawley J, 2005, TRANSATLANTIC SLAVE; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosa A, 2004, ANN HUM GENET, V68, P340, DOI 10.1046/j.1529-8817.2004.00100.x; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; SLATKIN M, 1995, GENETICS, V139, P457; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Walker AH, 1999, ENVIRON HEALTH PERSP, V107, P517, DOI 10.2307/3434392; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7842	10.1371/journal.pone.0007842	http://dx.doi.org/10.1371/journal.pone.0007842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MK	19946364	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827800005
J	Bangirana, P; John, CC; Idro, R; Opoka, RO; Byarugaba, J; Jurek, AM; Boivin, MJ				Bangirana, Paul; John, Chandy C.; Idro, Richard; Opoka, Robert O.; Byarugaba, Justus; Jurek, Anne M.; Boivin, Michael J.			Socioeconomic Predictors of Cognition in Ugandan Children: Implications for Community Interventions	PLOS ONE			English	Article							CEREBRAL MALARIA; DEVELOPING-COUNTRIES; HOME-ENVIRONMENT; KENYAN CHILDREN; WORKING-MEMORY; ABILITY; AGE; HIPPOCAMPAL; IMPAIRMENT; STRATEGIES	Background: Several interventions to improve cognition in at risk children have been suggested. Identification of key variables predicting cognition is necessary to guide these interventions. This study was conducted to identify these variables in Ugandan children and guide such interventions. Methods: A cohort of 89 healthy children (45 females) aged 5 to 12 years old were followed over 24 months and had cognitive tests measuring visual spatial processing, memory, attention and spatial learning administered at baseline, 6 months and 24 months. Nutritional status, child's educational level, maternal education, socioeconomic status and quality of the home environment were also measured at baseline. A multivariate, longitudinal model was then used to identify predictors of cognition over the 24 months. Results: A higher child's education level was associated with better memory (p = 0.03), attention (p = 0.005) and spatial learning scores over the 24 months (p = 0.05); higher nutrition scores predicted better visual spatial processing (p = 0.002) and spatial learning scores (p = 0.008); and a higher home environment score predicted a better memory score (p = 0.03). Conclusion: Cognition in Ugandan children is predicted by child's education, nutritional status and the home environment. Community interventions to improve cognition may be effective if they target multiple socioeconomic variables.			Bangirana, P (corresponding author), Makerere Univ, Sch Med, Dept Psychiat, Kampala, Uganda.	pbangirana@yahoo.com	John, Chandy/GNP-8431-2022; , Ridro/ABD-3556-2020	John, Chandy/0000-0002-1634-1411; Bangirana, Paul/0000-0002-7136-0594; Idro, Richard/0000-0003-4728-4605	FOGARTY INTERNATIONAL CENTER [R21TW006794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055349] Funding Source: NIH RePORTER; FIC NIH HHS [R21 TW006794] Funding Source: Medline; NINDS NIH HHS [R01 NS055349, 5R01NS055349] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abubakar A, 2008, EARLY HUM DEV, V84, P613, DOI 10.1016/j.earlhumdev.2008.02.003; Balding DJ, 2004, APPL LONGITUDINAL AN; Bangirana P, 2006, TROP MED INT HEALTH, V11, P1341, DOI 10.1111/j.1365-3156.2006.01685.x; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; BOIVIN MJ, 1995, NEUROPSYCHOLOGY, V9, P409, DOI 10.1037/0894-4105.9.3.409; Boivin MJ, 1996, J PSYCHOL, V130, P95, DOI 10.1080/00223980.1996.9914992; Boivin MJ, 1996, NEUROPSYCHOLOGY, V10, P588; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Caldwell B. M., 2001, HOME INVENTORY ADM M; Dupuy TR, 2005, TOVA MANUAL IBM PERS; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fernstrom JD, 2000, AM J CLIN NUTR, V71, p1669S, DOI 10.1093/ajcn/71.6.1669S; Giordani B, 1996, INT J DISABIL DEV ED, V43, P5, DOI DOI 10.1080/0156655960430102; Gottfried AE, 1998, CHILD DEV, V69, P1448, DOI 10.2307/1132277; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; IRWIN BD, 1994, LIFESPAN DEV PSYCHOL; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klein PS, 2004, INFANT YOUNG CHILD, V17, P340, DOI 10.1097/00001163-200410000-00007; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Kolb B, 2003, NEUROBIOL LEARN MEM, V79, P1, DOI 10.1016/S1074-7427(02)00021-7; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Molfese VJ, 2003, J LEARN DISABIL-US, V36, P59, DOI 10.1177/00222194030360010701; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Raine A, 2001, PSYCHOPHYSIOLOGY, V38, P254, DOI 10.1111/1469-8986.3820254; Reitan RM, 1974, CLIN NEUROPSYCHOLOGY; RICHTER LM, 1991, INF MENTAL HLTH J, V12, P88, DOI 10.1002/1097-0355(199122)12:2<88::AID-IMHJ2280120202>3.0.CO;2-Q; SCARR S, 1985, AM PSYCHOL, V40, P499; SIGMAN M, 1989, CHILD DEV, V60, P1463, DOI 10.2307/1130935; Sternberg R. J., 2002, DYNAMIC TESTING NATU; Sternberg RJ, 2004, AM PSYCHOL, V59, P325, DOI 10.1037/0003-066X.59.5.325; Thompson RJ, 1998, CHILD HEALTH CARE, V27, P1, DOI 10.1207/s15326888chc2701_1; *UCLA AC TECHN SER, DO I INT REGR MOD SO; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wamani H., 2004, INT J EQUITY HEALTH, V3, P1, DOI [10.1186/1475-9276-3-9/TABLES/2, DOI 10.1186/1475-9276-3-9/TABLES/2, 10.1186/1475-9276-3-9, DOI 10.1186/1475-9276-3-9]; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S	41	67	67	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7898	10.1371/journal.pone.0007898	http://dx.doi.org/10.1371/journal.pone.0007898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NJ	19936066	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004600004
J	Bomphrey, RJ; Walker, SM; Taylor, GK				Bomphrey, Richard J.; Walker, Simon M.; Taylor, Graham K.			The Typical Flight Performance of Blowflies: Measuring the Normal Performance Envelope of Calliphora vicina Using a Novel Corner-Cube Arena	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; VISUAL CONTROL; INTERCEPTION; HONEYBEES; BEHAVIOR; PURSUIT; FLY	Despite a wealth of evidence demonstrating extraordinary maximal performance, little is known about the routine flight performance of insects. We present a set of techniques for benchmarking performance characteristics of insects in free flight, demonstrated using a model species, and comment on the significance of the performance observed. Free-flying blowflies (Calliphora vicina) were filmed inside a novel mirrored arena comprising a large (1.6 m x 1.6 m x 1.6 m) corner-cube reflector using a single high-speed digital video camera (250 or 500 fps). This arrangement permitted accurate reconstruction of the flies' 3-dimensional trajectories without the need for synchronisation hardware, by virtue of the multiple reflections of a subject within the arena. Image sequences were analysed using custom-written automated tracking software, and processed using a self-calibrating bundle adjustment procedure to determine the subject's instantaneous 3-dimensional position. We illustrate our method by using these trajectory data to benchmark the routine flight performance envelope of our flies. Flight speeds were most commonly observed between 1.2 ms(-1) and 2.3 ms(-1), with a maximum of 2.5 ms(-1). Our flies tended to dive faster than they climbed, with a maximum descent rate (22.4 ms(-1)) almost double the maximum climb rate (1.2 ms(-1)). Modal turn rate was around 240 degrees s(-1), with maximal rates in excess of 1700 degrees s(-1). We used the maximal flight performance we observed during normal flight to construct notional physical limits on the blowfly flight envelope, and used the distribution of observations within that notional envelope to postulate behavioural preferences or physiological and anatomical constraints. The flight trajectories we recorded were never steady: rather they were constantly accelerating or decelerating, with maximum tangential accelerations and maximum centripetal accelerations on the order of 3 g.			Bomphrey, RJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	graham.taylor@zoo.ox.ac.uk	Taylor, Graham/A-5041-2010; Bomphrey, Richard/I-6272-2013	Bomphrey, Richard/0000-0002-4748-0510	EPSRC [EP/H004025/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004025/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBC5185731, BB/C518573/1] Funding Source: Medline; European Research Council [204513] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission)		Challis JH, 1999, J APPL BIOMECH, V15, P303, DOI 10.1123/jab.15.3.303; COLLETT TS, 1978, J COMP PHYSIOL, V125, P191, DOI 10.1007/BF00656597; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; COOPER M, 2003, CLOSE RANGE PHOTOGRA, P9; DAHMEN HJ, 1984, PROC R SOC SER B-BIO, V222, P107, DOI 10.1098/rspb.1984.0051; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; LAND MF, 1993, J COMP PHYSIOL A, V173, P595; LYNN P, 2000, INTRO SIGNAL PROCESS; Muller P, 2001, J EXP BIOL, V204, P1039; NACHTIGALL W, 1983, J COMP PHYSIOL, V150, P251, DOI 10.1007/BF00606375; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 2003, P ROY SOC B-BIOL SCI, V270, P2421, DOI 10.1098/rspb.2003.2542; Schilstra C, 1999, J EXP BIOL, V202, P1481; SCHILSTRA C, 1999, INSECT FLIGHT EYE MO; Taylor GK, 2003, J EXP BIOL, V206, P2803, DOI 10.1242/jeb.00501; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; WILKERSON RC, 1984, ANN ENTOMOL SOC AM, V77, P293, DOI 10.1093/aesa/77.3.293	20	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7852	10.1371/journal.pone.0007852	http://dx.doi.org/10.1371/journal.pone.0007852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924228	Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700007
J	Dasgupta, N; Mandl, KD; Brownstein, JS				Dasgupta, Nabarun; Mandl, Kenneth D.; Brownstein, John S.			Breaking the News or Fueling the Epidemic? Temporal Association between News Media Report Volume and Opioid-Related Mortality	PLOS ONE			English	Article							ILLICIT DRUGS; PRINT MEDIA; COVERAGE; SURVEILLANCE; CONSTRUCTION; BEHAVIOR; DEATHS; IMPACT	Background: Historical studies of news media have suggested an association between reporting and increased drug abuse. Period effects for substance use have been documented for different classes of legal and illicit substances, with the suspicion that media publicity may have played major roles in their emergence. Previous analyses have drawn primarily from qualitative evidence; the temporal relationship between media reporting volume and adverse health consequences has not been quantified nationally. We set out to explore whether we could find a quantitative relationship between media reports about prescription opioid abuse and overdose mortality associated with these drugs. We assessed whether increases in news media reports occurred before or after increases in overdose deaths. Methodology/Principal Findings: Our ecological study compared a monthly time series of unintentional poisoning deaths involving short-acting prescription opioid substances, from 1999 to 2005 using multiple cause-of-death data published by the National Center for Health Statistics, to monthly counts of English-language news articles mentioning generic and branded names of prescription opioids obtained from Google News Archives from 1999 to 2005. We estimated the association between media volume and mortality rates by time-lagged regression analyses. There were 24,272 articles and 30,916 deaths involving prescription opioids during the seven-year study period. Nationally, the number of articles mentioning prescription opioids increased dramatically starting in early 2001, following prominent coverage about the nonmedical use of OxyContin. We found a significant association between news reports and deaths, with media reporting preceding fatal opioid poisonings by two to six months and explaining 88% (p<0.0001, df 78) of the variation in mortality. Conclusions/Significance: While availability, structural, and individual predispositions are key factors influencing substance use, news reporting may enhance the popularity of psychoactive substances. Albeit ecological in nature, our finding suggests the need for further evaluation of the influence of news media on health. Reporting on prescription opioids conforms to historical patterns of news reporting on other psychoactive substances.			Dasgupta, N (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	john_brownstein@harvard.edu	Brownstein, John S/A-1438-2011	Dasgupta, Nabarun/0000-0002-4098-605X	NATIONAL LIBRARY OF MEDICINE [R21LM009263] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NLM NIH HHS [R21LM009263-01, R21 LM009263] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CIHR(Canadian Institutes of Health Research (CIHR)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000051; Barbour V, 2008, PLOS MED, V5, P681, DOI 10.1371/journal.pmed.0050118; BEAN P, 1994, COCAINE CRACK SUPPLY; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V279, P827, DOI 10.1001/jama.279.11.827; Boyd S., 2002, INT J DRUG POLICY, V13, P397, DOI DOI 10.1016/S0955-3959(02)00079-8; BRECHER EM, 1972, LICIT ILLICIT DRUGS, pR15; Brown S L, 2001, J Long Term Eff Med Implants, V11, P1; Brown SL, 1998, PUBLIC HEALTH REP, V113, P535; BROWNSTEIN HH, 1991, SOCIAL JUSTICE, V18, P85; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Brushwood David B, 2004, J Am Pharm Assoc (2003), V44, P439, DOI 10.1331/1544345041475779; Caburnay CA, 2003, HEALTH EDUC BEHAV, V30, P709, DOI 10.1177/1090198103255456; CASE P, 2005, HIST METHAMPHETAMINE; CATLIN P, 1989, NEWSLETTER JOURNALIS, V1, P7; Dasgupta N, 2008, GEOGRAPHY DRUG ADDIC; DAVIES JB, 1990, BRIT J ADDICT, V85, P811; DEQUINCEY T, 1924, T DEQUINCEYS CONFESS; FAN DP, 1994, INT J PUBLIC OPIN R, V6, P139, DOI 10.1093/ijpor/6.2.139; Fan DP, 1996, SUBST USE MISUSE, V31, P1413, DOI 10.3109/10826089609063984; Food and Drug Administration, 2007, FDA PUBL HLTH ADV ME; Food and Drug Administration, 2007, FDA PUBL HLTH ADV IM; Goldney R D, 2001, Crisis, V22, P173, DOI 10.1027//0227-5910.22.4.173; Hartman DM, 1999, J PSYCHOACTIVE DRUGS, V31, P423, DOI 10.1080/02791072.1999.10471772; Hawton K, 1999, BRIT MED J, V318, P972, DOI 10.1136/bmj.318.7189.972; Jauncey ME, 2005, DRUG ALCOHOL REV, V24, P401, DOI 10.1080/09595230500286021; JENKINS P, 1999, SYNTHETIC PANICS SYM, pR11; LESKOVEC J, 2009, KDD IN PRESS; Mayor S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a742; McAdams M, 2008, PHARMACOEPIDEM DR S, V17, P229, DOI 10.1002/pds.1535; MERRIAM J, 1989, COMMUNICATION CAMPAI; MEYER CR, 1992, MINN MED, V75, P7; Miroff N, 2008, WASH POST; MUSTO DF, 1973, AM DIS ORIGINS NARCO, pR13; NEPON J, 2009, CAN J PSYCHIAT; Nicholson B, 2007, SOUTH MED J, V100, P1028, DOI 10.1097/SMJ.0b013e3180f626ff; NIEDERKROTENTHA.T, 2009, EUR J PUBLIC HLTH; O'Carroll P W, 1994, MMWR Recomm Rep, V43, P9; O'Carroll P W, 1994, MMWR Recomm Rep, V43, P1; ORCUTT JD, 1993, SOC PROBL, V40, P190, DOI 10.1525/sp.1993.40.2.03x0325m; PATTERSON SJ, 1994, J DRUG EDUC, V24, P351, DOI 10.2190/GPW5-MEVU-1CTB-9RJ0; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; POCHNA P, 2000, NEW DRUG CHOICE SWEE, P1; *PRES COM LAW ENF, 1967, REP TASK FORC NARC D; Reese S. D., 1989, COMMUNICATION CAMPAI; REINARMAN C, 1997, CRACK AM DEMON DRUGS, pR16; Rosenbaum M, 2002, J PSYCHOACTIVE DRUGS, V34, P137, DOI 10.1080/02791072.2002.10399947; SHAFER J, 2006, PHAR FETCHED PHARM P; Sisask Merike, 2005, Arch Suicide Res, V9, P87, DOI 10.1080/13811110590512985; Stack S, 2002, INJ PREV, V8, pIV30, DOI 10.1136/ip.8.suppl_4.iv30; STOCKDALE JE, 2001, LEARNING DRINKING; *SUBST AB MENT HLT, 2007, PATT TRENDS NONM PRE; SZALAVITZ M, 2004, ACCIDENTAL ADDICT; Taylor S, 2008, PROBAT J, V55, P369, DOI 10.1177/0264550508096493; Tousignant M, 2005, SOC SCI MED, V60, P1919, DOI 10.1016/j.socscimed.2004.08.054; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007; Yanovitzky I, 2002, J STUD ALCOHOL, V63, P342, DOI 10.15288/jsa.2002.63.342; 1962, NEWSWEEK        0813, P42	57	54	54	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7758	10.1371/journal.pone.0007758	http://dx.doi.org/10.1371/journal.pone.0007758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521QH	19924221	Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700002
J	Mielgo, A; Torres, VA; Schmid, MC; Graf, R; Zeitlin, SG; Lee, P; Shields, DJ; Barbero, S; Jamora, C; Stupack, DG				Mielgo, Ainhoa; Torres, Vicente A.; Schmid, Michael C.; Graf, Ryon; Zeitlin, Samantha G.; Lee, Pedro; Shields, David J.; Barbero, Simone; Jamora, Colin; Stupack, Dwayne G.			The Death Effector Domains of Caspase-8 Induce Terminal Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; TRANSFECTED TUMORIGENIC CLONES; SMALL-CELL; CANCER; ACTIVATION; EXPRESSION; GROWTH; HACAT; ASSOCIATION; METASTASIS	The differentiation and senescence programs of metazoans play key roles in regulating normal development and preventing aberrant cell proliferation, such as cancer. These programs are intimately associated with both the mitotic and apoptotic pathways. Caspase-8 is an apical apoptotic initiator that has recently been appreciated to coordinate non-apoptotic roles in the cell. Most of these functions are attributed to the catalytic domain, however, the amino-terminal death effector domains (DED)s, which belong to the death domain superfamily of proteins, can also play key roles during development. Here we describe a novel role for caspase-8 DEDs in regulating cell differentiation and senescence. Caspase-8 DEDs accumulate during terminal differentiation and senescence of epithelial, endothelial and myeloid cells; genetic deletion or shRNA suppression of caspase-8 disrupts cell differentiation, while re-expression of DEDs rescues this phenotype. Among caspase-8 deficient neuroblastoma cells, DED expression attenuated tumor growth in vivo and proliferation in vitro via disruption of mitosis and cytokinesis, resulting in upregulation of p53 and induction of differentiation markers. These events occur independent of caspase-8 catalytic activity, but require a critical lysine (K156) in a microtubule-binding motif in the second DED domain. The results demonstrate a new function for the DEDs of caspase-8, and describe an unexpected mechanism that contributes to cell differentiation and senescence.			Mielgo, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Torres, Vicente/I-2437-2013	Mielgo, Ainhoa/0000-0002-4159-5931; Torres, Vicente A/0000-0002-5973-7248; Schmid, Michael/0000-0002-3445-0013	NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107263, CA107263] Funding Source: Medline; NIAMS NIH HHS [R01 AR053185, AR053185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Barbero S., 2008, J BIOL CHEM; Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blumenschein GR, 2008, J CLIN ONCOL, V26, P1879, DOI 10.1200/JCO.2007.12.2689; BREITKREUTZ D, 1991, CANCER RES, V51, P4402; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; FINLAY D, 2009, CANC RES; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Gniadecki R, 2003, EXP DERMATOL, V12, P453, DOI 10.1034/j.1600-0625.2003.00013.x; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Joseph B, 1999, BIOCHEM BIOPH RES CO, V262, P381, DOI 10.1006/bbrc.1999.1191; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mielgo A, 2009, ONCOGENE, V28, P3551, DOI 10.1038/onc.2009.210; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Sachs L, 1996, P NATL ACAD SCI USA, V93, P4742, DOI 10.1073/pnas.93.10.4742; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7879	10.1371/journal.pone.0007879	http://dx.doi.org/10.1371/journal.pone.0007879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924290	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700013
J	Kobayashi, T; Murayama, T				Kobayashi, Takuya; Murayama, Takashi			Cell Cycle-Dependent Microtubule-Based Dynamic Transport of Cytoplasmic Dynein in Mammalian Cells	PLOS ONE			English	Article							LIGHT-CHAIN BINDS; INTERMEDIATE CHAIN; CHROMOSOME MOVEMENT; FLUORESCENT PROTEIN; DYNACTIN COMPLEX; MOTOR PROTEINS; SPINDLE POLES; PLUS-END; KINETOCHORE; COLOCALIZATION	Background: Cytoplasmic dynein complex is a large multi-subunit microtubule (MT)-associated molecular motor involved in various cellular functions including organelle positioning, vesicle transport and cell division. However, regulatory mechanism of the cell-cycle dependent distribution of dynein has not fully been understood. Methodology/Principal Findings: Here we report live-cell imaging of cytoplasmic dynein in HeLa cells, by expressing multifunctional green fluorescent protein (mfGFP)-tagged 74-kDa intermediate chain (IC74). IC74-mfGFP was successfully incorporated into functional dynein complex. In interphase, dynein moved bi-directionally along with MTs, which might carry cargos such as transport vesicles. A substantial fraction of dynein moved toward cell periphery together with EB1, a member of MT plus end-tracking proteins (+TIPs), suggesting +TIPs-mediated transport of dynein. In late-interphase and prophase, dynein was localized at the centrosomes and the radial MT array. In prometaphase and metaphase, dynein was localized at spindle MTs where it frequently moved from spindle poles toward chromosomes or cell cortex. +TIPs may be involved in the transport of spindle dyneins. Possible kinetochore and cortical dyneins were also observed. Conclusions and Significance: These findings suggest that cytoplasmic dynein is transported to the site of action in preparation for the following cellular events, primarily by the MT-based transport. The MT-based transport may have greater advantage than simple diffusion of soluble dynein in rapid and efficient transport of the limited concentration of the protein.			Kobayashi, T (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 113, Japan.	takashim@juntendo.ac.jp						Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Banks JD, 2001, CURR BIOL, V11, pR128, DOI 10.1016/S0960-9822(01)00059-8; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; Kobayashi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003822; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; TELZER BR, 1979, J CELL BIOL, V81, P484, DOI 10.1083/jcb.81.3.484; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7	45	34	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7827	10.1371/journal.pone.0007827	http://dx.doi.org/10.1371/journal.pone.0007827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915671	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721900017
J	Spaulding, AC; Seals, RM; Page, MJ; Brzozowski, AK; Rhodes, W; Hammett, TM				Spaulding, Anne C.; Seals, Ryan M.; Page, Matthew J.; Brzozowski, Amanda K.; Rhodes, William; Hammett, Theodore M.			HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity	PLOS ONE			English	Article							HIV; INTERVENTION; EFFICACY; RISK	Because certain groups at high risk for HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome) come together in correctional facilities, seroprevalence was high early in the epidemic. The share of the HIV/AIDS epidemic borne by inmates of and persons released from jails and prisons in the United States (US) in 1997 was estimated in a previous paper. While the number of inmates and releasees has risen, their HIV seroprevalence rates have fallen. We sought to determine if the share of HIV/AIDS borne by inmates and releasees in the US decreased between 1997 and 2006. We created a new model of population flow in and out of correctional facilities to estimate the number of persons released in 1997 and 2006. In 1997, approximately one in five of all HIV-infected Americans was among the 7.3 million who left a correctional facility that year. Nine years later, only one in seven (14%) of infected Americans was among the 9.1 million leaving, a 29.3% decline in the share. For black and Hispanic males, two demographic groups with heightened incarceration rates, recently released inmates comprise roughly one in five of those groups' total HIV-infected persons, a figure similar to the proportion borne by the correctional population as a whole in 1997. Decreasing HIV seroprevalence among those admitted to jails and prisons, prolonged survival and aging of the US population with HIV/AIDS beyond the crime-prone years, and success with discharge planning programs targeting HIV-infected prisoners could explain the declining concentration of the epidemic among correctional populations. Meanwhile, the number of persons with HIV/AIDS leaving correctional facilities remains virtually identical. Jails and prisons continue to be potent targets for public health interventions. The fluid nature of incarcerated populations ensures that effective interventions will be felt not only in correctional facilities but also in communities to which releasees return.			Spaulding, AC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	ASpauld@emory.edu			NIAID NIH HHS [P30 AI050409] Funding Source: Medline; NICHD NIH HHS [T32 HD052460] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], BUREAU JUSTICE STAT; [Anonymous], 2009, HIV TEST IMPL GUID C; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beckwith CG, 2007, AIDS PATIENT CARE ST, V21, P41, DOI 10.1089/apc.2006.006; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; *CDCP, 2009, 14 HIV AIDS CDCP; *CDCP, 2008, HIV AIDS SURV REP, V18; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V47, P1115; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; GILLIARD DK, 1998, BUREAU JUSTICE STAT; Glaze L. E., 2007, BUREAU JUSTICE STAT; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; HARRISON PM, 2005, BUREAU JUSTICE STAT; KIM JY, 1997, J CORRECT HEALTH CAR, V4, P5; MacGowan R, 2009, SEX TRANSM DIS, V36, pS9, DOI 10.1097/OLQ.0b013e318148b6b1; Martin SS, 2003, J PSYCHOACTIVE DRUGS, V35, P435, DOI 10.1080/02791072.2003.10400490; MARUSCHAK L, 2006, BUREAU JUSTICE STAT; Maruschak L., 2021, MED PROBLEMS REPORTE; MARUSCHAK L, 2007, BUREAU JUSTICE STAT; MARUSCHAK LM, 2001, BUREAU JUSTICE STAT; *NEW YORK CITY DEP, 1999, HIV SCROPR UPD; Sabol W. J., 2007, PRISON JAIL INMATES; SABOL WJ, 2008, BUREAU JUSTICE STAT; Spaulding A. C., 2007, Journal of Correctional Health Care, V13, P93, DOI 10.1177/1078345807301347; SPAULDING AC, 2007, J CORRECTIONAL HLTH, V12, P93; Spaulding AC, 2009, SEX TRANSM DIS, V36, pS34, DOI 10.1097/OLQ.0b013e3180959e9f; WOHL D, 2006, 16 INT AIDS C; WOHL DA, 2007, BRIGHT PROJECT BRIDG; Wolitski RJ, 2006, AM J PUBLIC HEALTH, V96, P1854, DOI 10.2105/AJPH.2004.056044	30	261	264	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A16	A21	e7558	10.1371/journal.pone.0007558	http://dx.doi.org/10.1371/journal.pone.0007558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907649	gold, Green Published, Green Submitted			2022-12-27	WOS:000271685800002
J	Guerrera, IC; Astarita, G; Jais, JP; Sands, D; Nowakowska, A; Colas, J; Sermet-Gaudelus, I; Schuerenberg, M; Piomelli, D; Edelman, A; Ollero, M				Guerrera, Ida Chiara; Astarita, Giuseppe; Jais, Jean-Philippe; Sands, Dorota; Nowakowska, Anna; Colas, Julien; Sermet-Gaudelus, Isabelle; Schuerenberg, Martin; Piomelli, Daniele; Edelman, Aleksander; Ollero, Mario			A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; FATTY-ACID DEFICIENCY; CHILDREN; SUPPLEMENTATION; ABNORMALITIES; HOMOCYSTEINE; METABOLISM; MEMBRANE; MICE; PHOSPHATIDYLCHOLINE	The aim of this study was to search for lipid signatures in blood plasma from cystic fibrosis (CF) patients using a novel MALDI-TOF-ClinProTools (TM) strategy, initially developed for protein analysis, and thin layer chromatography coupled to MALDI-TOF (TLC-MALDI). Samples from 33 CF patients and 18 healthy children were subjected to organic extraction and column chromatography separation of lipid classes. Extracts were analyzed by MALDI-TOF, ion signatures were compared by the ClinProTools (TM) software and by parallel statistical analyses. Relevant peaks were identified by LC-MSn. The ensemble of analyses provided 11 and 4 peaks differentially displayed in CF vs healthy and in mild vs severe patients respectively. Ten ions were significantly decreased in all patients, corresponding to 4 lysophosphatidylcholine ( 18: 0, 18: 2, 20: 3, and 20: 5) and 6 phosphatidylcholine ( 36: 5, O-38: 0, 38: 4, 38: 5, 38: 6, and P-40:1) species. One sphingolipid, SM(d18:0), was significantly increased in all patients. Four PC forms ( 36: 3, 36: 5, 38: 5, and 38: 6) were consistently downregulated in severe vs mild patients. These observations were confirmed by TLC-MALDI. These results suggest that plasma phospholipid signatures may be able to discriminate mild and severe forms of CF, and show for the first time MALDI-TOF-ClinProTools (TM) as a suitable methodology for the search of lipid markers in CF.			Guerrera, IC (corresponding author), Univ Paris 05, IFR94, Paris, France.	mario.ollero@inserm.fr	Sands, Dorota/T-4598-2019; Astarita, Giuseppe/AAD-1239-2019; GUERRERA, Ida Chiara/GOJ-9151-2022; Ollero, Mario/AAJ-3545-2020; Ollero, Mario/Q-6147-2018; Astarita, Giuseppe/N-7346-2014	Sands, Dorota/0000-0002-4601-5158; GUERRERA, Ida Chiara/0000-0002-4832-6793; Ollero, Mario/0000-0003-3590-706X; Astarita, Giuseppe/0000-0001-6700-301X				Astarita G., 2009, J CHROMATOGR B; Astarita G, 2008, J LIPID RES, V49, P48, DOI 10.1194/jlr.M700354-JLR200; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; BURDGE GC, 1994, BRIT J NUTR, V71, P959, DOI 10.1079/BJN19940199; Cawood AL, 2005, CURR OPIN CLIN NUTR, V8, P153, DOI 10.1097/00075197-200503000-00008; Chen AH, 2005, AM J CLIN NUTR, V81, P686; CHRISTOPHE AB, 1994, LIPIDS, V29, P569, DOI 10.1007/BF02536629; CLANDININ MT, 1995, AM J CLIN NUTR, V62, P1268, DOI 10.1093/ajcn/62.6.1268; Davezac N, 2004, PROTEOMICS, V4, P3833, DOI 10.1002/pmic.200400850; Dombrowsky H, 2003, PEDIATR RES, V53, P447, DOI 10.1203/01.PDR.0000049937.30305.8A; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Dyatlovitskaya EV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P502, DOI 10.1023/A:1010250600604; Eidelman O, 2002, BIOCHEMISTRY-US, V41, P11161, DOI 10.1021/bi020289s; FARRELL PM, 1985, PEDIATR RES, V19, P104, DOI 10.1203/00006450-198501000-00028; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Fuchs B, 2008, ANAL BIOANAL CHEM, V392, P849, DOI 10.1007/s00216-008-2301-8; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GILLJAM H, 1988, CLIN CHIM ACTA, V176, P29, DOI 10.1016/0009-8981(88)90171-4; GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Innis SM, 2008, ANNU REV NUTR, V28, P55, DOI 10.1146/annurev.nutr.27.061406.093625; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Innis SM, 2006, J NUTR, V136, P2226, DOI 10.1093/jn/136.8.2226; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; LEVY E, 1993, AM J CLIN NUTR, V57, P573, DOI 10.1093/ajcn/57.4.573; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Ollero M, 2006, METABOLISM, V55, P1192, DOI 10.1016/j.metabol.2006.05.002; Ollero M, 2006, PROTEOMICS, V6, P4084, DOI 10.1002/pmic.200600028; Peretti N, 2006, AM J PHYSIOL-GASTR L, V290, pG609, DOI 10.1152/ajpgi.00332.2005; ROGIERS V, 1983, EUR J PEDIATR, V141, P39, DOI 10.1007/BF00445666; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rubin BK, 2003, CHEST, V123, P1792, DOI 10.1378/chest.123.6.1792; Scambi C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004782; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Sermet-Gaudelus I, 2005, AM J RESP CRIT CARE, V171, P1026, DOI 10.1164/rccm.200406-740OC; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Srivastava M, 2006, MOL GENET METAB, V87, P303, DOI 10.1016/j.ymgme.2005.10.021; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; Team. RDC, 2007, R LANG ENV STAT COMP; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; TRUDEL S, 2009, PLOS ONE IN PRESS; ULANE MM, 1994, CLIN CHIM ACTA, V230, P109, DOI 10.1016/0009-8981(94)90263-1; VAUGHAN WJ, 1978, SCIENCE, V199, P783, DOI 10.1126/science.203033; WILKINSON MM, 1988, J CELL SCI, V91, P221; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Wu YH, 2007, CELL MICROBIOL, V9, P1062, DOI 10.1111/j.1462-5822.2006.00852.x; Zhao ZW, 2007, J CLIN ONCOL, V25, P2696, DOI 10.1200/JCO.2006.08.5571	51	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7735	10.1371/journal.pone.0007735	http://dx.doi.org/10.1371/journal.pone.0007735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893743	Green Published, gold			2022-12-27	WOS:000271478000010
J	Kumagai, G; Okada, Y; Yamane, J; Nagoshi, N; Kitamura, K; Mukaino, M; Tsuji, O; Fujiyoshi, K; Katoh, H; Okada, S; Shibata, S; Matsuzaki, Y; Toh, S; Toyama, Y; Nakamura, M; Okano, H				Kumagai, Gentaro; Okada, Yohei; Yamane, Junichi; Nagoshi, Narihito; Kitamura, Kazuya; Mukaino, Masahiko; Tsuji, Osahiko; Fujiyoshi, Kanehiro; Katoh, Hiroyuki; Okada, Seiji; Shibata, Shinsuke; Matsuzaki, Yumi; Toh, Satoshi; Toyama, Yoshiaki; Nakamura, Masaya; Okano, Hideyuki			Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RESTRICTED PRECURSOR CELLS; IN-VIVO; AXONAL REGENERATION; GENE-EXPRESSION; CONTUSION INJURIES; PROMOTE RECOVERY; PROGENITOR CELLS; HUMAN ASTROCYTES; DNA METHYLATION	Transplantation of neural stem/progenitor cells (NS/PCs) following the sub-acute phase of spinal cord injury (SCI) has been shown to promote functional recovery in rodent models. However, the types of cells most effective for treating SCI have not been clarified. Taking advantage of our recently established neurosphere-based culture system of ES cell-derived NS/PCs, in which primary neurospheres (PNS) and passaged secondary neurospheres (SNS) exhibit neurogenic and gliogenic potentials, respectively, here we examined the distinct effects of transplanting neurogenic and gliogenic NS/PCs on the functional recovery of a mouse model of SCI. ES cell-derived PNS and SNS transplanted 9 days after contusive injury at the Th10 level exhibited neurogenic and gliogenic differentiation tendencies, respectively, similar to those seen in vitro. Interestingly, transplantation of the gliogenic SNS, but not the neurogenic PNS, promoted axonal growth, remyelination, and angiogenesis, and resulted in significant locomotor functional recovery after SCI. These findings suggest that gliogenic NS/PCs are effective for promoting the recovery from SCI, and provide essential insight into the mechanisms through which cellular transplantation leads to functional improvement after SCI.			Kumagai, G (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	masa@sc.itc.keio.ac.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Nakamura, Masaya/K-4111-2013; Okada, Yohei/L-1662-2013; Toh, Satoshi/K-5737-2013; Toyama, Yoshiaki/K-5743-2013; Tsuji, Osahiko/AHB-2622-2022; Shibata, Shinsuke/AAM-6620-2020	Okada, Seiji/0000-0002-5107-8209; Matsuzaki, Yumi/0000-0002-3729-2997				BAEHR M, 1990, GLIA, V3, P293, DOI 10.1002/glia.440030409; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Blondel O, 2000, J NEUROSCI, V20, P8012; BREGMAN BS, 1987, DEV BRAIN RES, V34, P265, DOI 10.1016/0165-3806(87)90214-8; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; COUTTS M, 2007, EXP NEUROL; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Davis LE, 2006, LANCET NEUROL, V5, P7, DOI 10.1016/S1474-4422(05)70259-3; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; GALLO V, 1990, EXP CELL RES, V187, P211, DOI 10.1016/0014-4827(90)90084-N; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NOBLE M, 1984, J NEUROSCI, V4, P1892; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; OKADA Y, 2008, STEM CELLS; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Winkler C, 1998, MOL CELL NEUROSCI, V11, P99, DOI 10.1006/mcne.1998.0674; Yoshida H, 2002, BRAIN RES, V944, P65, DOI 10.1016/S0006-8993(02)02708-7; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	50	86	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7706	10.1371/journal.pone.0007706	http://dx.doi.org/10.1371/journal.pone.0007706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893739	Green Published, gold, Green Submitted			2022-12-27	WOS:000271478000005
J	Tanaka, H; Yi, TM				Tanaka, Hiromasa; Yi, Tau-Mu			Reverse Engineering a Signaling Network Using Alternative Inputs	PLOS ONE			English	Article							YEAST PHEROMONE RESPONSE; SACCHAROMYCES-CEREVISIAE; G-PROTEIN; CONSTITUTIVE MUTANTS; EPISTASIS ANALYSIS; INTERACTION MAP; GENE NETWORKS; BUDDING YEAST; PATHWAY; PHOSPHORYLATION	One of the goals of systems biology is to reverse engineer in a comprehensive fashion the arrow diagrams of signal transduction systems. An important tool for ordering pathway components is genetic epistasis analysis, and here we present a strategy termed Alternative Inputs (AIs) to perform systematic epistasis analysis. An alternative input is defined as any genetic manipulation that can activate the signaling pathway instead of the natural input. We introduced the concept of an "AIs-Deletions matrix'' that summarizes the outputs of all combinations of alternative inputs and deletions. We developed the theory and algorithms to construct a pairwise relationship graph from the AIs-Deletions matrix capturing both functional ordering (upstream, downstream) and logical relationships (AND, OR), and then interpreting these relationships into a standard arrow diagram. As a proof-of-principle, we applied this methodology to a subset of genes involved in yeast mating signaling. This experimental pilot study highlights the robustness of the approach and important technical challenges. In summary, this research formalizes and extends classical epistasis analysis from linear pathways to more complex networks, facilitating computational analysis and reconstruction of signaling arrow diagrams.			Tanaka, H (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	tmy@uci.edu			NIGMS NIH HHS [P50 GM076516, R01 GM075309, R01GM75309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1991, Methods Enzymol, V194, P1; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; BLINDER D, 1989, CELL, V56, P479, DOI 10.1016/0092-8674(89)90250-X; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Hughes TR, 2005, NAT GENET, V37, P457, DOI 10.1038/ng0505-457; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Isalan M, 2009, BIOESSAYS, V31, P1110, DOI 10.1002/bies.200900072; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Tanaka H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006946; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zupan B, 2003, BIOINFORMATICS, V19, P383, DOI 10.1093/bioinformatics/btf871	36	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7622	10.1371/journal.pone.0007622	http://dx.doi.org/10.1371/journal.pone.0007622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898612	Green Published, gold			2022-12-27	WOS:000271232000006
J	Cole, JG; Jerse, AE				Cole, Jessica G.; Jerse, Ann E.			Functional Characterization of Antibodies against Neisseria gonorrhoeae Opacity Protein Loops	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; SEXUALLY-TRANSMITTED-DISEASES; SEROVAR-SPECIFIC IMMUNITY; OPA PROTEINS; GONOCOCCAL SALPINGITIS; ANTIGENIC VARIATION; SERUM RESISTANCE; TRACT INFECTION; IMMUNIZATION; EXPRESSION	Background: The development of a gonorrhea vaccine is challenged by the lack of correlates of protection. The antigenically variable neisserial opacity (Opa) proteins are expressed during infection and have a semivariable (SV) and highly conserved (4L) loop that could be targeted in a vaccine. Here we compared antibodies to linear (Ab(linear)) and cyclic (Ab(cyclic)) peptides that correspond to the SV and 4L loops and selected hypervariable (HV(2)) loops for surface-binding and protective activity in vitro and in vivo. Methods/Findings: Ab(SV) (cyclic) bound a greater number of different Opa variants than Ab(SV linear), including variants that differed by seven amino acids. Antibodies to the 4L peptide did not bind Opa-expressing bacteria. Ab(SV cyclic) and Ab(HV2) (cyclic), but not Ab(SV linear) or Ab(HV2 linear) agglutinated homologous Opa variants, and Ab(HV2BD) (cyclic) but not Ab(HV2BD) (linear) blocked the association of OpaB variants with human endocervical cells. Only Ab(HV2BD linear) were bactericidal against the serum resistant parent strain. Consistent with host restrictions in the complement cascade, the bactericidal activity of Ab(HV2BD linear) was increased 8-fold when rabbit complement was used. None of the antibodies was protective when administered vaginally to mice. Antibody duration in the vagina was short-lived, however, with <50% of the antibodies recovered 3 hrs post-administration. Conclusions: We conclude that an SV loop-specific cyclic peptide can be used to induce antibodies that recognize a broad spectrum of antigenically distinct Opa variants and have agglutination abilities. HV(2) loop-specific cyclic peptides elicited antibodies with agglutination and adherence blocking abilities. The use of human complement when testing the bactericidal activity of vaccine-induced antibodies against serum resistant gonococci is also important.	[Cole, Jessica G.; Jerse, Ann E.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Cole, JG (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	ajerse@usuhs.mil			NIH/NIAID STI-TM-CRC [U19 AI31496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496] Funding Source: NIH RePORTER	NIH/NIAID STI-TM-CRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by NIH/NIAID STI-TM-CRC grant U19 AI31496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina G, 2006, INFECT IMMUN, V74, P2224, DOI 10.1128/IAI.74.4.2224-2232.2006; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Bos MP, 1997, INFECT IMMUN, V65, P645, DOI 10.1128/IAI.65.2.645-650.1997; Bos MP, 2002, INFECT IMMUN, V70, P1715, DOI 10.1128/IAI.70.4.1715-1723.2002; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BUCHANAN TM, 1980, AM J OBSTET GYNECOL, V138, P978, DOI 10.1016/0002-9378(80)91091-1; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; CHRISTODOULIDES M, 1993, J GEN MICROBIOL, V139, P1729, DOI 10.1099/00221287-139-8-1729; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; de Jonge MI, 2004, VACCINE, V22, P4021, DOI 10.1016/j.vaccine.2004.03.047; de Jonge MI, 2003, INFECT IMMUN, V71, P2331, DOI 10.1128/IAI.71.5.2331-2340.2003; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; DEREE JM, 1986, J CLIN MICROBIOL, V24, P121, DOI 10.1128/JCM.24.1.121-125.1986; FARUKI H, 1985, NEW ENGL J MED, V313, P607, DOI 10.1056/NEJM198509053131004; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Garvin LE, 2008, INFECT IMMUN, V76, P3700, DOI 10.1128/IAI.00265-08; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Harvey HA, 2001, MOL MICROBIOL, V42, P659, DOI 10.1046/j.1365-2958.2001.02666.x; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Hook E. W., 1999, SEXU LLY TRANSMITTED, P451; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; LAMMEL CJ, 1985, J INFECT DIS, V152, P990, DOI 10.1093/infdis/152.5.990; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; McNabb Scott J N, 2008, MMWR Morb Mortal Wkly Rep, V55, P1; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Ngampasutadol J, 2005, P NATL ACAD SCI USA, V102, P17142, DOI 10.1073/pnas.0506471102; Ngampasutadol J, 2008, J IMMUNOL, V180, P3426, DOI 10.4049/jimmunol.180.5.3426; Pal S, 1997, VACCINE, V15, P575, DOI 10.1016/S0264-410X(97)00206-5; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Sherwood JK, 1996, BIOL REPROD, V54, P264, DOI 10.1095/biolreprod54.1.264; Simms AN, 2006, INFECT IMMUN, V74, P2965, DOI 10.1128/IAI.74.5.2965-2974.2006; Song W, 2008, VACCINE; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Villullas S, 2007, CELL MICROBIOL, V9, P329, DOI 10.1111/j.1462-5822.2006.00789.x; WHALEY KJ, 1994, J INFECT DIS, V169, P647, DOI 10.1093/infdis/169.3.647; ZAK K, 1984, J INFECT DIS, V149, P166, DOI 10.1093/infdis/149.2.166	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8108	10.1371/journal.pone.0008108	http://dx.doi.org/10.1371/journal.pone.0008108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956622	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828700019
J	Coates, JM; Page, L				Coates, John M.; Page, Lionel			A Note on Trader Sharpe Ratios	PLOS ONE			English	Article							TESTOSTERONE; 2ND	Traders in the financial world are assessed by the amount of money they make and, increasingly, by the amount of money they make per unit of risk taken, a measure known as the Sharpe Ratio. Little is known about the average Sharpe Ratio among traders, but the Efficient Market Hypothesis suggests that traders, like asset managers, should not outperform the broad market. Here we report the findings of a study conducted in the City of London which shows that a population of experienced traders attain Sharpe Ratios significantly higher than the broad market. To explain this anomaly we examine a surrogate marker of prenatal androgen exposure, the second-to-fourth finger length ratio (2D:4D), which has previously been identified as predicting a trader's long term profitability. We find that it predicts the amount of risk taken by traders but not their Sharpe Ratios. We do, however, find that the traders' Sharpe Ratios increase markedly with the number of years they have traded, a result suggesting that learning plays a role in increasing the returns of traders. Our findings present anomalous data for the Efficient Markets Hypothesis.	[Coates, John M.; Page, Lionel] Univ Cambridge, Judge Business Sch, Cambridge, England; [Page, Lionel] Westminster Business Sch, London, England	University of Cambridge; University of Westminster	Coates, JM (corresponding author), Univ Cambridge, Judge Business Sch, Cambridge, England.	jmc98@cam.ac.uk; liopage@gmail.com		Page, Lionel/0000-0002-6020-9733	Economic and Social Research Council; ESRC [ES/G005230/1] Funding Source: UKRI; Economic and Social Research Council [ES/G005230/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	JMC is supported by an Economic and Social Research Council program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; CAMERER C, 1997, ENG SCI, V1, P10; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cowles A, 1937, ECONOMETRICA, V5, P280, DOI 10.2307/1905515; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; GARVEY R, 2005, J EMPIR FINANC, V12, P629; GROSSMAN SJ, 1980, AM ECON REV, V70, P393; Harris JH, 1998, J FINANC ECON, V50, P39, DOI 10.1016/S0304-405X(98)00031-2; Ingersoll J, 2007, REV FINANC STUD, V20, P1503, DOI 10.1093/rfs/hhm025; KENDALL MG, 1953, J ROYAL STATISTICAL, V96, P11; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Odean Terence, 2004, DO INDIVIDUAL DAY TR; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; SHARPE WF, 1966, J BUS, V39, P119, DOI 10.1086/294846; Shiller R.J., 2005, IRRATIONAL EXUBERANC	18	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8036	10.1371/journal.pone.0008036	http://dx.doi.org/10.1371/journal.pone.0008036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MK	19946367	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800023
J	D'Angiulli, A; Warburton, W; Dahinten, S; Hertzman, C				D'Angiulli, Amedeo; Warburton, William; Dahinten, Susan; Hertzman, Clyde			Population-Level Associations between Preschool Vulnerability and Grade-Four Basic Skills	PLOS ONE			English	Article							SCHOOL READINESS; ACADEMIC-ACHIEVEMENT; CHILDREN; LITERACY; EMOTION	Background: This is a predictive validity study examining the extent to which developmental vulnerability at kindergarten entry (as measured by the Early Development Instrument, EDI) is associated with children's basic skills in 4th grade (as measured by the Foundation Skills Assessment, FSA). Methodology/Principal Findings: Relative risk analysis was performed on a large database linking individual-level EDI ratings to the scores the same children obtained on a provincial assessment of academic skills (FSA-Foundation Skills Assessment) four years later. We found that early vulnerability in kindergarten is associated with the basic skills that underlie populations of children's academic achievement in reading, writing and math, indicating that the Early Development Instrument permits to predict achievement-related skills four years in advance. Conclusions/Significance: The EDI can be used to predict children's educational trends at the population level and can help select early prevention and intervention programs targeting pre-school populations at minimum cost.	[D'Angiulli, Amedeo] Carleton Univ, Inst Interdisciplinary Studies, Ottawa, ON K1S 5B6, Canada; [D'Angiulli, Amedeo; Warburton, William; Dahinten, Susan; Hertzman, Clyde] Univ British Columbia, Human Early Learning Partnership, Vancouver, BC V5Z 1M9, Canada; [Dahinten, Susan] Univ British Columbia, Dept Nursing, Vancouver, BC V5Z 1M9, Canada; [Hertzman, Clyde] Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada	Carleton University; University of British Columbia; University of British Columbia; University of British Columbia	D'Angiulli, A (corresponding author), Carleton Univ, Inst Interdisciplinary Studies, Ottawa, ON K1S 5B6, Canada.	amedeo@connect.carleton.ca		Dahinten, Virginia Susan/0000-0002-5469-922X	Michael Smith Foundation for Health Research; Canadian Institute of Health Research; Canada Research Chairs Program; Social Sciences and Humanities Research Council of Canada	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Support was provided by the Michael Smith Foundation for Health Research, Canadian Institute of Health Research, Canada Research Chairs Program, and the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Brinkman S., 2007, EARLY EDUC DEV, V18, P427, DOI [10.1080/10409280701610812, DOI 10.1080/10409280701610812]; *BRIT COL MIN ED, 2002, BC PERF STAND; Doherty G., 1997, ZERO 6 BASIS SCH REA, V1st; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Graziano PA, 2007, J SCHOOL PSYCHOL, V45, P3, DOI 10.1016/j.jsp.2006.09.002; Grimm KJ, 2008, DEV NEUROPSYCHOL, V33, P410, DOI 10.1080/87565640801982486; Hart B., 1995, MEANINGFUL DIFFERENC; Hertzman C, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P21; Howse RB, 2003, J EXP EDUC, V71, P151, DOI 10.1080/00220970309602061; Janus M, 2007, EARLY DEV INSTRUMENT; JANUS M, 2000, SUMA CAN J POLICY RE, V1, P71; Janus M, 2007, CAN J BEHAV SCI, V39, P1, DOI 10.1037/cjbs2007001; KAGAN SL, 1992, YOUNG CHILDREN, V48, P48; KEATING P, 1999, DEV HLTH WEALTH NATI; KERSHAW P, 2005, CANADIAN W GEOGRAPHI, V40; Kuh D, 1997, LIFE COURSE APPROACH; Lemelin JP, 2007, CHILD DEV, V78, P1855, DOI 10.1111/j.1467-8624.2007.01103.x; Li J, 2009, EARLY YEARS, V29, P89, DOI 10.1080/09575140802689240; Li JH, 2007, EARLY YEARS-ABINGDON, V27, P221, DOI 10.1080/09575140701594384; Lonigan CJ, 2000, DEV PSYCHOL, V36, P596, DOI 10.1037//0012-1649.36.5.596; MCCAIN MN, 2007, EARLY YEARS STUDY, V2; Mustard JF, 2007, EARLY CHILD DEVELOPMENT FROM MEASUREMENT TO ACTION: A PRIORITY FOR GROWTH AND EQUITY, P253; Offord DR, 2000, ADDICT BEHAV, V25, P833, DOI 10.1016/S0306-4603(00)00132-5; Power C, 1997, BRIT MED BULL, V53, P210; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rush KL, 1999, TOP EARLY CHILD SPEC, V19, P3, DOI 10.1177/027112149901900101; SHAFFER RH, 2000, INT J BEHAV DEV, V1, P5; Spernak SA, 2006, CHILD YOUTH SERV REV, V28, P1251, DOI 10.1016/j.childyouth.2006.01.006; Storch SA, 2002, DEV PSYCHOL, V38, P934, DOI 10.1037//0012-1649.38.6.934; *US NAT ED GOAL PA, 1993, REC CHILDR EARL DEV	31	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7692	10.1371/journal.pone.0007692	http://dx.doi.org/10.1371/journal.pone.0007692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MK	19946366	gold, Green Published			2022-12-27	WOS:000272827800003
J	Manabe, T; Katayama, T; Tohyama, M				Manabe, Takayuki; Katayama, Taiichi; Tohyama, Masaya			HMGA1a Recognition Candidate DNA Sequences in Humans	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOBILITY GROUP-I(Y) PROTEIN; GENE-EXPRESSION; BREAST-CANCER; CYCLIN D3; BINDING; TRANSCRIPTION; I(Y); RNA; INDUCTION	High mobility group protein A1a (HMGA1a) acts as an architectural transcription factor and influences a diverse array of normal biological processes. It binds AT-rich sequences, and previous reports have demonstrated HMGA1a binding to the authentic promoters of various genes. However, the precise sequences that HMGA1a binds to remain to be clarified. Therefore, in this study, we searched for the sequences with the highest affinity for human HMGA1a using an existing SELEX method, and then compared the identified sequences with known human promoter sequences. Based on our results, we propose the sequences "-(G/A)-G-(A/T)-(A/T)-A-T-T-T-'' as HMGA1a-binding candidate sequences. Furthermore, these candidate sequences bound native human HMGA1a from SK-N-SH cells. When candidate sequences were analyzed by performing FASTAs against all known human promoter sequences, 500-900 sequences were hit by each one. Some of the extracted genes have already been proven or suggested as HMGA1a-binding promoters. The candidate sequences presented here represent important information for research into the various roles of HMGA1a, including cell differentiation, death, growth, proliferation, and the pathogenesis of cancer.	[Manabe, Takayuki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Aichi, Japan; [Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Dept Child Dev, United Grad Sch Child Dev, Osaka Univ, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan	Fujita Health University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Manabe, T (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Aichi, Japan.	manabe@fujita-hu.ac.jp						ABDULKADIR SA, 1995, J EXP MED, V182, P487, DOI 10.1084/jem.182.2.487; Adair JE, 2007, CANCER RES, V67, P6044, DOI 10.1158/0008-5472.CAN-06-1689; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Baldassarre G, 1999, J CLIN INVEST, V104, P865, DOI 10.1172/JCI6443; Baran B, 2009, EUR J CELL BIOL, V88, P743, DOI 10.1016/j.ejcb.2009.08.002; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; Chase MB, 1999, AM J HEMATOL, V60, P27, DOI 10.1002/(SICI)1096-8652(199901)60:1<27::AID-AJH6>3.0.CO;2-0; Chau KY, 2005, INT IMMUNOL, V17, P297, DOI 10.1093/intimm/dxh209; Chau KY, 2000, J NEUROSCI, V20, P7317; Chiappetta G, 2004, CLIN CANCER RES, V10, P7637, DOI 10.1158/1078-0432.CCR-04-0291; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Choi Dongseok, 2008, J Ocul Biol Dis Infor, V1, P37, DOI 10.1007/s12177-008-9007-1; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; DEMARTINO I, 2009, RE CANC S, V69, P1844; Duncan B, 2007, DNA CELL BIOL, V26, P745, DOI 10.1089/dna.2007.0629; Ebert MPA, 2001, J CANCER RES CLIN, V127, P449, DOI 10.1007/s004320100235; Fay J, 2009, J MED VIROL, V81, P897, DOI 10.1002/jmv.21406; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Gorla L, 2006, CELL SIGNAL, V18, P2272, DOI 10.1016/j.cellsig.2006.05.016; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Kappeler L, 2003, J NEUROENDOCRINOL, V15, P592, DOI 10.1046/j.1365-2826.2003.01039.x; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Kondo T, 2007, CLIN CANCER RES, V13, P4713, DOI 10.1158/1078-0432.CCR-07-0618; Liau SS, 2008, CANCER-AM CANCER SOC, V113, P302, DOI 10.1002/cncr.23560; Lin SC, 2006, MOL IMMUNOL, V43, P1325, DOI 10.1016/j.molimm.2005.09.007; Long JL, 2009, LARYNGOSCOPE, V119, P89, DOI 10.1002/lary.20062; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Manabe T, 2007, GENES CELLS, V12, P1179, DOI 10.1111/j.1365-2443.2007.01123.x; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mayer IA, 2009, CLIN BREAST CANCER, V9, pS50, DOI 10.3816/CBC.2009.s.005; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Okuda H, 2006, MOL CELL NEUROSCI, V33, P81, DOI 10.1016/j.mcn.2006.06.009; Onguru O, 2004, MODERN PATHOL, V17, P772, DOI 10.1038/modpathol.3800118; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Saeger W, 2001, ENDOCR PATHOL, V12, P39, DOI 10.1385/EP:12:1:39; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasaki M, 2001, CANCER RES, V61, P4809; Sawai H, 2001, PANCREAS, V23, P399, DOI 10.1097/00006676-200111000-00011; Schmutzler C, 2007, BIOL CHEM, V388, P1053, DOI 10.1515/BC.2007.122; Takamiya R, 2008, FEBS LETT, V582, P810, DOI 10.1016/j.febslet.2008.02.008; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Treff NR, 2004, ONCOGENE, V23, P8557, DOI 10.1038/sj.onc.1207926; Treff NR, 2004, ONCOGENE, V23, P777, DOI 10.1038/sj.onc.1207167; Wascher RA, 2001, BRIT J CANCER, V85, P1340, DOI 10.1054/bjoc.2001.2079; Yanagita T, 2005, NEUROSCI LETT, V374, P47, DOI 10.1016/j.neulet.2004.10.039; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8004	10.1371/journal.pone.0008004	http://dx.doi.org/10.1371/journal.pone.0008004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956671	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500028
J	Mitra, A; Liu, G; Song, JZ				Mitra, Apratim; Liu, George; Song, Jiuzhou			A Genome-Wide Analysis of Array-Based Comparative Genomic Hybridization (CGH) Data to Detect Intra-Species Variations and Evolutionary Relationships	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; COPY NUMBER; HAPLOTYPE MAP; WAVELET; COMPLEXITY; PHYLOGENY; FREQUENCY; SPECTRUM; IMPACT	Array-based comparative genomics hybridization (aCGH) has gained prevalence as an effective technique for measuring structural variations in the genome. Copy-number variations (CNVs) form a large source of genomic structural variation, but it is not known whether phenotypic differences between intra-species groups, such as divergent human populations, or breeds of a domestic animal, can be attributed to CNVs. Several computational methods have been proposed to improve the detection of CNVs from array CGH data, but few population studies have used CGH data for identification of intra-species differences. In this paper we propose a novel method of genome-wide comparison and classification using CGH data that condenses whole genome information, aimed at quantification of intra-species variations and discovery of shared ancestry. Our strategy included smoothing CGH data using an appropriate denoising algorithm, extracting features via wavelets, quantifying the information via wavelet power spectrum and hierarchical clustering of the resultant profile. To evaluate the classification efficiency of our method, we used simulated data sets. We applied it to aCGH data from human and bovine individuals and showed that it successfully detects existing intra-specific variations with additional evolutionary implications.	[Mitra, Apratim; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Liu, George] ARS, Bovine Funct Genom Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Mitra, A (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Liu, George/K-3371-2019; Song, Jiuzhou/AAD-6440-2020	Liu, George/0000-0003-0192-6705; 	University of Maryland;  [USDA-NRI 2008-00870]	University of Maryland; 	The authors are grateful for the support by USDA-NRI 2008-00870 and Flagship program of University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bapteste E, 2008, MOL BIOL EVOL, V25, P83, DOI 10.1093/mlbev/msm229; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Doolittle WF, 2007, CURR BIOL, V17, pR510, DOI 10.1016/j.cub.2007.05.003; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Hu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl730; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lauter J, 1996, BIOMETRICS, V52, P964, DOI 10.2307/2533057; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MAGOSSO E, APPL MATH C IN PRESS; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; MCCARROLL SA, 2007, NAT GENET; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Prabakaran S, 2006, INT J KNOWL-BASED IN, V10, P493, DOI 10.3233/KES-2006-10607; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Song JZ, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/39382; Song JZ, 2005, EVOL BIOINFORM, V1, P84; Song JZ, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-17; SONG JZ, 2005, P 2005 IEEE COMP SOC, V3; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Subramani P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-432; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tirtom H, 2008, EXPERT SYST APPL, V34, P746, DOI 10.1016/j.eswa.2006.10.009; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang Z, 2009, BRIEF BIOINFORM, V10, P1, DOI 10.1093/bib/bbn041; Zhong Y, 2006, BIOMED TECH, V51, P251, DOI 10.1515/BMT.2006.049	32	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7978	10.1371/journal.pone.0007978	http://dx.doi.org/10.1371/journal.pone.0007978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956659	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500009
J	Aragam, KG; Tamhane, UU; Kline-Rogers, E; Li, J; Fox, KAA; Goodman, SG; Eagle, KA; Gurm, HS				Aragam, Krishna G.; Tamhane, Umesh U.; Kline-Rogers, Eva; Li, Jin; Fox, Keith A. A.; Goodman, Shaun G.; Eagle, Kim A.; Gurm, Hitinder S.			Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; STRATIFICATION; THROMBOLYSIS; ASSOCIATION; MANAGEMENT; MORTALITY; REGISTRY; DEATH; TRIAL	Background: The Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk scores for in-hospital and 6-month mortality are established tools for assessing risk in Acute Coronary Syndrome (ACS) patients. The objective of our study was to compare the discriminative abilities of the TIMI and GRACE risk scores in a broad-spectrum, unselected ACS population and to assess the relative contributions of model simplicity and model composition to any observed differences between the two scoring systems. Methodology/Principal Findings: ACS patients admitted to the University of Michigan between 1999 and 2005 were divided into UA/NSTEMI (n = 2753) and STEMI (n = 698) subpopulations. The predictive abilities of the TIMI and GRACE scores for in-hospital and 6-month mortality were assessed by calibration and discrimination. There were 137 in-hospital deaths (4%), and among the survivors, 234 (7.4%) died by 6 months post-discharge. In the UA/NSTEMI population, the GRACE risk scores demonstrated better discrimination than the TIMI UA/NSTEMI score for in-hospital (C = 0.85, 95% CI: 0.81-0.89, versus 0.54, 95% CI: 0.48-0.60; p, 0.01) and 6-month (C = 0.79, 95% CI: 0.76-0.83, versus 0.56, 95% CI: 0.52-0.60; p, 0.01) mortality. Among STEMI patients, the GRACE and TIMI STEMI scores demonstrated comparably excellent discrimination for in-hospital (C = 0.84, 95% CI: 0.78-0.90 versus 0.83, 95% CI: 0.78-0.89; p = 0.83) and 6-month (C = 0.72, 95% CI: 0.63-0.81, versus 0.71, 95% CI: 0.64-0.79; p = 0.79) mortality. An analysis of refitted multivariate models demonstrated a marked improvement in the discriminative power of the TIMI UA/NSTEMI model with the incorporation of heart failure and hemodynamic variables. Study limitations included unaccounted for confounders inherent to observational, single institution studies with moderate sample sizes. Conclusions/Significance: The GRACE scores provided superior discrimination as compared with the TIMI UA/NSTEMI score in predicting in-hospital and 6-month mortality in UA/NSTEMI patients, although the GRACE and TIMI STEMI scores performed equally well in STEMI patients. The observed discriminative deficit of the TIMI UA/NSTEMI score likely results from the omission of key risk factors rather than from the relative simplicity of the scoring system.	[Aragam, Krishna G.; Tamhane, Umesh U.; Kline-Rogers, Eva; Li, Jin; Eagle, Kim A.; Gurm, Hitinder S.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Fox, Keith A. A.] Univ Edinburgh, Div Med & Radiol Sci, Edinburgh, Midlothian, Scotland; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada	University of Michigan System; University of Michigan; University of Edinburgh; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Aragam, KG (corresponding author), Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Gurm, Hitinder/0000-0002-1646-0218	Sanofiaventis; Pfizer; Blue Cross Blue Shield Foundation; Mardigian Foundation; University of Michigan Health System	Sanofiaventis(Sanofi-Aventis); Pfizer(Pfizer); Blue Cross Blue Shield Foundation; Mardigian Foundation; University of Michigan Health System(University of Michigan System)	The present work was supported in part by unrestricted grants from: Sanofiaventis, Pfizer, the Blue Cross Blue Shield Foundation, the Mardigian Foundation, and the University of Michigan Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Brilakis ES, 2003, AM HEART J, V146, P811, DOI 10.1016/S0002-8703(03)00455-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Morrow DA, 2003, AM HEART J, V146, P754, DOI 10.1016/S0002-8703(03)00460-5; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Ramsay G, 2007, QJM-INT J MED, V100, P11, DOI 10.1093/qjmed/hcl133; Sabatine MS, 2004, CIRCULATION, V109, P874, DOI 10.1161/01.CIR.0000112604.74713.35; Singh M, 2002, CIRCULATION, V106, P2309, DOI 10.1161/01.CIR.0000036598.12888.DE; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037; Weintraub WS, 2002, CIRCULATION, V106, P2292, DOI 10.1161/01.CIR.0000035925.23046.0B; Yan AT, 2007, EUR HEART J, V28, P1072, DOI 10.1093/eurheartj/ehm004; Yan AT, 2005, AM J CARDIOL, V96, P913, DOI 10.1016/j.amjcard.2005.05.046; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	25	101	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7947	10.1371/journal.pone.0007947	http://dx.doi.org/10.1371/journal.pone.0007947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956773	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827300006
J	Rajaram, MVS; Butchar, JP; Parsa, KVL; Cremer, TJ; Amer, A; Schlesinger, LS; Tridandapani, S				Rajaram, Murugesan V. S.; Butchar, Jonathan P.; Parsa, Kishore V. L.; Cremer, Thomas J.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela			Akt and SHIP Modulate Francisella Escape from the Phagosome and Induction of the Fas-Mediated Death Pathway	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY RESPONSE; MURINE MACROPHAGES; LIGAND INTERACTIONS; HUMAN MONOCYTES; T-LYMPHOCYTES; TULARENSIS; ACTIVATION; APOPTOSIS; CELLS; EXPRESSION	Francisella tularensis infects macrophages and escapes phago-lysosomal fusion to replicate within the host cytosol, resulting in host cell apoptosis. Here we show that the Fas-mediated death pathway is activated in infected cells and correlates with escape of the bacterium from the phagosome and the bacterial burden. Our studies also demonstrate that constitutive activation of Akt, or deletion of SHIP, promotes phago-lysosomal fusion and limits bacterial burden in the host cytosol, and the subsequent induction of Fas expression and cell death. Finally, we show that phagosomal escape/intracellular bacterial burden regulate activation of the transcription factors sp1/sp3, leading to Fas expression and cell death. These data identify for the first time host cell signaling pathways that regulate the phagosomal escape of Francisella, leading to the induction of Fas and subsequent host cell death.			Rajaram, MVS (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011; Amer, Amal/E-2643-2011; Rajaram, Murugesan/E-5203-2013; Tridandapani, Susheela/E-4209-2011	Parsa, Kishore/0000-0001-7883-2534; Rajaram, Murugesan/0000-0002-1515-1122	NCI NIH HHS [P01 CA095426] Funding Source: Medline; NHLBI NIH HHS [R01 HL094586-01A1, R01 HL094586] Funding Source: Medline; NIAID NIH HHS [U54 AI057153, R01 AI059406, R21 AI083871-01, 1-U54-AI-057153, R21 AI083871] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083871, R01AI059406, U54AI057153] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Baran J, 2001, INFECT IMMUN, V69, P1287, DOI 10.1128/IAI.69.3.1287-1297.2001; Barbieri MA, 1998, J BIOL CHEM, V273, P19367, DOI 10.1074/jbc.273.31.19367; Baumler CB, 1996, BLOOD, V88, P1741; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; CHEN Q, J IMMUNOL, V170, P5302; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; Drecktrah D, 2004, INFECT IMMUN, V72, P4331, DOI 10.1128/IAI.72.8.4331-4335.2004; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Fortier A H, 1994, Immunol Ser, V60, P349; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Golovliov I, 1996, FEMS IMMUNOL MED MIC, V13, P239, DOI 10.1111/j.1574-695X.1996.tb00244.x; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Pang HL, 1998, BIOCHEM J, V333, P209, DOI 10.1042/bj3330209; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; PARSA KV, 2008, MOL IMMUNOL; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rudi J, 1998, J CLIN INVEST, V102, P1506, DOI 10.1172/JCI2808; Rupper AC, 2001, J CELL SCI, V114, P1283; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang JD, 2000, INFECT IMMUN, V68, P4303, DOI 10.1128/IAI.68.7.4303-4311.2000; WICKSTRUM JR, 2009, INFECT IMMUN	51	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7919	10.1371/journal.pone.0007919	http://dx.doi.org/10.1371/journal.pone.0007919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936232	gold, Green Submitted, Green Published			2022-12-27	WOS:000272004800004
J	Ghelli, A; Porcelli, AM; Zanna, C; Vidoni, S; Mattioli, S; Barbieri, A; Iommarini, L; Pala, M; Achilli, A; Torroni, A; Rugolo, M; Carelli, V				Ghelli, Anna; Porcelli, Anna Maria; Zanna, Claudia; Vidoni, Sara; Mattioli, Stefano; Barbieri, Anna; Iommarini, Luisa; Pala, Maria; Achilli, Alessandro; Torroni, Antonio; Rugolo, Michela; Carelli, Valerio			The Background of Mitochondrial DNA Haplogroup J Increases the Sensitivity of Leber's Hereditary Optic Neuropathy Cells to 2,5-Hexanedione Toxicity	PLOS ONE			English	Article							N-HEXANE; PARKINSONS-DISEASE; APOPTOTIC DEATH; ORGANIC-SOLVENT; EXPRESSION; MUTATIONS; EXPOSURE; TOLUENE; ALCOHOL; CYBRIDS	Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disease due to mitochondrial DNA (mtDNA) point mutations in complex I subunit genes, whose incomplete penetrance has been attributed to both genetic and environmental factors. Indeed, the mtDNA background defined as haplogroup J is known to increase the penetrance of the 11778/ND4 and 14484/ND6 mutations. Recently it was also documented that the professional exposure to n-hexane might act as an exogenous trigger for LHON. Therefore, we here investigate the effect of the n-hexane neurotoxic metabolite 2,5-hexanedione (2,5-HD) on cell viability and mitochondrial function of different cell models (cybrids and fibroblasts) carrying the LHON mutations on different mtDNA haplogroups. The viability of control and LHON cybrids and fibroblasts, whose mtDNAs were completely sequenced, was assessed using the MTT assay. Mitochondrial ATP synthesis rate driven by complex I substrates was determined with the luciferine/luciferase method. Incubation with 2,5-HD caused the maximal loss of viability in control and LHON cells. The toxic effect of this compound was similar in control cells irrespective of the mtDNA background. On the contrary, sensitivity to 2,5-HD induced cell death was greatly increased in LHON cells carrying the 11778/ND4 or the 14484/ND6 mutation on haplogroup J, whereas the 11778/ND4 mutation in association with haplogroups U and H significantly improved cell survival. The 11778/ND4 mutation on haplogroup U was also more resistant to inhibition of complex I dependent ATP synthesis by 2,5-HD. In conclusion, this study shows that mtDNA haplogroups modulate the response of LHON cells to 2,5-HD. In particular, haplogroup J makes cells more sensitive to its toxic effect. This is the first evidence that an mtDNA background plays a role by interacting with an environmental factor and that 2,5-HD may be a risk element for visual loss in LHON. This proof of principle has broad implications for other neurodegenerative disorders such as Parkinson's disease.			Ghelli, A (corresponding author), Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Bologna, Italy.	annamaria.ghelli@unibo.it	Zanna, Claudia/GVT-1932-2022; Rugolo, Michela/AAY-8640-2020; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Iommarini, Luisa/J-2328-2018	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Iommarini, Luisa/0000-0002-6804-7302; Barbieri, Anna/0000-0001-8839-294X; Rugolo, Michela/0000-0002-4597-0452; Porcelli, Anna Maria/0000-0002-6209-0692; GHELLI, ANNA MARIA/0000-0003-0830-0000; Mattioli, Stefano/0000-0002-9639-7430; Pala, Maria/0000-0001-9202-8331; CARELLI, VALERIO/0000-0003-4923-6404	Telethon [GGP06233] Funding Source: Medline	Telethon(Fondazione Telethon)		Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonetta L, 2002, NAT MED, V8, P1050, DOI 10.1038/nm1002-1050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canton M, 1996, BBA-BIOENERGETICS, V1274, P39, DOI 10.1016/0005-2728(96)00008-4; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245; CULLOM ME, 1993, ARCH OPHTHALMOL-CHIC, V111, P1482, DOI 10.1001/archopht.1993.01090110048021; Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447; Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Ghelli A, 2008, INVEST OPHTH VIS SCI, V49, P671, DOI 10.1167/iovs.07-0880; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Gobba F, 2003, NEUROTOXICOLOGY, V24, P693, DOI 10.1016/S0161-813X(03)00037-8; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kiyokawa M, 1999, JPN J OPHTHALMOL, V43, P438, DOI 10.1016/S0021-5155(99)00102-1; La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Maruff P, 1998, BRAIN, V121, P1903, DOI 10.1093/brain/121.10.1903; McDermott C, 2007, TOXICOL IN VITRO, V21, P116, DOI 10.1016/j.tiv.2006.08.002; Meadows R, 1996, SOUTHERN MED J, V89, P455, DOI 10.1097/00007611-199605000-00001; MEDRANO CJ, 1989, NEUROTOXICOLOGY, V10, P249; Mishra DP, 2006, J BIOL CHEM, V281, P2133, DOI 10.1074/jbc.M508648200; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OGAWA Y, 1988, IND HEALTH, V26, P239, DOI 10.2486/indhealth.26.239; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; PERBELLINI L, 1982, INT ARCH OCC ENV HEA, V50, P351, DOI 10.1007/BF00377831; RAITTA C, 1978, A GRAEF ARCH KLIN EX, V209, P99, DOI 10.1007/BF00407843; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0; Sanchez RN, 2006, J NEURO-OPHTHALMOL, V26, P268, DOI 10.1097/01.wno.0000249320.27110.ab; Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607; SPENCER PS, 1978, ENVIRON HEALTH PERSP, V26, P97, DOI 10.2307/3428829; SPENCER PS, 1985, SCAND J WORK ENV HEA, V11, P53; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; TAKEUCHI Y, 1993, INT ARCH OCC ENV HEA, V65, pS227, DOI 10.1007/BF00381347; Torroni A, 1997, AM J HUM GENET, V60, P1107; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; WILLIAMS DML, 1988, J OTOLARYNGOL, V17, P321; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zhao WY, 1998, NEUROCHEM RES, V23, P837, DOI 10.1023/A:1022402810695	58	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7922	10.1371/journal.pone.0007922	http://dx.doi.org/10.1371/journal.pone.0007922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936068	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000272004600020
J	Graham, SP; Hassan, HK; Burkett-Cadena, ND; Guyer, C; Unnasch, TR				Graham, Sean P.; Hassan, Hassan K.; Burkett-Cadena, Nathan D.; Guyer, Craig; Unnasch, Thomas R.			Nestedness of Ectoparasite-Vertebrate Host Networks	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; ANIMAL MUTUALISTIC NETWORKS; WEST-NILE-VIRUS; COEVOLUTIONARY NETWORKS; SPECIES RICHNESS; BRIDGE VECTOR; MARINE FISH; PARASITE; ECOLOGY; COMMUNITIES	Determining the structure of ectoparasite-host networks will enable disease ecologists to better understand and predict the spread of vector-borne diseases. If these networks have consistent properties, then studying the structure of well-understood networks could lead to extrapolation of these properties to others, including those that support emerging pathogens. Borrowing a quantitative measure of network structure from studies of mutualistic relationships between plants and their pollinators, we analyzed 29 ectoparasite-vertebrate host networks-including three derived from molecular bloodmeal analysis of mosquito feeding patterns-using measures of nestedness to identify non-random interactions among species. We found significant nestedness in ectoparasite-vertebrate host lists for habitats ranging from tropical rainforests to polar environments. These networks showed non-random patterns of nesting, and did not differ significantly from published estimates of nestedness from mutualistic networks. Mutualistic and antagonistic networks appear to be organized similarly, with generalized ectoparasites interacting with hosts that attract many ectoparasites and more specialized ectoparasites usually interacting with these same "generalized'' hosts. This finding has implications for understanding the network dynamics of vector-born pathogens. We suggest that nestedness (rather than random ectoparasite-host associations) can allow rapid transfer of pathogens throughout a network, and expand upon such concepts as the dilution effect, bridge vectors, and host switching in the context of nested ectoparasite-vertebrate host networks.			Graham, SP (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	grahasp@auburn.edu		Burkett-Cadena, Nathan/0000-0001-6168-1637	PHS HHS [R01-A149724] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; ALLRED DM, 1966, BRIGHAM YOUNG U SCI; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Baker Anne S., 2003, Systematic and Applied Acarology Special Publications, V14, P1; Barros-Battesti DM, 2000, J MED ENTOMOL, V37, P820, DOI 10.1603/0022-2585-37.6.820; Barros-Battesti DM, 1998, MEM I OSWALDO CRUZ, V93, P719, DOI 10.1590/S0074-02761998000600003; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bezerra ELS, 2009, J ANIM ECOL, V78, P1096, DOI 10.1111/j.1365-2656.2009.01567.x; Bittencourt EB, 2003, MEM I OSWALDO CRUZ, V98, P793, DOI 10.1590/S0074-02762003000600015; Blick R, 2009, PERSPECT PLANT ECOL, V11, P41, DOI 10.1016/j.ppees.2008.10.002; Brennan J. M., 1955, Great Basin Naturalist, V15, P1; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; BUSENBERG S, 1990, J MATH BIOL, V28, P257, DOI 10.1007/BF00178776; CHOE JC, 1987, CAN J ZOOL, V65, P2998, DOI 10.1139/z87-454; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; Collinge SK, 2006, DIS ECOLOGY COMMUNIT; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Lyra-Neves Rachel M. de, 2003, Rev. Bras. Zool., V20, P481, DOI 10.1590/S0101-81752003000300019; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Dick CW, 2005, J PARASITOL, V91, P1015, DOI 10.1645/GE-536R.1; DUMROW R, 1985, AUST J ZOOL S, V114, P1; DUNNET GM, 1974, AUSTR J ZOOLOGY S, V30, P1; EDMUNDS LAFE R., 1951, PAN PACIFIC ENT, V27, P23; Fauci AS, 2004, JAMA-J AM MED ASSOC, V292, P1887, DOI 10.1001/jama.292.15.1887; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Ford P. L., 2004, FLEAS LICE MAMMALS N; GILOT B, 1990, EUR J EPIDEMIOL, V6, P357, DOI 10.1007/BF00151708; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Guegan JF, 1996, PARASITOL TODAY, V12, P367, DOI 10.1016/0169-4758(96)10054-5; GUEGAN JF, 1994, OECOLOGIA, V100, P184, DOI 10.1007/BF00317145; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; GUIMARAES PR, 2006, ENVIRON MODELL SOFTW, V21, P1521; Haas Glenn E., 2005, Journal of the Entomological Society of British Columbia, V102, P65; HAFNER MS, 1995, PHILOS T R SOC B, V349, P77, DOI 10.1098/rstb.1995.0093; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; HEATH A C G, 1977, Tuatara, V23, P26; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P125; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Krasnov BR, 2006, J ANIM ECOL, V75, P1330, DOI 10.1111/j.1365-2656.2006.01156.x; Labruna MB, 2007, EXP APPL ACAROL, V43, P147, DOI 10.1007/s10493-007-9106-x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lowenberg-Neto P, 2008, J TROP ECOL, V24, P575, DOI 10.1017/S0266467408005348; MAA T C, 1971, Pacific Insects Monograph, V(28, P1; MALMQVIST B, 2004, P ROY SOC LOND B BIO, V271, P152; Martins-Hatano F, 2002, J PARASITOL, V88, P36, DOI 10.1645/0022-3395(2002)088[0036:EAHSOL]2.0.CO;2; MATTHYSSE JG, 1990, EXP AP ARACOL, V8, P221; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Morand S, 2002, PARASITOLOGY, V124, pS57, DOI 10.1017/S0031182002001464; Murrell BP, 2003, J MED ENTOMOL, V40, P682, DOI 10.1603/0022-2585-40.5.682; MUZAFFAR SSB, 2000, THESIS MEMORIAL U NE; Nelder MP, 2005, VET PARASITOL, V129, P313, DOI 10.1016/j.vetpar.2004.02.029; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; OLLERTON J, 2007, P R SOC B, V217, P591; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; PARKER DD, 1959, J PARASITOL, V45, P597, DOI 10.2307/3274808; PHILIP CORNELIUS B., 1938, JOUR PARASITOL, V24, P483, DOI 10.2307/3272274; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Poulin R, 2001, INT J PARASITOL, V31, P1194, DOI 10.1016/S0020-7519(01)00262-4; PRICE MA, 1997, TECHNICAL B USDA, V1849; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; RHODE K, 1995, INT J PARASITOL, V25, P945; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Roberts F.H.S., 1970, AUSTR TICKS; Rohde K, 1998, INT J PARASITOL, V28, P461, DOI 10.1016/S0020-7519(97)00209-9; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; STARK HE, 1958, SIPHONAPTERA UTAH; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tenquist JD, 2001, J ROY SOC NEW ZEAL, V31, P481, DOI 10.1080/03014223.2001.9517666; Thebault E, 2008, OIKOS, V117, P555, DOI 10.1111/j.0030-1299.2008.16485.x; THOMPSON G. B., 1939, TRANS SOC BRIT ENT, V6, P1; Thompson GB, 1935, J ANIM ECOL, V4, P192, DOI 10.2307/1008; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; UILENGBERG G, 1979, TICKS MADAGASCAR IXO; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; VAZQUEZ DP, 2008, INTERACTION WEB DATA; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Wenzel RL., 1966, ECTOPARASITES PANAMA, DOI [10.5962/bhl.title.2633, DOI 10.5962/BHL.TITLE.2633]; Whitaker J. O, 1982, ECTOPARASITES MAMMAL; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; Wilson N, 2003, J BIOGEOGR, V30, P1207, DOI 10.1046/j.1365-2699.2003.00894.x; Worthen WB, 1996, OIKOS, V75, P471, DOI 10.2307/3545888; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2; Zar J. H., 1996, BIOSTATISTICAL ANAL	104	56	56	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7873	10.1371/journal.pone.0007873	http://dx.doi.org/10.1371/journal.pone.0007873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924299	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700010
J	Dunn, TA; Storm, DR; Feller, MB				Dunn, Timothy A.; Storm, Daniel R.; Feller, Marla B.			Calcium-Dependent Increases in Protein Kinase-A Activity in Mouse Retinal Ganglion Cells Are Mediated by Multiple Adenylate Cyclases	PLOS ONE			English	Article							BARREL MAP DEVELOPMENT; ELECTRICAL-ACTIVITY; SUBCELLULAR DYNAMICS; RETINOTOPIC MAP; SPERM-MOTILITY; CYCLIC-AMP; RAT RETINA; GROWTH; REFINEMENT; CAMP	Neurons undergo long term, activity dependent changes that are mediated by activation of second messenger cascades. In particular, calcium-dependent activation of the cyclic-AMP/Protein kinase A signaling cascade has been implicated in several developmental processes including cell survival, axonal outgrowth, and axonal refinement. The biochemical link between calcium influx and the activation of the cAMP/PKA pathway is primarily mediated through adenylate cyclases. Here, dual imaging of intracellular calcium concentration and PKA activity was used to assay the role of different classes of calcium-dependent adenylate cyclases (ACs) in the activation of the cAMP/PKA pathway in retinal ganglion cells (RGCs). Surprisingly, depolarization-induced calcium-dependent PKA transients persist in barrelless mice lacking AC1, the predominant calcium-dependent adenylate cyclase in RGCs, as well as in double knockout mice lacking both AC1 and AC8. Furthermore, in a subset of RGCs, depolarization-induced PKA transients persist during the inhibition of all transmembrane adenylate cyclases. These results are consistent with the existence of a soluble adenylate cyclase that plays a role in calcium-dependent activation of the cAMP/PKA cascade in neurons.			Dunn, TA (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	mfeller@berkeley.edu			NEI NIH HHS [R21 EY016417, R21 EY016417-02, R01EY013528, R01 EY013528, R01 EY013528-09] Funding Source: Medline; NIEHS NIH HHS [R01 ES015594, R01ES015594] Funding Source: Medline; NIMH NIH HHS [MH 073601, R01 MH073601] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013528, R21EY016417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdel-Majid RM, 2002, MOL BRAIN RES, V101, P62, DOI 10.1016/S0169-328X(02)00163-8; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; BORODINSKY LN, 2006, SCI STKE, pPE22; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARBECK MC, 2006, SCI STKE, pPL6; KAIN K, 2005, TRANSIENT ADHESION M; Koulen P, 1999, J NEUROSCI RES, V56, P397; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Moore SW, 2008, J NEUROSCI, V28, P3920, DOI 10.1523/JNEUROSCI.0547-08.2008; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2005, J COMP NEUROL, V486, P281, DOI 10.1002/cne.20528; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Plas DT, 2004, VISION RES, V44, P3357, DOI 10.1016/j.visres.2004.09.036; Qu J, 2008, DEV NEUROBIOL, V68, P1196, DOI 10.1002/dneu.20653; Santone R, 2006, J NEUROSCI RES, V84, P1020, DOI 10.1002/jnr.21009; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; SCHAMBRA B, 1994, NEUROSCIENCE, V62, P65, DOI 10.1016/0306-4522(94)90315-8; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wong ST, 2001, J BIOL CHEM, V276, P34206, DOI 10.1074/jbc.M103923200; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	52	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7877	10.1371/journal.pone.0007877	http://dx.doi.org/10.1371/journal.pone.0007877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924297	gold, Green Published, Green Submitted			2022-12-27	WOS:000271854200022
J	Waitumbi, JN; Anyona, SB; Hunja, CW; Kifude, CM; Polhemus, ME; Walsh, DS; Ockenhouse, CF; Heppner, DG; Leach, A; Lievens, M; Ballou, WR; Cohen, JD; Sutherland, CJ				Waitumbi, John N.; Anyona, Samuel B.; Hunja, Carol W.; Kifude, Carolyne M.; Polhemus, Mark E.; Walsh, Douglas S.; Ockenhouse, Chris F.; Heppner, D. Gray, Jr.; Leach, Amanda; Lievens, Marc; Ballou, W. Ripley; Cohen, Joe D.; Sutherland, Colin J.			Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PHASE 2A TRIAL; PLASMODIUM-FALCIPARUM; NAIVE ADULTS; DOUBLE-BLIND; EFFICACY; SAFETY; CHILDREN; IMMUNOGENICITY; DISEASE	Objective: RTS, S, a candidate vaccine for malaria, is a recombinant protein expressed in yeast containing part of the circumsporozoite protein (CSP) sequence of 3D7 strain of Plasmodium falciparum linked to the hepatitis B surface antigen in a hybrid protein. The RTS, S antigen is formulated with GSK Biologicals' proprietary Adjuvant Systems AS02(A) or AS01(B). A recent trial of the RTS,S/AS02(A) and RTS,S/AS01(B) vaccines evaluated safety, immunogenicity and impact on the development of parasitemia of the two formulations. Parasite isolates from this study were used to determine the molecular impact of RTS,S/AS02(A) and RTS,S/AS01(B) on the multiplicity of infection (MOI) and the csp allelic characteristics of subsequent parasitemias. Design: The distribution of csp sequences and the MOI of the infecting strains were examined at baseline and in breakthrough infections from vaccinated individuals and from those receiving a non-malarial vaccine. Setting: The study was conducted in Kombewa District, western Kenya. Participants: Semi-immune adults from the three study arms provided isolates at baseline and during break-through infections. Outcome: Parasite isolates used for determining MOI and divergence of csp T cell-epitopes were 191 at baseline and 87 from break-through infections. Results: Grouping recipients of RTS,S/AS01A and RTS,S/AS02B together, vaccine recipients identified as parasite-positive by microscopy contained significantly fewer parasite genotypes than recipients of the rabies vaccine comparator (median in pooled RTS, S groups: 3 versus 4 in controls, P = 0.0313). When analyzed separately, parasitaemic individuals in the RTS,S/AS01(B) group, but not the RTS,S/AS02(A) group, were found to have significantly fewer genotypes than the comparator group. Two individual amino acids found in the vaccine construct (Q339 in Th2R and D371 in Th3R) were observed to differ in incidence between vaccine and comparator groups but in different directions; parasites harboring Q339 were less common among pooled RTS,S/AS vaccine recipients than among recipients of rabies vaccine, whereas parasites with D371 were more common among the RTS,S/AS groups. Conclusions: It is concluded that both RTS,S/AS vaccines reduce multiplicity of infection. Our results do not support the hypothesis that RTS,S/AS vaccines elicit preferential effects against pfcsp alleles with sequence similarity to the 3D7 pfcsp sequence employed in the vaccine construct.			Waitumbi, JN (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya.	jwaitumbi@wrp-ksm.org	Leach, Amanda/AAS-1120-2020; Sutherland, Colin/AAN-3939-2020	Leach, Amanda/0000-0002-7114-9967; Sutherland, Colin/0000-0003-1592-6407; Kifude, Carolyne/0000-0002-0361-8645; ANYONA, SAMUEL B./0000-0001-5813-4018; Hunja, Carol/0000-0001-8122-4927				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2003, LANCET INFECT DIS, V3, P317; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Cortes A, 2004, EXP PARASITOL, V106, P22, DOI 10.1016/j.exppara.2004.01.010; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; *GLOB FUND FIGHT A, CURR GRANT COMM DISB; *GLOB FUND FIGHT A, 2006, FUND GLOB FIGHT HIV; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lengeler C, 2004, COCHRANE DB SYST REV, V2; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Stewart VA, 2006, VACCINE, V24, P6493, DOI 10.1016/j.vaccine.2006.06.035; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093	34	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7849	10.1371/journal.pone.0007849	http://dx.doi.org/10.1371/journal.pone.0007849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924281	Green Submitted, Green Published, gold			2022-12-27	WOS:000271854200005
J	Badea, TC; Hua, ZL; Smallwood, PM; Williams, J; Rotolo, T; Ye, X; Nathans, J				Badea, Tudor C.; Hua, Zhong L.; Smallwood, Philip M.; Williams, John; Rotolo, Thomas; Ye, Xin; Nathans, Jeremy			New Mouse Lines for the Analysis of Neuronal Morphology Using CreER(T)/loxP-Directed Sparse Labeling	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CRE-MEDIATED RECOMBINATION; DOPAMINERGIC AMACRINE CELL; TYROSINE-HYDROXYLASE; RABBIT RETINA; RAT-BRAIN; QUANTITATIVE-ANALYSIS; GENE-EXPRESSION; MONKEY RETINA; MICE	Background: Pharmacologic control of Cre-mediated recombination using tamoxifen-dependent activation of a Cre-estrogen receptor ligand binding domain fusion protein [CreER(T)] is widely used to modify and/or visualize cells in the mouse. Methods and Findings: We describe here two new mouse lines, constructed by gene targeting to the Rosa26 locus to facilitate Cre-mediated cell modification. These lines should prove particularly useful in the context of sparse labeling experiments. The R26rtTACreER line provides ubiquitous expression of CreER under transcriptional control by the tetracycline reverse transactivator (rtTA); dual control by doxycycline and tamoxifen provides an extended dynamic range of Cre-mediated recombination activity. The R26IAP line provides high efficiency Cre-mediated activation of human placental alkaline phosphatase (hPLAP), complementing the widely used, but low efficiency, Z/AP line. By crossing with mouse lines that direct cell-type specific CreER expression, the R26IAP line has been used to produce atlases of labeled cholinergic and catecholaminergic neurons in the mouse brain. The R26IAP line has also been used to visualize the full morphologies of retinal dopaminergic amacrine cells, among the largest neurons in the mammalian retina. Conclusions: The two new mouse lines described here expand the repertoire of genetically engineered mice available for controlled in vivo recombination and cell labeling using the Cre-lox system.			Badea, TC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	tbadea@mail.jhmi.edu; jnathans@jhmi.edu	Hua, Zhong/J-8149-2014; Badea, Tudor Constantin/B-1654-2018	Badea, Tudor Constantin/0000-0003-3086-6713; Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Backman CM, 2009, J NEUROSCI METH, V176, P16, DOI 10.1016/j.jneumeth.2008.08.024; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Lin B, 2006, J COMP NEUROL, V499, P797, DOI 10.1002/cne.21126; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Butcher Larry L., 1995, P1003; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; CASINI G, 1992, J COMP NEUROL, V326, P302, DOI 10.1002/cne.903260211; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forster A, 2005, NAT METHODS, V2, P27, DOI 10.1038/NMETH727; FOSTER GA, 1985, BRAIN RES, V330, P183, DOI 10.1016/0006-8993(85)90025-3; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heimer L., 1995, P579; HOKFELT T, 1977, MED BIOL, V55, P21; HOKFELT T, 1976, MED BIOL, V54, P427; KOLB H, 1990, J NEUROCYTOL, V19, P343, DOI 10.1007/BF01188404; Lin CX, 2009, GENESIS, V47, P352, DOI 10.1002/dvg.20506; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Macneil MA, 1999, J COMP NEUROL, V413, P305; MARIANI AP, 1988, J COMP NEUROL, V276, P81, DOI 10.1002/cne.902760106; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; MITROFANIS J, 1988, J COMP NEUROL, V276, P343, DOI 10.1002/cne.902760303; OLDFIELD BJ, 1995, RAT NERVOUS SYSTEM, P1003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; TRULSON ME, 1985, BRAIN RES BULL, V15, P229, DOI 10.1016/0361-9230(85)90142-X; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WULLE I, 1989, DEV BRAIN RES, V48, P59, DOI 10.1016/0165-3806(89)90093-X; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533	54	61	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7859	10.1371/journal.pone.0007859	http://dx.doi.org/10.1371/journal.pone.0007859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924248	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000013
J	King, GJ; Chen, KE; Robin, G; Forwood, JK; Heras, B; Thakur, AS; Kobe, B; Blomberg, SP; Martin, JL				King, Gordon J.; Chen, Kai-En; Robin, Gautier; Forwood, Jade K.; Heras, Begona; Thakur, Anil S.; Kobe, Bostjan; Blomberg, Simon P.; Martin, Jennifer L.			Interaction between Plate Make and Protein in Protein Crystallisation Screening	PLOS ONE			English	Article							HETEROGENEOUS NUCLEATION; WATER EQUILIBRATION; CRYSTALS; SURFACES	Background: Protein crystallisation screening involves the parallel testing of large numbers of candidate conditions with the aim of identifying conditions suitable as a starting point for the production of diffraction quality crystals. Generally, condition screening is performed in 96-well plates. While previous studies have examined the effects of protein construct, protein purity, or crystallisation condition ingredients on protein crystallisation, few have examined the effect of the crystallisation plate. Methodology/Principal Findings: We performed a statistically rigorous examination of protein crystallisation, and evaluated interactions between crystallisation success and plate row/column, different plates of same make, different plate makes and different proteins. From our analysis of protein crystallisation, we found a significant interaction between plate make and the specific protein being crystallised. Conclusions/Significance: Protein crystal structure determination is the principal method for determining protein structure but is limited by the need to produce crystals of the protein under study. Many important proteins are difficult to crystallise, so that identification of factors that assist crystallisation could open up the structure determination of these more challenging targets. Our findings suggest that protein crystallisation success may be improved by matching a protein with its optimal plate make.			King, GJ (corresponding author), Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld, Australia.	S.Blomberg1@uq.edu.au; j.martin@imb.uq.edu.au	Blomberg, Simone P/B-7613-2008; Forwood, Jade K/K-4123-2014; Heras, Begona/H-8686-2014; Kobe, Bostjan/D-1292-2009; Chen, Kai-En/T-8516-2019; Chen, Kevin Kai-En/D-2133-2017; King, Gordon/J-8718-2014; Martin, Jennifer L./A-6039-2010	Blomberg, Simone P/0000-0003-1062-0839; Forwood, Jade K/0000-0003-3267-9997; Heras, Begona/0000-0003-3469-7988; Kobe, Bostjan/0000-0001-9413-9166; Chen, Kai-En/0000-0003-1106-1629; Chen, Kevin Kai-En/0000-0003-1106-1629; Martin, Jennifer L./0000-0002-9225-8863				Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; ARAKALI SV, 1994, ACTA CRYSTALLOGR D, V50, P472, DOI 10.1107/S0907444994001770; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bergfors T., 1999, PROTEIN CRYSTALLIZAT; BLOW DM, 1994, PROTEIN SCI, V3, P1638, DOI 10.1002/pro.5560031003; BOX G.E.P., 2005, STAT EXPT DESIGN INN; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; CUDNEY R, 1994, ACTA CRYSTALLOGR D, V50, P414; Dai B., 2008, IME4 LINEAR MIXED EF; DETITTA GT, 1995, ACTA CRYSTALLOGR D, V51, P786, DOI 10.1107/S090744499500299X; Gelman A., 2004, BAYESIAN DATA ANAL; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Martins PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001998; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2018, R LANG ENV STAT COMP; Tang L, 2005, ACTA CRYSTALLOGR D, V61, P53, DOI 10.1107/S0907444904026009; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; Tickle I, 2004, CHEM SOC REV, V33, P558, DOI 10.1039/b314510g; Tosi G, 2008, ACTA CRYSTALLOGR D, V64, P1054, DOI 10.1107/S0907444908025079; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7851	10.1371/journal.pone.0007851	http://dx.doi.org/10.1371/journal.pone.0007851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924245	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000009
J	Baldassarre, M; Razinia, Z; Burande, CF; Lamsoul, I; Lutz, PG; Calderwood, DA				Baldassarre, Massimiliano; Razinia, Ziba; Burande, Clara F.; Lamsoul, Isabelle; Lutz, Pierre G.; Calderwood, David A.			Filamins Regulate Cell Spreading and Initiation of Cell Migration	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; STRUCTURAL BASIS; MOTILITY; MALFORMATIONS; COMPETITION; NEURONS; FILGAP	Mammalian filamins (FLNs) are a family of three large actin-binding proteins. FLNa, the founding member of the family, was implicated in migration by cell biological analyses and the identification of FLNA mutations in the neuronal migration disorder periventricular heterotopia. However, recent knockout studies have questioned the relevance of FLNa to cell migration. Here we have used shRNA-mediated knockdown of FLNa, FLNb or FLNa and FLNb, or, alternatively, acute proteasomal degradation of all three FLNs, to generate FLN-deficient cells and assess their ability to migrate. We report that loss of FLNa or FLNb has little effect on migration but that knockdown of FLNa and FLNb, or proteolysis of all three FLNs, impairs migration. The observed defect is primarily a deficiency in initiation of motility rather than a problem with maintenance of locomotion speed. FLN-deficient cells are also impaired in spreading. Re-expression of full length FLNa, but not re-expression of a mutated FLNa lacking immunoglobulin domains 19 to 21, reverts both the spreading and the inhibition of initiation of migration. Our results establish a role for FLNs in cell migration and spreading and suggest that compensation by other FLNs may mask phenotypes in single knockout or knockdown cells. We propose that interactions between FLNs and transmembrane or signalling proteins, mediated at least in part by immunoglobulin domains 19 to 21 are important for both cell spreading and initiation of migration.			Baldassarre, M (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	david.calderwood@yale.edu	Baldassarre, Massimiliano/E-6236-2011; Calderwood, David A/AAC-6954-2019; Baldassarre, Massimiliano/AAI-6581-2021; Lutz, Pierre/B-8822-2009	Baldassarre, Massimiliano/0000-0002-2498-4767; Calderwood, David A/0000-0002-0791-4142; Baldassarre, Massimiliano/0000-0002-2498-4767; Lutz, Pierre/0000-0003-0590-9101; Lamsoul, Isabelle/0000-0002-7769-5627	NIGMS NIH HHS [R01 GM068600] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fink JM, 1997, AM J HUM GENET, V61, P379, DOI 10.1086/514863; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; HARTWIG JH, 1980, J CELL BIOL, V87, P841, DOI 10.1083/jcb.87.3.841; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Meyer SC, 1998, J BIOL CHEM, V273, P3013, DOI 10.1074/jbc.273.5.3013; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Xie ZW, 1998, BIOCHEM BIOPH RES CO, V251, P914, DOI 10.1006/bbrc.1998.9506; Xu WF, 1998, BLOOD, V92, P1268, DOI 10.1182/blood.V92.4.1268.416k12_1268_1276; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	38	91	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7830	10.1371/journal.pone.0007830	http://dx.doi.org/10.1371/journal.pone.0007830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915675	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721900019
J	Seidelin, JB; Broom, OJ; Olsen, J; Nielsen, OH				Seidelin, Jakob Benedict; Broom, Oliver Jay; Olsen, Jorgen; Nielsen, Ole Haagen			Evidence for Impaired CARD15 Signalling in Crohn's Disease without Disease Linked Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MURAMYL DIPEPTIDE; FRAMESHIFT MUTATION; NOD2; PEPTIDOGLYCAN; ACTIVATION; INNATE; SUSCEPTIBILITY; MACROPHAGES; EXPRESSION	Background: Sensing of muramyl dipeptide (MDP) is impaired in Crohn's disease (CD) patients with disease-linked variants of the CARD15 (caspase activation and recruitment domain 15) gene. Animal studies suggest that normal CARD15 signalling prevents inflammatory bowel disease, and may be important for disease development in CD. However, only a small fraction of CD patients carry the disease linked CARD15 variants. The aim of this study was thus to investigate if changes could be found in CARD15 signalling in patients without disease associated CARD15 variants. Methodology/Principal Findings: By mapping the response to MDP in peripheral monocytes obtained from CD patients in remission not receiving immunosuppresives, an impaired response to MDP was found in patients without disease linked CARD15 variants compared to control monocytes. This impairment was accompanied by a decreased activation of I kappa B kinase alpha/beta (IKK alpha/beta), the initial step in the nuclear factor kappa B (NF kappa B) pathway, whereas activation of mitogen-activated protein (MAP)-kinases was unaffected. MDP additionally stimulates the inflammasome which is of importance for processing of cytokines. The inflammasome was constitutively activated in CD, but unresponsive to MDP both in CD and control monocytes. Conclusions/Significance: These results suggest that inhibited MDP-dependent pathways in CD patients not carrying the disease-associated CARD15 variants might be of importance for the pathogenesis of CD. The results reveal a dysfunctional immune response in CD patients, not able to sense relevant stimuli on the one hand, and on the other hand possessing constitutively active cytokine processing.			Seidelin, JB (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Gastroenterol, Med Sect, DK-1168 Copenhagen, Denmark.	jseidelin@dadlnet.dk	Nielsen, Ole Haagen/AAK-2482-2021; Seidelin, Jakob/B-7879-2013; Olsen, Jørgen/K-5355-2019	Nielsen, Ole Haagen/0000-0003-4612-8635; Seidelin, Jakob/0000-0003-3230-7966; Olsen, Jørgen/0000-0003-1974-6446				Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Korzenik JR, 2007, GUT, V56, P2, DOI 10.1136/gut.2006.095588; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; Milman N, 2007, RESPIRATION, V74, P76, DOI 10.1159/000090638; Mpofu CM, 2007, GASTROENTEROLOGY, V133, P1487, DOI 10.1053/j.gastro.2007.08.004; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peeters H, 2007, INT J IMMUNOGENET, V34, P181, DOI 10.1111/j.1744-313X.2007.00670.x; Riis L, 2007, INFLAMM BOWEL DIS, V13, P24, DOI 10.1002/ibd.20047; Seidelin JB, 2006, APMIS, V114, P508, DOI 10.1111/j.1600-0463.2006.apm_116.x; SINGER H, 1995, J EXP MED, V182, P1447; Uehori J, 2005, J IMMUNOL, V174, P7096, DOI 10.4049/jimmunol.174.11.7096; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7794	10.1371/journal.pone.0007794	http://dx.doi.org/10.1371/journal.pone.0007794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907652	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721400003
J	Anderson, MG; Moskat, C; Ban, M; Grim, T; Cassey, P; Hauber, ME				Anderson, Michael G.; Moskat, Csaba; Ban, Miklos; Grim, Tomas; Cassey, Phillip; Hauber, Mark E.			Egg Eviction Imposes a Recoverable Cost of Virulence in Chicks of a Brood Parasite	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; COMMON CUCKOO; REED WARBLERS; GROWTH; HOST; NESTLINGS; YOUNG; REJECTION; BEHAVIOR; NESTS	Background: Chicks of virulent brood parasitic birds eliminate their nestmates and avoid costly competition for foster parental care. Yet, efforts to evict nest contents by the blind and naked common cuckoo Cuculus canorus hatchling are counterintuitive as both adult parasites and large older cuckoo chicks appear to be better suited to tossing the eggs and young of the foster parents. Methodology/Principal Findings: Here we show experimentally that egg tossing imposed a recoverable growth cost of mass gain in common cuckoo chicks during the nestling period in nests of great reed warbler Acrocephalus arundinaceus hosts. Growth rates of skeletal traits and morphological variables involved in the solicitation of foster parental care remained similar between evictor and non-evictor chicks throughout development. We also detected no increase in predation rates for evicting nests, suggesting that egg tossing behavior by common cuckoo hatchlings does not increase the conspicuousness of nests. Conclusion: The temporary growth cost of egg eviction by common cuckoo hatchlings is the result of constraints imposed by rejecter host adults and competitive nestmates on the timing and mechanism of parasite virulence.			Anderson, MG (corresponding author), Massey Univ, Inst Nat Sci, Ecol & Conservat Grp, Albany Campus, Auckland, New Zealand.	mark.hauber@hunter.cuny.edu	Anderson, Michael G/E-3229-2010; Anderson, Michael/AAE-6706-2019; Grim, Tomas/A-2852-2008	Cassey, Phillip/0000-0002-2626-0172; Anderson, Michael/0000-0002-6981-8199; Grim, Tomas/0000-0002-5775-6269				Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; Antonov A, 2006, BEHAV ECOL SOCIOBIOL, V60, P11, DOI 10.1007/s00265-005-0132-6; Antonov A, 2008, ANIM BEHAV, V76, P1893, DOI 10.1016/j.anbehav.2008.08.016; Aviles JM, 2009, AUK, V126, P431, DOI 10.1525/auk.2009.08162; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1998, P ROY SOC B-BIOL SCI, V265, P673, DOI 10.1098/rspb.1998.0346; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dearborn DC, 1999, AUK, V116, P448, DOI 10.2307/4089378; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; Gil D, 2008, P R SOC B, V275, P549, DOI 10.1098/rspb.2007.1360; Grafen A., 2002, MODERN STAT LIFE SCI; Gridi-Papp M, 2006, NATURE, V442, P257, DOI 10.1038/442257b; Grim Tomas, 2006, Ornithological Science, V5, P237; Grim T, 2006, BEHAV ECOL SOCIOBIOL, V60, P716, DOI 10.1007/s00265-006-0215-z; Grim T, 2009, BEHAV ECOL, V20, P1138, DOI 10.1093/beheco/arp108; Grim T, 2009, ETHOLOGY, V115, P14, DOI 10.1111/j.1439-0310.2008.01574.x; Hansson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002794; Hauber ME, 2008, BEHAV ECOL, V19, P79, DOI 10.1093/beheco/arm108; Honza M, 2007, J AVIAN BIOL, V38, P385, DOI 10.1111/j.2007.0908-8857.03901.x; Hoover JP, 2006, OECOLOGIA, V149, P165, DOI 10.1007/s00442-006-0424-1; Jenner E, 1788, PHILOS T ROY SOC LON, V78, P219, DOI DOI 10.1098/RSTL.1788.0016; Kilner Rebecca M., 2006, Ornithological Science, V5, P243, DOI 10.2326/1347-0558(2006)5[243:RTGFCO]2.0.CO;2; Kilner Rebecca M., 2005, Ornithological Science, V4, P55, DOI 10.2326/osj.4.55; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kleven O, 1999, BEHAV ECOL SOCIOBIOL, V47, P41, DOI 10.1007/s002650050647; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Martin-Galvez D, 2005, ANIM BEHAV, V70, P1313, DOI 10.1016/j.anbehav.2005.03.031; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Moskat C, 2008, J AVIAN BIOL, V39, P663, DOI 10.1111/j.1600-048X.2008.04359.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Payne RB, 1998, BEHAV ECOL, V9, P64, DOI 10.1093/beheco/9.1.64; Polacikova L, 2009, EVOL ECOL, V23, P879, DOI 10.1007/s10682-008-9278-9; Rutila J, 2002, J AVIAN BIOL, V33, P414, DOI 10.1034/j.1600-048X.2002.02937.x; Saino N, 1998, OIKOS, V81, P217, DOI 10.2307/3547043; Schulze-Hagen K, 2009, J ORNITHOL, V150, P1, DOI 10.1007/s10336-008-0340-8; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Soler M, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P413, DOI 10.1007/0-306-47660-6_21; Soler Manuel, 2001, Acta Ethologica, V4, P59, DOI 10.1007/s102110100047; Wyllie I., 1981, CUCKOO	46	47	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A67	A73	e7725	10.1371/journal.pone.0007725	http://dx.doi.org/10.1371/journal.pone.0007725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907639	Green Published, gold			2022-12-27	WOS:000271685800008
J	Soumahoro, MK; Gerardin, P; Boelle, PY; Perrau, J; Fianu, A; Pouchot, J; Malvy, D; Flahault, A; Favier, F; Hanslik, T				Soumahoro, Man-Koumba; Gerardin, Patrick; Boelle, Pierre-Yves; Perrau, Joelle; Fianu, Adrian; Pouchot, Jacques; Malvy, Denis; Flahault, Antoine; Favier, Francois; Hanslik, Thomas			Impact of Chikungunya Virus Infection on Health Status and Quality of Life: A Retrospective Cohort Study	PLOS ONE			English	Article							REUNION ISLAND OUTBREAK; RHEUMATIC MANIFESTATIONS; RISK-FACTORS; DISEASE; BURDEN; ALPHAVIRUSES; PREVALENCE; DISORDERS; TRAVELERS; SYMPTOMS	Background: Persistent symptoms, mainly joint and muscular pain and depression, have been reported several months after Chikungunya virus (CHIKV) infection. Their frequency and their impact on quality of life have not been compared with those of an unexposed population. In the present study, we aimed to describe the frequency of prolonged clinical manifestations of CHIKV infection and to measure the impact on quality of life and health care consumption in comparison with that of an unexposed population, more than one year after infection. Methodology/Principal Findings: In a retrospective cohort study, 199 subjects who had serologically confirmed CHIKV infection (CHIK+) were compared with 199 sero-negative subjects (CHIK-) matched for age, gender and area of residence in La Reunion Island. Following an average time of 17 months from the acute phase of infection, participants were interviewed by telephone about current symptoms, medical consumption during the last 12 months and quality of life assessed by the 12-items Short-Form Health Survey (SF-12) scale. At the time of study, 112 (56%) CHIK+ persons reported they were fully recovered. CHIK+ complained more frequently than CHIK- of arthralgia (relative risk = 1.9; 95% confidence interval: 1.6-2.2), myalgia (1.9; 1.5-2.3), fatigue (2.3; 1.8-3), depression (2.5; 1.5-4.1) and hair loss (3.8; 1.9-7.6). There was no significant difference between CHIK+ and CHIK- subjects regarding medical consumption in the past year. The mean (SD) score of the SF-12 Physical Component Summary was 46.4 (10.8) in CHIK+ versus 49.1 (9.3) in CHIK- (p = 0.04). There was no significant difference between the two groups for the Mental Component Summary. Conclusions/Significance: More than one year following the acute phase of infection, CHIK+ subjects reported more disabilities than those who were CHIK-. These persistent disabilities, however, have no significant influence on medical consumption, and the impact on quality of life is moderate.			Soumahoro, MK (corresponding author), Univ Paris 06, Unite Mixte Rech Sante 707, Paris, France.	soumahor@u707.jussieu.fr	MALVY, Denis/T-7930-2019	Soumahoro, Man-Koumba/0000-0002-6482-3917; Boelle, Pierre-Yves/0000-0002-5367-8232				Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BRIGHTON SW, 1983, S AFR MED J, V63, P313; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; CONDON RJ, 1995, CLIN DIAGN VIROL, V3, P273, DOI 10.1016/S0928-0197(94)00043-3; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Cummings P, 2004, STATA J, V4, P274, DOI 10.1177/1536867X0400400305; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; FLAHAULT A, 2007, B ACAD NATL MED, V191, P125; Flahault A, 2007, B ACAD NAT MED PARIS, V191, P113, DOI 10.1016/S0001-4079(19)33100-0; FOURIE ED, 1979, S AFR MED J, V56, P130; Gandhi SK, 2001, CLIN THER, V23, P1080, DOI 10.1016/S0149-2918(01)80093-X; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002; Harley D, 2002, MED J AUSTRALIA, V177, P352, DOI 10.5694/j.1326-5377.2002.tb04836.x; Harley D, 2001, RHEUMATOLOGY, V40, P1319, DOI 10.1093/rheumatology/40.11.1319; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Hickie I, 2009, AUST NZ J PSYCHIAT, V43, P25, DOI 10.1080/00048670802534432; Hoffman DL, 2008, INT J CLIN PRACT, V62, P115, DOI 10.1111/j.1742-1241.2007.01638.x; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x; Laine M, 2002, RHEUMATOLOGY, V41, P829, DOI 10.1093/rheumatology/41.7.829; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Lokireddy S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-31; Mylonas AD, 2002, MED J AUSTRALIA, V177, P356, DOI 10.5694/j.1326-5377.2002.tb04837.x; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; PARDIGON N, 2008, PATHOL BIOL PARIS; Parola P, 2007, CLIN INFECT DIS, V45, P801, DOI 10.1086/521171; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Porterfield J. S., 1980, TOGAVIRUSES BIOL STR, P13; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Ramos-e-Silva M, 2008, CLIN DERMATOL, V26, P296, DOI 10.1016/j.clindermatol.2007.10.019; Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; Volpe A, 2008, REUMATISMO, V60, P136, DOI 10.4081/reumatismo.2008.136; WALKER G. M., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P496, DOI 10.1016/0035-9203(62)90073-1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	46	88	93	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A221	A226	e7800	10.1371/journal.pone.0007800	http://dx.doi.org/10.1371/journal.pone.0007800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19911058	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800023
J	Mazzucchelli, RI; Warming, S; Lawrence, SM; Ishii, M; Abshari, M; Washington, AV; Feigenbaum, L; Warner, AC; Sims, DJ; Li, WQ; Hixon, JA; Gray, DHD; Rich, BE; Morrow, M; Anver, MR; Cherry, J; Naf, D; Sternberg, LR; McVicar, DW; Farr, AG; Germain, RN; Rogers, K; Jenkins, NA; Copeland, NG; Durum, SK				Mazzucchelli, Renata I.; Warming, Soren; Lawrence, Scott M.; Ishii, Masaru; Abshari, Mehrnoosh; Washington, A. Valance; Feigenbaum, Lionel; Warner, Andrew C.; Sims, Davis J.; Li, Wen Qing; Hixon, Julie A.; Gray, Daniel H. D.; Rich, Benjamin E.; Morrow, Matthew; Anver, Miriam R.; Cherry, James; Naf, Dieter; Sternberg, Lawrence R.; McVicar, Daniel W.; Farr, Andrew G.; Germain, Ronald N.; Rogers, Keith; Jenkins, Nancy A.; Copeland, Neal G.; Durum, Scott K.			Visualization and Identification of IL-7 Producing Cells in Reporter Mice	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; CYTOKINE GENE-EXPRESSION; SEVERE COMBINED IMMUNODEFICIENCY; INTESTINAL EPITHELIAL-CELLS; HUMAN DENDRITIC CELLS; THYMIC STROMAL CELLS; EPIDERMAL T-CELLS; MESSENGER-RNA; IN-VIVO; INTERLEUKIN (IL)-7	Interleukin-7 (IL-7) is required for lymphocyte development and homeostasis although the actual sites of IL-7 production have never been clearly identified. We produced a bacterial artificial chromosome (BAC) transgenic mouse expressing ECFP in the Il7 locus. The construct lacked a signal peptide and ECFP (enhanced cyan fluorescent protein) accumulated inside IL-7-producing stromal cells in thoracic thymus, cervical thymus and bone marrow. In thymus, an extensive reticular network of IL-7-containing processes extended from cortical and medullary epithelial cells, closely contacting thymocytes. Central memory CD8 T cells, which require IL-7 and home to bone marrow, physically associated with IL-7-producing cells as we demonstrate by intravital imaging.			Mazzucchelli, RI (corresponding author), HSR TIGET, San Raffaele Telethon Inst Gene Therapy, Lab Gene Therapy & Primary Immunodeficiency, Milan, Italy.	durums@ncifcrf.gov	McVicar, Daniel/G-1970-2015; Gray, Daniel HD/A-3293-2013; Germain, Ronald N./Z-1945-2019; Warming, Soren/ABD-5729-2021; Germain, Ronald/ABE-7090-2020	Gray, Daniel HD/0000-0002-8457-8242; Abshari, Mehrnoosh/0000-0003-4217-0625; Warming, Soren/0000-0002-5721-0741; McVicar, Daniel/0000-0002-1112-5111; durum, scott/0000-0003-1307-9582	NATIONAL CANCER INSTITUTE [ZIABC009287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ariel A, 1997, EUR J IMMUNOL, V27, P2562, DOI 10.1002/eji.1830271015; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dooley J, 2006, J IMMUNOL, V176, P6484, DOI 10.4049/jimmunol.176.11.6484; FUNK PE, 1995, BLOOD, V86, P2661; Golden-Mason L, 2001, CYTOKINE, V14, P143, DOI 10.1006/cyto.2001.0852; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; GUNJI Y, 1991, BLOOD, V77, P2612; HE W, 1995, J IMMUNOL, V154, P3726; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kitazawa H, 1997, J IMMUNOL, V159, P2259; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Kroncke R, 1996, EUR J IMMUNOL, V26, P2541, DOI 10.1002/eji.1830261040; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Madrigal-Estebas L, 1997, HUM IMMUNOL, V58, P83, DOI 10.1016/S0198-8859(97)00230-9; MATSUE H, 1993, J INVEST DERMATOL, V101, P537, DOI 10.1111/1523-1747.ep12365917; MATSUE H, 1993, J IMMUNOL, V151, P6012; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MONTGOMERY RA, 1991, J IMMUNOL, V147, P554; Montgomery RA, 1997, CYTOKINE, V9, P717, DOI 10.1006/cyto.1997.0227; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; Murray AM, 1998, CYTOKINE, V10, P337, DOI 10.1006/cyto.1997.0302; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 2000, CURR OPIN IMMUNOL, V12, P468, DOI 10.1016/S0952-7915(00)00122-9; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Roye O, 1998, J IMMUNOL, V161, P4161; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Soslau G, 1997, CYTOKINE, V9, P405, DOI 10.1006/cyto.1996.0182; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Takeuchi T, 1998, HISTOPATHOLOGY, V32, P383; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tsuda S, 1996, J IMMUNOL, V156, P3233; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; Williams IR, 1997, J IMMUNOL, V159, P3044; WITTE PL, 1993, EUR J IMMUNOL, V23, P1809, DOI 10.1002/eji.1830230812; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	50	91	102	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7637	10.1371/journal.pone.0007637	http://dx.doi.org/10.1371/journal.pone.0007637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19907640	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658800002
J	Kishida, K; Tominaga, M; Matsubara, K; Taguchi, M; Noguchi, M; Tsunawake, N; Shidoji, Y				Kishida, Kunihiro; Tominaga, Mihoko; Matsubara, Kiminori; Taguchi, Masanori; Noguchi, Masanori; Tsunawake, Noriaki; Shidoji, Yoshihiro			An Association Analysis between Mitochondrial DNA A10398G Polymorphism and Temperament in Japanese Young Adults	PLOS ONE			English	Article							HEALTH	The mitochondrial (mt) DNA C5178A and A10398G polymorphisms have been reported to be associated with mental disorders such as bipolar disorder. However, the effects of these polymorphisms on temperament in healthy people are poorly understood. Evaluating healthy subjects can have the advantage of providing new strategies for maintaining psychological health and preventing mental illness. We examined the association between mtDNA polymorphisms and temperament in Japanese students. There was no significant difference in examined temperament when analysed by genotypes, 5178-10398 haplotypes, or sex. The subgroup analysis based on sex indicated that there was an interactive effect of the mtDNA A10398G polymorphism and sex on anxiety and obsession. This finding is preliminary and cannot exclude the possibility of false-positive due to small sample size (144 subjects) and multiple statistical testing. Further studies involving a larger sample size or other ethnic groups are necessary to confirm that mtDNA A10398G polymorphism can be a genetic factor for temperament.			Kishida, K (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Nagasaki 852, Japan.	kunihiro@sun.ac.jp	MATSUBARA, Kiminori/N-9804-2019	Kishida, Kunihiro/0000-0001-8496-7857				Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Gong JS, 1998, J CLIN BIOCHEM NUTR, V24, P105; Kato C, 2004, AM J MED GENET B, V128B, P76, DOI 10.1002/ajmg.b.20141; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.3.CO;2-H; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Rizzuto R, 2001, CURR OPIN NEUROBIOL, V11, P306, DOI 10.1016/S0959-4388(00)00212-9; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Yoshida T, 1998, PSYCHIAT CLIN NEUROS, V52, P413, DOI 10.1046/j.1440-1819.1998.00411.x	12	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7763	10.1371/journal.pone.0007763	http://dx.doi.org/10.1371/journal.pone.0007763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898620	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000008
J	Antonova, I; Lu, FM; Zablow, L; Udo, H; Hawkins, RD				Antonova, Irina; Lu, Fang-Min; Zablow, Leonard; Udo, Hiroshi; Hawkins, Robert D.			Rapid and Long-Lasting Increase in Sites for Synapse Assembly during Late-Phase Potentiation in Rat Hippocampal Neurons	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; FUNCTIONAL PRESYNAPTIC BOUTONS; SINGLE DENDRITIC SPINES; TERM POTENTIATION; IN-VIVO; NITRIC-OXIDE; MORPHOLOGICAL-CHANGES; TRANSPORT PACKETS; SILENT SYNAPSES; MEMORY STORAGE	Long-term potentiation in hippocampal neurons has stages that correspond to the stages of learning and memory. Early-phase (10-30 min) potentiation is accompanied by rapid increases in clusters or puncta of presynaptic and postsynaptic proteins, which depend on actin polymerization but not on protein synthesis. We have now examined changes in pre- and postsynaptic puncta and structures during glutamate-induced late-phase ( 3 hr) potentiation in cultured hippocampal neurons. We find that ( 1) the potentiation is accompanied by long-lasting maintenance of the increases in puncta, which depends on protein synthesis, ( 2) most of the puncta and synaptic structures are very dynamic, continually assembling and disassembling at sites that are more stable than the puncta or structures themselves, ( 3) the increase in presynaptic puncta appears to be due to both rapid and more gradual increases in the number of sites where the puncta may form, and also to the stabilization of existing puncta, ( 4) under control conditions, puncta of postsynaptic proteins behave similarly to puncta of presynaptic proteins and share sites with them, and ( 5) the increase in presynaptic puncta is accompanied by a similar increase in presumably presynaptic structures, which may form at distinct as well as shared sites. The new sites could contribute to the transition between the early and late phase mechanisms of plasticity by serving as seeds for the formation and maintenance of new synapses, thus acting as local "tags'' for protein synthesis-dependent synaptic growth during late-phase plasticity.			Antonova, I (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	rdh1@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045108] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045108, NS 045108] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; ARANCIO O, 1995, NATURE, V74, P39; BAILEY CH, 2008, LEARNING MEMORY COMP; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Burette A, 2002, J NEUROSCI, V22, P8961; Calixto E, 2003, J NEUROSCI, V23, P4842; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Grabham PW, 2005, J NEUROBIOL, V64, P202, DOI 10.1002/neu.20133; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hu JY, 2006, J NEUROSCI, V26, P1026, DOI 10.1523/JNEUROSCI.4258-05.2006; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Ninan I, 2006, EMBO J, V25, P4361, DOI 10.1038/sj.emboj.7601318; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Sapoznik S, 2006, LEARN MEMORY, V13, P719, DOI 10.1101/lm.351706; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Villareal G, 2007, CURR BIOL, V17, P2073, DOI 10.1016/j.cub.2007.10.053; Voronin LL, 2004, J PHYSIOL-LONDON, V557, P3, DOI 10.1113/jphysiol.2003.058966; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Winer B.J., 1991, STAT PRINCIPLES EXPT; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	73	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7690	10.1371/journal.pone.0007690	http://dx.doi.org/10.1371/journal.pone.0007690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893634	Green Published, Green Submitted, gold			2022-12-27	WOS:000271478000002
J	Ghaghada, KB; Ravoori, M; Sabapathy, D; Bankson, J; Kundra, V; Annapragada, A				Ghaghada, Ketan B.; Ravoori, Murali; Sabapathy, Divya; Bankson, James; Kundra, Vikas; Annapragada, Ananth			New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging	PLOS ONE			English	Article							ENHANCED MR-ANGIOGRAPHY; LIPOSOMAL DOXORUBICIN; RELAXIVITY; SIZE	Background: Liposomal-based gadolinium (Gd) nanoparticles have elicited significant interest for use as blood pool and molecular magnetic resonance imaging (MRI) contrast agents. Previous generations of liposomal MR agents contained gadolinium-chelates either within the interior of liposomes (core-encapsulated gadolinium liposomes) or presented on the surface of liposomes (surface-conjugated gadolinium liposomes). We hypothesized that a liposomal agent that contained both core-encapsulated gadolinium and surface-conjugated gadolinium, defined herein as dual-mode gadolinium (Dual-Gd) liposomes, would result in a significant improvement in nanoparticle-based T1 relaxivity over the previous generations of liposomal agents. In this study, we have developed and tested, both in vitro and in vivo, such a dual-mode liposomal-based gadolinium contrast agent. Methodology/Principal Findings: Three types of liposomal agents were fabricated: core-encapsulated, surface-conjugated and dual-mode gadolinium liposomes. In vitro physico-chemical characterizations of the agents were performed to determine particle size and elemental composition. Gadolinium-based and nanoparticle-based T1 relaxivities of various agents were determined in bovine plasma. Subsequently, the agents were tested in vivo for contrast-enhanced magnetic resonance angiography (CE-MRA) studies. Characterization of the agents demonstrated the highest gadolinium atoms per nanoparticle for Dual-Gd liposomes. In vitro, surface- conjugated gadolinium liposomes demonstrated the highest T1 relaxivity on a gadolinium-basis. However, Dual-Gd liposomes demonstrated the highest T1 relaxivity on a nanoparticlebasis. In vivo, Dual-Gd liposomes resulted in the highest signal-to-noise ratio (SNR) and contrast-to-noise ratio in CE-MRA studies. Conclusions/Significance: The dual-mode gadolinium liposomal contrast agent demonstrated higher particle-based T1 relaxivity, both in vitro and in vivo, compared to either the core-encapsulated or the surface- conjugated liposomal agent. The dual-mode gadolinium liposomes could enable reduced particle dose for use in CE-MRA and increased contrast sensitivity for use in molecular imaging.			Ghaghada, KB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX USA.	ananth.annapragada@uth.tmc.edu	Annapragada, Ananth/GOK-1576-2022; Bankson, James A./J-9798-2014; Ghaghada, Ketan/F-6825-2012	Bankson, James A./0000-0002-8574-154X; Annapragada, Ananth/0000-0002-3156-9617	NATIONAL CANCER INSTITUTE [P30CA016672, P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071504] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672, P50 CA140388, P30-CA016672] Funding Source: Medline; NIDDK NIH HHS [R90 DK071504, R90 DK71504] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anzalone Nicoletta, 2006, Eur Radiol, V16 Suppl 7, pM27, DOI 10.1007/s10406-006-0193-2; Ayyagari AL, 2006, MAGN RESON MED, V55, P1023, DOI 10.1002/mrm.20846; Bremerich J, 2007, EUR RADIOL, V17, P3017, DOI 10.1007/s00330-007-0712-0; Bucholz E, 2008, MAGN RESON MED, V60, P111, DOI 10.1002/mrm.21618; Choyke PL, 2003, J MAGN RESON IMAGING, V17, P509, DOI 10.1002/jmri.10304; Frias JC, 2004, J AM CHEM SOC, V126, P16316, DOI 10.1021/ja044911a; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Ghaghada KB, 2007, AM J NEURORADIOL, V28, P48; Ghaghada KB, 2005, J CONTROL RELEASE, V104, P113, DOI 10.1016/j.jconrel.2005.01.012; Ghaghada K, 2008, ACAD RADIOL, V15, P1259, DOI 10.1016/j.acra.2008.04.018; Hadizadeh DR, 2008, RADIOLOGY, V249, P701, DOI 10.1148/radiol.2492072033; Ishida O, 1999, INT J PHARM, V190, P49, DOI 10.1016/S0378-5173(99)00256-2; Karathanasis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005843; Knopp MV, 2003, J MAGN RESON IMAGING, V17, P694, DOI 10.1002/jmri.10313; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; McNeeley KM, 2009, BIOMATERIALS, V30, P3986, DOI 10.1016/j.biomaterials.2009.04.012; Mulder WJM, 2004, BIOCONJUGATE CHEM, V15, P799, DOI 10.1021/bc049949r; Port M, 2005, INVEST RADIOL, V40, P565, DOI 10.1097/01.rli.0000175388.98721.9b; Rosen MA, 2007, CLIN CANCER RES, V13, p770S, DOI 10.1158/1078-0432.CCR-06-1921; Saul JM, 2003, J CONTROL RELEASE, V92, P49, DOI 10.1016/S0168-3659(03)00295-5; Storrs RW, 1995, JMRI-J MAGN RESON IM, V5, P719, DOI 10.1002/jmri.1880050617; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; TILCOCK C, 1989, RADIOLOGY, V171, P77, DOI 10.1148/radiology.171.1.2928549; Tran TD, 2007, INT J NANOMED, V2, P515; Winter PM, 2003, MAGNET RESON MED, V50, P411, DOI 10.1002/mrm.10532; Zhang HL, 2007, J MAGN RESON IMAGING, V25, P13, DOI 10.1002/jmri.20767	26	73	79	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7628	10.1371/journal.pone.0007628	http://dx.doi.org/10.1371/journal.pone.0007628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893616	Green Submitted, Green Published, gold			2022-12-27	WOS:000271232000007
J	Jiang, XJ; Li, SB; Ravi, V; Venkatesh, B; Yu, WP				Jiang, Xiao-Juan; Li, Shaobing; Ravi, Vydianathan; Venkatesh, Byrappa; Yu, Wei-Ping			Identification and Comparative Analysis of the Protocadherin Cluster in a Reptile, the Green Anole Lizard	PLOS ONE			English	Article							CNR/PCDH-ALPHA GENES; GAMMA-PROTOCADHERINS; EVOLUTIONARY HISTORY; SEQUENCE-ANALYSIS; GENOMIC SEQUENCE; FAMILY; EXPRESSION; DIVERSITY; ORGANIZATION; SELECTION	Background: The vertebrate protocadherins are a subfamily of cell adhesion molecules that are predominantly expressed in the nervous system and are believed to play an important role in establishing the complex neural network during animal development. Genes encoding these molecules are organized into a cluster in the genome. Comparative analysis of the protocadherin subcluster organization and gene arrangements in different vertebrates has provided interesting insights into the history of vertebrate genome evolution. Among tetrapods, protocadherin clusters have been fully characterized only in mammals. In this study, we report the identification and comparative analysis of the protocadherin cluster in a reptile, the green anole lizard (Anolis carolinensis). Methodology/Principal Findings: We show that the anole protocadherin cluster spans over a megabase and encodes a total of 71 genes. The number of genes in the anole protocadherin cluster is significantly higher than that in the coelacanth (49 genes) and mammalian (54-59 genes) clusters. The anole protocadherin genes are organized into four subclusters: the delta, alpha, beta and gamma. This subcluster organization is identical to that of the coelacanth protocadherin cluster, but differs from the mammalian clusters which lack the delta subcluster. The gene number expansion in the anole protocadherin cluster is largely due to the extensive gene duplication in the gamma b subgroup. Similar to coelacanth and elephant shark protocadherin genes, the anole protocadherin genes have experienced a low frequency of gene conversion. Conclusions/Significance: Our results suggest that similar to the protocadherin clusters in other vertebrates, the evolution of anole protocadherin cluster is driven mainly by lineage-specific gene duplications and degeneration. Our analysis also shows that loss of the protocadherin delta subcluster in the mammalian lineage occurred after the divergence of mammals and reptiles. We present a model for the evolutionary history of the protocadherin cluster in tetrapods.			Jiang, XJ (corresponding author), Natl Inst Neurosci, Gene Regulat Lab, Singapore, Singapore.	weiping_yu@nni.com.sg	Ravi, Vydianathan/B-2759-2009	Ravi, Vydianathan/0000-0003-0807-7697; Venkatesh, Byrappa/0000-0003-3620-0277				Blank M, 2004, MOL CELL NEUROSCI, V26, P530, DOI 10.1016/j.mcn.2004.04.008; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamada S, 2001, NEUROSCI RES, V41, P207, DOI 10.1016/S0168-0102(01)00281-4; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060; Phillips GR, 2003, J NEUROSCI, V23, P5096; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sugino H, 2004, BIOCHEM BIOPH RES CO, V316, P437, DOI 10.1016/j.bbrc.2004.02.067; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Vanhalst K, 2001, FEBS LETT, V495, P120, DOI 10.1016/S0014-5793(01)02372-9; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yanase H, 2004, GENOMICS, V83, P717, DOI 10.1016/j.ygeno.2003.09.022; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu WP, 2008, P NATL ACAD SCI USA, V105, P3819, DOI 10.1073/pnas.0800398105; Yu WP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-49; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7614	10.1371/journal.pone.0007614	http://dx.doi.org/10.1371/journal.pone.0007614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898614	Green Published, Green Submitted, gold			2022-12-27	WOS:000271232000005
J	Basso, M; Samengo, G; Nardo, G; Massignan, T; D'Alessandro, G; Tartari, S; Cantoni, L; Marino, M; Cheroni, C; De Biasi, S; Giordana, MT; Strong, MJ; Estevez, AG; Salmona, M; Bendotti, C; Bonetto, V				Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; D'Alessandro, Giuseppina; Tartari, Silvia; Cantoni, Lavinia; Marino, Marianna; Cheroni, Cristina; De Biasi, Silvia; Giordana, Maria Teresa; Strong, Michael J.; Estevez, Alvaro G.; Salmona, Mario; Bendotti, Caterina; Bonetto, Valentina			Characterization of Detergent-Insoluble Proteins in ALS Indicates a Causal Link between Nitrative Stress and Aggregation in Pathogenesis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NITRIC-OXIDE SYNTHASE; SOD1 TRANSGENIC MICE; SUPEROXIDE-DISMUTASE PROTEINS; MOTOR-NEURON DEGENERATION; MOUSE MODEL; SPINAL-CORD; HYALINE INCLUSIONS; CU,ZN-SUPEROXIDE DISMUTASE; DISEASE PROGRESSION	Background: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron disease, and protein aggregation has been proposed as a possible pathogenetic mechanism. However, the aggregate protein constituents are poorly characterized so knowledge on the role of aggregation in pathogenesis is limited. Methodology/Principal Findings: We carried out a proteomic analysis of the protein composition of the insoluble fraction, as a model of protein aggregates, from familial ALS (fALS) mouse model at different disease stages. We identified several proteins enriched in the detergent-insoluble fraction already at a preclinical stage, including intermediate filaments, chaperones and mitochondrial proteins. Aconitase, HSC70 and cyclophilin A were also significantly enriched in the insoluble fraction of spinal cords of ALS patients. Moreover, we found that the majority of proteins in mice and HSP90 in patients were tyrosine-nitrated. We therefore investigated the role of nitrative stress in aggregate formation in fALS- like murine motor neuron-neuroblastoma (NSC-34) cell lines. By inhibiting nitric oxide synthesis the amount of insoluble proteins, particularly aconitase, HSC70, cyclophilin A and SOD1 can be substantially reduced. Conclusion/Significance: Analysis of the insoluble fractions from cellular/mouse models and human tissues revealed novel aggregation-prone proteins and suggests that nitrative stress contribute to protein aggregate formation in ALS.	[Estevez, Alvaro G.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; Bonetto, Valentina] Dulbecco Telethon Inst, Milan, Italy; [Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; D'Alessandro, Giuseppina; Tartari, Silvia; Cantoni, Lavinia; Salmona, Mario; Bonetto, Valentina] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, I-20157 Milan, Italy; [Marino, Marianna; Cheroni, Cristina; Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [De Biasi, Silvia] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Giordana, Maria Teresa] Univ Turin, Dept Neurosci, Turin, Italy; [Strong, Michael J.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Strong, Michael J.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Cornell University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Turin; Western University (University of Western Ontario); Western University (University of Western Ontario)	Basso, M (corresponding author), Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA.	valentina.bonetto@marionegri.it	Nardo, Giovanni/C-1406-2014; D'ALESSANDRO, GIUSEPPINA/L-6726-2019; D'Alessandro, Giuseppina/K-7825-2016; Cheroni, Cristina/AAO-2316-2020; Bendotti, Caterina/AAB-2273-2020; salmona, mario/AAA-7116-2020; Basso, Manuela/AAA-9147-2020; salmona, mario/ABI-4066-2020; Bonetto, Valentina/ABB-6383-2020; Bonetto, Valentina/I-4694-2018; Strong, Michael/AAU-5699-2020; Strong, Michael J/H-9689-2012	Nardo, Giovanni/0000-0002-1803-1484; D'ALESSANDRO, GIUSEPPINA/0000-0001-7220-6065; D'Alessandro, Giuseppina/0000-0001-7220-6065; Bendotti, Caterina/0000-0003-1055-1271; salmona, mario/0000-0002-9098-9873; Basso, Manuela/0000-0002-9278-8960; Bonetto, Valentina/0000-0003-0456-2054; Bonetto, Valentina/0000-0003-0456-2054; Strong, Michael/0000-0003-1988-6262; Cheroni, Cristina/0000-0002-0832-2333; massignan, tania/0000-0002-6176-2696	Telethon Foundation; Cariplo Foundation; Compagnia San Paolo Foundation; MIUR [RBIN04J58W]	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Compagnia San Paolo Foundation(Compagnia di San Paolo); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Telethon Foundation (www.telethon.it) (to V.B., C.B. and S.D.B), the Cariplo Foundation (http://www.fondazionecariplo.it) (to V.B., M.S. and C.B.), Compagnia San Paolo Foundation (http://www.compagnia.torino.it) (to V.B.) and MIUR (FIRB Protocol RBIN04J58W)(to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babetto E, 2005, MOL BRAIN RES, V140, P63, DOI 10.1016/j.molbrainres.2005.07.010; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Biasini E, 2006, PROTEOMICS, V6, P2823, DOI 10.1002/pmic.200500620; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Crow JP, 1997, J NEUROCHEM, V69, P1945; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldner FM, 1996, J COMP NEUROL, V372, P283; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Ikeda K, 1998, J NEUROL SCI, V160, P9, DOI 10.1016/S0022-510X(98)00224-X; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P531, DOI 10.1007/s00401-004-0923-2; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; MURAYAMA S, 1989, ACTA NEUROPATHOL, V78, P143, DOI 10.1007/BF00688202; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shibata N, 1998, ACTA NEUROPATHOL, V95, P136, DOI 10.1007/s004010050777; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Strong MJ, 1998, BIOCHEM BIOPH RES CO, V248, P157, DOI 10.1006/bbrc.1998.8930; Tartari S, 2009, FEBS J, V276, P2861, DOI 10.1111/j.1742-4658.2009.07010.x; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Upton-Rice MN, 1999, ANN NEUROL, V45, P413, DOI 10.1002/1531-8249(199903)45:3<413::AID-ANA24>3.0.CO;2-5; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	68	85	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8130	10.1371/journal.pone.0008130	http://dx.doi.org/10.1371/journal.pone.0008130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956584	Green Published, gold			2022-12-27	WOS:000272828800022
J	Kfutwah, A; Mary, JY; Lemen, B; Leke, R; Rousset, D; Barre-Sinoussi, F; Nerrienet, E; Menu, E; Ayouba, A				Kfutwah, Anfumbom; Mary, Jean Yves; Lemen, Brigitte; Leke, Robert; Rousset, Dominique; Barre-Sinoussi, Francoise; Nerrienet, Eric; Menu, Elisabeth; Ayouba, Ahidjo		ANRS 1267 Study Team	Plasmodium falciparum Infection Significantly Impairs Placental Cytokine Profile in HIV Infected Cameroonian Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; NECROSIS-FACTOR-ALPHA; CHONDROITIN SULFATE; PREGNANT-WOMEN; TH2 CYTOKINES; BIRTH-WEIGHT; EXPRESSION; MALARIA; MOTHER	Background: Placental cytokines play crucial roles in the establishment and maintenance of pregnancy as well as protecting the foetus from infections. Previous studies have suggested the implication of infections such as P. falciparum and HIV in the stimulation of placental cytokines. This study assessed the impact of P. falciparum on placental cytokine profiles between HIV-1 positive and negative women. Materials and Methods: P. falciparum infection was checked in peripheral and placental blood of HIV-1 negative and positive women by the thick blood smear test. Cytokines proteins and messenger RNAs were quantified by ELISA and real time PCR, respectively. Non-parametric tests were used for statistical analyses. Results: Placental and peripheral P. falciparum infections were not significantly associated with HIV-1 infection (OR: 1.4; 95% confidence interval (95% CI): 0.5-4.2; p = 0.50 and OR: 0.6; 95% CI: 0.3-1.4; p = 0.26, respectively). Conversely, placental P. falciparum parasitemia was significantly higher in the HIV-1 positive group (p = 0.04). We observed an increase of TNF-alpha mRNA median levels (p = 0.02) and a trend towards a decrease of IL-10 mRNA (p = 0.07) in placenta from HIV-1 positive women compared to the HIV negative ones leading to a median TNF-alpha/IL-10 mRNA ratio significantly higher among HIV-1 positive than among HIV-1 negative placenta (p = 0.004; 1.5 and 0.8, respectively). Significant decrease in median secreted cytokine levels were observed in placenta from HIV-1 positive women as compared to the HIV negative however these results are somewhat indicative since it appears that differences in cytokine levels (protein or mRNA) between HIV-1 positive and negative women depend greatly on P. falciparum infection. Within the HIV-1 positive group, TNF-alpha was the only cytokine significantly associated with clinical parameters linked with HIV-1 MTCT such as premature rupture of membranes, CD4 T-cell number, plasma viral load and delay of NVP intake before delivery. Conclusions: These results show that P. falciparum infection profoundly modifies the placenta cytokine environment and acts as a confounding factor, masking the impact of HIV-1 in co-infected women. This interplay between the two infections might have implications in the in utero MTCT of HIV-1 in areas where HIV-1 and P. falciparum co-circulate.	[Kfutwah, Anfumbom; Rousset, Dominique; Nerrienet, Eric; Ayouba, Ahidjo] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Mary, Jean Yves] Univ Paris 07, INSERM, Hop St Louis, U717, Paris, France; [Lemen, Brigitte] CASS, Yaounde, Cameroon; [Leke, Robert] Maternite Principale Hop Cent, Yaounde, Cameroon; [Barre-Sinoussi, Francoise; Menu, Elisabeth; Ayouba, Ahidjo] Inst Pasteur, Unit Regulat Infect Retrovirales, Paris, France	Centre Pasteur du Cameroun; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kfutwah, A (corresponding author), Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon.	ahidjo.ayouba@mpl.ird.fr	Ayouba, Ahidjo/G-8775-2017; Rousset, Dominique/S-5400-2019; Barre-Sinoussi, Françoise/G-8355-2011; MENU, Elisabeth/B-2886-2010	Ayouba, Ahidjo/0000-0002-5081-1632; Rousset, Dominique/0000-0002-1473-3147; MENU, Elisabeth/0000-0001-8844-9328	ANRS [1267]; Centre Pasteur du Cameroun, Institut Pasteur Paris; International Network of Institut Pasteur, INSERM; French Ministry of Foreign affairs (MAE)	ANRS(ANRSFrench National Research Agency (ANR)); Centre Pasteur du Cameroun, Institut Pasteur Paris; International Network of Institut Pasteur, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Foreign affairs (MAE)	ANRS (grant #1267), Centre Pasteur du Cameroun, Institut Pasteur Paris, the International Network of Institut Pasteur, INSERM. AK received a grant from the French Ministry of Foreign affairs (MAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayouba A, 2003, JAIDS-J ACQ IMM DEF, V34, P274, DOI 10.1097/00126334-200311010-00003; Ayouba A, 2003, AM J TROP MED HYG, V69, P447, DOI 10.4269/ajtmh.2003.69.447; Barin F, 2006, J INFECT DIS, V193, P1504, DOI 10.1086/503778; Behbahani H, 2000, AM J PATHOL, V157, P1811, DOI 10.1016/S0002-9440(10)64819-5; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Bodkin C, 2006, J CLIN NURS, V15, P735, DOI 10.1111/j.1365-2702.2006.01438.x; BOURINBAIAR AS, 1992, FEMS MICROBIOL LETT, V96, P27, DOI 10.1111/j.1574-6968.1992.tb05388.x; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaouat G, 1999, AM J REPROD IMMUNOL, V42, P1; Coulomb-L'Hermine A, 2000, AIDS RES HUM RETROV, V16, P1097, DOI 10.1089/08892220050075372; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Faye A, 2007, CLIN EXP IMMUNOL, V149, P430, DOI 10.1111/j.1365-2249.2007.03411.x; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Foli A, 1997, AIDS RES HUM RETROV, V13, P829, DOI 10.1089/aid.1997.13.829; Fox H., 1997, PATHOLOGY PLACENTA; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GAVIN L, 2006, J ADOLESC HLTH, V39; ISRAEL N, 1989, J IMMUNOL, V143, P3956; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kfutwah AKW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-36; Lacroix MC, 2005, ENDOCRINOLOGY, V146, P2434, DOI 10.1210/en.2004-1550; Lane BR, 1999, J IMMUNOL, V163, P3653; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; Menu E, 1997, Early Pregnancy, V3, P245; Moore JM, 2004, INFECT IMMUN, V72, P7022, DOI 10.1128/IAI.72.12.7022-7029.2004; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Moussa M, 1999, AM J REPROD IMMUNOL, V41, P312; Ng SC, 2002, AM J REPROD IMMUNOL, V48, P77, DOI 10.1034/j.1600-0897.2002.01105.x; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Patterson BK, 2001, J CLIN INVEST, V107, P287, DOI 10.1172/JCI11481; Pedroza-Martins L, 2006, AIDS, V20, P939, DOI 10.1097/01.aids.0000218563.12897.ba; Pornprasert S, 2006, PLACENTA, V27, P989, DOI 10.1016/j.placenta.2005.10.010; Pornprasert S, 2009, CURR HIV RES, V7, P211, DOI 10.2174/157016209787581472; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salmen S, 2004, CLIN EXP IMMUNOL, V137, P166, DOI 10.1111/j.1365-2249.2004.02503.x; Shearer WT, 1997, ACTA PAEDIATR, V86, P33; Skinner-Adams TS, 2008, TRENDS PARASITOL, V24, P264, DOI 10.1016/j.pt.2008.03.008; Soumelis V, 2002, HUM IMMUNOL, V63, P1206, DOI 10.1016/S0198-8859(02)00760-7; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Suguitan AL, 2003, AM J TROP MED HYG, V69, P574, DOI 10.4269/ajtmh.2003.69.574; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Tkachuk AN, 2001, J INFECT DIS, V183, P967, DOI 10.1086/319248; Velez DR, 2008, HUM REPROD, V23, P1902, DOI 10.1093/humrep/den170; VYAKARNAM A, 1990, AIDS, V4, P21, DOI 10.1097/00002030-199001000-00003; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199; Zachar V, 2002, AIDS RES HUM RETROV, V18, P839, DOI 10.1089/08892220260190317	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8114	10.1371/journal.pone.0008114	http://dx.doi.org/10.1371/journal.pone.0008114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956547	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828800012
J	He, X; Chen, CC; Hong, F; Fang, F; Sinha, S; Ng, HH; Zhong, S				He, Xin; Chen, Chieh-Chun; Hong, Feng; Fang, Fang; Sinha, Saurabh; Ng, Huck-Hui; Zhong, Sheng			A Biophysical Model for Analysis of Transcription Factor Interaction and Binding Site Arrangement from Genome-Wide Binding Data	PLOS ONE			English	Article							CIS-REGULATORY MODULES; DNA-BINDING; COOPERATIVE BINDING; GENE-EXPRESSION; DROSOPHILA; EVOLUTION; NETWORK; MOTIFS; PLURIPOTENCY; SEQUENCE	Background: How transcription factors (TFs) interact with cis-regulatory sequences and interact with each other is a fundamental, but not well understood, aspect of gene regulation. Methodology/Principal Findings: We present a computational method to address this question, relying on the established biophysical principles. This method, STAP (sequence to affinity prediction), takes into account all combinations and configurations of strong and weak binding sites to analyze large scale transcription factor (TF)-DNA binding data to discover cooperative interactions among TFs, infer sequence rules of interaction and predict TF target genes in new conditions with no TF-DNA binding data. The distinctions between STAP and other statistical approaches for analyzing cis-regulatory sequences include the utility of physical principles and the treatment of the DNA binding data as quantitative representation of binding strengths. Applying this method to the ChIP-seq data of 12 TFs in mouse embryonic stem (ES) cells, we found that the strength of TF-DNA binding could be significantly modulated by cooperative interactions among TFs with adjacent binding sites. However, further analysis on five putatively interacting TF pairs suggests that such interactions may be relatively insensitive to the distance and orientation of binding sites. Testing a set of putative Nanog motifs, STAP showed that a novel Nanog motif could better explain the ChIP-seq data than previously published ones. We then experimentally tested and verified the new Nanog motif. A series of comparisons showed that STAP has more predictive power than several state-of-the-art methods for cis-regulatory sequence analysis. We took advantage of this power to study the evolution of TF-target relationship in Drosophila. By learning the TF-DNA interaction models from the ChIP-chip data of D. melanogaster (Mel) and applying them to the genome of D. pseudoobscura (Pse), we found that only about half of the sequences strongly bound by TFs in Mel have high binding affinities in Pse. We show that prediction of functional TF targets from ChIP-chip data can be improved by using the conservation of STAP predicted affinities as an additional filter. Conclusions/Significance: STAP is an effective method to analyze binding site arrangements, TF cooperativity, and TF target genes from genome-wide TF-DNA binding data.	[He, Xin; Sinha, Saurabh; Zhong, Sheng] Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA; [Chen, Chieh-Chun; Zhong, Sheng] Univ Illinois, Dept Bioengn, Champaign, IL 61820 USA; [Hong, Feng; Zhong, Sheng] Univ Illinois, Dept Stat, Champaign, IL 61820 USA; [Fang, Fang; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore, Singapore	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	He, X (corresponding author), Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA.	szhong@illinois.edu	Ng, Huck Hui/A-1135-2009; Fang, Fang/G-7679-2016	NG, HUCK HUI/0000-0001-6352-8417; Fang, Fang/0000-0002-5272-302X	National Science Foundation [DBI08-45823]; NSF [DBI-0746303]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (http://www.nsf. gov/) DBI08-45823 (to SZ) and by an NSF Career Grant DBI-0746303 (to SS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BERG OG, 1988, TRENDS BIOCHEM SCI, V13, P207, DOI 10.1016/0968-0004(88)90085-0; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; CHEN X, 2008, COLD SPRING HARB S Q; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Datta D, 2008, BIOINFORMATICS, V24, P545, DOI 10.1093/bioinformatics/btm523; Davidson EH, 2006, REG GEN GEN REG; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Huang W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r225; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Kinoshita K, 2007, BIOCHEM BIOPH RES CO, V353, P686, DOI 10.1016/j.bbrc.2006.12.071; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Makeev VJ, 2003, NUCLEIC ACIDS RES, V31, P6016, DOI 10.1093/nar/gkg799; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Press W. H., 1992, ART SCI COMPUTING; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Teif VB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm268; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107; Zhou Q, 2008, NUCLEIC ACIDS RES, V36, P4137, DOI 10.1093/nar/gkn361; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zinzen RP, 2007, PLOS COMPUT BIOL, V3, P826, DOI 10.1371/journal.pcbi.0030084; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	70	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8155	10.1371/journal.pone.0008155	http://dx.doi.org/10.1371/journal.pone.0008155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956545	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828700023
J	Kwong, JC; Li, P; Redelmeier, DA				Kwong, Jeffrey C.; Li, Ping; Redelmeier, Donald A.			Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; CYTOKINE PRODUCTION; RISK; THERAPY; BIAS; ATORVASTATIN; OUTCOMES; RELEASE	Background: Statins possess immunomodulatory properties and have been proposed for reducing morbidity during an influenza pandemic. We sought to evaluate the effect of statins on hospitalizations and deaths related to seasonal influenza outbreaks. Methodology/Principal Findings: We conducted a population-based cohort study over 10 influenza seasons (1996 to 2006) using linked administrative databases in Ontario, Canada. We identified all adults older than 65 years who had received an influenza vaccination prior to the start of influenza season and distinguished those also prescribed statins (23%) from those not also prescribed statins (77%). Propensity-based matching, which accounted for each individual's likelihood of receiving a statin, yielded a final cohort of 2,240,638 patients, exactly half of whom received statins. Statins were associated with small protective effects against pneumonia hospitalization (odds ratio [OR] 0.92; 95% CI 0.89-0.95), 30-day pneumonia mortality (0.84; 95% CI 0.77-0.91), and all-cause mortality (0.87; 95% CI 0.84-0.89). These protective effects attenuated substantially after multivariate adjustment and when we excluded multiple observations for each individual, declined over time, differed across propensity score quintiles and risk groups, and were unchanged during post-influenza season periods. The main limitations of this study were the observational study design, the non-specific outcomes, and the lack of information on medications while hospitalized. Conclusions/Significance: Statin use is associated with a statistically significant but minimal protective effect against influenza morbidity that can easily be attributed to residual confounding. Public health officials and clinicians should focus on other measures to reduce morbidity and mortality from the next influenza pandemic.	[Kwong, Jeffrey C.; Li, Ping; Redelmeier, Donald A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Community Med, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Med & Hlth Policy, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Management, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Evaluat, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	Li, Ping/GYV-4914-2022		Canadian Institutes of Health Research (CIHR); CIHR Fellowship Award; Ontario Ministry of Health and Long-Term Care (MOHLTC); University of Toronto Department of Family; Community Medicine Research Scholar Award; Institute for Clinical Evaluative Sciences (ICES)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Fellowship Award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); University of Toronto Department of Family(University of Toronto); Community Medicine Research Scholar Award; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto)	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (www.cihr.ca). Dr. Kwong was supported by a CIHR Fellowship Award, an Ontario Ministry of Health and Long-Term Care (MOHLTC) Career Scientist Award, a University of Toronto Department of Family and Community Medicine Research Scholar Award, and the Institute for Clinical Evaluative Sciences (ICES). Dr. Redelmeier was supported by a Canadian Research Chair in Medical Decision Science. This work was made possible with the support of ICES which is funded in part by the Ontario MOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; [Anonymous], 2006, CAN IMM GUID; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Bessler H, 2005, CLIN IMMUNOL, V117, P73, DOI 10.1016/j.clim.2005.06.014; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chan B., 1999, SUPPLY PHYS SERVICES; DE BN, 1998, ATHEROSCLEROSIS, V139, P147; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hall R, 2001, CAN J AGING, V20, P175, DOI 10.1017/S0714980800012964; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iron K, 2008, LIVING DYING ONTARIO; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jialal I, 2001, CIRCULATION, V103, P1933; Jialal I, 2007, J CLIN ENDOCR METAB, V92, P3136, DOI 10.1210/jc.2007-0453; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kwong JC, 2007, VACCINE, V25, P1270, DOI 10.1016/j.vaccine.2006.10.004; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Li JJ, 2003, CORONARY ARTERY DIS, V14, P329, DOI 10.1097/01.mca.0000078062.22445.60; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Naylor CD, 1999, CARDIOVASCULAR HLTH; Okopien B, 2005, J CARDIOVASC PHARM, V46, P377, DOI 10.1097/01.fjc.0000175455.46245.c8; Pan American Health Organization [PAHO], 2004, 16 M VACC PREV DIS P; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tousoulis D, 2005, EUR J HEART FAIL, V7, P1126, DOI 10.1016/j.ejheart.2005.03.007; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; *WHO, 2009, CUM NUMB CONF HUM CA	43	75	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8087	10.1371/journal.pone.0008087	http://dx.doi.org/10.1371/journal.pone.0008087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956645	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400028
J	Pan, WL; Matizirofa, L; Workman, L; Hawkridge, T; Hanekom, W; Mahomed, H; Hussey, G; Hatherill, M				Pan, Wenli; Matizirofa, Lyness; Workman, Lesley; Hawkridge, Tony; Hanekom, Willem; Mahomed, Hassan; Hussey, Gregory; Hatherill, Mark			Comparison of Mantoux and Tine Tuberculin Skin Tests in BCG-Vaccinated Children Investigated for Tuberculosis	PLOS ONE			English	Article							RISK-FACTORS; LATENT TUBERCULOSIS; INFECTION; DIAGNOSIS; REACTIVITY; CONTACT; PREVALENCE; BURDEN; ASSAY	Background: Tuberculin skin tests (TSTs) are long-established screening methods for tuberculosis (TB). We aimed to compare agreement between the intradermal Mantoux and multipuncture percutaneous Tine methods and to quantify risk factors for a positive test result. Methodology/Principal Findings: 1512 South African children younger than 5 years of age who were investigated for tuberculosis (TB) during a Bacille Calmette Guerin (BCG) trial were included in this analysis. Children underwent both Mantoux and Tine tests. A positive test was defined as Mantoux >= 15 mm or Tine >= Grade 3 for the binary comparison. Agreement was evaluated using kappa (binary) and weighted kappa (hierarchical). Multivariate regression models identified independent risk factors for TST positivity. The Mantoux test was positive in 430 children (28.4%) and the Tine test in 496 children (32.8%, p < 0.0001), with observed binary agreement 87.3% (kappa 0.70) and hierarchical agreement 85.0% (weighted kappa 0.66). Among 173 children culture-positive for Mycobacterium tuberculosis, Mantoux was positive in 49.1% and Tine in 54.9%, p < 0.0001 (kappa 0.70). Evidence of digit preference was noted for Mantoux readings at 5 mm threshold intervals. After adjustment for confounders, a positive culture, suggestive chest radiograph, and proximity of TB contact were risk factors for a positive test using both TST methods. There were no independent associations between ethnicity, gender, age, or over-crowding, and TST result. Conclusions/Significance: The Tine test demonstrated a higher positive test rate than the Mantoux, with substantial agreement between TST methods among young BCG-vaccinated children. TB disease and exposure factors, but not demographic variables, were independent risk factors for a positive result using either test method. These findings suggest that the Tine might be a useful screening tool for childhood TB in resource-limited countries.	[Pan, Wenli] Dept Hlth, Haikou, Hainan Province, Peoples R China; [Pan, Wenli] Charite, German Acad Exchange Serv DAAD Program, D-13353 Berlin, Germany; [Pan, Wenli; Matizirofa, Lyness; Workman, Lesley; Hanekom, Willem; Mahomed, Hassan; Hussey, Gregory; Hatherill, Mark] Univ Cape Town, Inst Infect Dis & Mol Med, S African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Matizirofa, Lyness; Workman, Lesley; Hanekom, Willem; Mahomed, Hassan; Hussey, Gregory; Hatherill, Mark] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Hawkridge, Tony] Aeras Global TB Vaccine Fdn, Rockville, MD USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cape Town; University of Cape Town	Pan, WL (corresponding author), Dept Hlth, Haikou, Hainan Province, Peoples R China.	mark.hatherill@uct.ac.za		Matizirofa, Lyess/0000-0002-7050-0348; Hanekom, Willem/0000-0003-3070-6154	Aeras Global TB Vaccine Foundation; German Academic Exhange Service; Charite Medical University, Berlin, Germany	Aeras Global TB Vaccine Foundation; German Academic Exhange Service; Charite Medical University, Berlin, Germany	Funded in part by Aeras Global TB Vaccine Foundation. WP funded by the German Academic Exhange Service, Charite Medical University, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Bener A, 1996, RESP MED, V90, P89, DOI 10.1016/S0954-6111(96)90204-8; Besser RE, 2001, PEDIATRICS, V108, P305, DOI 10.1542/peds.108.2.305; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; BROWDER AA, 1972, AM REV RESPIR DIS, V105, P299; Carvalho ACC, 2001, AM J RESP CRIT CARE, V164, P2166, DOI 10.1164/ajrccm.164.12.2103078; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Davies GR, 2006, INT J TUBERC LUNG D, V10, P1023; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; *DOH, 2000, S AFR NAT TUB CONTR; *DOH, 2004, S AFR NAT TUB CONTR; *DOH, 2008, S AFR NAT TUB CONTR; Eilers RHC, 2004, INT J TUBERC LUNG D, V8, P232; FREIMAN I, 1976, S AFR MED J, V50, P5; Froehlich H, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e54; GROENEWALD P, 2004, BOLAND OVERBERG REGI; Gustafson P, 2007, EPIDEMIOLOGY, V18, P340, DOI 10.1097/01.ede.0000259987.46912.2b; HANSEN JP, 1982, J OCCUP ENVIRON MED, V24, P602, DOI 10.1097/00043764-198208000-00015; Hatherill M, 2009, ARCH DIS CHILD, V94, P195, DOI 10.1136/adc.2007.136929; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Hesseling AC, 2007, INT J TUBERC LUNG D, V11, P245; JOHNSON A, 1978, BRIT MED J, V2, P892, DOI 10.1136/bmj.2.6141.892-a; Joos TJ, 2006, INT J TUBERC LUNG D, V10, P883; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lobato MN, 1998, AM J RESP CRIT CARE, V158, P1871, DOI 10.1164/ajrccm.158.6.9804106; LUNN JA, 1980, BRIT MED J, V280, P223, DOI 10.1136/bmj.280.6209.223; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; Ozuah PO, 2001, JAMA-J AM MED ASSOC, V285, P451, DOI 10.1001/jama.285.4.451; Rathi SK, 2002, INT J TUBERC LUNG D, V6, P851; ROSENTHA.SR, 1965, PEDIATRICS, V36, P385; RUDD RM, 1982, LANCET, V2, P515; Saiman L, 2001, PEDIATRICS, V107, P999, DOI 10.1542/peds.107.5.999; Shingadia D, 2008, ARCH DIS CHILD, V93, P189, DOI 10.1136/adc.2007.129585; SINCLAIR DJM, 1979, BMJ-BRIT MED J, V1, P1325, DOI 10.1136/bmj.1.6174.1325; SNELL NJC, 1979, TUBERCLE, V60, P99, DOI 10.1016/0041-3879(79)90043-6; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WELKE H, 1976, S AFR MED J, V50, P2073; *WHO, 2003, WHOCDSTB2003313, P63; *WHO, 2008, GLOB TUB CONTR COUNT; Young J, 2005, PEDIATRICS, V115, pE647, DOI 10.1542/peds.2004-1685	48	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8085	10.1371/journal.pone.0008085	http://dx.doi.org/10.1371/journal.pone.0008085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956612	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400026
J	van Dellen, E; Douw, L; Baayen, JC; Heimans, JJ; Ponten, SC; Vandertop, WP; Velis, DN; Stam, CJ; Reijneveld, JC				van Dellen, Edwin; Douw, Linda; Baayen, Johannes C.; Heimans, Jan J.; Ponten, Sophie C.; Vandertop, W. Peter; Velis, Demetrios N.; Stam, Cornelis J.; Reijneveld, Jaap C.			Long-Term Effects of Temporal Lobe Epilepsy on Local Neural Networks: A Graph Theoretical Analysis of Corticography Recordings	PLOS ONE			English	Article							DISTURBED FUNCTIONAL CONNECTIVITY; SMALL-WORLD NETWORKS; BRAIN NETWORKS; TOPOLOGY; EEG; EPILEPTOGENESIS; PROGRESSION; TRANSITION; CLUSTERS; SURGERY	Purpose: Pharmaco-resistant temporal lobe epilepsy (TLE) is often treated with surgical intervention at some point. As epilepsy surgery is considered a last resort by most physicians, a long history of epileptic seizures prior to surgery is not uncommon. Little is known about the effects of ongoing TLE on neural functioning. A better understanding of these effects might influence the moment of surgical intervention. Functional connectivity (interaction between spatially distributed brain areas) and network structure (integration and segregation of information processing) are thought to be essential for optimal brain functioning. We report on the impact of TLE duration on temporal lobe functional connectivity and network characteristics. Methods: Functional connectivity of the temporal lobe at the time of surgery was assessed by means of interictal electrocorticography (ECoG) recordings of 27 TLE patients by using the phase lag index (PLI). Graphs (abstract network representations) were reconstructed from the PLI matrix and characterized by the clustering coefficient C (local clustering), the path length L (overall network interconnectedness), and the "small world index'' S (network configuration). Results: Functional connectivity (average PLI), clustering coefficients, and the small world index were negatively correlated with TLE duration in the broad frequency band (0.5-48 Hz). Discussion: Temporal lobe functional connectivity is lower in patients with longer TLE history, and longer TLE duration is correlated with more random network configuration. Our findings suggest that the neural networks of TLE patients become more pathological over time, possibly due to temporal lobe changes associated with long-standing lesional epilepsy.	[van Dellen, Edwin; Douw, Linda; Heimans, Jan J.; Ponten, Sophie C.; Reijneveld, Jaap C.] Vrije Univ Amsterdam, Dept Neurol, Med Ctr, Amsterdam, Netherlands; [Baayen, Johannes C.; Vandertop, W. Peter] Vrije Univ Amsterdam, Dept Neurosurg, Neurosurg Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands; [Velis, Demetrios N.] Dutch Epilepsy Clin Fdn, Dept Clin Neurophysiol, Heemstede, Netherlands; [Velis, Demetrios N.] Dutch Epilepsy Clin Fdn, Epilepsy Monitoring Unit, Heemstede, Netherlands; [Ponten, Sophie C.; Stam, Cornelis J.] Vrije Univ Amsterdam, Dept Clin Neurophysiol, Med Ctr, Amsterdam, Netherlands; [Reijneveld, Jaap C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Dellen, E (corresponding author), Vrije Univ Amsterdam, Dept Neurol, Med Ctr, Amsterdam, Netherlands.	E.vanDellen@vumc.nl	van Dellen, Edwin/AAL-6605-2020; van Dellen, Edwin/ABC-1501-2020; van Dellen, Edwin/AAU-6245-2020	van Dellen, Edwin/0000-0003-1828-5959; van Dellen, Edwin/0000-0003-1828-5959; Stam, Cornelis/0000-0001-9163-7274; Douw, Linda/0000-0001-7058-4062; Vandertop, William/0000-0001-5417-0265	National Epilepsy Foundation of the Netherlands	National Epilepsy Foundation of the Netherlands	This study was supported by the National Epilepsy Foundation of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomei F, 2008, NEUROCHIRURGIE, V54, P174, DOI 10.1016/j.neuchi.2008.02.013; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Ben-Ari Yehezkel, 2008, Epilepsy Curr, V8, P68, DOI 10.1111/j.1535-7511.2008.00241.x; Berg AT, 2004, CNS SPECTRUMS, V9, P136, DOI 10.1017/S109285290000849X; Berg AT, 2003, NEUROLOGY, V60, P186, DOI 10.1212/01.WNL.0000031792.89992.EC; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; BETTUS G, 2008, HUM BRAIN MAPP; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Engel J, 1993, SURG TREATMENT EPILE, P609; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Le Van Quyen M, 2005, CLIN NEUROPHYSIOL, V116, P559, DOI 10.1016/j.clinph.2004.10.014; Marchiori M, 2000, PHYSICA A, V285, P539, DOI 10.1016/S0378-4371(00)00311-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Micheloyannis S, 2005, NEUROSCI LETT, V373, P212, DOI 10.1016/j.neulet.2004.10.005; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Ryvlin P, 2003, EPILEPSIA, V44, P23, DOI 10.1046/j.1528-1157.44.s.5.4.x; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	46	108	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8081	10.1371/journal.pone.0008081	http://dx.doi.org/10.1371/journal.pone.0008081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956634	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100018
J	La Scola, B; Raoult, D				La Scola, Bernard; Raoult, Didier			Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							INITIAL ANTIMICROBIAL THERAPY; GRAM-NEGATIVE BACILLI; RAPID IDENTIFICATION; STAPHYLOCOCCUS-AUREUS; STREAM INFECTIONS; PATHOGENS; PCR; DESORPTION/IONIZATION; PNEUMONIA; FUNGEMIA	Background: With long delays observed between sampling and availability of results, the usefulness of blood cultures in the context of emergency infectious diseases has recently been questioned. Among methods that allow quicker bacterial identification from growing colonies, matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass spectrometry was demonstrated to accurately identify bacteria routinely isolated in a clinical biology laboratory. In order to speed up the identification process, in the present work we attempted bacterial identification directly from blood culture bottles detected positive by the automate. Methodology/Principal Findings: We prospectively analysed routine MALDI-TOF identification of bacteria detected in blood culture by two different protocols involving successive centrifugations and then lysis by trifluoroacetic acid or formic acid. Of the 562 blood culture broths detected as positive by the automate and containing one bacterial species, 370 (66%) were correctly identified. Changing the protocol from trifluoroacetic acid to formic acid improved identification of Staphylococci, and overall correct identification increased from 59% to 76%. Lack of identification was observed mostly with viridans streptococci, and only one false positive was observed. In the 22 positive blood culture broths that contained two or more different species, only one of the species was identified in 18 samples, no species were identified in two samples and false species identifications were obtained in two cases. The positive predictive value of bacterial identification using this procedure was 99.2%. Conclusions/Significance: MALDI-TOF MS is an efficient method for direct routine identification of bacterial isolates in blood culture, with the exception of polymicrobial samples and viridans streptococci. It may replace routine identification performed on colonies, provided improvement for the specificity of blood culture broths growing viridans streptococci is obtained in the near future.	[La Scola, Bernard] Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Marseille, France; Univ Mediterranee, Fac Med, IFR48, IRD 6236,CNRS,URMITE, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	La Scola, B (corresponding author), Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Marseille, France.	bernard.lascola@univmed.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704				Abe T, 2009, J INFECT CHEMOTHER, V15, P180, DOI 10.1007/s10156-009-0682-z; ANHALT JP, 1975, ANAL CHEM, V47, P219, DOI 10.1021/ac60352a007; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Carbonnelle E, 2007, J CLIN MICROBIOL, V45, P2156, DOI 10.1128/JCM.02405-06; Chapin KC, 2003, J CLIN MICROBIOL, V41, P4751, DOI 10.1128/JCM.41.10.4751-4754.2003; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; COYLE MB, 1984, J CLIN MICROBIOL, V20, P473, DOI 10.1128/JCM.20.3.473-477.1984; de Cueto M, 2004, J CLIN MICROBIOL, V42, P3734, DOI [10.1128/JCM.42.8.3734-3738.2004, 10.1128/jcm.42.8.3734-3738.2004]; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Du ZM, 2002, ANAL CHEM, V74, P5487, DOI 10.1021/ac020109k; Eigner U, 2005, J CLIN MICROBIOL, V43, P5256, DOI 10.1128/JCM.43.10.5256-5262.2005; Funke G, 2004, J CLIN MICROBIOL, V42, P1466, DOI 10.1128/JCM.42.4.1466-1470.2004; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; Gescher DM, 2008, INT J ANTIMICROB AG, V32, pS51, DOI 10.1016/j.ijantimicag.2008.06.007; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Jansen GJ, 2000, J CLIN MICROBIOL, V38, P814, DOI 10.1128/JCM.38.2.814-817.2000; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kristensen B, 2001, APMIS, V109, P284, DOI 10.1034/j.1600-0463.2001.d01-121.x; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Speers DJ, 1998, J CLIN MICROBIOL, V36, P1032, DOI 10.1128/JCM.36.4.1032-1034.1998; WALLET F, 2009, CLIN MICROBIOL  0818; WEINSTEIN MP, 1995, J CLIN MICROBIOL, V33, P978, DOI 10.1128/JCM.33.4.978-981.1995; Wellinghausen N, 2004, DIAGN MICR INFEC DIS, V48, P229, DOI 10.1016/j.diagmicrobio.2003.11.005; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; WILSON ML, 1995, J CLIN MICROBIOL, V33, P2265, DOI 10.1128/JCM.33.9.2265-2270.1995; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08	32	271	275	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8041	10.1371/journal.pone.0008041	http://dx.doi.org/10.1371/journal.pone.0008041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946369	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827800024
J	Reef, R; Kaniewska, P; Hoegh-Guldberg, O				Reef, Ruth; Kaniewska, Paulina; Hoegh-Guldberg, Ove			Coral Skeletons Defend against Ultraviolet Radiation	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; HUMIC-ACID BANDS; TRACE MATERIALS; PORITES-LUTEA; LIGHT; FLUORESCENT; REEF; PHOTOSYNTHESIS; REPAIR; ZOOXANTHELLAE	Background: Many coral reef organisms are photosynthetic or have evolved in tight symbiosis with photosynthetic symbionts. As such, the tissues of reef organisms are often exposed to intense solar radiation in clear tropical waters and have adapted to trap and harness photosynthetically active radiation (PAR). High levels of ultraviolet radiation (UVR) associated with sunlight, however, represent a potential problem in terms of tissue damage. Methodology/Principal Findings: By measuring UVR and PAR reflectance from intact and ground bare coral skeletons we show that the property of calcium carbonate skeletons to absorb downwelling UVR to a significant extent, while reflecting PAR back to the overlying tissue, has biological advantages. We placed cnidarians on top of bare skeletons and a UVR reflective substrate and showed that under ambient UVR levels, UVR transmitted through the tissues of cnidarians placed on top of bare skeletons were four times lower compared to their counterparts placed on a UVR reflective white substrate. In accordance with the lower levels of UVR measured in cnidarians on top of coral skeletons, a similar drop in UVR damage to their DNA was detected. The skeletons emitted absorbed UVR as yellow fluorescence, which allows for safe dissipation of the otherwise harmful radiation. Conclusions/Significance: Our study presents a novel defensive role for coral skeletons and reveals that the strong UVR absorbance by the skeleton can contribute to the ability of corals, and potentially other calcifiers, to thrive under UVR levels that are detrimental to most marine life.	[Reef, Ruth] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; Univ Queensland, Ctr Excellence Coral Reef Studies, ARC, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Reef, R (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia.	r.reef@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Reef, Ruth/0000-0001-6639-520X	Australian Research Council Centre of Excellence for Coral Reefs Studies	Australian Research Council Centre of Excellence for Coral Reefs Studies(Australian Research Council)	The Australian Research Council Centre of Excellence for Coral Reefs Studies http://www.coralcoe.org.au/funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; Anthony KRN, 2005, FUNCT ECOL, V19, P17, DOI 10.1111/j.0269-8463.2005.00925.x; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Apprill AM, 2007, CORAL REEFS, V26, P387, DOI 10.1007/s00338-007-0209-y; Barnes DJ, 2005, J EXP MAR BIOL ECOL, V322, P135, DOI 10.1016/j.jembe.2005.02.008; Barnes DJ, 1995, J EXP MAR BIOL ECOL, V194, P251, DOI 10.1016/0022-0981(95)00091-7; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; BROWN BE, 1991, CORAL REEFS, V10, P211, DOI 10.1007/BF00336776; Cockell CS, 1998, BIOL J LINN SOC, V63, P449, DOI 10.1006/bijl.1997.0201; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; DUNLAP WC, 1986, CORAL REEFS, V5, P155, DOI 10.1007/BF00298182; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fallon SJ, 2003, CORAL REEFS, V22, P389, DOI 10.1007/s00338-003-0322-5; FANG LS, 1992, CORAL REEFS, V11, P187, DOI 10.1007/BF00301991; Fasel A, 1997, J PHOTOCH PHOTOBIO B, V39, P96, DOI 10.1016/S1011-1344(96)00016-4; Frost LM., 2001, SCORPIONS 2001 MEMOR, P363; Gaft M., 2005, MODERN LUMINESCENCE; Heller J., 1961, CATCH 22; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; ISHAY JS, 1988, J LUMIN, V40-1, P221, DOI 10.1016/0022-2313(88)90164-0; JOKIEL PL, 1980, SCIENCE, V207, P1069, DOI 10.1126/science.207.4435.1069; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LAWRENCE R. F., 1954, JOUR ENT SOC S AFRICA, V17, P167; LIVINGSTON HD, 1971, LIMNOL OCEANOGR, V16, P786, DOI 10.4319/lo.1971.16.5.0786; Matthews BJH, 1996, MAR CHEM, V55, P317, DOI 10.1016/S0304-4203(96)00039-4; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; MILNE PJ, 1994, APPL SPECTROSC, V48, P1282, DOI 10.1366/0003702944027453; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; OLSON JM, 1986, PHOTOSYNTH RES, V9, P251, DOI 10.1007/BF00029748; Pingitore NE, 2002, MICROCHEM J, V71, P205, DOI 10.1016/S0026-265X(02)00012-7; RAVEN JA, 1991, J PHOTOCH PHOTOBIO B, V9, P239, DOI 10.1016/1011-1344(91)80158-E; Reef R, 2009, J EXP BIOL, V212, P2760, DOI 10.1242/jeb.031286; Richter DK, 2003, MINER PETROL, V79, P127, DOI 10.1007/s00710-003-0237-4; SCOFFIN TP, 1989, CORAL REEFS, V7, P169, DOI 10.1007/BF00301595; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; SHIBATA K, 1969, PLANT CELL PHYSIOL, V10, P325; Shirai K, 2008, GEOCHIM COSMOCHIM AC, V72, P5386, DOI 10.1016/j.gca.2008.07.026; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4; Stanley GD, 2006, SCIENCE, V312, P857, DOI 10.1126/science.1123701; SUSIC M, 1991, MAR CHEM, V33, P91, DOI 10.1016/0304-4203(91)90059-6; TAYLOR RB, 1995, J EXP MAR BIOL ECOL, V185, P255, DOI 10.1016/0022-0981(94)00155-7; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Wild FJ, 2000, CORAL REEFS, V19, P132, DOI 10.1007/s003380000084; [No title captured]; [No title captured]; [No title captured]	57	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7995	10.1371/journal.pone.0007995	http://dx.doi.org/10.1371/journal.pone.0007995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946361	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827800010
J	Tiede, BJ; Owens, LA; Li, F; DeCoste, C; Kang, YB				Tiede, Benjamin J.; Owens, Leah A.; Li, Feng; DeCoste, Christina; Kang, Yibin			A Novel Mouse Model for Non-Invasive Single Marker Tracking of Mammary Stem Cells In Vivo Reveals Stem Cell Dynamics throughout Pregnancy	PLOS ONE			English	Article							BREAST-CANCER; GLAND; DIFFERENTIATION; COMMITMENT	Mammary stem cells (MaSCs) play essential roles for the development of the mammary gland and its remodeling during pregnancy. However, the precise localization of MaSCs in the mammary gland and their regulation during pregnancy is unknown. Here we report a transgenic mouse model for luciferase-based single marker detection of MaSCs in vivo that we used to address these issues. Single transgene expressing mammary epithelial cells were shown to reconstitute mammary glands in vivo while immunohistochemical staining identified MaSCs in basal and luminal locations, with preponderance towards the basal position. By quantifying luciferase expression using bioluminescent imaging, we were able to track MaSCs non-invasively in individual mice over time. Using this model to monitor MaSC dynamics throughout pregnancy, we found that MaSCs expand in both total number and percentage during pregnancy and then drop down to or below baseline levels after weaning. However, in a second round of pregnancy, this expansion was not as extensive. These findings validate a powerful system for the analysis of MaSC dynamics in vivo, which will facilitate future characterization of MaSCs during mammary gland development and breast cancer.	[Tiede, Benjamin J.; Owens, Leah A.; Li, Feng; DeCoste, Christina; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Tiede, BJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu		Kang, Yibin/0000-0002-1626-6730; Owens, Leah/0000-0002-4232-3516	Department of Defense Era of Hope Scholar Award; NIH; New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research	Department of Defense Era of Hope Scholar Award(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research(United States Department of Defense)	YK was funded by a Department of Defense Era of Hope Scholar Award. BT is supported by an NIH training grant and by pre-doctoral fellowships from the New Jersey Commission on Cancer Research and the Department of Defense Breast Cancer Research Program. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; DEOME KB, 1959, CANCER RES, V19, P515; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002	17	20	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8035	10.1371/journal.pone.0008035	http://dx.doi.org/10.1371/journal.pone.0008035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946375	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827800022
J	Schrader, KA; Gorbatcheva, B; Senz, J; Heravi-Moussavi, A; Melnyk, N; Salamanca, C; Maines-Bandiera, S; Cooke, SL; Leung, P; Brenton, JD; Gilks, CB; Monahan, J; Huntsman, DG				Schrader, Kasmintan A.; Gorbatcheva, Bella; Senz, Janine; Heravi-Moussavi, Alireza; Melnyk, Nataliya; Salamanca, Clara; Maines-Bandiera, Sarah; Cooke, Susanna L.; Leung, Peter; Brenton, James D.; Gilks, C. Blake; Monahan, John; Huntsman, David G.			The Specificity of the FOXL2 c.402C > G Somatic Mutation: A Survey of Solid Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; GRANULOSA-CELL TUMOR; MELTING ANALYSIS; OVARY; AGGREGATION	Background: A somatic mutation in the FOXL2 gene is reported to be present in almost all (97%; 86/89) morphologically defined, adult-type, granulosa-cell tumors (A-GCTs). This FOXL2 c.402C>G mutation changes a highly conserved cysteine residue to a tryptophan (p.C134W). It was also found in a minority of other ovarian malignant stromal tumors, but not in benign ovarian stromal tumors or unrelated ovarian tumors or breast cancers. Methodology/Principal Findings: Herein we studied other cancers and cell lines for the presence of this mutation. We screened DNA from 752 tumors of epithelial and mesenchymal origin and 28 ovarian cancer cell lines and 52 other cancer cell lines of varied origin. We found the FOXL2 c>402C.G mutation in an unreported A-GCT case and the A-GCT-derived cell line KGN. All other tumors and cell lines analyzed were mutation negative. Conclusions/Significance: In addition to proving that the KGN cell line is a useful model to study A-GCTs, these data show that the c.402C>G mutation in FOXL2 is not commonly found in a wide variety of other cancers and therefore it is likely pathognomonic for A-GCTs and closely related tumors.	[Schrader, Kasmintan A.; Senz, Janine; Heravi-Moussavi, Alireza; Melnyk, Nataliya; Salamanca, Clara; Maines-Bandiera, Sarah; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Schrader, Kasmintan A.; Senz, Janine; Melnyk, Nataliya; Monahan, John] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Gorbatcheva, Bella; Huntsman, David G.] Novartis Inst Biomed Res, Cambridge, MA USA; [Cooke, Susanna L.; Brenton, James D.] Cambridge Res Inst, Cambridge, England; [Leung, Peter] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Gilks, C. Blake; Huntsman, David G.] Vancouver Gen Hosp, Genet Pathol & Evaluat Ctr, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency; Novartis; CRUK Cambridge Institute; University of Cambridge; Child & Family Research Institute; University of British Columbia; University of British Columbia	Schrader, KA (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	dhuntsma@bccancer.bc.ca	Brenton, James D/B-3174-2008; Huntsman, David/ABE-6082-2020	Brenton, James D/0000-0002-5738-6683; Schrader, Kasmintan/0000-0002-7413-4314; Leung, Peter/0000-0003-3152-3800; Monahan, John/0000-0002-3125-8704	Canadian Institutes of Health Research [MOP 97735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research MOP 97735. CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The high resolution melt assay used to screen the solid tumors was internally funded and performed at the Novartis Institutes for BioMedical Research. John Monahan and Bella Gorbatcheva of the Novartis Institutes for BioMedical Research designed this portion of the study, collected and analysed the resulting data. The decision to publish and preparation of the manuscript was done in collaboration with John Monahan and Bella Gorbatcheva.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Koukourakis GV, 2008, INTEGR CANCER THER, V7, P204, DOI 10.1177/1534735408322845; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; SHAH SP, 2009, N ENGL J MED	15	74	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7988	10.1371/journal.pone.0007988	http://dx.doi.org/10.1371/journal.pone.0007988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956657	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500018
J	Abe, Y; Urakami, H; Ostanin, D; Zibari, G; Hayashida, T; Kitagawa, Y; Grisham, MB				Abe, Yuta; Urakami, Hidejiro; Ostanin, Dmitry; Zibari, Gazi; Hayashida, Tetsu; Kitagawa, Yuko; Grisham, Matthew B.			Induction of Foxp3-Expressing Regulatory T-Cells by Donor Blood Transfusion Is Required for Tolerance to Rat Liver Allografts	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX ANTIGENS; HEPATIC ALLOGRAFTS; CLASS-I; HEART-TRANSPLANTATION; PROLONGED SURVIVAL; RECIPIENTS; INFILTRATION; CYCLOSPORINE; ANTIBODY; GRAFT	Background: Donor-specific blood transfusion (DST) prior to solid organ transplantation has been shown to induce long-term allograft survival in the absence of immunosuppressive therapy. Although the mechanisms underlying DST-induced allograft tolerance are not well defined, there is evidence to suggest DST induces one or more populations of antigen-specific regulatory cells that suppress allograft rejection. However, neither the identity nor the regulatory properties of these tolerogenic lymphocytes have been reported. Therefore, the objective of this study was to define the kinetics, phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft transplantation (LTx). Methodology/Principal Findings: Tolerance to Dark Agouti (DA; RT1(a)) rat liver allografts was induced by injection (iv) of 1 ml of heparinized DA blood to naive Lewis (LEW; RT1(I)) rats once per week for 4 weeks prior to LTx. We found that preoperative DST alone generates CD4(+) T-cells that when transferred into naive LEW recipients are capable of suppressing DA liver allograft rejection and promoting long-term survival of the graft and recipient. However, these DST-generated T-cells did not express the regulatory T-cell (Treg) transcription factor Foxp3 nor did they suppress alloantigen (DA)-induced activation of LEW T-cells in vitro suggesting that these lymphocytes are not fully functional regulatory Tregs. We did observe that DST+LTx (but not DST alone) induced the time-dependent formation of CD4(+)Foxp3(+) Tregs that potently suppressed alloantigen-induced activation of naive LEW T-cells in vitro and liver allograft rejection in vivo. Finally, we present data demonstrating that virtually all of the Foxp3-expressing Tregs reside within the CD4(+)CD45RC(-) population whereas in which approximately 50% of these Tregs express CD25. Conclusions/Significance: We conclude that preoperative DST, in the absence of liver allograft transplantation, induces the formation of CD4(+) T-cells that are not themselves Tregs but give rise directly or indirectly to fully functional CD4(+)CD45RC(-)Foxp3(+) Tregs when transferred into MHC mismatched recipients prior to LTx. These Tregs possess potent suppressive activity and are capable of suppressing acute liver allograft rejection. Understanding the mechanisms by which preoperative DST induces the generation of tolerogenic Tregs in the presence of alloantigens may lead to the development of novel antigen-specific immunological therapies for the treatment of solid organ rejection.	[Abe, Yuta; Urakami, Hidejiro; Ostanin, Dmitry; Grisham, Matthew B.] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Zibari, Gazi] Louisiana State Univ, Hlth Sci Ctr, Dept Surg, Shreveport, LA 71105 USA; [Hayashida, Tetsu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Keio University	Abe, Y (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA.	mgrish@lsuhsc.edu		Zibari, Gazi B./0000-0001-7689-4299; Ostanin, Dmitry/0000-0002-8015-7432				ALEXANDER JW, 1992, TRANSPLANTATION, V53, P423, DOI 10.1097/00007890-199202010-00030; ARMSTRONG HE, 1987, J EXP MED, V165, P891, DOI 10.1084/jem.165.3.891; BAQUERIZO A, 1989, TRANSPLANT P, V21, P1179; BUGEON L, 1992, TRANSPLANTATION, V54, P219, DOI 10.1097/00007890-199208000-00006; DALLMAN MJ, 1987, J EXP MED, V165, P566, DOI 10.1084/jem.165.2.566; Degauque N, 2007, EUR J IMMUNOL, V37, P147, DOI 10.1002/eji.200635879; Douillard P, 1999, EUR J IMMUNOL, V29, P1919, DOI 10.1002/(SICI)1521-4141(199906)29:06<1919::AID-IMMU1919>3.0.CO;2-8; Flye MW, 1995, TRANSPLANTATION, V60, P1395; *HLTH RES SERV ADM, 2007, 2007 ANN REP US ORG; Jain A, 2002, ANN SURG, V236, P429, DOI 10.1097/00000658-200210000-00005; Josien R, 1998, J CLIN INVEST, V102, P1920, DOI 10.1172/JCI4221; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kataoka M, 2003, J IMMUNOL, V171, P204, DOI 10.4049/jimmunol.171.1.204; KATZ MR, 1987, TRANSPLANTATION, V43, P499, DOI 10.1097/00007890-198704000-00008; Kitade H, 2005, J IMMUNOL, V175, P4963, DOI 10.4049/jimmunol.175.8.4963; Miyanari N, 1997, HEPATOLOGY, V25, P1008, DOI 10.1002/hep.510250436; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Opelz G, 1997, TRANSPLANTATION, V63, P964, DOI 10.1097/00007890-199704150-00010; Patel R, 1997, CLIN MICROBIOL REV, V10, P86, DOI 10.1128/CMR.10.1.86; POTTER DE, 1991, PEDIATR NEPHROL, V5, P168, DOI 10.1007/BF00852877; QUIGLEY RL, 1989, J IMMUNOL, V142, P463; Shimizu Y, 2001, TRANSPLANT P, V33, P150, DOI 10.1016/S0041-1345(00)01949-7; Urakami H, 2006, TRANSPLANT P, V38, P3244, DOI 10.1016/j.transproceed.2006.10.042; VANTWUYVER E, 1991, NEW ENGL J MED, V325, P1210, DOI 10.1056/NEJM199110243251704; Yamaguchi Y, 1996, J SURG RES, V61, P23, DOI 10.1006/jsre.1996.0075; YAMAGUCHI Y, 1989, TRANSPLANTATION, V47, P171, DOI 10.1097/00007890-198901000-00036	26	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7840	10.1371/journal.pone.0007840	http://dx.doi.org/10.1371/journal.pone.0007840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956764	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827300002
J	Choi, HY; Dieckmann, M; Herz, J; Niemeier, A				Choi, Hong Y.; Dieckmann, Marco; Herz, Joachim; Niemeier, Andreas			Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo	PLOS ONE			English	Article							VAN-BUCHEM-DISEASE; MINERAL DENSITY; VASCULAR WALL; DKK1-MEDIATED INHIBITION; CARTILAGE DEVELOPMENT; WNT PATHWAY; SOST GENE; MASS; DKK1; ANTAGONIST	Lrp4 is a multifunctional member of the low density lipoprotein-receptor gene family and a modulator of extracellular cell signaling pathways in development. For example, Lrp4 binds Wise, a secreted Wnt modulator and BMP antagonist. Lrp4 shares structural elements within the extracellular ligand binding domain with Lrp5 and Lrp6, two established Wnt co-receptors with important roles in osteogenesis. Sclerostin is a potent osteocyte secreted inhibitor of bone formation that directly binds Lrp5 and Lrp6 and modulates both BMP and Wnt signaling. The anti-osteogenic effect of sclerostin is thought to be mediated mainly by inhibition of Wnt signaling through Lrp5/6 within osteoblasts. Dickkopf1 (Dkk1) is another potent soluble Wnt inhibitor that binds to Lrp5 and Lrp6, can displace Lrp5-bound sclerostin and is itself regulated by BMPs. In a recent genome-wide association study of bone mineral density a significant modifier locus was detected near the SOST gene at 17q21, which encodes sclerostin. In addition, nonsynonymous SNPs in the LRP4 gene were suggestively associated with bone mineral density. Here we show that Lrp4 is expressed in bone and cultured osteoblasts and binds Dkk1 and sclerostin in vitro. MicroCT analysis of Lrp4 deficient mutant mice revealed shortened total femur length, reduced cortical femoral perimeter, and reduced total femur bone mineral content (BMC) and bone mineral density (BMD). Lumbar spine trabecular bone volume per total volume (BV/TV) was significantly reduced in the mutants and the serum and urinary bone turnover markers alkaline phosphatase, osteocalcin and desoxypyridinoline were increased. We conclude that Lrp4 is a novel osteoblast expressed Dkk1 and sclerostin receptor with a physiological role in the regulation of bone growth and turnover, which is likely mediated through its function as an integrator of Wnt and BMP signaling pathways.			Choi, HY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	Joachim.Herz@UTSouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Deal C, 2009, NAT CLIN PRACT RHEUM, V5, P20, DOI 10.1038/ncprheum0977; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; McClung Michael R, 2005, Curr Osteoporos Rep, V3, P57, DOI 10.1007/s11914-005-0005-y; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nagayama M, 2008, J DENT RES, V87, P244, DOI 10.1177/154405910808700309; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Perry MJ, 2008, BONE, V42, P216, DOI 10.1016/j.bone.2007.09.053; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tomita Y, 1998, J BIOCHEM-TOKYO, V124, P784, DOI 10.1093/oxfordjournals.jbchem.a022180; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamaguchi YL, 2006, GENE EXPR PATTERNS, V6, P607, DOI 10.1016/j.modgep.2005.11.013; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	61	156	166	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7930	10.1371/journal.pone.0007930	http://dx.doi.org/10.1371/journal.pone.0007930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936252	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004800011
J	Teyssier, C; Gallet, M; Rabier, B; Monfoulet, L; Dine, J; Macari, C; Espallergues, J; Horard, B; Giguere, V; Cohen-Solal, M; Chassande, O; Vanacker, JM				Teyssier, Catherine; Gallet, Marlene; Rabier, Benedicte; Monfoulet, Laurent; Dine, Julien; Macari, Claire; Espallergues, Julie; Horard, Beatrice; Giguere, Vincent; Cohen-Solal, Martine; Chassande, Olivier; Vanacker, Jean-Marc			Absence of ERR alpha in Female Mice Confers Resistance to Bone Loss Induced by Age or Estrogen-Deficiency	PLOS ONE			English	Article							RECEPTOR-RELATED RECEPTORS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATOR; OSTEOPONTIN DEFICIENCY; MINERAL CRYSTALLINITY; ORPHAN RECEPTOR; MOUSE BONE; RESORPTION; OSTEOPROTEGERIN; EXPRESSION	Background: ERR alpha is an orphan member of the nuclear hormone receptor superfamily, which acts as a transcription factor and is involved in various metabolic processes. ERR alpha is also highly expressed in ossification zones during mouse development as well as in human bones and cell lines. Previous data have shown that this receptor up-modulates the expression of osteopontin, which acts as an inhibitor of bone mineralization and whose absence results in resistance to ovariectomy-induced bone loss. Altogether this suggests that ERR alpha may negatively regulate bone mass and could impact on bone fragility that occurs in the absence of estrogens. Methods/Principal Findings: In this report, we have determined the in vivo effect of ERR alpha on bone, using knock-out mice. Relative to wild type animals, female ERR alpha KO bones do not age and are resistant to bone loss induced by estrogen-withdrawal. Strikingly male ERR alpha KO mice are indistinguishable from their wild type counterparts, both at the unchallenged or gonadectomized state. Using primary cell cultures originating from ERR alpha KO bone marrow, we also show that ERR alpha acts as an inhibitor of osteoblast differentiation. Conclusion/Significance: Down-regulating ERR alpha could thus be beneficial against osteoporosis.	[Teyssier, Catherine; Gallet, Marlene; Macari, Claire; Chassande, Olivier; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,Inst Natl Rech Agron, F-69365 Lyon, France; [Rabier, Benedicte; Monfoulet, Laurent; Dine, Julien; Chassande, Olivier] Univ Bordeaux 2, U577, INSERM, Bordeaux, France; [Espallergues, Julie] Univ Montpellier 2, U710, INSERM, Montpellier, France; [Horard, Beatrice] Ecole Normale Super Lyon, UMRS239, CNRS, Lab Biol Mol Cellule, Villeurbanne, France; [Giguere, Vincent] Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Cohen-Solal, Martine] Hop Lariboisiere, U606, INSERM, Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Teyssier, C (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,Inst Natl Rech Agron, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Monfoulet, Laurent-Emmanuel/O-6508-2016; Teyssier, Catherine/AAC-2395-2020; Chassande, Olivier/J-3582-2015; Cohen-Solal, Martine/P-7808-2017	Monfoulet, Laurent-Emmanuel/0000-0001-9836-0255; Teyssier, Catherine/0000-0003-4937-6503; Cohen-Solal, Martine/0000-0002-8582-8258; Giguere, Vincent/0000-0001-9567-3694				Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kavukcuoglu NB, 2007, J BIOMED MATER RES A, V83A, P136, DOI 10.1002/jbm.a.31081; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Laflamme N, 2005, J BONE MINER RES, V20, P938, DOI 10.1359/JBMR.050203; LAUDET V, 2002, NUCL RECEPTOR FACTBO; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NODA M, 2002, PRINCIPLES BONE BIOL, V1, P239; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	39	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7942	10.1371/journal.pone.0007942	http://dx.doi.org/10.1371/journal.pone.0007942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936213	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004800019
J	Baqri, RM; Turner, BA; Rheuben, MB; Hammond, BD; Kaguni, LS; Miller, KE				Baqri, Rehan M.; Turner, Brittany A.; Rheuben, Mary B.; Hammond, Bradley D.; Kaguni, Laurie S.; Miller, Kyle E.			Disruption of Mitochondrial DNA Replication in Drosophila Increases Mitochondrial Fast Axonal Transport In Vivo	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; POLYMERASE-GAMMA; OXIDATIVE-PHOSPHORYLATION; CATALYTIC SUBUNIT; ACCESSORY SUBUNIT; ALPERS-SYNDROME; POLG MUTATIONS; KINESIN; NEURONS; MELANOGASTER	Mutations in mitochondrial DNA polymerase (pol gamma) cause several progressive human diseases including Parkinson's disease, Alper's syndrome, and progressive external ophthalmoplegia. At the cellular level, disruption of pol gamma leads to depletion of mtDNA, disrupts the mitochondrial respiratory chain, and increases susceptibility to oxidative stress. Although recent studies have intensified focus on the role of mtDNA in neuronal diseases, the changes that take place in mitochondrial biogenesis and mitochondrial axonal transport when mtDNA replication is disrupted are unknown. Using high-speed confocal microscopy, electron microscopy and biochemical approaches, we report that mutations in pol gamma deplete mtDNA levels and lead to an increase in mitochondrial density in Drosophila proximal nerves and muscles, without a noticeable increase in mitochondrial fragmentation. Furthermore, there is a rise in flux of bidirectional mitochondrial axonal transport, albeit with slower kinesin-based anterograde transport. In contrast, flux of synaptic vesicle precursors was modestly decreased in pol gamma-alpha mutants. Our data indicate that disruption of mtDNA replication does not hinder mitochondrial biogenesis, increases mitochondrial axonal transport, and raises the question of whether high levels of circulating mtDNA-deficient mitochondria are beneficial or deleterious in mtDNA diseases.			Baqri, RM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kmiller@msu.edu		Miller, Kyle/0000-0003-0401-4736	NIGMS NIH HHS [GM45295, R01 GM045295] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; FRIEDE RL, 1977, J PHYSIOL-LONDON, V265, P507, DOI 10.1113/jphysiol.1977.sp011727; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; GOTT AL, 1990, HUM REPROD, V5, P104, DOI 10.1093/oxfordjournals.humrep.a137028; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; HOLLENBECK PJ, 1985, CELL BIOL INT REP, V9, P193, DOI 10.1016/0309-1651(85)90094-3; Iyengar B, 1999, GENETICS, V153, P1809; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Mansouri A, 2003, HEPATOLOGY, V38, P715, DOI 10.1053/jhep.2003.50353; MARTINEZAZORIN F, 2007, J NEUROCHEM; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; PILLING AD, 2006, MOL BIOL CELL; Samuels DC, 2006, IUBMB LIFE, V58, P403, DOI 10.1080/15216540600791571; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640	63	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7874	10.1371/journal.pone.0007874	http://dx.doi.org/10.1371/journal.pone.0007874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924234	Green Submitted, gold, Green Published			2022-12-27	WOS:000271854200020
J	Bray, I; Bryan, K; Prenter, S; Buckley, PG; Foley, NH; Murphy, DM; Alcock, L; Mestdagh, P; Vandesompele, J; Speleman, F; London, WB; McGrady, PW; Higgins, DG; O'Meara, A; O'Sullivan, M; Stallings, RL				Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank; London, Wendy B.; McGrady, Patrick W.; Higgins, Desmond G.; O'Meara, Anne; O'Sullivan, Maureen; Stallings, Raymond L.			Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival	PLOS ONE			English	Article							MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; 11Q; DELETIONS; THERAPY; 3P	MiRNAs regulate gene expression at a post-transcriptional level and their dysregulation can play major roles in the pathogenesis of many different forms of cancer, including neuroblastoma, an often fatal paediatric cancer originating from precursor cells of the sympathetic nervous system. We have analyzed a set of neuroblastoma (n = 145) that is broadly representative of the genetic subtypes of this disease for miRNA expression (430 loci by stem-loop RT qPCR) and for DNA copy number alterations (array CGH) to assess miRNA involvement in disease pathogenesis. The tumors were stratified and then randomly split into a training set (n = 96) and a validation set (n = 49) for data analysis. Thirty-seven miRNAs were significantly over-or under-expressed in MYCN amplified tumors relative to MYCN single copy tumors, indicating a potential role for the MYCN transcription factor in either the direct or indirect dysregulation of these loci. In addition, we also determined that there was a highly significant correlation between miRNA expression levels and DNA copy number, indicating a role for large-scale genomic imbalances in the dysregulation of miRNA expression. In order to directly assess whether miRNA expression was predictive of clinical outcome, we used the Random Forest classifier to identify miRNAs that were most significantly associated with poor overall patient survival and developed a 15 miRNA signature that was predictive of overall survival with 72.7% sensitivity and 86.5% specificity in the validation set of tumors. We conclude that there is widespread dysregulation of miRNA expression in neuroblastoma tumors caused by both over-expression of the MYCN transcription factor and by large-scale chromosomal imbalances. MiRNA expression patterns are also predicative of clinical outcome, highlighting the potential for miRNA mediated diagnostics and therapeutics.	[Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; O'Sullivan, Maureen; Stallings, Raymond L.] Our Ladys Childrens Hosp Crumlin, Childrens Res Ctr, Dublin, Ireland; [Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [London, Wendy B.; McGrady, Patrick W.] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL USA; [Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [O'Meara, Anne; O'Sullivan, Maureen] Our Ladys Childrens Hosp Crumlin, Dept Oncol, Dublin, Ireland; [O'Meara, Anne; O'Sullivan, Maureen] Our Ladys Childrens Hosp Crumlin, Dept Pathol, Dublin, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Ghent University; Ghent University Hospital; Children's Oncology Group (COG); State University System of Florida; University of Florida; University College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Bray, I (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Murphy, Derek/B-1285-2013; Higgins, des g/J-6314-2012; Vandesompele, Jo/W-3411-2018; Bray, Isabella/D-6179-2012; speleman, frank/AAR-5184-2020; London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021	Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; London, Wendy Beth/0000-0003-3571-6538; Mestdagh, Pieter/0000-0001-7821-9684; Higgins, Des/0000-0002-3952-3285; Bryan, Kenneth/0000-0002-9550-8354; O'Sullivan, Maureen/0000-0001-5838-1609	NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Breen CJ, 2000, CANCER GENET CYTOGEN, V120, P44, DOI 10.1016/S0165-4608(99)00252-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Spitz R, 2003, CLIN CANCER RES, V9, P52; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Vandesompele J, 1998, GENE CHROMOSOME CANC, V23, P141, DOI 10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wei JS, 2009, CLIN CANCER RES, V15, P5560, DOI 10.1158/1078-0432.CCR-08-3287; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	24	95	100	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7850	10.1371/journal.pone.0007850	http://dx.doi.org/10.1371/journal.pone.0007850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924232	Green Published, gold, Green Submitted			2022-12-27	WOS:000271851000008
J	Disset, A; Cheval, L; Soutourina, O; Van Huyen, JPD; Li, GR; Genin, C; Tostain, J; Loupy, A; Doucet, A; Rajerison, R				Disset, Antoine; Cheval, Lydie; Soutourina, Olga; Van Huyen, Jean-Paul Duong; Li, Guorong; Genin, Christian; Tostain, Jacques; Loupy, Alexandre; Doucet, Alain; Rajerison, Rabary			Tissue Compartment Analysis for Biomarker Discovery by Gene Expression Profiling	PLOS ONE			English	Article							MOLECULAR CLASSIFICATION; LASER-MICRODISSECTION; DISEASE	Background: Although high throughput technologies for gene profiling are reliable tools, sample/tissue heterogeneity limits their outcomes when applied to identify molecular markers. Indeed, inter-sample differences in cell composition contribute to scatter the data, preventing detection of small but relevant changes in gene expression level. To date, attempts to circumvent this difficulty were based on isolation of the different cell structures constituting biological samples. As an alternate approach, we developed a tissue compartment analysis (TCA) method to assess the cell composition of tissue samples, and applied it to standardize data and to identify biomarkers. Methodology/Principal Findings: TCA is based on the comparison of mRNA expression levels of specific markers of the different constitutive structures in pure isolated structures, on the one hand, and in the whole sample on the other. TCA method was here developed with human kidney samples, as an example of highly heterogeneous organ. It was validated by comparison of the data with those obtained by histo-morphometry. TCA demonstrated the extreme variety of composition of kidney samples, with abundance of specific structures varying from 5 to 95% of the whole sample. TCA permitted to accurately standardize gene expression level amongst >100 kidney biopsies, and to identify otherwise imperceptible molecular disease markers. Conclusions/Significance: Because TCA does not require specific preparation of sample, it can be applied to all existing tissue or cDNA libraries or to published data sets, inasmuch specific operational compartments markers are available. In human, where the small size of tissue samples collected in clinical practice accounts for high structural diversity, TCA is well suited for the identification of molecular markers of diseases, and the follow up of identified markers in single patients for diagnosis/prognosis and evaluation of therapy efficiency. In laboratory animals, TCA will interestingly be applied to central nervous system where tissue heterogeneity is a limiting factor.			Disset, A (corresponding author), Univ Paris 06, Lab Genom Physiol & Physiopathol Renale, UMRS 872, Paris, France.	alain.doucet@crc.jussieu.fr	Soutourina, Olga/F-2042-2015; Loupy, Alexandre/K-8512-2019	Soutourina, Olga/0000-0001-6439-7228; CHEVAL, LYDIE/0000-0003-2957-6487				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brochier C, 2008, PHYSIOL GENOMICS, V33, P170, DOI 10.1152/physiolgenomics.00125.2007; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x; de Borst MH, 2008, NAT CLIN PRACT NEPHR, V4, P265, DOI 10.1038/ncpneph0785; Fenton KA, 2008, MOL IMMUNOL, V45, P3117, DOI 10.1016/j.molimm.2008.03.001; Fink L, 2006, EXP TOXICOL PATHOL, V57, P25, DOI 10.1016/j.etp.2006.02.010; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Karsten S. L., 2008, CURR PROTOC NEUROSCI; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Razzaque MS, 1998, NEPHRON, V80, P434, DOI 10.1159/000045217; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7779	10.1371/journal.pone.0007779	http://dx.doi.org/10.1371/journal.pone.0007779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901995	Green Published, Green Submitted, gold			2022-12-27	WOS:000271658800014
J	Farrugia, W; Scott, AM; Ramsland, PA				Farrugia, William; Scott, Andrew M.; Ramsland, Paul A.			A Possible Role for Metallic Ions in the Carbohydrate Cluster Recognition Displayed by a Lewis Y Specific Antibody	PLOS ONE			English	Article							GROUP-RELATED ANTIGENS; HUMANIZED MONOCLONAL-ANTIBODY; GROWTH-FACTOR RECEPTORS; HUMAN SEMINAL PLASMA; BLOOD GROUP ANTIGENS; CRYSTAL-STRUCTURE; PHASE-I; 3-DIMENSIONAL STRUCTURES; ERBB RECEPTORS; SOLID TUMORS	Background: Lewis Y (Le(y)) is a blood group-related carbohydrate that is expressed at high surface densities on the majority of epithelial carcinomas and is a promising target for antibody-based immunotherapy. A humanized Le(y)-specific antibody (hu3S193) has shown encouraging safety, pharmacokinetic and tumor-targeting properties in recently completed Phase I clinical trials. Methodology/Principal Findings: We report the three-dimensional structures for both the free (unliganded) and bound (Le(y) tetrasaccharide) hu3S193 Fab from the same crystal grown in the presence of divalent zinc ions. There is no evidence of significant conformational changes occurring in either the Le(y) carbohydrate antigen or the hu3S193 binding site, which suggests a rigid fit binding mechanism. In the crystal, the hu3S193 Fab molecules are coordinated at their protein-protein interface by two zinc ions and in solution aggregation of Fab can be initiated by zinc, but not magnesium ions. Dynamic light scattering revealed that zinc ions could initiate a sharp transition from hu3S193 Fab monomers to large multimeric aggregates in solution. Conclusions/Significance: Zinc ions can mediate interactions between hu3S193 Fab in crystals and in solution. Whether metallic ion mediated aggregation of antibody occurs in vivo is not known, but the present results suggest that similar clustering mechanisms could occur when hu3S193 binds to Le(y) on cells, particularly given the high surface densities of antigen on the target tumor cells.			Farrugia, W (corresponding author), Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia.	pramsland@burnet.edu.au		Ramsland, Paul/0000-0002-2107-2738; Scott, Andrew/0000-0002-6656-295X				ALTSCHUH D, 1992, SCIENCE, V256, P92, DOI 10.1126/science.1566062; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU A, 1987, CANCER RES, V47, P2531; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5183, DOI 10.1021/bi00183a023; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Candelier JJ, 2000, HISTOCHEM CELL BIOL, V114, P113; Cao Y, 2001, GLYCOBIOLOGY, V11, P677, DOI 10.1093/glycob/11.8.677; Chacko S, 1996, J BIOL CHEM, V271, P12191, DOI 10.1074/jbc.271.21.12191; Chalabi S, 2002, J BIOL CHEM, V277, P32562, DOI 10.1074/jbc.M205152200; Ding YH, 1998, P NATL ACAD SCI USA, V95, P10443, DOI 10.1073/pnas.95.18.10443; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Esqueda AC, 2009, J AM CHEM SOC, V131, P11387, DOI 10.1021/ja901875v; Farhan H, 2006, J PHARMACOL EXP THER, V319, P1459, DOI 10.1124/jpet.106.107318; FOLIN M, 1994, BIOMETALS, V7, P75; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; HELLER D S, 1990, Pediatric Pathology, V10, P681; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Johns TG, 2007, CLIN CANCER RES, V13, P1911, DOI 10.1158/1078-0432.CCR-06-1453; Kelly MP, 2007, CLIN CANCER RES, V13, p5604S, DOI 10.1158/1078-0432.CCR-07-1071; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; KIM YS, 1986, CANCER RES, V46, P5985; KITAMURA K, 1994, P NATL ACAD SCI USA, V91, P12957, DOI 10.1073/pnas.91.26.12957; Klinger M, 2004, CANCER RES, V64, P1087, DOI 10.1158/0008-5472.CAN-03-2435; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Krug LM, 2007, J THORAC ONCOL, V2, P947, DOI 10.1097/JTO.0b013e3181560dcc; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Minas V, 2007, HISTOCHEM CELL BIOL, V128, P55, DOI 10.1007/s00418-007-0293-7; Moehler TM, 2008, J CELL PHYSIOL, V215, P27, DOI 10.1002/jcp.21285; MOLLICONE R, 1985, LAB INVEST, V53, P219; MORRISON B, 1979, CLIN CHEM, V25, P1799; MURATA K, 1992, AM J CLIN PATHOL, V98, P67, DOI 10.1093/ajcp/98.1.67; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai LH, 1996, NAT MED, V2, P350, DOI 10.1038/nm0396-350; Pai-Scherf LH, 2000, CLIN CANCER RES, V6, P1720; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Perera RM, 2007, NEOPLASIA, V9, P1099, DOI 10.1593/neo.07721; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; Reynolds M, 2008, MOL SIMULAT, V34, P447, DOI 10.1080/08927020701713878; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; SAKAMOTO J, 1986, CANCER RES, V46, P1553; Saleh MN, 2000, J CLIN ONCOL, V18, P2282, DOI 10.1200/JCO.2000.18.11.2282; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; Scott AM, 2000, CANCER RES, V60, P3254; Scott AM, 1997, CURR OPIN IMMUNOL, V9, P717, DOI 10.1016/S0952-7915(97)80054-4; Scott AM, 2007, CLIN CANCER RES, V13, P3286, DOI 10.1158/1078-0432.CCR-07-0284; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sundstrom M, 1996, EMBO J, V15, P6832, DOI 10.1002/j.1460-2075.1996.tb01074.x; Szolar OHJ, 2006, J PHARMACEUT BIOMED, V41, P1347, DOI 10.1016/j.jpba.2006.03.026; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vallas V, 2007, J MOL RECOGNIT, V20, P90, DOI 10.1002/jmr.814; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5; Yuriev E, 2005, IMMUNOL CELL BIOL, V83, P709, DOI 10.1111/j.1440-1711.2005.01374.x	59	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7777	10.1371/journal.pone.0007777	http://dx.doi.org/10.1371/journal.pone.0007777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901987	Green Published, gold			2022-12-27	WOS:000271658800013
J	Pagliuca, C; Draviam, VM; Marco, E; Sorger, PK; De Wulf, P				Pagliuca, Cinzia; Draviam, Viji M.; Marco, Eugenio; Sorger, Peter K.; De Wulf, Peter			Roles for the Conserved Spc105p/Kre28p Complex in Kinetochore-Microtubule Binding and the Spindle Assembly Checkpoint	PLOS ONE			English	Article							BUDDING YEAST KINETOCHORE; MOLECULAR ARCHITECTURE; PROTEIN; ATTACHMENT; GENE; LOCALIZATION; CYTOKINESIS; INTERFACE; STABILITY; COMPONENT	Background: Kinetochores attach sister chromatids to microtubules of the mitotic spindle and orchestrate chromosome disjunction at anaphase. Although S. cerevisiae has the simplest known kinetochores, they nonetheless contain,70 subunits that assemble on centromeric DNA in a hierarchical manner. Developing an accurate picture of the DNA-binding, linker and microtubule-binding layers of kinetochores, including the functions of individual proteins in these layers, is a key challenge in the field of yeast chromosome segregation. Moreover, comparison of orthologous proteins in yeast and humans promises to extend insight obtained from the study of simple fungal kinetochores to complex animal cell kinetochores. Principal Findings: We show that S. cerevisiae Spc105p forms a heterotrimeric complex with Kre28p, the likely orthologue of the metazoan kinetochore protein Zwint-1. Through systematic analysis of interdependencies among kinetochore complexes, focused on Spc105p/Kre28p, we develop a comprehensive picture of the assembly hierarchy of budding yeast kinetochores. We find Spc105p/Kre28p to comprise the third linker complex that, along with the Ndc80 and MIND linker complexes, is responsible for bridging between centromeric heterochromatin and kinetochore MAPs and motors. Like the Ndc80 complex, Spc105p/Kre28p is also essential for kinetochore binding by components of the spindle assembly checkpoint. Moreover, these functions are conserved in human cells. Conclusions/Significance: Spc105p/Kre28p is the last of the core linker complexes to be analyzed in yeast and we show it to be required for kinetochore binding by a discrete subset of kMAPs (Bim1p, Bik1p, Slk19p) and motors (Cin8p, Kar3p), all of which are nonessential. Strikingly, dissociation of these proteins from kinetochores prevents bipolar attachment, even though the Ndc80 and DASH complexes, the two best-studied kMAPs, are still present. The failure of Spc105 deficient kinetochores to bind correctly to spindle microtubules and to recruit checkpoint proteins in yeast and human cells explains the observed severity of missegregation phenotypes.			Pagliuca, C (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	peter.dewulf@ifom-ieo-campus.it	Marco, Eugenio/F-4583-2011	Marco, Eugenio/0000-0002-3675-263X; Draviam, Viji/0000-0001-8295-3689; Sorger, Peter/0000-0002-3364-1838; De Wulf, Peter/0000-0001-9772-5881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051464] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Cancer Research UK [9787] Funding Source: Medline; NIGMS NIH HHS [R01 GM051464, GM51464] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Bouck D, 2005, BIOCHEM CELL BIOL, V83, P696, DOI 10.1139/O05-161; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Collins KA, 2005, MOL BIOL CELL, V16, P5649, DOI 10.1091/mbc.E05-08-0771; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa Tatsuo, 2009, P133, DOI 10.1007/978-0-387-69076-6_6; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Hayette S, 2000, ONCOGENE, V19, P4446, DOI 10.1038/sj.onc.1203789; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Kerres A, 2004, MOL BIOL CELL, V15, P5255, DOI 10.1091/mbc.E04-06-0443; Kerres A, 2007, MOL BIOL CELL, V18, P2441, DOI 10.1091/mbc.E06-08-0738; Knockleby J, 2009, CELL CYCLE, V8, P2570, DOI 10.4161/cc.8.16.9267; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pot I, 2005, CELL CYCLE, V4, P1448, DOI 10.4161/cc.4.10.2106; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; Schittenhelm RB, 2009, EMBO J, V28, P2374, DOI 10.1038/emboj.2009.188; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Takimoto M, 2002, BRIT J CANCER, V86, P1757, DOI 10.1038/sj.bjc.6600328; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	58	48	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7640	10.1371/journal.pone.0007640	http://dx.doi.org/10.1371/journal.pone.0007640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19893618	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600018
J	Jones, JH; Salathe, M				Jones, James Holland; Salathe, Marcel			Early Assessment of Anxiety and Behavioral Response to Novel Swine-Origin Influenza A(H1N1)	PLOS ONE			English	Article							SOCIAL NETWORKS; RISK; PERCEPTIONS; IMPACT; MEDIA	Background: Since late April, 2009, a novel influenza virus A (H1N1), generally referred to as the "swine flu,'' has spread around the globe and infected hundreds of thousands of people. During the first few days after the initial outbreak in Mexico, extensive media coverage together with a high degree of uncertainty about the transmissibility and mortality rate associated with the virus caused widespread concern in the population. The spread of an infectious disease can be strongly influenced by behavioral changes (e.g., social distancing) during the early phase of an epidemic, but data on risk perception and behavioral response to a novel virus is usually collected with a substantial delay or after an epidemic has run its course. Methodology/Principal Findings: Here, we report the results from an online survey that gathered data (n = 6,249) about risk perception of the Influenza A( H1N1) outbreak during the first few days of widespread media coverage (April 28 - May 5, 2009). We find that after an initially high level of concern, levels of anxiety waned along with the perception of the virus as an immediate threat. Overall, our data provide evidence that emotional status mediates behavioral response. Intriguingly, principal component analysis revealed strong clustering of anxiety about swine flu, bird flu and terrorism. All three of these threats receive a great deal of media attention and their fundamental uncertainty is likely to generate an inordinate amount of fear vis-a-vis their actual threat. Conclusions/Significance: Our results suggest that respondents' behavior varies in predictable ways. Of particular interest, we find that affective variables, such as self-reported anxiety over the epidemic, mediate the likelihood that respondents will engage in protective behavior. Understanding how protective behavior such as social distancing varies and the specific factors that mediate it may help with the design of epidemic control strategies.	[Jones, James Holland] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Salathe, Marcel] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Jones, JH (corresponding author), Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA.	jhj1@stanford.edu		Jones, James/0000-0003-1680-6757; Salathe, Marcel/0000-0002-5079-7797	NICH [1K01HD051494]; Branco Weiss Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD051494] Funding Source: NIH RePORTER	NICH; Branco Weiss Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by award 1K01HD051494 from NICH (JHJ) and the Branco Weiss Foundation (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKMAN LF, 1984, ANNU REV PUBL HEALTH, V5, P413, DOI 10.1146/annurev.pu.05.050184.002213; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bernard HR, 2005, RES METHODS ANTHR QU, V4th; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; *CDCP, 2009, SOC MED CDC NOV H1N1; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303; FRASER C, 2009, PANDEMIC POTENTIAL S; Frost K, 1997, AM J PUBLIC HEALTH, V87, P842, DOI 10.2105/AJPH.87.5.842; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gray GM, 2002, HEALTH AFFAIR, V21, P106, DOI 10.1377/hlthaff.21.6.106; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; McLachlan G., 2000, WILEY SER PROB STAT; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; *OBJ PLAN, 2009, OP SURV SOFTW; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Venables WN., 2002, MODERN APPL STAT S 4; *WHO, 2009, INFL A H1N1 PAND AL; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization Director-General, 2009, INFL A H1N1; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	30	281	287	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8032	10.1371/journal.pone.0008032	http://dx.doi.org/10.1371/journal.pone.0008032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MW	19997505	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829000001
J	Arenas, A; Fernandez, VM; Farina, WM				Arenas, Andres; Fernandez, Vanesa M.; Farina, Walter M.			Associative Learning during Early Adulthood Enhances Later Memory Retention in Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; FLORAL ODORS; DISCRIMINATION; INSECT; RATS; HIVE; AGE; REPRESENTATIONS; DEPRIVATION; FORAGERS	Background: Cognitive experiences during the early stages of life play an important role in shaping the future behavior in mammals but also in insects, in which precocious learning can directly modify behaviors later in life depending on both the timing and the rearing environment. However, whether olfactory associative learning acquired early in the adult stage of insects affect memorizing of new learning events has not been studied yet. Methodology: Groups of adult honeybee workers that experienced an odor paired with a sucrose solution 5 to 8 days or 9 to 12 days after emergence were previously exposed to (i) a rewarded experience through the offering of scented food, or (ii) a non-rewarded experience with a pure volatile compound in the rearing environment. Principal Findings: Early rewarded experiences (either at 1-4 or 5-8 days of adult age) enhanced retention performance in 9-12-day-conditioned bees when they were tested at 17 days of age. The highest retention levels at this age, which could not be improved with prior rewarded experiences, were found for memories established at 5-8 days of adult age. Associative memories acquired at 9-12 days of age showed a weak effect on retention for some pure pre-exposed volatile compounds; whereas the sole exposure of an odor at any younger age did not promote long-term effects on learning performance. Conclusions: The associative learning events that occurred a few days after adult emergence improved memorizing in middle-aged bees. In addition, both the timing and the nature of early sensory inputs interact to enhance retention of new learning events acquired later in life, an important matter in the social life of honeybees.	[Arenas, Andres; Fernandez, Vanesa M.; Farina, Walter M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Estudio Insectos Sociales, IFIBYNE CONICET,Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Arenas, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Estudio Insectos Sociales, IFIBYNE CONICET,Dept Biodiversidad & Biol Expt, Pabellon 2, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar	Arenas, Andres/ABC-4886-2021	Farina, Walter/0000-0001-6411-489X	ANPCYT [01-1155]; University of Buenos Aires [X 077]; CONICET [PIP 112-200801-00150]	ANPCYT(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	ANPCYT (01-1155), University of Buenos Aires (X 077), CONICET (PIP 112-200801-00150) and Guggenheim fellowship to WMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 1971, INSECT SOC; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2008, APIDOLOGIE, V39, P714, DOI 10.1051/apido:2008053; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; CAUBET Y, 1991, ANIM BEHAV, V42, P977, DOI 10.1016/S0003-3472(05)80150-2; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Daly KC, 2001, J INSECT PHYSIOL, V47, P375, DOI 10.1016/S0022-1910(00)00117-7; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Ferguson HJ, 2001, ANIM BEHAV, V61, P527, DOI 10.1006/anbe.2000.1635; Fernandez VM, 2009, J COMP PHYSIOL A, V195, P759, DOI 10.1007/s00359-009-0453-4; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Garelick MG, 2005, P NATL ACAD SCI USA, V102, P9091, DOI 10.1073/pnas.0504017102; Gil M, 2005, J EXP BIOL, V208, P671, DOI 10.1242/jeb.01474; Holldobler B., 1980, Evolution of social behaviour: hypotheses and empirical tests, P35; Ichikawa N, 2003, APPL ENTOMOL ZOOL, V38, P203, DOI 10.1303/aez.2003.203; Iso H, 2007, BEHAV BRAIN RES, V179, P90, DOI 10.1016/j.bbr.2007.01.025; Laloi D, 2004, J INSECT BEHAV, V17, P385, DOI 10.1023/B:JOIR.0000031538.15346.e1; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Lodge DJ, 2003, BEHAV BRAIN RES, V141, P113, DOI 10.1016/S0166-4328(02)00328-5; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maleszka R, 2001, HORM BEHAV, V40, P403, DOI 10.1006/hbeh.2001.1705; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; NEAL WR, 1972, CHILD YOUTH CARE Q, V1, P157, DOI 10.1007/BF01543431; Oitzl MS, 2000, EUR J NEUROSCI, V12, P3771, DOI 10.1046/j.1460-9568.2000.00231.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosch G.A, 1925, Z VERGL PHYSIOL, V2, P571; SAHAKIAN BJ, 1975, BRAIN RES, V84, P195, DOI 10.1016/0006-8993(75)90975-0; Sandoz JC, 2000, ANIM BEHAV, V59, P1025, DOI 10.1006/anbe.2000.1395; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M	40	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8046	10.1371/journal.pone.0008046	http://dx.doi.org/10.1371/journal.pone.0008046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MU	19956575	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800006
J	Yesilaltay, A; Daniels, K; Pal, R; Krieger, M; Kocher, O				Yesilaltay, Ayce; Daniels, Kathleen; Pal, Rinku; Krieger, Monty; Kocher, Olivier			Loss of PDZK1 Causes Coronary Artery Occlusion and Myocardial Infarction in Paigen Diet-Fed Apolipoprotein E Deficient Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; SCAVENGER RECEPTOR; SR-BI; HEART-DISEASE; TARGETED DISRUPTION; CARDIAC DYSFUNCTION; HEPATIC EXPRESSION; LIPID-METABOLISM; PREMATURE DEATH	Background: PDZK1 is a four PDZ-domain containing protein that binds to the carboxy terminus of the HDL receptor, scavenger receptor class B type I (SR-BI), and regulates its expression, localization and function in a tissue-specific manner. PDZK1 knockout (KO) mice are characterized by a marked reduction of SR-BI protein expression (similar to 95%) in the liver (lesser or no reduction in other organs) with a concomitant 1.7 fold increase in plasma cholesterol. PDZK1 has been shown to be atheroprotective using the high fat/high cholesterol ('Western') diet-fed murine apolipoprotein E ( apoE) KO model of atherosclerosis, presumably because of its role in promoting reverse cholesterol transport via SR-BI. Principal Findings: Here, we have examined the effects of PDZK1 deficiency in apoE KO mice fed with the atherogenic 'Paigen' diet for three months. Relative to apoE KO, PDZK1/apoE double KO (dKO) mice showed increased plasma lipids (33% increase in total cholesterol; 49% increase in unesterified cholesterol; and 36% increase in phospholipids) and a 26% increase in aortic root lesions. Compared to apoE KO, dKO mice exhibited substantial occlusive coronary artery disease: 375% increase in severe occlusions. Myocardial infarctions, not observed in apoE KO mice (although occasional minimal fibrosis was noted), were seen in 7 of 8 dKO mice, resulting in 12 times greater area of fibrosis in dKO cardiac muscle. Conclusions: These results show that Paigen-diet fed PDZK1/apoE dKO mice represent a new animal model useful for studying coronary heart disease and suggest that PDZK1 may represent a valuable target for therapeutic intervention.	[Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yesilaltay, A (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	okocher@bidmc.harvard.edu			National Institutes of Health [HL-52212, HL66105, HL077780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL052212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health HL-52212 and HL66105 (MK), HL077780 (OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; BARR DP, 1951, AM J MED, V11, P480, DOI 10.1016/0002-9343(51)90183-0; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Braun A, 2008, ATHEROSCLEROSIS, V198, P77, DOI 10.1016/j.atherosclerosis.2007.10.012; Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; Chase A, 2007, CRIT CARE MED, V35, P2344, DOI 10.1097/01.CCM.0000282085.63409.FB; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; GLOMSET JA, 1968, J LIPID RES, V9, P155; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KARACKATTU S, 2006, THESIS MIT; KARACKATTU S, 2006, ARTERIOSCLER THROMB, P548; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Kumar V., 2005, ROBBINS COTRAN PATHO, P516; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Reardon CA, 2001, CURR OPIN LIPIDOL, V12, P167, DOI 10.1097/00041433-200104000-00010; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802	46	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8103	10.1371/journal.pone.0008103	http://dx.doi.org/10.1371/journal.pone.0008103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956623	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828700015
J	Parast, MM; Yu, H; Ciric, A; Salata, MW; Davis, V; Milstone, DS				Parast, Mana M.; Yu, Heather; Ciric, Aleksandar; Salata, Mark W.; Davis, Vannessa; Milstone, David S.			PPAR gamma Regulates Trophoblast Proliferation and Promotes Labyrinthine Trilineage Differentiation	PLOS ONE			English	Article							STEM-CELLS; PLACENTAL MORPHOLOGY; ALPHA HETERODIMERS; INSULIN-RESISTANCE; EXPRESSION DATA; GIANT-CELLS; GENE; TRANSCRIPTION; MICE; PROTEIN	Background: Abnormal trophoblast differentiation and function is the basis of many placenta-based pregnancy disorders, including pre-eclampsia and fetal growth restriction. PPAR gamma, a ligand-activated nuclear receptor, plays essential roles in placental development; null murine embryos die at midgestation due to abnormalities in all placental layers, in particular, small labyrinth and expanded giant cell layer. Previous studies have focused mostly on the role of PPAR gamma in trophoblast invasion. Based on the previously reported role of PPAR gamma in preadipocyte differentiation, we hypothesized that PPAR gamma also plays a pivotal role in trophoblast differentiation. To test this hypothesis, we report derivation of wild-type and PPAR gamma-null trophoblast stem (TS) cells. Methodology/Principal Findings: PPAR gamma-null TS cells showed defects in both proliferation and differentiation, specifically into labyrinthine trophoblast. Detailed marker analysis and functional studies revealed reduced differentiation of all three labyrinthine lineages, and enhanced giant cell differentiation, particularly the invasive subtypes. In addition, rosiglitazone, a specific PPAR gamma agonist, reduced giant cell differentiation, while inducing Gcm1, a key regulator in labyrinth. Finally, reintroducing PPAR gamma into null TS cells, using an adenovirus, normalized invasion and partially reversed defective labyrinthine differentiation, as assessed both by morphology and marker analysis. Conclusions/Significance: In addition to regulating trophoblast invasion, PPAR gamma plays a predominant role in differentiation of labyrinthine trophoblast lineages, which, along with fetal endothelium, form the vascular exchange interface with maternal blood. Elucidating cellular and molecular mechanisms mediating PPAR gamma action will help determine if modulating PPAR gamma activity, for which clinical pharmacologic agonists already exist, might modify the course of pregnancy disorders associated with placental dysfunction.	[Parast, Mana M.; Ciric, Aleksandar; Salata, Mark W.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Parast, Mana M.; Yu, Heather; Davis, Vannessa; Milstone, David S.] Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Ctr Excellence Vasc Biol, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital	Parast, MM (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	mparast@ucsd.edu; milstone@rascal.med.harvard.edu			National Institute of Child Health and Human Development [R01HD040895]; Department of Pathology at UCSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040895] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Pathology at UCSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by R01HD040895 (D. S. M.) from the National Institute of Child Health and Human Development, as well as funds from the Department of Pathology at UCSD (M. M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Huppertz B, 2006, PLACENTA, V27, pS3, DOI 10.1016/j.placenta.2006.01.007; Kibschull M, 2004, DEV BIOL, V273, P63, DOI 10.1016/j.ydbio.2004.04.037; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tarrade A, 2001, J CLIN ENDOCR METAB, V86, P5017, DOI 10.1210/jc.86.10.5017; Tarrade A, 2001, ENDOCRINOLOGY, V142, P4504, DOI 10.1210/en.142.10.4504; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	29	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8055	10.1371/journal.pone.0008055	http://dx.doi.org/10.1371/journal.pone.0008055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956639	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828400012
J	Zhou, LQ; Ma, XT; Arbeitman, MN; Sun, FZ				Zhou, Linqi; Ma, Xiaotu; Arbeitman, Michelle N.; Sun, Fengzhu			Chromatin Regulation and Gene Centrality Are Essential for Controlling Fitness Pleiotropy in Yeast	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; TRANSPORT	Background: There are a wide range of phenotypes that are due to loss-of-function or null mutations. Previously, the functions of gene products that distinguish essential from nonessential genes were characterized. However, the functions of products of non-essential genes that contribute to fitness remain minimally understood. Principal Findings: Using data from Saccharomyces cerevisiae, we investigated several gene characteristics, which we are able to measure, that are significantly associated with a gene's fitness pleiotropy. Fitness pleiotropy is a measurement of the gene's importance to fitness. These characteristics include: 1) whether the gene's product functions in chromatin regulation, 2) whether the regulation of the gene is influenced by chromatin state, measured by chromatin regulation effect (CRE), 3) whether the gene's product functions as a transcription factor (TF) and the number of genes a TF regulates, 4) whether the gene contains TATA-box, and 5) whether the gene's product is central in a protein interaction network. Partial correlation analysis was used to study how these characteristics interact to influence fitness pleiotropy. We show that all five characteristics that were measured are statistically significantly associated with fitness pleiotropy. However, fitness pleiotropy is not associated with the presence of TATA-box when CRE is controlled. In particular, two characteristics: 1) whether the regulation of a gene is more likely to be influenced by chromatin state, and 2) whether the gene product is central in a protein interaction network measured by the number of protein interactions were found to play the most important roles affecting a gene's fitness pleiotropy. Conclusions: These findings highlight the significance of both epigenetic gene regulation and protein interaction networks in influencing the fitness pleiotropy.	[Zhou, Linqi; Arbeitman, Michelle N.; Sun, Fengzhu] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Ma, Xiaotu] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Sun, Fengzhu] Tsinghua Univ, TNLIST Dept Automat, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China	University of Southern California; University of Texas System; University of Texas Dallas; Tsinghua University	Zhou, LQ (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	fsun@usc.edu	Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X; Arbeitman, Michelle/0000-0002-2437-4352	National Institutes of Health (NIH) [R21AG032743]; NIH Centers for Excellence in Genomic Sciences [P50 HG 002790]; Natural Science Foundation of China [60928007, 60805010]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032743] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Excellence in Genomic Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is partly supported by the National Institutes of Health (NIH) R21AG032743 and NIH Centers for Excellence in Genomic Sciences P50 HG 002790. FS is also partially supported by Natural Science Foundation of China 60928007 and 60805010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DENG MH, 2003, PAC S BIOCOMPUT, P197; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hakes L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-131; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8086	10.1371/journal.pone.0008086	http://dx.doi.org/10.1371/journal.pone.0008086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956643	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400027
J	Cheron, G; Sausbier, M; Sausbier, U; Neuhuber, W; Ruth, P; Dan, B; Servais, L				Cheron, Guy; Sausbier, Matthias; Sausbier, Ulrike; Neuhuber, Winfried; Ruth, Peter; Dan, Bernard; Servais, Laurent			BK Channels Control Cerebellar Purkinje and Golgi Cell Rhythmicity In Vivo	PLOS ONE			English	Article							FIELD POTENTIAL OSCILLATIONS; SYNAPTIC INTEGRATION; K+ CHANNELS; CONDUCTANCE; MODULATION; CORTEX; EXCITABILITY; DYSFUNCTION; PLASTICITY; PATTERNS	Calcium signaling plays a central role in normal CNS functioning and dysfunction. As cerebellar Purkinje cells express the major regulatory elements of calcium control and represent the sole integrative output of the cerebellar cortex, changes in neural activity-and calcium-mediated membrane properties of these cells are expected to provide important insights into both intrinsic and network physiology of the cerebellum. We studied the electrophysiological behavior of Purkinje cells in genetically engineered alert mice that do not express BK calcium-activated potassium channels and in wild-type mice with pharmacological BK inactivation. We confirmed BK expression in Purkinje cells and also demonstrated it in Golgi cells. We demonstrated that either genetic or pharmacological BK inactivation leads to ataxia and to the emergence of a beta oscillatory field potential in the cerebellar cortex. This oscillation is correlated with enhanced rhythmicity and synchronicity of both Purkinje and Golgi cells. We hypothesize that the temporal coding modification of the spike firing of both Purkinje and Golgi cells leads to the pharmacologically or genetically induced ataxia.	[Cheron, Guy; Servais, Laurent] Univ Mons, Lab Electrophysiol, Mons, Belgium; [Cheron, Guy; Dan, Bernard] Univ Libre Bruxelles, Lab Neurophysiol & Movement Biomech, Brussels, Belgium; [Sausbier, Matthias; Sausbier, Ulrike; Ruth, Peter] Univ Tubingen, Inst Pharm, Dept Pharmacol & Toxicol, Tubingen, Germany; [Neuhuber, Winfried] Univ Erlangen Nurnberg, Inst Anat, Erlangen, Germany; [Dan, Bernard] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Neurol, Brussels, Belgium; [Servais, Laurent] Hop Robert Debre, Dept Child Neurol, F-75019 Paris, France	University of Mons; Universite Libre de Bruxelles; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Erlangen Nuremberg; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Cheron, G (corresponding author), Univ Mons, Lab Electrophysiol, Mons, Belgium.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020	Servais, Laurent/0000-0001-9270-4061; Dan, Bernard/0000-0002-2051-9876	Fond National de la Recherche Scientifique (FNRS); Belgian Federal Science Policy Office, the European Space Agency [AO-2004, 118]; Belgian National Fund for Scientific Research (FNRS); Research funds of the Universite Libre de Bruxelles (ULB); Universite de Mons-Hainaut (Belgium)	Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office, the European Space Agency(Belgian Federal Science Policy Office); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Research funds of the Universite Libre de Bruxelles (ULB); Universite de Mons-Hainaut (Belgium)	L. S. was a research assistant of the Fond National de la Recherche Scientifique (FNRS) at the time of the study. This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004, 118), the Belgian National Fund for Scientific Research (FNRS), and research funds of the Universite Libre de Bruxelles (ULB) and the Universite de Mons-Hainaut (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BOWER JM, 1990, J COMP NEUROL, V302, P768, DOI 10.1002/cne.903020409; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Courtemanche R, 2005, J NEUROPHYSIOL, V93, P2039, DOI 10.1152/jn.00080.2004; Courtemanche R, 2002, J NEUROPHYSIOL, V88, P771, DOI 10.1152/jn.2002.88.2.771; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; De Zeeuw CI, 2008, NEURON, V58, P655, DOI 10.1016/j.neuron.2008.05.019; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Haghdoost-Yazdi H, 2008, BRAIN RES, V1212, P1, DOI 10.1016/j.brainres.2008.03.030; Hartmann MJ, 1998, J NEUROPHYSIOL, V80, P1598, DOI 10.1152/jn.1998.80.3.1598; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V409, P157, DOI 10.1113/jphysiol.1989.sp017490; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LeDoux MS, 2002, EXP BRAIN RES, V145, P457, DOI 10.1007/s00221-002-1127-4; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Mathie A, 2003, CEREBELLUM, V2, P11, DOI 10.1080/14734220310015593; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; McKay BE, 2004, EUR J NEUROSCI, V20, P729, DOI 10.1111/j.1460-9568.2004.03539.x; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Nakanishi S, 2005, TRENDS NEUROSCI, V28, P93, DOI 10.1016/j.tins.2004.12.004; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Servais L, 2005, BRAIN RES, V1055, P171, DOI 10.1016/j.brainres.2005.07.026; Servais L, 2005, NEUROSCIENCE, V134, P1247, DOI 10.1016/j.neuroscience.2005.06.001; Servais L, 2005, EUR J NEUROSCI, V22, P861, DOI 10.1111/j.1460-9568.2005.04275.x; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Simpson JI, 2005, PROG BRAIN RES, V148, P329, DOI 10.1016/S0079-6123(04)48026-1; SUGIHARA I, 1995, EUR J NEUROSCI, V7, P521, DOI 10.1111/j.1460-9568.1995.tb00657.x; Swensen AM, 2003, J NEUROSCI, V23, P9650; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004	50	33	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7991	10.1371/journal.pone.0007991	http://dx.doi.org/10.1371/journal.pone.0007991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956720	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500021
J	Choi, J; Oh, S; Lee, D; Oh, HJ; Park, JY; Lee, SB; Lim, DS				Choi, Juhyun; Oh, Sangphil; Lee, Dongjun; Oh, Hyun Jung; Park, Jik Young; Lee, Sean Bong; Lim, Dae-Sik			Mst1-FoxO Signaling Protects Naive T Lymphocytes from Cellular Oxidative Stress in Mice	PLOS ONE			English	Article							KINASE MST1; HISTONE H2B; CELLS; APOPTOSIS; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; SURVIVAL; GROWTH; HIPPO	Background: The Ste-20 family kinase Hippo restricts cell proliferation and promotes apoptosis for proper organ development in Drosophila. In C. elegans, Hippo homolog also regulates longevity. The mammalian Ste20-like protein kinase, Mst1, plays a role in apoptosis induced by various types of apoptotic stress. Mst1 also regulates peripheral naive T cell trafficking and proliferation in mice. However, its functions in mammals are not fully understood. Methodology/Principal Findings: Here, we report that the Mst1-FoxO signaling pathway plays a crucial role in survival, but not apoptosis, of naive T cells. In Mst1(-/-) mice, peripheral T cells showed impaired FoxO1/3 activation and decreased FoxO protein levels. Consistently, the FoxO targets, Sod2 and catalase, were significantly down-regulated in Mst1(-/-) T cells, thereby resulting in elevated levels of intracellular reactive oxygen species (ROS) and induction of apoptosis. Expression of constitutively active FoxO3a restored Mst1(-/-) T cell survival. Crossing Mst1 transgenic mice (Mst1 Tg) with Mst1(-/-) mice reduced ROS levels and restored normal numbers of peripheral naive T cells in Mst1 Tg; Mst1(-/-) progeny. Interestingly, peripheral T cells from Mst1(-/-) mice were hypersensitive to gamma-irradiation and paraquat-induced oxidative stresses, whereas those from Mst1 Tg mice were resistant. Conclusions/Significance: These data support the hypothesis that tolerance to increased levels of intracellular ROS provided by the Mst1-FoxOs signaling pathway is crucial for the maintenance of naive T cell homeostasis in the periphery.	[Choi, Juhyun; Oh, Sangphil; Lee, Dongjun; Oh, Hyun Jung; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Natl Res Lab Mol Genet, Dept Biol Sci, Biomed Res Ctr, Taejon 305701, South Korea; [Park, Jik Young; Lee, Sean Bong] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Korea Advanced Institute of Science & Technology (KAIST); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Choi, J (corresponding author), Korea Adv Inst Sci & Technol, Natl Res Lab Mol Genet, Dept Biol Sci, Biomed Res Ctr, Taejon 305701, South Korea.	daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011; Lee, Dongjun/ABF-4381-2021	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Dongjun/0000-0001-6828-401X; Lee, Sean/0000-0001-6211-3498	NRL (National Research Laboratory) Program; Nuclear Research Grant; 21st Century Frontier Functional Human Genome Project	NRL (National Research Laboratory) Program(Korea Science and Engineering Foundation); Nuclear Research Grant; 21st Century Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants from the NRL (National Research Laboratory) Program, a Nuclear Research Grant, and the 21<SUP>st</SUP> Century Frontier Functional Human Genome Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Cemek M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1691, DOI [10.1562/2006-06-15-RA-924, 10.1111/j.1751-1097.2006.tb09832.x]; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DONG Y, 2009, J IMMUNOL, V19, P19; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P353, DOI 10.1089/15230860260196155; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; OH S, 2009, MOL CELL BIOL; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	33	90	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8011	10.1371/journal.pone.0008011	http://dx.doi.org/10.1371/journal.pone.0008011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956688	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500034
J	Abplanalp, AL; Morris, IR; Parida, BK; Teale, JM; Berton, MT				Abplanalp, Allison L.; Morris, Ian R.; Parida, Bijaya K.; Teale, Judy M.; Berton, Michael T.			TLR-Dependent Control of Francisella tularensis Infection and Host Inflammatory Responses	PLOS ONE			English	Article							LIVE VACCINE STRAIN; TOLL-LIKE RECEPTOR-2; IMMUNE-RESPONSE; CUTTING EDGE; PROTECTIVE IMMUNITY; GAMMA-INTERFERON; DENDRITIC CELLS; INNATE IMMUNITY; INTRACELLULAR BACTERIUM; INTRANASAL VACCINATION	Background: Francisella tularensis is the causative agent of tularemia and is classified as a Category A select agent. Recent studies have implicated TLR2 as a critical element in the host protective response to F. tularensis infection, but questions remain about whether TLR2 signaling dominates the response in all circumstances and with all species of Francisella and whether F. tularensis PAMPs are predominantly recognized by TLR2/TLR1 or TLR2/TLR6. To address these questions, we have explored the role of Toll-like receptors (TLRs) in the host response to infections with F. tularensis Live Vaccine Strain (LVS) and F. tularensis subspecies (subsp.) novicida in vivo. Methodology/Principal Findings: C57BL/6 (B6) control mice and TLR-or MyD88-deficient mice were infected intranasally (i.n.) or intradermally (i.d.) with F. tularensis LVS or with F. tularensis subsp. novicida. B6 mice survived >21 days following infection with LVS by both routes and survival of TLR1(-/-), TLR4(-/-), and TLR6(-/-) mice infected i.n. with LVS was equivalent to controls. Survival of TLR2(-/-) and MyD88(-/-) mice, however, was significantly reduced compared to B6 mice, regardless of the route of infection or the subspecies of F. tularensis. TLR2(-/-) and MyD88(-/-) mice also showed increased bacterial burdens in lungs, liver, and spleen compared to controls following i.n. infection. Primary macrophages from MyD88(-/-) and TLR2(-/-) mice were significantly impaired in the ability to secrete TNF and other pro-inflammatory cytokines upon ex vivo infection with LVS. TNF expression was also impaired in vivo as demonstrated by analysis of bronchoalveolar lavage fluid and by in situ immunofluorescent staining. Conclusions/Significance: We conclude from these studies that TLR2 and MyD88, but not TLR4, play critical roles in the innate immune response to F. tularensis infection regardless of the route of infection or the subspecies. Moreover, signaling through TLR2 does not depend exclusively on TLR1 or TLR6 during F. tularensis LVS infection.			Abplanalp, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	berton@uthscsa.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007271, P01AI057986] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI7271, P01 AI057986, AI057986, T32 AI007271] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chen WX, 2005, IMMUNOL LETT, V97, P151, DOI 10.1016/j.imlet.2004.10.001; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Collazo CM, 2009, INFECT IMMUN, V77, P2010, DOI 10.1128/IAI.01322-08; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Larson CL, 1955, PUBLIC HEALTH REP, V70, P253, DOI 10.2307/4589039; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Macela A, 1996, FEMS IMMUNOL MED MIC, V13, P235, DOI 10.1111/j.1574-695X.1996.tb00243.x; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125	73	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7920	10.1371/journal.pone.0007920	http://dx.doi.org/10.1371/journal.pone.0007920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936231	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004800005
J	Willuweit, A; Velden, J; Godemann, R; Manook, A; Jetzek, F; Tintrup, H; Kauselmann, G; Zevnik, B; Henriksen, G; Drzezga, A; Pohlner, J; Schoor, M; Kemp, JA; von der Kammer, H				Willuweit, Antje; Velden, Joachim; Godemann, Robert; Manook, Andre; Jetzek, Fritz; Tintrup, Hartmut; Kauselmann, Gunther; Zevnik, Branko; Henriksen, Gjermund; Drzezga, Alexander; Pohlner, Johannes; Schoor, Michael; Kemp, John A.; von der Kammer, Heinz			Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA-DEPOSITION; TRANSGENIC MICE; PRECURSOR-PROTEIN; COGNITIVE DEFICITS; MUTANT PRESENILIN-1; IN-VIVO; PLAQUES; BRAIN; SENILE; NEUROPATHOLOGY	Background: Transgenic mice expressing mutated amyloid precursor protein (APP) and presenilin (PS)-1 or -2 have been successfully used to model cerebral beta-amyloidosis, one of the characteristic hallmarks of Alzheimer's disease (AD) pathology. However, the use of many transgenic lines is limited by premature death, low breeding efficiencies and late onset and high inter-animal variability of the pathology, creating a need for improved animal models. Here we describe the detailed characterization of a new homozygous double-transgenic mouse line that addresses most of these issues. Methodology/Principal Findings: The transgenic mouse line (ARTE10) was generated by co-integration of two transgenes carrying the K670N/M671L mutated amyloid precursor protein (APP(swe)) and the M146V mutated presenilin 1 (PS1) both under control of a neuron-specific promoter. Mice, hemi-as well as homozygous for both transgenes, are viable and fertile with good breeding capabilities and a low rate of premature death. They develop robust AD-like cerebral beta-amyloid plaque pathology with glial inflammation, signs of neuritic dystrophy and cerebral amyloid angiopathy. Using our novel image analysis algorithm for semi-automatic quantification of plaque burden, we demonstrate an early onset and progressive plaque deposition starting at 3 months of age in homozygous mice with low inter-animal variability and 100%-penetrance of the phenotype. The plaques are readily detected in vivo by PiB, the standard human PET tracer for AD. In addition, ARTE10 mice display early loss of synaptic markers and age-related cognitive deficits. By applying a gamma-secretase inhibitor we show a dose dependent reduction of soluble amyloid beta levels in the brain. Conclusions: ARTE10 mice develop a cerebral beta-amyloidosis closely resembling the beta-amyloid-related aspects of human AD neuropathology. Unifying several advantages of previous transgenic models, this line particularly qualifies for the use in target validation and for evaluating potential diagnostic or therapeutic agents targeting the amyloid pathology of AD.			Willuweit, A (corresponding author), Evotec Neurosci GmbH, Hamburg, Germany.	antje.willuweit@evotec.com; heinz.vonderkammer@evotec.com	Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522; Willuweit, Antje/0000-0002-6725-0755; Drzezga, Alexander/0000-0001-6018-716X				Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chubb C, 2006, NEUROBIOL AGING, V27, P1462, DOI 10.1016/j.neurobiolaging.2005.08.023; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Corder EH, 2000, EXP GERONTOL, V35, P851, DOI 10.1016/S0531-5565(00)00147-9; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; DUYCKAERTS C, 1999, ALZHEIMERS DIS RELAT; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Gordon MN, 2001, NEUROBIOL AGING, V22, P377, DOI 10.1016/S0197-4580(00)00249-9; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hogan B, 1994, MANIPULATING MOUSE E; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Horgan J, 2007, J ALZHEIMERS DIS, V12, P115; Howlett DR, 2008, HISTOL HISTOPATHOL, V23, P67, DOI 10.14670/HH-23.67; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hwang DY, 2005, CELL MOL NEUROBIOL, V25, P881, DOI 10.1007/s10571-005-4950-x; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luthi A, 1997, J NEUROSCI, V17, P4688; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MANN DMA, 1989, ANN MED, V21, P133, DOI 10.3109/07853898909149200; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; McLean CA, 2001, J ALZHEIMERS DIS, V3, P305, DOI 10.3233/JAD-2001-3305; Metsaars WP, 2003, NEUROBIOL AGING, V24, P563, DOI 10.1016/S0197-4580(02)00134-3; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Ozmen L, 2009, NEURODEGENER DIS, V6, P29, DOI 10.1159/000170884; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Richards JG, 2003, J NEUROSCI, V23, P8989; Rouleau I, 1996, BRAIN COGNITION, V31, P17, DOI 10.1006/brcg.1996.0022; RUDELLI RD, 1984, ACTA NEUROPATHOL, V64, P273, DOI 10.1007/BF00690393; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5	69	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7931	10.1371/journal.pone.0007931	http://dx.doi.org/10.1371/journal.pone.0007931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936202	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004800012
J	Bassat, Q; Mulenga, M; Tinto, H; Piola, P; Borrmann, S; Menendez, C; Nambozi, M; Valea, I; Nabasumba, C; Sasi, P; Bacchieri, A; Corsi, M; Ubben, D; Talisuna, A; D'Alessandro, U				Bassat, Quique; Mulenga, Modest; Tinto, Halidou; Piola, Patrice; Borrmann, Steffen; Menendez, Clara; Nambozi, Michael; Valea, Innocent; Nabasumba, Carolyn; Sasi, Philip; Bacchieri, Antonella; Corsi, Marco; Ubben, David; Talisuna, Ambrose; D'Alessandro, Umberto			Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial	PLOS ONE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM MALARIA; EFFICACY; AMODIAQUINE; ARTESUNATE; PAPUA; PHARMACOKINETICS; THERAPIES; SAFETY	Background: Artemisinin combination therapies (ACTs) are currently the preferred option for treating uncomplicated malaria. Dihydroartemisinin-piperaquine (DHA-PQP) is a promising fixed-dose ACT with limited information on its safety and efficacy in African children. Methodology/Principal Findings: The non-inferiority of DHA-PQP versus artemether-lumefantrine (AL) in children 6-59 months old with uncomplicated P. falciparum malaria was tested in five African countries (Burkina Faso, Kenya, Mozambique, Uganda and Zambia). Patients were randomised (2:1) to receive either DHA-PQP or AL. Non-inferiority was assessed using a margin of 25% for the lower limit of the one-sided 97.5% confidence interval on the treatment difference (DHA-PQP vs. AL) of the day 28 polymerase chain reaction (PCR) corrected cure rate. Efficacy analysis was performed in several populations, and two of them are presented here: intention-to-treat (ITT) and enlarged per-protocol (ePP). 1553 children were randomised, 1039 receiving DHA-PQP and 514 AL. The PCR-corrected day 28 cure rate was 90.4% (ITT) and 94.7% (ePP) in the DHA-PQP group, and 90.0% (ITT) and 95.3% (ePP) in the AL group. The lower limits of the one-sided 97.5% CI of the difference between the two treatments were 22.80% and 22.96%, in the ITT and ePP populations, respectively. In the ITT population, the Kaplan-Meier estimate of the proportion of new infections up to Day 42 was 13.55% (95% CI: 11.35%-15.76%) for DHA-PQP vs 24.00% (95% CI: 20.11%-27.88%) for AL (p<0.0001). Conclusions/Significance: DHA-PQP is as efficacious as AL in treating uncomplicated malaria in African children from different endemicity settings, and shows a comparable safety profile. The occurrence of new infections within the 42-day follow up was significantly lower in the DHA-PQP group, indicating a longer post-treatment prophylactic effect.			Bassat, Q (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.	udalessandro@itg.be	Bassat, Quique/P-2341-2016; Valea, Innocent/ABE-6694-2020; Menéndez, Clara/Q-3446-2016; Borrmann, Steffen/G-1838-2013; D'Alessandro, Umberto/D-3457-2015	Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907; Borrmann, Steffen/0000-0001-9189-4393; D'Alessandro, Umberto/0000-0001-6341-5009; Valea, Innocent/0000-0002-3085-0490; Tinto, Halidou/0000-0002-0472-3586				Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Grande T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001101; Hai TN, 2008, ACTA TROP, V107, P145, DOI 10.1016/j.actatropica.2008.05.013; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; KARUNAJEEWA HA, 2008, N ENGL J MED; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Nguyen Trong Chinh, 2008, Am J Trop Med Hyg, V79, P620; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Price RN, 2009, NEW ENGL J MED, V360, P1254, DOI 10.1056/NEJMc090023; PRICE RN, 2007, ANTIMICROB AGENTS CH; RANFORDCARTWRIGHT LC, 1993, PARASITOLOGY, V107, P11, DOI 10.1017/S003118200007935X; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Raynes K, 1999, INT J PARASITOL, V29, P367, DOI 10.1016/S0020-7519(98)00217-3; ROEBRUCK P, 1995, STAT MED, V14, P1583, DOI 10.1002/sim.4780141409; Sim IK, 2005, ANTIMICROB AGENTS CH, V49, P2407, DOI 10.1128/AAC.49.6.2407-2411.2005; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2006, GUID TREATM MAL; WHO, 2003, ASS MON ANT DRUG EFF; World Health Organization, 2008, WORLD MAL REP; Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	33	112	113	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7871	10.1371/journal.pone.0007871	http://dx.doi.org/10.1371/journal.pone.0007871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19936217	Green Published, gold			2022-12-27	WOS:000271854200018
J	Lee, MJ; Chang, CP; Lee, YH; Wu, YC; Tseng, HW; Tung, YY; Wu, MT; Chen, YH; Kuo, LT; Stephenson, D; Hung, SI; Wu, JY; Chang, C; Chen, YT; Chern, YJ				Lee, Ming-Jen; Chang, Ching-Pang; Lee, Yi-Hsin; Wu, Yi-Chih; Tseng, Hsu-Wen; Tung, Yu-Ying; Wu, Min-Tzu; Chen, Yen-Hui; Kuo, Lu-Ting; Stephenson, Dennis; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chen; Chen, Yuan-Tsong; Chern, Yijuang			Longitudinal Evaluation of an N-Ethyl-N-Nitrosourea-Created Murine Model with Normal Pressure Hydrocephalus	PLOS ONE			English	Article							CONGENITAL HYDROCEPHALUS; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; FLUID PRESSURE; MOUSE; DEFICIENCY; MUTATION; DISEASE; DAMAGE; GENES	Background: Normal-pressure hydrocephalus (NPH) is a neurodegenerative disorder that usually occurs late in adult life. Clinically, the cardinal features include gait disturbances, urinary incontinence, and cognitive decline. Methodology/Principal Findings: Herein we report the characterization of a novel mouse model of NPH (designated p23-ST1), created by N-ethyl-N-nitrosourea (ENU)-induced mutagenesis. The ventricular size in the brain was measured by 3-dimensional micro-magnetic resonance imaging (3D-MRI) and was found to be enlarged. Intracranial pressure was measured and was found to fall within a normal range. A histological assessment and tracer flow study revealed that the cerebral spinal fluid (CSF) pathway of p23-ST1 mice was normal without obstruction. Motor functions were assessed using a rotarod apparatus and a CatWalk gait automatic analyzer. Mutant mice showed poor rotarod performance and gait disturbances. Cognitive function was evaluated using auditory fear-conditioned responses with the mutant displaying both short-and long-term memory deficits. With an increase in urination frequency and volume, the mutant showed features of incontinence. Nissl substance staining and cell-type-specific markers were used to examine the brain pathology. These studies revealed concurrent glial activation and neuronal loss in the periventricular regions of mutant animals. In particular, chronically activated microglia were found in septal areas at a relatively young age, implying that microglial activation might contribute to the pathogenesis of NPH. These defects were transmitted in an autosomal dominant mode with reduced penetrance. Using a whole-genome scan employing 287 single-nucleotide polymorphic (SNP) markers and further refinement using six additional SNP markers and four microsatellite markers, the causative mutation was mapped to a 5.3-cM region on chromosome 4. Conclusions/Significance: Our results collectively demonstrate that the p23-ST1 mouse is a novel mouse model of human NPH. Clinical observations suggest that dysfunctions and alterations in the brains of patients with NPH might occur much earlier than the appearance of clinical signs. p23-ST1 mice provide a unique opportunity to characterize molecular changes and the pathogenic mechanism of NPH.			Lee, MJ (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan.	bmychern@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Kuo, Lu-Ting/AAU-3205-2021; Chang, Chen/B-5079-2009; Hung, Shuen-Iu/HHS-9012-2022; chern, yijuang/S-7013-2018; Hung, Shuen-Iu/ABB-2139-2021	chern, yijuang/0000-0002-5842-5429; Hung, Shuen-Iu/0000-0001-6531-5538; Lee, Ming-Jen/0000-0001-8732-2448; Kuo, Lu-Ting/0000-0002-1405-8700				ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Azzi GM, 1999, ACTA NEUROPATHOL, V98, P245, DOI 10.1007/s004010051076; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Chalmers RM, 1999, J NEUROL NEUROSUR PS, V67, P410, DOI 10.1136/jnnp.67.3.410; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Chizhikov V, 2006, MAMM GENOME, V17, P1025, DOI 10.1007/s00335-006-0033-7; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Clark FH, 1932, P NATL ACAD SCI USA, V18, P654, DOI 10.1073/pnas.18.11.654; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Factora R, 2006, CLIN GERIATR MED, V22, P645, DOI 10.1016/j.cger.2006.05.001; Fukumizu M, 1996, BRAIN DEV-JPN, V18, P40, DOI 10.1016/0387-7604(95)00103-4; GRAFFRADFORD NR, 1989, NEUROLOGY, V39, P1596, DOI 10.1212/WNL.39.12.1596; Gruneberg H, 1943, J GENET, V45, P22, DOI 10.1007/BF02982771; Gruneberg H, 1943, J GENET, V45, P1, DOI 10.1007/BF02982770; HAAN J, 1987, EUR NEUROL, V27, P216, DOI 10.1159/000116159; Hellstrom P, 2008, NEUROSURGERY, V63, P527, DOI 10.1227/01.NEU.0000325258.16934.BB; Iddon JL, 1999, J NEUROL NEUROSUR PS, V67, P723, DOI 10.1136/jnnp.67.6.723; Jones HC, 2004, EXP NEUROL, V190, P79, DOI 10.1016/j.expneurol.2004.06.019; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kazui Hiroaki, 2008, Brain and Nerve (Tokyo), V60, P225; Klinge P, 2002, ACTA NEUROCHIR SUPPL, V81, P51; Krauss JK, 1997, MOVEMENT DISORD, V12, P53, DOI 10.1002/mds.870120110; Krefft TA, 2004, ALZ DIS ASSOC DIS, V18, P35, DOI 10.1097/00002093-200401000-00007; Kuba H, 2002, J CLIN NEUROSCI, V9, P33, DOI 10.1054/jocn.2001.1010; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lee WT, 2004, PROG NEUROBIOL, V72, P87, DOI 10.1016/j.pneurobio.2004.02.002; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; MAEDA M, 1988, Neurological Research, V10, P93; Mangano FT, 1998, NEUROL RES, V20, P697; MCHUGH PR, 1964, Q J MED, V33, P297; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; MORI A, 1968, BRAIN NERVE (TOKYO), V20, P695; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Robinson ML, 2002, MAMM GENOME, V13, P625, DOI 10.1007/s00335-002-2201-8; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Sakakibara Ryuji, 2008, Brain and Nerve (Tokyo), V60, P233; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shinoda M, 1997, INT J NEUROSCI, V92, P9, DOI 10.3109/00207459708986386; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tarkowski E, 2003, NEUROBIOL AGING, V24, P707, DOI 10.1016/S0197-4580(02)00187-2; Ulfig N, 2004, BRAIN DEV-JPN, V26, P307, DOI 10.1016/S0387-7604(03)00172-4; VARADI V, 1988, AM J MED GENET, V29, P305, DOI 10.1002/ajmg.1320290209; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7868	10.1371/journal.pone.0007868	http://dx.doi.org/10.1371/journal.pone.0007868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924295	gold, Green Published, Green Submitted			2022-12-27	WOS:000271854200015
J	Thurlings, RM; Wijbrandts, CA; Bennink, RJ; Dohmen, SE; Voermans, C; Wouters, D; Izmailova, ES; Gerlag, DM; van Eck-Smit, BLF; Tak, PP				Thurlings, Rogier M.; Wijbrandts, Carla A.; Bennink, Roelof J.; Dohmen, Serge E.; Voermans, Carlijn; Wouters, Diana; Izmailova, Elena S.; Gerlag, Danielle M.; van Eck-Smit, Berthe L. F.; Tak, Paul P.			Monocyte Scintigraphy in Rheumatoid Arthritis: The Dynamics of Monocyte Migration in Immune-Mediated Inflammatory Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SYNOVIAL CELL INFILTRATE; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD; TISSUE; MACROPHAGES; BLOCKADE; JOINTS; INITIATION; REDUCTION	Background: Macrophages are principal drivers of synovial inflammation in rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease. Conceivably, synovial macrophages are continuously replaced by circulating monocytes in RA. Animal studies from the 1960s suggested that macrophage replacement by monocytes is a slow process in chronic inflammatory lesions. Translation of these data into the human condition has been hampered by the lack of available techniques to analyze monocyte migration in man. Methods/Principal Findings: We developed a technique that enabled us to analyze the migration of labelled autologous monocytes in RA patients using single photon emission computer tomography (SPECT). We isolated CD14+ monocytes by CliniMACS in 8 patients and labeled these with technetium-99m (Tc-99m-HMPAO). Monocytes were re-infused into the same patient. Using SPECT we calculated that a very small but specific fraction of 3.4x10(-3) (0.95-5.1x10(-3)) % of re-infused monocytes migrated to the inflamed joints, being detectable within one hour after re-infusion. Conclusions/Significance: The results indicate monocytes migrate continuously into the inflamed synovial tissue of RA patients, but at a slow macrophage-replacement rate. This suggests that the rapid decrease in synovial macrophages that occurs after antirheumatic treatment might rather be explained by an alteration in macrophage retention than in monocyte influx and that RA might be particularly sensitive to treatments targeting inflammatory cell retention.			Thurlings, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Noord Holland, Netherlands.	p.p.tak@amc.uva.nl	Thurlings, R.M./L-4689-2015; Voermans, Carlijn/GPP-3405-2022	Izmailova, Elena/0000-0002-7150-1748				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bennink RJ, 2008, J NUCL MED, V49, P1380, DOI 10.2967/jnumed.108.051755; Braakman E, 2008, CYTOTHERAPY, V10, P83, DOI 10.1080/14653240701787650; Burman A, 2005, JOINT BONE SPINE, V72, P10, DOI 10.1016/j.jbspin.2004.03.009; Chacko M, 2007, DERMATOL THER, V20, P265, DOI 10.1111/j.1529-8019.2007.00139.x; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Haringman JJ, 2003, ANN RHEUM DIS, V62, P715, DOI 10.1136/ard.62.8.715; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; LOEWI G, 1969, IMMUNOLOGY, V17, P489; McQueen FM, 2007, BEST PRACT RES CL RH, V21, P841, DOI 10.1016/j.berh.2007.05.001; Polzer K, 2008, ANN RHEUM DIS, V67, P1610, DOI 10.1136/ard.2007.083394; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saravanan Vadivelu, 2002, Expert Opin Pharmacother, V3, P845; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Smeets TJM, 2003, ANN RHEUM DIS, V62, P635, DOI 10.1136/ard.62.7.635; SPECTOR WG, 1967, J PATHOL BACTERIOL, V93, P101, DOI 10.1002/path.1700930109; SPECTOR WG, 1969, J PATH BAC, V92, P163; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Tak PP, 2006, BEST PRACT RES CL RH, V20, P929, DOI 10.1016/j.berh.2006.06.001; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; van Hemert FJ, 2005, ANN NUCL MED, V19, P345, DOI 10.1007/BF02984631; Van Hemert FJ, 2007, NUCL MED BIOL, V34, P933, DOI 10.1016/j.nucmedbio.2007.07.008; VANFURTH R, 1981, SCAND J RHEUMATOL, P13; Wijbrandts CA, 2008, ARTHRITIS RHEUM, V58, P3330, DOI 10.1002/art.23989; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; WOLBINK GJ, 1993, J IMMUNOL METHODS, V163, P67, DOI 10.1016/0022-1759(93)90240-8	33	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7865	10.1371/journal.pone.0007865	http://dx.doi.org/10.1371/journal.pone.0007865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924229	Green Published, Green Submitted, gold			2022-12-27	WOS:000271854200013
J	Zhang, QZ; Yamaza, T; Kelly, AP; Shi, SH; Wang, SL; Brown, J; Wang, L; French, SW; Shi, ST; Le, AD				Zhang, Qunzhou; Yamaza, Takayoshi; Kelly, A. Paul; Shi, Shihong; Wang, Songlin; Brown, Jimmy; Wang, Lina; French, Samuel W.; Shi, Songtao; Le, Anh D.			Tumor-Like Stem Cells Derived from Human Keloid Are Governed by the Inflammatory Niche Driven by IL-17/IL-6 Axis	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; GENE-EXPRESSION; T-CELLS; PROINFLAMMATORY CYTOKINES; DESTRUCTIVE ARTHRITIS; TELOMERASE ACTIVITY; HYPERTROPHIC SCARS; SELF-RENEWAL; BONE-MARROW	Background: Alterations in the stem cell niche are likely to contribute to tumorigenesis; however, the concept of niche promoted benign tumor growth remains to be explored. Here we use keloid, an exuberant fibroproliferative dermal growth unique to human skin, as a model to characterize benign tumor-like stem cells and delineate the role of their "pathological'' niche in the development of the benign tumor. Methods and Findings: Subclonal assay, flow cytometric and multipotent differentiation analyses demonstrate that keloid contains a new population of stem cells, named keloid derived precursor cells (KPCs), which exhibit clonogenicity, self-renewal, distinct embryonic and mesenchymal stem cell surface markers, and multipotent differentiation. KPCs display elevated telomerase activity and an inherently upregulated proliferation capability as compared to their peripheral normal skin counterparts. A robust elevation of IL-6 and IL-17 expression in keloid is confirmed by cytokine array, western blot and ELISA analyses. The altered biological functions are tightly regulated by the inflammatory niche mediated by an autocrine/paracrine cytokine IL-17/IL-6 axis. Utilizing KPCs transplanted subcutaneously in immunocompromised mice we generate for the first time a human keloid-like tumor model that is driven by the in vivo inflammatory niche and allows testing of the anti-tumor therapeutic effect of antibodies targeting distinct niche components, specifically IL-6 and IL-17. Conclusions/Significance: These findings support our hypothesis that the altered niche in keloids, predominantly inflammatory, contributes to the acquirement of a benign tumor-like stem cell phenotype of KPCs characterized by the uncontrolled self-renewal and increased proliferation, supporting the rationale for in vivo modification of the "pathological'' stem cell niche as a novel therapy for keloid and other mesenchymal benign tumors.			Zhang, QZ (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.	songtaos@usc.edu; anhle@usc.edu	Zhang, Qunzhou/X-4504-2019	Yamaza, Takayoshi/0000-0001-7055-3370	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [S11AR047359] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR011145, 2 P20 RR011145] Funding Source: Medline; NIAMS NIH HHS [AR47359, S11 AR047359] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Akino K, 2008, INT J DERMATOL, V47, P1112, DOI 10.1111/j.1365-4632.2008.03380.x; Akiyama M, 2002, CANCER RES, V62, P3876; [Anonymous], ARTHRITIS RES THER, DOI DOI 10.1186/AR1917; Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; De Coppi P, 2006, J SURG RES, V135, P85, DOI 10.1016/j.jss.2006.03.009; FEGHALI CA, 1994, AUTOIMMUNITY, V17, P309, DOI 10.3109/08916939409010671; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Ghazizadeh M, 2007, J INVEST DERMATOL, V127, P98, DOI 10.1038/sj.jid.5700564; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelly A Paul, 2004, Dermatol Ther, V17, P212, DOI 10.1111/j.1396-0296.2004.04022.x; KETCHUM LD, 1971, PLAST RECONSTR SURG, V48, P256, DOI 10.1097/00006534-197109000-00010; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kovacevic-Filipovic M, 2007, J CELL PHYSIOL, V212, P68, DOI 10.1002/jcp.21003; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; MACDONALD HR, 1984, EXP CELL BIOL, V52, P2; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Momcilovic M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-47; MOON JH, 2008, STEM CELLS DEV, V17, P1; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; TAN PLJ, 1990, J RHEUMATOL, V17, P1608; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Xie T, 2007, DEVELOPMENT, V134, P2001, DOI 10.1242/dev.002022; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Xue H, 2000, J SURG RES, V89, P74, DOI 10.1006/jsre.1999.5805; Yamagiwa Y, 2006, LIFE SCI, V78, P2494, DOI 10.1016/j.lfs.2005.10.015; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; YAO Z, 1995, J IMMUNOL, V155, P811; You S, 2004, EXP MOL MED, V36, P325, DOI 10.1038/emm.2004.43; Zhang QZ, 2003, J INVEST DERMATOL, V121, P1005, DOI 10.1046/j.1523-1747.2003.12564.x; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	81	75	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A192	A207	e7798	10.1371/journal.pone.0007798	http://dx.doi.org/10.1371/journal.pone.0007798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907660	Green Published, Green Submitted, gold			2022-12-27	WOS:000271685800021
J	Ludes-Meyers, JH; Kil, H; Parker-Thornburg, J; Kusewitt, DF; Bedford, MT; Aldaz, CM				Ludes-Meyers, John H.; Kil, Hyunsuk; Parker-Thornburg, Jan; Kusewitt, Donna F.; Bedford, Mark T.; Aldaz, C. Marcelo			Generation and Characterization of Mice Carrying a Conditional Allele of the Wwox Tumor Suppressor Gene	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITE; IN-VIVO; LETHAL DWARFISM; CANCER; PROTEIN; FRA16D; COMMON; CELLS; IDENTIFICATION; EXPRESSION	WWOX, the gene that spans the second most common human chromosomal fragile site, FRA16D, is inactivated in multiple human cancers and behaves as a suppressor of tumor growth. Since we are interested in understanding WWOX function in both normal and cancer tissues we generated mice harboring a conditional Wwox allele by flanking Exon 1 of the Wwox gene with LoxP sites. Wwox knockout (KO) mice were developed by breeding with transgenic mice carrying the Cre-recombinase gene under the control of the adenovirus EIIA promoter. We found that Wwox KO mice suffered from severe metabolic defect(s) resulting in growth retardation and all mice died by 3 wk of age. All Wwox KO mice displayed significant hypocapnia suggesting a state of metabolic acidosis. This finding and the known high expression of Wwox in kidney tubules suggest a role for Wwox in acid/base balance. Importantly, Wwox KO mice displayed histopathological and hematological signs of impaired hematopoeisis, leukopenia, and splenic atrophy. Impaired hematopoeisis can also be a contributing factor to metabolic acidosis and death. Hypoglycemia and hypocalcemia was also observed affecting the KO mice. In addition, bone metabolic defects were evident in Wwox KO mice. Bones were smaller and thinner having reduced bone volume as a consequence of a defect in mineralization. No evidence of spontaneous neoplasia was observed in Wwox KO mice. We have generated a new mouse model to inactivate the Wwox tumor suppressor gene conditionally. This will greatly facilitate the functional analysis of Wwox in adult mice and will allow investigating neoplastic transformation in specific target tissues.			Ludes-Meyers, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA.	maaldaz@mdanderson.org	Kusewitt, Donna F/E-8107-2011; Aldaz, C. Marcelo/E-7868-2011; Bedford, Mark T/E-7856-2011	Aldaz, C. Marcelo/0000-0002-2453-2939; 	NCI NIH HHS [R01 CA102444-04, R01 CA102444-06A1, R01 CA102444-02, R01 CA102444-03, R01 CA102444, R01 CA102444-07, R01 CA102444-05, R01 CA102444-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Gourley C, 2009, CANCER RES, V69, P4835, DOI 10.1158/0008-5472.CAN-08-2974; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Krummel KA, 2000, GENOMICS, V69, P37, DOI 10.1006/geno.2000.6321; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; Nunez MI, 2006, J MOL HISTOL, V37, P115, DOI 10.1007/s10735-006-9046-5; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramos D, 2006, ADV EXP MED BIOL, V587, P149; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Suzuki H, 2009, GENES BRAIN BEHAV, V8, P650, DOI 10.1111/j.1601-183X.2009.00502.x; Suzuki H, 2007, COMPARATIVE MED, V57, P360; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006	28	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7775	10.1371/journal.pone.0007775	http://dx.doi.org/10.1371/journal.pone.0007775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936220	Green Published, Green Submitted, gold			2022-12-27	WOS:000271658800012
J	Nakamura, K; Salomonis, N; Tomoda, K; Yamanaka, S; Conklin, BR				Nakamura, Kenta; Salomonis, Nathan; Tomoda, Kiichiro; Yamanaka, Shinya; Conklin, Bruce R.			G(i)-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ISLET-ACTIVATING PROTEIN; STRESS FIBER FORMATION; STEM-CELLS; TRANSDUCTION PATHWAYS; ADENYLATE-CYCLASE; ADP-RIBOSYLATION; PERTUSSIS TOXIN; SURVIVAL; LINES	Background: Reprogramming adult human somatic cells to create human induced pluripotent stem (hiPS) cell colonies involves a dramatic morphological and organizational transition. These colonies are morphologically indistinguishable from those of pluripotent human embryonic stem (hES) cells. G protein-coupled receptors (GPCRs) are required in diverse developmental processes, but their role in pluripotent colony morphology and organization is unknown. We tested the hypothesis that G(i)-coupled GPCR signaling contributes to the characteristic morphology and organization of human pluripotent colonies. Methodology/Principal Findings: Specific and irreversible inhibition of G(i)-coupled GPCR signaling by pertussis toxin markedly altered pluripotent colony morphology. Wild-type hES and hiPS cells formed monolayer colonies, but colonies treated with pertussis toxin retracted inward, adopting a dense, multi-layered conformation. The treated colonies were unable to reform after a scratch wound insult, whereas control colonies healed completely within 48 h. In contrast, activation of an alternative GPCR pathway, G(s)-coupled signaling, with cholera toxin did not affect colony morphology or the healing response. Pertussis toxin did not alter the proliferation, apoptosis or pluripotency of pluripotent stem cells. Conclusions/Significance: Experiments with pertussis toxin suggest that G(i) signaling plays a critical role in the morphology and organization of pluripotent colonies. These results may be explained by a G(i)-mediated density-sensing mechanism that propels the cells radially outward. GPCRs are a promising target for modulating the formation and organization of hiPS and hES cell colonies and may be important for understanding somatic cell reprogramming and for engineering pluripotent stem cells for therapeutic applications.			Nakamura, K (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	kenta.nakamura@ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664] Funding Source: NIH RePORTER; NCRR NIH HHS [RR18928-01, C06 RR018928] Funding Source: Medline; NHLBI NIH HHS [R01 HL060664, R01 HL-60664] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bakthavatsalam D, 2007, CURR BIOL, V17, P892, DOI 10.1016/j.cub.2007.04.029; Boguslawski G, 2000, BIOCHEM BIOPH RES CO, V272, P603, DOI 10.1006/bbrc.2000.2822; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; DANIELLO C, 2009, CIRC RES; Deery WJ, 2002, J BIOL CHEM, V277, P31972, DOI 10.1074/jbc.M204539200; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hashimoto Y, 2005, INT J MOL MED, V16, P787; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Larue L, 1996, DEVELOPMENT, V122, P3185; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; POLLARD KS, 2002, METHOD IDENTIFY SIGN; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Seitz G, 2005, ANN NY ACAD SCI, V1044, P84, DOI 10.1196/annals.1349.011; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	49	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7780	10.1371/journal.pone.0007780	http://dx.doi.org/10.1371/journal.pone.0007780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936228	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658800015
J	Loutfy, MR; Hart, TA; Mohammed, SS; Su, DS; Ralph, ED; Walmsley, SL; Soje, LC; Muchenje, M; Rachlis, AR; Smaill, FM; Angel, JB; Raboud, JM; Silverman, MS; Tharao, WE; Gough, K; Yudin, MH				Loutfy, Mona R.; Hart, Trevor A.; Mohammed, Saira S.; Su, DeSheng; Ralph, Edward D.; Walmsley, Sharon L.; Soje, Lena C.; Muchenje, Marvelous; Rachlis, Anita R.; Smaill, Fiona M.; Angel, Jonathan B.; Raboud, Janet M.; Silverman, Michael S.; Tharao, Wangari E.; Gough, Kevin; Yudin, Mark H.		Ontario HIV Fertility Res Team	Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study	PLOS ONE			English	Article							SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; INFECTED WOMEN; RISK BEHAVIOR; PREGNANCY; MEN; CHILDREN; HIV/AIDS; PEOPLE; HEALTH	Background: Improvements in life expectancy and quality of life for HIV-positive women coupled with reduced vertical transmission will likely lead numerous HIV-positive women to consider becoming pregnant. In order to clarify the demand, and aid with appropriate health services planning for this population, our study aims to assess the fertility desires and intentions of HIV-positive women of reproductive age living in Ontario, Canada. Methodology/Principal Findings: A cross-sectional study with recruitment stratified to match the geographic distribution of HIV-positive women of reproductive age (18-52) living in Ontario was carried out. Women were recruited from 38 sites between October 2007 and April 2009 and invited to complete a 189-item self-administered survey entitled "The HIV Pregnancy Planning Questionnaire" designed to assess fertility desires, intentions and actions. Logistic regression models were fit to calculate unadjusted and adjusted odds ratios of significant predictors of fertility intentions. The median age of the 490 participating HIV-positive women was 38 (IQR, 32-43) and 61%, 52%, 47% and 74% were born outside of Canada, living in Toronto, of African ethnicity and currently on antiretroviral therapy, respectively. Of total respondents, 69% (95% CI, 64%-73%) desired to give birth and 57% (95% CI, 53%-62%) intended to give birth in the future. In the multivariable model, the significant predictors of fertility intentions were: younger age (age < 40) (p < 0.0001), African ethnicity (p < 0.0001), living in Toronto (p = 0.002), and a lower number of lifetime births (p = 0.02). Conclusions/Significance: The proportions of HIV-positive women of reproductive age living in Ontario desiring and intending pregnancy were higher than reported in earlier North American studies. Proportions were more similar to those reported from African populations. Healthcare providers and policy makers need to consider increasing services and support for pregnancy planning for HIV-positive women. This may be particularly significant in jurisdictions with high levels of African immigration.	[Loutfy, Mona R.; Mohammed, Saira S.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Loutfy, Mona R.; Walmsley, Sharon L.; Rachlis, Anita R.; Gough, Kevin] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hart, Trevor A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Hart, Trevor A.; Raboud, Janet M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Su, DeSheng; Walmsley, Sharon L.; Raboud, Janet M.] Univ Hlth Network, Toronto, ON, Canada; [Ralph, Edward D.] St Josephs Hlth Care, Infect Dis Care Program, London, ON, Canada; [Soje, Lena C.] Black Coalit AIDS Prevent, Toronto, ON, Canada; [Muchenje, Marvelous; Tharao, Wangari E.] Womens Hlth Womens Hands, Toronto, ON, Canada; [Rachlis, Anita R.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Smaill, Fiona M.] McMaster Univ, Med Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada; [Angel, Jonathan B.] Ottawa Hosp, Ottawa, ON, Canada; [Angel, Jonathan B.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Silverman, Michael S.] Lakeridge Hlth Ctr, Oshawa, ON, Canada; [Gough, Kevin] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Yudin, Mark H.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Toronto Metropolitan University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Loutfy, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada.	mona.loutfy@wchospital.ca	Silverman, Michael/J-3776-2014	Silverman, Michael/0000-0002-0389-7656; Hart, Trevor/0000-0001-5107-7452; Angel, Jonathan B/0000-0003-3102-4462; Walmsley, Sharon/0000-0002-3959-5692	CANFAR; Canadian Foundation for AIDS Research; Ontario Ministry of Health and Long-term Care; AIDS Bureau; Ontario HIV Treatment Network	CANFAR; Canadian Foundation for AIDS Research; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); AIDS Bureau; Ontario HIV Treatment Network	This work was supported by a grant from CANFAR, the Canadian Foundation for AIDS Research, and the Ontario Ministry of Health and Long-term Care, AIDS Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, a number of investigators are the recipients of salary support from the Canadian Institutes of Health Research (MRL, TAH) and the Ontario HIV Treatment Network (SLW, JBA, JR).	Aka-Dago-Akribi H, 1999, REPROD HEALTH MATTER, V7, P20, DOI DOI 10.1016/S0968-8080(99)90108-8; Baek C, 2005, ADDRESSING FAMILY PL; Bedimo-Rung Ariane Lisann, 2005, J Natl Med Assoc, V97, P1403; Caffrey P, 2009, GLOB PUBLIC HEALTH, V4, P271, DOI 10.1080/17441690902769651; Chama C, 2007, J OBSTET GYNAECOL, V27, P812, DOI 10.1080/01443610701711706; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Doyal L, 2005, SOC SCI MED, V60, P1729, DOI 10.1016/j.socscimed.2004.08.041; Dyer SJ, 2004, HUM REPROD, V19, P960, DOI 10.1093/humrep/deh195; Dyer SJ, 2002, HUM REPROD, V17, P1663, DOI 10.1093/humrep/17.6.1663; Feldman R, 2003, REPROD HEALTH MATTER, V11, P162, DOI 10.1016/S0968-8080(03)02284-5; Fowler F.J., 2014, SURV RES METHODS-GER, V5th ed.; Germain A, 2009, INT J GYNECOL OBSTET, V106, P185, DOI 10.1016/j.ijgo.2009.03.038; *HLTH CAN, 2007, NOV 2007 HIV AIDS EP; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; KLINE A, 1995, SOC SCI MED, V40, P1539, DOI 10.1016/0277-9536(94)00280-7; Kulczycki A, 2007, STUD FAMILY PLANN, V38, P333, DOI 10.1111/j.1728-4465.2007.00145.x; Gogna ML, 2009, SOC SCI MED, V69, P813, DOI 10.1016/j.socscimed.2009.06.002; London L, 2008, DEV WORLD BIOETH, V8, P11, DOI 10.1111/j.1471-8847.2007.00223.x; LOUTFY M, 2009, 18 CAN C HIV AIDS RE; Mellors Shaun, 2008, HIV AIDS Policy Law Rev, V13, P89; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; MOHAMMED S, 2008, ONT HIV TREATM NETW; Morin P, 2003, PAEDIATR PERINAT EP, V17, P97, DOI 10.1046/j.1365-3016.2003.00461.x; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Nobrega AA, 2007, AIDS PATIENT CARE ST, V21, P261, DOI 10.1089/apc.2006.0116; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; Oosterhoff P, 2008, CULT HEALTH SEX, V10, P403, DOI 10.1080/13691050801915192; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; *PER HIV GUID WORK, 2009, PUBL HLTH SERV TASK; Remis, 2007, RACE ETHNICITY PERSO; Remis RS, 2010, REPORT HIV AIDS ONTA; Richardson D, 1992, Health Visit, V65, P159; Richter DL, 2002, WOMEN HEALTH, V36, P81, DOI 10.1300/J013v36n01_06; Santos N., 1998, Reproductive Health Matters, V6, P31, DOI 10.1016/S0968-8080(98)90005-2; Siegel K, 2001, PSYCHOL WOMEN QUART, V25, P112, DOI 10.1111/1471-6402.00013; Smith DJ, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000298101.56614.af; Sowell RL, 2002, AIDS CARE, V14, P181, DOI 10.1080/09540120220104695; Sowell RL., 1999, J FAMILY NURS, V5, P316, DOI DOI 10.1177/107484079900500305; Stanwood NL, 2007, CONTRACEPTION, V75, P294, DOI 10.1016/j.contraception.2006.12.012; STREIMER DL, 2003, HLTH MEASUREMENT SCA; Titus MJ, 2009, INT J GYNECOL OBSTET, V106, P137, DOI 10.1016/j.ijgo.2009.03.026; *UNAIDS WHO, 2008, 07 AIDS EP UPD DEC 2; Voyer, 1994, CAN J AGING, V13, P392; WELSEY Y, 2000, HEALTH CARE WOMEN IN, V21, P291; Wesley Y, 2003, J NURS SCHOLARSHIP, V35, P37, DOI 10.1111/j.1547-5069.2003.00037.x; YUDIN MH, 2008, FERTIL STERIL S1, V90, pS380; 2009, HIV AIDS POLICY LAW, V14, P49	56	106	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e7925	10.1371/journal.pone.0007925	http://dx.doi.org/10.1371/journal.pone.0007925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NB	19997556	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829500001
J	Holmes, MV; Shah, T; Vickery, C; Smeeth, L; Hingorani, AD; Casas, JP				Holmes, Michael V.; Shah, Tina; Vickery, Christine; Smeeth, Liam; Hingorani, Aroon D.; Casas, Juan P.			Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies	PLOS ONE			English	Article							GENETIC ASSOCIATIONS; DISEASE; GENOME; COMMON; VARIANTS; RISK; POLYMORPHISMS; DESIGN; VKORC1; CYP2C9	Background: Studies of the genetic basis of drug response could help clarify mechanisms of drug action/metabolism, and facilitate development of genotype-based predictive tests of efficacy or toxicity (pharmacogenetics). Objectives: We conducted a systematic review and field synopsis of pharmacogenetic studies to quantify the scope and quality of available evidence in this field in order to inform future research. Data Sources: Original research articles were identified in Medline, reference lists from 24 meta-analyses/systematic reviews/review articles and U.S. Food and Drug Administration website of approved pharmacogenetic tests. Study Eligibility Criteria, Participants, and Intervention Criteria: We included any study in which either intended or adverse response to drug therapy was examined in relation to genetic variation in the germline or cancer cells in humans. Study Appraisal and Synthesis Methods: Study characteristics and data reported in abstracts were recorded. We further analysed full text from a random 10% subset of articles spanning the different subclasses of study. Results: From 102,264 Medline hits and 1,641 articles from other sources, we identified 1,668 primary research articles (1987 to 2007, inclusive). A high proportion of remaining articles were reviews/commentaries ( ratio of reviews to primary research approximately 25: 1). The majority of studies (81.8%) were set in Europe and North America focussing on cancer, cardiovascular disease and neurology/psychiatry. There was predominantly a candidate gene approach using common alleles, which despite small sample sizes (median 93 [IQR 40-222]) with no trend to an increase over time, generated a high proportion (74.5%) of nominally significant (p<0.05) reported associations suggesting the possibility of significance-chasing bias. Despite 136 examples of gene/drug interventions being the subject of >= 4 studies, only 31 meta-analyses were identified. The majority (69.4%) of end-points were continuous and likely surrogate rather than hard (binary) clinical end-points. Conclusions and Implications of Key Findings: The high expectation but limited translation of pharmacogenetic research thus far may be explained by the preponderance of reviews over primary research, small sample sizes, a mainly candidate gene approach, surrogate markers, an excess of nominally positive to truly positive associations and paucity of meta-analyses. Recommendations based on these findings should inform future study design to help realise the goal of personalised medicines. Systematic Review Registration Number: Not Registered	[Holmes, Michael V.; Shah, Tina; Vickery, Christine; Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London, England; [Smeeth, Liam; Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Hingorani, Aroon D.] UCL, Dept Epidemiol, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Holmes, MV (corresponding author), UCL, Ctr Clin Pharmacol, London, England.	a.hingorani@ucl.ac.uk; Juan.Pablo-Casas@lshtm.ac.uk	Holmes, Michael/AAA-2208-2021; Smeeth, Liam/X-5862-2018	Shah, Tina/0000-0001-7724-7210; Smeeth, Liam/0000-0002-9168-6022; Hingorani, Aroon/0000-0001-8365-0081	British Heart Foundation [FS05/125]; Wellcome Trust Senior Research Fellowship in Clinical Science [082178]; Academic Clinical Fellowship from the National Institute for Health Research; Medical Research Council [G0802432]; MRC [G0802432] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Academic Clinical Fellowship from the National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work reported was not the subject of a specific research grant. Aroon D. Hingorani is funded by a Senior Research Fellowship from the British Heart Foundation (FS05/125). Liam Smeeth is funded by a Wellcome Trust Senior Research Fellowship in Clinical Science (082178). Michael V. Holmes is funded by an Academic Clinical Fellowship from the National Institute for Health Research and a Population Health Scientist Fellowship from the Medical Research Council (G0802432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bromley CM, 2009, PHARMACOGENOMICS J, V9, P14, DOI 10.1038/tpj.2008.11; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Colombo S, 2008, J INFECT DIS, V198, P864, DOI 10.1086/591184; CONNOR S, 2003, INDEPENDENT; *FDA, 2006, TABL VAL GEN BIOM CO; *FDA, 2009, TABL VAL GEN BIOM CO; Frank B, 2008, J NATL CANCER I, V100, P437, DOI 10.1093/jnci/djn037; Frodsham AJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-31; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Higgins JPT, 2007, AM J EPIDEMIOL, V166, P863, DOI 10.1093/aje/kwm248; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Hynicka LM, 2008, ANN PHARMACOTHER, V42, P1298, DOI 10.1345/aph.1L127; Ioannidis JPA, 2008, AM J EPIDEMIOL, V168, P374, DOI 10.1093/aje/kwn156; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; KRAFT P, 2009, NAT REV GENET; Lemonick M, 2001, TIME, P28; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; MARR K, 2008, WASHINGTON POST; McClain MR, 2008, GENET MED, V10, P89, DOI 10.1097/GIM.0b013e31815bf924; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; *NIH, PHARM RES NETW; Pennisi E, 2007, SCIENCE, V318, P1842, DOI 10.1126/science.318.5858.1842; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; POLLACK A, 2005, NY TIMES        1108; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Sagoo GS, 2008, AM J EPIDEMIOL, V168, P1233, DOI 10.1093/aje/kwn235; *SCHIZ RES FOR, SCHIZ SZGENE; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Tang SS, 2009, NUCLEIC ACIDS RES, V37, pD858, DOI 10.1093/nar/gkn770; Woodcock J, 2009, NEW ENGL J MED, V360, P811, DOI 10.1056/NEJMe0810630	48	78	84	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e7960	10.1371/journal.pone.0007960	http://dx.doi.org/10.1371/journal.pone.0007960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956635	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000272828800002
J	Shen, A; Lupardus, PJ; Morell, M; Ponder, EL; Sadaghiani, AM; Garcia, KC; Bogyo, M				Shen, Aimee; Lupardus, Patrick J.; Morell, Montse; Ponder, Elizabeth L.; Sadaghiani, A. Masoud; Garcia, K. Christopher; Bogyo, Matthew			Simplified, Enhanced Protein Purification Using an Inducible, Autoprocessing Enzyme Tag	PLOS ONE			English	Article							RECOMBINANT PROTEINS; RTX TOXIN; EXPRESSION; DOMAIN; FUSION; ACTIVATION	We introduce a new method for purifying recombinant proteins expressed in bacteria using a highly specific, inducible, self-cleaving protease tag. This tag is comprised of the Vibrio cholerae MARTX toxin cysteine protease domain (CPD), an autoprocessing enzyme that cleaves exclusively after a leucine residue within the target protein-CPD junction. Importantly, V. cholerae CPD is specifically activated by inositol hexakisphosphate (InsP(6)), a eukaryotic-specific small molecule that is absent from the bacterial cytosol. As a result, when His(6)-tagged CPD is fused to the C-terminus of target proteins and expressed in Escherichia coli, the full-length fusion protein can be purified from bacterial lysates using metal ion affinity chromatography. Subsequent addition of InsP(6) to the immobilized fusion protein induces CPD-mediated cleavage at the target protein-CPD junction, releasing untagged target protein into the supernatant. This method condenses affinity chromatography and fusion tag cleavage into a single step, obviating the need for exogenous protease addition to remove the fusion tag(s) and increasing the efficiency of tag separation. Furthermore, in addition to being timesaving, versatile, and inexpensive, our results indicate that the CPD purification system can enhance the expression, integrity, and solubility of intractable proteins from diverse organisms.	[Shen, Aimee; Morell, Montse; Ponder, Elizabeth L.; Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Sadaghiani, A. Masoud] Stanford Sch Med, Dept Syst & Chem Biol, Stanford, CA USA; [Garcia, K. Christopher] Stanford Sch Med, Howard Hughes Inst, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Shen, A (corresponding author), Stanford Sch Med, Dept Pathol, Stanford, CA USA.	mbogyo@stanford.edu	Ponder, Elizabeth/E-5147-2011	Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	Burroughs Wellcome Foundation; NIH [R01 AI078947, R01 EB005011]; Damon Runyon Cancer Research Fellowship; Keck Foundation; Howard Hughes Medical Institute; Stanford Dean's Fellowship; Beautriu de Pinos of Agaur Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Fellowship; Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Dean's Fellowship; Beautriu de Pinos of Agaur Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Burroughs Wellcome Foundation grant and NIH grants R01 AI078947 and R01 EB005011 to M. B., the Damon Runyon Cancer Research Fellowship to P.J.L., a Keck Foundation and Howard Hughes Medical Institute grant to K.C.G., a Stanford Dean's Fellowship to A. S., and a Beautriu de Pinos of Agaur Fellowship to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parkar AA, 2000, PROTEIN EXPRES PURIF, V20, P152, DOI 10.1006/prep.2000.1280; PONDER EL, 2009, NAT CHEM BI IN PRESS; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Zhang AH, 2001, GENE, V275, P241, DOI 10.1016/S0378-1119(01)00663-1	19	65	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8119	10.1371/journal.pone.0008119	http://dx.doi.org/10.1371/journal.pone.0008119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956581	Green Published, gold			2022-12-27	WOS:000272828800015
J	McCormick, PJ; Segarra, M; Gasperini, P; Gulino, AV; Tosato, G				McCormick, Peter J.; Segarra, Marta; Gasperini, Paola; Gulino, A. Virginia; Tosato, Giovanna			Impaired Recruitment of Grk6 and beta-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; BONE-MARROW; BETA-ARRESTIN; FACTOR-I; G-CSF; NEUTROPHIL HOMEOSTASIS; EXTRACELLULAR SIGNAL; MYELOID CELLS; STEM-CELLS; CXCL12	WHIM (warts, hypogammaglobulinemia, infections, and myelokatexis) syndrome is a rare immunodeficiency syndrome linked to heterozygous mutations of the chemokine receptor CXCR4 resulting in truncations of its cytoplasmic tail. Leukocytes from patients with WHIM syndrome display impaired CXCR4 internalization and enhanced chemotaxis in response to its unique ligand SDF-1/CXCL12, which likely contribute to the clinical manifestations. Here, we investigated the biochemical mechanisms underlying CXCR4 deficiency in WHIM syndrome. We report that after ligand activation, WHIM-associated mutant CXCR4 receptors lacking the carboxy-terminal 19 residues internalize and activate Erk 1/2 slower than wild-type (WT) receptors, while utilizing the same trafficking endocytic pathway. Recruitment of beta-Arrestin 2, but not beta-Arrestin 1, to the active WHIM-mutant receptor is delayed compared to the WT CXCR4 receptor. In addition, while both kinases Grk3 and Grk6 bind to WT CXCR4 and are critical to its trafficking to the lysosomes, Grk6 fails to associate with the WHIM-mutant receptor whereas Grk3 associates normally. Since beta-Arrestins and Grks play critical roles in phosphorylation and internalization of agonist-activated G protein-coupled receptors, these results provide a molecular basis for CXCR4 dysfunction in WHIM syndrome.	[McCormick, Peter J.; Segarra, Marta; Gasperini, Paola; Gulino, A. Virginia; Tosato, Giovanna] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McCormick, PJ (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mccormpe@mail.nih.gov	Segarra, Marta/ABE-2312-2020; McCormick, Peter/E-7387-2012	McCormick, Peter/0000-0002-2225-5181; Gulino, Virginia/0000-0003-1724-4450; Gasperini, Paola/0000-0002-3016-9742; Tosato, Giovanna/0000-0003-1663-3227	National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; Gulino AV, 2004, BLOOD, V104, P444, DOI 10.1182/blood-2003-10-3532; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Imai K, 1999, BRIT J HAEMATOL, V106, P905, DOI 10.1046/j.1365-2141.1999.01644.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Peng SB, 2005, MOL CANCER RES, V3, P227; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Raaijmakers MHGP, 2008, CURR OPIN HEMATOL, V15, P301, DOI 10.1097/MOH.0b013e328303e14c; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Sierra MDLL, 2007, BLOOD, V110, P2276, DOI 10.1182/blood-2007-03-081448; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Yao L, 2003, BLOOD, V102, P3900, DOI 10.1182/blood-2003-02-0641; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	52	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8102	10.1371/journal.pone.0008102	http://dx.doi.org/10.1371/journal.pone.0008102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956569	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828700014
J	Zhang, JG; Li, J; Deng, HW				Zhang, Jigang; Li, Jian; Deng, Hong-Wen			Identifying Gene Interaction Enrichment for Gene Expression Data	PLOS ONE			English	Article							SET ENRICHMENT; MICROARRAY DATA; GLOBAL TEST; P53; LOCI; DISCOVERY; FRAMEWORK; PROTEIN; GROWTH; CANCER	Gene set analysis allows the inclusion of knowledge from established gene sets, such as gene pathways, and potentially improves the power of detecting differentially expressed genes. However, conventional methods of gene set analysis focus on gene marginal effects in a gene set, and ignore gene interactions which may contribute to complex human diseases. In this study, we propose a method of gene interaction enrichment analysis, which incorporates knowledge of predefined gene sets (e.g. gene pathways) to identify enriched gene interaction effects on a phenotype of interest. In our proposed method, we also discuss the reduction of irrelevant genes and the extraction of a core set of gene interactions for an identified gene set, which contribute to the statistical variation of a phenotype of interest. The utility of our method is demonstrated through analyses on two publicly available microarray datasets. The results show that our method can identify gene sets that show strong gene interaction enrichments. The enriched gene interactions identified by our method may provide clues to new gene regulation mechanisms related to the studied phenotypes. In summary, our method offers a powerful tool for researchers to exhaustively examine the large numbers of gene interactions associated with complex human diseases, and can be a useful complement to classical gene set analyses which only considers single genes in a gene set.	[Zhang, Jigang; Li, Jian; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Systemat Biomed Res Ctr, Shanghai 201800, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; University of Shanghai for Science & Technology	Zhang, JG (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Li, Jian/G-4445-2015	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; Missouri Life Sciences Research Board Center [09-1101]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Missouri Life Sciences Research Board Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The investigators of this work were partially supported by grants from National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, and P50 AR055081) and Missouri Life Sciences Research Board center (Missouri State Funding 09-1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Aston CE, 2005, HUM GENET, V116, P208, DOI 10.1007/s00439-004-1206-7; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLEEKER FE, 2008, ONCOGENE; Broberg P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r41; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Cohen J., 2003, APPL MULTIPLE REGRES; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fabian Z, 2006, J CELL BIOCHEM, V99, P1431, DOI 10.1002/jcb.21019; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gottlieb TM, 1996, BBA-REV CANCER, V1287, P77, DOI 10.1016/0304-419X(95)00019-C; Gulati AP, 2006, MOL CARCINOGEN, V45, P26, DOI 10.1002/mc.20149; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu Q, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-431; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Rougemont J, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-15; Roy S, 2008, FREE RADICAL BIO MED, V44, P180, DOI 10.1016/j.freeradbiomed.2007.01.025; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu XS, 2008, EUR J HUM GENET, V16, P644, DOI 10.1038/sj.ejhg.5202004; Yan XT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-362; Zhang JX, 2007, BIOINFORMATICS, V23, P2903, DOI 10.1093/bioinformatics/btm482; Zhang JG, 2008, AM J HUM GENET, V83, P269, DOI 10.1016/j.ajhg.2008.07.009	32	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8064	10.1371/journal.pone.0008064	http://dx.doi.org/10.1371/journal.pone.0008064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956614	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400018
J	Arijs, I; De Hertogh, G; Lemaire, K; Quintens, R; Van Lommel, L; Van Steen, K; Leemans, P; Cleynen, I; Van Assche, G; Vermeire, S; Geboes, K; Schuit, F; Rutgeerts, P				Arijs, Ingrid; De Hertogh, Gert; Lemaire, Katleen; Quintens, Roel; Van Lommel, Leentje; Van Steen, Kristel; Leemans, Peter; Cleynen, Isabelle; Van Assche, Gert; Vermeire, Severine; Geboes, Karel; Schuit, Frans; Rutgeerts, Paul			Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment	PLOS ONE			English	Article							ALPHA-DEFENSIN EXPRESSION; ILEAL CROHNS-DISEASE; ULCERATIVE-COLITIS; COLON; MICE; INDUCTION; SYSTEM; ILEUM	Background: Antimicrobial peptides (AMPs) protect the host intestinal mucosa against microorganisms. Abnormal expression of defensins was shown in inflammatory bowel disease (IBD), but it is not clear whether this is a primary defect. We investigated the impact of anti-inflammatory therapy with infliximab on the mucosal gene expression of AMPs in IBD. Methodology/Principal Findings: Mucosal gene expression of 81 AMPs was assessed in 61 IBD patients before and 4-6 weeks after their first infliximab infusion and in 12 control patients, using Affymetrix arrays. Quantitative real-time reverse-transcription PCR and immunohistochemistry were used to confirm microarray data. The dysregulation of many AMPs in colonic IBD in comparison with control colons was widely restored by infliximab therapy, and only DEFB1 expression remained significantly decreased after therapy in the colonic mucosa of IBD responders to infliximab. In ileal Crohn's disease (CD), expression of two neuropeptides with antimicrobial activity, PYY and CHGB, was significantly decreased before therapy compared to control ileums, and ileal PYY expression remained significantly decreased after therapy in CD responders. Expression of the downregulated AMPs before and after treatment (DEFB1 and PYY) correlated with villin 1 expression, a gut epithelial cell marker, indicating that the decrease is a consequence of epithelial damage. Conclusions/Significance: Our study shows that the dysregulation of AMPs in IBD mucosa is the consequence of inflammation, but may be responsible for perpetuation of inflammation due to ineffective clearance of microorganisms.	[Arijs, Ingrid; Cleynen, Isabelle; Van Assche, Gert; Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Arijs, Ingrid; Lemaire, Katleen; Quintens, Roel; Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Leuven, Belgium; [De Hertogh, Gert; Geboes, Karel] Univ Hosp Gasthuisberg, Dept Morphol & Mol Pathol, B-3000 Leuven, Belgium; [Van Steen, Kristel; Leemans, Peter] Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium; [Rutgeerts, Paul] Univ Hosp Gasthuisberg, Leuven Food Sci & Nutr Res Ctr LFoRCe, B-3000 Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; University of Liege; KU Leuven; University Hospital Leuven	Arijs, I (corresponding author), Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium.	Frans.Schuit@med.kuleuven.be; paul.rutgeerts@uz.kuleuven.be	Arijs, Ingrid/AAJ-3163-2020; Quintens, Roel/G-5339-2017	Quintens, Roel/0000-0002-4359-3403; Arijs, Ingrid/0000-0002-9415-083X; Van Steen, Kristel/0000-0001-9868-5033; Vermeire, Severine/0000-0001-9942-3019	Fund for Scientific Research - Flanders (FWO) Belgium [G.0440.06]	Fund for Scientific Research - Flanders (FWO) Belgium(FWO)	This work was supported by a grant from the Fund for Scientific Research - Flanders (FWO) Belgium (FWO project nr.G.0440.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006285; Arijs I, 2009, GUT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dianda L, 1997, AM J PATHOL, V150, P91; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Krause A, 2003, PROTEIN SCI, V12, P143, DOI 10.1110/ps.0213603; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	35	153	158	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7984	10.1371/journal.pone.0007984	http://dx.doi.org/10.1371/journal.pone.0007984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956723	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827500014
J	Rodder, D; Schmidtlein, S; Veith, M; Lotters, S				Roedder, Dennis; Schmidtlein, Sebastian; Veith, Michael; Loetters, Stefan			Alien Invasive Slider Turtle in Unpredicted Habitat: A Matter of Niche Shift or of Predictors Studied?	PLOS ONE			English	Article							TRACHEMYS-SCRIPTA-ELEGANS; RED-EARED SLIDER; CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; TEMPERATURE; PERFORMANCE; MODELS; ECOLOGY; SPACE	Background: Species Distribution Models (SDMs) aim on the characterization of a species' ecological niche and project it into geographic space. The result is a map of the species' potential distribution, which is, for instance, helpful to predict the capability of alien invasive species. With regard to alien invasive species, recently several authors observed a mismatch between potential distributions of native and invasive ranges derived from SDMs and, as an explanation, ecological niche shift during biological invasion has been suggested. We studied the physiologically well known Slider turtle from North America which today is widely distributed over the globe and address the issue of ecological niche shift versus choice of ecological predictors used for model building, i.e., by deriving SDMs using multiple sets of climatic predictor. Principal Findings: In one SDM, predictors were used aiming to mirror the physiological limits of the Slider turtle. It was compared to numerous other models based on various sets of ecological predictors or predictors aiming at comprehensiveness. The SDM focusing on the study species' physiological limits depicts the target species' worldwide potential distribution better than any of the other approaches. Conclusion: These results suggest that a natural history-driven understanding is crucial in developing statistical models of ecological niches (as SDMs) while "comprehensive'' or "standard'' sets of ecological predictors may be of limited use.	[Roedder, Dennis; Veith, Michael; Loetters, Stefan] Univ Trier, Biogeog Dept, Trier, Germany; [Schmidtlein, Sebastian] Univ Bonn, Dept Geog, Sebastian Schmidtlein, D-5300 Bonn, Germany	Universitat Trier; University of Bonn	Rodder, D (corresponding author), Univ Trier, Biogeog Dept, Trier, Germany.	loetters@uni-trier.de	Schmidtlein, Sebastian/Q-2919-2016; Rödder, Dennis/A-7043-2010; Rödder, Dennis/AAT-8644-2021	Rödder, Dennis/0000-0002-6108-1639; Schmidtlein, Sebastian/0000-0003-1888-1865	'Graduiertenforderung des Landes Nordrhein-Westfalen'; Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany	'Graduiertenforderung des Landes Nordrhein-Westfalen'; Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany	This work has been supported by grants from the 'Graduiertenforderung des Landes Nordrhein-Westfalen' and the Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany ('Die Folgen des Global Change fur Bioressourcen, Gesetzgebung und Standardsetzung'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCARI GC, 1993, J ANAT, V183, P21; BAILEY JR, 1995, J COMP PHYSIOL B, V164, P622, DOI 10.1007/BF00389803; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CREWS D, 1994, DEV GENET, V15, P297, DOI 10.1002/dvg.1020150310; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; GARSTKA WR, 1991, COMP BIOCHEM PHYS A, V98, P271, DOI 10.1016/0300-9629(91)90532-H; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Hijmans R.J., 2001, DIVA GIS VERSION 1 4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutchison V.H., 1979, P207; HUTCHISON VICTOR H., 1966, HERPETOLOGIA, V22, P32; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; LAMB T, 1995, ECOTOXICOLOGY, V4, P5, DOI 10.1007/BF00350647; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lowe S., 2000, ENCY BIOL INVASIONS; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Ota Hidetoshi, 2004, Global Environmental Research, V8, P133; Packard GC, 1997, COPEIA, P339, DOI 10.2307/1447753; PARMENTER RR, 1980, COPEIA, P503, DOI 10.2307/1444528; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perry Gad, 2007, APPLIED HERPETOLOGY, V4, P88, DOI 10.1163/157075407779766723; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ramsay Neil F., 2007, V2, P161; RODDER D, 2009, CLIMATE CHANGE ECOLO; Rodder D, 2009, J NAT HIST, V43, P2525, DOI 10.1080/00222930903100550; Rodder D, 2009, NORTH-WEST J ZOOL, V5, P16; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Telecky Teresa M., 2001, Turtle and Tortoise Newsletter, V4, P8; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tucker JK, 1998, J HERPETOL, V32, P431, DOI 10.2307/1565459; Tucker JK, 1998, J HERPETOL, V32, P124, DOI 10.2307/1565492; Welk E, 2002, DIVERS DISTRIB, V8, P219, DOI 10.1046/j.1472-4642.2002.00144.x; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	56	149	157	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7843	10.1371/journal.pone.0007843	http://dx.doi.org/10.1371/journal.pone.0007843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956684	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827500001
J	Liao, D; Luo, YP; Markowitz, D; Xiang, R; Reisfeld, RA				Liao, Debbie; Luo, Yunping; Markowitz, Dorothy; Xiang, Rong; Reisfeld, Ralph A.			Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model	PLOS ONE			English	Article							DENDRITIC CELLS; SUPPRESSOR-CELLS; APOPTOTIC CELLS; MYELOID CELLS; INFLAMMATION; RECRUITMENT; PROTEASE; IMMUNOGENICITY; IMMUNOTHERAPY; CALRETICULIN	Background: Local inflammation associated with solid tumors commonly results from factors released by tumor cells and the tumor stroma, and promotes tumor progression. Cancer associated fibroblasts comprise a majority of the cells found in tumor stroma and are appealing targets for cancer therapy. Here, our aim was to determine the efficacy of targeting cancer associated fibroblasts for the treatment of metastatic breast cancer. Methodology/Principal Findings: We demonstrate that cancer associated fibroblasts are key modulators of immune polarization in the tumor microenvironment of a 4T1 murine model of metastatic breast cancer. Elimination of cancer associated fibroblasts in vivo by a DNA vaccine targeted to fibroblast activation protein results in a shift of the immune microenvironment from a Th2 to Th1 polarization. This shift is characterized by increased protein expression of IL-2 and IL-7, suppressed recruitment of tumor-associated macrophages, myeloid derived suppressor cells, T regulatory cells, and decreased tumor angiogenesis and lymphangiogenesis. Additionally, the vaccine improved anti-metastatic effects of doxorubicin chemotherapy and enhanced suppression of IL-6 and IL-4 protein expression while increasing recruitment of dendritic cells and CD8(+) T cells. Treatment with the combination therapy also reduced tumor-associated Vegf, Pdgfc, and GM-CSF mRNA and protein expression. Conclusions/Significance: Our findings demonstrate that cancer associated fibroblasts promote tumor growth and metastasis through their role as key modulators of immune polarization in the tumor microenvironment and are valid targets for therapy of metastatic breast cancer.	[Liao, Debbie; Luo, Yunping; Markowitz, Dorothy; Xiang, Rong; Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Xiang, Rong] Nankai Univ, Sch Med, Dept Immunol, Tianjin, Peoples R China	Scripps Research Institute; Nankai University	Liao, D (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	reisfeld@scripps.edu			National Institutes of Health (NIH) [T32 HL007195-31]; DOD BCRP [BC050141]; National Science Foundation of China (NSFC) [30672389]; NSFC 973 [2007CB914804]; NSFC 863 [2007AA021010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP(United States Department of Defense); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC 973(National Basic Research Program of China); NSFC 863(National Natural Science Foundation of China (NSFC)National High Technology Research and Development Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grant T32 HL007195-31 (to L. K. Curtiss, The Scripps Research Institute), DOD BCRP grant BC050141 (to R. A. R.), National Science Foundation of China (NSFC) grant 30672389 (to R. X.), NSFC 973 program grant 2007CB914804 (to R. X.), and NSFC 863 program grant 2007AA021010 (to R. X.). This is TSRI manuscript number 20046-IMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bocchia M, 2000, HAEMATOLOGICA, V85, P1172; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ERLER JT, 2008, CLIN EXP METASTASIS; GATELY MK, 1992, CELL IMMUNOL, V143, P127, DOI 10.1016/0008-8749(92)90011-D; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawakami K, 2001, CRIT REV IMMUNOL, V21, P299; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kosmaczewska A, 2008, ARCH IMMUNOL THER EX, V56, P181, DOI 10.1007/s00005-008-0018-1; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ochsenbein AF, 2005, SPRINGER SEMIN IMMUN, V27, P19, DOI 10.1007/s00281-004-0192-0; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Waterhouse NJ, 2007, APOPTOSIS, V12, P631, DOI 10.1007/s10495-007-0057-9; Wolf BB, 2008, MINI-REV MED CHEM, V8, P719, DOI 10.2174/138955708784567449; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	44	314	337	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7965	10.1371/journal.pone.0007965	http://dx.doi.org/10.1371/journal.pone.0007965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956757	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827300020
J	Yen, MY; Wu, TSJ; Chiu, AWH; Wong, WW; Wang, PE; Chan, TC; King, CC				Yen, Muh-Yong; Wu, Tsung-Shu Joseph; Chiu, Allen Wen-Hsiang; Wong, Wing-Wai; Wang, Po-En; Chan, Ta-Chien; King, Chwan-Chuen			Taipei's Use of a Multi-Channel Mass Risk Communication Program to Rapidly Reverse an Epidemic of Highly Communicable Disease	PLOS ONE			English	Article							ACUTE HEMORRHAGIC CONJUNCTIVITIS; COXSACKIEVIRUS A24 VARIANT; INFLUENZA-LIKE ILLNESS; OUTBREAK; HUMANS; KOREA; GHANA	Background: In September 2007, an outbreak of acute hemorrhagic conjunctivitis (AHC) occurred in Keelung City and spread to Taipei City. In response to the epidemic, a new crisis management program was implemented and tested in Taipei. Methodology and Principal Findings: Having noticed that transmission surged on weekends during the Keelung epidemic, Taipei City launched a multi-channel mass risk communications program that included short message service (SMS) messages sent directly to approximately 2.2 million Taipei residents on Friday, October 12th, 2007. The public was told to keep symptomatic students from schools and was provided guidelines for preventing the spread of the disease at home. Epidemiological characteristics of Taipei's outbreak were analyzed from 461 sampled AHC cases. Median time from exposure to onset of the disease was 1 day. This was significantly shorter for cases occurring in family clusters than in class clusters (mean+/-SD: 2.6+/-3.2 vs. 4.39+/-4.82 days, p = 0.03), as well as for cases occurring in larger family clusters as opposed to smaller ones (1.261.7 days vs. 3.9+/-4.0 days, p<0.01). Taipei's program had a significant impact on patient compliance. Home confinement of symptomatic children increased from 10% to 60% (p<0.05) and helped curb the spread of AHC. Taipei experienced a rapid decrease in AHC cases between the Friday of the SMS announcement and the following Monday, October 15, (0.70% vs. 0.36%). By October 26, AHC cases reduced to 0.01%. The success of this risk communication program in Taipei (as compared to Keelung) is further reflected through rapid improvements in three epidemic indicators: (1) significantly lower crude attack rates (1.95% vs. 14.92%, p<0.001), (2) a short epidemic period of AHC (13 vs. 34 days), and (3) a quick drop in risk level (1,2 weeks) in Taipei districts that border Keelung (the original domestic epicenter). Conclusions and Significance: The timely launch of this systematic, communication-based intervention proved effective at preventing a dangerous spike in AHC and was able to bring this high-risk disease under control. We recommend that public health officials incorporate similar methods into existing guidelines for preventing pandemic influenza and other emerging infectious diseases.	[Yen, Muh-Yong; Chiu, Allen Wen-Hsiang; Wong, Wing-Wai] Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan; [Yen, Muh-Yong] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Wu, Tsung-Shu Joseph; Chan, Ta-Chien; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Wu, Tsung-Shu Joseph] Luke Int Norway, Notteroy, Norway; [Chiu, Allen Wen-Hsiang] Natl Yang Ming Univ, Dept Urol, Taipei 112, Taiwan; [Wang, Po-En] Dept Hlth, Chilung, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University	Yen, MY (corresponding author), Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan.	myyen1121@gmail.com; chwanchuen@gmail.com	Wu, Tsung Shu Joseph/K-6138-2018	Wu, Tsung Shu Joseph/0000-0001-6155-9340; King, Chwan-Chuen/0000-0002-6078-2601	Taipei City Government [96001-62-032]	Taipei City Government	This study was financially supported by Taipei City Government Grant 96001-62-032. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, CONTROL COMMUNICABLE; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Berry TR, 2007, HEALTH COMMUN, V21, P35, DOI 10.1080/10410230701283322; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; BRANDFUL JAM, 1990, E AFR MED J, V67, P878; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236; CHATTERJEE S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; CHOU MY, 1988, AM J EPIDEMIOL, V127, P795, DOI 10.1093/oxfordjournals.aje.a114861; CHRISTOPHER S, 1982, J INFECT DIS, V146, P16, DOI 10.1093/infdis/146.1.16; Du Ry van Beest Holle M, 2005, EUROSURVEILLANCE, V10, P264; Ghazali O., 2003, SMJ Singapore Medical Journal, V44, P511; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; KUO PC, 2009, EYE; Leveque N, 2007, EUR J CLIN MICROBIOL, V26, P199, DOI 10.1007/s10096-007-0265-9; LIN TL, 2008, TAIWAN EPIDEMIOLOGY, V23, P303; Madhavan H N, 2000, Indian J Ophthalmol, V48, P159; MIRKOVIC RR, 1973, B WORLD HEALTH ORGAN, V49, P341; NGUYENVANTAM JS, 2006, EUROSURVEILL; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Park K, 2006, J MED VIROL, V78, P91, DOI 10.1002/jmv.20508; PATRIARCA PA, 1983, JAMA-J AM MED ASSOC, V249, P1283, DOI 10.1001/jama.249.10.1283; Pitrelli Nico, 2007, Ann Ist Super Sanita, V43, P336; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Sandrock C, 2007, CRIT CARE, V11, DOI 10.1186/cc5675; Thomas James C, 2009, J Public Health Manag Pract, V15, pE16, DOI 10.1097/01.PHH.0000346021.06803.76; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0; YEN MY, 2007, TAIWAN EPIDEMIOLOGY, V23, P16; YINMURPHY M, 1993, AM J OPHTHALMOL, V116, P212; Zhao H, 2007, Euro Surveill, V12, pE3; 2004, MMWR MORB MORTAL WKL, V53, P632	31	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7962	10.1371/journal.pone.0007962	http://dx.doi.org/10.1371/journal.pone.0007962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956722	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827300018
J	De Biase, I; Chutake, YK; Rindler, PM; Bidichandani, SI				De Biase, Irene; Chutake, Yogesh K.; Rindler, Paul M.; Bidichandani, Sanjay I.			Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription	PLOS ONE			English	Article							TRIPLET-REPEAT EXPANSION; DOT-TTC REPEATS; HUMAN PROMOTERS; HUMAN-CELLS; GENE; RNA; CHROMATIN; HETEROCHROMATIN; COHESIN; DNA	Background: Over 15 inherited diseases are caused by expansion of triplet-repeats. Friedreich ataxia (FRDA) patients are homozygous for an expanded GAA triplet-repeat sequence in intron 1 of the FXN gene. The expanded GAA triplet-repeat results in deficiency of FXN gene transcription, which is reversed via administration of histone deacetylase inhibitors indicating that transcriptional silencing is at least partially due to an epigenetic abnormality. Methodology/Principal Findings: We found a severe depletion of the chromatin insulator protein CTCF (CCCTC-binding factor) in the 5'UTR of the FXN gene in FRDA, and coincident heterochromatin formation involving the +1 nucleosome via enrichment of H3K9me3 and recruitment of heterochromatin protein 1. We identified FAST-1 (FXN Antisense Transcript - 1), a novel antisense transcript that overlaps the CTCF binding site in the 5'UTR, which was expressed at higher levels in FRDA. The reciprocal relationship of deficient FXN transcript and higher levels of FAST-1 seen in FRDA was reproduced in normal cells via knockdown of CTCF. Conclusions/Significance: CTCF depletion constitutes an epigenetic switch that results in increased antisense transcription, heterochromatin formation and transcriptional deficiency in FRDA. These findings provide a mechanistic basis for the transcriptional silencing of the FXN gene in FRDA, and broaden our understanding of disease pathogenesis in triplet-repeat diseases.			De Biase, I (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	Sanjay-Bidichandani@ouhsc.edu		Bidichandani, Sanjay/0000-0001-6191-6475				Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lunyak VV, 2008, CURR OPIN CELL BIOL, V20, P281, DOI 10.1016/j.ceb.2008.03.018; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	41	87	89	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7914	10.1371/journal.pone.0007914	http://dx.doi.org/10.1371/journal.pone.0007914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19956589	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004600017
J	Dindo, M; Whiten, A; de Waal, FBM				Dindo, Marietta; Whiten, Andrew; de Waal, Frans B. M.			In-Group Conformity Sustains Different Foraging Traditions in Capuchin Monkeys (Cebus apella)	PLOS ONE			English	Article							CHILDREN HOMO-SAPIENS; TOOL USE; ARTIFICIAL FRUIT; SOCIAL DIFFUSION; APES APE; CHIMPANZEES; IMITATION; TRANSMISSION; MARMOSETS; CULTURE	Background: Decades of research have revealed rich cultural repertoires encompassing multiple traditions in wild great apes, a picture crucially complemented by experimental simulations with captive apes. Studies with wild capuchin monkeys, the most encephalized simian species, have indicated a New World convergence on these cultural phenomena, involving multiple traditions and tool use. However, experimental studies to date are in conflict with such findings in concluding that capuchins, like other monkeys, show minimal capacities for social learning. Methodology/Principal Findings: Here we report a new experimental approach in which the alpha male of each of two groups of capuchins was trained to open an artificial foraging device in a quite different way, using either a slide or lift action, then reunited with his group. In each group a majority of monkeys, 8 of 11 and 13 of 14, subsequently mastered the task. Seventeen of the successful 21 monkeys discovered the alternative action to that seeded in the group, performing it a median of 4 times. Nevertheless, all 21 primarily adopted the technique seeded by their group's alpha male. Median proportions of slide versus lift were 0.96 for the group seeded with slide versus 0.01 for the group seeded with lift. Conclusions/Significance: These results suggest a striking effect of social conformity in learned behavioral techniques, consistent with field reports of capuchin traditions and convergent on the only other species in which such cultural phenomena have been reported, chimpanzees and humans.			Dindo, M (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9AJ, Fife, Scotland.	aw2@st-andrews.ac.uk		Whiten, Andrew/0000-0003-2426-5890	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165, RR-00165] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, ANIM COGN, V10, P283, DOI 10.1007/s10071-006-0069-9; Bugnyar T, 1997, ANIM BEHAV, V54, P817, DOI 10.1006/anbe.1996.0497; Caldwell CA, 2004, ANIM COGN, V7, P77, DOI 10.1007/s10071-003-0192-9; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; Chapais Bernard, 1992, P29; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Custance D, 1999, J COMP PSYCHOL, V113, P13, DOI 10.1037/0735-7036.113.1.13; Custance D, 1998, BEHAV BRAIN SCI, V21, P118, DOI 10.1017/S0140525X98260705; DAWSON BV, 1965, ANIM BEHAV, V13, P470, DOI 10.1016/0003-3472(65)90108-9; de Waal F., 2001, APE SUSHI MASTER CUL; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; deWaal FBM, 1996, J COMP PSYCHOL, V110, P147, DOI 10.1037/0735-7036.110.2.147; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Fragaszy D, 2004, LEARN BEHAV, V32, P24; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Fredman T, 2008, ANIM COGN, V11, P295, DOI 10.1007/s10071-007-0117-0; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; GALEF BG, 1990, INTERPRETATION EXPLA, V1, P74; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Imanishi K., 1957, PSYCHOLOGIA, V1, P47; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Moura ACD, 2004, SCIENCE, V306, P1909, DOI 10.1126/science.1102558; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; PERRY S, 2009, ANIMAL COGNITION; Pesendorfer MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004472; Price E, 2007, BEHAV PROCESS, V74, P13, DOI 10.1016/j.beproc.2006.09.003; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1997, PRIMATE COGNITION; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Visalberghi E., 1990, P247, DOI 10.1017/CBO9780511665486.011; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; Watanabe K, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P405; WATANABE K, 1994, NATO ADV SCI INST SE, V78, P81; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031	50	68	71	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7858	10.1371/journal.pone.0007858	http://dx.doi.org/10.1371/journal.pone.0007858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521QH	19924242	gold, Green Published, Green Submitted			2022-12-27	WOS:000271936700008
J	Hancock, WW; Ozkaynak, E				Hancock, Wayne W.; Oezkaynak, Engin			Three Distinct Domains Contribute to Nuclear Transport of Murine Foxp3	PLOS ONE			English	Article							T-CELL FUNCTION; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; ENTEROPATHY; BINDING; IPEX; LOCALIZATION; ACTIVATION; EXPRESSION; MUTATIONS	Foxp3, a 47-kDa transcription factor, is necessary for the function of CD4+CD25+regulatory T cells (Tregs), with an essential role in the control of self-reactive T cells and in preventing autoimmunity. Activation of Tregs by TCR engagement results in upregulation of Foxp3 expression, followed by its rapid nuclear transport and binding to chromatin. Here, we identify three distinct Foxp3 domains that contribute to nuclear transport. The first domain (Domain 1) comprises the C-terminal 12 amino acids. The second domain (Domain 2) is located immediately N-terminal to the forkhead domain (FHD), recently reported to be a binding site for the runt-related transcription factor 1/acute myeloid leukemia 1 (Runx1/AML1). The third domain (Domain 3) is located within the N-terminal first 51 amino acids. Unlike the known nuclear localization signals (NLSs), none of these three regions are rich in basic residues and do not bear any similarity to known monopartite or bipartite NLSs that have one or more clusters of basic amino acids. The basic arginine-lysine-lysine-arginine (RKKR) sequence, located 12-aa from the C-terminal end of Foxp3 was previously reported to be a nuclear localization signal (NLS) for several proteins, including for a GFP-Foxp3 hybrid. Evidence is provided here that in the full-length native Foxp3 RKKR does not function as an NLS. The data reported in this study indicates that Foxp3 achieves nuclear transport by binding to other nuclear factors and co-transporting with them to the nucleus.			Hancock, WW (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA.	ozkaynak@email.chop.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072420] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI072420, 1R21AI72420-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605, DOI 10.1002/j.1460-2075.1988.tb02986.x; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; Nilsson I, 1998, J MOL BIOL, V284, P1185, DOI 10.1006/jmbi.1998.2219; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x	28	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7890	10.1371/journal.pone.0007890	http://dx.doi.org/10.1371/journal.pone.0007890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924293	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700022
J	Poh, YC; Na, S; Chowdhury, F; Ouyang, MX; Wang, YX; Wang, N				Poh, Yeh-Chuin; Na, Sungsoo; Chowdhury, Farhan; Ouyang, Mingxing; Wang, Yingxiao; Wang, Ning			Rapid Activation of Rac GTPase in Living Cells by Force Is Independent of Src	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; IN-VIVO; MEMBRANE; MECHANOTRANSDUCTION; DYNAMICS	It is well known that mechanical forces are crucial in regulating functions of every tissue and organ in a human body. However, it remains unclear how mechanical forces are transduced into biochemical activities and biological responses at the cellular and molecular level. Using the magnetic twisting cytometry technique, we applied local mechanical stresses to living human airway smooth muscle cells with a magnetic bead bound to the cell surface via transmembrane adhesion molecule integrins. The temporal and spatial activation of Rac, a small guanosine triphosphatase, was quantified using a fluorescent resonance energy transfer (FRET) method that measures changes in Rac activity in response to mechanical stresses by quantifying intensity ratios of ECFP (enhanced cyan fluorescent protein as a donor) and YPet (a variant yellow fluorescent protein as an acceptor) of the Rac biosensor. The applied stress induced rapid activation (less than 300 ms) of Rac at the cell periphery. In contrast, platelet derived growth factor (PDGF) induced Rac activation at a much later time (>30 sec). There was no stress-induced Rac activation when a mutant form of the Rac biosensor (RacN17) was transfected or when the magnetic bead was coated with transferrin or with poly-L-lysine. It is known that PDGF-induced Rac activation depends on Src activity. Surprisingly, pre-treatment of the cells with specific Src inhibitor PP1 or knocking-out Src gene had no effects on stress-induced Rac activation. In addition, eliminating lipid rafts through extraction of cholesterol from the plasma membrane did not prevent stress-induced Rac activation, suggesting a raft-independent mechanism in governing the Rac activation upon mechanical stimulation. Further evidence indicates that Rac activation by stress depends on the magnitudes of the applied stress and cytoskeletal integrity. Our results suggest that Rac activation by mechanical forces is rapid, direct and does not depend on Src activation. These findings suggest that signaling pathways of mechanical forces via integrins might be fundamentally different from those of growth factors.			Poh, YC (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	yingxiao@illinois.edu; nwangrw@illinois.edu	Ouyang, Mingxing/AAF-5896-2019; Ouyang, Mingxing/C-9130-2011; Ouyang, Mingxing/F-8907-2019; Wang, Ning/B-6966-2008; Ouyang, Mingxing/J-4529-2013; Chowdhury, Farhan/D-1496-2009	Ouyang, Mingxing/0000-0002-2910-0713; Chowdhury, Farhan/0000-0003-1527-2677	NCI NIH HHS [R21 CA139272-01, CA139272, R21 CA139272] Funding Source: Medline; NIGMS NIH HHS [R01 GM072744, GM 072744] Funding Source: Medline; NINDS NIH HHS [R01 NS063405, NS063405] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eckes B, 1998, J CELL SCI, V111, P1897; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Na SS, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.134pl1; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 1995, BIOCHEM CELL BIOL, V73, P327, DOI 10.1139/o95-041; Wang YX, 2009, INTEGR BIOL-UK, V1, P565, DOI 10.1039/b913093b; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469	25	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7886	10.1371/journal.pone.0007886	http://dx.doi.org/10.1371/journal.pone.0007886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924282	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700018
J	Uemura, K; Lill, CM; Li, XJ; Peters, JA; Ivanov, A; Fan, ZY; DeStrooper, B; Bacskai, BJ; Hyman, BT; Berezovska, O				Uemura, Kengo; Lill, Christina M.; Li, Xuejing; Peters, Jessica A.; Ivanov, Alexander; Fan, Zhanyun; DeStrooper, Bart; Bacskai, Brian J.; Hyman, Bradley T.; Berezovska, Oksana			Allosteric Modulation of PS1/gamma-Secretase Conformation Correlates with Amyloid beta(42/40) Ratio	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GAMMA-SECRETASE ACTIVITY; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; CATALYTIC PORE; BETA-PROTEIN; PRESENILIN; NOTCH; APP	Background: Presenilin 1(PS1) is the catalytic subunit of gamma-secretase, the enzyme responsible for the A beta C-terminal cleavage site, which results in the production of A beta peptides of various lengths. Production of longer forms of the A beta peptide occur in patients with autosomal dominant Alzheimer disease (AD) due to mutations in presenilin. Many modulators of gamma-secretase function have been described. We hypothesize that these modulators act by a common mechanism by allosterically modifying the structure of presenilin. Methodology/Principal Findings: To test this hypothesis we generated a genetically encoded GFP-PS1-RFP (G-PS1-R) FRET probe that allows monitoring of the conformation of the PS1 molecule in its native environment in live cells. We show that G-PS1-R can be incorporated into the gamma-secretase complex, reconstituting its activity in PS1/2 deficient cells. Using Forster resonance energy transfer (FRET)-based approaches we show that various pharmacological and genetic manipulations that target either gamma-secretase components (PS1, Pen2, Aph1) or gamma-secretase substrate (amyloid precursor protein, APP) and are known to change A beta(42) production are associated with a consistent conformational change in PS1. Conclusions/ Significance: These results strongly support the hypothesis that allosteric changes in PS1 conformation underlie changes in the A beta(42/40) ratio. Direct measurement of physiological and pathological changes in the conformation of PS1/gamma-secretase may provide insight into molecular mechanism of A beta(42) generation, which could be exploited therapeutically.			Uemura, K (corresponding author), Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Alzheimer Res Unit, Charlestown, MA 02129 USA.	oberezovska@partners.org	Lill, Christina/J-9449-2015; Lill, Christina M/GSI-4054-2022; De Strooper, Bart/F-6507-2012; Bacskai, Brian/AAE-9583-2021	Lill, Christina/0000-0002-2805-1307; De Strooper, Bart/0000-0001-5455-5819; 	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG026593] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG026593, AG 15379, AG026593, P01 AG015379] Funding Source: Medline; NIBIB NIH HHS [EB000768, R01 EB000768] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; [陈启宏 CHEN Qihong], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P42; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Herl L, 2009, MOL CELL NEUROSCI, V41, P166, DOI 10.1016/j.mcn.2009.02.008; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	38	70	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7893	10.1371/journal.pone.0007893	http://dx.doi.org/10.1371/journal.pone.0007893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924286	Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700023
J	Brower, CS; Varshavsky, A				Brower, Christopher S.; Varshavsky, Alexander			Ablation of Arginylation in the Mouse N-End Rule Pathway: Loss of Fat, Higher Metabolic Rate, Damaged Spermatogenesis, and Neurological Perturbations	PLOS ONE			English	Article							MEDIATED GERMLINE MOSAICISM; UBIQUITIN LIGASE; DEGRADATION; PROTEIN; MICE; CRE; PROTEASOME; EXPRESSION; APOPTOSIS; SEQUENCES	In the N-end rule pathway of protein degradation, the destabilizing activity of N-terminal Asp, Glu or (oxidized) Cys residues requires their conjugation to Arg, which is recognized directly by pathway's ubiquitin ligases. N-terminal arginylation is mediated by the Ate1 arginyltransferase, whose physiological substrates include the Rgs4, Rgs5 and Rgs16 regulators of G proteins. Here, we employed the Cre-lox technique to uncover new physiological functions of N-terminal arginylation in adult mice. We show that postnatal deletion of mouse Ate1 (its unconditional deletion is embryonic lethal) causes a rapid decrease of body weight and results in early death of similar to 15% of Ate1-deficient mice. Despite being hyperphagic, the surviving Ate1-deficient mice contain little visceral fat. They also exhibit an increased metabolic rate, ectopic induction of the Ucp1 uncoupling protein in white fat, and are resistant to diet-induced obesity. In addition, Ate1-deficient mice have enlarged brains, an enhanced startle response, are strikingly hyperkinetic, and are prone to seizures and kyphosis. Ate1-deficient males are also infertile, owing to defects in Ate1(-/-) spermatocytes. The remarkably broad range of specific biological processes that are shown here to be perturbed by the loss of N-terminal arginylation will make possible the dissection of regulatory circuits that involve Ate1 and either its known substrates, such as Rgs4, Rgs5 and Rgs16, or those currently unknown.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Brower, CS (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu			National Institutes of Health [GM31530, DK39520]; American Asthma Foundation; March of Dimes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK039520, R01DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants to A.V. from the National Institutes of Health (GM31530 and DK39520), the American Asthma Foundation, and the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Dauger S, 1998, RESP PHYSIOL, V112, P215, DOI 10.1016/S0034-5687(98)00027-9; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; GEYER MA, 1998, CURR PROTOC NEUROSCI; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Joyner AL, 2000, GENE TARGETING PRACT; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nagy A., 2002, MANIPULATING MOUSE E; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wasserman K, 2005, PRINCIPLES EXERCISE; Weber P, 2003, BIOL REPROD, V68, P553, DOI 10.1095/biolreprod.102.005801; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200	47	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7757	10.1371/journal.pone.0007757	http://dx.doi.org/10.1371/journal.pone.0007757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915679	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000271721900002
J	Nishitsuji, H; Hayashi, T; Takahashi, T; Miyano, M; Kannagi, M; Masuda, T				Nishitsuji, Hironori; Hayashi, Takaya; Takahashi, Takuya; Miyano, Masashi; Kannagi, Mari; Masuda, Takao			Augmentation of Reverse Transcription by Integrase through an Interaction with Host Factor, SIP1/Gemin2 Is Critical for HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SPINAL MUSCULAR-ATROPHY; FINGER-LIKE DOMAIN; NONDIVIDING CELLS; BINDING DOMAIN; TY3 INTEGRASE; PROTEIN; LEDGF/P75; COMPLEX; IDENTIFICATION	There has been accumulating evidence for the involvement of retroviral integrase (IN) in the reverse transcription of viral RNA. We previously identified a host factor, survival motor neuron-interacting protein 1 (SIP1/Gemin2) that binds to human immunodeficiency virus type 1 (HIV-1) IN and supports HIV-1 infection apparently at reverse transcription step. Here, we demonstrated that HIV-1 IN together with SIP1 augments reverse transcriptase (RT) activity by enhancing the assembly of RT on viral RNA in vitro. Synthetic peptides corresponding to the binding motifs within IN that inhibited the IN-SIP1 interaction abrogated reverse transcription in vitro and in vivo. Furthermore, knockdown of SIP1 reduced intracellular stability and multimer formation of IN through proteasome-mediated degradation machinery. Taken together, SIP1 appears to stabilize functional multimer forms of IN, thereby promoting the assembly of IN and RT on viral RNA to allow efficient reverse transcription, which is a prerequisite for efficient HIV-1 infection.			Nishitsuji, H (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, Chiba, Japan.	tmasu.impt@tmd.ac.jp						ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cullen BR, 2001, CELL, V105, P697, DOI 10.1016/S0092-8674(01)00392-0; Devroe E, 2003, J CELL SCI, V116, P4401, DOI 10.1242/jcs.00747; Dobard CW, 2007, J VIROL, V81, P10037, DOI 10.1128/JVI.00519-07; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 1997, J VIROL, V71, P3507, DOI 10.1128/JVI.71.5.3507-3514.1997; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gleenberg IO, 2007, J MOL BIOL, V369, P1230, DOI 10.1016/j.jmb.2007.03.073; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; MASUDA T, 1995, J VIROL, V69, P6687, DOI 10.1128/JVI.69.11.6687-6696.1995; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V239, P715, DOI 10.1006/bbrc.1997.7541; Nomura Y, 2006, J BIOCHEM, V139, P753, DOI 10.1093/jb/mvj085; Nymark-McMahon MH, 2002, J VIROL, V76, P2804, DOI 10.1128/JVI.76.6.2804-2816.2002; Nymark-McMahon MH, 1999, J VIROL, V73, P453, DOI 10.1128/JVI.73.1.453-465.1999; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; TADDEO B, 1994, J VIROL, V68, P8401, DOI 10.1128/JVI.68.12.8401-8405.1994; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	52	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7825	10.1371/journal.pone.0007825	http://dx.doi.org/10.1371/journal.pone.0007825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915660	gold, Green Published			2022-12-27	WOS:000271721900015
J	Gillett, A; Maratou, K; Fewings, C; Harris, RA; Jagodic, M; Aitman, T; Olsson, T				Gillett, Alan; Maratou, Klio; Fewings, Chris; Harris, Robert A.; Jagodic, Maja; Aitman, Tim; Olsson, Tomas			Alternative Splicing and Transcriptome Profiling of Experimental Autoimmune Encephalomyelitis Using Genome-Wide Exon Arrays	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; QUANTITATIVE TRAIT LOCI; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; INTERLEUKIN-7 RECEPTOR; MICROARRAY EXPERIMENTS; CEREBROSPINAL-FLUID; CONTROLLED TRIAL	Background: Multiple Sclerosis (MS) is a chronic inflammatory disease causing demyelination and nerve loss in the central nervous system. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS that is widely used to investigate complex pathogenic mechanisms. Transcriptional control through isoform selection and mRNA levels determines pathway activation and ultimately susceptibility to disease. Methodology/Principal Findings: We have studied the role of alternative splicing and differential expression in lymph node cells from EAE-susceptible Dark Agouti (DA) and EAE-resistant Piebald Virol Glaxo. AV1 (PVG) inbred rat strains using Affymetrix Gene Chip Rat Exon 1.0 ST Arrays. Comparing the two strains, we identified 11 differentially spliced and 206 differentially expressed genes at day 7 post-immunization, as well as 9 differentially spliced and 144 differentially expressed genes upon autoantigen re-stimulation. Functional clustering and pathway analysis implicate genes for glycosylation, lymphocyte activation, potassium channel activity and cellular differentiation in EAE susceptibility. Conclusions/Significance: Our results demonstrate that alternative splicing occurs during complex disease and may govern EAE susceptibility. Additionally, transcriptome analysis not only identified previously defined EAE pathways regulating the immune system, but also novel mechanisms. Furthermore, several identified genes overlap known quantitative trait loci, providing novel causative candidate targets governing EAE.			Gillett, A (corresponding author), Karolinska Hosp, Ctr Mol Med, Dept Clin Neurosci, Karolinska Inst,Neuroimmunol Unit, Solna, Sweden.	Alan.Gillett@ki.se	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Maratou, Klio/0000-0001-6061-2322; Olsson, Tomas/0000-0002-2938-1877; Aitman, Timothy/0000-0002-7875-4502				Achiron A, 2007, ANN NY ACAD SCI, V1107, P155, DOI 10.1196/annals.1381.017; AMOR S, 1994, J IMMUNOL, V153, P4349; Arthur AT, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-17; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Avasarala JR, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-2; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Becanovic K, 2003, EUR J IMMUNOL, V33, P1907, DOI 10.1002/eji.200323692; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Chen JX, 2004, GENE, V340, P61, DOI 10.1016/j.gene.2004.05.028; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Della Beffa C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-571; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; HEDREUL MT, 2009, J NEUROIMMUNOL; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jagodic M, 2005, J IMMUNOL, V174, P918, DOI 10.4049/jimmunol.174.2.918; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Jagodic M, 2006, GENOMICS, V88, P737, DOI 10.1016/j.ygeno.2006.08.013; Jiang Y, 1998, J NEUROIMMUNOL, V86, P1, DOI 10.1016/S0165-5728(98)00005-8; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; LEE SC, 1986, J CELL BIOL, V102, P1200, DOI 10.1083/jcb.102.4.1200; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Matsumoto Y, 1998, EUR J IMMUNOL, V28, P1681, DOI 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T; Millefiorini E, 1997, J NEUROL, V244, P153, DOI 10.1007/s004150050066; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Sheng JR, 2005, GENETICS, V170, P283, DOI 10.1534/genetics.104.035261; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN DM, 1992, CELL IMMUNOL, V145, P263, DOI 10.1016/0008-8749(92)90330-R; Walter S, 2002, J NEUROIMMUNOL, V132, P1, DOI 10.1016/S0165-5728(02)00308-9; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang G, 2008, BIOCHEM BIOPH RES CO, V374, P204, DOI 10.1016/j.bbrc.2008.07.003; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	63	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7773	10.1371/journal.pone.0007773	http://dx.doi.org/10.1371/journal.pone.0007773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19915720	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658800011
J	Triana-Baltzer, GB; Gubareva, LV; Nicholls, JM; Pearce, MB; Mishin, VP; Belser, JA; Chen, LM; Chan, RWY; Chan, MCW; Hedlund, M; Larson, JL; Moss, RB; Katz, JM; Tumpey, TM; Fang, F				Triana-Baltzer, Gallen B.; Gubareva, Larisa V.; Nicholls, John M.; Pearce, Melissa B.; Mishin, Vasiliy P.; Belser, Jessica A.; Chen, Li-Mei; Chan, Renee W. Y.; Chan, Michael C. W.; Hedlund, Maria; Larson, Jeffrey L.; Moss, Ronald B.; Katz, Jacqueline M.; Tumpey, Terrence M.; Fang, Fang			Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein	PLOS ONE			English	Article							A H5N1; OSELTAMIVIR RESISTANCE; RECEPTOR SPECIFICITY; B VIRUSES; TRANSMISSION; SENSITIVITY; DIFFERENTIATION; MORTALITY; INFECTION; TROPISM	Background: The recent emergence of a novel pandemic influenza A(H1N1) strain in humans exemplifies the rapid and unpredictable nature of influenza virus evolution and the need for effective therapeutics and vaccines to control such outbreaks. However, resistance to antivirals can be a formidable problem as evidenced by the currently widespread oseltamivir- and adamantane-resistant seasonal influenza A viruses (IFV). Additional antiviral approaches with novel mechanisms of action are needed to combat novel and resistant influenza strains. DAS181 (Fludase (TM)) is a sialidase fusion protein in early clinical development with in vitro and in vivo preclinical activity against a variety of seasonal influenza strains and highly pathogenic avian influenza strains (A/H5N1). Here, we use in vitro, ex vivo, and in vivo models to evaluate the activity of DAS181 against several pandemic influenza A( H1N1) viruses. Methods and Findings: The activity of DAS181 against several pandemic influenza A( H1N1) virus isolates was examined in MDCK cells, differentiated primary human respiratory tract culture, ex-vivo human bronchi tissue and mice. DAS181 efficiently inhibited viral replication in each of these models and against all tested pandemic influenza A( H1N1) strains. DAS181 treatment also protected mice from pandemic influenza A(H1N1)-induced pathogenesis. Furthermore, DAS181 antiviral activity against pandemic influenza A( H1N1) strains was comparable to that observed against seasonal influenza virus including the H274Y oseltamivir- resistant influenza virus. Conclusions: The sialidase fusion protein DAS181 exhibits potent inhibitory activity against pandemic influenza A( H1N1) viruses. As inhibition was also observed with oseltamivir- resistant IFV ( H274Y), DAS181 may be active against the antigenically novel pandemic influenza A( H1N1) virus should it acquire the H274Y mutation. Based on these and previous results demonstrating DAS181 broad-spectrum anti-IFV activity, DAS181 represents a potential therapeutic agent for prevention and treatment of infections by both emerging and seasonal strains of IFV.			Triana-Baltzer, GB (corresponding author), NexBio Inc, San Diego, CA USA.	ffang@nexbio.com	Chan, Renee Wan Yi/AAA-6598-2020; Chan, Renee/D-4799-2012; Chan, Michael Chi Wai/C-4212-2009; Nicholls, John Malcolm/C-4375-2009	Chan, Renee Wan Yi/0000-0001-6485-0926; Chan, Michael Chi Wai/0000-0001-8174-8405; Nicholls, John Malcolm/0000-0001-7217-7444	NIAID NIH HHS [R44 AI056786, U01 AI070281] Funding Source: Medline; PHS HHS [HHSN266200600015C] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI056786, U01AI070281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; BELSHE RB, 2009, N ENGL J MED; *CDC, 2009, FLU VIEW WEEKL US IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Garten RJ, 2009, SCIENCE; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gupta RK, 2006, NEW ENGL J MED, V354, P1423; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; MILLER MA, 2009, N ENGL J MED; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nettesheim P, 2000, J AEROSOL MED, V13, P207, DOI 10.1089/jam.2000.13.207; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; NICHOLLS JM, 2009, ANTIMICROB AGENTS CH; Nicholls JM, 2008, J ANTIMICROB CHEMOTH, V62, P426, DOI 10.1093/jac/dkn167; *NOV SWIN OR INFL, 2009, N ENGL J MED; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; SHINDE V, 2009, N ENGL J MED; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118, DOI 10.1152/ajplung.2000.278.6.L1118; TRIANABALTZER GB, 2009, DAS181 SIALIDA UNPUB; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548	52	81	85	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7788	10.1371/journal.pone.0007788	http://dx.doi.org/10.1371/journal.pone.0007788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893747	Green Submitted, gold, Green Published			2022-12-27	WOS:000271478000013
J	Lopez-Bao, JV; Rodriguez, A; Palomares, F				Lopez-Bao, Jose V.; Rodriguez, Alejandro; Palomares, Francisco			Competitive Asymmetries in the Use of Supplementary Food by the Endangered Iberian Lynx (Lynx pardinus)	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; ANNUAL FECUNDITY; MANAGEMENT; DISPERSAL; DONANA; CONSERVATION; INDIVIDUALS; POPULATION; ABUNDANCE; PATTERNS	Background: As a conservation tool, supplementary feeding programs may be directed to specific individuals or sectors of the target population whose productivity or survival is thought to be limited by food scarcity. However, the use of supplemental food by different sex and age classes has received little attention. We studied individual variation in the access of the endangered Iberian lynx (Lynx pardinus) to supplementary food. Methodology/Principal Findings: From 5349 pictures taken with automatic cameras placed in 25 feeding stations, we identified 28 individuals whose sex and age were known. All individuals known to live in areas subjected to supplementation regularly visited feeding stations. Food consumption was not proportional to expected variations in energy demand within sex and age classes. Food consumption by males was higher than by females, and increased with age, in agreement with a despotic distribution. Food consumption also increased with lynx body mass, and this pattern held for individuals sharing the same breeding territories. The access of inferior competitors increased with the number of feeding stations available within lynx territories. Conclusions/Significance: All lynx exposed to food supplementation made a regular use of extra food but individuals predicted to be competitively dominant visited stations more frequently than subordinates of the same breeding territory. Our results suggest that insufficient provision of supplementary food could restrict the access of juveniles, or even adult females, to feeding stations. Limited consumption by these target individuals may compromise the efficiency of the supplementary feeding programme at the population level, in endangered species that, as the Iberian lynx, exhibit marked sexual dimorphism in body size.			Lopez-Bao, JV (corresponding author), CSIC, Dept Conservat Biol, Estac Biol Donana, E-41080 Seville, Spain.	jvlb@ebd.csic.es	Rodríguez, Alejandro/E-7709-2011; Palomares, Francisco/F-5327-2016	Rodríguez, Alejandro/0000-0001-9367-3420; Palomares, Francisco/0000-0002-4655-7205; Lopez-Bao, Jose Vicente/0000-0001-9213-998X				ALDAMA JJ, 1991, J WILDLIFE MANAGE, V55, P635, DOI 10.2307/3809512; BEKOFF M, 1977, AM NAT, V111, P715, DOI 10.1086/283201; BELTRAN JF, 1993, J MAMMAL, V74, P852, DOI 10.2307/1382423; Boland CRJ, 1997, J ANIM ECOL, V66, P683, DOI 10.2307/5921; Bose M, 2007, IBIS, V149, P490, DOI 10.1111/j.1474-919X.2007.00674.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; DELIBES M, 2000, NATURE ENV SERIES, V111, P44; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Elliott GP, 2001, BIOL CONSERV, V99, P121, DOI 10.1016/S0006-3207(00)00191-9; Fernandez N, 2002, J ZOOL, V258, P1, DOI 10.1017/S0952836902001140; Ferreras P, 2004, BEHAV ECOL, V15, P31, DOI 10.1093/beheco/arg097; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; FERRERAS P, 2009, BIOL CONSERVATION WI; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Galindo-Leal C, 1998, J MAMMAL, V79, P1131, DOI 10.2307/1383004; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Gosling L.M., 2000, BEHAV CONSERVATION, P438; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; Lopez-Bao JV, 2008, BIOL CONSERV, V141, P1857, DOI 10.1016/j.biocon.2008.05.002; Meretsky VJ, 1999, J WILDLIFE MANAGE, V63, P107, DOI 10.2307/3802491; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; MORENO S, 1995, BIOL CONSERV, V73, P81, DOI 10.1016/0006-3207(94)00106-Z; Moreno S, 2007, WILDLIFE RES, V34, P652, DOI 10.1071/WR06142; Murray DL, 2002, J ANIM ECOL, V71, P614, DOI 10.1046/j.1365-2656.2002.00632.x; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Palomares F, 2001, J APPL ECOL, V38, P9, DOI 10.1046/j.1365-2664.2001.00565.x; Palomares F, 2001, WILDLIFE MONOGR, P1; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Partridge ST, 2001, J WILDLIFE MANAGE, V65, P191, DOI 10.2307/3802897; Phillips M.K., 1988, Conservation Biology, V2, P139, DOI 10.1111/j.1523-1739.1988.tb00164.x; Preston KL, 2006, ECOLOGY, V87, P160, DOI 10.1890/05-0344; RANDALL B, 1987, BEHAVIOUR, V101, P225; REVILLA E, 2007, PROYECTOS INVESTIGAC, P307; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Rodgers AR., 1998, HRE HOME RANGE EXTEN; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SANDELL M, 1989, CARNIVORE BEHAV ECOL, V1, P164; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009	43	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7610	10.1371/journal.pone.0007610	http://dx.doi.org/10.1371/journal.pone.0007610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19898611	Green Published, Green Submitted, gold			2022-12-27	WOS:000271194600010
J	Salemi, M; Lamers, SL; Huysentruyt, LC; Galligan, D; Gray, RR; Morris, A; McGrath, MS				Salemi, Marco; Lamers, Susanna L.; Huysentruyt, Leanne C.; Galligan, Derek; Gray, Rebecca R.; Morris, Alanna; McGrath, Michael S.			Distinct Patterns of HIV-1 Evolution within Metastatic Tissues in Patients with Non-Hodgkins Lymphoma	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; MAXIMUM-LIKELIHOOD; AIDS; MACROPHAGES; INFERENCE; COMMON; CELLS; IDENTIFICATION; RECOMBINATION; PHYLOGENIES	Despite highly active antiretroviral therapy (HAART), AIDS related lymphoma (ARL) occurs at a significantly higher rate in patients infected with the Human Immunodeficiency Virus (HIV) than in the general population. HIV-infected macrophages are a known viral reservoir and have been shown to have lymphomagenic potential in SCID mice; therefore, there is an interest in determining if a viral component to lymphomagenesis also exists. We sequenced HIV-1 envelope gp120 clones obtained post mortem from several tumor and non-tumor tissues of two patients who died with AIDS-related Non-Hodgkin's lymphoma (ARL-NH). Similar results were found in both patients: 1) high-resolution phylogenetic analysis showed a significant degree of compartmentalization between lymphoma and non-lymphoma viral sub-populations while viral sub-populations from lymph nodes appeared to be intermixed within sequences from tumor and non-tumor tissues, 2) a 100-fold increase in the effective HIV population size in tumor versus non-tumor tissues was associated with the emergence of lymphadenopathy and aggressive metastatic ARL, and 3) HIV gene flow among lymph nodes, normal and metastatic tissues was non-random. The different population dynamics between the viruses found in tumors versus the non-tumor associated viruses suggest that there is a significant relationship between HIV evolution and lymphoma pathogenesis. Moreover, the study indicates that HIV could be used as an effective marker to study the origin and dissemination of lymphomas in vivo.	[Salemi, Marco; Gray, Rebecca R.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Lamers, Susanna L.] BioInfoExperts, Thibodaux, LA USA; [Huysentruyt, Leanne C.; Galligan, Derek; Morris, Alanna; McGrath, Michael S.] Univ Calif San Francisco, Dept Med Hematol & Oncol, San Francisco, CA 94143 USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu; mmcgrath@php.ucsf.edu			Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; NIH [U01 CA096230-06, U01 CA066529-14];  [NS063897];  [AI065265];  [CA09126]; NATIONAL CANCER INSTITUTE [U01CA096230, U01CA066529, T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063897] Funding Source: NIH RePORTER	Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. S. research is supported in part by PHS R01 awards NS063897 and AI065265, the Laura McClamma Fellowship, the Center for Research in Pediatric Immune Deficiency and Stephany W. Holloway University Chair for AIDS Research. R.R.G. is supported by a T32 award CA09126. S.L.L., L.C.H, D.G, A.M. and M. S. M are supported from NIH grants U01 CA096230-06 and U01 CA066529-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay LR, 2007, CLIN LYMPHOMA MYELOM, V7, P272, DOI 10.3816/CLM.2007.n.002; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Gibson J. D., 1997, NUCL ACIDS RES, V25, P4876; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grogg KL, 2007, J CLIN PATHOL, V60, P1365, DOI 10.1136/jcp.2007.051953; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HERNDIER BG, 1994, AIDS, V8, P1025, DOI 10.1097/00002030-199408000-00003; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kelley T, 2007, LEUKEMIA LYMPHOMA, V48, P2403, DOI 10.1080/10428190701665954; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; Maddison W. P., 2003, MACCLADE VERSION 4 A; MCGRATH MS, 1995, J ACQ IMMUN DEF SYND, V8, P379; Navarro WH, 2006, BLOOD, V107, P13, DOI 10.1182/blood-2004-11-4278; Ng VL, 1998, IMMUNOL REV, V162, P293, DOI 10.1111/j.1600-065X.1998.tb01449.x; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Pybus OG, 2000, GENETICS, V155, P1429; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; SHIRAMIZU B, 1997, J ACQUIR IMMUNE DEFI, V14; SLATKIN M, 1989, GENETICS, V123, P603; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford DL, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P267; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zenger E, 2002, CANCER RES, V62, P5536	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8153	10.1371/journal.pone.0008153	http://dx.doi.org/10.1371/journal.pone.0008153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997510	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829000011
J	Alchanati, I; Teicher, C; Cohen, G; Shemesh, V; Barr, HM; Nakache, P; Ben-Avraham, D; Idelevich, A; Angel, I; Livnah, N; Tuvia, S; Reiss, Y; Taglicht, D; Erez, O				Alchanati, Iris; Teicher, Carmit; Cohen, Galit; Shemesh, Vivian; Barr, Haim M.; Nakache, Philippe; Ben-Avraham, Danny; Idelevich, Anna; Angel, Itzchak; Livnah, Nurit; Tuvia, Shmuel; Reiss, Yuval; Taglicht, Daniel; Erez, Omri			The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2 alpha Cleavage Complex - A Potentially New Drug Target	PLOS ONE			English	Article							POLYCOMB-GROUP PROTEINS; TOPOISOMERASE-II-ALPHA; HEMATOPOIETIC STEM-CELLS; MYC TRANSGENIC MICE; H2A UBIQUITYLATION; SELF-RENEWAL; CANCER-CELLS; IN-VITRO; DNA; BMI-1	Background: The topoisomerases Top1, Top2 alpha and Top2 beta are important molecular targets for antitumor drugs, which specifically poison Top1 or Top2 isomers. While it was previously demonstrated that poisoned Top1 and Top2 beta are subject to proteasomal degradation, this phenomena was not demonstrated for Top2 alpha. Methodology/Principal Findings: We show here that Top2 alpha is subject to drug induced proteasomal degradation as well, although at a lower rate than Top2 beta. Using an siRNA screen we identified Bmi1 and Ring1A as subunits of an E3 ubiquitin ligase involved in this process. We show that silencing of Bmi1 inhibits drug-induced Top2 alpha degradation, increases the persistence of Top2 alpha-DNA cleavage complex, and increases Top2 drug efficacy. The Bmi1/Ring1A ligase ubiquitinates Top2 alpha in-vitro and cellular overexpression of Bmi1 increases drug induced Top2a ubiquitination. A small-molecular weight compound, identified in a screen for inhibitors of Bmi1/Ring1A ubiquitination activity, also prevents Top2 alpha ubiquitination and drug-induced Top2 alpha degradation. This ubiquitination inhibitor increases the efficacy of topoisomerase 2 poisons in a synergistic manner. Conclusions/Significance: The discovery that poisoned Top2 alpha is undergoing proteasomal degradation combined with the involvement of Bmi1/Ring1A, allowed us to identify a small molecule that inhibits the degradation process. The Bmi1/Ring1A inhibitor sensitizes cells to Top2 drugs, suggesting that this type of drug combination will have a beneficial therapeutic outcome. As Bmi1 is also a known oncogene, elevated in numerous types of cancer, the identified Bmi1/Ring1A ubiquitin ligase inhibitors can also be potentially used to directly target the oncogenic properties of Bmi1.	[Alchanati, Iris; Teicher, Carmit; Cohen, Galit; Shemesh, Vivian; Barr, Haim M.; Nakache, Philippe; Ben-Avraham, Danny; Idelevich, Anna; Angel, Itzchak; Livnah, Nurit; Tuvia, Shmuel; Reiss, Yuval; Taglicht, Daniel; Erez, Omri] Proteologics Ltd, Rehovot, Israel		Alchanati, I (corresponding author), Proteologics Ltd, Rehovot, Israel.	omri@proteologics.com	Ben-Avraham, Dan/H-2971-2013		Proteologics Ltd (PRL)	Proteologics Ltd (PRL)	Proteologics Ltd (PRL) provided funding for this research, and employed all authors for this manuscript. PRL therefore played a role in study design, data collection and analysis, decision to publish, and preparation and approval of the manuscript. PRL gave permission and full support for the publication this manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Bandele OJ, 2008, BIOCHEMISTRY-US, V47, P11900, DOI 10.1021/bi800981j; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brown JM, 1999, CANCER RES, V59, P5863; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Holden Joseph A., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P1, DOI 10.2174/1568011013354859; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kim HD, 1999, J CELL PHYSIOL, V180, P97, DOI 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nayak MS, 2007, CANCER RES, V67, P5831, DOI 10.1158/0008-5472.CAN-06-4533; Ogiso Y, 2000, CANCER RES, V60, P2429; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Shinagawa H, 2008, ANTIOXID REDOX SIGN, V10, P939, DOI 10.1089/ars.2007.1851; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Xiao H, 2005, ONCOGENE, V24, P8105, DOI 10.1038/sj.onc.1208958; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Yun J, 1995, ONCOL RES, V7, P583; Yun JS, 2004, J BIOL CHEM, V279, P31296, DOI 10.1074/jbc.M401411200; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	46	58	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8104	10.1371/journal.pone.0008104	http://dx.doi.org/10.1371/journal.pone.0008104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956605	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828700016
J	Zhang, J; Niyogi, P; McPeek, MS				Zhang, Jun; Niyogi, Partha; McPeek, Mary Sara			Laplacian Eigenfunctions Learn Population Structure	PLOS ONE			English	Article							GENETIC ASSOCIATION; COMPLEX TRAITS; STRATIFICATION; MODEL	Principal components analysis has been used for decades to summarize genetic variation across geographic regions and to infer population migration history. More recently, with the advent of genome-wide association studies of complex traits, it has become a commonly-used tool for detection and correction of confounding due to population structure. However, principal components are generally sensitive to outliers. Recently there has also been concern about its interpretation. Motivated from geometric learning, we describe a method based on spectral graph theory. Regarding each study subject as a node with suitably defined weights for its edges to close neighbors, one can form a weighted graph. We suggest using the spectrum of the associated graph Laplacian operator, namely, Laplacian eigenfunctions, to infer population structure. In simulations and real data on a ring species of birds, Laplacian eigenfunctions reveal more meaningful and less noisy structure of the underlying population, compared with principal components. The proposed approach is simple and computationally fast. It is expected to become a promising and basic method for population genetics and disease association studies.	[Zhang, Jun] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Niyogi, Partha; McPeek, Mary Sara] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Niyogi, Partha] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [McPeek, Mary Sara] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Zhang, J (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	junzhang@galton.uchicago.edu	zhang, jun/B-5061-2012		NIH [R01 HG001645]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support from NIH grant R01 HG001645 (to M.S.M.) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; CAVALLISFORZA L, GENETICS TODAY, V3; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chung F., 1997, SPECTRAL GRAPH THEOR; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Felsenstein J., 2002, MODERN DEV THEORETIC, P118; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEE A, 2009, GENETIC EPIDEMIOLOGY, V33; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Rosenberg S., 1997, LONDON MATH SOC STUD, DOI DOI 10.1017/CBO9780511623783; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; ZHANG J, 2009, BMC P IN PRESS; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7928	10.1371/journal.pone.0007928	http://dx.doi.org/10.1371/journal.pone.0007928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956572	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828700001
J	Agarwal, R; Mori, Y; Cheng, YL; Jin, Z; Olaru, AV; Hamilton, JP; David, S; Selaru, FM; Yang, J; Abraham, JM; Montgomery, E; Morin, PJ; Meltzer, SJ				Agarwal, Rachana; Mori, Yuriko; Cheng, Yulan; Jin, Zhe; Olaru, Alexandru V.; Hamilton, James P.; David, Stefan; Selaru, Florin M.; Yang, Jian; Abraham, John M.; Montgomery, Elizabeth; Morin, Patrice J.; Meltzer, Stephen J.			Silencing of Claudin-11 Is Associated with Increased Invasiveness of Gastric Cancer Cells	PLOS ONE			English	Article							TIGHT JUNCTION; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; DOWN-REGULATION; HMLH1 PROMOTER; GENE PROMOTER; EXPRESSION; CARCINOMA; PROTEIN; HYPERMETHYLATION	Background: Claudins are membrane proteins that play critical roles in tight junction (TJ) formation and function. Members of the claudin gene family have been demonstrated to be aberrantly regulated, and to participate in the pathogenesis of various human cancers. In the present study, we report that claudin-11 (CLDN11) is silenced in gastric cancer via hypermethylation of its promoter region. Methodology/Principal Findings: Levels of CLDN11 methylation and mRNA expression were measured in primary gastric cancer tissues, noncancerous gastric mucosae, and cell lines of gastric origin using quantitative methylation-specific PCR (qMSP) and quantitative reverse transcriptase-PCR (qRT-PCR), respectively. Analyses of paired gastric cancers and adjacent normal gastric tissues revealed hypermethylation of the CLDN11 promoter region in gastric cancers, and this hypermethylation was significantly correlated with downregulation of CLDN11 expression vs. normal tissues. The CLDN11 promoter region was also hypermethylated in all gastric cancer cell lines tested relative to immortalized normal gastric epithelial cells. Moreover, CLDN11 mRNA expression was inversely correlated with its methylation level. Treatment of CLDN11-nonexpressing gastric cancer cells with 5-aza-29-deoxycytidine restored CLDN11 expression. Moreover, siRNA-mediated knockdown of CLDN11 expression in normal gastric epithelial cells increased their motility and invasiveness. Conclusions/Significance: These data suggest that hypermethylation of CLDN11, leading to downregulated expression, contributes to gastric carcinogenesis by increasing cellular motility and invasiveness. A further understanding of the mechanisms underlying the role of claudin proteins in gastric carcinogenesis will likely help in the identification of novel approaches for diagnosis and therapy of gastric cancer.	[Agarwal, Rachana; Mori, Yuriko; Cheng, Yulan; Jin, Zhe; Olaru, Alexandru V.; Hamilton, James P.; David, Stefan; Selaru, Florin M.; Yang, Jian; Abraham, John M.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Montgomery, Elizabeth] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Morin, Patrice J.] NIA, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Agarwal, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	ragarwa9@jhmi.edu		Selaru, Florin/0000-0001-7990-8238	United States National Institutes of Health [CA085069, CA138677, CA146799]; NATIONAL CANCER INSTITUTE [R01CA146799, U01CA085069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000395] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States National Institutes of Health grants CA085069, CA138677 and CA146799 to SJ Meltzer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772; Cunningham SC, 2006, CANCER EPIDEM BIOMAR, V15, P281, DOI 10.1158/1055-9965.EPI-05-0539; David S, 2009, BIOCHEM BIOPH RES CO, V378, P605, DOI 10.1016/j.bbrc.2008.11.078; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; FINK C, 2009, HISTOCHEM CELL BIOL; Fleisher AS, 1999, CANCER RES, V59, P1090; Fukudome Y, 2000, INT J CANCER, V88, P579, DOI 10.1002/1097-0215(20001115)88:4<579::AID-IJC10>3.0.CO;2-U; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang GH, 1999, LAB INVEST, V79, P903; Katoh M, 2003, INT J MOL MED, V11, P683; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Lee YY, 1997, CANCER, V80, P1889, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1889::AID-CNCR3>3.0.CO;2-J; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Leung SY, 1999, CANCER RES, V59, P159; Lui WY, 2007, J CELL PHYSIOL, V211, P638, DOI 10.1002/jcp.20970; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Michl P, 2003, CANCER RES, V63, P6265; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Mullin JM, 1997, J EXP ZOOL, V279, P484, DOI 10.1002/(SICI)1097-010X(19971201)279:5<484::AID-JEZ11>3.0.CO;2-8; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; RHYU MG, 1994, ONCOGENE, V9, P29; Sanada Y, 2006, J PATHOL, V208, P633, DOI 10.1002/path.1922; Schmutte C, 1997, CANCER RES, V57, P3010; Suzuki H, 1999, INT J CANCER, V83, P309, DOI 10.1002/(SICI)1097-0215(19991029)83:3<309::AID-IJC4>3.0.CO;2-Z; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; TAMURA G, 1995, CANCER RES, V55, P1933; Toyota M, 1999, CANCER RES, V59, P5438; Weinstein R S, 1976, Adv Cancer Res, V23, P23, DOI 10.1016/S0065-230X(08)60543-6; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	40	75	81	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8002	10.1371/journal.pone.0008002	http://dx.doi.org/10.1371/journal.pone.0008002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956721	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500027
J	Launay, JM; Del Pino, M; Chironi, G; Callebert, J; Peoc'h, K; Megnien, JL; Mallet, J; Simon, A; Rendu, F				Launay, Jean-Marie; Del Pino, Muriel; Chironi, Gilles; Callebert, Jacques; Peoc'h, Katell; Megnien, Jean-Louis; Mallet, Jacques; Simon, Alain; Rendu, Francine			Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LUNG-CANCER; CARDIOVASCULAR-DISEASE; PROMOTER METHYLATION; SUSCEPTIBILITY LOCUS; HABITUAL SMOKERS; DNA METHYLATION; HEAVY SMOKERS; B ACTIVITY; TOBACCO	Background: Postulating that serotonin (5-HT), released from smoking-activated platelets could be involved in smoking-induced vascular modifications, we studied its catabolism in a series of 115 men distributed as current smokers (S), never smokers (NS) and former smokers (FS) who had stopped smoking for a mean of 13 years. Methodology/Principal Findings: 5-HT, monoamine oxidase (MAO-B) activities and amounts were measured in platelets, and 5-hydroxyindolacetic acid (5-HIAA)-the 5-HT/MAO catabolite-in plasma samples. Both platelet 5-HT and plasma 5-HIAA levels were correlated with the 10-year cardiovascular Framingham relative risk (P<0.01), but these correlations became non-significant after adjustment for smoking status, underlining that the determining risk factor among those taken into account in the Framingham risk calculation was smoking. Surprisingly, the platelet 5-HT content was similar in S and NS but lower in FS with a parallel higher plasma level of 5-HIAA in FS. This was unforeseen since MAO-B activity was inhibited during smoking (P<0.00001). It was, however, consistent with a higher enzyme protein concentration found in S and FS than in NS (P<0.001). It thus appears that MAO inhibition during smoking was compensated by a higher synthesis. To investigate the persistent increase in MAO-B protein concentration, a study of the methylation of its gene promoter was undertaken in a small supplementary cohort of similar subjects. We found that the methylation frequency of the MAOB gene promoter was markedly lower (P<0.0001) for S and FS vs. NS due to cigarette smoke-induced increase of nucleic acid demethylase activity. Conclusions/Significance: This is one of the first reports that smoking induces an epigenetic modification. A better understanding of the epigenome may help to further elucidate the physiopathology and the development of new therapeutic approaches to tobacco addiction. The results could have a larger impact than cardiovascular damage, considering that MAO-dependent 5-HT catabolism is also involved in addiction, predisposition to cancer, behaviour and mental health.	[Launay, Jean-Marie; Callebert, Jacques; Peoc'h, Katell] Univ Paris 05, Hop Lariboisiere, AP HP,Fac Pharm, Serv Biochim & Biol Mol Equipe Associee EA 3621, Paris, France; [Del Pino, Muriel; Chironi, Gilles; Megnien, Jean-Louis; Simon, Alain; Rendu, Francine] Univ Paris 06, CNRS, UMR 7131, Hop Broussais, Paris, France; [Chironi, Gilles; Megnien, Jean-Louis; Simon, Alain] Hop Europeen Georges Pompidou Broussais, AP HP, Ctr Med Prevent Cardiovasc, Paris, France; [Mallet, Jacques] UPMC, CNRS, Hop La Pitie Salpetriere,UMR 7091, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, Paris, France; [Rendu, Francine] INSERM, Fac Med Pitie Salpetriere, UMRS Inserm 956, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Launay, JM (corresponding author), Univ Paris 05, Hop Lariboisiere, AP HP,Fac Pharm, Serv Biochim & Biol Mol Equipe Associee EA 3621, Paris, France.	francine.rendu@upmc.fr	callebert, jacques/L-4569-2017; Peoc'h, Katell/V-1604-2017	Peoc'h, Katell/0000-0002-8203-1243	CNRS; ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This work was supported by grants from the CNRS and the ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baryshnikova E, 2008, CLIN CANCER RES, V14, P1913, DOI 10.1158/1078-0432.CCR-07-1741; Berggren U, 2007, ALCOHOL ALCOHOLISM, V42, P267, DOI 10.1093/alcalc/agm031; BERLIN I, 1995, BIOL PSYCHIAT, V38, P756, DOI 10.1016/0006-3223(95)00084-4; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; Carney RM, 2007, AM J PSYCHIAT, V164, P1307, DOI 10.1176/appi.ajp.2007.07071053; CESURA AM, 1987, J NEUROCHEM, V48, P170, DOI 10.1111/j.1471-4159.1987.tb13143.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Fowler JS, 2000, AM J PSYCHIAT, V157, P1864, DOI 10.1176/appi.ajp.157.11.1864; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Fowler JS, 2003, P NATL ACAD SCI USA, V100, P11600, DOI 10.1073/pnas.1833106100; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fusegawa Y, 1999, THROMB RES, V93, P271, DOI 10.1016/S0049-3848(98)00184-4; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Gilbert DG, 2003, NICOTINE TOB RES, V5, P813, DOI 10.1080/14622200310001614575; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Lewis A, 2007, NEUROTOXICOLOGY, V28, P182, DOI 10.1016/j.neuro.2006.05.019; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Nair S, 2001, PLATELETS, V12, P20, DOI 10.1080/09537100120046020; ORELAND L, 1981, LIFE SCI, V29, P2511, DOI 10.1016/0024-3205(81)90706-2; Page IH., 1968, Serotonin; Pernerstorfer T, 1998, BRIT J HAEMATOL, V102, P1229; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Rommelspacher H, 2002, EUR J PHARMACOL, V441, P115, DOI 10.1016/S0014-2999(02)01452-8; Rybaczyk LA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-134; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Schwartz K, 2005, EUR NEUROPSYCHOPHARM, V15, P235, DOI 10.1016/j.euroneuro.2004.11.001; Serebruany VL, 2001, AM J CARDIOL, V87, P1398, DOI 10.1016/S0002-9149(01)01562-4; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; SIMON A, 1995, CIRCULATION, V92, P1114; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Takajo Y, 2001, J AM COLL CARDIOL, V38, P1320, DOI 10.1016/S0735-1097(01)01583-2; Talhout R, 2007, EUR NEUROPSYCHOPHARM, V17, P627, DOI 10.1016/j.euroneuro.2007.02.013; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Van Tiel ED, 2002, ANN EPIDEMIOL, V12, P378, DOI 10.1016/S1047-2797(01)00282-4; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Witschi H, 2002, TOXICOL SCI, V68, P322, DOI 10.1093/toxsci/68.2.322; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717	53	104	108	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7959	10.1371/journal.pone.0007959	http://dx.doi.org/10.1371/journal.pone.0007959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956754	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827300016
J	Meda, SA; Stevens, MC; Folley, BS; Calhoun, VD; Pearlson, GD				Meda, Shashwath A.; Stevens, Michael C.; Folley, Bradley S.; Calhoun, Vince D.; Pearlson, Godfrey D.			Evidence for Anomalous Network Connectivity during Working Memory Encoding in Schizophrenia: An ICA Based Analysis	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; 1ST-DEGREE RELATIVES; BASAL GANGLIA; NEURAL BASIS; FMRI; ACTIVATION; ENDOPHENOTYPE; RECOGNITION; MAINTENANCE	Background: Numerous neuroimaging studies report abnormal regional brain activity during working memory performance in schizophrenia, but few have examined brain network integration as determined by "functional connectivity" analyses. Methodology/Principal Findings: We used independent component analysis (ICA) to identify and characterize dysfunctional spatiotemporal networks in schizophrenia engaged during the different stages (encoding and recognition) of a Sternberg working memory fMRI paradigm. 37 chronic schizophrenia and 54 healthy age/gender-matched participants performed a modified Sternberg Item Recognition fMRI task. Time series images preprocessed with SPM2 were analyzed using ICA. Schizophrenia patients showed relatively less engagement of several distinct "normal" encoding-related working memory networks compared to controls. These encoding networks comprised 1) left posterior parietal-left dorsal/ventrolateral prefrontal cortex, cingulate, basal ganglia, 2) right posterior parietal, right dorsolateral prefrontal cortex and 3) default mode network. In addition, the left fronto-parietal network demonstrated a load-dependent functional response during encoding. Network engagement that differed between groups during recognition comprised the posterior cingulate, cuneus and hippocampus/parahippocampus. As expected, working memory task accuracy differed between groups (p < 0.0001) and was associated with degree of network engagement. Functional connectivity within all three encoding-associated functional networks correlated significantly with task accuracy, which further underscores the relevance of abnormal network integration to well-described schizophrenia working memory impairment. No network was significantly associated with task accuracy during the recognition phase. Conclusions/Significance: This study extends the results of numerous previous schizophrenia studies that identified isolated dysfunctional brain regions by providing evidence of disrupted schizophrenia functional connectivity using ICA within widely-distributed neural networks engaged for working memory cognition.			Meda, SA (corresponding author), Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.	smeda01@harthosp.org	Stevens, Michael C/M-7678-2017; Calhoun, Vince D./ACN-9399-2022	Stevens, Michael C/0000-0002-3799-5465; Calhoun, Vince D./0000-0001-9058-0747	NIBIB NIH HHS [1R01EB000840, R01 EB000840] Funding Source: Medline; NIMH NIH HHS [R01 MH052886, MH60504, R01 MH060504, L30 MH081244-01, MH52886, R37 MH043775, L30 MH081244, MH43775, R01 MH043775] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052886, R37MH043775, R01MH060504, R01MH043775] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2007, J NEUROSCI, V27, P3429, DOI 10.1523/JNEUROSCI.4273-06.2007; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; CALHOUN VD, 2008, NEUROIMAGE; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Das P, 2007, SCHIZOPHR RES, V90, P284, DOI 10.1016/j.schres.2006.11.023; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; First MB, 2002, PSYCHOPATHOLOGY, V35, P67, DOI 10.1159/000065121; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Gruber O, 2006, NEUROSCI LETT, V405, P24, DOI 10.1016/j.neulet.2006.06.062; Haenschel C, 2007, ARCH GEN PSYCHIAT, V64, P1229, DOI 10.1001/archpsyc.64.11.1229; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Jessen F, 2003, AM J PSYCHIAT, V160, P1305, DOI 10.1176/appi.ajp.160.7.1305; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Quintana J, 2003, BIOL PSYCHIAT, V53, P12, DOI 10.1016/S0006-3223(02)01435-X; Ragland JD, 2001, AM J PSYCHIAT, V158, P1114, DOI 10.1176/appi.ajp.158.7.1114; Scheibel RS, 2004, CORTEX, V40, P218, DOI 10.1016/S0010-9452(08)70957-2; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stephan KE, 2001, PSYCHOL MED, V31, P1065, DOI 10.1017/S0033291701004330; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; STEVENS MC, 2007, HUM BRAIN MAPP; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wexler BE, 1998, ARCH GEN PSYCHIAT, V55, P1093, DOI 10.1001/archpsyc.55.12.1093; White T, 2022, HUM BRAIN MAPP, V43, P278, DOI 10.1002/hbm.25120; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward TS, 2006, NEUROSCIENCE, V139, P317, DOI 10.1016/j.neuroscience.2005.05.043; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	43	89	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7911	10.1371/journal.pone.0007911	http://dx.doi.org/10.1371/journal.pone.0007911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NJ	19936244	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004600015
J	Garcia-Pichel, F; Wojciechowski, MF				Garcia-Pichel, Ferran; Wojciechowski, Martin F.			The Evolution of a Capacity to Build Supra-Cellular Ropes Enabled Filamentous Cyanobacteria to Colonize Highly Erodible Substrates	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; STABILIZATION	Background: Several motile, filamentous cyanobacteria display the ability to self-assemble into tightly woven or twisted groups of filaments that form macroscopic yarns or ropes, and that are often centimeters long and 50-200 mu m in diameter. Traditionally, this trait has been the basis for taxonomic definition of several genera, notably Microcoleus and Hydrocoleum, but the trait has not been associated with any plausible function. Method and Findings: Through the use of phylogenetic reconstruction, we demonstrate that pedigreed, rope-building cyanobacteria from various habitats do not form a monophyletic group. This is consistent with the hypothesis that rope-building ability was fixed independently in several discrete clades, likely through processes of convergent evolution or lateral transfer. Because rope-building cyanobacteria share the ability to colonize geologically unstable sedimentary substrates, such as subtidal and intertidal marine sediments and non-vegetated soils, it is also likely that this supracellular differentiation capacity imparts a particular fitness advantage in such habitats. The physics of sediment and soil erosion in fact predict that threads in the 50-200 mu m size range will attain optimal characteristics to stabilize such substrates on contact. Conclusions: Rope building is a supracellular morphological adaptation in filamentous cyanobacteria that allows them to colonize physically unstable sedimentary environments, and to act as successful pioneers in the biostabilization process.			Garcia-Pichel, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ferran@asu.edu						Abed RMM, 2003, J PHYCOL, V39, P862, DOI 10.1046/j.1529-8817.2003.02180.x; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Castenholz RW, 1989, BERGEYS MANUAL SYSTE, V3, p[1771, 1780, 1794]; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; Garcia-Pichel F., 2002, ENCY ENV MICROBIOLOG, P1019; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; GarciaPichel F, 1996, SCI MAR, V60, P73; GARCIAPICHEL F, 2000, ENCY MICROBIOLOGY; Geitler L, 1932, CYANOPHYCEAE; GRANT J, 1987, NATURE, V330, P244, DOI 10.1038/330244a0; Greeley R., 1985, WIND GEOLOGICAL PROC, P333, DOI DOI 10.1017/CBO9780511573071; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; Lick W, 2004, J HYDRAUL ENG-ASCE, V130, P755, DOI 10.1061/(ASCE)0733-9429(2004)130:8(755); LIVINGSTONE I, 1996, AEOLIAN GEOMORPHOLOG, P221; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; LORNE J, 2006, FEMS MICROBIOLOGY LE, V189; McKenna H. A, 2004, HDB FIBER ROPE TECHN; Paterson DM, 1999, ADV ECOL RES, V29, P155; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WIEGESMUND MA, 2008, J PHYCOL, V44, P1572; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; YALLOP ML, 1994, ESTUAR COAST SHELF S, V39, P565, DOI 10.1016/S0272-7714(06)80010-7	30	108	112	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7801	10.1371/journal.pone.0007801	http://dx.doi.org/10.1371/journal.pone.0007801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924246	Green Submitted, Green Published, gold			2022-12-27	WOS:000271854200003
J	Shen, J; Ma, JP; Wang, QH				Shen, Jun; Ma, Jianpeng; Wang, Qinghua			Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918	PLOS ONE			English	Article							AMINO-ACID SITES; RECEPTOR-BINDING PROPERTIES; A H1N1 VIRUSES; DETECTING POSITIVE SELECTION; CODON-SUBSTITUTION MODELS; SWINE INFLUENZA; MAXIMUM-LIKELIHOOD; PANDEMIC INFLUENZA; UNITED-STATES; PHYLOGENETIC ANALYSIS	The Pandemic (H1N1) 2009 is spreading to numerous countries and causing many human deaths. Although the symptoms in humans are mild at present, fears are that further mutations in the virus could lead to a potentially more dangerous outbreak in subsequent months. As the primary immunity-eliciting antigen, hemagglutinin (HA) is the major agent for host-driven antigenic drift in A(H3N2) virus. However, whether and how the evolution of HA is influenced by existing immunity is poorly understood for A(H1N1). Here, by analyzing hundreds of A(H1N1) HA sequences since 1918, we show the first evidence that host selections are indeed present in A(H1N1) HAs. Among a subgroup of human A(H1N1) HAs between 1918 similar to 2008, we found strong diversifying (positive) selection at HA(1) 156 and 190. We also analyzed the evolutionary trends at HA(1) 190 and 225 that are critical determinants for receptor-binding specificity of A(H1N1) HA. Different A(H1N1) viruses appeared to favor one of these two sites in host-driven antigenic drift: epidemic A(H1N1) HAs favor HA(1) 190 while the 1918 pandemic and swine HAs favor HA(1) 225. Thus, our results highlight the urgency to understand the interplay between antigenic drift and receptor binding in HA evolution, and provide molecular signatures for monitoring future antigenically drifted 2009 pandemic and seasonal A(H1N1) influenza viruses.			Shen, J (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	jpma@bcm.tmc.edu; qinghuaw@bcm.tmc.edu			NIAID NIH HHS [R01 AI067839, R01-AI067839] Funding Source: Medline; NIGMS NIH HHS [R01-GM067801, R01 GM067801, R01 GM067801-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067801] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; COLLINS SD, 1951, PUBLIC HEALTH REP, V66, P1487, DOI 10.2307/4587915; DANIELS RS, 1984, VIROLOGY, V138, P174, DOI 10.1016/0042-6822(84)90158-2; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delport W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000242; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; DONATELLI I, 1991, J MED VIROL, V34, P248, DOI 10.1002/jmv.1890340410; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISAACS A, 1952, Bull World Health Organ, V6, P287; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; LOGAN W P D, 1951, Lancet, V1, P264; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; MUNSTER VJ, 2009, SCIENCE; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; Nielsen R, 1998, GENETICS, V148, P929; NOBUSAWA E, 1987, VIROLOGY, V159, P10, DOI 10.1016/0042-6822(87)90342-4; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RASMUSSEN AF, 1948, AM J HYG, V47, P142, DOI 10.1093/oxfordjournals.aje.a119191; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALK JE, 1949, AM J PUBLIC HEALTH, V39, P345; SARTWELL PE, 1948, AM J HYG, V47, P135, DOI 10.1093/oxfordjournals.aje.a119190; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Seoighe C, 2007, MOL BIOL EVOL, V24, P1025, DOI 10.1093/molbev/msm021; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shen J, 2009, J MED VIROL, V81, P114, DOI 10.1002/jmv.21335; Shi WF, 2008, SCI CHINA SER C, V51, P987, DOI 10.1007/s11427-008-0131-8; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1931, SCIENCE, V73, P214, DOI 10.1126/science.73.1886.214; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SOLOVYOV A, 2009, EURO SURVEILL, V14; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Viboud C, 2006, EMERG INFECT DIS, V12, P661, DOI 10.3201/eid1204.050695; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; XU XY, 1993, VIRUS RES, V28, P37; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; MMWR MORB MORTAL WKL, V58, P521	87	59	62	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7789	10.1371/journal.pone.0007789	http://dx.doi.org/10.1371/journal.pone.0007789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924230	Green Published, gold, Green Submitted			2022-12-27	WOS:000271854200002
J	Sousa, AGP; Marquezine, GF; Lemos, PA; Martinez, E; Lopes, N; Hueb, WA; Krieger, JE; Pereira, AC				Sousa, Andre Gustavo P.; Marquezine, Guilherme F.; Lemos, Pedro A.; Martinez, Eulogio; Lopes, Neuza; Hueb, Whady A.; Krieger, Jose E.; Pereira, Alexandre C.			TCF7L2 Polymorphism rs7903146 Is Associated with Coronary Artery Disease Severity and Mortality	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; CANCER RISK; MASS-II; POPULATION; VARIANT; HYPERGLYCEMIA; ANGIOPLASTY; MEDICINE; SURGERY	Background: TCF7L2 polymorphisms have been consistently associated with type 2 diabetes mellitus in different populations and type 2 diabetes mellitus is a major risk factor for cardiovascular disease, especially coronary artery disease. This study aimed to evaluate the association between TCF7L2 polymorphism rs7903146 and coronary artery disease in diabetic and non-diabetic subjects. Methods and Results: two populations were studied in order to assess severity of coronary artery disease and cardiovascular events incidence. Eight-hundred and eighty nine subjects who were referred for cardiac catheterization for coronary artery disease diagnosis were cross-sectionally evaluated for coronary lesions (atherosclerotic burden) and 559 subjects from the MASS-II Trial were prospectively followed-up for 5 years and assessed for major cardiovascular events incidence. As expected, rs7903146 T allele was associated with diabetes. Although diabetic patients had a higher prevalence of coronary lesions, no association between TCF7L2 genotype and coronary lesions was found in this subgroup. However, non-diabetic individuals carrying the T allele were associated with a significantly higher frequency of coronary lesions than non-diabetic non-carriers of the risk allele (adjusted OR = 2.32 95% CI 1.27-4.24, p = 0.006). Moreover, presence of multi-vessel coronary artery disease was also associated with the CT or TT genotypes in non-diabetics. Similarly, from the prospective sample analysis, non-diabetics carrying the CT/TT genotypes had significantly more composite cardiovascular end-points events than CC carriers (p = 0.049), mainly due to an increased incidence of death (p = 0.004). Conclusions: rs7903146 T allele is associated with diabetes and, in non-diabetic individuals, with a higher prevalence and severity of coronary artery disease and cardiovascular events. name of registry site (see list below), registration number, trial registration URL in brackets.			Sousa, AGP (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	lbmpereira@incor.usp.br	Lemos, Pedro A./G-5758-2013; Hueb, Whady/A-7919-2013; Krieger, Jose E/C-3117-2011; Pereira, Alexandre/HHN-1038-2022	Lemos, Pedro A./0000-0002-6782-750X; Hueb, Whady/0000-0002-3166-6054; Krieger, Jose E/0000-0001-5464-1792; 				Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; *IDF, 2004, INT DIAB FED DIAB AT; Lanz JR, 2005, CLIN CHIM ACTA, V362, P176, DOI 10.1016/j.cccn.2005.06.004; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marquezine GF, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-106; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Pereira AC, 2006, J AM COLL CARDIOL, V48, P948, DOI 10.1016/j.jacc.2005.11.094; Schettert IT, 2006, THROMB RES, V118, P679, DOI 10.1016/j.thromres.2005.11.009; Wajchenberg Bernardo Léo, 2007, Arq Bras Endocrinol Metab, V51, P212, DOI 10.1590/S0004-27302007000200010; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466	19	49	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7697	10.1371/journal.pone.0007697	http://dx.doi.org/10.1371/journal.pone.0007697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924244	Green Published, Green Submitted, gold			2022-12-27	WOS:000271854200001
J	de Vries, HS; Plantinga, TS; van Krieken, JH; Stienstra, R; van Bodegraven, AA; Festen, EAM; Weersma, RK; Crusius, JBA; Linskens, RK; Joosten, LAB; Netea, MG; de Jong, DJ				de Vries, Hilbert S.; Plantinga, Theo S.; van Krieken, J. Han; Stienstra, Rinke; van Bodegraven, Ad A.; Festen, Eleonora A. M.; Weersma, Rinse K.; Crusius, J. Bart A.; Linskens, Ronald K.; Joosten, Leo A. B.; Netea, Mihai G.; de Jong, Dirk J.			Genetic Association Analysis of the Functional c.714T > G Polymorphism and Mucosal Expression of Dectin-1 in Inflammatory Bowel Disease	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; CROHNS-DISEASE; ULCERATIVE-COLITIS; INNATE IMMUNITY; CARD9; CELLS; NOD2; INTERLEUKIN-17; PATHOGENESIS; RECOGNITION	Background: Dectin-1 is a pattern recognition receptor (PRR) expressed by myeloid cells that specifically recognizes beta-1,3 glucan, a polysaccharide and major component of the fungal cell wall. Upon activation, dectin-1 signaling converges, similar to NOD2, on the adaptor molecule CARD9 which is associated with inflammatory bowel disease (IBD). An early stop codon polymorphism (c.714T>G) in DECTIN-1 results in a loss-of-function (p.Y238X) and impaired cytokine responses, including TNF-alpha, interleukin (IL)-1 beta and IL-17 upon in vitro stimulation with Candida albicans or beta-glucan. The aim of the present study was to test the hypothesis that the DECTIN-1 c.714T>G (p.Y238X) polymorphism is associated with lower disease susceptibility or severity in IBD and to investigate the level of dectin-1 expression in inflamed and non-inflamed colon tissue of IBD patients. Methodology: Paraffin embedded tissue samples from non-inflamed and inflamed colon of IBD patients and from diverticulitis patients were immunohistochemically stained for dectin- 1 and related to CD68 macrophage staining. Genomic DNA of IBD patients (778 patients with Crohn's disease and 759 patients with ulcerative colitis) and healthy controls (n = 772) was genotyped for the c.714T>G polymorphism and genotype-phenotype interactions were investigated. Principal Findings: Increased expression of dectin- 1 was observed in actively inflamed colon tissue, as compared to non-inflamed tissue of the same patients. Also an increase in dectin- 1 expression was apparent in diverticulitis tissue. No statistically significant difference in DECTIN-1 c.714T>G allele frequencies was observed between IBD patients and healthy controls. Furthermore, no differences in clinical characteristics could be observed related to DECTIN-1 genotype, neither alone, nor stratified for NOD2 genotype. Conclusions: Our data demonstrate that dectin- 1 expression is elevated on macrophages, neutrophils, and other immune cells involved in the inflammatory reaction in IBD. The DECTIN-1 c.714T>G polymorphism however, is not a major susceptibility factor for developing IBD.			de Vries, HS (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands.	D.deJong@mdl.umcn.nl	van Krieken, Joannes H J M/D-4138-2009; van Bodegraven, Ad A/L-3180-2013; Netea, Mihai/N-5155-2014; Plantinga, Theo S./A-6895-2015; van Bodegraven, Ad/ABG-4367-2020; de Jong, D.J./L-4417-2015; Festen, Eleonora A.M./S-3557-2016; Joosten, Leo AB/H-3138-2015; Stienstra, Rinke/A-4763-2015; Weersma, Rinse/ABE-3807-2021	van Krieken, Joannes H J M/0000-0001-6544-1040; Plantinga, Theo S./0000-0003-4990-6084; Joosten, Leo AB/0000-0001-6166-9830; Stienstra, Rinke/0000-0001-6729-7193; de Vries, Hilbert/0000-0003-4058-6459; Festen, Eleonora/0000-0002-3255-6930				Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; FERWERDA B, NEW ENGLAND IN PRESS; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Oostenbrug LE, 2006, DIGEST LIVER DIS, V38, P834, DOI 10.1016/j.dld.2006.06.042; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; Russell RK, 2005, INFLAMM BOWEL DIS, V11, P955, DOI 10.1097/01.MIB.0000183423.38037.f3; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Underhill D, 2008, INFLAMM BOWEL DIS, V14, P1147, DOI 10.1002/ibd.20402; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	26	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7818	10.1371/journal.pone.0007818	http://dx.doi.org/10.1371/journal.pone.0007818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915667	Green Published, gold			2022-12-27	WOS:000271721400015
J	Ouattara, K; Lemasson, A; Zuberbuhler, K				Ouattara, Karim; Lemasson, Alban; Zuberbuehler, Klaus			Campbell's Monkeys Use Affixation to Alter Call Meaning	PLOS ONE			English	Article							ALARM CALL; CAROLINA CHICKADEES; CAPTIVE GROUP; DIANA; INFORMATION; SYSTEM; COMBINATIONS; LANGUAGE; PRIMATE; CONTEXT	Human language has evolved on a biological substrate with phylogenetic roots deep in the primate lineage. Here, we describe a functional analogy to a common morphological process in human speech, affixation, in the alarm calls of free-ranging adult Campbell's monkeys (Cercopithecus campbelli campbelli). We found that male alarm calls are composed of an acoustically variable stem, which can be followed by an acoustically invariable suffix. Using long-term observations and predator simulation experiments, we show that suffixation in this species functions to broaden the calls' meaning by transforming a highly specific eagle alarm to a general arboreal disturbance call or by transforming a highly specific leopard alarm call to a general alert call. We concluded that, when referring to specific external events, non-human primates can generate meaningful acoustic variation during call production that is functionally equivalent to suffixation in human language.	[Ouattara, Karim; Lemasson, Alban] Univ Rennes 1, Lab EthoS Ethol Anim & Humaine, UMR 6552, CNRS,Stn Biol, Paimpont, France; [Ouattara, Karim; Zuberbuehler, Klaus] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire; [Ouattara, Karim] Univ Cocody, Lab Zool & Biol Anim, Abidjan, Cote Ivoire; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of St Andrews	Ouattara, K (corresponding author), Univ Rennes 1, Lab EthoS Ethol Anim & Humaine, UMR 6552, CNRS,Stn Biol, Paimpont, France.	kz3@st-and.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X				Aitchison J., 2000, SEEDS SPEECH LANGUAG; Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2008, BEHAV ECOL SOCIOBIOL, V62, P549, DOI 10.1007/s00265-007-0479-y; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Arnold K, 2006, ANIM BEHAV, V72, P643, DOI 10.1016/j.anbehav.2005.11.017; Bourliere F, 1970, OLD WORLD MONKEYS EV, P297; CHOMSKY N, 1981, PHILOS T ROY SOC B, V295, P223, DOI 10.1098/rstb.1981.0135; Clarke E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000073; Clucas BA, 2004, BEHAV ECOL SOCIOBIOL, V57, P187, DOI 10.1007/s00265-004-0847-9; Freeberg TM, 2002, ANIM BEHAV, V63, P837, DOI 10.1006/anbe.2001.1981; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; Geissmann T, 2002, BIOL REV, V77, P57, DOI 10.1017/S1464793101005826; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Holland J, 2000, ANIM BEHAV, V60, P463, DOI 10.1006/anbe.2000.1529; Lemasson A, 2005, J COMP PSYCHOL, V119, P220, DOI 10.1037/0735-7036.119.2.220; Lemasson A, 2004, J COMP PSYCHOL, V118, P347, DOI 10.1037/0735-7036.118.3.347; Lemasson A, 2004, BIOACOUSTICS, V14, P111, DOI 10.1080/09524622.2004.9753518; Lemasson A, 2003, CR BIOL, V326, P1185, DOI 10.1016/j.crvi.2003.10.005; Lemasson A, 2006, AM J PRIMATOL, V68, P1161, DOI 10.1002/ajp.20315; Lieberman P., 1975, ORIGINS LANGUAGE; Marler P., 1977, RECOGNITION COMPLEX, P17; Masataka N., 2003, ONSET LANGUAGE; Oller D. K., 2008, EVOLUTION COMMUNICAT; Ouattara K, 2009, ANIM BEHAV, V78, P35, DOI 10.1016/j.anbehav.2009.03.014; Owren M. J., 2008, EVOLUTION COMMUNICAT, P169; Papworth S, 2008, BIOL LETTERS, V4, P472, DOI 10.1098/rsbl.2008.0299; Riede T, 2006, J HUM EVOL, V50, P222, DOI 10.1016/j.jhevol.2005.10.005; Riede T, 2005, J HUM EVOL, V48, P85, DOI 10.1016/j.jhevol.2004.10.002; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; Riede T, 2003, J ACOUST SOC AM, V113, P2919, DOI 10.1121/1.1567278; Schel AM, 2009, J COMP PSYCHOL, V123, P136, DOI 10.1037/a0014280; Snowdon C.T., 1997, SOCIAL INFLUENCES VO, DOI [10.1017/CBO9780511758843, DOI 10.1017/CBO9780511758843]; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Wolters S, 2003, BEHAVIOUR, V140, P371, DOI 10.1163/156853903321826684; Yip MJ, 2006, TRENDS COGN SCI, V10, P442, DOI 10.1016/j.tics.2006.08.001; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334	41	124	127	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7808	10.1371/journal.pone.0007808	http://dx.doi.org/10.1371/journal.pone.0007808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518UW	19915663	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721400009
J	Meredith, LW; Sivakumaran, H; Major, L; Suhrbier, A; Harrich, D				Meredith, Luke W.; Sivakumaran, Haran; Major, Lee; Suhrbier, Andreas; Harrich, David			Potent Inhibition of HIV-1 Replication by a Tat Mutant	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSDOMINANT NEGATIVE MUTANT; BETA-GALACTOSIDASE; GENE-EXPRESSION; BASIC DOMAIN; NUCLEOLAR LOCALIZATION; REVERSE TRANSCRIPTION; MUTATIONAL ANALYSIS; SENSITIVE METHOD; MAMMALIAN-CELLS	Herein we describe a mutant of the two-exon HIV-1 Tat protein, termed Nullbasic, that potently inhibits multiple steps of the HIV-1 replication cycle. Nullbasic was created by replacing the entire arginine-rich basic domain of wild type Tat with glycine/alanine residues. Like similarly mutated one-exon Tat mutants, Nullbasic exhibited transdominant negative effects on Tat-dependent transactivation. However, unlike previously reported mutants, we discovered that Nullbasic also strongly suppressed the expression of unspliced and singly-spliced viral mRNA, an activity likely caused by redistribution and thus functional inhibition of HIV-1 Rev. Furthermore, HIV-1 virion particles produced by cells expressing Nullbasic had severely reduced infectivity, a defect attributable to a reduced ability of the virions to undergo reverse transcription. Combination of these inhibitory effects on transactivation, Rev-dependent mRNA transport and reverse transcription meant that permissive cells constitutively expressing Nullbasic were highly resistant to a spreading infection by HIV-1. Nullbasic and its activities thus provide potential insights into the development of potent antiviral therapeutics that target multiple stages of HIV-1 infection.			Meredith, LW (corresponding author), Univ Birmingham, HCV Res Grp, Sch Immun & Infect, Birmingham, W Midlands, England.	David.Harrich@qimr.edu.au	; Harrich, David/H-6668-2016	Suhrbier, Andreas/0000-0001-8986-9025; Harrich, David/0000-0003-3690-0150; Sivakumaran, Haran/0000-0002-4691-4989; Meredith, Luke/0000-0002-3802-8290				Apolloni A, 2003, J VIROL, V77, P9912, DOI 10.1128/JVI.77.18.9912-9921.2003; Apolloni A, 2007, CURR HIV RES, V5, P474, DOI 10.2174/157016207781662443; ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; BALBONI PG, 1993, J MED VIROL, V41, P289, DOI 10.1002/jmv.1890410406; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caputo A, 1996, GENE THER, V3, P235; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DUNDR M, 1995, J CELL SCI, V108, P2811; ECHETEBU CO, 1994, J ACQ IMMUN DEF SYND, V7, P655; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Felber BK, 2007, ADV PHARMACOL, V55, P161, DOI 10.1016/S1054-3589(07)55005-2; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MODESTI N, 1991, NEW BIOL, V3, P759; Orsini MJ, 1996, J VIROL, V70, P8055, DOI 10.1128/JVI.70.11.8055-8063.1996; PEARSON L, 1990, P NATL ACAD SCI USA, V87, P5079, DOI 10.1073/pnas.87.13.5079; Rossi C, 1997, GENE THER, V4, P1261, DOI 10.1038/sj.gt.3300522; RUBEN S, 1989, J VIROL, V63, P1; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Smulevitch S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-6; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Truant R, 1999, MOL CELL BIOL, V19, P1210; Ulich C, 1996, J VIROL, V70, P4871, DOI 10.1128/JVI.70.7.4871-4876.1996; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7769	10.1371/journal.pone.0007769	http://dx.doi.org/10.1371/journal.pone.0007769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901984	gold, Green Published			2022-12-27	WOS:000271658800008
J	Ranjan, AK; Kumar, U; Hardikar, AA; Poddar, P; Nair, PD; Hardikar, AA				Ranjan, Amaresh K.; Kumar, Umesh; Hardikar, Ashutosh A.; Poddar, Pankaj; Nair, Prabha D.; Hardikar, Anandwardhan A.			Human Blood Vessel-Derived Endothelial Progenitors for Endothelialization of Small Diameter Vascular Prosthesis	PLOS ONE			English	Article							ARTERY-BYPASS SURGERY; PERCUTANEOUS CORONARY INTERVENTION; EXPANDED POLYTETRAFLUOROETHYLENE; THROMBUS GROWTH; DACRON GRAFTS; CELLS; PLATELET; DEPOSITION; COVERAGE; COLLAGEN	Background: Coronary bypass graft failure as a result of acute thrombosis and intimal hyperplasia has been the major challenge in surgical procedures involving small-diameter vascular prosthesis. Coating synthetic grafts with patients' own endothelial cells has been suggested to improve the patency rate and overall success of bypass surgeries. Methodology/Principal Findings: We isolated endothelial progenitor cells (EPCs) from leftover pieces of human saphenous vein/mammary artery. We demonstrate that EPCs can be expanded to generate millions of cells under low-density culture conditions. Exposure to high-density conditions induces differentiation to endothelial cell phenotype. EPC-derived endothelial cells show expression of CD144(high), CD31, and vWF. We then assessed the ability of differentiated endothelial cells to adhere and grow on small diameter expanded polytetrafluoroethylene (ePTFE) tubings. Since ePTFE tubings are highly hydrophobic, we optimized protocols to introduce hydrophilic groups on luminal surface of ePTFE tubings. We demonstrate here a stepwise protocol that involves introduction of hydrophilic moieties and coating with defined ECM components that support adhesion of endothelial cells, but not of blood platelets. Conclusion/Significance: Our data confirms that endothelial progenitors obtained from adult human blood vessels can be expanded in vitro under xenoprotein-free conditions, for potential use in endothelialization of small diameter ePTFE grafts. These endothelialized grafts may represent a promising treatment strategy for improving the clinical outcome of small-caliber vascular grafts in cardiac bypass surgeries.			Ranjan, AK (corresponding author), Natl Ctr Cell Sci, Stem Cells & Diabet Sect, Pune, Maharashtra, India.	anand@isletbiology.com	Hardikar, Ashutosh A/J-7638-2013; Poddar, Pankaj/G-5174-2010; Nair, Prabha/AAE-4517-2019; Kumar, Umesh/B-3737-2014; Hardikar, Anandwardhan/ACF-7730-2022; Ranjan, Amaresh/AAG-7664-2020	Hardikar, Ashutosh A/0000-0003-3558-6454; Poddar, Pankaj/0000-0002-2273-588X; Ranjan, Amaresh/0000-0002-2505-0552; Ranjan, Amaresh/0000-0001-7529-7409				Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224; Appoo J, 2004, CIRCULATION, V110, pII13, DOI 10.1161/01.CIR.0000128345.69540.ed; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AVCIADALI M, 2009, J TISSUE ENG REGEN M; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bevilacqua S, 2009, ANN THORAC SURG, V87, P496, DOI 10.1016/j.athoracsur.2008.05.038; BUJAN J, 1992, HISTOL HISTOPATHOL, V7, P635; BULL HA, 1988, BRIT J SURG, V75, P671, DOI 10.1002/bjs.1800750716; CAMPEAU L, 1975, CIRCULATION, V52, P369, DOI 10.1161/01.CIR.52.3.369; CARR HMH, 1992, ARTIF ORGANS, V16, P342; Cho JH, 2006, BLOOD, V108, P2229, DOI 10.1182/blood-2006-02-002063; Cikirikcioglu M, 2006, INT J ARTIF ORGANS, V29, P990, DOI 10.1177/039139880602901010; Dalsing M C, 1989, Ann Vasc Surg, V3, P127, DOI 10.1016/S0890-5096(06)62005-0; Davies A H, 1996, Cardiovasc Surg, V4, P161, DOI 10.1016/0967-2109(96)82307-6; ESKIN SG, 1983, ARTIF ORGANS, V7, P31, DOI 10.1111/j.1525-1594.1983.tb04156.x; FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1; Furukawa KS, 2000, ASAIO J, V46, P696, DOI 10.1097/00002480-200011000-00009; GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409; GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P1289; Halama T, 1999, INT ARCH ALLERGY IMM, V120, P237, DOI 10.1159/000024273; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Jeschke MG, 1999, J VASC SURG, V29, P168, DOI 10.1016/S0741-5214(99)70358-7; Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66; Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; LESECHE G, 1995, ANN VASC SURG, V9, P325, DOI 10.1007/BF02135295; Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1; Majka SM, 2003, J CLIN INVEST, V111, P71, DOI 10.1172/JCI200316157; Matuskova J, 2006, ARTERIOSCL THROM VAS, V26, P1391, DOI 10.1161/01.ATV.0000216282.58291.c6; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90; NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770; Okrainec K, 2004, AM HEART J, V148, P7, DOI 10.1016/j.ahj.2003.11.027; OZAKI CK, 1995, J BIOMED MATER RES, V29, P647; Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109; Pasterkamp G, 2000, CARDIOVASC RES, V45, P843, DOI 10.1016/S0008-6363(99)00377-6; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Randone B, 2005, J SURG RES, V127, P70, DOI 10.1016/j.jss.2004.09.005; Rasmussen C, 1997, EUR J CARDIO-THORAC, V12, P847, DOI 10.1016/S1010-7940(97)00268-6; Rihal CS, 2003, CIRCULATION, V108, P2439, DOI 10.1161/01.CIR.0000094405.21583.7C; SAAD EM, 1993, J VASC SURG, V18, P587, DOI 10.1016/0741-5214(93)90068-W; Sampram ESK, 2004, J VASC INTERV RADIOL, V15, P379, DOI 10.1097/01.RVI.0000121409.46920.B8; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3; Walluscheck KP, 2005, J CARDIOVASC SURG, V46, P425; Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6; WANG ZG, 1990, J VASC SURG, V12, P168, DOI 10.1067/mva.1990.21906; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315	54	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7718	10.1371/journal.pone.0007718	http://dx.doi.org/10.1371/journal.pone.0007718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890388	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700011
J	Miyamoto, T; Dubin, AE; Petrus, MJ; Patapoutian, A				Miyamoto, Takashi; Dubin, Adrienne E.; Petrus, Matt J.; Patapoutian, Ardem			TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice	PLOS ONE			English	Article							SENSITIVE GUANYLYL CYCLASE; CHANNEL ACTIVATION; THERMAL HYPERALGESIA; PUNGENT COMPOUNDS; S-NITROSYLATION; INOS-DEFICIENT; PAIN; SYNTHASE; CYSTEINE; CGMP	Nitric oxide (NO) can induce acute pain in humans and plays an important role in pain sensitization caused by inflammation and injury in animal models. There is evidence that NO acts both in the central nervous system via a cyclic GMP pathway and in the periphery on sensory neurons through unknown mechanisms. It has recently been suggested that TRPV1 and TRPA1, two polymodal ion channels that sense noxious stimuli impinging on peripheral nociceptors, are activated by NO in heterologous systems. Here, we investigate the relevance of this activation. We demonstrate that NO donors directly activate TRPV1 and TRPA1 in isolated inside-out patch recordings. Cultured primary sensory neurons display both TRPV1- and TRPA1-dependent responses to NO donors. BH4, an essential co-factor for NO production, causes activation of a subset of DRG neurons as assayed by calcium imaging, and this activation is at least partly dependent on nitric oxide synthase activity. We show that BH4-induced calcium influx is ablated in DRG neurons from TRPA1/TRPV1 double knockout mice, suggesting that production of endogenous levels of NO can activate these ion channels. In behavioral assays, peripheral NO-induced nociception is compromised when TRPV1 and TRPA1 are both ablated. These results provide genetic evidence that the peripheral nociceptive action of NO is mediated by both TRPV1 and TRPA1.			Miyamoto, T (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org			NINDS NIH HHS [R01NS049104, R01 NS049104] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049104] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; AKOPIAN AN, 2007, J PHYSL; Aley KO, 1998, J NEUROSCI, V18, P7008; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Boettger MK, 2007, EUR J PAIN, V11, P810, DOI 10.1016/j.ejpain.2006.12.008; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHIZHBEA, 2006, AM PAIN SOC M; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; FUJITA F, 2008, J CLIN INVEST; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HOLTHUSEN H, 1994, NEUROSCI LETT, V165, P71, DOI 10.1016/0304-3940(94)90712-9; HU H, 2009, NAT CHEM BIOL; HUGHES SR, 1990, EUR J PHARMACOL, V191, P481, DOI 10.1016/0014-2999(90)94184-Y; IALENTI A, 1992, EUR J PHARMACOL, V211, P177, DOI 10.1016/0014-2999(92)90526-A; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; KITTO KF, 1992, NEUROSCI LETT, V148, P1, DOI 10.1016/0304-3940(92)90790-E; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MAJEWSKI M, 1995, CELL TISSUE RES, V281, P445, DOI 10.1007/BF00417862; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; MELLER ST, 1992, EUR J PHARMACOL, V214, P93, DOI 10.1016/0014-2999(92)90102-A; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; TAYLORCLARK TE, 2009, MOL PHARM; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thomas DA, 1996, NEUROSCI LETT, V210, P124, DOI 10.1016/0304-3940(96)12670-7; Vales-Gomez Mar, 2003, BMC Immunol, V4, P4, DOI 10.1186/1471-2172-4-4; VIZZARD MA, 1995, NEUROSCIENCE, V67, P1, DOI 10.1016/0306-4522(95)00137-8; WANG S, 2008, BRAIN; Wei JY, 1998, J MOL NEUROSCI, V10, P53, DOI 10.1007/BF02737085; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zochodne DW, 2005, CELL MOL BIOL, V51, P255, DOI 10.1170/T626	58	148	150	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7596	10.1371/journal.pone.0007596	http://dx.doi.org/10.1371/journal.pone.0007596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893614	Green Published, Green Submitted, gold			2022-12-27	WOS:000271232000001
J	Halder, AK; Gurley, ES; Naheed, A; Saha, SK; Brooks, WA; El Arifeen, S; Sazzad, HMS; Kenah, E; Luby, SP				Halder, Amal K.; Gurley, Emily S.; Naheed, Aliya; Saha, Samir K.; Brooks, W. Abdullah; El Arifeen, Shams; Sazzad, Hossain M. S.; Kenah, Eben; Luby, Stephen P.			Causes of Early Childhood Deaths in Urban Dhaka, Bangladesh	PLOS ONE			English	Article							MORTALITY; CHILDREN; SLUMS	Data on causes of early childhood death from low-income urban areas are limited. The nationally representative Bangladesh Demographic and Health Survey 2007 estimates 65 children died per 1,000 live births. We investigated rates and causes of under-five deaths in an urban community near two large pediatric hospitals in Dhaka, Bangladesh and evaluated the impact of different recall periods. We conducted a survey in 2006 for 6971 households and a follow up survey in 2007 among eligible remaining households or replacement households. The initial survey collected information for all children under five years old who died in the previous year; the follow up survey on child deaths in the preceding five years. We compared mortality rates based on 1-year recall to the 4 years preceding the most recent 1 year. The initial survey identified 58 deaths among children,5 years in the preceding year. The follow up survey identified a mean 53 deaths per year in the preceding five years (SD67.3). Under-five mortality rate was 34 and neonatal mortality was 15 per thousand live births during 2006-2007. The leading cause of under-five death was respiratory infections (22%). The mortality rates among children under 4 years old for the two time periods (most recent 1-year recall and the 4 years preceding the most recent 1 year) were similar (36 versus 32). The child mortality in urban Dhaka was substantially lower than the national rate. Mortality rates were not affected by recall periods between 1 and 5 years.	[Halder, Amal K.; Gurley, Emily S.; Naheed, Aliya; Brooks, W. Abdullah; El Arifeen, Shams; Sazzad, Hossain M. S.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDR B, PIDVS, Dhaka 1000, Bangladesh; [Saha, Samir K.] Dhaka Shishu Hosp, Dept Microbiol, Dhaka, Bangladesh; [Kenah, Eben] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat & Global Hlth, Seattle, WA 98195 USA; [Kenah, Eben] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Kenah, Eben] Univ Washington, Sch Publ Hlth & Community Med, Dept Global Hlth, Seattle, WA 98195 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Halder, AK (corresponding author), Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDR B, PIDVS, GPO Box 128, Dhaka 1000, Bangladesh.	amalk@icddrb.org	A, Naheed/AHB-2941-2022; Sazzad, Hossain M S/C-2517-2015; A, Naheed/AHB-2940-2022; Brooks, W. Abdullah/AAD-3876-2021; Gurley, Emily S/B-7903-2010	A, Naheed/0000-0002-6016-5603; Sazzad, Hossain M S/0000-0001-6231-0205; A, Naheed/0000-0002-6016-5603; Brooks, W. Abdullah/0000-0001-9871-5546; Gurley, Emily S/0000-0002-8648-9403; Arifeen, Shams/0000-0002-5372-5932	Johns Hopkins University Bloomberg School of Public Health; IHP-HNPRP; National Institute of General Medical Sciences [F32GM085945]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085945] Funding Source: NIH RePORTER	Johns Hopkins University Bloomberg School of Public Health; IHP-HNPRP; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Department of Health and Human Services National Vaccine Program Office (NVPO) through the United States Agency for International Development Global Bureau's Global Research Activity Cooperative Agreement with Johns Hopkins University Bloomberg School of Public Health, and the Government of Bangladesh through IHP-HNPRP. Eben Kenah's contribution to this manuscript was supported by National Institute of General Medical Sciences grant F32GM085945. ICDDR, B acknowledges with gratitude the commitment of NVPO, IHP- HNPRP and the National Institute of General Medical Sciences to the Centre's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Arifeen S. E., 2005, CAUSES DEATH CHILDRE; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Baqui AH, 2001, ACTA PAEDIATR, V90, P682, DOI 10.1080/080352501750258775; CLAESON M, 2000, B WHO, V78; Hussain A, 1999, TROP MED INT HEALTH, V4, P758, DOI 10.1046/j.1365-3156.1999.00485.x; Kalbfleish J. D., 2002, STAT ANAL FAILURE TI; KAMAL GM, 1994, SECONDARY ANAL BANGL; Luby SP, 2008, TROP MED INT HEALTH, V13, P835, DOI 10.1111/j.1365-3156.2008.02074.x; *MDG MON, 2009, TRACK MILL DEV GOALS; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation International Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB) International and Associates for Community and Population Research (ACPR)., 2008, BANGL URB HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; SALWAY SM, 1994, J DIARRHOEAL DIS RES, V12, P187; Sting A., 1990, OFFIZIELLES GESUNDHE, V52, P277; *UNICEF, 2009, CHILD MORT TOLL DIPS; WHO, 2019, INT STAT CLASS DIS R, V10th; *WHO, 1991, WHOARI9120	18	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8145	10.1371/journal.pone.0008145	http://dx.doi.org/10.1371/journal.pone.0008145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997507	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829000006
J	Lluis, JM; Llacuna, L; von Montfort, C; Barcena, C; Enrich, C; Morales, A; Fernandez-Checa, JC				Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Enrich, Carlos; Morales, Albert; Fernandez-Checa, Jose C.			GD3 Synthase Overexpression Sensitizes Hepatocarcinoma Cells to Hypoxia and Reduces Tumor Growth by Suppressing the cSrc/NF-kappa B Survival Pathway	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; T-CELLS; INDUCIBLE FACTORS; GANGLIOSIDE GD3; HEPATOMA-CELLS; HUMAN-LIVER; APOPTOSIS; ACTIVATION; PHOSPHORYLATION; CHEMOTHERAPY	Background: Hypoxia-mediated HIF-1 alpha stabilization and NF-kappa B activation play a key role in carcinogenesis by fostering cancer cell survival, angiogenesis and tumor invasion. Gangliosides are integral components of biological membranes with an increasingly recognized role as signaling intermediates. In particular, ganglioside GD3 has been characterized as a proapoptotic lipid effector by promoting cell death signaling and suppression of survival pathways. Thus, our aim was to analyze the role of GD3 in hypoxia susceptibility of hepatocarcinoma cells and in vivo tumor growth. Methodology/Principal Findings: We generated and characterized a human hepatocarcinoma cell line stably expressing GD3 synthase (Hep3B-GD3), which catalyzes the synthesis of GD3 from GM3. Despite increased GD3 levels (2-3 fold), no significant changes in cell morphology or growth were observed in Hep3B-GD3 cells compared to wild type Hep3B cells under normoxia. However, exposure of Hep3B-GD3 cells to hypoxia (2% O-2) enhanced reactive oxygen species (ROS) generation, resulting in decreased cell survival, with similar findings observed in Hep3B cells exposed to increasing doses of exogenous GD3. In addition, hypoxia-induced c-Src phosphorylation at tyrosine residues, NF-kappa B activation and subsequent expression of Mn-SOD were observed in Hep3B cells but not in Hep3B-GD3 cells. Moreover, MnTBAP, an antioxidant with predominant SOD mimetic activity, reduced ROS generation, protecting Hep3B-GD3 cells from hypoxia-induced death. Finally, lower tumor growth, higher cell death and reduced Mn-SOD expression were observed in Hep3B-GD3 compared to Hep3B tumor xenografts. Conclusion: These findings underscore a role for GD3 in hypoxia susceptibility by disabling the c-Src/NF-kappa B survival pathway resulting in lower Mn-SOD expression, which may be of relevance in hepatocellular carcinoma therapy.	[Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Morales, Albert; Fernandez-Checa, Jose C.] IIBB CSIC, Dept Cell Death & Proliferat, Barcelona, Spain; [Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Morales, Albert; Fernandez-Checa, Jose C.] CIBEREHD, IDIBAPS CIBEK, Hosp Clin, Liver Unit, Barcelona, Spain; [Lluis, Josep M.; Enrich, Carlos] Univ Barcelona, Fac Med, Dept Cellular Biol, Barcelona 7, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Southern California	Lluis, JM (corresponding author), IIBB CSIC, Dept Cell Death & Proliferat, Barcelona, Spain.	amorales@clinic.ub.es; checa229@yahoo.com	Fernández-Checa, José Carlos/L-8342-2014; Morales, Albert/E-2988-2013	Fernández-Checa, José Carlos/0000-0003-3422-2990; Morales, Albert/0000-0001-8702-2269; Barcena, Cristina/0000-0002-9640-5568; Enrich, Carlos/0000-0003-0382-2993	CIBEREHD; Instituto de Salud Carlos III [FIS06/0395, FIS07/1039, SAF2006-06789, SAF2008-02199]; Ministry of Science and Innovation from Spain; Research Center for Liver and Pancreatic Diseases; US National Institute on Alcohol Abuse and Alcoholism [P50-AA-11999]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	CIBEREHD; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Science and Innovation from Spain(Spanish Government); Research Center for Liver and Pancreatic Diseases; US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant support: CIBEREHD and grants FIS06/0395, FIS07/1039, SAF2006-06789 and SAF2008-02199 by Instituto de Salud Carlos III and Ministry of Science and Innovation from Spain, and from the Research Center for Liver and Pancreatic Diseases, P50-AA-11999 funded by the US National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Bennewith KL, 2002, CANCER RES, V62, P6827; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Birkle S, 1999, J NEUROCHEM, V72, P954, DOI 10.1046/j.1471-4159.1999.0720954.x; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Colell A, 2004, FEBS LETT, V560, P63, DOI 10.1016/S0014-5793(04)00071-7; Colell Anna, 2001, FASEB Journal, V15, P1068; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hummel I, 2005, FEBS LETT, V579, P3381, DOI 10.1016/j.febslet.2005.05.003; HYNDS DL, 1995, J NEUROCHEM, V65, P2251; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Moon SK, 2006, FASEB J, V20, P1387, DOI 10.1096/fj.05-4618com; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; NILSSON O, 1982, J LIPID RES, V23, P327; Paris R, 2002, J BIOL CHEM, V277, P49870, DOI 10.1074/jbc.M208303200; Prinetti A, 2001, J NEUROCHEM, V78, P1162, DOI 10.1046/j.1471-4159.2001.00515.x; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; RUCKHABERLE E, 2009, J CANC RES CLIN ONCO; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saqr HE, 2006, J NEUROCHEM, V96, P1301, DOI 10.1111/j.1471-4159.2005.03640.x; SPITALNIK PF, 1989, ARCH BIOCHEM BIOPHYS, V273, P578, DOI 10.1016/0003-9861(89)90518-3; TANNO M, 1987, JPN J MED, V26, P147, DOI 10.2169/internalmedicine1962.26.147; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Uzzo RG, 1999, J CLIN INVEST, V104, P769, DOI 10.1172/JCI6775; Wang XQ, 2002, J BIOL CHEM, V277, P40410, DOI 10.1074/jbc.M207117200; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zhong H, 1999, CANCER RES, V59, P5830	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8059	10.1371/journal.pone.0008059	http://dx.doi.org/10.1371/journal.pone.0008059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956670	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828100011
J	Trousson, A; Makoukji, J; Petit, PX; Bernard, S; Slomianny, C; Schumacher, M; Massaad, C				Trousson, Amalia; Makoukji, Joelle; Petit, Patrice X.; Bernard, Sophie; Slomianny, Christian; Schumacher, Michael; Massaad, Charbel			Cross-Talk between Oxysterols and Glucocorticoids: Differential Regulation of Secreted Phopholipase A2 and Impact on Oligodendrocyte Death	PLOS ONE			English	Article							LIVER-X-RECEPTOR; SMOOTH-MUSCLE-CELLS; MULTIPLE-SCLEROSIS; PHOSPHOLIPASE A(2); P160 COACTIVATORS; SCHWANN-CELLS; LXR-ALPHA; CHOLESTEROL; 24S-HYDROXYCHOLESTEROL; PROLIFERATION	Background: Oxysterols are oxidized forms of cholesterol. They have been shown to be implicated in cholesterol turnover, inflammation and in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis. Glial cells are targets of oxysterols: they inhibit astrocyte proliferation after brain injury, and we have previously shown that 25-hydroxycholesterol (25OH) provokes oligodendrocyte apoptosis and stimulates the expression of sPLA2 type IIA (sPLA2-IIA), which has a protective effect. Methodology/Principal Findings: As glucocorticoids are well-known for their anti-inflammatory effects, our aim was to understand their direct effects on oxysterol-induced responses in oligodendrocytes (sPLA2-IIA stimulation and apoptosis). We demonstrate that the synthetic glucocorticoid dexamethasone (Dex) abolishes the stimulation of sPLA2-IIA by 25-hydroxycholesterol (25-OH). This inhibition is mediated by the glucocorticoid receptor (GR), which decreases the expression of the oxysterol receptor Pregnane X Receptor (PXR) and interferes with oxysterol signaling by recruiting a common limiting coactivator PGC1 alpha. Consistent with the finding that sPLA2-IIA can partially protect oligodendrocytes against oxysterol-triggered apoptosis, we demonstrate here that the inhibition of sPLA2-IIA by Dex accelerates the apoptotic phenomenon, leading to a shift towards necrosis. We have shown by atomic force microscopy and electron microscopy that 25-OH and Dex alters oligodendrocyte shape and disorganizes the cytoplasm. Conclusions/Significance: Our results provide a new understanding of the cross-talk between oxysterol and glucocorticoid signaling pathways and their respective roles in apoptosis and oligodendrocyte functions.	[Trousson, Amalia; Schumacher, Michael; Massaad, Charbel] INSERM, UMR788, Le Kremlin Bicetre, France; [Trousson, Amalia; Schumacher, Michael; Massaad, Charbel] Univ Paris 11, IFR 93, Le Kremlin Bicetre, France; [Trousson, Amalia; Makoukji, Joelle; Bernard, Sophie; Massaad, Charbel] CNRS, UPR 2228, Paris, France; [Trousson, Amalia; Makoukji, Joelle; Bernard, Sophie; Massaad, Charbel] Univ Paris 05, IFR95, Paris, France; [Petit, Patrice X.] Inst Cochin, CNRS, UMR8104, Canc Apoptosis & Mitochondria Team, Paris, France; [Slomianny, Christian] INSERM, U800, Villeneuve Dascq, France; [Slomianny, Christian] Univ Lille 1, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Trousson, A (corresponding author), INSERM, UMR788, Le Kremlin Bicetre, France.	charbel.massaad@parisdescartes.fr	Schumacher, Michael/G-3581-2013; Petit, patrice/AAF-6774-2020; Petit, Patrice X./A-3692-2009; Slomianny, Christian/L-8285-2018	Schumacher, Michael/0000-0001-6117-5371; Petit, Patrice X./0000-0002-5038-9101; BERNARD, Sophie/0000-0001-8039-1301	Inserm; CNRS; University Paris-Sud; University Paris Descartes	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud; University Paris Descartes	This article has been prepared with financial support from Inserm, CNRS, University Paris-Sud, and University Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L Klembt, 2005, Eur Cell Mater, V10, P61; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Arioka M, 2005, FEBS LETT, V579, P2693, DOI 10.1016/j.febslet.2005.03.092; Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200; Bjorkhem I, 2001, J LIPID RES, V42, P366; BOCHELEN D, 1995, J NEUROCHEM, V65, P2194; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Feutz AC, 2001, GLIA, V34, P241, DOI 10.1002/glia.1058; Greger DL, 2007, J ANIM PHYSIOL AN N, V91, P62, DOI 10.1111/j.1439-0396.2006.00642.x; Grenier J, 2006, MOL ENDOCRINOL, V20, P254, DOI 10.1210/me.2005-0061; Grenier J, 2004, MOL ENDOCRINOL, V18, P2866, DOI 10.1210/me.2004-0241; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Lutjohann D, 2000, J LIPID RES, V41, P195; Massaad C, 2000, BIOCHEM J, V350, P123, DOI 10.1042/0264-6021:3500123; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Rufini S, 1999, AM J PHYSIOL-CELL PH, V277, pC814, DOI 10.1152/ajpcell.1999.277.4.C814; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Schmidt A, 1999, MOL CELL ENDOCRINOL, V155, P51, DOI 10.1016/S0303-7207(99)00115-X; Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66; Specty O, 2001, FEBS LETT, V490, P88, DOI 10.1016/S0014-5793(00)02414-5; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V312, P716, DOI 10.1016/j.bbrc.2003.10.174; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; Touqui Lhousseine, 2001, Current Molecular Medicine (Hilversum), V1, P739, DOI 10.2174/1566524013363258; TROUSSON A, 2009, J NEUROCHEM; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114	38	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8080	10.1371/journal.pone.0008080	http://dx.doi.org/10.1371/journal.pone.0008080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956653	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828100017
J	Xu, Y; Mori, T; Qin, XM; Yan, HP; Egli, M; Johnson, CH				Xu, Yao; Mori, Tetsuya; Qin, Ximing; Yan, Heping; Egli, Martin; Johnson, Carl Hirschie			Intramolecular Regulation of Phosphorylation Status of the Circadian Clock Protein KaiC	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; IN-VITRO; CYANOBACTERIA; SYSTEM; RHYTHM; OSCILLATION; EXPRESSION; INSIGHTS; FEEDBACK; BINDING	Background: KaiC, a central clock protein in cyanobacteria, undergoes circadian oscillations between hypophosphorylated and hyperphosphorylated forms in vivo and in vitro. Structural analyses of KaiC crystals have identified threonine and serine residues in KaiC at three residues (T426, S431, and T432) as potential sites at which KaiC is phosphorylated; mutation of any of these three sites to alanine abolishes rhythmicity, revealing an essential clock role for each residue separately and for KaiC phosphorylation in general. Mass spectrometry studies confirmed that the S431 and T432 residues are key phosphorylation sites, however, the role of the threonine residue at position 426 was not clear from the mass spectrometry measurements. Methodology and Principal Findings: Mutational approaches and biochemical analyses of KaiC support a key role for T426 in control of the KaiC phosphorylation status in vivo and in vitro and demonstrates that alternative amino acids at residue 426 dramatically affect KaiC's properties in vivo and in vitro, especially genetic dominance/recessive relationships, KaiC dephosphorylation, and the formation of complexes of KaiC with KaiA and KaiB. These mutations alter key circadian properties, including period, amplitude, robustness, and temperature compensation. Crystallographic analyses indicate that the T426 site is phosphorylatible under some conditions, and in vitro phosphorylation assays of KaiC demonstrate labile phosphorylation of KaiC when the primary S431 and T432 sites are blocked. Conclusions and Significance: T426 is a crucial site that regulates KaiC phosphorylation status in vivo and in vitro and these studies underscore the importance of KaiC phosphorylation status in the essential cyanobacterial circadian functions. The regulatory roles of these phosphorylation sites-including T426-within KaiC enhance our understanding of the molecular mechanism underlying circadian rhythm generation in cyanobacteria.	[Xu, Yao; Mori, Tetsuya; Qin, Ximing; Yan, Heping; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Egli, Martin] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Johnson, Carl H/I-4655-2014; Qin, Ximing/J-6485-2012	Mori, Tetsuya/0000-0001-6036-5261	National Institute of General Medical Sciences [GM067152, GM073845]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073845, R01GM067152] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (GM067152 to CHJ and GM073845 to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ditty JL, 2009, BACTERIAL CIRCADIAN; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mori T, 2001, SEMIN CELL DEV BIOL, V12, P271, DOI 10.1006/scdb.2001.0254; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; PATTANAYEK R, 2009, PLOS ONE IN PRESS; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2001, FEBS LETT, V496, P86, DOI 10.1016/S0014-5793(01)02408-5; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168	29	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7509	10.1371/journal.pone.0007509	http://dx.doi.org/10.1371/journal.pone.0007509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946629	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800001
J	Bayley, JP; van Minderhout, I; Hogendoorn, PCW; Cornelisse, CJ; van der Wal, A; Prins, FA; Teppema, L; Dahan, A; Devilee, P; Taschner, PEM				Bayley, Jean-Pierre; van Minderhout, Ivonne; Hogendoorn, Pancras C. W.; Cornelisse, Cees J.; van der Wal, Annemieke; Prins, Frans A.; Teppema, Luc; Dahan, Albert; Devilee, Peter; Taschner, Peter E. M.			Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma	PLOS ONE			English	Article							SUCCINATE-DEHYDROGENASE; GENE; MUTATIONS; SYSTEM; H19	Background: Mitochondrial succinate dehydrogenase (SDH) is a component of both the tricarboxylic acid cycle and the electron transport chain. Mutations of SDHD, the first protein of intermediary metabolism shown to be involved in tumorigenesis, lead to the human tumors paraganglioma (PGL) and pheochromocytoma (PC). SDHD is remarkable in showing an 'imprinted' tumor suppressor phenotype. Mutations of SDHD show a very high penetrance in man and we postulated that knockout of Sdhd would lead to the development of PGL/PC, probably in aged mice. Methodology/Principal Findings: We generated a conventional knockout of Sdhd in the mouse, removing the entire third exon. We also crossed this mouse with a knockout of H19, a postulated imprinted modifier gene of Sdhd tumorigenesis, to evaluate if loss of these genes together would lead to the initiation or enhancement of tumor development. Homozygous knockout of Sdhd results in embryonic lethality. No paraganglioma or other tumor development was seen in Sdhd KO mice followed for their entire lifespan, in sharp contrast to the highly penetrant phenotype in humans. Heterozygous Sdhd KO mice did not show hyperplasia of paraganglioma-related tissues such as the carotid body or of the adrenal medulla, or any genotype-related pathology, with similar body and organ weights to wildtype mice. A cohort of Sdhd/H19 KO mice developed several cases of profound cardiac hypertrophy, but showed no evidence of PGL/PC. Conclusions: Knockout of Sdhd in the mouse does not result in a disease phenotype. H19 may not be an initiator of PGL/PC tumorigenesis.	[Bayley, Jean-Pierre; van Minderhout, Ivonne; Devilee, Peter; Taschner, Peter E. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Teppema, Luc; Dahan, Albert] Leiden Univ, Med Ctr, Dept Anaesthesiol, Leiden, Netherlands; [Hogendoorn, Pancras C. W.; Cornelisse, Cees J.; van der Wal, Annemieke; Prins, Frans A.; Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bayley, JP (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	j.p.l.bayley@lumc.nl	Dahan, Albert/B-8845-2008; Devilee, Peter/GXV-8005-2022; Hogendoorn, Pancras C.W./H-5859-2015; Hogendoorn, Pancras/O-6494-2019; DEVILEE, PETER/ABR-2140-2022; Taschner, Peter/J-8853-2014	Dahan, Albert/0000-0003-3161-3945; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Hogendoorn, Pancras/0000-0002-1513-8104; Taschner, Peter/0000-0001-9621-465X	Dutch Cancer Society [RUL2002-2723]; European Union [518200]	Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission)	This work was supported by grants from the Dutch Cancer Society (Koningin Wilhelmina Fonds, RUL2002-2723) and the European Union 6th Framework Program (Project No: 518200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1999, CELL MOL BIOL, V45, P737; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2006, J CLIN ENDOCR METAB, V91, P827, DOI 10.1210/jc.2005-1862; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hensen EF, 2004, ONCOGENE, V23, P4076, DOI 10.1038/sj.onc.1207591; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Margetts CDE, 2005, ENDOCR-RELAT CANCER, V12, P161, DOI 10.1677/erc.1.00865; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Riemann K, 2004, CANCER GENET CYTOGEN, V150, P128, DOI 10.1016/j.cancergencyto.2003.10.013; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105	16	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7987	10.1371/journal.pone.0007987	http://dx.doi.org/10.1371/journal.pone.0007987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956719	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500017
J	Cerchia, L; Esposito, CL; Jacobs, AH; Tavitian, B; de Franciscis, V				Cerchia, Laura; Esposito, Carla Lucia; Jacobs, Andreas H.; Tavitian, Bertrand; de Franciscis, Vittorio			Differential SELEX in Human Glioma Cell Lines	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO SELECTION; VASCULAR-PERMEABILITY; SYSTEMATIC EVOLUTION; TARGETED THERAPIES; AMPLICON VECTORS; EMERGING CLASS; LUNG-CANCER; APTAMERS; LIGANDS	The hope of success of therapeutic interventions largely relies on the possibility to distinguish between even close tumor types with high accuracy. Indeed, in the last ten years a major challenge to predict the responsiveness to a given therapeutic plan has been the identification of tumor specific signatures, with the aim to reduce the frequency of unwanted side effects on oncologic patients not responding to therapy. Here, we developed an in vitro evolution-based approach, named differential whole cell SELEX, to generate a panel of high affinity nucleic acid ligands for cell surface epitopes. The ligands, named aptamers, were obtained through the iterative evolution of a random pool of sequences using as target human U87MG glioma cells. The selection was designed so as to distinguish U87MG from the less malignant cell line T98G. We isolated molecules that generate unique binding patterns sufficient to unequivocally identify any of the tested human glioma cell lines analyzed and to distinguish high from low or non-tumorigenic cell lines. Five of such aptamers act as inhibitors of specific intracellular pathways thus indicating that the putative target might be important surface signaling molecules. Differential whole cell SELEX reveals an exciting strategy widely applicable to cancer cells that permits generation of highly specific ligands for cancer biomarkers.	[Cerchia, Laura; de Franciscis, Vittorio] CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Esposito, Carla Lucia] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Jacobs, Andreas H.] Univ Munster, EIMI, Munster, Germany; [Jacobs, Andreas H.] Max Planck Inst Neurol Res, Lab Gene Therapy & Mol Imaging, Cologne, Germany; [Tavitian, Bertrand] INSERM ERM 103, CEA DSV DRM Serv Hosp Frederic, Orsay, France	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Munster; Max Planck Society; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Cerchia, L (corresponding author), CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, Naples, Italy.	defranci@unina.it	Tavitian, Bertrand M/P-6578-2018; Jacobs, Andreas H./AAA-6794-2020; Esposito, Carla L/K-5246-2016	Tavitian, Bertrand M/0000-0002-5349-8194; Esposito, Carla L/0000-0003-0624-6821; Cerchia, Laura/0000-0002-7633-7932	C.N.R.; Associazione Italiana Ricerca sul Cancro; AIRC; MIUR-FIRB [RBIN04J4J7]; EU [503569]	C.N.R.(Consiglio Nazionale delle Ricerche (CNR)); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); EU(European Commission)	This work was supported by funds from: C.N.R., Associazione Italiana Ricerca sul Cancro ( L. C.), AIRC, MIUR-FIRB (RBIN04J4J7), EU grant EMIL (European Molecular Imaging Laboratories Network) contract No 503569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2003, BIOCHEM J, V372, P897, DOI 10.1042/BJ20021530; Cerchia L, 2002, FEBS LETT, V528, P12, DOI 10.1016/S0014-5793(02)03275-1; Cerchia Laura, 2007, Methods Mol Biol, V361, P187; Cerchia Laura, 2009, V535, P59, DOI 10.1007/978-1-59745-557-2_5; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207, DOI 10.1007/BF00691091; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Jacobs AH, 2003, HUM GENE THER, V14, P277, DOI 10.1089/10430340360535823; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pallini R, 2006, INT J CANCER, V118, P2158, DOI 10.1002/ijc.21613; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Rueger MA, 2005, GENE THER, V12, P588, DOI 10.1038/sj.gt.3302462; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zanca C, 2008, J CELL MOL MED, V12, P2416, DOI 10.1111/j.1582-4934.2008.00283.x	32	51	57	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7971	10.1371/journal.pone.0007971	http://dx.doi.org/10.1371/journal.pone.0007971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956692	Green Published, gold			2022-12-27	WOS:000272827500006
J	You, S; Poulton, L; Cobbold, S; Liu, CP; Rosenzweig, M; Ringler, D; Lee, WH; Segovia, B; Bach, JF; Waldmann, H; Chatenoud, L				You, Sylvaine; Poulton, Lynn; Cobbold, Steve; Liu, Chih-Pin; Rosenzweig, Michael; Ringler, Douglas; Lee, Wen-Hui; Segovia, Berta; Bach, Jean-Francois; Waldmann, Herman; Chatenoud, Lucienne			Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; COSTIMULATORY RECEPTOR; ANTITUMOR IMMUNITY; LIGAND GITRL; CUTTING EDGE; ACTIVATION; INSULIN	Background: The cross-talk between pathogenic T lymphocytes and regulatory T cells (Tregs) plays a major role in the progression of autoimmune diseases. Our objective is to identify molecules and/or pathways involved in this interaction and representing potential targets for innovative therapies. Glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand are key players in the T effector/Treg interaction. GITR is expressed at low levels on resting T cells and is significantly up-regulated upon activation. Constitutive high expression of GITR is detected only on Tregs. GITR interacts with its ligand mainly expressed on antigen presenting cells and endothelial cells. It has been suggested that GITR triggering activates effector T lymphocytes while inhibiting Tregs thus contributing to the amplification of immune responses. In this study, we examined the role of GITR/GITRLigand interaction in the progression of autoimmune diabetes. Methods and Findings: Treatment of 10-day-old non-obese diabetic (NOD) mice, which spontaneously develop diabetes, with an agonistic GITR-specific antibody induced a significant acceleration of disease onset (80% at 12 weeks of age). This activity was not due to a decline in the numbers or functional capacity of CD4(+)CD25(+)Foxp3(+) Tregs but rather to a major activation of 'diabetogenic' T cells. This conclusion was supported by results showing that anti-GITR antibody exacerbates diabetes also in CD28(-/-) NOD mice, which lack Tregs. In addition, treatment of NOD mice, infused with the diabetogenic CD4(+)BDC2.5 T cell clone, with GITR-specific antibody substantially increased their migration, proliferation and activation within the pancreatic islets and draining lymph nodes. As a mirror image, blockade of the GITR/GITRLigand pathway using a neutralizing GITRLigand-specific antibody significantly protected from diabetes even at late stages of disease progression. Experiments using the BDC2.5 T cell transfer model suggested that the GITRLigand antibody acted by limiting the homing and proliferation of pathogenic T cells in pancreatic lymph nodes. Conclusion: GITR triggering plays an important costimulatory role on diabetogenic T cells contributing to the development of autoimmune responses. Therefore, blockade of the GITR/GITRLigand pathway appears as a novel promising clinically oriented strategy as GITRLigand-specific antibody applied at an advanced stage of disease progression can prevent overt diabetes.			You, S (corresponding author), Univ Paris 05, Paris, France.	sylvaine.you@inserm.fr	You, Sylvaine/AAF-5600-2021; waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019; Lee, Wen Hwa/G-1250-2013	You, Sylvaine/0000-0002-1578-5205; Lee, Wen Hwa/0000-0002-4098-5225; Cobbold, Stephen/0000-0003-1206-4880; Waldmann, Herman/0000-0001-7519-6720	Medical Research Council [G7904009] Funding Source: Medline; MRC [G7904009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BAE EM, 2007, MOL IMMUNOL; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bot A, 2001, J IMMUNOL, V167, P2950, DOI 10.4049/jimmunol.167.5.2950; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Cuzzocrea S, 2005, FASEB J, V19, P1253, DOI 10.1096/fj.04-3556com; Cuzzocrea S, 2007, FASEB J, V21, P117, DOI 10.1096/fj.06-6611com; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Esparza EM, 2005, J IMMUNOL, V174, P7875, DOI 10.4049/jimmunol.174.12.7875; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kamimura Y, 2009, J IMMUNOL, V182, P2708, DOI 10.4049/jimmunol.0803704; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PETERSON JD, 1995, IMMUNOLOGY, V85, P455; Piao J, 2009, IMMUNOLOGY, V127, P489, DOI 10.1111/j.1365-2567.2008.03036.x; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Santucci L, 2007, GUT, V56, P52, DOI 10.1136/gut.2006.091181; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shin HH, 2002, FEBS LETT, V514, P275, DOI 10.1016/S0014-5793(02)02379-7; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tisch R, 1999, J IMMUNOL, V163, P1178; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Tuyaerts S, 2007, J LEUKOCYTE BIOL, V82, P93, DOI 10.1189/jlb.0906568; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011	59	35	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7848	10.1371/journal.pone.0007848	http://dx.doi.org/10.1371/journal.pone.0007848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936238	gold, Green Submitted, Green Published			2022-12-27	WOS:000272004800002
J	Morimoto, H; Kanatsu-Shinohara, M; Takashima, S; Chuma, S; Nakatsuji, N; Takehashi, M; Shinohara, T				Morimoto, Hiroko; Kanatsu-Shinohara, Mito; Takashima, Seiji; Chuma, Shinichiro; Nakatsuji, Norio; Takehashi, Masanori; Shinohara, Takashi			Phenotypic Plasticity of Mouse Spermatogonial Stem Cells	PLOS ONE			English	Article							LONG-TERM CULTURE; C-KIT; SELF-RENEWAL; TYROSINE KINASE; IN-VITRO; PROLIFERATION; SPERMATOGENESIS; DIFFERENTIATION; TRANSPLANTATION; TESTIS	Background: Spermatogonial stem cells (SSCs) continuously undergo self-renewal division to support spermatogenesis. SSCs are thought to have a fixed phenotype, and development of a germ cell transplantation technique facilitated their characterization and prospective isolation in a deterministic manner; however, our in vitro SSC culture experiments indicated heterogeneity of cultured cells and suggested that they might not follow deterministic fate commitment in vitro. Methodology and Principal Findings: In this study, we report phenotypic plasticity of SSCs. Although c-kit tyrosine kinase receptor (Kit) is not expressed in SSCs in vivo, it was upregulated when SSCs were cultured on laminin in vitro. Both Kit(-) and Kit(+) cells in culture showed comparable levels of SSC activity after germ cell transplantation. Unlike differentiating spermatogonia that depend on Kit for survival and proliferation, Kit expressed on SSCs did not play any role in SSC self-renewal. Moreover, Kit expression on SSCs changed dynamically once proliferation began after germ cell transplantation in vivo. Conclusions/Significance: These results indicate that SSCs can change their phenotype according to their microenvironment and stochastically express Kit. Our results also suggest that activated and non-activated SSCs show distinct phenotypes.			Morimoto, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan.	tshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139				Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; CHIBA S, 1991, BLOOD, V78, P2261; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; CLERMONT Y, 1968, AM J ANAT, V122, P237, DOI 10.1002/aja.1001220205; De Rooij DG, 2000, J ANDROL, V21, P776; DYM M, 1970, AM J ANAT, V128, P265, DOI 10.1002/aja.1001280302; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P236, DOI 10.1095/biolreprod.104.035659; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P1801, DOI 10.1095/biolreprod.102.012575; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohta H, 2000, DEVELOPMENT, V127, P2125; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	35	69	73	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7909	10.1371/journal.pone.0007909	http://dx.doi.org/10.1371/journal.pone.0007909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936070	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004600013
J	Li, MH; Valimaki, K; Piha, M; Pakkala, T; Merila, J				Li, Meng-Hua; Valimaki, Kaisa; Piha, Markus; Pakkala, Timo; Merila, Juha			Extrapair Paternity and Maternity in the Three-Toed Woodpecker, Picoides tridactylus: Insights from Microsatellite-Based Parentage Analysis	PLOS ONE			English	Article							PAIR PATERNITY; MATING SYSTEM; FOREST; BIRDS; PARASITISM; INFERENCE; SUCCESS; QUALITY	Molecular techniques have revealed that avian mating systems are more diverse and complex than previously thought. We used microsatellite markers to determine genetic parentage, the prevalence of extrapair paternity and quasi-parasitism (i.e. situations where a male's extrapair mate lay in his nest) in a socially monogamous population of three-toed woodpeckers (Picoides tridactylus) in southern Finland. A total of 129 adults and nestlings, representing 5-9 families annually from 20042007, were genotyped at up to ten microsatellite loci. The results of genetic assignment tests confirmed that monogamous parentage characterized the majority (84.6%, 22/26) of broods, and that most (93.8%, 75/80) nestlings were the offspring of their social parents. Two of 80 nestlings (2.5%) in two of 26 broods (7.7%) were sired by extrapair males and quasi-parasitism occurred in 3.8% (3/80) of nestlings and 7.7% (2/26) of broods. Hence, the levels of extrapair parentage were low, possibly because both genetic polygyny and polyandry are constrained by the high paternal effort required for parental care. The co-occurrence of low levels of extrapair paternity and quasi-parasitism are discussed in light of ecological and behavioural factors characterizing the species biology.			Li, MH (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Ecol Genet Res Unit, Helsinki, Finland.	menghua.li@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072; Piha, Markus/0000-0002-8482-6162				Alves MAS, 1998, ANIM BEHAV, V56, P1323, DOI 10.1006/anbe.1998.0910; Bennett P. M., 2002, OX ECOL EV; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2004, BEHAV ECOL SOCIOBIOL, V56, P191, DOI 10.1007/s00265-004-0766-9; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hill CE, 2005, J FIELD ORNITHOL, V76, P119, DOI 10.1648/0273-8570-76.2.119; Hoyt JS, 2002, CAN J FOREST RES, V32, P1881, DOI [10.1139/x02-109, 10.1139/X02-109]; Hughes JM, 2003, MOL ECOL, V12, P3441, DOI 10.1046/j.1365-294X.2003.01997.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McRae SB, 1999, BEHAV ECOL SOCIOBIOL, V47, P104, DOI 10.1007/s002650050655; Nei M., 1987, MOL EVOLUTIONARY GEN; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Pakkala T, 2002, SILVA FENN, V36, P279, DOI 10.14214/sf.563; Pakkala T, 2006, ANN ZOOL FENN, V43, P137; Pechacek P, 2005, BEHAVIOUR, V142, P1093, DOI 10.1163/156853905774405281; Pechacek P, 2004, J WILDLIFE MANAGE, V68, P683, DOI 10.2193/0022-541X(2004)068[0683:CDOAAY]2.0.CO;2; Pechacek P, 2006, ANN ZOOL FENN, V43, P165; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Ruge K., 1971, Ornithologische Beobachter, V68, P256; SABRINA ST, 2008, J AVIAN BIOL, V39, P579; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Valimaki K, 2008, MOL ECOL RESOUR, V8, P1152, DOI 10.1111/j.1755-0998.2008.02209.x; WEATHERHEAD PJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P81, DOI 10.1007/s0026550370081; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Wiktander U, 2000, J AVIAN BIOL, V31, P447, DOI 10.1034/j.1600-048X.2000.310003.x; WINKLER H., 2002, HDB BIRDS WORLD, VVII, P296	34	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7895	10.1371/journal.pone.0007895	http://dx.doi.org/10.1371/journal.pone.0007895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924300	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700025
J	Ote, I; Lebrun, M; Vandevenne, P; Bontems, S; Medina-Palazon, C; Manet, E; Piette, J; Sadzot-Delvaux, C				Ote, Isabelle; Lebrun, Marielle; Vandevenne, Patricia; Bontems, Sebastien; Medina-Palazon, Cahora; Manet, Evelyne; Piette, Jacques; Sadzot-Delvaux, Catherine			Varicella-Zoster Virus IE4 Protein Interacts with SR Proteins and Exports mRNAs through the TAP/NXF1 Pathway	PLOS ONE			English	Article							IMMEDIATE-EARLY PROTEIN; NUCLEAR EXPORT; SPLICING FACTORS; NUCLEOCYTOPLASMIC EXPORT; TRANSACTIVATOR PROTEIN; VIRAL REPLICATION; UNSPLICED RNA; TREX COMPLEX; ICP27; BINDING	Available data suggest that the Varicella-Zoster virus (VZV) IE4 protein acts as an important regulator on VZV and cellular genes expression and could exert its functions at post-transcriptional level. However, the molecular mechanisms supported by this protein are not yet fully characterized. In the present study, we have attempted to clarify this IE4-mediated gene regulation and identify some cellular partners of IE4. By yeast two-hybrid and immunoprecipitation analysis, we showed that IE4 interacts with three shuttling SR proteins, namely ASF/SF2, 9G8 and SRp20. We positioned the binding domain in the IE4 RbRc region and we showed that these interactions are not bridged by RNA. We demonstrated also that IE4 strongly interacts with the main SR protein kinase, SRPK1, and is phosphorylated in in vitro kinase assay on residue Ser-136 contained in the Rb domain. By Northwestern analysis, we showed that IE4 is able to bind RNA through its arginine-rich region and in immunoprecipitation experiments the presence of RNA stabilizes complexes containing IE4 and the cellular export factors TAP/NXF1 and Aly/REF since the interactions are RNase-sensitive. Finally, we determined that IE4 influences the export of reporter mRNAs and clearly showed, by TAP/NXF1 knockdown, that VZV infection requires the TAP/NXF1 export pathway to express some viral transcripts. We thus highlighted a new example of viral mRNA export factor and proposed a model of IE4-mediated viral mRNAs export.			Ote, I (corresponding author), Univ Liege, GIGA R, Lab Virol & Immunol, Liege, Belgium.	csadzot@ulg.ac.be	MANET, Evelyne/G-5644-2019; Lebrun, Marielle/GVT-8895-2022	MANET, Evelyne/0000-0001-7619-9982; 				Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Batisse J, 2005, J VIROL, V79, P14102, DOI 10.1128/JVI.79.22.14102-14111.2005; Baudoux L, 2000, J BIOL CHEM, V275, P32822, DOI 10.1074/jbc.M001444200; Bell I, 2007, J VIROL, V81, P5437, DOI 10.1128/JVI.02609-06; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cohen JI, 2005, J VIROL, V79, P6969, DOI 10.1128/JVI.79.11.6969-6975.2005; Cohrs RJ, 2002, J VIROL, V76, P7228, DOI 10.1128/JVI.76.14.7228-7238.2002; DEBRUS S, 1995, J VIROL, V69, P3240, DOI 10.1128/JVI.69.5.3240-3245.1995; Defechereux P, 1997, J VIROL, V71, P7073, DOI 10.1128/JVI.71.9.7073-7079.1997; DEFECHEREUX P, 1993, J VIROL, V67, P4379, DOI 10.1128/JVI.67.7.4379-4385.1993; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hiriart E, 2003, J BIOL CHEM, V278, P37790, DOI 10.1074/jbc.M305925200; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; MORIUCHI M, 1995, VIROLOGY, V208, P376, DOI 10.1006/viro.1995.1164; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; PERERA LP, 1994, J VIROL, V68, P2468, DOI 10.1128/JVI.68.4.2468-2477.1994; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; RODRIGUEZ PL, 1994, BIOTECHNIQUES, V17, P702; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; Sato B, 2003, J VIROL, V77, P12369, DOI 10.1128/JVI.77.22.12369-12372.2003; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Souki SK, 2009, J VIROL, V83, P8970, DOI 10.1128/JVI.00801-09; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Toth Z, 2006, NUCLEIC ACIDS RES, V34, P1237, DOI 10.1093/nar/gkl007; Toth Z, 2008, FRONT BIOSCI-LANDMRK, V13, P2939, DOI 10.2741/2899; Zhang Z, 2007, J VIROL, V81, P9024, DOI 10.1128/JVI.02666-06	49	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7882	10.1371/journal.pone.0007882	http://dx.doi.org/10.1371/journal.pone.0007882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924249	gold, Green Published, Green Submitted			2022-12-27	WOS:000271936700015
J	Ploemen, IHJ; Prudencio, M; Douradinha, BG; Ramesar, J; Fonager, J; van Gemert, GJ; Luty, AJF; Hermsen, CC; Sauerwein, RW; Baptista, FG; Mota, MM; Waters, AP; Que, I; Lowik, CWGM; Khan, SM; Janse, CJ; Franke-Fayard, BMD				Ploemen, Ivo H. J.; Prudencio, Miguel; Douradinha, Bruno G.; Ramesar, Jai; Fonager, Jannik; van Gemert, Geert-Jan; Luty, Adrian J. F.; Hermsen, Cornelus C.; Sauerwein, Robert W.; Baptista, Fernanda G.; Mota, Maria M.; Waters, Andrew P.; Que, Ivo; Lowik, Clemens W. G. M.; Khan, Shahid M.; Janse, Chris J.; Franke-Fayard, Blandine M. D.			Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HIGH-EFFICIENCY TRANSFECTION; IN-VIVO; EXOERYTHROCYTIC STAGES; DRUG DISCOVERY; BLOOD STAGES; PARASITES; BERGHEI; INFECTION; MICE	The quantitative analysis of Plasmodium development in the liver in laboratory animals in cultured cells is hampered by low parasite infection rates and the complicated methods required to monitor intracellular development. As a consequence, this important phase of the parasite's life cycle has been poorly studied compared to blood stages, for example in screening antimalarial drugs. Here we report the use of a transgenic P. berghei parasite, PbGFP-Luc(CON), expressing the bioluminescent reporter protein luciferase to visualize and quantify parasite development in liver cells both in culture and in live mice using real-time luminescence imaging. The reporter-parasite based quantification in cultured hepatocytes by real-time imaging or using a microplate reader correlates very well with established quantitative RT-PCR methods. For the first time the liver stage of Plasmodium is visualized in whole bodies of live mice and we were able to discriminate as few as 1-5 infected hepatocytes per liver in mice using 2D-imaging and to identify individual infected hepatocytes by 3D-imaging. The analysis of liver infections by whole body imaging shows a good correlation with quantitative RT-PCR analysis of extracted livers. The luminescence-based analysis of the effects of various drugs on in vitro hepatocyte infection shows that this method can effectively be used for in vitro screening of compounds targeting Plasmodium liver stages. Furthermore, by analysing the effect of primaquine and tafenoquine in vivo we demonstrate the applicability of real time imaging to assess parasite drug sensitivity in the liver. The simplicity and speed of quantitative analysis of liver-stage development by real-time imaging compared to the PCR methodologies, as well as the possibility to analyse liver development in live mice without surgery, opens up new possibilities for research on Plasmodium liver infections and for validating the effect of drugs and vaccines on the liver stage of Plasmodium.			Ploemen, IHJ (corresponding author), RUNMC, Dept Med Microbiol, Nijmegen, Netherlands.	bfranke@lumc.nl	Mota, Maria/AAF-2048-2019; Douradinha, Bruno/H-6945-2012; Prudêncio, Miguel/D-2032-2012; Prudêncio, Miguel/ABD-9282-2021; Luty, Adrian/CAH-2547-2022; Douradinha, Bruno/R-5832-2017; Hermsen, C.C./L-4368-2015; Fonager, Jannik/AAJ-8292-2020; Sauerwein, Robert/C-8519-2013; Waters, Andy P/C-9377-2009	Prudêncio, Miguel/0000-0003-1746-6029; Prudêncio, Miguel/0000-0003-1746-6029; Waters, Andy P/0000-0001-8900-2982; Luty, Adrian John Frederick/0000-0001-8830-3425; Fonager, Jannik/0000-0003-1688-1482; Mota, Maria Manuel/0000-0002-2858-1041; Douradinha, Bruno/0000-0002-9980-4505; Khan, Shahid/0000-0002-0533-4670; , Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205	Wellcome Trust [083811] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adak T, 2001, CLIN DIAGN LAB IMMUN, V8, P891, DOI 10.1128/CDLI.8.5.891-894.2001; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; BATES MD, 1990, AM J TROP MED HYG, V42, P532, DOI 10.4269/ajtmh.1990.42.532; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carraz M, 2008, BIOORGAN MED CHEM, V16, P6186, DOI 10.1016/j.bmc.2008.04.033; Craft JC, 2008, CURR OPIN MICROBIOL, V11, P428, DOI 10.1016/j.mib.2008.09.003; Cui Liwang, 2009, V470, P263, DOI 10.1007/978-1-59745-204-5_18; Cunha-Rodrigues Margarida, 2006, BMC Microbiol, V6, P73, DOI 10.1186/1471-2180-6-73; Cunha-Rodrigues M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002732; Evers A, 2008, BIOL CHEM, V389, P1523, DOI 10.1515/BC.2008.167; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Francois G, 1997, INT J PARASITOL, V27, P29, DOI 10.1016/S0020-7519(96)00171-3; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Henriquez NV, 2007, CLIN EXP METASTAS, V24, P699, DOI 10.1007/s10585-007-9115-5; Heussler V, 2006, TRENDS PARASITOL, V22, P192, DOI 10.1016/j.pt.2006.03.001; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KOK P, 2007, P SOC PHOTO-OPT INS, V6509, P1; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Lanteri Charlotte A, 2007, Recent Pat Antiinfect Drug Discov, V2, P95, DOI 10.2174/157489107780832640; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; LI J, 1991, EXP PARASITOL, V72, P450, DOI 10.1016/0014-4894(91)90091-A; Matuschewski K, 2007, CELL MOL LIFE SCI, V64, P3007, DOI 10.1007/s00018-007-7263-z; Menard R, 2007, B ACAD NAT MED PARIS, V191, P1261, DOI 10.1016/S0001-4079(19)32945-0; Mikolajczak SA, 2006, MOL MICROBIOL, V62, P1499, DOI 10.1111/j.1365-2958.2006.05470.x; MOST H, 1975, AM J TROP MED HYG, V24, P179, DOI 10.4269/ajtmh.1975.24.179; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; PETERS W, 1993, ANN TROP MED PARASIT, V87, P547, DOI 10.1080/00034983.1993.11812809; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rettig GR, 2006, ANAL BIOCHEM, V355, P90, DOI 10.1016/j.ab.2006.04.026; Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; Shanks GD, 2001, CLIN INFECT DIS, V33, P1968, DOI 10.1086/324081; Sharrock WW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-94; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Sturm A, 2009, PROTIST, V160, P51, DOI 10.1016/j.protis.2008.08.002; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Thiberge S, 2007, NAT PROTOC, V2, P1811, DOI 10.1038/nprot.2007.257; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; Walsh DS, 2004, J INFECT DIS, V190, P1456, DOI 10.1086/424468; Waters AP, 2005, SCIENCE, V307, P528, DOI 10.1126/science.1108598; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006	61	180	182	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7881	10.1371/journal.pone.0007881	http://dx.doi.org/10.1371/journal.pone.0007881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924309	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700014
J	Binder, H; Fasold, M; Glomb, T				Binder, Hans; Fasold, Mario; Glomb, Torsten			Mismatch and G-Stack Modulated Probe Signals on SNP Microarrays	PLOS ONE			English	Article							LIGHT-DIRECTED SYNTHESIS; HIGH-DENSITY; OLIGONUCLEOTIDE PROBES; GENECHIP-MICROARRAYS; DNA MICROARRAYS; NONSPECIFIC HYBRIDIZATION; HOOK-CALIBRATION; THERMODYNAMICS; STABILITY; DUPLEXES	Background: Single nucleotide polymorphism (SNP) arrays are important tools widely used for genotyping and copy number estimation. This technology utilizes the specific affinity of fragmented DNA for binding to surface-attached oligonucleotide DNA probes. We analyze the variability of the probe signals of Affymetrix GeneChip SNP arrays as a function of the probe sequence to identify relevant sequence motifs which potentially cause systematic biases of genotyping and copy number estimates. Methodology/Principal Findings: The probe design of GeneChip SNP arrays enables us to disentangle different sources of intensity modulations such as the number of mismatches per duplex, matched and mismatched base pairings including nearest and next-nearest neighbors and their position along the probe sequence. The effect of probe sequence was estimated in terms of triple-motifs with central matches and mismatches which include all 256 combinations of possible base pairings. The probe/target interactions on the chip can be decomposed into nearest neighbor contributions which correlate well with free energy terms of DNA/DNA-interactions in solution. The effect of mismatches is about twice as large as that of canonical pairings. Runs of guanines (G) and the particular type of mismatched pairings formed in cross-allelic probe/target duplexes constitute sources of systematic biases of the probe signals with consequences for genotyping and copy number estimates. The poly-G effect seems to be related to the crowded arrangement of probes which facilitates complex formation of neighboring probes with at minimum three adjacent G's in their sequence. Conclusions: The applied method of "triple-averaging'' represents a model-free approach to estimate the mean intensity contributions of different sequence motifs which can be applied in calibration algorithms to correct signal values for sequence effects. Rules for appropriate sequence corrections are suggested.			Binder, H (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.	binder@izbi.uni-leipzig.de	Binder, Hans/U-5519-2018	Binder, Hans/0000-0002-2242-4678				Bhasi K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl520; Binder H, 2006, Bioinformatics of Genome Regulation and Structure II, P451, DOI 10.1007/0-387-29455-4_43; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Binder H, 2005, BIOPHYS J, V89, P337, DOI 10.1529/biophysj.104.055343; Binder H, 2004, J PHYS CHEM B, V108, P18015, DOI 10.1021/jp049592o; Binder H, 2004, J PHYS CHEM B, V108, P18003, DOI 10.1021/jp049593g; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS491, DOI 10.1088/0953-8984/18/18/S02; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS537, DOI 10.1088/0953-8984/18/18/S04; Binder H, 2009, J PHYS CHEM B, V113, P2874, DOI 10.1021/jp808118m; Binder H, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-11; Binder H, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-12; BRUUN CM, 2007, NUCL ACIDS RES, V3; BURDEN C, 2009, PHYSICOCHEMICA UNPUB; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Burden CJ, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016004; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; DEUTSCH JM, 2004, ARXIVQBIOBM0406039V1; DI X, 2005, BIOINFORMATICS; FASOLD M, 2009, GGG BIAS GENEC UNPUB; Ferrantini A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-3; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Heim T, 2006, J PHYS-CONDENS MAT, V18, pS525, DOI 10.1088/0953-8984/18/18/S03; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; LAFRAMBOISE T, 2006, HARVARD U BIOSTATIST, V44, P1; Langdon WB, 2009, BRIEF BIOINFORM, V10, P259, DOI 10.1093/bib/bbp018; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Marcelino LA, 2006, P NATL ACAD SCI USA, V103, P13629, DOI 10.1073/pnas.0601476103; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4211, DOI 10.1093/nar/gkg476; McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Naiser T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218301; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Naiser T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-48; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pirrung MC, 1998, J ORG CHEM, V63, P241, DOI 10.1021/jo970872s; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Seringhaus M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-635; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Shen F, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-27; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Suhnel J, 2001, BIOPOLYMERS, V61, P32, DOI 10.1002/1097-0282(2001)61:1<32::AID-BIP10063>3.0.CO;2-B; Suzuki S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-373; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; Vetterling W.T., 1989, NUMERICAL RECIPES; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wu CL, 2007, BIOINFORMATICS, V23, P2566, DOI 10.1093/bioinformatics/btm271; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	59	7	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7862	10.1371/journal.pone.0007862	http://dx.doi.org/10.1371/journal.pone.0007862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924253	gold, Green Published, Green Submitted			2022-12-27	WOS:000271854200010
J	Gurvitz, A				Gurvitz, Aner			A C. elegans Model for Mitochondrial Fatty Acid Synthase II: The Longevity-Associated Gene W09H1.5/mecr-1 Encodes a 2-trans-Enoyl-Thioester Reductase	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; 2-ENOYL THIOESTER REDUCTASES; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; ESCHERICHIA-COLI; CAENORHABDITIS-ELEGANS; PEROXISOME PROLIFERATION; TRYPANOSOMA-BRUCEI; YEAST MITOCHONDRIA; RNAI SCREEN	Our recognition of the mitochondria as being important sites of fatty acid biosynthesis is continuously unfolding, especially in light of new data becoming available on compromised fatty acid synthase type 2 (FASII) in mammals. For example, perturbed regulation of murine 17 beta-HSD8 encoding a component of the mitochondrial FASII enzyme 3-oxoacyl-thioester reductase is implicated in polycystic kidney disease. In addition, over-expression in mice of the Mecr gene coding for 2-trans-enoyl-thioester reductase, also of mitochondrial FASII, leads to impaired heart function. However, mouse knockouts for mitochondrial FASII have hitherto not been reported and, hence, there is a need to develop alternate metazoan models such as nematodes or fruit flies. Here, the identification of Caenorhabditis elegans W09H1.5/MECR-1 as a 2-trans-enoyl-thioester reductase of mitochondrial FASII is reported. To identify MECR-1, Saccharomyces cerevisiae etr1 Delta mutant cells were employed that are devoid of mitochondrial 2-trans-enoyl-thioester reductase Etr1p. These yeast mutants fail to synthesize sufficient levels of lipoic acid or form cytochrome complexes, and cannot respire or grow on non-fermentable carbon sources. A mutant yeast strain ectopically expressing nematode mecr-1 was shown to contain reductase activity and resemble the self-complemented mutant strain for these phenotype characteristics. Since MECR-1 was not intentionally targeted for compartmentalization using a yeast mitochondrial leader sequence, this inferred that the protein represented a physiologically functional mitochondrial 2-trans-enoyl-thioester reductase. In accordance with published findings, RNAi-mediated knockdown of mecr-1 in C. elegans resulted in life span extension, presumably due to mitochondrial dysfunction. Moreover, old mecr-1(RNAi) worms had better internal organ appearance and were more mobile than control worms, indicating a reduced physiological age. This is the first report on RNAi work dedicated specifically to curtailing mitochondrial FASII in metazoans. The availability of affected survivors will help to position C. elegans as an excellent model for future pursuits in the emerging field of mitochondrial FASII research.			Gurvitz, A (corresponding author), Med Univ Vienna, Inst Physiol, Ctr Physiol Pathophysiol & Immunol, Sect Physiol Lipid Metab, Vienna, Austria.	aner.gurvitz@meduniwien.ac.at			Austrian Science Fund FWF [P 20764] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Ausubel FM, 1988, MOL REPROD DEV; Autio KJ, 2008, FEBS LETT, V582, P729, DOI 10.1016/j.febslet.2008.01.051; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; BOKERSCHMITT E, 1982, J BACTERIOL, V151, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DOMMES V, 1984, J BIOL CHEM, V259, P1781; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FILIPITS M, 1993, GENE, V132, P49, DOI 10.1016/0378-1119(93)90513-3; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Gurvitz A, 2008, APPL ENVIRON MICROB, V74, P5078, DOI 10.1128/AEM.00655-08; Gurvitz A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/235868; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2005, BIOCHEM SOC T, V33, P1162, DOI 10.1042/BST0331162; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; JONES EW, 1977, GENETICS, V85, P23; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Rose MD., 1990, METHODS YEAST GENETI; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; STUMPF PK, 1963, BIOCHIM BIOPHYS ACTA, V70, P20, DOI 10.1016/0006-3002(63)90715-7; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; YAMAZOE M, 1994, J BIOL CHEM, V269, P15244; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	55	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7791	10.1371/journal.pone.0007791	http://dx.doi.org/10.1371/journal.pone.0007791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924289	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000002
J	Oze, I; Hotta, K; Kiura, K; Ochi, N; Takigawa, N; Fujiwara, Y; Tabata, M; Tanimoto, M				Oze, Isao; Hotta, Katsuyuki; Kiura, Katsuyuki; Ochi, Nobuaki; Takigawa, Nagio; Fujiwara, Yoshiro; Tabata, Masahiro; Tanimoto, Mitsune			Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results	PLOS ONE			English	Article							RANDOMIZED-TRIAL; CHEMOTHERAPY; CISPLATIN; CYCLOPHOSPHAMIDE; VINCRISTINE; DOXORUBICIN; ETOPOSIDE; ETOPOSIDE/CISPLATIN; TOPOTECAN; SURVIVAL	Background: Few studies have formally assessed whether treatment outcomes have improved substantially over the years for patients with extensive disease small-cell lung cancer (ED-SCLC) enrolled in phase III trials. The objective of the current investigation was to determine the time trends in outcomes for the patients in those trials. Methods and Findings: We searched for trials that were reported between January 1981 and August 2008. Phase III randomized controlled trials were eligible if they compared first-line, systemic chemotherapy for ED-SCLC. Data were evaluated by using a linear regression analysis. Results: In total, 52 trials were identified that had been initiated between 1980 and 2006; these studies involved 10,262 patients with 110 chemotherapy arms. The number of randomized patients and the proportion of patients with good performance status (PS) increased over time. Cisplatin-based regimens, especially cisplatin and etoposide (PE) regimen, have increasingly been studied, whereas cyclophosphamide, doxorubicin, and vincristine-based regimens have been less investigated. Multiple regression analysis showed no significant improvement in survival over the years. Additionally, the use of a PE regimen did not affect survival, whereas the proportion of patients with good PS and the trial design of assigning prophylactic cranial irradiation were significantly associated with favorable outcome. Conclusions and Significance: The survival of patients with ED-SCLC enrolled in phase III trials did not improve significantly over the years, suggesting the need for further development of novel targets, newer agents, and comprehensive patient care.			Oze, I (corresponding author), Okayama Univ Hosp, Dept Resp Med, Okayama, Japan.	khotta@md.okayama-u.ac.jp	Oze, Isao/E-8288-2018; KIURA, Katsuyuki/B-1991-2011; Wang, Weili/D-1546-2011	Oze, Isao/0000-0002-0762-1147; Kiura, Katsuyuki/0000-0002-9172-9379				Baka S, 2008, BRIT J CANCER, V99, P442, DOI 10.1038/sj.bjc.6604480; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; Chute JP, 1999, J CLIN ONCOL, V17, P1794, DOI 10.1200/JCO.1999.17.6.1794; Eckardt JR, 2006, J CLIN ONCOL, V24, P2044, DOI 10.1200/JCO.2005.03.3332; FUKUOKA M, 1991, J NATL CANCER I, V83, P855, DOI 10.1093/jnci/83.12.855; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; HEIGENER DF, 2008, TOPOTECAN CISPLATIN; Hotta K, 2009, ANN ONCOL, V20, P829, DOI 10.1093/annonc/mdp020; Hotta K, 2007, CANCER-AM CANCER SOC, V109, P939, DOI 10.1002/cncr.22478; Ignatiadis M, 2005, CLIN LUNG CANCER, V7, P183, DOI 10.3816/CLC.2005.n.034; IHDE DC, 1995, CHEST, V107, pS243, DOI 10.1378/chest.107.6_Supplement.243S; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Kubota K, 2004, J CLIN ONCOL, V22, P254, DOI 10.1200/JCO.2004.06.114; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Noda W, 2002, NEW ENGL J MED, V346, P85, DOI 10.1056/NEJMoa003034; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; SMYTH JF, 1989, CHEST, V96, pS61, DOI 10.1378/chest.96.1_Supplement.61S; STAHEL RA, 1989, LUNG CANC, V5; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; von Pawel J, 1999, J CLIN ONCOL, V17, P658, DOI 10.1200/JCO.1999.17.2.658; ZELEN M, 1973, CANCER CHEMOTH REP 3, V4, P31	24	75	78	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7835	10.1371/journal.pone.0007835	http://dx.doi.org/10.1371/journal.pone.0007835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915681	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721900022
J	Snellman, G; Melhus, H; Gedeborg, R; Olofsson, S; Wolk, A; Pedersen, NL; Michaelsson, K				Snellman, Greta; Melhus, Hakan; Gedeborg, Rolf; Olofsson, Sylvia; Wolk, Alicja; Pedersen, Nancy L.; Michaelsson, Karl			Seasonal Genetic Influence on Serum 25-Hydroxyvitamin D Levels: A Twin Study	PLOS ONE			English	Article							VITAMIN-D STATUS; BONE-MINERAL DENSITY; PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; DIETARY-INTAKE; D DEFICIENCY; HUMAN-SKIN; RISK; POPULATION; EXPOSURE	Background: Although environmental factors, mainly nutrition and UV-B radiation, have been considered major determinants of vitamin D status, they have only explained a modest proportion of the variation in serum 25-hydroxyvitamin D. We aimed to study the seasonal impact of genetic factors on serum 25-hydroxyvitamin D concentrations. Methodology/Principal findings: 204 same-sex twins, aged 39-85 years and living at northern latitude 60 degrees, were recruited from the Swedish Twin Registry. Serum 25-hydroxyvitamin D was analysed by high-pressure liquid chromatography and mass spectrometry. Genetic modelling techniques estimated the relative contributions of genetic, shared and individual-specific environmental factors to the variation in serum vitamin D. The average serum 25-hydroxyvitamin D concentration was 84.8 nmol/l (95% CI 81.0-88.6) but the seasonal variation was substantial, with 24.2 nmol/l (95% CI 16.3-32.2) lower values during the winter as compared to the summer season. Half of the variability in 25-hydroxyvitamin D during the summer season was attributed to genetic factors. In contrast, the winter season variation was largely attributable to shared environmental influences (72%; 95% CI 48-86%), i.e., solar altitude. Individual-specific environmental influences were found to explain one fourth of the variation in serum 25-hydroxyvitamin D independent of season. Conclusions/Significance: There exists a moderate genetic impact on serum vitamin D status during the summer season, probably through the skin synthesis of vitamin D. Further studies are warranted to identify the genes impacting on vitamin D status.			Snellman, G (corresponding author), Univ Uppsala Hosp, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden.	greta.snellman@surgsci.uu.se	Gedeborg, Rolf/AAV-6702-2020; Michaelsson, Karl/AAM-9094-2021	Gedeborg, Rolf/0000-0002-8850-7863; Michaelsson, Karl/0000-0003-2815-1217				Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CLEMENS TL, 1982, LANCET, V1, P74; Cui Y, 2006, CANCER EPIDEM BIOMAR, V15, P1427, DOI 10.1158/1055-9965.EPI-06-0075; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Glendenning P, 2006, ANN CLIN BIOCHEM, V43, P23, DOI 10.1258/000456306775141650; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 1997, STAT MODELLING; PERSSON T, 2000, METEOROLOGY CLIMAOLO, V89; Saquib N, 2006, OSTEOPOROSIS INT, V17, P1734, DOI 10.1007/s00198-006-0191-1; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; SOWERS MR, 1986, AM J CLIN NUTR, V43, P621, DOI 10.1093/ajcn/43.4.621; Tsugawa N, 2005, ANAL CHEM, V77, P3001, DOI 10.1021/ac048249c; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	38	84	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7747	10.1371/journal.pone.0007747	http://dx.doi.org/10.1371/journal.pone.0007747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915719	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721900006
J	Pontzer, H; Allen, V; Hutchinson, JR				Pontzer, Herman; Allen, Vivian; Hutchinson, John R.			Biomechanics of Running Indicates Endothermy in Bipedal Dinosaurs	PLOS ONE			English	Article							THEROPOD DINOSAUR; SENSITIVITY-ANALYSIS; OXYGEN-CONSUMPTION; BODY TEMPERATURES; GROWTH-RATES; EVOLUTION; BIRDS; COST; ENERGETICS; PHYLOGENY	Background: One of the great unresolved controversies in paleobiology is whether extinct dinosaurs were endothermic, ectothermic, or some combination thereof, and when endothermy first evolved in the lineage leading to birds. Although it is well established that high, sustained growth rates and, presumably, high activity levels are ancestral for dinosaurs and pterosaurs (clade Ornithodira), other independent lines of evidence for high metabolic rates, locomotor costs, or endothermy are needed. For example, some studies have suggested that, because large dinosaurs may have been homeothermic due to their size alone and could have had heat loss problems, ectothermy would be a more plausible metabolic strategy for such animals. Methodology/Principal Findings: Here we describe two new biomechanical approaches for reconstructing the metabolic rate of 14 extinct bipedal dinosauriforms during walking and running. These methods, well validated for extant animals, indicate that during walking and slow running the metabolic rate of at least the larger extinct dinosaurs exceeded the maximum aerobic capabilities of modern ectotherms, falling instead within the range of modern birds and mammals. Estimated metabolic rates for smaller dinosaurs are more ambiguous, but generally approach or exceed the ectotherm boundary. Conclusions/Significance: Our results support the hypothesis that endothermy was widespread in at least larger non-avian dinosaurs. It was plausibly ancestral for all dinosauriforms (perhaps Ornithodira), but this is perhaps more strongly indicated by high growth rates than by locomotor costs. The polarity of the evolution of endothermy indicates that rapid growth, insulation, erect postures, and perhaps aerobic power predated advanced "avian" lung structure and high locomotor costs.			Pontzer, H (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	hpontzer@artsci.wustl.edu	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038; Pontzer, Herman/0000-0003-2397-6543				ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Bennett A.F., 1976, P127; Bennett A.F., 1986, P207; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2005, J VERTEBR PALEONTOL, V25, P835, DOI 10.1671/0272-4634(2005)025[0835:NIOSHA]2.0.CO;2; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; FARLOW JO, 1995, ANNU REV ECOL SYST, V26, P445, DOI 10.1146/annurev.es.26.110195.002305; Farmer CG, 2000, AM NAT, V155, P326, DOI 10.1086/303323; Farmer CG, 2003, AM NAT, V162, P826, DOI 10.1086/380922; GATESY SM, 1991, J ZOOL, V224, P577, DOI 10.1111/j.1469-7998.1991.tb03786.x; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gleeson TT, 2002, COMP BIOCHEM PHYS A, V133, P259, DOI 10.1016/S1095-6433(02)00164-2; Gunga HC, 2007, NATURWISSENSCHAFTEN, V94, P623, DOI 10.1007/s00114-007-0234-2; HAUBOLD H, 1999, ZBL GEOL PALAONT 1, V7, P783; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; JOHNALDER HB, 1986, PHYSIOL ZOOL, V59, P523, DOI 10.1086/physzool.59.5.30156116; Kleiber M, 1961, FIRE LIFE; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Maddison WP, 2019, MESQUITE MODULAR SYS; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; OSTROM JH, 1980, COLD LOOK WARM BLOOD, P15; Owerkowicz T, 1999, SCIENCE, V284, P1661, DOI 10.1126/science.284.5420.1661; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Paul G., 1988, PREDATORY DINOSAURS; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Reid R.E.H., 1997, P449; Ricqles A. de, 1974, EVOL THEORY, V1, P51; Roberts TJ, 1998, J EXP BIOL, V201, P2753; Ruben JA, 1996, SCIENCE, V273, P1204, DOI 10.1126/science.273.5279.1204; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Schweitzer MH, 2001, J EXP ZOOL, V291, P317, DOI 10.1002/jez.1132; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; SERENO P, 1991, J VERTEBR PALEONTOL, V2, P1; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wedel M. J., 2008, J EXP ZOOL PART A, V311A, P1; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	70	50	50	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A127	A135	e7783	10.1371/journal.pone.0007783	http://dx.doi.org/10.1371/journal.pone.0007783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19911059	Green Published, gold			2022-12-27	WOS:000271685800014
J	Staikowsky, F; Talarmin, F; Grivard, P; Souab, A; Schuffenecker, I; Le Roux, K; Lecuit, M; Michault, A				Staikowsky, Frederik; Talarmin, Francois; Grivard, Philippe; Souab, Abdel; Schuffenecker, Isabelle; Le Roux, Karin; Lecuit, Marc; Michault, Alain			Prospective Study of Chikungunya Virus Acute Infection in the Island of La Reunion during the 2005-2006 Outbreak	PLOS ONE			English	Article							INDIAN-OCEAN; DISEASE; DIAGNOSIS; TRAVELERS; EPIDEMIC; DENGUE; FEVER	Background: Chikungunya virus (CHIKV) is a recently re-emerged arthropod borne virus responsible for a massive outbreak in the Indian Ocean and India, and extended to Southeast Asia as well as Italy. CHIKV has adapted to Aedes albopictus, an anthropophilic mosquito species widely distributed in Asia, Europe, Africa and America. Our objective was to determine the clinical and biological features of patients at the acute phase of CHIKV infection. Methods and Findings: A prospective study enrolled 274 consecutive patients with febrile arthralgia recorded at the Emergency Department of the Groupe Hospitalier Sud-Reunion between March and May 2006. Three groups were defined: one group of 180 viremic patients ( positive CHIKV RT-PCR), one group of 34 patients with acute post-viremic infection ( negative CHIKV RT-PCR, positive anti-CHIKV IgM and negative IgG), and one group of 46 uninfected patients ( negative CHIKV RT-PCR, anti-CHIKV IgM and IgG). Bivariate analyses of clinical and biological features between groups were performed. Patients with CHIKV viremia presented typically with asymmetrical bilateral polyarthralgia (96.5%) affecting the lower (98%) and small joints (74.8%), as well as asthenia (88.6%), headache (70%), digestive trouble (63.3%), myalgia (59%), exanthems (47.8%), conjunctival hyperhemia (23%) and adenopathy (8.9%). Vertigo, cutaneous dysesthesia, pharyngitis and haemorrhages were seldom observed. So far unreported symptoms such as chondrocostal arthralgia (20%), entesopathies (1.6%), talalgia (14%) were also noted. Prurit was less frequent during the viremic than post-viremic phase (13.9% vs. 41.2%; p < 0.001), whereas lymphopenia was more frequent (87.6% vs. 39.4%; p < 0.001). Others biological abnormalities included leukopenia (38.3%), thrombocytopenia (37.3%), increased ASAT and ALAT blood levels (31.6 and 7.3%, respectively) and hypocalcemia (38.7%). Lymphopenia <1,000/mm(3) was very closely associated with viremic patients (Yule coefficient 0.82, positive predictive value 92.3%). Age under 65 was associated with a benign course, as no patients younger than 65 had to be hospitalized (Yule coefficient 0.78). Conclusions: The diagnosis of CHIKV infection in acute phase is based on commonly accepted clinical criteria ( fever and arthralgia), however clinical and biological diffrences exist in acute phase depending on whether or not the patient is within the viremic phase of the infection.			Staikowsky, F (corresponding author), Ctr Hosp Reg La Reunion, Emergency Dept, Grp Hosp Sud Reunion, St Pierre, La Reunion, France.	frederik.staikowsky@chr-reunion.fr	Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063				Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BRIGHTON SW, 1983, S AFR MED J, V63, P313; CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; DELLER JJ, 1968, AM J TROP MED HYG, V17, P107; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; FOURIE ED, 1979, S AFR MED J, V56, P130; GARNIER PP, 2006, B SOC PATHOL EXOT, V99, P143; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002; KENNEDY AC, 1980, J RHEUMATOL, V7, P231; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Maiti C R, 1978, J Indian Med Assoc, V70, P256; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MARTINET O, 2006, B SOC PATHO EXOT, V99, P138; Mazaud R, 1971, Bull Soc Pathol Exot Filiales, V64, P22; OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Paganin F, 2007, INTENS CARE MED, V33, P1959, DOI 10.1007/s00134-007-0776-y; Perrau J, 2007, EC REUNION, V129, P16; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424; SUTTON RNP, 1984, LANCET, V1, P1243; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WEISS HJ, 1965, P SOC EXP BIOL MED, V119, P427, DOI 10.3181/00379727-119-30201	36	88	91	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7603	10.1371/journal.pone.0007603	http://dx.doi.org/10.1371/journal.pone.0007603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19893613	Green Published, Green Submitted, gold			2022-12-27	WOS:000271194600008
J	Freeman, E; Verghese, P				Freeman, Elliot; Verghese, Preeti			Peeling Plaids Apart: Context Counteracts Cross-Orientation Contrast Masking	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; HUMAN-VISION; SPATIAL DISCRIMINATIONS; SPEED DISCRIMINATION; PERCEIVED CONTRAST; SURROUND CONTRAST; MOTION PERCEPTION; ATTENTION; UNCERTAINTY; SEGMENTATION	Background: Contrast discrimination for an image is usually harder if another image is superimposed on top. We asked whether such contrast masking may be enhanced or relieved depending on cues promoting integration of both images as a single pattern, versus segmentation into two independent components. Methodology & Principal Findings: Contrast discrimination thresholds for a foveal test grating were sharply elevated in the presence of a perfectly overlapping orthogonally-oriented mask grating. However thresholds returned to the unmasked baseline when a surround grating was added, having the same orientation and phase of either the test or mask grating. Both such masking and 'unmasking' effects were much stronger for moving than static stimuli. Conclusions & Significance: Our results suggest that common-fate motion reinforces the perception of a single coherent plaid pattern, while the surround helps to identify each component independently, thus peeling the plaid apart again. These results challenge current models of early vision, suggesting that higher-level surface organization influences contrast encoding, determining whether the contrast of a grating may be recovered independently from that of its mask.	[Freeman, Elliot] City Univ London, Dept Psychol, London EC1V 0HB, England; [Verghese, Preeti] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	City University London; The Smith-Kettlewell Eye Research Institute	Freeman, E (corresponding author), City Univ London, Dept Psychol, London EC1V 0HB, England.	elliot.freeman@city.ac.uk		Freeman, Elliot/0000-0001-7234-824X	UK Biotechnology and Biological Sciences Research Council [S20366]; Brunel Research Initiative and Enterprise Fund; City University research fund; NSF [0347051, 0642728]; Biotechnology and Biological Sciences Research Council [S20366] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Brunel Research Initiative and Enterprise Fund; City University research fund; NSF(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Smith-Kettlewell Eye Research Institute funds to EF (Rachel C Atkinson Fellowship) and to PV. Additional support came from the UK Biotechnology and Biological Sciences Research Council grant S20366 (EF), the Brunel Research Initiative and Enterprise Fund (EF), City University research fund (EF), and NSF grants 0347051 and 0642728 (PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Cheng EM, 2008, PARKINSONISM RELAT D, V14, P8, DOI 10.1016/j.parkreldis.2007.05.001; Foley JM, 1997, VISION RES, V37, P2781; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Georgeson MA, 1997, VISION RES, V37, P3255, DOI 10.1016/S0042-6989(97)00124-7; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Grossberg S, 2000, VISION RES, V40, P1413, DOI 10.1016/S0042-6989(99)00229-1; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Mareschal I, 2001, VISION RES, V41, P1915, DOI 10.1016/S0042-6989(01)00082-7; Matthews N, 1999, VISION RES, V39, P2205, DOI 10.1016/S0042-6989(98)00300-9; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Meese TS, 2004, J VISION, V4, P930, DOI 10.1167/4.10.8; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Olzak LA, 2005, J OPT SOC AM A, V22, P2230, DOI 10.1364/JOSAA.22.002230; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Petrov Y, 2006, J VISION, V6, P170, DOI 10.1167/6.2.8; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Qiu FTT, 2007, NAT NEUROSCI, V10, P283, DOI 10.1038/nn1853; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; ROSS J, 1993, VISION RES, V33, P2051, DOI 10.1016/0042-6989(93)90003-F; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; van der Smagt MJ, 2005, J NEUROPHYSIOL, V94, P576, DOI 10.1152/jn.00366.2004; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; VOGELS R, 1988, PERCEPTION, V17, P565, DOI 10.1068/p170565; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Weidenbacher U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005909; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; WELCH L, 1990, PERCEPTION, V19, P425, DOI 10.1068/p190425; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yazdanbakhsh A, 2004, NEURAL NETWORKS, V17, P707, DOI 10.1016/j.neunet.2004.06.005; Yu C, 2003, J VISION, V3, P527, DOI 10.1167/3.8.1; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8123	10.1371/journal.pone.0008123	http://dx.doi.org/10.1371/journal.pone.0008123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MU	19956546	Green Published, Green Accepted, gold			2022-12-27	WOS:000272828800017
J	Rand, DG; Pfeiffer, T				Rand, David G.; Pfeiffer, Thomas			Systematic Differences in Impact across Publication Tracks at PNAS	PLOS ONE			English	Article								Background: Citation data can be used to evaluate the editorial policies and procedures of scientific journals. Here we investigate citation counts for the three different publication tracks of the Proceedings of the National Academy of Sciences of the United States of America (PNAS). This analysis explores the consequences of differences in editor and referee selection, while controlling for the prestige of the journal in which the papers appear. Methodology/Principal Findings: We find that papers authored and "Contributed" by NAS members (Track III) are on average cited less often than papers that are "Communicated" for others by NAS members (Track I) or submitted directly via the standard peer review process (Track II). However, we also find that the variance in the citation count of Contributed papers, and to a lesser extent Communicated papers, is larger than for direct submissions. Therefore when examining the 10% most-cited papers from each track, Contributed papers receive the most citations, followed by Communicated papers, while Direct submissions receive the least citations. Conclusion/Significance: Our findings suggest that PNAS "Contributed" papers, in which NAS-member authors select their own reviewers, balance an overall lower impact with an increased probability of publishing exceptional papers. This analysis demonstrates that different editorial procedures are associated with different levels of impact, even within the same prominent journal, and raises interesting questions about the most appropriate metrics for judging an editorial policy's success.	[Rand, David G.; Pfeiffer, Thomas] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Harvard Univ, Berkman Ctr Internet & Soc, Cambridge, MA 02138 USA	Harvard University; Harvard University	Rand, DG (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	drand@fas.harvard.edu	Pfeiffer, Thomas/R-1339-2019; Rand, David G./B-3716-2009	Pfeiffer, Thomas/0000-0002-0592-577X; Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	National Science Foundation-National Institutes of Health [R01GM078986]; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	National Science Foundation-National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Science Foundation-National Institutes of Health joint program in mathematical biology (NIH grant R01GM078986), the John Templeton Foundation (http://www.templeton.org/), J. Epstein and the Society in Science/The Branco Weiss Fellowship (http://www.society-in-science.ethz.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; [Anonymous], 2005, P NATL ACAD SCI USA, V102, P6241, DOI 10.1073/pnas.0502713102; Bergstrom CT, 2006, FRONT ECOL ENVIRON, V4, P488, DOI 10.1890/1540-9295(2006)4[488:TEOEJ]2.0.CO;2; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; JULAIN J, 2005, LINEAR MODELS R; Kean S, 2009, SCIENCE, V325, P1486, DOI 10.1126/science.325_1486b; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; LARIVIERE V, 2009, ARXIV09083177V0901PH; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; MacCallum CJ, 2006, PLOS BIOL, V4, P661, DOI 10.1371/journal.pbio.0040176; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793	14	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8092	10.1371/journal.pone.0008092	http://dx.doi.org/10.1371/journal.pone.0008092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956649	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700008
J	Falagas, ME; Akrivos, PD; Alexiou, VG; Saridakis, V; Moutos, T; Peppas, G; Kondilis, BK				Falagas, Matthew E.; Akrivos, Patrick D.; Alexiou, Vangelis G.; Saridakis, Vasilios; Moutos, Theofanis; Peppas, George; Kondilis, Barbara K.			Patients' Perception of Quality of Pre-Operative Informed Consent in Athens, Greece: A Pilot Study	PLOS ONE			English	Article							DECISION-MAKING; CLINICAL-TRIAL; INFORMATION; PARTICIPATION; FORMS	Background: We sought to perform a study to record and evaluate patients' views of the way surgeons communicate informed consent (IC) in Greece. Methodology/Principal Findings: A prospective pilot study was carried out in Athens from 9/2007 to 4/2008. The study sample was extracted from patients, operated by eight different surgeons, who volunteered to fill in a post-surgery self-report questionnaire on IC. A composite delivered information index and a patient-physician relationship index were constructed for the purposes of the analysis. In total, 77 patients (42 males) volunteered to respond to the questionnaire. The delivered information index scores ranged from 3 to 10, the mean score was 8, and the standard deviation (SD) was 1.9. All patients were aware of their underlying diagnosis and reason for surgery. However, a considerable proportion of the respondents (14.3%) achieved a score below or equal to 5. The patient-physician relationship scores ranged from 0 to 20, the mean score was 16 and the standard deviation (SD) was 4.3. The better the patient-physician relationship, the more information was finally delivered to the patient from the physician (Spearman's rank-order correlation coefficient was 0.4 and p<0.001). Delivered information index was significantly higher among participants who comprehended the right to informed consent, compared to participants who did not (p<0.001), and among participants who were given information regarding other possible therapeutic options (p = 0.001). 43% of the respondents answered that less than 10 minutes were spent on the consent process, 58.4% of patients stated that they had not been informed about other possible therapeutic choices and 28.6% did not really comprehend their legal rights to IC. Conclusions: Despite the inherent limitations and the small sample size that do not permit to draw any firm conclusions, results indicate that a successful IC process may be associated with specific elements such as the patient-physician relationship, the time spent by the physician to inform the patient, a participant's comprehension of the right to IC and the provision of information regarding other possible therapeutic options.	[Falagas, Matthew E.; Akrivos, Patrick D.; Alexiou, Vangelis G.; Moutos, Theofanis; Peppas, George; Kondilis, Barbara K.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Akrivos, Patrick D.; Kondilis, Barbara K.] Hellen Amer Univ, Athens, Greece; [Saridakis, Vasilios] Agia Barbara Gen Hosp W Attica, Dept Surg, Athens, Greece; [Moutos, Theofanis] Henry Dunant Hosp, Dept Ophthalmol, Athens, Greece; [Peppas, George] Henry Dunant Hosp, Dept Surg, Athens, Greece	Alfa Institute Of Biomedical Sciences; Tufts University; Hellenic American University; Henry Dunant Hospital; Henry Dunant Hospital	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Alexiou, Vangelis/GLR-9050-2022	Alexiou, Vangelis/0000-0003-1388-4880	Marie Curie Reintegration Grant	Marie Curie Reintegration Grant(European Commission)	Partial funds utilized from a Marie Curie Reintegration Grant to Barbara K. Kondilis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass PF, 2002, ACAD MED, V77, P1039, DOI 10.1097/00001888-200210000-00021; Bottrell MM, 2000, ARCH SURG-CHICAGO, V135, P26, DOI 10.1001/archsurg.135.1.26; CASSILETH BR, 1980, NEW ENGL J MED, V302, P896, DOI 10.1056/NEJM198004173021605; CHRISTOPOULOS P, 1977, WORLD J SURG, V31, P1587; Cox K, 2002, PATIENT EDUC COUNS, V46, P31, DOI 10.1016/S0738-3991(01)00147-1; Coyne CA, 2003, J CLIN ONCOL, V21, P836, DOI 10.1200/JCO.2003.07.022; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; DAWES PJD, 1994, J ROY SOC MED, V87, P149; Dormandy E, 2007, PATIENT EDUC COUNS, V66, P278, DOI 10.1016/j.pec.2007.01.001; Guarino P, 2006, J CLIN EPIDEMIOL, V59, P608, DOI 10.1016/j.jclinepi.2005.11.009; HAFEEZ A, 2007, BJU INT, V60, P294; *HELL NAT COMM, 2008, HELL NAT COMM BIOETH; Kusec S, 2006, PATIENT EDUC COUNS, V60, P294, DOI 10.1016/j.pec.2005.10.009; Langdon IJ, 2002, ANN ROY COLL SURG, V84, P404, DOI 10.1308/003588402760978201; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Merakou Koula, 1999, Eur J Health Law, V6, P71, DOI 10.1163/15718099920522695; Schneider C.E., 1998, PRACTICE AUTONOMY; SUTHERLAND HJ, 1989, J ROY SOC MED, V82, P260, DOI 10.1177/014107688908200506; TOBIAS JS, 1993, BRIT MED J, V307, P1199, DOI 10.1136/bmj.307.6913.1199; Wackerbarth SB, 2007, PATIENT EDUC COUNS, V66, P43, DOI 10.1016/j.pec.2006.10.003; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012	23	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8073	10.1371/journal.pone.0008073	http://dx.doi.org/10.1371/journal.pone.0008073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MN	19956713	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828100013
J	Meir, A; Rubinsky, B				Meir, Arie; Rubinsky, Boris			Distributed Network, Wireless and Cloud Computing Enabled 3-D Ultrasound; a New Medical Technology Paradigm	PLOS ONE			English	Article							COST	Medical technologies are indispensable to modern medicine. However, they have become exceedingly expensive and complex and are not available to the economically disadvantaged majority of the world population in underdeveloped as well as developed parts of the world. For example, according to the World Health Organization about two thirds of the world population does not have access to medical imaging. In this paper we introduce a new medical technology paradigm centered on wireless technology and cloud computing that was designed to overcome the problems of increasing health technology costs. We demonstrate the value of the concept with an example; the design of a wireless, distributed network and central (cloud) computing enabled three-dimensional (3-D) ultrasound system. Specifically, we demonstrate the feasibility of producing a 3-D high end ultrasound scan at a central computing facility using the raw data acquired at the remote patient site with an inexpensive low end ultrasound transducer designed for 2-D, through a mobile device and wireless connection link between them. Producing high-end 3D ultrasound images with simple low-end transducers reduces the cost of imaging by orders of magnitude. It also removes the requirement of having a highly trained imaging expert at the patient site, since the need for hand-eye coordination and the ability to reconstruct a 3-D mental image from 2-D scans, which is a necessity for high quality ultrasound imaging, is eliminated. This could enable relatively untrained medical workers in developing nations to administer imaging and a more accurate diagnosis, effectively saving the lives of people.			Meir, A (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Serv Humanity & Soc, Ctr Bioengn, Jerusalem, Israel.	arie.coach@gmail.com	Rubinsky, Boris/B-4439-2010	Rubinsky, Boris/0000-0002-2794-1543				Ali A, 2007, COMPUT BIOL MED, V37, P1141, DOI 10.1016/j.compbiomed.2006.10.003; BUDE RO, 1995, J CLIN ULTRASOUND, V23, P271, DOI 10.1002/jcu.1870230413; DICKSON BW, 2008, THESIS WORCESTER POL; Gee A, 2003, PATTERN RECOGN LETT, V24, P757, DOI 10.1016/S0167-8655(02)00180-0; GOES CE, 2006, IFMBE P WORLD C MED, P2456; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; KELLY IMG, 1994, RADIOLOGY, V192, P253, DOI 10.1148/radiology.192.1.8208948; Kwok R, 2009, NATURE, V458, P959, DOI 10.1038/458959a; Laufer S, 2009, IEEE T BIO-MED ENG, V56, P525, DOI 10.1109/TBME.2008.2003105; Laufer S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005178; MARTINI MG, 2007, C P IEEE ENG MED BIO, P3082; Mercier L, 2005, ULTRASOUND MED BIOL, V31, P587, DOI 10.1016/j.ultrasmedbio.2005.03.001; MOSER M, 2008, VISION MODELING VISU, P217; Otten DM, 2004, TECHNOL CANCER RES T, V3, P125, DOI 10.1177/153303460400300205; RAHNI AAA, 2008, P 4 KUAL LUMP INT C; RUBINSKY B, 2004, Patent No. 6725087; *WHO, WHO REP DIAGN IM; *WHO, WHO REP ESS DIAGN IM; World Health Organization-WHO, 2003, ESS HLTH TECHN STRAT	19	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7974	10.1371/journal.pone.0007974	http://dx.doi.org/10.1371/journal.pone.0007974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936236	Green Published, gold			2022-12-27	WOS:000272004600023
J	Steegers-Theunissen, RP; Obermann-Borst, SA; Kremer, D; Lindemans, J; Siebel, C; Steegers, EA; Slagboom, PE; Heijmans, BT				Steegers-Theunissen, Regine P.; Obermann-Borst, Sylvia A.; Kremer, Dennis; Lindemans, Jan; Siebel, Cissy; Steegers, Eric A.; Slagboom, P. Eline; Heijmans, Bastiaan T.			Periconceptional Maternal Folic Acid Use of 400 mu g per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; DNA METHYLATION; BECKWITH-WIEDEMANN; FETAL-GROWTH; FORTIFICATION; CANCER; SUPPLEMENTATION; HOMOCYSTEINE; ASSOCIATION; PREVALENCE	Background: Countries worldwide recommend women planning pregnancy to use daily 400 mg of synthetic folic acid in the periconceptional period to prevent birth defects in children. The underlying mechanisms of this preventive effect are not clear, however, epigenetic modulation of growth processes by folic acid is hypothesized. Here, we investigated whether periconceptional maternal folic acid use and markers of global DNA methylation potential (S-adenosylmethionine and S-adenosylhomocysteine blood levels) in mothers and children affect methylation of the insulin-like growth factor 2 gene differentially methylation region (IGF2 DMR) in the child. Moreover, we tested whether the methylation of the IGF2 DMR was independently associated with birth weight. Methodology/Principal Findings: IGF2 DMR methylation in 120 children aged 17 months (SD 0.3) of whom 86 mothers had used and 34 had not used folic acid periconceptionally were studied. Methylation was measured of 5 CpG dinucleotides covering the DMR using a mass spectrometry-based method. Children of mother who used folic acid had a 4.5% higher methylation of the IGF2 DMR than children who were not exposed to folic acid (49.5% vs. 47.4%; p = 0.014). IGF2 DMR methylation of the children also was associated with the S-adenosylmethionine blood level of the mother but not of the child (+1.7% methylation per SD S-adenosylmethionine; p = 0.037). Finally, we observed an inverse independent association between IGF2 DMR methylation and birth weight (21.7% methylation per SD birthweight; p = 0.034). Conclusions: Periconceptional folic acid use is associated with epigenetic changes in IGF2 in the child that may affect intrauterine programming of growth and development with consequences for health and disease throughout life. These results indicate plasticity of IGF2 methylation by periconceptional folic acid use.			Steegers-Theunissen, RP (corresponding author), Univ Med Ctr, Erasmus MC, Div Obstet & Prenatal Med, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl	Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; AROSIO M, 1995, J ENDOCRINOL INVEST, V18, P346, DOI 10.1007/BF03347836; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; De Wals P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godwin KA, 2008, CAN J PUBLIC HEALTH, V99, P271, DOI 10.1007/BF03403753; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Nurk E, 2004, AM J CLIN NUTR, V79, P812; Ray JG, 2003, J PEDIATR-US, V143, P805, DOI 10.1067/S0022-3476(03)00495-5; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Scholl TO, 1996, AM J CLIN NUTR, V63, P520, DOI 10.1093/ajcn/63.4.520; Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Trollmann R, 1996, EUR J PEDIATR SURG, V6, P42; van Driel LMJW, 2008, OBSTET GYNECOL, V112, P277, DOI 10.1097/AOG.0b013e31817dd058; Verkleij-Hagoort AC, 2006, BJOG-INT J OBSTET GY, V113, P1412, DOI 10.1111/j.1471-0528.2006.01109.x; Waterland RA, 2003, J NUTR, V133, P238, DOI 10.1093/jn/133.1.238; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; WILLET W, 1998, NUTR EPIDEMIOLOGY, P38; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	34	331	343	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7845	10.1371/journal.pone.0007845	http://dx.doi.org/10.1371/journal.pone.0007845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924280	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000005
J	Fontela, PS; Pai, NP; Schiller, I; Dendukuri, N; Ramsay, A; Pai, M				Fontela, Patricia Scolari; Pai, Nitika Pant; Schiller, Ian; Dendukuri, Nandini; Ramsay, Andrew; Pai, Madhukar			Quality and Reporting of Diagnostic Accuracy Studies in TB, HIV and Malaria: Evaluation Using QUADAS and STARD Standards	PLOS ONE			English	Article							GRADING QUALITY; TUBERCULOSIS; STRENGTH; TRIALS	Background: Poor methodological quality and reporting are known concerns with diagnostic accuracy studies. In 2003, the QUADAS tool and the STARD standards were published for evaluating the quality and improving the reporting of diagnostic studies, respectively. However, it is unclear whether these tools have been applied to diagnostic studies of infectious diseases. We performed a systematic review on the methodological and reporting quality of diagnostic studies in TB, malaria and HIV. Methods: We identified diagnostic accuracy studies of commercial tests for TB, malaria and HIV through a systematic search of the literature using PubMed and EMBASE (2004-2006). Original studies that reported sensitivity and specificity data were included. Two reviewers independently extracted data on study characteristics and diagnostic accuracy, and used QUADAS and STARD to evaluate the quality of methods and reporting, respectively. Findings: Ninety (38%) of 238 articles met inclusion criteria. All studies had design deficiencies. Study quality indicators that were met in less than 25% of the studies included adequate description of withdrawals (6%) and reference test execution (10%), absence of index test review bias (19%) and reference test review bias (24%), and report of uninterpretable results (22%). In terms of quality of reporting, 9 STARD indicators were reported in less than 25% of the studies: methods for calculation and estimates of reproducibility (0%), adverse effects of the diagnostic tests (1%), estimates of diagnostic accuracy between subgroups (10%), distribution of severity of disease/other diagnoses (11%), number of eligible patients who did not participate in the study (14%), blinding of the test readers (16%), and description of the team executing the test and management of indeterminate/outlier results (both 17%). The use of STARD was not explicitly mentioned in any study. Only 22% of 46 journals that published the studies included in this review required authors to use STARD. Conclusion: Recently published diagnostic accuracy studies on commercial tests for TB, malaria and HIV have moderate to low quality and are poorly reported. The more frequent use of tools such as QUADAS and STARD may be necessary to improve the methodological and reporting quality of future diagnostic accuracy studies in infectious diseases.			Fontela, PS (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020; Fontela, Patricia/S-6455-2019	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Pant Pai, Nitika/0000-0002-4672-0500	Canadian Institutes of Health Research [MOP-89918] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Aregawi M, 2008, WORLD MALARIA REPORT; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cot M, 2005, REV EPIDEMIOL SANTE, V53, P291, DOI 10.1016/S0398-7620(05)84606-1; DYE C, 2008, GLOBAL TUBERCULOSIS; Hopkins H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2606; International Committee of Medical Journal Editors, 2008, BIOMEDICAL J UNPUB; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Pai M, 2008, SEMIN RESP CRIT CARE, V29, P560, DOI 10.1055/s-0028-1085707; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2009, EXPERT REV MOL DIAGN, V9, P637, DOI [10.1586/erm.09.48, 10.1586/ERM.09.48]; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1522, 10.1038/nrmicro1568, 10.1038/nrmico1522]; Rama KRBS, 2006, CLIN ORTHOP RELAT R, P237, DOI 10.1097/01.blo.0000205906.44103.a3; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Siddiqui MAR, 2005, BRIT J OPHTHALMOL, V89, P261, DOI 10.1136/bjo.2004.051862; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; *STAND REP DIAGN A, 2008, STARD STAT NEWS; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-20; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; *WHO, 2007, NEW WHO POL US LIQ M; Wilczynski NL, 2008, RADIOLOGY, V248, P817, DOI 10.1148/radiol.2483072067; World Health Organization, 2008, WHO POL STAT MOL LIN	30	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7753	10.1371/journal.pone.0007753	http://dx.doi.org/10.1371/journal.pone.0007753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915664	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721900010
J	Nemajerova, A; Palacios, G; Nowak, NJ; Matsui, SI; Petrenko, O				Nemajerova, Alice; Palacios, Gustavo; Nowak, Norma J.; Matsui, Sei-ichi; Petrenko, Oleksi			Targeted Deletion of p73 in Mice Reveals Its Role in T Cell Development and Lymphomagenesis	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR FUNCTIONS; V(D)J RECOMBINATION; THYMIC LYMPHOMAS; IN-VIVO; P53-DEPENDENT APOPTOSIS; INTRAGENIC DELETIONS; DNA-DAMAGE; P53 FAMILY; MOUSE	Transcriptional silencing of the p73 gene through methylation has been demonstrated in human leukemias and lymphomas. However, the role of p73 in the malignant process remains to be explored. We show here that p73 acts as a T cell-specific tumor suppressor in a genetically defined mouse model, and that concomitant ablation of p53 and p73 predisposes mice to an increased incidence of thymic lymphomas compared to the loss of p53 alone. Our results demonstrate a causal role for loss of p73 in progression of T cell lymphomas to the stage of aggressive, disseminated disease. We provide evidence that tumorigenesis in mice lacking p53 and p73 proceeds through mechanisms involving altered patterns of gene expression, defects in early T cell development, impaired apoptosis, and the ensuing accumulation of chromosomal aberrations. Collectively, our data imply that tumor suppressive properties of p73 are highly dependent on cellular context, wherein p73 plays a major role in T cell development and neoplasia.			Nemajerova, A (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	apetrenko@notes.cc.sunysb.edu						Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Corn PG, 1999, CANCER RES, V59, P3352; Cowell JK, 2004, CANCER GENET CYTOGEN, V151, P36, DOI 10.1016/j.cancergencyto.2003.09.012; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Gutierrez MI, 2003, LEUKEMIA, V17, P1845, DOI 10.1038/sj.leu.2403060; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Lista F, 1997, CANCER RES, V57, P4408; Martinez-Delgado B, 2002, INT J CANCER, V102, P15, DOI 10.1002/ijc.10618; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Murga C, 2002, J BIOL CHEM, V277, P39156, DOI 10.1074/jbc.M203553200; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nowak NJ, 2007, GENET MED, V9, P585, DOI 10.1097/GIM.0b013e3181461c4a; Ohi H, 2007, ONCOGENE, V26, P5280, DOI 10.1038/sj.onc.1210325; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Perez-Losada J, 2005, ONCOGENE, V24, P5521, DOI 10.1038/sj.onc.1208799; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Puig P, 2003, CLIN CANCER RES, V9, P5642; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Sakata J, 2004, CARCINOGENESIS, V25, P1069, DOI 10.1093/carcin/bgh094; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Talos F, 2007, MOL CELL, V27, P647, DOI 10.1016/j.molcel.2007.06.036; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tsuji H, 2004, CANCER RES, V64, P8882, DOI 10.1158/0008-5472.CAN-03-1163; Tsuji H, 2009, MUTAT RES-FUND MOL M, V660, P22, DOI 10.1016/j.mrfmmm.2008.10.002; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A136	A145	e7784	10.1371/journal.pone.0007784	http://dx.doi.org/10.1371/journal.pone.0007784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907659	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800015
J	Englert, AC; Greene, MJ				Englert, Amy C.; Greene, Michael J.			Chemically-Mediated Roostmate Recognition and Roost Selection by Brazilian Free-Tailed Bats (Tadarida brasiliensis)	PLOS ONE			English	Article							SCENT RECOGNITION; CHIROPTERA; DISCRIMINATION; MOLOSSIDAE; MEXICANA; ODOR; CUES	Background: The Brazilian free-tailed bat (Tadarida brasiliensis) is an exceptionally social and gregarious species of chiropteran known to roost in assemblages that can number in the millions. Chemical recognition of roostmates within these assemblages has not been extensively studied despite the fact that an ability to chemically recognize individuals could play an important role in forming and stabilizing complex suites of social interactions. Methodology/Principal Findings: Individual bats were given a choice between three roosting pouches: one permeated with the scent of a group of roostmates, one permeated with the scent of non-roostmates, and a clean control. Subjects rejected non-roostmate pouches with greater frequency than roostmate pouches or blank control pouches. Also, bats chose to roost in the roostmate scented pouches more often than the non-roostmate or control pouches. Conclusions/Significance: We demonstrated that T. brasiliensis has the ability to chemically recognize roostmates from non-roostmates and a preference for roosting in areas occupied by roostmates. It is important to investigate these behaviors because of their potential importance in colony dynamics and roost choice.			Englert, AC (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	michael.greene@ucdenver.edu						Bloss J, 2002, J CHEM ECOL, V28, P819, DOI 10.1023/A:1015296928423; Bloss J, 1999, ACTA CHIROPTEROL, V1, P31; Bouchard S, 2001, J ZOOL, V254, P109, DOI 10.1017/S0952836901000607; DEFANIS E, 1995, ANIM BEHAV, V49, P835; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; LOUGHRY WJ, 1991, J MAMMAL, V72, P624, DOI 10.2307/1382150; Nielsen LT, 2006, J CAVE KARST STUD, V68, P27; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646	11	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7781	10.1371/journal.pone.0007781	http://dx.doi.org/10.1371/journal.pone.0007781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901986	Green Submitted, Green Published, gold			2022-12-27	WOS:000271658800016
J	Meyer, M; Rubsamen, D; Slany, R; Illmer, T; Stabla, K; Roth, P; Stiewe, T; Eilers, M; Neubauer, A				Meyer, Mona; Ruebsamen, Daniela; Slany, Robert; Illmer, Thomas; Stabla, Kathleen; Roth, Petra; Stiewe, Thorsten; Eilers, Martin; Neubauer, Andreas			Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; ACUTE-MYELOGENOUS-LEUKEMIA; WILD-TYPE P53; INDUCED SENESCENCE; IN-VIVO; K-RAS; ANTAGONIST NUTLIN-3; SOMATIC ACTIVATION; MUTATIONS; APOPTOSIS	Acute myeloid leukemia (AML) is a clonal disease originating from myeloid progenitor cells with a heterogeneous genetic background. High-dose cytarabine is used as the standard consolidation chemotherapy. Oncogenic RAS mutations are frequently observed in AML, and are associated with beneficial response to cytarabine. Why AML-patients with oncogenic RAS benefit most from high-dose cytarabine post-remission therapy is not well understood. Here we used bone marrow cells expressing a conditional MLL-ENL-ER oncogene to investigate the interaction of oncogenic RAS and chemotherapeutic agents. We show that oncogenic RAS synergizes with cytotoxic agents such as cytarabine in activation of DNA damage checkpoints, resulting in a p53-dependent genetic program that reduces clonogenicity and increases myeloid differentiation. Our data can explain the beneficial effects observed for AML patients with oncogenic RAS treated with higher dosages of cytarabine and suggest that induction of p53-dependent differentiation, e. g. by interfering with Mdm2-mediated degradation, may be a rational approach to increase cure rate in response to chemotherapy. The data also support the notion that the therapeutic success of cytotoxic drugs may depend on their ability to promote the differentiation of tumor-initiating cells.			Meyer, M (corresponding author), Univ Marburg, Klin Hamatol Onkol & Immunol, Marburg, Germany.	neubauer@mailer.uni-marburg.de		Eilers, Martin/0000-0002-0376-6533; Stiewe, Thorsten/0000-0003-0134-7826				Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BOS JL, 1989, CANCER RES, V49, P4682; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braun BS, 2006, BLOOD, V108, P2041, DOI 10.1182/blood-2006-01-013490; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Capizzi RL, 1996, INVEST NEW DRUG, V14, P249, DOI 10.1007/BF00194527; Chan IT, 2006, BLOOD, V108, P1708, DOI 10.1182/blood-2006-04-015040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; COGHLAN DW, 1994, LEUKEMIA, V8, P1682; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Darley RL, 1999, EXP HEMATOL, V27, P1599, DOI 10.1016/S0301-472X(99)00100-9; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; GOTTLIEB E, 1994, EMBO J, V13, P1368, DOI 10.1002/j.1460-2075.1994.tb06390.x; Groth A, 2000, J BIOL CHEM, V275, P27473; Gu L, 2008, LEUKEMIA, V22, P730, DOI 10.1038/leu.2008.11; HAWLEY RG, 1995, ONCOGENE, V11, P1113; HIBI S, 1993, BLOOD, V81, P1841; HUANG CL, 1988, LEUKEMIA, V2, P518; Illmer T, 2005, CLIN CANCER RES, V11, P3217, DOI 10.1158/1078-0432.CCR-04-2232; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; LARSEN J, 1992, ONCOGENE, V7, P1903; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; NAGLER A, 1986, EXP HEMATOL, V14, P241; NEUBAUER A, 1994, BLOOD, V83, P1603; Neubauer A, 2008, J CLIN ONCOL, V26, P4603, DOI 10.1200/JCO.2007.14.0418; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; RADICH JP, 1992, LEUKEMIA LYMPHOMA, V6, P325, DOI 10.3109/10428199209053564; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schreiner S, 2001, CANCER RES, V61, P6480; Secchiero P, 2007, NEOPLASIA, V9, P853, DOI 10.1593/neo.07523; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen SW, 2004, EXP HEMATOL, V32, P852, DOI 10.1016/j.exphem.2004.06.001; Shen S, 2007, EXP HEMATOL, V35, P908, DOI 10.1016/j.exphem.2007.02.011; SHEN WPV, 1987, ONCOGENE, V1, P157; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wiederschain D, 2005, J BIOL CHEM, V280, P24315, DOI 10.1074/jbc.M412237200; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zeisig BB, 2003, ONCOGENE, V22, P1629, DOI 10.1038/sj.onc.1206104	59	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7768	10.1371/journal.pone.0007768	http://dx.doi.org/10.1371/journal.pone.0007768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890398	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700020
J	Navarro, B; Pantaleo, V; Gisel, A; Moxon, S; Dalmay, T; Bisztray, G; Di Serio, F; Burgyan, J				Navarro, Beatriz; Pantaleo, Vitantonio; Gisel, Andreas; Moxon, Simon; Dalmay, Tamas; Bisztray, Gyoergy; Di Serio, Francesco; Burgyan, Jozsef			Deep Sequencing of Viroid-Derived Small RNAs from Grapevine Provides New Insights on the Role of RNA Silencing in Plant-Viroid Interaction	PLOS ONE			English	Article							SHORT INTERFERING RNAS; IN-VIVO; GENE; ARABIDOPSIS; REPLICATION; PATHWAY; GENOME; HOP; IDENTIFICATION; ACCUMULATION	Background: Viroids are circular, highly structured, non-protein-coding RNAs that, usurping cellular enzymes and escaping host defense mechanisms, are able to replicate and move through infected plants. Similarly to viruses, viroid infections are associated with the accumulation of viroid-derived 21-24 nt small RNAs (vd-sRNAs) with the typical features of the small interfering RNAs characteristic of RNA silencing, a sequence-specific mechanism involved in defense against invading nucleic acids and in regulation of gene expression in most eukaryotic organisms. Methodology/Principal Findings: To gain further insights on the genesis and possible role of vd-sRNAs in plant-viroid interaction, sRNAs isolated from Vitis vinifera infected by Hop stunt viroid (HSVd) and Grapevine yellow speckle viroid 1 (GYSVd1) were sequenced by the high-throughput platform Solexa-Illumina, and the vd-sRNAs were analyzed. The large majority of HSVd-and GYSVd1-sRNAs derived from a few specific regions (hotspots) of the genomic (+) and (2) viroid RNAs, with a prevalence of those from the (2) strands of both viroids. When grouped according to their sizes, vd-sRNAs always assumed a distribution with prominent 21-, 22- and 24-nt peaks, which, interestingly, mapped at the same hotspots. Conclusions/Significance: These findings show that different Dicer-like enzymes (DCLs) target viroid RNAs, preferentially accessing to the same viroid domains. Interestingly, our results also suggest that viroid RNAs may interact with host enzymes involved in the RNA-directed DNA methylation pathway, indicating more complex scenarios than previously thought for both vd-sRNAs genesis and possible interference with host gene expression.			Navarro, B (corresponding author), CNR, Ist Virol Vegetale, I-10126 Turin, Italy.	f.diserio@ba.ivv.cnr.it; J.burgyan@ivv.cnr.it	Navarro, Beatriz/B-9128-2015; Pantaleo, Vitantonio/C-9349-2012; Di Serio, Francesco/I-5191-2012; Dalmay, Tamas/E-1377-2011; Moxon, Simon/A-5385-2010; Pantaleo, Vitantonio/L-6543-2019; Gisel, Andreas/AAW-2335-2020; Burgyan, Jozsef/C-7511-2012	Navarro, Beatriz/0000-0001-8981-1018; Pantaleo, Vitantonio/0000-0001-6677-6504; Di Serio, Francesco/0000-0003-2822-704X; Dalmay, Tamas/0000-0003-1492-5429; Pantaleo, Vitantonio/0000-0001-6677-6504; Moxon, Simon/0000-0003-4644-1816; GISEL, ANDREAS/0000-0001-7218-9488				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Blevins T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005932; BRANCH AD, 1988, P NATL ACAD SCI USA, V85, P9128, DOI 10.1073/pnas.85.23.9128; BRANCH AD, 1984, SCIENCE, V223, P450, DOI 10.1126/science.6197756; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Daros JA, 2002, EMBO J, V21, P749, DOI 10.1093/emboj/21.4.749; Daros JA, 2006, EMBO REP, V7, P593, DOI 10.1038/sj.embor.7400706; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Denti MA, 2004, PLANT J, V37, P762, DOI 10.1111/j.1365-313X.2004.02001.x; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; Diener TO, 2003, NAT REV MICROBIOL, V1, P75, DOI 10.1038/nrmicro736; Ding B, 1997, PLANT J, V12, P931, DOI 10.1046/j.1365-313X.1997.12040931.x; DING B, 2009, ANN REV PHYTOPATHOL; Ding B, 2007, MOL PLANT MICROBE IN, V20, P7, DOI 10.1094/MPMI-20-0007; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Flores R, 2000, ADV VIRUS RES, V55, P271, DOI 10.1016/S0065-3527(00)55006-4; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Gas ME, 2008, J VIROL, V82, P10321, DOI 10.1128/JVI.01229-08; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; Haag JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004110; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Ho T, 2006, J VIROL METHODS, V136, P217, DOI 10.1016/j.jviromet.2006.05.016; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; KEESE P, 1985, P NATL ACAD SCI USA, V82, P4582, DOI 10.1073/pnas.82.14.4582; Little A., 2003, Viroids, P195; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Markarian N, 2004, ARCH VIROL, V149, P397, DOI 10.1007/s00705-003-0215-5; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Navarro JA, 1999, VIROLOGY, V253, P77, DOI 10.1006/viro.1998.9497; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P2730, DOI 10.1093/nar/16.6.2730; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qi YJ, 2003, PLANT CELL, V15, P2566, DOI 10.1105/tpc.016576; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sano T, 2001, VIRUS GENES, V22, P53, DOI 10.1023/A:1008182302704; Schwind N, 2009, MOL PLANT PATHOL, V10, P459, DOI [10.1111/j.1364-3703.2009.00546.x, 10.1111/J.1364-3703.2009.00546.X]; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; St-Pierre P, 2009, VIROLOGY, V383, P178, DOI 10.1016/j.virol.2008.11.008; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tabler M, 2004, TRENDS PLANT SCI, V9, P339, DOI 10.1016/j.tplants.2004.05.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wah YFWC, 1997, J VIROL METHODS, V63, P57, DOI 10.1016/S0166-0934(96)02115-5; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	96	104	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7686	10.1371/journal.pone.0007686	http://dx.doi.org/10.1371/journal.pone.0007686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890399	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700006
J	Izquierdo, E; Canete, JD; Celis, R; Santiago, B; Usategui, A; Sanmarti, R; del Rey, MJ; Pablos, JL				Izquierdo, Elena; Canete, Juan D.; Celis, Raquel; Santiago, Begona; Usategui, Alicia; Sanmarti, Raimon; del Rey, Manuel J.; Pablos, Jose L.			Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLLAGEN-INDUCED ARTHRITIS; ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; VASCULAR NORMALIZATION; ANGIOGENESIS; VEGF; RECRUITMENT; HYPOXIA; METHOTREXATE	Background: Angiogenesis is considered an important factor in the pathogenesis of Rheumatoid Arthritis (RA) where it has been proposed as a therapeutic target. In other settings, active angiogenesis is characterized by pathologic, immature vessels that lack periendothelial cells. We searched for the presence of immature vessels in RA synovium and analyzed the dynamics of synovial vasculature along the course of the disease, particularly after therapeutic response to TNF antagonists. Methodology/Principal Findings: Synovial arthroscopic biopsies from RA, osteoarthritis (OA) and normal controls were analyzed by double labeling of endothelium and pericytes/smooth muscle mural cells to identify and quantify mature/immature blood vessels. To analyze clinicopathological correlations, a cross-sectional study on 82 synovial biopsies from RA patients with variable disease duration and severity was performed. A longitudinal analysis was performed in 25 patients with active disease rebiopsied after anti-TNF-alpha therapy. We found that most RA synovial tissues contained a significant fraction of immature blood vessels lacking periendothelial coverage, whereas they were rare in OA, and inexistent in normal synovial tissues. Immature vessels were observed from the earliest phases of the disease but their presence or density was significantly increased in patients with longer disease duration, higher activity and severity, and stronger inflammatory cell infiltration. In patients that responded to anti-TNF-alpha therapy, immature vessels were selectively depleted. The mature vasculature was similarly expanded in early or late disease and unchanged by therapy. Conclusion/Significance: RA synovium contains a significant fraction of neoangiogenic, immature blood vessels. Progression of the disease increases the presence and density of immature but not mature vessels and only immature vessels are depleted in response to anti-TNF alpha therapy. The different dynamics of the mature and immature vascular fractions has important implications for the development of anti-angiogenic interventions in RA.	[Izquierdo, Elena; Santiago, Begona; Usategui, Alicia; del Rey, Manuel J.; Pablos, Jose L.] Hosp 12 Octubre, Serv Reumatol, Madrid, Spain; [Canete, Juan D.; Celis, Raquel; Sanmarti, Raimon] IDIBAPS, Unitat Artritis, Serv Reumatol, Hosp Clin Barcelona, Barcelona, Spain	Hospital Universitario 12 de Octubre; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Izquierdo, E (corresponding author), Hosp 12 Octubre, Serv Reumatol, Madrid, Spain.	jlpablos@h12o.es	Del Rey, Manuel/O-6114-2014; Izquierdo, Elena/Z-1861-2019; Celis, Raquel/K-5520-2017; Cañete, Juan D/AAV-8910-2021; Usategui, Alicia/O-6476-2014; crespillo, Juan D. cañete/M-4428-2017; Sanmarti, Raimon/M-4434-2017	Del Rey, Manuel/0000-0002-8180-1584; Izquierdo, Elena/0000-0002-3355-2798; Celis, Raquel/0000-0002-5096-4532; Cañete, Juan D/0000-0003-2606-0573; Usategui, Alicia/0000-0001-8874-9523; crespillo, Juan D. cañete/0000-0003-2606-0573; Sanmarti, Raimon/0000-0002-8864-3806	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS 05/060, RD08/0075]; Fondo de Investigacion Sanitaria	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (FIS 05/060 and RETICS program, RD08/0075, RIER), Spain. EI was supported by predoctoral training program from Fondo de Investigacion Sanitaria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; Ballara S, 2001, ARTHRITIS RHEUM, V44, P2055, DOI 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2; BALUK P, 2009, J CLIN INVEST; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Canete JD, 2004, ARTHRITIS RHEUM, V50, P1636, DOI 10.1002/art.20181; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; FITZGERALD O, 1991, ANN RHEUM DIS, V50, P792, DOI 10.1136/ard.50.11.792; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Giatromanolaki A, 2001, J PATHOL, V194, P101, DOI 10.1002/path.842; Goedkoop AY, 2004, ARTHRITIS RES THER, V6, pR326, DOI 10.1186/ar1182; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; KOCH AE, 1994, J IMMUNOL, V152, P4149; Lu J, 2000, J IMMUNOL, V164, P5922, DOI 10.4049/jimmunol.164.11.5922; Miotla J, 2000, LAB INVEST, V80, P1195, DOI 10.1038/labinvest.3780127; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; NAGASHIMA M, 1995, J RHEUMATOL, V22, P1624; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Pessler F, 2008, ANN RHEUM DIS, V67, P1184, DOI 10.1136/ard.2008.087775; Saleem B, 2009, ARTHRITIS RHEUM-US, V60, P1915, DOI 10.1002/art.24596; Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647; Taylor PC, 2005, RHEUMATOLOGY, V44, P721, DOI 10.1093/rheumatology/keh524; Walsh DA, 1998, AM J PATHOL, V152, P691; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Zittermann SI, 2006, J LEUKOCYTE BIOL, V80, P247, DOI 10.1189/jlb.1205718	40	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8131	10.1371/journal.pone.0008131	http://dx.doi.org/10.1371/journal.pone.0008131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956574	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800023
J	Shimada, S				Shimada, Sotaro			Modulation of Motor Area Activity by the Outcome for a Player during Observation of a Baseball Game	PLOS ONE			English	Article							IMITATION; ACTIVATION; MECHANISMS; DANCERS; NIRS; FMRI	Background: Observing competitive games such as sports is a pervasive entertainment among humans. The inclination to watch others play may be based on our social-cognitive ability to understand the internal states of others. The mirror neuron system, which is activated when a subject observes the actions of others, as well as when they perform the same action themselves, seems to play a crucial role in this process. Our previous study showed that activity of the mirror neuron system was modulated by the outcome of the subject's favored player during observation of a simple competitive game (rock-paper-scissors). However, whether the mirror neuron system responds similarly in a more complex and naturalistic sports game has not yet been fully investigated. Methodology/Principal Findings: In the present study, we measured the activity of motor areas when the subjects, who were amateur baseball field players (non-pitchers), watched short movie clips of scenes in professional baseball games. The subjects were instructed to support either a batter or a pitcher when observing the movie clip. The results showed that activity in the motor area exhibited a strong interaction between the subject's supported side (batter or pitcher) and the outcome (a hit or an out). When the subject supported the batter, motor area activity was significantly higher when the batter made an out than when he made a hit. However, such modulation was not apparent when the subject supported the pitcher. Conclusions/Significance: This result indicates that mirror neuron system activity is modulated by the outcome for a particular player in a competitive game even when observing a complex and naturalistic sports game. We suggest that our inclination to watch competitive games is facilitated by this characteristic of the mirror neuron system.	Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kanagawa, Japan	Meiji University	Shimada, S (corresponding author), Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kanagawa, Japan.	sshimada@isc.meiji.ac.jp	Shimada, Sotaro/AAC-2484-2019		JSPS (Japan Society for the Promotion of Science) [19700249]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a Grant-in-Aid for young scientists from JSPS (19700249). JSPS (Japan Society for the Promotion of Science) http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Shimada S, 2009, NEUROREPORT, V20, P979, DOI 10.1097/WNR.0b013e32832d2d36; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005	22	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8034	10.1371/journal.pone.0008034	http://dx.doi.org/10.1371/journal.pone.0008034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946372	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827800021
J	Guo, JH; Cagatay, T; Zhou, GJ; Chan, CC; Blythe, S; Suyama, K; Zheng, L; Pan, KF; Qian, CP; Hamelin, R; Thibodeau, SN; Klein, PS; Wharton, KA; Liu, WG				Guo, Jianhui; Cagatay, Tolga; Zhou, Guangjin; Chan, Chih-Chiang; Blythe, Shelby; Suyama, Kaye; Zheng, Li; Pan, Kaifeng; Qian, Chiping; Hamelin, Richard; Thibodeau, Stephen N.; Klein, Peter S.; Wharton, Keith A., Jr.; Liu, Wanguo			Mutations in the Human naked cuticle Homolog NKD1 Found in Colorectal Cancer Alter Wnt/Dvl/beta-Catenin Signaling	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; WNT PATHWAY; MISMATCH REPAIR; BETA-CATENIN; MICROSATELLITE INSTABILITY; NEGATIVE REGULATION; GENETIC ALTERATIONS; DROSOPHILA; ANTAGONIST; ACTIVATION	Background: Mutation of Wnt signal antagonists Apc or Axin activates beta-catenin signaling in many cancers including the majority of human colorectal adenocarcinomas. The phenotype of apc or axin mutation in the fruit fly Drosophila melanogaster is strikingly similar to that caused by mutation in the segment-polarity gene, naked cuticle (nkd). Nkd inhibits Wnt signaling by binding to the Dishevelled (Dsh/Dvl) family of scaffold proteins that link Wnt receptor activation to beta-catenin accumulation and TCF-dependent transcription, but human NKD genes have yet to be directly implicated in cancer. Methodology/Principal Findings: We identify for the first time mutations in NKD1 - one of two human nkd homologs - in a subset of DNA mismatch repair-deficient colorectal tumors that are not known to harbor mutations in other Wnt-pathway genes. The mutant Nkd1 proteins are defective at inhibiting Wnt signaling; in addition, the mutant Nkd1 proteins stabilize beta-catenin and promote cell proliferation, in part due to a reduced ability of each mutant Nkd1 protein to bind and destabilize Dvl proteins. Conclusions/Significance: Our data raise the hypothesis that specific NKD1 mutations promote Wnt-dependent tumorigenesis in a subset of DNA mismatch-repair-deficient colorectal adenocarcinomas and possibly other Wnt-signal driven human cancers.	[Guo, Jianhui; Qian, Chiping; Liu, Wanguo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Cagatay, Tolga; Chan, Chih-Chiang; Wharton, Keith A., Jr.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX USA; [Cagatay, Tolga; Chan, Chih-Chiang; Wharton, Keith A., Jr.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dept Mol Biol, Dallas, TX USA; [Zhou, Guangjin; Zheng, Li; Pan, Kaifeng; Qian, Chiping; Thibodeau, Stephen N.; Liu, Wanguo] Mayo Clin, Dept Lab Med & Pathol, Mayo Clin Coll Med, Rochester, MN USA; [Blythe, Shelby; Klein, Peter S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Suyama, Kaye] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Hamelin, Richard] INSERM, Equipe Microsatellites & Canc U938, Paris, France; [Suyama, Kaye] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Blythe, Shelby; Wharton, Keith A., Jr.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; University of Pennsylvania; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; Stanford University; University of Pennsylvania	Guo, JH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, Stanley S Scott Canc Ctr, New Orleans, LA USA.	kwhartonjr@gmail.com; wliu2@lsuhsc.edu	Chan, Chih-Chiang/G-4923-2011; Guo, Jianhui/AAJ-6220-2020; zhou, guangjin/F-9031-2011; CHAN, CHIH-CHIANG/AGM-3463-2022	CHAN, CHIH-CHIANG/0000-0003-2626-3805; Blythe, Shelby/0000-0003-4986-2579	American Cancer Society Institutional Research Grant; National Institutes of Health [R01-GM65404, R01-CA60117]; Mayo Clinic/Foundation; NATIONAL CANCER INSTITUTE [R01CA060117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065404, R01GM076621] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic/Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an American Cancer Society Institutional Research Grant ( to K. W.); the National Institutes of Health (R01-GM65404 to K. W.; R01-CA60117 to S. N. T.); and the Mayo Clinic/Foundation ( to W. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Boland CR, 1998, CANCER RES, V58, P5248; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chan CC, 2007, DEV BIOL, V311, P538, DOI 10.1016/j.ydbio.2007.09.002; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Duval A, 1999, CANCER RES, V59, P4213; Duval A, 2002, CANCER RES, V62, P2447; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Guo JH, 2004, BIOCHEM BIOPH RES CO, V324, P922, DOI 10.1016/j.bbrc.2004.09.133; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hlubek F, 2007, FRONT BIOSCI, V12, P458, DOI 10.2741/2075; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Katoh M, 2001, INT J ONCOL, V19, P963; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rousset R, 2002, J BIOL CHEM, V277, P49019, DOI 10.1074/jbc.M203246200; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; SOKOL SY, 1995, DEVELOPMENT, V121, P3487; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Toft NJ, 1998, J PATHOL, V185, P123; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Waldrop S, 2006, GENETICS, V174, P331, DOI 10.1534/genetics.106.061853; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	48	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7982	10.1371/journal.pone.0007982	http://dx.doi.org/10.1371/journal.pone.0007982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956716	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827500012
J	Liu, SM; Okada, T; Assmann, A; Soto, J; Liew, CW; Bugger, H; Shirihai, OS; Abel, ED; Kulkarni, RN				Liu, Siming; Okada, Terumasa; Assmann, Anke; Soto, Jamie; Liew, Chong Wee; Bugger, Heiko; Shirihai, Orian S.; Abel, E. Dale; Kulkarni, Rohit N.			Insulin Signaling Regulates Mitochondrial Function in Pancreatic beta-Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; N-TERMINAL KINASE; INDUCED C-JUN; IGF-I; GLUCOSE-HOMEOSTASIS; INTERACTING PROTEIN; OXIDATIVE STRESS; DOWN-REGULATION; SURVIVAL; GLUCOKINASE	Insulin/IGF-I signaling regulates the metabolism of most mammalian tissues including pancreatic islets. To dissect the mechanisms linking insulin signaling with mitochondrial function, we first identified a mitochondria-tethering complex in beta-cells that included glucokinase (GK), and the pro-apoptotic protein, BAD(S). Mitochondria isolated from beta-cells derived from beta-cell specific insulin receptor knockout (beta IRKO) mice exhibited reduced BAD(S), GK and protein kinase A in the complex, and attenuated function. Similar alterations were evident in islets from patients with type 2 diabetes. Decreased mitochondrial GK activity in beta IRKOs could be explained, in part, by reduced expression and altered phosphorylation of BAD(S). The elevated phosphorylation of p70S6K and JNK1 was likely due to compensatory increase in IGF-1 receptor expression. Re-expression of insulin receptors in beta IRKO cells partially restored the stoichiometry of the complex and mitochondrial function. These data indicate that insulin signaling regulates mitochondrial function and have implications for beta-cell dysfunction in type 2 diabetes.	[Liu, Siming; Okada, Terumasa; Assmann, Anke; Liew, Chong Wee; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Soto, Jamie; Bugger, Heiko; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Soto, Jamie; Bugger, Heiko; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Liu, Siming; Okada, Terumasa; Assmann, Anke; Liew, Chong Wee; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Boston University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Liu, SM (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	Rohit.Kulkarni@joslin.harvard.edu	Bugger, Heiko/ABA-4180-2021	Shirihai, Orian/0000-0002-9502-2661; Liew, Chong Wee/0000-0001-9904-0958; Bugger, Heiko/0000-0002-3524-0405; Assmann, Anke/0000-0003-0298-3410; Abel, E. Dale/0000-0001-5290-0738	NIH [DK RO1 68721, DK RO1 67536, HL RO1 73167]; Joslin DERC [P30DK36836]; German Research Foundation DFG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068721, R01DK056690, P30DK036836, R01DK067536, R01DK035914] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin DERC; German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the NIH DK RO1 68721 (R. N. K.), NIH DK RO1 67536 (R. N. K.), NIH HL RO1 73167 (E. D. A.), and the Joslin DERC P30DK36836 (Specialized Assay and Advanced Microscopy Cores). HB was supported by a grant from the German Research Foundation DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E. Dale, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P219, DOI 10.2174/1568008054064869; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Che WY, 2002, CIRC RES, V90, P1222, DOI 10.1161/01.RES.0000021127.83364.7D; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; FERNANDEZ S, 2007, BIOCH BIOPHYS ACTA; Gollapudi S, 2003, INT J ONCOL, V22, P597; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Ichii H, 2005, AM J TRANSPLANT, V5, P21, DOI 10.1111/j.1600-6143.2005.00698.x; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Lin Y, 2006, J BIOL CHEM, V281, P23525, DOI 10.1074/jbc.M601487200; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Matschinsky FM, 2006, DIABETES, V55, P1; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; O'Neill BT, 2007, CELL METAB, V6, P294, DOI 10.1016/j.cmet.2007.09.001; Oberkofler H, 2006, ENDOCRINOLOGY, V147, P966, DOI 10.1210/en.2005-0817; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Veluthakal R, 2005, APOPTOSIS, V10, P841, DOI 10.1007/s10495-005-0431-4; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	55	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7983	10.1371/journal.pone.0007983	http://dx.doi.org/10.1371/journal.pone.0007983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956695	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500013
J	McCarty, JP; Jorgensen, JG; Wolfenbarger, LL				McCarty, John P.; Jorgensen, Joel G.; Wolfenbarger, L. LaReesa			Behavior of Buff-Breasted Sandpipers (Tryngites subruficollis) during Migratory Stopover in Agricultural Fields	PLOS ONE			English	Article							SOUTHERN HIGH-PLAINS; MIGRANT SHOREBIRDS; HABITAT USE; BIRDS; ABUNDANCE; CONSERVATION; GRASSLANDS; PESTICIDES; MORTALITY	Background: Understanding the behavior of birds in agricultural habitats can be the first step in evaluating the conservation implications of birds' use of landscapes shaped by modern agriculture. The existence and magnitude of risk from agricultural practices and the quality of resources agricultural lands provide will be determined largely by how birds use these habitats. Buff-breasted Sandpipers (Tryngites subruficollis) are a species of conservation concern. During spring migration large numbers of Buff-breasted Sandpipers stopover in row crop fields in the Rainwater Basin region of Nebraska. We used behavioral observations as a first step in evaluating how Buff-breasted Sandpipers use crop fields during migratory stopover. Methodology/Principal Findings: We measured behavior during migratory stopover using scan and focal individual sampling to determine how birds were using crop fields. Foraging was the most frequent behavior observed, but the intensity of foraging changed over the course of the day with a distinct mid-day low point. Relative to other migrating shorebirds, Buff-breasted Sandpipers spent a significant proportion of their time in social interactions including courtship displays. Conclusions/Significance: Our results show that the primary use of upland agricultural fields by migrating Buff-breasted Sandpipers is foraging while wetlands are used for maintenance and resting. The importance of foraging in row crop fields suggests that both the quality of food resources available in fields and the possible risks from dietary exposure to agricultural chemicals will be important to consider when developing conservation plans for Buff-breasted Sandpipers migrating through the Great Plains.	[McCarty, John P.; Wolfenbarger, L. LaReesa] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Jorgensen, Joel G.] Nebraska Game & Pk Commiss, Nongame Bird Program, Lincoln, NE USA	University of Nebraska System	McCarty, JP (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	jmccarty@unomaha.edu	McCarty, John P/E-9797-2011	McCarty, John P/0000-0002-6278-5451	Nebraska State Wildlife Grant Program [T-43-R]; Department of Biology at the University of Nebraska at Omaha; Nebraska Game and Parks Commission	Nebraska State Wildlife Grant Program; Department of Biology at the University of Nebraska at Omaha; Nebraska Game and Parks Commission	Funding was provided by a grant from the Nebraska State Wildlife Grant Program (T-43-R - http://www.ngpc.state.ne.us/wildlife/programs/grants/).Additional support was provided by the Department of Biology at the University of Nebraska at Omaha and the Nebraska Game and Parks Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, after being awarded this grant one author (Jorgensen) was hired by the agency that awarded the grant.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andrei AE, 2007, WATERBIRDS, V30, P326, DOI 10.1675/1524-4695(2007)030[0326:BOMSIS]2.0.CO;2; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; BRENNAN EK, 2006, THESIS TEXAS TU LUBB; Brown S, 2001, US SHOREBIRD CONSERV; Burton NHK, 2005, BIRD STUDY, V52, P120, DOI 10.1080/00063650509461381; Corson MS, 1998, ECOL MODEL, V105, P299, DOI 10.1016/S0304-3800(97)00174-9; Davis CA, 1998, CONDOR, V100, P266, DOI 10.2307/1370267; De Leon MT, 1999, CONDOR, V101, P645, DOI 10.2307/1370194; DIETRICH DR, 1995, ARCH ENVIRON CON TOX, V29, P140, DOI 10.1007/BF00213099; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Gillings S, 2005, AUK, V122, P1249, DOI 10.1642/0004-8038(2005)122[1249:DSDNPN]2.0.CO;2; Grue CE, 1997, AM ZOOL, V37, P369; Isacch JP, 2003, WATERBIRDS, V26, P494, DOI 10.1675/1524-4695(2003)026[0494:HUBNSI]2.0.CO;2; Isacch JP, 2003, J FIELD ORNITHOL, V74, P233, DOI 10.1648/0273-8570-74.3.233; Jorgensen J. G., 2007, THESIS U NEBRASKA OM; JORGENSEN JG, 2007, INT WADER STUDY GROU, V112, P45; Jorgensen JG, 2008, CONDOR, V110, P63, DOI 10.1525/cond.2008.110.1.63; Kostecke RM, 2003, WATERBIRDS, V26, P192, DOI 10.1675/1524-4695(2003)026[0192:NBOAAI]2.0.CO;2; Krapu GL, 2004, WILDLIFE SOC B, V32, P127, DOI 10.2193/0091-7648(2004)32[127:LWCMLI]2.0.CO;2; Kuwae T, 2007, MAR BIOL, V151, P663, DOI 10.1007/s00227-006-0506-y; Lanctot RB, 2002, WILSON BULL, V114, P44, DOI 10.1676/0043-5643(2002)114[0044:CSOTBB]2.0.CO;2; LANCTOT RB, 1994, BIRDS N AM, V91; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; MINEAU P, 2005, PSWGTR191 USDA; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; ORING LEWIS W., 1964, AUK, V81, P83; Rottenborn SC, 1996, WILSON BULL, V108, P783; Shepherd PCF, 2004, J WILDLIFE MANAGE, V68, P61, DOI 10.2193/0022-541X(2004)068[0061:MAAHPO]2.0.CO;2; Skagen SK, 2006, AUK, V123, P313, DOI 10.1642/0004-8038(2006)123[313:MSATCO]2.0.CO;2; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; U.S. Shorebird Conservation Plan, 2004, HIGH PRIOR SHOR 2004; *US EPA, 2008, FEB 5 8 2008 FIFRA S; Vyas NB, 1999, TOXICOL IND HEALTH, V15, P186, DOI 10.1191/074823399678846628; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; WINDINGSTAD RM, 1989, J WILDLIFE DIS, V25, P38, DOI 10.7589/0090-3558-25.1.38; Young Jessica R., 2005, P616	37	3	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8000	10.1371/journal.pone.0008000	http://dx.doi.org/10.1371/journal.pone.0008000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956768	Green Published, gold			2022-12-27	WOS:000272827500026
J	Pennings, JLA; Koster, MPH; Rodenburg, W; Schielen, PCJI; de Vries, A				Pennings, Jeroen L. A.; Koster, Maria P. H.; Rodenburg, Wendy; Schielen, Peter C. J. I.; de Vries, Annemieke			Discovery of Novel Serum Biomarkers for Prenatal Down Syndrome Screening by Integrative Data Mining	PLOS ONE			English	Article							PLACENTAL GROWTH-HORMONE; MATERNAL SERUM; 2ND TRIMESTER; ACTIVIN-A; PROTEOMIC ANALYSIS; AMNIOTIC-FLUID; MOUSE MODEL; 1ST-TRIMESTER; PREGNANCIES; IDENTIFICATION	Background: To facilitate the experimental search for novel maternal serum biomarkers in prenatal Down Syndrome screening, we aimed to create a set of candidate biomarkers using a data mining approach. Methodology/Principal Findings: Because current screening markers are derived from either fetal liver or placental trophoblasts, we reasoned that new biomarkers can primarily be found to be derived from these two tissues. By applying a three-stage filtering strategy on publicly available data from different sources, we identified 49 potential blood-detectable protein biomarkers. Our set contains three biomarkers that are currently widely used in either first-or second-trimester screening (AFP, PAPP-A and f beta-hCG), as well as ten other proteins that are or have been examined as prenatal serum markers. This supports the effectiveness of our strategy and indicates the set contains other markers potentially applicable for screening. Conclusions/Significance: We anticipate the set will help support further experimental studies for the identification of new Down Syndrome screening markers in maternal blood.	[Pennings, Jeroen L. A.; Rodenburg, Wendy; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands; [Koster, Maria P. H.; Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening LIS, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl	Schielen, Peter/AAP-4539-2020	Pennings, Jeroen L.A./0000-0002-9188-6358				Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARKER EV, 1994, ENDOCRINOLOGY, V134, P982, DOI 10.1210/en.134.2.982; Baviera G, 2004, J Matern Fetal Neonatal Med, V16, P241; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; Christiansen M, 2007, PRENATAL DIAG, V27, P1, DOI 10.1002/pd.1600; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Dalgliesh GL, 2001, PLACENTA, V22, P227, DOI 10.1053/plac.2000.0598; Donalson K, 2008, PRENATAL DIAG, V28, P904, DOI 10.1002/pd.2043; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Koster MPH, 2009, PRENATAL DIAG, V29, P857, DOI 10.1002/pd.2294; KOSTER MP, 2009, PRENAT DIAG IN PRESS; Lambert-Messerlian G M, 1996, J Med Screen, V3, P58; Lambert-Messerlian GM, 1998, EUR J ENDOCRINOL, V138, P425, DOI 10.1530/eje.0.1380425; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Moghadam S, 1998, FETAL DIAGN THER, V13, P291, DOI 10.1159/000020856; Nagalla SR, 2007, J PROTEOME RES, V6, P1245, DOI 10.1021/pr060539h; Newby D, 2000, PLACENTA, V21, P263, DOI 10.1053/plac.1999.0469; Oh JE, 2004, PROTEOMICS, V4, P1145, DOI 10.1002/pmic.200300654; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Papadopoulou E, 2008, FETAL DIAGN THER, V23, P211, DOI 10.1159/000116743; Patterson D, 2005, NAT REV GENET, V6, P137, DOI 10.1038/nrg1525; Poon LCY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.029; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; R Core Team, 2020, R LANG ENV STAT COMP; Rozovski U, 2007, HUM REPROD, V22, P2538, DOI 10.1093/humrep/dem214; Shapiro BL, 1997, HUM GENET, V99, P421, DOI 10.1007/s004390050383; Spencer K, 2008, PRENATAL DIAG, V28, P422, DOI 10.1002/pd.1994; Spencer K, 2008, PRENATAL DIAG, V28, P338, DOI 10.1002/pd.1978; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su YN, 2002, PRENATAL DIAG, V22, P8, DOI 10.1002/pd.218; Tsangaris GT, 2006, PROTEOMICS, V6, P4410, DOI 10.1002/pmic.200600085; Wald NJ, 1997, PRENATAL DIAG, V17, P821, DOI 10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.3.CO;2-X; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wallace EM, 1999, CLIN ENDOCRINOL, V50, P669, DOI 10.1046/j.1365-2265.1999.00716.x; Wortelboer EJ, 2009, PRENATAL DIAG, V29, P866, DOI 10.1002/pd.2300; Wortelboer EJ, 2009, PRENATAL DIAG, V29, P588, DOI 10.1002/pd.2247; Wright A, 2004, AM J MED GENET A, V130A, P354, DOI 10.1002/ajmg.a.30254; Yang JH, 2008, CHILD NERV SYST, V24, P893, DOI 10.1007/s00381-008-0595-7	45	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8010	10.1371/journal.pone.0008010	http://dx.doi.org/10.1371/journal.pone.0008010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956656	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500033
J	Smith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F				Smith, Steven G.; Joosten, Simone A.; Verscheure, Virginie; Pathan, Ansar A.; McShane, Helen; Ottenhoff, Tom H. M.; Dockrell, Hazel M.; Mascart, Francoise			Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; INTERFERON-GAMMA; FLOW-CYTOMETRY; T-CELLS; IMMUNITY; INFECTION; VACCINE; ASSAYS; IMMUNOGENICITY; ENUMERATION	A number of different interferon-gamma ELISpot protocols are in use in laboratories studying antigen-specific immune responses. It is therefore unclear how results from different assays compare, and what factors most significantly influence assay outcome. One such difference is that some laboratories use a short in vitro stimulation period of cells before they are transferred to the ELISpot plate; this is commonly done in the case of frozen cells, in order to enhance assay sensitivity. Other differences that may be significant include antibody coating of plates, the use of media with or without serum, the serum source and the number of cells added to the wells. The aim of this paper was to identify which components of the different ELISpot protocols influenced assay sensitivity and inter-laboratory variation. Four laboratories provided protocols for quantifying numbers of interferon-gamma spot forming cells in human peripheral blood mononuclear cells stimulated with Mycobacterium tuberculosis derived antigens. The differences in the protocols were compared directly. We found that several sources of variation in assay protocols can be eliminated, for example by avoiding serum supplementation and using AIM-V serum free medium. In addition, the number of cells added to ELISpot wells should also be standardised. Importantly, delays in peripheral blood mononuclear cell processing before stimulation had a marked effect on the number of detectable spot forming cells; processing delay thus should be minimised as well as standardised. Finally, a pre-stimulation culture period improved the sensitivity of the assay, however this effect may be both antigen and donor dependent. In conclusion, small differences in ELISpot protocols in routine use can affect the results obtained and care should be given to conditions selected for use in a given study. A pre-stimulation step may improve the sensitivity of the assay, particularly when cells have been previously frozen.	[Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Joosten, Simone A.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Pathan, Ansar A.; McShane, Helen] Jenner Inst, Oxford, England; [Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite Libre de Bruxelles; University of Oxford; Jenner Institute; Universite Libre de Bruxelles	Smith, SG (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	steven.smith@lshtm.ac.uk	Joosten, Simone/E-4731-2011; Joosten, Simone A/F-1357-2011	Joosten, Simone A/0000-0002-9878-0863; McShane, Helen/0000-0002-2126-5142; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806	European Commission [LSHP-CT-2003-503367]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was initiated in and supported by the Correlates of Immunity work package (WP4) of TBVAC, supported by the European Commission, within the 6th Framework Program; contract LSHP-CT-2003-503367. Funder URL: http://cordis.europa.eu/fp6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Doherty TM, 2005, J IMMUNOL METHODS, V298, P129, DOI 10.1016/j.jim.2005.01.013; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; OTTENHOFF TH, 2009, EUR J IMMUNOL; Ottenhoff THM, 2003, ADV EXP MED BIOL, V531, P279; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Tassignon J, 2005, J IMMUNOL METHODS, V305, P188, DOI 10.1016/j.jim.2005.07.014; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934	20	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7972	10.1371/journal.pone.0007972	http://dx.doi.org/10.1371/journal.pone.0007972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956718	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000272827500007
J	Mabon, ME; Scott, BA; Crowder, CM				Mabon, Meghann E.; Scott, Barbara A.; Crowder, C. Michael			Divergent Mechanisms Controlling Hypoxic Sensitivity and Lifespan by the DAF-2/Insulin/IGF-Receptor Pathway	PLOS ONE			English	Article							C-ELEGANS; DAF-16; TARGETS; LONGEVITY; GENES; IDENTIFICATION; EXPRESSION; SURVIVAL; SIGNALS; MEMBER	Organisms and their cells vary greatly in their tolerance of low oxygen environments (hypoxia). A delineation of the determinants of hypoxia tolerance is incomplete, despite intense interest for its implications in diseases such as stroke and myocardial infarction. The insulin/IGF-1 receptor (IGFR) signaling pathway controls survival of Caenorhabditis elegans from a variety of stressors including aging, hyperthermia, and hypoxia. daf-2 encodes a C. elegans IGFR homolog whose primary signaling pathway modulates the activity of the FOXO transcription factor DAF-16. DAF-16 regulates the transcription of a large number of genes, some of which have been shown to control aging. To identify genes that selectively regulate hypoxic sensitivity, we compared the whole-organismal transcriptomes of three daf-2 reduction-of-function alleles, all of which are hypoxia resistant, thermotolerant, and long lived, but differ in their rank of severities for these phenotypes. The transcript levels of 172 genes were increased in the most hypoxia resistant daf-2 allele, e1370, relative to the other alleles whereas transcripts from only 10 genes were decreased in abundance. RNAi knockdown of 6 of the 10 genes produced a significant increase in organismal survival after hypoxic exposure as would be expected if down regulation of these genes by the e1370 mutation was responsible for hypoxia resistance. However, RNAi knockdown of these genes did not prolong lifespan. These genes definitively separate the mechanisms of hypoxic sensitivity and lifespan and identify biological strategies to survive hypoxic injury.			Mabon, ME (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045905] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Gems D, 1998, GENETICS, V150, P129; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MABON ME, 2009, GENETICS IN PRESS; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PINKSTONGOSSE J, 2007, NAT GENET; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Riddle DL, 1997, C ELEGANS, P739; Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Timmons Lisa, 2006, V351, P119; Tops BBJ, 2006, COLD SPRING HARB SYM, V71, P189, DOI 10.1101/sqb.2006.71.035; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	31	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7937	10.1371/journal.pone.0007937	http://dx.doi.org/10.1371/journal.pone.0007937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936206	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004800016
J	Mutch, DM; Fuhrmann, JC; Rein, D; Wiemer, JC; Bouillot, JL; Poitou, C; Clement, K				Mutch, David M.; Fuhrmann, Jens C.; Rein, Dietrich; Wiemer, Jan C.; Bouillot, Jean-Luc; Poitou, Christine; Clement, Karine			Metabolite Profiling Identifies Candidate Markers Reflecting the Clinical Adaptations Associated with Roux-en-Y Gastric Bypass Surgery	PLOS ONE			English	Article							WEIGHT-LOSS; INSULIN-RESISTANCE; BARIATRIC SURGERY; BODY-COMPOSITION; OBESE SUBJECTS; RISK-FACTORS; FOLLOW-UP; ACID; MICE; CERAMIDES	Background: Roux-en-Y gastric bypass (RYGB) surgery is associated with weight loss, improved insulin sensitivity and glucose homeostasis, and a reduction in co-morbidities such as diabetes and coronary heart disease. To generate further insight into the numerous metabolic adaptations associated with RYGB surgery, we profiled serum metabolites before and after gastric bypass surgery and integrated metabolite changes with clinical data. Methodology and Principal Findings: Serum metabolites were detected by gas and liquid chromatography-coupled mass spectrometry before, and 3 and 6 months after RYGB in morbidly obese female subjects (n = 14; BMI = 46.2+/-1.7). Subjects showed decreases in weight-related parameters and improvements in insulin sensitivity post surgery. The abundance of 48% (83 of 172) of the measured metabolites changed significantly within the first 3 months post RYGB (p < 0.05), including sphingosines, unsaturated fatty acids, and branched chain amino acids. Dividing subjects into obese (n = 9) and obese/diabetic (n = 5) groups identified 8 metabolites that differed consistently at all time points and whose serum levels changed following RYGB: asparagine, lysophosphatidylcholine (C18:2), nervonic (C24:1) acid, p-Cresol sulfate, lactate, lycopene, glucose, and mannose. Changes in the aforementioned metabolites were integrated with clinical data for body mass index (BMI) and estimates for insulin resistance (HOMA-IR). Of these, nervonic acid was significantly and negatively correlated with HOMA-IR (p = 0.001, R = 20.55). Conclusions: Global metabolite profiling in morbidly obese subjects after RYGB has provided new information regarding the considerable metabolic alterations associated with this surgical procedure. Integrating clinical measurements with metabolomics data is capable of identifying markers that reflect the metabolic adaptations following RYGB.			Mutch, DM (corresponding author), Univ Guelph, Guelph, ON N1G 2W1, Canada.	dmutch@uoguelph.ca; dietrich.rein@metanomics-health.de	Rein, Dietrich/AAN-3694-2020; Poitou, Christine/GVT-6117-2022; Clément, karine/R-1120-2017	Rein, Dietrich/0000-0003-0076-1865; Poitou, Christine/0000-0001-7769-6331; Mutch, David/0000-0002-0908-7259; Fuhrmann, Jens/0000-0001-5730-381X				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Brolin RE, 2000, J GASTROINTEST SURG, V4, P464, DOI 10.1016/S1091-255X(00)80087-6; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; Calpe-Berdiel L, 2009, CURR ATHEROSCLER REP, V11, P391, DOI 10.1007/s11883-009-0059-x; Carey DG, 2006, OBES SURG, V16, P1602, DOI 10.1381/096089206779319347; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Clements RH, 2006, AM SURGEON, V72, P1196; Couzin J, 2008, SCIENCE, V320, P438, DOI 10.1126/science.320.5875.438; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Dungan KM, 2008, EXPERT REV MOL DIAGN, V8, P9, DOI 10.1586/14737159.8.1.9; Fazylov R, 2008, OBES SURG, V18, P644, DOI 10.1007/s11695-007-9279-8; Giusti V, 2004, OBES SURG, V14, P239, DOI 10.1381/096089204322857636; Gray RE, 2003, AM J PHYSIOL-ENDOC M, V284, pE726, DOI 10.1152/ajpendo.00371.2002; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holdstock C, 2005, INT J OBESITY, V29, P1275, DOI 10.1038/sj.ijo.0803000; HOLLAND WL, 2008, ENDOCR REV; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Kushner RF., 2006, CURR OPIN ENDOCRINOL, V13, P405, DOI [10.1097/01.med.0000244220.53163.85, DOI 10.1097/01.MED.0000244220.53163.85]; Lampe JW, 2007, SEMIN CANCER BIOL, V17, P347, DOI 10.1016/j.semcancer.2007.05.003; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Malinowski SS, 2006, AM J MED SCI, V331, P219, DOI 10.1097/00000441-200604000-00009; Mutch DM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r38; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oda E, 2005, INT HEART J, V46, P975, DOI 10.1536/ihj.46.975; Perez-Tilve D, 2008, CELL METAB, V8, P177, DOI 10.1016/j.cmet.2008.08.012; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Straczkowski Marek, 2008, Rev Diabet Stud, V5, P13, DOI 10.1900/RDS.2008.5.13; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Williams DB, 2007, SURG OBES RELAT DIS, V3, P8, DOI 10.1016/j.soard.2006.10.003; Yamada H, 2002, J ANAL TOXICOL, V26, P17, DOI 10.1093/jat/26.1.17; Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426; Zierath JR, 2007, CELL METAB, V5, P161, DOI 10.1016/j.cmet.2007.02.005	43	95	100	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7905	10.1371/journal.pone.0007905	http://dx.doi.org/10.1371/journal.pone.0007905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936240	gold, Green Submitted, Green Published			2022-12-27	WOS:000272004600009
J	Brunner, PC; Keller, N; McDonald, BA				Brunner, Patrick C.; Keller, Nicolas; McDonald, Bruce A.			Wheat Domestication Accelerated Evolution and Triggered Positive Selection in the beta-Xylosidase Enzyme of Mycosphaerella graminicola	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; IN-VITRO; DIVERSIFYING SELECTION; BOTRYTIS-CINEREA; PLANT DEFENSE; PROTEIN; XYLANASE; PATHOGENICITY; POPULATIONS; PATTERNS	Plant cell wall degrading enzymes (PCWDEs) of plant pathogens are receiving increasing interest for their potential to trigger plant defense reactions. In an antagonistic co-evolutionary arms race between host and pathogen, PCWDEs could be under strong selection. Here, we tested the hypothesis that PCWDEs in the fungal wheat pathogen Mycosphaerella graminicola have been positively selected by analyzing ratios of non-synonymous and synonymous nucleotide changes in the genes encoding these enzymes. Analyses of five PCWDEs demonstrated that one (beta-xylosidase) has been under strong positive selection and experienced an accelerated rate of evolution. In contrast, PCWDEs in the closest relatives of M. graminicola collected from wild grasses did not show evidence for selection or deviation from a molecular clock. Since the genealogical divergence of M. graminicola from these latter species coincided with the onset of agriculture, we hypothesize that the recent domestication of the host plant and/or agricultural practices triggered positive selection in beta-xylosidase and that this enzyme played a key role in the emergence of a host-specialized pathogen.			Brunner, PC (corresponding author), Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol, Zurich, Switzerland.	patrick.brunner@agrl.ethz.ch	Brunner, Patrick C/F-5400-2011; McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172				Banke S, 2005, MOL ECOL, V14, P1881, DOI 10.1111/j.1365-294X.2005.02536.x; Banke S, 2004, FUNGAL GENET BIOL, V41, P226, DOI 10.1016/j.fgb.2003.09.006; Belien T, 2006, MOL PLANT MICROBE IN, V19, P1072, DOI 10.1094/MPMI-19-1072; Bishop JG, 2005, MOL BIOL EVOL, V22, P1531, DOI 10.1093/molbev/msi146; COOPER RM, 1988, PHYSIOL MOL PLANT P, V32, P33, DOI 10.1016/S0885-5765(88)80004-3; COOPER RM, 1983, BIOCH PLANT PATHOLOG, P101; De Lorenzo G., 1997, MYCOTA PLANT RELATIO, P61; Debyser W, 1999, J CEREAL SCI, V30, P39, DOI 10.1006/jcrs.1999.0272; Di Matteo A, 2006, PHYTOCHEMISTRY, V67, P528, DOI 10.1016/j.phytochem.2005.12.025; Douaiher MN, 2007, PLANT PATHOL, V56, P79, DOI 10.1111/j.1365-3059.2006.01460.x; Douaiher MN, 2007, EUR J PLANT PATHOL, V117, P71, DOI 10.1007/s10658-006-9073-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Esquerre-Tugaye MT, 2000, PLANT PHYSIOL BIOCH, V38, P157, DOI 10.1016/S0981-9428(00)00161-3; EYAL Z, 1985, PHYTOPATHOLOGY, V75, P1456, DOI 10.1094/Phyto-75-1456; EYAL Z, 1973, PHYTOPATHOLOGY, V63, P945; Fay JC, 2000, GENETICS, V155, P1405; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GUTTMANN DS, 2006, MOL CELL, V5, P1003; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kang Z, 2000, J PHYTOPATHOL, V148, P263, DOI 10.1046/j.1439-0434.2000.00489.x; Kapat A, 1998, MYCOL RES, V102, P1017, DOI 10.1017/S0953756297006023; Kimura M., 1983, P208; Lalaoui F, 2000, PLANT PATHOL, V49, P727, DOI 10.1046/j.1365-3059.2000.00491.x; LEHTINEN U, 1993, PHYSIOL MOL PLANT P, V43, P121, DOI 10.1006/pmpp.1993.1045; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; McDonald BA, 1999, SEPTORIA ON CEREALS: A STUDY OF PATHOSYSTEMS, P44; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McLauchlan WR, 1999, BIOCHEM J, V338, P441, DOI 10.1042/0264-6021:3380441; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Schurch S, 2004, MOL PLANT MICROBE IN, V17, P1114, DOI 10.1094/MPMI.2004.17.10.1114; Stotz HU, 2000, PHYSIOL MOL PLANT P, V56, P117, DOI 10.1006/pmpp.2000.0258; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; TAJIMA F, 1989, GENETICS, V123, P585; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Wubben JP, 1999, APPL ENVIRON MICROB, V65, P1596; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7884	10.1371/journal.pone.0007884	http://dx.doi.org/10.1371/journal.pone.0007884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924304	Green Submitted, gold, Green Published			2022-12-27	WOS:000271936700017
J	Chen, C; Liu, CP				Chen, Cyndi; Liu, Chih-Pin			Regulatory Function of a Novel Population of Mouse Autoantigen-Specific Foxp3(-) Regulatory T Cells Depends on IFN-gamma, NO, and Contact with Target Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; RECEPTOR TRANSGENIC MICE; INTERFERON-GAMMA; NITRIC-OXIDE; IMMUNOLOGICAL-TOLERANCE; IMMUNE-RESPONSES; MECHANISMS; IDENTIFICATION; AUTOIMMUNITY; PROGRESSION	Background: Both naturally arising Foxp3(+) and antigen-induced Foxp3(-) regulatory T cells (Treg) play a critical role in regulating immune responses, as well as in preventing autoimmune diseases and graft rejection. It is known that antigen-specific Treg are more potent than polyclonal Treg in suppressing pathogenic immune responses that cause autoimmunity and inflammation. However, difficulty in identifying and isolating a sufficient number of antigen-specific Treg has limited their use in research to elucidate the mechanisms underlying their regulatory function and their potential role in therapy. Methodology/Principal Findings: Using a novel class II MHC tetramer, we have isolated a population of CD4(+) Foxp3(-) T cells specific for the autoantigen glutamic acid decarboxylase p286-300 peptide (NR286 T cells) from diabetes-resistant non-obese resistant (NOR) mice. These Foxp3(-) NR286 T cells functioned as Treg that were able to suppress target T cell proliferation in vitro and inhibit type 1 diabetes in animals. Unexpected results from mechanistic studies in vitro showed that their regulatory function was dependent on not only IFN-gamma and nitric oxide, but also on cell contact with target cells. In addition, separating NR286 Treg from target T cells in transwell assays abolished both production of NO and suppression of target T cells, regardless of whether IFN-gamma was produced in cell cultures. Therefore, production of NO, not IFN-gamma, was cell contact dependent, suggesting that NO may function downstream of IFN-gamma in mediating regulatory function of NR286 Treg. Conclusions/Significance: These studies identified a unique population of autoantigen-specific Foxp3(-) Treg that can exert their regulatory function dependent on not only IFN-gamma and NO but also cell contact with target cells.			Chen, C (corresponding author), Beckman Res Inst, Dept Immunol, Duarte, CA USA.	cpliu@coh.org						Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Billiau A, 1998, ANN NY ACAD SCI, V856, P22, DOI 10.1111/j.1749-6632.1998.tb08309.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen C, 2006, J IMMUNOL, V176, P3449, DOI 10.4049/jimmunol.176.6.3449; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Huang FP, 1998, EUR J IMMUNOL, V28, P4062, DOI 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kim SK, 2004, P NATL ACAD SCI USA, V101, P14204, DOI 10.1073/pnas.0405500101; Liu CP, 2000, P NATL ACAD SCI USA, V97, P14596, DOI 10.1073/pnas.250390997; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MARTINOROZCO N, EUR J IMMUNOL, V39, P216; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Rosloniec EF, 2002, ARTHRITIS RES, V4, P333, DOI 10.1186/ar432; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schloot NC, 2002, DIABETES-METAB RES, V18, P64, DOI 10.1002/dmrr.256; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Steinman L, 2001, MULT SCLER, V7, P275, DOI 10.1177/135245850100700501; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; van der Veen RC, 1999, CELL IMMUNOL, V193, P194, DOI 10.1006/cimm.1999.1471; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2004, J IMMUNOL, V173, P6777, DOI 10.4049/jimmunol.173.11.6777; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	43	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7863	10.1371/journal.pone.0007863	http://dx.doi.org/10.1371/journal.pone.0007863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924236	gold, Green Submitted, Green Published			2022-12-27	WOS:000271854200011
J	Zajac, P; Oberg, C; Ahmadian, A				Zajac, Pawel; Oberg, Christine; Ahmadian, Afshin			Analysis of Short Tandem Repeats by Parallel DNA Threading	PLOS ONE			English	Article							EUKARYOTIC GENOMES; MICROSATELLITES; EVOLUTION	The majority of studies employing short tandem repeats (STRs) require investigation of several of these genetic markers. As such, we demonstrate the feasibility of the trinucleotide threading (TnT) approach for scalable analysis of STRs. The TnT method represents a parallel amplification alternative that addresses the obstacles associated with multiplex PCR. In this study, analysis of the STR fragments was performed with capillary gel electrophoresis; however, it should be possible to combine our approach with the massive 454 sequencing platform to considerably increase the number of targeted STRs.			Zajac, P (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden.	afshin.ahmadian@biotech.kth.se						Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Montelius K, 2008, FORENSIC SCI INT-GEN, V2, pE49, DOI 10.1016/j.fsigen.2007.12.005; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pettersson E, 2008, HUM MUTAT, V29, P323, DOI 10.1002/humu.20655; Pourmand N, 2007, P NATL ACAD SCI USA, V104, P6146, DOI 10.1073/pnas.0700921104; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Zajac P, 2008, GENOMICS, V91, P209, DOI 10.1016/j.ygeno.2007.10.012	17	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7823	10.1371/journal.pone.0007823	http://dx.doi.org/10.1371/journal.pone.0007823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915680	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721900014
J	Djuardi, Y; Wibowo, H; Supali, T; Ariawan, I; Bredius, RGM; Yazdanbakhsh, M; Rodrigues, LC; Sartono, E				Djuardi, Yenny; Wibowo, Heri; Supali, Taniawati; Ariawan, Iwan; Bredius, Robbert G. M.; Yazdanbakhsh, Maria; Rodrigues, Laura C.; Sartono, Erliyani			Determinants of the Relationship between Cytokine Production in Pregnant Women and Their Infants	PLOS ONE			English	Article							IMMUNE-RESPONSES; HELMINTH INFECTIONS; IN-UTERO; FETAL; REACTIVITY; CHILDHOOD; EXPOSURE; ALLERGEN; ASTHMA; GROWTH	Exposure to environmental factors during fetal life and infancy is thought to play an important role in the early development of innate and adaptive immunity. The immunological relationship between mother and infant and the effect that environmental exposures have during pregnancy and early childhood have not been studied extensively. Here the production of cytokines was measured in 146 pairs of mothers and their 2-month-old infants. The effect of place of residence, socio-economic variables, parasitic infections as well as maternal and child characteristics on measured cytokine production was determined. Mothers producing high levels of IL-10, IFN-gamma and IL-5 were more likely to have infants who also produced high levels of these cytokines either spontaneously (OR 2.6(95% CI 1.2-5.4), OR 2.9(CI 1.3-6.6), OR 11.2(CI 4.6-27.2), respectively) or in response to PHA (IL-10: OR 3.0(CI 1.4-6.6), IFN-gamma: OR 2.0(CI 1.0-4.2), respectively) even after adjustment for potential confounding variables. This was not the case for TNF-alpha. In response to LPS, place of residence was a strong determinant of infant IL-10 (OR 0.2(CI 0.1-0.9)) and TNF-alpha (OR 0.3(CI 0.1-0.9)) production. Maternal protozoan infections was independently associated with reduced infant IL10 in response to PHA and to LPS as well as reduced TNF-alpha and IFN-gamma in response to PHA. These results indicate strong relationship between maternal and infant's cellular immune responses even after taking into account many environmental influences that could affect infant's response directly or indirectly through uterine microenvironment. However, place of residence and intestinal infections may still directly affect the immune responses of the infant. Taken together, the study provides evidence for imprinted cytokine responses of an infant which may have implications for their reaction to incoming antigens, warranting further investigation into the role that genetics or epigenetics play in shaping the cytokine response by an infant to self or external antigens.			Djuardi, Y (corresponding author), Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia.	yenny_djuardi@yahoo.com	Yazdanbakhsh, Maria/AAI-3996-2020; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Djuardi, Yenny/AGP-5890-2022; Bredius, Robbert/AAF-2592-2019	Yazdanbakhsh, Maria/0000-0002-7666-1441; Rodrigues, Laura Cunha/0000-0001-9008-660X; Wibowo, Heri/0000-0001-7708-5135; Bredius, Robbert/0000-0001-8151-1539				Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Cirioni O, 1999, EUR J EPIDEMIOL, V15, P389, DOI 10.1023/A:1007551218671; de Almeida MF, 2007, REV SAUDE PUBL, V41, P35, DOI 10.1590/S0034-89102007000100006; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; Fievet N, 1996, PARASITE IMMUNOL, V18, P483, DOI 10.1046/j.1365-3024.1996.d01-19.x; Figueiredo CA, 2009, ENVIRON HEALTH PERSP, V117, P845, DOI 10.1289/ehp.0800366; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Grogan JL, 1996, EUR J IMMUNOL, V26, P1365, DOI 10.1002/eji.1830260628; Jiang B, 2003, CLIN DIAGN LAB IMMUN, V10, P995, DOI 10.1128/CDLI.10.6.995-1001.2003; Jones AC, 1996, PEDIATR ALLERGY IMMU, V7, P109, DOI 10.1111/j.1399-3038.1996.tb00117.x; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; King CL, 1998, J IMMUNOL, V160, P3578; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; Krauss-Etschmann S, 2008, J ALLERGY CLIN IMMUN, V121, P464, DOI 10.1016/j.jaci.2007.09.018; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; Petersen E, 2007, PARASITOLOGY, V134, P1855, DOI 10.1017/S0031182007000182; Pit DSS, 2000, ALLERGY, V55, P732, DOI 10.1034/j.1398-9995.2000.00477.x; Prescott SL, 2005, CLIN EXP ALLERGY, V35, P417, DOI 10.1111/j.1365-2222.2005.02171.x; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; Soboslay PT, 1999, CLIN EXP IMMUNOL, V117, P130; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VanDurenSchmidt K, 1997, PEDIATR RES, V41, P128, DOI 10.1203/00006450-199701000-00020; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Warner JA, 1998, CLIN EXP ALLERGY, V28, P35	32	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7711	10.1371/journal.pone.0007711	http://dx.doi.org/10.1371/journal.pone.0007711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898617	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000002
J	Royer, DL; Meyerson, LA; Robertson, KM; Adams, JM				Royer, Dana L.; Meyerson, Laura A.; Robertson, Kevin M.; Adams, Jonathan M.			Phenotypic Plasticity of Leaf Shape along a Temperature Gradient in Acer rubrum	PLOS ONE			English	Article							MORPHOLOGICAL VARIATION; FOSSIL LEAVES; POPULATIONS; MARGIN; SIZE; CLIMATE; GROWTH; RESPONSES; INDEX	Both phenotypic plasticity and genetic determination can be important for understanding how plants respond to environmental change. However, little is known about the plastic response of leaf teeth and leaf dissection to temperature. This gap is critical because these leaf traits are commonly used to reconstruct paleoclimate from fossils, and such studies tacitly assume that traits measured from fossils reflect the environment at the time of their deposition, even during periods of rapid climate change. We measured leaf size and shape in Acer rubrum derived from four seed sources with a broad temperature range and grown for two years in two gardens with contrasting climates (Rhode Island and Florida). Leaves in the Rhode Island garden have more teeth and are more highly dissected than leaves in Florida from the same seed source. Plasticity in these variables accounts for at least 6-19 % of the total variance, while genetic differences among ecotypes probably account for at most 69-87 %. This study highlights the role of phenotypic plasticity in leaf-climate relationships. We suggest that variables related to tooth count and leaf dissection in A. rubrum can respond quickly to climate change, which increases confidence in paleoclimate methods that use these variables.			Royer, DL (corresponding author), Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA.	droyer@wesleyan.edu	Meyerson, Laura/K-9013-2012; Meyerson, Laura A./AAN-6688-2020; Meyerson, Laura A./S-2979-2019; Robertson, Kevin/AAT-9357-2021; Meyerson, Laura/D-4487-2013	Meyerson, Laura A./0000-0002-1283-3865; Royer, Dana/0000-0003-0976-953X				Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Behrensmeyer Anna K., 1992, P15; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Christophel D, 2004, NEW PHYTOL, V161, P327, DOI 10.1111/j.1469-8137.2004.00989.x; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Dilcher DL., 1973, VEGETATION VEGETATIO, P39; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Flann C, 2002, AUST SYST BOT, V15, P205, DOI 10.1071/SB01018; Godfrey RK., 1988, TREES SHRUBS WOODY V; GOSLER AG, 1994, BOT J LINN SOC, V115, P211, DOI 10.1111/j.1095-8339.1994.tb01779.x; Greenwood DR, 2005, NEW PHYTOL, V166, P355, DOI 10.1111/j.1469-8137.2005.01380.x; Greenwood DR, 2004, PALAIOS, V19, P129, DOI 10.1669/0883-1351(2004)019<0129:PEULAI>2.0.CO;2; Gregory KM, 1996, PALAEOGEOGR PALAEOCL, V124, P39, DOI 10.1016/0031-0182(96)00015-6; Groot EP, 2000, J PLANT GROWTH REGUL, V19, P77, DOI 10.1007/s003440000008; GUREVITCH J, 1988, AM J BOT, V75, P1298, DOI 10.2307/2444452; Hovenden MJ, 2004, NEW PHYTOL, V161, P585, DOI 10.1046/j.1469-8137.2003.00931.x; Hovenden MJ, 2006, NEW PHYTOL, V169, P291, DOI 10.1111/j.1469-8137.2005.01585.x; Hovenden MJ, 2001, AUST J BOT, V49, P427, DOI 10.1071/BT01001; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Imbert E, 2000, NEW PHYTOL, V147, P601, DOI 10.1046/j.1469-8137.2000.00724.x; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Morecroft MD, 1996, NEW PHYTOL, V134, P471, DOI 10.1111/j.1469-8137.1996.tb04364.x; Nicotra AB, 2008, OECOLOGIA, V154, P625, DOI 10.1007/s00442-007-0865-1; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Raunkiaer C, 1934, LIFE FORMS PLANTS ST; Richards PW, 1939, J ECOL, V27, P1, DOI 10.2307/2256298; Roth-Nebelsick A, 2001, PLANT CELL ENVIRON, V24, P631, DOI 10.1046/j.1365-3040.2001.00712.x; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Sack L, 2006, AM J BOT, V93, P829, DOI 10.3732/ajb.93.6.829; Semchenko M, 2007, ANN BOT-LONDON, V100, P83, DOI 10.1093/aob/mcm074; STUCKY JM, 2001, COMMON WOODY PIEDMON; Thomas SC, 1996, AM J BOT, V83, P106, DOI 10.2307/2445962; Tsukaya H, 1997, MOL GEN GENET, V256, P231, DOI 10.1007/s004380050565; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; VOGEL S, 1970, J EXP BOT, V21, P91, DOI 10.1093/jxb/21.1.91; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; WOLFE JA, 1993, US GEOL SURV B, V2040, P71; Wolfe JA, 1979, US GEOLOGICAL SURVEY, V1106, P1, DOI DOI 10.3133/PP1106	49	95	101	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7653	10.1371/journal.pone.0007653	http://dx.doi.org/10.1371/journal.pone.0007653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893620	gold, Green Published, Green Submitted			2022-12-27	WOS:000271232000014
J	Shi, XL; Marie, D; Jardillier, L; Scanlan, DJ; Vaulot, D				Shi, Xiao Li; Marie, Dominique; Jardillier, Ludwig; Scanlan, David J.; Vaulot, Daniel			Groups without Cultured Representatives Dominate Eukaryotic Picophytoplankton in the Oligotrophic South East Pacific Ocean	PLOS ONE			English	Article							GENETIC DIVERSITY; WIDESPREAD OCCURRENCE; MICROMONAS-PUSILLA; MEDITERRANEAN SEA; RIBOSOMAL-RNA; MARINE; PICOPLANKTON; PHYTOPLANKTON; ULTRAPHYTOPLANKTON; CYANOBACTERIA	Background: Photosynthetic picoeukaryotes (PPE) with a cell size less than 3 mm play a critical role in oceanic primary production. In recent years, the composition of marine picoeukaryote communities has been intensively investigated by molecular approaches, but their photosynthetic fraction remains poorly characterized. This is largely because the classical approach that relies on constructing 18S rRNA gene clone libraries from filtered seawater samples using universal eukaryotic primers is heavily biased toward heterotrophs, especially alveolates and stramenopiles, despite the fact that autotrophic cells in general outnumber heterotrophic ones in the euphotic zone. Methodology/Principal Findings: In order to better assess the composition of the eukaryotic picophytoplankton in the South East Pacific Ocean, encompassing the most oligotrophic oceanic regions on earth, we used a novel approach based on flow cytometry sorting followed by construction of 18S rRNA gene clone libraries. This strategy dramatically increased the recovery of sequences from putative autotrophic groups. The composition of the PPE community appeared highly variable both vertically down the water column and horizontally across the South East Pacific Ocean. In the central gyre, uncultivated lineages dominated: a recently discovered clade of Prasinophyceae (IX), clades of marine Chrysophyceae and Haptophyta, the latter division containing a potentially new class besides Prymnesiophyceae and Pavlophyceae. In contrast, on the edge of the gyre and in the coastal Chilean upwelling, groups with cultivated representatives (Prasinophyceae clade VII and Mamiellales) dominated. Conclusions/Significance: Our data demonstrate that a very large fraction of the eukaryotic picophytoplankton still escapes cultivation. The use of flow cytometry sorting should prove very useful to better characterize specific plankton populations by molecular approaches such as gene cloning or metagenomics, and also to obtain into culture strains representative of these novel groups.			Shi, XL (corresponding author), UPMC Paris 06, Roscoff, France.	vaulot@sb-roscoff.fr	Vaulot, Daniel/T-6649-2019; Scanlan, David J/G-4080-2016; Jardillier, Ludwig E/H-8486-2015	Vaulot, Daniel/0000-0002-0717-5685; Scanlan, David J/0000-0003-3093-4245; Jardillier, Ludwig E/0000-0003-4982-5807	Natural Environment Research Council [NE/C003160/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersen RA, 1999, PROTIST, V150, P71, DOI 10.1016/S1434-4610(99)70010-6; BOOTH BC, 1987, J PHYCOL, V23, P245, DOI 10.1111/j.1529-8817.1987.tb04132.x; Bravo-Sierra E, 2003, J PHYCOL, V39, P577, DOI 10.1046/j.1529-8817.2003.02181.x; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Claustre H, 2008, BIOGEOSCIENCES, V5, P679, DOI 10.5194/bg-5-679-2008; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Foulon E, 2008, ENVIRON MICROBIOL, V10, P2433, DOI 10.1111/j.1462-2920.2008.01673.x; Fuller NJ, 2006, LIMNOL OCEANOGR, V51, P2502, DOI 10.4319/lo.2006.51.6.2502; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; Grob C, 2007, BIOGEOSCIENCES, V4, P837, DOI 10.5194/bg-4-837-2007; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawachi Masanobu, 2002, Phycological Research, V50, P31, DOI 10.1111/j.1440-1835.2002.tb00134.x; Klepac-Ceraj V., 2006, ONLINE J BIOINFORM, V7, P15; Komuro C, 2005, DEEP-SEA RES PT II, V52, P2206, DOI 10.1016/j.dsr2.2005.08.006; Le Gall F, 2008, BIOGEOSCIENCES, V5, P203, DOI 10.5194/bg-5-203-2008; Lepere C, 2009, ENVIRON MICROBIOL, V11, P3105, DOI 10.1111/j.1462-2920.2009.02015.x; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Marie D, 2006, FEMS MICROBIOL ECOL, V55, P403, DOI 10.1111/j.1574-6941.2005.00058.x; MARIE D, FEMS MICROBIOL UNPUB; Masquelier S, 2008, BIOGEOSCIENCES, V5, P311, DOI 10.5194/bg-5-311-2008; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2006, AQUAT MICROB ECOL, V45, P171, DOI 10.3354/ame045171; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; Moon-van der Staay SY, 2000, LIMNOL OCEANOGR, V45, P98, DOI 10.4319/lo.2000.45.1.0098; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	51	122	127	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7657	10.1371/journal.pone.0007657	http://dx.doi.org/10.1371/journal.pone.0007657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893617	Green Published, gold, Green Submitted			2022-12-27	WOS:000271232000015
J	Lee, VJ; Yap, J; Ong, JBS; Chan, KP; Lin, RTP; Chan, SP; Goh, KT; Leo, YS; Chen, MIC				Lee, Vernon J.; Yap, Jonathan; Ong, Jimmy B. S.; Chan, Kwai-Peng; Lin, Raymond T. P.; Chan, Siew Pang; Goh, Kee Tai; Leo, Yee-Sin; Chen, Mark I-Cheng			Influenza Excess Mortality from 1950-2000 in Tropical Singapore	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; PANDEMIC INFLUENZA; DENGUE EPIDEMIC; IMPACT; ENGLAND; WALES; POPULATION; INFECTIONS; PREVENTION	Introduction: Tropical regions have been shown to exhibit different influenza seasonal patterns compared to their temperate counterparts. However, there is little information about the burden of annual tropical influenza epidemics across time, and the relationship between tropical influenza epidemics compared with other regions. Methods: Data on monthly national mortality and population was obtained from 1947 to 2003 in Singapore. To determine excess mortality for each month, we used a moving average analysis for each month from 1950 to 2000. From 1972, influenza viral surveillance data was available. Before 1972, information was obtained from serial annual government reports, peer-reviewed journal articles and press articles. Results: The influenza pandemics of 1957 and 1968 resulted in substantial mortality. In addition, there were 20 other time points with significant excess mortality. Of the 12 periods with significant excess mortality post-1972, only one point (1988) did not correspond to a recorded influenza activity. For the 8 periods with significant excess mortality periods before 1972 excluding the pandemic years, 2 years (1951 and 1953) had newspaper reports of increased pneumonia deaths. Excess mortality could be observed in almost all periods with recorded influenza outbreaks but did not always exceed the 95% confidence limits of the baseline mortality rate. Conclusion: Influenza epidemics were the likely cause of most excess mortality periods in post-war tropical Singapore, although not every epidemic resulted in high mortality. It is therefore important to have good influenza surveillance systems in place to detect influenza activity.	[Lee, Vernon J.; Yap, Jonathan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.; Ong, Jimmy B. S.; Chen, Mark I-Cheng] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Lee, Vernon J.; Chen, Mark I-Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Chan, Kwai-Peng] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Lin, Raymond T. P.; Goh, Kee Tai] Minist Hlth, Singapore, Singapore; [Chan, Siew Pang] SIM, Singapore, Singapore; [Leo, Yee-Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Chen, Mark I-Cheng] Duke NUS Grad Med Sch, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; Australian National University; Singapore General Hospital; Ministry of Health-Singapore; Tan Tock Seng Hospital; National University of Singapore	Lee, VJ (corresponding author), Minist Def, Biodef Ctr, Singapore, Singapore.	vernonljm@hotmail.com	Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536				ALLING DW, 1981, AM J EPIDEMIOL, V113, P30, DOI 10.1093/oxfordjournals.aje.a113063; AZOICAI D, BACTERIOL VIRUSOL PA, V39, P185; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Besselaar TG, 1999, J MED VIROL, V59, P561, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;561::AID-JMV22&gt;3.0.CO;2-5; BRAMMER T, 2002, MORBIDITY MORTALITY, V51, pSS7; CHAPMAN L E, 1992, Morbidity and Mortality Weekly Report, V41, P35; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Claas E C, 1994, Ned Tijdschr Geneeskd, V138, P1966; CLIFFORD RE, 1977, INT J EPIDEMIOL, V6, P115, DOI 10.1093/ije/6.2.115; Curran M, 1998, Commun Dis Intell, V22, P69; *DEP PATH SING GEN, 2000, MED REP 1973 2000; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; GILL PW, 1972, MED J AUSTRALIA, V2, P242, DOI 10.5694/j.1326-5377.1972.tb47264.x; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P67, DOI 10.1017/S0022172400053778; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Kuszewski K, 1999, Przegl Epidemiol, V53, P45; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Leo YS, 2009, LANCET INFECT DIS, V9, P457, DOI 10.1016/S1473-3099(09)70182-3; LUI KJ, 1985, AM J PUBLIC HEALTH, V77, P712; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; RAGONA G, 1978, J HYG-CAMBRIDGE, V80, P249, DOI 10.1017/S0022172400053602; Rao BL, 1997, INDIAN J MED RES, V106, P223; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SOUSA VO, 1974, B WORLD HEALTH ORGAN, V50, P475; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; Tangkanakul Waraluk, 2000, Journal of the Medical Association of Thailand, V83, P1005; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2006, EMERG INFECT DIS, V12, P661, DOI 10.3201/eid1204.050695; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Weber J M, 1994, Can Commun Dis Rep, V20, P177; Zgorzelska K, 1990, Przegl Epidemiol, V44, P299; 1953, STRAITS TIMES   0829, P4; 1953, STRAITS TIMES   0820, P7; 1951, STRAITS TIMES   0901, P4; 1951, STRAITS TIMES   0909, P5; 1951, STRAITS TIMES   0927, P7; 1951, STRAITS TIMES   0825, P4	47	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8096	10.1371/journal.pone.0008096	http://dx.doi.org/10.1371/journal.pone.0008096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956611	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828700010
J	Kilkenny, C; Parsons, N; Kadyszewski, E; Festing, MFW; Cuthill, IC; Fry, D; Hutton, J; Altman, DG				Kilkenny, Carol; Parsons, Nick; Kadyszewski, Ed; Festing, Michael F. W.; Cuthill, Innes C.; Fry, Derek; Hutton, Jane; Altman, Douglas G.			Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals	PLOS ONE			English	Article							CONSORT STATEMENT; GUIDELINES; INSTRUCTIONS; JOURNALS	For scientific, ethical and economic reasons, experiments involving animals should be appropriately designed, correctly analysed and transparently reported. This increases the scientific validity of the results, and maximises the knowledge gained from each experiment. A minimum amount of relevant information must be included in scientific publications to ensure that the methods and results of a study can be reviewed, analysed and repeated. Omitting essential information can raise scientific and ethical concerns. We report the findings of a systematic survey of reporting, experimental design and statistical analysis in published biomedical research using laboratory animals. Medline and EMBASE were searched for studies reporting research on live rats, mice and non-human primates carried out in UK and US publicly funded research establishments. Detailed information was collected from 271 publications, about the objective or hypothesis of the study, the number, sex, age and/or weight of animals used, and experimental and statistical methods. Only 59% of the studies stated the hypothesis or objective of the study and the number and characteristics of the animals used. Appropriate and efficient experimental design is a critical component of high-quality science. Most of the papers surveyed did not use randomisation (87%) or blinding (86%), to reduce bias in animal selection and outcome assessment. Only 70% of the publications that used statistical methods described their methods and presented the results with a measure of error or variability. This survey has identified a number of issues that need to be addressed in order to improve experimental design and reporting in publications describing research using animals. Scientific publication is a powerful and important source of information; the authors of scientific publications therefore have a responsibility to describe their methods and results comprehensively, accurately and transparently, and peer reviewers and journal editors share the responsibility to ensure that published studies fulfil these criteria.	[Kilkenny, Carol] Natl Ctr Replacement Refinement & Reduct Anim Res, London, England; [Parsons, Nick] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Kadyszewski, Ed] Pfizer Global Res & Dev, Groton, CT USA; [Festing, Michael F. W.] Anim Procedures Comm, London, England; [Cuthill, Innes C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Fry, Derek] Home Off, Shrewsbury, Salop, England; [Hutton, Jane] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Warwick; Pfizer; University of Bristol; University of Warwick; University of Oxford	Kilkenny, C (corresponding author), Natl Ctr Replacement Refinement & Reduct Anim Res, London, England.	carol.kilkenny@nc3rs.org.uk	Parsons, Nick/AAA-8713-2019; Altman, Douglas G/A-9714-2012	Parsons, Nick/0000-0001-9975-888X	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs); National Institutes for Health/Office of Laboratory Animal Welfare (NIH/OLAW)	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Institutes for Health/Office of Laboratory Animal Welfare (NIH/OLAW)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This survey was co-funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and the National Institutes for Health/Office of Laboratory Animal Welfare (NIH/OLAW)(http://grants.nih.gov/grants/olaw/olaw.htm). NIH/OLAW had no role in study design, data collection and analysis, or preparation of the manuscript. Members of the NC3Rs Experimental Design Working Group (EDWG; independent, unpaid experts in experimental design and statistics) designed the survey. The NC3Rs paid independent Information Specialists to search published databases, and two independent statisticians Nick Parsons and Ed Kadyszewski to collect and analyse the data. The data were also analysed, and the manuscript prepared and submitted, by the NC3Rs (Carol Kilkenny) in consultation with members of the EDWG.	Alfaro V, 2005, METHOD FIND EXP CLIN, V27, P495, DOI 10.1358/mf.2005.27.7.921309; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Bennett LT, 2004, J APPL ECOL, V41, P585, DOI 10.1111/j.0021-8901.2004.00924.x; BEYNEN AC, 2003, DESIGN ANIMAL EXPT P, P219; COCHRANE AL, 1972, INT J EPIDEMIOL, V1, P89, DOI 10.1093/ije/1.2.89; Dell Ralph B, 2002, ILAR J, V43, P207; Festing Michael F W, 2002, ILAR J, V43, P244; FESTING MW, 2002, LAB ANIMAL HDB, V14, P1; FREEMAN J, 2008, DISPLAY DATA; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Jafari Peyman, 2006, BMC Med Inform Decis Mak, V6, P27, DOI 10.1186/1472-6947-6-27; Johnson Paula D, 2002, ILAR J, V43, P202; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; MCCANCE I, 1995, AUST VET J, V72, P322, DOI 10.1111/j.1751-0813.1995.tb07534.x; Morris CE, 2002, MICROBIOL MOL BIOL R, V66, P592, DOI 10.1128/MMBR.66.4.592-616.2002; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Obrink KJ, 2000, LAB ANIM, V34, P121, DOI 10.1258/002367700780457608; Peters JL, 2006, J ENVIRON SCI HEAL B, V41, P1245, DOI 10.1080/03601230600857130; RUSSELL W. M. S., 1959; Shaw Robert, 2002, ILAR J, V43, P223; Smidt N, 2005, RADIOLOGY, V235, P347, DOI 10.1148/radiol.2352040507; Smith JA, 1997, LAB ANIM, V31, P312, DOI 10.1258/002367797780596176; Stone SP, 2007, J ANTIMICROB CHEMOTH, V59, P833, DOI 10.1093/jac/dkm055; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; *WORK COMM BIOL CH, 1985, LAB ANIM, V19, P106	31	513	535	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e7824	10.1371/journal.pone.0007824	http://dx.doi.org/10.1371/journal.pone.0007824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956596	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400001
J	Aghajanian, A; Wittchen, ES; Campbell, SL; Burridge, K				Aghajanian, Amir; Wittchen, Erika S.; Campbell, Sharon L.; Burridge, Keith			Direct Activation of RhoA by Reactive Oxygen Species Requires a Redox-Sensitive Motif	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; PROTEIN-TYROSINE PHOSPHATASES; ACTIN STRESS FIBERS; HYDROGEN-PEROXIDE; SIGNAL-TRANSDUCTION; CELL-ADHESION; NADPH OXIDASES; S-NITROSATION; P115 RHOGEF; GTPASES	Background: Rho family GTPases are critical regulators of the cytoskeleton and affect cell migration, cell-cell adhesion, and cell-matrix adhesion. As with all GTPases, their activity is determined by their guanine nucleotide-bound state. Understanding how Rho proteins are activated and inactivated has largely focused on regulatory proteins such as guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). However, recent in vitro studies have indicated that GTPases may also be directly regulated by redox agents. We hypothesized that this redox-based mechanism occurs in cells and affects cytoskeletal dynamics, and in this report we conclude this is indeed a novel mechanism of regulating the GTPase RhoA. Methodology/Principal Findings: In this report, we show that RhoA can be directly activated by reactive oxygen species (ROS) in cells, and that this requires two critical cysteine residues located in a unique redox-sensitive motif within the phosphoryl binding loop. First, we show that ROS can reversibly activate RhoA and induce stress fiber formation, a well characterized readout of RhoA activity. To determine the role of cysteine residues in this mechanism of regulation, we generated cysteine to alanine RhoA mutants. Mutation of these cysteines abolishes ROS-mediated activation and stress fiber formation, indicating that these residues are critical for redox-regulation of RhoA. Importantly, these mutants maintain the ability to be activated by GEFs. Conclusions/Significance: Our findings identify a novel mechanism for the regulation of RhoA in cells by ROS, which is independent of classical regulatory proteins. This mechanism of regulation may be particularly relevant in pathological conditions where ROS are generated and the cellular redox-balance altered, such as in asthma and ischemia-reperfusion injury.	[Aghajanian, Amir; Wittchen, Erika S.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Aghajanian, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	amir@med.unc.edu		campbell, sharon/0000-0003-0311-409X; Aghajanian, Amir/0000-0002-3671-7957	NIH [GM029860, HL080166, HL045100, T32 GM008719]; North Carolina University Cancer Research Fund; NIH NRSA [1F30HL094063]; NATIONAL CANCER INSTITUTE [R01CA089614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100, P01HL080166, F30HL094063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, R01GM029860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina University Cancer Research Fund; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM029860 (KB), HL080166 (KB), HL045100 (KB and SLC) and a North Carolina University Cancer Research Fund Innovation Award (KB and SLC). AA received support from NIH Medical Scientist Training Program Grant T32 GM008719 and NIH NRSA 1F30HL094063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Dada LA, 2007, J CELL SCI, V120, P2214, DOI 10.1242/jcs.003038; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; DeYulia GJ, 2005, BIOCHEM BIOPH RES CO, V334, P38, DOI 10.1016/j.bbrc.2005.06.056; GARRELS JI, 1989, J BIOL CHEM, V264, P5299; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; HARRAZ MM, 2008, J CLIN INVEST; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; JOHNSON A, 1989, AM J PHYSIOL, V256, pH1012, DOI 10.1152/ajpheart.1989.256.4.H1012; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kojima K, 2007, EUR J PHARMACOL, V556, P151, DOI 10.1016/j.ejphar.2006.11.007; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; LIU SM, 1995, EXP CELL RES, V217, P1, DOI 10.1006/excr.1995.1056; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; RABE KF, 1995, AM J PHYSIOL-LUNG C, V269, pL332, DOI 10.1152/ajplung.1995.269.3.L332; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SHASBY DM, 1985, BLOOD, V65, P605; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tudor KSRS, 2001, CYTOKINE, V15, P196, DOI 10.1006/cyto.2001.0922; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Wittchen ES, 2008, METHOD ENZYMOL, V443, P285, DOI 10.1016/S0076-6879(08)02014-4; Zhu LK, 2006, AM J PHYSIOL-HEART C, V290, pH365, DOI 10.1152/ajpheart.00812.2005; Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	57	149	153	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8045	10.1371/journal.pone.0008045	http://dx.doi.org/10.1371/journal.pone.0008045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956681	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100007
J	Hobson, KA; Wunder, MB; Van Wilgenburg, SL; Clark, RG; Wassenaar, LI				Hobson, Keith A.; Wunder, Michael B.; Van Wilgenburg, Steven L.; Clark, Robert G.; Wassenaar, Leonard I.			A Method for Investigating Population Declines of Migratory Birds Using Stable Isotopes: Origins of Harvested Lesser Scaup in North America	PLOS ONE			English	Article							LONG-TERM POPULATION; AYTHYA-AFFINIS; BOREAL FOREST; SURVIVAL; FEATHERS; HYDROGEN; PINTAIL; FLYWAY	Background: Elucidating geographic locations from where migratory birds are recruited into adult breeding populations is a fundamental but largely elusive goal in conservation biology. This is especially true for species that breed in remote northern areas where field-based demographic assessments are logistically challenging. Methodology/Findings: Here we used hydrogen isotopes (delta D) to determine natal origins of migrating hatch-year lesser scaup (Aythya affinis) harvested by hunters in the United States from all North American flyways during the hunting seasons of 1999-2000 (n = 412) and 2000-2001 (n = 455). We combined geospatial, observational, and analytical data sources, including known scaup breeding range, delta D values of feathers from juveniles at natal sites, models of delta D for growing-season precipitation, and scaup band-recovery data to generate probabilistic natal origin landscapes for individual scaup. We then used Monte Carlo integration to model assignment uncertainty from among individual delta D variance estimates from birds of known molt origin and also from band-return data summarized at the flyway level. We compared the distribution of scaup natal origin with the distribution of breeding population counts obtained from systematic long-term surveys. Conclusions/Significance: Our analysis revealed that the proportion of young scaup produced in the northern (above 60 degrees N) versus the southern boreal and Prairie-Parkland region was inversely related to the proportions of breeding adults using these regions, suggesting that despite having a higher relative abundance of breeding adults, the northern boreal region was less productive for scaup recruitment into the harvest than more southern biomes. Our approach for evaluating population declines of migratory birds (particularly game birds) synthesizes all available distributional data and exploits the advantages of intrinsic isotopic markers that link individuals to geography.	[Hobson, Keith A.; Van Wilgenburg, Steven L.; Clark, Robert G.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA	Environment & Climate Change Canada; University of Colorado System; University of Colorado Denver	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Bond, Alexander L/A-3786-2010; Hobson, Keith/Q-9306-2019; Wassenaar, Leonard I/B-7508-2009; Wassenaar, Leonard/AAY-7081-2020	Wassenaar, Leonard/0000-0001-5532-0771; Van Wilgenburg, Steven/0000-0002-6742-4567	Environment Canada; U.S. Fish and Wildlife Service; Ducks Unlimited Canada	Environment Canada(CGIAR); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Ducks Unlimited Canada	Funding was provided through operating grants from Environment Canada to KAH, RGC and LIW and by the U.S. Fish and Wildlife Service (P. Padding, Robert Blohm) and Ducks Unlimited Canada (Michael G. Anderson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afton AD, 2001, J WILDLIFE MANAGE, V65, P781, DOI 10.2307/3803028; Anteau MJ, 2006, CAN J ZOOL, V84, P779, DOI 10.1139/Z06-047; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; Austin JE, 2000, WILDLIFE SOC B, V28, P254; Austin JE, 2002, J WILDLIFE MANAGE, V66, P874, DOI 10.2307/3803152; AUSTIN JE, 1998, 338 BIRDS N AM; Badzinski SS, 2006, WILDLIFE SOC B, V34, P664, DOI 10.2193/0091-7648(2006)34[664:DOLAGS]2.0.CO;2; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brook RW, 2005, WILDLIFE BIOL, V11, P3, DOI 10.2981/0909-6396(2005)11[3:EOSMCO]2.0.CO;2; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Corcoran RM, 2007, J WILDLIFE MANAGE, V71, P127, DOI 10.2193/2005-534; Corcoran RM, 2009, HYDROBIOLOGIA, V620, P77, DOI 10.1007/s10750-008-9616-5; DeVink JM, 2008, AUK, V125, P291, DOI 10.1525/auk.2008.06171; Greenberg R, 1999, CONSERV BIOL, V13, P553, DOI 10.1046/j.1523-1739.1999.97478.x; Hebert CE, 2005, J WILDLIFE MANAGE, V69, P101, DOI 10.2193/0022-541X(2005)069&lt;0101:SIPEFP&gt;2.0.CO;2; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2006, WATERBIRDS, V29, P137, DOI 10.1675/1524-4695(2006)29[137:USHIAO]2.0.CO;2; Johnson Douglas H., 1992, P446; Koons DN, 2006, AVIAN CONSERV ECOL, V1; Legendre P., 2012, NUMERICAL ECOLOGY; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Quinlan R, 2005, GLOBAL CHANGE BIOL, V11, P1381, DOI 10.1111/j.1365-2486.2005.00981.x; Rotella JJ, 2003, CONDOR, V105, P336, DOI 10.1650/0010-5422(2003)105[0336:SOFLSE]2.0.CO;2; Rouse WR, 1997, HYDROL PROCESS, V11, P873, DOI 10.1002/(SICI)1099-1085(19970630)11:8<873::AID-HYP510>3.0.CO;2-6; Sauer J. R., 2004, N AM BREEDING BIRD S; Shannon JP, 2003, ISOT ENVIRON HEALT S, V39, P1, DOI 10.1080/1025601031000102215; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smith G.W., 1995, 5 NAT BIOL SERV; *US FISH WILDL SER, UNPUB; Walker J, 2005, J WILDLIFE MANAGE, V69, P592, DOI 10.2193/0022-541X(2005)069[0592:SOSDIT]2.0.CO;2; Walker J, 2005, J WILDLIFE MANAGE, V69, P582, DOI 10.2193/0022-541X(2005)069[0582:NSOSAO]2.0.CO;2; Walsh KA, 2006, HYDROBIOLOGIA, V567, P101, DOI 10.1007/s10750-006-0102-7; WEBSTER MS, 2005, BIRDS TWO WORLDS ECO, P119; Wunder MB, 2005, OECOLOGIA, V144, P607, DOI 10.1007/s00442-005-0071-y; WUNDER MB, 2009, ISOSCAPES U IN PRESS; Wunder MB, 2007, THESIS COLORADO STAT	40	96	101	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7915	10.1371/journal.pone.0007915	http://dx.doi.org/10.1371/journal.pone.0007915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946360	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827800007
J	Chan, AS; Jensen, KK; Skokos, D; Doty, S; Lederman, HK; Kaplan, RN; Rafii, S; Rivella, S; Lyden, D				Chan, April S.; Jensen, Kristian K.; Skokos, Dimitris; Doty, Stephen; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Rivella, Stefano; Lyden, David			Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; RECEPTOR GENE-EXPRESSION; STEM-CELL NICHES; PROGENITOR CELLS; MARROW NICHE; PROTEINS; DIFFERENTIATION; CANCER; ANGIOGENESIS; METASTASIS	Background: The bone-bone marrow interface is an area of the bone marrow microenvironment in which both bone remodeling cells, osteoblasts and osteoclasts, and hematopoietic cells are anatomically juxtaposed. The close proximity of these cells naturally suggests that they interact with one another, but these interactions are just beginning to be characterized. Methodology/Principal Findings: An Id1(-/-) mouse model was used to assess the role of Id1 in the bone marrow microenvironment. Micro-computed tomography and fracture tests showed that Id1(-/-) mice have reduced bone mass and increased bone fragility, consistent with an osteoporotic phenotype. Osteoclastogenesis and pit formation assays revealed that loss of Id1 increased osteoclast differentiation and resorption activity, both in vivo and in vitro, suggesting a cell autonomous role for Id1 as a negative regulator of osteoclast differentiation. Examination by flow cytometry of the hematopoietic compartment of Id1(-/-) mice showed an increase in myeloid differentiation. Additionally, we found increased expression of osteoclast genes, TRAP, Oscar, and CTSK in the Id1(-/-) bone marrow microenvironment. Lastly, transplantation of wild-type bone marrow into Id1(-/-) mice repressed TRAP, Oscar, and CTSK expression and activity and rescued the hematopoietic and bone phenotype in these mice. Conclusions/Significance: In conclusion, we demonstrate an osteoporotic phenotype in Id1(-/-) mice and a mechanism for Id1 transcriptional control of osteoclast-associated genes. Our results identify Id1 as a principal player responsible for the dynamic cross-talk between bone and bone marrow hematopoietic cells.	[Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Lyden, David] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rivella, Stefano; Lyden, David] Cornell Univ, Weill Med Coll, Childrens Canc & Blood Fdn Labs, Dept Pediat Hematol Oncol, New York, NY 10021 USA; [Skokos, Dimitris] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Doty, Stephen] Hosp Special Surg, New York, NY 10021 USA; [Kaplan, Rosandra N.; Lyden, David] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Cornell University; Cornell University; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University	Chan, AS (corresponding author), Weill Cornell Med Coll, Dept Pediat, New York, NY USA.	str2010@med.cornell.edu; dcl2001@med.cornell.edu	Rivella, Stefano/A-1597-2010	Chan, April/0000-0002-4797-7009; Rivella, Stefano/0000-0002-0938-6558	National Cancer Institute [R01CA098234]; National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation; Children's Cancer and Blood Foundation; NATIONAL CANCER INSTITUTE [R01CA098234, ZIABC011332] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation; Children's Cancer and Blood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (R01CA098234); Susan G. Komen for the Cure; National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation and the Children's Cancer and Blood Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin JH, 2001, BIOL BLOOD MARROW TR, V7, P473, DOI 10.1053/bbmt.2001.v7.pm11669214; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; LISTER J, 1995, J BIOL CHEM, V270, P17939, DOI 10.1074/jbc.270.30.17939; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Okaji Y, 2006, EUR J CANCER, V42, P668, DOI 10.1016/j.ejca.2005.11.016; Palacio S, 2001, EUR J ENDOCRINOL, V144, P431, DOI 10.1530/eje.0.1440431; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Reddy SV, 2004, CRIT REV EUKAR GENE, V14, P255, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.20; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; SHUNO Y, 2008, J SURG RES; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	47	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7955	10.1371/journal.pone.0007955	http://dx.doi.org/10.1371/journal.pone.0007955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956687	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500003
J	Doeschl-Wilson, A; Sawalha, R; Gubbins, S; Villanueva, B				Doeschl-Wilson, Andrea; Sawalha, Rami; Gubbins, Simon; Villanueva, Beatriz			Implications of Conflicting Associations of the Prion Protein (PrP) Gene with Scrapie Susceptibility and Fitness on the Persistence of Scrapie	PLOS ONE			English	Article							SHEEP FLOCK; BRITISH SHEEP; GREAT-BRITAIN; POPULATION-DYNAMICS; BREEDING PROGRAMS; NATURAL SCRAPIE; TSE RESISTANCE; GENOTYPE; TRAITS; POLYMORPHISMS	Background: Existing mathematical models for scrapie dynamics in sheep populations assume that the PrP gene is only associated with scrapie susceptibility and with no other fitness related traits. This assumption contrasts recent findings of PrP gene associations with post-natal lamb survival in scrapie free Scottish Blackface populations. Lambs with scrapie resistant genotypes were found to have significantly lower survival rates than those with susceptible genotypes. The present study aimed to investigate how these conflicting PrP gene associations may affect the dynamic patterns of PrP haplotype frequencies and disease prevalence. Methodology/Principal Findings: A deterministic mathematical model was developed to explore how the associations between PrP genotype and both scrapie susceptibility and postnatal lamb mortality affect the prevalence of scrapie and the associated change in PrP gene frequencies in a closed flock of sheep. The model incorporates empirical evidence on epidemiological and biological characteristics of scrapie and on mortality rates induced by causes other than scrapie. The model results indicate that unfavorable associations of the scrapie resistant PrP haplotypes with post-natal lamb mortality, if sufficiently strong, can increase scrapie prevalence during an epidemic, and result in scrapie persisting in the population. The range of model parameters, for which such effects were observed, is realistic but relatively narrow. Conclusions/Significance: The results of the present model suggest that for most parameter combinations an unfavourable association between PrP genotype and post-natal lamb mortality does not greatly alter the dynamics of scrapie and, hence, would not have an adverse impact on a breeding programme. There were, however, a range of scenarios, narrow, but realistic, in which such an unfavourable association resulted in an increased prevalence and in the persistence of infection. Consequently, associations between PrP genotypes and fitness traits should be taken into account when designing future models and breeding programmes.	[Doeschl-Wilson, Andrea; Sawalha, Rami; Villanueva, Beatriz] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Gubbins, Simon] Pirbright Labs, Inst Anim Hlth, Surrey, England; [Villanueva, Beatriz] Minist Ciencia Innovac, Dept Mejora Genet Anim, Inst Nacl Invest & Tecnol Agr & Alimentaria SGIT, Madrid, Spain	Scottish Agricultural College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Doeschl-Wilson, A (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	andrea.wilson@sac.ac.uk		Gubbins, Simon/0000-0003-0538-4173; Wilson, Andrea/0000-0002-2658-6973	Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC) [IAH1320]; BBSRC [BBS/E/I/00001320] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001320] Funding Source: researchfish	Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government. SG also acknowledges funding from the Biotechnology and Biological Sciences Research Council (BBSRC) [grant code IAH1320]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Falconer D. S., 1996, INTRO QUANTITATIVE G; FOSTER JD, 1989, VET REC, V125, P415, DOI 10.1136/vr.125.16.415; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gubbins S, 2006, PREV VET MED, V73, P17, DOI 10.1016/j.prevetmed.2005.08.001; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2005, PREV VET MED, V67, P143, DOI 10.1016/j.prevetmed.2004.08.007; Gubbins S, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-3; Hagenaars TJ, 2000, MATH BIOSCI, V168, P117, DOI 10.1016/S0025-5564(00)00048-1; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; Lewis RM, 2000, LIVEST PROD SCI, V67, P129, DOI 10.1016/S0301-6226(00)00182-2; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Matthews L, 2001, ARCH VIROL, V146, P1173, DOI 10.1007/s007050170113; Moore RC, 2009, ANIMAL, V3, P336, DOI 10.1017/S1751731108003637; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Pritchard TC, 2008, ANIMAL, V2, P1421, DOI 10.1017/S1751731108002747; Roden JA, 2006, PREV VET MED, V73, P1, DOI 10.1016/j.prevetmed.2005.08.002; Sawalha RM, 2007, J ANIM SCI, V85, P632, DOI 10.2527/jas.2006-372; Sawalha RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001236; SLATE J, 2005, P R SOC B, V272, P2337; Stringer SM, 1998, MATH BIOSCI, V153, P79, DOI 10.1016/S0025-5564(98)10036-6; Sweeney T, 2008, VET RES, V39, DOI 10.1051/vetres:2008004; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427; Woolhouse MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1205, DOI 10.1098/rspb.1998.0421; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	28	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7970	10.1371/journal.pone.0007970	http://dx.doi.org/10.1371/journal.pone.0007970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956715	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500005
J	Han, L; Wierenga, ATJ; Rozenveld-Geugien, M; van de Lande, K; Vellenga, E; Schuringa, JJ				Han, Lina; Wierenga, Albertus T. J.; Rozenveld-Geugien, Marjan; van de Lande, Kim; Vellenga, Edo; Schuringa, Jan Jacob			Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM/PROGENITOR CELLS; LONG-TERM MAINTENANCE; SELF-RENEWAL; CONSTITUTIVE ACTIVATION; STAT5A(-/-)5B(-/-) MICE; BONE-MARROW; FLT3; DIFFERENTIATION; ENGRAFTMENT	Background: Signal Transducer and Activator of Transcription 5 (STAT5) plays critical roles in normal and leukemic hematopoiesis. However, the manner in which STAT5 responds to early-acting and lineage-restricted cytokines, particularly in leukemic stem/progenitor cells, is largely unknown. Methodology/Principal Findings: We optimized a multiparametric flow cytometry protocol to analyze STAT5 phosphorylation upon cytokine stimulation in stem and progenitor cell compartments at a single-cell level. In normal cord blood (CB) cells, STAT5 phosphorylation was efficiently induced by TPO, IL-3 and GM-CSF within CD34(+)CD38(-) hematopoietic stem cells (HSCs). EPO- and SCF-induced STAT5 phosphorylation was largely restricted to the megakaryocyte-erythroid progenitor (MEP) compartment, while G-CSF as well IL-3 and GM-CSF were most efficient in inducing STAT5 phosphorylation in the myeloid progenitor compartments. Strikingly, mobilized adult peripheral blood (PB) CD34(+) cells responded much less efficiently to cytokine-induced STAT5 activation, with the exception of TPO. In leukemic stem and progenitor cells, highly distinct cytokine responses were observed, differing significantly from their normal counterparts. These responses could not be predicted by the expression level of cytokine receptors. Also, heterogeneity existed in cytokine requirements for long-term expansion of AML CD34(+) cells on stroma. Conclusions/Significance: In conclusion, our optimized multiparametric flow cytometry protocols allow the analysis of signal transduction at the single cell level in normal and leukemic stem and progenitor cells. Our study demonstrates highly distinctive cytokine responses in STAT5 phosphorylation in both normal and leukemic stem/progenitor cells.	[Han, Lina; Wierenga, Albertus T. J.; Rozenveld-Geugien, Marjan; van de Lande, Kim; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Han, Lina] Harbin Med Univ, Clin Coll 1, Dept Hematol, Harbin, Peoples R China	University of Groningen; Harbin Medical University	Han, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.	j.schuringa@int.umcg.nl	Han, Lina/J-5119-2015	Han, Lina/0000-0003-1538-1734	NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004); NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008); KWF [RUG 2009-4275]	NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004)(Netherlands Organization for Scientific Research (NWO)); NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008)(Netherlands Organization for Scientific Research (NWO)); KWF	This work was supported by grants from the NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004), NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008), and KWF (Koningin Wilhelmina Fonds, RUG 2009-4275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Drayer AL, 2005, STEM CELLS, V23, P240, DOI 10.1634/stemcells.2004-0153; Fatrai S, 2008, EXP HEMATOL, V36, P1254, DOI 10.1016/j.exphem.2008.04.015; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Grebien F, 2008, BLOOD, V111, P4511, DOI 10.1182/blood-2007-07-102848; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herrera C, 2001, BRIT J HAEMATOL, V114, P920, DOI 10.1046/j.1365-2141.2001.02974.x; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kieslinger M, 2000, GENE DEV, V14, P232; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Liu G, 2007, EXP HEMATOL, V35, P1684, DOI 10.1016/j.exphem.2007.08.026; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Moshaver B, 2008, STEM CELLS, V26, P3059, DOI 10.1634/stemcells.2007-0861; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Olthof SG, 2008, STEM CELLS, V26, P1732, DOI 10.1634/stemcells.2007-0899; Pallis M, 2003, LEUKEMIA RES, V27, P803, DOI 10.1016/S0145-2126(03)00012-2; Recher C, 2005, CELL CYCLE, V4, P1540; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Ustun C, 2009, LEUKEMIA RES, V33, P735, DOI 10.1016/j.leukres.2008.09.027; Van Etten RA, 2007, ONCOGENE, V26, P6738, DOI 10.1038/sj.onc.1210758; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013	48	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7989	10.1371/journal.pone.0007989	http://dx.doi.org/10.1371/journal.pone.0007989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956772	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500019
J	Volke, M; Gale, DP; Maegdefrau, U; Schley, G; Klanke, B; Bosserhoff, AK; Maxwell, PH; Eckardt, KU; Warnecke, C				Volke, Melanie; Gale, Daniel P.; Maegdefrau, Ulrike; Schley, Gunnar; Klanke, Bernd; Bosserhoff, Anja-Katrin; Maxwell, Patrick H.; Eckardt, Kai-Uwe; Warnecke, Christina			Evidence for a Lack of a Direct Transcriptional Suppression of the Iron Regulatory Peptide Hepcidin by Hypoxia-Inducible Factors	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ANTIMICROBIAL PEPTIDE; GENE-EXPRESSION; FACTOR (HIF)-1-ALPHA; C/EBP-ALPHA; ERYTHROPOIETIN; HIF-2-ALPHA; ANEMIA; INFLAMMATION; MODULATION	Background: Hepcidin is a major regulator of iron metabolism and plays a key role in anemia of chronic disease, reducing intestinal iron uptake and release from body iron stores. Hypoxia and chemical stabilizers of the hypoxia-inducible transcription factor (HIF) have been shown to suppress hepcidin expression. We therefore investigated the role of HIF in hepcidin regulation. Methodology/Principal Findings: Hepcidin mRNA was down-regulated in hepatoma cells by chemical HIF stabilizers and iron chelators, respectively. In contrast, the response to hypoxia was variable. The decrease in hepcidin mRNA was not reversed by HIF-1 alpha or HIF-2 alpha knock-down or by depletion of the HIF and iron regulatory protein (IRP) target transferrin receptor 1 (TfR1). However, the response of hepcidin to hypoxia and chemical HIF inducers paralleled the regulation of transferrin receptor 2 (TfR2), one of the genes critical to hepcidin expression. Hepcidin expression was also markedly and rapidly decreased by serum deprivation, independent of transferrin-bound iron, and by the phosphatidylinositol 3 (PI3) kinase inhibitor LY294002, indicating that growth factors are required for hepcidin expression in vitro. Hepcidin promoter constructs mirrored the response of mRNA levels to interleukin-6 and bone morphogenetic proteins, but not consistently to hypoxia or HIF stabilizers, and deletion of the putative HIF binding motifs did not alter the response to different hypoxic stimuli. In mice exposed to carbon monoxide, hypoxia or the chemical HIF inducer N-oxalylglycine, liver hepcidin 1 mRNA was elevated rather than decreased. Conclusions/Significance: Taken together, these data indicate that hepcidin is neither a direct target of HIF, nor indirectly regulated by HIF through induction of TfR1 expression. Hepcidin mRNA expression in vitro is highly sensitive to the presence of serum factors and PI3 kinase inhibition and parallels TfR2 expression.			Volke, M (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany.	christina.warnecke@uk-erlangen.de	Gale, Daniel/D-5594-2013; Bosserhoff, Anja/GNH-4801-2022; Maxwell, Patrick H/C-5557-2008	Gale, Daniel/0000-0002-9170-1579; Maxwell, Patrick H/0000-0002-0338-2679; Bosserhoff, Anja/0000-0001-8147-394X; Schley, Gunnar/0000-0001-9929-5854	Medical Research Council [G0600420] Funding Source: Medline; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; ASHBY DR, 2009, HAEMATOLOGICA   1014; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bayele HK, 2006, BLOOD, V108, P4237, DOI 10.1182/blood-2005-07-027037; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Braliou GG, 2008, J HEPATOL, V48, P801, DOI 10.1016/j.jhep.2007.12.021; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2008, CURR OPIN HEMATOL, V15, P169, DOI 10.1097/MOH.0b013e3282f73335; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Rothhammer T, 2005, CANCER RES, V65, P448; Scharf JG, 2005, ENDOCRINOLOGY, V146, P5433, DOI 10.1210/en.2005-0948; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Sowter HM, 2003, CANCER RES, V63, P6130; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631	49	69	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7875	10.1371/journal.pone.0007875	http://dx.doi.org/10.1371/journal.pone.0007875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924283	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700011
J	Delignieres, D; Torre, K; Lemoine, L				Delignieres, Didier; Torre, Kjerstin; Lemoine, Loic			Long-Range Correlation in Synchronization and Syncopation Tapping: A Linear Phase Correction Model	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; CEREBELLAR LESIONS; DRAWING MOVEMENTS; HUMAN COGNITION; MOTOR CONTROL; TIME-SERIES; 1/F NOISE; COORDINATION; INTERVALS; EXPONENTS	We propose in this paper a model for accounting for the increase in long-range correlations observed in asynchrony series in syncopation tapping, as compared with synchronization tapping. Our model is an extension of the linear phase correction model for synchronization tapping. We suppose that the timekeeper represents a fractal source in the system, and that a process of estimation of the half-period of the metronome, obeying a random-walk dynamics, combines with the linear phase correction process. Comparing experimental and simulated series, we show that our model allows accounting for the experimentally observed pattern of serial dependence. This model complete previous modeling solutions proposed for self-paced and synchronization tapping, for a unifying framework of event-based timing.			Delignieres, D (corresponding author), Univ Montpellier 1, Motor Efficiency & Deficiency Lab, Montpellier, France.	didier.delignieres@univ-montp1.fr		Lauwereyns, Jan/0000-0003-0551-2550				Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; Chen YQ, 2001, J MOTOR BEHAV, V33, P3, DOI 10.1080/00222890109601897; Delignieres D, 2004, HUM MOVEMENT SCI, V23, P87, DOI 10.1016/j.humov.2004.07.001; Delignieres D, 2008, ACTA PSYCHOL, V127, P382, DOI 10.1016/j.actpsy.2007.07.007; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Huys R, 2008, UNDERST COMPLEX SYST, P77, DOI 10.1007/978-3-540-74479-5_4; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Kello CT, 2007, J EXP PSYCHOL GEN, V136, P551, DOI 10.1037/0096-3445.136.4.551; Lemoine L, 2006, CAN J EXP PSYCHOL, V60, P247, DOI 10.1037/cjep2006023; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Schoner G, 2002, BRAIN COGNITION, V48, P31, DOI 10.1006/brcg.2001.1302; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; TORRE K, 2009, MOTOR CONTR IN PRESS; Torre K, 2007, BRIT J MATH STAT PSY, V60, P85, DOI 10.1348/000711005X89513; Torre K, 2008, BIOL CYBERN, V99, P159, DOI 10.1007/s00422-008-0247-8; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	29	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7822	10.1371/journal.pone.0007822	http://dx.doi.org/10.1371/journal.pone.0007822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518VB	19915658	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721900013
J	Oh, WS; Jeong, PY; Joo, HJ; Lee, JE; Moon, YS; Cheon, HM; Kim, JH; Lee, YU; Shim, YH; Paik, YK				Oh, Wan-Suk; Jeong, Pan-Young; Joo, Hyoe-Jin; Lee, Jeong-Eui; Moon, Yil-Seong; Cheon, Hyang-Mi; Kim, Jung-Ho; Lee, Yong-Uk; Shim, Yhong-Hee; Paik, Young-Ki			Identification and Characterization of a Dual-Acting Antinematodal Agent against the Pinewood Nematode, Bursaphelenchus xylophilus	PLOS ONE			English	Article							TRUNK-INJECTION AGENT; WOOD NEMATODE; CAENORHABDITIS-ELEGANS; EMAMECTIN BENZOATE; WILT DISEASE; CANDIDA-ALBICANS; BLUE-STAIN; FUNGI; INHIBITION; BERBERINE	The pinewood nematode (PWN), Bursaphelenchus xylophilus, is a mycophagous and phytophagous pathogen responsible for the current widespread epidemic of the pine wilt disease, which has become a major threat to pine forests throughout the world. Despite the availability of several preventive trunk-injection agents, no therapeutic trunk-injection agent for eradication of PWN currently exists. In the characterization of basic physiological properties of B. xylophilus YB-1 isolates, we established a high-throughput screening (HTS) method that identifies potential hits within approximately 7 h. Using this HTS method, we screened 206 compounds with known activities, mostly antifungal, for antinematodal activities and identified HWY-4213 (1-n-undecyl-2-[2-fluorphenyl] methyl-3,4-dihydro-6,7-dimethoxy-isoquinolinium chloride), a highly water-soluble protoberberine derivative, as a potent nematicidal and antifungal agent. When tested on 4 year-old pinewood seedlings that were infected with YB-1 isolates, HWY-4213 exhibited a potent therapeutic nematicidal activity. Further tests of screening 39 Caenorhabditis elegans mutants deficient in channel proteins and B. xylophilus sensitivity to Ca(2+) channel blockers suggested that HWY-4213 targets the calcium channel proteins. Our study marks a technical breakthrough by developing a novel HTS method that leads to the discovery HWY-4213 as a dual-acting antinematodal and antifungal compound.			Oh, WS (corresponding author), Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr	Shim, Yhong-hee/D-6691-2011; Lee, Yong-Uk/D-6703-2011	Shim, Yhong-hee/0000-0002-8660-4176; 				Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; BRENNER S, 1974, GENETICS, V77, P71; CHIOU WF, 1991, EUR J PHARMACOL, V204, P35; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Espinel-Ingroff A, 2002, J CLIN MICROBIOL, V40, P3204, DOI 10.1128/JCM.40.9.3204-3208.2002; Fielding NJ, 1996, FORESTRY, V69, P35, DOI 10.1093/forestry/69.1.35; Hanawa F, 2001, PHYTOCHEMISTRY, V57, P223, DOI 10.1016/S0031-9422(00)00514-8; Hasegawa K, 2004, DEV GROWTH DIFFER, V46, P153, DOI 10.1111/j.1440-169X.2003.00734.x; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; *KOR MIN HLTH WELF, 2001, HMP98D10003 KOR MIN; Maehara N, 2005, NEMATOLOGY, V7, P161, DOI 10.1163/1568541054879557; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MOON YS, 2007, SANLIM, V192, P74; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; National Committee for Clinical Laboratory Standard, 2002, M38A NAT COMM CLIN L; Park KS, 2001, J ANTIMICROB CHEMOTH, V47, P513, DOI 10.1093/jac/47.5.513; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; SanchezChapula J, 1996, BRIT J PHARMACOL, V117, P1427, DOI 10.1111/j.1476-5381.1996.tb15302.x; Santos DA, 2006, J CLIN MICROBIOL, V44, P98, DOI 10.1128/JCM.44.1.98-101.2006; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Song LS, 2000, BRIT J PHARMACOL, V129, P893, DOI 10.1038/sj.bjp.0703132; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Steiner G, 1934, J AGRIC RES, V48, P0949; Suzuki K., 2002, Dendrobiology, V48, P71; Takai K, 2003, PEST MANAG SCI, V59, P365, DOI 10.1002/ps.651; Takai K, 2001, PEST MANAG SCI, V57, P463, DOI 10.1002/ps.301; Takai K, 2000, PEST MANAG SCI, V56, P937, DOI 10.1002/1526-4998(200010)56:10<937::AID-PS213>3.0.CO;2-B; Wang Y, 2005, NEMATOLOGY, V7, P459, DOI 10.1163/156854105774355545	29	15	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A22	A30	e7593	10.1371/journal.pone.0007593	http://dx.doi.org/10.1371/journal.pone.0007593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907651	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800003
J	Rex, CS; Colgin, LL; Jia, YS; Casale, M; Yanagihara, TK; Debenedetti, M; Gall, CM; Kramar, EA; Lynch, G				Rex, Christopher S.; Colgin, Laura L.; Jia, Yousheng; Casale, Malcolm; Yanagihara, Theodore K.; Debenedetti, Maria; Gall, Christine M.; Kramar, Eniko A.; Lynch, Gary			Origins of an Intrinsic Hippocampal EEG Pattern	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CA3 PYRAMIDAL CELLS; ENTORHINAL CORTEX LESIONS; SPONTANEOUS SHARP WAVES; MOSSY FIBER SYNAPSE; DENTATE GYRUS; GRANULE CELLS; I-H; THETA-RHYTHM; RAT	Sharp waves (SPWs) are irregular waves that originate in field CA3 and spread throughout the hippocampus when animals are alert but immobile or as a component of the sleep EEG. The work described here used rat hippocampal slices to investigate the factors that initiate SPWs and govern their frequency. Acute transection of the mossy fibers reduced the amplitude but not the frequency of SPWs, suggesting that activity in the dentate gyrus may enhance, but is not essential for, the CA3 waves. However, selective destruction of the granule cells and mossy fibers by in vivo colchicine injections profoundly depressed SPW frequency. Reducing mossy fiber release with an mGluR2 receptor agonist or enhancing it with forskolin respectively depressed or increased the incidence of SPWs. Collectively, these results indicate that SPWs can be triggered by constitutive release from the mossy fibers. The waves were not followed by large after-hyperpolarizing potentials and their frequency was not strongly affected by blockers of various slow potassium channels. Antagonists of GABA-B mediated IPSCs also had little effect on incidence. It appears from these results that the spacing of SPWs is not dictated by slow potentials. However, modeling work suggests that the frequency and variance of large mEPSCs from the mossy boutons can account for the temporal distribution of the waves. Together, these results indicate that constitutive release from the mossy fiber terminal boutons regulates the incidence of SPWs and their contribution to information processing in hippocampus.			Rex, CS (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	glynch@uci.edu	Rex, Christopher/F-2112-2010	Colgin, Laura/0000-0002-4853-8913	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045260, T32NS045540, R01NS051823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000096] Funding Source: NIH RePORTER; NIA NIH HHS [AG00096, T32 AG000096] Funding Source: Medline; NINDS NIH HHS [NS051823, T32 NS045540, P01 NS045260, R01 NS051823, NS045540, NS45260] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral David G., 1995, P443; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Colgin LL, 2004, J NEUROPHYSIOL, V92, P3385, DOI 10.1152/jn.00478.2004; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Draguhn A, 2000, J CLIN NEUROPHYSIOL, V17, P361, DOI 10.1097/00004691-200007000-00003; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; GOLDSCHMIDT RB, 1980, P NATL ACAD SCI-BIOL, V77, P3047, DOI 10.1073/pnas.77.5.3047; HALL P, 1982, J ROY STAT SOC B MET, V44, P37; Hamzei-Sichani F, 2007, P NATL ACAD SCI USA, V104, P12548, DOI 10.1073/pnas.0705281104; Henze DA, 1997, J NEUROPHYSIOL, V77, P1075, DOI 10.1152/jn.1997.77.3.1075; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; Henze DA, 1996, J COMP NEUROL, V369, P331, DOI 10.1002/(SICI)1096-9861(19960603)369:3<331::AID-CNE1>3.0.CO;2-6; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kirschstein T, 2004, NEUROPHARMACOLOGY, V47, P157, DOI 10.1016/j.neuropharm.2004.04.004; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; KONOPACKI J, 1987, BRAIN RES, V405, P196, DOI 10.1016/0006-8993(87)91009-2; Kramar EA, 2003, NEUROSCIENCE, V118, P387, DOI 10.1016/S0306-4522(02)00916-8; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LOTHMAN EW, 1982, EXP NEUROL, V78, P293, DOI 10.1016/0014-4886(82)90048-6; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; McBain CJ, 2008, PROG BRAIN RES, V169, P225, DOI 10.1016/S0079-6123(07)00013-1; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MONMAUR P, 1986, BRAIN RES, V365, P269, DOI 10.1016/0006-8993(86)91638-0; Mori M, 2007, P NATL ACAD SCI USA, V104, P7640, DOI 10.1073/pnas.0702164104; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; SOLIS JM, 1992, J NEUROSCI, V12, P3466; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; STEWARD O, 1992, HIPPOCAMPUS, V2, P247, DOI 10.1002/hipo.450020305; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V70, P73, DOI 10.1016/0013-4694(88)90197-6; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P532, DOI 10.1016/0013-4694(88)90165-4; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P541, DOI 10.1016/0013-4694(88)90166-6; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vertes Robert P, 2004, Behav Cogn Neurosci Rev, V3, P173, DOI 10.1177/1534582304273594; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; YLINEN A, 1995, J NEUROSCI, V15, P30; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang Liang, 2006, Critical Reviews in Neurobiology, V18, P159	64	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A82	A94	e7761	10.1371/journal.pone.0007761	http://dx.doi.org/10.1371/journal.pone.0007761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907647	Green Published, Green Submitted, gold			2022-12-27	WOS:000271685800010
J	Aujla, N; Abrams, KR; Davies, MJ; Taub, N; Skinner, TC; Khunti, K				Aujla, Navneet; Abrams, Keith R.; Davies, Melanie J.; Taub, Nick; Skinner, Timothy C.; Khunti, Kamlesh			The Prevalence of Depression in White-European and South-Asian People with Impaired Glucose Regulation and Screen-Detected Type 2 Diabetes Mellitus	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTOR; FOLLOW-UP; SYMPTOMS; METAANALYSIS; HEALTH; ADULTS; RELIABILITY; VALIDITY; LONDON	There is a clear relationship between depression and diabetes. However, the directionality of the relationship remains unclear and very little research has considered a multi-ethnic population. The aim of this study was to determine the prevalence of depression in a White-European (WE) and South-Asian (SA) population attending a community diabetes screening programme, and to explore the association of depression with screen-detected Type 2 diabetes mellitus (T2DM) and impaired glucose regulation (IGR). Methodology/Principal Findings: Participants were recruited from general practices in Leicestershire (United Kingdom) between August 2004 and December 2007. 4682 WE (40-75 years) and 1327 SA participants (25-75 years) underwent an Oral Glucose Tolerance Test, detailed history, anthropometric measurements and completed the World Health Organisation-Five (WHO-5) Wellbeing Index. Depression was defined by a WHO-5 wellbeing score <= 13. Unadjusted prevalence of depression for people in the total sample with T2DM and IGR was 21.3% (21.6% in WE, 20.6% in SA, p = 0.75) and 26.0% (25.3% in WE, 28.9% in SA, p = 0.65) respectively. For people with normal glucose tolerance, the prevalence was 25.1% (24.9% in WE, 26.4% in SA, p = 0.86). Age-adjusted prevalences were higher for females than males. Odds ratios adjusted for age, gender, and ethnicity, showed no significant increase in prevalent depression for people with T2DM (OR = 0.95, 95% CI 0.62 to 1.45) or IGR (OR = 1.17, 95% CI 0.96 to 1.42). Conclusions: Prior to the knowledge of diagnosis, depression was not significantly more prevalent in people with screen detected T2DM or IGR. Differences in prevalent depression between WE and SA people were also not identified. In this multi-ethnic population, female gender was significantly associated with depression.			Aujla, N (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	na137@le.ac.uk	Skinner, Timothy C/N-2221-2013; /ABC-9527-2021; Davies, Michael/AGX-9184-2022; Abrams, Keith/AAA-2557-2020; Davies, Michael J/H-4939-2011; Davies, Michael/GWV-2527-2022	Skinner, Timothy C/0000-0002-0018-6963; Davies, Michael/0000-0002-5196-6919; Davies, Michael J/0000-0002-5196-6919; Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371; Abrams, Keith/0000-0002-7557-1567				Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; ALI S, 2009, DIABETIC MED S1, V26, pA74; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129; Asghar S, 2007, DIABETIC MED, V24, P872, DOI 10.1111/j.1464-5491.2007.02136.x; Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Brown LC, 2005, DIABETES CARE, V28, P1063, DOI 10.2337/diacare.28.5.1063; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172; Chowdhury TA, 2006, POSTGRAD MED J, V82, P211, DOI 10.1136/pgmj.2005.036673; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; *DP COMM LOC GOV, 2007, ENGL IND DEPR 2007 S; Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751; Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; Holt RIG, 2009, DIABETIC MED, V26, P641, DOI 10.1111/j.1464-5491.2009.02742.x; Icks A, 2008, DIABETIC MED, V25, P1330, DOI 10.1111/j.1464-5491.2008.02585.x; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Khunti K, 2008, DIABETIC MED, V25, P1454, DOI 10.1111/j.1464-5491.2008.02620.x; Knol MJ, 2009, DIABETOLOGIA, V52, P425, DOI 10.1007/s00125-008-1249-8; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Leimkuhler AMM, 2007, J AFFECT DISORDERS, V98, P65, DOI 10.1016/j.jad.2006.07.007; Mather HM, 1998, DIABETIC MED, V15, P53, DOI 10.1002/(SICI)1096-9136(199801)15:1<53::AID-DIA521>3.0.CO;2-V; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Clinical Excellence, 2006, OB GUID PREV ID ASS; Rhee MK, 2008, DIABETIC MED, V25, P1361, DOI 10.1111/j.1464-5491.2008.02543.x; Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494; SINGLETON N, 2001, PREVALENCE DEPRESSIO; van den Akker M, 2004, ACTA PSYCHIAT SCAND, V110, P178; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zhao W, 2006, PUBLIC HEALTH, V120, P696, DOI 10.1016/j.puhe.2006.04.012	33	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7755	10.1371/journal.pone.0007755	http://dx.doi.org/10.1371/journal.pone.0007755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	517ZM	19898618	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000005
J	Ioerger, TR; Koo, S; No, EG; Chen, XH; Larsen, MH; Jacobs, WR; Pillay, M; Sturm, AW; Sacchettini, JC				Ioerger, Thomas R.; Koo, Sunwoo; No, Eun-Gyu; Chen, Xiaohua; Larsen, Michelle H.; Jacobs, William R., Jr.; Pillay, Manormoney; Sturm, A. Willem; Sacchettini, James C.			Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa	PLOS ONE			English	Article							LEVEL STREPTOMYCIN RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; IS6110 INSERTIONS; MUTATIONS; EVOLUTION; METHYLTRANSFERASE; EMERGENCE; STRAIN; SPREAD	The KZN strain family of Mycobacterium tuberculosis is a highly virulent strain endemic to the KwaZulu-Natal region of South Africa, which has recently experienced an outbreak of extensively-drug resistant tuberculosis. To investigate the causes and evolution of drug-resistance, we determined the DNA sequences of several clinical isolates - one drug-susceptible, one multi-drug resistant, and nine extensively drug-resistant - using whole-genome sequencing. Analysis of polymorphisms among the strains is consistent with the drug-susceptibility profiles, in that well-known mutations are observed that are correlated with resistance to isoniazid, rifampicin, kanamycin, ofloxacin, ethambutol, and pyrazinamide. However, the mutations responsible for rifampicin resistance in rpoB and pyrazinamide in pncA are in different nucleotide positions in the multi-drug-resistant and extensively drug-resistant strains, clearly showing that they acquired these mutations independently, and that the XDR strain could not have evolved directly from the MDR strain (though it could have arisen from another similar MDR strain). Sequencing of eight additional XDR strains from other areas of KwaZulu-Natal shows that they have identical drug resistant mutations to the first one sequenced, including the same polymorphisms at sites associated with drug resistance, supporting the theory that this represents a case of clonal expansion.			Ioerger, TR (corresponding author), Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA.	ioerger@cs.tamu.edu		Jacobs, William/0000-0003-3321-3080; Koo, Sunwoo/0000-0003-2715-909X				Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Fang Z, 2001, J BACTERIOL, V183, P5279, DOI 10.1128/JB.183.18.5279-5284.2001; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsen M.H., 2007, CURRENT PROTOCOLS MI; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nishimura K, 2007, J BACTERIOL, V189, P3876, DOI 10.1128/JB.01776-06; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Romanowski MJ, 2002, PROTEINS, V47, P563, DOI 10.1002/prot.10121; Sampson S, 2001, J CLIN MICROBIOL, V39, P3423, DOI 10.1128/JCM.39.9.3423-3424.2001; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636, DOI 10.1128/AAC.41.3.636; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; van Doorn HR, 2008, INT J TUBERC LUNG D, V12, P736; Victor TC, 2004, J CLIN MICROBIOL, V42, P769, DOI 10.1128/JCM.42.2.769-772.2004; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	37	125	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7778	10.1371/journal.pone.0007778	http://dx.doi.org/10.1371/journal.pone.0007778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890396	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700022
J	Ljubicic, S; Bezzi, P; Vitale, N; Regazzi, R				Ljubicic, Sanda; Bezzi, Paola; Vitale, Nicolas; Regazzi, Romano			The GTPase RalA Regulates Different Steps of the Secretory Process in Pancreatic beta-Cells	PLOS ONE			English	Article							INSULIN EXOCYTOSIS; PLASMA-MEMBRANE; EXOCYST COMPLEX; PHOSPHOLIPASE-D; ACTIVATION; ASTROCYTES; EXPRESSION; GLUTAMATE; RELEASE; FUSION	Background: RalA and RalB are multifuntional GTPases involved in a variety of cellular processes including proliferation, oncogenic transformation and membrane trafficking. Here we investigated the mechanisms leading to activation of Ral proteins in pancreatic beta-cells and analyzed the impact on different steps of the insulin- secretory process. Methodology/Principal Findings: We found that RalA is the predominant isoform expressed in pancreatic islets and insulin-secreting cell lines. Silencing of this GTPase in INS-1E cells by RNA interference led to a decrease in secretagogue-induced insulin release. Real-time measurements by fluorescence resonance energy transfer revealed that RalA activation in response to secretagogues occurs within 3-5 min and reaches a plateau after 10-15 min. The activation of the GTPase is triggered by increases in intracellular Ca(2+) and cAMP and is prevented by the L-type voltage-gated Ca(2+) channel blocker Nifedipine and by the protein kinase A inhibitor H89. Defective insulin release in cells lacking RalA is associated with a decrease in the secretory granules docked at the plasma membrane detected by Total Internal Reflection Fluorescence microscopy and with a strong impairment in Phospholipase D1 activation in response to secretagogues. RalA was found to be activated by RalGDS and to be severely hampered upon silencing of this GDP/GTP exchange factor. Accordingly, INS-1E cells lacking RalGDS displayed a reduction in hormone secretion induced by secretagogues and in the number of insulin-containing granules docked at the plasma membrane. Conclusions/Significance: Taken together, our data indicate that RalA activation elicited by the exchange factor RalGDS in response to a rise in intracellular Ca(2+) and cAMP controls hormone release from pancreatic beta-cell by coordinating the execution of different events in the secretory pathway.			Ljubicic, S (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland.	Romano.Regazzi@unil.ch	Bezzi, Paola/AAP-2440-2020; Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907; Regazzi, Romano/0000-0002-9773-2915				Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Li G, 2007, J NEUROSCI, V27, P190, DOI 10.1523/JNEUROSCI.2537-06.2007; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Marchaland J, 2008, J NEUROSCI, V28, P9122, DOI 10.1523/JNEUROSCI.0040-08.2008; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37	40	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7770	10.1371/journal.pone.0007770	http://dx.doi.org/10.1371/journal.pone.0007770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890390	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700021
J	Novitsky, V; Wang, R; Margolin, L; Baca, J; Kebaabetswe, L; Rossenkhan, R; Bonney, C; Herzig, M; Nkwe, D; Moyo, S; Musonda, R; Woldegabriel, E; van Widenfelt, E; Makhema, J; Lagakos, S; Essex, M				Novitsky, Vladimir; Wang, Rui; Margolin, Lauren; Baca, Jeannie; Kebaabetswe, Lemme; Rossenkhan, Raabya; Bonney, Caitlin; Herzig, Michaela; Nkwe, David; Moyo, Sikhulile; Musonda, Rosemary; Woldegabriel, Elias; van Widenfelt, Erik; Makhema, Joseph; Lagakos, Stephen; Essex, M.			Timing Constraints of In Vivo Gag Mutations during Primary HIV-1 Subtype C Infection	PLOS ONE			English	Article							T-CELL RESPONSES; VIRAL LOAD; LYMPHOCYTE ESCAPE; IMMUNE ESCAPE; CD8(+); REVERSION; EVOLUTION; IDENTIFICATION; TRANSMISSION; ASSOCIATIONS	Background: Aiming to answer the broad question "When does mutation occur?'' this study examined the time of appearance, dominance, and completeness of in vivo Gag mutations in primary HIV-1 subtype C infection. Methods: A primary HIV-1C infection cohort comprised of 8 acutely and 34 recently infected subjects were followed frequently up to 500 days post-seroconversion (p/s). Gag mutations were analyzed by employing single-genome amplification and direct sequencing. Gag mutations were determined in relation to the estimated time of seroconversion. Time of appearance, dominance, and completeness was compared for different types of in vivo Gag mutations. Results: Reverse mutations to the wild type appeared at a median (IQR) of 62 (44; 139) days p/s, while escape mutations from the wild type appeared at 234 (169; 326) days p/s (p<0.001). Within the subset of mutations that became dominant, reverse and escape mutations appeared at 54 (30; 78) days p/s and 104 (47; 198) days p/s, respectively (p<0.001). Among the mutations that reached completeness, reverse and escape mutations appeared at 54 (30; 78) days p/s and 90 (44; 196) days p/s, respectively (p = 0.006). Time of dominance for reverse mutations to and escape mutations from the wild type was 58 (44; 105) days p/s and 219 (90; 326) days p/s, respectively (p<0.001). Time of completeness for reverse and escape mutations was 152 (100; 176) days p/s and 243 (101; 370) days p/s, respectively (p = 0.001). Fitting a Cox proportional hazards model with frailties confirmed a significantly earlier time of appearance (hazard ratio (HR): 2.6; 95% CI: 2.3-3.0), dominance (4.8 (3.4-6.8)), and completeness (3.6 (2.3-5.5)) of reverse mutations to the wild type Gag than escape mutations from the wild type. Some complex mutational pathways in Gag included sequential series of reversions and escapes. Conclusions: The study identified the timing of different types of in vivo Gag mutations in primary HIV-1 subtype C infection in relation to the estimated time of seroconversion. Overall, the in vivo reverse mutations to the wild type occurred significantly earlier than escape mutations from the wild type. This shorter time to incidence of reverse mutations remained in the subsets of in vivo Gag mutations that reached dominance or completeness.			Novitsky, V (corresponding author), Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Moyo, Sikhulile/E-1464-2015; Wang, Rui/X-1699-2019	Moyo, Sikhulile/0000-0003-3821-4592; Wang, Rui/0000-0001-5007-193X	FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024643, R01AI057027] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000004] Funding Source: Medline; NIAID NIH HHS [R37 AI024643, R01 AI057027, R37 AI24643] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2009, J EXP MED, V206, P1215, DOI 10.1084/jem.20091094; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J EXP MED, V180, P779, DOI 10.1084/jem.180.3.779; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; NDONGALA ML, 2009, CLIN IMMUNOL; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; NOVITSKY V, 2009, J ACQUIR IM IN PRESS; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky VA, 2006, VIROLOGY, V349, P142, DOI 10.1016/j.virol.2006.02.006; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Ray S.C., 2008, MARGFREQ; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Serwanga J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004188; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	59	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7727	10.1371/journal.pone.0007727	http://dx.doi.org/10.1371/journal.pone.0007727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890401	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700014
J	De Marco, L; Gillio-Tos, A; Fiano, V; Ronco, G; Krogh, V; Palli, D; Panico, S; Tumino, R; Vineis, P; Merletti, F; Richiardi, L; Sacerdote, C				De Marco, Laura; Gillio-Tos, Anna; Fiano, Valentina; Ronco, Guglielmo; Krogh, Vittorio; Palli, Domenico; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Merletti, Franco; Richiardi, Lorenzo; Sacerdote, Carlotta			Occult HCV Infection: An Unexpected Finding in a Population Unselected for Hepatic Disease	PLOS ONE			English	Article							C VIRUS-INFECTION; MOLECULAR EPIDEMIOLOGY PROJECT; BLOOD MONONUCLEAR-CELLS; HEPATOCELLULAR-CARCINOMA; MIXED CRYOGLOBULINEMIA; LEUKOCYTE-REDUCTION; PERSISTENCE; CANCER; RNA; ETIOLOGY	Background: Occult Hepatitis C virus (HCV) infection is a new pathological entity characterized by presence of liver disease and absence or very low levels of detectable HCV-RNA in serum. Abnormal values of liver enzymes and presence of replicative HCV-RNA in peripheral blood mononuclear cells are also observed. Aim of the study was to evaluate occult HCV occurrence in a population unselected for hepatic disease. Methodology/Principal Findings: We chose from previous epidemiological studies three series of subjects (n = 276, age range 40-65 years) unselected for hepatic disease. These subjects were tested for the presence of HCV antibodies and HCV-RNA in plasma and in the peripheral blood mononuclear cells (PBMCs) by using commercial systems. All subjects tested negative for HCV antibodies and plasma HCV-RNA and showed normal levels of liver enzymes; 9/276 patients (3.3%) were positive for HCV-RNA in PBMCs, identifying a subset of subjects with potential occult HCV infection. We could determine the HCV type for 8 of the 9 patients finding type 1a (3 patients), type 1b (2 patients), and type 2a (3 patients). Conclusions: The results of this study show evidence that occult HCV infection may occur in a population unselected for hepatic disease. A potential risk of HCV infection spread by subjects harbouring occult HCV infection should be considered. Design of prospective studies focusing on the frequency of infection in the general population and on the clinical evolution of occult HCV infection will be needed to verify this unexpected finding.	[De Marco, Laura; Gillio-Tos, Anna; Fiano, Valentina; Merletti, Franco; Richiardi, Lorenzo; Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy; [Ronco, Guglielmo; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Ctr Oncol Prevent, Turin, Italy; [Krogh, Vittorio] Natl Canc Inst, Epidemiol Unit, I-20133 Milan, Italy; [Palli, Domenico] ISPO, Mol & Nutr Epidemiol Unit, Canc Res & Prevent Inst, Florence, Italy; [Panico, Salvatore] Univ Naples Federico 2, Dept Clin & Expt Med, Naples, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Turin; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Civile M.P. Arezzo Hospital; Imperial College London	De Marco, L (corresponding author), Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy.	gilliotos_demarco@yahoo.it	Panico, Salvatore/K-6506-2016; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; De Marco, Laura/J-7254-2016; richiardi, lorenzo/J-3480-2018	Panico, Salvatore/0000-0002-5498-8312; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; De Marco, Laura/0000-0003-2167-9270; richiardi, lorenzo/0000-0003-0316-9402; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Gillio-Tos, Anna/0000-0001-6553-5362; PALLI, Domenico/0000-0002-5558-2437; FIANO, VALENTINA/0000-0001-7978-372X	Italian Association for Cancer Research; Compagnia di San Paolo/FIRMS; Piedmont Region and the Italian Ministry of University and Research (MIUR); European Union; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo/FIRMS(Compagnia di San Paolo); Piedmont Region and the Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research, the Compagnia di San Paolo/FIRMS, the Piedmont Region and the Italian Ministry of University and Research (MIUR), European Union, Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Barril G, 2008, J AM SOC NEPHROL, V19, P2288, DOI 10.1681/ASN.2008030293; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Berasain C, 2000, GUT, V47, P429, DOI 10.1136/gut.47.3.429; Carreno V, 2008, REV MED VIROL, V18, P139, DOI 10.1002/rmv.569; Carreno V, 2006, WORLD J GASTROENTERO, V12, P6922, DOI 10.3748/wjg.v12.i43.2000; Casato M, 2003, J VIRAL HEPATITIS, V10, P455, DOI 10.1046/j.1365-2893.2003.00462.x; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; Chang TT, 1996, HEPATOLOGY, V23, P977; Clarke B, 1997, J GEN VIROL, V78, P2397, DOI 10.1099/0022-1317-78-10-2397; Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x; Comar M, 2006, J CLIN PATHOL, V59, P526, DOI 10.1136/jcp.2005.033050; CUYPERS HTM, 1992, J CLIN MICROBIOL, V30, P3220, DOI 10.1128/JCM.30.12.3220-3224.1992; Feld JJ, 2005, HEPATOLOGY, V41, P23, DOI 10.1002/hep.20561; FERAY C, 1992, J CLIN INVEST, V89, P1361, DOI 10.1172/JCI115723; Giannini C, 2006, HEPATOLOGY, V43, P1166, DOI 10.1002/hep.21132; Gordon SC, 2005, AM J GASTROENTEROL, V100, P1754, DOI 10.1111/j.1572-0241.2005.50483.x; Kopko PM, 2000, CURR OPIN HEMATOL, V7, P397, DOI 10.1097/00062752-200011000-00013; Laskus T, 2002, J INFECT DIS, V185, P417, DOI 10.1086/338635; Lerat H, 2004, J INFECT DIS, V189, P3, DOI 10.1086/380203; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Murphy MF, 1999, TRANSFUS MED REV, V13, P75, DOI 10.1016/S0887-7963(99)80001-7; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Palli D, 1999, ADV EXP MED BIOL, V472, P21; Pardo M, 2007, J VIRAL HEPATITIS, V14, P36, DOI 10.1111/j.1365-2893.2006.00783.x; Pardo M, 2006, ALIMENT PHARM THER, V23, P1153, DOI 10.1111/j.1365-2036.2006.02886.x; Pham TNQ, 2009, J VIRAL HEPATITIS, V16, P547, DOI 10.1111/j.1365-2893.2009.01092.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Pham TNQ, 2008, GASTROENTEROLOGY, V134, P812, DOI 10.1053/j.gastro.2007.12.011; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Radkowski M, 2005, J INFECT DIS, V191, P1730, DOI 10.1086/429834; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Sacerdote C, 2007, MUTAGENESIS, V22, P281, DOI 10.1093/mutage/gem014; Sharma AD, 2000, ANESTH ANALG, V90, P1315, DOI 10.1097/00000539-200006000-00010; *STAT OFF, 2005, GUID UK TRANSF SERV; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706	38	62	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8128	10.1371/journal.pone.0008128	http://dx.doi.org/10.1371/journal.pone.0008128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956542	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800021
J	Buscarlet, M; Hermann, R; Lo, R; Tang, YM; Joachim, K; Stifani, S				Buscarlet, Manuel; Hermann, Robert; Lo, Rita; Tang, Yeman; Joachim, Kerline; Stifani, Stefano			Cofactor-Activated Phosphorylation Is Required for Inhibition of Cortical Neuron Differentiation by Groucho/TLE1	PLOS ONE			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; TRANSDUCIN-LIKE-ENHANCER; NERVOUS-SYSTEM; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; DROSOPHILA GROUCHO; PROGENITOR CELLS; PROTEINS; SPLIT; LOOP	Background: Transcriptional co-repressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family regulate the expression of a variety of genes and are involved in numerous developmental processes in both invertebrate and vertebrate species. More specifically, Gro/TLE1 participates in mechanisms that inhibit/delay the differentiation of cerebral cortex neural progenitor cells into neurons during mammalian forebrain development. The anti-neurogenic function of Gro/TLE1 depends on the formation of protein complexes with specific DNA-binding transcription factors that engage Gro/TLE1 through WRP(W/Y) sequences. Interaction with those transcription partners results in Gro/TLE1 recruitment to selected DNA sites and causes increased Gro/TLE1 phosphorylation. The physiological significance of the latter event, termed "cofactor-activated phosphorylation," had not been determined. Therefore, this study aimed at clarifying the role of cofactor-activated phosphorylation in the anti-neurogenic function of Gro/TLE1. Methods and Principal Findings: A combination of site-directed mutagenesis, mass spectrometry, biochemistry, primary cell culture, and immunocytochemical assays was utilized to characterize point mutations of Ser-286, a residue that is phosphorylated in vivo and is located within the serine/proline-rich (SP) domain of Gro/TLE1. Mutation of Ser-286 to alanine or glutamic acid does not perturb the interaction of Gro/TLE1 with DNA-binding partners, including the basic helix-loophelix transcription factor Hes1, a prototypical anti-neurogenic WRP(W/Y) motif protein. Ser-286 mutations do not prevent the recruitment of Gro/TLE1 to DNA, but they impair cofactor-activated phosphorylation and weaken the interaction of Gro/TLE1 with chromatin. These effects are correlated with an impairment of the anti-neurogenic activity of Gro/TLE1. Similar results were obtained when mutations of Ser-289 and Ser-298, which are also located within the SP domain of Gro/TLE1, were analyzed. Conclusion: Based on the positive correlation between Gro/TLE1 cofactor-activated phosphorylation and ability to inhibit cortical neuron differentiation, we propose that hyperphosphorylation induced by cofactor binding plays a positive role in the regulation of Gro/TLE1 anti-neurogenic activity.	[Buscarlet, Manuel; Hermann, Robert; Lo, Rita; Tang, Yeman; Joachim, Kerline; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Buscarlet, M (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-13957]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by Operating Grant MOP-13957 awarded to S. S. by the Canadian Institutes of Health Research (www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Ghosh MM, 1995, BIOREMED SER, V3, P15; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Javed A, 2000, J CELL SCI, V113, P2221; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8107	10.1371/journal.pone.0008107	http://dx.doi.org/10.1371/journal.pone.0008107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956621	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700018
J	Koh, KP; Sundrud, MS; Rao, A				Koh, Kian Peng; Sundrud, Mark S.; Rao, Anjana			Domain Requirements and Sequence Specificity of DNA Binding for the Forkhead Transcription Factor FOXP3	PLOS ONE			English	Article							REGULATORY T-CELLS; NF-KAPPA-B; IMMUNE DYSREGULATION; NUCLEAR FACTOR; HELIX PROTEIN; TARGET GENES; MUTATIONS; FAMILY; MOUSE; MICE	The forkhead, winged-helix transcription factor FOXP3 is preferentially expressed in T regulatory (Treg) cells and is critical for their immunosuppressive function. Mutations that abolish FOXP3 function lead to systemic autoimmunity in mice and humans. However, the manner by which FOXP3 recognizes cognate DNA elements is unclear. Here we identify an in vitro optimized DNA sequence to assess FOXP3 DNA binding by electrophoretic mobility shift assay (EMSA). The optimized sequence contains two tandem copies of a core DNA element resembling, but not identical to, the canonical forkhead (FKH) binding element. The tandem nature of this optimized FOXP3-binding oligonucleotide suggests a requirement for multimerization, and EMSA experiments confirm that both the DNA-binding FKH domain and an intact leucine-zipper domain, which mediates homo-multimerization of FOXP3, are required for DNA binding. These results establish a practical framework for understanding the molecular basis by which FOXP3 regulates gene transcription and programs Treg suppressive function.	[Koh, Kian Peng] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Immune Dis Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Koh, KP (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@idi.harvard.edu	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175	NIH [ROI AI48213, R37 CA42471]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R37CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grants to A. R. (ROI AI48213 and R37 CA42471). M. S. S was supported by the Irvington Institute fellowship program of the Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hinman RM, 2009, INT IMMUNOL, V21, P831, DOI 10.1093/intimm/dxp049; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaestner KH, 2000, GENE DEV, V14, P142; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	40	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8109	10.1371/journal.pone.0008109	http://dx.doi.org/10.1371/journal.pone.0008109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956618	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828700020
J	Kotevski, A; Cook, WD; Vaux, DL; Callus, BA				Kotevski, Aneta; Cook, Wendy D.; Vaux, David L.; Callus, Bernard A.			Identification of an Xiap-Like Pseudogene on Mouse Chromosome 7	PLOS ONE			English	Article							APOPTOSIS PROTEIN XIAP; NMR STRUCTURE; INHIBITOR; MUTAGENESIS	The most thoroughly characterized mammalian IAP is XIAP/BIRC4, which can inhibit caspases 9, 3 and 7, but may also regulate apoptosis through interactions with other proteins such as Smac/DIABLO, HtrA2/Omi, XAF1, TAK1, cIAP1, and cIAP2. High throughput sequencing of the mouse genome revealed the existence of a gene resembling Xiap/Birc4 on mouse chromosome 7. To confirm the existence of this gene, and to determine its functional significance, we performed Southern and Northern blot analysis. This showed the presence of the Xiap-like gene in both wild-type and Xiap gene knock-out mice, but the corresponding mRNA was not detected in any tissues examined by Northern blot. Analysis of the gene sequence in all three possible reading frames predicts that expression of this gene would not give rise to a full-length protein, but only non-functional truncated polypeptides. Because its nucleotide sequence is 92% identical to Xiap, but it has no introns corresponding to those of Xiap, we conclude that Xiap-ps1 is a pseudogene generated by retro- transposition of a spliced Xiap message to chromosome 7.	[Kotevski, Aneta; Cook, Wendy D.; Vaux, David L.; Callus, Bernard A.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Callus, Bernard A.] Univ Western Australia, Western Australian Inst Med Res, Crawley, WA, Australia; [Callus, Bernard A.] Univ Western Australia, Sch Biomol Biomed & Chem Sci, Crawley, WA, Australia	La Trobe University; University of Western Australia; University of Western Australia	Kotevski, A (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia.	D.Vaux@latrobe.edu.au	Vaux, David L/C-7249-2013; Cook, Wendy/N-7506-2019	Vaux, David L/0000-0003-2703-1651; 	National Health and Medical Research Council [433063, 461221]; Leukemia and Lymphoma Center Grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Center Grant	Funding was received from the National Health and Medical Research Council (433063, 461221) and a Leukemia and Lymphoma Center Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Ekert PG, 2001, J CELL BIOL, V152, P483, DOI 10.1083/jcb.152.3.483; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Lu Xuanyong, 2005, Int J Med Sci, V2, P30; Richter BWM, 2001, MOL CELL BIOL, V21, P4292, DOI 10.1128/MCB.21.13.4292-4301.2001; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	10	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8078	10.1371/journal.pone.0008078	http://dx.doi.org/10.1371/journal.pone.0008078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956646	Green Published, gold			2022-12-27	WOS:000272828400024
J	Guerrier, G; Zounoun, M; Delarosa, O; Defourny, I; Lacharite, M; Brown, V; Pedalino, B				Guerrier, Gilles; Zounoun, Malaika; Delarosa, Olimpia; Defourny, Isabelle; Lacharite, Michelo; Brown, Vincent; Pedalino, Biagio			Malnutrition and Mortality Patterns among Internally Displaced and Non-Displaced Population Living in a Camp, a Village or a Town in Eastern Chad	PLOS ONE			English	Article								Background: Certain population groups have been rendered vulnerable in Chad because of displacement of more than 200,000 people over the last three years as a result of mass violence against civilians in the east of the country. The objective of the study was to assess mortality and nutritional patterns among displaced and non-displaced population living in camps, villages and a town in the Ouddai and Salamat regions of Chad. Methodology: Between May and October 2007, two stage, 30-cluster household surveys were conducted among 43,900 internally displaced persons (IDPs) living in camps in Ouaddai region (n = 898 households), among 19,400 non-displaced persons (NDPs) living in 42 villages in Ouaddai region (n = 900 households) and among 17,000 NDPs living in a small town in Salamat region (n = 901 households). Data collection included anthropometric measurements, measles vaccination rates and retrospective mortality. Crude mortality rate (CMR), mortality rate among children younger than 5 years (U5MR), causes of death and the prevalence of wasting (weight-for-height z score <-2) among children aged 6 to 59 months were the main outcome measures. Conclusions: The CMR among the 4902 IDPs in Gozbeida camps, 4477 NDPs living in a village and 4073 NDPs living in a town surveyed was 1.8 (95% CI, 1.2-2.8), 0.3 (95% CI, 0.2-0.4), 0.3 (95% CI, 0.2-0.5) per 10,000 per day, respectively. The U5MR in a camp (n = 904), a village (n = 956) and a town (n = 901) was 4.1 (95% CI, 2.1-7.7), 0.5 (95% CI, 0.3-0.9) and 0.7 (95% CI, 0.4-1.4) per 10,000 per day, respectively. Diarrhoea was reported to be the main cause of death. Acute malnutrition rates (according to the WHO definition) among 904 IDP children, 956 NDPs children living in a village, 901 NDP children living in a town aged 6 to 59 months were 20.6% (95% CI, 17.9%-23.3%), 16.4% (95% CI, 14.0%-18.8%) and 10.1% (95% CI, 8.1%-12.2%) respectively. The study found a high mortality rate among IDPs and an elevated prevalence of wasting not only in IDP camps but also in villages located in the same region. The town-dweller population remains at risk of malnutrition. Appropriate contingency plans need to be made to ensure acceptable living standards for these populations.	[Guerrier, Gilles; Zounoun, Malaika; Brown, Vincent; Pedalino, Biagio] Epictr, Paris, France; [Delarosa, Olimpia] Med Sans Frontieres, Barcelona, Spain; [Defourny, Isabelle; Lacharite, Michelo] Med Sans Frontieres, Paris, France	Doctors Without Borders; Doctors Without Borders	Guerrier, G (corresponding author), Epictr, Paris, France.	guerriergilles@hotmail.com			Medecins sans Frontieres-France; Medecins sans Frontieres-Spain	Medecins sans Frontieres-France; Medecins sans Frontieres-Spain	This research was funded entirely by Medecins sans Frontieres-France and Medecins sans Frontieres-Spain. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; CHEDORGE D, 2009, REV EMERGENCY OPERAT; CHOTARD S, 2006, ASSESSMENT CHILD NUT; DUFFIELD A, 2004, ANAL SAVE CHILDREN U; *FEWS NET, 2008, NOV 24 SIT REP FAM E; *FEWS NET, 2007, OCT 17 SIT REP FAM E; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; LOUTAN L, 1984, LANCET, V1, P945; Porignon D, 2000, J EPIDEMIOL COMMUN H, V54, P6, DOI 10.1136/jech.54.1.6; The Sphere Project, 2004, HUM CHART MIN STAND; *UN HIGH COM REF, 1999, HDB EM; United Nations High Commissioner for Refugees, 2007, STAT WORLDS REF; WOODRUFF BA, 2002, FIELD EXCHANGE, V17, P16; World Health Organization, 1999, WHO REC SURV STAND; *WORLD MED ASS, 2004, DECL HELS 2004	18	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8077	10.1371/journal.pone.0008077	http://dx.doi.org/10.1371/journal.pone.0008077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956627	Green Published, gold			2022-12-27	WOS:000272828100015
J	Hagman, R; Ronnberg, E; Pejler, G				Hagman, Ragnvi; Ronnberg, Elin; Pejler, Gunnar			Canine Uterine Bacterial Infection Induces Upregulation of Proteolysis-Related Genes and Downregulation of Homeobox and Zinc Finger Factors	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; NF-KAPPA-B; SERGLYCIN PROTEOGLYCAN; SEPSIS; EXPRESSION; PROTEIN; PYOMETRA; METABOLITE; BITCHES; DIAGNOSIS	Background: Bacterial infection with the severe complication of sepsis is a frequent and serious condition, being a major cause of death worldwide. To cope with the plethora of occurring bacterial infections there is therefore an urgent need to identify molecular mechanisms operating during the host response, in order both to identify potential targets for therapeutic intervention and to identify biomarkers for disease. Here we addressed this issue by studying global gene expression in uteri from female dogs suffering from spontaneously occurring uterine bacterial infection. Principal Findings: The analysis showed that almost 800 genes were significantly (p<0.05) upregulated (>2-fold) in the uteri of diseased animals. Among these were numerous chemokine and cytokine genes, as well as genes associated with inflammatory cell extravasation, anti-bacterial action, the complement system and innate immune responses, as well as proteoglycan-associated genes. There was also a striking representation of genes associated with proteolysis. Robust upregulation of immunoglobulin components and genes involved in antigen presentation was also evident, indicating elaboration of a strong adaptive immune response. The bacterial infection was also associated with a significant downregulation of almost 700 genes, of which various homeobox and zinc finger transcription factors were highly represented. Conclusions/Significance: Together, these finding outline the molecular patterns involved in bacterial infection of the uterus. The study identified altered expression of numerous genes not previously implicated in bacterial disease, and several of these may be evaluated for potential as biomarkers of disease or as therapeutic targets. Importantly, since humans and dogs show genetic similarity and develop diseases that share many characteristics, the molecular events identified here are likely to reflect the corresponding situation in humans afflicted by similar disease.	[Hagman, Ragnvi] Swedish Univ Agr Sci, Dept Clin Sci, Div Small Anim, Uppsala, Sweden; [Ronnberg, Elin; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Hagman, R (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Div Small Anim, Uppsala, Sweden.	Ragnvi.Hagman@kv.slu.se; Gunnar.Pejler@afb.slu.se	Ronnberg, Elin/ABA-8898-2020	Ronnberg, Elin/0000-0002-4628-9968	Formas; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Michael Forsgren Foundation; Agria Insurance Co; Swedish Kennel Club Research Foundation	Formas(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Michael Forsgren Foundation; Agria Insurance Co; Swedish Kennel Club Research Foundation	This work was supported by grants from Formas (GP), The Swedish Research Council (GP), Torsten and Ragnar Soderberg Foundation (GP), Michael Forsgren Foundation (RH), Agria Insurance Co and Swedish Kennel Club Research Foundation (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Brady CA, 2001, VET CLIN N AM-SMALL, V31, P1147, DOI 10.1016/S0195-5616(01)50097-2; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egenvall A, 2001, J VET INTERN MED, V15, P530, DOI 10.1892/0891-6640(2001)015&lt;0530:BROPII&gt;2.3.CO;2; Fransson BA, 2007, AM J VET RES, V68, P1281, DOI 10.2460/ajvr.68.12.1281; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; GRANSTROM E, 1982, METHOD ENZYMOL, V86, P320; Gupta S, 2008, EXPERT OPIN THER TAR, V12, P291, DOI 10.1517/14728222.12.3.291; Hagman R, 2006, THERIOGENOLOGY, V66, P198, DOI 10.1016/j.theriogenology.2005.11.002; Hagman R, 2006, ACTA VET SCAND, V47, P55, DOI 10.1186/1751-0147-47-55; Hagman R, 2005, VET REC, V157, P193, DOI 10.1136/vr.157.7.193; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Higgins MA, 2003, TOXICOL SCI, V74, P470, DOI 10.1093/toxsci/kfg142; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hong JW, 2003, P NATL ACAD SCI USA, V100, P12301, DOI 10.1073/pnas.2133048100; Houston G, 2009, CLIN MICROBIOL INFEC, V15, P319, DOI 10.1111/j.1469-0691.2009.02751.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson SB, 2007, ANN SURG, V245, P611, DOI 10.1097/01.sla.0000251619.10648.32; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lindahl U, 1999, HAEMOSTASIS, V29, P38; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Llewelyn M, 2001, INTENS CARE MED, V27, pS10, DOI 10.1007/PL00003792; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Moroy T, 2008, IMMUNOBIOLOGY, V213, P341, DOI 10.1016/j.imbio.2007.11.004; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Parrillo J E, 1993, N Engl J Med, V328, P1471; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Raymond WW, 2005, ARCH BIOCHEM BIOPHYS, V435, P311, DOI 10.1016/j.abb.2004.12.025; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Trivedi CM, 2007, ATHEROSCLEROSIS, V195, pE50, DOI 10.1016/j.atherosclerosis.2007.04.055; Vandijck DM, 2008, DIMENS CRIT CARE NUR, V27, P244, DOI 10.1097/01.DCC.0000338868.31917.0e; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; Vincent JL, 2000, ACTA CLIN BELG, V55, P79, DOI 10.1080/17843286.2000.11754275; WENSMAN H, 2008, BREAST CANC RES TREA; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	56	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8039	10.1371/journal.pone.0008039	http://dx.doi.org/10.1371/journal.pone.0008039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956711	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100004
J	Kavasery, R; Maru, DSR; Cornman-Homonoff, J; Sylla, LN; Smith, D; Altice, FL				Kavasery, Ravi; Maru, Duncan Smith-Rohrberg; Cornman-Homonoff, Joshua; Sylla, Laurie N.; Smith, David; Altice, Frederick L.			Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial	PLOS ONE			English	Article							INCARCERATED WOMEN; HEALTH-CARE; DISORDERS; PRISONS; PREVALENCE; INFECTION; DETAINEES	Background: Ten million Americans enter jails annually. The objective was to evaluate new CDC guidelines for routine opt-out HIV testing and examine the optimal time to implement routine opt-out HIV testing among newly incarcerated jail detainees. Methods: This prospective, controlled trial of routine opt-out HIV testing was conducted among 323 newly incarcerated female inmates in Connecticut's only women's jail. 323 sequential entrants to the women's jail over a five week period in August and September 2007 were assigned to be offered routine opt-out HIV testing at one of three points after incarceration: immediate (same day, n = 108), early (next day, n = 108), or delayed (7 days, n = 107). The primary outcome was the proportion of women in each group consenting to testing. Results: Routine opt-out HIV testing was significantly highest (73%) among the early testing group compared to 55% for immediate and 50% for 7 days post-entry groups. Other factors significantly (p = 0.01) associated with being HIV tested were younger age and low likelihood of early release from jail based on bond value or type of charge for which women were arrested. Conclusions: In this correctional facility, routine opt-out HIV testing in a jail setting was feasible, with highest rates of testing if performed the day after incarceration. Lower testing rates were seen with immediate testing, where there is a high prevalence of inability or unwillingness to test, and with delayed testing, where attrition from jail increases with each passing day.	[Kavasery, Ravi; Maru, Duncan Smith-Rohrberg; Cornman-Homonoff, Joshua; Sylla, Laurie N.; Smith, David; Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT 06520 USA	Yale University	Altice, FL (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT 06520 USA.	frederick.altice@yale.edu		Cornman-Homonoff, Joshua/0000-0002-9009-8384; Maru, Duncan/0000-0002-5923-6910	National Institutes on Drug Abuse [K24 DA017072]; Infectious Diseases Society of America; Health Services Resources Agency [H97 HA 08541]; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Infectious Diseases Society of America; Health Services Resources Agency; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this project was provided in part by the National Institutes on Drug Abuse (K24 DA017072), the Infectious Diseases Society of America and the Health Services Resources Agency Special Projects of National Significance (H97 HA 08541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Altice FL, 2005, J URBAN HEALTH, V82, P312, DOI 10.1093/jurban/jti055; Altice FL, 1998, J ACQ IMMUN DEF SYND, V18, P444, DOI 10.1097/00042560-199808150-00005; [Anonymous], 2006, MMWR RECOMM REP; APPELBAUM P, 1996, MACARTHUR COMPETENCE; Basu Sanjay, 2005, AIDS Public Policy J, V20, P3; Beckwith CG, 2007, AIDS PATIENT CARE ST, V21, P41, DOI 10.1089/apc.2006.006; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2009, HIV TEST IMPL GUID C, P1; CUNNIF MA, 2002, JAIL CROWDING UNDERS; Fazel S, 2005, CURR OPIN PSYCHIATR, V18, P550, DOI 10.1097/01.yco.0000179496.38558.d9; FELTHOUS AR, 1994, B AM ACAD PSYCH LAW, V22, P477; Frottier P, 2002, SOC PSYCH PSYCH EPID, V37, P68, DOI 10.1007/s127-002-8217-7; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; HAMMETT TM, 1999, 1996 1997 UPDATE HIV; Kavasery R, 2007, AIDS PATIENT CARE ST, V21, P715, DOI 10.1089/apc.2007.0039; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Lazzarini Z, 2000, AIDS PUBLIC POLICY J, V15, P105; Liddicoat RV, 2006, J URBAN HEALTH, V83, P1127, DOI 10.1007/s11524-006-9095-9; MacGowan R, 2009, SEX TRANSM DIS, V36, pS9, DOI 10.1097/OLQ.0b013e318148b6b1; MARUSCHAK L, 2004, HIV PRISONS JAILS; MARUSCHAK LM, 2006, HIV PRISONS 2004; Mumola C, 2005, SUICIDE HOMICIDE STA; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Puz Carol A, 2005, Crit Care Nurs Clin North Am, V17, P297, DOI 10.1016/j.ccell.2005.04.001; SPAULDING AC, 2007, ENHANCING LINKAGES H; Springer Sandra A, 2005, Curr HIV/AIDS Rep, V2, P165, DOI 10.1007/s11904-005-0011-9; Teplin LA, 1996, ARCH GEN PSYCHIAT, V53, P505; TEPLIN LA, 1994, AM J PUBLIC HEALTH, V84, P290, DOI 10.2105/AJPH.84.2.290; *US CDCP, 2003, QUAL ASS GUID TEST U; Varghese B, 2001, J URBAN HEALTH, V78, P304, DOI 10.1093/jurban/78.2.304; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wynia MK, 2006, PLOS MED, V3, P701, DOI 10.1371/journal.pmed.0030244	35	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7648	10.1371/journal.pone.0007648	http://dx.doi.org/10.1371/journal.pone.0007648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MK	19946370	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800002
J	Liu, JX; Song, JX				Liu, Jingxian; Song, Jianxing			Insights into Protein Aggregation by NMR Characterization of Insoluble SH3 Mutants Solubilized in Salt-Free Water	PLOS ONE			English	Article							FOLDING TRANSITION-STATE; LACTALBUMIN MOLTEN GLOBULE; BETA-LACTOGLOBULIN; BACKBONE DYNAMICS; PURE WATER; MOLECULAR-DYNAMICS; CIRCULAR-DICHROISM; SPECTRAL DENSITIES; DENATURED STATE; CHEMICAL-SHIFTS	Protein aggregation in vivo has been extensively associated with a large spectrum of human diseases. On the other hand, mechanistic insights into protein aggregation in vitro were incomplete due to the inability in solubilizing insoluble proteins for high-resolution biophysical investigations. However, a new avenue may be opened up by our recent discovery that previously-thought insoluble proteins can in fact be solubilized in salt-free water. Here we use this approach to study the NMR structural and dynamic properties of an insoluble SH3 mutant with a naturally-occurring insertion of Val22 at the tip of the diverging turn. The obtained results reveal: 1) regardless of whether the residue is Val, Ala, Asp or Arg, the insertion will render the first hNck2 SH3 domain to be insoluble in buffers. Nevertheless, all four mutants could be solubilized in salt-free water and appear to be largely unfolded as evident from their CD and NMR HSQC spectra. 2) Comparison of the chemical shift deviations reveals that while in V22-SH3 the second helical region is similarly populated as in the wild-type SH3 at pH 2.0, the first helical region is largely unformed. 3) In V22-SH3, many non-native medium-range NOEs manifest to define non-native helical conformations. In the meanwhile a small group of native-like long-range NOEs still persists, indicating the existence of a rudimentary native-like tertiary topology. 4) Although overall, V22-SH3 has significantly increased backbone motions on the ps-ns time scale, some regions still own restricted backbone motions as revealed by analyzing N-15 relaxation data. Our study not only leads to the establishment of the first high-resolution structural and dynamic picture for an insoluble protein, but also shed more light on the molecular events for the nonhierarchical folding mechanism. Furthermore, a general mechanism is also proposed for in vivo protein aggregation triggered by the genetic mutation and posttranslational modification.	[Liu, Jingxian; Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Liu, JX (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Song, Jianxing/J-3617-2013	Song, Jianxing/0000-0003-0224-6322	Ministry of Education (MOE) of Singapore [R-154-000-388-112]	Ministry of Education (MOE) of Singapore(Ministry of Education, Singapore)	This study is supported by the Ministry of Education (MOE) of Singapore Tier 2 Grant R-154-000-388-112 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r; Arai M, 1998, J MOL BIOL, V275, P149, DOI 10.1006/jmbi.1997.1456; Avbelj F, 2004, P NATL ACAD SCI USA, V101, P17394, DOI 10.1073/pnas.0407969101; Bai P, 2001, PROTEIN SCI, V10, P55, DOI 10.1110/ps.34101; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Chikenji G, 2000, P NATL ACAD SCI USA, V97, P14273, DOI 10.1073/pnas.97.26.14273; Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DAVIDSON AR, 1994, P NATL ACAD SCI USA, V91, P2146, DOI 10.1073/pnas.91.6.2146; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAK K, 2009, POLYELECTROLYTE DOMA, V48, P3669; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Ding F, 2005, STRUCTURE, V13, P1047, DOI 10.1016/j.str.2005.04.009; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; ENGLANDER SW, 2002, BIOPHYS CHEM, V10, P101; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fujiwara K, 1999, BIOCHEMISTRY-US, V38, P4455, DOI 10.1021/bi982683p; Gnanakaran S, 2003, BIOPHYS J, V84, P1548, DOI 10.1016/S0006-3495(03)74966-2; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Gruebele M, 1998, NAT STRUCT BIOL, V5, P662, DOI 10.1038/1354; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; Hamada D, 1997, J MOL BIOL, V269, P479, DOI 10.1006/jmbi.1997.1055; Hubner IA, 2005, J MOL BIOL, V349, P424, DOI 10.1016/j.jmb.2005.03.050; ISHIMA R, 1995, J BIOMOL NMR, V6, P217, DOI 10.1007/BF00211786; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009; Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; Li MF, 2007, BIOCHEM BIOPH RES CO, V360, P128, DOI 10.1016/j.bbrc.2007.06.031; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Li MF, 2006, PROTEIN SCI, V15, P1835, DOI 10.1110/ps.062306906; Li W, 2000, HISTOL HISTOPATHOL, V15, P947, DOI 10.14670/HH-15.947; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Liu JX, 2008, BIOPHYS J, V95, P4803, DOI 10.1529/biophysj.107.125641; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Mayer BJ, 2001, J CELL SCI, V114, P1253; Park S, 2006, J BIOMOL NMR, V34, P203, DOI 10.1007/s10858-006-0019-5; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG ZY, 1995, PHILOS T ROY SOC B, V348, P43, DOI 10.1098/rstb.1995.0044; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHWARZINGER S, J BIOMOL NMR, V18, P43; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Song JX, 1998, J MOL BIOL, V280, P167, DOI 10.1006/jmbi.1998.1826; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Viguera AR, 2001, J MOL BIOL, V311, P357, DOI 10.1006/jmbi.2001.4738; Wei Z, 2005, J MOL BIOL, V348, P205, DOI 10.1016/j.jmb.2005.02.028; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816	71	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7805	10.1371/journal.pone.0007805	http://dx.doi.org/10.1371/journal.pone.0007805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956763	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827300001
J	Ma, WX; Zhao, L; Fontainhas, AM; Fariss, RN; Wong, WT				Ma, Wenxin; Zhao, Lian; Fontainhas, Aurora M.; Fariss, Robert N.; Wong, Wai T.			Microglia in the Mouse Retina Alter the Structure and Function of Retinal Pigmented Epithelial Cells: A Potential Cellular Interaction Relevant to AMD	PLOS ONE			English	Article							MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; SUBRETINAL MICROGLIA; FRACTALKINE RECEPTOR; UNITED-STATES; IMMUNE-SYSTEM; NITRIC-OXIDE; IN-VITRO; DRUSEN; INFLAMMATION	Background: Age-related macular degeneration (AMD) is a leading cause of legal blindness in the elderly in the industrialized word. While the immune system in the retina is likely to be important in AMD pathogenesis, the cell biology underlying the disease is incompletely understood. Clinical and basic science studies have implicated alterations in the retinal pigment epithelium (RPE) layer as a locus of early change. Also, retinal microglia, the resident immune cells of the retina, have been observed to translocate from their normal position in the inner retina to accumulate in the subretinal space close to the RPE layer in AMD eyes and in animal models of AMD. Methodology/Principal Findings: In this study, we examined the effects of retinal microglia on RPE cells using 1) an in vitro model where activated retinal microglia are co-cultured with primary RPE cells, and 2) an in vivo mouse model where retinal microglia are transplanted into the subretinal space. We found that retinal microglia induced in RPE cells 1) changes in RPE structure and distribution, 2) increased expression and secretion of pro-inflammatory, chemotactic, and pro-angiogenic molecules, and 3) increased extent of in vivo choroidal neovascularization in the subretinal space. Conclusions/Significance: These findings share similarities with important pathological features found in AMD and suggest the relevance of microglia-RPE interactions in AMD pathogenesis. We speculate that the migration of retinal microglia into the subretinal space in early stages of the disease induces significant changes in RPE cells that perpetuate further microglial accumulation, increase inflammation in the outer retina, and fosters an environment conducive for the formation of neovascular changes responsible for much of vision loss in advanced AMD.			Ma, WX (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000463, ZICEY000459] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bok Dean, 2005, Retina, V25, pS61, DOI 10.1097/00006982-200512001-00028; BRESSLER NM, 1994, RETINA-J RET VIT DIS, V14, P130, DOI 10.1097/00006982-199414020-00006; Campochiaro P A, 1999, Mol Vis, V5, P34; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; GOUREAU O, 1992, BIOCHEM BIOPH RES CO, V186, P854, DOI 10.1016/0006-291X(92)90824-5; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Green W R, 1999, Mol Vis, V5, P27; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Guo L, 1999, INVEST OPHTH VIS SCI, V40, P2676; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Huang LW, 1999, J BIOL CHEM, V274, P38183, DOI 10.1074/jbc.274.53.38183; HUANG W, 2009, NEURON GLIA BIOL, P1; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Kvanta A, 2000, CURR EYE RES, V21, P684, DOI 10.1076/0271-3683(200009)21:3;1-R;FT684; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Lampugnani MG, 1999, METH MOL B, V96, P177; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; LIANG KJ, 2009, INVEST OPHTHALMOL VI; LIVERSIDGE J, 1990, CURR EYE RES, V9, P131, DOI 10.3109/02713689008999432; LYNCH MA, 2009, MOL NEUROBIOL; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Osusky R, 1997, OPHTHALMIC RES, V29, P124, DOI 10.1159/000268006; Osusky R, 1997, OPHTHALMIC RES, V29, P31, DOI 10.1159/000267988; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Streilein JW, 2002, VISION RES, V42, P487, DOI 10.1016/S0042-6989(01)00185-7; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang LP, 2007, MOL VIS, V13, P2048; Zamiri Parisa, 2007, Chem Immunol Allergy, V92, P86, DOI 10.1159/000099259; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhao L, 2007, MOL VIS, V13, P873	61	153	160	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7945	10.1371/journal.pone.0007945	http://dx.doi.org/10.1371/journal.pone.0007945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936204	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004800021
J	den Broeder, MJ; van der Linde, H; Brouwer, JR; Oostra, BA; Willemsen, R; Ketting, RF				den Broeder, Marjo J.; van der Linde, Herma; Brouwer, Judith R.; Oostra, Ben A.; Willemsen, Rob; Ketting, Rene F.			Generation and Characterization of Fmr1 Knockout Zebrafish	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; CRANIOFACIAL DEVELOPMENT; DENDRITIC SPINES; MUTANT EMBRYOS; GENE; EXPRESSION; MICE; MORPHOGENESIS	Fragile X syndrome (FXS) is one of the most common known causes of inherited mental retardation. The gene mutated in FXS is named FMR1, and is well conserved from human to Drosophila. In order to generate a genetic tool to study FMR1 function during vertebrate development, we generated two mutant alleles of the fmr1 gene in zebrafish. Both alleles produce no detectable Fmr protein, and produce viable and fertile progeny with lack of obvious phenotypic features. This is in sharp contrast to published results based on morpholino mediated knock-down of fmr1, reporting defects in craniofacial development and neuronal branching in embryos. These phenotypes we specifically addressed in our knock-out animals, revealing no significant deviations from wild-type animals, suggesting that the published morpholino based fmr1 phenotypes are potential experimental artifacts. Therefore, their relation to fmr1 biology is questionable and morpholino induced fmr1 phenotypes should be avoided in screens for potential drugs suitable for the treatment of FXS. Importantly, a true genetic zebrafish model is now available which can be used to study FXS and to derive potential drugs for FXS treatment.			den Broeder, MJ (corresponding author), Royal Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	r.willemsen@erasmusmc.nl; r.ketting@hubrecht.eu	den Broeder, Marjo/L-1316-2013	Ketting, Rene/0000-0001-6161-5621				AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Appel B, 1995, DEVELOPMENT, V121, P4117; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van 't Padje S, 2005, DEV GENES EVOL, V215, P198, DOI 10.1007/s00427-005-0466-0; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wienholds E, 2004, METHOD CELL BIOL, V77, P69; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	33	65	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7910	10.1371/journal.pone.0007910	http://dx.doi.org/10.1371/journal.pone.0007910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936290	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600014
J	van Haagen, HHHBM; 't Hoen, PAC; Bovo, AB; de Morree, A; van Mulligen, EM; Chichester, C; Kors, JA; den Dunnen, JT; van Ommen, GJB; van der Maarel, SM; Kern, VM; Mons, B; Schuemie, MJ				van Haagen, Herman H. H. B. M.; 't Hoen, Peter A. C.; Bovo, Alessandro Botelho; de Morree, Antoine; van Mulligen, Erik M.; Chichester, Christine; Kors, Jan A.; den Dunnen, Johan T.; van Ommen, Gert-Jan B.; van der Maarel, Silvere M.; Kern, Vinicius Medina; Mons, Barend; Schuemie, Martijn J.			Novel Protein-Protein Interactions Inferred from Literature Context	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; CONCEPT PROFILES; INTERACTION MAP; GENE; CALPAIN-3; KNOWLEDGE; DYSFERLIN; IDENTIFICATION; DISCOVERY; COMPONENT	We have developed a method that predicts Protein-Protein Interactions (PPIs) based on the similarity of the context in which proteins appear in literature. This method outperforms previously developed PPI prediction algorithms that rely on the conjunction of two protein names in MEDLINE abstracts. We show significant increases in coverage (76% versus 32%) and sensitivity (66% versus 41% at a specificity of 95%) for the prediction of PPIs currently archived in 6 PPI databases. A retrospective analysis shows that PPIs can efficiently be predicted before they enter PPI databases and before their interaction is explicitly described in the literature. The practical value of the method for discovery of novel PPIs is illustrated by the experimental confirmation of the inferred physical interaction between CAPN3 and PARVB, which was based on frequent co-occurrence of both proteins with concepts like Z-disc, dysferlin, and alpha-actinin. The relationships between proteins predicted by our method are broader than PPIs, and include proteins in the same complex or pathway. Dependent on the type of relationships deemed useful, the precision of our method can be as high as 90%. The full set of predicted interactions is available in a downloadable matrix and through the webtool Nermal, which lists the most likely interaction partners for a given protein. Our framework can be used for prioritizing potential interaction partners, hitherto undiscovered, for follow-up studies and to aid the generation of accurate protein interaction maps.			van Haagen, HHHBM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Biosemant Assoc, NL-2300 RA Leiden, Netherlands.	hvanhaagen@lumc.nl	dunnen, johan den/ABH-4228-2020; Hoen, Peter A 't/D-3950-2018; 't Hoen, Peter/A-4857-2012; Kern, Vinícius Medina/C-5574-2009; van der Maarel, Silvere/X-3631-2018	dunnen, johan den/0000-0002-6304-1710; Hoen, Peter A 't/0000-0003-4450-3112; Kern, Vinícius Medina/0000-0001-9240-304X; van der Maarel, Silvere/0000-0001-8103-711X; van Mulligen, Erik/0000-0003-1377-9386; de Morree, Antoine/0000-0002-8316-4531; Bovo, Alessandro/0000-0001-5863-9032; Mons, Barend/0000-0003-3934-0072; Schuemie, Martijn/0000-0002-0817-5361				Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; BENHUR A, 2006, CHOOSING NEGATIVE EX; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boutet Emmanuel, 2007, V406, P89; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen LF, 2005, BIOINFORMATICS, V21, P248, DOI 10.1093/bioinformatics/bth496; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Jelier R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-14; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; KORS JA, 2005, BIOLINK; Kuffner R, 2005, BIOINFORMATICS, V21, P259, DOI 10.1093/bioinformatics/bti1143; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schuemie M, 2007, PROTEOMICS, V7, P921, DOI 10.1002/pmic.200600693; Schuemie MJ, 2007, J BIOMED INFORM, V40, P316, DOI 10.1016/j.jbi.2006.09.002; SCHUEMIE MJ, 2007, BIOCR 2 WORKSH MADR; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tuason O, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P238; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141	47	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7894	10.1371/journal.pone.0007894	http://dx.doi.org/10.1371/journal.pone.0007894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924298	Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700024
J	Beildeck, ME; Islam, M; Shah, S; Welsh, J; Byers, SW				Beildeck, Marcy E.; Islam, Md; Shah, Salimuddin; Welsh, JoEllen; Byers, Stephen W.			Control of TCF-4 Expression by VDR and Vitamin D in the Mouse Mammary Gland and Colorectal Cancer Cell Lines	PLOS ONE			English	Article							HUMAN-COLON-CANCER; BETA-CATENIN; D-RECEPTOR; ANDROGEN RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTIONAL ACTIVITY; CRYSTAL-STRUCTURE; NUCLEAR RECEPTOR; CARCINOMA CELLS; C-MYC	Background: The vitamin D receptor (VDR) pathway is important in the prevention and potentially in the treatment of many cancers. One important mechanism of VDR action is related to its interaction with the Wnt/beta-catenin pathway. Agonist-bound VDR inhibits the oncogenic Wnt/beta-catenin/TCF pathway by interacting directly with beta-catenin and in some cells by increasing cadherin expression which, in turn, recruits beta-catenin to the membrane. Here we identify TCF-4, a transcriptional regulator and beta-catenin binding partner as an indirect target of the VDR pathway. Methodology/Principal Findings: In this work, we show that TCF-4 (gene name TCF7L2) is decreased in the mammary gland of the VDR knockout mouse as compared to the wild-type mouse. Furthermore, we show 1,25(OH)(2)D-3 increases TCF-4 at the RNA and protein levels in several human colorectal cancer cell lines, the effect of which is completely dependent on the VDR. In silico analysis of the human and mouse TCF7L2 promoters identified several putative VDR binding elements. Although TCF7L2 promoter reporters responded to exogenous VDR, and 1,25(OH)(2)D-3, mutation analysis and chromatin immunoprecipitation assays, showed that the increase in TCF7L2 did not require recruitment of the VDR to the identified elements and indicates that the regulation by VDR is indirect. This is further confirmed by the requirement of de novo protein synthesis for this up-regulation. Conclusions/Significance: Although it is generally assumed that binding of beta-catenin to members of the TCF/LEF family is cancer-promoting, recent studies have indicated that TCF-4 functions instead as a transcriptional repressor that restricts breast and colorectal cancer cell growth. Consequently, we conclude that the 1,25(OH)(2)D-3/VDR-mediated increase in TCF-4 may have a protective role in colon cancer as well as diabetes and Crohn's disease.			Beildeck, ME (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu			NCI NIH HHS [P30 CA051008, P30 CA51008, R01-CA-129-813] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA129813] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Alonso M, 1998, BIOCHEM BIOPH RES CO, V247, P882, DOI 10.1006/bbrc.1998.8884; Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Augenlicht LH, 1999, CANCER RES, V59, P5856; AUGENLICHT LH, 1999, CANCER RES, V59, P353; Bordonaro M, 1999, CELL GROWTH DIFFER, V10, P713; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CAO X, 1993, J BIOL CHEM, V268, P27371; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; DARWISH HM, 1992, P NATL ACAD SCI USA, V89, P603, DOI 10.1073/pnas.89.2.603; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Falzon M, 1996, MOL ENDOCRINOL, V10, P672, DOI 10.1210/me.10.6.672; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; GILL R, 1993, J BONE MINER RES, V8, pS223; GIULIANO AR, 1991, ARCH BIOCHEM BIOPHYS, V285, P261, DOI 10.1016/0003-9861(91)90358-P; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; HALLINE AG, 1994, ENDOCRINOLOGY, V134, P1710, DOI 10.1210/en.134.4.1710; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; PETERSON MD, 1992, J CELL SCI, V102, P581; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; RENOUF M, 2007, EXPT BIOL; Rini C, 2008, PSYCHO-ONCOL, V17, P354, DOI 10.1002/pon.1227; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rother K, 2004, GASTROENTEROLOGY, V126, pA80; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Schrader M, 1997, BIOCHEM BIOPH RES CO, V230, P646, DOI 10.1006/bbrc.1996.6025; SHABAHANG M, 1993, CANCER RES, V53, P3712; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Shulewitz M, 2006, ONCOGENE, V25, P4361, DOI 10.1038/sj.onc.1209470; Skarosi SF, 1999, GASTROENTEROLOGY, V116, pA506; Song LN, 2008, J BIOL CHEM, V283, P25988, DOI 10.1074/jbc.M800325200; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Truica CI, 2000, CANCER RES, V60, P4709; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang GF, 1998, MOL CELL BIOL, V18, P6023, DOI 10.1128/MCB.18.10.6023; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wilson AJ, 2002, CANCER RES, V62, P6006; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zinser GA, 2004, J STEROID BIOCHEM, V89-90, P433, DOI 10.1016/j.jsbmb.2004.03.012; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	68	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7872	10.1371/journal.pone.0007872	http://dx.doi.org/10.1371/journal.pone.0007872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924301	gold, Green Submitted, Green Published			2022-12-27	WOS:000271854200019
J	Homer, N; Merriman, B; Nelson, SF				Homer, Nils; Merriman, Barry; Nelson, Stanley F.			BFAST: An Alignment Tool for Large Scale Genome Resequencing	PLOS ONE			English	Article							HOMOLOGY SEARCH; DNA; GENERATION; SEEDS; BLAST	Background: The new generation of massively parallel DNA sequencers, combined with the challenge of whole human genome resequencing, result in the need for rapid and accurate alignment of billions of short DNA sequence reads to a large reference genome. Speed is obviously of great importance, but equally important is maintaining alignment accuracy of short reads, in the 25-100 base range, in the presence of errors and true biological variation. Methodology: We introduce a new algorithm specifically optimized for this task, as well as a freely available implementation, BFAST, which can align data produced by any of current sequencing platforms, allows for user-customizable levels of speed and accuracy, supports paired end data, and provides for efficient parallel and multi-threaded computation on a computer cluster. The new method is based on creating flexible, efficient whole genome indexes to rapidly map reads to candidate alignment locations, with arbitrary multiple independent indexes allowed to achieve robustness against read errors and sequence variants. The final local alignment uses a Smith-Waterman method, with gaps to support the detection of small indels. Conclusions: We compare BFAST to a selection of large-scale alignment tools - BLAT, MAQ, SHRiMP, and SOAP - in terms of both speed and accuracy, using simulated and real-world datasets. We show BFAST can achieve substantially greater sensitivity of alignment in the context of errors and true variants, especially insertions and deletions, and minimize false mappings, while maintaining adequate speed compared to other current methods. We show BFAST can align the amount of data needed to fully resequence a human genome, one billion reads, with high sensitivity and accuracy, on a modest computer cluster in less than 24 hours. BFAST is available at http://bfast.sourceforge.net.			Homer, N (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA.	barrym@ucla.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114	NIMH NIH HHS [R01 MH071852] Funding Source: Medline; NINDS NIH HHS [U24 NS052108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS052108] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; COX A, 2007, ELAND EFFICIENT LOCA; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Homer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-175; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Ilie L, 2007, BIOINFORMATICS, V23, P2969, DOI 10.1093/bioinformatics/btm422; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; RUMBLE SM, 2008, SHRIMP SHORT READING; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sun YN, 2005, J COMPUT BIOL, V12, P847, DOI 10.1089/cmb.2005.12.847; 2008, APPL BIOSYSTEMS INCO	22	365	416	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A95	A106	e7767	10.1371/journal.pone.0007767	http://dx.doi.org/10.1371/journal.pone.0007767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907642	gold, Green Published			2022-12-27	WOS:000271685800011
J	Kuningas, M; May, L; Tamm, R; van Bodegom, D; van den Biggelaar, AHJ; Meij, JJ; Frolich, M; Ziem, JB; Suchiman, HED; Metspalu, A; Slagboom, PE; Westendorp, RGJ				Kuningas, Maris; May, Linda; Tamm, Riin; van Bodegom, David; van den Biggelaar, Anita H. J.; Meij, Johannes J.; Froelich, Marijke; Ziem, Juventus B.; Suchiman, Helena E. D.; Metspalu, Andres; Slagboom, P. Eline; Westendorp, Rudi G. J.			Selection for Genetic Variation Inducing Pro-Inflammatory Responses under Adverse Environmental Conditions in a Ghanaian Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-10 TRANSCRIPTION; CYTOKINE PRODUCTION; CHILDREN; MORTALITY; RISK; POLYMORPHISMS; INFECTION; RECEPTOR; IL10	Background: Chronic inflammation is involved in the pathogenesis of chronic age-associated, degenerative diseases. Pro-inflammatory host responses that are deleterious later in life may originate from evolutionary selection for genetic variation mediating resistance to infectious diseases under adverse environmental conditions. Methodology/Principal Findings: In the Upper-East region of Ghana where infection has remained the leading cause of death, we studied the effect on survival of genetic variations at the IL10 gene locus that have been associated with chronic diseases. Here we show that an IL10 haplotype that associated with a pro-inflammatory innate immune response, characterised by low IL-10 (p = 0.028) and high TNF-alpha levels (p = 1.39 x 10(-3)), was enriched among Ghanaian elders (p = 2.46 x10(-6)). Furthermore, in an environment where the source of drinking water (wells/rivers vs. boreholes) influences mortality risks (HR 1.28, 95% CI [1.09-1.50]), we observed that carriers of the pro-inflammatory haplotype have a survival advantage when drinking from wells/rivers but a disadvantage when drinking from boreholes (p(interaction) = 0.013). Resequencing the IL10 gene region did not uncover any additional common variants in the pro-inflammatory haplotype to those SNPs that were initially genotyped. Conclusions/Significance: Altogether, these data lend strong arguments for the selection of pro-inflammatory host responses to overcome fatal infection and promote survival in adverse environments.			Kuningas, M (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	R.G.J.Westendorp@lumc.nl	Suchiman, H. Eka D./F-5024-2017; Slagboom, P. Eline/R-4790-2016; Meij, Johannes/ABB-6973-2021	Suchiman, H. Eka D./0000-0002-7168-5516; Slagboom, P. Eline/0000-0002-2875-4723; Ziem, Juventus/0000-0002-5130-8764; van Bodegom, David/0000-0002-5691-8342				Ates O, 2008, RHEUMATOL INT, V28, P1123, DOI 10.1007/s00296-008-0594-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Drenos F, 2006, BIOGERONTOLOGY, V7, P287, DOI 10.1007/s10522-006-9027-9; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Hartgers FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000227; HEISKANEN M, 2009, POLYMORPHISM IL10 PR; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Le Souef PN, 2000, LANCET, V356, P242; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; May L, 2009, CYTOKINE, V45, P184, DOI 10.1016/j.cyto.2008.12.010; Meij JJ, 2009, T ROY SOC TROP MED H, V103, P173, DOI 10.1016/j.trstmh.2008.09.015; MOLYNEUX ME, 1993, CYTOKINE, V5, P604, DOI 10.1016/S1043-4666(05)80011-0; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Shier RP, 1996, TROP MED INT HEALTH, V1, P334, DOI 10.1046/j.1365-3156.1996.d01-55.x; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; Van Bodegom D, 2007, ANN NY ACAD SCI, V1100, P84, DOI 10.1196/annals.1395.007; van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662; VANBODEGOM D, 2009, T R SOC TROP MED HYG; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6	34	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A174	A180	e7795	10.1371/journal.pone.0007795	http://dx.doi.org/10.1371/journal.pone.0007795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907653	Green Submitted, Green Published, gold			2022-12-27	WOS:000271685800019
J	D'Avanzo, N; Pekhletski, R; Backx, PH				D'Avanzo, Nazzareno; Pekhletski, Roman; Backx, Peter H.			P-Loop Residues Critical for Selectivity in K+ Channels Fail to Confer Selectivity to Rabbit HCN4 Channels	PLOS ONE			English	Article							DIFFERENT ACTIVATION KINETICS; SHAKER POTASSIUM CHANNELS; VOLTAGE-SENSING MECHANISM; MOLECULAR-BASIS; IONIC SELECTIVITY; SINOATRIAL NODE; PACEMAKER CHANNELS; MYELINATED NERVE; ORGANIC CATIONS; SODIUM-CHANNEL	HCN channels are thought to be structurally similar to K-v channels, but show much lower selectivity for K+. The similar to 3.3 angstrom selectivity filter of K+ channels is formed by the pore-lining sequence XT(V/I)GYG, with X usually T, and is held stable by key residues in the P-loop. Differences in the P-loop sequence of HCN channels (eg. the pore- lining sequence L(478)C(479)IGYG) suggest these residues could account for differences in selectivity between these channel families. Despite being expressed, L478T/C479T HCN4 channels did not produce current. Since threonine in the second position is highly conserved in K+ channels, we also studied C479T channels. Based on permeability ratios (P-X/P-K), C479T HCN4 channels (K+(1). Rb+(0.85). Cs+(0.59). Li+(0.50)>= Na+(0.49)) were less selective than WT rabbit HCN4 (K+(1)> Rb+(0.48)>Cs+(0.31)>= Na+(0.29)>Li+(0.03)), indicating that the TIGYG sequence is insufficient to confer K+ selectivity to HCN channels. C479T HCN4 channels had an increased permeability to large organic cations than WT HCN4 channels, as well as increased unitary K+ conductance, and altered channel gating. Collectively, these results suggest that HCN4 channels have larger pores than K+ channels and replacement of the cysteine at position 479 with threonine further increases pore size. Furthermore, selected mutations in other regions linked previously to pore stability in K+ channels (ie. S475D, S475E and F471W/K472W) were also unable to confer K+ selectivity to C479T HCN4 channels. Our findings establish the presence of the TIGYG pore- lining sequence does not confer K+ selectivity to rabbit HCN4 channels, and suggests that differences in selectivity of HCN4 versus K+ channels originate from differences outside the P-loop region.			D'Avanzo, N (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	p.backx@utoronto.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Azene EM, 2005, BIOCHEM BIOPH RES CO, V327, P1131, DOI 10.1016/j.bbrc.2004.12.127; Azene EM, 2003, J PHYSIOL-LONDON, V547, P349, DOI 10.1113/jphysiol.2003.039768; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; CORONADO R, 1980, J GEN PHYSIOL, V76, P425, DOI 10.1085/jgp.76.4.425; CORONADO R, 1987, BIOPHYS J, V51, P497, DOI 10.1016/S0006-3495(87)83371-4; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; EISENMAN G, 1962, Biophys J, V2, P259; Giorgetti A, 2005, BIOPHYS J, V89, P932, DOI 10.1529/biophysj.104.045286; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; HO WK, 1994, PFLUG ARCH EUR J PHY, V426, P68, DOI 10.1007/BF00374672; HUSH NS, 1948, AUST J SCI RES SER A, V1, P480, DOI 10.1071/CH9480480; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Yool AJ, 1996, BIOPHYS J, V71, P2467, DOI 10.1016/S0006-3495(96)79440-7; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7712	10.1371/journal.pone.0007712	http://dx.doi.org/10.1371/journal.pone.0007712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890386	Green Submitted, Green Published, gold			2022-12-27	WOS:000271459700009
J	Astle, DE; Nobre, AC; Scerif, G				Astle, Duncan Edward; Nobre, Anna Christina; Scerif, Gaia			Applying an Attentional Set to Perceived and Remembered Features	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; COGNITIVE CONTROL; ORIENTING ATTENTION; SPATIAL ATTENTION; TASK; COMPONENTS; SWITCH; ERP; MECHANISMS; INFORMATION	Previous research has examined our ability to attend selectively to particular features of perceptual objects, as well as our ability to switch from attending to one type of feature to another. This is usually done in the context of anticipatory attentional-set control, comparing the neural mechanisms involved as participants prepare to attend to the same stimulus feature as on the previous trial ("task-stay'' trials) with those required as participants prepare to attend to a different stimulus feature to that previously attended ("task-switch'' trials). We wanted to establish how participants maintain or switch attentional set retrospectively, as they attend to features of objects held in visual short-term memory (VSTM). We found that switching, relative to maintaining attentional set retrospectively, was associated with a performance cost, which can be reduced over time. This control process was mirrored by a large parietal and frontal amplitude difference in the event-related brain potentials (ERPs) and significant differences in global field power (GFP) between switch and stay trials. However, when taking into account the switch/stay GFP differences, thereby controlling for this difference in amplitude, we could not distinguish these trial types topographically. By contrast, we found clear topographic differences between preparing an anticipatory feature-based attentional set versus applying it retrospectively within VSTM. These complementary topographical and amplitude analyses suggested that anticipatory and retrospective set control recruited a qualitatively different configuration of underlying neural generators. In contrast, switch/stay differences were largely quantitative, with them differing primarily in terms of amplitude rather than topography.			Astle, DE (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	Duncan.astle@psy.ox.ac.uk		Nobre, Anna Christina/0000-0001-5762-2802; Astle, Duncan/0000-0002-7042-5392	ESRC [ES/F025505/1] Funding Source: UKRI; Economic and Social Research Council [ES/F025505/1] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Astle DE, 2008, EUR J NEUROSCI, V28, P1404, DOI 10.1111/j.1460-9568.2008.06439.x; Astle DE, 2006, BRAIN RES, V1125, P94, DOI 10.1016/j.brainres.2006.09.092; Astle DE, 2008, J COGNITIVE NEUROSCI, V20, P255, DOI 10.1162/jocn.2008.20015; Astle DE, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.006.2009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fabiani M, 2003, PSYCHOPHYSIOLOGY, V40, P472, DOI 10.1111/1469-8986.00049; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Lavric A, 2008, EUR J NEUROSCI, V28, P1016, DOI 10.1111/j.1460-9568.2008.06372.x; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2006, BRAIN RES, V1105, P20, DOI 10.1016/j.brainres.2006.03.033; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; LURIA R, 2009, J COGN NEUROSCI; Makovski T, 2008, J EXP PSYCHOL LEARN, V34, P369, DOI 10.1037/0278-7393.34.2.369; MICHEL CM, 1992, INT J PSYCHOPHYSIOL, V12, P133, DOI 10.1016/0167-8760(92)90004-U; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Mueller SC, 2007, BRAIN RES, V1157, P56, DOI 10.1016/j.brainres.2007.04.046; Mueller SC, 2009, NEUROIMAGE, V45, P191, DOI 10.1016/j.neuroimage.2008.11.019; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Nicholson R, 2005, PSYCHOPHYSIOLOGY, V42, P540, DOI 10.1111/j.1469-8986.2005.00350.x; Nicholson R, 2006, BRAIN RES, V1095, P107, DOI 10.1016/j.brainres.2006.04.016; Nobre AC, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.004.2007; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2002, J COGNITIVE NEUROSCI, V14, P1139, DOI 10.1162/089892902760807159; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; SWAINSON R, 2006, BRAIN RES; Verbruggen F, 2007, J EXP PSYCHOL LEARN, V33, P342, DOI 10.1037/0278-7393.33.2.342; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Wylie GR, 2009, J COGNITIVE NEUROSCI, V21, P105, DOI 10.1162/jocn.2009.21009; Wylie GR, 2003, NEUROIMAGE, V20, P2322, DOI 10.1016/j.neuroimage.2003.08.010	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7613	10.1371/journal.pone.0007613	http://dx.doi.org/10.1371/journal.pone.0007613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	512FP	19898613	Green Published, Green Submitted, gold			2022-12-27	WOS:000271232000004
J	Odsbu, I; Morigen, KS				Odsbu, Ingvild; Morigen, Kirsten Skarstad			A Reduction in Ribonucleotide Reductase Activity Slows Down the Chromosome Replication Fork but Does Not Change Its Localization	PLOS ONE			English	Article							COLI SEQA PROTEIN; IRRADIATED ESCHERICHIA-COLI; DNA-REPLICATION; DIPHOSPHATE REDUCTASE; DEOXYRIBONUCLEOTIDE SYNTHESIS; DIVISION CYCLE; MUTANT; CELLS; HYPERSTRUCTURE; SEQUESTRATION	Background: It has been proposed that the enzymes of nucleotide biosynthesis may be compartmentalized or concentrated in a structure affecting the organization of newly replicated DNA. Here we have investigated the effect of changes in ribonucleotide reductase (RNR) activity on chromosome replication and organization of replication forks in Escherichia coli. Methodology/Principal Findings: Reduced concentrations of deoxyribonucleotides (dNTPs) obtained by reducing the activity of wild type RNR by treatment with hydroxyurea or by mutation, resulted in a lengthening of the replication period. The replication fork speed was found to be gradually reduced proportionately to moderate reductions in nucleotide availability. Cells with highly extended C periods showed a "delay'' in cell division i.e. had a higher cell mass. Visualization of SeqA structures by immunofluorescence indicated no change in organization of the new DNA upon moderate limitation of RNR activity. Severe nucleotide limitation led to replication fork stalling and reversal. Well defined SeqA structures were not found in situations of extensive replication fork repair. In cells with stalled forks obtained by UV irradiation, considerable DNA compaction was observed, possibly indicating a reorganization of the DNA into a "repair structure'' during the initial phase of the SOS response. Conclusion/Significance: The results indicate that the replication fork is slowed down in a controlled manner during moderate nucleotide depletion and that a change in the activity of RNR does not lead to a change in the organization of newly replicated DNA. Control of cell division but not control of initiation was affected by the changes in replication elongation.			Odsbu, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway.	kirsten.skarstad@rr-research.no						Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Fossum S, 2003, MOL MICROBIOL, V47, P619, DOI 10.1046/j.1365-2958.2003.t01-1-03329.x; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; FUCHS JA, 1972, NATURE-NEW BIOL, V238, P69, DOI 10.1038/newbio238069a0; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; Godoy VG, 2006, EMBO J, V25, P868, DOI 10.1038/sj.emboj.7600986; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grompone G, 2002, MOL MICROBIOL, V44, P1331, DOI 10.1046/j.1365-2958.2002.02962.x; GUARINO E, 2007, J BACTERIOL; Guarino E, 2007, J BACTERIOL, V189, P3496, DOI 10.1128/JB.01632-06; Guarne A, 2005, EMBO J, V24, P1502, DOI 10.1038/sj.emboj.7600634; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Guzman EC, 2002, MOL MICROBIOL, V43, P487, DOI 10.1046/j.1365-2958.2002.02761.x; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Jacobson BA, 1998, MOL MICROBIOL, V28, P1307, DOI 10.1046/j.1365-2958.1998.00896.x; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Kim J, 2005, MOL MICROBIOL, V55, P1502, DOI 10.1111/j.1365-2958.2004.04486.x; MANWARING JD, 1979, J BACTERIOL, V138, P245, DOI 10.1128/JB.138.1.245-248.1979; MATHEWS CK, 1993, PROG NUCLEIC ACID RE, V44, P167, DOI 10.1016/S0079-6603(08)60220-2; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; MOORE EC, 1985, PHARMACOL THERAPEUT, V27, P167; Morigen, 2001, BBA-GENE STRUCT EXPR, V1521, P73; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Norris V, 2000, MOL MICROBIOL, V37, P696, DOI 10.1046/j.1365-2958.2000.02019.x; Norris V, 2007, MICROBIOL MOL BIOL R, V71, P230, DOI 10.1128/MMBR.00035-06; Odsbu I, 2005, GENES CELLS, V10, P1039, DOI 10.1111/j.1365-2443.2005.00898.x; Onogi T, 1999, MOL MICROBIOL, V31, P1775, DOI 10.1046/j.1365-2958.1999.01313.x; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; PAYNE SM, 1982, ANAL BIOCHEM, V123, P151, DOI 10.1016/0003-2697(82)90636-4; Rudolph CJ, 2008, DNA REPAIR, V7, P1589, DOI 10.1016/j.dnarep.2008.06.012; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Shen RK, 2004, J BIOL CHEM, V279, P32225, DOI 10.1074/jbc.M402750200; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Thellier M, 2006, FEBS J, V273, P4287, DOI 10.1111/j.1742-4658.2006.05425.x; Torheim NK, 2000, MOL MICROBIOL, V37, P629, DOI 10.1046/j.1365-2958.2000.02031.x; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999	50	38	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7617	10.1371/journal.pone.0007617	http://dx.doi.org/10.1371/journal.pone.0007617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19898675	Green Submitted, Green Published, gold			2022-12-27	WOS:000271194600011
J	Madinier, A; Bertrand, N; Mossiat, C; Prigent-Tessier, A; Beley, A; Marie, C; Garnier, P				Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Beley, Alain; Marie, Christine; Garnier, Philippe			Microglial Involvement in Neuroplastic Changes Following Focal Brain Ischemia in Rats	PLOS ONE			English	Article							IRON CHELATOR 2,2'-DIPYRIDYL; MARROW CHIMERIC MICE; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; CELL-DEATH; NEURODEGENERATIVE DISORDERS; RESIDENT MICROGLIA; INFLAMMATION	The pathogenesis of ischemic stroke is a complex sequence of events including inflammatory reaction, for which the microglia appears to be a major cellular contributor. However, whether post-ischemic activation of microglial cells has beneficial or detrimental effects remains to be elucidated, in particular on long term brain plasticity events. The objective of our study was to determine, through modulation of post-stroke inflammatory response, to what extent microglial cells are involved in some specific events of neuronal plasticity, neurite outgrowth and synaptogenesis. Since microglia is a source of neurotrophic factors, the identification of the brain-derived neurophic factor (BDNF) as possible molecular actor involved in these events was also attempted. As a means of down-regulating the microglial response induced by ischemia, 3-aminobenzamide (3-AB, 90 mg/kg, i.p.) was used to inhibit the poly(ADP-ribose) polymerase-1 (PARP-1). Indeed, PARP-1 contributes to the activation of the transcription factor NF-kB, which is essential to the upregulation of proinflammatory genes, in particular responsible for microglial activation/proliferation. Experiments were conducted in rats subjected to photothrombotic ischemia which leads to a strong and early microglial cells activation/proliferation followed by an infiltration of macrophages within the cortical lesion, events evaluated at serial time points up to 1 month post-ictus by immunostaining for OX-42 and ED-1. Our most striking finding was that the decrease in acute microglial activation induced by 3-AB was associated with a long term down-regulation of two neuronal plasticity proteins expression, synaptophysin (marker of synaptogenesis) and GAP-43 (marker of neuritogenesis) as well as to a significant decrease in tissue BDNF production. Thus, our data argue in favour of a supportive role for microglia in brain neuroplasticity stimulation possibly through BDNF production, suggesting that a targeted protection of microglial cells could represent an innovative approach to potentiate post-stroke neuroregeneration.	[Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Marie, Christine; Garnier, Philippe] Unite INSERM U887 Motricite Plastic, Dijon, France; [Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Beley, Alain; Marie, Christine; Garnier, Philippe] Univ Bourgogne, Dijon, France; [Bertrand, Nathalie; Beley, Alain; Garnier, Philippe] IUT, Dept Genie Biol, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Madinier, A (corresponding author), Unite INSERM U887 Motricite Plastic, Dijon, France.	pgarnier@u-bourgogne.fr		marie, christine/0000-0003-3724-0713; Garnier, Philippe/0000-0002-7877-3113; tessier, anne/0000-0001-6655-5074	Conseil Regional de Bourgogne, France	Conseil Regional de Bourgogne, France(Region Bourgogne-Franche-Comte)	This work was supported by grants from the Conseil Regional de Bourgogne, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor PE, 1999, J NEUROSCI, V19, P1708; Batchelor PE, 2008, BRAIN RES, V1209, P49, DOI 10.1016/j.brainres.2008.02.098; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CHAMAK B, 1995, NEUROSCIENCE, V69, P177, DOI 10.1016/0306-4522(95)00236-C; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Couturier JY, 2003, EXP NEUROL, V184, P973, DOI 10.1016/S0014-4886(03)00367-4; Demougeot C, 2004, J PHARMACOL EXP THER, V311, P1080, DOI 10.1124/jpet.104.072744; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Feuerstein GZ, 2001, ARCH NEUROL-CHICAGO, V58, P672, DOI 10.1001/archneur.58.4.672; GRIESBACH GS, 2009, BRAIN RES; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kim BJ, 2009, J NEUROL SCI, V279, P70, DOI 10.1016/j.jns.2008.12.025; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nakajima K, 2008, NEUROSCI LETT, V436, P331, DOI 10.1016/j.neulet.2008.03.058; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1999, NEUROREPORT, V10, P2017, DOI 10.1097/00001756-199907130-00005; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991, DOI 10.1097/00004647-199809000-00008; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3547, DOI 10.2174/138161208786848829; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Van Hoecke M, 2005, EUR J NEUROSCI, V22, P1045, DOI 10.1111/j.1460-9568.2005.04297.x; Van Hoecke M, 2007, MOL CELL NEUROSCI, V34, P40, DOI 10.1016/j.mcn.2006.09.009; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; WATERHOUSE EG, 2009, MOL CELL NEUROSCI; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1602/neurorx.2.1.120; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	76	106	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8101	10.1371/journal.pone.0008101	http://dx.doi.org/10.1371/journal.pone.0008101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956568	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700013
J	Thurber, GM; Figueiredo, JL; Weissleder, R				Thurber, Greg M.; Figueiredo, Jose L.; Weissleder, Ralph			Multicolor Fluorescent Intravital Live Microscopy (FILM) for Surgical Tumor Resection in a Mouse Xenograft Model	PLOS ONE			English	Article							IN-VIVO; CANCER XENOGRAFTS; MICROVESSEL AREA; BREAST-CANCER; ANTIBODY; GROWTH; IDENTIFICATION; PROBES; MICE; INFLAMMATION	Background: Complete surgical resection of neoplasia remains one of the most efficient tumor therapies. However, malignant cell clusters are often left behind during surgery due to the inability to visualize and differentiate them against host tissue. Here we establish the feasibility of multicolor fluorescent intravital live microscopy (FILM) where multiple cellular and/or unique tissue compartments are stained simultaneously and imaged in real time. Methodology/Principal Findings: Theoretical simulations of imaging probe localization were carried out for three agents with specificity for cancer cells, stromal host response, or vascular perfusion. This transport analysis gave insight into the probe pharmacokinetics and tissue distribution, facilitating the experimental design and allowing predictions to be made about the localization of the probes in other animal models and in the clinic. The imaging probes were administered systemically at optimal time points based on the simulations, and the multicolor FILM images obtained in vivo were then compared to conventional pathological sections. Our data show the feasibility of real time in vivo pathology at cellular resolution and molecular specificity with excellent agreement between intravital and traditional in vitro immunohistochemistry. Conclusions/Significance: Multicolor FILM is an accurate method for identifying malignant tissue and cells in vivo. The imaging probes distributed in a manner similar to predictions based on transport principles, and these models can be used to design future probes and experiments. FILM can provide critical real time feedback and should be a useful tool for more effective and complete cancer resection.	[Thurber, Greg M.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Thurber, GM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA.	rweissleder@mgh.harvard.edu		/0000-0003-0828-4143; Thurber, Greg/0000-0001-7570-2080	 [P50 CA86355];  [U24 CA092782];  [T32 CA079443]; NATIONAL CANCER INSTITUTE [U24CA092782, P50CA086355, T32CA079443] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants P50 CA86355, U24 CA092782, and T32 CA079443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bogdanov AA, 2002, NEOPLASIA, V4, P228, DOI 10.1038/sj.neo.7900238; Bremer C, 2002, RADIOLOGY, V222, P814, DOI 10.1148/radiol.2223010812; CLAUSS MA, 1990, CANCER RES, V50, P3487; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; DEBOER M, 2009, MICROMETASTASES ISOL, P653; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Elias DR, 2008, CANCER BIOMARK, V4, P287, DOI 10.3233/CBM-2008-4602; Fatouros M, 2005, EXPERT REV ANTICANC, V5, P737, DOI 10.1586/14737140.5.4.737; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Ishizawa T, 2009, CANCER-AM CANCER SOC, V115, P2491, DOI 10.1002/cncr.24291; JAKOWATZ JG, 1985, CANCER RES, V45, P5700; Ke S, 2003, CANCER RES, V63, P7870; Kelloff GJ, 2005, CLIN CANCER RES, V11, P7967, DOI 10.1158/1078-0432.CCR-05-1302; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Leimgruber A, 2009, NEOPLASIA, V11, P459, DOI 10.1593/neo.09356; LEWIS JJ, 1997, ASS LOCAL RECURRENCE, P646; Liu GZ, 2005, EUR J NUCL MED MOL I, V32, P1115, DOI 10.1007/s00259-005-1853-5; Mertz KD, 2007, HUM PATHOL, V38, P1454, DOI 10.1016/j.humpath.2007.05.017; NAHRENDORF M, 2009, HYBRID IN VIVO FMT C; Newman JR, 2008, CANCER BIOL THER, V7, P1063, DOI 10.4161/cbt.7.7.6109; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; NIMURA H, 2004, INFRARED RAY ELECT E, P575; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001; SHETH RA, 2009, GYNECOLOGIC ONCOLOGY; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Sullivan CAW, 2009, HUM PATHOL, V40, P156, DOI 10.1016/j.humpath.2008.07.005; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Thurber GM, 2008, CANCER RES, V68, P3334, DOI 10.1158/0008-5472.CAN-07-3018; Thurber GM, 2007, J NUCL MED, V48, P995, DOI 10.2967/jnumed.106.037069; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wasserberg N, 2008, J SURG ONCOL, V98, P611, DOI 10.1002/jso.21036; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zou P, 2009, MOL PHARMACEUT, V6, P428, DOI 10.1021/mp9000052; 2009, NATURE, V459, P629	46	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8053	10.1371/journal.pone.0008053	http://dx.doi.org/10.1371/journal.pone.0008053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956597	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400011
J	Wu, CY; Martel, J; Young, D; Young, JD				Wu, Cheng-Yeu; Martel, Jan; Young, David; Young, John D.			Fetuin-A/Albumin-Mineral Complexes Resembling Serum Calcium Granules and Putative Nanobacteria: Demonstration of a Dual Inhibition-Seeding Concept	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; ACID-CONTAINING PROTEIN; TAMM-HORSFALL PROTEIN; HYDROXYAPATITE FORMATION; IN-VITRO; BONE SIALOPROTEIN; RANDALLS PLAQUE; CALCIFYING NANOPARTICLES; PHOSPHATE PRECIPITATION; VASCULAR CALCIFICATION	Serum-derived granulations and purported nanobacteria (NB) are pleomorphic apatite structures shown to resemble calcium granules widely distributed in nature. They appear to be assembled through a dual inhibitory-seeding mechanism involving proteinaceous factors, as determined by protease (trypsin and chymotrypsin) and heat inactivation studies. When inoculated into cell culture medium, the purified proteins fetuin-A and albumin fail to induce mineralization, but they will readily combine with exogenously added calcium and phosphate, even in submillimolar amounts, to form complexes that will undergo morphological transitions from nanoparticles to spindles, films, and aggregates. As a mineralization inhibitor, fetuin-A is much more potent than albumin, and it will only seed particles at higher mineral-to-protein concentrations. Both proteins display a bell-shaped, dose-dependent relationship, indicative of the same dual inhibitory-seeding mechanism seen with whole serum. As ascertained by both seeding experiments and gel electrophoresis, fetuin-A is not only more dominant but it appears to compete avidly for nanoparticle binding at the expense of albumin. The nanoparticles formed in the presence of fetuin-A are smaller than their albumin counterparts, and they have a greater tendency to display a multilayered ring morphology. In comparison, the particles seeded by albumin appear mostly incomplete, with single walls. Chemically, spectroscopically, and morphologically, the protein-mineral particles resemble closely serum granules and NB. These particles are thus seen to undergo an amorphous to crystalline transformation, the kinetics and completeness of which depend on the protein-to-mineral ratios, with low ratios favoring faster conversion to crystals. Our results point to a dual inhibitory-seeding, de-repression model for the assembly of particles in supersaturated solutions like serum. The presence of proteins and other inhibitory factors tend to block apatite nuclei formation or to stabilize the nascent nuclei as amorphous or semi-crystalline spherical nanoparticles, until the same inhibitory influences are overwhelmed or derepressed, whereby the apatite nuclei grow in size to coalesce into crystalline spindles and films-a mechanism that may explain not only the formation of calcium granules in nature but also normal or ectopic calcification in the body.	[Wu, Cheng-Yeu; Martel, Jan; Young, David; Young, John D.] Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Gueishan, Taiwan; [Martel, Jan] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Gueishan, Taiwan; [Young, David] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Young, John D.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; [Young, John D.] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Massachusetts Institute of Technology (MIT); Rockefeller University; Ming Chi University of Technology	Wu, CY (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Chang Gung University [FMRPD2T02]; Mingchi University of Technology [0XB0]	Chang Gung University; Mingchi University of Technology	This study was supported by Primordia Institute of New Sciences and Medicine and by grants from Chang Gung University (FMRPD2T02) and from Mingchi University of Technology (0XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Addadi L, 2008, NATO SCI PEACE SEC B, P1, DOI 10.1007/978-1-4020-6823-2_1; Aho K, 2003, J CLIN MICROBIOL, V41, P3460, DOI 10.1128/JCM.41.7.3460-3461.2003; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230; Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272; Arvidsson A, 2009, J MATER SCI-MATER M, V20, P1869, DOI 10.1007/s10856-009-3755-8; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; BESARAB A, 1981, J CLIN PATHOL, V34, P1361, DOI 10.1136/jcp.34.12.1361; Beshensky AM, 2001, J AM SOC NEPHROL, V12, P2108, DOI 10.1681/ASN.V12102108; Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P57, DOI 10.1007/BF02557680; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; BOSKEY AL, 2008, METAL IONS LIFE SCI, V4, P457; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0; CHEN CC, 1985, CALCIFIED TISSUE INT, V37, P395, DOI 10.1007/BF02553709; CHEN CC, 1984, CALCIFIED TISSUE INT, V36, P285, DOI 10.1007/BF02405332; CHEN CC, 1986, CALCIFIED TISSUE INT, V39, P324, DOI 10.1007/BF02555199; Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j; Chen WC, 2001, MOL UROL, V5, P1, DOI 10.1089/109153601750124186; CHRISTOFFERSEN J, 1989, J CRYST GROWTH, V94, P767, DOI 10.1016/0022-0248(89)90102-4; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Combes C, 1999, J MATER SCI-MATER M, V10, P153, DOI 10.1023/A:1008933406806; Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X; CUERPO EG, 2000, ARCH ESP UROL, V53, P291; Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z; DOI Y, 1989, CALCIFIED TISSUE INT, V44, P200, DOI 10.1007/BF02556565; DOI Y, 1984, J DENT RES, V63, P98, DOI 10.1177/00220345840630021801; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; EANES ED, 1992, GLYCOBIOLOGY, V2, P571, DOI 10.1093/glycob/2.6.571; EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730; EANES ED, 1994, CALCIFIED TISSUE INT, V55, P176, DOI 10.1007/BF00425872; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2008, SEMIN NEPHROL, V28, P111, DOI 10.1016/j.semnephrol.2008.01.004; Evan AP, 2007, ANAT REC, V290, P1315, DOI 10.1002/ar.20580; Evan AP, 2005, UROL RES, V33, P383, DOI 10.1007/s00240-005-0488-0; Evan AP, 2005, KIDNEY INT, V68, P145, DOI 10.1111/j.1523-1755.2005.00388.x; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; EVAN AP, 2009, PEDIAT NEPH IN PRESS; Fang JY, 2008, EUR J PHARM BIOPHARM, V70, P633, DOI 10.1016/j.ejpb.2008.05.008; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; FUJISAWA R, 1987, CALCIFIED TISSUE INT, V41, P44, DOI 10.1007/BF02555130; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; GARNETT J, 1990, BIOCHEM J, V266, P863; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P21, DOI 10.1016/0162-0134(94)85129-8; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hunter GK, 1999, CALCIFIED TISSUE INT, V65, P226, DOI 10.1007/s002239900688; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; JAHNENDECHENT W, 2004, PROGR BIOL MOL BIOL, P243; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jones JA, 2008, CURR CLIN UROL, P221, DOI 10.1007/978-1-59745-472-8_17; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2005, NEPHROL DIAL TRANSPL, V20, P673, DOI 10.1093/ndt/gfh734; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Komaba H, 2009, KIDNEY INT, V75, P874, DOI 10.1038/ki.2009.52; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; LINDE A, 1989, CONNECT TISSUE RES, V21, P527; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0; Ma YH, 2009, BIOMATERIALS, V30, P3343, DOI 10.1016/j.biomaterials.2009.02.034; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Maniscalco Benedict S., 2004, Pathophysiology, V11, P95, DOI 10.1016/j.pathophys.2004.06.001; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; MANN S, 2001, BIOMINERALIZATION PR, P38; Marques PAAP, 2004, J MATER CHEM, V14, P1861, DOI 10.1039/b403495c; Marques PAAP, 2003, BIOMATERIALS, V24, P451, DOI 10.1016/S0142-9612(02)00358-7; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MARTIN RI, 1994, J MATER SCI-MATER M, V5, P96, DOI 10.1007/BF00121697; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MENANTEAU J, 1982, METAB BONE DIS RELAT, V4, P157, DOI 10.1016/0221-8747(82)90030-3; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; NANCOLLAS GH, 1990, J DENT RES, V69, P1678, DOI 10.1177/00220345900690101001; Nishio S, 2000, MOL UROL, V4, P383; NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583; Patard Louis, 2003, JOP, V4, P92; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Price PA, 2009, J BIOL CHEM, V284, P4594, DOI 10.1074/jbc.M803205200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; RAJ PA, 1992, J BIOL CHEM, V267, P5968; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Rees SG, 2004, BIOMATERIALS, V25, P971, DOI 10.1016/S0142-9612(03)00618-5; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.0.CO;2-6; ROMBERG RW, 1985, J BIOL CHEM, V260, P2728; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schoppet M, 2008, KIDNEY INT, V73, P384, DOI 10.1038/sj.ki.5002696; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8; Shaw WJ, 2000, J AM CHEM SOC, V122, P7118, DOI 10.1021/ja000878q; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Shoskes DA, 2005, J UROLOGY, V173, P474, DOI 10.1097/01.ju.0000150062.60633.b2; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Singh S, 2008, J COLLOID INTERF SCI, V319, P322, DOI 10.1016/j.jcis.2007.09.059; Smirnov GV, 2008, CONTEMP PROBL ECOL+, V1, P111, DOI 10.1134/S1995425508010128; Sommer AP, 2006, CHEMOTHERAPY, V52, P95, DOI 10.1159/000092475; Sommer AP, 2006, J ENVIRON MONITOR, V8, P341, DOI 10.1039/b512496d; Sommer AP, 2006, CRYST GROWTH DES, V6, P492, DOI 10.1021/cg050418e; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Strate T, 2003, INT J COLORECTAL DIS, V18, P97, DOI 10.1007/s00384-002-0432-5; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Sugars RV, 2003, CONNECT TISSUE RES, V44, P189, DOI 10.1080/713713596; Suvorova EI, 1999, J MICROSC-OXFORD, V196, P46, DOI 10.1046/j.1365-2818.1999.00608.x; Suvorova EI, 2001, CRYSTALLOGR REP+, V46, P722, DOI 10.1134/1.1405856; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Tsortos A, 1996, J COLLOID INTERF SCI, V177, P257, DOI 10.1006/jcis.1996.0029; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; VODYANOY V, 2007, P SOC PHOTO-OPT INST, V6694, P1; Waddington R. J., 2003, European Cells & Materials, V6, P12; Wainwright M, 2004, MICROBIOL-SGM, V150, P756, DOI 10.1099/mic.0.26907-0; Wainwright M, 2003, FEMS MICROBIOL LETT, V218, P161, DOI 10.1111/j.1574-6968.2003.tb11513.x; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen HB, 2003, J BIOMED MATER RES A, V64A, P483, DOI 10.1002/jbm.a.10401; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Westenfeld R, 2007, TRENDS CARDIOVAS MED, V17, P124, DOI 10.1016/j.tcm.2007.02.005; Wickramasinghe JT, 2006, ASTROPHYS SPACE SCI, V305, P411, DOI 10.1007/s10509-006-9181-1; WIKIEL K, 1994, ARCH ORAL BIOL, V39, P715, DOI 10.1016/0003-9969(94)90099-X; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	223	60	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8058	10.1371/journal.pone.0008058	http://dx.doi.org/10.1371/journal.pone.0008058			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956594	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828400013
J	Becerra, L; Harris, W; Grant, M; George, E; Boas, D; Borsook, D				Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Boas, David; Borsook, David			Diffuse Optical Tomography Activation in the Somatosensory Cortex: Specific Activation by Painful vs. Non-Painful Thermal Stimuli	PLOS ONE			English	Article							MEDIAN NERVE-STIMULATION; REPRESENTATION; FMRI	Background: Pain is difficult to assess due to the subjective nature of self-reporting. The lack of objective measures of pain has hampered the development of new treatments as well as the evaluation of current ones. Functional MRI studies of pain have begun to delineate potential brain response signatures that could be used as objective read-outs of pain. Using Diffuse Optical Tomography (DOT), we have shown in the past a distinct DOT signal over the somatosensory cortex to a noxious heat stimulus that could be distinguished from the signal elicited by innocuous mechanical stimuli. Here we further our findings by studying the response to thermal innocuous and noxious stimuli. Methodology/Principal Findings: Innocuous and noxious thermal stimuli were applied to the skin of the face of the first division (ophthalmic) of the trigeminal nerve in healthy volunteers (N = 6). Stimuli temperatures were adjusted for each subject to evoke warm (equivalent to a 3/10) and painful hot (7/10) sensations in a verbal rating scale (0/10 = no/max pain). A set of 26 stimuli (5 sec each) was applied for each temperature with inter-stimulus intervals varied between 8 and 15 sec using a Peltier thermode. A DOT system was used to capture cortical responses on both sides of the head over the primary somatosensory cortical region (S1). For the innocuous stimuli, group results indicated mainly activation on the contralateral side with a weak ipsilateral response. For the noxious stimuli, bilateral activation was observed with comparable amplitudes on both sides. Furthermore, noxious stimuli produced a temporal biphasic response while innocuous stimuli produced a monophasic response. Conclusions/Significance: These results are in accordance with fMRI and our other DOT studies of innocuous mechanical and noxious heat stimuli. The data indicate the differentiation of DOT cortical responses for pain vs. innocuous stimuli that may be useful in assessing objectively acute pain.	[Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Borsook, David] McLean Hosp, PAIN, Belmont, MA 02178 USA; [Boas, David] McLean Hosp, Photon Migrat Lab, Belmont, MA 02178 USA; [Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Boas, David; Borsook, David] Massachusetts Gen Hosp, Charlestown, MA USA; [Becerra, Lino; Harris, Will; Grant, Margaret; Boas, David] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Engn, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Becerra, L (corresponding author), McLean Hosp, PAIN, 115 Mill St, Belmont, MA 02178 USA.	lbecerra@partners.org			Mayday Foundation; NINDS [K24 NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	Mayday Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Mayday Foundation and a NINDS Mentor Training Grant to DB (K24 NS064050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Moulton EA, 2009, HUM BRAIN MAPP, V30, P757, DOI 10.1002/hbm.20541; NICHOLSON AN, 1978, BRIT J CLIN PHARMACO, V6, P3, DOI 10.1111/j.1365-2125.1978.tb01673.x; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Suzuki T, 2004, JPN J PHYSIOL, V54, P161, DOI 10.2170/jjphysiol.54.161	13	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8016	10.1371/journal.pone.0008016	http://dx.doi.org/10.1371/journal.pone.0008016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956637	gold, Green Published			2022-12-27	WOS:000272827500038
J	May, K; Grube, M; Malhotra, I; Long, CA; Singh, S; Mandaliya, K; Siegmund, W; Fusch, C; Schneider, H; King, CL				May, Karen; Grube, Markus; Malhotra, Indu; Long, Carole A.; Singh, Sanjay; Mandaliya, Kishor; Siegmund, Werner; Fusch, Christoph; Schneider, Henning; King, Christopher L.			Antibody-Dependent Transplacental Transfer of Malaria Blood-Stage Antigen Using a Human Ex Vivo Placental Perfusion Model	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; IMMUNE-COMPLEX; CORD-BLOOD; DIAPLACENTAL TRANSPORT; FC-RECEPTORS; IN-UTERO; IGG; TRANSMISSION; INFECTION	Prenatal exposure to allergens or antigens released by infections during pregnancy can stimulate an immune response or induce immunoregulatory networks in the fetus affecting susceptibility to infection and disease later in life. How antigen crosses from the maternal to fetal environment is poorly understood. One hypothesis is that transplacental antigen transfer occurs as immune complexes, via receptor-mediated transport across the syncytiotrophoblastic membrane and endothelium of vessels in fetal villi. This hypothesis has never been directly tested. Here we studied Plasmodium falciparum merozoite surface protein 1 (MSP1) that is released upon erythrocyte invasion. We found MSP1 in cord blood from a third of newborns of malaria-infected women and in >90% following treatment with acid dissociation demonstrating MSP1 immune complexes. Using an ex vivo human placental model that dually perfuses a placental cotyledon with independent maternal and fetal circuits, immune-complexed MSP1 transferred from maternal to fetal circulation. MSP1 alone or with non-immune plasma did not transfer; pre-incubation with human plasma containing anti-MSP1 was required. MSP1 bound to IgG was detected in the fetal perfusate. Laser scanning confocal microscopy demonstrated MSP1 in the fetal villous stroma, predominantly in fetal endothelial cells. MSP1 co-localized with IgG in endothelial cells, but not with placental macrophages. Thus we show, for the first time, antibody-dependent transplacental transfer of an antigen in the form of immune complexes. These studies imply frequent exposure of the fetus to certain antigens with implications for management of maternal infections during pregnancy and novel approaches to deliver vaccines or drugs to the fetus.	[May, Karen; Grube, Markus; Siegmund, Werner] Univ Greifswald, Dept Pharmacol, Greifswald, Germany; [Fusch, Christoph] Univ Greifswald, Dept Pediat, Greifswald, Germany; [Malhotra, Indu; King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Long, Carole A.; Singh, Sanjay] NIH, Malaria Vaccine Dev Unit, Bethesda, MD 20892 USA; [Long, Carole A.; Singh, Sanjay] NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; [Mandaliya, Kishor] Mombasa Gen Hosp, Kenyan Minist Hlth, Pathol Serv, Mombasa, Kenya; [Schneider, Henning] Univ Bern, Dept Obstet & Gynecol, CH-3000 Bern, Switzerland; [King, Christopher L.] Louis B Stokes Vet Affairs Med Ctr, Cleveland, OH USA	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Case Western Reserve University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; University of Bern; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	May, K (corresponding author), Univ Greifswald, Dept Pharmacol, Greifswald, Germany.	cxk21@case.edu			Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald; National Institutes of Health [AI064687]; Veterans Affairs Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, R01AI064687] Funding Source: NIH RePORTER	Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald, National Institutes of Health grant AI064687, and the Veterans Affairs Research Service. HS was Alfried Krupp Wissenschaftskolleg Fellow. The Department of Obstetrics and Gynecology, University of Greifswald provided the fresh placentas for the perfusion studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJORIA R, 1992, J PHARM PHARMACOL, V44, P952, DOI 10.1111/j.2042-7158.1992.tb07073.x; BAUMAN WA, 1981, P NATL ACAD SCI-BIOL, V78, P4588, DOI 10.1073/pnas.78.7.4588; Biswas Sukla, 1999, Indian Journal of Malariology, V36, P33; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; BUSE MG, 1962, J CLIN INVEST, V41, P29, DOI 10.1172/JCI104464; Casas R, 2004, CLIN EXP ALLERGY, V34, P591, DOI 10.1111/j.1365-2222.2004.1924.x; Casas R, 2001, PEDIATR ALLERGY IMMU, V12, P59, DOI 10.1034/j.1399-3038.2001.012002059.x; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Edelbauer M, 2003, INT ARCH ALLERGY IMM, V130, P25, DOI 10.1159/000068373; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Gabriel S, 2002, PARASITE IMMUNOL, V24, P521, DOI 10.1046/j.1365-3024.2002.00494.x; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; HOLT P, 2004, CHEM IMMUNOL ALLERGY, V84; Jakobsen PH, 1998, IMMUNOLOGY, V93, P264, DOI 10.1046/j.1365-2567.1998.00421.x; Kaneda T, 1997, J PEDIATR-US, V130, P730, DOI 10.1016/S0022-3476(97)80014-5; Kassberger F, 2002, PARASITOL RES, V88, P1073, DOI 10.1007/s00436-002-0715-3; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kristoffersen EK, 1996, EUR J IMMUNOL, V26, P1668, DOI 10.1002/eji.1830260741; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Leach JL, 1996, J IMMUNOL, V157, P3317; Leach L, 1997, MICROSC RES TECHNIQ, V38, P137; LEHNER PJ, 1988, T ROY SOC TROP MED H, V82, P822, DOI 10.1016/0035-9203(88)90006-5; Linnemann K, 2000, J CLIN ENDOCR METAB, V85, P4298, DOI 10.1210/jc.85.11.4298; Loibichler C., 2002, Clinical and Experimental Allergy, V32, P1546, DOI 10.1046/j.1365-2222.2002.01479.x; MAENO Y, 1993, AM J TROP MED HYG, V49, P574, DOI 10.4269/ajtmh.1993.49.574; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Malek A, 1998, AM J REPROD IMMUNOL, V40, P347; Malek A, 1997, AM J REPROD IMMUNOL, V38, P263; MALEK A, 1994, PFLUG ARCH EUR J PHY, V427, P157, DOI 10.1007/BF00585955; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2006, J INFECT DIS, V194, P176, DOI 10.1086/505150; MARSHALL DE, 1983, T ROY SOC TROP MED H, V77, P470, DOI 10.1016/0035-9203(83)90116-5; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENON RK, 1990, NEW ENGL J MED, V323, P309, DOI 10.1056/NEJM199008023230505; Metenou S, 2007, J IMMUNOL, V178, P2770, DOI 10.4049/jimmunol.178.5.2770; Mibei EK, 2008, PARASITE IMMUNOL, V30, P334, DOI 10.1111/j.1365-3024.2008.01030.x; Mibei EK, 2005, AM J TROP MED HYG, V72, P593, DOI 10.4269/ajtmh.2005.72.593; MILES SA, 1993, NEW ENGL J MED, V328, P297, DOI 10.1056/NEJM199302043280501; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P61, DOI 10.1111/j.1365-3024.2008.01076.x; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Redd SC, 1996, AM J TROP MED HYG, V55, P57, DOI 10.4269/ajtmh.1996.55.57; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Szepfalusi Z, 2000, PEDIATR RES, V48, P404, DOI 10.1203/00006450-200009000-00024; Takizawa T, 2005, J IMMUNOL, V175, P2331, DOI 10.4049/jimmunol.175.4.2331; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	61	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7986	10.1371/journal.pone.0007986	http://dx.doi.org/10.1371/journal.pone.0007986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956710	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500016
J	Bar, M; Sharfman, M; Schuster, S; Avni, A				Bar, Maya; Sharfman, Miya; Schuster, Silvia; Avni, Adi			The Coiled-Coil Domain of EHD2 Mediates Inhibition of LeEix2 Endocytosis and Signaling	PLOS ONE			English	Article							ETHYLENE-INDUCING XYLANASE; NICOTIANA-TABACUM; VESICLE TRAFFICKING; DYNAMIN RECRUITMENT; TRICHODERMA-VIRIDE; PROTEIN; ARABIDOPSIS; MEMBRANE; RECEPTOR; ACTIN	Endocytosis has been suggested to be crucial for the induction of plant immunity in several cases. We have previously shown that two Arabidopsis proteins, AtEHD1 and AtEHD2, are involved in endocytosis in plant systems. AtEHD2 has an inhibitory effect on endocytosis of transferrin, FM-4-64, and LeEix2. There are many works in mammalian systems detailing the importance of the various domains in EHDs but, to date, the domains of plant EHD2 that are required for its inhibitory activity on endocytosis remained unknown. In this work we demonstrate that the coiled-coil domain of EHD2 is crucial for the ability of EHD2 to inhibit endocytosis in plants, as mutant EHD2 forms lacking the coiled-coil lost the ability to inhibit endocytosis and signaling of LeEix2. The coiled-coil was also required for binding of EHD2 to the LeEix2 receptor. It is therefore probable that binding of EHD2 to the LeEix2 receptor is required for inhibition of LeEix2 internalization. We also show herein that the P-loop of EHD2 is important for EHD2 to function properly. The EH domain of AtEHD2 does not appear to be involved in inhibition of endocytosis. Moreover, AtEHD2 influences actin organization and may exert its inhibitory effect on endocytosis through actin re-distribution. The coiled-coil domain of EHD2 functions in inhibition of endocytosis, while the EH domain does not appear to be involved in inhibition of endocytosis.			Bar, M (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	Lpavni@post.tau.ac.il	Avni, Adi/R-9048-2017	Avni, Adi/0000-0003-2092-9768; Bar, Maya/0000-0002-7823-9121				Abu-Abied M, 2006, PLANT J, V48, P367, DOI 10.1111/j.1365-313X.2006.02883.x; Aniento F, 2005, PROTOPLASMA, V226, P3, DOI 10.1007/s00709-005-0101-y; AVNI A, 1994, PLANT PHYSIOL, V106, P1049, DOI 10.1104/pp.106.3.1049; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; BAILEY BA, 1992, PLANT PHYSIOL, V100, P1615, DOI 10.1104/pp.100.3.1615; Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2009, PLANT J, V59, P600, DOI 10.1111/j.1365-313X.2009.03897.x; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Carbone R, 1997, CANCER RES, V57, P5498; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; DEAN JFD, 1989, PHYTOPATHOLOGY, V79, P1071; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hanania U, 1997, PLANT J, V12, P113, DOI 10.1046/j.1365-313X.1997.12010113.x; Happel N, 2004, PLANT J, V37, P678, DOI 10.1111/j.1365-313X.2003.01995.x; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Samaj J, 2005, TRENDS CELL BIOL, V15, P425, DOI 10.1016/j.tcb.2005.06.006; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Silady RA, 2008, PLANT J, V53, P29, DOI 10.1111/j.1365-313X.2007.03314.x; SMITH CA, 2004, MOL BIOL CELL; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	56	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7973	10.1371/journal.pone.0007973	http://dx.doi.org/10.1371/journal.pone.0007973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936242	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600022
J	Kam, YW; Okumura, Y; Kido, H; Ng, LFP; Bruzzone, R; Altmeyer, R				Kam, Yiu-Wing; Okumura, Yuushi; Kido, Hiroshi; Ng, Lisa F. P.; Bruzzone, Roberto; Altmeyer, Ralf			Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-A VIRUSES; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYTIC CLEAVAGE; MURINE CORONAVIRUS; MEMBRANE-FUSION; DC-SIGN; CONFORMATIONAL-CHANGES; FUNCTIONAL RECEPTOR; TRIGGERS INFECTION	Background: Entry of enveloped viruses into host cells requires the activation of viral envelope glycoproteins through cleavage by either intracellular or extracellular proteases. In order to gain insight into the molecular basis of protease cleavage and its impact on the efficiency of viral entry, we investigated the susceptibility of a recombinant native full-length S-protein trimer (triSpike) of the severe acute respiratory syndrome coronavirus (SARS-CoV) to cleavage by various airway proteases. Methodology/Principal Findings: Purified triSpike proteins were readily cleaved in vitro by three different airway proteases: trypsin, plasmin and TMPRSS11a. High Performance Liquid Chromatography (HPLC) and amino acid sequencing analyses identified two arginine residues (R667 and R797) as potential protease cleavage site(s). The effect of protease-dependent enhancement of SARS-CoV infection was demonstrated with ACE2 expressing human bronchial epithelial cells 16HBE. Airway proteases regulate the infectivity of SARS-CoV in a fashion dependent on previous receptor binding. The role of arginine residues was further shown with mutant constructs (R667A, R797A or R797AR667A). Mutation of R667 or R797 did not affect the expression of S-protein but resulted in a differential efficacy of pseudotyping into SARS-CoVpp. The R667A SARS-CoVpp mutant exhibited a lack of virus entry enhancement following protease treatment. Conclusions/Significance: These results suggest that SARS S-protein is susceptible to airway protease cleavage and, furthermore, that protease mediated enhancement of virus entry depends on specific conformation of SARS S-protein upon ACE2 binding. These data have direct implications for the cell entry mechanism of SARS-CoV along the respiratory system and, furthermore expand the possibility of identifying potential therapeutic agents against SARS-CoV.			Kam, YW (corresponding author), Univ Hong Kong, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	bruzzone@hku.hk	Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009; Kam, Yiu/AAI-4148-2021	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Kam, Yiu/0000-0002-8360-9537; Ng, Lisa/0000-0003-4071-5222				Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chen Y, 2000, EUR J BIOCHEM, V267, P3189, DOI 10.1046/j.1432-1327.2000.01346.x; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; GAERTNER DJ, 1991, ARCH VIROL, V118, P57, DOI 10.1007/BF01311303; GARTEN W, 1980, J GEN VIROL, V50, P135, DOI 10.1099/0022-1317-50-1-135; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; GOMBOLD JL, 1993, J VIROL, V67, P4504, DOI 10.1128/JVI.67.8.4504-4512.1993; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Holmes KV, 2001, ADV EXP MED BIOL, V494, P173; Jackwood MW, 2001, AVIAN DIS, V45, P366, DOI 10.2307/1592976; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kido H, 2004, BIOL CHEM, V385, P1029, DOI 10.1515/BC.2004.133; Kido H, 1999, MOL CELLS, V9, P235; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Mossel EC, 2005, J VIROL, V79, P3846, DOI 10.1128/JVI.79.6.3846-3850.2005; Murakami M, 2001, EUR J BIOCHEM, V268, P2847, DOI 10.1046/j.1432-1327.2001.02166.x; Nagai Yoshiyuki, 1993, Trends in Microbiology, V1, P81, DOI 10.1016/0966-842X(93)90112-5; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; REDDEL RR, 1988, CANCER RES, V48, P1904; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sato M, 2003, BIOL CHEM, V384, P219, DOI 10.1515/BC.2003.024; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STORZ J, 1992, ARCH VIROL, V125, P193, DOI 10.1007/BF01309637; STORZ J, 1981, INFECT IMMUN, V31, P1214, DOI 10.1128/IAI.31.3.1214-1222.1981; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; TASHIRO M, 1983, ARCH VIROL, V77, P127, DOI 10.1007/BF01309262; Towatari T, 2002, EUR J BIOCHEM, V269, P2613, DOI 10.1046/j.1432-1033.2002.02937.x; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yamada YK, 1998, ADV EXP MED BIOL, V440, P89; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhu J, 1999, EUR RESPIR J, V13, P1318, DOI 10.1183/09031936.99.13613299	62	105	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7870	10.1371/journal.pone.0007870	http://dx.doi.org/10.1371/journal.pone.0007870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924243	gold, Green Published			2022-12-27	WOS:000271854200017
J	Ulvenes, LV; Aasland, O; Nylenna, M; Kristiansen, IS				Ulvenes, Lidziya Vanahel; Aasland, Olaf; Nylenna, Magne; Kristiansen, Ivar Sonbo			Norwegian Physicians' Knowledge of and Opinions about Evidence-Based Medicine: Cross-Sectional Study	PLOS ONE			English	Article							QUESTIONNAIRE SURVEY; EBM	Objective: To answer five research questions: Do Norwegian physicians know about the three important aspects of EBM? Do they use EBM methods in their clinical practice? What are their attitudes towards EBM? Has EBM in their opinion changed medical practice during the last 10 years? Do they use EBM based information sources? Design: Cross sectional survey in 2006. Setting: Norway. Participants: 966 doctors who responded to a questionnaire (70% response rate). Results: In total 87% of the physicians mentioned the use of randomised clinical trials as a key aspect of EBM, while 53% of them mentioned use of clinical expertise and only 19% patients' values. 40% of the respondents reported that their practice had always been evidence-based. Many respondents experienced difficulties in using EBM principles in their clinical practice because of lack of time and difficulties in searching EBM based literature. 80% agreed that EBM helps physicians towards better practice and 52% that it improves patients' health. As reasons for changes in medical practice 86% of respondents mentioned medical progress, but only 39% EBM. Conclusions: The results of the study indicate that Norwegian physicians have a limited knowledge of the key aspects of EBM but a positive attitude towards the concept. They had limited experience in the practice of EBM and were rather indifferent to the impact of EBM on medical practice. For solving a patient problem, physicians would rather consult a colleague than searching evidence based resources such as the Cochrane Library.			Ulvenes, LV (corresponding author), Norwegian Directorate Hlth, Oslo, Norway.	lidavanagel@gmail.com						Cochrane AL., 1972, EFFECTIVENESS EFFICI, P92; Dickenson D, 2002, HEALTH CARE ANAL, V10, P243, DOI 10.1023/A:1022995623172; ELSTEIN A, 2006, EVIDENCE BASED MED I, P1; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; Gerber A, 2007, J MED ETHICS, V33, P394, DOI 10.1136/jme.2006.017913; Green ML, 2005, ACAD MED, V80, P176, DOI 10.1097/00001888-200502000-00016; GREENHALGH T, 2001, READ PAPER; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hadley Julie A, 2007, BMC Med Educ, V7, P11, DOI 10.1186/1472-6920-7-11; Kitto S, 2007, ANZ J SURG, V77, P231, DOI 10.1111/j.1445-2197.2007.04022.x; Kotaska AR, 2004, BRIT MED J, V329, P1039, DOI 10.1136/bmj.329.7473.1039; Kristiansen I. S., 2006, EVIDENCE BASED MED I; Lambert H, 2006, SOC SCI MED, V62, P2633, DOI 10.1016/j.socscimed.2005.11.023; Lockwood DNJ, 2004, BRIT MED J, V329, P1020, DOI 10.1136/bmj.329.7473.1020; McAlister FA, 1999, J GEN INTERN MED, V14, P236, DOI 10.1046/j.1525-1497.1999.00323.x; *OECD, 2009, OECD HLTH DAT 2008 F; Oliveri RS, 2004, J EVAL CLIN PRACT, V10, P219, DOI 10.1111/j.1365-2753.2003.00477.x; Parker M, 2005, Med Humanit, V31, P23, DOI 10.1136/jmh.2004.000195; Parker Malcolm, 2002, Med Health Care Philos, V5, P273, DOI 10.1023/A:1021116516342; Reilly BM, 2004, BMJ-BRIT MED J, V329, P991, DOI 10.1136/bmj.329.7473.991; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scott I, 2000, AUST NZ J MED, V30, P319, DOI 10.1111/j.1445-5994.2000.tb00832.x; Sehon SR, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-14; Straus SE, 2000, CAN MED ASSOC J, V163, P837; TRACY SC, 2005, CAN FAM PHYSICIAN, V51, P1106; Veness Michael, 2003, Australas Radiol, V47, P409, DOI 10.1046/j.1440-1673.2003.01211.x	26	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7828	10.1371/journal.pone.0007828	http://dx.doi.org/10.1371/journal.pone.0007828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915708	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000271721900018
J	Wang, DB; Yang, RF; Zhang, ZP; Bi, LJ; You, XY; Wei, HP; Zhou, YF; Yu, ZN; Zhang, XE				Wang, Dian-Bing; Yang, Ruifu; Zhang, Zhi-Ping; Bi, Li-Jun; You, Xiang-Yu; Wei, Hong-Ping; Zhou, Ya-Feng; Yu, Ziniu; Zhang, Xian-En			Detection of B. anthracis Spores and Vegetative Cells with the Same Monoclonal Antibodies	PLOS ONE			English	Article							BACILLUS-CEREUS GROUP; GENETIC-RELATIONSHIPS; MASS-SPECTROMETRY; S-LAYER; PCR; SUBTILIS; THURINGIENSIS; COMPONENT; BACTERIA; SEQUENCE	Bacillus anthracis, the causative agent of anthrax disease, could be used as a biothreat reagent. It is vital to develop a rapid, convenient method to detect B. anthracis. In the current study, three high affinity and specificity monoclonal antibodies (mAbs, designated 8G3, 10C6 and 12F6) have been obtained using fully washed B. anthracis spores as an immunogen. These mAbs, confirmed to direct against EA1 protein, can recognize the surface of B. anthracis spores and intact vegetative cells with high affinity and species-specificity. EA1 has been well known as a major S-layer component of B. anthracis vegetative cells, and it also persistently exists in the spore preparations and bind tightly to the spore surfaces even after rigorous washing. Therefore, these mAbs can be used to build a new and rapid immunoassay for detection of both life forms of B. anthracis, either vegetative cells or spores.			Wang, DB (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	x.zhang@wh.iov.cn	Wang, Dian-Bing/AFQ-6894-2022; ZHANG, Xian-En/AAJ-5579-2021	Wang, Dian-Bing/0000-0001-6225-7010; 				ASH C, 1992, FEMS MICROBIOL LETT, V23, P73; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; BEYER W, 1995, MICROBIOL RES, V150, P179, DOI 10.1016/S0944-5013(11)80054-6; Castanha ER, 2006, J MICROBIOL METH, V67, P230, DOI 10.1016/j.mimet.2006.03.024; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; Dang JL, 2001, APPL ENVIRON MICROB, V67, P3665, DOI 10.1128/AEM.67.8.3665-3670.2001; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Elhanany E, 2001, RAPID COMMUN MASS SP, V15, P2110, DOI 10.1002/rcm.491; FRITZ DL, 1995, LAB INVEST, V73, P691; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; HENDERSON I, 1994, INT J SYST BACTERIOL, V44, P99, DOI 10.1099/00207713-44-1-99; HENRIQUES AO, 1995, J BACTERIOL, V177, P3394, DOI 10.1128/jb.177.12.3394-3406.1995; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kleine-Albers C, 1989, Zentralbl Veterinarmed B, V36, P226; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Lee MA, 1999, J APPL MICROBIOL, V87, P218, DOI 10.1046/j.1365-2672.1999.00908.x; Love TE, 2008, J IMMUNOL METHODS, V334, P1, DOI 10.1016/j.jim.2007.12.022; Mechaly A, 2008, APPL ENVIRON MICROB, V74, P818, DOI 10.1128/AEM.01244-07; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 1998, J BACTERIOL, V180, P52, DOI 10.1128/JB.180.1.52-58.1998; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; PEROSA F, 1990, J IMMUNOL METHODS, V128, P9, DOI 10.1016/0022-1759(90)90458-8; Qi YA, 2001, APPL ENVIRON MICROB, V67, P3720, DOI 10.1128/AEM.67.8.3720-3727.2001; SKOTTMAN T, 2007, EUR J CLIN MICROBIOL; SONENSHEIN AL, 1974, J BACTERIOL, V120, P253, DOI 10.1128/JB.120.1.253-265.1974; Swiecki MK, 2006, J IMMUNOL, V176, P6076, DOI 10.4049/jimmunol.176.10.6076; Wang SH, 2006, ANAL CHEM, V78, P997, DOI 10.1021/ac0512352; Williams DD, 2004, J BACTERIOL, V186, P566, DOI 10.1128/JB.186.2.566-569.2004; Williams DD, 2003, APPL ENVIRON MICROB, V69, P6288, DOI 10.1128/AEM.69.10.6288-6293.2003	34	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7810	10.1371/journal.pone.0007810	http://dx.doi.org/10.1371/journal.pone.0007810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915677	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721900004
J	Gallego-Ortega, D; de Molina, AR; Ramos, MA; Valdes-Mora, F; Barderas, MG; Sarmentero-Estrada, J; Lacal, JC				Gallego-Ortega, David; Ramirez de Molina, Ana; Angeles Ramos, Maria; Valdes-Mora, Fatima; Gonzalez Barderas, Maria; Sarmentero-Estrada, Jacinto; Carlos Lacal, Juan			Differential Role of Human Choline Kinase alpha and beta Enzymes in Lipid Metabolism: Implications in Cancer Onset and Treatment	PLOS ONE			English	Article							ETHANOLAMINE KINASE; BREAST-CANCER; RHO GTPASES; CHOLINE/ETHANOLAMINE KINASE; PHOSPHOLIPID-METABOLISM; MITOGENIC ACTIVITY; MOLECULAR-CLONING; RAT-KIDNEY; ACTIVATION; PURIFICATION	Background: The Kennedy pathway generates phosphocoline and phosphoethanolamine through its two branches. Choline Kinase (ChoK) is the first enzyme of the Kennedy branch of synthesis of phosphocholine, the major component of the plasma membrane. ChoK family of proteins is composed by ChoK alpha and ChoK beta isoforms, the first one with two different variants of splicing. Recently ChoK alpha has been implicated in the carcinogenic process, since it is over-expressed in a variety of human cancers. However, no evidence for a role of ChoK beta in carcinogenesis has been reported. Methodology/Principal Findings: Here we compare the in vitro and in vivo properties of ChoK alpha 1 and ChoK beta in lipid metabolism, and their potential role in carcinogenesis. Both ChoK alpha 1 and ChoK beta showed choline and ethanolamine kinase activities when assayed in cell extracts, though with different affinity for their substrates. However, they behave differentially when overexpressed in whole cells. Whereas ChoK beta display an ethanolamine kinase role, ChoK alpha 1 present a dual choline/ethanolamine kinase role, suggesting the involvement of each ChoK isoform in distinct biochemical pathways under in vivo conditions. In addition, while overexpression of ChoK alpha 1 is oncogenic when overexpressed in HEK293T or MDCK cells, ChoK beta overexpression is not sufficient to induce in vitro cell transformation nor in vivo tumor growth. Furthermore, a significant upregulation of ChoK alpha 1 mRNA levels in a panel of breast and lung cancer cell lines was found, but no changes in ChoK beta mRNA levels were observed. Finally, MN58b, a previously described potent inhibitor of ChoK with in vivo antitumoral activity, shows more than 20-fold higher efficiency towards ChoK alpha 1 than ChoK beta. Conclusion/Significance: This study represents the first evidence of the distinct metabolic role of ChoK alpha and ChoK beta isoforms, suggesting different physiological roles and implications in human carcinogenesis. These findings constitute a step forward in the design of an antitumoral strategy based on ChoK inhibition.	[Gallego-Ortega, David; Ramirez de Molina, Ana; Angeles Ramos, Maria; Valdes-Mora, Fatima; Sarmentero-Estrada, Jacinto; Carlos Lacal, Juan] CSIC UAM La Paz, Inst Invest Biomed, Translat Oncol Unit, Madrid, Spain; [Ramirez de Molina, Ana; Angeles Ramos, Maria; Sarmentero-Estrada, Jacinto; Carlos Lacal, Juan] Ctr Nacl Biotecnol, CD Pharma, Madrid, Spain; [Gonzalez Barderas, Maria] Hosp Nacl Paraplej, Dept Vasc Physiopathol, SESCAM, Toledo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Nacional de Paraplejicos	Gallego-Ortega, D (corresponding author), CSIC UAM La Paz, Inst Invest Biomed, Translat Oncol Unit, Madrid, Spain.	jclacal@cnb.csic.es	de Molina, Ana Ramirez/AAA-3848-2019; Mora, Fatima Valdes/AAB-9728-2021; Gallego-Ortega, David/AAK-9067-2020; Lacal, Juan Carlos/AAL-2235-2020; estrada, jacinto sarmentero/C-6777-2019; Lacal, Juan Carlos/N-9064-2015	Mora, Fatima Valdes/0000-0001-7490-0114; Gallego-Ortega, David/0000-0002-2347-7835; estrada, jacinto sarmentero/0000-0002-0118-4919; Barderas, Maria G./0000-0003-4290-4721; Lacal, Juan Carlos/0000-0002-1908-2777				Aboagye EO, 1999, CANCER RES, V59, P80; Al-Saffar NMS, 2006, CANCER RES, V66, P427, DOI 10.1158/0008-5472.CAN-05-1338; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1393, P179, DOI 10.1016/S0005-2760(98)00062-9; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Aznar S, 2001, PROG NUCLEIC ACID RE, V67, P193, DOI 10.1016/S0079-6603(01)67029-6; Banez-Coronel M, 2008, CURR CANCER DRUG TAR, V8, P709, DOI 10.2174/156800908786733432; Bell JD, 1998, NMR BIOMED, V11, P354, DOI 10.1002/(SICI)1099-1492(1998110)11:7<354::AID-NBM515>3.0.CO;2-N; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; CARNERO A, 1994, ONCOGENE, V9, P1387; CARNERO A, 1993, J CELL BIOCHEM, V52, P440, DOI 10.1002/jcb.240520408; Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; de Molina AR, 2004, CANCER LETT, V206, P137, DOI 10.1016/j.canlet.2003.08.031; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Gallego-Ortega D, 2006, INT J ONCOL, V29, P335; GIBELLINI F, 2008, BIOCH J; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2006, PHARMACOGENOMICS, V7, P1109, DOI 10.2217/14622416.7.7.1109; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; ISHIDATE K, 1985, BIOCHIM BIOPHYS ACTA, V836, P119; ISHIDATE K, 1984, J BIOL CHEM, V259, P4706; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Kurhanewicz J, 2000, NEOPLASIA, V2, P166, DOI 10.1038/sj.neo.7900081; Lacal J C, 2001, IDrugs, V4, P419; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; PORTER TJ, 1990, J BIOL CHEM, V265, P414; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; RAMIREZ DM, 2001, BIOCHEM BIOPH RES CO, V285, P873; Rodriguez-Gonzalez A, 2005, INT J ONCOL, V26, P999; Rodriguez-Gonzalez A, 2003, ONCOGENE, V22, P8803, DOI 10.1038/sj.onc.1207062; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Rodriguez-Gonzalez Agustin, 2003, Prog Cell Cycle Res, V5, P191; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Teichert F, 2008, PROSTATE, V68, P1035, DOI 10.1002/pros.20761; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; UCHIDA T, 1992, J BIOL CHEM, V267, P10156; UCHIDA T, 1990, BIOCHIM BIOPHYS ACTA, V1043, P281, DOI 10.1016/0005-2760(90)90028-V; WEINHOLD PA, 1974, BIOCHEMISTRY-US, V13, P5135, DOI 10.1021/bi00722a013; WU G, 2007, J BIOL CHEM; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	58	79	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7819	10.1371/journal.pone.0007819	http://dx.doi.org/10.1371/journal.pone.0007819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915674	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721400016
J	Kreijtz, JHCM; Suezer, Y; de Mutsert, G; van Amerongen, G; Schwantes, A; van den Brand, JMA; Fouchier, RAM; Lower, J; Osterhaus, ADME; Sutter, G; Rimmelzwaan, GF				Kreijtz, Joost H. C. M.; Suezer, Yasemin; de Mutsert, Gerrie; van Amerongen, Geert; Schwantes, Astrid; van den Brand, Judith M. A.; Fouchier, Ron A. M.; Loewer, Johannes; Osterhaus, Albert D. M. E.; Sutter, Gerd; Rimmelzwaan, Guus F.			MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization	PLOS ONE			English	Article							PANDEMIC INFLUENZA; A VIRUS; IMMUNE-RESPONSES; RANDOMIZED-TRIAL; ANKARA; INFECTION; VECTOR; STRAIN; SAFETY; MACAQUES	Human infections with highly pathogenic avian influenza viruses of the H5N1 subtype, frequently reported since 2003, result in high morbidity and mortality. It is feared that these viruses become pandemic, therefore the development of safe and effective vaccines is desirable. MVA-based H5N1 vaccines already proved to be effective when two immunizations with high doses were used. Dose-sparing strategies would increase the number of people that can be vaccinated when the amount of vaccine preparations that can be produced is limited. Furthermore, protective immunity is induced ideally after a single immunization. Therefore the minimal requirements for induction of protective immunity with a MVA-based H5N1 vaccine were assessed in mice. To this end, mice were vaccinated once or twice with descending doses of a recombinant MVA expressing the HA gene of influenza virus A/Vietnam/1194/04. The protective efficacy was determined after challenge infection with the homologous clade 1 virus and a heterologous virus derived from clade 2.1, A/Indonesia/5/05 by assessing weight loss, virus replication and histopathological changes. It was concluded that MVA-based vaccines allowed significant dose-sparing and afford cross-clade protection, also after a single immunization, which are favorable properties for an H5N1 vaccine candidate.			Kreijtz, JHCM (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	g.rimmelzwaan@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Sutter, Gerd/0000-0001-6143-082X				Belyakov IM, 1999, P NATL ACAD SCI USA, V96, P4512, DOI 10.1073/pnas.96.8.4512; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Cosma A, 2003, VACCINE, V22, P21, DOI 10.1016/S0264-410X(03)00538-3; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; FRANK AL, 1980, J CLIN MICROBIOL, V12, P426, DOI 10.1128/JCM.12.3.426-432.1980; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Govorkova E A, 1999, Dev Biol Stand, V98, P39; Govorkova EA, 1999, DEV BIOL STAND, V8, P73; Harrop R, 2006, CLIN CANCER RES, V12, P3416, DOI 10.1158/1078-0432.CCR-05-2732; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V97, P73, DOI 10.1002/bit.21139; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kodihalli S, 1999, J VIROL, V73, P2094, DOI 10.1128/JVI.73.3.2094-2098.1999; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Mayr A, 1978, Dev Biol Stand, V41, P225; Nerome K, 1999, Dev Biol Stand, V98, P53; Nerome K, 1999, DEV BIOL STAND, V98, P73; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; Palese P, 2006, EMERG INFECT DIS, V12, P61, DOI 10.3201/eid1201.051043; PALMER D, 1975, HAEMAGGLUTINATION IN, P25; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2009, EXPERT REV VACCINES, V8, P447, DOI 10.1586/ERV.09.4; Ruat C, 2008, J VIROL, V82, P2565, DOI 10.1128/JVI.01928-07; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; *WHO, 2009, NEW INFL A HIN1 NUMB; *WHO, 2009, 211 WHO; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003	42	39	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7790	10.1371/journal.pone.0007790	http://dx.doi.org/10.1371/journal.pone.0007790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915662	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721400002
J	Katayama, K; Zine, A; Ota, M; Matsumoto, Y; Inoue, T; Fritzsch, B; Aruga, J				Katayama, Kei-ichi; Zine, Azel; Ota, Maya; Matsumoto, Yoshifumi; Inoue, Takashi; Fritzsch, Bernd; Aruga, Jun			Disorganized Innervation and Neuronal Loss in the Inner Ear of Slitrk6-Deficient Mice	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SENSORY EPITHELIA; AXON GUIDANCE; AUDITORY DEVELOPMENT; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; CELL FATE; EXPRESSION; ROLES; SURVIVAL	Slitrks are type I transmembrane proteins that share conserved leucine-rich repeat domains similar to those in the secreted axonal guidance molecule Slit. They also show similarities to Ntrk neurotrophin receptors in their carboxy-termini, sharing a conserved tyrosine residue. Among 6 Slitrk family genes in mammals, Slitrk6 has a unique expression pattern, with strong expression in the sensory epithelia of the inner ear. We generated Slitrk6-knockout mice and investigated the development of their auditory and vestibular sensory organs. Slitrk6-deficient mice showed pronounced reduction in the cochlear innervation. In the vestibule, the innervation to the posterior crista was often lost, reduced, or sometimes misguided. These defects were accompanied by the loss of neurons in the spiral and vestibular ganglia. Cochlear sensory epithelia from Slitrk6-knockout mice have reduced ability in promoting neurite outgrowth of spiral ganglion neurons. Indeed the Slitrk6-deficient inner ear showed a mild but significant decrease in the expression of Bdnf and Ntf3, both of which are essential for the innervation and survival of sensory neurons. In addition, the expression of Ntrk receptors, including their phosphorylated forms was decreased in Slitrk6-knockout cochlea. These results suggest that Slitrk6 promotes innervation and survival of inner ear sensory neurons by regulating the expression of trophic and/or tropic factors including neurotrophins from sensory epithelia.			Katayama, K (corresponding author), RIKEN, Brain Sci Inst, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp	Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644; Fritzsch, Bernd/0000-0002-4882-8398	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005590, R01 DC005590-07] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; BIANCHI LM, 1993, DEV BIOL, V159, P353, DOI 10.1006/dbio.1993.1247; BIANCHI LM, 2005, JARO-J ASSOC RES OTO, V16, P355; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; COLE KS, 1992, BRAIN RES, V575, P223; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fekete DM, 1996, CURR OPIN NEUROBIOL, V6, P533, DOI 10.1016/S0959-4388(96)80061-4; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 1998, INT J DEV NEUROSCI, V16, P493, DOI 10.1016/S0736-5748(98)00043-4; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Fritzsch B, 1997, SEMIN CELL DEV BIOL, V8, P277, DOI 10.1006/scdb.1997.0144; Giraldez F, 2007, INT J DEV BIOL, V51, P429, DOI 10.1387/ijdb.072390fg; Hossain WA, 2008, J NEUROSCI RES, V86, P2376, DOI 10.1002/jnr.21685; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; KATAYAMA K, 2009, MOL PSYCHIA IN PRESS; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kim WY, 2001, DEVELOPMENT, V128, P417; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Marzella PL, 1999, HEARING RES, V138, P73, DOI 10.1016/S0378-5955(99)00152-5; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Pirvola U, 2003, CURR TOP DEV BIOL, V57, P207, DOI 10.1016/S0070-2153(03)57007-7; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SCHECTERSON LC, 1994, HEARING RES, V73, P92, DOI 10.1016/0378-5955(94)90286-0; SCHIMMANG T, 1995, DEVELOPMENT, V121, P3381; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stankovic KM, 2003, HEARING RES, V185, P97, DOI 10.1016/S0378-5955(03)00298-3; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Webber A, 2006, ANAT REC PART A, V288A, P390, DOI 10.1002/ar.a.20299	44	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A151	A162	e7786	10.1371/journal.pone.0007786	http://dx.doi.org/10.1371/journal.pone.0007786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936227	gold, Green Published			2022-12-27	WOS:000271685800017
J	Zhang, EY; Chen, AY; Zhu, BT				Zhang, Elizabeth Yan; Chen, Aaron Yun; Zhu, Bao Ting			Mechanism of Dinitrochlorobenzene-Induced Dermatitis in Mice: Role of Specific Antibodies in Pathogenesis	PLOS ONE			English	Article							CONTACT HYPERSENSITIVITY; T-CELLS; ATOPIC-DERMATITIS; IN-VITRO; ELICITATION; SUPPRESSION; RESPONSES; CD4(+); SENSITIZATION; LYMPHOCYTES	Background: Dinitrochlorobenzene-induced contact hypersensitivity is widely considered as a cell-mediated rather than antibody-mediated immune response. At present, very little is known about the role of antigen-specific antibodies and B cells in the development of dinitrochlorobenzene-induced hypersensitivity reactions, and this is the subject of the present investigation. Methodology/Principal Findings: Data obtained from multiple lines of experiments unequivocally showed that the formation of dinitrochlorobenzene-specific Abs played an important role in the development of dinitrochlorobenzene-induced contact hypersensitivity. The appearance of dinitrochlorobenzene-induced skin dermatitis matched in timing the appearance of the circulating dinitrochlorobenzene-specific antibodies. Adoptive transfer of sera containing dinitrochlorobenzene-specific antibodies from dinitrochlorobenzene-treated mice elicited a much stronger hypersensitivity reaction than the adoptive transfer of lymphocytes from the same donors. Moreover, dinitrochlorobenzene-induced contact hypersensitivity was strongly suppressed in B cell-deficient mice with no DNCB-specific antibodies. It was also observed that treatment of animals with dinitrochlorobenzene polarized Th cells into Th2 differentiation by increasing the production of Th2 cytokines while decreasing the production of Th1 cytokines. Conclusions/Significance: In striking contrast to the long-held belief that dinitrochlorobenzene-induced contact hypersensitivity is a cell-mediated immune response, the results of our present study demonstrated that the production of dinitrochlorobenzene-specific antibodies by activated B cells played an indispensible role in the pathogenesis of dinitrochlorobenzene-induced CHS. These findings may provide new possibilities in the treatment of human contact hypersensitivity conditions.			Zhang, EY (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Sch Med, Kansas City, KS 66103 USA.	BTZhu@kumc.edu			NATIONAL CANCER INSTITUTE [R01CA097109, R01CA092391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NCI NIH HHS [CA92391, R01 CA092391, CA97109, R01 CA097109] Funding Source: Medline; NCRR NIH HHS [P20 RR021940, P20RR021940] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; Campos RA, 2006, IMMUNOLOGY, V117, P536, DOI 10.1111/j.1365-2567.2006.02330.x; CARAPETO FJ, 1976, ARCH DERMATOL, V112, P1095, DOI 10.1001/archderm.112.8.1095; COHEN S, 1971, J EXP MED, V133, P133, DOI 10.1084/jem.133.1.133; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; GARRIGUE JL, 1994, CONTACT DERMATITIS, V30, P231, DOI 10.1111/j.1600-0536.1994.tb00650.x; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Larsen JM, 2007, CONTACT DERMATITIS, V57, P300, DOI 10.1111/j.1600-0536.2007.01230.x; LEUNG DYM, 1995, J ALLERGY CLIN IMMUN, V96, P302, DOI 10.1016/S0091-6749(95)70049-8; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Nagai H, 1999, J PHARMACOL EXP THER, V288, P43; Nagai J, 1998, J PHARMACOL EXP THER, V285, P422; Nakazawa M, 1997, J ALLERGY CLIN IMMUN, V99, P673, DOI 10.1016/S0091-6749(97)70030-7; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Perone MJ, 2009, J IMMUNOL, V182, P2641, DOI 10.4049/jimmunol.0800839; SHAALA AY, 1980, BRIT J DERMATOL, V103, P159, DOI 10.1111/j.1365-2133.1980.tb06585.x; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; THOMSON JA, 1993, IMMUNOLOGY, V78, P185; Traidl C, 1999, J INVEST DERMATOL, V112, P476, DOI 10.1046/j.1523-1747.1999.00550.x; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Wang BH, 2001, J LEUKOCYTE BIOL, V70, P185; Wang LF, 1999, CLIN EXP ALLERGY, V29, P271; Warbrick EV, 2002, J APPL TOXICOL, V22, P1, DOI 10.1002/jat.830; Watanabe H, 2002, J INTERF CYTOK RES, V22, P407, DOI 10.1089/10799900252952181; Watanabe R, 2007, AM J PATHOL, V171, P560, DOI 10.2353/ajpath.2007.061279; Weigmann B, 1997, SCAND J IMMUNOL, V45, P308, DOI 10.1046/j.1365-3083.1997.d01-402.x; Xu H, 1997, J IMMUNOL, V158, P4721; Yamada N, 1995, J ALLERGY CLIN IMMUN, V96, P1069, DOI 10.1016/S0091-6749(95)70192-3; Yokozeki H, 2000, J EXP MED, V191, P995, DOI 10.1084/jem.191.6.995	34	47	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7703	10.1371/journal.pone.0007703	http://dx.doi.org/10.1371/journal.pone.0007703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890385	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700007
J	Araya-Ajoy, YM; Chaves-Campos, J; Kalko, EKV; DeWoody, JA				Araya-Ajoy, Yi-men; Chaves-Campos, Johel; Kalko, Elisabeth K. V.; DeWoody, J. Andrew			High-Pitched Notes during Vocal Contests Signal Genetic Diversity in Ocellated Antbirds	PLOS ONE			English	Article							GENOME-WIDE HETEROZYGOSITY; BIRD SONG; SEXUAL SELECTION; MALE QUALITY; MATE CHOICE; BODY-SIZE; PERFORMANCE; EVOLUTION; FREQUENCY; HYPOTHESES	Animals use honest signals to assess the quality of competitors during aggressive interactions. Current theory predicts that honest signals should be costly to produce and thus reveal some aspects of the phenotypic or genetic quality of the sender. In songbirds, research indicates that biomechanical constraints make the production of some acoustic features costly. Furthermore, recent studies have found that vocal features are related to genetic diversity. We linked these two lines of research by evaluating if constrained acoustic features reveal male genetic diversity during aggressive interactions in ocellated antbirds (Phaenostictus mcleannani). We recorded the aggressive vocalizations of radiotagged males at La Selva Biological Station in Costa Rica, and found significant variation in the highest frequency produced among individuals. Moreover, we detected a negative relationship between the frequency of the highest pitched note and vocalization duration, suggesting that high pitched notes might constrain the duration of vocalizations through biomechanical and/or energetic limitations. When we experimentally exposed wild radiotagged males to simulated acoustic challenges, the birds increased the pitch of their vocalization. We also found that individuals with higher genetic diversity (as measured by zygosity across 9 microsatellite loci) produced notes of higher pitch during aggressive interactions. Overall, our results suggest that the ability to produce high pitched notes is an honest indicator of male genetic diversity in male-male aggressive interactions.	[Araya-Ajoy, Yi-men] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Chaves-Campos, Johel; DeWoody, J. Andrew] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [DeWoody, J. Andrew] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Universidad Costa Rica; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Araya-Ajoy, YM (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	jchaves@purdue.edu	Chaves-Campos, Johel/AAF-9147-2020; DeWoody, James Andrew/C-4909-2008	Chaves-Campos, Johel/0000-0001-8026-7626; DeWoody, James Andrew/0000-0002-7315-5631	U. S. National Science Foundation [DDIG 0608231, DEB 0514815]; Organization for Tropical Studies; American Ornithologists' Union; Cooper Ornithological Society; Sigma Xi Society; Deutscher Akademischer Austausch Dienst; Cornell Laboratory of Ornithology; Neotropical Ornithological Society; Direct For Biological Sciences [0851933] Funding Source: National Science Foundation	U. S. National Science Foundation(National Science Foundation (NSF)); Organization for Tropical Studies; American Ornithologists' Union; Cooper Ornithological Society; Sigma Xi Society; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Cornell Laboratory of Ornithology; Neotropical Ornithological Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was partially funded by the U. S. National Science Foundation (DDIG 0608231 to J.C-C and DEB 0514815 to J.A.D.), the Organization for Tropical Studies (to Y.A-A and J.C-C.), the American Ornithologists' Union, Cooper Ornithological Society, and Sigma Xi Society (to J.C-C.), the Deutscher Akademischer Austausch Dienst (DAAD; ISAP program), Cornell Laboratory of Ornithology (Raven License Award) and the Neotropical Ornithological Society (to Y. A-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. US National Science Foundation http://www.nsf.gov/Organization for Tropical Studies http://www.ots.ac.cr/American Ornithologists' Union http://www.aou.org/Cooper Ornithological Society http://www.cooper.org/Sigma Xi Society http://www.sigmaxi.org/Idea Wild http://www.ideawild.org/Deutscher Akademischer Austausch Dienst http://www.daad.de/en/index.html Cornell Laboratory of Ornithology http://www.birds.cornell.edu/Neotropical Ornithological Society http://www.ibiologia.unam.mx/links/neo/neo.html	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Cardoso GC, 2007, BEHAV ECOL, V18, P1051, DOI 10.1093/beheco/arm078; Charpentier MJE, 2008, BEHAV GENET, V38, P151, DOI 10.1007/s10519-008-9191-6; Chaves-Campos J, 2008, MOL ECOL, V17, P2963, DOI 10.1111/j.1365-294X.2008.03811.x; Chaves-Campos J, 2009, P ROY SOC B-BIOL SCI, V276, P3995, DOI 10.1098/rspb.2009.0730; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; DeWoody YD, 2005, J HERED, V96, P85, DOI 10.1093/jhered/esi017; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; FLEISCHER RC, 1983, NATURE, V304, P628, DOI 10.1038/304628a0; Fromhage L, 2009, EVOLUTION, V63, P684, DOI 10.1111/j.1558-5646.2008.00575.x; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hood GM, 2006, POPTOOLS VERSION 2 7; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Janicke T, 2008, ANIM BEHAV, V75, P91, DOI 10.1016/j.anbehav.2007.04.007; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; KROODSMA DE, 1990, ANIM BEHAV, V40, P1138, DOI 10.1016/S0003-3472(05)80180-0; KROODSMA DE, 1984, AUK, V101, P13, DOI 10.1093/auk/101.1.13; Lambrechts Marcel M., 1996, P305; LEONARD ML, 1995, ANIM BEHAV, V49, P1283, DOI 10.1006/anbe.1995.0160; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Marshall RC, 2003, P ROY SOC B-BIOL SCI, V270, pS248, DOI 10.1098/rsbl.2003.0081; MITTON JB, 1997, SELECTION NATURAL PO; MOLLER AP, 1991, ANIM BEHAV, V41, P723, DOI 10.1016/S0003-3472(05)80909-1; Ortego J, 2007, MOL ECOL, V16, P2383, DOI 10.1111/j.1365-294X.2007.03322.x; Pfaff JA, 2007, P ROY SOC B-BIOL SCI, V274, P2035, DOI 10.1098/rspb.2007.0170; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 2004, NATURES MUSIC SCI BI; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; R Core Team, 2020, R LANG ENV STAT COMP; Raposo Marcos A., 2003, Lundiana, V4, P35; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Seddon N, 2005, EVOLUTION, V59, P200; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Suthers Roderick A., 2004, P272, DOI 10.1016/B978-012473070-0/50012-8; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; WAGNER WE, 1992, ANIM BEHAV, V44, P449, DOI 10.1016/0003-3472(92)90055-E; WALLSCHLAGER D, 1980, EXPERIENTIA, V36, P412, DOI 10.1007/BF01975119; Willis E.O., 1973, Smithsonian Contributions to Zoology, VNo. 144, P1; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	62	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8137	10.1371/journal.pone.0008137	http://dx.doi.org/10.1371/journal.pone.0008137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956580	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828800028
J	Chhikara, M; Wang, SB; Kern, SJ; Ferreyra, GA; Barb, JJ; Munson, PJ; Danner, RL				Chhikara, Maneesha; Wang, Shuibang; Kern, Steven J.; Ferreyra, Gabriela A.; Barb, Jennifer J.; Munson, Peter J.; Danner, Robert L.			Carbon Monoxide Blocks Lipopolysaccharide-Induced Gene Expression by Interfering with Proximal TLR4 to NF-kappa B Signal Transduction in Human Monocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED LUNG INJURY; THERAPEUTIC APPLICATIONS; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; INDUCED ACTIVATION; ENDOTHELIAL-CELLS; HEME OXYGENASE; MAPK PATHWAY; PPAR-GAMMA	Carbon monoxide (CO) is an endogenous messenger that suppresses inflammation, modulates apoptosis and promotes vascular remodeling. Here, microarrays were employed to globally characterize the CO (250 ppm) suppression of early (1 h) LPS-induced inflammation in human monocytic THP-1 cells. CO suppressed 79 of 101 immediate-early genes induced by LPS; 19% (15/79) were transcription factors and most others were cytokines, chemokines and immune response genes. The prototypic effects of CO on transcription and protein production occurred early but decreased rapidly. CO activated p38 MAPK, ERK1/2 and Akt and caused an early and transitory delay in LPS-induced JNK activation. However, selective inhibitors of these kinases failed to block CO suppression of LPS-induced IL-1 beta, an inflammation marker. Of CO-suppressed genes, 81% (64/79) were found to have promoters with putative NF-kappa B binding sites. CO was subsequently shown to block LPS-induced phosphorylation and degradation of IkB alpha in human monocytes, thereby inhibiting NF-kappa B signal transduction. CO broadly suppresses the initial inflammatory response of human monocytes to LPS by reshaping proximal events in TLR4 signal transduction such as stress kinase responses and early NF-kappa B activation. These rapid, but transient effects of CO may have therapeutic applications in acute pulmonary and vascular injury.	[Chhikara, Maneesha; Wang, Shuibang; Kern, Steven J.; Ferreyra, Gabriela A.; Danner, Robert L.] NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA; [Barb, Jennifer J.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chhikara, M (corresponding author), NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA.	rdanner@cc.nih.gov		Barb, Jennifer/0000-0003-3022-0154	National Institutes of Health Clinical Center; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000188, ZIACL001164, ZIACL001158] Funding Source: NIH RePORTER	National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CLINICAL CENTER	This study was supported by intramural funds from the National Institutes of Health Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Conde de la Rosa L, 2008, FREE RADICAL BIO MED, V44, P1323, DOI 10.1016/j.freeradbiomed.2007.12.011; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hoetzel A, 2007, ANTIOXID REDOX SIGN, V9, P2013, DOI 10.1089/ars.2007.1762; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kaizu T, 2005, SURGERY, V138, P229, DOI 10.1016/j.surg.2005.06.015; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Kohmotoa J, 2007, AM J TRANSPLANT, V7, P2279, DOI 10.1111/j.1600-6143.2007.01940.x; Masini E, 2008, FASEB J, V22, P3380, DOI 10.1096/fj.08-107110; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Morse D, 2002, ANTIOXID REDOX SIGN, V4, P331, DOI 10.1089/152308602753666389; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nakao A, 2006, J CELL MOL MED, V10, P650, DOI 10.1111/j.1582-4934.2006.tb00426.x; Ning W, 2005, AM J PHYSIOL-LUNG C, V289, pL268, DOI 10.1152/ajplung.00168.2004; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2006, CURR OPIN PHARMACOL, V6, P257, DOI 10.1016/j.coph.2006.03.002; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Sarady JK, 2002, AM J RESP CELL MOL, V27, P739, DOI 10.1165/rcmb.4816; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Suh GY, 2006, AM J RESP CELL MOL, V35, P220, DOI 10.1165/rcmb.2005-0154OC; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Zhang JH, 2007, J BIOL CHEM, V282, P1003, DOI 10.1074/jbc.M607609200; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	49	50	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8139	10.1371/journal.pone.0008139	http://dx.doi.org/10.1371/journal.pone.0008139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956541	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800029
J	Ii, H; Yokoyama, N; Yoshida, S; Tsutsumi, K; Hatakeyama, S; Sato, T; Ishihara, K; Akiba, S				Ii, Hiromi; Yokoyama, Naoki; Yoshida, Shintaro; Tsutsumi, Kae; Hatakeyama, Shinji; Sato, Takashi; Ishihara, Keiichi; Akiba, Satoshi			Alleviation of High-Fat Diet-Induced Fatty Liver Damage in Group IVA Phospholipase A(2)-Knockout Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; PROSTAGLANDIN D-2; BODY-WEIGHT; IN-VIVO; LEPTIN; ADIPONECTIN; ADIPOCYTES	Hepatic fat deposition with hepatocellular damage, a feature of non-alcoholic fatty liver disease, is mediated by several putative factors including prostaglandins. In the present study, we examined whether group IVA phospholipase A(2) (IVA-PLA(2)), which catalyzes the first step in prostanoid biosynthesis, is involved in the development of fatty liver, using IVA-PLA(2)-knockout mice. Male wild-type mice on high-fat diets (20% fat and 1.25% cholesterol) developed hepatocellular vacuolation and liver hypertrophy with an increase in the serum levels of liver damage marker aminotransferases when compared with wild-type mice fed normal diets. These high-fat diet-induced alterations were markedly decreased in IVA-PLA(2)-knockout mice. Hepatic triacylglycerol content was lower in IVA-PLA(2)-knockout mice than in wild-type mice under normal dietary conditions. Although high-fat diets increased hepatic triacylglycerol content in both genotypes, the degree was lower in IVA-PLA(2)-knockout mice than in wild-type mice. Under the high-fat dietary conditions, IVA-PLA(2)-knockout mice had lower epididymal fat pad weight and smaller adipocytes than wild-type mice. The serum level of prostaglandin E-2, which has a fat storage effect, was lower in IVA-PLA(2)-knockout mice than in wild-type mice, irrespective of the kind of diet. In both genotypes, high-fat diets increased serum leptin levels equally between the two groups, but did not affect the serum levels of adiponectin, resistin, free fatty acid, triacylglycerol, glucose, or insulin. Our findings suggest that a deficiency of IVA-PLA(2) alleviates fatty liver damage caused by high-fat diets, probably because of the lower generation of IVA-PLA(2) metabolites, such as prostaglandin E-2. IVA-PLA(2) could be a promising therapeutic target for obesity-related diseases including nonalcoholic fatty liver disease.	[Ii, Hiromi; Yokoyama, Naoki; Yoshida, Shintaro; Sato, Takashi; Ishihara, Keiichi; Akiba, Satoshi] Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashina Ku, Kyoto 607, Japan; [Tsutsumi, Kae; Hatakeyama, Shinji] Novartis Inst BioMed Res, Tsukuba, Ibaraki, Japan	Kyoto Pharmaceutical University; Novartis	Ii, H (corresponding author), Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashina Ku, Kyoto 607, Japan.	akiba@mb.kyoto-phu.ac.jp	Ishihara, Keiichi/M-5743-2019; Hatakeyama, Shinji/I-8873-2019	Hatakeyama, Shinji/0000-0002-0166-2773	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Research Foundation (Japan)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Research Foundation (Japan)	This work was supported by a Grant-in-Aid for Scientific Research from, and by the Open Research Program of, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Takeda Research Foundation ( Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100; Fain JN, 2000, J LIPID RES, V41, P1689; Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ii H, 2008, PROSTAG OTH LIPID M, V86, P12, DOI 10.1016/j.prostaglandins.2007.12.002; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P1081, DOI 10.1210/jc.2005-1056; Peeraully MR, 2006, PFLUG ARCH EUR J PHY, V453, P177, DOI 10.1007/s00424-006-0118-x; PEREZ S, 2006, BIOCHIM BIOPHYS ACTA, V176, P160; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38	32	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8089	10.1371/journal.pone.0008089	http://dx.doi.org/10.1371/journal.pone.0008089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956652	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828700007
J	Norgate, M; Chamings, J; Pavlova, A; Bull, JK; Murray, ND; Sunnucks, P				Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Murray, Neil D.; Sunnucks, Paul			Mitochondrial DNA Indicates Late Pleistocene Divergence of Populations of Heteronympha merope, an Emerging Model in Environmental Change Biology	PLOS ONE			English	Article							CLIMATE-CHANGE; MOLECULAR PHYLOGENY; RANGE EXPANSION; LEPIDOPTERA; MUTATION; BUTTERFLIES; EVOLUTION; PHYLOGEOGRAPHY; BIOGEOGRAPHY; SEQUENCES	Knowledge of historical changes in species range distribution provides context for investigating adaptive potential and dispersal ability. This is valuable for predicting the potential impact of environmental change on species of interest. Butterflies are one of the most important taxa for studying such impacts, and Heteronympha merope has the potential to provide a particularly valuable model, in part due to the existence of historical data on morphological traits and glycolytic enzyme variation. This study investigates the population genetic structure and phylogeography of H. merope, comparing the relative resolution achieved through partial DNA sequences of two mitochondrial loci, COI and ND5. These data are used to define the relationship between subspecies, showing that the subspecies are reciprocally monophyletic. On this basis, the Western Australian subspecies H. m. duboulayi is genetically distinct from the two eastern subspecies. Throughout the eastern part of the range, levels of migration and the timing of key population splits of potential relevance to climatic adaptation are estimated and indicate Late Pleistocene divergence both of the Tasmanian subspecies and of an isolated northern population from the eastern mainland subspecies H. m. merope. This information is then used to revisit historical data and provides support for the importance of clinal variation in wing characters, as well as evidence for selective pressure acting on allozyme loci phosphoglucose isomerase and phosphoglucomutase in H. merope. The study has thus confirmed the value of H. merope as a model organism for measuring responses to environmental change, offering the opportunity to focus on isolated populations, as well as a latitudinal gradient, and to use historical changes to test the accuracy of predictions for the future.	[Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Australian Ctr Biodivers, Clayton, Vic, Australia; [Murray, Neil D.] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia	Monash University; Monash University; La Trobe University	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	paul.sunnucks@sci.monash.edu.au	Pavlova, Alexandra/H-4749-2014	Pavlova, Alexandra/0000-0001-9455-4124; Sunnucks, Paul/0000-0002-8139-7059; Bull, James/0000-0002-0274-4359	Australian Research Council [DP0772837]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council grant DP0772837 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albre J, 2008, MOL PHYLOGENET EVOL, V47, P196, DOI 10.1016/j.ympev.2008.01.009; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Braby MF, 2000, BUTTERFLIES AUSTR TH; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Broughton RE, 2006, MOL BIOL EVOL, V23, P1516, DOI 10.1093/molbev/msl013; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2004, MOL ECOL, V13, P3329, DOI 10.1111/j.1365-294X.2004.02340.x; GU HN, 1991, BIOCHEM GENET, V29, P345, DOI 10.1007/BF00554142; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Karl I, 2008, FUNCT ECOL, V22, P887, DOI 10.1111/j.1365-2435.2008.01438.x; Kato Y, 2004, SYST ENTOMOL, V29, P1, DOI 10.1111/j.1365-3113.2004.00238.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Li W. H, 1997, MOL EVOLUTION; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitikka V, 2008, BIODIVERS CONSERV, V17, P623, DOI 10.1007/s10531-007-9287-y; Morin X, 2008, BIOL LETTERS, V4, P573, DOI 10.1098/rsbl.2008.0181; Narita S, 2007, GENETICA, V131, P241, DOI 10.1007/s10709-006-9134-1; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Nei M, 2000, MOL EVOLUTION PHYLOG; Ounap E, 2009, AUST J ENTOMOL, V48, P113, DOI 10.1111/j.1440-6055.2009.00695.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PEARSE FK, 1982, EVOLUTION, V36, P1251, DOI 10.1111/j.1558-5646.1982.tb05494.x; PEARSE FK, 1981, AUST J ZOOL, V29, P631; PEARSE FK, 1978, GEOGRAPHIC VARIATION; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Schneider S, 1999, GENETICS, V152, P1079; Scriber JM, 2002, ECOGRAPHY, V25, P184, DOI 10.1034/j.1600-0587.2002.250206.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas I, 1996, J BIOGEOGR, V23, P717, DOI 10.1111/j.1365-2699.1996.tb00032.x; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ward PI, 2004, MOL ECOL, V13, P3213, DOI 10.1111/j.1365-294X.2004.02293.x; Watt WB, 1996, MOL BIOL EVOL, V13, P699, DOI 10.1093/oxfordjournals.molbev.a025631; Yagi T, 2001, GENES GENET SYST, V76, P229, DOI 10.1266/ggs.76.229; Yagi T, 1999, J MOL EVOL, V48, P42, DOI 10.1007/PL00006443	63	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7950	10.1371/journal.pone.0007950	http://dx.doi.org/10.1371/journal.pone.0007950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956696	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500002
J	Calado, RT; Regal, JA; Kleiner, DE; Schrump, DS; Peterson, NR; Pons, V; Chanock, SJ; Lansdorp, PM; Young, NS				Calado, Rodrigo T.; Regal, Joshua A.; Kleiner, David E.; Schrump, David S.; Peterson, Nathan R.; Pons, Veronica; Chanock, Stephen J.; Lansdorp, Peter M.; Young, Neal S.			A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; NODULAR REGENERATIVE HYPERPLASIA; DOMINANT DYSKERATOSIS-CONGENITA; APLASTIC-ANEMIA; REVERSE-TRANSCRIPTASE; CANCER; GENE; RNA; VARIANTS; 5P15.33	Background: Telomerase is an enzyme specialized in maintaining telomere lengths in highly proliferative cells. Loss-of-function mutations cause critical telomere shortening and are associated with the bone marrow failure syndromes dyskeratosis congenita and aplastic anemia and with idiopathic pulmonary fibrosis. Here, we sought to determine the spectrum of clinical manifestations associated with telomerase loss-of-function mutations. Methodology/Principal Findings: Sixty-nine individuals from five unrelated families with a variety of hematologic, hepatic, and autoimmune disorders were screened for telomerase complex gene mutations; leukocyte telomere length was measured by flow fluorescence in situ hybridization in mutation carriers and some non-carriers; the effects of the identified mutations on telomerase activity were determined; and genetic and clinical data were correlated. In six generations of a large family, a loss-of-function mutation in the telomerase enzyme gene TERT associated with severe telomere shortening and a range of hematologic manifestations, from macrocytosis to acute myeloid leukemia, with severe liver diseases marked by fibrosis and inflammation, and one case of idiopathic pulmonary fibrosis but not with autoimmune disorders. Additionally, we identified four unrelated families in which loss-of-function TERC or TERT gene mutations tracked with marrow failure, pulmonary fibrosis, and a spectrum of liver disorders. Conclusions/Significance: These results indicate that heterozygous telomerase loss-of-function mutations associate with but are not determinant of a large spectrum of hematologic and liver abnormalities, with the latter sometimes occurring in the absence of marrow failure. Our findings, along with the link between pulmonary fibrosis and telomerase mutations, also suggest a common pathogenic mechanism for fibrotic diseases in which defective telomere repair plays important role.			Calado, RT (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.	calador@nhlbi.nih.gov	Kleiner, David E/N-2770-2013; Calado, Rodrigo T./G-2619-2011	Kleiner, David E/0000-0003-3442-4453; Calado, Rodrigo T./0000-0002-7966-6029	NATIONAL CANCER INSTITUTE [ZICBC010687] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [MOP38075, GMH79042] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; ALTER BP, 1994, APLASTIC ANEMIA ACQU, P325; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Gonzalez-Huezo Maria S, 2006, Ann Hepatol, V5, P166; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hosgood HD, 2009, LUNG CANC; Kaufman DW, 1991, DRUG ETIOLOGY AGRANU; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Qazilbash MH, 1997, ACTA HAEMATOL-BASEL, V97, P164; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Talbot-Smith A, 2009, THORAX, V64, P440, DOI 10.1136/thx.2008.099796; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	36	159	162	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7926	10.1371/journal.pone.0007926	http://dx.doi.org/10.1371/journal.pone.0007926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936245	gold, Green Submitted, Green Published			2022-12-27	WOS:000272004800008
J	Mas, E; Danjoux, M; Garcia, V; Carpentier, S; Segui, B; Levade, T				Mas, Emmanuel; Danjoux, Marie; Garcia, Virginie; Carpentier, Stephane; Segui, Bruno; Levade, Thierry			IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; NF-KAPPA-B; FACTOR-ALPHA; TNF-ALPHA; HEPATOCYTE APOPTOSIS; HEPATIC STEATOSIS; ALCOHOLIC STEATOHEPATITIS; INTERLEUKIN-6 DOES/DOES; GLUCOSE-HOMEOSTASIS	Background: The role of inflammation in the pathogenesis of non-alcoholic steatohepatitis (NASH), a common cause of liver disease, is still poorly understood. This study aimed at assessing the involvement of a major inflammatory cytokine, IL-6, in NASH. Materials and Methods: Steatohepatitis was induced by feeding wild-type or IL-6(-/-) mice for 5 weeks with a methionine and choline-deficient (MCD) diet. Results: Whereas MCD diet-induced weight loss and decreases in serum glucose, cholesterol and triglyceride levels were similar in both genotypes, serum alanine aminotransferase was less elevated in IL-6(-/-) mice than in wild-type animals. Despite having a comparable liver steatosis score, IL-6-deficient mice exhibited less lobular inflammation than their wildtype littermates. Liver gene expression of TGF-beta and MCP-1 was also strongly attenuated in mutant mice; a more modest reduction was observed for PPAR-gamma and F4/80 transcripts as well as proteins. Chromatographic analysis of liver lipids demonstrated that MCD diet induced in normal and mutant mice a similar decrease in the ratio of phosphatidylcholine to phosphatidylethanolamine. However, the diet-induced increase in the levels of sphingomyelin and ceramide was less important in IL-6(-/-) mice. Conclusion: Altogether, these results indicate that IL-6 deficiency does not block the development of NASH; yet, IL-6 plays a critical role in the accompanying liver inflammation.			Mas, E (corresponding author), Fac Med Toulouse, INSERM, U858, Toulouse, France.	thierry.levade@inserm.fr	Mas, Emmanuel/ABF-6249-2020; GARCIA, Virginie/W-8313-2019; Ségui, Bruno/O-8957-2014; Levade, Thierry/O-8948-2014	Mas, Emmanuel/0000-0001-5425-7352; GARCIA, Virginie/0000-0002-9761-7036; Ségui, Bruno/0000-0002-6119-1889; 				Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Bahcecioglu IH, 2005, HEPATO-GASTROENTEROL, V52, P1549; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; Deutschman CS, 2006, CRIT CARE MED, V34, P2613, DOI 10.1097/01.CCM.0000240229.98275.07; Diehl AM, 2005, HEPATOL RES, V33, P138, DOI 10.1016/j.hepres.2005.09.022; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fernandez-Checa JC, 2005, ALCOHOL CLIN EXP RES, V29, p151S, DOI 10.1097/01.alc.0000189285.04059.b3; FOLCH J, 1957, J BIOL CHEM, V226, P497; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gyamfi MA, 2008, BIOCHEM PHARMACOL, V75, P981, DOI 10.1016/j.bcp.2007.09.030; Haque M, 2002, BEST PRACT RES CL GA, V16, P709, DOI 10.1053/bega.2002.0325; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; HILL DB, 1992, J LAB CLIN MED, V119, P547; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kirsch R, 2006, J GASTROEN HEPATOL, V21, P174, DOI 10.1111/j.1440-1746.2005.04220.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larter CZ, 2006, J HEPATOL, V44, P253, DOI 10.1016/j.jhep.2005.11.030; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malagarie-Cazenave S, 2004, J BIOL CHEM, V279, P18648, DOI 10.1074/jbc.M314294200; MALAGARIECAZENA.S, 2002, EXPERT REV MOL MED, P1; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; McGettrick HM, 2009, EUR J IMMUNOL, V39, P113, DOI 10.1002/eji.200838232; Memon RA, 2001, NAT MED, V7, P2, DOI 10.1038/83316; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2007, CURR OPIN CLIN NUTR, V10, P265, DOI 10.1097/MCO.0b013e3280ebb5b3; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9	60	61	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7929	10.1371/journal.pone.0007929	http://dx.doi.org/10.1371/journal.pone.0007929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936233	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004800010
J	Pogozelski, AR; Geng, TY; Li, P; Yin, XH; Lira, VA; Zhang, M; Chi, JT; Yan, Z				Pogozelski, Andrew R.; Geng, Tuoyu; Li, Ping; Yin, Xinhe; Lira, Vitor A.; Zhang, Mei; Chi, Jen-Tsan; Yan, Zhen			p38 gamma Mitogen-Activated Protein Kinase Is a Key Regulator in Skeletal Muscle Metabolic Adaptation in Mice	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; PGC-1-ALPHA TRANSCRIPTION; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; CYTOCHROME-C; EXERCISE; CALCINEURIN; ANGIOGENESIS; SPECIFICITY; INTENSITY	Regular endurance exercise induces skeletal muscle contractile and metabolic adaptations, conferring salutary health benefits, such as protection against the metabolic syndrome. The plasticity of skeletal muscle has been extensively investigated, but how the adaptive processes are precisely controlled is largely unknown. Using muscle-specific gene deletion in mice, we now show that p38 gamma mitogen-activated protein kinase (MAPK), but not p38 alpha and p38 beta, is required for endurance exercise-induced mitochondrial biogenesis and angiogenesis, whereas none of the p38 isoforms are required for IIb-to-IIa fiber-type transformation. These phenotypic findings were further supported by microarray and real-time PCR analyses revealing contractile activity-dependent p38 gamma target genes, including peroxisome proliferator-activated receptor gamma co-activator-1 alpha (Pgc-1 alpha) and vascular endothelial growth factor (Vegf), in skeletal muscle following motor nerve stimulation. Gene transfer-mediated overexpression of a dominant negative form of p38 gamma, but not that of p38 alpha or p38 beta, blocked motor nerve stimulation-induced Pgc-1 alpha transcription. These findings provide direct evidence for an obligated role of p38 gamma MAPK-PGC-1 alpha regulatory axis in endurance exercise-induced metabolic adaptation, but not contractile adaptation, in skeletal muscle.			Pogozelski, AR (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	zhen.yan@virginia.edu	Lira, Vitor/AAN-3403-2021; Chi, Jen-Tsan/AAI-4125-2020; Lira, Vitor/B-1709-2013	Lira, Vitor/0000-0002-3162-3804; Chi, Jen-Tsan/0000-0003-3433-903X; Lira, Vitor/0000-0002-3162-3804; Li, Ping/0000-0002-4549-9517; Yan, Zhen/0000-0002-4826-9813	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [AR050429, R01 AR050429] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; AKIMOTO T, 2008, AM J PHYSL CELL PHYS; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; Boppart MD, 2000, J PHYSIOL-LONDON, V526, P663, DOI 10.1111/j.1469-7793.2000.00663.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gute Dean, 1994, Microcirculation (New York), V1, P183, DOI 10.3109/10739689409148273; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HICKSON RC, 1981, J APPL PHYSIOL, V51, P746, DOI 10.1152/jappl.1981.51.3.746; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Kjaer M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yu M, 2001, J PHYSIOL-LONDON, V536, P273, DOI 10.1111/j.1469-7793.2001.00273.x	47	105	108	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7934	10.1371/journal.pone.0007934	http://dx.doi.org/10.1371/journal.pone.0007934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936205	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004800015
J	Marengo, EB; Commodaro, AG; Peron, JPS; de Moraes, LV; Portaro, FCV; Belfort, R; Rizzo, LV; Sant'Anna, OA				Marengo, Eliana B.; Commodaro, Alessandra Goncalves; Peron, Jean Pierre S.; de Moraes, Luciana V.; Portaro, Fernanda C. V.; Belfort, Rubens, Jr.; Rizzo, Luiz Vicente; Sant'Anna, Osvaldo Augusto			Administration of Mycobacterium leprae rHsp65 Aggravates Experimental Autoimmune Uveitis in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; B-CELL EPITOPES; BEHCETS-DISEASE; T-CELLS; GENETIC SUSCEPTIBILITY; IMMUNE-RESPONSES; STRESS PROTEINS; PEPTIDE 336-351; ORAL TOLERANCE; UVEORETINITIS	The 60kDa heat shock protein family, Hsp60, constitutes an abundant and highly conserved class of molecules that are highly expressed in chronic-inflammatory and autoimmune processes. Experimental autoimmune uveitis [EAU] is a T cell mediated intraocular inflammatory disease that resembles human uveitis. Mycobacterial and homologous Hsp60 peptides induces uveitis in rats, however their participation in aggravating the disease is poorly known. We here evaluate the effects of the Mycobacterium leprae Hsp65 in the development/progression of EAU and the autoimmune response against the eye through the induction of the endogenous disequilibrium by enhancing the entropy of the immunobiological system with the addition of homologous Hsp. B10. RIII mice were immunized subcutaneously with interphotoreceptor retinoid-binding protein [IRBP], followed by intraperitoneally inoculation of M. leprae recombinant Hsp65 [rHsp65]. We evaluated the proliferative response, cytokine production and the percentage of CD4(+)IL-17(+), CD4(+)IFN-gamma(+) and CD4(+)Foxp3(+) cells ex vivo, by flow cytometry. Disease severity was determined by eye histological examination and serum levels of anti-IRBP and anti-Hsp60/65 measured by ELISA. EAU scores increased in the Hsp65 group and were associated with an expansion of CD4(+)IFN-gamma(+) and CD4(+)IL-17(+) T cells, corroborating with higher levels of IFN-gamma. Our data indicate that rHsp65 is one of the managers with a significant impact over the immune response during autoimmunity, skewing it to a pathogenic state, promoting both Th1 and Th17 commitment. It seems comprehensible that the specificity and primary function of Hsp60 molecules can be considered as a potential pathogenic factor acting as a whistleblower announcing chronic-inflammatory diseases progression.			Marengo, EB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	gbrazil@usp.br	Rizzo, Luiz Vicente/B-4458-2009; Portaro, Fernanda/I-6644-2015; Belfort, Rubens/E-2252-2012; de Moraes, Luciana/M-1619-2013; Portaro, F/B-8397-2012; Peron, Jean Pierre S/F-9248-2012	Belfort, Rubens/0000-0002-8422-3898; de Moraes, Luciana/0000-0001-6605-5547; Commodaro, Alessandra/0000-0002-7816-6508				Atherton E., 1990, SOLID PHASE PEPTIDE; Biozzi G, 1979, Curr Top Microbiol Immunol, V85, P31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cancino-Diaz JC, 2004, BRIT J OPHTHALMOL, V88, P247, DOI 10.1136/bjo.2003.023390; CASPI RR, 1988, J IMMUNOL, V140, P1490; Caspi RR, 1996, J IMMUNOL, V157, P2668; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; Direskeneli H, 1996, SCAND J IMMUNOL, V43, P464, DOI 10.1046/j.1365-3083.1996.d01-53.x; DUDANI AK, 1989, INFECT IMMUN, V57, P2786, DOI 10.1128/IAI.57.9.2786-2793.1989; George J, 2001, J AM COLL CARDIOL, V38, P900, DOI 10.1016/S0735-1097(01)01440-1; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hu W, 1998, EUR J IMMUNOL, V28, P2444, DOI 10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N; Huhtinen M, 2001, INVEST OPHTH VIS SCI, V42, P1816; IBANEZ OM, 1992, EUR J IMMUNOL, V22, P2555, DOI 10.1002/eji.1830221014; Kaneko S, 1997, CLIN EXP IMMUNOL, V108, P204, DOI 10.1046/j.1365-2249.1997.3611265.x; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Lehner T, 1997, Int Rev Immunol, V14, P21, DOI 10.3109/08830189709116842; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Marengo EB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003025; MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P1; MOR F, 1992, J CLIN INVEST, V90, P2447, DOI 10.1172/JCI116136; Moudgil KD, 2008, TRENDS IMMUNOL, V29, P412, DOI 10.1016/j.it.2008.06.003; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; PERVIN K, 1993, J IMMUNOL, V151, P2273; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prigogine I, 2003, ANN NY ACAD SCI, V988, P128, DOI 10.1111/j.1749-6632.2003.tb06091.x; PRIGOGINE I, 1978, SCIENCE, V201, P777, DOI 10.1126/science.201.4358.777; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2004, BIOMED PHARMACOTHER, V58, P276, DOI 10.1016/j.biopha.2004.04.011; Quintana FJ, 2004, J AUTOIMMUN, V22, P297, DOI 10.1016/j.jaut.2004.03.003; Quintana FJ, 2001, J AUTOIMMUN, V17, P191, DOI 10.1006/jaut.2001.0544; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Rizzo LV, 1999, J IMMUNOL, V162, P2613; Rizzo LV, 1996, J IMMUNOL, V156, P1654; Rossmann A, 2008, EXP GERONTOL, V43, P229, DOI 10.1016/j.exger.2007.11.009; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; Stanford M, 2004, CLIN EXP IMMUNOL, V137, P201, DOI 10.1111/j.1365-2249.2004.02520.x; STANFORD MR, 1994, CLIN EXP IMMUNOL, V97, P226; Sun B, 1997, J IMMUNOL, V159, P1004; Tanaka T, 1999, OCUL IMMUNOL INFLAMM, V7, P69, DOI 10.1076/ocii.7.2.69.4018; THOLE JER, 1988, MICROB PATHOGENESIS, V4, P71, DOI 10.1016/0882-4010(88)90049-6; Uchio E, 1998, EXP EYE RES, V67, P719, DOI 10.1006/exer.1998.0574; Van Eden W, 2007, ANN NY ACAD SCI, V1113, P217, DOI 10.1196/annals.1391.020; Weitgasser R, 2003, EXP CLIN ENDOCR DIAB, V111, P127, DOI 10.1055/s-2003-39784; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P520, DOI 10.1001/archopht.1997.01100150522013; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	62	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7912	10.1371/journal.pone.0007912	http://dx.doi.org/10.1371/journal.pone.0007912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936251	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004600016
J	Serazin, AC; Dana, AN; Hillenmeyer, ME; Lobo, NF; Coulibaly, MB; Willard, MB; Harker, BW; Sharakhov, IV; Collins, FH; Ribeiro, JMC; Besansky, NJ				Serazin, Andrew C.; Dana, Ali N.; Hillenmeyer, Maureen E.; Lobo, Neil F.; Coulibaly, Mamadou B.; Willard, Michael B.; Harker, Brent W.; Sharakhov, Igor V.; Collins, Frank H.; Ribeiro, Jose M. C.; Besansky, Nora J.			Comparative Analysis of the Global Transcriptome of Anopheles funestus from Mali, West Africa	PLOS ONE			English	Article							SALIVARY-GLAND TRANSCRIPTOME; MALARIA VECTOR; PROTEIN FAMILIES; EVOLUTION; DATABASE; GENE; MOSQUITO; TOOL; DNA; GENERATION	Background: Anopheles funestus is a principal vector of malaria across much of tropical Africa and is considered one of the most efficient of its kind, yet studies of this species have lagged behind those of its broadly sympatric congener, An. gambiae. In aid of future genomic sequencing of An. funestus, we explored the whole body transcriptome, derived from mixed stage progeny of wild-caught females from Mali, West Africa. Principal Findings: Here we report the functional annotation and comparative genomics of 2,005 expressed sequence tags (ESTs) from An. funestus, which were assembled with a previous EST set from adult female salivary glands from the same mosquito. The assembled ESTs provided for a nonredundant catalog of 1,035 transcripts excluding mitochondrial sequences. Conclusions/Significance: Comparison of the An. funestus and An. gambiae transcriptomes using computational and macroarray approaches revealed a high degree of sequence identity despite an estimated 20-80 MY divergence time between lineages. A phylogenetically broader comparative genomic analysis indicated that the most rapidly evolving proteins- those involved in immunity, hematophagy, formation of extracellular structures, and hypothetical conserved proteins- are those that probably play important roles in how mosquitoes adapt to their nutritional and external environments, and therefore could be of greatest interest in disease control.			Serazin, AC (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	jribeiro@niaid.nih.gov; nbesansk@nd.edu	Sharakhov, Igor/B-1972-2008; Coulibaly, Mamadou/AAE-7006-2019	Sharakhov, Igor/0000-0003-0752-3747; Ribeiro, Jose/0000-0002-9107-0818	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048842, ZIAAI000810] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [R01 AI048842, AI48842] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2003, AFR MAL REP 2003; [Anonymous], 1968, ANOPHELINAE AFR S SA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Evertsz EM, 2001, BIOTECHNIQUES, V31, P1182, DOI 10.2144/01315dd03; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; MORTON BR, 1993, J MOL EVOL, V37, P273, DOI 10.1007/BF00175504; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wondji CS, 2005, GENETICS, V171, P1779, DOI 10.1534/genetics.105.044800; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x	31	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7976	10.1371/journal.pone.0007976	http://dx.doi.org/10.1371/journal.pone.0007976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936243	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600025
J	Pitel, AL; Aupee, AM; Chetelat, G; Mezenge, F; Beaunieux, H; de la Sayette, V; Viader, F; Baron, JC; Eustache, F; Desgranges, B				Pitel, Anne-Lise; Aupee, Anne-Marie; Chetelat, Gael; Mezenge, Florence; Beaunieux, Helene; de la Sayette, Vincent; Viader, Fausto; Baron, Jean-Claude; Eustache, Francis; Desgranges, Beatrice			Morphological and Glucose Metabolism Abnormalities in Alcoholic Korsakoff's Syndrome: Group Comparisons and Individual Analyses	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; WERNICKES ENCEPHALOPATHY; MEMORY IMPAIRMENT; WHITE-MATTER; ALZHEIMERS-DISEASE; VOLUME DEFICITS; MAMMILLARY BODY; WORKING-MEMORY; GREY-MATTER	Background: Gray matter volume studies have been limited to few brain regions of interest, and white matter and glucose metabolism have received limited research attention in Korsakoff's syndrome (KS). Because of the lack of brain biomarkers, KS was found to be underdiagnosed in postmortem studies. Methodology/Principal Findings: Nine consecutively selected patients with KS and 22 matched controls underwent both structural magnetic resonance imaging and F-18-fluorodeoxyglucose positron emission tomography examinations. Using a whole-brain analysis, the between-group comparisons of gray matter and white matter density and relative glucose uptake between patients with KS and controls showed the involvement of both the frontocerebellar and the Papez circuits, including morphological abnormalities in their nodes and connection tracts and probably resulting hypometabolism. The direct comparison of the regional distribution and degree of gray matter hypodensity and hypometabolism within the KS group indicated very consistent gray matter distribution of both abnormalities, with a single area of significant difference in the middle cingulate cortex showing greater hypometabolism than hypodensity. Finally, the analysis of the variability in the individual patterns of brain abnormalities within our sample of KS patients revealed that the middle cingulate cortex was the only brain region showing significant GM hypodensity and hypometabolism in each of our 9 KS patients. Conclusions/Significance: These results indicate widespread brain abnormalities in KS including both gray and white matter damage mainly involving two brain networks, namely, the fronto-cerebellar circuit and the Papez circuit. Furthermore, our findings suggest that the middle cingulate cortex may play a key role in the pathophysiology of KS and could be considered as a potential in vivo brain biomarker.			Pitel, AL (corresponding author), Univ Caen Basse Normandie, EPHE, INSERM, Unite U923,GIP Cyceron,CHU Cote de Nacre, Caen, France.	desgranges-b@chu-caen.fr	Chetelat, Gael/G-2316-2015; Desgranges, Béatrice/L-7739-2015; Helene, Beaunieux/G-3751-2010; de la Sayette, Vincent/L-8074-2015; Pitel, Anne Lise/L-9693-2015; Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021	Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; Gael, Chetelat/0000-0002-4889-7932; BEAUNIEUX, HELENE/0000-0003-1354-6558; PITEL, Anne Lise/0000-0001-8573-9506; baron, jean-claude/0000-0002-5264-2588				ADAMS RD, 1962, TROUBLES MEMOIRE APP, P272; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; American Psychiatric A, 1994, DIAGN STAT MAN MENT; Aupee AM, 2001, NEUROIMAGE, V13, P1164, DOI 10.1006/nimg.2001.0762; Beauregard D, 1971, TEST AUTOMATISMES VE; BUTTERS N, 1980, ALCOHOLIC KORSAKOFFS; Caine D, 1997, J NEUROL NEUROSUR PS, V62, P51, DOI 10.1136/jnnp.62.1.51; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; CHANRAUD S, 2008, NEUROPSYCHOPHARMACOL; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; CHRISTIE JE, 1988, PSYCHOL MED, V18, P319, DOI 10.1017/S0033291700007868; Colchester A, 2001, J NEUROL NEUROSUR PS, V71, P13, DOI 10.1136/jnnp.71.1.13; CRAVIOTO H, 1961, ARCH NEUROL-CHICAGO, V4, P510, DOI 10.1001/archneur.1961.00450110040005; Delay J, 1969, SYNDROME KORSAKOFF; Delis DC., 2000, CALIFORNIA VERBAL LE; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; Desmond JE, 2003, NEUROIMAGE, V19, P1510, DOI 10.1016/S1053-8119(03)00102-2; Emsley R, 1996, ALCOHOL ALCOHOLISM, V31, P479; Fama R, 2004, J INT NEUROPSYCH SOC, V10, P427, DOI 10.1017/S135561770410310X; GILMAN S, 1990, ANN NEUROL, V28, P775, DOI 10.1002/ana.410280608; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; HALLIDAY G, 1993, J NEUROPATH EXP NEUR, V52, P567, DOI 10.1097/00005072-199311000-00003; HALLIDAY G, 1992, BRAIN RES, V598, P33, DOI 10.1016/0006-8993(92)90164-5; Harding AJ, 1997, HIPPOCAMPUS, V7, P78, DOI 10.1002/(SICI)1098-1063(1997)7:1<78::AID-HIPO8>3.3.CO;2-B; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; JACOBSON RR, 1990, PSYCHOL MED, V20, P321, DOI 10.1017/S0033291700017633; Jauhar P, 2000, ALCOHOL ALCOHOLISM, V35, P212, DOI 10.1093/alcalc/35.2.212; JERNIGAN TL, 1991, NEUROPSYCHOPHARMACOL, V4, P175; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; JOYCE EM, 1994, PSYCHIAT RES, V54, P225, DOI 10.1016/0165-1781(94)90017-5; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Krabbendam L, 2000, J NEUROPSYCH CLIN N, V12, P44, DOI 10.1176/jnp.12.1.44; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; MAIR WGP, 1979, BRAIN, V102, P749, DOI 10.1093/brain/102.4.749; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Mori S., 2005, MRI ATLAS HUMAN WHIT; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Paller KA, 1997, J COGNITIVE NEUROSCI, V9, P277, DOI 10.1162/jocn.1997.9.2.277; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pitel AL, 2008, ALCOHOL CLIN EXP RES, V32, P1229, DOI 10.1111/j.1530-0277.2008.00677.x; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Quarantelli M, 2004, J NUCL MED, V45, P192; Raven J. C., 1954, PROGRESSIVE MATRICE; Reed LJ, 2003, CORTEX, V39, P1027, DOI 10.1016/S0010-9452(08)70876-1; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Richardson MP, 1997, BRAIN, V120, P1961, DOI 10.1093/brain/120.11.1961; Rocher AB, 2003, NEUROIMAGE, V20, P1894, DOI 10.1016/j.neuroimage.2003.07.002; Rousset OG, 1998, J NUCL MED, V39, P904; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Shear PK, 1996, ALCOHOL CLIN EXP RES, V20, P1489, DOI 10.1111/j.1530-0277.1996.tb01153.x; Sheedy D, 1999, ALCOHOL CLIN EXP RES, V23, P1624, DOI 10.1111/j.1530-0277.1999.tb04053.x; SHIMAMURA AP, 1988, J NEUROSCI, V8, P4400; Signoret JL, 1991, BATTERIE EFFICIENCE; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; Sullivan EV, 2003, NEUROLOGY, V61, P1716, DOI 10.1212/01.WNL.0000098940.31882.BB; Sullivan EV, 2001, ALCOHOL CLIN EXP RES, V25, P1206, DOI 10.1097/00000374-200108000-00017; Sullivan EV, 1999, ALCOHOL CLIN EXP RES, V23, P1629, DOI 10.1097/00000374-199910000-00010; Sullivan EV, 2000, NEUROPSYCHOLOGY, V14, P341, DOI 10.1037//0894-4105.14.3.341; Talairach J., 1988, COPLANAR STEREOTAXIC; TORVIK A, 1982, J NEUROL SCI, V56, P233, DOI 10.1016/0022-510X(82)90145-9; Van Laere KJ, 2001, RADIOLOGY, V221, P810, DOI 10.1148/radiol.2213010295; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Victor M, 1971, Contemp Neurol Ser, V7, P1; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Visser PJ, 1999, J NEUROL NEUROSUR PS, V67, P774, DOI 10.1136/jnnp.67.6.774; Weschler D., 2001, WESCHLER ADULT INTEL	79	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7748	10.1371/journal.pone.0007748	http://dx.doi.org/10.1371/journal.pone.0007748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518VB	19936229	Green Submitted, gold, Green Published			2022-12-27	WOS:000271721900007
J	Grini, PE; Thorstensen, T; Alm, V; Vizcay-Barrena, G; Windju, SS; Jorstad, TS; Wilson, ZA; Aalen, RB				Grini, Paul E.; Thorstensen, Tage; Alm, Vibeke; Vizcay-Barrena, Gema; Windju, Susanne S.; Jorstad, Tommy S.; Wilson, Zoe A.; Aalen, Reidunn B.			The ASH1 HOMOLOG 2 (ASHH2) Histone H3 Methyltransferase Is Required for Ovule and Anther Development in Arabidopsis	PLOS ONE			English	Article							FLOWERING-LOCUS-C; ABORTED-MICROSPORES AMS; SET DOMAIN PROTEINS; WINTER-ANNUAL HABIT; TRANSCRIPTION FACTOR; H3K36 METHYLATION; GENE ENCODES; WILD-TYPE; THALIANA; POLLEN	Background: SET-domain proteins are histone lysine (K) methyltransferases (HMTase) implicated in defining transcriptionally permissive or repressive chromatin. The Arabidopsis ASH1 HOMOLOG 2 (ASHH2) protein (also called SDG8, EFS and CCR1) has been suggested to methylate H3K4 and/or H3K36 and is similar to Drosophila ASH1, a positive maintainer of gene expression, and yeast Set2, a H3K36 HMTase. Mutation of the ASHH2 gene has pleiotropic developmental effects. Here we focus on the role of ASHH2 in plant reproduction. Methodology/Principal Findings: A slightly reduced transmission of the ashh2 allele in reciprocal crosses implied involvement in gametogenesis or gamete function. However, the main requirement of ASHH2 is sporophytic. On the female side, close to 80% of mature ovules lack embryo sac. On the male side, anthers frequently develop without pollen sacs or with specific defects in the tapetum layer, resulting in reduction in the number of functional pollen per anther by up to similar to 90%. In consistence with the phenotypic findings, an ASHH2 promoter-reporter gene was expressed at the site of megaspore mother cell formation as well as tapetum layers and pollen. ashh2 mutations also result in homeotic changes in floral organ identity. Transcriptional profiling identified more than 300 up-regulated and 600 down-regulated genes in ashh2 mutant inflorescences, whereof the latter included genes involved in determination of floral organ identity, embryo sac and anther/pollen development. This was confirmed by real-time PCR. In the chromatin of such genes (AP1, AtDMC1 and MYB99) we observed a reduction of H3K36 trimethylation (me3), but not H3K4me3 or H3K36me2. Conclusions/Significance: The severe distortion of reproductive organ development in ashh2 mutants, argues that ASHH2 is required for the correct expression of genes essential to reproductive development. The reduction in the ashh2 mutant of H3K36me3 on down-regulated genes relevant to the observed defects, implicates ASHH2 in regulation of gene expression via H3K36 trimethylation in chromatin of Arabidopsis inflorescences.			Grini, PE (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	reidunn.aalen@imbv.uio.no	Grini, Paul/H-9471-2016; Aalen, Reidunn B/AAE-6912-2019; Grini, Paul/N-5948-2019	Grini, Paul/0000-0003-3898-6277; Aalen, Reidunn B/0000-0001-8174-1342; Grini, Paul/0000-0003-3898-6277; Thorstensen, Tage/0000-0001-6430-3578; Wilson, Zoe A/0000-0003-0948-8770				Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cazzonelli CI, 2009, PLANT CELL, V21, P39, DOI 10.1105/tpc.108.063131; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Dong GF, 2008, BIOCHEM BIOPH RES CO, V373, P659, DOI 10.1016/j.bbrc.2008.06.096; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Grini PE, 2002, GENETICS, V162, P1911; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Howden R, 1998, GENETICS, V149, P621; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; JACKSON D, 1992, PLANT MOL PATHOLOGY, P163; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kim HS, 2008, BIOCHEM BIOPH RES CO, V368, P419, DOI 10.1016/j.bbrc.2008.01.104; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Klimyuk VI, 1997, PLANT J, V11, P1, DOI 10.1046/j.1365-313X.1997.11010001.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; R Development Core Team, 2007, R LANG ENV STAT COMP; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Saleh A, 2007, NUCLEIC ACIDS RES, V35, P6290, DOI 10.1093/nar/gkm464; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Schmitz RJ, 2009, PLANT PHYSIOL, V149, P1196, DOI 10.1104/pp.108.131508; Schneitz K, 1997, DEVELOPMENT, V124, P1367; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Soppe WJJ, 1999, DEVELOPMENT, V126, P4763; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Stabell M, 2007, BIOCHEM BIOPH RES CO, V359, P784, DOI 10.1016/j.bbrc.2007.05.189; Thorstensen T, 2008, PLANT MOL BIOL, V66, P47, DOI 10.1007/s11103-007-9251-y; Tompa R, 2007, GENETICS, V175, P585, DOI 10.1534/genetics.106.067751; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	56	81	87	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7817	10.1371/journal.pone.0007817	http://dx.doi.org/10.1371/journal.pone.0007817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915673	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721400014
J	Adachi, M; Liu, Y; Fujii, K; Calderwood, SK; Nakai, A; Imai, K; Shinomura, Y				Adachi, Masaaki; Liu, Yaohua; Fujii, Kyoko; Calderwood, Stuart K.; Nakai, Akira; Imai, Kohzoh; Shinomura, Yasuhisa			Oxidative Stress Impairs the Heat Stress Response and Delays Unfolded Protein Recovery	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; TARGETED DISRUPTION; INDUCED APOPTOSIS; CELL-SURVIVAL; PHOSPHORYLATION; HYPERTHERMIA; THERMOTOLERANCE; PROTECTION; BINDING	Background: Environmental changes, air pollution and ozone depletion are increasing oxidative stress, and global warming threatens health by heat stress. We now face a high risk of simultaneous exposure to heat and oxidative stress. However, there have been few studies investigating their combined adverse effects on cell viability. Principal Findings: Pretreatment of hydrogen peroxide (H(2)O(2)) specifically and highly sensitized cells to heat stress, and enhanced loss of mitochondrial membrane potential. H(2)O(2) exposure impaired the HSP40/HSP70 induction as heat shock response (HSR) and the unfolded protein recovery, and enhanced eIF2 alpha phosphorylation and/or XBP1 splicing, land marks of ER stress. These H(2)O(2)-mediated effects mimicked enhanced heat sensitivity in HSF1 knockdown or knockout cells. Importantly, thermal preconditioning blocked H(2)O(2)-mediated inhibitory effects on refolding activity and rescued HSF1 +/+ MEFs, but neither blocked the effects nor rescued HSF1 -/- MEFs. These data strongly suggest that inhibition of HSR and refolding activity is crucial for H(2)O(2)-mediated enhanced heat sensitivity. Conclusions: H(2)O(2) blocks HSR and refolding activity under heat stress, thereby leading to insufficient quality control and enhancing ER stress. These uncontrolled stress responses may enhance cell death. Our data thus highlight oxidative stress as a crucial factor affecting heat tolerance.			Adachi, M (corresponding author), Sapporo Med Univ, Sch Med, Div Mol Oncol & Mol Diag, Sapporo, Hokkaido, Japan.	adachi@sapmed.ac.jp						Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Burdon R H, 1987, Free Radic Res Commun, V3, P129, DOI 10.3109/10715768709069778; Chan WH, 2000, J CELL BIOCHEM, V78, P73, DOI 10.1002/(SICI)1097-4644(20000701)78:1<73::AID-JCB7>3.0.CO;2-P; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heine GF, 2008, J BIOL CHEM, V283, P9555, DOI 10.1074/jbc.M707700200; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Ito H, 1999, LIFE SCI, V64, P755, DOI 10.1016/S0024-3205(98)00617-1; Jardine DS, 2007, PEDIATR REV, V28, P249, DOI 10.1542/pir.28-7-249; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; RANU RS, 1976, P NATL ACAD SCI USA, V73, P4349, DOI 10.1073/pnas.73.12.4349; SKIBBA JL, 1991, INT J HYPERTHER, V7, P749, DOI 10.3109/02656739109056444; Sucholeiki R, 2005, SEMIN NEUROL, V25, P307, DOI 10.1055/s-2005-917667; Valenzuela MT, 1997, INT J CANCER, V72, P307, DOI 10.1002/(SICI)1097-0215(19970717)72:2<307::AID-IJC18>3.3.CO;2-S; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhang Y, 2006, CELL DEATH DIFFER, V13, P129, DOI 10.1038/sj.cdd.4401686	25	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A57	A66	e7719	10.1371/journal.pone.0007719	http://dx.doi.org/10.1371/journal.pone.0007719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936221	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800007
J	Chisari, M; Saini, DK; Cho, JH; Kalyanaraman, V; Gautam, N				Chisari, Mariangela; Saini, Deepak Kumar; Cho, Joon-Ho; Kalyanaraman, Vani; Gautam, N.			G Protein Subunit Dissociation and Translocation Regulate Cellular Response to Receptor Stimulation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; BETA-GAMMA COMPLEX; LIVING CELLS; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; PHOSPHOLIPASE-C; FUSION PROTEINS; GOLGI-COMPLEX; KINASE-C	We examined the role of G proteins in modulating the response of living cells to receptor activation. The response of an effector, phospholipase C-beta to M3 muscarinic receptor activation was measured using sensors that detect the generation of inositol triphosphate or diacylglycerol. The recently discovered translocation of G beta gamma from plasma membrane to endomembranes on receptor activation attenuated this response. A FRET based G protein sensor suggested that in contrast to translocating G beta gamma, non- translocating G beta gamma subunits do not dissociate from the alpha q subunit on receptor activation leading to prolonged retention of the heterotrimer state and an accentuated response. M3 receptors with tethered alpha q induced differential responses to receptor activation in cells with or without an endogenous translocation capable gamma subunit. G protein heterotrimer dissociation and beta gamma translocation are thus unanticipated modulators of the intensity of a cell's response to an extracellular signal.			Chisari, M (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	gautam@wustl.edu			NIGMS NIH HHS [GM69027, R01 GM080558, R01 GM069027, GM080558] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080558, R01GM069027] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Elias R, 2004, MOL VIS, V10, P672; Evanko DS, 2005, CELL SIGNAL, V17, P1218, DOI 10.1016/j.cellsig.2004.12.008; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hou YM, 2000, J BIOL CHEM, V275, P38961, DOI 10.1074/jbc.C000604200; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; Milligan G, 2002, RECEPTOR CHANNEL, V8, P309, DOI 10.1080/10606820214639; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	39	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A181	A191	e7797	10.1371/journal.pone.0007797	http://dx.doi.org/10.1371/journal.pone.0007797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936219	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800020
J	Struble, JM; Gill, RT				Struble, Julie M.; Gill, Ryan T.			Genome-Scale Identification Method Applied to Find Cryptic Aminoglycoside Resistance Genes in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; COMPENSATORY MUTATIONS; EVOLUTION; BINDING; HFQ; GENETICS; SITE; SALMONELLA; MECHANISMS	Background: The ability of bacteria to rapidly evolve resistance to antibiotics is a critical public health problem. Resistance leads to increased disease severity and death rates, as well as imposes pressure towards the discovery and development of new antibiotic therapies. Improving understanding of the evolution and genetic basis of resistance is a fundamental goal in the field of microbiology. Results: We have applied a new genomic method, Scalar Analysis of Library Enrichments (SCALEs), to identify genomic regions that, given increased copy number, may lead to aminoglycoside resistance in Pseudomonas aeruginosa at the genome scale. We report the result of selections on highly representative genomic libraries for three different aminoglycoside antibiotics (amikacin, gentamicin, and tobramycin). At the genome-scale, we show significant (p<0.05) overlap in genes identified for each aminoglycoside evaluated. Among the genomic segments identified, we confirmed increased resistance associated with an increased copy number of several genomic regions, including the ORF of PA5471, recently implicated in MexXY efflux pump related aminoglycoside resistance, PA4943-PA4946 (encoding a probable GTP-binding protein, a predicted host factor I protein, a delta 2-isopentenylpyrophosphate transferase, and DNA mismatch repair protein mutL), PA0960-PA0963 (encoding hypothetical proteins, a probable cold shock protein, a probable DNA-binding stress protein, and aspartyl-tRNA synthetase), a segment of PA4967 (encoding a topoisomerase IV subunit B), as well as a chimeric clone containing two inserts including the ORFs PA0547 and PA2326 (encoding a probable transcriptional regulator and a probable hypothetical protein, respectively). Conclusions: The studies reported here demonstrate the application of new a genomic method, SCALEs, which can be used to improve understanding of the evolution of antibiotic resistance in P. aeruginosa. In our demonstration studies, we identified a significant number of genomic regions that increased resistance to multiple aminoglycosides. We identified genetic regions that include open reading frames that encode for products from many functional categories, including genes related to O-antigen synthesis, DNA repair, and transcriptional and translational processes.			Struble, JM (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	rtg@colorado.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI064338, R21AI055773] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI055773, K25 AI064338, R21 AI055773-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAKKER EP, 1992, J GEN MICROBIOL, V138, P563, DOI 10.1099/00221287-138-3-563; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; BENVENISTE R, 1973, ANTIMICROB AGENTS CH, V4, P402, DOI 10.1128/AAC.4.4.402; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHANDLER PM, 1974, MUTAT RES, V23, P15, DOI 10.1016/0165-1218(74)90217-1; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Courvalin P, 1999, RES MICROBIOL, V150, P367, DOI 10.1016/S0923-2508(99)80071-0; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Hall BG, 2004, NAT REV MICROBIOL, V2, P430, DOI 10.1038/nrmicro888; HOLLOWAY BW, 1969, BACTERIOL REV, V33, P419, DOI 10.1128/MMBR.33.3.419-443.1969; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Kerkhoven R, 2004, BIOINFORMATICS, V20, P1812, DOI 10.1093/bioinformatics/bth159; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lawhorn BG, 2004, J BIOL CHEM, V279, P43555, DOI 10.1074/jbc.M404284200; Lee JK, 2005, INT J ANTIMICROB AG, V25, P290, DOI 10.1016/j.ijantimicag.2004.11.012; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Levin BR, 2000, GENETICS, V154, P985; Lindgren PK, 2005, ANTIMICROB AGENTS CH, V49, P2343, DOI 10.1128/AAC.49.6.2343-2351.2005; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch MD, 2006, BIOTECHNOL BIOENG, V94, P151, DOI 10.1002/bit.20836; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; MATSUNAGA K, 1986, ANTIMICROB AGENTS CH, V30, P468, DOI 10.1128/AAC.30.3.468; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; MILLER GH, 1995, J CHEMOTHERAPY, V7, P17; MINGEOTLECLERCQ M, 1999, ANTIMICROBIAL AGENTS, V43; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Muffler A, 1997, J BACTERIOL, V179, P445; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; NUGENT ME, 1979, NATURE, V282, P422, DOI 10.1038/282422a0; Oyamada Y, 2006, J MED MICROBIOL, V55, P1395, DOI 10.1099/jmm.0.46636-0; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Salipante SJ, 2003, ANTIMICROB AGENTS CH, V47, P3840, DOI 10.1128/AAC.47.12.3840-3845.2003; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Struble JM, 2006, ANTIMICROB AGENTS CH, V50, P2506, DOI 10.1128/AAC.01640-05; Sun HK, 2007, INT J ANTIMICROB AG, V29, P230, DOI 10.1016/j.ijantimicag.2006.10.004; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vytvytska O, 2000, GENE DEV, V14, P1109; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Yokoyama K, 2003, LANCET, V362, P1888, DOI 10.1016/S0140-6736(03)14959-8; Zhu H, 1999, NUCLEIC ACIDS RES, V27, P910, DOI 10.1093/nar/27.3.910; ZIMELIS VM, 1973, J INFECT DIS, V127, P663, DOI 10.1093/infdis/127.6.663	61	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A6	A15	e6576	10.1371/journal.pone.0006576	http://dx.doi.org/10.1371/journal.pone.0006576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907650	Green Submitted, gold, Green Published			2022-12-27	WOS:000271685800001
J	Heeringa, SF; Moeller, CC; Du, JY; Yue, LX; Hinkes, B; Chernin, G; Vlangos, CN; Hoyer, PF; Reiser, J; Hildebrandt, F				Heeringa, Saskia F.; Moeller, Clemens C.; Du, Jianyang; Yue, Lixia; Hinkes, Bernward; Chernin, Gil; Vlangos, Christopher N.; Hoyer, Peter F.; Reiser, Jochen; Hildebrandt, Friedhelm			A Novel TRPC6 Mutation That Causes Childhood FSGS	PLOS ONE			English	Article							GLOMERULAR PROTEIN; NEPHROTIC SYNDROME; STEROID-RESISTANT; SLIT DIAPHRAGM; CHANNELS; PODOCIN; NPHS2; ACTIVATION; NEPHRIN; DISEASE	Background: TRPC6, encoding a member of the transient receptor potential (TRP) superfamily of ion channels, is a calcium-permeable cation channel, which mediates capacitive calcium entry into the cell. Until today, seven different mutations in TRPC6 have been identified as a cause of autosomal-dominant focal segmental glomerulosclerosis (FSGS) in adults. Methodology/Principal Findings: Here we report a novel TRPC6 mutation that leads to early onset FSGS. We identified one family in whom disease segregated with a novel TRPC6 mutation (M132T), that also affected pediatric individuals as early as nine years of age. Twenty-one pedigrees compatible with an autosomal-dominant mode of inheritance and biopsy-proven FSGS were selected from a worldwide cohort of 550 families with steroid resistant nephrotic syndrome (SRNS). Whole cell current recordings of the mutant TRPC6 channel, compared to the wild-type channel, showed a 3 to 5-fold increase in the average out-and inward TRPC6 current amplitude. The mean inward calcium current of M132T was 10-fold larger than that of wild-type TRPC6. Interestingly, M132T mutants also lacked time-dependent inactivation. Generation of a novel double mutant M132T/N143S did not further augment TRPC6 channel activity. Conclusions: In summary, our data shows that TRPC6 mediated FSGS can also be found in children. The large increase in channel currents and impaired channel inactivation caused by the M132T mutant leads to an aggressive phenotype that underlines the importance of calcium dose channeled through TRPC6.			Heeringa, SF (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Du, Jianyang/B-3883-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R01DK076683] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL078960, R01 HL078960-05] Funding Source: Medline; NIDDK NIH HHS [P50-DK039255, R01 DK076683, R01-DK076683, P50 DK039255] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hsu YJ, 2007, BBA-MOL BASIS DIS, V1772, P928, DOI 10.1016/j.bbadis.2007.02.001; Huber TB, 2007, NEPHRON EXP NEPHROL, V106, pE27, DOI 10.1159/000101789; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ichikawa I, 1996, PEDIATR NEPHROL, V10, P374; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; MOLLER CC, 2008, J AM SOC NEPHROL; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ruf RG, 2004, KIDNEY INT, V66, P564, DOI 10.1111/j.1523-1755.2004.00775.x; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Troyanov S, 2004, KIDNEY INT, V66, P1199, DOI 10.1111/j.1523-1755.2004.00873.x; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; ZHU B, 2008, MUTAT RES; 1998, LANCET, V1, P380	29	120	129	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7771	10.1371/journal.pone.0007771	http://dx.doi.org/10.1371/journal.pone.0007771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936226	Green Submitted, Green Published, gold			2022-12-27	WOS:000271658800009
J	Leu, NA; Kurosaka, S; Kashina, A				Leu, Nicolae Adrian; Kurosaka, Satoshi; Kashina, Anna			Conditional Tek Promoter-Driven Deletion of Arginyltransferase in the Germ Line Causes Defects in Gametogenesis and Early Embryonic Lethality in Mice	PLOS ONE			English	Article							RNA-PROTEIN TRANSFERASE; CYTOSKELETON; OOCYTE; ARGINYLATION; MATURATION	Posttranslational protein arginylation mediated by Ate1 is essential for cardiovascular development, actin cytoskeleton functioning, and cell migration. Ate1 plays a role in the regulation of cytoskeleton and is essential for cardiovascular development and angiogenesis-capillary remodeling driven by in-tissue migration of endothelial cells. To address the role of Ate1 in cytoskeleton-dependent processes and endothelial cell function during development, we produced a conditional mouse knockout with Ate1 deletion driven by Tek endothelial receptor tyrosine kinase promoter expressed in the endothelium and in the germ line. Contrary to expectations, Tek-Ate1 mice were viable and had no visible angiogenesis-related phenotypes; however, these mice showed reproductive defects, with high rates of embryonic lethality in the second generation, at stages much earlier than the complete Ate1 knockout strain. While some of the early lethality originated from the subpopulation of embryos with homozygous Tek-Cre transgene-a problem that has not previously been reported for this commercial mouse strain-a distinct subpopulation of embryos had lethality at early post-implantation stages that could be explained only by a previously unknown defect in gametogenesis originating from Tek-driven Ate1 deletion in premeiotic germs cells. These results demonstrate a novel role of Ate1 in germ cell development.			Leu, NA (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu			NHLBI NIH HHS [R01 HL084419-03, 5R01HL084419, R01 HL084419-02, R01 HL084419] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084419] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALZI E, 1990, J BIOL CHEM, V265, P7464; BEMENT WM, 1992, MICROSC RES TECHNIQ, V22, P23, DOI 10.1002/jemt.1070220105; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Coticchio G, 2004, ANN NY ACAD SCI, V1034, P132, DOI 10.1196/annals.1335.016; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Rai R, 2008, DEVELOPMENT, V135, P3881, DOI 10.1242/dev.022723; Rai R, 2006, EMBO REP, V7, P800, DOI 10.1038/sj.embor.7400747; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; VANHINSBERGH VW, 2008, CARDIOVASC RES; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Wong CH, 2005, DEV BIOL, V286, P1, DOI 10.1016/j.ydbio.2005.08.001	20	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7734	10.1371/journal.pone.0007734	http://dx.doi.org/10.1371/journal.pone.0007734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890395	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700018
J	Tomita, H; Sugano, E; Fukazawa, Y; Isago, H; Sugiyama, Y; Hiroi, T; Ishizuka, T; Mushiake, H; Kato, M; Hirabayashi, M; Shigemoto, R; Yawo, H; Tamai, M				Tomita, Hiroshi; Sugano, Eriko; Fukazawa, Yugo; Isago, Hitomi; Sugiyama, Yuka; Hiroi, Teru; Ishizuka, Toru; Mushiake, Hajime; Kato, Megumi; Hirabayashi, Masumi; Shigemoto, Ryuichi; Yawo, Hiromu; Tamai, Makoto			Visual Properties of Transgenic Rats Harboring the Channelrhodopsin-2 Gene Regulated by the Thy-1.2 Promoter	PLOS ONE			English	Article							GANGLION-CELLS; PHOTORECEPTOR CELLS; MORPHOMETRIC-ANALYSIS; SPATIAL VISION; RETINA; EXPRESSION; DEGENERATION; ANTIGEN; ADULT; MICE	Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa. If the ChR2 gene is transferred to retinal ganglion cells (RGCs), which send visual information to the brain, the RGCs may be repurposed to act as photoreceptors. In this study, by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter, we tested the possibility that direct photoactivation of RGCs could restore effective vision. Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors. This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.			Tomita, H (corresponding author), Tohoku Univ, Sendai, Miyagi 980, Japan.	hiroshi-tomita@iiare.tohoku.ac.jp	Hirabayashi, Masumi/C-8935-2019; Fukazawa, Yugo/H-9899-2012; Shigemoto, Ryuichi/E-3628-2013; Tomita, Hiroshi/O-2135-2018; Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Hirabayashi, Masumi/0000-0002-1059-5883; Fukazawa, Yugo/0000-0001-7436-8797; Shigemoto, Ryuichi/0000-0001-8761-9444; Tomita, Hiroshi/0000-0003-1051-2301; Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Mushiake, Hajime/0000-0002-5130-4720				BARCLAY AN, 1978, J NEUROCHEM, V31, P1375, DOI 10.1111/j.1471-4159.1978.tb06563.x; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; BRECHA NC, 1994, J COMP NEUROL, V345, P602, DOI 10.1002/cne.903450410; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; DABIN I, 1995, GLIA, V14, P23, DOI 10.1002/glia.440140105; Dowling JE, 1999, BRAIN RES BULL, V50, P317, DOI 10.1016/S0361-9230(99)00154-9; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FIELDS KL, 1978, CELL, V14, P43, DOI 10.1016/0092-8674(78)90299-4; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayworth CR, 2008, J TOXICOL ENV HEAL A, V71, P1582, DOI 10.1080/15287390802414190; Huang H, 2005, EXP EYE RES, V80, P727, DOI 10.1016/j.exer.2004.11.019; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kaldi I, 2003, MOL VIS, V9, P337; KELLEY KA, 1994, MOL BRAIN RES, V24, P261, DOI 10.1016/0169-328X(94)90139-2; Kerrison JB, 2005, INVEST OPHTH VIS SCI, V46, P2932, DOI 10.1167/iovs.04-1237; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Leung CKS, 2008, J NEUROSCI METH, V168, P475, DOI 10.1016/j.jneumeth.2007.10.018; Li F, 2001, EXP EYE RES, V73, P569, DOI 10.1006/exer.2001.1068; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MASON DW, 1980, BIOCHEM J, V187, P1; McGill TJ, 2004, INVEST OPHTH VIS SCI, V45, P932, DOI 10.1167/iovs.03-0964; MORRIS RJ, 1977, EUR J IMMUNOL, V7, P360, DOI 10.1002/eji.1830070607; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Noell W K, 1966, Invest Ophthalmol, V5, P450; PERRY VH, 1984, J NEUROCYTOL, V13, P809, DOI 10.1007/BF01148495; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sato H, 2005, INVEST OPHTH VIS SCI, V46, P791, DOI 10.1167/iovs.04-0867; STONE JL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1634, DOI 10.1001/archopht.1992.01080230134038; Sugano E, 2005, INVEST OPHTH VIS SCI, V46, P3341, DOI 10.1167/iovs.04-1351; Takahashi R, 1999, TRANSGENIC RES, V8, P397, DOI 10.1023/A:1008910629235; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009	47	106	118	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7679	10.1371/journal.pone.0007679	http://dx.doi.org/10.1371/journal.pone.0007679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19893752	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700004
J	Bua, DJ; Kuo, AJ; Cheung, P; Liu, CL; Migliori, V; Espejo, A; Casadio, F; Bassi, C; Amati, B; Bedford, MT; Guccione, E; Gozani, O				Bua, Dennis J.; Kuo, Alex J.; Cheung, Peggie; Liu, Chih Long; Migliori, Valentina; Espejo, Alexsandra; Casadio, Fabio; Bassi, Christian; Amati, Bruno; Bedford, Mark T.; Guccione, Ernesto; Gozani, Or			Epigenome Microarray Platform for Proteome-Wide Dissection of Chromatin-Signaling Networks	PLOS ONE			English	Article								Knowledge of protein domains that function as the biological effectors for diverse post-translational modifications of histones is critical for understanding how nuclear and epigenetic programs are established. Indeed, mutations of chromatin effector domains found within several proteins are associated with multiple human pathologies, including cancer and immunodeficiency syndromes. To date, relatively few effector domains have been identified in comparison to the number of modifications present on histone and non-histone proteins. Here we describe the generation and application of human modified peptide microarrays as a platform for high-throughput discovery of chromatin effectors and for epitope-specificity analysis of antibodies commonly utilized in chromatin research. Screening with a library containing a majority of the Royal Family domains present in the human proteome led to the discovery of TDRD7, JMJ2C, and MPP8 as three new modified histone-binding proteins. Thus, we propose that peptide microarray methodologies are a powerful new tool for elucidating molecular interactions at chromatin.			Bua, DJ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ogozani@stanford.edu	guccione, ernesto/G-9874-2011; Kuo, Alex/AAL-2845-2020; Gozani, Or P/I-6157-2013; Amati, Bruno/AAM-3418-2020; Bedford, Mark T/E-7856-2011	Bua, Dennis/0000-0002-5709-0268; Gozani, Or/0000-0002-1365-4463; Migliori, Valentina/0000-0003-4978-2245; Espejo, Alexsandra/0000-0002-8841-7219; Amati, Bruno/0000-0002-2958-1799	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025800] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA025800, 5R21-DA025800] Funding Source: Medline; PHS HHS [PA-08-190] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; RAMONMAIQUES S, 2007, NATL ACAD SCI US, V104, P18993; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	39	77	79	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6789	10.1371/journal.pone.0006789	http://dx.doi.org/10.1371/journal.pone.0006789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19956676	Green Published, gold, Green Submitted			2022-12-27	WOS:000269335000031
J	McGovern, G; Mabbott, N; Jeffrey, M				McGovern, Gillian; Mabbott, Neil; Jeffrey, Martin			Scrapie Affects the Maturation Cycle and Immune Complex Trapping by Follicular Dendritic Cells in Mice	PLOS ONE			English	Article							PRION PROTEIN ACCUMULATION; GERMINAL CENTER REACTION; SHEEP; PRP; SPLEEN; INFECTION; BRAIN; MOUSE; PATHOGENESIS; EXPRESSION	Transmissible spongiform encephalopathies (TSEs) or prion diseases are infectious neurological disorders of man and animals, characterised by abnormal disease-associated prion protein (PrP(d)) accumulations in the brain and lymphoreticular system (LRS). Prior to neuroinvasion, TSE agents often accumulate to high levels within the LRS, apparently without affecting immune function. However, our analysis of scrapie-affected sheep shows that PrP(d) accumulations within the LRS are associated with morphological changes to follicular dendritic cells (FDCs) and tingible body macrophages (TBMs). Here we examined FDCs and TBMs in the mesenteric lymph nodes (MLNs) of scrapie-affected mice by light and electron microscopy. In MLNs from uninfected mice, FDCs could be morphologically categorised into immature, mature and regressing forms. However, in scrapie-affected MLNs this maturation cycle was adversely affected. FDCs characteristically trap and retain immune complexes on their surfaces, which they display to B-lymphocytes. In scrapie-affected MLNs, some FDCs were found where areas of normal and abnormal immune complex retention occurred side by side. The latter colocalised with PrP(d) plasmalemmal accumulations. Our data suggest this previously unrecognised morphology represents the initial stage of an abnormal FDC maturation cycle. Alterations to the FDCs included PrP(d) accumulation, abnormal cell membrane ubiquitin and excess immunoglobulin accumulation. Regressing FDCs, in contrast, appeared to lose their membrane-attached PrP(d). Together, these data suggest that TSE infection adversely affects the maturation and regression cycle of FDCs, and that PrP(d) accumulation is causally linked to the abnormal pathology observed. We therefore support the hypothesis that TSEs cause an abnormality in immune function.	[McGovern, Gillian; Jeffrey, Martin] Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland; [Mabbott, Neil] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Mabbott, Neil] Univ Edinburgh, Royal Dick Sch Vet Sci, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	McGovern, G (corresponding author), Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland.	g.mcgovern@vla.defra.gsi.gov.uk	McGOVERN, GILLIAN/C-3441-2011; Jeffrey, Martin/D-2251-2009; Mabbott, Neil/AAF-8777-2020	McGOVERN, GILLIAN/0000-0001-5344-5909; Mabbott, Neil/0000-0001-7395-1796	Veterinary laboratory Agency Seedcorn; UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/D00831X/2, BBS/E/A/00001659, BB/D00831X/1, BB/D00831X/3, BBS/E/A/00001660] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00831X/3, BB/D00831X/1, BBS/E/A/00001660, BBS/E/A/00001659, BBS/E/I/00000989, BB/D00831X/2] Funding Source: researchfish	Veterinary laboratory Agency Seedcorn; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Veterinary laboratory Agency Seedcorn inward investment fund and UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; DICKINSON AG, 1969, J COMP PATHOL, V79, P15, DOI 10.1016/0021-9975(69)90021-8; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Eaton SL, 2007, J GEN VIROL, V88, P1384, DOI 10.1099/vir.0.82197-0; Eaton SL, 2009, VET IMMUNOL IMMUNOP, V131, P105, DOI 10.1016/j.vetimm.2009.02.012; FARQUHAR CF, 1993, TRANSMISSIBLE SPONGI, P301; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; HEINEN E, 1995, FOLLICULAR DENDRITIC, P5; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Jeffrey M, 2000, J PATHOL, V191, P323, DOI 10.1002/1096-9896(200007)191:3&lt;323::AID-PATH629&gt;3.0.CO;2-Z; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2000, ARCH VIROL, P23; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; LANGEVELD JPM, 1993, TRANSMISSIBLE SPONGI, P315; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Manson J., 1992, Neurodegeneration, V1, P45; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; McGovern G, 2009, VET PATHOL, V46, P233, DOI 10.1354/vp.46-2-233; McGovern G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001304; MILLER GW, 1975, P NATL ACAD SCI USA, V72, P418, DOI 10.1073/pnas.72.2.418; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; NOSSAL GJV, 1994, IMMUNOL REV, V137, P173, DOI 10.1111/j.1600-065X.1994.tb00664.x; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; RADEMAKERS LHPM, 1992, CELL TISSUE RES, V269, P359, DOI 10.1007/BF00319629; RADOUX D, 1985, ADV EXP MED BIOL, V186, P185; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; Sukumar S, 2008, CELL TISSUE RES, V332, P89, DOI 10.1007/s00441-007-0566-4; Taylor PR, 2002, EUR J IMMUNOL, V32, P1888; TEW JG, 1982, J RETICULOENDOTH SOC, V31, P371; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; VEERMAN AJP, 1975, CELL TISSUE RES, V156, P417, DOI 10.1007/BF00225103; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8186	10.1371/journal.pone.0008186	http://dx.doi.org/10.1371/journal.pone.0008186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997557	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829700002
J	Edeling, MA; Sanker, S; Shima, T; Umasankar, PK; Honing, S; Kim, HY; Davidson, LA; Watkins, SC; Tsang, M; Owen, DJ; Traub, LM				Edeling, Melissa A.; Sanker, Subramaniam; Shima, Takaki; Umasankar, P. K.; Hoening, Stefan; Kim, Hye Y.; Davidson, Lance A.; Watkins, Simon C.; Tsang, Michael; Owen, David J.; Traub, Linton M.			Structural Requirements for PACSIN/Syndapin Operation during Zebrafish Embryonic Notochord Development	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; CONVERGENT EXTENSION; TRANSGENIC ZEBRAFISH; CATION CHANNEL; CELL-ADHESION; SYNDAPIN-I; BODY AXIS; PROTEIN; DOMAIN; MORPHOGENESIS	PACSIN/Syndapin proteins are membrane-active scaffolds that participate in endocytosis. The structure of the Drosophila Syndapin N-terminal EFC domain reveals a crescent shaped antiparallel dimer with a high affinity for phosphoinositides and a unique membrane-inserting prong upon the concave surface. Combined structural, biochemical and reverse genetic approaches in zebrafish define an important role for Syndapin orthologue, Pacsin3, in the early formation of the notochord during embryonic development. In pacsin3-morphant embryos, midline convergence of notochord precursors is defective as axial mesodermal cells fail to polarize, migrate and differentiate properly. The pacsin3 morphant phenotype of a stunted body axis and contorted trunk is rescued by ectopic expression of Drosophila Syndapin, and depends critically on both the prong that protrudes from the surface of the bowed Syndapin EFC domain and the ability of the antiparallel dimer to bind tightly to phosphoinositides. Our data confirm linkage between directional migration, endocytosis and cell specification during embryonic morphogenesis and highlight a key role for Pacsin3 in this coupling in the notochord.	[Edeling, Melissa A.; Owen, David J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sanker, Subramaniam; Umasankar, P. K.; Watkins, Simon C.; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Shima, Takaki; Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Kim, Hye Y.; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Edeling, MA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	traub@pitt.edu	Watkins, Simon/ABG-2590-2021; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022; TSANG, Michael/E-2758-2013; Tsang, Michael W/I-9305-2014	Watkins, Simon/0000-0003-4092-1552; Tsang, Michael/0000-0001-7123-0063; TSANG, Michael/0000-0001-6384-2422; Tsang, Michael W/0000-0001-7123-0063; Umasankar, Perunthottathu/0000-0001-5548-1022; KIM, HYE YOUNG/0000-0002-3600-4180; Traub, Linton/0000-0002-1303-0298	NIH [R01 DK53249, P30 DK79307, R01 HD044750, R01 HL088016]; Wellcome Trust Senior Fellowship; German Science Foundation [SFB 635, SFB670]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053249, P30DK079307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Fellowship(Wellcome Trust); German Science Foundation(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants R01 DK53249 and pilot project on P30 DK79307 to LMT, R01 HD044750 to LAD and R01 HL088016 to MT, a Wellcome Trust Senior Fellowship to DJO, and German Science Foundation grants (SFB 635 and SFB670) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2007, MOL BIOSYST, V3, P51, DOI 10.1039/b613673g; Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chen WB, 2001, DEVELOPMENT, V128, P2385; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Granato M, 1996, DEVELOPMENT, V123, P399; Haendel MA, 2004, TOXICOL SCI, V81, P390, DOI 10.1093/toxsci/kfh202; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Harvey SA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000101; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hotta K, 2007, DEV GROWTH DIFFER, V49, P373, DOI 10.1111/j.1440-169x.2007.00935.x; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kumar V, 2009, MOL CELL NEUROSCI, V40, P234, DOI 10.1016/j.mcn.2008.10.011; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Modregger J, 2000, J CELL SCI, V113, P4511; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Odenthal J, 1996, DEVELOPMENT, V123, P103; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pagnon-Minot A, 2008, DEV BIOL, V316, P21, DOI 10.1016/j.ydbio.2007.12.033; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stemple DL, 1996, DEVELOPMENT, V123, P117; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Sumoy L, 2001, GENE, V262, P199, DOI 10.1016/S0378-1119(00)00531-X; Teraoka H, 2006, TOXICOL APPL PHARM, V212, P24, DOI 10.1016/j.taap.2005.06.016; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tilton F, 2006, TOXICOL APPL PHARM, V216, P55, DOI 10.1016/j.taap.2006.04.014; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	92	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8150	10.1371/journal.pone.0008150	http://dx.doi.org/10.1371/journal.pone.0008150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997509	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000272829000008
J	Israni, N; Goswami, R; Kumar, A; Rani, R				Israni, Neetu; Goswami, Ravinder; Kumar, Avinash; Rani, Rajni			Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TRANSCRIPTIONAL REPRESSION; 1,25-DIHYDROXYVITAMIN D-3; GENE POLYMORPHISMS; NOD MICE; LINKAGE DISEQUILIBRIUM; ALLELIC VARIATION; HORMONE-RECEPTOR; DOWN-REGULATION; PROTEIN-LEVELS	Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where interaction and integration of immune response genes along with environmental factors play a role in autoimmune destruction of the insulin producing Pancreatic Beta cells. Methodology/Principal Findings: We have studied four single nucleotide polymorphisms (FokI site in Exon 2, BsmI and ApaI sites in Intron 8 and TaqI site in exon 9) in the vitamin D receptor (VDR) gene using PCR-RFLP and HLA-DRB1 alleles using PCR and hybridization with sequence specific oligonucleotide probes and studied their interaction using LD based statistics for non-linked loci followed by sequence analysis of the vitamin D response element (VDRE) present in the promoter region of HLA-DRB1*0301. Haplotypes, constructed using SHEsis program for four single nucleotide polymorphisms in the VDR gene, were studied for their interaction with HLA-DRB1 alleles in 233 T1D patients and 191 healthy controls from North India. A significant increase of haplotypes FBAt and fBAT (p<0.02, OR = 1.44 and p<0.002, OR = 3.23 respectively) was observed in the patients. Both the haplotypes FBAt and fBAT were significantly increased in male patients with age at onset less than 18 years; however, fBAT was significantly increased in female patients irrespective of their age at onset. LD based statistics showed significant interaction between the high producer F and T alleles with HLA-DRB1*0301. F and T alleles of VDR have been shown to contribute to VDR mRNA independently. The promoter sequence analysis of HLA-DRB1*0301 showed presence of VDRE involved in higher expression of HLA-DRB1*030, which was confirmed by flow cytometry and real time PCR analysis. Conclusions/Significance: These data suggest that the interaction between VDR and HLA alleles is mediated by VDRE present in the promoter region of HLA-DRB1*0301 allele, which may be detrimental for the manifestation of T1D in the absence of 1,25-(OH)(2)D(3) in early childhood due to poor expression of DRB1*0301 in the thymus resulting in autoimmunity.	[Israni, Neetu; Kumar, Avinash; Rani, Rajni] Natl Inst Immunol, Mol Immunogenet Grp, New Delhi 110067, India; [Goswami, Ravinder] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); All India Institute of Medical Sciences (AIIMS) New Delhi	Israni, N (corresponding author), Natl Inst Immunol, Mol Immunogenet Grp, New Delhi 110067, India.	rajni@nii.res.in	Rani, Rajni/AAF-5860-2020		Department of Science and Technology (DST); Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India; National Institute of Immunology, New Delhi, India	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); National Institute of Immunology, New Delhi, India	The project was funded in part by a grant from Department of Science and Technology (DST), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and partly by Core funds of National Institute of Immunology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Angel B, 2004, EUR J EPIDEMIOL, V19, P1085, DOI 10.1007/s10654-004-1026-z; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bianco MG, 2004, EUR J ENDOCRINOL, V151, P641, DOI 10.1530/eje.0.1510641; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 1998, J IMMUNOL, V160, P5314; Chang TJ, 2000, CLIN ENDOCRINOL, V52, P575, DOI 10.1046/j.1365-2265.2000.00985.x; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; EMERY P, 1993, HUM IMMUNOL, V38, P137, DOI 10.1016/0198-8859(93)90531-5; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FARACO JH, 1989, NUCLEIC ACIDS RES, V17, P2150, DOI 10.1093/nar/17.5.2150; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; Goswami R, 2006, J CLIN ENDOCR METAB, V91, P4256, DOI 10.1210/jc.2006-1005; Gross C, 1996, J BONE MINER RES, V11, P1850; Gross C, 1998, J BONE MINER RES, V13, P1691, DOI 10.1359/jbmr.1998.13.11.1691; Guja C, 2002, J CELL MOL MED, V6, P75, DOI 10.1111/j.1582-4934.2002.tb00312.x; Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Gysemans CA, 2005, ENDOCRINOLOGY, V146, P1956, DOI 10.1210/en.2004-1322; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HUSTMYER FG, 1993, HUM MOL GENET, V2, P487, DOI 10.1093/hmg/2.4.487; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Komine M, 1999, ARCH DERMATOL RES, V291, P500, DOI 10.1007/s004030050444; Kumar R, 2007, TISSUE ANTIGENS, V69, P557, DOI 10.1111/j.1399-0039.2007.00817.x; LEMIRE JM, 1992, J CELL BIOCHEM, V49, P26, DOI 10.1002/jcb.240490106; LOUIS P, 1993, IMMUNOGENETICS, V38, P21, DOI 10.1007/BF00216386; MATHIEU C, 1992, DIABETES, V41, P1491, DOI 10.2337/diabetes.41.11.1491; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; McDermott MF, 1997, DIABETOLOGIA, V40, P971, DOI 10.1007/s001250050776; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; Ponsonby AL, 2008, AM J EPIDEMIOL, V168, P358, DOI 10.1093/aje/kwn142; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Ramachandran A, 1996, DIABETES RES CLIN PR, V34, P79, DOI 10.1016/S0168-8227(96)01338-1; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Rani R, 2004, TISSUE ANTIGENS, V64, P145, DOI 10.1111/j.1399-0039.2004.00246.x; Rani R, 1998, TISSUE ANTIGENS, V52, P37, DOI 10.1111/j.1399-0039.1998.tb03021.x; Rani R, 1998, TISSUE ANTIGENS, V52, P147, DOI 10.1111/j.1399-0039.1998.tb02278.x; RIGBY WFC, 1990, BLOOD, V76, P189, DOI 10.1182/blood.V76.1.189.bloodjournal761189; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SKJODT H, 1990, J CLIN INVEST, V85, P1421, DOI 10.1172/JCI114586; Skrabic V, 2003, DIABETES RES CLIN PR, V59, P31, DOI 10.1016/S0168-8227(02)00195-X; Takeuchi A, 1998, J IMMUNOL, V160, P209; Towers TL, 1999, MOL CELL BIOL, V19, P4191; Turpeinen H, 2003, EUR J ENDOCRINOL, V149, P591, DOI 10.1530/eje.0.1490591; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; Zmuda JM, 2000, EPIDEMIOL REV, V22, P203, DOI 10.1093/oxfordjournals.epirev.a018033; DIABETES CARE S1, V26, pS5	64	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8023	10.1371/journal.pone.0008023	http://dx.doi.org/10.1371/journal.pone.0008023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956544	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800005
J	Leitz, J; Kuballa, T; Rehm, J; Lachenmeier, DW				Leitz, Jenny; Kuballa, Thomas; Rehm, Juergen; Lachenmeier, Dirk W.			Chemical Analysis and Risk Assessment of Diethyl Phthalate in Alcoholic Beverages with Special Regard to Unrecorded Alcohol	PLOS ONE			English	Article							HEALTH CONSEQUENCES; ETHYL CARBAMATE; PRODUCTS; QUALITY; CONSUMPTION; TOXICOLOGY; ESTERS; FOOD	Background: Phthalates are synthetic compounds with a widespread field of applications. For example, they are used as plasticizers in PVC plastics and food packaging, or are added to personal care products. Diethyl phthalate (DEP) may be used to denature alcohol, e.g., for cosmetic purposes. Public health concerns of phthalates include carcinogenic, teratogenic, hepatotoxic and endocrine effects. The aim of this study was to develop and validate a method for determining phthalates in alcohol samples and to provide a risk assessment for consumers of such products. Methodology/Principal Findings: A liquid-liquid extraction procedure was optimized by varying the following parameters: type of extraction solvent (cyclohexane, n-hexane, 1,1,2-trichlorotrifluoroethane), the ratio extraction solvent/sample volume (1:1 to 50:1) and the number of extraction repetitions (1-10). The best extraction yield (99.9%) was achieved with the solvent 1,1,2-trichlorotrifluoroethane, an extraction solvent volume/sample volume ratio of 10: 1 and a double extraction. For quantification, gas chromatography/mass spectrometry with deuterated internal standards was used. The investigated samples were alcoholic beverages and unrecorded alcohol products from different countries (n = 257). Two unrecorded alcohol samples from Lithuania contained diethyl phthalate in concentrations of 608 mg/L and 210 mg/L. Conclusions/Significance: The consumption of the phthalate-positive unrecorded alcohols would exceed tolerable daily intakes as derived from animal experiments. Both positive samples were labelled as cosmetic alcohol, but had clearly been offered for human consumption. DEP seems to be unsuitable as a denaturing agent as it has no effect on the organoleptic properties of ethanol. In light of our results that DEP might be consumed by humans in unrecorded alcohols, the prohibition of its use as a denaturing agent should be considered.	[Leitz, Jenny; Kuballa, Thomas; Lachenmeier, Dirk W.] CVUA, Karlsruhe, Germany; [Rehm, Juergen] CAMH, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Technische Universitat Dresden	Leitz, J (corresponding author), CVUA, Karlsruhe, Germany.	lachenmeier@web.de	Lachenmeier, Dirk W/A-3210-2008; Rem, Jürgen/H-1309-2011	Lachenmeier, Dirk W/0000-0002-3115-864X; 	European Commission Seventh Framework Programme; AMPHORA (Alcohol Measures for Public Health Research Alliance) [223059]; Hospital Clinic de Barcelona	European Commission Seventh Framework Programme(European Commission); AMPHORA (Alcohol Measures for Public Health Research Alliance); Hospital Clinic de Barcelona	The work reported in this manuscript was partially financed by the European Commission Seventh Framework Programme Project AMPHORA (Alcohol Measures for Public Health Research Alliance), project number 223059, granted to the Hospital Clinic de Barcelona (http://www.amphoraproject.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton R, 2005, EFSA J, V3, DOI 10.2903/j.efsa.2005.204/full; Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF DIETH PHTH; Aurela B, 1999, FOOD ADDIT CONTAM, V16, P571, DOI 10.1080/026520399283713; BROWN D, 1978, FOOD COSMET TOXICOL, V16, P415, DOI 10.1016/S0015-6264(78)80258-2; Chou K, 2006, J MED TOXICOL, V2, P126, DOI 10.1007/BF03161027; Cosmetic Ingredient Review Expert, 2005, INT J TOXICOL, V24, P1, DOI 10.1080/10915810590918625; Del Carlo M, 2008, FOOD CHEM, V111, P771, DOI 10.1016/j.foodchem.2008.04.065; DIN, 1994, 32645 DIN; Ejim O. S., 2007, AFR J DRUG ALCOHOL S, V6, P65; *EUR COUNC, 1993, OFF J EUROP COMM L, V290, P14; Gruber L, 1998, DEUT LEBENSM-RUNDSCH, V94, P177; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; *ISO, 2005, 170252005 ISO IEC; Kanteres F, 2009, SCI TOTAL ENVIRON, V407, P5861, DOI 10.1016/j.scitotenv.2009.08.012; Kanteres F, 2009, ADDICTION, V104, P752, DOI 10.1111/j.1360-0443.2009.02507.x; Kueseng P, 2007, J ENVIRON SCI HEAL B, V42, P569, DOI 10.1080/03601230701389488; Lachenmeier DW, 2007, ALCOHOL CLIN EXP RES, V31, P1613, DOI 10.1111/j.1530-0277.2007.00474.x; Lachenmeier DW, 2009, ALCOHOL CLIN EXP RES, V33, P1757, DOI 10.1111/j.1530-0277.2009.01013.x; Lachenmeier DW, 2009, ADDICTION, V104, P875, DOI 10.1111/j.1360-0443.2009.02587.x; Lachenmeier DW, 2009, DEUT LEBENSM-RUNDSCH, V105, P507; Lachenmeier DW, 2009, INT J ENV RES PUB HE, V6, P2090, DOI 10.3390/ijerph6082090; Lachenmeier DW, 2009, INT J ENV RES PUB HE, V6, P349, DOI 10.3390/ijerph6010349; Lachenmeier DW, 2009, ALCOHOL ALCOHOLISM, V44, P93, DOI 10.1093/alcalc/agn095; LOUPY A, 1986, J ORG CHEM, V51, P740, DOI 10.1021/jo00355a032; Mikula P, 2005, CZECH J FOOD SCI, V23, P217, DOI 10.17221/3394-CJFS; *NTP, 1995, 429 NTP TR US DEP HH; Pfordt J, 2004, DEUT LEBENSM-RUNDSCH, V100, P431; RAPP A, 1994, BRANNTWEINWIRTSCH, V134, P286; Rehm J, 2010, DRUG ALCOHOL REV, V29, P426, DOI 10.1111/j.1465-3362.2009.00140.x; Roth M, 2007, DEUT LEBENSM-RUNDSCH, V103, P45; Savchuk SA, 2006, J ANAL CHEM+, V61, P1198, DOI 10.1134/S1061934806120136; SCHWETLICK K, 2001, ORGANIKUM, P241; Shibko S I, 1973, Environ Health Perspect, V3, P131, DOI 10.2307/3428039; *USEPA, 2003, 84662 CASRN USEPA; WHO, 2003, CONCISE INT CHEM ASS, V52, P1020	36	45	50	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8127	10.1371/journal.pone.0008127	http://dx.doi.org/10.1371/journal.pone.0008127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956573	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828800020
J	Ravindran, S; Lodoen, MB; Verhelst, SHL; Bogyo, M; Boothroyd, JC				Ravindran, Sandeep; Lodoen, Melissa B.; Verhelst, Steven H. L.; Bogyo, Matthew; Boothroyd, John C.			4-Bromophenacyl Bromide Specifically Inhibits Rhoptry Secretion during Toxoplasma Invasion	PLOS ONE			English	Article							HOST-CELL PENETRATION; GRANULE PROTEIN GRA7; PHOSPHOLIPASE A(2); GONDII; PARASITE; MACROPHAGES; EXPRESSION; VIRULENCE; MUTANTS; FORMS	Toxoplasma gondii is a eukaryotic parasite of the phylum Apicomplexa that is able to infect a wide variety of host cells. During its active invasion process it secretes proteins from discrete secretory organelles: the micronemes, rhoptries and dense granules. Although a number of rhoptry proteins have been shown to be involved in important interactions with the host cell, very little is known about the mechanism of secretion of any Toxoplasma protein into the host cell. We used a chemical inhibitor of phospholipase A2s, 4-bromophenacyl bromide (4-BPB), to look at the role of such lipases in the secretion of Toxoplasma proteins. We found that 4-BPB was a potent inhibitor of rhoptry secretion in Toxoplasma invasion. This drug specifically blocked rhoptry secretion but not microneme secretion, thus effectively showing that the two processes can be de-coupled. It affected parasite motility and invasion, but not attachment or egress. Using propargyl- or azido-derivatives of the drug (so-called click chemistry derivatives) and a series of 4-BPB-resistant mutants, we found that the drug has a very large number of target proteins in the parasite that are involved in at least two key steps: invasion and intracellular growth. This potent compound, the modified "click-chemistry'' forms of it, and the resistant mutants should serve as useful tools to further study the processes of Toxoplasma early invasion, in general, and rhoptry secretion, in particular.	[Ravindran, Sandeep; Lodoen, Melissa B.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Verhelst, Steven H. L.] Tech Univ Munich, Ctr Integrat Prot Sci Munich, D-8050 Freising Weihenstephan, Germany; [Bogyo, Matthew] Stanford Univ, Dept Pathol & Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Technical University of Munich; Stanford University	Ravindran, S (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jboothr@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Bogyo, Matthew/0000-0003-3753-4412; Verhelst, Steven/0000-0002-7400-1319	N.I.H [AI21423, AI078947, RR020843]; Stanford Graduate Fellowship; Giannini Foundation Medical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI021423, R01AI078947] Funding Source: NIH RePORTER	N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Giannini Foundation Medical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the N.I.H. (AI21423, AI078947 and RR020843), a Stanford Graduate Fellowship (to S. R.) and an A. P. Giannini Foundation Medical Research Fellowship (to M. B. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cassaing S, 2000, INT J PARASITOL, V30, P1137, DOI 10.1016/S0020-7519(00)00101-6; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dunn JD, 2008, INFECT IMMUN, V76, P5853, DOI 10.1128/IAI.01667-07; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Jacobs D, 1998, MOL BIOCHEM PARASIT, V91, P237, DOI 10.1016/S0166-6851(97)00204-1; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; LODOEN MB, 2009, CELLULAR MICROBIOLOG; Marin JEG, 1996, CELL IMMUNOL, V169, P218, DOI 10.1006/cimm.1996.0112; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Radke JR, 2000, EXP PARASITOL, V96, P168, DOI 10.1006/expr.2000.4568; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SAFFER LD, 1989, AM J TROP MED HYG, V40, P145, DOI 10.4269/ajtmh.1989.40.145; SAFFER LD, 1991, J PROTOZOOL, V38, P454, DOI 10.1111/j.1550-7408.1991.tb04816.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; THARDIN JF, 1993, INFECT IMMUN, V61, P1432, DOI 10.1128/IAI.61.4.1432-1441.1993; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	37	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8143	10.1371/journal.pone.0008143	http://dx.doi.org/10.1371/journal.pone.0008143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956582	Green Published, gold			2022-12-27	WOS:000272828800031
J	Kartal, O; Ebenhoh, O				Kartal, Oender; Ebenhoeh, Oliver			Ground State Robustness as an Evolutionary Design Principle in Signaling Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; TRANSDUCTION; MOTIFS; CELL; ORGANIZATION; SPECIFICITY; DATABASE; BIOLOGY; SYSTEMS; DOMAINS	The ability of an organism to survive depends on its capability to adapt to external conditions. In addition to metabolic versatility and efficient replication, reliable signal transduction is essential. As signaling systems are under permanent evolutionary pressure one may assume that their structure reflects certain functional properties. However, despite promising theoretical studies in recent years, the selective forces which shape signaling network topologies in general remain unclear. Here, we propose prevention of autoactivation as one possible evolutionary design principle. A generic framework for continuous kinetic models is used to derive topological implications of demanding a dynamically stable ground state in signaling systems. To this end graph theoretical methods are applied. The index of the underlying digraph is shown to be a key topological property which determines the so-called kinetic ground state (or off-state) robustness. The kinetic robustness depends solely on the composition of the subdigraph with the strongly connected components, which comprise all positive feedbacks in the network. The component with the highest index in the feedback family is shown to dominate the kinetic robustness of the whole network, whereas relative size and girth of these motifs are emphasized as important determinants of the component index. Moreover, depending on topological features, the maintenance of robustness differs when networks are faced with structural perturbations. This structural off-state robustness, defined as the average kinetic robustness of a network's neighborhood, turns out to be useful since some structural features are neutral towards kinetic robustness, but show up to be supporting against structural perturbations. Among these are a low connectivity, a high divergence and a low path sum. All results are tested against real signaling networks obtained from databases. The analysis suggests that ground state robustness may serve as a rationale for some structural peculiarities found in intracellular signaling networks.	[Kartal, Oender; Ebenhoeh, Oliver] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kartal, Oender; Ebenhoeh, Oliver] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Ebenhoeh, Oliver] Univ Aberdeen, Inst Complex Syst, Aberdeen, Scotland	Max Planck Society; University of Potsdam; University of Aberdeen	Kartal, O (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	kartal@mpimp-golm.mpg.de	Ebenhoeh, Oliver/C-8974-2011	Ebenhoeh, Oliver/0000-0002-7229-7398; Kartal, Onder/0000-0002-4203-9662	Scottish Funding Council; Scottish Universities Life Science Alliance (SULSA)	Scottish Funding Council; Scottish Universities Life Science Alliance (SULSA)	German Ministry of Education and Research (BMBF), GoFORSYS research initiative. Funding provided by the Scottish Funding Council, Scottish Universities Life Science Alliance (SULSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BANGJENSEN J, 2001, DIGRAPHS THEORY ALGO; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Binder Bernd, 2005, Genome Inform, V16, P164; Binder Bernd, 2004, Genome Inform, V15, P13; Brualdi R., 1982, LINEAR MULTILINEAR A, V11, P143, DOI DOI 10.1080/03081088208817439; CAMBIER JC, SCI SIGNAL; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; COOPER CDH, 1973, MATH Z, V131, P213, DOI 10.1007/BF01187238; Cvetkovic DM, 1995, SPECTRA GRAPHS; Ebenhoh O, 2003, B MATH BIOL, V65, P323, DOI 10.1016/S0092-8240(03)00002-8; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; GLEICH DF, MATLAB BGL 4 0; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; Gough NR, 2002, ANN NY ACAD SCI, V971, P585, DOI 10.1111/j.1749-6632.2002.tb04532.x; Hammerstein Peter, 2006, Biological Theory, V1, P90, DOI 10.1162/biot.2006.1.1.90; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Horn RA, 1999, MATRIX ANAL; HORVATH CM, SCI SIGNAL; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KOBILKA BK, SCI SIGNAL; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MISHRA L, SCI SIGNAL; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Soyer OS, 2006, J THEOR BIOL, V238, P416, DOI 10.1016/j.jtbi.2005.05.030; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wagner A, 2004, ADV COMPLEX SYST, V7, P419, DOI 10.1142/S0219525904000251; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; WAGNER A, 2003, SCI STKE, pPE41; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Zhang XD, 2002, ACTA MATH SIN, V18, P293, DOI 10.1007/s101140200157	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8001	10.1371/journal.pone.0008001	http://dx.doi.org/10.1371/journal.pone.0008001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956601	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700004
J	Kalantzis, G; Shouval, HZ				Kalantzis, Georgios; Shouval, Harel Z.			Structural Plasticity Can Produce Metaplasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; DENDRITIC SPINES; SYNAPTIC PLASTICITY; BIOPHYSICAL MODEL; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; CA2+; LTP	Background: Synaptic plasticity underlies many aspect of learning memory and development. The properties of synaptic plasticity can change as a function of previous plasticity and previous activation of synapses, a phenomenon called metaplasticity. Synaptic plasticity not only changes the functional connectivity between neurons but in some cases produces a structural change in synaptic spines; a change thought to form a basis for this observed plasticity. Here we examine to what extent structural plasticity of spines can be a cause for metaplasticity. This study is motivated by the observation that structural changes in spines are likely to affect the calcium dynamics in spines. Since calcium dynamics determine the sign and magnitude of synaptic plasticity, it is likely that structural plasticity will alter the properties of synaptic plasticity. Methodology/Principal Findings: In this study we address the question how spine geometry and alterations of N-methyl-D-aspartic acid (NMDA) receptors conductance may affect plasticity. Based on a simplified model of the spine in combination with a calcium-dependent plasticity rule, we demonstrated that after the induction phase of plasticity a shift of the long term potentiation (LTP) or long term depression (LTD) threshold takes place. This induces a refractory period for further LTP induction and promotes depotentiation as observed experimentally. That resembles the BCM metaplasticity rule but specific for the individual synapse. In the second phase, alteration of the NMDA response may bring the synapse to a state such that further synaptic weight alterations are feasible. We show that if the enhancement of the NMDA response is proportional to the area of the post synaptic density (PSD) the plasticity curves most likely return to the initial state. Conclusions/Significance: Using simulations of calcium dynamics in synaptic spines, coupled with a biophysically motivated calcium-dependent plasticity rule, we find under what conditions structural plasticity can form the basis of synapse specific metaplasticity.	[Kalantzis, Georgios; Shouval, Harel Z.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kalantzis, G (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA.	kalantzi@bcm.edu; harel.shouval@uth.tmc.edu			National Institute of Health [2 P01-NS038310-06A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grant 2 P01-NS038310-06A2 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2003, BIOL CYBERN, V89, P214, DOI 10.1007/s00422-003-0422-x; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1990, SCIENCE, V249, P973, DOI 10.1126/science.2396098; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holcman D, 2004, BIOPHYS J, V87, P81, DOI 10.1529/biophysj.103.035972; HOLMES WR, 1990, J NEUROPHYSIOL, V63, P1148, DOI 10.1152/jn.1990.63.5.1148; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; JAHR CE, 1990, J NEUROSCI, V10, P3178; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Keller DX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002045; Kim CH, 1999, J NEUROSCI, V19, P4314; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Racca C, 2000, J NEUROSCI, V20, P2512; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; Shouval HZ, 2005, J NEUROPHYSIOL, V93, P1069, DOI 10.1152/jn.00504.2004; Shouval HZ, 2002, BIOL CYBERN, V87, P383, DOI 10.1007/s00422-002-0362-x; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sorra KE, 1998, J NEUROSCI, V18, P658; Takumi Y, 1999, ANN NY ACAD SCI, V868, P474, DOI 10.1111/j.1749-6632.1999.tb11316.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Volfovsky N, 1999, J NEUROPHYSIOL, V82, P450, DOI 10.1152/jn.1999.82.1.450; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeung LC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011907; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	54	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8062	10.1371/journal.pone.0008062	http://dx.doi.org/10.1371/journal.pone.0008062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956610	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828400016
J	Walshe, VA; Hattotuwagama, CK; Doytchinova, IA; Wong, M; Macdonald, IK; Mulder, A; Claas, FHJ; Pellegrino, P; Turner, J; Williams, I; Turnbull, EL; Borrow, P; Flower, DR				Walshe, Valerie A.; Hattotuwagama, Channa K.; Doytchinova, Irini A.; Wong, MaiLee; Macdonald, Isabel K.; Mulder, Arend; Claas, Frans H. J.; Pellegrino, Pierre; Turner, Jo; Williams, Ian; Turnbull, Emma L.; Borrow, Persephone; Flower, Darren R.			Integrating In Silico and In Vitro Analysis of Peptide Binding Affinity to HLA-Cw*0102: A Bioinformatic Approach to the Prediction of New Epitopes	PLOS ONE			English	Article							T-CELL RESPONSES; MHC BINDING; HLA-C; MOLECULE HLA-A-ASTERISK-0201; QUANTITATIVE PREDICTION; HIV-1 INFECTION; RECOGNITION; DIVERSITY; VIRUS; IDENTIFICATION	Background: Predictive models of peptide-Major Histocompatibility Complex (MHC) binding affinity are important components of modern computational immunovaccinology. Here, we describe the development and deployment of a reliable peptide-binding prediction method for a previously poorly-characterized human MHC class I allele, HLA-Cw*0102. Methodology/Findings: Using an in-house, flow cytometry-based MHC stabilization assay we generated novel peptide binding data, from which we derived a precise two-dimensional quantitative structure-activity relationship (2D-QSAR) binding model. This allowed us to explore the peptide specificity of HLA-Cw*0102 molecule in detail. We used this model to design peptides optimized for HLA-Cw*0102-binding. Experimental analysis showed these peptides to have high binding affinities for the HLA-Cw*0102 molecule. As a functional validation of our approach, we also predicted HLA-Cw*0102-binding peptides within the HIV-1 genome, identifying a set of potent binding peptides. The most affine of these binding peptides was subsequently determined to be an epitope recognized in a subset of HLA-Cw*0102-positive individuals chronically infected with HIV-1. Conclusions/Significance: A functionally-validated in silico-in vitro approach to the reliable and efficient prediction of peptide binding to a previously uncharacterized human MHC allele HLA-Cw*0102 was developed. This technique is generally applicable to all T cell epitope identification problems in immunology and vaccinology.	[Walshe, Valerie A.; Hattotuwagama, Channa K.; Doytchinova, Irini A.; Wong, MaiLee; Macdonald, Isabel K.; Turnbull, Emma L.; Borrow, Persephone; Flower, Darren R.] Univ Oxford, Jenner Inst, Compton, Berks, England; [Mulder, Arend; Claas, Frans H. J.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Pellegrino, Pierre; Turner, Jo; Williams, Ian] Royal Free & Univ Coll London, Sch Med, Ctr Sexual Hlth & HIV Res, London, England; [Pellegrino, Pierre; Turner, Jo; Williams, Ian] Camden Primary Care Trust, London, England	University of Oxford; Jenner Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; UCL Medical School	Walshe, VA (corresponding author), Hlth Protect Agcy, Ctr Emergency Preparedness & Response, Salisbury, Wilts, England.	darren.flower@jenner.ac.uk	Doytchinova, Irini/A-2949-2011; Flower, Darren/F-1263-2010; Doytchinova, Irini/ABG-3962-2020	Flower, Darren/0000-0002-8542-7067; Doytchinova, Irini/0000-0002-1469-1768; Borrow, Persephone/0000-0002-3877-9780	Biotechnology and Biological Sciences Research Council SRC [BB/D004020/1]; Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation [37384]; Edward Jenner Institute for Vaccine Research (EJIVR); Wellcome Trust [WT079287MA]; BBSRC [BB/D004020/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D004020/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council SRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Edward Jenner Institute for Vaccine Research (EJIVR); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council SRC Grant BB/D004020/1 and the Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation (# 37384). No part of the work was supported by the University of Oxford. Early stages of the work were funded by The Edward Jenner Institute for Vaccine Research (EJIVR). The Edward Jenner Institute for Vaccine Research thanks its erstwhile charitable sponsors: the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Department of Health, and GlaxoSmithKline. These funding bodies had no role of any kind in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. GlaxoSmithKline did not directly fund the work described here, but did make an indirect charitable donation to the core funding of the EJIVR. PB and DRF received salary support from Senior Jenner Fellowships, and are both Jenner Institute Investigators. IKM and DRF drew additional support from the Wellcome Trust Grant WT079287MA.	Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Blythe MJ, 2002, BIOINFORMATICS, V18, P434, DOI 10.1093/bioinformatics/18.3.434; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Brooks A G, 2000, Rev Immunogenet, V2, P433; Calderone CT, 2001, J AM CHEM SOC, V123, P6262, DOI 10.1021/ja003016y; Cao J, 2008, J VIROL, V82, P495, DOI 10.1128/JVI.01096-07; Davies MN, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-5; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Doytchinova IA, 2004, METHODS, V34, P444, DOI 10.1016/j.ymeth.2004.06.007; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Doytchinova IA, 2003, BIOINFORMATICS, V19, P2263, DOI 10.1093/bioinformatics/btg312; Doytchinova IA, 2002, J PROTEOME RES, V1, P263, DOI 10.1021/pr015513z; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Doytchinova IA, 2006, MOL IMMUNOL, V43, P2037, DOI 10.1016/j.molimm.2005.12.013; Doytchinova IA, 2007, J CHEM INF MODEL, V47, P234, DOI 10.1021/ci600318z; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flower DR, 1998, J MOL GRAPH MODEL, V16, P239, DOI 10.1016/S1093-3263(98)80008-9; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1997, AIDS, V11, P1884, DOI 10.1097/00002030-199715000-00016; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Guan PP, 2003, PROTEIN ENG, V16, P11, DOI 10.1093/proeng/gzg005; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Hattotuwagama CK, 2004, ORG BIOMOL CHEM, V2, P3274, DOI 10.1039/b409656h; Hauptmann G, 2004, CURR OPIN IMMUNOL, V16, P668, DOI 10.1016/j.coi.2004.07.001; Heinonen KM, 2008, CRIT REV IMMUNOL, V28, P441, DOI 10.1615/CritRevImmunol.v28.i5.40; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; KORBER BTM, 2007, LAUR074752 LOS AL NA; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Lopes AR, 2003, J IMMUNOL, V171, P307, DOI 10.4049/jimmunol.171.1.307; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McSparron H, 2003, J CHEM INF COMP SCI, V43, P1276, DOI 10.1021/ci030461e; Mulder A, 1998, TISSUE ANTIGENS, V52, P393, DOI 10.1111/j.1399-0039.1998.tb03062.x; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schuler Mathias M., 2007, V409, P75; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; STUBER G, 1992, EUR J IMMUNOL, V22, P2697, DOI 10.1002/eji.1830221033; Thananchai H, 2009, AIDS, V23, P189, DOI 10.1097/QAD.0b013e32831fb55a; Tong Joo Chuan, 2007, Immunome Res, V3, P7, DOI 10.1186/1745-7580-3-7; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; *TRIP INC, SYBYL6 9; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; Willett P, 1995, TRENDS BIOTECHNOL, V13, P516, DOI 10.1016/S0167-7799(00)89015-0; Wilson I A, 1993, Semin Immunol, V5, P75, DOI 10.1006/smim.1993.1011; Yokoyama WM, 2005, IMMUNOL RES, V32, P317, DOI 10.1385/IR:32:1-3:317; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579	64	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8095	10.1371/journal.pone.0008095	http://dx.doi.org/10.1371/journal.pone.0008095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956609	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000272828400031
J	Protopopoff, N; Van Bortel, W; Speybroeck, N; Van Geertruyden, JP; Baza, D; D'Alessandro, U; Coosemans, M				Protopopoff, Natacha; Van Bortel, Wim; Speybroeck, Niko; Van Geertruyden, Jean-Pierre; Baza, Dismas; D'Alessandro, Umberto; Coosemans, Marc			Ranking Malaria Risk Factors to Guide Malaria Control Efforts in African Highlands	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TARGETED VECTOR CONTROL; PUBLIC-HEALTH IMPACT; ANOPHELES-GAMBIAE; CLIMATE-CHANGE; WESTERN KENYA; ENVIRONMENTAL-MANAGEMENT; USAMBARA MOUNTAINS; LAND-COVER; SPATIAL-DISTRIBUTION	Introduction: Malaria is re-emerging in most of the African highlands exposing the non immune population to deadly epidemics. A better understanding of the factors impacting transmission in the highlands is crucial to improve well targeted malaria control strategies. Methods and Findings: A conceptual model of potential malaria risk factors in the highlands was built based on the available literature. Furthermore, the relative importance of these factors on malaria can be estimated through "classification and regression trees'', an unexploited statistical method in the malaria field. This CART method was used to analyse the malaria risk factors in the Burundi highlands. The results showed that Anopheles density was the best predictor for high malaria prevalence. Then lower rainfall, no vector control, higher minimum temperature and houses near breeding sites were associated by order of importance to higher Anopheles density. Conclusions: In Burundi highlands monitoring Anopheles densities when rainfall is low may be able to predict epidemics. The conceptual model combined with the CART analysis is a decision support tool that could provide an important contribution toward the prevention and control of malaria by identifying major risk factors.	[Protopopoff, Natacha; Van Bortel, Wim; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Protopopoff, Natacha] Med Sans Frontieres Belgium, Brussels, Belgium; [Speybroeck, Niko] Inst Trop Med Prince Leopold, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Sch Publ Hlth, B-1200 Brussels, Belgium; [Baza, Dismas] Minist Hlth, Programme Lutte Malad Transmissibles & Carentiell, Bujumbura, Burundi; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Universite Catholique Louvain; University of Antwerp	Protopopoff, N (corresponding author), Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be	D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014; Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021	D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van Bortel, Wim/0000-0002-6644-518X; Speybroeck, Niko/0000-0003-3322-3502; Protopopoff, Natacha/0000-0001-6698-4936	MSF-Belgium; Belgian co-operation	MSF-Belgium; Belgian co-operation	This work was funded by MSF-Belgium and the Belgian co-operation. MSF Belgium has a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The Belgian cooperation has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bjorkman AB, 2005, ACTA TROP, V94, P163, DOI 10.1016/j.actatropica.2005.04.015; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Bonora S, 2001, TRENDS PARASITOL, V17, P572, DOI 10.1016/S1471-4922(01)02095-5; Bousema JT, 2003, TROP MED INT HEALTH, V8, P427, DOI 10.1046/j.1365-3156.2003.01047.x; Breiman L, 1993, CLASSIFICATION REGRE; Carlson JC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-33; COOSEMANS MH, 1985, ANN SOC BELG MED TR, V65, P187; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Elghazali G, 2003, East Mediterr Health J, V9, P570; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; GARNHAM PCC, 1945, BRIT MED J, V2, P45, DOI 10.1136/bmj.2.4410.45; GARNHAM PCC, 1948, TROP MED HYG, V51, P156; Gaudart Jean, 2005, BMC Med Res Methodol, V5, P22, DOI 10.1186/1471-2288-5-22; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hay SI, 2002, EMERG INFECT DIS, V8, P543, DOI 10.3201/eid0806.010309; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HELD TK, 1994, Q J MED, V87, P17; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; KHAEMBA BM, 1994, E AFR MED J, V71, P159; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Koenraadt CJM, 2006, TROP MED INT HEALTH, V11, P1195, DOI 10.1111/j.1365-3156.2006.01675.x; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; MCCARTHY FD, 2000, NBER WORKING PAPERS, V7541; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mouchet J, 1997, B SOC PATHOL EXOT, V90, P162; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Negash K, 2005, East Afr Med J, V82, P186; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-93; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Schwetz J., 1948, Acta Tropica Basle, V5, P78; Seyoum A, 2002, East Afr Med J, V79, P485; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Sissoko MS, 2004, ACTA TROP, V89, P161, DOI 10.1016/j.actatropica.2003.10.015; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Sowunmi A, 2003, TROP MED INT HEALTH, V8, P783, DOI 10.1046/j.1365-3156.2003.01093.x; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; STEVENS PA, 1984, B WORLD HEALTH ORGAN, V62, P77; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Thomas CJ, 2004, TRENDS PARASITOL, V20, P216, DOI 10.1016/j.pt.2004.03.001; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; Van Geertruyden JP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-134; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WHO, 2000, AB DECL PLAN ACT EXT; WHO, 2006, AFR MAL REP 2006; Yohannes M, 2005, TROP MED INT HEALTH, V10, P1274, DOI 10.1111/j.1365-3156.2005.01512.x; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; [No title captured]	100	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8022	10.1371/journal.pone.0008022	http://dx.doi.org/10.1371/journal.pone.0008022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946627	Green Published, gold, Green Accepted			2022-12-27	WOS:000272827800014
J	Lee, E; Jeong, J; Kim, SE; Song, EJ; Kang, SW; Lee, KJ				Lee, Eunsun; Jeong, Jaeho; Kim, Sung Eun; Song, Eun Joo; Kang, Sang Won; Lee, Kong-Joo			Multiple Functions of Nm23-H1 Are Regulated by Oxido-Reduction System	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; NERVE GROWTH-FACTOR; NF-KAPPA-B; METASTASIS SUPPRESSOR; TUMOR-METASTASIS; DNA-BINDING; OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATIONS; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR	Nucleoside diphosphate kinase (NDPK, Nm23), a housekeeping enzyme, is known to be a multifunctional protein, acting as a metastasis suppressor, transactivation activity on c-myc, and regulating endocytosis. The cellular mechanisms regulating Nm23 functions are poorly understood. In this study, we identified the modifications and interacting proteins of Nm23-H1 in response to oxidative stress. We found that Cys109 in Nm23-H1 is oxidized to various oxidation states including intra-and inter-disulfide crosslinks, glutathionylation, and sulfonic acid formation in response to H2O2 treatment both in vivo and in vitro. The cross-linking sites and modifications of oxidized Nm23-H1 were identified by peptide sequencing using UPLC ESIq-TOF tandem MS. Glutathionylation and oxidation of Cys109 inhibited the NDPK enzymatic activity of Nm23-H1. We also found that thioredoxin reductase 1 (TrxR1) is an interacting protein of Nm23-H1, and it binds specifically to oxidized Nm23-H1. Oxidized Nm23 is a substrate of NADPH-TrxR1-thioredoxin shuttle system, and the disulfide crosslinking is reversibly reduced and the enzymatic activity is recovered by this system. Oxidation of Cys109 in Nm23-H1 inhibited its metastatic suppressor activity as well as the enzymatic activities. The mutant, Nm23-H1 C109A, retained both the enzymatic and metastasis suppressor activities under oxidative stress. This suggests that key enzymatic and metastasis suppressor functions of Nm23-H1 are regulated by oxido-reduction of its Cys109.	[Lee, Eunsun] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Coll Pharm, Seoul, South Korea; Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, E (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Coll Pharm, Seoul, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666				Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Freije JMP, 1996, CURR TOP MICROBIOL, V213, P215; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Heo YJ, 1997, J CHROMATOGR A, V781, P251; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ishijima Y, 1999, FEBS LETT, V445, P155, DOI 10.1016/S0014-5793(99)00116-7; JI L, 1995, J BIOL CHEM, V270, P13392, DOI 10.1074/jbc.270.22.13392; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Kim SY, 1997, MOL CELLS, V7, P630; Kim SY, 2001, J BIOCHEM MOL BIOL, V34, P355; Kim SY, 2000, CELL GROWTH DIFFER, V11, P485; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; Kraeft SK, 1996, EXP CELL RES, V227, P63, DOI 10.1006/excr.1996.0250; LEONE A, 1993, ONCOGENE, V8, P2325; LUNDSTROMLJUNG J, 1995, FEBS LETT, V357, P305, DOI 10.1016/0014-5793(94)01386-F; Murakami M, 2008, INT J CANCER, V123, P500, DOI 10.1002/ijc.23568; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; NAKAYAMA T, 1992, J NATL CANCER I, V84, P1349, DOI 10.1093/jnci/84.17.1349; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ouatas T, 2003, J BIOENERG BIOMEMBR, V35, P73, DOI 10.1023/A:1023497924277; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; POSTEL EH, 1994, J BIOL CHEM, V269, P8627; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	49	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7949	10.1371/journal.pone.0007949	http://dx.doi.org/10.1371/journal.pone.0007949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956735	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827300008
J	Amato, R; Pinelli, M; Monticelli, A; Marino, D; Miele, G; Cocozza, S				Amato, Roberto; Pinelli, Michele; Monticelli, Antonella; Marino, Davide; Miele, Gennaro; Cocozza, Sergio			Genome-Wide Scan for Signatures of Human Population Differentiation and Their Relationship with Natural Selection, Functional Pathways and Diseases	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; POSITIVE SELECTION; PURIFYING SELECTION; COMMON DISEASE; GENE; DIVERSITY; EVOLUTION; VARIANTS; SIGNALS; RISK	Genetic differences both between individuals and populations are studied for their evolutionary relevance and for their potential medical applications. Most of the genetic differentiation among populations are caused by random drift that should affect all loci across the genome in a similar manner. When a locus shows extraordinary high or low levels of population differentiation, this may be interpreted as evidence for natural selection. The most used measure of population differentiation was devised by Wright and is known as fixation index, or F-ST. We performed a genome-wide estimation of F-ST on about 4 millions of SNPs from HapMap project data. We demonstrated a heterogeneous distribution of F-ST values between autosomes and heterochromosomes. When we compared the F-ST values obtained in this study with another evolutionary measure obtained by comparative interspecific approach, we found that genes under positive selection appeared to show low levels of population differentiation. We applied a gene set approach, widely used for microarray data analysis, to detect functional pathways under selection. We found that one pathway related to antigen processing and presentation showed low levels of F-ST, while several pathways related to cell signalling, growth and morphogenesis showed high F-ST values. Finally, we detected a signature of selection within genes associated with human complex diseases. These results can help to identify which process occurred during human evolution and adaptation to different environments. They also support the hypothesis that common diseases could have a genetic background shaped by human evolution.			Amato, R (corresponding author), Univ Salerno, Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	roamato@na.infn.it	Cocozza, Sergio/F-6488-2010; Miele, Gennaro/F-3628-2010; Miele, Gennaro/AAG-6782-2020; Pinelli, Michele/A-1584-2010	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578; Pinelli, Michele/0000-0002-5927-1185; Amato, Roberto/0000-0001-8633-9221				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; FUJII T, 2007, BIOL PSYCHIAT, V31, P873, DOI DOI 10.1016/J.PNPBP.2007.01.027; Green ML, 2007, DEV DYNAM, V236, P613, DOI 10.1002/dvdy.21048; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Iorio F, 2009, J COMPUT BIOL, V16, P241, DOI 10.1089/cmb.2008.10TT; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Keller MC, 2006, BEHAV BRAIN SCI, V29, P429, DOI 10.1017/S0140525X06459094; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kimura M, 1985, NEUTRAL THEORY MOL E; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lahiri S. N., 2003, RESAMPLING METHODS D, P115; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Peng B, 2007, GENETICS, V175, P763, DOI 10.1534/genetics.106.058164; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tarazona-Santos E, 2008, HUM MUTAT, V29, P623, DOI 10.1002/humu.20667; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Weicker JJ, 2001, EVOLUTION, V55, P2601; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; WRIGHT S, 1951, ANN EUGENIC, V15, P323	63	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7927	10.1371/journal.pone.0007927	http://dx.doi.org/10.1371/journal.pone.0007927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936260	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004800009
J	Ahmet, I; Spangler, E; Shukitt-Hale, B; Joseph, JA; Ingram, DK; Talan, M				Ahmet, Ismayil; Spangler, Edward; Shukitt-Hale, Barbara; Joseph, James A.; Ingram, Donald K.; Talan, Mark			Survival and Cardioprotective Benefits of Long-Term Blueberry Enriched Diet in Dilated Cardiomyopathy Following Myocardial Infarction in Rats	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CARDIAC MYOCYTE APOPTOSIS; QUALITY-OF-LIFE; HEART-FAILURE; BEHAVIORAL DEFICITS; DISEASE; DEATH	Background: Despite remarkable progress in treatment of chronic heart failure (CHF) over the last two decades, mortality, personal suffering and cost remain staggering, and effective interventions are still a challenge. Previously we reported that a blueberry-enriched diet (BD) attenuated necroapoptosis and inflammation in periinfarct area in a rat model of myocardial infarction (MI). Objectives: To test the hypothesis that BD will attenuate the course of CHF, including mortality and cardiac remodeling during the first year after induction of MI in rats. Method and Results: Two weeks after coronary artery ligation, rats were divided into two groups of similar average MI size, measured by echocardiography, and then 12-mo dietary regimens were initiated as follows: ad libitum regular diet (control, CD, n = 27) and isocaloric food with 2% blueberry supplement (BD, n = 27) also available ad libitum. These dietary groups were compared to each other and to sham group (SH). Mortality over the 12 mo was reduced by 22% in BD compared with CD (p<0.01). In the course of developing CHF, BD had no effect on the body weight, heart rate or blood pressure. Bimonthly Echo revealed significant attenuation of the LV chamber remodeling, LV posterior wall thinning, and MI expansion in BD compared with CD. In fact, BD arrested the MI expansion. Conclusion: This is the first experimental evidence that a blueberry-enriched diet has positive effects on the course of CHF and thus warrants consideration for clinical evaluation.			Ahmet, I (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov		Shukitt-Hale, Barbara/0000-0002-3810-1910	NATIONAL INSTITUTE ON AGING [ZIAAG000811] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmet I, 2005, HEART FAIL REV, V10, P289, DOI 10.1007/s10741-005-7543-3; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005954; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Heart Failure Society Of America, 2006, J Card Fail, V12, pe1; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; HOCHMAN JS, 1982, CIRCULATION, V65, P1446, DOI 10.1161/01.CIR.65.7.1446; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Prior RL, 2000, J AOAC INT, V83, P950; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7975	10.1371/journal.pone.0007975	http://dx.doi.org/10.1371/journal.pone.0007975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936253	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600024
J	MacConaill, LE; Campbell, CD; Kehoe, SM; Bass, AJ; Hatton, C; Niu, LL; Davis, M; Yao, KL; Hanna, M; Mondal, C; Luongo, L; Emery, CM; Baker, AC; Philips, J; Goff, DJ; Fiorentino, M; Rubin, MA; Polyak, K; Chan, J; Wang, YX; Fletcher, JA; Santagata, S; Corso, G; Roviello, F; Shivdasani, R; Kieran, MW; Ligon, KL; Stiles, CD; Hahn, WC; Meyerson, ML; Garraway, LA				MacConaill, Laura E.; Campbell, Catarina D.; Kehoe, Sarah M.; Bass, Adam J.; Hatton, Charles; Niu, Lili; Davis, Matt; Yao, Keluo; Hanna, Megan; Mondal, Chandrani; Luongo, Lauren; Emery, Caroline M.; Baker, Alissa C.; Philips, Juliet; Goff, Deborah J.; Fiorentino, Michelangelo; Rubin, Mark A.; Polyak, Kornelia; Chan, Jennifer; Wang, Yuexiang; Fletcher, Jonathan A.; Santagata, Sandro; Corso, Gianni; Roviello, Franco; Shivdasani, Ramesh; Kieran, Mark W.; Ligon, Keith L.; Stiles, Charles D.; Hahn, William C.; Meyerson, Matthew L.; Garraway, Levi A.			Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GEFITINIB; CETUXIMAB; KRAS; ASTROCYTOMAS; CHEMOTHERAPY; DUPLICATION; COMBINATION; ACTIVATION	Background: Detection of critical cancer gene mutations in clinical tumor specimens may predict patient outcomes and inform treatment options; however, high-throughput mutation profiling remains underdeveloped as a diagnostic approach. We report the implementation of a genotyping and validation algorithm that enables robust tumor mutation profiling in the clinical setting. Methodology: We developed and implemented an optimized mutation profiling platform ("OncoMap'') to interrogate similar to 400 mutations in 33 known oncogenes and tumor suppressors, many of which are known to predict response or resistance to targeted therapies. The performance of OncoMap was analyzed using DNA derived from both frozen and FFPE clinical material in a diverse set of cancer types. A subsequent in-depth analysis was conducted on histologically and clinically annotated pediatric gliomas. The sensitivity and specificity of OncoMap were 93.8% and 100% in fresh frozen tissue; and 89.3% and 99.4% in FFPE-derived DNA. We detected known mutations at the expected frequencies in common cancers, as well as novel mutations in adult and pediatric cancers that are likely to predict heightened response or resistance to existing or developmental cancer therapies. OncoMap profiles also support a new molecular stratification of pediatric low-grade gliomas based on BRAF mutations that may have immediate clinical impact. Conclusions: Our results demonstrate the clinical feasibility of high-throughput mutation profiling to query a large panel of "actionable'' cancer gene mutations. In the future, this type of approach may be incorporated into both cancer epidemiologic studies and clinical decision making to specify the use of many targeted anticancer agents.			MacConaill, LE (corresponding author), Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA.	Levi_Garraway@dfci.harvard.edu	Davis, Matt/F-9045-2012; Wang, Yuexiang/GNH-5248-2022; Corso, Giovanni/AAN-5976-2020; Fiorentino, Michelangelo/AAB-8056-2022; Meyerson, Matthew L/E-7123-2012	Hatton, Charlie/0000-0001-9903-4291; Rubin, Mark/0000-0002-8321-9950; Santagata, Sandro/0000-0002-7528-9668; Kieran, Mark/0000-0003-2184-7692	NCI NIH HHS [K08 CA134931, R21CA126674, K08CA134931, R21 CA126674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA134931, R21CA126674] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cheng Y, 2000, HISTOPATHOLOGY, V37, P437, DOI 10.1046/j.1365-2559.2000.01005.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho DC, 2009, J CLIN ONCOL, V27; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ogino S, 2005, CLIN CANCER RES, V11, P6650, DOI 10.1158/1078-0432.CCR-05-0738; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PEARCE M, 2009, NATURE METHODS, V6; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Prenen H, 2006, PHARMACOLOGY, V77, P11, DOI 10.1159/000091943; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Van Cutsem E, 2009, J CLIN ONCOL, V27, P4509, DOI DOI 10.1200/jco.2009.27.18s.lba4509; Velasco A, 2006, HUM PATHOL, V37, P1465, DOI 10.1016/j.humpath.2006.05.007; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985	27	291	305	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7887	10.1371/journal.pone.0007887	http://dx.doi.org/10.1371/journal.pone.0007887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924296	Green Published, gold			2022-12-27	WOS:000271936700019
J	Zhang, P; Zucchelli, M; Bruce, S; Hambiliki, F; Stavreus-Evers, A; Levkov, L; Skottman, H; Kerkela, E; Kere, J; Hovatta, O				Zhang, Pu; Zucchelli, Marco; Bruce, Sara; Hambiliki, Fredwell; Stavreus-Evers, Anneli; Levkov, Lev; Skottman, Heli; Kerkela, Erja; Kere, Juha; Hovatta, Outi			Transcriptome Profiling of Human Pre-Implantation Development	PLOS ONE			English	Article							PYRUVATE UPTAKE; MOUSE OOCYTES; IN-VITRO; GENES; SELECTION	Background: Preimplantation development is a crucial step in early human development. However, the molecular basis of human preimplantation development is not well known. Methodology: By applying microarray on 397 human oocytes and embryos at six developmental stages, we studied the transcription dynamics during human preimplantation development. Principal Findings: We found that the preimplantation development consisted of two main transitions: from metaphase-II oocyte to 4-cell embryo where mainly the maternal genes were expressed, and from 8-cell embryo to blastocyst with down-regulation of the maternal genes and up-regulation of embryonic genes. Human preimplantation development proved relatively autonomous. Genes predominantly expressed in oocytes and embryos are well conserved during evolution. Significance: Our database and findings provide fundamental resources for understanding the genetic network controlling early human development.			Zhang, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	outi.hovatta@ki.se	Kerkelä, Erja/P-9459-2016; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kerkelä, Erja/0000-0002-2923-5300; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Skottman, Heli/0000-0002-4127-8792				Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CONAGHAN J, 1993, J ASSIST REPROD GEN, V10, P21, DOI 10.1007/BF01204436; CUI XS, 2006, MOL REPROD DEV; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Jeffery IB, 2007, BIOINFORMATICS, V23, P298, DOI 10.1093/bioinformatics/btl597; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mamo S, 2006, REPROD DOMEST ANIM, V41, P527, DOI 10.1111/j.1439-0531.2006.00708.x; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; TURNER K, 1994, HUM REPROD, V9, P2362, DOI 10.1093/oxfordjournals.humrep.a138453; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; ZHANG P, 2006, FERTIL STERIL; Zhang P, 2007, FERTIL STERIL, V87, P677, DOI 10.1016/j.fertnstert.2006.07.1509	28	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7844	10.1371/journal.pone.0007844	http://dx.doi.org/10.1371/journal.pone.0007844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924284	Green Published, gold, Green Submitted			2022-12-27	WOS:000271851000004
J	Frank, DN; Wilson, SS; St Amand, AL; Pace, NR				Frank, Daniel N.; Wilson, Shandra S.; St Amand, Allison L.; Pace, Norman R.			Culture-Independent Microbiological Analysis of Foley Urinary Catheter Biofilms	PLOS ONE			English	Article							TRACT-INFECTION; BACTERIAL BIOFILMS; MICROBIAL DIVERSITY; COLONIZATION; PREVENTION; NUMBER; ARB; ERA	Background: Prevention of catheter-associated urinary tract infection (CAUTI), a leading cause of nosocomial disease, is complicated by the propensity of bacteria to form biofilms on indwelling medical devices [ 1,2,3,4,5]. Methodology/Principal Findings: To better understand the microbial diversity of these communities, we report the results of a culture-independent bacterial survey of Foley urinary catheters obtained from patients following total prostatectomy. Two patient subsets were analyzed, based on treatment or no treatment with systemic fluoroquinolone antibiotics during convalescence. Results indicate the presence of diverse polymicrobial assemblages that were most commonly observed in patients who did not receive systemic antibiotics. The communities typically contained both Gram-positive and Gram-negative microorganisms that included multiple potential pathogens. Conclusion/Significance: Prevention and treatment of CAUTI must take into consideration the possible polymicrobial nature of any particular infection.			Frank, DN (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	norman.pace@colorado.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barford JMT, 2008, BJU INT, V102, P67, DOI 10.1111/j.1464-410X.2008.07465.x; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Clec'h C, 2007, INFECT CONT HOSP EP, V28, P1367, DOI 10.1086/523279; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2009, WOUND REPAIR REGEN, V17, P163, DOI 10.1111/j.1524-475X.2009.00472.x; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2003, J CLIN MICROBIOL, V41, P295, DOI 10.1128/JCM.41.1.295-303.2003; GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macleod SM, 2007, J MED MICROBIOL, V56, P1549, DOI 10.1099/jmm.0.47395-0; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; Matsukawa M, 2005, UROLOGY, V65, P440, DOI 10.1016/j.urology.2004.10.065; NICKEL JC, 1989, UROLOGY, V34, P284; NICKEL JC, 1985, CAN J SURG, V28, P50; Nickel JC, 1985, CAN J SURG, V28, P54; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; TENNEY JH, 1987, UROLOGY, V30, P444, DOI 10.1016/0090-4295(87)90376-1; Trautner BW, 2005, CURR OPIN INFECT DIS, V18, P37, DOI 10.1097/00001432-200502000-00007; WARREN JW, 1991, MED CLIN N AM, V75, P481, DOI 10.1016/S0025-7125(16)30465-5; Warren JW, 1997, INFECT DIS CLIN N AM, V11, P609, DOI 10.1016/S0891-5520(05)70376-7	33	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7811	10.1371/journal.pone.0007811	http://dx.doi.org/10.1371/journal.pone.0007811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907661	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721400010
J	Miragaia, M; de Lencastre, H; Perdreau-Remington, F; Chambers, HF; Higashi, J; Sullam, PM; Lin, J; Wong, KI; King, KA; Otto, M; Sensabaugh, GF; Diep, BA				Miragaia, Maria; de Lencastre, Herminia; Perdreau-Remington, Francoise; Chambers, Henry F.; Higashi, Julie; Sullam, Paul M.; Lin, Jessica; Wong, Kester I.; King, Katherine A.; Otto, Michael; Sensabaugh, George F.; Diep, Binh An			Genetic Diversity of Arginine Catabolic Mobile Element in Staphylococcus epidermidis	PLOS ONE			English	Article							ACME-ARCA GENE; AUREUS; SEQUENCE; CLONE; IDENTIFICATION; COMBINATION; RESISTANCE; VIRULENCE; USA300; MEC	Background: The methicillin-resistant Staphylococcus aureus clone USA300 contains a novel mobile genetic element, arginine catabolic mobile element ( ACME), that contributes to its enhanced capacity to grow and survive within the host. Although ACME appears to have been transferred into USA300 from S. epidermidis, the genetic diversity of ACME in the latter species remains poorly characterized. Methodology/Principal Findings: To assess the prevalence and genetic diversity of ACME, 127 geographically diverse S. epidermidis isolates representing 86 different multilocus sequence types (STs) were characterized. ACME was found in 51% (65/127) of S. epidermidis isolates. The vast majority (57/65) of ACME-containing isolates belonged to the predominant S. epidermidis clonal complex CC2. ACME was often found in association with different allotypes of staphylococcal chromosome cassette mec (SCCmec) which also encodes the recombinase function that facilities mobilization ACME from the S. epidermidis chromosome. Restriction fragment length polymorphism, PCR scanning and DNA sequencing allowed for identification of 39 distinct ACME genetic variants that differ from one another in gene content, thereby revealing a hitherto uncharacterized genetic diversity within ACME. All but one ACME variants were represented by a single S. epidermidis isolate; the singular variant, termed ACME-I.02, was found in 27 isolates, all of which belonged to the CC2 lineage. An evolutionary model constructed based on the eBURST algorithm revealed that ACME-I.02 was acquired at least on 15 different occasions by strains belonging to the CC2 lineage. Conclusions/Significance: ACME-I.02 in diverse S. epidermidis isolates were nearly identical in sequence to the prototypical ACME found in USA300 MRSA clone, providing further evidence for the interspecies transfer of ACME from S. epidermidis into USA300.			Miragaia, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	bdiep@medsfgh.ucsf.edu	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; Otto, Michael/0000-0002-2222-4115; /0000-0001-6816-8932	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, R01AI041513, R01AI057433, R01AI070289] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057433, R01 AI041513, R01 AI070289] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; GOERING RV, 2007, J CLIN MICROBIOL; JAFFE HW, 1980, J INFECT DIS, V141, P738, DOI 10.1093/infdis/141.6.738; KELLEY K, 2008, INT S STAPH STAPH IN; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lina G, 2000, GRAM-POSITIVE PATHOGENS, P450; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; MONTGOMERY CP, 2009, INFECT IMMUN; NOBLE W. C., 1981, MICROBIOLOGY HUMAN S; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; WENER KM, 2006, 44 ANN M INF DIS SOC, P118; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003	20	82	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7722	10.1371/journal.pone.0007722	http://dx.doi.org/10.1371/journal.pone.0007722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893740	Green Submitted, Green Published, gold			2022-12-27	WOS:000271478000008
J	Gorres, KL; Pua, KH; Raines, RT				Gorres, Kelly L.; Pua, Khian Hong; Raines, Ronald T.			Stringency of the 2-His-1-Asp Active-Site Motif in Prolyl 4-Hydroxylase	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; CAENORHABDITIS-ELEGANS; DIRECTED MUTAGENESIS; DIOXYGEN ACTIVATION; CRYSTAL-STRUCTURE; HALOGENASE CYTC3; IRON; COLLAGEN; ENZYMES; 2-HIS-1-CARBOXYLATE	The non-heme iron(II) dioxygenase family of enzymes contain a common 2-His-1-carboxylate iron-binding motif. These enzymes catalyze a wide variety of oxidative reactions, such as the hydroxylation of aliphatic C-H bonds. Prolyl 4-hydroxylase (P4H) is an alpha-ketoglutarate-dependent iron(II) dioxygenase that catalyzes the post-translational hydroxylation of proline residues in protocollagen strands, stabilizing the ensuing triple helix. Human P4H residues His412, Asp414, and His483 have been identified as an iron-coordinating 2-His-1-carboxylate motif. Enzymes that catalyze oxidative halogenation do so by a mechanism similar to that of P4H. These halogenases retain the active-site histidine residues, but the carboxylate ligand is replaced with a halide ion. We replaced Asp414 of P4H with alanine (to mimic the active site of a halogenase) and with glycine. These substitutions do not, however, convert P4H into a halogenase. Moreover, the hydroxylase activity of D414A P4H cannot be rescued with small molecules. In addition, rearranging the two His and one Asp residues in the active site eliminates hydroxylase activity. Our results demonstrate a high stringency for the iron-binding residues in the P4H active site. We conclude that P4H, which catalyzes an especially demanding chemical transformation, is recalcitrant to change.			Gorres, KL (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	NIAMS NIH HHS [R01 AR044276] Funding Source: Medline; NIGMS NIH HHS [T32 GM008505] Funding Source: Medline; FDA HHS [T32 BM008505] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044276] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P2081, DOI 10.1021/bi0271493; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Gorres KL, 2008, BIOCHEMISTRY-US, V47, P9447, DOI 10.1021/bi8009373; Gorres KL, 2009, ANAL BIOCHEM, V386, P181, DOI 10.1016/j.ab.2008.11.046; Grzyska PK, 2007, J INORG BIOCHEM, V101, P797, DOI 10.1016/j.jinorgbio.2007.01.011; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Kersteen EA, 2004, PROTEIN EXPRES PURIF, V38, P279, DOI 10.1016/j.pep.2004.09.008; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988; Leitgeb S, 2008, BIOCHEM SOC T, V36, P1180, DOI 10.1042/BST0361180; McGinnis K, 1996, BIOCHEMISTRY-US, V35, P3957, DOI 10.1021/bi951520n; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Searls T, 2005, J LIPID RES, V46, P1660, DOI 10.1194/jlr.M500034-JLR200; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355	28	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7635	10.1371/journal.pone.0007635	http://dx.doi.org/10.1371/journal.pone.0007635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890397	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700001
J	Lei, Z; Li, B; Yang, ZS; Fang, HS; Zhang, GM; Feng, ZH; Huang, B				Lei, Zhang; Li, Bo; Yang, Zhuoshun; Fang, Haoshu; Zhang, Gui-Mei; Feng, Zuo-Hua; Huang, Bo			Regulation of HIF-1 alpha and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration	PLOS ONE			English	Article							HYPOXIA-INDUCED ANGIOGENESIS; INDUCIBLE FACTOR 1-ALPHA; FACTOR-I HIF-1; INDUCED APOPTOSIS; CANCER; MICRORNAS; MICROENVIRONMENT; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION	The regulation of HIF-1 alpha is considered to be realized by pVHL-mediated ubiquitin-26S proteasome pathway at a post-transcriptional level. The discovery of a class of small noncoding RNAs, called microRNAs, implies alternative mechanism of regulation of HIF-1 alpha. Here, we show that miR-20b plays an important role in fine-tuning the adaptation of tumor cells to oxygen concentration. The inhibition of miR-20b increased the protein levels of HIF-1 alpha and VEGF in normoxic tumor cells; the increase of miR-20b in hypoxic tumor cells, nevertheless, decreased the protein levels of HIF-1 alpha and VEGF. By using luciferase reporter vector system, we confirmed that miR-20b directly targeted the 3'UTR of Hif1a and Vegfa. On the other hand, the forced overexpression of HIF-1 alpha in normoxic tumor cells downregulated miR-20b expression. However, HIF-1 alpha knockdown in hypoxic tumor cells caused the increase of miR-20b. The differential expression of miR-20b has important biological significance in tumor cells, either enhancing the growth or favoring the survival of tumor cells upon the oxygen supply. Thus, we identify a novel molecular regulation mechanism through which miR-20b regulates HIF-1 alpha and VEGF and is regulated by HIF-1 alpha so to keep tumor cells adapting to different oxygen concentrations.			Lei, Z (corresponding author), Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430074, Peoples R China.	tjhuangbo@hotmail.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Choi KS, 2003, J BIOCHEM MOL BIOL, V36, P120; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giaccia AJ, 1996, SEMIN RADIAT ONCOL, V6, P46, DOI 10.1016/S1053-4296(96)80035-X; Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; RICHTER JE, 1999, CLIN PRACTICE GASTRO, V1, P1; Ruan Hangjun, 1999, Neoplasia (New York), V1, P431, DOI 10.1038/sj.neo.7900059; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Sodhi A, 2000, CANCER RES, V60, P4873; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; Sun Y, 2009, BREAST CANC RES TREA; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; VAUPEL P, 1989, CANCER RES, V49, P6449; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wincewicz A, 2007, PATHOLOGY, V39, P334, DOI 10.1080/00313020701329765	35	155	163	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7629	10.1371/journal.pone.0007629	http://dx.doi.org/10.1371/journal.pone.0007629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893619	Green Submitted, gold, Green Published			2022-12-27	WOS:000271232000008
J	Schibler, L; Gibbs, L; Benoist-Lasselin, C; Decraene, C; Martinovic, J; Loget, P; Delezoide, AL; Gonzales, M; Munnich, A; Jais, JP; Legeai-Mallet, L				Schibler, Laurent; Gibbs, Linda; Benoist-Lasselin, Catherine; Decraene, Charles; Martinovic, Jelena; Loget, Philippe; Delezoide, Anne-Lise; Gonzales, Marie; Munnich, Arnold; Jais, Jean-Philippe; Legeai-Mallet, Laurence			New Insight on FGFR3-Related Chondrodysplasias Molecular Physiopathology Revealed by Human Chondrocyte Gene Expression Profiling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; ENDOCHONDRAL BONE-FORMATION; ACTIVATED PROTEIN-KINASE; NATRIURETIC PEPTIDE; THANATOPHORIC DYSPLASIA; SKELETAL DEVELOPMENT; ACTIN CYTOSKELETON; FGFR3 MUTATIONS; DIFFERENTIATION; PROLIFERATION	Endochondral ossification is the process by which the appendicular skeleton, facial bones, vertebrae and medial clavicles are formed and relies on the tight control of chondrocyte maturation. Fibroblast growth factor receptor ( FGFR) 3 plays a role in bone development and maintenance and belongs to a family of proteins which differ in their ligand affinities and tissue distribution. Activating mutations of the FGFR3 gene lead to craniosynostosis and multiple types of skeletal dysplasia with varying degrees of severity: thanatophoric dysplasia (TD), achondroplasia and hypochondroplasia. Despite progress in the characterization of FGFR3-mediated regulation of cartilage development, many aspects remain unclear. The aim and the novelty of our study was to examine whole gene expression differences occurring in primary human chondrocytes isolated from normal cartilage or pathological cartilage from TD-affected fetuses, using Affymetrix technology. The phenotype of the primary cells was confirmed by the high expression of chondrocytic markers. Altered expression of genes associated with many cellular processes was observed, including cell growth and proliferation, cell cycle, cell adhesion, cell motility, metabolic pathways, signal transduction, cell cycle process and cell signaling. Most of the cell cycle process genes were down-regulated and consisted of genes involved in cell cycle progression, DNA biosynthesis, spindle dynamics and cytokinesis. About eight percent of all modulated genes were found to impact extracellular matrix (ECM) structure and turnover, especially glycosaminoglycan (GAG) and proteoglycan biosynthesis and sulfation. Altogether, the gene expression analyses provide new insight into the consequences of FGFR3 mutations in cell cycle regulation, onset of pre-hypertrophic differentiation and concomitant metabolism changes. Moreover, impaired motility and ECM properties may also provide clues about growth plate disorganization. These results also suggest that many signaling pathways may be directly or indirectly altered by FGFR3 and confirm the crucial role of FGFR3 in the control of growth plate development.			Schibler, L (corresponding author), Univ Paris 05, Hop Necker, INSERM, Unite U781, Paris, France.	Laurence.legeai-mallet@inserm.fr	Legeai-Mallet, Laurence/E-6112-2016; SCHIBLER, laurent/AAQ-2630-2021	Legeai-Mallet, Laurence/0000-0003-4989-5856; BENOIST, Catherine/0000-0003-1779-0312; SCHIBLER, Laurent/0000-0003-3137-0859				Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Benoist-Lasselin C, 2007, FEBS LETT, V581, P2593, DOI 10.1016/j.febslet.2007.04.079; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs L, 2007, BBA-MOL CELL RES, V1773, P502, DOI 10.1016/j.bbamcr.2006.12.010; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Harrison RE, 2004, J CELL SCI, V117, P2151, DOI 10.1242/jcs.00955; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Laplantine E, 2002, J CELL BIOL, V158, P741, DOI 10.1083/jcb.200205025; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Minina E, 2001, DEVELOPMENT, V128, P4523; Moon NS, 2008, DEV CELL, V14, P1, DOI 10.1016/j.devcel.2007.12.017; Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nojima H, 2008, NAT CELL BIOL, V10, P971, DOI 10.1038/ncb1757; Nowroozi N, 2005, HUM MOL GENET, V14, P1529, DOI 10.1093/hmg/ddi161; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ozasa A, 2005, BONE, V36, P1056, DOI 10.1016/j.bone.2005.03.006; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Rozenblatt-Rosen O, 2002, J CELL SCI, V115, P553; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sahni M, 2001, DEVELOPMENT, V128, P2119; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Tare RS, 2008, BONE, V42, P113, DOI 10.1016/j.bone.2007.08.032; Teixeira CC, 2008, DEV BIOL, V319, P171, DOI 10.1016/j.ydbio.2008.04.031; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WOODS A, 2009, J CELL MOL MED; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	69	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7633	10.1371/journal.pone.0007633	http://dx.doi.org/10.1371/journal.pone.0007633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898608	Green Published, Green Submitted, gold			2022-12-27	WOS:000271232000011
J	Perez-Sala, D; Boya, P; Ramos, I; Herrera, M; Stamatakis, K				Perez-Sala, Dolores; Boya, Patricia; Ramos, Irene; Herrera, Monica; Stamatakis, Konstantinos			The C-Terminal Sequence of RhoB Directs Protein Degradation through an Endo-Lysosomal Pathway	PLOS ONE			English	Article							MEMBRANE; RAS; LOCALIZATION; TRAFFICKING; EXPRESSION; ENDOSOMES; AUTOPHAGY; DISEASE; GTPASES; ATPASE	Background: Protein degradation is essential for cell homeostasis. Targeting of proteins for degradation is often achieved by specific protein sequences or posttranslational modifications such as ubiquitination. Methodology/Principal Findings: By using biochemical and genetic tools we have monitored the localization and degradation of endogenous and chimeric proteins in live primary cells by confocal microscopy and ultra-structural analysis. Here we identify an eight amino acid sequence from the C-terminus of the short-lived GTPase RhoB that directs the rapid degradation of both RhoB and chimeric proteins bearing this sequence through a lysosomal pathway. Elucidation of the RhoB degradation pathway unveils a mechanism dependent on protein isoprenylation and palmitoylation that involves sorting of the protein into multivesicular bodies, mediated by the ESCRT machinery. Moreover, RhoB sorting is regulated by late endosome specific lipid dynamics and is altered in human genetic lipid traffic disease. Conclusions/Significance: Our findings characterize a short-lived cytosolic protein that is degraded through a lysosomal pathway. In addition, we define a novel motif for protein sorting and rapid degradation, which allows controlling protein levels by means of clinically used drugs.	[Perez-Sala, Dolores; Ramos, Irene; Herrera, Monica; Stamatakis, Konstantinos] CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain; [Boya, Patricia] CSIC, Dept Mol & Cellular Med, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Perez-Sala, D (corresponding author), CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain.	dperezsala@cib.csic.es	Perez-Sala, Dolores/L-5969-2014; Boya, Patricia/P-8345-2019; RAMOS, IRENE/AAS-4772-2021; Boya, Patricia/K-2911-2014; Stamatakis, Konstantinos/A-6596-2017	Perez-Sala, Dolores/0000-0003-0600-665X; Boya, Patricia/0000-0003-3045-951X; RAMOS, IRENE/0000-0002-0223-0120; Boya, Patricia/0000-0003-3045-951X; Stamatakis, Konstantinos/0000-0001-9934-3502	MCI [SAF2006-03489]; RETICS "RIRAAF'' [RD07/0064/0007]; ISCIII [BFU2006-00508]	MCI; RETICS "RIRAAF''; ISCIII(Instituto de Salud Carlos III)	This work was supported by grants from MCI, SAF2006-03489 and RETICS "RIRAAF'' RD07/0064/0007 from ISCIII to DPS and BFU2006-00508 to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Huang M, 2006, ONCOGENE, V25, P1281, DOI 10.1038/sj.onc.1209174; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Malcolm T, 2003, ONCOGENE, V22, P6142, DOI 10.1038/sj.onc.1206638; Marchetti A, 2004, J CELL SCI, V117, P6053, DOI 10.1242/jcs.01524; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Perez-Sala D, 1999, CELL DEATH DIFFER, V6, P722, DOI 10.1038/sj.cdd.4400557; ROBERTSON D, 1995, J HISTOCHEM CYTOCHEM, V43, P471, DOI 10.1177/43.5.7537292; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sachse M, 2004, J CELL SCI, V117, P1699, DOI 10.1242/jcs.00998; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	44	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8117	10.1371/journal.pone.0008117	http://dx.doi.org/10.1371/journal.pone.0008117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956591	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800014
J	Wu, M; Yang, XR; Chan, C				Wu, Ming; Yang, Xuerui; Chan, Christina			A Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A Discrete Modeling Approach	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; KINASE C-ZETA; PROTEIN-KINASE; SERINE/THREONINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; INDUCED APOPTOSIS	A major challenge in systems biology is to develop a detailed dynamic understanding of the functions and behaviors in a particular cellular system, which depends on the elements and their inter-relationships in a specific network. Computational modeling plays an integral part in the study of network dynamics and uncovering the underlying mechanisms. Here we proposed a systematic approach that incorporates discrete dynamic modeling and experimental data to reconstruct a phenotype-specific network of cell signaling. A dynamic analysis of the insulin signaling system in liver cells provides a proof-of-concept application of the proposed methodology. Our group recently identified that double-stranded RNA-dependent protein kinase (PKR) plays an important role in the insulin signaling network. The dynamic behavior of the insulin signaling network is tuned by a variety of feedback pathways, many of which have the potential to cross talk with PKR. Given the complexity of insulin signaling, it is inefficient to experimentally test all possible interactions in the network to determine which pathways are functioning in our cell system. Our discrete dynamic model provides an in silico model framework that integrates potential interactions and assesses the contributions of the various interactions on the dynamic behavior of the signaling network. Simulations with the model generated testable hypothesis on the response of the network upon perturbation, which were experimentally evaluated to identify the pathways that function in our particular liver cell system. The modeling in combination with the experimental results enhanced our understanding of the insulin signaling dynamics and aided in generating a context-specific signaling network.	[Wu, Ming; Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Yang, Xuerui; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Wu, M (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Wu, Ming/K-4074-2014	Yang, Xuerui/0000-0002-7731-2147	National Institute of Health [R01GM079688, R21CA126136, R21RR024439, P42 ES004911]; National Science Foundation [DBI 0701709]; MSU Foundation; Center for Systems Biology; Michigan State University (MSU); NATIONAL CANCER INSTITUTE [R21CA126136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MSU Foundation; Center for Systems Biology; Michigan State University (MSU); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was supported in part by the National Institute of Health (R01GM079688, R21CA126136, R21RR024439 and P42 ES004911), the National Science Foundation (DBI 0701709), and the MSU Foundation and the Center for Systems Biology. M. W. is supported in part by Michigan State University (MSU) Quantitative Biology and Modeling Fellowship.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Greil F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048701; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Morimoto H, 2004, J BIOCHEM, V136, P433, DOI 10.1093/jb/mvh144; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Patti Mary-Elizabeth, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P89; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; White MF, 1996, PHILOS T ROY SOC B, V351, P181, DOI 10.1098/rstb.1996.0015; WU M, 2009, DYNAMIC ANAL I UNPUB; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; YANG X, 2009, DOWNSTREAM TAR UNPUB; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8040	10.1371/journal.pone.0008040	http://dx.doi.org/10.1371/journal.pone.0008040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956598	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828700006
J	Couturier, E; du Pont, SC; Douady, S				Couturier, Etienne; du Pont, Sylvain Courrech; Douady, Stephane			A Global Regulation Inducing the Shape of Growing Folded Leaves	PLOS ONE			English	Article							LEAF; DYNAMICS	Shape is one of the important characteristics for the structures observed in living organisms. Whereas biologists have proposed models where the shape is controlled on a molecular level [1], physicists, following Turing [2] and d'Arcy Thomson [3], have developed theories where patterns arise spontaneously [4]. Here, we propose that volume constraints restrict the possible shapes of leaves. Focusing on palmate leaves (with lobes), the central observation is that developing leaves first grow folded inside a bud, limited by the previous and subsequent leaves. We show that the lobe perimeters end at the border of this small volume. This induces a direct relationship between the way it was folded and the final unfolded shape of the leaf. These dependencies can be approximated as simple geometrical relationships that we confirm on both folded embryonic and unfolded mature leaves. We find that independent of their position in the phylogenetic tree, these relationships work for folded species, but do not work for non-folded species. This global regulation for the leaf growth could come from a mechanical steric constraint. Such steric regulation should be more general and considered as a new simple means of global regulation.	[Couturier, Etienne] CNRS, Lab MSC, UMR 7057, Paris, France; Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Couturier, E (corresponding author), CNRS, Lab MSC, UMR 7057, Mat & Syst Complexes, Paris, France.	douady@lps.ens.fr	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X				Adanson M., 1763, FAMILLES PLANTES CON; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Boudaoud A, 2000, NATURE, V407, P718, DOI 10.1038/35037535; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; CLOS D, 1870, MONOGRAPHIE PREFOLIA; DEMAINE ED, 1998, P 10 ANN ACM SIAM S, P891; Douady S, 1996, J THEOR BIOL, V178, P255, DOI 10.1006/jtbi.1996.0024; Franks NR, 2000, P ROY SOC B-BIOL SCI, V267, P1295, DOI 10.1098/rspb.2000.1141; Gunawardena AHLAN, 2006, BOT J LINN SOC, V150, P25, DOI 10.1111/j.1095-8339.2006.00487.x; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; KAPLAN DR, 1982, CAN J BOT, V60, P2939, DOI 10.1139/b82-355; Kobayashi H, 1998, P ROY SOC B-BIOL SCI, V265, P147, DOI 10.1098/rspb.1998.0276; Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; MELVILLE R, 1969, Botanical Journal of the Linnean Society, V62, P1, DOI 10.1111/j.1095-8339.1969.tb01952.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Thompson D. W., 1917, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	24	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7968	10.1371/journal.pone.0007968	http://dx.doi.org/10.1371/journal.pone.0007968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956690	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827300022
J	Vernier, PT; Levine, ZA; Wu, YH; Joubert, V; Ziegler, MJ; Mir, LM; Tieleman, DP				Vernier, P. Thomas; Levine, Zachary A.; Wu, Yu-Hsuan; Joubert, Vanessa; Ziegler, Matthew J.; Mir, Lluis M.; Tieleman, D. Peter			Electroporating Fields Target Oxidatively Damaged Areas in the Cell Membrane	PLOS ONE			English	Article							PULSED ELECTRIC-FIELD; MOLECULAR-DYNAMICS SIMULATIONS; BILAYER LIPID-MEMBRANES; MAMMALIAN-CELLS; PLASMA-MEMBRANE; PORE FORMATION; HIGH-INTENSITY; GENE-TRANSFER; FLUORESCENCE MICROSCOPY; ANTIMICROBIAL PEPTIDES	Reversible electropermeabilization (electroporation) is widely used to facilitate the introduction of genetic material and pharmaceutical agents into living cells. Although considerable knowledge has been gained from the study of real and simulated model membranes in electric fields, efforts to optimize electroporation protocols are limited by a lack of detailed understanding of the molecular basis for the electropermeabilization of the complex biomolecular assembly that forms the plasma membrane. We show here, with results from both molecular dynamics simulations and experiments with living cells, that the oxidation of membrane components enhances the susceptibility of the membrane to electropermeabilization. Manipulation of the level of oxidative stress in cell suspensions and in tissues may lead to more efficient permeabilization procedures in the laboratory and in clinical applications such as electrochemotherapy and electrotransfection-mediated gene therapy.	[Vernier, P. Thomas] Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90089 USA; [Vernier, P. Thomas; Levine, Zachary A.; Ziegler, Matthew J.] Univ So Calif, Viterbi Sch Engn, Inst Informat Sci, MOSIS, Los Angeles, CA USA; [Levine, Zachary A.] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Wu, Yu-Hsuan; Ziegler, Matthew J.] Univ So Calif, Viterbi Sch Engn, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA USA; [Joubert, Vanessa; Mir, Lluis M.] Inst Gustave Roussy, CNRS, Unite Mixte Rech Vectorol & Gene Transfer 8121, Villejuif, France; [Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Joubert, Vanessa; Mir, Lluis M.] Univ Paris 11, UMR 8121, Orsay, France	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; University of Calgary; UDICE-French Research Universities; Universite Paris Saclay	Vernier, PT (corresponding author), Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90089 USA.	vernier@mosis.com	Tieleman, D. Peter/A-4790-2011; MIR, Lluis M/AAJ-9110-2020; Vernier, P. Thomas/D-7926-2016	Tieleman, D. Peter/0000-0001-5507-0688; Vernier, P. Thomas/0000-0003-2335-1500	Air Force Office of Scientific Research, MOSIS, University of Southern California [FA9550-08-1-0096]; CNRS Institut Gustave Roussy; Clinigene EU Noe [LSHB-CT-2006-018933]; ANR PNANO [ANR-08-PNANO-024]; Natural Sciences and Engineering Research Council (Canada)	Air Force Office of Scientific Research, MOSIS, University of Southern California(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); CNRS Institut Gustave Roussy; Clinigene EU Noe; ANR PNANO(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Air Force Office of Scientific Research - Grant #FA9550-08-1-0096; MOSIS, University of Southern California; CNRS Institut Gustave Roussy; the Clinigene EU Noe (LSHB-CT-2006-018933); the ANR PNANO project Nanopulsebiochip (ANR-08-PNANO-024); and the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; Ayuyan AG, 2006, BIOPHYS J, V91, P2172, DOI 10.1529/biophysj.106.087387; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; BENZ R, 1980, BIOCHIM BIOPHYS ACTA, V597, P637, DOI 10.1016/0005-2736(80)90236-9; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bockmann RA, 2008, BIOPHYS J, V95, P1837, DOI 10.1529/biophysj.108.129437; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; Brielmeier M, 1998, NUCLEIC ACIDS RES, V26, P2082, DOI 10.1093/nar/26.9.2082; Cemazar M, 1998, ELECTRO MAGNETOBIOL, V17, P263; Chiaramonte R, 2001, J CELL BIOCHEM, V82, P437, DOI 10.1002/jcb.1158; CHIZMADZHEV YA, 1980, BIOELECTROCH BIOENER, V7, P83, DOI 10.1016/0302-4598(80)87034-6; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Dyrka W, 2008, J COMPUT CHEM, V29, P1876, DOI 10.1002/jcc.20947; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; GABRIEL B, 1994, EUR J BIOCHEM, V223, P25, DOI 10.1111/j.1432-1033.1994.tb18962.x; Gabriel B, 1998, EUR BIOPHYS J BIOPHY, V27, P291, DOI 10.1007/s002490050136; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Girotti A W, 1985, J Free Radic Biol Med, V1, P87; Gurtovenko AA, 2005, J AM CHEM SOC, V127, P17570, DOI 10.1021/ja053129n; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HICKMAN SE, 1994, BLOOD, V84, P2452; Hojman P, 2008, HUM GENE THER, V19, P1249, DOI 10.1089/hum.2008.059; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jacob RF, 2005, J BIOL CHEM, V280, P39380, DOI 10.1074/jbc.M507587200; Joshi RP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011913; KINOSITA K, 1977, BIOCHIM BIOPHYS ACTA, V471, P227, DOI 10.1016/0005-2736(77)90252-8; Kol MA, 2003, BIOCHEMISTRY-US, V42, P231, DOI 10.1021/bi0268403; Kramar P, 2007, BIOELECTROCHEMISTRY, V70, P23, DOI 10.1016/j.bioelechem.2006.03.022; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MACCARRONE M, 1995, BIOCHEM BIOPH RES CO, V206, P238, DOI 10.1006/bbrc.1995.1033; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Mattila JP, 2008, BBA-BIOMEMBRANES, V1778, P2041, DOI 10.1016/j.bbamem.2008.03.020; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller KJ, 2001, J MEMBRANE BIOL, V184, P161, DOI 10.1007/s00232-001-0084-3; Naguib YMA, 1998, ANAL BIOCHEM, V265, P290, DOI 10.1006/abio.1998.2931; Neu JC, 1999, PHYS REV E, V59, P3471, DOI 10.1103/PhysRevE.59.3471; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; POPESCU D, 1991, BIOELECTROCH BIOENER, V25, P91, DOI 10.1016/0302-4598(91)87021-8; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Rols MP, 2006, BBA-BIOMEMBRANES, V1758, P423, DOI 10.1016/j.bbamem.2006.01.005; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; SUGAR IP, 1984, BIOPHYS CHEM, V19, P211, DOI 10.1016/0301-4622(84)87003-9; Sukhorukov VL, 2005, J MEMBRANE BIOL, V206, P187, DOI 10.1007/s00232-005-0791-2; Tang T, 2007, IEEE T DIELECT EL IN, V14, P878, DOI 10.1109/TDEI.2007.4286519; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tavazzi B, 2000, EUR J BIOCHEM, V267, P684, DOI 10.1046/j.1432-1327.2000.01042.x; TEISSIE J, 1981, BIOCHEMISTRY-US, V20, P1548, DOI 10.1021/bi00509a022; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhou Y, 2007, BIOMATERIALS, V28, P1298, DOI 10.1016/j.biomaterials.2006.10.016; Ziegler MJ, 2008, J PHYS CHEM B, V112, P13588, DOI 10.1021/jp8027726; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	79	93	94	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7966	10.1371/journal.pone.0007966	http://dx.doi.org/10.1371/journal.pone.0007966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956595	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827300021
J	Salt, AM				Salt, Alun M.			The Astronomical Orientation of Ancient Greek Temples	PLOS ONE			English	Article								Despite its appearing to be a simple question to answer, there has been no consensus as to whether or not the alignments of ancient Greek temples reflect astronomical intentions. Here I present the results of a survey of archaic and classical Greek temples in Sicily and compare them with temples in Greece. Using a binomial test I show strong evidence that there is a preference for solar orientations. I then speculate that differences in alignment patterns between Sicily and Greece reflect differing pressures in the expression of ethnic identity.			Salt, AM (corresponding author), Univ Leicester, Sch Archaeol & Ancient Hist, Leicester, Leics, England.	alun.m.salt@gmail.com		Salt, Alun/0000-0002-1261-4283				Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AVENI AF, 2000, J HIST ASTRONOMY S, V25, pS51; Bates B, 2006, VIEWING SKY PRESENT, V15, P27; Boardman J., 1999, GREEKS OVERSEAS, V4th; BONCASA N, 1970, HIMERA I CAMPAGNE SC, P51; BOUTSIKAS E, 2007, ARCHAEOASTRONOMY ARC, P19; BREA LB, 1986, IL TEMPIO AFRODITE A; CULTRERA L, 1951, MONUMENTI ANTICHI, V41, P701; de Miro E., 1966, KOKALOS, V12, P221; DEANGELIS F, 2004, MEGARA HYBLAIA SELIN; DEMIRO E, 1994, VALLE TEMPLI; DEMIRO E, 2003, AGRIGENTO H SANTUARI; DI VITA A., 1988, ANNUARIO SCUOLA ARCH, V62, P7; Dinsmoor Sr. W. B., 1975, ARCHITECTURE ANCIENT; DINSMOOR WB, 1939, P AM PHILOS SOC, V80, P95; Dominguez Monedero A. J., 2006, GREEK COLONISATION A, VI, P253; Fisher NI, 1995, STAT ANAL CIRCULAR D; GABRICI E, 1927, MONUMENTI ANTICHI, V22, P5; Gullini G., 1985, SIKANIE STORIA CIVIL, P415; HALL J, 2004, GREEK IDENTITY W MED, P35; Hannah R, 2009, TIME IN ANTIQUITY; HERBERT SC, 1984, PALESTINE EXPLORATIO, V116, P31; Hodos Tamar, 2006, LOCAL RESPONSES COLO; Marconi P., 1929, AGRIGENTO TOPOGRAFIA; NISSEN H, 1869, TEMPLUM ANTIQUARISCH; ORLANDINI P, 1968, RIV I NAZL ARCHEOLOG, V15, P22; ORSI, 1919, MONUMENTI ANTICHI, V25, P353; PELAGATTI P, 1972, B ARTE, V57, P211; PELAGATTI P, 1968, KOKALOS, V14, P344; Penrose FC, 1901, PHILOS T R SOC LOND, V196, P389, DOI 10.1098/rsta.1901.0007; PENROSE FC, 1899, P ROY SOC LONDON, V65, P370; PENROSE FC, 1897, P ROY SOC LONDON, V61, P76; Peterson J. W. M., 2007, OXFORD J ARCHAEOL, VXXVI, P103; POMPEO L, 1999, IL COMPLESSO ARCHITE; Retallack GJ, 2008, ANTIQUITY, V82, P640, DOI 10.1017/S0003598X00097283; Ross TD, 2003, COMPUT BIOL MED, V33, P509, DOI 10.1016/S0010-4825(03)00019-2; Salt A, 2005, ANTIQUITY, V79, P564, DOI 10.1017/S0003598X00114504; TUSA V., 1967, KOKALOS, V13, P186; VALLET G, 1976, MEGARA HYBLAEA, V1; Voza G., 1968, KOKALOS, V14-15, P360; WHITELEY J, 2001, ARCHAEOLOGY ANCIENT	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7903	10.1371/journal.pone.0007903	http://dx.doi.org/10.1371/journal.pone.0007903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936239	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600007
J	Goncalves, RLS; Machado, ACL; Paiva-Silva, GO; Sorgine, MHF; Momoli, MM; Oliveira, JHM; Vannier-Santos, MA; Galina, A; Oliveira, PL; Oliveira, MF				Goncalves, Renata L. S.; Machado, Ana Carolina L.; Paiva-Silva, Gabriela O.; Sorgine, Marcos H. F.; Momoli, Marisa M.; Oliveira, Jose Henrique M.; Vannier-Santos, Marcos A.; Galina, Antonio; Oliveira, Pedro L.; Oliveira, Marcus F.			Blood-Feeding Induces Reversible Functional Changes in Flight Muscle Mitochondria of Aedes aegypti Mosquito	PLOS ONE			English	Article							REACTIVE OXYGEN; LIFE-SPAN; OXIDATIVE PHOSPHORYLATION; SUPEROXIDE-PRODUCTION; RESPIRATORY ENZYMES; HYDROGEN-PEROXIDE; RESTRICTION; PROTEIN; MIDGUT; STRESS	Background: Hematophagy poses a challenge to blood-feeding organisms since products of blood digestion can exert cellular deleterious effects. Mitochondria perform multiple roles in cell biology acting as the site of aerobic energy-transducing pathways, and also an important source of reactive oxygen species (ROS), modulating redox metabolism. Therefore, regulation of mitochondrial function should be relevant for hematophagous arthropods. Here, we investigated the effects of blood-feeding on flight muscle ( FM) mitochondria from the mosquito Aedes aegypti, a vector of dengue and yellow fever. Methodology/Principal Findings: Blood-feeding caused a reversible reduction in mitochondrial oxygen consumption, an event that was parallel to blood digestion. These changes were most intense at 24 h after blood meal (ABM), the peak of blood digestion, when oxygen consumption was inhibited by 68%. Cytochromes c and a+a(3) levels and cytochrome c oxidase activity of the electron transport chain were all reduced at 24 h ABM. Ultrastructural and molecular analyses of FM revealed that mitochondria fuse upon blood meal, a condition related to reduced ROS generation. Consistently, BF induced a reversible decrease in mitochondrial H2O2 formation during blood digestion, reaching their lowest values at 24 h ABM where a reduction of 51% was observed. Conclusion: Blood-feeding triggers functional and structural changes in hematophagous insect mitochondria, which may represent an important adaptation to blood feeding.			Goncalves, RLS (corresponding author), Univ Fed Rio de Janeiro, Lab Bioquim Redox, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	maroli@bioqmed.ufrj.br	Vannier-Santos, Marcos/AAG-5053-2021; Machado, Ana Carolina Loyola/AAR-7959-2021; Vannier-Santos, Marcos/G-5517-2012; Oliveira, Marcus/G-3158-2011; Galina, Antonio/A-9292-2008; Vannier-Santos, Marcos A/L-3649-2013; L. Oliveira, Pedro/A-9438-2010	Vannier-Santos, Marcos/0000-0001-9241-2261; Machado, Ana Carolina Loyola/0000-0002-4313-3730; Oliveira, Marcus/0000-0002-9890-8425; Oliveira, Jose Henrique M./0000-0003-3814-5312; L. Oliveira, Pedro/0000-0003-0307-354X				AVIDOR Y, 1959, BIOCHEM J, V72, P8, DOI 10.1042/bj0720008; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRIEGEL H, 1975, J INSECT PHYSIOL, V21, P1597, DOI 10.1016/0022-1910(75)90197-3; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; BURSELL E, 1975, COMP BIOCHEM PHYS B, V52, P235, DOI 10.1016/0305-0491(75)90057-7; CHANCE B, 1955, J BIOL CHEM, V217, P395; CHANCE B, 1955, J BIOL CHEM, V217, P409; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clements A., 1992, DEV NUTR REPROD; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Giulivi C, 2008, BIOCHEM J, V415, P309, DOI 10.1042/BJ20080973; GONDA O, 1957, BIOCHEM J, V67, P487, DOI 10.1042/bj0670487; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pennington JE, 2003, J INSECT PHYSIOL, V49, P115, DOI 10.1016/S0022-1910(02)00267-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Riva A, 2006, MECH AGEING DEV, V127, P917, DOI 10.1016/j.mad.2006.09.002; SACKTOR BERTRAM, 1965, P483; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; TANDLER B, 1969, J CELL BIOL, V41, P477, DOI 10.1083/jcb.41.2.477; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; WIGGLESWORTH VB, 1982, TISSUE CELL, V14, P501, DOI 10.1016/0040-8166(82)90043-X; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	56	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7854	10.1371/journal.pone.0007854	http://dx.doi.org/10.1371/journal.pone.0007854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924237	gold, Green Published, Green Submitted			2022-12-27	WOS:000271851000011
J	Mallick, B; Ghosh, Z; Chakrabarti, J				Mallick, Bibekanand; Ghosh, Zhumur; Chakrabarti, Jayprokas			MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; CORONAVIRUS REPLICATION; NUCLEOCAPSID PROTEIN; LUNG; IDENTIFICATION; EXPRESSION; DETERMINANTS; RECEPTOR; TARGETS	Severe acute respiratory syndrome (SARS), caused by the coronavirus SARS-CoV, is an acute infectious disease with significant mortality. A typical clinical feature associated with SARS is pulmonary fibrosis and associated lung failure. In the aftermath of the SARS epidemic, although significant progress towards understanding the underlying molecular mechanism of the infection has been made, a large gap still remains in our knowledge regarding how SARS-CoV interacts with the host cell at the onset of infection. The rapidly changing viral genome adds another variable to this equation. We have focused on a novel concept of microRNA (miRNA)-mediated host-virus interactions in bronchoalveolar stem cells (BASCs) at the onset of infection by correlating the "BASC-microRNome" with their targets within BASCs and viral genome. This work encompasses miRNA array data analysis, target prediction, and miRNA-mRNA enrichment analysis and develops a complex interaction map among disease-related factors, miRNAs, and BASCs in SARS pathway, which will provide some clues for diagnostic markers to view an overall interplay leading to disease progression. Our observation reveals the BASCs (Sca-1+ CD34+ CD45- Pecam-), a subset of Oct-4+ ACE2+ epithelial colony cells at the broncho-alveolar duct junction, to be the prime target cells of SARS-CoV infection. Upregulated BASC miRNAs-17*, -574-5p, and -214 are co-opted by SARS-CoV to suppress its own replication and evade immune elimination until successful transmission takes place. Viral Nucleocapsid and Spike protein targets seem to co-opt downregulated miR-223 and miR-98 respectively within BASCs to control the various stages of BASC differentiation, activation of inflammatory chemokines, and downregulation of ACE2. All these effectively accounts for a successful viral transmission and replication within BASCs causing continued deterioration of lung tissues and apparent loss of capacity for lung repair. Overall, this investigation reveals another mode of exploitation of cellular miRNA machinery by virus to their own advantage.			Mallick, B (corresponding author), Indian Assoc Cultivat Sci, Computat Biol Grp, Kolkata 700032, W Bengal, India.	zhumurg@stanford.edu	Mallick, Bibekanand/AAT-7013-2021	Mallick, Bibekanand/0000-0003-4311-0720; Ghosh, Zhumur/0000-0002-4877-7551				Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonville CA, 2003, J VIROL, V77, P1237, DOI 10.1128/JVI.77.2.1237-1244.2003; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Chang J, 2000, VIROLOGY, V266, P17, DOI 10.1006/viro.1999.0077; Chen YX, 2007, J EXP MED, V204, P2529, DOI 10.1084/jem.20070462; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; EVANS MJ, 1978, LAB INVEST, V38, P648; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; GHOSH Z, 2007, BIOCHEM BIOPH RES CO, V37, P1035; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Imai Y, 2008, EXP PHYSIOL, V93, P543, DOI 10.1113/expphysiol.2007.040048; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; JIN DY, 2009, HONG KONG MED J S2, V15, pS37; Kim CF, 2007, AM J PHYSIOL-LUNG C, V293, pL1092, DOI 10.1152/ajplung.00015.2007; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Law HKW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-35; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li XP, 2008, AM J PHYSIOL-LUNG C, V295, pL178, DOI 10.1152/ajplung.00009.2008; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martin U, 2008, METHODS, V45, P121, DOI 10.1016/j.ymeth.2008.05.009; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; MILAN S, 2008, INFECT GENET EVOL, V8, P397; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Oudit GY, 2009, NEPHROL DIAL TRANSPL, V24, P1362, DOI 10.1093/ndt/gfp065; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tokuda A, 2000, J IMMUNOL, V164, P2745, DOI 10.4049/jimmunol.164.5.2745; Watanabe Y, 2007, FEBS LETT, V581, P4603, DOI 10.1016/j.febslet.2007.08.049; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Wu CJ, 2005, ANTIVIR RES, V65, P45, DOI 10.1016/j.antiviral.2004.09.005; Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Ye R, 2004, J VIROL, V78, P9904, DOI 10.1128/JVI.78.18.9904-9917.2004; Yilla M, 2005, VIRUS RES, V107, P93, DOI 10.1016/j.virusres.2004.09.004; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200	67	86	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7837	10.1371/journal.pone.0007837	http://dx.doi.org/10.1371/journal.pone.0007837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915717	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721900023
J	Shanaube, K; Sismanidis, C; Ayles, H; Beyers, N; Schaap, A; Lawrence, KA; Barker, A; Godfrey-Faussett, P				Shanaube, Kwame; Sismanidis, Charalambos; Ayles, Helen; Beyers, Nulda; Schaap, Ab; Lawrence, Katherine-Anne; Barker, Annie; Godfrey-Faussett, Peter			Annual Risk of Tuberculous Infection Using Different Methods in Communities with a High Prevalence of TB and HIV in Zambia and South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; CALMETTE-GUERIN; CHILDREN; TRANSMISSION; VACCINATION; EPIDEMIC; ZAMSTAR; DESIGN; TRENDS	Background: The annual risk of tuberculous infection (ARTI) is a key epidemiological indicator of the extent of transmission in a community. Several methods have been suggested to estimate the prevalence of tuberculous infection using tuberculin skin test data. This paper explores the implications of using different methods to estimate prevalence of infection and ARTI. The effect of BCG vaccination on these estimates is also investigated. Methodology/Principal Findings: Tuberculin surveys among school children in 16 communities in Zambia and 8 in South Africa (SA) were performed in 2005, as part of baseline data collection and for randomisation purposes of the ZAMSTAR study. Infection prevalence and ARTI estimates were calculated using five methods: different cut-offs with or without adjustments for sensitivity, the mirror method, and mixture analysis. A total of 49,835 children were registered for the surveys, of which 25,048 (50%) had skin tests done and 22,563 (90%) of those tested were read. Infection prevalence was higher in the combined SA than Zambian communities. The mirror method resulted in the least difference of 7.8%, whereas that estimated by the cut-off methods varied from 12.2% to 17.3%. The ARTI in the Zambian and SA communities was between 0.8% and 2.8% and 2.5% and 4.2% respectively, depending on the method used. In the SA communities, the ARTI was higher among the younger children. BCG vaccination had little effect on these estimates. Conclusions/Significance: ARTI estimates are dependent on the calculation method used. All methods agreed that there were substantial differences in infection prevalence across the communities, with higher rates in SA. Although TB notification rates have increased over the past decades, the difference in cumulative exposure between younger and older children is less dramatic and a rise in risk of infection in parallel with the estimated incidence of active tuberculosis cannot be excluded.			Shanaube, K (corresponding author), Univ Teaching Hosp, ZAMBART Project, Lusaka, Zambia.	kshanaube@zambart.org.zm		Shanaube, Kwame/0000-0001-7899-0890; Ayles, Helen/0000-0003-4108-2842	Medical Research Council [G0700837] Funding Source: Medline; MRC [G0700837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Arnadottir T, 2001, INT J TUBERC LUNG D, V5, P391; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Bachtiar A, 2008, INT J TUBERC LUNG D, V12, P255; Bosman MCJ, 1998, INT J TUBERC LUNG D, V2, P272; Bowerman RJ, 2004, INT J TUBERC LUNG D, V8, P1228; *CENTR STAT OFF ZA, 2003, ZAMB DHS EDDATA SURV; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Davies GR, 2006, INT J TUBERC LUNG D, V10, P1023; *DEP ED REP S AFR, 2006, ED STAT S AFR GLANC; Dubuis M, 2004, INT J TUBERC LUNG D, V8, P1065; Egwaga SA, 2006, AIDS, V20, P915, DOI 10.1097/01.aids.0000218557.44284.83; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; FOURIE PB, 1983, TUBERCLE, V64, P181, DOI 10.1016/0041-3879(83)90013-2; Gopi PG, 2006, INDIAN J MED RES, V124, P71; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; MIGLIORI GB, 1994, EUR RESPIR J, V7, P946; Nagelkerke NJD, 2000, INT J TUBERC LUNG D, V4, P314; Neuenschwander BE, 2000, INT J TUBERC LUNG D, V4, P719; Neuenschwander BE, 2002, AM J EPIDEMIOL, V155, P654, DOI 10.1093/aje/155.7.654; Odhiambo JA, 1999, AM J PUBLIC HEALTH, V89, P1078, DOI 10.2105/AJPH.89.7.1078; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pretorius C, 2009, CLIN INFECT DIS, V48, P994, DOI 10.1086/597357; Rieder H, 2005, EUR RESPIR J, V25, P181, DOI 10.1183/09031936.04.00103804; Rieder HL, 2008, CLIN INFECT DIS, V47, P356, DOI 10.1086/589751; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; SHASHIDHAR JS, 2002, IND J TUB, V49, P147; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; Styblo K, 2001, INT J TUBERC LUNG D, V5, P103; Styblo K., 1985, B INT UNION TUBERC, V60, P117; STYBLO K, 1995, TSRU PROGR REPORT, V1, P140; Trebucq A, 2005, INT J TUBERC LUNG D, V9, P1097; Tupasi TE, 2000, INT J TUBERC LUNG D, V4, P216; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; Villate JI, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-240; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; World Health Organization, 2008, GLOB TUB CONTR SURV	43	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7749	10.1371/journal.pone.0007749	http://dx.doi.org/10.1371/journal.pone.0007749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915666	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000271721900008
J	van Lunteren, E; Moyer, M				van Lunteren, Erik; Moyer, Michelle			Gene Expression Profiling in the Type 1 Diabetes Rat Diaphragm	PLOS ONE			English	Article							STREPTOZOTOCIN-TREATED RATS; SKELETAL-MUSCLE; GLUCOSE UPTAKE; FATTY-ACIDS; MICROARRAY ANALYSIS; KETONE BODIES; CONTRACTILE CHARACTERISTICS; ACTION-POTENTIALS; INSULIN-TREATMENT; NOD MICE	Background: Respiratory muscle contractile performance is impaired by diabetes, mechanisms of which included altered carbohydrate and lipid metabolism, oxidative stress and changes in membrane electrophysiology. The present study examined to what extent these cellular perturbations involve changes in gene expression. Methodology/Principal Findings: Diaphragm muscle from streptozotocin-diabetic rats was analyzed with Affymetrix gene expression arrays. Diaphragm from diabetic rats had 105 genes with at least +/- 2-fold significantly changed expression (55 increased, 50 decreased), and these were assigned to gene ontology groups based on over-representation analysis using DAVID software. There was increased expression of genes involved in palmitoyl-CoA hydrolase activity (a component of lipid metabolism) (P = 0.037, n = 2 genes, fold change 4.2 to 27.5) and reduced expression of genes related to carbohydrate metabolism (P = 0.000061, n = 8 genes, fold change -2.0 to -8.5). Other gene ontology groups among upregulated genes were protein ubiquitination (P = 0.0053, n = 4, fold change 2.2 to 3.4), oxidoreductase activity (P = 0.024, n = 8, fold change 2.1 to 6.0), and morphogenesis (P = 0.012, n = 10, fold change 2.1 to 4.3). Other downregulated gene groups were extracellular region (including extracellular matrix and collagen) (P = 0.00032, n = 13, fold change -2.2 to -3.7) and organogenesis (P = 0.032, n = 7, fold change -2.1 to -3.7). Real-time PCR confirmed the directionality of changes in gene expression for 30 of 31 genes tested. Conclusions/Significance: These data indicate that in diaphragm muscle type 1 diabetes increases expression of genes involved in lipid energetics, oxidative stress and protein ubiquitination, decreases expression of genes involved in carbohydrate metabolism, and has little effect on expression of ion channel genes. Reciprocal changes in expression of genes involved in carbohydrate and lipid metabolism may change the availability of energetic substrates and thereby directly modulate fatigue resistance, an important issue for a muscle like the diaphragm which needs to contract without rest for the entire lifetime of the organism.			van Lunteren, E (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Dept Med, Pulm Crit Care & Sleep Div, Cleveland, OH USA.	exv4@cwru.edu			NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070697] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA43703, P30 CA043703] Funding Source: Medline; NHLBI NIH HHS [HL-70697, R01 HL070697] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AYTE J, 1990, P NATL ACAD SCI USA, V87, P3874, DOI 10.1073/pnas.87.10.3874; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; BEATTY CH, 1959, J BIOL CHEM, V234, P11; BELOFFCH.A, 1968, BIOCHEM J, V110, P529, DOI 10.1042/bj1100529; BELOFFCHAIN A, 1971, BIOCHEM J, V125, P97, DOI 10.1042/bj1250097; CATERSON ID, 1982, BIOCHEM J, V208, P53, DOI 10.1042/bj2080053; CHORVATHOVA V, 1981, PHYSIOL BOHEMOSLOV, V30, P259; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Eckenrode SE, 2004, DIABETES, V53, P366, DOI 10.2337/diabetes.53.2.366; Fahim MA, 1998, ANAT RECORD, V251, P240, DOI 10.1002/(SICI)1097-0185(199806)251:2<240::AID-AR13>3.0.CO;2-O; Fan QL, 2003, KIDNEY INT, V64, P1978, DOI 10.1046/j.1523-1755.2003.00312.x; Fernandes R, 2004, MOL VIS, V10, P618; FOSTER JM, 1954, J BIOL CHEM, V211, P797; GARLAND PB, 1964, BIOCHEM J, V93, P665, DOI 10.1042/bj0930665; GARLAND PB, 1964, BIOCHEM J, V93, P678, DOI 10.1042/bj0930678; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; GILBERT RE, 1995, KIDNEY INT, V48, P1216, DOI 10.1038/ki.1995.405; GROSSIE J, 1982, DIABETES, V31, P194, DOI 10.2337/diabetes.31.3.194; Haufroid V, 2003, EUR J CLIN PHARMACOL, V59, P29, DOI 10.1007/s00228-003-0566-6; Hida W, 1996, AM J RESP CRIT CARE, V153, P1875, DOI 10.1164/ajrccm.153.6.8665049; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; IANUZZO CD, 1982, J APPL PHYSIOL, V52, P1471, DOI 10.1152/jappl.1982.52.6.1471; Ishwaran H, 2003, J AM STAT ASSOC, V98, P438, DOI 10.1198/016214503000224; Katoh J, 1996, J INT MED RES, V24, P209, DOI 10.1177/030006059602400205; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Knoll KE, 2005, PHYSIOL GENOMICS, V21, P222, DOI 10.1152/physiolgenomics.00231.2004; Kubo E, 2005, DIABETOLOGIA, V48, P790, DOI 10.1007/s00125-005-1687-5; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lin BC, 1998, J BIOL CHEM, V273, P31656, DOI 10.1074/jbc.273.48.31656; Liu ZQ, 2000, BIOCHEM BIOPH RES CO, V276, P1255, DOI 10.1006/bbrc.2000.3609; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; McGuire M, 1998, EXP PHYSIOL, V83, P481, DOI 10.1113/expphysiol.1998.sp004131; McGuire M, 1999, EXP PHYSIOL, V84, P1051, DOI 10.1111/j.1469-445X.1999.01916.x; McGuire M, 2001, CLIN EXP PHARMACOL P, V28, P184, DOI 10.1046/j.1440-1681.2001.03433.x; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; PAULUS SF, 1983, DIABETES, V32, P1035, DOI 10.2337/diabetes.32.11.1035; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; Raza H, 2004, DIABETES, V53, P185, DOI 10.2337/diabetes.53.1.185; REGENSTEINER JG, 1995, MED SCI SPORT EXER, V27, P661; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Scano G, 2000, CHEST, V117, P960, DOI 10.1378/chest.117.4.960; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE888, DOI 10.1152/ajpendo.00190.2004; STEARNS SB, 1979, J LIPID RES, V20, P654; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; Sullivan CJ, 2005, PHYSIOL GENOMICS, V23, P192, DOI 10.1152/physiolgenomics.00112.2005; van Lunteren E, 2006, PHYSIOL GENOMICS, V25, P85, DOI 10.1152/physiolgenomics.00226.2005; van Lunteren E, 2003, RESP PHYSIOL NEUROBI, V135, P9, DOI 10.1016/S1569-9048(03)00038-7; van Lunteren E, 2008, RESP PHYSIOL NEUROBI, V161, P41, DOI 10.1016/j.resp.2007.11.005; Van Lunteren E, 2007, AM J PHYSIOL-ENDOC M, V293, pE759, DOI 10.1152/ajpendo.00191.2007; van Lunteren E, 2007, RESP PHYSIOL NEUROBI, V156, P103, DOI 10.1016/j.resp.2006.11.007; van Lunteren E, 2006, RESP PHYSIOL NEUROBI, V153, P157, DOI 10.1016/j.resp.2005.09.015; Voss MD, 2005, DIABETOLOGIA, V48, P2622, DOI 10.1007/s00125-005-0025-2; WANKE T, 1993, AM REV RESPIR DIS, V148, P1335, DOI 10.1164/ajrccm/148.5.1335; WANKE T, 1992, RESPIRATION, V59, P233; WANKE T, 1992, DIABETIC MED, V9, P252, DOI 10.1111/j.1464-5491.1992.tb01771.x; WANKE T, 1991, AM REV RESPIR DIS, V143, P97, DOI 10.1164/ajrccm/143.1.97; Wilson KHS, 2003, DIABETES, V52, P2151, DOI 10.2337/diabetes.52.8.2151; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	65	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7832	10.1371/journal.pone.0007832	http://dx.doi.org/10.1371/journal.pone.0007832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915678	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721900021
J	Ou, GW; Rompikuntal, PK; Bitar, A; Lindmark, B; Vaitkevicius, K; Wai, SN; Hammarstrom, ML				Ou, Gangwei; Rompikuntal, Pramod Kumar; Bitar, Aziz; Lindmark, Barbro; Vaitkevicius, Karolis; Wai, Sun Nyunt; Hammarstrom, Marie-Louise			Vibrio cholerae Cytolysin Causes an Inflammatory Response in Human Intestinal Epithelial Cells That Is Modulated by the PrtV Protease	PLOS ONE			English	Article							EL-TOR HEMOLYSIN; VACCINE; STRAINS; TOXIN; ACTIVATION; LIVE; O1; PURIFICATION; VACUOLATION; EXPRESSION	Background: Vibrio cholerae is the causal intestinal pathogen of the diarrheal disease cholera. It secretes the protease PrtV, which protects the bacterium from invertebrate predators but reduces the ability of Vibrio-secreted factor(s) to induce interleukin-8 (IL-8) production by human intestinal epithelial cells. The aim was to identify the secreted component(s) of V. cholerae that induces an epithelial inflammatory response and to define whether it is a substrate for PrtV. Methodology/Principal Findings: Culture supernatants of wild type V. cholerae O1 strain C6706, its derivatives and pure V. cholerae cytolysin (VCC) were analyzed for the capacity to induce changes in cytokine mRNA expression levels, IL-8 and tumor necrosis factor-alpha (TNF-alpha) secretion, permeability and cell viability when added to the apical side of polarized tight monolayer T84 cells used as an in vitro model for human intestinal epithelium. Culture supernatants were also analyzed for hemolytic activity and for the presence of PrtV and VCC by immunoblot analysis. Conclusions/Significance: We suggest that VCC is capable of causing an inflammatory response characterized by increased permeability and production of IL-8 and TNF-alpha in tight monolayers. Pure VCC at a concentration of 160 ng/ml caused an inflammatory response that reached the magnitude of that caused by Vibrio-secreted factors, while higher concentrations caused epithelial cell death. The inflammatory response was totally abolished by treatment with PrtV. The findings suggest that low doses of VCC initiate a local immune defense reaction while high doses lead to intestinal epithelial lesions. Furthermore, VCC is indeed a substrate for PrtV and PrtV seems to execute an environment-dependent modulation of the activity of VCC that may be the cause of V. cholerae reactogenicity.			Ou, GW (corresponding author), Umea Univ, Dept Clin Microbiol Immunol, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se; marie-louise.hammarstrom@climi.umu.se	Vaitkevicius, Karolis/R-9714-2016; rompikuntal, pramod/C-6917-2015	Vaitkevicius, Karolis/0000-0001-9309-3653; rompikuntal, pramod/0000-0002-4754-4676; Wai, Sun Nyunt/0000-0003-4793-4671; Hammarstrom, Marie-Louise/0000-0001-6182-4423				ALM RA, 1991, VACCINE, V9, P588, DOI 10.1016/0264-410X(91)90247-4; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Blumberg RS, 2005, J INTERF CYTOK RES, V25, P209, DOI 10.1089/jir.2005.25.209; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; COSTER TS, 1995, LANCET, V345, P949, DOI 10.1016/S0140-6736(95)90698-3; Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Hava DL, 2001, J MICROBIOL METH, V46, P217, DOI 10.1016/S0167-7012(01)00276-7; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; KAPER JB, 1984, NATURE, V308, P655, DOI 10.1038/308655a0; Levine Myron M., 1995, Papua New Guinea Medical Journal, V38, P325; Mel SF, 2000, INFECT IMMUN, V68, P6487, DOI 10.1128/IAI.68.11.6487-6492.2000; Mitra R, 2000, INFECT IMMUN, V68, P1928, DOI 10.1128/IAI.68.4.1928-1933.2000; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Pichel M, 2003, J CLIN MICROBIOL, V41, P124, DOI 10.1128/JCM.41.1.124-134.2003; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; TACKET CO, 1995, J INFECT DIS, V172, P883, DOI 10.1093/infdis/172.3.883; TAYLOR DN, 1994, J INFECT DIS, V170, P1518, DOI 10.1093/infdis/170.6.1518; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaitkevicius K, 2008, FEBS J, V275, P3167, DOI 10.1111/j.1742-4658.2008.06470.x; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeva A, 2004, J BIOL CHEM, V279, P25143, DOI 10.1074/jbc.M313913200; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; YAMAMOTO K, 1984, INFECT IMMUN, V45, P192, DOI 10.1128/IAI.45.1.192-196.1984; Zhou X, 2004, INFECT IMMUN, V72, P389, DOI 10.1128/IAI.72.1.389-397.2004; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zitzer A, 1997, INFECT IMMUN, V65, P1293, DOI 10.1128/IAI.65.4.1293-1298.1997	34	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7806	10.1371/journal.pone.0007806	http://dx.doi.org/10.1371/journal.pone.0007806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907657	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721400007
J	Doi, N; Hoshi, Y; Itokawa, M; Usui, C; Yoshikawa, T; Tachikawa, H				Doi, Nagafumi; Hoshi, Yoko; Itokawa, Masanari; Usui, Chie; Yoshikawa, Takeo; Tachikawa, Hirokazu			Persistence Criteria for Susceptibility Genes for Schizophrenia: a Discussion from an Evolutionary Viewpoint	PLOS ONE			English	Article							DIFFERENTIAL FERTILITY; REPRODUCTIVE RATES; MUTATION-RATE; PARENTAL AGE; PATERNAL AGE; ASSOCIATION; RISK; VARIANTS; DISEASE; COMMON	Background: The central paradox of schizophrenia genetics is that susceptibility genes are preserved in the human gene-pool against a strong negative selection pressure. Substantial evidence of epidemiology suggests that nuclear susceptibility genes, if present, should be sustained by mutation-selection balance without heterozygote advantage. Therefore, putative nuclear susceptibility genes for schizophrenia should meet special conditions for the persistence of the disease as well as the condition of bearing a positive association with the disease. Methodology/Principal Findings: We deduced two criteria that every nuclear susceptibility gene for schizophrenia should fulfill for the persistence of the disease under general assumptions of the multifactorial threshold model. The first criterion demands an upper limit of the case-control difference of the allele frequencies, which is determined by the mutation rate at the locus, and the prevalence and the selection coefficient of the disease. The second criterion demands an upper limit of odds ratio for a given allele frequency in the unaffected population. When we examined the top 30 genes at SZGene and the recently reported common variants on chromosome 6p with the criteria using the epidemiological data in a large-sampled Finnish cohort study, it was suggested that most of these are unlikely to confer susceptibility to schizophrenia. The criteria predict that the common disease/common variant hypothesis is unlikely to fit schizophrenia and that nuclear susceptibility genes of moderate effects for schizophrenia, if present, are limited to 'rare variants', 'very common variants', or variants with exceptionally high mutation rates. Conclusions/Significance: If we assume the nuclear DNA model for schizophrenia, it should have many susceptibility genes of exceptionally high mutation rates; alternatively, it should have many disease-associated resistance genes of standard mutation rates on different chromosomes. On the other hand, the epidemiological data show that pathogenic genes, if located in the mitochondrial DNA, could persist through sex-related mechanisms.			Doi, N (corresponding author), Ibaraki Prefectural Tomobe Hosp, Dept Psychiat, Kasama, Ibaraki, Japan.	n.doi@pref.ibaraki.lg.jp	Yoshikawa, Takeo/F-9599-2019	Itokawa, Masanari/0000-0003-4433-8030				Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; BOOK J A, 1953, Acta Genet Stat Med, V4, P1; Brune M, 2004, NEUROSCI BIOBEHAV R, V28, P41, DOI 10.1016/j.neubiorev.2003.10.002; BUCK C, 1975, BRIT J PSYCHIAT, V127, P235, DOI 10.1192/bjp.127.3.235; Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; CROW TJ, 1995, BRIT J PSYCHIAT, V167, P12, DOI 10.1192/bjp.167.1.12; Doi N, 2007, AM J MED GENET B, V144B, P165, DOI 10.1002/ajmg.b.30365; Doi N, 2007, AM J MED GENET B, V144B, P1, DOI 10.1002/ajmg.b.30348; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; ERLENMEYERKIMLI.L, 1978, ANN REV SCHIZOPHRENI, V5, P298; ESSENMOLLER E, 1935, ACTA PSYCHIAT NEUROL, V8, P1; FANANAS L, 1995, ACTA PSYCHIAT SCAND, V91, P202, DOI 10.1111/j.1600-0447.1995.tb09767.x; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; HARRISON G, 1991, BRIT J PSYCHIAT, V159, P811, DOI 10.1192/bjp.159.6.811; Haukka J, 2003, AM J PSYCHIAT, V160, P460, DOI 10.1176/appi.ajp.160.3.460; HAVERKAMP F, 1982, ARCH PSYCHIAT NERVEN, V232, P439, DOI 10.1007/BF00345599; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Jablensky A., 1995, P206; Karlsson JL, 1974, ACTA PSYCHIAT SCAND, V247, P77; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kinney DK, 2000, CREATIVITY RES J, V13, P17; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LARSON CA, 1973, ACTA PSYCHIAT SCAND, V49, P272, DOI 10.1111/j.1600-0447.1973.tb04421.x; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; LINDELIUS R, 1970, ACTA PSYCHIAT SCAND, P216; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; McGrath JJ, 1999, ACTA PSYCHIAT SCAND, V99, P441, DOI 10.1111/j.1600-0447.1999.tb00990.x; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Nachman MW, 2000, GENETICS, V156, P297; NANKO S, 1993, ACTA PSYCHIAT SCAND, V87, P400, DOI 10.1111/j.1600-0447.1993.tb03395.x; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nimgaonkar VL, 1998, ACTA PSYCHIAT SCAND, V98, P348, DOI 10.1111/j.1600-0447.1998.tb10097.x; ODEGARD O, 1980, ACTA PSYCHIAT SCAND, V62, P212, DOI 10.1111/j.1600-0447.1980.tb00609.x; ODONOVAN MC, 2008, NAT GENET; Ohashi J, 2002, ANN HUM GENET, V66, P297, DOI [10.1046/j.1469-1809.2002.00119.x, 10.1017/S0003480002001197]; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Osby U, 2001, SCHIZOPHR RES, V47, P247, DOI 10.1016/S0920-9964(00)00124-9; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; RIMMER J, 1976, ACTA PSYCHIAT SCAND, V54, P161, DOI 10.1111/j.1600-0447.1976.tb00108.x; RISCH N, 1987, AM J HUM GENET, V41, P218; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Shaner A, 2004, SCHIZOPHR RES, V70, P101, DOI 10.1016/j.schres.2003.09.014; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SIPOS A, 2004, BRIT MED J, DOI DOI 10.1136/BMJ938243.672396.55; SLATER E, 1971, SOC BIOL, V18, pS60; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Vogel F., 1997, HUMAN GENETICS PROBL; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zammit S, 2003, BRIT J PSYCHIAT, V183, P405, DOI 10.1192/bjp.183.5.405	68	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A208	A220	e7799	10.1371/journal.pone.0007799	http://dx.doi.org/10.1371/journal.pone.0007799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19911060	Green Submitted, Green Published, gold			2022-12-27	WOS:000271685800022
J	Mitterer, H; McQueen, JM				Mitterer, Holger; McQueen, James M.			Foreign Subtitles Help but Native-Language Subtitles Harm Foreign Speech Perception	PLOS ONE			English	Article							ADAPTATION	Understanding foreign speech is difficult, in part because of unusual mappings between sounds and words. It is known that listeners in their native language can use lexical knowledge (about how words ought to sound) to learn how to interpret unusual speech-sounds. We therefore investigated whether subtitles, which provide lexical information, support perceptual learning about foreign speech. Dutch participants, unfamiliar with Scottish and Australian regional accents of English, watched Scottish or Australian English videos with Dutch, English or no subtitles, and then repeated audio fragments of both accents. Repetition of novel fragments was worse after Dutch-subtitle exposure but better after English-subtitle exposure. Native-language subtitles appear to create lexical interference, but foreign-language subtitles assist speech learning by indicating which words (and hence sounds) are being spoken.			Mitterer, H (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	holger.mitterer@mpi.nl	McQueen, James M./B-2212-2010; Mitterer, Holger/D-1908-2010	McQueen, James M./0000-0003-3734-6286; Mitterer, Holger/0000-0003-4318-0032				ADANK P, 2009, HUMAN PERCEPTION PER, V35, P520; Bertelson P, 2003, PSYCHOL SCI, V14, P592, DOI 10.1046/j.0956-7976.2003.psci_1470.x; Best C., 2007, HONOR JAMES EMIL FLE, V1334, P1, DOI DOI 10.1075/LLLT.17.07BES; Bird SA, 2002, APPL PSYCHOLINGUIST, V23, P509, DOI 10.1017/S0142716402004022; BORRAS I, 1994, MOD LANG J, V78, P61, DOI 10.2307/329253; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; Broersma M, 2008, SYSTEM, V36, P22, DOI 10.1016/j.system.2007.11.003; Clahsen H, 2006, TRENDS COGN SCI, V10, P564, DOI 10.1016/j.tics.2006.10.002; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Clarke-Davidson CM, 2008, PERCEPT PSYCHOPHYS, V70, P604, DOI 10.3758/PP.70.4.604; Connine CM, 2009, J MEM LANG, V61, P412, DOI 10.1016/j.jml.2009.07.003; d'Ydewalle G, 1999, J PSYCHOLINGUIST RES, V28, P227, DOI 10.1023/A:1023202130625; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; DEBOT K, 1986, SECOND LANG RES, V2, P72; Del Toro G., 2006, LABERINTO FAUNO; Hervais-Adelman A, 2008, J EXP PSYCHOL HUMAN, V34, P460, DOI 10.1037/0096-1523.34.2.460; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kraljic T, 2008, COGNITION, V107, P54, DOI 10.1016/j.cognition.2007.07.013; Kraljic T, 2008, PSYCHOL SCI, V19, P332, DOI 10.1111/j.1467-9280.2008.02090.x; LAMBERT WE, 1981, APPL PSYCHOLINGUIST, V2, P133, DOI 10.1017/S0142716400000904; Macdonald A, 1996, TRAINSPOTTING; Maye J, 2008, COGNITIVE SCI, V32, P543, DOI 10.1080/03640210802035357; MCKENNA R, 2002, KATH KIM, V1; McQueen JM, 2006, COGNITIVE SCI, V30, P1113, DOI 10.1207/s15516709cog0000_79; Mitterer H, 2008, PSYCHOL SCI, V19, P629, DOI 10.1111/j.1467-9280.2008.02133.x; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Norris D, 2006, Q J EXP PSYCHOL, V59, P1505, DOI 10.1080/17470210600739494; *OECD PISA, 2007, PISA 2006 SCI COMP T; Ullman M.T., 2001, BILING-LANG COGN, V4, P105, DOI [10.1017/S1366728901000220, DOI 10.1017/S1366728901000220]; VANDERLINDEN S, 2007, J EXPT PSYCHOL HUMAN, V33, P1483; VANORDEN GC, 1987, MEM COGNITION, V15, P181, DOI 10.3758/BF03197716; Yoshino S., 2000, LANGUAGE LAB, V37, P111; [No title captured], DOI DOI 10.1016/J.JML.2007.12.005	33	104	104	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A146	A150	e7785	10.1371/journal.pone.0007785	http://dx.doi.org/10.1371/journal.pone.0007785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19918371	gold, Green Published, Green Submitted			2022-12-27	WOS:000271685800016
J	Ikeda, M; Hirono, M; Sugiyama, T; Moriya, T; Ikeda-Sagara, M; Eguchi, N; Urade, Y; Yoshioka, T				Ikeda, Masayuki; Hirono, Moritoshi; Sugiyama, Takashi; Moriya, Takahiro; Ikeda-Sagara, Masami; Eguchi, Naomi; Urade, Yoshihiro; Yoshioka, Tohru			Phospholipase C-beta 4 Is Essential for the Progression of the Normal Sleep Sequence and Ultradian Body Temperature Rhythms in Mice	PLOS ONE			English	Article							SUPERIOR COLLICULUS; LATERAL GENICULATE; PARADOXICAL SLEEP; VISUAL RESPONSE; OREXIN; RECEPTORS; HYPOCRETIN; STATES; NOREPINEPHRINE; MODULATION	Background: The sleep sequence: i) non-REM sleep, ii) REM sleep, and iii) wakefulness, is stable and widely preserved in mammals, but the underlying mechanisms are unknown. It has been shown that this sequence is disrupted by sudden REM sleep onset during active wakefulness (i. e., narcolepsy) in orexin-deficient mutant animals. Phospholipase C (PLC) mediates the signaling of numerous metabotropic receptors, including orexin receptors. Among the several PLC subtypes, the beta 4 subtype is uniquely localized in the geniculate nucleus of thalamus which is hypothesized to have a critical role in the transition and maintenance of sleep stages. In fact, we have reported irregular theta wave frequency during REM sleep in PLC-beta 4-deficient mutant (PLC-beta 4-/-) mice. Daily behavioral phenotypes and metabotropic receptors involved have not been analyzed in detail in PLC-beta 4-/- mice, however. Methodology/Principal Findings: Therefore, we analyzed 24-h sleep electroencephalogram in PLC-beta 4-/- mice. PLC-beta 4-/- mice exhibited normal non-REM sleep both during the day and nighttime. PLC-beta 4-/- mice, however, exhibited increased REM sleep during the night, their active period. Also, their sleep was fragmented with unusual wake-to-REM sleep transitions, both during the day and nighttime. In addition, PLC-beta 4-/- mice reduced ultradian body temperature rhythms and elevated body temperatures during the daytime, but had normal homeothermal response to acute shifts in ambient temperatures (22 degrees C-4 degrees C). Within the most likely brain areas to produce these behavioral phenotypes, we found that, not orexin, but group-1 metabotropic glutamate receptor (mGluR)-mediated Ca2+ mobilization was significantly reduced in the dorsal lateral geniculate nucleus (LGNd) of PLC-beta 4-/- mice. Voltage clamp recordings revealed that group-1 mGluR-mediated currents in LGNd relay neurons (inward in wild-type mice) were outward in PLC-beta 4-/- mice. Conclusions/Significance: These lines of evidence indicate that impaired LGNd relay, possibly mediated via group-1 mGluR, may underlie irregular sleep sequences and ultradian body temperature rhythms in PLC-beta 4-/- mice.			Ikeda, M (corresponding author), Toyama Univ, Grad Sch Innovat Life Sci, Dept Chronobiol, Toyama 930, Japan.	msikeda@sci.u-toyama.ac.jp		Ikeda, Masayuki/0000-0002-6833-9495; Hirono, Moritoshi/0000-0001-6068-1045; Sugiyama, Takashi/0000-0002-7872-1540				Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Bayer L, 2002, J NEUROSCI, V22, P7835; Boutrel B, 1999, J NEUROSCI, V19, P3204; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Govindaiah G, 2006, NEUROPHARMACOLOGY, V51, P414, DOI 10.1016/j.neuropharm.2006.03.030; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hirono M, 2001, J BIOL CHEM, V276, P45236, DOI 10.1074/jbc.M105413200; Hunsley MS, 2006, GENES BRAIN BEHAV, V5, P451, DOI 10.1111/j.1601-183X.2005.00179.x; Hunsley MS, 2003, SLEEP, V26, P521; Ikeda M, 2000, NEUROSCI LETT, V279, P185, DOI 10.1016/S0304-3940(99)00943-X; Ikeda M, 2000, NEUROREPORT, V11, P907, DOI 10.1097/00001756-200004070-00002; Jenkins TC, 2007, BRAIN RES, V1178, P83, DOI 10.1016/j.brainres.2007.07.098; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Kameyama M, 2003, BIOCHEM BIOPH RES CO, V304, P153, DOI 10.1016/S0006-291X(03)00536-9; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; McCarley RW, 1999, SLEEP DISORDERS MED, P21; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Miller AM, 1999, BEHAV NEUROSCI, V113, P755, DOI 10.1037/0735-7044.113.4.755; Miller AM, 1998, P NATL ACAD SCI USA, V95, P8957, DOI 10.1073/pnas.95.15.8957; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Neto FL, 2000, BRAIN RES, V854, P93, DOI 10.1016/S0006-8993(99)02326-4; Parmentier R, 2002, J NEUROSCI, V22, P7695; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Sugiyama T, 1999, BIOCHEM BIOPH RES CO, V265, P473, DOI 10.1006/bbrc.1999.1628; Thakkar M M, 1999, Sleep Res Online, V2, P112; Tobler I, 1997, J NEUROSCI, V17, P1869; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; White AM, 2003, BRIT J PHARMACOL, V140, P1421, DOI 10.1038/sj.bjp.0705570; Wurts SW, 2000, J NEUROSCI, V20, P4300; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	39	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7737	10.1371/journal.pone.0007737	http://dx.doi.org/10.1371/journal.pone.0007737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898623	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000004
J	Dal Secco, V; Soldani, C; Debrat, C; Asperti-Boursin, F; Donnadieu, E; Viola, A; Sarukhan, A				Dal Secco, Valentina; Soldani, Cristiana; Debrat, Claire; Asperti-Boursin, Francois; Donnadieu, Emmanuel; Viola, Antonella; Sarukhan, Adelaida			Tunable Chemokine Production by Antigen Presenting Dendritic Cells in Response to Changes in Regulatory T Cell Frequency in Mouse Reactive Lymph Nodes	PLOS ONE			English	Article							HIGH ENDOTHELIAL VENULES; IN-VIVO; IMMUNE-RESPONSE; STEADY-STATE; MIGRATION; IMMATURE; FOXP3; RECRUITMENT; MICE; MICROENVIRONMENTS	Background: Although evidence exists that regulatory T cells (Tregs) can suppress the effector phase of immune responses, it is clear that their major role is in suppressing T cell priming in secondary lymphoid organs. Recent experiments using two photon laser microscopy indicate that dendritic cells (DCs) are central to Treg cell function and that the in vivo mechanisms of T cell regulation are more complex than those described in vitro. Principal Findings: Here we have sought to determine whether and how modulation of Treg numbers modifies the lymph node (LN) microenvironment. We found that pro-inflammatory chemokines-CCL2 (MCP-1) and CCL3 (MIP-la)-are secreted in the LN early (24 h) after T cell activation, that this secretion is dependent on antigen-specific DC-T cell interactions, and that it was inversely related to the frequency of Tregs specific for the same antigen. Furthermore, we demonstrate that Tregs modify the chemoattractant properties of antigen-presenting DCs, which, as the frequency of Tregs increases, fail to produce CCL2 and CCL3 and to attract antigen-specific T cells. Conclusions: These results substantiate a major role of Tregs in LN patterning during antigen-specific immune responses.			Dal Secco, V (corresponding author), Ist Clin Humanitas IRCCS, Milan, Italy.	antonella.viola@humanitas.it	Donnadieu, Emmanuel/P-4566-2017; Agatea, Lisa/L-8267-2016; Viola, Antonella/A-4321-2015	Soldani, Cristiana/0000-0001-5041-9588; Sarukhan, Adelaida/0000-0003-3747-6304; Viola, Antonella/0000-0002-0125-9271	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ALLAN SE, 2008, IMMUNOL REV, V391, P421; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Betts GJ, 2006, ADV DRUG DELIVER REV, V58, P948, DOI 10.1016/j.addr.2006.05.006; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; CHUNG DJ, 2009, BLOOD; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gallimore AM, 2008, ONCOGENE, V27, P5886, DOI 10.1038/onc.2008.269; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Levings MK, 2006, ADV IMMUNOL, V92, P119, DOI 10.1016/S0065-2776(06)92003-3; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Sozzani S, 1998, J IMMUNOL, V161, P1083; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Terme M, 2008, J IMMUNOL, V180, P4679, DOI 10.4049/jimmunol.180.7.4679; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	44	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7696	10.1371/journal.pone.0007696	http://dx.doi.org/10.1371/journal.pone.0007696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893746	Green Published, Green Submitted, gold			2022-12-27	WOS:000271478000003
J	Skalska, J; Brookes, PS; Nadtochiy, SM; Hilchey, SP; Jordan, CT; Guzman, ML; Maggirwar, SB; Briehl, MM; Bernstein, SH				Skalska, Jolanta; Brookes, Paul S.; Nadtochiy, Sergiy M.; Hilchey, Shannon P.; Jordan, Craig T.; Guzman, Monica L.; Maggirwar, Sanjay B.; Briehl, Margaret M.; Bernstein, Steven H.			Modulation of Cell Surface Protein Free Thiols: A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide	PLOS ONE			English	Article							OXIDATIVE STRESS; REDOX REGULATION; CANCER-CELLS; APOPTOSIS; PATHWAY; LINES; SUSCEPTIBILITY; THIOREDOXIN-1; LYMPHOMAS; RESPONSES	Background: There has been much interest in targeting intracellular redox pathways as a therapeutic approach for cancer. Given recent data to suggest that the redox status of extracellular protein thiol groups (i.e. exofacial thiols) effects cell behavior, we hypothesized that redox active anti-cancer agents would modulate exofacial protein thiols. Methodology/Principal Findings: To test this hypothesis, we used the sesquiterpene lactone parthenolide, a known anticancer agent. Using flow cytometry, and western blotting to label free thiols with Alexa Fluor 633 C(5) maleimide dye and N-biotinoyl)-N-(iodoacetyl) ethylendiamine (BIAM), respectively, we show that parthenolide decreases the level of free exofacial thiols on Granta mantle lymphoma cells. In addition, we used immuno-precipitation techniques to identify the central redox regulator thioredoxin, as one of the surface protein thiol targets modified by parthenolide. To examine the functional role of parthenolide induced surface protein thiol modification, we pretreated Granta cells with cell impermeable glutathione (GSH), prior to exposure to parthenolide, and showed that GSH pretreatment; (a) inhibited the interaction of parthenolide with exofacial thiols; (b) inhibited parthenolide mediated activation of JNK and inhibition of NF kappa B, two well established mechanisms of parthenolide activity and; (c) blocked the cytotoxic activity of parthenolide. That GSH had no effect on the parthenolide induced generation of intracellular reactive oxygen species supports the fact that GSH had no effect on intracellular redox. Together these data support the likelihood that GSH inhibits the effect of parthenolide on JNK, NF kappa B and cell death through its direct inhibition of parthenolide's modulation of exofacial thiols. Conclusions/Significance: Based on these data, we postulate that one component of parthenolide's anti-lymphoma activity derives from its ability to modify the redox state of critical exofacial thiols. Further, we propose that cancer cell exofacial thiols may be important and novel targets for therapy.	[Skalska, Jolanta; Hilchey, Shannon P.; Jordan, Craig T.; Guzman, Monica L.; Bernstein, Steven H.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Brookes, Paul S.; Nadtochiy, Sergiy M.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Maggirwar, Sanjay B.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Briehl, Margaret M.] Univ Arizona, Arizona Canc Ctr, Dept Pathol, Tucson, AZ USA	University of Rochester; University of Rochester; University of Rochester; Arizona Center Cancer Care; University of Arizona	Skalska, J (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA.	Steven_Bernstein@urmc.rochester.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465; Brookes, Paul/0000-0002-8639-8413	NIH/NCI [1 P50-CA130805-01]; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA130805] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Lymphoma Spore Grant (NIH/NCI 1 P50-CA130805-01; Project 2 SHB, MB, SPH, PSB) and a Lymphoma Research Foundation Mantle Cell Lymphoma Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech David J, 2007, Channels (Austin), V1, P400; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; Jadayel DM, 1997, LEUKEMIA, V11, P64, DOI 10.1038/sj.leu.2400555; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kim JH, 2005, CANCER RES, V65, P6312, DOI 10.1158/0008-5472.CAN-04-4193; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lecane PS, 2005, CANCER RES, V65, P11676, DOI 10.1158/0008-5472.CAN-05-2754; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Mattila AM, 2008, SCAND J IMMUNOL, V68, P159, DOI 10.1111/j.1365-3083.2008.02129.x; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nakshatri H, 2004, ONCOGENE, V23, P7330, DOI 10.1038/sj.onc.1207995; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Ray DM, 2006, EXP HEMATOL, V34, P1202, DOI 10.1016/j.exphem.2006.04.026; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; RIMOKH R, 1994, BLOOD, V83, P3689; Sahaf B, 2005, ARCH BIOCHEM BIOPHYS, V434, P26, DOI 10.1016/j.abb.2004.11.015; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Steele AJ, 2006, LEUKEMIA, V20, P1073, DOI 10.1038/sj.leu.2404230; Tanaka T, 2003, LIFE SCI, V73, P2985, DOI 10.1016/S0024-3205(03)00708-2; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; WINTER JN, 1984, BLOOD, V63, P140; Yip-Schneider MT, 2005, MOL CANCER THER, V4, P587, DOI 10.1158/1535-7163.MCT-04-0215	31	53	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8115	10.1371/journal.pone.0008115	http://dx.doi.org/10.1371/journal.pone.0008115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956548	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800013
J	Zhang, L; Bonham, AJ; Li, J; Pei, YF; Chen, J; Papasian, CJ; Deng, HW				Zhang, Lei; Bonham, Aaron J.; Li, Jian; Pei, Yu-Fang; Chen, Jie; Papasian, Christopher J.; Deng, Hong-Wen			Family-Based Bivariate Association Tests for Quantitative Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-LINKAGE; SEMIPARAMETRIC TEST; UNRELATED SAMPLES; LOCI; STRATIFICATION; DISEQUILIBRIUM; POPULATIONS; PHENOTYPE; PEDIGREE	The availability of a large number of dense SNPs, high-throughput genotyping and computation methods promotes the application of family-based association tests. While most of the current family-based analyses focus only on individual traits, joint analyses of correlated traits can extract more information and potentially improve the statistical power. However, current TDT-based methods are low-powered. Here, we develop a method for tests of association for bivariate quantitative traits in families. In particular, we correct for population stratification by the use of an integration of principal component analysis and TDT. A score test statistic in the variance-components model is proposed. Extensive simulation studies indicate that the proposed method not only outperforms approaches limited to individual traits when pleiotropic effect is present, but also surpasses the power of two popular bivariate association tests termed FBAT-GEE and FBAT-PC, respectively, while correcting for population stratification. When applied to the GAW16 datasets, the proposed method successfully identifies at the genome-wide level the two SNPs that present pleiotropic effects to HDL and TG traits.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Bonham, Aaron J.; Li, Jian; Pei, Yu-Fang; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Chen, Jie] Univ Missouri, Dept Math & Stat, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology; Beijing Jiaotong University	Zhang, L (corresponding author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China.	dengh@umkc.edu	Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Zhang, Lei/0000-0002-1007-4834; Chen, Jie/0000-0003-2151-5276; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Science Foundation of China; Huo Ying Dong Education Foundation; Shanghai Leading Academic Discipline [S30501]; Xi'an Jiaotong University, and the Ministry of Education of China; Xi'an Jiaotong University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); Xi'an Jiaotong University, and the Ministry of Education of China; Xi'an Jiaotong University(Xi'an Jiaotong University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The investigators of this work also benefited from grants from the National Science Foundation of China, Huo Ying Dong Education Foundation, Shanghai Leading Academic Discipline Project (S30501), HuNan Province, Xi'an Jiaotong University, and the Ministry of Education of China. Computing support was partially provided by the High Performance Computing Cluster Center at Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; de Andrade M, 2005, GENET EPIDEMIOL, V29, pS91, DOI 10.1002/gepi.20115; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; JIANG CJ, 1995, GENETICS, V140, P1111; Jung JS, 2008, GENET EPIDEMIOL, V32, P396, DOI 10.1002/gepi.20313; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; ZHANG L, 2009, ANN HUMAN G IN PRESS; Zhang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006502; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2008, AM J HUM GENET, V82, P352, DOI 10.1016/j.ajhg.2007.10.009	30	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8133	10.1371/journal.pone.0008133	http://dx.doi.org/10.1371/journal.pone.0008133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956578	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828800024
J	Neves-Costa, A; Will, WR; Vetter, AT; Miller, JR; Varga-Weisz, P				Neves-Costa, Ana; Will, W. Ryan; Vetter, Anna T.; Miller, J. Ross; Varga-Weisz, Patrick			The SNF2-Family Member Fun30 Promotes Gene Silencing in Heterochromatic Loci	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; ORIGIN RECOGNITION COMPLEX; RIBOSOMAL DNA LOCUS; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-BINDING; CUE DOMAIN; PROTEIN; YEAST; REPLICATION	Chromatin regulates many key processes in the nucleus by controlling access to the underlying DNA. SNF2-like factors are ATP-driven enzymes that play key roles in the dynamics of chromatin by remodelling nucleosomes and other nucleoprotein complexes. Even simple eukaryotes such as yeast contain members of several subfamilies of SNF2-like factors. The FUN30/ETL1 subfamily of SNF2 remodellers is conserved from yeasts to humans, but is poorly characterized. We show that the deletion of FUN30 leads to sensitivity to the topoisomerase I poison camptothecin and to severe cell cycle progression defects when the Orc5 subunit is mutated. We demonstrate a role of FUN30 in promoting silencing in the heterochromatin-like mating type locus HMR, telomeres and the rDNA repeats. Chromatin immunoprecipitation experiments demonstrate that Fun30 binds at the boundary element of the silent HMR and within the silent HMR. Mapping of nucleosomes in vivo using micrococcal nuclease demonstrates that deletion of FUN30 leads to changes of the chromatin structure at the boundary element. A point mutation in the ATP-binding site abrogates the silencing function of Fun30 as well as its toxicity upon overexpression, indicating that the ATPase activity is essential for these roles of Fun30. We identify by amino acid sequence analysis a putative CUE motif as a feature of FUN30/ETL1 factors and show that this motif assists Fun30 activity. Our work suggests that Fun30 is directly involved in silencing by regulating the chromatin structure within or around silent loci.	[Neves-Costa, Ana; Will, W. Ryan; Vetter, Anna T.; Miller, J. Ross; Varga-Weisz, Patrick] Babraham Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Neves-Costa, A (corresponding author), Inst Mol Med, Cell Biol Immune Syst Unit, Lisbon, Portugal.	Patrick.varga-weisz@bbsrc.ac.uk	Neves-Costa, Ana/AAJ-7066-2021	Neves-Costa, Ana/0000-0001-6506-7829; Varga-Weisz, Patrick/0000-0001-7409-8686	Portuguese Fundacao Para a Ciencia e a Tecnologia; DAAD German Academic Exchange Service; Biotechnology and Biological Sciences Research Council; EU Epigenome Network of Excellence; Biotechnology and Biological Sciences Research Council [BB/F020236/1] Funding Source: researchfish; Medical Research Council [G0701175] Funding Source: researchfish; BBSRC [BB/F020236/1] Funding Source: UKRI; MRC [G0701175] Funding Source: UKRI	Portuguese Fundacao Para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); DAAD German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Epigenome Network of Excellence; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a studentship of the Portuguese Fundacao Para a Ciencia e a Tecnologia to A.N.-C., a stipend of the DAAD German Academic Exchange Service to A.V., and by the Biotechnology and Biological Sciences Research Council and by the EU Epigenome Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cuperus G, 2002, GENETICS, V162, P633; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Finn R., 2003, CURR PROTOC BIOINFOR; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guthrie C, 1991, GUIDE YEAST GENETICS; Harlow E., 1988, ANTIBODIES LAB MANUA; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; KENT NA, 1995, NUCLEIC ACIDS RES, V23, P3786, DOI 10.1093/nar/23.18.3786; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mueller JE, 2007, J MOL BIOL, V371, P1, DOI 10.1016/j.jmb.2007.04.089; Mueller JE, 2007, BIOCHEM BIOPH RES CO, V361, P1017, DOI 10.1016/j.bbrc.2007.07.140; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2001, GENE DEV, V15, P955; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524	66	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8111	10.1371/journal.pone.0008111	http://dx.doi.org/10.1371/journal.pone.0008111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956593	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828700022
J	Sui, SJH; Fedynak, A; Hsiao, WWL; Langille, MGI; Brinkman, FSL				Sui, Shannan J. Ho; Fedynak, Amber; Hsiao, William W. L.; Langille, Morgan G. I.; Brinkman, Fiona S. L.			The Association of Virulence Factors with Genomic Islands	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; PATHOGENICITY ISLANDS; HORIZONTAL TRANSFER; COMMON THEMES; IN-VIVO; GENES; EVOLUTION; IDENTIFICATION; DATABASE; CRISPR	Background: It has been noted that many bacterial virulence factor genes are located within genomic islands (GIs; clusters of genes in a prokaryotic genome of probable horizontal origin). However, such studies have been limited to single genera or isolated observations. We have performed the first large-scale analysis of multiple diverse pathogens to examine this association. We additionally identified genes found predominantly in pathogens, but not non-pathogens, across multiple genera using 631 complete bacterial genomes, and we identified common trends in virulence for genes in GIs. Furthermore, we examined the relationship between GIs and clustered regularly interspaced palindromic repeats (CRISPRs) proposed to confer resistance to phage. Methodology/Principal Findings: We show quantitatively that GIs disproportionately contain more virulence factors than the rest of a given genome (p<1E-40 using three GI datasets) and that CRISPRs are also over-represented in GIs. Virulence factors in GIs and pathogen-associated virulence factors are enriched for proteins having more "offensive" functions, e. g. active invasion of the host, and are disproportionately components of type III/IV secretion systems or toxins. Numerous hypothetical pathogen-associated genes were identified, meriting further study. Conclusions/Significance: This is the first systematic analysis across diverse genera indicating that virulence factors are disproportionately associated with GIs. "Offensive" virulence factors, as opposed to host-interaction factors, may more often be a recently acquired trait (on an evolutionary time scale detected by GI analysis). Newly identified pathogen-associated genes warrant further study. We discuss the implications of these results, which cement the significant role of GIs in the evolution of many pathogens.	[Sui, Shannan J. Ho; Fedynak, Amber; Hsiao, William W. L.; Langille, Morgan G. I.; Brinkman, Fiona S. L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Sui, SJH (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	brinkman@sfu.ca	Langille, Morgan/D-4775-2009; Brinkman, Fiona/N-3195-2013	Brinkman, Fiona/0000-0002-0584-4099; Langille, Morgan/0000-0002-6604-3009; /0000-0002-6191-4709	International Business Machines Corporation (IBM); Genome Canada/Genome BC; Cystic Fibrosis Foundation; SFU Community Trust Endowment Fund; MSFHR/CIHR; Canadian Cystic Fibrosis Foundation Kin Canada	International Business Machines Corporation (IBM)(International Business Machines (IBM)); Genome Canada/Genome BC(Genome Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); SFU Community Trust Endowment Fund; MSFHR/CIHR(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation Kin Canada	This work was funded by grants from International Business Machines Corporation (IBM), Genome Canada/Genome BC (http://www.genomecanada.ca), the Cystic Fibrosis Foundation (http://www.cff.org), and the SFU Community Trust Endowment Fund. WWLH and FSLB are a Michael Smith Foundation for Health Research (MSFHR;www.msfhr.org) Trainee and Senior Scholar, respectively, and they are also Canadian Institutes for Health Research (CIHR;www.cihr-irsc.gc.ca) Doctoral award and New Investigator award recipients, respectively. MGIL is a recipient of a MSFHR/CIHR bioinformatics training award and SJHS is a recipient of the 2009 Canadian Cystic Fibrosis Foundation Kin Canada Fellowship (www.cysticfibrosis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-154; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boutet Emmanuel, 2007, V406, P89; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gandon S, 2003, P ROY SOC B-BIOL SCI, V270, P1129, DOI 10.1098/rspb.2003.2370; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2005, BIOINFORMATICS, V21, P293, DOI 10.1093/bioinformatics/bti015; Hentschel U, 2001, MICROBES INFECT, V3, P545, DOI 10.1016/S1286-4579(01)01410-1; Holden M, 2004, NAT REV MICROBIOL, V2, P91, DOI 10.1038/nrmicro825; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Russmann H, 2004, INT J MED MICROBIOL, V293, P565, DOI 10.1078/1438-4221-00289; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shukla HD, 2005, CRIT REV MICROBIOL, V31, P11, DOI 10.1080/10408410590912952; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Soubeyrand B, 2002, NATURE, V417, P609, DOI 10.1038/417609b; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vernikos GS, 2008, GENOME RES, V18, P331, DOI 10.1101/gr.7004508; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zhang R, 2006, MICROBES INFECT, V8, P1613, DOI 10.1016/j.micinf.2005.11.019; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	56	102	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8094	10.1371/journal.pone.0008094	http://dx.doi.org/10.1371/journal.pone.0008094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956607	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700009
J	Gougelet, A; Mansuy, A; Blay, JY; Alberti, L; Vermot-Desroches, C				Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent; Vermot-Desroches, Claudine			Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti-IL-6 Antibody	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; WILD-TYPE P53; BREAST-CANCER; TYROSINE PHOSPHORYLATION; PROGNOSTIC VALUE; DOWN-REGULATION; CIS-DIAMMINEDICHLOROPLATINUM	Background: Production of high levels of IL-6 is often correlated with resistance to cytotoxics or ionizing radiations, in cancer cell lines as in various cancer patients. We investigated whether monoclonal antibodies directed against IL-6 may enable to reverse resistance of cancer cell lines. Methodology/Principal Findings: We exposed ten haematological cancer cells from lymphoma, myeloma, or leukemia origins to cytotoxics or ionizing radiations and assessed the effects of anti-IL-6 antibody addition on cell proliferation, apoptosis, or IL-6 signaling. A strong correlation between IL-6 secretion, measured by ELISA, and resistance to doxorubicin as ionizing radiations was observed in the multiple myeloma U266 and the Burkitt's lymphoma Daudi and Namalwa cells. Although an anti-IL-6 antibody combined to both treatments efficiently blocked IL-6 signaling in U266 cells, expressing the IL-6 receptor gp80, it did not increase treatment-induced anti-proliferative and pro-apoptotic effects on these cells, as well as on Daudi and Namalwa cells. This lack of effect could be related to diverse factors: 1) a higher release of the soluble form of IL-6 receptor gp80 in response to doxorubicin and irradiation from all cell lines, 2) an impaired level of the IL-6 pathway inhibitor SOCS3 in Daudi cells, and 3) an increased release of IL-10 and TNF alpha, two cytokines involved in cell radio- and chemoresistance. Conclusions/Significance: These data support the fact that IL-6 is not the preponderant actor of cell resistance to cytotoxics and ionizing radiations, which seems to be regulated by a complex network of proteins.	[Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent] Ctr Leon Berard, INSERM, U590, Equipe Cytokines & Canc, F-69373 Lyon, France; [Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent] IID Biotech, Conticanet Consortium FP6 06188, Dardilly, France; [Blay, Jean-Yves] EORTC, Brussels, Belgium; [Vermot-Desroches, Claudine] IDD Tech, Dardilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; European Organisation for Research & Treatment of Cancer	Gougelet, A (corresponding author), Ctr Leon Berard, INSERM, U590, Equipe Cytokines & Canc, F-69373 Lyon, France.	gougelet@lyon.fnclcc.fr	Blay, Jean-Yves/N-3966-2016; Gougelet, Angelique/E-2071-2017; Alberti, Laurent/HHZ-3296-2022	Blay, Jean-Yves/0000-0001-7190-120X; Gougelet, Angelique/0000-0001-7464-9804; Alberti, Laurent/0000-0002-7686-1750	Ligue Nationale contre le Cancer; Lyon BioPole	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Lyon BioPole	This work has been supported by the Ligue Nationale contre le Cancer (grants from the Ain department) and the Lyon BioPole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmansu M, 2005, CYTOKINE, V31, P41, DOI 10.1016/j.cyto.2005.02.009; Alas S, 2001, CANCER RES, V61, P5137; Alas S, 2001, CLIN CANCER RES, V7, P709; Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; BARUT BA, 1992, LEUKEMIA RES, V16, P951, DOI 10.1016/0145-2126(92)90073-G; BORSELLINO N, 1995, CANCER RES, V55, P4633; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Conze D, 2001, CANCER RES, V61, P8851; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Dedoussis GVZ, 1999, EXP CELL RES, V249, P269, DOI 10.1006/excr.1999.4442; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guillemard V, 2004, CURR CANCER DRUG TAR, V4, P313, DOI 10.2174/1568009043332989; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Jourdan M, 1999, EUR CYTOKINE NETW, V10, P65; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Klein B, 1990, Eur Cytokine Netw, V1, P193; KLEIN B, 1989, BLOOD, V73, P517; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lotem J, 1996, P NATL ACAD SCI USA, V93, P12507, DOI 10.1073/pnas.93.22.12507; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; MIZUTANI Y, 1994, J UROLOGY, V151, P1697, DOI 10.1016/S0022-5347(17)35347-8; MIZUTANI Y, 1995, CANCER RES, V55, P590; Moreau P, 2000, BRIT J HAEMATOL, V109, P661, DOI 10.1046/j.1365-2141.2000.02093.x; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Negrier S, 2004, J CLIN ONCOL, V22, P2371, DOI 10.1200/JCO.2004.06.121; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Otero DC, 2006, J IMMUNOL, V177, P6593, DOI 10.4049/jimmunol.177.10.6593; Park J, 2008, ANTI-CANCER DRUG, V19, P777, DOI 10.1097/CAD.0b013e32830c236a; Petrini B., 1992, In Vivo (Attiki), V6, P531; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Shinomiya N, 2000, INT J RADIAT ONCOL, V47, P767, DOI 10.1016/S0360-3016(99)00517-9; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Tamatani T, 2004, INT J CANCER, V108, P912, DOI 10.1002/ijc.11640; Trikha M, 2003, CLIN CANCER RES, V9, P4653; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; Visco C, 2004, LEUKEMIA LYMPHOMA, V45, P2085, DOI 10.1080/10428190410001712234; Voorzanger N, 1996, CANCER RES, V56, P5499; Voorzanger-Rousselot N, 1998, BLOOD, V92, P3381, DOI 10.1182/blood.V92.9.3381.421k02_3381_3387; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhou ZH, 2005, APOPTOSIS, V10, P123, DOI 10.1007/s10495-005-6067-6	47	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8026	10.1371/journal.pone.0008026	http://dx.doi.org/10.1371/journal.pone.0008026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956602	Green Published, gold			2022-12-27	WOS:000272828400005
J	Pattanayek, R; Mori, T; Xu, Y; Pattanayek, S; Johnson, CH; Egli, M				Pattanayek, Rekha; Mori, Tetsuya; Xu, Yao; Pattanayek, Sabuj; Johnson, Carl H.; Egli, Martin			Structures of KaiC Circadian Clock Mutant Proteins: A New Phosphorylation Site at T426 and Mechanisms of Kinase, ATPase and Phosphatase	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; DIFFRACTION DATA; OSCILLATION; SYSTEM; AUTOPHOSPHORYLATION; EXPRESSION; FEEDBACK; RHYTHMS; COMPLEX; MODEL	Background: The circadian clock of the cyanobacterium Synechococcus elongatus can be reconstituted in vitro by three proteins, KaiA, KaiB and KaiC. Homo-hexameric KaiC displays kinase, phosphatase and ATPase activities; KaiA enhances KaiC phosphorylation and KaiB antagonizes KaiA. Phosphorylation and dephosphorylation of the two known sites in the C-terminal half of KaiC subunits, T432 and S431, follow a strict order (TS -> pTS -> pTpS -> TpS -> TS) over the daily cycle, the origin of which is not understood. To address this void and to analyze the roles of KaiC active site residues, in particular T426, we determined structures of single and double P-site mutants of S. elongatus KaiC. Methodology and Principal Findings: The conformations of the loop region harboring P-site residues T432 and S431 in the crystal structures of six KaiC mutant proteins exhibit subtle differences that result in various distances between Thr (or Ala/Asn/Glu) and Ser (or Ala/Asp) residues and the ATP gamma-phosphate. T432 is phosphorylated first because it lies consistently closer to P gamma. The structures of the S431A and T432E/S431A mutants reveal phosphorylation at T426. The environments of the latter residue in the structures and functional data for T426 mutants in vitro and in vivo imply a role in dephosphorylation. Conclusions and Significance: We provide evidence for a third phosphorylation site in KaiC at T426. T426 and S431 are closely spaced and a KaiC subunit cannot carry phosphates at both sites simultaneously. Fewer subunits are phosphorylated at T426 in the two KaiC mutants compared to phosphorylated T432 and/or S431 residues in the structures of wt and other mutant KaiCs, suggesting that T426 phosphorylation may be labile. The structures combined with functional data for a host of KaiC mutant proteins help rationalize why S431 trails T432 in the loss of its phosphate and shed light on the mechanisms of the KaiC kinase, ATPase and phosphatase activities.	[Pattanayek, Rekha; Pattanayek, Sabuj; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Mori, Tetsuya; Xu, Yao; Johnson, Carl H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Pattanayek, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	martin.egli@vanderbilt.edu	Johnson, Carl H/I-4655-2014	Mori, Tetsuya/0000-0001-6036-5261	USPHS [R01 GM073845, R01 GM067152]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067152, R01GM073845, R37GM067152] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by USPHS research grants R01 GM073845 (ME) and R01 GM067152 (CHJ). Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team (LS-CAT) at sector 21 of the Advanced Photon Source (APS), Argonne, IL. Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. W-31-109-Eng-38. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Egli Martin, 2009, P121, DOI 10.1007/978-3-540-88431-6_7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim SA, 2001, BIOCHEM BIOPH RES CO, V282, P773, DOI 10.1006/bbrc.2001.4651; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Leipe DD, 2000, GENOME RES, V10, P5; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Vakonakis Ioannis, 2009, P103, DOI 10.1007/978-3-540-88431-6_6; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; XU Y, 2009, PLOS ONE IN PRESS	39	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e7529	10.1371/journal.pone.0007529	http://dx.doi.org/10.1371/journal.pone.0007529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956664	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100001
J	Suarez, R; Villalon, A; Kunzle, H; Mpodozis, J				Suarez, Rodrigo; Villalon, Aldo; Kuenzle, Heinz; Mpodozis, Jorge			Transposition and Intermingling of G alpha i2 and G alpha o Afferences into Single Vomeronasal Glomeruli in the Madagascan Lesser Tenrec Echinops telfairi	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; G-PROTEINS; DIFFERENTIAL LOCALIZATION; POSTERIOR DIVISIONS; SEGREGATED PATHWAYS; AXONAL PROJECTIONS; MULTIGENE FAMILY; SENSORY NEURONS; HEDGEHOG TENREC	The vomeronasal system (VNS) mediates pheromonal communication in mammals. From the vomeronasal organ, two populations of sensory neurons, expressing either G alpha i2 or G alpha o proteins, send projections that end in glomeruli distributed either at the rostral or caudal half of the accessory olfactory bulb (AOB), respectively. Neurons at the AOB contact glomeruli of a single subpopulation. The dichotomic segregation of AOB glomeruli has been described in opossums, rodents and rabbits, while Primates and Laurasiatheres present the G alpha i2-pathway only, or none at all (such as apes, some bats and aquatic species). We studied the AOB of the Madagascan lesser tenrec Echinops telfairi (Afrotheria: Afrosoricida) and found that G alpha i2 and G alpha o proteins are expressed in rostral and caudal glomeruli, respectively. However, the segregation of vomeronasal glomeruli at the AOB is not exclusive, as both pathways contained some glomeruli transposed into the adjoining subdomain. Moreover, some glomeruli seem to contain intermingled afferences from both pathways. Both the transposition and heterogeneity of vomeronasal afferences are features, to our knowledge, never reported before. The organization of AOB glomeruli suggests that synaptic integration might occur at the glomerular layer. Whether intrinsic AOB neurons may make synaptic contact with axon terminals of both subpopulations is an interesting possibility that would expand our understanding about the integration of vomeronasal pathways.	[Suarez, Rodrigo; Villalon, Aldo] Univ Chile, Fac Med, Escuela Posgrado, Santiago 7, Chile; [Suarez, Rodrigo; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7, Chile; [Villalon, Aldo] Univ Diego Portales, Fac Ciencias Salud, Santiago, Chile; [Kuenzle, Heinz] Univ Munich, Anat Anstalt, D-8000 Munich, Germany	Universidad de Chile; Universidad de Chile; University Diego Portales; University of Munich	Suarez, R (corresponding author), Univ Chile, Fac Med, Escuela Posgrado, Santiago 7, Chile.	rsuarezsaa@gmail.com	mpodozis, jorge/A-1992-2013; Suarez, Rodrigo/J-1529-2014; Suarez, Rodrigo/N-9437-2016	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652	FEBA (Fundacion para Estudios Biomedicos Avanzados); MecesupUCH 0306; Conicyt (Termino de tesis doctoral); Fondecyt [1080094]; Deutsche Forschungsgemeinschaft [Ku 624/3-3]	FEBA (Fundacion para Estudios Biomedicos Avanzados); MecesupUCH 0306; Conicyt (Termino de tesis doctoral)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge financial support from FEBA (Fundacion para Estudios Biomedicos Avanzados), Mecesup UCH 0306, Conicyt (Termino de tesis doctoral), Fondecyt (1080094) and Deutsche Forschungsgemeinschaft (Ku 624/3-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Berghard A, 1996, J NEUROSCI, V16, P909; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Halem HA, 2001, EUR J NEUROSCI, V13, P389, DOI 10.1046/j.1460-9568.2001.01382.x; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura K, 1999, EUR J NEUROSCI, V11, P2254, DOI 10.1046/j.1460-9568.1999.00646.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1997, NEUROREPORT, V8, P1887, DOI 10.1097/00001756-199705260-00019; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Knoll B, 2003, DEVELOPMENT, V130, P5073, DOI 10.1242/dev.00726; Kosaka K, 2005, NEUROSCI RES, V53, P353, DOI 10.1016/j.neures.2005.08.004; Kunzle H, 2007, ANIM REPROD SCI, V97, P364, DOI 10.1016/j.anireprosci.2006.02.011; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Martinez-Marcos A, 1999, EUR J NEUROSCI, V11, P3789, DOI 10.1046/j.1460-9568.1999.00797.x; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Matsuoka M, 1999, NEUROSCI RES, V35, P189, DOI 10.1016/S0168-0102(99)00082-6; Mohedano-Moriano A, 2007, EUR J NEUROSCI, V25, P2065, DOI 10.1111/j.1460-9568.2007.05472.x; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Peele P, 2003, EUR J NEUROSCI, V18, P622, DOI 10.1046/j.1460-9568.2003.02790.x; Radtke-Schuller S, 2000, J COMP NEUROL, V423, P687, DOI 10.1002/1096-9861(20000807)423:4<687::AID-CNE12>3.0.CO;2-F; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Suarez R, 2009, BEHAV BRAIN RES, V198, P306, DOI 10.1016/j.bbr.2008.11.009; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Sugai T, 2006, NEUROREPORT, V17, P1663, DOI 10.1097/01.wnr.0000239950.14954.59; Takigami S, 2000, CHEM SENSES, V25, P387, DOI 10.1093/chemse/25.4.387; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Wekesa KS, 1999, BRAIN RES, V837, P117, DOI 10.1016/S0006-8993(99)01630-3; Yonekura J, 2008, MOL CELL NEUROSCI, V37, P708, DOI 10.1016/j.mcn.2007.12.016; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004	48	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8005	10.1371/journal.pone.0008005	http://dx.doi.org/10.1371/journal.pone.0008005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956694	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827500029
J	Ayora-Talavera, G; Shelton, H; Scull, MA; Ren, JY; Jones, IM; Pickles, RJ; Barclay, WS				Ayora-Talavera, Guadalupe; Shelton, Holly; Scull, Margaret A.; Ren, Junyuan; Jones, Ian M.; Pickles, Raymond J.; Barclay, Wendy S.			Mutations in H5N1 Influenza Virus Hemagglutinin that Confer Binding to Human Tracheal Airway Epithelium	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; AVIAN H5N1; CILIATED CELLS; A VIRUS; REPLICATION; TRANSMISSION; INFECTION; AMINO-ACID-226; ADAPTATION; CULTURES	The emergence in 2009 of a swine-origin H1N1 influenza virus as the first pandemic of the 21st Century is a timely reminder of the international public health impact of influenza viruses, even those associated with mild disease. The widespread distribution of highly pathogenic H5N1 influenza virus in the avian population has spawned concern that it may give rise to a human influenza pandemic. The mortality rate associated with occasional human infection by H5N1 virus approximates 60%, suggesting that an H5N1 pandemic would be devastating to global health and economy. To date, the H5N1 virus has not acquired the propensity to transmit efficiently between humans. The reasons behind this are unclear, especially given the high mutation rate associated with influenza virus replication. Here we used a panel of recombinant H5 hemagglutinin ( HA) variants to demonstrate the potential for H5 HA to bind human airway epithelium, the predominant target tissue for influenza virus infection and spread. While parental H5 HA exhibited limited binding to human tracheal epithelium, introduction of selected mutations converted the binding profile to that of a current human influenza strain HA. Strikingly, these amino-acid changes required multiple simultaneous mutations in the genomes of naturally occurring H5 isolates. Moreover, H5 HAs bearing intermediate sequences failed to bind airway tissues and likely represent mutations that are an evolutionary "dead end.'' We conclude that, although genetic changes that adapt H5 to human airways can be demonstrated, they may not readily arise during natural virus replication. This genetic barrier limits the likelihood that current H5 viruses will originate a human pandemic.			Ayora-Talavera, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England.	w.barclay@imperial.ac.uk	Scull, Margaret/K-9963-2019; Ayora-Talavera, Guadalupe/AAH-3165-2019; Jones, Ian/AAF-4986-2019	Ayora-Talavera, Guadalupe/0000-0002-2829-6945; Jones, Ian/0000-0002-7738-2516; shelton, Holly/0000-0002-5776-0735; Barclay, Wendy/0000-0002-3948-0895; Scull, Margaret/0000-0002-6860-2468	MRC [G0500597] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077844, P50HL084934, R21HL080098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER; Medical Research Council [G0500597] Funding Source: Medline; NHLBI NIH HHS [R01 HL77844-1, R21 HL080098, R01 HL077844, R21 HL080098-01, 5 P50 HL084934, P50 HL084934] Funding Source: Medline; NIAID NIH HHS [5-T32-AI007419, T32 AI007419] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust)		Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Barclay WS, 2007, BIOORGAN MED CHEM, V15, P4038, DOI 10.1016/j.bmc.2007.03.085; Bartlett EJ, 2008, J VIROL, V82, P8059, DOI 10.1128/JVI.02263-07; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lee J, 2008, VACCINE; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Medeiros R, 2007, ANTIVIR THER, V12, P571; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Owen RE, 2007, J VIROL, V81, P11170, DOI 10.1128/JVI.01217-07; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; QI L, 2009, J VIROL; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; *WHO, 2009, CUM NUMB CONF HUM CA; World Health Organization, 2009, PAND H1N1 2009 UPD 6; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	46	51	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7836	10.1371/journal.pone.0007836	http://dx.doi.org/10.1371/journal.pone.0007836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924306	gold, Green Submitted, Green Published			2022-12-27	WOS:000271936700006
J	Finlayson, AE; Freeman, KW				Finlayson, Alexander E.; Freeman, Kevin W.			A Cell Motility Screen Reveals Role for MARCKS-Related Protein in Adherens Junction Formation and Tumorigenesis	PLOS ONE			English	Article							KINASE SUBSTRATE MARCKS; MESENCHYMAL TRANSITION; TUMOR INVASION; CANCER-CELLS; CALMODULIN; PHOSPHORYLATION; METASTASIS; EFFECTOR; PROTEOLYSIS; PODOPLANIN	Invasion through the extracellular matrix (ECM) is important for wound healing, immunological responses and metastasis. We established an invasion-based cell motility screen using Boyden chambers overlaid with Matrigel to select for pro-invasive genes. By this method we identified antisense to MARCKS related protein (MRP), whose family member MARCKS is a target of miR-21, a microRNA involved in tumor growth, invasion and metastasis in multiple human cancers. We confirmed that targeted knockdown of MRP, in both EpRas mammary epithelial cells and PC3 prostate cancer cells, promoted in vitro cell migration that was blocked by trifluoperazine. Additionally, we observed increased immunofluoresence of E-cadherin, beta-catenin and APC at sites of cell-cell contact in EpRas cells with MRP knockdown suggesting formation of adherens junctions. By wound healing assay we observed that reduced MRP supported collective cell migration, a type of cell movement where adherens junctions are maintained. However, destabilized adherens junctions, like those seen in EpRas cells, are frequently important for oncogenic signaling. Consequently, knockdown of MRP in EpRas caused loss of tumorigenesis in vivo, and reduced Wnt3a induced TCF reporter signaling in vitro. Together our data suggest that reducing MRP expression promotes formation of adherens junctions in EpRas cells, allowing collective cell migration, but interferes with oncogenic beta-catenin signaling and tumorigenesis.			Finlayson, AE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kevin.freeman@childrens.harvard.edu			NATIONAL CANCER INSTITUTE [F32CA112989] Funding Source: NIH RePORTER; National Institute for Health Research [ACF-2009-13-022] Funding Source: researchfish; NCI NIH HHS [F32 CA112989] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research(National Institute for Health Research (NIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Chang S, 1996, J BIOL CHEM, V271, P1174, DOI 10.1074/jbc.271.2.1174; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; Ramsden JJ, 2000, INT J BIOCHEM CELL B, V32, P475, DOI 10.1016/S1357-2725(99)00152-1; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006	27	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7833	10.1371/journal.pone.0007833	http://dx.doi.org/10.1371/journal.pone.0007833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924305	Green Submitted, gold, Green Published			2022-12-27	WOS:000271936700004
J	Javerzat, S; Franco, M; Herbert, J; Platonova, N; Peille, AL; Pantesco, V; De Vos, J; Assou, S; Bicknell, R; Bikfalvi, A; Hagedorn, M				Javerzat, Sophie; Franco, Melanie; Herbert, John; Platonova, Natalia; Peille, Anne-Lise; Pantesco, Veronique; De Vos, John; Assou, Said; Bicknell, Roy; Bikfalvi, Andreas; Hagedorn, Martin			Correlating Global Gene Regulation to Angiogenesis in the Developing Chick Extra-Embryonic Vascular System	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTEGRIN-LINKED KINASE; INTUSSUSCEPTIVE CAPILLARY GROWTH; CHORIOALLANTOIC MEMBRANE CAM; CELL-SUBSTRATE INTERACTION; TUMOR ANGIOGENESIS; PLACENTAL DEVELOPMENT; DEPENDENT MECHANISM; REDUNDANT ROLES; BREAST-CANCER	Background: Formation of blood vessels requires the concerted regulation of an unknown number of genes in a spatial-, time-and dosage-dependent manner. Determining genes, which drive vascular maturation is crucial for the identification of new therapeutic targets against pathological angiogenesis. Methology/Principal Findings: We accessed global gene regulation throughout maturation of the chick chorio-allantoic membrane (CAM), a highly vascularized tissue, using pan genomic microarrays. Seven percent of analyzed genes showed a significant change in expression (>2-fold, FDR<5%) with a peak occurring from E7 to E10, when key morphogenetic and angiogenic genes such as BMP4, SMO, HOXA3, EPAS1 and FGFR2 were upregulated, reflecting the state of an activated endothelium. At later stages, a general decrease in gene expression occurs, including genes encoding mitotic factors or angiogenic mediators such as CYR61, EPAS1, MDK and MYC. We identified putative human orthologs for 77% of significantly regulated genes and determined endothelial cell enrichment for 20% of the orthologs in silico. Vascular expression of several genes including ENC1, FSTL1, JAM2, LDB2, LIMS1, PARVB, PDE3A, PRCP, PTRF and ST6GAL1 was demonstrated by in situ hybridization. Up to 9% of the CAM genes were also overexpressed in human organs with related functions, such as placenta and lung or the thyroid. 21-66% of CAM genes enriched in endothelial cells were deregulated in several human cancer types (P<.0001). Interfering with PARVB (encoding parvin, beta) function profoundly changed human endothelial cell shape, motility and tubulogenesis, suggesting an important role of this gene in the angiogenic process. Conclusions/Significance: Our study underlines the complexity of gene regulation in a highly vascularized organ during development. We identified a restricted number of novel genes enriched in the endothelium of different species and tissues, which may play crucial roles in normal and pathological angiogenesis.			Javerzat, S (corresponding author), Univ Bordeaux 1, INSERM, U920, Lab Mecanismes Mol Angiogenese, F-33405 Talence, France.	m.hagedorn@angio.u-bordeaux1.fr	De Vos, John/A-5703-2010; FRANCO, Melanie/I-1612-2015	De Vos, John/0000-0003-1880-4130; FRANCO, Melanie/0000-0001-6519-4131; assou, said/0000-0001-6448-7995; Hagedorn, Martin/0000-0002-0960-5116; Bicknell, Roy/0000-0002-0941-8919				Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Cooke VG, 2008, METHOD ENZYMOL, V444, P1, DOI 10.1016/S0076-6879(08)02801-2; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djonov VG, 2000, ANAT EMBRYOL, V202, P347, DOI 10.1007/s004290000126; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; EICHMANN A, 1993, MECH DEVELOP, V42, P33, DOI 10.1016/0925-4773(93)90096-G; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fawcett SR, 2004, GENE EXPR PATTERNS, V4, P29, DOI 10.1016/j.modgep.2003.08.003; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Gellhaus Alexandra, 2007, Reprod Sci, V14, P46, DOI 10.1177/1933719107309816; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hagedorn M, 2004, DEV DYNAM, V230, P23, DOI 10.1002/dvdy.20020; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hosokawa H, 2002, J CELL SCI, V115, P1487; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jeimy SB, 2008, PLATELETS, V19, P83, DOI 10.1080/09537100701832157; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; KURZ H, 1995, DEV DYNAM, V203, P174, DOI 10.1002/aja.1002030206; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Loboda A, 2006, VASC PHARMACOL, V44, P206, DOI 10.1016/j.vph.2005.11.007; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Makino Y, 2001, J CLIN ENDOCR METAB, V86, P5079, DOI 10.1210/jc.86.10.5079; Marin F, 2004, DEV DYNAM, V230, P144, DOI 10.1002/dvdy.20027; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pai JT, 2005, GENE, V347, P21, DOI 10.1016/j.gene.2004.12.034; Papoutsi M, 2001, DEV DYNAM, V222, P238, DOI 10.1002/dvdy.1187; PATAN S, 1993, ANAT EMBRYOL, V187, P121; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PLATE KH, 1994, BRAIN PATHOL, V4, P207, DOI 10.1111/j.1750-3639.1994.tb00835.x; Pruett ND, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-93; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Reynolds PR, 2004, J BIOL CHEM, V279, P37124, DOI 10.1074/jbc.M405254200; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296; Ruoslahti E, 1997, J CLIN INVEST, V99, P1149, DOI 10.1172/JCI119269; Schlatter P, 1997, MICROVASC RES, V54, P65, DOI 10.1006/mvre.1997.2022; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Song M, 2007, BIOCHEM BIOPH RES CO, V357, P924, DOI 10.1016/j.bbrc.2007.04.033; St Croix B, 2000, SCIENCE, V289, P1197; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yamada Y, 1997, GENOMICS, V42, P483, DOI 10.1006/geno.1997.4774; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zhong HB, 2006, P NATL ACAD SCI USA, V103, P16800, DOI 10.1073/pnas.0603959103	97	47	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7856	10.1371/journal.pone.0007856	http://dx.doi.org/10.1371/journal.pone.0007856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924294	Green Published, gold			2022-12-27	WOS:000271854200006
J	Wang, RW; Ridley, J; Sun, BF; Zheng, Q; Dunn, DW; Cook, J; Shi, L; Zhang, YP; Yu, DW				Wang, Rui-Wu; Ridley, Jo; Sun, Bao-Fa; Zheng, Qi; Dunn, Derek W.; Cook, James; Shi, Lei; Zhang, Ya-Ping; Yu, Douglas W.			Interference Competition and High Temperatures Reduce the Virulence of Fig Wasps and Stabilize a Fig-Wasp Mutualism	PLOS ONE			English	Article							SEX-RATIO ADJUSTMENT; POLLINATING WASPS; MONOECIOUS FIGS; TRADE-OFF; EVOLUTIONARY CONFLICTS; PLANT MUTUALISM; HOST SANCTIONS; DIOECIOUS FIG; BODY-SIZE; ALLOCATION	Fig trees are pollinated by fig wasps, which also oviposit in female flowers. The wasp larvae gall and eat developing seeds. Although fig trees benefit from allowing wasps to oviposit, because the wasp offspring disperse pollen, figs must prevent wasps from ovipositing in all flowers, or seed production would cease, and the mutualism would go extinct. In Ficus racemosa, we find that syconia ('figs') that have few foundresses (ovipositing wasps) are underexploited in the summer (few seeds, few galls, many empty ovules) and are overexploited in the winter (few seeds, many galls, few empty ovules). Conversely, syconia with many foundresses produce intermediate numbers of galls and seeds, regardless of season. We use experiments to explain these patterns, and thus, to explain how this mutualism is maintained. In the hot summer, wasps suffer short lifespans and therefore fail to oviposit in many flowers. In contrast, cooler temperatures in the winter permit longer wasp lifespans, which in turn allows most flowers to be exploited by the wasps. However, even in winter, only in syconia that happen to have few foundresses are most flowers turned into galls. In syconia with higher numbers of foundresses, interference competition reduces foundress lifespans, which reduces the proportion of flowers that are galled. We further show that syconia encourage the entry of multiple foundresses by delaying ostiole closure. Taken together, these factors allow fig trees to reduce galling in the wasp-benign winter and boost galling (and pollination) in the wasp-stressing summer. Interference competition has been shown to reduce virulence in pathogenic bacteria. Our results show that interference also maintains cooperation in a classic, cooperative symbiosis, thus linking theories of virulence and mutualism. More generally, our results reveal how frequency-dependent population regulation can occur in the fig-wasp mutualism, and how a host species can 'set the rules of the game' to ensure mutualistic behavior in its symbionts.			Wang, RW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, ECEC, Kunming, Yunnan, Peoples R China.	dougwyu@gmail.com	Cook, James M/D-6423-2011; Cook, James/S-2128-2019; Yu, Douglas W./D-2536-2009	Cook, James M/0000-0001-8447-6126; Cook, James/0000-0001-8447-6126; Yu, Douglas W./0000-0001-8551-5609	Natural Environment Research Council [NE/C511264/1, NE/C511305/1, NE/C511264/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anstett MC, 1998, P ROY SOC B-BIOL SCI, V265, P45, DOI 10.1098/rspb.1998.0262; Anstett MC, 1996, J EVOLUTION BIOL, V9, P417, DOI 10.1046/j.1420-9101.1996.9040417.x; Anstett MC, 2001, OIKOS, V95, P476, DOI 10.1034/j.1600-0706.2001.950313.x; Anstett MC, 1997, TRENDS ECOL EVOL, V12, P94, DOI 10.1016/S0169-5347(96)10064-1; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; ASPI J, 1995, J INSECT BEHAV, V8, P67, DOI 10.1007/BF01990970; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Cook JM, 2004, J EVOLUTION BIOL, V17, P238, DOI 10.1111/j.1420-9101.2003.00683.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; COOK JM, ECOLOGICAL IN PRESS; CORNER E. J. H., 1965, GARD BULL [SINGAPORE], V21, P1; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dufay M, 2003, OIKOS, V100, P3, DOI 10.1034/j.1600-0706.2003.12053.x; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; Edwards DP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1321, DOI 10.1007/s00265-007-0369-3; Edwards DP, 2007, ANIM BEHAV, V74, P377, DOI 10.1016/j.anbehav.2006.07.022; Edwards DP, 2006, P ROY SOC B-BIOL SCI, V273, P595, DOI 10.1098/rspb.2005.3273; Ferdy JB, 2002, J THEOR BIOL, V217, P219, DOI 10.1006/jtbi.2002.3018; GALIL J, 1971, NEW PHYTOL, V70, P773, DOI 10.1111/j.1469-8137.1971.tb02578.x; Ganeshaiah KN, 1999, BIOTROPICA, V31, P312, DOI 10.1111/j.1744-7429.1999.tb00143.x; GRAFEN A, 1991, P ROY SOC B-BIOL SCI, V245, P73, DOI 10.1098/rspb.1991.0090; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HASSELL MP, 1969, NATURE, V223, P1133, DOI 10.1038/2231133a0; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; HERRE EA, 1997, SOCIAL COMPETITION C, V1; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jousselin E, 2004, INT J PLANT SCI, V165, P587, DOI 10.1086/386558; Jousselin E, 2003, OECOLOGIA, V134, P381, DOI 10.1007/s00442-002-1116-0; Jousselin E, 2001, ECOL ENTOMOL, V26, P602, DOI 10.1046/j.1365-2311.2001.00368.x; Kathuria P, 1999, OIKOS, V87, P520, DOI 10.2307/3546816; KHADARI B, 1995, AM J BOT, V82, P992, DOI 10.2307/2446228; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; KITANO H, 2006, MOL SYSTEMS BIOL; Kjellberg F, 2001, P ROY SOC B-BIOL SCI, V268, P1113, DOI 10.1098/rspb.2001.1633; May RM, 1976, THEORETICAL ECOLOGY; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; MOORE J, 2003, ANIM BEHAV, P1101; MURRAY MG, 1985, BIOL J LINN SOC, V26, P69, DOI 10.1111/j.1095-8312.1985.tb01552.x; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; PATINO S, 1994, OECOLOGIA, V100, P13, DOI 10.1007/BF00317125; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; R Core Team, 2018, R LANG ENV STAT COMP; Raja S, 2008, P ROY SOC B-BIOL SCI, V275, P1603, DOI 10.1098/rspb.2008.0136; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI [10.1111/j.1558-5646.1999.tb03796.x, 10.2307/2640797]; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; Ruf C, 2000, NATURWISSENSCHAFTEN, V87, P193, DOI 10.1007/s001140050702; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; van Baalen M, 2001, OIKOS, V95, P211, DOI 10.1034/j.1600-0706.2001.950203.x; Vigneux F, 2008, J EVOLUTION BIOL, V21, P1245, DOI 10.1111/j.1420-9101.2008.01576.x; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wang RW, 2008, J ANIM ECOL, V77, P616, DOI 10.1111/j.1365-2656.2008.01359.x; Wang RW, 2005, J INTEGR PLANT BIOL, V47, P144, DOI 10.1111/j.1744-7909.2005.00034.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Weiblen GD, 2001, P ROY SOC B-BIOL SCI, V268, P651, DOI 10.1098/rspb.2000.1389; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; YAMAMURA N, 1993, THEOR POPUL BIOL, V44, P95, DOI 10.1006/tpbi.1993.1020; Yang Da-ron, 2000, Forest Research, V13, P477; Yu DW, 2004, P ROY SOC B-BIOL SCI, V271, P1185, DOI 10.1098/rspb.2003.2630	72	40	49	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7802	10.1371/journal.pone.0007802	http://dx.doi.org/10.1371/journal.pone.0007802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915668	Green Published, gold, Green Submitted			2022-12-27	WOS:000271721400005
J	Campos, JL; Siegle, JH; Mohler, BJ; Bulthoff, HH; Loomis, JM				Campos, Jennifer L.; Siegle, Joshua H.; Mohler, Betty J.; Buelthoff, Heinrich H.; Loomis, Jack M.			Imagined Self-Motion Differs from Perceived Self-Motion: Evidence from a Novel Continuous Pointing Method	PLOS ONE			English	Article							MOTOR IMAGERY; MENTAL PRACTICE; IDIOTHETIC NAVIGATION; VISUAL-PERCEPTION; PATH-INTEGRATION; TRAVEL DISTANCE; NONVISUAL CUES; OPTIC FLOW; MOVEMENT; LOCOMOTION	Background: The extent to which actual movements and imagined movements maintain a shared internal representation has been a matter of much scientific debate. Of the studies examining such questions, few have directly compared actual full-body movements to imagined movements through space. Here we used a novel continuous pointing method to a) provide a more detailed characterization of self-motion perception during actual walking and b) compare the pattern of responding during actual walking to that which occurs during imagined walking. Methodology/Principal Findings: This continuous pointing method requires participants to view a target and continuously point towards it as they walk, or imagine walking past it along a straight, forward trajectory. By measuring changes in the pointing direction of the arm, we were able to determine participants' perceived/imagined location at each moment during the trajectory and, hence, perceived/imagined self-velocity during the entire movement. The specific pattern of pointing behaviour that was revealed during sighted walking was also observed during blind walking. Specifically, a peak in arm azimuth velocity was observed upon target passage and a strong correlation was observed between arm azimuth velocity and pointing elevation. Importantly, this characteristic pattern of pointing was not consistently observed during imagined self-motion. Conclusions/Significance: Overall, the spatial updating processes that occur during actual self-motion were not evidenced during imagined movement. Because of the rich description of self-motion perception afforded by continuous pointing, this method is expected to have significant implications for several research areas, including those related to motor imagery and spatial cognition and to applied fields for which mental practice techniques are common (e.g. rehabilitation and athletics).			Campos, JL (corresponding author), Toronto Rehabil Inst, iDAPT Technol Res & Dev, Toronto, ON, Canada.	campos.jennifer@torontorehab.on.ca	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; 				Allen GL, 2004, PERCEPT PSYCHOPHYS, V66, P170, DOI 10.3758/BF03194870; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; BERTHOZ A, 1995, SCIENCE, V269, P95, DOI 10.1126/science.7604286; Bertin RJV, 2004, EXP BRAIN RES, V154, P11, DOI 10.1007/s00221-003-1524-3; Bremmer F, 1999, EXP BRAIN RES, V127, P33, DOI 10.1007/s002210050771; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; DECETY J, 1989, BRAIN COGNITION, V11, P87, DOI 10.1016/0278-2626(89)90007-9; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; DECETY J, 1990, EUR ARCH PSY CLIN N, V240, P39, DOI 10.1007/BF02190091; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Dickstein R, 2007, PHYS THER, V87, P942, DOI 10.2522/ptj.20060331; Dietrich A, 2008, METHODS, V45, P319, DOI 10.1016/j.ymeth.2008.04.004; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Ellard CG, 2003, PERCEPTION, V32, P567, DOI 10.1068/p5041; ELLIOTT D, 1986, J EXP PSYCHOL HUMAN, V12, P388, DOI 10.1037/0096-1523.12.3.388; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Frenz H, 2005, VISION RES, V45, P1679, DOI 10.1016/j.visres.2004.12.019; Frenz H, 2003, VISION RES, V43, P2173, DOI 10.1016/S0042-6989(03)00337-7; Fukusima SS, 1997, J EXP PSYCHOL HUMAN, V23, P86, DOI 10.1037/0096-1523.23.1.86; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Hettinger LJ, 2002, HUM FAC ER, P471; Howard I. P., 1986, HDB HUMAN PERCEPTION, V1, P181; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Ivanenko YP, 1997, J PHYSIOL-LONDON, V502, P223, DOI 10.1111/j.1469-7793.1997.223bl.x; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kallie CS, 2007, J EXP PSYCHOL HUMAN, V33, P183, DOI 10.1037/0096-1523.33.1.183; Klatzky RL, 1998, PSYCHOL SCI, V9, P293, DOI 10.1111/1467-9280.00058; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; KUNZ BR, J EXP PSYCH IN PRESS; Lappe M, 2007, EXP BRAIN RES, V180, P35, DOI 10.1007/s00221-006-0835-6; Loomis Jack M., 2008, EMBODIMENT EGOSPACE; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; May M, 1996, MEMORY AND PROCESSING OF VISUAL AND SPATIAL INFORMATION, P418; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; MITTELSTAEDT ML, 1991, ZOOL JAHRB ALLG ZOOL, V95, P427; Ooi TL, 2006, PERCEPTION, V35, P605, DOI 10.1068/p5492; Papaxanthis C, 2002, BEHAV BRAIN RES, V134, P209, DOI 10.1016/S0166-4328(02)00030-X; Plumert JM., 2005, ACM T APPL PERCEPT, V2, P216, DOI [10.1145/1077399.1077402, DOI 10.1145/1077399.1077402]; Pylyshyn ZW, 2002, BEHAV BRAIN SCI, V25, P157, DOI 10.1017/S0140525X02000043; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; Riecke BE, 2002, PRESENCE-VIRTUAL AUG, V11, P443, DOI 10.1162/105474602320935810; RIESER JJ, 1990, PERCEPTION, V19, P675, DOI 10.1068/p190675; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; SEGAL SJ, 1970, J EXP PSYCHOL, V83, P458, DOI 10.1037/h0028840; Seidman SH, 2008, EXP BRAIN RES, V184, P13, DOI 10.1007/s00221-007-1072-3; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SHOLL MJ, 1989, J EXP PSYCHOL LEARN, V15, P110, DOI 10.1037/0278-7393.15.1.110; Siegle JH, 2009, EXP BRAIN RES, V195, P429, DOI 10.1007/s00221-009-1805-6; STEENHUIS RE, 1988, J MOTOR BEHAV, V20, P399; Stevens JA, 2005, COGNITION, V95, P329, DOI 10.1016/j.cognition.2004.02.008; Sun HJ, 2004, PERCEPTION, V33, P49, DOI 10.1068/p5145; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; THOMSON JA, 1983, J EXP PSYCHOL HUMAN, V9, P427, DOI 10.1037/0096-1523.9.3.427; Waller D, 2007, PSYCHOL RES-PSYCH FO, V71, P322, DOI 10.1007/s00426-006-0087-x; YAMAMOTO N, 2008, J VIS, V8, P1149; Yong NA, 2007, J NEUROPHYSIOL, V97, P1100, DOI 10.1152/jn.00694.2006	65	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A163	A173	e7793	10.1371/journal.pone.0007793	http://dx.doi.org/10.1371/journal.pone.0007793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907655	Green Published, gold			2022-12-27	WOS:000271685800018
J	Kono, N; Arakawa, K; Ogawa, R; Kido, N; Oshita, K; Ikegami, K; Tamaki, S; Tomita, M				Kono, Nobuaki; Arakawa, Kazuharu; Ogawa, Ryu; Kido, Nobuhiro; Oshita, Kazuki; Ikegami, Keita; Tamaki, Satoshi; Tomita, Masaru			Pathway Projector: Web-Based Zoomable Pathway Browser Using KEGG Atlas and Google Maps API	PLOS ONE			English	Article							METABOLIC PATHWAYS; BIOLOGICAL PATHWAYS; BIOCYC COLLECTION; SYSTEMS BIOLOGY; EXPRESSION DATA; GENOME BROWSER; DATABASE; RESOURCES; NETWORKS; TOOLS	Background: Biochemical pathways provide an essential context for understanding comprehensive experimental data and the systematic workings of a cell. Therefore, the availability of online pathway browsers will facilitate post-genomic research, just as genome browsers have contributed to genomics. Many pathway maps have been provided online as part of public pathway databases. Most of these maps, however, function as the gateway interface to a specific database, and the comprehensiveness of their represented entities, data mapping capabilities, and user interfaces are not always sufficient for generic usage. Methodology/Principal Findings: We have identified five central requirements for a pathway browser: (1) availability of large integrated maps showing genes, enzymes, and metabolites; (2) comprehensive search features and data access; (3) data mapping for transcriptomic, proteomic, and metabolomic experiments, as well as the ability to edit and annotate pathway maps; (4) easy exchange of pathway data; and (5) intuitive user experience without the requirement for installation and regular maintenance. According to these requirements, we have evaluated existing pathway databases and tools and implemented a web-based pathway browser named Pathway Projector as a solution. Conclusions/Significance: Pathway Projector provides integrated pathway maps that are based upon the KEGG Atlas, with the addition of nodes for genes and enzymes, and is implemented as a scalable, zoomable map utilizing the Google Maps API. Users can search pathway-related data using keywords, molecular weights, nucleotide sequences, and amino acid sequences, or as possible routes between compounds. In addition, experimental data from transcriptomic, proteomic, and metabolomic analyses can be readily mapped. Pathway Projector is freely available for academic users at http://www.g-language.org/PathwayProjector/.			Kono, N (corresponding author), Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan.	gaou@sfc.keio.ac.jp		Arakawa, Kazuharu/0000-0002-2893-4919; Kono, Nobuaki/0000-0001-5960-7956				Adriaens ME, 2008, DRUG DISCOV TODAY, V13, P856, DOI 10.1016/j.drudis.2008.06.013; Arakawa K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-168; Arakawa K, 2003, BIOINFORMATICS, V19, P305, DOI 10.1093/bioinformatics/19.2.305; Arakawa K., 2008, GENES GENOMES GENOMI, V2, P1; Arakawa K, 2006, J PESTIC SCI, V31, P282, DOI 10.1584/jpestics.31.282; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; Arakawa K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-31; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chung HJ, 2005, NUCLEIC ACIDS RES, V33, pW621, DOI 10.1093/nar/gki450; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DIMITROPOULOS D, 2006, CURR PROTOC BIOINFOR, V14, P3; Ekins S, 2007, METH MOL B, V356, P319; Elliott B, 2008, BIOINFORMATICS, V24, P2526, DOI 10.1093/bioinformatics/btn459; Fleischmann A, 2004, NUCLEIC ACIDS RES, V32, pD434, DOI 10.1093/nar/gkh119; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hucka M., 2004, Systems Biology, V1, P41, DOI 10.1049/sb:20045008; Hull D, 2006, NUCLEIC ACIDS RES, V34, pW729, DOI 10.1093/nar/gkl320; Itoh M, 2009, BIOINFORMATICS, V25, P958, DOI 10.1093/bioinformatics/btp086; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KONO N, 2008, WEB BASED ZOOMABLE P; KONO N, 2009, PATHWAY PROJECTOR WE; Kono Nobuaki, 2006, In Silico Biology, V6, P621; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Maltsev N, 2006, NUCLEIC ACIDS RES, V34, pD369, DOI 10.1093/nar/gkj095; Mangan ME, 2008, BIOTECHNOL ANN REV, V14, P63, DOI 10.1016/S1387-2656(08)00003-3; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582; Mlecnik B, 2005, NUCLEIC ACIDS RES, V33, pW633, DOI 10.1093/nar/gki391; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tao Ying, 2004, Biosilico, V2, P237; Uchiyama I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-472; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Zhang Z, 2009, BRIEF BIOINFORM, V10, P1, DOI 10.1093/bib/bbn041; Zhu MJ, 2009, INT J BIOL SCI, V5, P161, DOI 10.7150/ijbs.5.161	53	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A47	A56	e7710	10.1371/journal.pone.0007710	http://dx.doi.org/10.1371/journal.pone.0007710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907644	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800006
J	Miller, K; Kim, A; Kilimnik, G; Jo, J; Moka, U; Periwal, V; Hara, M				Miller, Kevin; Kim, Abraham; Kilimnik, German; Jo, Junghyo; Moka, Uchenna; Periwal, Vipul; Hara, Manami			Islet Formation during the Neonatal Development in Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ENDOCRINE PANCREAS; REGENERATION; PROGENITORS; POLYPEPTIDE; LANGERHANS; SECRETION; GHRELIN; INVOLVE	The islet of Langerhans is a unique micro-organ within the exocrine pancreas, which is composed of insulin-secreting beta-cells, glucagon-secreting alpha-cells, somatostatin-secreting delta-cells, pancreatic polypeptide-secreting PP cells and ghrelin-secreting epsilon-cells. Islets also contain non-endocrine cell types such as endothelial cells. However, the mechanism(s) of islet formation is poorly understood due to technical difficulties in capturing this dynamic event in situ. We have developed a method to monitor beta-cell proliferation and islet formation in the intact pancreas using transgenic mice in which the beta-cells are specifically tagged with a fluorescent protein. Endocrine cells proliferate contiguously, forming branched cord-like structures in both embryos and neonates. Our study has revealed long stretches of interconnected islets located along large blood vessels in the neonatal pancreas. Alpha-cells span the elongated islet-like structures, which we hypothesize represent sites of fission and facilitate the eventual formation of discrete islets. We propose that islet formation occurs by a process of fission following contiguous endocrine cell proliferation, rather than by local aggregation or fusion of isolated beta-cells and islets. Mathematical modeling of the fission process in the neonatal islet formation is also presented.			Miller, K (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@midway.uchicago.edu	Periwal, Vipul/I-1728-2012; Hara, Masayuki/AAH-4361-2019; Jo, Junghyo/D-4889-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, R56DK081527, ZIADK075038] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK081527, DK-081527, P30 DK020595, P60 DK020595, DK-20595] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Bouwens L, 1996, J HISTOCHEM CYTOCHEM, V44, P947, DOI 10.1177/44.9.8773559; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Broglio F, 2006, FRONT HORM RES, V35, P102, DOI 10.1159/000094313; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FLOYD JC, 1980, CLIN GASTROENTEROL, V9, P657; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hara M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1041, DOI 10.1152/ajpendo.00365.2005; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hill JT, 2009, REGUL PEPTIDES, V157, P51, DOI 10.1016/j.regpep.2009.02.013; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Kendall M.G., 1958, DISTRIBUTION THEORY, V1; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lee CS, 2006, DIABETES, V55, P269; LONOVICS J, 1981, ARCH SURG-CHICAGO, V116, P1256; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PICTET R, 1972, HDB PHYSL ENDOCRINOL, V7, P25; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; SAMOLS E, 1986, CLIN ENDOCRINOL META, V15, P33, DOI 10.1016/S0300-595X(86)80041-X; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; WEIR GC, 1990, J CLIN INVEST, V85, P983, DOI 10.1172/JCI114574; WEIR GC, 1985, ADV EXP MED BIOL, V188, P403; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	30	54	58	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7739	10.1371/journal.pone.0007739	http://dx.doi.org/10.1371/journal.pone.0007739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893748	Green Published, gold, Green Submitted			2022-12-27	WOS:000271478000012
J	Cheng, D; Tsai, SJ; Hong, CJ; Yang, AC				Cheng, Daniel; Tsai, Shih-Jen; Hong, Chen-Jee; Yang, Albert C.			Reduced Physiological Complexity in Robust Elderly Adults with the APOE epsilon 4 Allele	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; CHANGING COMPLEXITY; COGNITIVE FUNCTION; BRAIN ATROPHY; E PHENOTYPES; ASSOCIATION; GENOTYPE; DYNAMICS	Background: It is unclear whether the loss of physiological complexity during the aging process is due to genetic variations. The APOE gene has been studied extensively in regard to its relationship with aging-associated medical illness. We hypothesize that diminished physiological complexity, as measured by heart rate variability, is influenced by polymorphisms in the APOE allele among elderly individuals. Methodology/Principal Findings: A total of 102 robust, non-demented, elderly subjects with normal functions of daily activities participated in this study (97 males and 5 females, aged 79.2 +/- 4.4 years, range 72-92 years). Among these individuals, the following two APOE genotypes were represented: epsilon 4 non-carriers (n = 87, 85.3%) and epsilon 4 carriers (n = 15, 14.7%). Multi-scale entropy (MSE), an analysis used in quantifying complexity for nonlinear time series, was employed to analyze heart-rate dynamics. Reduced physiological complexity, as measured by MSE, was significantly associated with the presence of the APOE epsilon 4 allele in healthy elderly subjects, as compared to APOE epsilon 4 allele non-carriers (24.6 +/- 5.5 versus28.9 +/- 5.2, F = 9.429, p = 0.003, respectively). Conclusions/Significance: This finding suggests a role for the APOE gene in the diminished physiological complexity seen in elderly populations.			Cheng, D (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	ccyang@physionet.org	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X				Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Camm AJ, 1996, CIRCULATION, V93, P1043; Chiu KM, 2007, AUTON NEUROSCI-BASIC, V132, P76, DOI 10.1016/j.autneu.2006.10.008; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Ghebremedhin E, 2001, NEUROLOGY, V56, P1696, DOI 10.1212/WNL.56.12.1696; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger JJ, 2001, CIRCULATION, V103, P1977; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Ho KKL, 1997, CIRCULATION, V96, P842; Hong CJ, 1996, NEUROLOGY, V46, P1749, DOI 10.1212/WNL.46.6.1749; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; Kirkwood TBL, 2002, NEUROBIOL AGING, V23, P21, DOI 10.1016/S0197-4580(01)00260-3; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; Liu HC, 1999, NEUROLOGY, V53, P962, DOI 10.1212/WNL.53.5.962; Makikallio TH, 1999, AM J CARDIOL, V83, P880, DOI 10.1016/S0002-9149(98)01068-6; MALLIANI A, 1994, BRIT HEART J, V71, P1; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Mortensen EL, 2001, NEUROLOGY, V57, P89, DOI 10.1212/WNL.57.1.89; MYERS RH, 1996, FRAMINGHM STUDY NEUR, V46, P673; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Peng Chung-Kang, 1994, Integrative Physiological and Behavioral Science, V29, P283, DOI 10.1007/BF02691332; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Rosvall L, 2009, NEUROBIOL AGING, V30, P1545, DOI 10.1016/j.neurobiolaging.2007.12.003; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Tsai SJ, 2008, NEUROSCI LETT, V433, P158, DOI 10.1016/j.neulet.2007.12.057; TSUJI H, 1994, CIRCULATION, V90, P878, DOI 10.1161/01.CIR.90.2.878; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Yang ACC, 2008, J AM GERIATR SOC, V56, P958, DOI 10.1111/j.1532-5415.2008.01662.x; Yeh GY, 2008, SLEEP MED, V9, P527, DOI 10.1016/j.sleep.2007.06.003; Yeh GY, 2004, AM J MED, V117, P541, DOI 10.1016/j.amjmed.2004.04.016	47	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7733	10.1371/journal.pone.0007733	http://dx.doi.org/10.1371/journal.pone.0007733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890394	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700017
J	Ayollo, DV; Zhitnyak, IY; Vasiliev, JM; Gloushankova, NA				Ayollo, Dmitry V.; Zhitnyak, Irina Y.; Vasiliev, Jury M.; Gloushankova, Natalya A.			Rearrangements of the Actin Cytoskeleton and E-Cadherin-Based Adherens Junctions Caused by Neoplasic Transformation Change Cell-Cell Interactions	PLOS ONE			English	Article							CONTACT FORMATION; RHO; RAC; POLYMERIZATION; DYNAMICS; ADHESION; KINASE; ORGANIZATION; PROTEIN; CORTACTIN	E-cadherin-mediated cell-cell adhesion, which is essential for the maintenance of the architecture and integrity of epithelial tissues, is often lost during carcinoma progression. To better understand the nature of alterations of cell-cell interactions at the early stages of neoplastic evolution of epithelial cells, we examined the line of nontransformed IAR-2 epithelial cells and their descendants, lines of IAR-6-1 epithelial cells transformed with dimethylnitrosamine and IAR1170 cells transformed with N-RasG12D. IAR-6-1 and IAR1170 cells retained E-cadherin, displayed discoid or polygonal morphology, and formed monolayers similar to IAR-2 monolayer. Fluorescence staining, however, showed that in IAR1170 and IAR-6-1 cells the marginal actin bundle, which is typical of nontransformed IAR-2 cells, disappeared, and the continuous adhesion belt (tangential adherens junctions (AJs)) was replaced by radially oriented E-cadherin-based AJs. Time-lapse imaging of IAR-6-1 cells stably transfected with GFP-E-cadherin revealed that AJs in transformed cells are very dynamic and unstable. The regulation of AJ assembly by Rho family small GTPases was different in nontransformed and in transformed IAR epithelial cells. As our experiments with the ROCK inhibitor Y-27632 and the myosin II inhibitor blebbistatin have shown, the formation and maintenance of radial AJs critically depend on myosin II-mediated contractility. Using the RNAi technique for the depletion of mDia1 and loading cells with N17Rac, we established that mDia1 and Rac are involved in the assembly of tangential AJs in nontransformed epithelial cells but not in radial AJs in transformed cells. Neoplastic transformation changed cell-cell interactions, preventing contact paralysis after the establishment of cell-cell contact and promoting dynamic cell-cell adhesion and motile behavior of cells. It is suggested that the disappearance of the marginal actin bundle and rearrangements of AJs may change the adhesive function of E-cadherin and play an active role in migratory activity of carcinoma cells.	[Ayollo, Dmitry V.; Zhitnyak, Irina Y.; Vasiliev, Jury M.; Gloushankova, Natalya A.] Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia	N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Ayollo, DV (corresponding author), Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia.	natglu@hotmail.com	Zhitnyak, Irina Y/I-2967-2015; Gloushankova, Natalya/S-2577-2019	Zhitnyak, Irina Y/0000-0002-6717-3745; Gloushankova, Natalya/0000-0002-2044-2063; AYOLLO, Dmitry/0000-0002-9915-7918	Russian Foundation for Basic Research [08-04-00408a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was funded from the Russian Foundation for Basic Research (Grant 08-04-00408a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Bieling P, 1996, J CLIN ONCOL, V14, P848, DOI 10.1200/JCO.1996.14.3.848; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; El Sayegh TY, 2004, J CELL SCI, V117, P5117, DOI 10.1242/jcs.01385; Gillett CE, 2001, J PATHOL, V193, P433, DOI 10.1002/path.831; Gloushankova NA, 1997, P NATL ACAD SCI USA, V94, P879, DOI 10.1073/pnas.94.3.879; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; MONTESANO R, 1975, INT J CANCER, V16, P550, DOI 10.1002/ijc.2910160405; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; STROMSKAYA TP, 1995, FEBS LETT, V368, P373, DOI 10.1016/0014-5793(95)00662-S; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311	40	41	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8027	10.1371/journal.pone.0008027	http://dx.doi.org/10.1371/journal.pone.0008027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956566	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828400006
J	Navon, R; Wang, H; Steinfeld, I; Tsalenko, A; Ben-Dor, A; Yakhini, Z				Navon, Roy; Wang, Hui; Steinfeld, Israel; Tsalenko, Anya; Ben-Dor, Amir; Yakhini, Zohar			Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR CLASSIFICATION; COLORECTAL-CANCER; BREAST-CANCER; IDENTIFICATION; PROFILES; DISEASE; CELLS; RNA; ACCUMULATION	Background: microRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clinically meaningful differential expression can be obscured by inter-patient variation. In this study we aim to identify miRNAs with consistent differential expression in multiple tumor types using a novel data analysis approach. Methods: Using microarrays we profiled the expression of more than 700 miRNAs in 28 matched tumor/normal samples from 8 different tumor types (breast, colon, liver, lung, lymphoma, ovary, prostate and testis). This set is unique in putting emphasis on minimizing tissue type and patient related variability using normal and tumor samples from the same patient. We develop scores for comparing miRNA expression in the above matched sample data based on a rigorous characterization of the distribution of order statistics over a discrete state set, including exact p-values. Specifically, we compute a Rank Consistency Score (RCoS) for every miRNA measured in our data. Our methods are also applicable in various other contexts. We compare our methods, as applied to matched samples, to paired t-test and to the Wilcoxon Signed Rank test. Results: We identify consistent (across the cancer types measured) differentially expressed miRNAs. 41 miRNAs are under-expressed in cancer compared to normal, at FDR (False Discovery Rate) of 0.05 and 17 are over-expressed at the same FDR level. Differentially expressed miRNAs include known oncomiRs (e. g miR-96) as well as miRNAs that were not previously universally associated with cancer. Specific examples include miR-133b and miR-486-5p, which are consistently down regulated and mir-629* which is consistently up regulated in cancer, in the context of our cohort. Data is available in GEO. Software is available at: http://bioinfo.cs.technion.ac.il/people/zohar/RCoS/	[Navon, Roy; Steinfeld, Israel; Ben-Dor, Amir; Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel; [Wang, Hui; Tsalenko, Anya] Agilent Labs, Santa Clara, CA USA; [Navon, Roy] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Steinfeld, Israel] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Agilent Technologies; Agilent Technologies; Tel Aviv University; Technion Israel Institute of Technology	Navon, R (corresponding author), Agilent Labs, Tel Aviv, Israel.	rnavon@gmail.com		Yakhini, Zohar/0000-0002-0420-5412	European Union	European Union(European Commission)	RN, IS and ZY were partially supported by a European Union FP6 grant, under the framework of the MultiKnowledge Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, ONCOL REP, V16, P845; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 1967, HDB METHODS APPL STA; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Ben-Dor A, 2001, P 5 ANN INT C COMP M, P31, DOI DOI 10.1145/369133.369167; BENDOR A, 2007, FRAMEWORK IDENTIFYIN, P122; Benjamini Y, CONTROLLING FALSE DI; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evans DL, 2006, INFORMS J COMPUT, V18, P19, DOI 10.1287/ijoc.1040.0105; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hollander M., 1973, NONPARAMETRIC STAT M; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Lebanony D, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.22018; Levy AM, 2005, P NATL ACAD SCI USA, V102, P14831, DOI 10.1073/pnas.0506849102; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Rice J., 1995, MATH STAT DATA ANAL; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; AGILENT FEATURE EXTR	54	140	152	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8003	10.1371/journal.pone.0008003	http://dx.doi.org/10.1371/journal.pone.0008003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946373	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827800012
J	Blank, HM; Gajjar, S; Belyanin, A; Polymenis, M				Blank, Heidi M.; Gajjar, Shefali; Belyanin, Andrey; Polymenis, Michael			Sulfur Metabolism Actively Promotes Initiation of Cell Division in Yeast	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; MITOCHONDRIAL PROTEIN ABF2P; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; AMINO-ACIDS; CYCLE; DYSFUNCTION; MECHANISM; GENOME; MUTATIONS	Background: Sulfur metabolism is required for initiation of cell division, but whether or not it can actively promote cell division remains unknown. Methodology/Principal Findings: Here we show that yeast cells with more mtDNA have an expanded reductive phase of their metabolic cycle and an increased sulfur metabolic flux. We also show that in wild type cells manipulations of sulfur metabolic flux phenocopy the enhanced growth rate of cells with more mtDNA. Furthermore, introduction of a hyperactive cystathionine-beta-synthase (CBS) allele in wild type cells accelerates initiation of DNA replication. Conclusions/Significance: Our results reveal a novel connection between a key sulfur metabolic enzyme, CBS, and the cell cycle. Since the analogous hyperactive CBS allele in human CBS suppresses other disease-causing CBS mutations, our findings may be relevant for human pathology. Taken together, our results demonstrate the importance of sulfur metabolism in actively promoting initiation of cell division.	[Blank, Heidi M.; Gajjar, Shefali; Belyanin, Andrey; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Blank, HM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Polymenis, Michael/AAJ-3389-2021		National Science Foundation [MCB-0818248]; Direct For Biological Sciences [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Belew MS, 2009, PROTEIN EXPRES PURIF, V64, P139, DOI 10.1016/j.pep.2008.10.012; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kaiser C., 1994, METHODS YEAST GENETI; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kraus JP, 1999, HUM MUTAT, V13, P362; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stigter D, 2004, BIOPHYS CHEM, V110, P171, DOI 10.1016/j.bpc.2004.01.012; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763	40	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8018	10.1371/journal.pone.0008018	http://dx.doi.org/10.1371/journal.pone.0008018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956742	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500039
J	Fujioka, K; Arakawa, E; Kita, J; Aoyama, Y; Okuda, T; Manome, Y; Yamamoto, K				Fujioka, Kouki; Arakawa, Eiji; Kita, Jun-ichi; Aoyama, Yoshihiro; Okuda, Toshiro; Manome, Yoshinobu; Yamamoto, Kenji			Combination of Real-Value Smell and Metaphor Expression Aids Yeast Detection	PLOS ONE			English	Article							ELECTRONIC NOSE TECHNOLOGY; ODORANT RECEPTORS; RECOGNITION; SYSTEM	Background: Smell provides important information about the quality of food and drink. Most well-known for their expertise in wine tasting, sommeliers sniff out the aroma of wine and describe them using beautiful metaphors. In contrast, electronic noses, devices that mimic our olfactory recognition system, also detect smells using their sensors but describe them using electronic signals. These devices have been used to judge the freshness of food or detect the presence of pathogenic microorganisms. However, unlike information from gas chromatography, it is difficult to compare odour information collected by these devices because they are made for smelling specific smells and their data are relative intensities. Methodology: Here, we demonstrate the use of an absolute-value description method using known smell metaphors, and early detection of yeast using the method. Conclusions: This technique may help distinguishing microbial-contamination of food products earlier, or improvement of the food-product qualities.			Fujioka, K (corresponding author), Int Med Ctr Japan, Int Clin Res Ctr, Tokyo, Japan.	backen@ri.imcj.go.jp	Fujioka, Kouki/AAL-7517-2021; Fujioka, Kouki/J-9328-2014	Fujioka, Kouki/0000-0002-9472-2922; Fujioka, Kouki/0000-0002-9472-2922; Manome, Yoshinobu/0000-0002-8755-8976				Aoyama Y., 2006, J INTEGRATED STUDY D, V17, P266; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAPONE S, 2005, J ARGENT CHEM SOC, V93, P123; Centeno JA, 2002, J DAIRY SCI, V85, P3164, DOI 10.3168/jds.S0022-0302(02)74404-4; Dryer L, 1999, TRENDS PHARMACOL SCI, V20, P413, DOI 10.1016/S0165-6147(99)01381-4; DUBOURDIEU DT, 2000, ROLE YEASTS GRAPE FL, P196; Fechner G.T., 1966, INTRO FECHNER; Gardner JW, 1998, MEAS SCI TECHNOL, V9, P120, DOI 10.1088/0957-0233/9/1/016; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Keshri G, 2002, J APPL MICROBIOL, V92, P165, DOI 10.1046/j.1365-2672.2002.01515.x; Kita J., 2007, SHIMADZU REV, V64, P63; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; Natale C.D, 2003, HDB MACHINE OLFACTIO, P505; Pavlou A, 2002, LETT APPL MICROBIOL, V35, P366, DOI 10.1046/j.1472-765X.2002.01197.x; PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; SCHWEIZERBERBERICH PM, 1994, SENSOR ACTUAT B-CHEM, V18, P282, DOI 10.1016/0925-4005(94)87095-0; Tanaka M, 2004, J DENT RES, V83, P317, DOI 10.1177/154405910408300409; Tanaka T, 1998, BIOSCI BIOTECH BIOCH, V62, P1440, DOI 10.1271/bbb.62.1440; Thaler ER, 2001, AM J RHINOL, V15, P291, DOI 10.1177/194589240101500501; WINQUIST F, 1993, MEAS SCI TECHNOL, V4, P1493, DOI 10.1088/0957-0233/4/12/029	23	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7939	10.1371/journal.pone.0007939	http://dx.doi.org/10.1371/journal.pone.0007939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936215	Green Submitted, gold, Green Published			2022-12-27	WOS:000272004800017
J	Pennetier, C; Costantini, C; Corbel, V; Licciardi, S; Dabire, RK; Lapied, B; Chandre, F; Hougard, JM				Pennetier, Cedric; Costantini, Carlo; Corbel, Vincent; Licciardi, Severine; Dabire, Roch K.; Lapied, Bruno; Chandre, Fabrice; Hougard, Jean-Marc			Synergy between Repellents and Organophosphates on Bed Nets: Efficacy and Behavioural Response of Natural Free-Flying An. gambiae Mosquitoes	PLOS ONE			English	Article							RESISTANT ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS MOSQUITOS; PYRETHROID RESISTANCE; INSECT REPELLENTS; EXPERIMENTAL HUTS; MALARIA VECTORS; TREATED NETS; SAFETY; DEET; COMBINATION	Background: Chemicals are used on bed nets in order to prevent infected bites and to kill aggressive malaria vectors. Because pyrethroid resistance has become widespread in the main malaria vectors, research for alternative active ingredients becomes urgent. Mixing a repellent and a non-pyrethroid insecticide seemed to be a promising tool as mixtures in the laboratory showed the same features as pyrethroids. Methodology/Principal Findings: We present here the results of two trials run against free-flying Anopheles gambiae populations comparing the effects of two insect repellents (either DEET or KBR 3023, also known as icaridin) and an organophosphate insecticide at low-doses (pirimiphos-methyl, PM) used alone and in combination on bed nets. We showed that mixtures of PM and the repellents induced higher exophily, blood feeding inhibition and mortality among wild susceptible and resistant malaria vectors than compounds used alone. Nevertheless the synergistic interactions are only involved in the high mortality induced by the two mixtures. Conclusion: These field trials argue in favour of the strategy of mixing repellent and organophosphate on bed nets to better control resistant malaria vectors.			Pennetier, C (corresponding author), IRD, CCPV, UR016, Montpellier, France.	cedric.pennetier@ird.fr	Pennetier, Cedric/K-2010-2016; Dabire, Roch Kounbobr/ABF-3525-2020; Costantini, Carlo/F-3470-2012; Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016	Costantini, Carlo/0000-0003-1016-129X; Chandre, Fabrice/0000-0002-1994-9705; corbel, vincent/0000-0003-0995-3257; Pennetier, Cedric/0000-0002-3362-6371; Lapied, Bruno/0000-0002-0354-4375				Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Buka RL, 2004, CURR OPIN PEDIATR, V16, P378, DOI 10.1097/01.mop.0000133082.32384.76; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Collett D., 1991, MODELLING BINARY DAT; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costantini C, 1996, CIBA F SYMP, V200, P124; Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209; Crawley M.J., 1993, GLIM ECOLOGISTS; Darriet F, 2002, B SOC PATHOL EXOT, V95, P299; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Kendrick DB, 2006, CURR OPIN PEDIATR, V18, P180, DOI 10.1097/01.mop.0000193273.54742.6f; KILLEEN GF, 2007, T R SOC TROP MED HYG; Koren G, 2003, CAN MED ASSOC J, V169, P209; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; MEHR ZA, 1990, J AM MOSQUITO CONTR, V6, P469; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2006, T ROY SOC TROP MED H, V100, P1091, DOI 10.1016/j.trstmh.2006.04.005; NGUESSAN R, 2007, T R SOC TROP MED HYG; PAYNE CD, 1987, GLIM SYSTEM RELEASE; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Pennetier C, 2008, EMERG INFECT DIS, V14, P1707, DOI 10.3201/eid1411.071575; Pennetier C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-38; PETERS W, 1990, ANN PARASIT HUM COMP, V65, P103, DOI 10.1051/parasite/1990651103; TOMLIN CDS, 2000, PESTICIDE MANUEL WOR; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Torr SJ, 2005, TRENDS PARASITOL, V21, P537, DOI 10.1016/j.pt.2005.08.021; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2006, GUIDELINES TESTING M; WHO UNICEF, 2005, WORLD MALARIA REPORT; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7896	10.1371/journal.pone.0007896	http://dx.doi.org/10.1371/journal.pone.0007896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936249	Green Published, gold			2022-12-27	WOS:000272004600002
J	Kim, YC; Morrison, SL				Kim, Yun-Cheol; Morrison, Sherie L.			A Rapid and Economic In-House DNA Purification Method Using Glass Syringe Filters	PLOS ONE			English	Article								Background: Purity, yield, speed and cost are important considerations in plasmid purification, but it is difficult to achieve all of these at the same time. Currently, there are many protocols and kits for DNA purification, however none maximize all four considerations. Methodology/Principal Findings: We now describe a fast, efficient and economic in-house protocol for plasmid preparation using glass syringe filters. Plasmid yield and quality as determined by enzyme digestion and transfection efficiency were equivalent to the expensive commercial kits. Importantly, the time required for purification was much less than that required using a commercial kit. Conclusions/Significance: This method provides DNA yield and quality similar to that obtained with commercial kits, but is more rapid and less costly.			Kim, YC (corresponding author), Invitrogen, Camarillo, CA USA.	kyc8402@ucla.edu						Ausubel F. M., 2001, CURRENT PROTOCOLS MO; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gerstein AS., 2001, MOL BIOL PROBLEM SOL; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Itoh M, 1999, GENOME RES, V9, P463; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; MAITRA R, 1994, INDIAN J BIOCHEM BIO, V31, P97; *QIAG INC, 2005, QIAG PLASM PUR HDB; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sambrook J., 2001, MOL CLONING LAB MANU; VAUGHANLARRY, 2001, PURIFICATION PLASMID	14	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7750	10.1371/journal.pone.0007750	http://dx.doi.org/10.1371/journal.pone.0007750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924285	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700001
J	Russ, BE; Cohen, YE				Russ, Brian E.; Cohen, Yale E.			Rhesus Monkeys' Valuation of Vocalizations during a Free-Choice Task	PLOS ONE			English	Article							DISCRIMINATION; MACAQUES; CALLS; FIELD	Adaptive behavior requires that animals integrate current and past information with their decision-making. One important type of information is auditory-communication signals (i.e., species-specific vocalizations). Here, we tested how rhesus monkeys incorporate the opportunity to listen to different species-specific vocalizations into their decision-making processes. In particular, we tested how monkeys value these vocalizations relative to the opportunity to get a juice reward. To test this hypothesis, monkeys chose one of two targets to get a varying juice reward; at one of those targets, in addition to the juice reward, a vocalization was presented. By titrating the juice amounts at the two targets, we quantified the relationship between the monkeys' juice choices relative to the opportunity to listen to a vocalization. We found that, rhesus were not willing to give up a large juice reward to listen to vocalizations indicating that, relative to a juice reward, listening to vocalizations has a low value.			Russ, BE (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	ycohen@mail.med.upenn.edu		Russ, Brian/0000-0003-0320-1257	NIDCD NIH HHS [5R01DC007172, R01 DC007172, 5R01DC00922] Funding Source: Medline; NIMH NIH HHS [F31 MH075634, 5F31MH075634] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007172, R01DC000922] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adachi I, 2007, BEHAV PROCESS, V74, P27, DOI 10.1016/j.beproc.2006.09.004; Andersson M, 1996, SEXUAL SELECTION; Bell AH, 2003, EUR J NEUROSCI, V18, P2867, DOI 10.1111/j.1460-9568.2003.02976.x; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Bon L, 2006, EXP BRAIN RES, V168, P441, DOI 10.1007/s00221-005-0197-5; Bon L, 1997, EXP BRAIN RES, V113, P180, DOI 10.1007/BF02454156; BUTLER RA, 1958, AM J PSYCHOL, V71, P591, DOI 10.2307/1420258; BUTLER RA, 1957, J COMP PHYSIOL PSYCH, V50, P239, DOI 10.1037/h0045931; Cheney D. L., 1990, MONKEYS SEE WORLD IN; COHEN YE, 2009, MULTIMODAL ACTIVITY; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fitch WT, 2003, SPR HDB AUD, V16, P65; Gifford GW, 2004, J NEUROPHYSIOL, V91, P2929, DOI 10.1152/jn.01117.2003; Gifford GW, 2003, BRAIN BEHAV EVOLUT, V61, P213, DOI 10.1159/000070704; Glimcher PW, 2003, BRADFORD BOOKS, P1; Greenfield MD, 2002, SIGNALERS RECEIVERS; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; HAUSER MD, 1997, EVOLUTION COMMUNICAT; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; LAU WWL, 2000, HEARING WHALES DOLPH; Macmillan N. A., 1991, DETECTION THEORY USE; Mech D., 2003, WOLVES BEHAV ECOLOGY; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; RECANZONE GH, 2009, INTERACTIONS AUDITOR; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Watson KK, 2008, PHILOS T R SOC B, V363, P3825, DOI 10.1098/rstb.2008.0159	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7834	10.1371/journal.pone.0007834	http://dx.doi.org/10.1371/journal.pone.0007834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924223	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700005
J	Alvarez, Y; Astudillo, O; Jensen, L; Reynolds, AL; Waghorne, N; Brazil, DP; Cao, YH; O'Connor, JJ; Kennedy, BN				Alvarez, Yolanda; Astudillo, Olaya; Jensen, Lasse; Reynolds, Alison L.; Waghorne, Nora; Brazil, Derek P.; Cao, Yihai; O'Connor, John J.; Kennedy, Breandan N.			Selective Inhibition of Retinal Angiogenesis by Targeting PI3 Kinase	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; 3-KINASE INHIBITOR; MODEL; VEGF; SUPPRESSION; RETINOPATHY; MECHANISMS; ZEBRAFISH; ANTITUMOR; THERAPY	Ocular neovascularisation is a pathological hallmark of some forms of debilitating blindness including diabetic retinopathy, age related macular degeneration and retinopathy of prematurity. Current therapies for delaying unwanted ocular angiogenesis include laser surgery or molecular inhibition of the pro-angiogenic factor VEGF. However, targeting of angiogenic pathways other than, or in combination to VEGF, may lead to more effective and safer inhibitors of intraocular angiogenesis. In a small chemical screen using zebrafish, we identify LY294002 as an effective and selective inhibitor of both developmental and ectopic hyaloid angiogenesis in the eye. LY294002, a PI3 kinase inhibitor, exerts its anti-angiogenic effect in a dose-dependent manner, without perturbing existing vessels. Significantly, LY294002 delivered by intraocular injection, significantly inhibits ocular angiogenesis without systemic side-effects and without diminishing visual function. Thus, targeting of PI3 kinase pathways has the potential to effectively and safely treat neovascularisation in eye disease.			Alvarez, Y (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol, Dublin 2, Ireland.	yolanda.alvarez@ucd.ie; brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689; Reynolds, Alison/0000-0002-3147-0094; O'Connor, John/0000-0001-8229-8602; Brazil, Derek/0000-0003-1375-1076; Jensen, Lasse/0000-0003-2338-357X				Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Campochiaro PA, 2004, INVEST OPHTH VIS SCI, V45, P922, DOI 10.1167/iovs.03-0955; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Doukas J, 2008, J CELL PHYSIOL, V216, P29, DOI 10.1002/jcp.21426; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; FLEISCH VJ, 2008, MEASUREMENTS LARVAL, DOI DOI 10.1103/PDB.PROT4973; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; HAYAT M, 1987, PRINCIPLES TECHNIQUE; Hernandez C, 2007, EXPERT OPIN INV DRUG, V16, P1209, DOI 10.1517/13543784.16.8.1209; Ihle NT, 2009, MOL CANCER THER, V8, P1, DOI 10.1158/1535-7163.MCT-08-0801; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jia SD, 2009, CURR OPIN CELL BIOL, V21, P199, DOI 10.1016/j.ceb.2008.12.007; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Takahashi K, 2009, ARCH OPHTHALMOL-CHIC, V127, P494, DOI 10.1001/archophthalmol.2009.27; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Yu WZ, 2008, OPHTHALMIC RES, V40, P19, DOI 10.1159/000111154; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	41	58	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7867	10.1371/journal.pone.0007867	http://dx.doi.org/10.1371/journal.pone.0007867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924235	Green Published, gold, Green Submitted			2022-12-27	WOS:000271854200014
J	Palmer, CD; Rahman, FZ; Sewell, GW; Ahmed, A; Ashcroft, M; Bloom, SL; Segal, AW; Smith, AM				Palmer, Christine D.; Rahman, Farooq Z.; Sewell, Gavin W.; Ahmed, Afshan; Ashcroft, Margaret; Bloom, Stuart L.; Segal, Anthony W.; Smith, Andrew M.			Diminished Macrophage Apoptosis and Reactive Oxygen Species Generation after Phorbol Ester Stimulation in Crohn's Disease	PLOS ONE			English	Article							PROTEIN-KINASE-C; INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; T-CELLS; PKC-DELTA; ACTIVATION; EXPRESSION; NEUTROPHIL; BAX; P53	Background: Crohn's Disease (CD) is a chronic relapsing disorder characterized by granulomatous inflammation of the gastrointestinal tract. Although its pathogenesis is complex, we have recently shown that CD patients have a systemic defect in macrophage function, which results in the defective clearance of bacteria from inflammatory sites. Methodology/Principal Findings: Here we have identified a number of additional macrophage defects in CD following diacylglycerol (DAG) homolog phorbol-12-myristate-13-acetate (PMA) activation. We provide evidence for decreased DNA fragmentation, reduced mitochondrial membrane depolarization, impaired reactive oxygen species production, diminished cytochrome c release and increased IL-6 production compared to healthy subjects after PMA exposure. The observed macrophage defects in CD were stimulus-specific, as normal responses were observed following p53 activation and endoplasmic reticulum stress. Conclusion: These findings add to a growing body of evidence highlighting disordered macrophage function in CD and, given their pivotal role in orchestrating inflammatory responses, defective apoptosis could potentially contribute to the pathogenesis of CD.			Palmer, CD (corresponding author), UCL, Dept Med, Ctr Mol Med, London, England.	andrew.m.smith@ucl.ac.uk	Palmer, Christine/GXH-4415-2022	Sewell, Gavin/0000-0002-3002-9248; Palmer, Christine Denise/0000-0003-3213-0398; Smith, Andrew/0000-0002-4691-5973; Segal, Anthony/0000-0001-7602-9043	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Boirivant M, 1999, GASTROENTEROLOGY, V116, P557, DOI 10.1016/S0016-5085(99)70177-0; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Budas GR, 2007, BIOCHEM SOC T, V35, P1052, DOI 10.1042/BST0351052; Bufan B, 2009, INT IMMUNOPHARMACOL, V9, P910, DOI 10.1016/j.intimp.2009.03.016; Carol M, 2006, J LEUKOCYTE BIOL, V79, P917, DOI 10.1189/jlb.0405188; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Chan HTC, 2003, CANCER RES, V63, P5480; Di Sabatino A, 2004, GUT, V53, P70, DOI 10.1136/gut.53.1.70; Doering J, 2004, GUT, V53, P1632, DOI 10.1136/gut.2003.037911; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fong CC, 2007, TOXICOLOGY, V236, P16, DOI 10.1016/j.tox.2007.03.024; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Herman S, 2005, INFLAMM RES, V54, P273, DOI 10.1007/s00011-005-1355-8; Ina K, 1999, J IMMUNOL, V163, P1081; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Itoh J, 2001, GUT, V49, P35, DOI 10.1136/gut.49.1.35; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kobayashi T, 2004, HISTOCHEM CELL BIOL, V122, P323, DOI 10.1007/s00418-004-0674-0; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; KUSUGAMI K, 1995, DIGEST DIS SCI, V40, P949, DOI 10.1007/BF02064182; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; MAEDA M, 1992, IMMUNOPHARM IMMUNOT, V14, P451, DOI 10.3109/08923979209005404; MAHIDA YR, 1991, GUT, V32, P1531, DOI 10.1136/gut.32.12.1531; Marks DJB, 2007, INFLAMM RES, V56, P168, DOI 10.1007/s00011-006-6119-6; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Mathew J, 2008, FREE RADICAL BIO MED, V45, P413, DOI 10.1016/j.freeradbiomed.2008.04.031; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Pajak B, 2008, ADV MED SCI-POLAND, V53, P21, DOI 10.2478/v10039-008-0028-6; Park JK, 2008, PLACENTA, V29, P584, DOI 10.1016/j.placenta.2008.03.007; Phillips DC, 2003, BRIT J PHARMACOL, V138, P501, DOI 10.1038/sj.bjp.0705054; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rahman FZ, 2008, INFLAMM BOWEL DIS, V14, P1443, DOI 10.1002/ibd.20449; Rahman FZ, 2009, IMMUNOLOGY, V128, P253, DOI 10.1111/j.1365-2567.2009.03112.x; Reinisch W, 1999, AM J GASTROENTEROL, V94, P2156; Rodenburg RJT, 2000, ARTHRITIS RHEUM, V43, P1941, DOI 10.1002/1529-0131(200009)43:9<1941::AID-ANR4>3.0.CO;2-O; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206; THELEN M, 1993, PHYSIOL REV, V73, P797, DOI 10.1152/physrev.1993.73.4.797; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waterhouse NJ, 2006, CELL DEATH DIFFER, V13, P607, DOI 10.1038/sj.cdd.4401772; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08	58	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7787	10.1371/journal.pone.0007787	http://dx.doi.org/10.1371/journal.pone.0007787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907654	Green Submitted, Green Published, gold			2022-12-27	WOS:000271721400001
J	Jacob, ST; Moore, CC; Banura, P; Pinkerton, R; Meya, D; Opendi, P; Reynolds, SJ; Kenya-Mugisha, N; Mayanja-Kizza, H; Scheld, WM				Jacob, Shevin T.; Moore, Christopher C.; Banura, Patrick; Pinkerton, Relana; Meya, David; Opendi, Pius; Reynolds, Steven J.; Kenya-Mugisha, Nathan; Mayanja-Kizza, Harriet; Scheld, W. Michael		PRISM-U Study Grp	Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; SEPTIC SHOCK; ADULTS; MORTALITY; BACTEREMIA; MALAWI; CARE; PREDICTORS; MEDICINE; THERAPY	Background: Sepsis likely contributes to the high burden of infectious disease morbidity and mortality in low income countries. Data regarding sepsis management in sub-Saharan Africa are limited. We conducted a prospective observational study reporting the management and outcomes of severely septic patients in two Ugandan hospitals. We describe their epidemiology, management, and clinical correlates for mortality. Methodology/Results: Three-hundred eighty-two patients fulfilled enrollment criteria for a severe sepsis syndrome. Vital signs, management and laboratory results were recorded. Outcomes measured included in-hospital and post-dischargemortality. Most patients were HIV-infected (320/377, 84.9%) with a median CD4+ T cell (CD4) count of 52 cells/mm(3) (IQR, 16-131 cells/mm(3)). Overall mortality was 43.0%, with 23.7% in-hospital mortality (90/380) and 22.3% post-discharge mortality (55/247). Significant predictors of in-hospital mortality included admission Glasgow Coma Scale and Karnofsky Performance Scale (KPS), tachypnea, leukocytosis and thrombocytopenia. Discharge KPS and early fluid resuscitation were significant predictors of post-discharge mortality. Among HIV-infected patients, CD4 count was a significant predictor of post-discharge mortality. Median volume of fluid resuscitation within the first 6 hours of presentation was 500 mLs (IQR 250-1000 mls). Fifty-two different empiric antibacterial regimens were used during the study. Bacteremic patients were more likely to die in hospital than non-bacteremic patients (OR 1.83, 95% CI = 1.01-3.33). Patients with Mycobacterium tuberculosis (MTB) bacteremia (25/249) had higher in-hospital mortality (OR 1.97, 95% CI = 1.19-327) and lower median CD4 counts (p = 0.001) than patients without MTB bacteremia. Conclusion: Patients presenting with sepsis syndromes to two Ugandan hospitals had late stage HIV infection and high mortality. Bacteremia, especially from MTB, was associated with increased in-hospital mortality. Most clinical predictors of in-hospital mortality were easily measurable and can be used for triaging patients in resource-constrained settings. Procurement of low cost and high impact treatments like intravenous fluids and empiric antibiotics may help decrease sepsis-associated mortality in resource-constrained settings.			Jacob, ST (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	sjacob2@uw.edu	Jacob, Shevin/CAF-0449-2022; Mayanja-Kizza, Harriet/AAM-5372-2020; Meya, David/AAO-2796-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Kenya Mugisha, Nathan/0000-0002-2100-1833; Reynolds, Steven/0000-0002-5403-2759; Jacob, Shevin/0000-0003-2425-9394; , David/0000-0002-8854-0321; Meya, David/0000-0002-4138-240X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785OC; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Anyama Norbert, 2003, Afr Health Sci, V3, P87; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; Awad AI, 2007, ANN PHARMACOTHER, V41, P1249, DOI 10.1345/aph.1K068; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bochud PY, 2001, INTENS CARE MED, V27, pS33, DOI 10.1007/PL00003796; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; *HLTH CTR DISTR OU, 2004, INT MAN AD AD ILLN I; *HMIS, 2008, DAT MAS REG REF HOSP; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP STA; KARNOFSKY D, 1961, CLIN PHARMACOL THER, V2, P709; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leibovici L, 1998, J INTERN MED, V244, P379; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Moore CC, 2009, AM J TROP MED HYG, V80, P723, DOI 10.4269/ajtmh.2009.80.723; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Ogwal-Okeng J W, 2004, East Afr Med J, VSuppl, pS12; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2005, CAN MED ASSOC J, V173, P1054, DOI 10.1503/cmaj.050632; Sharma B, 2007, ANAESTH INTENS CARE, V35, P874, DOI 10.1177/0310057X0703500604; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; THEODOSIS C, 2006, INT AIDS C TOR; Vincent JL, 2002, CRIT CARE, V6, pS1, DOI 10.1186/cc1860; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; *WHO, 2007, CLIN MAN HIV AIDS DI	46	98	103	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A115	A126	e7782	10.1371/journal.pone.0007782	http://dx.doi.org/10.1371/journal.pone.0007782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907656	Green Published, gold, Green Submitted			2022-12-27	WOS:000271685800013
J	Skilton, RJ; Cutcliffen, LT; Barlow, D; Wang, YB; Salim, O; Lambden, PR; Clarke, IN				Skilton, Rachel J.; Cutcliffen, Lesley T.; Barlow, David; Wang, Yibing; Salim, Omar; Lambden, Paul R.; Clarke, Ian N.			Penicillin Induced Persistence in Chlamydia trachomatis: High Quality Time Lapse Video Analysis of the Developmental Cycle	PLOS ONE			English	Article							BINDING PROTEINS; GENOME SEQUENCE; CELL-CULTURE; PEPTIDOGLYCAN; INCLUSION; INFECTIVITY; MORPHOLOGY; PARADIGM; PSITTACI; CHP2	Background: Chlamydia trachomatis is a major human pathogen with a unique obligate intracellular developmental cycle that takes place inside a modified cytoplasmic structure known as an inclusion. Following entry into a cell, the infectious elementary body (EB) differentiates into a non - infectious replicative form known as a reticulate body (RB). RBs divide by binary fission and at the end of the cycle they redifferentiate into EBs. Treatment of C. trachomatis with penicillin prevents maturation of RBs which survive and enlarge to become aberrant RBs within the inclusion in a non - infective persistent state. Persistently infected individuals may be a reservoir for chlamydial infection. The C. trachomatis genome encodes the enzymes for peptidoglycan ( PG) biosynthesis but a PG sacculus has never been detected. This coupled to the action of penicillin is known as the chlamydial anomaly. We have applied video microscopy and quantitative DNA assays to the chlamydial developmental cycle to assess the effects of penicillin treatment and establish a framework for investigating penicillin induced chlamydial persistence. Principal Findings: Addition of penicillin at the time of cell infection does not prevent uptake and the establishment of an inclusion. EB to RB transition occurs but bacterial cytokinesis is arrested by the second binary fission. RBs continue to enlarge but not divide in the presence of penicillin. The normal developmental cycle can be recovered by the removal of penicillin although the large, aberrant RBs do not revert to the normal smaller size but remain present to the completion of the developmental cycle. Chromosomal and plasmid DNA replication is unaffected by the addition of penicillin but the arrest of bacterial cytokinesis under these conditions results in RBs accumulating multiple copies of the genome. Conclusions: We have applied video time lapse microscopy to the study of the chlamydial developmental cycle. Linked with accurate measures of genome replication this provides a defined framework to analyse the developmental cycle and to investigate and provide new insights into the effects of antibiotic treatments. Removal of penicillin allows recovery of the normal developmental cycle by 10-20 hrs and the process occurs by budding from aberrant RBs.			Skilton, RJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Mol Microbiol Grp, Southampton, Hants, England.	inc@soton.ac.uk		Clarke, Ian/0000-0002-4938-1620	Wellcome Trust [080348] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Armstrong JA, 1967, J GEN MICROBIOL, V129, P2001; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; CLARK RB, 1982, MED MICROBIOL IMMUN, V171, P151, DOI 10.1007/BF02123623; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hatch TP, 1999, CHLAMYDIA, P29; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; JOHNSON FWA, 1977, J ANTIMICROB CHEMOTH, V3, P49, DOI 10.1093/jac/3.1.49; KRAMER MJ, 1971, INFECT IMMUN, V3, P333, DOI 10.1128/IAI.3.2.333-341.1971; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Liu BL, 2000, J VIROL, V74, P3464, DOI 10.1128/JVI.74.8.3464-3469.2000; MATSUMOTO A, 1970, J BACTERIOL, V101, P278, DOI 10.1128/JB.101.1.278-285.1970; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; MOULDER JW, 1993, INFECT AGENT DIS, V2, P87; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; Pavelka MS, 2007, TRENDS MICROBIOL, V15, P147, DOI 10.1016/j.tim.2007.02.003; PEELING RW, 1991, INFECT IMMUN, V59, P2624, DOI 10.1128/IAI.59.8.2624-2630.1991; PHILLIPS DM, 1984, J ULTRA MOL STRUCT R, V88, P244, DOI 10.1016/S0022-5320(84)90122-9; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Rockey DD, 2000, PROKARYOTIC DEVELOPMENT, P403; SCHACHTER J, 1990, SCAND J INFECT DIS, P55; Scidmore MA, 1996, INFECT IMMUN, V64, P5366, DOI 10.1128/IAI.64.12.5366-5372.1996; Skilton RJ, 2007, J BACTERIOL, V189, P4957, DOI 10.1128/JB.00235-07; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Storey C, 2001, ANTIMICROB AGENTS CH, V45, P303, DOI 10.1128/AAC.45.1.303-305.2001; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; WARD ME, 1983, BRIT MED BULL, V39, P109, DOI 10.1093/oxfordjournals.bmb.a071800; Wilson DP, 2009, J BACTERIOL, V191, P5734, DOI 10.1128/JB.00293-09; Wilson DP, 2004, B MATH BIOL, V66, P523, DOI 10.1016/j.bulm.2003.09.001	33	67	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7723	10.1371/journal.pone.0007723	http://dx.doi.org/10.1371/journal.pone.0007723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893744	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000271478000009
J	Huang, T; Cui, WR; Hu, LL; Feng, KY; Li, YX; Cai, YD				Huang, Tao; Cui, WeiRen; Hu, Lele; Feng, KaiYan; Li, Yi-Xue; Cai, Yu-Dong			Prediction of Pharmacological and Xenobiotic Responses to Drugs Based on Time Course Gene Expression Profiles	PLOS ONE			English	Article							COMPARATIVE TOXICOGENOMICS DATABASE; SIGNAL-TRANSDUCTION; CLINICAL IMPORTANCE; FUNCTIONAL DOMAIN; CONNECTIVITY MAP; CYTOCHROMES P450; DISCOVERY; METABOLISM; TOXICITY; PROTEINS	More and more people are concerned by the risk of unexpected side effects observed in the later steps of the development of new drugs, either in late clinical development or after marketing approval. In order to reduce the risk of the side effects, it is important to look out for the possible xenobiotic responses at an early stage. We attempt such an effort through a prediction by assuming that similarities in microarray profiles indicate shared mechanisms of action and/or toxicological responses among the chemicals being compared. A large time course microarray database derived from livers of compound-treated rats with thirty-four distinct pharmacological and toxicological responses were studied. The mRMR (Minimum-Redundancy-Maximum-Relevance) method and IFS (Incremental Feature Selection) were used to select a compact feature set (141 features) for the reduction of feature dimension and improvement of prediction performance. With these 141 features, the Leave-one-out cross-validation prediction accuracy of first order response using NNA (Nearest Neighbor Algorithm) was 63.9%. Our method can be used for pharmacological and xenobiotic responses prediction of new compounds and accelerate drug development.	[Cui, WeiRen; Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cui, WeiRen] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Huang, Tao; Li, Yi-Xue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Tao; Feng, KaiYan; Li, Yi-Xue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Huang, T (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979				Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017; Boorman GA, 2002, TOXICOL PATHOL, V30, P15, DOI 10.1080/01926230252824671; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Davis AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-48; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025; Gueguen Y, 2006, ANN BIOL CLIN-PARIS, V64, P535; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li SJ, 2007, J BIOMOL STRUCT DYN, V25, P49, DOI 10.1080/07391102.2007.10507154; Li SJ, 2006, COMPUT BIOL CHEM, V30, P203, DOI 10.1016/j.compbiolchem.2006.02.002; Li WJ, 2008, MOL DIVERS, V12, P171, DOI 10.1007/s11030-008-9093-9; LU L, 2009, MOL DIVERS; Mattingly CJ, 2006, TOXICOL SCI, V92, P587, DOI 10.1093/toxsci/kfl008; Morgan Kevin T, 2004, Toxicol Pathol, V32 Suppl 1, P13, DOI 10.1080/01926230490424789; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Niu B, 2009, MOL DIVERS, V13, P313, DOI 10.1007/s11030-009-9116-1; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Ulrich R, 2002, NAT REV DRUG DISCOV, V1, P84, DOI 10.1038/nrd710; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018	39	75	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8126	10.1371/journal.pone.0008126	http://dx.doi.org/10.1371/journal.pone.0008126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956587	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800019
J	Kim, Y; Comte, I; Szabo, G; Hockberger, P; Szele, FG				Kim, Yongsoo; Comte, Isabelle; Szabo, Gabor; Hockberger, Philip; Szele, Francis G.			Adult Mouse Subventricular Zone Stem and Progenitor Cells Are Sessile and Epidermal Growth Factor Receptor Negatively Regulates Neuroblast Migration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; NEURAL STEM; MAMMALIAN BRAIN; FACTOR-ALPHA; POSTNATAL NEUROGENESIS; NEURONAL MIGRATION; TRANSGENIC MICE; RAT BRAIN; EGFR	Background: The adult subventricular zone (SVZ) contains stem and progenitor cells that generate neuroblasts throughout life. Although it is well accepted that SVZ neuroblasts are migratory, recent evidence suggests their progenitor cells may also exhibit motility. Since stem and progenitor cells are proliferative and multipotential, if they were also able to move would have important implications for SVZ neurogenesis and its potential for repair. Methodology/Principal Findings: We studied whether SVZ stem and/or progenitor cells are motile in transgenic GFP+ slices with two photon time lapse microscopy and post hoc immunohistochemistry. We found that stem and progenitor cells; mGFAP-GFP+ cells, bright nestin-GFP+ cells and Mash1+ cells were stationary in the SVZ and rostral migratory stream (RMS). In our search for motile progenitor cells, we uncovered a population of motile beta III-tubulin+ neuroblasts that expressed low levels of epidermal growth factor receptor (EGFr). This was intriguing since EGFr drives proliferation in the SVZ and affects migration in other systems. Thus we examined the potential role of EGFr in modulating SVZ migration. Interestingly, EGFr(low) neuroblasts moved slower and in more tortuous patterns than EGFr-negative neuroblasts. We next questioned whether EGFr stimulation affects SVZ cell migration by imaging Gad65-GFP+ neuroblasts in the presence of transforming growth factor alpha (TGF-alpha), an EGFr-selective agonist. Indeed, acute exposure to TGF-alpha decreased the percentage of motile cells by approximately 40%. Conclusions/Significance: In summary, the present study directly shows that SVZ stem and progenitor cells are static, that EGFr is retained on some neuroblasts, and that EGFr stimulation negatively regulates migration. This result suggests an additional role for EGFr signaling in the SVZ.	[Kim, Yongsoo] Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Hockberger, Philip] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Szele, Francis G.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Northwestern University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Northwestern University; Feinberg School of Medicine; University of Oxford	Kim, Y (corresponding author), Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA.	francis.szele@dpag.ox.ac.uk	Kim, Yongsoo/C-9163-2009; Szabo, Gabor/A-5087-2008; Kim, Yongsoo/AAE-4970-2020	Kim, Yongsoo/0000-0002-4277-0279; Szabo, Gabor/0000-0001-5438-5151; Kim, Yongsoo/0000-0002-4277-0279; Hockberger, Philip/0000-0002-4013-4885	NIH [NS-42253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	FGS and PH supported by NIH grant NS-42253 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; COSKUN V, 2007, EUR J NEUROSCI; Craig CG, 1996, J NEUROSCI, V16, P2649; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; EMMETT CJ, 1991, J COMP NEUROL, V311, P330, DOI 10.1002/cne.903110304; EMMETT CJ, 1988, BRAIN RES, V447, P223, DOI 10.1016/0006-8993(88)91123-7; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gritti A, 1999, J NEUROSCI, V19, P3287; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Lehmann R, 2001, CURR OPIN GENET DEV, V11, P457, DOI 10.1016/S0959-437X(00)00217-3; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; NAGOSHI N, 2009, J CELL BIOCH; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; PASTRANA E, 2009, P NATL ACAD SCI US; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SATO H, 2005, CANC GENE THER; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Tropepe V, 1997, J NEUROSCI, V17, P7850; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	62	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8122	10.1371/journal.pone.0008122	http://dx.doi.org/10.1371/journal.pone.0008122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956583	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800016
J	Hong, YY; Li, HZ; Ye, JJ; Miki, Y; Yuan, YC; Sasano, H; Evans, DB; Chen, SA				Hong, Yanyan; Li, Hongzhi; Ye, Jingjing; Miki, Yasuhiro; Yuan, Yate-Ching; Sasano, Hironobu; Evans, Dean B.; Chen, Shiuan			Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; HUMAN BREAST; ELECTROSTATIC INTERACTIONS; BINDING DOMAIN; REDUCTASE; ESTROGEN; IMMUNOHISTOCHEMISTRY; CYTOCHROME-P-450; VALIDATION; INHIBITION	Immunohistochemistry is one of the most suitable methods for the detection of intratumoral aromatase in order to identify patients who may respond to aromatase inhibitor therapy in hormone-dependent breast cancer. Previous studies showed statistically significant correlation between results of immnuohistochemistry and biochemical analysis in carcinoma components stained by aromatase monoclonal antibody 677. In this study, determination of the antigenic peptides recognized by aromatase antibodies through epitope mapping, combined with the new knowledge on aromatase-reductase interaction, provide insights for understanding various immunostaining patterns using different aromatase antibodies. Our studies on aromatase-reductase interaction also provided critical information on how aromatase and reductase interact with each other on the endoplasmic reticulum membrane, and identified key residues, including K108 of aromatase, that are involved in the interaction with reductase. Through epitope mapping and taking into consideration the interference with aromatase immunohistochemical staining by NADPH-cytochrome P450 reductase, we demonstrated that monoclonal antibody 677 is a suitable antibody for an assessment of intratumoral aromatase activity in breast cancer patients for making clinical management decisions. These results also provide valuable information to identify new aromatase antibodies for immunohistochemical diagnosis of hormone-dependent breast cancer in future.	[Hong, Yanyan; Ye, Jingjing; Chen, Shiuan] Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA; [Miki, Yasuhiro; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 980, Japan; [Li, Hongzhi; Yuan, Yate-Ching] Beckman Res Inst City Hope, Div Informat Sci, Duarte, CA USA; [Evans, Dean B.] Novartis Pharma Ag, Novartis Inst Biomed Res, Oncol Res, Zurich, Switzerland	City of Hope; Beckman Research Institute of City of Hope; Tohoku University; City of Hope; Beckman Research Institute of City of Hope; Novartis	Hong, YY (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA.	schen@coh.org	Li, Hongzhi/E-8530-2012		National Institutes of Health [CA44735, CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA044735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health [CA44735 (SC), and CA33572 (the City of Hope Cancer Center Grant)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARDT R, 1987, BIOCHEM INT, V14, P823; BERNHARDT R, 1988, BIOMED BIOCHIM ACTA, V47, P581; BEZWODA WR, 1987, ONCOLOGY, V44, P345, DOI 10.1159/000226509; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; ESTEBAN JM, 1992, AM J PATHOL, V140, P337; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hong YY, 2007, MOL ENDOCRINOL, V21, P401, DOI 10.1210/me.2006-0281; Hong YY, 2009, ANN NY ACAD SCI, V1155, P112, DOI 10.1111/j.1749-6632.2009.03703.x; JAMES V H T, 1987, Steroids, V50, P269, DOI 10.1016/0039-128X(83)90077-6; Lu Q, 1996, ENDOCRINOLOGY, V137, P3061, DOI 10.1210/en.137.7.3061; MILLER W R, 1987, Steroids, V50, P537, DOI 10.1016/0039-128X(87)90037-7; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; NADLER SG, 1988, ARCH BIOCHEM BIOPHYS, V261, P418, DOI 10.1016/0003-9861(88)90358-X; NADLER SG, 1991, ARCH BIOCHEM BIOPHYS, V290, P277, DOI 10.1016/0003-9861(91)90542-Q; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; Sasano H, 1998, ENDOCR REV, V19, P593, DOI 10.1210/er.19.5.593; SASANO H, 1994, HUM PATHOL, V25, P530, DOI 10.1016/0046-8177(94)90127-9; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Sasano H, 2003, J STEROID BIOCHEM, V86, P239, DOI 10.1016/S0960-0760(03)00363-7; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Shenton KC, 1998, BREAST CANCER RES TR, V49, pS101, DOI 10.1023/A:1006033813899; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; STAYTON PS, 1990, BIOCHEMISTRY-US, V29, P7381, DOI 10.1021/bi00484a005; STROBEL HW, 1989, DRUG METAB REV, V20, P519, DOI 10.3109/03602538909103558; Turner KJ, 2002, J ENDOCRINOL, V172, P21, DOI 10.1677/joe.0.1720021; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; ZHOU D, 1990, CANCER RES, V50, P6949	30	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8050	10.1371/journal.pone.0008050	http://dx.doi.org/10.1371/journal.pone.0008050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956630	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828400009
J	Sakar, Y; Nazaret, C; Letteron, P; Omar, AA; Avenati, M; Viollet, B; Ducroc, R; Bado, A				Sakar, Yassine; Nazaret, Corinne; Letteron, Philippe; Omar, Amal Ait; Avenati, Mathilde; Viollet, Benoit; Ducroc, Robert; Bado, Andre			Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; RAT SMALL-INTESTINE; DIET-INDUCED OBESITY; LUMINAL LEPTIN; FOOD-INTAKE; INSULIN SENSITIVITY; SIGNALING PATHWAY; SUGAR ABSORPTION; GENE-EXPRESSION; GASTRIC-MUCOSA	Background and Aims: The small intestine is the major site of absorption of dietary sugars. The rate at which they enter and exit the intestine has a major effect on blood glucose homeostasis. In this study, we determine the effects of luminal leptin on activity/expression of GLUT2 and GLUT5 transporters in response to sugars intake and analyse their physiological consequences. Methodology: Wistar rats, wild type and AMPK alpha(-/-)(2) mice were used. In vitro and in vivo isolated jejunal loops were used to quantify transport of fructose and galactose in the absence and the presence of leptin. The effects of fructose and galactose on gastric leptin release were determined. The effects of leptin given orally without or with fructose were determined on the expression of GLUT2/5, on some gluconeogenesis and lipogenic enzymes in the intestine and the liver. Principal Findings: First, in vitro luminal leptin activating its receptors coupled to PKC beta II and AMPK alpha, increased insertion of GLUT2/5 into the brush-border membrane leading to enhanced galactose and fructose transport. Second in vivo, oral fructose but not galactose induced in mice a rapid and potent release of gastric leptin in gastric juice without significant changes in plasma leptin levels. Moreover, leptin given orally at a dose reproducing comparable levels to those induced by fructose, stimulated GLUT5-fructose transport, and potentiated fructose-induced: i) increase in blood glucose and mRNA levels of key gluconeogenesis enzymes; ii) increase in blood triglycerides and reduction of mRNA levels of intestinal and hepatic Fasting-induced adipocyte factor (Fiaf) and iii) increase in SREBP-1c, ACC-1, FAS mRNA levels and dephosphorylation/activation of ACC-1 in liver. Conclusion/Significance: These data identify for the first time a positive regulatory control loop between gut leptin and fructose in which fructose triggers release of gastric leptin which, in turn, up-regulates GLUT5 and concurrently modulates metabolic functions in the liver. This loop appears to be a new mechanism (possibly pathogenic) by which fructose consumption rapidly becomes highly lipogenic and deleterious.	[Sakar, Yassine; Nazaret, Corinne; Letteron, Philippe; Omar, Amal Ait; Avenati, Mathilde; Ducroc, Robert; Bado, Andre] INSERM, U773, Ctr Rech Biomed Bichat Beaujon, UFR Med Paris Denis Diderot 7,Claude Bernard IFR0, Paris, France; [Viollet, Benoit] INSERM, U567, Paris, France; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sakar, Y (corresponding author), INSERM, U773, Ctr Rech Biomed Bichat Beaujon, UFR Med Paris Denis Diderot 7,Claude Bernard IFR0, Paris, France.	andre.bado@inserm.fr	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; BADO, Andre/0000-0002-8007-1460	INSERM (Institut National de la Sante et de la Recherche Medicale); UFR of Medicine of University Paris 7 Denis Diderot	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); UFR of Medicine of University Paris 7 Denis Diderot	This work was supported by the INSERM (Institut National de la Sante et de la Recherche Medicale), the UFR of Medicine of University Paris 7 Denis Diderot, and by a grant (to YS) of Societe Francophone de Nutrition Clinique et Metabolisme (SFNEP- Antadir Federation), a grant (to RD) of Association pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM-Becton Dickinson), and a grant (to AB) of Institut Benjamin Delessert. The funders have no role in study design, data collection, analysis, decision to publish or to prepare the manuscript.	Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Begriche K, 2008, AM J PHYSIOL-ENDOC M, V294, pE939, DOI 10.1152/ajpendo.00379.2007; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cammisotto PG, 2006, AM J PHYSIOL-GASTR L, V290, pG242, DOI 10.1152/ajpgi.00334.2005; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Cheeseman CI, 1997, AM J PHYSIOL-REG I, V273, pR1965, DOI 10.1152/ajpregu.1997.273.6.R1965; Chong MFF, 2007, AM J CLIN NUTR, V85, P1511, DOI 10.1093/ajcn/85.6.1511; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Cui XL, 2005, AM J PHYSIOL-GASTR L, V288, pG1310, DOI 10.1152/ajpgi.00550.2004; Cui XL, 2004, PHYSIOL GENOMICS, V18, P206, DOI 10.1152/physiolgenomics.00056.2004; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gouyon F, 2003, BIOCHEM J, V375, P167, DOI 10.1042/BJ20030661; Guilmeau S, 2004, CURR OPIN PHARMACOL, V4, P561, DOI 10.1016/j.coph.2004.06.008; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Helliwell PA, 2003, J BIOL CHEM, V278, P28644, DOI 10.1074/jbc.M301479200; Hirsh AJ, 1998, J BIOL CHEM, V273, P14545, DOI 10.1074/jbc.273.23.14545; Ishikawa Y, 1997, BBA-MOL CELL RES, V1357, P306, DOI 10.1016/S0167-4889(97)00043-8; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Plaisancie P, 2006, AM J PHYSIOL-GASTR L, V290, pG805, DOI 10.1152/ajpgi.00433.2005; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Steinberg GR, 2003, AM J PHYSIOL-ENDOC M, V284, pE648, DOI 10.1152/ajpendo.00318.2002; TARTAGLIA LA, 1995, OB R CELL, V83, P1263; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; White DW, 1999, J CELL BIOCHEM, V73, P278, DOI 10.1002/(SICI)1097-4644(19990501)73:2<278::AID-JCB13>3.0.CO;2-W	51	61	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e7935	10.1371/journal.pone.0007935	http://dx.doi.org/10.1371/journal.pone.0007935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956534	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828400002
J	Meeks, LR; Addepalli, B; Hunt, AG				Meeks, Lisa R.; Addepalli, Balasubrahmanyam; Hunt, Arthur G.			Characterization of Genes Encoding Poly(A) Polymerases in Plants: Evidence for Duplication and Functional Specialization	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RNA; EXPRESSION; BINDING; TESTIS; TPAP; DOMAIN	Background: Poly(A) polymerase is a key enzyme in the machinery that mediates mRNA 3' end formation in eukaryotes. In plants, poly(A) polymerases are encoded by modest gene families. To better understand this multiplicity of genes, poly(A) polymerase-encoding genes from several other plants, as well as from Selaginella, Physcomitrella, and Chlamydomonas, were studied. Methodology/Principal Findings: Using bioinformatics tools, poly(A) polymerase-encoding genes were identified in the genomes of eight species in the plant lineage. Whereas Chlamydomonas reinhardtii was found to possess a single poly(A) polymerase gene, other species possessed between two and six possible poly(A) polymerase genes. With the exception of four intron-lacking genes, all of the plant poly(A) polymerase genes (but not the C. reinhardtii gene) possessed almost identical intron positions within the poly(A) polymerase coding sequences, suggesting that all plant poly(A) polymerase genes derive from a single ancestral gene. The four Arabidopsis poly(A) polymerase genes were found to be essential, based on genetic analysis of T-DNA insertion mutants. GFP fusion proteins containing three of the four Arabidopsis poly(A) polymerases localized to the nucleus, while one such fusion protein was localized in the cytoplasm. The fact that this latter protein is largely pollen-specific suggests that it has important roles in male gametogenesis. Conclusions/Significance: Our results indicate that poly(A) polymerase genes have expanded from a single ancestral gene by a series of duplication events during the evolution of higher plants, and that individual members have undergone sorts of functional specialization so as to render them essential for plant growth and development. Perhaps the most interesting of the plant poly(A) polymerases is a novel cytoplasmic poly(A) polymerase that is expressed in pollen in Arabidopsis; this is reminiscent of spermatocyte-specific cytoplasmic poly(A) polymerases in mammals.	[Meeks, Lisa R.; Addepalli, Balasubrahmanyam; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA	University of Kentucky	Meeks, LR (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu	Hunt, Arthur/A-8040-2009	Hunt, Arthur/0000-0002-0008-4158; Addepalli, Balasubrahmanyam/0000-0001-6257-7700	NSF [MCB-0313472]; USDA-NRI [2002-35301-12284]	NSF(National Science Foundation (NSF)); USDA-NRI(United States Department of Agriculture (USDA))	This research was supported by NSF Grant MCB-0313472 and USDA-NRI grant 2002-35301-12284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli B, 2004, BBA-GENE STRUCT EXPR, V1679, P117, DOI 10.1016/j.bbaexp.2004.06.001; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Howden R, 1998, GENETICS, V149, P621; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Kashiwabara S, 2002, SCIENCE, V298, P1999, DOI 10.1126/science.1074632; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lee YJ, 2000, FEBS LETT, V487, P287, DOI 10.1016/S0014-5793(00)02367-X; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; STOMP AM, 1992, GUS PROTOCOLS USING; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x; Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942; Zhuang TG, 2004, J REPROD DEVELOP, V50, P207, DOI 10.1262/jrd.50.207	23	18	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8082	10.1371/journal.pone.0008082	http://dx.doi.org/10.1371/journal.pone.0008082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956626	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828100019
J	Kavasery, R; Maru, DSR; Sylla, LN; Smith, D; Altice, FL				Kavasery, Ravi; Maru, Duncan Smith-Rohrberg; Sylla, Laurie N.; Smith, David; Altice, Frederick L.			A Prospective Controlled Trial of Routine Opt-Out HIV Testing in a Men's Jail	PLOS ONE			English	Article								Background: Approximately 10 million Americans enter jails annually. The Centers for Disease Control and Prevention now recommends routine opt-out HIV testing in these settings. The logistics for performing routine opt-out HIV testing within jails, however, remain controversial. The objective of this study was to evaluate the optimal time to routinely HIV test newly incarcerated jail detainees using an opt-out strategy. Methods: This prospective, controlled trial of routine opt-out HIV testing was conducted among 298 newly incarcerated male inmates in an urban men's jail in New Haven, Connecticut. 298 sequential entrants to the men's jail over a three week period in March and April 2008 were assigned to be offered routine opt-out HIV testing at one of three points after incarceration: immediate (same day, n = 103), early (next day, n = 98), or delayed (7 days, n = 97). The primary outcome was the proportion of men in each group consenting to testing. Results: Routine opt-out HIV testing was significantly higher for the early (53%: AOR = 2.6; 95% CI = 1.5 to 4.7) and immediate (45%: AOR = 2.3; 95% CI = 1.3 to 4.0) testing groups compared to the delayed (33%) testing group. The immediate and early testing groups, however, did not significantly differ (p = 0.67). In multivariate analyses, factors significantly associated with routine opt-out HIV testing were assignment to the 'early' testing group (p = 0.0003) and low (bond >= $5,000, immigration or federal charges or pre-sentencing > 30 days) likelihood of early release (p = 0.04). Two subjects received preliminary positive results and one of them was subsequently confirmed HIV seropositive. Conclusions: In this men's jail where attrition was high, routine opt-out HIV testing was not only feasible, but resulted in the highest rates of HIV testing when performed within 24 hours of incarceration.	[Kavasery, Ravi; Maru, Duncan Smith-Rohrberg; Sylla, Laurie N.; Smith, David; Altice, Frederick L.] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA	Yale University	Altice, FL (corresponding author), Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA.	frederick.altice@yale.edu		Maru, Duncan/0000-0002-5923-6910	Infectious Diseases Society of America; Health Services Resources Agency Special Projects of National Significance [H97 HA 08541]; National Institutes on Drug Abuse [K24 DA017072]; National Institutes of Health [GM07205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	Infectious Diseases Society of America; Health Services Resources Agency Special Projects of National Significance; National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this project was provided in part by the Infectious Diseases Society of America and the Health Services Resources Agency Special Projects of National Significance (H97 HA 08541). Career development awards were provided by the National Institutes on Drug Abuse (K24 DA017072, Altice) and National Institutes of Health (GM07205, Maru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MMWR RECOMM REP; Beckwith CG, 2007, AIDS PATIENT CARE ST, V21, P41, DOI 10.1089/apc.2006.006; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2009, HIV TEST IMPL GUID C, P1; Kavasery R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007648; Kendrick SR, 2004, AIDS, V18, P2208, DOI 10.1097/00002030-200411050-00017; MacGowan R, 2009, SEX TRANSM DIS, V36, pS9, DOI 10.1097/OLQ.0b013e318148b6b1; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Sabol W. J., 2007, PRISON JAIL INMATES; SPAULDING AC, 2007, ENHANCING LINKAGES H; Varghese B, 2001, J URBAN HEALTH, V78, P304, DOI 10.1093/jurban/78.2.304	11	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8056	10.1371/journal.pone.0008056	http://dx.doi.org/10.1371/journal.pone.0008056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946371	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827800025
J	Koushik, SV; Blank, PS; Vogel, SS				Koushik, Srinagesh V.; Blank, Paul S.; Vogel, Steven S.			Anomalous Surplus Energy Transfer Observed with Multiple FRET Acceptors	PLOS ONE			English	Article							INTRINSICALLY FLUORESCENT PROTEINS; LIVING CELLS; SPECTROSCOPIC RULER; CRYSTAL-STRUCTURE; LIVE CELLS; ACTIVATION; MATURATION; MICROSCOPY; EFFICIENCY; DYNAMICS	Background: Forster resonance energy transfer (FRET) is a mechanism where energy is transferred from an excited donor fluorophore to adjacent chromophores via non-radiative dipole-dipole interactions. FRET theory primarily considers the interactions of a single donor-acceptor pair. Unfortunately, it is rarely known if only a single acceptor is present in a molecular complex. Thus, the use of FRET as a tool for measuring protein-protein interactions inside living cells requires an understanding of how FRET changes with multiple acceptors. When multiple FRET acceptors are present it is assumed that a quantum of energy is either released from the donor, or transferred in toto to only one of the acceptors present. The rate of energy transfer between the donor and a specific acceptor (k(D -> A)) can be measured in the absence of other acceptors, and these individual FRET transfer rates can be used to predict the ensemble FRET efficiency using a simple kinetic model where the sum of all FRET transfer rates is divided by the sum of all radiative and non-radiative transfer rates. Methodology/Principal Findings: The generality of this approach was tested by measuring the ensemble FRET efficiency in two constructs, each containing a single fluorescent-protein donor (Cerulean) and either two or three FRET acceptors (Venus). FRET transfer rates between individual donor-acceptor pairs within these constructs were calculated from FRET efficiencies measured after systematically introducing point mutations to eliminate all other acceptors. We find that the amount of energy transfer observed in constructs having multiple acceptors is significantly greater than the FRET efficiency predicted from the sum of the individual donor to acceptor transfer rates. Conclusions/Significance: We conclude that either an additional energy transfer pathway exists when multiple acceptors are present, or that a theoretical assumption on which the kinetic model prediction is based is incorrect.	[Koushik, Srinagesh V.; Vogel, Steven S.] NIAAA, NIH, Rockville, MD 20852 USA; [Blank, Paul S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Vogel, SS (corresponding author), NIAAA, NIH, Rockville, MD 20852 USA.	stevevog@mail.nih.gov	Vogel, Steven/A-3585-2012; Blank, Paul/Q-9673-2019	Vogel, Steven/0000-0002-3005-2667	NIH; NIAAA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the intramural research program of the NIH, NIAAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DL, 1999, RESONANCE ENERGY TRA; Becker W, 2005, ADV TIME CORRELATED; Bevington PR., 2002, DATA REDUCTION ERROR; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P846; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Clegg RM, 2009, LAB TECH BIOCHEM MOL, V33, P1, DOI 10.1016/S0075-7535(08)00001-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gadella TWJ, 2009, LAB TECH BIOCHEM MOL, V33, P395, DOI 10.1016/S0075-7535(08)00009-0; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Gilmore J, 2008, J PHYS CHEM A, V112, P2162, DOI 10.1021/jp710243t; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hess ST, 2003, BIOPHYS J, V85, P2566, DOI 10.1016/S0006-3495(03)74679-7; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Koushik SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940367; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lounis B, 2001, J PHYS CHEM B, V105, P5048, DOI 10.1021/jp010116x; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Periasamy A., 2005, MOL IMAGING FRET MIC; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sarkar P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3156842; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Valeur B, 2002, MOL FLUORESCENCE; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Vogel SS, 2009, FLIM MICROSCOPY BIOL, P245; Vogel SS, 2009, LAB TECH BIOCHEM MOL, V33, P351, DOI 10.1016/S0075-7535(08)00008-9; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	43	59	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8031	10.1371/journal.pone.0008031	http://dx.doi.org/10.1371/journal.pone.0008031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946626	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827800019
J	Wu, CJ; Cai, TX; Rikova, K; Merberg, D; Kasif, S; Steffen, M				Wu, Chang-Jiun; Cai, Tianxi; Rikova, Klarisa; Merberg, David; Kasif, Simon; Steffen, Martin			A Predictive Phosphorylation Signature of Lung Cancer	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; MASS-SPECTROMETRY; KINASES; CLASSIFICATION; INHIBITION; VALIDATION; CARCINOMAS; REGRESSION; PROTEOMICS	Background: Aberrant activation of signaling pathways drives many of the fundamental biological processes that accompany tumor initiation and progression. Inappropriate phosphorylation of intermediates in these signaling pathways are a frequently observed molecular lesion that accompanies the undesirable activation or repression of pro- and antioncogenic pathways. Therefore, methods which directly query signaling pathway activation via phosphorylation assays in individual cancer biopsies are expected to provide important insights into the molecular "logic'' that distinguishes cancer and normal tissue on one hand, and enables personalized intervention strategies on the other. Results: We first document the largest available set of tyrosine phosphorylation sites that are, individually, differentially phosphorylated in lung cancer, thus providing an immediate set of drug targets. Next, we develop a novel computational methodology to identify pathways whose phosphorylation activity is strongly correlated with the lung cancer phenotype. Finally, we demonstrate the feasibility of classifying lung cancers based on multi-variate phosphorylation signatures. Conclusions: Highly predictive and biologically transparent phosphorylation signatures of lung cancer provide evidence for the existence of a robust set of phosphorylation mechanisms (captured by the signatures) present in the majority of lung cancers, and that reliably distinguish each lung cancer from normal. This approach should improve our understanding of cancer and help guide its treatment, since the phosphorylation signatures highlight proteins and pathways whose phosphorylation should be inhibited in order to prevent unregulated proliferation.	[Wu, Chang-Jiun; Kasif, Simon; Steffen, Martin] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Rikova, Klarisa] Cell Signaling Technol, Danvers, MA USA; [Merberg, David] Vertex Pharmaceut, Cambridge, MA USA; [Kasif, Simon] Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Kasif, Simon] Boston Univ, Ctr Adv Genom Technol, Boston, MA 02215 USA; [Steffen, Martin] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Vertex Pharmaceuticals; Harvard University; Boston Children's Hospital; Boston University; Boston University	Steffen, M (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	steffen@bu.edu		Steffen, Martin/0000-0002-7853-7364	National Human Genome Research Institute [R01 HG003367-01A1]; American Lung Association [RG-52430-N]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Lung Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by a grant from the National Human Genome Research Institute (R01 HG003367-01A1 to S. K.), and the American Lung Association (RG-52430-N to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Goeman JJ, 2008, STAT APPL GENET MOL, V7; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; Huang SM, 1999, CANCER RES, V59, P1935; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KOPANTZEV EP, 2008, LUNG CANC; KREBS EG, 1993, BIOSCIENCE REP, V13, P127, DOI 10.1007/BF01149958; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MANNING BD, 2002, SCI STKE, pPE49; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Petrelli A, 2008, CURR MED CHEM, V15, P422; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sawyers CL, 2007, NATURE, V449, P993, DOI 10.1038/449993a; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stang A, 2006, LUNG CANCER, V52, P29, DOI 10.1016/j.lungcan.2005.11.012; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Triano EA, 2003, CANCER RES, V63, P3092; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777	45	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7994	10.1371/journal.pone.0007994	http://dx.doi.org/10.1371/journal.pone.0007994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946374	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827800009
J	Dessing, MC; Hirst, RA; de Vos, AF; van der Poll, T				Dessing, Mark C.; Hirst, Robert A.; de Vos, Alex F.; van der Poll, Tom			Role of Toll-Like Receptors 2 and 4 in Pulmonary Inflammation and Injury Induced by Pneumolysin in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE PNEUMOLYSIN; INDUCED LUNG INFLAMMATION; LIPOTEICHOIC ACID LTA; CELL-WALL; LIPOPOLYSACCHARIDE; INDUCTION; VIRULENCE; RECOGNITION; PROTEIN; MD-2	Background: Pneumolysin (PLN) is an intracellular toxin of Streptococcus pneumoniae that has been implicated as a major virulence factor in infections caused by this pathogen. Conserved bacterial motifs are recognized by the immune system by pattern recognition receptors among which the family of Toll-like receptors (TLRs) prominently features. The primary objective of the present study was to determine the role of TLR2 and TLR4 in lung inflammation induced by intrapulmonary delivery of PLN. Methodology/Results: First, we confirmed that purified PLN activates cells via TLR4 (not via TLR2) in vitro, using human embryonic kidney cells transfected with either TLR2 or TLR4. Intranasal administration of PLN induced an inflammatory response in the pulmonary compartment of mice in vivo, as reflected by influx of neutrophils, release of proinflammatory cytokines and chemokines, and a rise in total protein concentrations in bronchoalveolar lavage fluid. These PLN-induced responses were dependent in part, not only on TLR4, but also on TLR2, as indicated by studies using TLR deficient mice. Conclusion: These data suggest that although purified PLN is recognized by TLR4 in vitro, PLN elicits lung inflammation in vivo by mechanisms that may involve multiple TLRs.	[Dessing, Mark C.; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [Dessing, Mark C.; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Hirst, Robert A.] Univ Leicester, Dept Infect Inflammat & Immun, Leicester, Leics, England	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Leicester	Dessing, MC (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands.	m.c.dessing@amc.uva.nl	Hirst, Robert/AAD-1649-2022	Hirst, Robert Anthony/0000-0003-1989-1790	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	Mark Dessing was supported by an institutional research grant from the Academic Medical Center, Amsterdam, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; Benton KA, 1997, INFECT IMMUN, V65, P1237, DOI 10.1128/IAI.65.4.1237-1244.1997; Bernatoniene J, 2008, J INFECT DIS, V198, P1823, DOI 10.1086/593177; Bernstein JM, 1999, CHEST, V115, p9S, DOI 10.1378/chest.115.suppl_1.9S; BERRY AM, 1992, MICROB PATHOGENESIS, V12, P87, DOI 10.1016/0882-4010(92)90111-Z; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Campbell GD, 1999, CHEST, V115, p14S, DOI 10.1378/chest.115.suppl_1.14S; Cockeran R, 2002, J INFECT DIS, V186, P562, DOI 10.1086/341563; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Ellingsen EA, 2002, MED SCI MONITOR, V8, pBR149; FELDMAN C, 1990, MICROB PATHOGENESIS, V9, P275, DOI 10.1016/0882-4010(90)90016-J; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; HOULDSWORTH S, 1994, INFECT IMMUN, V62, P1501, DOI 10.1128/IAI.62.4.1501-1503.1994; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; JOHNSON MK, 1977, FEMS MICROBIOL LETT, V2, P243; KANCLERSKI K, 1987, J CLIN MICROBIOL, V25, P222, DOI 10.1128/JCM.25.2.222-225.1987; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Maus UA, 2004, J IMMUNOL, V173, P1307, DOI 10.4049/jimmunol.173.2.1307; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; MITCHELL TJ, 1989, BIOCHIM BIOPHYS ACTA, V1007, P67, DOI 10.1016/0167-4781(89)90131-0; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PATON JC, 1983, INFECT IMMUN, V41, P1212, DOI 10.1128/IAI.41.3.1212-1216.1983; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Rijneveld AW, 2002, J INFECT DIS, V185, P123, DOI 10.1086/338008; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9	46	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7993	10.1371/journal.pone.0007993	http://dx.doi.org/10.1371/journal.pone.0007993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956717	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500022
J	Stauber, M; Sachidanandan, C; Morgenstern, C; Ish-Horowicz, D				Stauber, Michael; Sachidanandan, Chetana; Morgenstern, Christina; Ish-Horowicz, David			Differential Axial Requirements for Lunatic Fringe and Hes7 Transcription during Mouse Somitogenesis	PLOS ONE			English	Article							SOMITE SEGMENTATION CLOCK; CENTRAL-NERVOUS-SYSTEM; PRESOMITIC MESODERM; DYNAMIC EXPRESSION; NOTCH PATHWAY; ZEBRAFISH SOMITOGENESIS; OSCILLATOR MECHANISM; PARAXIAL MESODERM; DEFICIENT MICE; GENE	Vertebrate segmentation is regulated by the "segmentation clock'', which drives cyclic expression of several genes in the caudal presomitic mesoderm (PSM). One such gene is Lunatic fringe (Lfng), which encodes a modifier of Notch signalling, and which is also expressed in a stripe at the cranial end of the PSM, adjacent to the newly forming somite border. We have investigated the functional requirements for these modes of Lfng expression during somitogenesis by generating mice in which Lfng is expressed in the cranial stripe but strongly reduced in the caudal PSM, and find that requirements for Lfng activity alter during axial growth. Formation of cervical, thoracic and lumbar somites/vertebrae, but not sacral and adjacent tail somites/vertebrae, depends on caudal, cyclic Lfng expression. Indeed, the sacral region segments normally in the complete absence of Lfng and shows a reduced requirement for another oscillating gene, Hes7, indicating that the architecture of the clock alters as segmentation progresses. We present evidence that Lfng controls dorsal-ventral axis specification in the tail, and also suggest that Lfng controls the expression or activity of a long-range signal that regulates axial extension.	[Stauber, Michael; Sachidanandan, Chetana; Morgenstern, Christina; Ish-Horowicz, David] London Res Inst, Canc Res UK, Lab Dev Genet, London, England	Cancer Research UK	Stauber, M (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany.	david.horowicz@cancer.org.uk		Morgenstern, Christina/0000-0003-2943-9634; Ish-Horowicz, David/0000-0001-5684-7129	Cancer Research UK; Max Planck Society	Cancer Research UK(Cancer Research UK); Max Planck Society(Max Planck Society)	This research was funded by Cancer Research UK, and an Otto Hahn Medal fellowship of the Max Planck Society (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Blair SS, 2000, CURR BIOL, V10, pR608, DOI 10.1016/S0960-9822(00)00633-3; Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen J, 2005, GENESIS, V43, P196, DOI 10.1002/gene.20171; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Elmasri H, 2004, GENE EXPR PATTERNS, V4, P553, DOI 10.1016/j.modgep.2004.02.003; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gossler A., 2002, MOUSE DEV, P127; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Holley SA, 2002, DEVELOPMENT, V129, P1175; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; Kaufman MH, 1994, ATLAS MOUSE DEV; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Leve C, 2001, DEV GENES EVOL, V211, P493, DOI 10.1007/s00427-001-0181-4; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; OKA C, 1995, DEVELOPMENT, V121, P3291; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Prince VE, 2001, MECH DEVELOP, V105, P175, DOI 10.1016/S0925-4773(01)00398-7; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Sato Y, 2002, DEVELOPMENT, V129, P3633; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wilson V, 1996, MECH DEVELOP, V55, P79, DOI 10.1016/0925-4773(95)00493-9; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	74	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7996	10.1371/journal.pone.0007996	http://dx.doi.org/10.1371/journal.pone.0007996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956724	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827500023
J	Kingsley, C; Peters, B; Babaahmady, K; Pomeroy, L; Rahman, D; Vaughan, R; Lehner, T				Kingsley, Cherry; Peters, Barry; Babaahmady, Kaboutar; Pomeroy, Laura; Rahman, Durdana; Vaughan, Robert; Lehner, Thomas			Heterosexual and Homosexual Partners Practising Unprotected Sex May Develop Allogeneic Immunity and to a Lesser Extent Tolerance	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; MUCOSAL ALLOIMMUNIZATION; HIV-1; TRANSMISSION; RESPONSES; DISEASE; SURFACE; TYPE-1	Background: Epidemiological studies suggest that allogeneic immunity may inhibit HIV-1 transmission from mother to baby and is less frequent in multiparous than uniparous women. Alloimmune responses may also be elicited during unprotected heterosexual intercourse, which is associated ex vivo with resistance to HIV infection. Methodology/Principal Findings: The investigation was carried out in well-defined heterosexual and homosexual monogamous partners, practising unprotected sex and a heterosexual cohort practising protected sex. Allogeneic CD4(+) and CD8(+) T cell proliferative responses were elicited by stimulating PBMC with the partners' irradiated monocytes and compared with 3(rd) party unrelated monocytes, using the CFSE method. Significant increase in allogeneic proliferative responses was found in the CD4(+) and CD8(+) T cells to the partners' irradiated monocytes, as compared with 3(rd) party unrelated monocytes (p <= 0.001). However, a significant decrease in proliferative responses, especially of CD8(+) T cells to the partners' compared with 3(rd) party monocytes was consistent with tolerization, in both the heterosexual and homosexual partners (p<0.01). Examination of CD4(+)CD25(+)FoxP3(+) regulatory T cells by flow cytometry revealed a significantly greater proportion of these cells in the homosexual than heterosexual partners practising unprotected sex (p<0.05). Ex vivo studies of infectivity of PBMC with HIV-1 showed significantly greater inhibition of infectivity of PBMC from heterosexual subjects practising unprotected compared with those practising protected sex (p = 0.02). Conclusions/Significance: Both heterosexual and homosexual monogamous partners practising unprotected sex develop allogeneic CD4(+) and CD8(+) T cell proliferative responses to the partners' unmatched cells and a minority may be tolerized. However, a greater proportion of homosexual rather than heterosexual partners developed CD4(+)CD25FoxP3(+) regulatory T cells. These results, in addition to finding greater inhibition of HIV-1 infectivity in PBMC ex vivo in heterosexual partners practising unprotected, compared with those practising protected sex, suggest that allogeneic immunity may play a significant role in the immuno-pathogenesis of HIV-1 infection.	[Kingsley, Cherry; Babaahmady, Kaboutar; Rahman, Durdana; Lehner, Thomas] Guys Hosp, Kings Coll London, Mucosal Immunol Unit, London SE1 9RT, England; [Peters, Barry; Pomeroy, Laura] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Vaughan, Robert] Guys Hosp, Kings Coll London, Dept Tissue Typing, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kingsley, C (corresponding author), Guys Hosp, Kings Coll London, Mucosal Immunol Unit, London SE1 9RT, England.	thomas.lehner@kcl.ac.uk			St. Thomas' Charitable Foundation; European Union Europrise [LSHP-CT-2006-037611]	St. Thomas' Charitable Foundation; European Union Europrise	This project was supported by the Guy's and St. Thomas' Charitable Foundation and the European Union Europrise (LSHP-CT-2006-037611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Bergmeier LA, 2005, J GEN VIROL, V86, P2231, DOI 10.1099/vir.0.80802-0; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Jeffrey PL, 2009, EUR J IMMUNOL, V39, P1956, DOI 10.1002/eji.200939228; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/s004310050339; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; Kristiansen TB, 2001, J IMMUNOL METHODS, V252, P147, DOI 10.1016/S0022-1759(01)00349-0; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Steger U, 2006, TRANSPLANTATION, V82, P1202, DOI 10.1097/01.tp.0000235913.58337.b4; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7938	10.1371/journal.pone.0007938	http://dx.doi.org/10.1371/journal.pone.0007938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956755	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827300003
J	Santagata, S; Maire, CL; Idbaih, A; Geffers, L; Correll, M; Holton, K; Quackenbush, J; Ligon, KL				Santagata, Sandro; Maire, Cecile L.; Idbaih, Ahmed; Geffers, Lars; Correll, Mick; Holton, Kristina; Quackenbush, John; Ligon, Keith L.			CRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LEBER CONGENITAL AMAUROSIS; GENE-EXPRESSION PATTERNS; TRANSCRIPTION FACTOR CRX; CONE-ROD DYSTROPHY; GERM-CELL TUMORS; S-ANTIGEN; TRILATERAL RETINOBLASTOMA; PARENCHYMAL TUMORS; HOMEOBOX GENE	Background: CRX is a homeobox transcription factor whose expression and function is critical to maintain retinal and pineal lineage cells and their progenitors. To determine the biologic and diagnostic potential of CRX in human tumors of the retina and pineal, we examined its expression in multiple settings. Methodology/Principal Findings: Using situ hybridization and immunohistochemistry we show that Crx RNA and protein expression are exquisitely lineage restricted to retinal and pineal cells during normal mouse and human development. Gene expression profiling analysis of a wide range of human cancers and cancer cell lines also supports that CRX RNA is highly lineage restricted in cancer. Immunohistochemical analysis of 22 retinoblastomas and 13 pineal parenchymal tumors demonstrated strong expression of CRX in over 95% of these tumors. Importantly, CRX was not detected in the majority of tumors considered in the differential diagnosis of pineal region tumors (n = 78). The notable exception was medulloblastoma, 40% of which exhibited CRX expression in a heterogeneous pattern readily distinguished from that seen in retino-pineal tumors. Conclusions/Significance: These findings describe new potential roles for CRX in human cancers and highlight the general utility of lineage restricted transcription factors in cancer biology. They also identify CRX as a sensitive and specific clinical marker and a potential lineage dependent therapeutic target in retinoblastoma and pineoblastoma.			Santagata, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu	; Idbaih, Ahmed/N-8746-2017	Ligon, Keith/0000-0002-7733-600X; Geffers, Lars/0000-0001-6800-4305; Idbaih, Ahmed/0000-0001-5290-1204; Quackenbush, John/0000-0002-2702-5879; Santagata, Sandro/0000-0002-7528-9668	NINDS NIH HHS [NS047213, K08 NS064168, K08 NS047213, NS064168] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047213, K08NS064168] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amoaku WMK, 1996, CANCER, V78, P858, DOI 10.1002/(SICI)1097-0142(19960815)78:4<858::AID-CNCR24>3.0.CO;2-T; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CZERWIONKA M, 1989, ACTA NEUROPATHOL, V78, P629, DOI 10.1007/BF00691290; De Girolami U, 2008, REV NEUROL-FRANCE, V164, P882, DOI 10.1016/j.neurol.2008.01.008; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; DEPOTTER P, 1994, J PEDIATR OPHTHALMOL, V31, P26; Eberhart CG, 2004, J NEUROPATH EXP NEUR, V63, P441, DOI 10.1093/jnen/63.5.441; Fevre-Montange M, 2006, J NEUROPATH EXP NEUR, V65, P675, DOI 10.1097/01.jnen.0000225907.90052.e3; Folpe AL, 2002, ADV ANAT PATHOL, V9, P198, DOI 10.1097/00125480-200205000-00003; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Garraway LA, 2006, CANCER RES, V66, P2506, DOI 10.1158/0008-5472.CAN-05-4604; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilheeney SW, 2008, J NEURO-ONCOL, V89, P89, DOI 10.1007/s11060-008-9589-2; Glasker S, 2006, CANCER RES, V66, P4167, DOI 10.1158/0008-5472.CAN-05-3505; GONZALEZFERNANDEZ F, 1992, AM J PATHOL, V141, P363; Gulino A, 2008, CURR OPIN ONCOL, V20, P668, DOI 10.1097/CCO.0b013e32831369f4; HASSOUN J, 1983, ACTA NEUROPATHOL, V62, P31, DOI 10.1007/BF00684917; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; HERRICK MK, 1979, BRAIN, V102, P289, DOI 10.1093/brain/102.2.289; Hirato J, 2001, J NEURO-ONCOL, V54, P239, DOI 10.1023/A:1012721723387; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; IRONSIDE JW, 2001, DIAGNOSTIC PATHOLOGY, P253; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; JAFFEY PB, 1995, J NEUROPATH EXP NEUR, V54, P664, DOI 10.1097/00005072-199509000-00008; Jouvet A, 2000, BRAIN PATHOL, V10, P49; JOUVET A, 1994, ACTA NEUROPATHOL, V88, P334; Kivela T, 1999, J CLIN ONCOL, V17, P1829, DOI 10.1200/JCO.1999.17.6.1829; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; KORF HW, 1986, ACTA NEUROPATHOL, V69, P165, DOI 10.1007/BF00687054; Li MK, 2004, ADV ANAT PATHOL, V11, P101, DOI 10.1097/00125480-200403000-00004; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LOPES MBS, 1993, J NEUROPATH EXP NEUR, V52, P516; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MARAZIOTIS T, 1992, ACTA NEUROPATHOL, V84, P355; MENA H, 1995, HUM PATHOL, V26, P20, DOI 10.1016/0046-8177(95)90110-8; MIN KW, 1987, LAB INVEST, V57, P724; Ngan KW, 2008, J CLIN NEUROSCI, V15, P149, DOI 10.1016/j.jocn.2006.08.013; NIELSEN SL, 1975, J NEUROPATH EXP NEUR, V34, P148, DOI 10.1097/00005072-197503000-00003; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Parwani AV, 2005, CANCER CYTOPATHOL, V105, P80, DOI 10.1002/cncr.20849; PERENTES E, 1986, ACTA NEUROPATHOL, V71, P224, DOI 10.1007/BF00688043; Ponzoni M, 2007, ADV ANAT PATHOL, V14, P25, DOI 10.1097/PAP.0b013e31802f0495; Rath MF, 2007, EXP EYE RES, V85, P65, DOI 10.1016/j.exer.2007.02.016; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romeo S, 2006, J PATHOL, V209, P143, DOI 10.1002/path.1987; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Santagata S, 2006, AM J SURG PATHOL, V30, P1613, DOI 10.1097/01.pas.0000213320.04919.1a; Sawai J, 2003, NEUROPATHOLOGY, V23, P119, DOI 10.1046/j.1440-1789.2003.00488.x; Schegloff EA, 1999, THEOR CULT SOC, V16, P1; Scheithauer BW, 2008, BRAIN PATHOL, V18, P307, DOI 10.1111/j.1750-3639.2008.00179.x; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; VANVEEN T, 1986, P NATL ACAD SCI USA, V83, P912; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vogel Hannes, 2003, Ann Diagn Pathol, V7, P387, DOI 10.1016/j.anndiagpath.2003.09.007; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441	67	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7932	10.1371/journal.pone.0007932	http://dx.doi.org/10.1371/journal.pone.0007932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936203	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004800013
J	Au, C; Benedetto, A; Anderson, J; Labrousse, A; Erikson, K; Ewbank, JJ; Aschner, M				Au, Catherine; Benedetto, Alexandre; Anderson, Joel; Labrousse, Arnaud; Erikson, Keith; Ewbank, Jonathan J.; Aschner, Michael			SMF-1, SMF-2 and SMF-3 DMT1 Orthologues Regulate and Are Regulated Differentially by Manganese Levels in C. elegans	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BLOOD-BRAIN-BARRIER; MICROCYTIC ANEMIA; METAL TRANSPORTER; IRON TRANSPORT; APICAL SECRETION; PROTEIN; NRAMP2; MEMBRANE; FAMILY	Manganese (Mn) is an essential metal that can exert toxic effects at high concentrations, eventually leading to Parkinsonism. A major transporter of Mn in mammals is the divalent-metal transporter (DMT1). We characterize here DMT1-like proteins in the nematode C. elegans, which regulate and are regulated by Mn and iron (Fe) content. We identified three new DMT1-like genes in C. elegans: smf-1, smf-2 and smf-3. All three can functionally substitute for loss of their yeast orthologues in S. cerevisiae. In the worm, deletion of smf-1 or smf-3 led to an increased Mn tolerance, while loss of smf-2 led to increased Mn sensitivity. smf mRNA levels measured by QRT-PCR were up-regulated upon low Mn and down-regulated upon high Mn exposures. Translational GFP-fusions revealed that SMF-1 and SMF-3 strongly localize to partially overlapping apical regions of the gut epithelium, suggesting a differential role for SMF-1 and SMF-3 in Mn nutritional intake. Conversely, SMF-2 was detected in the marginal pharyngeal epithelium, possibly involved in metal-sensing. Analysis of metal content upon Mn exposure in smf mutants revealed that SMF-3 is required for normal Mn uptake, while smf-1 was dispensable. Higher smf-2 mRNA levels correlated with higher Fe content, supporting a role for SMF-2 in Fe uptake. In smf-1 and smf-3 but not in smf-2 mutants, increased Mn exposure led to decreased Fe levels, suggesting that both metals compete for transport by SMF-2. Finally, SMF-3 was post-translationally and reversibly down-regulated following Mn-exposure. In sum, we unraveled a complex interplay of transcriptional and post-translational regulations of 3 DMT1-like transporters in two adjacent tissues, which regulate metal-content in C. elegans.			Au, C (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37203 USA.	michael.aschner@vanderbilt.edu	Ewbank, Jonathan J/G-4948-2010; Benedetto, Alexandre/W-5930-2019; Benedetto, Alexandre/A-5766-2014	Ewbank, Jonathan J/0000-0002-1257-6862; Benedetto, Alexandre/0000-0002-4593-2114; Benedetto, Alexandre/0000-0002-4593-2114; Anderson, Joel/0000-0002-6216-4014; Au, Catherine/0000-0002-1923-9121; Labrousse, Arnaud/0000-0002-6525-6627	NIEHS NIH HHS [R01 ES010563, R01 ES10563] Funding Source: Medline; NINDS NIH HHS [R15 NS] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6; Aschner M, 2002, NEUROTOXICOLOGY, V23, P123, DOI 10.1016/S0161-813X(01)00097-3; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Aschner M, 2000, ENVIRON HEALTH PERSP, V108, P429, DOI 10.2307/3454532; ASCHNER M, 1991, NEUROSCI BIOBEHAV R, V15, P333, DOI 10.1016/S0149-7634(05)80026-0; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; BANSAL SK, 1985, ECOTOX ENVIRON SAFE, V9, P373, DOI 10.1016/0147-6513(85)90055-7; Beaumont C, 2006, BLOOD, V107, P4168, DOI 10.1182/blood-2005-10-4269; BRENNER S, 1974, GENETICS, V77, P71; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Canonne-Hergaux FS, 2002, KIDNEY INT, V62, P147, DOI 10.1046/j.1523-1755.2002.00405.x; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200; Courville P, 2006, BIOCHEM CELL BIOL, V84, P960, DOI 10.1139/O06-193; Dorman DC, 2004, INHAL TOXICOL, V16, P481, DOI 10.1080/08958370490439687; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Fitsanakis VA, 2005, TOXICOL APPL PHARM, V204, P343, DOI 10.1016/j.taap.2004.11.013; Fleming MD, 1998, J LAB CLIN MED, V132, P464, DOI 10.1016/S0022-2143(98)90123-8; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guven K, 1998, TOXICOL LETT, V99, P91, DOI 10.1016/S0378-4274(98)00128-3; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang WH, 2004, J TOXICOL-CLIN TOXIC, V42, P305, DOI 10.1081/CLT-120037433; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Knopfel M, 2005, BIOCHEMISTRY-US, V44, P3454, DOI 10.1021/bi048768; Lam-Yuk-Tseung S, 2005, BLOOD CELL MOL DIS, V35, P212, DOI 10.1016/j.bcmd.2005.05.008; Lam-Yuk-Tseung S, 2006, BLOOD CELL MOL DIS, V36, P347, DOI 10.1016/j.bcmd.2006.01.011; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Liao SL, 2001, NEUROREPORT, V12, P3877, DOI 10.1097/00001756-200112210-00004; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lin YT, 2006, FREE RADICAL BIO MED, V40, P1185, DOI 10.1016/j.freeradbiomed.2005.11.007; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Malecki EA, 1999, J NEUROSCI RES, V56, P113; Mango Susan E, 2007, WormBook, P1; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mims MP, 2005, HEMATOLOGY, V10, P339, DOI 10.1080/10245330500093419; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; MURPHY VA, 1991, J NEUROCHEM, V57, P948, DOI 10.1111/j.1471-4159.1991.tb08242.x; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Pfeifer GD, 2004, SCI TOTAL ENVIRON, V334, P397, DOI 10.1016/j.scitotenv.2004.04.043; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; Ponnapakkam T, 2003, INT J TOXICOL, V22, P227, DOI 10.1080/10915810305103; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Priwitzerova M, 2005, BLOOD, V106, P3985, DOI 10.1182/blood-2005-04-1550; PROHASKA JR, 1987, PHYSIOL REV, V67, P858, DOI 10.1152/physrev.1987.67.3.858; RABIN O, 1993, J NEUROCHEM, V61, P509; Ressler T, 1999, J SYNCHROTRON RADIAT, V6, P656, DOI 10.1107/S0909049598015623; Rollin H, 2005, ENVIRON RES, V97, P93, DOI 10.1016/j.envres.2004.05.003; Roth JA, 2002, J NEUROSCI RES, V68, P76, DOI 10.1002/jnr.10207; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; SARIC M, 1986, AM J IND MED, V9, P217, DOI 10.1002/ajim.4700090303; Searle S, 1998, J CELL SCI, V111, P2855; STEINBERG SF, 1986, J PHARMACOL EXP THER, V237, P764; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Techau ME, 2007, J BIOL CHEM, V282, P35646, DOI 10.1074/jbc.M707057200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; WEDLER FC, 1984, CURR TOP CELL REGUL, V24, P153; ZHANG SZ, 2008, NEUROBIOL AGING	92	65	74	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7792	10.1371/journal.pone.0007792	http://dx.doi.org/10.1371/journal.pone.0007792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924247	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700003
J	Bai, B; Song, WG; Ji, YW; Liu, X; Tian, L; Wang, C; Chen, DW; Zhang, XN; Zhang, MH				Bai, Bo; Song, Wengang; Ji, Yewei; Liu, Xi; Tian, Lei; Wang, Chao; Chen, Dongwei; Zhang, Xiaoning; Zhang, Minghui			Microglia and Microglia-Like Cell Differentiated from DC Inhibit CD4 T Cell Proliferation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REGULATORY DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; SPLEEN MACROPHAGES DIFFERENTIATE; MULTIPLE-SCLEROSIS; BLOOD MONOCYTES; ASTROCYTES; BRAIN; CNS; MICROENVIRONMENT	The central nervous system (CNS) is generally regarded as a site of immune privilege, whether the antigen presenting cells (APCs) are involved in the immune homeostasis of the CNS is largely unknown. Microglia and DCs are major APCs in physiological and pathological conditions, respectively. In this work, primary microglia and microglia-like cells obtained by co-culturing mature dendritic cells with CNS endothelial cells in vitro were functional evaluated. We found that microglia not only cannot prime CD4 T cells but also inhibit mature DCs (maDCs) initiated CD4 T cells proliferation. More importantly, endothelia from the CNS can differentiate maDCs into microglia-like cells (MLCs), which possess similar phenotype and immune inhibitory function as microglia. Soluble factors including NO lie behind the suppression of CD4 T cell proliferation induced by both microglia and MLCs. All the data indicate that under physiological conditions, microglia play important roles in maintaining immune homeostasis of the CNS, whereas in a pathological situation, the infiltrated DCs can be educated by the local microenvironment and differentiate into MLCs with inhibitory function.			Bai, B (corresponding author), Taishan Med Coll, Dept Neurobiol, Tai An, Shandong, Peoples R China.	drugman@tsinghua.edu.cn; mh-zhang@tsinghua.edu.cn	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812				Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372; Li GL, 2007, BLOOD, V110, P2872, DOI 10.1182/blood-2006-10-050583; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Perry VH, 1998, J NEUROIMMUNOL, V90, P113; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; SCHMIDTMAYER J, 1994, GLIA, V12, P259, DOI 10.1002/glia.440120403; SIEVERS J, 1994, GLIA, V12, P245, DOI 10.1002/glia.440120402; Smits HH, 2005, TRENDS IMMUNOL, V26, P123, DOI 10.1016/j.it.2005.01.002; Sozzani S, 2007, TRENDS IMMUNOL, V28, P385, DOI 10.1016/j.it.2007.07.006; Strauss L, 2005, MED SCI MONITOR, V11, pBR280; Suter T, 2003, EUR J IMMUNOL, V33, P2998, DOI 10.1002/eji.200323611; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Wilms H, 1997, CELL TISSUE RES, V287, P447, DOI 10.1007/s004410050769; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; ZIPORI D, 1985, BLOOD, V66, P447	29	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7869	10.1371/journal.pone.0007869	http://dx.doi.org/10.1371/journal.pone.0007869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924241	gold, Green Published, Green Submitted			2022-12-27	WOS:000271854200016
J	Armer, HEJ; Mariggi, G; Png, KMY; Genoud, C; Monteith, AG; Bushby, AJ; Gerhardt, H; Collinson, LM				Armer, Hannah E. J.; Mariggi, Giovanni; Png, Ken M. Y.; Genoud, Christel; Monteith, Alexander G.; Bushby, Andrew J.; Gerhardt, Holger; Collinson, Lucy M.			Imaging Transient Blood Vessel Fusion Events in Zebrafish by Correlative Volume Electron Microscopy	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; RECONSTRUCTION	The study of biological processes has become increasingly reliant on obtaining high-resolution spatial and temporal data through imaging techniques. As researchers demand molecular resolution of cellular events in the context of whole organisms, correlation of non-invasive live-organism imaging with electron microscopy in complex three-dimensional samples becomes critical. The developing blood vessels of vertebrates form a highly complex network which cannot be imaged at high resolution using traditional methods. Here we show that the point of fusion between growing blood vessels of transgenic zebrafish, identified in live confocal microscopy, can subsequently be traced through the structure of the organism using Focused Ion Beam/Scanning Electron Microscopy (FIB/SEM) and Serial Block Face/Scanning Electron Microscopy (SBF/SEM). The resulting data give unprecedented microanatomical detail of the zebrafish and, for the first time, allow visualization of the ultrastructure of a time-limited biological event within the context of a whole organism.			Armer, HEJ (corresponding author), Canc Res UK, London Res Inst, Electron Microscopy Unit, London, England.	lucy.collinson@cancer.org.uk	Gerhardt, Holger/G-4610-2011; Bushby, Andy/AAJ-8342-2020; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Gerhardt, Holger/0000-0001-9228-7472; genoud, christel/0000-0002-0933-9911; Monteith, Alexander George/0000-0003-1731-0446	Engineering and Physical Sciences Research Council [EP/F019882/1] Funding Source: researchfish; EPSRC [EP/F019882/1] Funding Source: UKRI; Cancer Research UK Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)		Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Drobne D, 2007, MICROSC RES TECHNIQ, V70, P895, DOI 10.1002/jemt.20494; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lebbink MN, 2007, J STRUCT BIOL, V158, P327, DOI 10.1016/j.jsb.2006.12.001; Lebbink MN, 2009, J STRUCT BIOL, V166, P156, DOI 10.1016/j.jsb.2009.01.006; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; Prenitzer BI, 2003, MICROSC MICROANAL, V9, P216, DOI [10.1017/S1431927603030034, 10.1017/S143192760030034]; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; White JG, 1986, PHILOS T R SOC LON B, P1, DOI [10.1098/rstb.1986.0056, DOI 10.1098/RSTB.1986.0056]	19	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7716	10.1371/journal.pone.0007716	http://dx.doi.org/10.1371/journal.pone.0007716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893745	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000271478000007
J	Gotzek, D; Ross, KG				Gotzek, Dietrich; Ross, Kenneth G.			Current Status of a Model System: The Gene Gp-9 and Its Association with Social Organization in Fire Ants	PLOS ONE			English	Article							SOLENOPSIS-INVICTA HYMENOPTERA; ODORANT-BINDING PROTEIN; EXPERIMENTAL CONVERSION; PHEROMONE; EVOLUTION; COLONIES; WORKER; POPULATION; FORMICIDAE; INSECT	The Gp-9 gene in fire ants represents an important model system for studying the evolution of social organization in insects as well as a rich source of information relevant to other major evolutionary topics. An important feature of this system is that polymorphism in social organization is completely associated with allelic variation at Gp-9, such that single-queen colonies (monogyne form) include only inhabitants bearing B-like alleles while multiple-queen colonies (polygyne form) additionally include inhabitants bearing b-like alleles. A recent study of this system by Leal and Ishida ( 2008) made two major claims, the validity and significance of which we examine here. After reviewing existing literature, analyzing the methods and results of Leal and Ishida ( 2008), and generating new data from one of their study sites, we conclude that their claim that polygyny can occur in Solenopsis invicta in the U. S. A. in the absence of expression of the b-like allele Gp-9 b is unfounded. Moreover, we argue that available information on insect OBPs ( the family of proteins to which GP-9 belongs), on the evolutionary/population genetics of Gp-9, and on pheromonal/behavioral control of fire ant colony queen number fails to support their view that GP-9 plays no role in the chemosensory-mediated communication that underpins regulation of social organization. Our analyses lead us to conclude that there are no new reasons to question the existing consensus view of the Gp-9 system outlined in Gotzek and Ross ( 2007).			Gotzek, D (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	GotzekD@si.edu						Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Caldera EJ, 2008, BIOL INVASIONS, V10, P1457, DOI 10.1007/s10530-008-9219-0; Cassill D, 2003, BEHAV ECOL SOCIOBIOL, V54, P441, DOI 10.1007/s00265-003-0639-7; Crozier RH, 2002, NAT GENET, V30, P4, DOI 10.1038/ng0102-4; DeHeer CJ, 1999, AM NAT, V153, P660, DOI 10.1086/303205; Fletcher D.J.C., 1986, Advances in Invertebrate Reproduction, V4, P305; FLETCHER DJC, 1981, SCIENCE, V212, P73, DOI 10.1126/science.212.4490.73; FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; FLETCHER DJC, 1980, ANN ENTOMOL SOC AM, V73, P658, DOI 10.1093/aesa/73.6.658; FLETCHER DJC, 1983, J COMP PHYSIOL, V153, P467, DOI 10.1007/BF00612601; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Fritz GN, 2006, GENETICS, V173, P207, DOI 10.1534/genetics.106.056358; GADAU J, 2009, ORG INSECT SOC GENOM; GLANCEY B M, 1973, Journal of the Georgia Entomological Society, V8, P237; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Goodisman MAD, 2000, J INSECT BEHAV, V13, P455, DOI 10.1023/A:1007770404496; Goodisman MAD, 1999, ANN ENTOMOL SOC AM, V92, P563, DOI 10.1093/aesa/92.4.563; Goodisman MAD, 2000, EVOLUTION, V54, P606, DOI 10.1111/j.0014-3820.2000.tb00062.x; Goodisman MAD, 2007, BIOL INVASIONS, V9, P571, DOI 10.1007/s10530-006-9059-8; Gotzek D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001088; Gotzek D, 2008, J INSECT BEHAV, V21, P337, DOI 10.1007/s10905-008-9130-7; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; GREENBERG L, 1985, J KANSAS ENTOMOL SOC, V58, P9; Hallar BL, 2007, GENETICA, V131, P69, DOI 10.1007/s10709-006-9114-5; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 1999, J EVOLUTION BIOL, V12, P672, DOI 10.1046/j.1420-9101.1999.00064.x; Keller L, 2002, CURR BIOL, V12, pR180, DOI 10.1016/S0960-9822(02)00737-6; King JR, 2009, BIOL INVASIONS, V11, P373, DOI 10.1007/s10530-008-9254-x; Krieger MJB, 1999, HEREDITY, V82, P142, DOI 10.1038/sj.hdy.6884600; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Krieger MJB, 2005, BIOESSAYS, V27, P91, DOI 10.1002/bies.20129; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003762; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Lescop E, 2009, BIOCHEMISTRY-US, V48, P2431, DOI 10.1021/bi802300k; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Liu NN, 2004, GENE, V327, P81, DOI 10.1016/j.gene.2003.11.002; Mescher MC, 2003, ANN ENTOMOL SOC AM, V96, P810, DOI 10.1603/0013-8746(2003)096[0810:DOTTSF]2.0.CO;2; MESCHER MC, 2001, THESIS U GEORGIA ATH; Murphy Robert W., 1996, P51; Nagnan-Le Meillour P, 2009, J CHEM ECOL, V35, P752, DOI 10.1007/s10886-009-9663-z; PAESEN GC, 1995, INSECT BIOCHEM MOLEC, V25, P401, DOI 10.1016/0965-1748(94)00085-V; Pasteur N., 1988, PRACTICAL ISOZYME GE; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Ross KG, 2008, P ROY SOC B-BIOL SCI, V275, P2231, DOI 10.1098/rspb.2008.0412; ROSS KG, 1988, BEHAV ECOL SOCIOBIOL, V23, P341, DOI 10.1007/BF00303708; Ross KG, 1997, GENETICS, V147, P643; Ross KG, 1996, P NATL ACAD SCI USA, V93, P3021, DOI 10.1073/pnas.93.7.3021; ROSS KG, 1985, BEHAV ECOL SOCIOBIOL, V17, P349, DOI 10.1007/BF00293212; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, GENETICS, V145, P961; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Ross KG, 2003, GENETICS, V165, P1853; ROSS KG, 1985, EVOLUTION, V39, P888, DOI 10.1111/j.1558-5646.1985.tb00430.x; Ross KG, 2002, BEHAV ECOL SOCIOBIOL, V51, P287, DOI [10.1007/s00265-001-0431-5, 10.1007/S00265-001-0431-5]; ROSS KG, 1988, BIOL J LINN SOC, V34, P105, DOI 10.1111/j.1095-8312.1988.tb01952.x; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; SHOEMAKER DD, 1992, HEREDITY, V69, P573, DOI 10.1038/hdy.1992.173; Sumner S, 2006, ANN ZOOL FENN, V43, P423; Taber SW, 2000, FIRE ANTS; Tschinkel WR, 2006, FIRE ANTS; Valles SM, 2003, INSECT SOC, V50, P199, DOI 10.1007/s00040-003-0662-8; van der Meer R.K., 1986, P201; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Vargo Edward L., 1998, P293; Vargo EL, 1999, PHYSIOL ENTOMOL, V24, P370, DOI 10.1046/j.1365-3032.1999.00153.x; VOGT RG, 2005, ENDOCRINOLOGY, V3, P753; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; WILLER DE, 1986, PHYSIOL ENTOMOL, V11, P475, DOI 10.1111/j.1365-3032.1986.tb00441.x; Xu PX, 2005, SCIENCE, V310, P798, DOI 10.1126/science.1121249; Yang CC, 2008, INSECT SOC, V55, P54, DOI 10.1007/s00040-007-0969-y	81	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7713	10.1371/journal.pone.0007713	http://dx.doi.org/10.1371/journal.pone.0007713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893635	Green Published, Green Submitted, gold			2022-12-27	WOS:000271478000006
J	Gamez-Pozo, A; Sanchez-Navarro, I; Nistal, M; Calvo, E; Madero, R; Diaz, E; Camafeita, E; de Castro, J; Lopez, JA; Gonzalez-Baron, M; Espinosa, E; Vara, JAF				Gamez-Pozo, Angelo; Sanchez-Navarro, Iker; Nistal, Manuel; Calvo, Enrique; Madero, Rosario; Diaz, Esther; Camafeita, Emilio; de Castro, Javier; Antonio Lopez, Juan; Gonzalez-Baron, Manuel; Espinosa, Enrique; Fresno Vara, Juan Angel			MALDI Profiling of Human Lung Cancer Subtypes	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; IMAGING MASS-SPECTROMETRY; PROTEOMIC PATTERNS; BREAST-CANCER; CELL-LINES; EXPRESSION; CLASSIFICATION; PHOSPHOPROTEOME; REPRODUCIBILITY; ADENOCARCINOMA	Background: Proteomics is expected to play a key role in cancer biomarker discovery. Although it has become feasible to rapidly analyze proteins from crude cell extracts using mass spectrometry, complex sample composition hampers this type of measurement. Therefore, for effective proteome analysis, it becomes critical to enrich samples for the analytes of interest. Despite that one-third of the proteins in eukaryotic cells are thought to be phosphorylated at some point in their life cycle, only a low percentage of intracellular proteins is phosphorylated at a given time. Methodology/Principal Findings: In this work, we have applied chromatographic phosphopeptide enrichment techniques to reduce the complexity of human clinical samples. A novel method for high-throughput peptide profiling of human tumor samples, using Parallel IMAC and MALDI-TOF MS, is described. We have applied this methodology to analyze human normal and cancer lung samples in the search for new biomarkers. Using a highly reproducible spectral processing algorithm to produce peptide mass profiles with minimal variability across the samples, lineal discriminant-based and decision tree-based classification models were generated. These models can distinguish normal from tumor samples, as well as differentiate the various non-small cell lung cancer histological subtypes. Conclusions/Significance: A novel, optimized sample preparation method and a careful data acquisition strategy is described for high-throughput peptide profiling of small amounts of human normal lung and lung cancer samples. We show that the appropriate combination of peptide expression values is able to discriminate normal lung from non-small cell lung cancer samples and among different histological subtypes. Our study does emphasize the great potential of proteomics in the molecular characterization of cancer.	[Gamez-Pozo, Angelo; Sanchez-Navarro, Iker; Nistal, Manuel; Diaz, Esther; de Castro, Javier; Gonzalez-Baron, Manuel; Espinosa, Enrique; Fresno Vara, Juan Angel] Hosp Univ La Paz, Lab Mol Pathol & Oncol, Unidad Invest, Madrid, Spain; [Calvo, Enrique; Camafeita, Emilio; Antonio Lopez, Juan] CNIC, Unidad Proteom, Madrid, Spain; [Madero, Rosario] Hosp Univ La Paz, Unidad Bioestadist, Madrid, Spain	Hospital Universitario La Paz; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario La Paz	Gamez-Pozo, A (corresponding author), Hosp Univ La Paz, Lab Mol Pathol & Oncol, Unidad Invest, Madrid, Spain.	jfresnov.hulp@salud.madrid.org	Lopez, Juan Antonio/G-7750-2015; Fresno Vara, Juan Angel/F-6702-2010; Gamez-Pozo, Angelo/N-2506-2014; Vara, Juan Ángel Fresno/Y-9928-2019	Lopez, Juan Antonio/0000-0002-9097-6060; Fresno Vara, Juan Angel/0000-0003-1527-1252; Gamez-Pozo, Angelo/0000-0002-8931-0624; Vara, Juan Ángel Fresno/0000-0003-1527-1252; De Castro, Javier/0000-0002-3622-6306; Espinosa Arranz, Enrique/0000-0001-6562-7902				Abramovitz M, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-5; Albrethsen J, 2007, CLIN CHEM, V53, P852, DOI 10.1373/clinchem.2006.082644; BLOBEL GA, 1984, VIRCHOWS ARCH B, V45, P407, DOI 10.1007/BF02889883; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Callesen AK, 2008, RAPID COMMUN MASS SP, V22, P291, DOI 10.1002/rcm.3364; Chang TJ, 1998, ONCOL REP, V5, P469; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fukunaga Y, 2002, LUNG CANCER-J IASLC, V38, P31, DOI 10.1016/S0169-5002(02)00109-5; Ge GT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-275; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ishii T, 2008, TUMOR BIOL, V29, P57, DOI 10.1159/000132572; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim JW, 1998, GYNECOL ONCOL, V71, P266, DOI 10.1006/gyno.1998.5195; Makrantoni V, 2005, YEAST, V22, P401, DOI 10.1002/yea.1220; Meyerson M, 2005, J CLIN ONCOL, V23, P3219, DOI 10.1200/JCO.2005.15.511; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Persson A, 2006, CURR OPIN MOL THER, V8, P185; Pusch W, 2005, CURR PHARM DESIGN, V11, P2577, DOI 10.2174/1381612054546932; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHEK N, 1988, CANCER RES, V48, P6354; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Zhang Xinyi, 2004, J Biomol Tech, V15, P167	37	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7731	10.1371/journal.pone.0007731	http://dx.doi.org/10.1371/journal.pone.0007731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890392	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700016
J	Darsigny, M; Babeu, JP; Dupuis, AA; Furth, EE; Seidman, EG; Levy, E; Verdu, EF; Gendron, FP; Boudreau, F				Darsigny, Mathieu; Babeu, Jean-Philippe; Dupuis, Andree-Anne; Furth, Emma E.; Seidman, Ernest G.; Levy, Emile; Verdu, Elena F.; Gendron, Fernand-Pierre; Boudreau, Francois			Loss of Hepatocyte-Nuclear-Factor-4 alpha Affects Colonic Ion Transport and Causes Chronic Inflammation Resembling Inflammatory Bowel Disease in Mice	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; APOPTOSIS; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PATHOGENESIS; CONTRIBUTES; PROTEINS; RECEPTOR	Background: Hnf4 alpha, an epithelial specific transcriptional regulator, is decreased in inflammatory bowel disease and protects against chemically-induced colitis in mice. However, the precise role of this factor in maintaining normal inflammatory homeostasis of the intestine remains unclear. The aim of this study was to evaluate the sole role of epithelial Hnf4 alpha in the maintenance of gut inflammatory homeostasis in mice. Methodology/Principal Findings: We show here that specific epithelial deletion of Hnf4 alpha in mice causes spontaneous chronic intestinal inflammation leading to focal areas of crypt dropout, increased cytokines and chemokines secretion, immune cell infiltrates and crypt hyperplasia. A gene profiling analysis in diseased Hnf4 alpha null colon confirms profound genetic changes in cell death and proliferative behaviour related to cancer. Among the genes involved in the immune protection through epithelial barrier function, we identify the ion transporter claudin-15 to be down-modulated early in the colon of Hnf4 alpha mutants. This coincides with a significant decrease of mucosal ion transport but not of barrier permeability in young animals prior to the manifestation of the disease. We confirm that claudin-15 is a direct Hnf4 alpha gene target in the intestinal epithelial context and is down-modulated in mouse experimental colitis and inflammatory bowel disease. Conclusion: Our results highlight the critical role of Hnf4 alpha to maintain intestinal inflammatory homeostasis during mouse adult life and uncover a novel function for Hnf4 alpha in the regulation of claudin-15 expression. This establishes Hnf4 alpha as a mediator of ion epithelial transport, an important process for the maintenance of gut inflammatory homeostasis.			Darsigny, M (corresponding author), Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Francois.Boudreau@usherbrooke.ca	Gendron, Fernand-Pierre/AAN-2965-2021		Canadian Institutes of Health Research [CTP-82942, MOP-897702] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Black DD, 2007, AM J PHYSIOL-GASTR L, V293, pG519, DOI 10.1152/ajpgi.00189.2007; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F., 2007, FASEB J; Burum-Auensen E, 2007, J CLIN PATHOL, V60, P1403, DOI 10.1136/jcp.2006.044305; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Huang RP, 2005, EXPERT OPIN THER TAR, V9, P601, DOI 10.1517/14728222.9.3.601; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; MONTROSE MH, 2003, TXB GASTROENTEROLOGY, P308; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Resta-Lenert SC, 2009, ANN NY ACAD SCI, V1165, P175, DOI 10.1111/j.1749-6632.2009.04042.x; Ruemmele FM, 2002, J PEDIATR GASTR NUTR, V34, P254, DOI 10.1097/00005176-200203000-00005; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Varghese AK, 2006, GASTROENTEROLOGY, V130, P1743, DOI 10.1053/j.gastro.2006.02.007; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	37	91	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7609	10.1371/journal.pone.0007609	http://dx.doi.org/10.1371/journal.pone.0007609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898610	Green Published, Green Submitted, gold			2022-12-27	WOS:000271232000003
J	Xu, D; Zhang, Y				Xu, Dong; Zhang, Yang			Generating Triangulated Macromolecular Surfaces by Euclidean Distance Transform	PLOS ONE			English	Article							SOLVENT-ACCESSIBLE SURFACE; ANALYTICAL SHAPE; COMPUTATION; EFFICIENT; PROTEINS; AREAS; APPROXIMATION; DOCKING; VOLUME	Macromolecular surfaces are fundamental representations of their three-dimensional geometric shape. Accurate calculation of protein surfaces is of critical importance in the protein structural and functional studies including ligand-protein docking and virtual screening. In contrast to analytical or parametric representation of macromolecular surfaces, triangulated mesh surfaces have been proved to be easy to describe, visualize and manipulate by computer programs. Here, we develop a new algorithm of EDTSurf for generating three major macromolecular surfaces of van der Waals surface, solvent-accessible surface and molecular surface, using the technique of fast Euclidean Distance Transform (EDT). The triangulated surfaces are constructed directly from volumetric solids by a Vertex-Connected Marching Cube algorithm that forms triangles from grid points. Compared to the analytical result, the relative error of the surface calculations by EDTSurf is <2-4% depending on the grid resolution, which is 1.5-4 times lower than the methods in the literature; and yet, the algorithm is faster and costs less computer memory than the comparative methods. The improvements in both accuracy and speed of the macromolecular surface determination should make EDTSurf a useful tool for the detailed study of protein docking and structure predictions. Both source code and the executable program of EDTSurf are freely available at http://zhang.bioinformatics.ku.edu/EDTSurf.	[Xu, Dong; Zhang, Yang] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Xu, Dong; Zhang, Yang] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Xu, Dong; Zhang, Yang] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; University of Kansas; University of Kansas	Xu, D (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	YZ, YZ/B-3243-2011; xu, dong/I-7737-2013	xu, dong/0000-0002-6616-1427	Alfred P. Sloan Foundation; NSF [0746198]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported by the Alfred P. Sloan Foundation, NSF Career Award 0746198 and the National Institute of General Medical Sciences Grant GM083107 and GM084222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DUNCAN BS, 1993, BIOPOLYMERS, V33, P219, DOI 10.1002/bip.360330204; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GREER J, 1978, P NATL ACAD SCI USA, V75, P303, DOI 10.1073/pnas.75.1.303; Hayryan S, 2005, J COMPUT CHEM, V26, P334, DOI 10.1002/jcc.20125; HUANG CT, 1994, IEEE T PATTERN ANAL, V16, P443, DOI 10.1109/34.277600; Juffer AH, 1998, J COMPUT AID MOL DES, V12, P289, DOI 10.1023/A:1016089901704; Kanamori E, 2007, PROTEINS, V69, P832, DOI 10.1002/prot.21737; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang J, 1998, PROTEINS, V33, P1; Liang J, 1997, BIOPHYS J, V73, P1830, DOI 10.1016/S0006-3495(97)78213-4; Locasale JW, 2009, J MOL BIOL, V386, P1054, DOI 10.1016/j.jmb.2009.01.007; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; PERROT G, 1992, J COMPUT CHEM, V13, P1, DOI 10.1002/jcc.540130102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rychkov G, 2007, J COMPUT CHEM, V28, P1974, DOI 10.1002/jcc.20550; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; VINCENT L, 1991, EXACT EUCLIDEAN DIST, P520; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; XIANG ZX, 1995, J COMPUT CHEM, V16, P512, DOI 10.1002/jcc.540160414; Xu D, 2006, LECT NOTES COMPUT SC, V4261, P72; YE QZ, 1988, SIGNED EUCLIDEAN DIS, P495; Zavodszky MI, 2002, J COMPUT AID MOL DES, V16, P883, DOI 10.1023/A:1023866311551; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang YJ, 2006, COMPUT AIDED GEOM D, V23, P510, DOI 10.1016/j.cagd.2006.01.008	34	73	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8140	10.1371/journal.pone.0008140	http://dx.doi.org/10.1371/journal.pone.0008140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956577	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828800030
J	Eleftherohorinou, H; Wright, V; Hoggart, C; Hartikainen, AL; Jarvelin, MR; Balding, D; Coin, L; Levin, M				Eleftherohorinou, Hariklia; Wright, Victoria; Hoggart, Clive; Hartikainen, Anna-Liisa; Jarvelin, Marjo-Riitta; Balding, David; Coin, Lachlan; Levin, Michael			Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NF-KAPPA-B; TYPE-1 DIABETES RISK; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; PROMOTER REGION; LOCI; PREDICTION; POLYMORPHISMS; PATHOGENESIS	Although the introduction of genome-wide association studies (GWAS) have greatly increased the number of genes associated with common diseases, only a small proportion of the predicted genetic contribution has so far been elucidated. Studying the cumulative variation of polymorphisms in multiple genes acting in functional pathways may provide a complementary approach to the more common single SNP association approach in understanding genetic determinants of common disease. We developed a novel pathway-based method to assess the combined contribution of multiple genetic variants acting within canonical biological pathways and applied it to data from 14,000 UK individuals with 7 common diseases. We tested inflammatory pathways for association with Crohn's disease (CD), rheumatoid arthritis (RA) and type 1 diabetes (T1D) with 4 non-inflammatory diseases as controls. Using a variable selection algorithm, we identified variants responsible for the pathway association and evaluated their use for disease prediction using a 10 fold cross-validation framework in order to calculate out-of-sample area under the Receiver Operating Curve (AUC). The generalisability of these predictive models was tested on an independent birth cohort from Northern Finland. Multiple canonical inflammatory pathways showed highly significant associations (p 10(-3) -10(-20)) with CD, T1D and RA. Variable selection identified on average a set of 205 SNPs (149 genes) for T1D, 350 SNPs (189 genes) for RA and 493 SNPs (277 genes) for CD. The pattern of polymorphisms at these SNPS were found to be highly predictive of T1D (91% AUC) and RA (85% AUC), and weakly predictive of CD (60% AUC). The predictive ability of the T1D model (without any parameter refitting) had good predictive ability (79% AUC) in the Finnish cohort. Our analysis suggests that genetic contribution to common inflammatory diseases operates through multiple genes interacting in functional pathways.	[Eleftherohorinou, Hariklia; Wright, Victoria; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Div Med, London, England; [Eleftherohorinou, Hariklia; Hoggart, Clive; Jarvelin, Marjo-Riitta; Balding, David; Coin, Lachlan] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol, Dept Epidemiol & Publ Hlth, London, England; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Natl Inst Hlth & Welf, Dept Child & Adolescent Hlth, Oulu, Finland	Imperial College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Eleftherohorinou, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Div Med, London, England.	m.levin@imperial.ac.uk	Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Balding, David/G-9898-2011	Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Balding, David/0000-0002-1480-6115; Wright, Victoria/0000-0001-7826-1516; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Levin, Michael/0000-0003-2767-6919	Wellcome Trust [076113]; Academy of Finland [104781, 120315]; Biocenter, University of Oulu, Finland [5R01HL087679-02]; STAMPEED [1RL1MH083268-01]; ENGAGE [HEALTH-F4-2007-201413]; ESPID; European Network for Genetic-Epidemiological Studies; Imperial College Faculty of Medicine; Medical Research Council [G0300766] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; MRC [G0300766] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Biocenter, University of Oulu, Finland; STAMPEED; ENGAGE; ESPID; European Network for Genetic-Epidemiological Studies; Imperial College Faculty of Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. For the NFBC1966, the financial support was received from the Academy of Finland (project grants 104781, 120315), Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413. Lachlan Coin is supported by a research council UK fellowship; Victoria Wright is supported by a grant from ESPID, Clive Hoggart is supported by the European Network for Genetic-Epidemiological Studies, Hariklia Eleftherohorinou is supported by the Imperial College Faculty of Medicine studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni F, 2007, AUTOIMMUN REV, V6, P529, DOI 10.1016/j.autrev.2007.03.009; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BARRETT JC, 2009, NAT GENET; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Brandtzaeg P, 2002, CURR OPIN INFECT DIS, V15, P247, DOI 10.1097/00001432-200206000-00006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buzzetti R, 2004, DIABETES-METAB RES, V20, P137, DOI 10.1002/dmrr.426; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Hahn C G, 1999, Bipolar Disord, V1, P81, DOI 10.1034/j.1399-5618.1999.010204.x; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kirsten H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2683; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Kwiatkowski Dominic P., 2006, Parassitologia (Rome), V48, P450; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Martinez A, 2001, ARTHRITIS RHEUM-US, V44, P1261, DOI 10.1002/1529-0131(200106)44:6<1261::AID-ART217>3.0.CO;2-L; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Noble JA, 2008, HUM IMMUNOL, V69, P291, DOI 10.1016/j.humimm.2008.02.003; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Skyler JS, 2007, CLIN PHARMACOL THER, V81, P768, DOI 10.1038/sj.clpt.6100179; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	60	112	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8068	10.1371/journal.pone.0008068	http://dx.doi.org/10.1371/journal.pone.0008068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956648	Green Published, gold			2022-12-27	WOS:000272828400020
J	Santos, SFA; Luz, LL; Szucs, P; Lima, D; Derkach, VA; Safronov, BV				Santos, Sonia F. A.; Luz, Liliana L.; Szucs, Peter; Lima, Deolinda; Derkach, Victor A.; Safronov, Boris V.			Transmission Efficacy and Plasticity in Glutamatergic Synapses Formed by Excitatory Interneurons of the Substantia Gelatinosa in the Rat Spinal Cord	PLOS ONE			English	Article							DORSAL-HORN NEURONS; LOCAL CIRCUIT CONNECTIONS; ACUTE NOXIOUS-STIMULATION; LONG-TERM POTENTIATION; HAMSTER LAMINA-III; PROTEIN-KINASE-II; AMPA RECEPTORS; PATCH-CLAMP; CENTRAL SENSITIZATION; NOCICEPTIVE SYNAPSES	Background: Substantia gelatinosa (SG, lamina II) is a spinal cord region where most unmyelinated primary afferents terminate and the central nociceptive processing begins. The glutamatergic excitatory interneurons (EINs) form the majority of the SG neuron population, but little is known about the mechanisms of signal processing in their synapses. Methodology: To describe the functional organization and properties of excitatory synapses formed by SG EINs, we did non-invasive recordings from 183 pairs of monosynaptically connected neurons. An intact presynaptic SG EIN was specifically stimulated through the cell-attached pipette while the evoked EPSCs/EPSPs were recorded through perforated-patch from a postsynaptic neuron (laminae I-III). Principal Findings: We found that the axon of an SG EIN forms multiple functional synapses on the dendrites of a postsynaptic neuron. In many cases, EPSPs evoked by stimulating an SG EIN were sufficient to elicit spikes in a postsynaptic neuron. EPSCs were carried through both Ca2+-permeable (CP) and Ca2+-impermeable (CI) AMPA receptors (AMPARs) and showed diverse forms of functional plasticity. The synaptic efficacy could be enhanced through both activation of silent synapses and strengthening of already active synapses. We have also found that a high input resistance (R-IN, > 0.5 G Omega) of the postsynaptic neuron is necessary for resolving distal dendritic EPSCs/EPSPs and correct estimation of their efficacy. Conclusions/Significance: We conclude that the multiple synapses formed by an SG EIN on a postsynaptic neuron increase synaptic excitation and provide basis for diverse forms of plasticity. This functional organization can be important for sensory, i.e. nociceptive, processing in the spinal cord.	[Santos, Sonia F. A.; Luz, Liliana L.; Szucs, Peter; Safronov, Boris V.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Santos, Sonia F. A.; Luz, Liliana L.; Lima, Deolinda; Safronov, Boris V.] Univ Porto, Fac Med, Lab Biol Celular & Mol, P-4100 Oporto, Portugal; [Derkach, Victor A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Universidade do Porto; Universidade do Porto; Oregon Health & Science University	Santos, SFA (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	safronov@ibmc.up.pt	Szucs, Peter/A-4441-2013; Luz, Liliana L/A-4208-2019; Safronov, Boris/K-2219-2013	Luz, Liliana L/0000-0001-8109-3891; Safronov, Boris/0000-0002-4614-3184; Szucs, Peter/0000-0003-4635-6427; Lima, Deolinda/0000-0002-5723-0777	Portuguese Foundation for Science and Technology; Medical Research Foundation; NIH [NS027037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the grant from the Portuguese Foundation for Science and Technology (to B. V. S.), Medical Research Foundation grant (to V. A. D.) and NIH grant NS027037 (to Thomas Soderling and V. A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; ARAKI T, 1962, J NEUROPHYSIOL, V25, P772, DOI 10.1152/jn.1962.25.6.772; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; BERRY MS, 1976, BRAIN RES, V105, P1, DOI 10.1016/0006-8993(76)90919-7; Bertil H., 2001, ION CHANNELS EXCITAB; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Graham BA, 2008, J NEUROPHYSIOL, V99, P2048, DOI 10.1152/jn.01176.2007; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Kato G, 2007, J PHYSIOL-LONDON, V580, P815, DOI 10.1113/jphysiol.2007.128314; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Larsson M, 2006, J NEUROSCI, V26, P4198, DOI 10.1523/JNEUROSCI.0352-06.2006; Larsson M, 2005, EUR J NEUROSCI, V21, P2445, DOI 10.1111/j.1460-9568.2005.04081.x; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2003, J NEUROSCI, V23, P8752; Lu Y, 2008, J NEUROPHYSIOL, V99, P1051, DOI 10.1152/jn.00027.2008; Marty Alain, 1995, P31; Melnick IV, 2004, J PHYSIOL-LONDON, V559, P383, DOI 10.1113/jphysiol.2004.066415; Melnick IV, 2004, J NEUROPHYSIOL, V91, P646, DOI 10.1152/jn.00883.2003; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morisset V, 2001, J NEUROPHYSIOL, V86, P40, DOI 10.1152/jn.2001.86.1.40; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Pedersen LM, 2005, BRAIN RES, V1041, P66, DOI 10.1016/j.brainres.2005.02.004; Polgar E, 2008, J NEUROSCI, V28, P13150, DOI 10.1523/JNEUROSCI.4053-08.2008; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Safronov BV, 2007, J NEUROSCI METH, V164, P292, DOI 10.1016/j.jneumeth.2007.05.010; Safronov BV, 1997, J PHYSIOL-LONDON, V503, P371, DOI 10.1111/j.1469-7793.1997.371bh.x; Safronov BV, 1999, PROG NEUROBIOL, V59, P217, DOI 10.1016/S0301-0082(98)00051-3; Safronov BV, 1999, J PHYSIOL-LONDON, V514, P729, DOI 10.1111/j.1469-7793.1999.729ad.x; Safronov BV, 2000, BIOPHYS J, V78, P2998, DOI 10.1016/S0006-3495(00)76838-X; Santos SFA, 2004, ANESTHESIOLOGY, V101, P1177, DOI 10.1097/00000542-200411000-00018; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Schneider SP, 2008, J NEUROPHYSIOL, V99, P1306, DOI 10.1152/jn.00962.2007; Szucs P, 2009, J NEUROSCI METH, V177, P369, DOI 10.1016/j.jneumeth.2008.10.024; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3	56	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8047	10.1371/journal.pone.0008047	http://dx.doi.org/10.1371/journal.pone.0008047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956641	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400008
J	Shepherd, AK; Singh, R; Wesley, CS				Shepherd, Andrew K.; Singh, Ravinder; Wesley, Cedric S.			Notch mRNA Expression in Drosophila Embryos Is Negatively Regulated at the Level of mRNA 3 ' Processing	PLOS ONE			English	Article							CELL-FATE; POLY(A) POLYMERASE; GENETIC CIRCUITRY; TRUNCATED NOTCH; DELTA; LOCUS; POLYADENYLATION; MELANOGASTER; MUTATIONS; RECEPTOR	Notch receptor regulates differentiation of almost all tissues and organs during animal development. Many mechanisms function at the protein level to finely regulate Notch activity. Here we provide evidence for Notch regulation at an earlier step - mRNA 3' processing. Processing at the Notch consensus polyadenylation site appears by default to be suppressed in Drosophila embryos. Interference with this suppression, by a mutation, results in increased levels of polyadenylated Notch mRNA, excess Notch signaling, and severe developmental defects. We propose that Notch mRNA 3' processing is negatively regulated to limit the production of Notch protein and render it a controlling factor in the generation of Notch signaling.	[Shepherd, Andrew K.; Wesley, Cedric S.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Singh, Ravinder] Univ Colorado, Dept Mol Cell & Dev Biol, Boulder, CO 80309 USA	University of Vermont; University of Colorado System; University of Colorado Boulder	Shepherd, AK (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	cwesley@uvm.edu			National Institutes of Health [R01 NS43122]; Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; National Institutes of Health COBRE [P20 RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01 NS43122; the Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; and the National Institutes of Health COBRE grant P20 RR016435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; ALTON AK, 1989, DEV GENET, V10, P261, DOI 10.1002/dvg.1020100315; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashburner M., 2004, DROSOPHILA LAB HDB; Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Brennan K, 1997, GENETICS, V147, P177; CABRERA CV, 1990, DEVELOPMENT, V110, P733; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Danckwardt S, 2004, BLOOD, V104, P428, DOI 10.1182/blood-2003-08-2894; DELACONCHA A, 1988, GENETICS, V118, P499; Emerson SG, 2005, BIOL BLOOD MARROW TR, V11, P1, DOI 10.1016/S1083-8791(04)00985-1; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HARDINGTHEOBALD ER, 2007, N ND 1 MOL LESION; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Herranz H, 2006, BIOESSAYS, V28, P113, DOI 10.1002/bies.20366; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Murata T, 2001, DEV BIOL, V233, P137, DOI 10.1006/dbio.2001.0205; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Okano H, 2002, J CELL SCI, V115, P1355; PALKA J, 1990, DEVELOPMENT, V109, P167; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SHELLENBARGER DL, 1975, GENETICS, V81, P143; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wilusz CJ, 2001, RNA, V7, P1416; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; ZANGAR RC, 1995, BIOTECHNIQUES, V18, P465; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8063	10.1371/journal.pone.0008063	http://dx.doi.org/10.1371/journal.pone.0008063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956683	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828400017
J	van der Plas, MJA; van Dissel, JT; Nibbering, PH				van der Plas, Mariena J. A.; van Dissel, Jaap T.; Nibbering, Peter H.			Maggot Secretions Skew Monocyte-Macrophage Differentiation Away from a Pro-Inflammatory to a Pro-Angiogenic Type	PLOS ONE			English	Article							DIABETIC FOOT ULCERS; MIGRATION INHIBITORY FACTOR; APOPTOTIC CELLS; CYCLIC-AMP; INNATE IMMUNITY; CHRONIC WOUNDS; LEG ULCERS; CYTOKINE; THERAPY; EXPRESSION	Background: Maggots of the blowfly Lucilia sericata are used for the treatment of chronic wounds. Earlier we reported maggot secretions to inhibit pro-inflammatory responses of human monocytes. The aim of this study was to investigate the effect of maggot secretions on the differentiation of monocytes into pro-inflammatory (MO-1) and anti-inflammatory/proangiogenic macrophages (MO-2) as these cells play a central role in wound healing. Methodology/Principal Findings: Freshly isolated monocytes were incubated with secretions and GM-CSF or M-CSF for 6 days and then stimulated with LPS or LTA for 18 h. The expression of cell surface molecules and the levels of cytokines, chemokines and growth factors in supernatants were measured. Our results showed secretions to affect monocyte-macrophage differentiation leading to MO-1 with a partial MO-2-like morphology but lacking CD163, which is characteristic for MO-2. In response to LPS or LTA, secretions-differentiated MO-1 produced less pro-inflammatory cytokines (TNF-alpha, IL-12p40 and MIF) than control cells. Similar results were observed for MO-2 when stimulated with low concentrations of LPS. Furthermore, secretions dose-dependently led to MO-1 and MO-2 characterized by an altered chemokine production. Secretions led to MO-2, but not MO-1, producing enhanced levels of the growth factors bFGF and VEGF, as compared to control cells. The expression of cell-surface receptors involved in LPS/LTA was enhanced by secretions, that of CD86 and HLA-DR down-regulated, while receptors involved in phagocytosis remained largely unaffected. Conclusions: Maggot secretions skew the differentiation of monocytes into macrophages away from a pro-inflammatory to a pro-angiogenic type.	[van der Plas, Mariena J. A.; van Dissel, Jaap T.; Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [van der Plas, Mariena J. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Plas, MJA (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	p.h.nibbering@lumc.nl	van der Plas, Mariena/GYV-3702-2022	van der Plas, Mariena/0000-0002-3233-2881	Kinetics Concepts Inc. (KCI); Europe Holding (Amstelveen, the Netherlands)	Kinetics Concepts Inc. (KCI); Europe Holding (Amstelveen, the Netherlands)(Netherlands Government)	This work was financially supported by a research grant of Kinetics Concepts Inc. (KCI), Europe Holding (Amstelveen, the Netherlands). The role of this funder was the following: the salary of the first author was paid by KCI. The funder has read and approved the manuscript. There were no restrictions with respect to publication of this manuscript.	Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong DG, 2005, J AM PODIAT MED ASSN, V95, P254, DOI 10.7547/0950254; Baer ES, 1931, J BONE JOINT SURG, V13, P438; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; BRIGGAMAN RA, 1984, J EXP MED, V160, P1027, DOI 10.1084/jem.160.4.1027; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CHEN SM, 1997, WOUND REPAIR REGEN, V5, P23; Distler JHW, 2003, Q J NUCL MED, V47, P149; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Herrick S, 1997, LAB INVEST, V77, P281; Hirano Y, 2007, EUR J PHARMACOL, V560, P81, DOI 10.1016/j.ejphar.2007.01.003; Jeffcoate WJ, 2006, DIABETES CARE, V29, P1784, DOI 10.2337/dc06-0306; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lavery LA, 2008, DIABETES CARE, V31, P154, DOI 10.2337/dc07-1302; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Makino M, 2007, MICROBES INFECT, V9, P70, DOI 10.1016/j.micinf.2006.10.011; Meier B, 2001, PROTOPLASMA, V217, P117, DOI 10.1007/BF01289420; Mumcuoglu KY, 1998, DIABETES CARE, V21, P2030, DOI 10.2337/diacare.21.11.2030; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sherman RA, 2003, DIABETES CARE, V26, P446, DOI 10.2337/diacare.26.2.446; SHERMAN RA, 1993, AM J TROP MED HYG  S, P266; Steenvoorde P, 2007, ANN ROY COLL SURG, V89, P598, DOI 10.1308/003588407X205404; STODDARD SR, 1995, J AM PODIAT MED ASSN, V85, P218, DOI 10.7547/87507315-85-4-218; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; van der Plas MJA, 2009, DIABETOLOGIA, V52, P1962, DOI 10.1007/s00125-009-1432-6; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; WAHL SM, 1985, CIBA F SYMP, V114, P175; Wang Shouyu, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P472; Waugh HV, 2006, B MATH BIOL, V68, P197, DOI 10.1007/s11538-005-9022-3; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Zidek Z, 1999, EUR CYTOKINE NETW, V10, P319	54	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8071	10.1371/journal.pone.0008071	http://dx.doi.org/10.1371/journal.pone.0008071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956650	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400021
J	Hall, KD; Guo, J; Dore, M; Chow, CC				Hall, Kevin D.; Guo, Juen; Dore, Michael; Chow, Carson C.			The Progressive Increase of Food Waste in America and Its Environmental Impact	PLOS ONE			English	Article							ENERGY-EXPENDITURE; BODY-FAT; MASS	Food waste contributes to excess consumption of freshwater and fossil fuels which, along with methane and CO2 emissions from decomposing food, impacts global climate change. Here, we calculate the energy content of nationwide food waste from the difference between the US food supply and the food consumed by the population. The latter was estimated using a validated mathematical model of metabolism relating body weight to the amount of food eaten. We found that US per capita food waste has progressively increased by similar to 50% since 1974 reaching more than 1400 kcal per person per day or 150 trillion kcal per year. Food waste now accounts for more than one quarter of the total freshwater consumption and similar to 300 million barrels of oil per year.	[Hall, Kevin D.; Guo, Juen; Dore, Michael; Chow, Carson C.] NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hall, KD (corresponding author), NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov; carsonc@niddk.nih.gov	Chow, Carson C/A-7970-2009; Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG USEP, 2009, US EM INV 2009 INV U; Blaxter K, 1989, ENERGY METABOLISM AN; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; DIAZ EO, 1992, AM J CLIN NUTR, V56, P641, DOI 10.1093/ajcn/56.4.641; FAO, 2001, FOOD BALANCE SHEETS; FORBES GB, 1987, NUTR REV, V45, P225; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Griffin M, 2009, AGR HUM VALUES, V26, P67, DOI 10.1007/s10460-008-9178-1; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; HALL KD, 2009, BR J NUTR UNPUB; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Horrigan L, 2002, ENVIRON HEALTH PERSP, V110, P445, DOI 10.1289/ehp.02110445; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kantor L. S., 1997, FoodReview, V20, P2; Muth MK, 2007, EXPLORATORY RES ESTI; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Putnam J., 2002, FoodReview, V25, P2; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Smil V., 2000, FEEDING WORLD CHALLE; SWINBURN B, 2009, AM J CLIN NUTR; *US EN INF ADM, US PROD SUPPL CRUD O; *US EPA OFF SOL WA, 2007, MUN SOL WAST US 2007; USDA Economic Research Service, FOOD AV PER CAP DAT; Ventour L., 2008, FOOD WE WASTE WRAP E; Von Braun J., 2008, GLOBALIZATION FOOD A; Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087, DOI 10.1210/jc.85.3.1087; WIGGINS S, 2008, RISING FOOD PRICES C	31	310	320	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7940	10.1371/journal.pone.0007940	http://dx.doi.org/10.1371/journal.pone.0007940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946359	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827800008
J	Kelkar, A; Thakur, V; Ramaswamy, R; Deobagkar, D				Kelkar, Ashwin; Thakur, Vivek; Ramaswamy, Ramakrishna; Deobagkar, Deepti			Characterisation of Inactivation Domains and Evolutionary Strata in Human X Chromosome through Markov Segmentation	PLOS ONE			English	Article							DNA-SEQUENCE; NUCLEOTIDE; PROFILE	Markov segmentation is a method of identifying compositionally different subsequences in a given symbolic sequence. We have applied this technique to the DNA sequence of the human X chromosome to analyze its compositional structure. The human X chromosome is known to have acquired DNA through distinct evolutionary events and is believed to be composed of five evolutionary strata. In addition, in female mammals all copies of X chromosome in excess of one are transcriptionally inactivated. The location of a gene is correlated with its ability to undergo inactivation, but correlations between evolutionary strata and inactivation domains are less clear. Our analysis provides an accurate estimate of the location of stratum boundaries and gives a high-resolution map of compositionally different regions on the X chromosome. This leads to the identification of a novel stratum, as well as segments wherein a group of genes either undergo inactivation or escape inactivation in toto. We identify oligomers that appear to be unique to inactivation domains alone.	[Thakur, Vivek; Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Kelkar, Ashwin; Deobagkar, Deepti] Pune Univ, Dept Zool, Pune, Maharashtra, India; [Thakur, Vivek] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India; [Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Savitribai Phule Pune University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Jawaharlal Nehru University, New Delhi	Ramaswamy, R (corresponding author), Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India.	r.ramaswamy@mail.jnu.ac.in; dddeo@unipune.ernet.in	Ramaswamy, Ramakrishna/L-5306-2019	Ramaswamy, Ramakrishna/0000-0002-9085-8224; Kelkar, Ashwin/0000-0002-2208-5258	University Grants Commission (UGC); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), India	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work has been supported (research fellowships and project grants) by University Grants Commission (UGC), Department of Biotechnology (DBT), and Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAD RK, 2007, ADV COMPUTATIONAL ME, P107; Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; BernaolaGalvan P, 1996, PHYS REV E, V53, P5181, DOI 10.1103/PhysRevE.53.5181; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Deobagkar DD, 2003, J GENET, V82, P13, DOI 10.1007/BF02715875; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; LAHN BT, 1999, SCIENCE, V286, P5441; Li WT, 2002, COMPUT CHEM, V26, P491, DOI 10.1016/S0097-8485(02)00010-4; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Smit A, 1996, REPEATMASKER OPEN 30; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thakur V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011915; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7885	10.1371/journal.pone.0007885	http://dx.doi.org/10.1371/journal.pone.0007885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946363	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000272827800006
J	Song, GS; Wang, L				Song, Guisheng; Wang, Li			A Conserved Gene Structure and Expression Regulation of miR-433 and miR-127 in Mammals	PLOS ONE			English	Article							OVERLAPPING GENES; HUMAN GENOME; ANTISENSE TRANSCRIPTS; MICRORNAS; REGION; LOCUS; MECHANISM; EVOLUTION; CLUSTER; ORIGIN	MicroRNAs play essential roles in many cellular processes. However, limited information is available regarding the gene structure and transcriptional regulation of miRNAs. We explored the gene cluster encoding miR-433/127 in mammalian species using bioinformatics and in vitro "gene'' expression approaches. Multiple sequence alignments (MSA) showed that the precursors of miR-433 and of miR-127 exhibited 95% and 100% similarity, respectively, in human, chimpanzee, horse, dog, monkey, rat, cow, and mouse. MSA of the promoter sequences of miR-433 and of miR-127 revealed lower sequence similarity among these mammalian species. However, the distance between miR-433 and miR-127 was strikingly similar, which was between 986 and 1007 bp and the position of transcription factor (TF) binding motifs, including estrogen related receptor response element (ERRE), was well conserved. Transient transfection assays showed that promoters of miR-433 and of miR-127 from human, rat, and dog were activated by estrogen related receptor gamma (ERR gamma) and inhibited by small heterodimer partner (SHP). ChIP assays confirmed the physical association of ERR gamma with the endogenous promoters of miR-433 and miR-127. In vitro over-expression of the human, rat, or dog miR-433/127 loci in cells, using an expression vector containing miR-433/127 and their promoter regions, markedly induced a differential expression of both primary and mature miR-433 and miR-127, indicating that miR-433 and miR-127 were possessed from their independent promoters. Our studies for the first time demonstrate a conserved gene structure and transcriptional regulation of miR-433 and miR-127 in mammals. The data suggest that the miR-433/127 loci may have evolved from a common gene of origin.	[Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu	song, guisheng/E-4913-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachman NJ, 1999, MAMM GENOME, V10, P506, DOI 10.1007/s003359901031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kiyosawa H, 2002, CYTOGENET GENOME RES, V99, P151, DOI 10.1159/000071587; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Misener SR, 2000, BBA-GENE STRUCT EXPR, V1492, P269, DOI 10.1016/S0167-4781(00)00096-8; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shintani S, 1999, GENETICS, V152, P743; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhuo D, 2001, GENOME RES, V11, P904, DOI 10.1101/gr.GR-1645R	27	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7829	10.1371/journal.pone.0007829	http://dx.doi.org/10.1371/journal.pone.0007829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946636	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827800004
J	Castello, A; Franco, D; Moral-Lopez, P; Berlanga, JJ; Alvarez, E; Wimmer, E; Carrasco, L				Castello, Alfredo; Franco, David; Moral-Lopez, Pablo; Berlanga, Juan J.; Alvarez, Enrique; Wimmer, Eckard; Carrasco, Luis			HIV-1 Protease Inhibits Cap- and Poly(A)-Dependent Translation upon eIF4GI and PABP Cleavage	PLOS ONE			English	Article							INITIATION-FACTOR 4G; RIBOSOME ENTRY SITE; MESSENGER-RNA TRANSLATION; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; POLIOVIRUS 2A(PRO); CELL-FREE; IMMUNODEFICIENCY-VIRUS; IN-VITRO; MAMMALIAN-CELLS	A number of viral proteases are able to cleave translation initiation factors leading to the inhibition of cellular translation. This is the case of human immunodeficiency virus type 1 protease (HIV-1 PR), which hydrolyzes eIF4GI and poly(A)-binding protein (PABP). Here, the effect of HIV-1 PR on cellular and viral protein synthesis has been examined using cell-free systems. HIV-1 PR strongly hampers translation of pre-existing capped luc mRNAs, particularly when these mRNAs contain a poly(A) tail. In fact, HIV-1 PR efficiently blocks cap-and poly(A)-dependent translation initiation in HeLa extracts. Addition of exogenous PABP to HIV-1 PR treated extracts partially restores the translation of polyadenylated luc mRNAs, suggesting that PABP cleavage is directly involved in the inhibition of poly(A)-dependent translation. In contrast to these data, PABP cleavage induced by HIV-1 PR has little impact on the translation of polyadenylated encephalomyocarditis virus internal ribosome entry site (IRES)-containing mRNAs. In this case, the loss of poly(A)-dependent translation is compensated by the IRES transactivation provided by eIF4G cleavage. Finally, translation of capped and polyadenylated HIV-1 genomic mRNA takes place in HeLa extracts when eIF4GI and PABP have been cleaved by HIV-1 PR. Together these results suggest that proteolytic cleavage of eIF4GI and PABP by HIV-1 PR blocks cap-and poly(A)-dependent initiation of translation, leading to the inhibition of cellular protein synthesis. However, HIV-1 genomic mRNA can be translated under these conditions, giving rise to the production of Gag polyprotein.	[Castello, Alfredo; Moral-Lopez, Pablo; Berlanga, Juan J.; Alvarez, Enrique; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Canto Blanco, Spain; [Franco, David; Wimmer, Eckard] SUNY Stony Brook, Long Isl City, NY USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Castello, A (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	lcarrasco@cbm.uam.es	Palomares, Alfredo Castello/K-8062-2019; Berlanga, Juan José/N-1718-2015; Carrasco, Luis/E-2435-2012; Castello, Alfredo/U-6317-2018; Franco, David/AAQ-6839-2021; Carrasco, Luis/H-3001-2017	Palomares, Alfredo Castello/0000-0002-1499-4662; Berlanga, Juan José/0000-0002-2408-6561; Castello, Alfredo/0000-0002-1499-4662; Carrasco, Luis/0000-0003-3833-8835; Alvarez Vazquez, Enrique/0000-0002-4889-175X	DGICYT [BFU2009-07352]; FIPSE [24720/08]; Fundacion Ramon Areces	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FIPSE; Fundacion Ramon Areces	This study was supported by Grants from DGICYT (BFU2009-07352) and FIPSE 24720/08. The Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa'' by the Fundacion Ramon Areces is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; AVIV H, 1971, P NATL ACAD SCI USA, V68, P2303, DOI 10.1073/pnas.68.9.2303; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Barco A, 2000, J VIROL, V74, P2383, DOI 10.1128/JVI.74.5.2383-2392.2000; Bonderoff JM, 2008, J VIROL, V82, P9389, DOI 10.1128/JVI.00006-08; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Camerini V, 2008, J VIROL, V82, P3574, DOI 10.1128/JVI.02038-07; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; CHENG S, 2007, J BIOL CHEM; Cosson B, 2002, BIOL CELL, V94, P205, DOI 10.1016/S0248-4900(02)01194-2; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; Franco D, 2005, J VIROL, V79, P6358, DOI 10.1128/JVI.79.10.6358-6367.2005; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; GROOM HC, 2009, J GEN VIROL; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; MADER S, 1995, MOL CELL BIOL, V15, P4990; Martinez-Salas E, 2004, CURR PHARM DESIGN, V10, P3757, DOI 10.2174/1381612043382657; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Michel YM, 2001, MOL CELL BIOL, V21, P4097, DOI 10.1128/MCB.21.13.4097-4109.2001; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Novoa I, 1999, MOL CELL BIOL, V19, P2445; Novoa I, 1997, BIOCHEMISTRY-US, V36, P7802, DOI 10.1021/bi9631172; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Ricci EP, 2008, RNA, V14, P1443, DOI 10.1261/rna.813608; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Svitkin Yuri V., 2004, V257, P155; Svitkin YV, 2001, RNA, V7, P1743; SVITKIN YV, 1978, VIROLOGY, V87, P199, DOI 10.1016/0042-6822(78)90172-1; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; VENTOSO I, 1995, J VIROL, V69, P6280, DOI 10.1128/JVI.69.10.6280-6288.1995; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Willcocks MM, 2004, J GEN VIROL, V85, P1125, DOI 10.1099/vir.0.19564-0; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	65	51	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7997	10.1371/journal.pone.0007997	http://dx.doi.org/10.1371/journal.pone.0007997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956697	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000272827500024
J	Drahos, KE; Welsh, JD; Finkielstein, CV; Capelluto, DGS				Drahos, Karen E.; Welsh, John D.; Finkielstein, Carla V.; Capelluto, Daniel G. S.			Sulfatides Partition Disabled-2 in Response to Platelet Activation	PLOS ONE			English	Article							PTB DOMAIN; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; AGGREGATION; CELLS; MEMBRANE; INTERNALIZATION; INHIBITION; EXPRESSION; RECEPTOR	Background: aggregation is Disabled-2 (Dab2), which is released to the extracellular surface upon platelet activation. Dab2 inhibits platelet aggregation through its phosphotyrosine-binding (PTB) domain by competing with fibrinogen for alpha IIb beta 3 integrin receptor binding by an unknown mechanism. Methodology/Principal Findings: Using protein-lipid overlay and liposome-binding assays, we identified that the N-terminal region of Dab2, including its PTB domain (N-PTB), specifically interacts with sulfatides. Moreover, we determined that such interaction is mediated by two conserved basic motifs with a dissociation constant (K-d) of 0.6 mu M as estimated by surface plasmon resonance (SPR) analysis. In addition, liposome-binding assays combined with mass spectroscopy studies revealed that thrombin, a strong platelet agonist, cleaved N-PTB at a site located between the basic motifs, a region that becomes protected from thrombin cleavage when bound to sulfatides. Sulfatides on the platelet surface interact with coagulation proteins, playing a major role in haemostasis. Our results show that sulfatides recruit N-PTB to the platelet surface, sequestering it from integrin receptor binding during platelet activation. This is a transient recruitment that follows N-PTB internalization by an actin-dependent process. Conclusions/Significance: Our experimental data support a model where two pools of Dab2 co-exist at the platelet surface, in both sulfatide-and integrin receptor-bound states, and their balance controls the extent of the clotting response.	[Drahos, Karen E.; Capelluto, Daniel G. S.] Virginia Polytech Inst & State Univ, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA; [Drahos, Karen E.; Welsh, John D.; Finkielstein, Carla V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Drahos, KE (corresponding author), Virginia Polytech Inst & State Univ, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA.	finkielc@vt.edu; capellut@vt.edu		finkielstein, carla/0000-0002-8417-4643	Department of Biological Sciences, Virginia Polytechnic Institute and State University	Department of Biological Sciences, Virginia Polytechnic Institute and State University	This work was supported by the Department of Biological Sciences, Virginia Polytechnic Institute and State University to DGSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anupam K, 2006, WORLD J GASTROENTERO, V12, P6041, DOI 10.3748/wjg.v12.i37.6041; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BAJORATH J, 1994, BIOCHEMISTRY-US, V33, P1332, DOI 10.1021/bi00172a007; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Berntson Z, 1998, J NEUROSCI RES, V52, P559, DOI 10.1002/(SICI)1097-4547(19980601)52:5<559::AID-JNR8>3.0.CO;2-B; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bodin S, 2005, J CELL SCI, V118, P759, DOI 10.1242/jcs.01648; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; FUJIMOTO T, 1982, J CLIN INVEST, V69, P1212, DOI 10.1172/JCI110560; Hailstones D, 1998, J LIPID RES, V39, P369; HANSSON CG, 1978, J BIOCHEM-TOKYO, V83, P813, DOI 10.1093/oxfordjournals.jbchem.a131977; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; Ida M, 2004, J BIOCHEM, V135, P583, DOI 10.1093/jb/mvh071; Isaac G, 2006, FEBS J, V273, P1782, DOI 10.1111/j.1742-4658.2006.05195.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Kushi Y, 1996, BBA-LIPID LIPID MET, V1304, P254, DOI 10.1016/S0005-2760(96)00125-7; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Merten M, 2005, ARTERIOSCL THROM VAS, V25, P258, DOI 10.1161/01.ATV.0000149675.83552.83; Merten M, 2001, CIRCULATION, V104, P2955, DOI 10.1161/hc4901.100383; Miller MW, 2009, P NATL ACAD SCI USA, V106, P719, DOI 10.1073/pnas.0811622106; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nakayama T, 2008, INT J HEMATOL, V87, P363, DOI 10.1007/s12185-008-0065-8; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1988, ARCH BIOCHEM BIOPHYS, V267, P405, DOI 10.1016/0003-9861(88)90046-X; Sandhoff R, 2005, BBA-MOL CELL BIOL L, V1687, P52, DOI 10.1016/j.bbalip.2004.11.011; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Stolt PC, 2005, J BIOL CHEM, V280, P9671, DOI 10.1074/jbc.M413356200; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WencelDrake JD, 1996, BLOOD, V87, P602, DOI 10.1182/blood.V87.2.602.bloodjournal872602; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	54	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8007	10.1371/journal.pone.0008007	http://dx.doi.org/10.1371/journal.pone.0008007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956625	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827500030
J	Monahan, WB				Monahan, William B.			A Mechanistic Niche Model for Measuring Species' Distributional Responses to Seasonal Temperature Gradients	PLOS ONE			English	Article							CLIMATE-CHANGE; ECOLOGICAL NICHES; ENVELOPE MODELS; FIELD SPARROW; CONSTRAINTS; ENERGY; RANGE; EVOLUTION; HABITAT; IMPACT	Niche theory is central to understanding how species respond geographically to climate change. It defines a species' realized niche in a biological community, its fundamental niche as determined by physiology, and its potential niche-the fundamental niche in a given environment or geographic space. However, most predictions of the effects of climate change on species' distributions are limited to correlative models of the realized niche, which assume that species are in distributional equilibrium with respect to the variables or gradients included in the model. Here, I present a mechanistic niche model that measures species' responses to major seasonal temperature gradients that interact with the physiology of the organism. I then use lethal physiological temperatures to parameterize the model for bird species in North and South America and show that most focal bird species are not in direct physiological equilibrium with the gradients. Results also show that most focal bird species possess broad thermal tolerances encompassing novel climates that could become available with climate change. I conclude with discussion of how mechanistic niche models may be used to (i) gain insights into the processes that cause species to respond to climate change and (ii) build more accurate correlative distribution models in birds and other species.			Monahan, WB (corresponding author), Audubon Calif, Emeryville, CA USA.	wmonahan@audubon.org						*AM ORN UN, 2009, AOU CHECK LIST N AM; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barton N.H, 2001, INTEGRATING ECOLOGY, P365; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Blem C.R., 1973, Ornithological Monographs, VNo. 14, P96; Bohning-Gaese K, 2003, J EVOLUTION BIOL, V16, P956, DOI 10.1046/j.1420-9101.2003.00605.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; CLEMANS RJ, 1973, CONDOR, V76, P358; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COX GW, 1961, ECOLOGY, V42, P253, DOI 10.2307/1932077; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Holt RD, 2004, AM NAT, V164, P187, DOI 10.1086/422343; HOLT RD, 1992, EVOLUTIONARY ECOLOGY, V6, P443; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KENDEIGH SC, 1969, WILSON BULL, V81, P441; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; KONTOGIANNIS JE, 1968, PHYSIOL ZOOL, V41, P54, DOI 10.1086/physzool.41.1.30158484; LEVINS R, 1966, AM SCI, V54, P421; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Long J.L., 1981, INTRO BIRDS WORLD WO; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Monahan WB, 2008, BIOL LETTERS, V4, P595, DOI 10.1098/rsbl.2008.0154; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mustin K, 2007, CLIM RES, V35, P165, DOI 10.3354/cr00723; *NAT CLIM DAT CTR, 2009, GLOB MEAS EXTR TEMP; Nosil P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001907; OLSON JB, 1980, AUK, V97, P704; OSMOND CB, 1987, BIOSCIENCE, V37, P38, DOI 10.2307/1310176; OWEN RB, 1970, CONDOR, V72, P153, DOI 10.2307/1366625; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEST GEORGE C., 1960, AUK, V77, P306; WILLIAMS JE, 1982, J WILDLIFE MANAGE, V46, P588, DOI 10.2307/3808549; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; WOODWARD FI, 1990, PHILOS T ROY SOC B, V326, P585, DOI 10.1098/rstb.1990.0033; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825; ZIMMERMA.JL, 1965, PHYSIOL ZOOL, V38, P370, DOI 10.1086/physzool.38.4.30152415; [No title captured]	62	55	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7921	10.1371/journal.pone.0007921	http://dx.doi.org/10.1371/journal.pone.0007921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936234	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004800006
J	Bruel-Jungerman, E; Veyrac, A; Dufour, F; Horwood, J; Laroche, S; Davis, S				Bruel-Jungerman, Elodie; Veyrac, Alexandra; Dufour, Franck; Horwood, Jennifer; Laroche, Serge; Davis, Sabrina			Inhibition of PI3K-Akt Signaling Blocks Exercise-Mediated Enhancement of Adult Neurogenesis and Synaptic Plasticity in the Dentate Gyrus	PLOS ONE			English	Article							PROTEIN-KINASE-B; LONG-TERM POTENTIATION; NEURAL PROGENITOR CELLS; ELEMENT-BINDING PROTEIN; HIPPOCAMPAL NEUROGENESIS; GENE-EXPRESSION; GROWTH-FACTOR; ENVIRONMENTAL ENRICHMENT; PHYSICAL-ACTIVITY; RAT HIPPOCAMPUS	Background: Physical exercise has been shown to increase adult neurogenesis in the dentate gyrus and enhances synaptic plasticity. The antiapoptotic kinase, Akt has also been shown to be phosphorylated following voluntary exercise; however, it remains unknown whether the PI3K-Akt signaling pathway is involved in exercise-induced neurogenesis and the associated facilitation of synaptic plasticity in the dentate gyrus. Methodology/Principal Findings: To gain insight into the potential role of this signaling pathway in exercise-induced neurogenesis and LTP in the dentate gyrus rats were infused with the PI3K inhibitor, LY294002 or vehicle control solution (icv) via osmotic minipumps and exercised in a running wheel for 10 days. Newborn cells in the dentate gyrus were date-labelled with BrdU on the last 3 days of exercise. Then, they were either returned to the home cage for 2 weeks to assess exercise-induced LTP and neurogenesis in the dentate gyrus, or were killed on the last day of exercise to assess proliferation and activation of the PI3K-Akt cascade using western blotting. Conclusions/Significance: Exercise increases cell proliferation and promotes survival of adult-born neurons in the dentate gyrus. Immediately after exercise, we found that Akt and three downstream targets, BAD, GSK3 beta and FOXO1 were activated. LY294002 blocked exercise-induced phosphorylation of Akt and downstream target proteins. This had no effect on exercise-induced cell proliferation, but it abolished most of the beneficial effect of exercise on the survival of newly generated dentate gyrus neurons and prevented exercise-induced increase in dentate gyrus LTP. These results suggest that activation of the PI3 kinase-Akt signaling pathway plays a significant role via an antiapoptotic function in promoting survival of newly formed granule cells generated during exercise and the associated increase in synaptic plasticity in the dentate gyrus.			Bruel-Jungerman, E (corresponding author), UPMC, INSERM, Inst Fer Moulin, U839 S, Paris, France.	sabrina.davis@u-psud.fr	Veyrac, Alexandra/G-8313-2017	VEYRAC, Alexandra/0000-0002-8063-4016				Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chen MJ, 2005, MOL BRAIN RES, V135, P181, DOI 10.1016/j.molbrainres.2004.12.001; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Galvan V, 2006, MINI-REV MED CHEM, V6, P667, DOI 10.2174/138955706777435742; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kelly A, 2003, J NEUROSCI, V23, P5354; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morgan D, 2007, EXP NEUROL, V205, P330, DOI 10.1016/j.expneurol.2007.03.006; Muller AP, 2008, NEUROCHEM RES, V33, P880, DOI 10.1007/s11064-007-9530-7; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park SM, 2008, CELL PROLIFERAT, V41, P248, DOI 10.1111/j.1365-2184.2008.00514.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schweitzer NB, 2006, NEUROCHEM INT, V48, P9, DOI 10.1016/j.neuint.2005.08.006; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shen H, 2001, NEUROSCIENCE, V107, P219, DOI 10.1016/S0306-4522(01)00315-3; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	70	92	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7901	10.1371/journal.pone.0007901	http://dx.doi.org/10.1371/journal.pone.0007901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936256	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004600006
J	Vaughan, MB; Ramirez, RD; Andrews, CM; Wright, WE; Shay, JW				Vaughan, Melville B.; Ramirez, Ruben D.; Andrews, Capri M.; Wright, Woodring E.; Shay, Jerry W.			H-Ras Expression in Immortalized Keratinocytes Produces an Invasive Epithelium in Cultured Skin Equivalents	PLOS ONE			English	Article							BASEMENT-MEMBRANE; EPIDERMAL CARCINOGENESIS; INTERMEDIATE-FILAMENTS; 3-DIMENSIONAL MODELS; STEM-CELLS; IN-VITRO; FIBROBLASTS; GROWTH; DIFFERENTIATION; TUMORIGENESIS	Background: Ras proteins affect both proliferation and expression of collagen-degrading enzymes, two important processes in cancer progression. Normal skin architecture is dependent both on the coordinated proliferation and stratification of keratinocytes, as well as the maintenance of a collagen-rich basement membrane. In the present studies we sought to determine whether expression of H-ras in skin keratinocytes would affect these parameters during the establishment and maintenance of an in vitro skin equivalent. Methodology/Principal Findings: Previously described cdk4 and hTERT immortalized foreskin keratinocytes were engineered to express ectopically introduced H-ras. Skin equivalents, composed of normal fibroblast-contracted collagen gels overlaid with keratinocytes (immortal or immortal expressing H-ras), were prepared and incubated for 3 weeks. Harvested tissues were processed and sectioned for histology and antibody staining. Antigens specific to differentiation (involucrin, keratin-14, p63), basement-membrane formation (collagen IV, laminin-5), and epithelial to mesenchymal transition (EMT; e-cadherin, vimentin) were studied. Results showed that H-ras keratinocytes produced an invasive, disorganized epithelium most apparent in the lower strata while immortalized keratinocytes fully stratified without invasive properties. The superficial strata retained morphologically normal characteristics. Vimentin and p63 co-localization increased with H-ras overexpression, similar to basal wound-healing keratinocytes. In contrast, the cdk4 and hTERT immortalized keratinocytes differentiated similarly to normal unimmortalized keratinocytes. Conclusions/Significance: The use of isogenic derivatives of stable immortalized keratinocytes with specified genetic alterations may be helpful in developing more robust in vitro models of cancer progression.			Vaughan, MB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	mvaughan4@uco.edu; Jerry.Shay@utsouthwestern.edu	Vaughan, Melville B/J-6637-2016; Shay, Jerry W/F-7878-2011	Vaughan, Melville B/0000-0003-4648-6141; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016478] Funding Source: Medline; PHS HHS [P2PRR016478] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andriani F, 2004, INT J CANCER, V108, P348, DOI 10.1002/ijc.11525; Biddle D, 1996, ARCH DERMATOL RES, V288, P621, DOI 10.1007/s004030050113; BOUKAMP P, 1990, CANCER RES, V50, P2840; Chamulitrat W, 2003, EUR J CELL BIOL, V82, P313, DOI 10.1078/0171-9335-00317; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Escamez MJ, 2004, J INVEST DERMATOL, V123, P1182, DOI 10.1111/j.0022-202X.2004.23473.x; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Garlick JA, 2007, ADV BIOCHEM ENG BIOT, V103, P207; Gollahon LS, 1996, ONCOGENE, V12, P715; GUARINO M, 1995, HISTOL HISTOPATHOL, V10, P171; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5; MARINKOVICH MP, 1993, DEV DYNAM, V197, P255, DOI 10.1002/aja.1001970404; Nova D, 2003, CLIN EXP METASTAS, V20, P675, DOI 10.1023/B:CLIN.0000006816.09548.31; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; PARENTEAU N, 1994, KERATINOCYTE METHODS, P45; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; QUINTANILLA M, 1991, CARCINOGENESIS, V12, P1875, DOI 10.1093/carcin/12.10.1875; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Ridky TW, 2004, CELL CYCLE, V3, P621; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Roig AI, 2009, RADIAT RES, V171, P33, DOI 10.1667/RR1415.1; Shay JW, 2005, ANN NY ACAD SCI, V1057, P479, DOI 10.1196/annals.1356.037; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tornakidi P, 2003, J PATHOL, V200, P298, DOI 10.1002/path.1366; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vaughan MB, 2004, REJUV RES, V7, P99, DOI 10.1089/1549168041552982; Vosseler S, 2009, INT J CANCER, V125, P2296, DOI 10.1002/ijc.24589; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Windsor ML, 2009, AUSTRALAS J DERMATOL, V50, P29, DOI 10.1111/j.1440-0960.2008.00512.x; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7908	10.1371/journal.pone.0007908	http://dx.doi.org/10.1371/journal.pone.0007908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936293	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004600012
J	Delprat, A; Negre, B; Puig, M; Ruiz, A				Delprat, Alejandra; Negre, Barbara; Puig, Marta; Ruiz, Alfredo			The Transposon Galileo Generates Natural Chromosomal Inversions in Drosophila by Ectopic Recombination	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; P-ELEMENT TRANSPOSASE; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; YERSINIA-PESTIS; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; BORDETELLA-PERTUSSIS; EVOLUTIONARY HISTORY; POPULATION-GENETICS	Background: Transposable elements (TEs) are responsible for the generation of chromosomal inversions in several groups of organisms. However, in Drosophila and other Dipterans, where inversions are abundant both as intraspecific polymorphisms and interspecific fixed differences, the evidence for a role of TEs is scarce. Previous work revealed that the transposon Galileo was involved in the generation of two polymorphic inversions of Drosophila buzzatii. Methodology/Principal Findings: To assess the impact of TEs in Drosophila chromosomal evolution and shed light on the mechanism involved, we isolated and sequenced the two breakpoints of another widespread polymorphic inversion from D. buzzatii, 2z(3). In the non inverted chromosome, the 2z(3) distal breakpoint was located between genes CG2046 and CG10326 whereas the proximal breakpoint lies between two novel genes that we have named Dlh and Mdp. In the inverted chromosome, the analysis of the breakpoint sequences revealed relatively large insertions (2,870-bp and 4,786-bp long) including two copies of the transposon Galileo (subfamily Newton), one at each breakpoint, plus several other TEs. The two Galileo copies: (i) are inserted in opposite orientation; (ii) present exchanged target site duplications; and (iii) are both chimeric. Conclusions/Significance: Our observations provide the best evidence gathered so far for the role of TEs in the generation of Drosophila inversions. In addition, they show unequivocally that ectopic recombination is the causative mechanism. The fact that the three polymorphic D. buzzatii inversions investigated so far were generated by the same transposon family is remarkable and is conceivably due to Galileo's unusual structure and current (or recent) transpositional activity.			Delprat, A (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.	Alfredo.Ruiz@uab.es	Negre, Barbara/F-2540-2013; Puig, Marta/F-7885-2016; Ruiz, Alfredo/AAB-2759-2019; Delprat Obeaga, Alejandra/F-8007-2016; Ruiz, Alfredo/ABH-2402-2020; Obeaga, Alejandra Delprat/AAE-6301-2021	Negre, Barbara/0000-0002-7333-3979; Puig, Marta/0000-0002-4439-6372; Delprat Obeaga, Alejandra/0000-0002-5187-802X; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andolfatto P, 2000, GENETICS, V154, P1681; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beall EL, 1997, GENE DEV, V11, P2137, DOI 10.1101/gad.11.16.2137; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; BERGMAN CM, 2002, GENOME BIOL, V3, P86, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0086; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Casals F, 2005, GENETICS, V169, P2047, DOI 10.1534/genetics.104.035048; Casals F, 2003, MOL BIOL EVOL, V20, P674, DOI 10.1093/molbev/msg070; Casals F, 2006, CHROMOSOMA, V115, P403, DOI 10.1007/s00412-006-0071-7; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; CIRERA S, 1995, GENETICS, V139, P321; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coulibaly MB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000849; da Costa OP, 2009, CHROMOSOMA, V118, P349, DOI 10.1007/s00412-008-0201-5; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans AL, 2007, GENETICS, V177, P1303, DOI 10.1534/genetics.107.073932; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Gonzalez J, 2005, GENOME RES, V15, P885, DOI 10.1101/gr.3263105; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Gray YHM, 1996, GENETICS, V144, P1601; HASSON E, 1995, J EVOLUTION BIOL, V8, P369, DOI 10.1046/j.1420-9101.1995.8030369.x; HASSON E, 1991, J EVOLUTION BIOL, V4, P209, DOI 10.1046/j.1420-9101.1991.4020209.x; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Huang JT, 2008, PLANT CELL, V20, P2019, DOI 10.1105/tpc.108.060582; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iriarte PJF, 2003, HEREDITY, V91, P51, DOI 10.1038/sj.hdy.6800280; Ji XL, 2008, GENOMICS, V91, P249, DOI 10.1016/j.ygeno.2007.10.014; Jordan IK, 1998, J MOL EVOL, V47, P14, DOI 10.1007/PL00006358; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidwell MG, 2002, MOBILE DNA, P59; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KREITMAN M, 1991, GENETICS, V127, P565; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Laayouni H, 2000, GENETICS, V156, P1797; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; LEVIS R, 1982, CELL, V30, P551, DOI 10.1016/0092-8674(82)90252-5; Lewis SM, 2006, DNA REPAIR, V5, P1146, DOI 10.1016/j.dnarep.2006.05.014; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Marzo M, 2008, P NATL ACAD SCI USA, V105, P2957, DOI 10.1073/pnas.0712110105; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; MCDONALD JF, 1993, CURR OPIN GENET DEV, V3, P855, DOI 10.1016/0959-437X(93)90005-A; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; Nag DK, 1997, GENETICS, V146, P835; Navarro A, 1997, GENETICS, V146, P695; Negre B, 2005, GENOME RES, V15, P692, DOI 10.1101/gr.3468605; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortiz MD, 2009, GENETICA, V135, P67, DOI 10.1007/s10709-008-9259-5; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pereira Vini, 2009, PLoS One, V4, pe4321, DOI 10.1371/journal.pone.0004321; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; Piccinali RV, 2007, J MOL EVOL, V64, P158, DOI 10.1007/s00239-005-0224-y; PICOLOGLOU S, 1988, MOL GEN GENET, V211, P272, DOI 10.1007/BF00330604; Powell J. R., 1997, PROGR PROSPECTS EVOL; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Redder P, 2006, J BACTERIOL, V188, P4198, DOI 10.1128/JB.00061-06; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI [10.1111/j.1558-5646.1999.tb03796.x, 10.2307/2640797]; ROEDER GS, 1983, MOL GEN GENET, V190, P117; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUIZ A, 1993, HEREDITY, V70, P582, DOI 10.1038/hdy.1993.85; RUIZ A, 1986, EVOLUTION, V40, P740, DOI 10.1111/j.1558-5646.1986.tb00534.x; Ruiz A., 1984, Genetica Iberica, V36, P13; Runcie DE, 2009, GENETICA, V136, P5, DOI 10.1007/s10709-008-9296-0; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schaeffer SW, 2008, GENETICS, V179, P1601, DOI 10.1534/genetics.107.086074; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH PA, 1991, ADV GENET, V29, P229, DOI 10.1016/S0065-2660(08)60109-1; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; SVOBODA YHM, 1995, GENETICS, V139, P1601; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang M, 2007, J BIOL CHEM, V282, P29002, DOI 10.1074/jbc.M704106200; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; WESLEY CS, 1994, P NATL ACAD SCI USA, V91, P3132, DOI 10.1073/pnas.91.8.3132; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Zhang JB, 2009, GENE DEV, V23, P755, DOI 10.1101/gad.1776909; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P8326, DOI 10.1073/pnas.151008498; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	113	52	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7883	10.1371/journal.pone.0007883	http://dx.doi.org/10.1371/journal.pone.0007883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19936241	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700016
J	Kimura, HJ; Chen, CY; Tzou, SC; Rocchi, R; Landek-Salgado, MA; Suzuki, K; Kimura, M; Rose, NR; Caturegli, P				Kimura, Hiroaki J.; Chen, Cindy Y.; Tzou, Shey-Cherng; Rocchi, Roberto; Landek-Salgado, Melissa A.; Suzuki, Koichi; Kimura, Miho; Rose, Noel R.; Caturegli, Patrizio			Immunoproteasome Overexpression Underlies the Pathogenesis of Thyroid Oncocytes and Primary Hypothyroidism: Studies in Humans and Mice	PLOS ONE			English	Article							PROTEASOME WORSENS ATHEROSCLEROSIS; AUTOIMMUNE-DISEASES; SJOGRENS-SYNDROME; INTERFERON-GAMMA; LMP2 EXPRESSION; NOD MICE; INHIBITION; SUBUNITS; CELL; BORTEZOMIB	Background: Oncocytes of the thyroid gland (Hurthle cells) are found in tumors and autoimmune diseases. They have a unique appearance characterized by abundant granular eosinophilic cytoplasm and hyperchromatic nucleus. Their pathogenesis has remained, thus far, unknown. Methodology/Principal Findings: Using transgenic mice chronically expressing IFN gamma in thyroid gland, we showed changes in the thyroid follicular epithelium reminiscent of the human oncocyte. Transcriptome analysis comparing transgenic to wild type thyrocytes revealed increased levels of immunoproteasome subunits like LMP2 in transgenics, suggesting an important role of the immunoproteasome in oncocyte pathogenesis. Pharmacologic blockade of the proteasome, in fact, ameliorated the oncocytic phenotype. Genetic deletion of LMP2 subunit prevented the development of the oncocytic phenotype and primary hypothyroidism. LMP2 was also found expressed in oncocytes from patients with Hashimoto thyroiditis and Hurthle cell tumors. Conclusions/Significance: In summary, we report that oncocytes are the result of an increased immunoproteasome expression secondary to a chronic inflammatory milieu, and suggest LMP2 as a novel therapeutic target for the treatment of oncocytic lesions and autoimmune hypothyroidism.			Kimura, HJ (corresponding author), Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21218 USA.	pcat@jhmi.edu	Kimura, Hiroaki/E-3224-2010; Suzuki, Koichi/C-4177-2013	Kimura, Hiroaki/0000-0002-7441-0382; Landek-Salgado, Melissa/0000-0002-4707-2066; Suzuki, Koichi/0000-0001-8659-4660	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080334, R01DK055670, R56DK055670] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK055670, DK55670, R01 DK055670, R21 DK080334, DK080334] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Benvenga S, 2008, HORM METAB RES, V40, P323, DOI 10.1055/s-2008-1073155; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; Caturegli P, 2005, THYROID, V15, P121, DOI 10.1089/thy.2005.15.121; Caturegli P, 2000, P NATL ACAD SCI USA, V97, P1719, DOI 10.1073/pnas.020522597; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Egerer K, 2002, J RHEUMATOL, V29, P2045; Egerer T, 2006, ARTHRITIS RHEUM-US, V54, P1501, DOI 10.1002/art.21782; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Fukai T, 2007, CIRC RES, V101, P859, DOI 10.1161/CIRCRESAHA.107.164020; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi T, 2000, NAT MED, V6, P1065, DOI 10.1038/80353; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Kessler BM, 2000, NAT MED, V6, P1064, DOI 10.1038/80346; Kimura H, 2005, INT J EXP PATHOL, V86, P97, DOI 10.1111/j.0959-9673.2005.00418.x; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; Krause S, 2006, ANN RHEUM DIS, V65, P1021, DOI 10.1136/ard.2005.045930; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Ludwig A, 2008, CIRC RES, V102, pE37, DOI 10.1161/CIRCRESAHA.107.168963; Maksymowych WP, 2000, J RHEUMATOL, V27, P183; Montone KT, 2008, ARCH PATHOL LAB MED, V132, P1241, DOI 10.1043/1543-2165(2008)132[1241:TTHOCA]2.0.CO;2; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Runnels HA, 2000, NAT MED, V6, P1064, DOI 10.1038/80349; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scheffler S, 2008, RHEUMATOLOGY, V47, P622, DOI 10.1093/rheumatology/ken042; TALLINI G, 1992, ACTA PATHOL JAPON, V42, P305; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; VivesPi M, 1997, TISSUE ANTIGENS, V50, P153, DOI 10.1111/j.1399-0039.1997.tb02854.x	39	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7857	10.1371/journal.pone.0007857	http://dx.doi.org/10.1371/journal.pone.0007857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924240	Green Published, gold, Green Submitted			2022-12-27	WOS:000271854200007
J	Chakrabarti, AK; Pawar, SD; Cherian, SS; Koratkar, SS; Jadhav, SM; Pal, B; Raut, S; Thite, V; Kode, SS; Keng, SS; Payyapilly, BJ; Mullick, J; Mishra, AC				Chakrabarti, Alok K.; Pawar, Shailesh D.; Cherian, Sarah S.; Koratkar, Santosh S.; Jadhav, Santosh M.; Pal, Biswajoy; Raut, Satish; Thite, Vishal; Kode, Sadhana S.; Keng, Sachin S.; Payyapilly, Bestin J.; Mullick, Jayati; Mishra, Akhilesh C.			Characterization of the Influenza A H5N1 Viruses of the 2008-09 Outbreaks in India Reveals a Third Introduction and Possible Endemicity	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; PATHOGENICITY; RESISTANCE; HEMAGGLUTININ; INHIBITORS; EFFICIENCY; POULTRY	Widespread infection of highly pathogenic avian influenza A H5N1 was reported from backyard and commercial poultry in West Bengal (WB), an eastern state of India in early 2008. Infection gradually spread to Tripura, Assam and Sikkim, the northeastern states, with 70 outbreaks reported between January 2008 and May 2009. Whole genome sequence analysis of three isolates from WB, one isolate from Tripura along with the analysis of hemagglutinin (HA) and neuraminidase (NA) genes of 17 other isolates was performed during this study. In the HA gene phylogenetic tree, all the 2008-09 Indian isolates belonged to EMA3 sublineage of clade 2.2. The closest phylogenetic relationship was found to be with the 2007-09 isolates from Bangladesh and not with the earlier 2006 and 2007 Indian isolates implying a third introduction into the country. The receptor-binding pocket of HA1 of two isolates from WB showed S221P mutation, one of the markers predicted to be associated with human receptor specificity. Two substitutions E119A (2 isolates of WB) and N294S (2 other isolates of WB) known to confer resistance to NA inhibitors were observed in the active site of neuraminidase. Several additional mutations were observed within the 2008-09 Indian isolates indicating genetic diversification. Overall, the study is indicative of a possible endemicity in the eastern and northeastern parts of the country, demanding active surveillance specifically in view of the critical mutations that have been observed in the influenza A H5N1 viruses.			Chakrabarti, AK (corresponding author), Natl Inst Virol, Microbial Containment Complex, Pune, Maharashtra, India.	acm1750@rediffmail.com	Cherian, Sarah/ABA-6207-2021; Koratkar, Santosh/GLN-7548-2022; Cherian, /411001/H-1332-2016; Raut, Satish/AAP-2262-2021; Jadhav, Santoshkumar/AAB-7634-2021	Koratkar, Santosh/0000-0002-9413-950X; Keng, Sachin/0000-0002-4831-9745				ARNOLD SM, 2006, ANTIMICROB AGENTS CH, V50, P2395; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; BROOKS WA, 2009, EMERG INFECT DIS, V15, P7; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2009, ANTIMICROB AGENTS CH, V53, P1039, DOI 10.1128/AAC.01446-08; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Ilyushina NA, 2009, ANTIVIR RES, V82, pA71, DOI 10.1016/j.antiviral.2009.02.176; ISLAM MR, BANGK INT C AV INFL; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OIE, UPD HIGHL PATH AV IN; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; SEOSH SH, 2007, NAT MED, V8, P950; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; *WHO, WHO H5N1 AV INFL TIM; *WHO, REC LAB TESTS ID AV; World Health Organization, CUM NUMB CONF HUM CA; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; 2009, CONTINUING PROGR UNI	42	61	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7846	10.1371/journal.pone.0007846	http://dx.doi.org/10.1371/journal.pone.0007846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924254	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000006
J	Li, L; Fridley, BL; Kalari, K; Jenkins, G; Batzler, A; Weinshilboum, RM; Wang, LW				Li, Liang; Fridley, Brooke L.; Kalari, Krishna; Jenkins, Gregory; Batzler, Anthony; Weinshilboum, Richard M.; Wang, Liewei			Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ETOPOSIDE-INDUCED CYTOTOXICITY; HARDY-WEINBERG EQUILIBRIUM; GENE-EXPRESSION; CYTOSINE-ARABINOSIDE; VAV PROTEINS; LUNG-CANCER; EXACT TESTS; CELL-LINES; VARIANTS	Cancer patients show large individual variation in their response to chemotherapeutic agents. Gemcitabine (dFdC) and AraC, two cytidine analogues, have shown significant activity against a variety of tumors. We previously used expression data from a lymphoblastoid cell line-based model system to identify genes that might be important for the two drug cytotoxicity. In the present study, we used that same model system to perform a genome-wide association (GWA) study to test the hypothesis that common genetic variation might influence both gene expression and response to the two drugs. Specifically, genome-wide single nucleotide polymorphisms (SNPs) and mRNA expression data were obtained using the Illumina 550K (R) HumanHap550 SNP Chip and Affymetrix U133 Plus 2.0 GeneChip, respectively, for 174 ethnically-defined "Human Variation Panel" lymphoblastoid cell lines. Gemcitabine and AraC cytotoxicity assays were performed to obtain IC(50) values for the cell lines. We then performed GWA studies with SNPs, gene expression and IC(50) of these two drugs. This approach identified SNPs that were associated with gemcitabine or AraC IC(50) values and with the expression regulation for 29 genes or 30 genes, respectively. One SNP in IQGAP2 (rs3797418) was significantly associated with variation in both the expression of multiple genes and gemcitabine and AraC IC(50). A second SNP in TGM3 (rs6082527) was also significantly associated with multiple gene expression and gemcitabine IC50. To confirm the association results, we performed siRNA knock down of selected genes with expression that was associated with rs3797418 and rs6082527 in tumor cell and the knock down altered gemcitabine or AraC sensitivity, confirming our association study results. These results suggest that the application of GWA approaches using cell-based model systems, when combined with complementary functional validation, can provide insights into mechanisms responsible for variation in cytidine analogue response.			Li, L (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	wang.liewei@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Kalari, Krishna/0000-0001-8944-8378; Li, Liang/0000-0003-1893-1965	NCI NIH HHS [R01 CA132780, K22 CA130828, CA102701, R01 CA138461, P20 CA102701, P50 CA102701] Funding Source: Medline; NIGMS NIH HHS [U01 GM061388, R01 GM28157, U19 GM061388, GM61388, R01 GM028157] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA130828, R01CA138461, P50CA102701, R01CA132780, P20CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061388, R01GM028157, U19GM061388] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Campbell TB, 2000, AIDS, V14, P2109, DOI 10.1097/00002030-200009290-00006; CHOY E, 2009, PLOS GENET, V4, P1; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Duan SW, 2007, CANCER RES, V67, P5425, DOI 10.1158/0008-5472.CAN-06-4431; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Feng WH, 2002, CANCER RES, V62, P1920; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gullans SR, 2006, NEW ENGL J MED, V355, P2042, DOI 10.1056/NEJMcibr065953; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gwee PC, 2005, PHARMACOGENET GENOM, V15, P91, DOI 10.1097/01213011-200502000-00005; Half E, 2002, CANCER RES, V62, P1676; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; HEINEMANN V, 1992, CANCER RES, V52, P533; HEINEMANN V, 1988, CANCER RES, V48, P4024; HERTEL LW, 1990, CANCER RES, V50, P4417; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Kern W, 2006, CANCER-AM CANCER SOC, V107, P116, DOI 10.1002/cncr.21543; Kim SR, 2006, DRUG METAB PHARMACOK, V21, P248, DOI 10.2133/dmpk.21.248; Kim SR, 2008, DRUG METAB PHARMACOK, V23, P379, DOI 10.2133/dmpk.23.379; Kindler Hedy Lee, 2005, Clin Adv Hematol Oncol, V3, P420; Kwon WS, 2006, PHARMACOGENET GENOM, V16, P429, DOI 10.1097/01.fpc.0000204999.29924.da; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Li J, 2005, HUM MOL GENET, V14, pR163, DOI 10.1093/hmg/ddi267; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Lokiec F, 2007, B CANCER, V94, pS85; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schadt EE, 2005, CURR OPIN BIOTECH, V16, P647, DOI 10.1016/j.copbio.2005.10.005; Schaid DJ, 2006, AM J HUM GENET, V79, P1071, DOI 10.1086/510257; Schoch C, 2001, BRIT J HAEMATOL, V112, P118, DOI 10.1046/j.1365-2141.2001.02511.x; Seve P, 2005, LUNG CANCER, V49, P363, DOI 10.1016/j.lungcan.2005.04.008; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shukla SJ, 2008, PHARMACOGENET GENOM, V18, P253, DOI 10.1097/FPC.0b013e3282f5e605; Smid K, 2006, NUCLEOS NUCLEOT NUCL, V25, P1001, DOI 10.1080/15257770600890269; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Trenkle T, 2000, GENE, V245, P139, DOI 10.1016/S0378-1119(00)00026-3; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Wu XF, 2001, CARCINOGENESIS, V22, P923, DOI 10.1093/carcin/22.6.923; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yonemori K, 2005, CLIN CANCER RES, V11, P2620, DOI 10.1158/1078-0432.CCR-04-1497; [No title captured]	63	65	71	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7765	10.1371/journal.pone.0007765	http://dx.doi.org/10.1371/journal.pone.0007765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898621	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658000009
J	Fontaine, JF; Mirebeau-Prunier, D; Raharijaona, M; Franc, B; Triau, S; Rodien, P; Goeau-Brissonniere, O; Karayan-Tapon, L; Mello, M; Houlgatte, R; Malthiery, Y; Savagner, F				Fontaine, Jean-Fred; Mirebeau-Prunier, Delphine; Raharijaona, Mahatsangy; Franc, Brigitte; Triau, Stephane; Rodien, Patrice; Goeau-Brissonniere, Olivier; Karayan-Tapon, Lucie; Mello, Marielle; Houlgatte, Remi; Malthiery, Yves; Savagner, Frederique			Increasing the Number of Thyroid Lesions Classes in Microarray Analysis Improves the Relevance of Diagnostic Markers	PLOS ONE			English	Article							GENE-EXPRESSION; TISSUE MICROARRAY; CARCINOMA; PAPILLARY; TUMORS; CANCER; CLASSIFICATION; PROFILES; METAANALYSIS; PROGRESSION	Background: Genetic markers for thyroid cancers identified by microarray analysis have offered limited predictive accuracy so far because of the few classes of thyroid lesions usually taken into account. To improve diagnostic relevance, we have simultaneously analyzed microarray data from six public datasets covering a total of 347 thyroid tissue samples representing 12 histological classes of follicular lesions and normal thyroid tissue. Our own dataset, containing about half the thyroid tissue samples, included all categories of thyroid lesions. Methodology/Principal Findings: Classifier predictions were strongly affected by similarities between classes and by the number of classes in the training sets. In each dataset, sample prediction was improved by separating the samples into three groups according to class similarities. The cross-validation of differential genes revealed four clusters with functional enrichments. The analysis of six of these genes (APOD, APOE, CLGN, CRABP1, SDHA and TIMP1) in 49 new samples showed consistent gene and protein profiles with the class similarities observed. Focusing on four subclasses of follicular tumor, we explored the diagnostic potential of 12 selected markers (CASP10, CDH16, CLGN, CRABP1, HMGB2, ALPL2, ADAMTS2, CABIN1, ALDH1A3, USP13, NR2F2, KRTHB5) by real-time quantitative RT-PCR on 32 other new samples. The gene expression profiles of follicular tumors were examined with reference to the mutational status of the Pax8-PPAR gamma, TSHR, GNAS and NRAS genes. Conclusion/Significance: We show that diagnostic tools defined on the basis of microarray data are more relevant when a large number of samples and tissue classes are used. Taking into account the relationships between the thyroid tumor pathologies, together with the main biological functions and pathways involved, improved the diagnostic accuracy of the samples. Our approach was particularly relevant for the classification of microfollicular adenomas.			Fontaine, JF (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	frederique.savagner@univ-angers.fr	Prunier, Delphine/K-3301-2015; Fontaine, Jean-Fred/GNP-2904-2022; Houlgatte, Remi/P-3020-2017; Rodien, Patrice/AAT-7909-2021	Fontaine, Jean-Fred/0000-0002-1101-4091; MELLO, Marielle/0000-0002-5454-3559				Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Barden CB, 2003, CLIN CANCER RES, V9, P1792; Baris O, 2004, J CLIN ENDOCR METAB, V89, P994, DOI 10.1210/jc.2003-031238; Barroeta JE, 2006, ENDOCR PATHOL, V17, P225, DOI 10.1385/EP:17:3:225; Bourasseau I, 2000, THYROID, V10, P761, DOI 10.1089/thy.2000.10.761; Carinci F, 2005, INT J IMMUNOPATH PH, V18, P513, DOI 10.1177/039463200501800311; Corvilain B, 2001, CLIN ENDOCRINOL, V55, P143, DOI 10.1046/j.1365-2265.2001.01365.x; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Dudoit S, 2002, GENOME BIOL, V3; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Eszlinger M, 2006, J CLIN ENDOCR METAB, V91, P1934, DOI 10.1210/jc.2005-1620; Eszlinger M, 2005, J CLIN ENDOCR METAB, V90, P1163, DOI 10.1210/jc.2004-1242; Eszlinger M, 2008, J CLIN ENDOCR METAB, V93, P3286, DOI 10.1210/jc.2008-0201; Finley DJ, 2004, SURGERY, V136, P1160, DOI 10.1016/j.surg.2004.05.061; Fontaine JF, 2008, ONCOGENE, V27, P2228, DOI 10.1038/sj.onc.1210853; Franc B, 2003, HUM PATHOL, V34, P1092, DOI 10.1016/S0046-8177(03)00403-9; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Giordano TJ, 2006, CLIN CANCER RES, V12, P1983, DOI 10.1158/1078-0432.CCR-05-2039; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Hawthorn L, 2004, HEAD NECK-J SCI SPEC, V26, P1069, DOI 10.1002/hed.20099; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang Y, 2003, INT J CANCER, V104, P735, DOI 10.1002/ijc.11006; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kubat M, 1998, IEEE T NEURAL NETWOR, V9, P813, DOI 10.1109/72.712154; Lacroix L, 2005, AM J PATHOL, V167, P223, DOI 10.1016/S0002-9440(10)62967-7; Lloyd RV, 2004, AM J SURG PATHOL, V28, P1336, DOI 10.1097/01.pas.0000135519.34847.f6; Netea-Maier RT, 2008, CANCER RES, V68, P1572, DOI 10.1158/0008-5472.CAN-07-5020; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Nucera C, 2005, J ENDOCRINOL INVEST, V28, P106, DOI 10.1007/BF03345351; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; SAVIN S, 2008, HUM PATHOL IN PRESS; Schmid KW, 2006, VIRCHOWS ARCH, V448, P385, DOI 10.1007/s00428-006-0162-0; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; Soiland H, 2007, CELL ONCOL, V29, P195; Stolf BS, 2005, CANCER LETT, V227, P59, DOI 10.1016/j.canlet.2004.11.050; Taylor KL, 2008, J INTERF CYTOK RES, V28, P733, DOI 10.1089/jir.2008.0030; Vasko V, 2003, J CLIN ENDOCR METAB, V88, P2745, DOI 10.1210/jc.2002-021186; Wasenius VM, 2003, CLIN CANCER RES, V9, P68; Watanabe T, 2009, CANCER, V115, P283, DOI 10.1002/cncr.24023; Wattel S, 2005, ONCOGENE, V24, P6902, DOI 10.1038/sj.onc.1208849; Weber F, 2005, J CLIN ENDOCR METAB, V90, P2512, DOI 10.1210/jc.2004-2028; Yeh MW, 2004, THYROID, V14, P207, DOI 10.1089/105072504773297885; Yukinawa N, 2006, BMC GENOMICS, V7, P1, DOI 10.1186/1471-2164-7-190	50	13	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7632	10.1371/journal.pone.0007632	http://dx.doi.org/10.1371/journal.pone.0007632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19893615	Green Published, gold, Green Accepted			2022-12-27	WOS:000271232000010
J	Pawitan, Y; Seng, KC; Magnusson, PKE				Pawitan, Yudi; Seng, Ku Chee; Magnusson, Patrik K. E.			How Many Genetic Variants Remain to Be Discovered?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CYSTIC-FIBROSIS; CANCER; POPULATION; GENOTYPE; DISEASES; TRAITS; RISK	A great majority of genetic markers discovered in recent genome-wide association studies have small effect sizes, and they explain only a small fraction of the genetic contribution to the diseases. How many more variants can we expect to discover and what study sizes are needed? We derive the connection between the cumulative risk of the SNP variants to the latent genetic risk model and heritability of the disease. We determine the sample size required for case-control studies in order to achieve a certain expected number of discoveries in a collection of most significant SNPs. Assuming similar allele frequencies and effect sizes of the currently validated SNPs, complex phenotypes such as type-2 diabetes would need approximately 800 variants to explain its 40% heritability. Much smaller numbers of variants are needed if we assume rare-variants but higher penetrance models. We estimate that up to 50,000 cases and an equal number of controls are needed to discover 800 common low-penetrant variants among the top 5000 SNPs. Under common and rare low-penetrance models, the very large studies required to discover the numerous variants are probably at the limit of practical feasibility. Under rare-variant with medium- to high-penetrance models (odds-ratios between 1.6 and 4.0), studies comparable in size to many existing studies are adequate provided the genotyping technology can interrogate more and rarer variants.	[Pawitan, Yudi; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Seng, Ku Chee] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore	Karolinska Institutet; National University of Singapore	Pawitan, Y (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	yudi.pawitan@ki.se	Magnusson, Patrik KE/C-4458-2017	Magnusson, Patrik KE/0000-0002-7315-7899	Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore	Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore(National University of Singapore)	Funded by the Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; McKone EF, 2006, CHEST, V130, P1441, DOI 10.1378/chest.130.5.1441; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Noh M, 2006, GENET EPIDEMIOL, V30, P37, DOI 10.1002/gepi.20099; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SHAM PC, 1997, STAT HUMAN GENETICS; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	22	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e7969	10.1371/journal.pone.0007969	http://dx.doi.org/10.1371/journal.pone.0007969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956539	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800003
J	Huang, LL; Cheng, TC; Xu, PZ; Cheng, DJ; Fang, T; Xia, QY				Huang, Lulin; Cheng, Tingcai; Xu, Pingzhen; Cheng, Daojun; Fang, Ting; Xia, Qingyou			A Genome-Wide Survey for Host Response of Silkworm, Bombyx mori during Pathogen Bacillus bombyseptieus Infection	PLOS ONE			English	Article							BORDER MEMBRANE-VESICLES; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; AMINOPEPTIDASE-N; IMMUNOGLOBULIN SUPERFAMILY; THURINGIENSIS-RESISTANT; DOMESTICATED SILKWORM; HELICOVERPA-ARMIGERA; PERITROPHIC MEMBRANE; BINDING PROTEIN	Host-pathogen interactions are complex relationships, and a central challenge is to reveal the interactions between pathogens and their hosts. Bacillus bombysepticus (Bb) which can produces spores and parasporal crystals was firstly separated from the corpses of the infected silkworms (Bombyx mori). Bb naturally infects the silkworm can cause an acute fuliginosa septicaemia and kill the silkworm larvae generally within one day in the hot and humid season. Bb pathogen of the silkworm can be used for investigating the host responses after the infection. Gene expression profiling during four time-points of silkworm whole larvae after Bb infection was performed to gain insight into the mechanism of Bb-associated host whole body effect. Genome-wide survey of the host genes demonstrated many genes and pathways modulated after the infection. GO analysis of the induced genes indicated that their functions could be divided into 14 categories. KEGG pathway analysis identified that six types of basal metabolic pathway were regulated, including genetic information processing and transcription, carbohydrate metabolism, amino acid and nitrogen metabolism, nucleotide metabolism, metabolism of cofactors and vitamins, and xenobiotic biodegradation and metabolism. Similar to Bacillus thuringiensis (Bt), Bb can also induce a silkworm poisoning-related response. In this process, genes encoding midgut peritrophic membrane proteins, aminopeptidase N receptors and sodium/calcium exchange protein showed modulation. For the first time, we found that Bb induced a lot of genes involved in juvenile hormone synthesis and metabolism pathway upregulated. Bb also triggered the host immune responses, including cellular immune response and serine protease cascade melanization response. Real time PCR analysis showed that Bb can induce the silkworm systemic immune response, mainly by the Toll pathway. Anti-microorganism peptides (AMPs), including of Attacin, Lebocin, Enbocin, Gloverin and Moricin families, were upregulated at 24 hours post the infection.	[Huang, Lulin; Xu, Pingzhen; Cheng, Daojun; Fang, Ting; Xia, Qingyou] Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Cheng, Tingcai; Xia, Qingyou] Chongqing Univ, Inst Agron & Life Sci, Chongqing 630044, Peoples R China; [Huang, Lulin] Sichuan Acad Agr Sci, Inst Econ Crops Breeding & Cultivat, Chengdu, Peoples R China	Southwest University - China; Chongqing University; Sichuan Academy of Agricultural Sciences (SAAS)	Xia, QY (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2005CBI21000]; Ministry of Education Development Plan of Changjiang Scholars; Innovative Team [IRT0750]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education Development Plan of Changjiang Scholars; Innovative Team	This work was supported by research grants from the National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx), grant number No. 2005CBI21000, to QYX; the Ministry of Education Development Plan of Changjiang Scholars and their Innovative Team, grant number IRT0750, to QYX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; Ashok Y, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252jc1; Aslett M, 2006, YEAST, V23, P913, DOI 10.1002/yea.1420; BECK WS, 1953, CANCER RES, V13, P309; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; BORGHETTI P, 2009, VET IMMUNOL IMMUNOPA; BOUTROS A R, 1962, Can Anaesth Soc J, V9, P353; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dean DH, 1996, GENE, V179, P111, DOI 10.1016/S0378-1119(96)00442-8; Dingwall C, 1990, Semin Cell Biol, V1, P11; Dutz W, 1971, Pathol Annu, V6, P209; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gan H, 2001, INSECT BIOCHEM MOLEC, V31, P887, DOI 10.1016/S0965-1748(01)00034-0; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Glinski Zdzislaw, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P149; Goldberg AV, 2002, J INVERTEBR PATHOL, V80, P148, DOI 10.1016/S0022-2011(02)00101-5; Grace Michael J., 2004, Antiviral Chemistry & Chemotherapy, V15, P287; HARTMAN ERNEST, 1931, LINGNAN SCI JOUR, V10, P279; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOFTE H, 1989, MICROBIOL REV, V53, P242; Huang L, 2009, INSECT MOL BIOL, V18, P517, DOI 10.1111/j.1365-2583.2009.00896.x; Ibiza-Palacios MS, 2008, BIOCHEM J, V409, P215, DOI 10.1042/BJ20070956; Ihara H, 2008, J INVERTEBR PATHOL, V98, P177, DOI 10.1016/j.jip.2008.02.007; Ingle SS, 2001, CURR MICROBIOL, V43, P255, DOI 10.1007/s002840010297; Jung JJ, 2007, ONCOL REP, V18, P593; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kamatani N, 1997, Nihon Naika Gakkai Zasshi, V86, P374; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karumbaiah L, 2007, COMP BIOCHEM PHYS B, V146, P139, DOI 10.1016/j.cbpb.2006.10.104; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LAFORCE FM, 1994, CLIN INFECT DIS, V19, P1009, DOI 10.1093/clinids/19.6.1009; Lan N, 2003, CURR OPIN CHEM BIOL, V7, P44, DOI 10.1016/S1367-5931(02)00020-0; Lavazec C, 2005, INSECT MOL BIOL, V14, P163, DOI 10.1111/j.1365-2583.2004.00541.x; LECHNER AJ, 1993, MICROSC RES TECHNIQ, V26, P444, DOI 10.1002/jemt.1070260512; LEE MK, 1992, J BIOL CHEM, V267, P3115; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; Li S, 2005, INSECT BIOCHEM MOLEC, V35, P1235, DOI 10.1016/j.ibmb.2005.06.005; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Masoudi-Nejad Ali, 2007, V406, P437; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Meidanis J, 2002, MICROBIOL MOL BIOL R, V66, P272, DOI 10.1128/MMBR.66.2.272-299.2002; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Molina-Heredia FP, 2006, P NATL ACAD SCI USA, V103, P14750, DOI 10.1073/pnas.0510828103; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Neill JD, 2003, BIOLOGICALS, V31, P97, DOI 10.1016/S1045-1056(03)00022-8; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oyama T, 2001, Nihon Rinsho, V59 Suppl 2, P156; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pandian GN, 2008, APPL ENVIRON MICROB, V74, P1324, DOI 10.1128/AEM.01901-07; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Prestwich GD, 1996, ARCH INSECT BIOCHEM, V32, P407, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;407::AID-ARCH13&gt;3.0.CO;2-G; Priyadharshini P., 2008, Current Biotica, V2, P181; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rees JS, 2009, J INVERTEBR PATHOL, V100, P139, DOI 10.1016/j.jip.2009.01.002; Roth CW, 2003, MOL CELLS, V15, P150; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sanchis V, 1999, J Soc Biol, V193, P523; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Shinkawa A, 1999, CURR MICROBIOL, V39, P14, DOI 10.1007/PL00006820; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; SLAMA K, 1971, ANNU REV BIOCHEM, V40, P1079, DOI 10.1146/annurev.bi.40.070171.005243; SRIVASTAVA US, 1985, PROG FOOD NUTR SCI, V9, P63; Szarowicz SE, 2009, INFECT IMMUN, V77, P2455, DOI 10.1128/IAI.00839-08; Takase H, 2009, DEV COMP IMMUNOL, V33, P789, DOI 10.1016/j.dci.2009.01.005; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tanaka H, 2005, BBA-GENE STRUCT EXPR, V1730, P10, DOI 10.1016/j.bbaexp.2005.05.007; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; THEOPOLD U, 1995, GENE, V156, P247, DOI 10.1016/0378-1119(95)00019-3; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Towb P, 1998, DEVELOPMENT, V125, P2443; UDAYASURIYAN V, 1994, BIOSCI BIOTECH BIOCH, V58, P830, DOI 10.1271/bbb.58.830; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Vieira CU, 2008, ARCH INSECT BIOCHEM, V67, P97, DOI 10.1002/arch.20224; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; WALTERS LL, 1993, J MED ENTOMOL, V30, P179, DOI 10.1093/jmedent/30.1.179; Wang F, 2006, VIRUS GENES, V33, P351, DOI 10.1007/s11262-006-0075-7; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yaoi K, 1999, FEBS LETT, V463, P221, DOI 10.1016/S0014-5793(99)01626-9; Zegers ND, 1999, J APPL MICROBIOL, V87, P309, DOI 10.1046/j.1365-2672.1999.00900.x; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Zhang RJ, 2009, SCI CHINA SER C, V52, P163, DOI 10.1007/s11427-009-0019-2; Zhou YJ, 2002, BIOSCI BIOTECH BIOCH, V66, P1488, DOI 10.1271/bbb.66.1488; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105	116	88	105	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8098	10.1371/journal.pone.0008098	http://dx.doi.org/10.1371/journal.pone.0008098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956592	gold, Green Published, Green Submitted			2022-12-27	WOS:000272828700011
J	Aguilar, JL; Kulkarni, R; Randis, TM; Soman, S; Kikuchi, A; Yin, YX; Ratner, AJ				Aguilar, Jorge L.; Kulkarni, Ritwij; Randis, Tara M.; Soman, Sandeep; Kikuchi, Alexander; Yin, Yuxin; Ratner, Adam J.			Phosphatase-Dependent Regulation of Epithelial Mitogen-Activated Protein Kinase Responses to Toxin-Induced Membrane Pores	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; FORMING TOXINS; MAPK PHOSPHATASES; CELL-SURVIVAL; P38 MAPK; PATHWAYS; PNEUMOLYSIN; INHIBITION; PP2A; 2A	Diverse bacterial species produce pore-forming toxins (PFT) that can puncture eukaryotic cell membranes. Host cells respond to sublytic concentrations of PFT through conserved intracellular signaling pathways, including activation of mitogen-activated protein kinases (MAPK), which are critical to cell survival. Here we demonstrate that in respiratory epithelial cells p38 and JNK MAPK were phosphorylated within 30 min of exposure to pneumolysin, the PFT from Streptococcus pneumoniae. This activation was tightly regulated, and dephosphorylation of both MAPK occurred within 60 min following exposure. Pretreatment of epithelial cells with inhibitors of cellular phosphatases, including sodium orthovanadate, calyculin A, and okadaic acid, prolonged and intensified MAPK activation. Specific inhibition of MAPK phosphatase-1 did not affect the kinetics of MAPK activation in PFT-exposed epithelial cells, but siRNA-mediated knockdown of serine/threonine phosphatases PP1 and PP2A were potent inhibitors of MAPK dephosphorylation. These results indicate an important role for PP1 and PP2A in termination of epithelial responses to PFT and only a minor contribution of dual-specificity phosphatases, such as MAPK phosphatase-1, which are the major regulators of MAPK signals in other cell types. Epithelial regulation of MAPK signaling in response to membrane disruption involves distinct pathways and may require different strategies for therapeutic interventions.	[Aguilar, Jorge L.; Kulkarni, Ritwij; Randis, Tara M.; Soman, Sandeep; Kikuchi, Alexander; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Ratner, Adam J.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10027 USA; [Yin, Yuxin] Columbia Univ, Dept Radiat Oncol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Aguilar, JL (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Randis, Tara/0000-0003-0348-6766; Ratner, Adam/0000-0003-1761-794X	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID) [AI065450]; Stony WoldHerbert Fund; Louis V. Gerstner, Jr., Scholars Program; Irving Scholars Program; John M. Driscoll, M. D., Children's Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065450] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stony WoldHerbert Fund; Louis V. Gerstner, Jr., Scholars Program; Irving Scholars Program; John M. Driscoll, M. D., Children's Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID: AI065450), the Stony WoldHerbert Fund (Grant-in-Aid), the Louis V. Gerstner, Jr., Scholars Program, the Irving Scholars Program, and the John M. Driscoll, M. D., Children's Fund (to A. J. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; Boudreau RTM, 2004, J LEUKOCYTE BIOL, V76, P1075, DOI 10.1189/jlb.1003498; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gould JM, 2002, J INFECT DIS, V186, P361, DOI 10.1086/341658; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Korchev YE, 1998, BIOCHEM J, V329, P571; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; St-Onge M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004902; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8076	10.1371/journal.pone.0008076	http://dx.doi.org/10.1371/journal.pone.0008076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956644	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400023
J	Vinton, SD; Perry, L; Reinhard, KJ; Santoro, CM; Teixeira-Santos, I				Vinton, Sheila Dorsey; Perry, Linda; Reinhard, Karl J.; Santoro, Calogero M.; Teixeira-Santos, Isabel			Impact of Empire Expansion on Household Diet: The Inka in Northern Chile's Atacama Desert	PLOS ONE			English	Article							CENTRAL ANDES; MAIZE; PERU; COPROLITES; PARASITISM; STATE	The impact of expanding civilization on the health of American indigenous societies has long been studied. Most studies have focused on infections and malnutrition that occurred when less complex societies were incorporated into more complex civilizations. The details of dietary change, however, have rarely been explored. Using the analysis of starch residues recovered from coprolites, here we evaluate the dietary adaptations of indigenous farmers in northern Chile's Atacama Desert during the time that the Inka Empire incorporated these communities into their economic system. This system has been described as "complementarity" because it involves interaction and trade in goods produced at different Andean elevations. We find that as local farming societies adapted to this new asymmetric system, a portion of their labor had to be given up to the Inka elite through a corvee tax system for maize production. In return, the Inka system of complementarity introduced previously rare foods from the Andean highlands into local economies. These changes caused a disruption of traditional communities as they instituted a state-level economic system on local farmers. Combined with previously published infection information for the same populations under Inka rule, the data suggest that there may have been a dual health impact from disruption of nutrition and introduction of crowd disease.	[Vinton, Sheila Dorsey] Univ Kentucky, Dept Anthropol, Lexington, KY 40506 USA; [Perry, Linda] Smithsonian Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC USA; [Reinhard, Karl J.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Santoro, Calogero M.] Univ Tarapaca, Dept Antropol, Inst Alta Invest, Arica, Chile; [Santoro, Calogero M.] Ctr Invest Hombre Desierto, Arica, Chile; [Teixeira-Santos, Isabel] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil	University of Kentucky; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Nebraska System; University of Nebraska Lincoln; Universidad de Tarapaca; Fundacao Oswaldo Cruz	Vinton, SD (corresponding author), Univ Kentucky, Dept Anthropol, Lexington, KY 40506 USA.	kreinhard1@mac.com	Reinhard, Karl/AAT-7881-2020; Santoro, Calogero M/J-4584-2014	Santoro, Calogero M/0000-0002-3702-8408	FONDECYT [1030312, 1050595]; Direccion de Investigaciones y Post Grado; Centro de Investigaciones del Hombre en el Desierto (CIHDE); Universidad de Tarapaca, Arica; DEST; Fenner School; ANU; University of New England (Armidale NSW, Australia); University of Nebraska - Lincoln; Escola Nacional de Saude Publica; Fundacao Oswaldo Cruz; Rio de Janeiro, Brazil; Instituto Alta Investigacion; Departamento de Antropologia, Arica, Chile; Centro de Investigaciones del Hombre en el Desierto, Arica, Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigaciones y Post Grado; Centro de Investigaciones del Hombre en el Desierto (CIHDE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CIHDE); Universidad de Tarapaca, Arica; DEST(Australian GovernmentDepartment of Industry, Innovation and Science); Fenner School; ANU(Australian National University); University of New England (Armidale NSW, Australia); University of Nebraska - Lincoln; Escola Nacional de Saude Publica; Fundacao Oswaldo Cruz; Rio de Janeiro, Brazil; Instituto Alta Investigacion; Departamento de Antropologia, Arica, Chile; Centro de Investigaciones del Hombre en el Desierto, Arica, Chile	Funding for the research presented here came from FONDECYT Grants 1030312 and 1050595, the Direccion de Investigaciones y Post Grado, the Centro de Investigaciones del Hombre en el Desierto (CIHDE), Universidad de Tarapaca, Arica, and a DEST Endeavour Research Fellowship (Australian Government), Visiting Fellowships at the National Museum of Australia and the Fenner School, ANU, the University of New England (Armidale NSW, Australia), a graduate research grant from the University of Nebraska - Lincoln and the Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil through a Brazilian CAPES Programa Professor Visitante Estrangeiro grant for 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KR and ITS completed the maize analysis at the Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil. The processed starch samples are archived in the School of Natural Resources, University of Nebraska at Lincoln. The original samples were processed for parasites and macroscopic remains at the Museo Arqueologico San Miguel de Azapa. The research was hosted and sponsored by the Instituto Alta Investigacion, Departamento de Antropologia, Universidad de Tarapaca, Arica, Chile and the Centro de Investigaciones del Hombre en el Desierto, Arica, Chile.	[Anonymous], 1983, CHUNGARA, V10, P77; [Anonymous], 2008, NATURAL RESOURCES; Babot M.P., 2003, TERRA AUSTRALIS, V19, P69; Bryant VM, 2003, SCIENCE, V299, P1029, DOI 10.1126/science.1081624; DAltroy Terence, 1992, PROVINCIAL POWER INK; DALTROY TN, 1984, AM ANTIQUITY, V49, P334, DOI 10.2307/280022; Dillehay TD, 2006, CHUNGARA, V38, P249, DOI 10.4067/S0717-73562006000200008; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; HASTORF CA, 1990, AM ANTIQUITY, V55, P262, DOI 10.2307/281647; HASTORF CA, 1993, AM ANTHROPOL, V95, P115, DOI 10.1525/aa.1993.95.1.02a00060; Henry AG, 2009, J ARCHAEOL SCI, V36, P915, DOI 10.1016/j.jas.2008.11.008; Hidalgo Lehuede Jorge, 1998, ACT 4 C INT ETN, P32; HOLDEN TG, 1991, WORLD ARCHAEOL, V22, P320, DOI 10.1080/00438243.1991.9980149; MORRIS C, 1985, HUANUCO PAMPA INCA C; Murra J., 1985, ANDEAN ECOLOGY CIVIL, P15; MURRA J, 1980, EC ORG INCA STATE; Murra John V, 1975, FORMACIONES EC POLIT; MURRA JV, 1972, INIGO ORTIZ ZUNIGA V, V2, P428; N??ez Lautaro., 1982, B I FRANCES ESTUDIOS, V11, P91; Perry L, 2006, NATURE, V440, P76, DOI 10.1038/nature04294; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Pohl MED, 2007, P NATL ACAD SCI USA, V104, P6870, DOI 10.1073/pnas.0701425104; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Reinhard K.J., 1992, ARCHAEOLOGICAL METHO, P245; Reinhard KJ, 2007, INT J OSTEOARCHAEOL, V17, P531, DOI 10.1002/oa.886; Reinhard KJ, 2006, PALAEOGEOGR PALAEOCL, V237, P92, DOI 10.1016/j.palaeo.2005.11.030; REINHARD KJ, 1988, AM J PHYS ANTHROPOL, V77, P355, DOI 10.1002/ajpa.1330770308; Santoro C, 2003, MEM I OSWALDO CRUZ, V98, P161, DOI 10.1590/S0074-02762003000900024; Santoro Calogero M., 1995, THESIS U PITTSBURGH; SANTORO CM, 2009, CHUNGARA RE IN PRESS, V41; VanBuren M, 1996, AM ANTHROPOL, V98, P338; VINTON SD, 1997, THESIS U NEBRASKA LI; WILLIAMS IR, 1980, PREHISTORIC TRAILS A, P195; WIVINIS GP, 1967, STARCH CHEM TECHNO 2, P649	34	37	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8069	10.1371/journal.pone.0008069	http://dx.doi.org/10.1371/journal.pone.0008069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	533MN	19956668	Green Published, gold			2022-12-27	WOS:000272828100012
J	Cooper, VS; Carlson, WA; LiPuma, JJ				Cooper, Vaughn S.; Carlson, Wendy A.; LiPuma, John J.			Susceptibility of Caenorhabditis elegans to Burkholderia Infection Depends on Prior Diet and Secreted Bacterial Attractants	PLOS ONE			English	Article							CEPACIA GENOMOVAR-III; CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; INNATE IMMUNITY; COMPLEX; MODEL; EPIDEMIOLOGY; PATHOGENESIS; CENOCEPACIA	The nematode Caenorhabditis elegans may be killed by certain pathogenic bacteria and thus is a model organism for studying interactions between bacteria and animal hosts. However, growing nematodes on prey bacteria may influence their susceptibility to potential pathogens. A method of axenic nematode culture was developed to isolate and quantify interactions between C. elegans and potentially pathogenic strains of the Burkholderia cepacia complex. Studying these dynamics in liquid solution rather than on agar surfaces minimized nematode avoidance behavior and resolved more differences among isolates. Most isolates of B. cenocepacia, B. ambifaria and B. cepacia caused 60-80% mortality of nematodes after 7 days, whereas isolates of B. multivorans caused less mortality (<25%) and supported nematode reproduction. However, some B. cenocepacia isolates recovered from chronic infections were much less virulent (5-28% mortality). As predicted, prior diet altered the outcome of interactions between nematodes and bacteria. When given the choice between Burkholderia and E. coli as prey on agar, axenically raised nematodes initially preferred most lethal Burkholderia isolates to E. coli as a food source, but this was not the case for nematodes fed E. coli, which avoided toxic Burkholderia. This food preference was associated with the cell-free supernatant and thus secreted compounds likely mediated bacterial-nematode interactions. This model, which isolates interactions between bacteria and nematodes from the effects of prior feeding, demonstrates that bacteria can influence nematode behavior and their susceptibility to pathogens.	[Cooper, Vaughn S.; Carlson, Wendy A.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan	Cooper, VS (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	vaughn.cooper@unh.edu		Cooper, Vaughn/0000-0001-7726-0765	New Hampshire Agricultural Experiment Station [H-496]; University of Michigan; National Science Foundation (NSF) [DBI-0618719]; Cystic Fibrosis Foundation	New Hampshire Agricultural Experiment Station; University of Michigan(University of Michigan System); National Science Foundation (NSF)(National Science Foundation (NSF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the New Hampshire Agricultural Experiment Station grant H-496 to V. S. C., by the Mott Golf Classic Scholar Award from the University of Michigan to J.J.L. and V. S. C, and by National Science Foundation (NSF) DBI-0618719 to the University of New Hampshire. J.J.L. is supported by the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Baldwin A, 2008, J CLIN MICROBIOL, V46, P290, DOI 10.1128/JCM.01818-07; Bargmann C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; BIRREN BW, 2005, GENOME SEQUENCE BURK; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Chen JS, 2001, J PEDIATR-US, V139, P643, DOI 10.1067/mpd.2001.118430; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; CLEGG ED, 2002, USE CEHR AXENIC MEDI; Coenye T, 2003, MICROBIOL-SGM, V149, P77, DOI 10.1099/mic.0.25850-0; Coenye T, 2002, J CLIN MICROBIOL, V40, P3300, DOI 10.1128/JCM.40.9.3300-3307.2002; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Engledow AS, 2004, J BACTERIOL, V186, P6015, DOI 10.1128/JB.186.18.6015-6024.2004; Forrester S, 2007, FOODBORNE PATHOG DIS, V4, P67, DOI 10.1089/fpd.2006.64; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Henry DA, 1997, J CLIN MICROBIOL, V35, P614, DOI 10.1128/JCM.35.3.614-619.1997; HINRICH S, 2007, MOL MICROBIOL, V66, P563; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kidd TJ, 2008, RES MICROBIOL, V159, P194, DOI 10.1016/j.resmic.2008.01.001; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Ledson MJ, 2002, THORAX, V57, P142, DOI 10.1136/thorax.57.2.142; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; LiPuma J J, 1998, Curr Opin Pulm Med, V4, P337, DOI 10.1097/00063198-199811000-00005; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; LiPuma JJ, 2003, J NEMATOL, V35, P212; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Smith MP, 2002, FEMS MICROBIOL LETT, V210, P181, DOI 10.1111/j.1574-6968.2002.tb11178.x; SPRINGMAN AC, 2009, APPL ENVIRON MICROB; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tomlin KL, 2004, J MICROBIOL METH, V57, P95, DOI 10.1016/j.mimet.2003.12.007; UEHLINGER S, 2009, INFECT IMMUN; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Wopperer J, 2006, APPL ENVIRON MICROB, V72, P1579, DOI 10.1128/AEM.72.2.1579-1587.2006; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	62	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7961	10.1371/journal.pone.0007961	http://dx.doi.org/10.1371/journal.pone.0007961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956737	Green Submitted, gold, Green Published			2022-12-27	WOS:000272827300017
J	Bruzzone, S; Fruscione, F; Morando, S; Ferrando, T; Poggi, A; Garuti, A; D'Urso, A; Selmo, M; Benvenuto, F; Cea, M; Zoppoli, G; Moran, E; Soncini, D; Ballestrero, A; Sordat, B; Patrone, F; Mostoslavsky, R; Uccelli, A; Nencioni, A				Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, Alessandro; Garuti, Anna; D'Urso, Agustina; Selmo, Martina; Benvenuto, Federica; Cea, Michele; Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Ballestrero, Alberto; Sordat, Bernard; Patrone, Franco; Mostoslavsky, Raul; Uccelli, Antonio; Nencioni, Alessio			Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE	PLOS ONE			English	Article							BIOSYNTHESIS INHIBITOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CELL-SURVIVAL; CYCLING ASSAY; APOPTOSIS; PATHWAY; FK866; ENZYME; DEATH; CD38	Nicotinamide phosphoribosyltransferase (Nampt) inhibitors such as FK866 are potent inhibitors of NAD(+) synthesis that show promise for the treatment of different forms of cancer. Based on Nampt upregulation in activated T lymphocytes and on preliminary reports of lymphopenia in FK866 treated patients, we have investigated FK866 for its capacity to interfere with T lymphocyte function and survival. Intracellular pyridine nucleotides, ATP, mitochondrial function, viability, proliferation, activation markers and cytokine secretion were assessed in resting and in activated human T lymphocytes. In addition, we used experimental autoimmune encephalomyelitis (EAE) as a model of T-cell mediated autoimmune disease to assess FK866 efficacy in vivo. We show that activated, but not resting, T lymphocytes undergo massive NAD(+) depletion upon FK866-mediated Nampt inhibition. As a consequence, impaired proliferation, reduced IFN-gamma and TNF-alpha production, and finally autophagic cell demise result. We demonstrate that upregulation of the NAD(+)-degrading enzyme poly-(ADP-ribose)polymerase (PARP) by activated T cells enhances their susceptibility to NAD(+) depletion. In addition, we relate defective IFN-gamma and TNF-alpha production in response to FK866 to impaired Sirt6 activity. Finally, we show that FK866 strikingly reduces the neurological damage and the clinical manifestations of EAE. In conclusion, Nampt inhibitors (and possibly Sirt6 inhibitors) could be used to modulate T cell-mediated immune responses and thereby be beneficial in immune-mediated disorders.			Bruzzone, S (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Genoa, Italy.	A.Nencioni@gmx.net	Poggi, Alessandro/K-6664-2016; fruscione, floriana/AAA-8747-2020; Zoppoli, Gabriele/A-9540-2010; Soncini, Debora/AAB-2230-2019; UCCELLI, Antonio/E-7343-2012; Zoppoli, Gabriele/B-6935-2016; cea, Michele/K-3863-2018; Nencioni, Alessio/K-3692-2018; Ballestrero, Alberto/K-7546-2016; Bruzzone, Santina/A-4264-2015; Zoppoli, Gabriele/B-6935-2016	Poggi, Alessandro/0000-0002-1860-430X; Soncini, Debora/0000-0001-5156-498X; UCCELLI, Antonio/0000-0002-2008-6038; Zoppoli, Gabriele/0000-0003-3890-5588; cea, Michele/0000-0002-1530-6729; Ballestrero, Alberto/0000-0002-2601-7711; Bruzzone, Santina/0000-0003-2034-3716; DUrso, Agustina/0000-0003-1406-4390; NENCIONI, ALESSIO/0000-0001-5068-8884; Zoppoli, Gabriele/0000-0002-1619-1708; fruscione, floriana/0000-0002-4054-645X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK088190] Funding Source: Medline; NIGMS NIH HHS [R01 GM093072] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Belka C, 2000, ONCOGENE, V19, P1181, DOI 10.1038/sj.onc.1203401; BERGER SJ, 1987, EXP CELL RES, V169, P149, DOI 10.1016/0014-4827(87)90233-3; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; MCNERNEY R, 1989, BIOCHIM BIOPHYS ACTA, V1009, P185, DOI 10.1016/0167-4781(89)90099-7; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miglino M, 2006, LEUKEMIA LYMPHOMA, V47, P1348, DOI 10.1080/10428190500525607; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nencioni A, 2003, J IMMUNOL, V171, P5148, DOI 10.4049/jimmunol.171.10.5148; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poggi A, 2005, J IMMUNOL, V174, P2653, DOI 10.4049/jimmunol.174.5.2653; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	43	123	143	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7897	10.1371/journal.pone.0007897	http://dx.doi.org/10.1371/journal.pone.0007897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936064	Green Published, Green Submitted, gold			2022-12-27	WOS:000272004600003
J	Vinas, J; Tudela, S				Vinas, Jordi; Tudela, Sergi			A Validated Methodology for Genetic Identification of Tuna Species (Genus Thunnus)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR-IDENTIFICATION; HISTORICAL DEMOGRAPHY; CYTOCHROME-B; ATLANTIC; FISH; DIFFERENTIATION; DISCRIMINATION; TELEOSTEI	Background Tuna species of the genus Thunnus, such as the bluefin tunas, are some of the most important and yet most endangered trade fish in the world. Identification of these species in traded forms, however, may be difficult depending on the presentation of the products, which may hamper conservation efforts on trade control. In this paper, we validated a genetic methodology that can fully distinguish between the eight Thunnus species from any kind of processed tissue. Methodology: After testing several genetic markers, a complete discrimination of the eight tuna species was achieved using Forensically Informative Nucleotide Sequencing based primarily on the sequence variability of the hypervariable genetic marker mitochondrial DNA control region (mtDNA CR), followed, in some specific cases, by a second validation by a nuclear marker rDNA first internal transcribed spacer (ITS1). This methodology was able to distinguish all tuna species, including those belonging to the subgenus Neothunnus that are very closely related, and in consequence can not be differentiated with other genetic markers of lower variability. This methodology also took into consideration the presence of introgression that has been reported in past studies between T. thynnus, T. orientalis and T. alalunga. Finally, we applied the methodology to cross-check the species identity of 26 processed tuna samples. Conclusions: Using the combination of two genetic markers, one mitochondrial and another nuclear, allows a full discrimination between all eight tuna species. Unexpectedly, the genetic marker traditionally used for DNA barcoding, cytochrome oxidase 1, could not differentiate all species, thus its use as a genetic marker for tuna species identification is questioned.			Vinas, J (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain.	jordi.vinas@udg.edu	Viñas, Jordi/A-5397-2010; 赵, 鹏/B-8401-2009	Viñas, Jordi/0000-0003-0193-1141; 				BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Bottero MT, 2007, J BIOTECHNOL, V129, P575, DOI 10.1016/j.jbiotec.2007.01.032; Bremer JRA, 1998, MAR BIOL, V132, P547, DOI 10.1007/s002270050420; Bremer JRA, 1997, J FISH BIOL, V50, P540, DOI 10.1006/jfbi.1996.0321; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; BREMER JRA, 1994, THESIS U TORONTO TOR; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow S, 1995, J MOL EVOL, V41, P741, DOI 10.1007/BF00173154; Collette BB, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P149; Collette Bruce B., 2001, Fish Physiology, V19, P1; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; FAO, 2010, STAT WORLD FISH AQ; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINNERTY JR, 1995, FISH B-NOAA, V93, P78; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lenstra J. A., 2003, Food authenticity and traceability, P34, DOI 10.1533/9781855737181.1.34; Lin WF, 2007, FOOD CONTROL, V18, P1050, DOI 10.1016/j.foodcont.2006.07.001; Lin WF, 2005, J FOOD DRUG ANAL, V13, P382; Lockley AK, 2000, J AGR FOOD CHEM, V48, P4463, DOI 10.1021/jf000387p; Mallet J, 2003, TRENDS ECOL EVOL, V18, P57, DOI 10.1016/S0169-5347(02)00061-7; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; Michelini E, 2007, J AGR FOOD CHEM, V55, P7638, DOI 10.1021/jf070902k; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nauen C. E., 1983, FAO FISH SYNOP, V2, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; Orrell TM, 2006, B MAR SCI, V79, P505; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Paine MA, 2007, B MAR SCI, V80, P353; Rasmussen RS, 2008, COMPR REV FOOD SCI F, V7, P280, DOI 10.1111/j.1541-4337.2008.00046.x; ROB O, 2008, FISH FISH, V9, P462; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; *SCRS, 2008, 2008 ATL BLUEF TUN S; Smith PJ, 2001, NEW ZEAL J MAR FRESH, V35, P843, DOI 10.1080/00288330.2001.9517046; Takashima Y, 2006, FISHERIES SCI, V72, P1054, DOI 10.1111/j.1444-2906.2006.01256.x; Takeyama H, 2001, J FISH BIOL, V58, P1646, DOI 10.1111/j.1095-8649.2001.tb02319.x; Takeyama H, 2000, MAR BIOTECHNOL, V2, P309; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Terol J, 2002, J AGR FOOD CHEM, V50, P963, DOI 10.1021/jf011032o; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	45	95	100	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7606	10.1371/journal.pone.0007606	http://dx.doi.org/10.1371/journal.pone.0007606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19898615	Green Published, gold			2022-12-27	WOS:000271147400010
J	Kusi, KA; Faber, BW; Thomas, AW; Remarque, EJ				Kusi, Kwadwo A.; Faber, Bart W.; Thomas, Alan W.; Remarque, Edmond J.			Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; MALARIA VACCINE; PASSIVE-IMMUNIZATION; PROTECTS MICE; IN-VITRO; ANTIBODIES; CANDIDATE; INVASION; AMA1	Apical Membrane Antigen 1 (AMA1), a merozoite protein essential for red cell invasion, is a candidate malaria vaccine component. Immune responses to AMA1 can protect in experimental animal models and antibodies isolated from AMA1-vaccinated or malaria-exposed humans can inhibit parasite multiplication in vitro. The parasite is haploid in the vertebrate host and the genome contains a single copy of AMA1, yet on a population basis a number of AMA1 molecular surface residues are polymorphic, a property thought to be primarily as a result of selective immune pressure. After immunisation with AMA1, antibodies more effectively inhibit strains carrying homologous AMA1 genes, suggesting that polymorphism may compromise vaccine efficacy. Here, we analyse induction of broad strain inhibitory antibodies with a multi-allele Plasmodium falciparum AMA1 (PfAMA1) vaccine, and determine the relative importance of cross-reactive and strain-specific IgG fractions by competition ELISA and in vitro parasite growth inhibition assays. Immunisation of rabbits with a PfAMA1 allele mixture yielded an increased proportion of antibodies to epitopes common to all vaccine alleles, compared to single allele immunisation. Competition ELISA with the anti-PfAMA1 antibody fraction that is cross-reactive between FVO and 3D7 AMA1 alleles showed that over 80% of these common antibodies were shared with other PfAMA1 alleles. Furthermore, growth inhibition assays revealed that for any PfAMA1 allele (FVO or 3D7), the cross-reactive fraction alone, on basis of weight, had the same functional capacity on homologous parasites as the total affinity-purified IgGs (cross-reactive+strain-specific). By contrast, the strain-specific IgG fraction of either PfAMA1 allele showed slightly less inhibition of red cell invasion by homologous strains. Thus multi-allele immunisation relatively increases the levels of antibodies to common allele epitopes. This explains the broadened cross inhibition of diverse malaria parasites, and suggests multi-allele approaches warrant further clinical investigation.	[Kusi, Kwadwo A.; Faber, Bart W.; Thomas, Alan W.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kusi, Kwadwo A.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana	University of Ghana	Kusi, KA (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	Thomas@bprc.nl	Kusi, Kwadwo Asamoah/J-5941-2019; Remarque, Ed/AAE-8643-2020; Remarque, Edmond J/B-2217-2010	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative (EMVI) [5-2007]; European Malaria Vaccine Development Association (EMVDA) [LSHP-CT-2007-037506]; Ghana Education Trust	European Malaria Vaccine Initiative (EMVI); European Malaria Vaccine Development Association (EMVDA)(European Commission); Ghana Education Trust	This work was funded by the European Malaria Vaccine Initiative (EMVI), grant number 5-2007, and the European Malaria Vaccine Development Association (EMVDA), grant number LSHP-CT-2007-037506. KAK was also supported by the Ghana Education Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Barclay VC, 2008, VACCINE, V26, P6099, DOI 10.1016/j.vaccine.2008.09.004; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; FABER BW, 2008, VACCINE; Good MF, 1998, ANNU REV IMMUNOL, V16, P57, DOI 10.1146/annurev.immunol.16.1.57; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kostolansky F, 2000, J GEN VIROL, V81, P1727, DOI 10.1099/0022-1317-81-7-1727; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2001, GENETICS, V158, P1505; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Stanley SL, 1998, LANCET, V352, P1163, DOI 10.1016/S0140-6736(05)60525-9; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; WHO, 2008, WORLD HLTH REPORT 20; ZAMAN S, 1993, ARCH DIS CHILD, V68, P198, DOI 10.1136/adc.68.2.198	42	61	61	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8110	10.1371/journal.pone.0008110	http://dx.doi.org/10.1371/journal.pone.0008110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956619	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700021
J	Malakhova, M; Kurinov, I; Liu, KD; Zheng, D; D'Angelo, I; Shim, JH; Steinman, V; Bode, AM; Dong, ZG				Malakhova, Margarita; Kurinov, Igor; Liu, Kangdong; Zheng, Duo; D'Angelo, Igor; Shim, Jung-Hyun; Steinman, Valerie; Bode, Ann M.; Dong, Zigang			Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2	PLOS ONE			English	Article							CANCER-CELL-PROLIFERATION; PROTEIN-KINASE; CRYSTAL-STRUCTURE; DOCKING SITE; MOTIF PHOSPHORYLATION; HISTONE H3; AMP-PNP; C-SRC; ACTIVATION; IDENTIFICATION	The p90 ribosomal protein kinase 2 (RSK2) is a highly expressed Ser/Thr kinase activated by growth factors and is involved in cancer cell proliferation and tumor promoter-induced cell transformation. RSK2 possesses two non-identical kinase domains, and the structure of its N-terminal domain (NTD), which is responsible for phosphorylation of a variety of substrates, is unknown. The crystal structure of the NTD RSK2 was determined at 1.8 angstrom resolution in complex with AMP-PNP. The N-terminal kinase domain adopted a unique active conformation showing a significant structural diversity of the kinase domain compared to other kinases. The NTD RSK2 possesses a three-stranded beta B-sheet inserted in the N-terminal lobe, resulting in displacement of the alpha C-helix and disruption of the Lys-Glu interaction, classifying the kinase conformation as inactive. The purified protein was phosphorylated at Ser227 in the T-activation loop and exhibited in vitro kinase activity. A key characteristic is the appearance of a new contact between Lys216 (beta B-sheet) and the beta-phosphate of AMP-PNP. Mutation of this lysine to alanine impaired both NTDs in vitro and full length RSK2 ex vivo activity, emphasizing the importance of this interaction. Even though the N-terminal lobe undergoes structural re-arrangement, it possesses an intact hydrophobic groove formed between the alpha C-helix, the beta 4-strand, and the beta B-sheet junction, which is occupied by the N-terminal tail. The presence of a unique beta B-sheet insert in the N-lobe suggests a different type of activation mechanism for RSK2.	[Malakhova, Margarita; Liu, Kangdong; Zheng, Duo; Shim, Jung-Hyun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA; [Kurinov, Igor] Cornell Univ, NE CAT, APS, Argonne, IL USA; [D'Angelo, Igor] Canadian Light Source Inc, Canadian Macromol Crystallog Facil, Saskatoon, SK, Canada; [Steinman, Valerie] Coll St Benedict, Dept Biochem, St Joseph, MN USA	University of Minnesota System; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; University of Saskatchewan; College of Saint Benedict & Saint Johns University	Malakhova, M (corresponding author), Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA.	mailtozgdong@hi.umn.edu		Shim, Jung-Hyun/0000-0002-4062-4016	Hormel Foundation; National Institutes of Health (NIH) [CA027502, CA077646, CA120388, R37CA08164, ES016548]; NATIONAL CANCER INSTITUTE [P01CA027502, R01CA120388, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by The Hormel Foundation and National Institutes of Health (NIH) grants CA027502, CA077646, CA120388, R37CA08164, and ES016548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Clark DE, 2005, CANCER RES, V65, P3108; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Engh RA, 2001, ADV ENZYME REGUL, V41, P121, DOI 10.1016/S0065-2571(00)00010-8; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schwab MS, 2001, CURR BIOL, V11, P141, DOI 10.1016/S0960-9822(01)00045-8; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Silverman E, 2004, MOL CELL BIOL, V24, P10573, DOI 10.1128/MCB.24.24.10573-10583.2004; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	59	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8044	10.1371/journal.pone.0008044	http://dx.doi.org/10.1371/journal.pone.0008044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956600	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400007
J	Emrich, SM; Al-Aidroos, N; Pratt, J; Ferber, S				Emrich, Stephen M.; Al-Aidroos, Naseem; Pratt, Jay; Ferber, Susanne			Visual Search Elicits the Electrophysiological Marker of Visual Working Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; OBJECT CORRESPONDENCE; SPATIAL ATTENTION; NEURAL MEASURES; GUIDANCE; INTEGRATION; MECHANISMS; CAPACITY; ACCESS	Background: Although limited in capacity, visual working memory (VWM) plays an important role in many aspects of visually-guided behavior. Recent experiments have demonstrated an electrophysiological marker of VWM encoding and maintenance, the contralateral delay activity (CDA), which has been shown in multiple tasks that have both explicit and implicit memory demands. Here, we investigate whether the CDA is evident during visual search, a thoroughly-researched task that is a hallmark of visual attention but has no explicit memory requirements. Methodology/Principal Findings: The results demonstrate that the CDA is present during a lateralized search task, and that it is similar in amplitude to the CDA observed in a change-detection task, but peaks slightly later. The changes in CDA amplitude during search were strongly correlated with VWM capacity, as well as with search efficiency. These results were paralleled by behavioral findings showing a strong correlation between VWM capacity and search efficiency. Conclusions/Significance: We conclude that the activity observed during visual search was generated by the same neural resources that subserve VWM, and that this activity reflects the maintenance of previously searched distractors.	[Emrich, Stephen M.; Al-Aidroos, Naseem; Pratt, Jay; Ferber, Susanne] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Ferber, Susanne] Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Emrich, SM (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	steve.emrich@utoronto.ca	Al-Aidroos, Naseem/A-5930-2009	Emrich, Stephen/0000-0002-8768-1333; Al-Aidroos, Naseem/0000-0002-7440-752X; Pratt, Jay/0000-0002-4902-5095	NSERC [480593, 261203-08, 482547]; CIHR [79256]; ERA	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); ERA	This research was supported by NSERC discovery grants awarded to JP (480593) and SF (261203-08), NSERC research tools and instruments grant to SF and JP (482547), CIHR operating (79256) and ERA grants to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MR, 2006, VIS COGN, V14, P150, DOI 10.1080/13506280600574487; Beck MR, 2006, J EXP PSYCHOL HUMAN, V32, P235, DOI 10.1037/0096-1523.32.2.235; Boot WR, 2004, PSYCHON B REV, V11, P854, DOI 10.3758/BF03196712; Brisson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003967; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Emrich SM, 2008, PERCEPT PSYCHOPHYS, V70, P1552, DOI 10.3758/PP.70.8.1552; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gilchrist ID, 2000, CURR BIOL, V10, P1209, DOI 10.1016/S0960-9822(00)00729-6; Goolsby BA, 2009, PSYCHON B REV, V16, P133, DOI 10.3758/PBR.16.1.133; Hollingworth A, 2008, J EXP PSYCHOL GEN, V137, P163, DOI 10.1037/0096-3445.137.1.163; Hollingworth A, 2009, ATTEN PERCEPT PSYCHO, V71, P936, DOI 10.3758/APP.71.4.936; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Horowitz TS, 2001, PERCEPT PSYCHOPHYS, V63, P272, DOI 10.3758/BF03194468; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; IRWIN DE, 1988, J EXP PSYCHOL GEN, V117, P276, DOI 10.1037/0096-3445.117.3.276; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Miller J, 2009, PSYCHOPHYSIOLOGY, V46, P300, DOI 10.1111/j.1469-8986.2008.00761.x; Mitchell DJ, 2008, CEREB CORTEX, V18, P1788, DOI 10.1093/cercor/bhm205; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1243, DOI 10.1037/0096-1523.32.5.1243; Peterson MS, 2007, PERCEPT PSYCHOPHYS, V69, P123, DOI 10.3758/BF03194459; Peterson MS, 2001, PSYCHOL SCI, V12, P287, DOI 10.1111/1467-9280.00353; Richard AM, 2008, COGNITION, V109, P66, DOI 10.1016/j.cognition.2008.07.004; Robitaille N, 2007, BRAIN RES, V1185, P158, DOI 10.1016/j.brainres.2007.09.004; Robitaille N, 2006, CAN J EXP PSYCHOL, V60, P101, DOI 10.1037/cjep2006011; Soto D, 2006, VISION RES, V46, P1010, DOI 10.1016/j.visres.2005.09.008; Soto D, 2005, J EXP PSYCHOL HUMAN, V31, P248, DOI 10.1037/0096-1523.31.2.248; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; Soto D, 2007, P NATL ACAD SCI USA, V104, P17186, DOI 10.1073/pnas.0703706104; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; Woodman GF, 2003, PSYCHOL SCI, V14, P605, DOI 10.1046/j.0956-7976.2003.psci_1472.x; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Woodward M, 2007, SOFTW TEST VERIF REL, V17, P1, DOI 10.1002/stvr.366	51	66	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8042	10.1371/journal.pone.0008042	http://dx.doi.org/10.1371/journal.pone.0008042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MN	19956663	Green Published, gold			2022-12-27	WOS:000272828100005
J	Bidon, C; Lachuer, J; Molgo, J; Wierinckx, A; de la Porte, S; Pignol, B; Christen, Y; Meloni, R; Koenig, H; Faucon-Biguet, N; Mallet, J				Bidon, Caroline; Lachuer, Joel; Molgo, Jordi; Wierinckx, Anne; de la Porte, Sabine; Pignol, Bernadette; Christen, Yves; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques			The Extract of Ginkgo biloba EGb 761 Reactivates a Juvenile Profile in the Skeletal Muscle of Sarcopenic Rats by Transcriptional Reprogramming	PLOS ONE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; CALORIC RESTRICTION; LIFE-SPAN; BETA; COLLAGEN; GLUCOSE; REGENERATION; METABOLISM; RESISTANCE	Background: Sarcopenia is a major public health problem in industrialized nations, placing an increasing burden on public healthcare systems because the loss of skeletal muscle mass and strength that characterizes this affection increases the dependence and the risk of injury caused by sudden falls in elderly people. Albeit exercise and caloric restriction improve sarcopenia-associated decline of the muscular performances, a more suitable and focused pharmacological treatment is still lacking. Methodology/Principal Findings: In order to evaluate such a possible treatment, we investigated the effects of EGb 761, a Ginkgo biloba extract used in chronic age-dependent neurological disorders, on the function of the soleus muscle in aged rats. EGb 761 induced a gain in muscular mass that was associated with an improvement of the muscular performances as assessed by biochemical and electrophysiological tests. DNA microarray analysis shows that these modifications are accompanied by the transcriptional reprogramming of genes related to myogenesis through the TGF beta signaling pathway and to energy production via fatty acids and glucose oxidation. EGb 761 restored a more juvenile gene expression pattern by regenerating the aged muscle and reversing the age-related metabolic shift from lipids to glucose utilization. Conclusions/Significance: Thus, EGb 761 may represent a novel treatment for sarcopenia both more manageable and less cumbersome than exercise and caloric restriction.	[Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Biotechnol & Biotherapie UMR 7225, Paris, France; [Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] Hop La Pitie Salpetriere, INSERM, CRICM UMR S 975, Paris, France; [Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] UPMC Univ Paris 06, Paris, France; [Lachuer, Joel; Wierinckx, Anne] INSERM, Lab Neurooncol & Neuroinflammat U842, F-69008 Lyon, France; [Lachuer, Joel] ProfileXpert, IFR19, Bron, France; [Lachuer, Joel] Univ Lyon 1, UMR S842, F-69365 Lyon, France; [Molgo, Jordi; de la Porte, Sabine] CNRS, Inst Neurobiol Alfred Fessard, Cellular & Mol Neurobiol Lab, UPR9040, Gif Sur Yvette, France; [Christen, Yves] Ipsen, Boulogne Billancourt, France; [Pignol, Bernadette] Ipsen Res Labs, Les Ulis, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ipsen	Bidon, C (corresponding author), Hop La Pitie Salpetriere, CNRS, Biotechnol & Biotherapie UMR 7225, Paris, France.	jacques.mallet@upmc.fr	de la PORTE, Sabine/AAE-4208-2022; de la Porte, Sabine/N-5275-2018; Wierinckx, Anne/AAF-5233-2021; Meloni, Rolando/GOJ-7446-2022	de la PORTE, Sabine/0000-0002-7725-8646; Wierinckx, Anne/0000-0002-0186-6645; Meloni, Rolando/0000-0002-6464-8469; lachuer, joel/0000-0002-5209-5094	IPSEN; Beaufour-Ipsen; C.N.R.S.	IPSEN(Ipsen); Beaufour-Ipsen(Ipsen); C.N.R.S.(Centre National de la Recherche Scientifique (CNRS)European Commission)	This work was partly financed by IPSEN ("Institut des produits de synthese et d'extraction naturelle'') http://web2.ipsen.com/. CB was the recipient of a thesis bursary from IPSEN. BP and YC are employed by IPSEN. This work was supported by Beaufour-Ipsen and the C.N.R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8; Ahtikoski AM, 2003, ACTA PHYSIOL SCAND, V177, P473, DOI 10.1046/j.1365-201X.2003.01061.x; Armand AS, 2003, DEV DYNAM, V227, P256, DOI 10.1002/dvdy.10306; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Blaak EE, 1999, J CLIN ENDOCR METAB, V84, P3764, DOI 10.1210/jc.84.10.3764; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; CHRISTEN Y, 2004, OXIDAT STRESS DIS, P145; Criscuolo F, 2005, P ROY SOC B-BIOL SCI, V272, P803, DOI 10.1098/rspb.2004.3044; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Faulkner JA, 1995, ADV EXP MED BIOL, V384, P471; Fontaniere S, 2006, ENDOCR-RELAT CANCER, V13, P1223, DOI 10.1677/erc.1.01294; HANSON AN, 1983, ANAL BIOCHEM, V130, P32, DOI 10.1016/0003-2697(83)90646-2; HEPPLE RT, 2003, SCI AGING KNOWLEDGE, V46, pPE31; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Ker RF, 2002, COMP BIOCHEM PHYS A, V133, P987, DOI 10.1016/S1095-6433(02)00171-X; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lynch Gordon S, 2004, Expert Opin Emerg Drugs, V9, P345, DOI 10.1517/14728214.9.2.345; Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Navarro A, 2001, FRONT BIOSCI-LANDMRK, V6, pD26, DOI 10.2741/Navarro; Nguyen-Huu T, 2005, ANESTHESIOLOGY, V103, P788, DOI 10.1097/00000542-200510000-00017; Oh KS, 2007, EXP MOL MED, V39, P385, DOI 10.1038/emm.2007.43; Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sastre J, 2002, CELL MOL BIOL, V48, P685; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Vianna CR, 2001, PHYSIOL GENOMICS, V5, P137, DOI 10.1152/physiolgenomics.2001.5.3.137; Watanabe CMH, 2001, P NATL ACAD SCI USA, V98, P6577, DOI 10.1073/pnas.111126298; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; Winter JC, 1998, PHYSIOL BEHAV, V63, P425, DOI 10.1016/S0031-9384(97)00464-2; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yamaza H, 2002, MICROSC RES TECHNIQ, V59, P325, DOI 10.1002/jemt.10212; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7998	10.1371/journal.pone.0007998	http://dx.doi.org/10.1371/journal.pone.0007998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956636	gold, Green Submitted, Green Published			2022-12-27	WOS:000272827500025
J	Doly, S; Bertran-Gonzalez, J; Callebert, J; Bruneau, A; Banas, SM; Belmer, A; Boutourlinsky, K; Herve, D; Launay, JM; Maroteaux, L				Doly, Stephane; Bertran-Gonzalez, Jesus; Callebert, Jacques; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Launay, Jean-Marie; Maroteaux, Luc			Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice	PLOS ONE			English	Article							RAT NUCLEUS-ACCUMBENS; RELEASE IN-VIVO; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; GENE-EXPRESSION; DOPAMINE RELEASE; REVERSES HYPERTHERMIA; ECSTASY; COCAINE; SENSITIZATION; D1	The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and serotonin transporters to produce efflux of dopamine and serotonin, respectively, in regions of the brain that have been implicated in reward. However, the role of serotonin/dopamine interactions in the behavioral effects of MDMA remains unclear. We previously showed that MDMA-induced locomotion, serotonin and dopamine release are 5-HT2B receptor-dependent. The aim of the present study was to determine the contribution of serotonin and 5-HT2B receptors to the reinforcing properties of MDMA. We show here that 5-HT2B-/- mice do not exhibit behavioral sensitization or conditioned place preference following MDMA (10 mg/kg) injections. In addition, MDMA-induced reinstatement of conditioned place preference after extinction and locomotor sensitization development are each abolished by a 5-HT2B receptor antagonist (RS127445) in wild type mice. Accordingly, MDMA-induced dopamine D1 receptor-dependent phosphorylation of extracellular regulated kinase in nucleus accumbens is abolished in mice lacking functional 5-HT2B receptors. Nevertheless, high doses (30 mg/kg) of MDMA induce dopamine-dependent but serotonin and 5-HT2B receptor-independent behavioral effects. These results underpin the importance of 5-HT2B receptors in the reinforcing properties of MDMA and illustrate the importance of dose-dependent effects of MDMA on serotonin/dopamine interactions.	[Doly, Stephane; Bertran-Gonzalez, Jesus; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Maroteaux, Luc] INSERM, U839, Paris, France; [Doly, Stephane; Bertran-Gonzalez, Jesus; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Maroteaux, Luc] Univ Paris 06, Inst Fer Moulin, UMR S0839, Paris, France; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, AP HP, Serv Biochim, F-75475 Paris, France; [Callebert, Jacques; Launay, Jean-Marie] INSERM, U942, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Doly, S (corresponding author), INSERM, U839, Paris, France.	luc.maroteaux@upmc.fr	Belmer, Arnauld/AAE-2554-2019; doly, stephane/Y-2318-2019; callebert, jacques/L-4569-2017; Bertran-Gonzalez, J/L-1410-2017; Maroteaux, Luc/H-4585-2019; HERVE, Denis/E-2929-2017	Belmer, Arnauld/0000-0001-6640-5631; doly, stephane/0000-0002-3517-8605; Bertran-Gonzalez, J/0000-0002-3794-1782; Maroteaux, Luc/0000-0002-9499-8603; HERVE, Denis/0000-0003-1376-1522	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; Fondation pour les Maladies Orphelines; Association pour la Recherche contre le Cancer; French Ministry of Research (Agence Nationale pour la Recherche); European Community	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour les Maladies Orphelines; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Community(European Commission)	This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie and grants from the Fondation de France, the Fondation pour la Recherche Medicale, the Fondation pour les Maladies Orphelines, the Association pour la Recherche contre le Cancer, the French Ministry of Research (Agence Nationale pour la Recherche) and the European Community. LM's team is an "Equipe FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2007, J NEUROCHEM, V102, P121, DOI 10.1111/j.1471-4159.2007.04451.x; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Ball KT, 2005, PSYCHOPHARMACOLOGY, V181, P676, DOI 10.1007/s00213-005-0038-z; Bankson MG, 2004, J NEUROCHEM, V91, P852, DOI 10.1111/j.1471-4159.2004.02763.x; Bankson MG, 2001, J PHARMACOL EXP THER, V297, P846; Baumann MH, 2000, SYNAPSE, V36, P102, DOI 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; BERGER UV, 1992, EUR J PHARMACOL, V215, P153, DOI 10.1016/0014-2999(92)90023-W; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Blessing WW, 2003, J NEUROSCI, V23, P6385; Bonaventure P, 2002, BRAIN RES, V943, P38, DOI 10.1016/S0006-8993(02)02504-0; Bonhaus DW, 1999, BRIT J PHARMACOL, V127, P1075, DOI 10.1038/sj.bjp.0702632; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456; Choi DS, 1996, FEBS LETT, V391, P45, DOI 10.1016/0014-5793(96)00695-3; Crespi D, 1997, BRIT J PHARMACOL, V121, P1735, DOI 10.1038/sj.bjp.0701325; Daniela E, 2004, PHARMACOL BIOCHEM BE, V77, P745, DOI 10.1016/j.pbb.2004.01.008; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; Doly S, 2008, J NEUROSCI, V28, P2933, DOI 10.1523/JNEUROSCI.5723-07.2008; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; Federici M, 2007, BIOL PSYCHIAT, V62, P680, DOI 10.1016/j.biopsych.2006.11.019; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; Harrison TS, 2004, DRUGS, V64, P1715; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; Koch S, 1997, J NEURAL TRANSM, V104, P135, DOI 10.1007/BF01273176; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; NASH JF, 1991, J PHARMACOL EXP THER, V259, P820; Nelson LS, 2007, CLIN TOXICOL, V45, P315, DOI 10.1080/15563650701285289; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Parrott AC, 2004, PSYCHOPHARMACOLOGY, V173, P234, DOI 10.1007/s00213-003-1712-7; Ramos M, 2004, PSYCHOPHARMACOLOGY, V177, P100, DOI 10.1007/s00213-004-1937-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rothman RB, 2007, AAPS J, V9, pE1, DOI 10.1208/aapsj0901001; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Salzmann J, 2003, BRIT J PHARMACOL, V140, P831, DOI 10.1038/sj.bjp.0705506; Scearce-Levie K, 1999, PSYCHOPHARMACOLOGY, V141, P154, DOI 10.1007/s002130050819; Schmuck K, 1996, EUR J NEUROSCI, V8, P959, DOI 10.1111/j.1460-9568.1996.tb01583.x; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shioda K, 2008, NEUROTOXICOLOGY, V29, P1030, DOI 10.1016/j.neuro.2008.07.005; Slot LAB, 2008, BEHAV PHARMACOL, V19, P145, DOI 10.1097/FBP.0b013e3282f62cb2; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Valjent E, 2000, J NEUROSCI, V20, P8701; VALJENT E, 2009, NEUROPSYCHOPHARMACOL; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wainscott DB, 1996, J PHARMACOL EXP THER, V276, P720; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004	58	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7952	10.1371/journal.pone.0007952	http://dx.doi.org/10.1371/journal.pone.0007952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956756	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827300010
J	Niu, XM; Nouraie, M; Campbell, A; Rana, S; Minniti, CP; Sable, C; Darbari, D; Dham, N; Reading, NS; Prchal, JT; Kato, GJ; Gladwin, MT; Castro, OL; Gordeuk, VR				Niu, Xiaomei; Nouraie, Mehdi; Campbell, Andrew; Rana, Sohail; Minniti, Caterina P.; Sable, Craig; Darbari, Deepika; Dham, Niti; Reading, N. Scott; Prchal, Josef T.; Kato, Gregory J.; Gladwin, Mark T.; Castro, Oswaldo L.; Gordeuk, Victor R.			Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; REGURGITANT JET VELOCITY; GENE-EXPRESSION; PULSE OXIMETRY; RISK-FACTOR; HEMOLYSIS; DEATH; VEGF; ENDOTHELIUM; ACTIVATION	Background: Pulmonary hypertension and left ventricular diastolic dysfunction are complications of sickle cell disease. Pulmonary hypertension is associated with hemolysis and hypoxia, but other unidentified factors are likely involved in pathogenesis as well. Design and Methods: Plasma concentrations of three angiogenic markers (fibroblast growth factor, platelet derived growth factor-BB [PDGF-BB], vascular endothelial growth factor [VEGF]) and seven inflammatory markers implicated in pulmonary hypertension in other settings were determined by Bio-Plex suspension array in 237 children and adolescents with sickle cell disease at steady state and 43 controls. Tricuspid regurgitation velocity (which reflects systolic pulmonary artery pressure), mitral valve E/Edti ratio (which reflects left ventricular diastolic dysfunction), and a hemolytic component derived from four markers of hemolysis and hemoglobin oxygen saturation were also determined. Results: Plasma concentrations of interleukin-8, interleukin-10 and VEGF were elevated in the patients with sickle cell disease compared to controls (P <= 0.003). By logistic regression, greater values for PDGF-BB (P = 0.009), interleukin-6 (P = 0.019) and the hemolytic component (P = 0.026) were independently associated with increased odds of elevated tricuspid regurgitation velocity while higher VEGF concentrations were associated with decreased odds (P = 0.005) among the patients with sickle cell disease. These findings, which are consistent with reports that PDGF-BB stimulates and VEGF inhibits vascular smooth muscle cell proliferation, did not apply to E/Etdi. Conclusions: Circulating concentrations of angiogenic and pro-Inflammatory markers are altered in sickle cell disease children and adolescents with elevated tricuspid regurgitation velocity, a subgroup that may be at risk for developing worsening pulmonary hypertension. Further studies to understand the molecular changes in these children are indicated.	[Niu, Xiaomei; Nouraie, Mehdi; Rana, Sohail; Castro, Oswaldo L.; Gordeuk, Victor R.] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Darbari, Deepika] Childrens Natl Med Ctr, Dept Hematol, Washington, DC 20010 USA; [Sable, Craig; Dham, Niti] Childrens Natl Med Ctr, Dept Cardiol, Washington, DC 20010 USA; [Campbell, Andrew] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Minniti, Caterina P.; Kato, Gregory J.] Natl Heart Lung & Blood Inst, Pulm & Vasc Med Branch, Ctr Clin, NIH, Bethesda, MD USA; [Reading, N. Scott; Prchal, Josef T.] Univ Utah, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Reading, N. Scott; Prchal, Josef T.] Univ Utah, Vet Adm Hosp, Salt Lake City, UT USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA USA	Howard University; Children's National Health System; Children's National Health System; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niu, XM (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	vgordeuk@howard.edu	Campbell, Andrew/AAX-8590-2020; Gordeuk, Victor/AAG-6577-2019; Nouraie, Seyed Mehdi/O-4071-2018; Minniti, Caterina/AAX-3187-2021; Reading, Noel/J-8911-2016; Kato, Gregory J/I-7615-2014	Campbell, Andrew/0000-0002-8829-0043; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Reading, Noel/0000-0003-0806-5661; Kato, Gregory J/0000-0003-4465-3217	National Heart, Lung and Blood Institute [2 R25 HL003679-08, 1 R01 HL079912-02]; National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD [2MOI RR10284-10]; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679, R01HL079912, ZIAHL006016] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by grants no. 2 R25 HL003679-08 and 1 R01 HL079912-02 from the National Heart, Lung and Blood Institute; by Howard University GCRC grant no. 2MOI RR10284-10 from the National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD; and by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Bourantas KL, 1998, EUR J HAEMATOL, V61, P49; Damas JK, 2004, CIRCULATION, V110, P999, DOI 10.1161/01.CIR.0000139859.68513.FC; Dorfmuller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112; Duits AJ, 2003, ANN HEMATOL, V82, P171, DOI 10.1007/S00277-003-0610-8; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guzman MJ, 2008, J SURG RES, V150, P286, DOI 10.1016/j.jss.2007.12.772; Hargrave DR, 2003, BLOOD, V101, P846, DOI 10.1182/blood-2002-05-1392; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; Hibbert JM, 2005, EXP BIOL MED, V230, P68; Holtzclaw JD, 2004, AM J RESP CRIT CARE, V169, P687, DOI 10.1164/rccm.200302-224OC; Homi J, 1997, CLIN LAB HAEMATOL, V19, P17, DOI 10.1046/j.1365-2257.1997.00215.x; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Humbert M, 2008, AM J RESP CRIT CARE, V177, P574, DOI 10.1164/rccm.200801-029UP; Ito T, 2007, CIRC RES, V101, P734, DOI 10.1161/CIRCRESAHA.107.153023; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Jones R, 2006, ULTRASTRUCT PATHOL, V30, P267, DOI 10.1080/01913120600820336; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Klings ES, 2008, AM J HEMATOL, V83, P547, DOI 10.1002/ajh.21187; Liem RI, 2007, HAEMATOLOGICA, V92, P1549, DOI 10.3324/haematol.11576; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P287, DOI 10.1159/000237166; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Partovian C, 2000, AM J RESP CELL MOL, V23, P762, DOI 10.1165/ajrcmb.23.6.4106; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; PATEL N, 2008, BLOOD; Patterson KC, 2006, ANN INTERN MED, V145, P152, DOI 10.7326/0003-4819-145-2-200607180-00020; PEREZ AV, 2009, INT J CARDIOL; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pont-Kingdon G, 2007, BIOTECHNIQUES, V42, P191, DOI 10.2144/000112330; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Preston IR, 2007, ANTIOXID REDOX SIGN, V9, P711, DOI 10.1089/ars.2007.1587; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; RACKOFF WR, 1993, BLOOD, V81, P3422; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; SAMUELS MP, 1992, ARCH DIS CHILD, V67, P925, DOI 10.1136/adc.67.7.925; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035; Taylor SC, 1997, J NATL MED ASSOC, V89, P753; Uong EC, 2006, J PEDIATR-US, V149, P707, DOI 10.1016/j.jpeds.2006.06.038; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Wanstall JC, 2002, CARDIOVASC RES, V55, P361, DOI 10.1016/S0008-6363(02)00440-6; Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28; Zilberman MV, 2007, AM J HEMATOL, V82, P433, DOI 10.1002/ajh.20866	61	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7956	10.1371/journal.pone.0007956	http://dx.doi.org/10.1371/journal.pone.0007956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956689	Green Published, gold, Green Accepted			2022-12-27	WOS:000272827300013
J	Raharijaona, M; Le Pennec, S; Poirier, J; Mirebeau-Prunier, D; Rouxel, C; Jacques, C; Fontaine, JF; Malthiery, Y; Houlgatte, R; Savagner, F				Raharijaona, Mahatsangy; Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Houlgatte, Remi; Savagner, Frederique			PGC-1-Related Coactivator Modulates Mitochondrial-Nuclear Crosstalk through Endogenous Nitric Oxide in a Cellular Model of Oncocytic Thyroid Tumours	PLOS ONE			English	Article							RESPIRATORY GENE-EXPRESSION; CYCLE PROGRESSION; INDUCIBLE COACTIVATOR; SIGNALING PATHWAYS; ENERGY-METABOLISM; MAMMALIAN-CELLS; FACTORS NRF-1; BIOGENESIS; TRANSCRIPTION; PGC-1-ALPHA	Background: The PGC-1 related coactivator (PRC), which shares structural and functional features with PGC-1 alpha, is believed to regulate several metabolic pathways as well as mitochondrial biogenesis. Its involvement in the early programming of cell proliferation suggests the existence of finely regulated crosstalk between mitochondrial functions and the cell cycle status. Methodology/Principal Findings: PRC-regulated pathways were explored in a cell-line model derived from mitochondrial-rich tumours with an essentially oxidative metabolism and specifically high PRC expression. The functional status of mitochondria was compared to the results of microarray analysis under conditions of temporal PRC inhibition. To specify the fine PRC regulation, the expression levels of the genes and proteins involved in the oxidative phosphorylation process were studied by real time quantitative PCR and western blotting. As in earlier studies on PGC-1 alpha, we investigated the role of nitric oxide in PRC-regulated mitochondrial biogenesis and determined its action in the control of the phosphorylation status of the mitogen-activated protein kinase pathway. Conclusion/Significance: We found that nitric oxide rapidly influences PRC expression at the transcriptional level. Focusing on mitochondrial energetic metabolism, we observed that PRC differentially controls respiratory chain complexes and coupling efficiency in a time-dependent manner to maintain mitochondrial homeostasis. Our results highlight the key role of PRC in the rapid modulation of metabolic functions in response to the status of the cell cycle.	[Raharijaona, Mahatsangy; Houlgatte, Remi; Savagner, Frederique] Inst Thorax, UMR 915, INSERM, Nantes, France; [Raharijaona, Mahatsangy; Houlgatte, Remi] Univ Nantes, Nantes, France; [Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Savagner, Frederique] INSERM, UMR 694, Angers, France; [Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Savagner, Frederique] Univ Angers, Angers, France; [Mirebeau-Prunier, Delphine; Malthiery, Yves; Savagner, Frederique] CHU Angers, Biochim Lab, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Raharijaona, M (corresponding author), Inst Thorax, UMR 915, INSERM, Nantes, France.	frederique.savagner@univ-angers.fr	LE PENNEC, Soazig/H-3817-2017; Fontaine, Jean-Fred/GNP-2904-2022; Houlgatte, Remi/P-3020-2017; Prunier, Delphine/K-3301-2015	Fontaine, Jean-Fred/0000-0002-1101-4091; Rouxel, Clotilde/0000-0002-9374-3609	French Ministry of Research; Institut National de la Recherche Medicale (INSERM); University Hospital of Angers; Ligue Contre le Cancer	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Hospital of Angers; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the French Ministry of Research, the Institut National de la Recherche Medicale (INSERM), the University Hospital of Angers and the Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Au HC, 1998, EUR J BIOCHEM, V251, P164, DOI 10.1046/j.1432-1327.1998.2510164.x; Baris O, 2005, ONCOGENE, V24, P4155, DOI 10.1038/sj.onc.1208578; Baris O, 2004, J CLIN ENDOCR METAB, V89, P994, DOI 10.1210/jc.2003-031238; Barlow C, 2006, AM J RESP CELL MOL, V34, P7, DOI 10.1165/rcmb.2005-0153OC; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Brookes PS, 2002, METHOD ENZYMOL, V359, P305; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontaine JF, 2008, ONCOGENE, V27, P2228, DOI 10.1038/sj.onc.1210853; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Patel A, 2002, J ENDOCRINOL INVEST, V25, P675, DOI 10.1007/BF03345100; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Savagner F, 2001, THYROID, V11, P327, DOI 10.1089/10507250152039055; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Tanaka T, 2005, FREE RADICAL BIO MED, V38, P1231, DOI 10.1016/j.freeradbiomed.2005.01.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	52	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7964	10.1371/journal.pone.0007964	http://dx.doi.org/10.1371/journal.pone.0007964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956726	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827300019
J	Gordon, A; Videa, E; Saborio, S; Lopez, R; Kuan, G; Reingold, A; Balmaseda, A; Harris, E				Gordon, Aubree; Videa, Elsa; Saborio, Saira; Lopez, Roger; Kuan, Guillermina; Reingold, Arthur; Balmaseda, Angel; Harris, Eva			Performance of an Influenza Rapid Test in Children in a Primary Healthcare Setting in Nicaragua	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL CULTURE; VIRUS-INFECTION; A+B TEST; DIAGNOSIS; ACCURACY; IMPACT	Background: Influenza is major public health threat worldwide, yet the diagnostic accuracy of rapid tests in developing country settings is not well described. Methodology/Principal Findings: To investigate the diagnostic accuracy of the QuickVue Influenza A+B test in a primary care setting in a developing country, we performed a prospective study of diagnostic accuracy of the QuickVue Influenza A+B test in comparison to reverse transcriptase-polymerase chain reaction (RT-PCR) in a primary healthcare setting in children aged 2 to 12 years in Managua, Nicaragua. The sensitivity and specificity of the QuickVue test compared to RT-PCR were 68.5% (95% CI 63.4, 73.3) and 98.1% (95% CI 96.9, 98.9), respectively, for children with a fever or history of a fever and cough and/or sore throat. Test performance was found to be lower on the first day that symptoms developed in comparison to test performance on days two or three of illness. Conclusions/Significance: Our study found that the QuickVue Influenza A+B test performed as well in a developing country primary healthcare facility setting as in developed country settings.			Gordon, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	eharris@berkeley.edu	Gordon, Aubree/X-1113-2019	Gordon, Aubree/0000-0002-9352-7877				Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092; Mehlmann M, 2007, J CLIN MICROBIOL, V45, P1234, DOI 10.1128/JCM.02202-06; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; Pregliasco F, 1998, J MED VIROL, V56, P168, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;168::AID-JMV11&gt;3.0.CO;2-C; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Simmerman JM, 2007, INT J INFECT DIS, V11, P166, DOI 10.1016/j.ijid.2006.01.005; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; World Health Organization, GLOB AG INFL SURV CO	20	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7907	10.1371/journal.pone.0007907	http://dx.doi.org/10.1371/journal.pone.0007907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936063	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600011
J	Herraez, DL; Bauchet, M; Tang, K; Theunert, C; Pugach, I; Li, J; Nandineni, MR; Gross, A; Scholz, M; Stoneking, M				Herraez, David Lopez; Bauchet, Marc; Tang, Kun; Theunert, Christoph; Pugach, Irina; Li, Jing; Nandineni, Madhusudan R.; Gross, Arnd; Scholz, Markus; Stoneking, Mark			Genetic Variation and Recent Positive Selection in Worldwide Human Populations: Evidence from Nearly 1 Million SNPs	PLOS ONE			English	Article							LACTASE PERSISTENCE; NATURAL-SELECTION; WIDE ANALYSIS; GENOME; DIVERSITY; ASSOCIATION; COLONIZATION; POLYMORPHISM; EXPANSIONS; ADMIXTURE	Background: Genome-wide scans of hundreds of thousands of single-nucleotide polymorphisms (SNPs) have resulted in the identification of new susceptibility variants to common diseases and are providing new insights into the genetic structure and relationships of human populations. Moreover, genome-wide data can be used to search for signals of recent positive selection, thereby providing new insights into the genetic adaptations that occurred as modern humans spread out of Africa and around the world. Methodology: We genotyped approximately 500,000 SNPs in 255 individuals (5 individuals from each of 51 worldwide populations) from the Human Genome Diversity Panel (HGDP-CEPH). When merged with non-overlapping SNPs typed previously in 250 of these same individuals, the resulting data consist of over 950,000 SNPs. We then analyzed the genetic relationships and ancestry of individuals without assigning them to populations, and we also identified candidate regions of recent positive selection at both the population and regional (continental) level. Conclusions: Our analyses both confirm and extend previous studies; in particular, we highlight the impact of various dispersals, and the role of substructure in Africa, on human genetic diversity. We also identified several novel candidate regions for recent positive selection, and a gene ontology (GO) analysis identified several GO groups that were significantly enriched for such candidate genes, including immunity and defense related genes, sensory perception genes, membrane proteins, signal receptors, lipid binding/metabolism genes, and genes involved in the nervous system. Among the novel candidate genes identified are two genes involved in the thyroid hormone pathway that show signals of selection in African Pygmies that may be related to their short stature.			Herraez, DL (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	stoneking@eva.mpg.de	Tang, Kun/GSD-3218-2022	Gross, Arnd/0000-0002-5961-5507; Nandineni, Madhusudan Reddy/0000-0002-8933-4503				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cann HM, 2002, SCIENCE, V296, P261; DIAMOND JM, 1991, NATURE, V354, P111, DOI 10.1038/354111a0; DORMITZER PR, 1989, AM J PHYS ANTHROPOL, V78, P527, DOI 10.1002/ajpa.1330780408; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Fix AG, 2002, HUM BIOL, V74, P1, DOI 10.1353/hub.2002.0003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; GREENBERG JH, 1972, J AFR HIST, V13, P189, DOI 10.1017/S0021853700011427; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Hoggart CJ, 2007, GENETICS, V177, P1725, DOI 10.1534/genetics.106.069088; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kimura R, 2008, MOL BIOL EVOL, V25, P1750, DOI 10.1093/molbev/msn128; Koronyo-Hamaoui M, 2004, AM J MED GENET B, V131B, P76, DOI 10.1002/ajmg.b.20154; Kuhar MJ, 2002, NEUROPEPTIDES, V36, P1, DOI 10.1054/npep.2002.0887; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritsner M, 2002, BIOL PSYCHIAT, V51, P788, DOI 10.1016/S0006-3223(01)01348-8; ROSE SR, 1995, PEDIATR RES, V38, P967, DOI 10.1203/00006450-199512000-00023; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sultan M, 2008, JCPSP-J COLL PHYSICI, V18, P493, DOI 08.2008/JCPSP.493497; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; TISHKOFF SA, 2009, SCIENCE; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	56	103	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7888	10.1371/journal.pone.0007888	http://dx.doi.org/10.1371/journal.pone.0007888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521QH	19924308	Green Submitted, Green Published, gold			2022-12-27	WOS:000271936700020
J	Halama, N; Zoernig, I; Spille, A; Westphal, K; Schirmacher, P; Jaeger, D; Grabe, N				Halama, Niels; Zoernig, Inka; Spille, Anna; Westphal, Kathi; Schirmacher, Peter; Jaeger, Dirk; Grabe, Niels			Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; T-CELLS; PROGNOSTIC ROLE; OVARIAN-CANCER; METASTASIS; SURVIVAL; RATIO	Background: Determining the correct number of positive immune cells in immunohistological sections of colorectal cancer and other tumor entities is emerging as an important clinical predictor and therapy selector for an individual patient. This task is usually obstructed by cell conglomerates of various sizes. We here show that at least in colorectal cancer the inclusion of immune cell conglomerates is indispensable for estimating reliable patient cell counts. Integrating virtual microscopy and image processing principally allows the high-throughput evaluation of complete tissue slides. Methodology/Principal findings: For such large-scale systems we demonstrate a robust quantitative image processing algorithm for the reproducible quantification of cell conglomerates on CD3 positive T cells in colorectal cancer. While isolated cells (28 to 80 mm(2)) are counted directly, the number of cells contained in a conglomerate is estimated by dividing the area of the conglomerate in thin tissues sections (<= 6 mu m) by the median area covered by an isolated T cell which we determined as 58 mm(2). We applied our algorithm to large numbers of CD3 positive T cell conglomerates and compared the results to cell counts obtained manually by two independent observers. While especially for high cell counts, the manual counting showed a deviation of up to 400 cells/mm(2) (41% variation), algorithm-determined T cell numbers generally lay in between the manually observed cell numbers but with perfect reproducibility. Conclusion: In summary, we recommend our approach as an objective and robust strategy for quantifying immune cell densities in immunohistological sections which can be directly implemented into automated full slide image processing systems.			Halama, N (corresponding author), Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany.	Niels.Grabe@bioquant.uni-heidelberg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016	Grabe, Niels/0000-0003-1732-3706; Halama, Niels/0000-0003-0344-6027				Choi YJ, 2008, MODERN PATHOL, V21, P1224, DOI 10.1038/modpathol.2008.106; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; FUCHS TJ, 2008, COMPUTATIONAL PATHOL, P1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grabe N, 2008, Pathologe, V29 Suppl 2, P259, DOI 10.1007/s00292-008-1083-2; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Halama Niels, 2009, Cancer Immun, V9, P1; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Matkowski R, 2009, ANTICANCER RES, V29, P2445; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Naito Y, 1998, CANCER RES, V58, P3491; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; SALAMA P, 2008, J CLIN ONCOL, V27, P168; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	17	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7847	10.1371/journal.pone.0007847	http://dx.doi.org/10.1371/journal.pone.0007847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924291	Green Submitted, gold, Green Published			2022-12-27	WOS:000271851000007
J	Chomiak, T; Hu, B				Chomiak, Taylor; Hu, Bin			What Is the Optimal Value of the g-Ratio for Myelinated Fibers in the Rat CNS? A Theoretical Approach	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SQUID GIANT-AXON; WHITE-MATTER; SHEATH THICKNESS; NEURONAL MORPHOLOGY; CEREBRAL-CORTEX; SURAL NERVE; CONDUCTION; REMYELINATION; OLIGODENDROCYTES	Background: The biological process underlying axonal myelination is complex and often prone to injury and disease. The ratio of the inner axonal diameter to the total outer diameter or g-ratio is widely utilized as a functional and structural index of optimal axonal myelination. Based on the speed of fiber conduction, Rushton was the first to derive a theoretical estimate of the optimal g-ratio of 0.6 [1]. This theoretical limit nicely explains the experimental data for myelinated axons obtained for some peripheral fibers but appears significantly lower than that found for CNS fibers. This is, however, hardly surprising given that in the CNS, axonal myelination must achieve multiple goals including reducing conduction delays, promoting conduction fidelity, lowering energy costs, and saving space. Methodology/Principal Findings: In this study we explore the notion that a balanced set-point can be achieved at a functional level as the micro-structure of individual axons becomes optimized, particularly for the central system where axons tend to be smaller and their myelin sheath thinner. We used an intuitive yet novel theoretical approach based on the fundamental biophysical properties describing axonal structure and function to show that an optimal g-ratio can be defined for the central nervous system (approximate to 0.77). Furthermore, by reducing the influence of volume constraints on structural design by about 40%, this approach can also predict the g-ratio observed in some peripheral fibers (approximate to 0.6). Conclusions/Significance: These results support the notion of optimization theory in nervous system design and construction and may also help explain why the central and peripheral systems have evolved different g-ratios as a result of volume constraints.			Chomiak, T (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	tgchomia@ucalgary.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		ADAM A, 1988, ANAT EMBRYOL, V178, P537, DOI 10.1007/BF00305041; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AWISZUS F, 1990, BIOL CYBERN, V64, P69, DOI 10.1007/BF00203632; Balabanov R, 2006, J NEUROSCI, V26, P5143, DOI 10.1523/JNEUROSCI.0737-06.2006; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Benninger Y, 2006, J NEUROSCI, V26, P7665, DOI 10.1523/JNEUROSCI.0444-06.2006; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273, DOI 10.1113/jphysiol.1978.sp012384; Brosamle C, 2000, J NEUROCYTOL, V29, P499, DOI 10.1023/A:1007297712821; Chau WK, 2000, RESTOR NEUROL NEUROS, V16, P105; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Chomiak T, 2008, J NEUROPHYSIOL, V100, P327, DOI 10.1152/jn.90392.2008; Chomiak T, 2007, J PHYSIOL-LONDON, V579, P403, DOI 10.1113/jphysiol.2006.124057; Cole KS, 1939, J GEN PHYSIOL, V22, P671, DOI 10.1085/jgp.22.5.671; Curtis HJ, 1938, J GEN PHYSIOL, V21, P757, DOI 10.1085/jgp.21.6.757; DELORENZO AJ, 1956, ANAT REC, V124, P328; EHRLICH D, 1985, CELL TISSUE RES, V239, P661; Elder GA, 2001, J NEUROSCI RES, V65, P493, DOI 10.1002/jnr.1179; FAHRENKAMP I, 1987, ANAT EMBRYOL, V177, P115, DOI 10.1007/BF00572535; FERNANDEZMORAN H, 1959, REV MOD PHYS, V31, P319, DOI 10.1103/RevModPhys.31.319; FRAHER JP, 1992, J COMP NEUROL, V323, P551, DOI 10.1002/cne.903230407; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Grandis M, 2004, EXP NEUROL, V190, P213, DOI 10.1016/j.expneurol.2004.07.008; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Jeronimo A, 2005, J ANAT, V206, P93, DOI 10.1111/j.0021-8782.2005.00368.x; KERNS JM, 1980, J COMP NEUROL, V189, P291, DOI 10.1002/cne.901890206; Klopfleisch S, 2008, J NEUROSCI, V28, P13609, DOI 10.1523/JNEUROSCI.2765-08.2008; KOESTER J, 2000, PRINCIPLES NEURAL SC, P140; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Paus T, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.014.2009; Perge JA, 2009, J NEUROSCI, V29, P7917, DOI 10.1523/JNEUROSCI.5200-08.2009; Perrot R, 2007, J NEUROSCI, V27, P9573, DOI 10.1523/JNEUROSCI.1224-07.2007; QUARLES RH, 1978, J NEUROBIOL, V9, P217, DOI 10.1002/neu.480090304; Ramon y Cajal S., 1899, TEXTURA SISTEMA NERV; RASMINSKY M, 1978, PHYSL PATHOBIOLOGY A, P361; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Shepherd GM, 1999, FUNDAMENTAL NEUROSCI, P107; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; TASAKI I, 1955, AM J PHYSIOL, V181, P639, DOI 10.1152/ajplegacy.1955.181.3.639; THOMAS PK, 1990, ACTA NEUROPATHOL, V79, P375, DOI 10.1007/BF00308713; Wallace VCJ, 2003, J NEUROSCI, V23, P3221; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; WAXMAN SG, 1976, EXP NEUROL, V53, P115, DOI 10.1016/0014-4886(76)90287-9; WAXMAN SG, 1978, PHYSL PATHOBIOLOGY A, P169; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	71	268	271	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7754	10.1371/journal.pone.0007754	http://dx.doi.org/10.1371/journal.pone.0007754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915661	Green Submitted, gold, Green Published			2022-12-27	WOS:000271721900001
J	Aghokeng, AF; Mpoudi-Ngole, E; Dimodi, H; Atem-Tambe, A; Tongo, M; Butel, C; Delaporte, E; Peeters, M				Aghokeng, Avelin F.; Mpoudi-Ngole, Eitel; Dimodi, Henriette; Atem-Tambe, Arrah; Tongo, Marcel; Butel, Christelle; Delaporte, Eric; Peeters, Martine			Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon	PLOS ONE			English	Article							GENETIC DIVERSITY; INFECTION; ASSAYS; IDENTIFICATION; CHIMPANZEES; REDUCTION; ALGORITHM; STRATEGY; WINDOW	Background: Increased access to HIV testing is essential in working towards universal access to HIV prevention and treatment in resource-limited countries. We here evaluated currently used HIV diagnostic tests and algorithms in Cameroon for their ability to correctly identify HIV infections. Methods: We estimated sensitivity, specificity, and positive and negative predictive values of 5 rapid/simple tests, of which 3 were used by the national program, and 2 fourth generation ELISAs. The reference panel included 500 locally collected samples; 187 HIV-1 M, 10 HIV-1 O, 259 HIV negative and 44 HIV indeterminate plasmas. Results: None of the 5 rapid assays and only 1 ELISA reached the current WHO/UNAIDS recommendations on performance of HIV tests of at least 99% sensitivity and 98% specificity. Overall, sensitivities ranged between 94.1% and 100%, while specificities were 88.0% to 98.8%. The combination of all assays generated up to 9% of samples with indeterminate HIV status, because they reacted discordantly with at least one of the different tests. Including HIV indeterminate samples in test efficiency calculations significantly decreased specificities to a range from 77.9% to 98.0%. Finally, two rapid assays failed to detect all HIV-1 group O variants tested, with one rapid test detecting only 2 out of 10 group O specimens. Conclusion: In the era of ART scaling-up in Africa, significant proportions of false positive but also false negative results are still observed with HIV screening tests commonly used in Africa, resulting in inadequate treatment and prevention strategies. Depending on tests or algorithms used, up to 6% of HIV-1 M and 80% of HIV-1 O infected patients in Cameroon do not receive ART and adequate counseling to prevent further transmission due to low sensitivities. Also, the use of tests with low specificities could imply inclusion of up to 12% HIV negative people in ART programs and increase budgets in addition to inconveniences caused to patients.			Aghokeng, AF (corresponding author), IRD, Virol Lab IMPM, Yaounde, Cameroon.	aghokeng@ird.fr	Delaporte, Eric/J-5397-2018; Tongo, Marcel/AAB-4155-2019	Delaporte, Eric/0000-0002-1822-9853; Tongo, Marcel/0000-0002-5262-892X; AGHOKENG FOBANG, Avelin/0000-0002-1414-0237				Aghokeng AF, 2004, JAIDS-J ACQ IMM DEF, V37, P1632, DOI 10.1097/00126334-200412150-00018; [Anonymous], 2007, MANUAL ESTIMATING NA; Apetrei C, 1996, AIDS, V10, pF57, DOI 10.1097/00002030-199612000-00002; Ayouba A, 2001, EMERG INFECT DIS, V7, P466, DOI 10.3201/eid0703.017321; Constantine NT, 2005, INDIAN J MED RES, V121, P519; Corcoran C, 2008, CLIN INFECT DIS, V46, DOI 10.1086/524892; FRANSEN K, 1994, MOL CELL PROBE, V8, P317, DOI 10.1006/mcpr.1994.1043; Gautheret-Dejean A, 2008, CLIN INFECT DIS, V46, P1936, DOI 10.1086/588561; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gurtler L, 1998, J VIROL METHODS, V75, P27, DOI 10.1016/S0166-0934(98)00094-9; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; LOUSSERTAJAKA I, 1994, LANCET, V343, P1393, DOI 10.1016/S0140-6736(94)92524-0; Mahe C, 2002, INT J EPIDEMIOL, V31, P985, DOI 10.1093/ije/31.5.985; Mfinanga G S, 2007, Tanzan Health Res Bull, V9, P44; Novitsky V, 2007, CLIN INFECT DIS, V45, pE68, DOI 10.1086/520683; Rouet F, 2004, J CLIN MICROBIOL, V42, P4147, DOI 10.1128/JCM.42.9.4147-4153.2004; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; *UNAIDS, 2008, CAM COUNTR PROGR REP; Urassa W, 2002, J VIROL METHODS, V100, P115, DOI 10.1016/S0166-0934(01)00408-6; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Vergne L, 2003, VIROLOGY, V310, P254, DOI 10.1016/S0042-6822(03)00167-3; Weber B, 1998, J CLIN MICROBIOL, V36, P2235, DOI 10.1128/JCM.36.8.2235-2239.1998; *WHO CDC, 2001, GUID APPR EV HIV TES; Yang CF, 2000, J INFECT DIS, V181, P1791, DOI 10.1086/315439	25	56	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7702	10.1371/journal.pone.0007702	http://dx.doi.org/10.1371/journal.pone.0007702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893738	Green Published, Green Submitted, gold			2022-12-27	WOS:000271478000004
J	Heron, J; Hanson, JVM; Whitaker, D				Heron, James; Hanson, James V. M.; Whitaker, David			Effect before Cause: Supramodal Recalibration of Sensorimotor Timing	PLOS ONE			English	Article							TEMPORAL-ORDER; MOTOR ADAPTATION; TIME PERCEPTION; SELF-AGENCY; SCHIZOPHRENIA; SIMULTANEITY; DISCRIMINATION; CONSEQUENCES; MECHANISMS; JUDGMENTS	Background: Our motor actions normally generate sensory events, but how do we know which events were self generated and which have external causes? Here we use temporal adaptation to investigate the processing stage and generality of our sensorimotor timing estimates. Methodology/Principal Findings: Adaptation to artificially-induced delays between action and event can produce a startling percept-upon removal of the delay it feels as if the sensory event precedes its causative action. This temporal recalibration of action and event occurs in a quantitatively similar manner across the sensory modalities. Critically, it is robust to the replacement of one sense during the adaptation phase with another sense during the test judgment. Conclusions/Significance: Our findings suggest a high-level, supramodal recalibration mechanism. The effects are well described by a simple model which attempts to preserve the expected synchrony between action and event, but only when causality indicates it is reasonable to do so. We further demonstrate that this model successfully characterises related adaptation data from outside the sensorimotor domain.			Heron, J (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	j.heron2@bradford.ac.uk	Heron, James/H-1792-2012	Heron, James/0000-0003-3857-5056	EPSRC [EP/F055986/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F055986/1] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Asai T, 2008, PSYCHIAT CLIN NEUROS, V62, P115, DOI 10.1111/j.1440-1819.2007.01768.x; Asai T, 2007, J MOTOR BEHAV, V39, P162, DOI 10.3200/JMBR.39.3.162-168; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Bedford FL, 2001, CAH PSYCHOL COGN, V20, P113; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Helson H, 1964, ADAPTATION LEVEL THE; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; IVRY R, 1995, HUMAN PERCEPTION PEF, V21, P3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KEELE SW, 1985, B PSYCHONOMIC SOC, V273, P273; Kennedy JS, 2009, Q J EXP PSYCHOL, V62, P453, DOI 10.1080/17470210801985235; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Meegan DV, 2000, NAT NEUROSCI, V3, P860, DOI 10.1038/78757; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Pesavento MJ, 2006, EXP BRAIN RES, V174, P435, DOI 10.1007/s00221-006-0476-9; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Waszak F, 2005, EXP BRAIN RES, V162, P346, DOI 10.1007/s00221-004-2183-8; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; WELCH R, 1986, HDB PERCEPTION PERFO; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942	49	71	74	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7681	10.1371/journal.pone.0007681	http://dx.doi.org/10.1371/journal.pone.0007681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	515HI	19890383	Green Published, gold			2022-12-27	WOS:000271459700005
J	Sachdeva, R; Banerjea, AC; Malla, N; Dubey, ML				Sachdeva, Rakhee; Banerjea, Akhil C.; Malla, Nancy; Dubey, Mohan Lal			Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model	PLOS ONE			English	Article							T-CELL EPITOPES; MAJOR SURFACE GLYCOPROTEIN; HEAT-SHOCK PROTEINS; IMMUNE-RESPONSES; MYCOBACTERIAL HEAT-SHOCK-PROTEIN-70; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; CYTOKINES; HSP70; LYMPHOCYTES	Polytope approach of genetic immunization is a promising strategy for the prevention of infectious disease as it is capable of generating effective cell mediated immunity by delivering the T cell epitopes assembled in series. Leishmaniasis is a significant world wide health problem for which no vaccine exists. In this study we have compared immunogenicity and efficacy of three types of DNA vaccines: single antigen Gp63 (Gp63/pcDNA), polytope (Poly/pcDNA) and Polytope fused with hsp70 (Poly/hsp/pcDNA) against visceral leishmaniasis in susceptible BALB/c mice. Mice vaccinated with these plasmids generated strong Th1 immune response as seen by dominating IFN-gamma over IL-10 cytokine. Interestingly, cytotoxic responses generated by polytope DNA plasmid fused with hsp70 of Leishmania donovani were significantly higher when compared to polytope and single antigen Gp63 vaccine. Challenge studies revealed that the parasite load in liver and spleen was significantly lower with Poly/hsp/pcDNA vaccination compared to other vaccines. Therefore, our study indicates that polytope DNA vaccine is a feasible, practical and effective approach for visceral leishmaniasis.	[Sachdeva, Rakhee; Malla, Nancy; Dubey, Mohan Lal] Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh 160012, India; [Banerjea, Akhil C.] Natl Inst Immunol, New Delhi 110067, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sachdeva, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh 160012, India.	mldubey@gmail.com		Sachdeva, Rakhee/0000-0001-9624-5624	Indian Council of Medical Research, New Delhi [Immuno/18/11/21/2002-ECD-1]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	Financial assistance from Indian Council of Medical Research, New Delhi supported this work: Grant No. Immuno/18/11/21/2002-ECD-1 and URL ishttp://icmr.nic.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bazhan SI, 2004, VACCINE, V22, P1672, DOI 10.1016/j.vaccine.2003.09.048; BOGDAN C, 1993, IMMUNOBIOLOGY, V189, P356, DOI 10.1016/S0171-2985(11)80366-9; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Chen CH, 2000, CANCER RES, V60, P1035; CURRY AJ, 1994, INFECT IMMUN, V62, P1733, DOI 10.1128/IAI.62.5.1733-1741.1994; Di Paolo NC, 2006, CANCER RES, V66, P960, DOI 10.1158/0008-5472.CAN-05-2388; Duraiswamy J, 2004, CANCER RES, V64, P1483, DOI 10.1158/0008-5472.CAN-03-2196; Fonseca DPAJ, 2001, INFECT IMMUN, V69, P4839, DOI 10.1128/IAI.69.8.4839-4845.2001; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; KAYE PM, 1991, J IMMUNOL, V146, P2763; Khalil EAG, 2005, CLIN EXP IMMUNOL, V140, P349, DOI 10.1111/j.1365-2249.2005.02768.x; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Loing E, 2000, J IMMUNOL, V164, P900, DOI 10.4049/jimmunol.164.2.900; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; ORMEROD MG, 1989, FURTHER APPL CELL BI, P265; Ozbilge H, 2006, J MED MICROBIOL, V55, P1329, DOI 10.1099/jmm.0.46667-0; Peng ML, 2006, VACCINE, V24, P887, DOI 10.1016/j.vaccine.2005.12.050; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; RUSSO DM, 1993, J IMMUNOL, V150, P4713; Saha S, 2006, INDIAN J MED RES, V123, P245; Schirmbeck R, 2003, J IMMUNOL, V171, P1240, DOI 10.4049/jimmunol.171.3.1240; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; SUHRBIER A, 1998, INT C AIDS, V12, P277; Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207; Sukumaran B, 2003, VACCINE, V21, P1292, DOI 10.1016/S0264-410X(02)00352-3; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Suzue K, 1996, J IMMUNOL, V156, P873; Thomson SA, 1998, J IMMUNOL, V160, P1717; Toes REM, 1997, P NATL ACAD SCI USA, V94, P14660, DOI 10.1073/pnas.94.26.14660; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Trinchieri G, 2001, J EXP MED, V194, pF53, DOI 10.1084/jem.194.10.f53; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; Tsagozis P, 2005, PARASITOL INT, V54, P139, DOI 10.1016/j.parint.2005.02.005; Udono H, 2001, INT IMMUNOL, V13, P1233, DOI 10.1093/intimm/13.10.1233; Walker PS, 1998, HUM GENE THER, V9, P1899, DOI 10.1089/hum.1998.9.13-1899; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K; Wei WZ, 2001, J IMMUNOL METHODS, V258, P141, DOI 10.1016/S0022-1759(01)00484-7; Woodberry T, 1999, J VIROL, V73, P5320, DOI 10.1128/JVI.73.7.5320-5325.1999; XU D, 1995, IMMUNOLOGY, V84, P173; YANG DM, 1991, IMMUNOLOGY, V72, P3	51	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e7880	10.1371/journal.pone.0007880	http://dx.doi.org/10.1371/journal.pone.0007880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956549	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800001
J	Takahashi, K; Narita, M; Yokura, M; Ichisaka, T; Yamanaka, S				Takahashi, Kazutoshi; Narita, Megumi; Yokura, Midori; Ichisaka, Tomoko; Yamanaka, Shinya			Human Induced Pluripotent Stem Cells on Autologous Feeders	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; LINES; ESTABLISHMENT; MAINTENANCE; CULTURE; DIFFERENTIATION; EFFICIENT; MOUSE; STO	Background: For therapeutic usage of induced Pluripotent Stem (iPS) cells, to accomplish xeno-free culture is critical. Previous reports have shown that human embryonic stem (ES) cells can be maintained in feeder-free condition. However, absence of feeder cells can be a hostile environment for pluripotent cells and often results in karyotype abnormalities. Instead of animal feeders, human fibroblasts can be used as feeder cells of human ES cells. However, one still has to be concerned about the existence of unidentified pathogens, such as viruses and prions in these nonautologous feeders. Methodology/Principal Findings: This report demonstrates that human induced Pluripotent Stem (iPS) cells can be established and maintained on isogenic parental feeder cells. We tested four independent human skin fibroblasts for the potential to maintain self-renewal of iPS cells. All the fibroblasts tested, as well as their conditioned medium, were capable of maintaining the undifferentiated state and normal karyotypes of iPS cells. Furthermore, human iPS cells can be generated on isogenic parental fibroblasts as feeders. These iPS cells carried on proliferation over 19 passages with undifferentiated morphologies. They expressed undifferentiated pluripotent cell markers, and could differentiate into all three germ layers via embryoid body and teratoma formation. Conclusions/Significance: These results suggest that autologous fibroblasts can be not only a source for iPS cells but also be feeder layers. Our results provide a possibility to solve the dilemma by using isogenic fibroblasts as feeder layers of iPS cells. This is an important step toward the establishment of clinical grade iPS cells.	[Takahashi, Kazutoshi; Narita, Megumi; Yokura, Midori; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto, Japan; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Takahashi, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto, Japan.	takahash@cira.kyoto-u.ac.jp; yamanaka@cira.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST); National Institute of Biomedical Innovation (NIBIO); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Japan Science and Technology Agency (JST), National Institute of Biomedical Innovation (NIBIO), Japan Society for the Promotion of Science (JSPS). All of them are non-profit foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park JH, 2003, BIOL REPROD, V69, P2007, DOI 10.1095/biolreprod.103.017467; Park SP, 2004, HUM REPROD, V19, P676, DOI 10.1093/humrep/deh102; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rittie L, 2005, METH MOLEC MED, V117, P83; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	22	72	83	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8067	10.1371/journal.pone.0008067	http://dx.doi.org/10.1371/journal.pone.0008067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956543	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828800007
J	Barrenas, F; Chavali, S; Holme, P; Mobini, R; Benson, M				Barrenas, Fredrik; Chavali, Sreenivas; Holme, Petter; Mobini, Reza; Benson, Mikael			Network Properties of Complex Human Disease Genes Identified through Genome-Wide Association Studies	PLOS ONE			English	Article							TOPOLOGICAL FEATURES; INTERACTOME; MICROARRAY; EXPRESSION; CENTRALITY; DISORDERS; TRAITS	Background: Previous studies of network properties of human disease genes have mainly focused on monogenic diseases or cancers and have suffered from discovery bias. Here we investigated the network properties of complex disease genes identified by genome-wide association studies (GWAs), thereby eliminating discovery bias. Principal findings: We derived a network of complex diseases (n = 54) and complex disease genes (n = 349) to explore the shared genetic architecture of complex diseases. We evaluated the centrality measures of complex disease genes in comparison with essential and monogenic disease genes in the human interactome. The complex disease network showed that diseases belonging to the same disease class do not always share common disease genes. A possible explanation could be that the variants with higher minor allele frequency and larger effect size identified using GWAs constitute disjoint parts of the allelic spectra of similar complex diseases. The complex disease gene network showed high modularity with the size of the largest component being smaller than expected from a randomized null-model. This is consistent with limited sharing of genes between diseases. Complex disease genes are less central than the essential and monogenic disease genes in the human interactome. Genes associated with the same disease, compared to genes associated with different diseases, more often tend to share a protein-protein interaction and a Gene Ontology Biological Process. Conclusions: This indicates that network neighbors of known disease genes form an important class of candidates for identifying novel genes for the same disease.	[Barrenas, Fredrik; Chavali, Sreenivas; Mobini, Reza; Benson, Mikael] Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden; [Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	University of Gothenburg; Umea University; Sungkyunkwan University (SKKU)	Barrenas, F (corresponding author), Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden.	fredrik.barrenas@gu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Mobini, Reza/0000-0002-3690-5739	Swedish Research Council; European Commission; Swedish Foundation for Strategic Research; WCU (World Class University); Ministry of Education, Science and Technology [R31-R312008-000-10029-0]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); WCU (World Class University); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Swedish Research Council, The European Commission, The Swedish Foundation for Strategic Research (PH), and the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology R31-R312008-000-10029-0 (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Benson M, 2007, ACTA OTO-LARYNGOL, V127, P1074, DOI 10.1080/00016480701200277; Benson M, 2009, ALLERGY, V64, P1286, DOI 10.1111/j.1398-9995.2009.01991.x; Benson M, 2006, CURR MOL MED, V6, P695, DOI 10.2174/156652406778195044; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holme P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046111; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Mobini R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-19; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467	25	82	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8090	10.1371/journal.pone.0008090	http://dx.doi.org/10.1371/journal.pone.0008090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956617	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400029
J	Sohn, JA; Litwin, S; Seeger, C				Sohn, Ji A.; Litwin, Samuel; Seeger, Christoph			Mechanism for CCC DNA Synthesis in Hepadnaviruses	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; REVERSE TRANSCRIPTION; VIRAL-DNA; REPLICATION; PROTEIN; GENOME; WOODCHUCK; INTERMEDIATE; HEPATOCYTES	Hepadnavirus replication requires the synthesis of a covalently closed circular (CCC) DNA from the relaxed circular (RC) viral genome by an unknown mechanism. CCC DNA formation could require enzymatic activities of the viral reverse transcriptase (RT), or cellular DNA repair enzymes, or both. Physical mapping of the 59 and 39 ends of RC DNA and sequence analysis of CCC DNA revealed that CCC DNA synthesis requires the removal of the RT and an RNA oligomer from the 59 ends of minus and plus strand DNA, respectively, removal of sequences from the terminally redundant minus strand, completion of the less than full-length plus strand, and ligation of the ends. Two models have been proposed that could explain CCC DNA formation. The first (model 1) invokes a role for the RT to catalyze a cleavage-ligation reaction leading to the formation of a unit length minus strand in CCC DNA and a DNA repair reaction for the completion and ligation of plus strand DNA; the second (model 2) predicts that CCC DNA formation depends entirely on cellular DNA repair enzymes. To determine which mechanism is utilized, we developed cell lines expressing duck hepatitis B virus genomes carrying mutations permitting us to follow the fate of viral DNA sequences during their conversion from RC to CCC DNA. Our results demonstrated that the oligomer at the 59 end of minus strand DNA is completely or at least partially removed prior to CCC DNA synthesis. The results indicated that both RC DNA strands undergo DNA repair reactions carried out by the cellular DNA repair machinery as predicted by model 2. Thus, our study provided the basis for the identification of the cellular components required for CCC DNA formation.	[Sohn, Ji A.; Litwin, Samuel; Seeger, Christoph] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Sohn, JA (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	seeger@fccc.edu			NIH; Commonwealth of Pennsylvania	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania	Supported by grants from NIH and an appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; GUO H, 2009, J VIROL; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; LENHOFF RJ, 1994, J VIROL, V68, P5706, DOI 10.1128/JVI.68.9.5706-5713.1994; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; LIEN JM, 1986, J VIROL, V57, P229, DOI 10.1128/JVI.57.1.229-236.1986; Loeb DD, 1997, J VIROL, V71, P152, DOI 10.1128/JVI.71.1.152-160.1997; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; MASON WS, 1983, VIROLOGY, V131, P375, DOI 10.1016/0042-6822(83)90505-6; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; ROTH MJ, 1984, J BIOL CHEM, V259, P556; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; Seeger C, 1996, VIROLOGY, V222, P430, DOI 10.1006/viro.1996.0440; SEEGER C, 2006, HEPADNAVIRUS; SEEGER C, 2007, HEPADNAVIRUSES; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; TAGAWA M, 1986, VIROLOGY, V152, P477, DOI 10.1016/0042-6822(86)90151-0; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Yang WG, 1996, J VIROL, V70, P4567, DOI 10.1128/JVI.70.7.4567-4575.1996; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	29	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8093	10.1371/journal.pone.0008093	http://dx.doi.org/10.1371/journal.pone.0008093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956651	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400030
J	Bhanja, P; Saha, S; Kabarriti, R; Liu, LB; Roy-Chowdhury, N; Roy-Chowdhury, J; Sellers, RS; Alfieri, AA; Guha, C				Bhanja, Payel; Saha, Subhrajit; Kabarriti, Rafi; Liu, Laibin; Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta; Sellers, Rani S.; Alfieri, Alan A.; Guha, Chandan			Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; R-SPONDIN; EPITHELIUM; GENE; SURVIVAL; DAMAGE; LRP6; IRRADIATION; HOMEOSTASIS; PROTEINS	Background: Radiation-induced gastrointestinal syndrome (RIGS) results from a combination of direct cytocidal effects on intestinal crypt and endothelial cells and subsequent loss of the mucosal barrier, resulting in electrolyte imbalance, diarrhea, weight loss, infection and mortality. Because R-spondin1 (Rspo1) acts as a mitogenic factor for intestinal stem cells, we hypothesized that systemic administration of Rspo1 would amplify the intestinal crypt cells and accelerate the regeneration of the irradiated intestine, thereby, ameliorating RIGS. Methods and Findings: Male C57Bl/6 mice received recombinant adenovirus expressing human R-spondin1 (AdRspo1) or E. coli Lacz (AdLacz), 1-3 days before whole body irradiation (WBI) or abdominal irradiation (AIR). Post-irradiation survival was assessed by Kaplan Meier analysis. RIGS was assessed by histological examination of intestine after hematoxilin and eosin staining, immunohistochemical staining of BrdU incorporation, Lgr5 and beta-catenin expression and TUNEL staining. The xylose absorption test (XAT) was performed to evaluate the functional integrity of the intestinal mucosal barrier. In order to examine the effect of R-spondin1 on tumor growth, AdRspo1 and AdLacZ was administered in the animals having palpable tumor and then exposed to AIR. There was a significant increase in survival in AdRspo1 cohorts compared to AdLacZ (p<0.003) controls, following WBI (10.4 Gy). Significant delay in tumor growth was observed after AIR in both cohorts AdRspo1 and AdLacZ but AdRspo1 treated animals showed improved survival compared to AdLacZ. Histological analysis and XAT demonstrated significant structural and functional regeneration of the intestine in irradiated animals following AdRspo1 treatment. Immunohistochemical analysis demonstrated an increase in Lgr5+ve crypt cells and the translocation of beta-catenin from the cytosol to nucleus and upregulation of beta-catenin target genes in AdRspo1-treated mice, as compared to AdLacz-treated mice. Conclusion: Rspo1 promoted radioprotection against RIGS and improved survival of mice exposed to WBI. The mechanism was likely related to induction of the Wnt-beta-catenin pathway and promotion of intestinal stem cell regeneration. Rspo1 has protective effect only on normal intestinal tissue but not in tumors after AIR and thereby may increase the therapeutic ratio of chemoradiation therapy in patients undergoing abdominal irradiation for GI malignancies.	[Bhanja, Payel; Saha, Subhrajit; Kabarriti, Rafi; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Sellers, Rani S.; Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Sellers, Rani S.; Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bhanja, P (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net	SAHA, SUBHRAJIT/AAJ-9272-2021	SAHA, SUBHRAJIT/0000-0002-7287-073X	Department of Radiation Oncology	Department of Radiation Oncology	The work has been supported internally by the Department of Radiation Oncology and no commercial support or other benefits were received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; COIA LR, 1995, INT J RADIAT ONCOL, V31, P1213, DOI 10.1016/0360-3016(94)00419-L; EBERTS TJ, 1979, CLIN CHEM, V25, P1440; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; HANSON WR, 1983, RADIAT RES, V96, P393, DOI 10.2307/3576222; HAUERJENSEN M, 1990, ACTA ONCOL, V29, P401, DOI 10.3109/02841869009090022; Inagaki-Ohara K, 2001, ONCOGENE, V20, P812, DOI 10.1038/sj.onc.1204172; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Monti P., 2005, BRIT J RADIOL, P89, DOI DOI 10.1259/BJR/53186341; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1995, INT J CANCER, V62, P356, DOI 10.1002/ijc.2910620321; POTTEN CS, 1988, J CELL SCI, P45; Potten CS, 1997, BRIT J CANCER, V75, P1454, DOI 10.1038/bjc.1997.249; Potten CS, 1997, COMP BIOCHEM PHYS B, V118, P473, DOI 10.1016/S0305-0491(97)00219-8; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; POTTEN CS, 1981, INT J RADIAT BIOL, V40, P321, DOI 10.1080/09553008114551251; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zimmerer T, 2008, Z GASTROENTEROL, V46, P441, DOI 10.1055/s-2008-1027150	39	87	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8014	10.1371/journal.pone.0008014	http://dx.doi.org/10.1371/journal.pone.0008014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956666	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500036
J	Li, XX; Wong, GLH; To, KF; Wong, VWS; Lai, LH; Chow, DKL; Lau, JYW; Sung, JJY; Ding, CM				Li, Xiao-Xing; Wong, Grace Lai-Hung; To, Ka-Fai; Wong, Vincent Wai-Sun; Lai, Larry Hin; Chow, Dorothy Kai-Lai; Lau, James Yun-Wong; Sung, Joseph Jao-Yiu; Ding, Chunming			Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS; GUT MICROBIOTA; RIBOSOMAL DNA; DIVERSITY; OBESITY; FLORA; IDENTIFICATION; MICROFLORA	Recent 16S ribosomal RNA gene (rRNA) molecular profiling of the stomach mucosa revealed a surprising complexity of microbiota. Helicobacter pylori infection and non-steroidal anti-inflammatory drug (NSAID) use are two main contributors to gastritis and peptic ulcer. However, little is known about the association between other members of the stomach microbiota and gastric diseases. In this study, cloning and sequencing of the 16S rRNA was used to profile the stomach microbiota from normal and gastritis patients. One hundred and thirty three phylotypes from eight bacterial phyla were identified. The stomach microbiota was found to be closely adhered to the mucosa. Eleven Streptococcus phylotypes were successfully cultivated from the biopsies. One to two genera represented a majority of clones within any of the identified phyla. We further developed two real-time quantitative PCR assays to quantify the relative abundance of the Firmicutes phylum and the Streptococcus genus. Significantly higher abundance of the Firmicutes phylum and the Streptococcus genus within the Firmicutes phylum was observed in patients with antral gastritis, compared with normal controls. This study suggests that the genus taxon level can largely represent much higher taxa such as the phylum. The clinical relevance and the mechanism underlying the altered microbiota composition in gastritis require further functional studies.	[Li, Xiao-Xing; Sung, Joseph Jao-Yiu; Ding, Chunming] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Lai, Larry Hin; Chow, Dorothy Kai-Lai; Lau, James Yun-Wong; Sung, Joseph Jao-Yiu] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ding, Chunming] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Li, XX (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	cmding@gmail.com	Lau, James Y. W./O-2612-2016; Sung, Joseph J. Y./R-3203-2018; Lai, Larry H/D-3513-2011; Li, Xiao-xing/B-9114-2008; Wong, Vincent WS/K-3864-2014; Ding, Chunming/B-2593-2008; Wong, Grace LH/L-8586-2014	Lau, James Y. W./0000-0003-0122-4068; Sung, Joseph J. Y./0000-0003-3125-5199; Li, Xiao-xing/0000-0001-8791-7505; Wong, Vincent WS/0000-0003-2215-9410; Ding, Chunming/0000-0002-2063-5594; Wong, Grace LH/0000-0002-2863-9389	Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	This work is supported by the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LP, 1999, J CLIN MICROBIOL, V37, P1069, DOI 10.1128/JCM.37.4.1069-1076.1999; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; ECKLOFF BW, 1994, INT J SYST BACTERIOL, V44, P320, DOI 10.1099/00207713-44-2-320; EDWARDS U, 1989, NUCLEIC ACIDS RES, V16, P7843; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GUERRE J, 1986, PATHOL BIOL, V34, P57; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hume G, 2002, PATHOLOGY, V34, P561, DOI 10.1080/0031302021000035965; Kimura K, 2000, GASTROENTEROL CLIN N, V29, P609, DOI 10.1016/S0889-8553(05)70133-3; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MARSHALL BJ, 1984, LANCET, V1, P1311; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Monstein HJ, 2000, J MED MICROBIOL, V49, P817, DOI 10.1099/0022-1317-49-9-817; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Quivey RG, 2001, CRIT REV ORAL BIOL M, V12, P301, DOI 10.1177/10454411010120040201; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tiveljung A, 1998, J MED MICROBIOL, V47, P695, DOI 10.1099/00222615-47-8-695; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	40	150	170	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7985	10.1371/journal.pone.0007985	http://dx.doi.org/10.1371/journal.pone.0007985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956741	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827500015
J	Brown, SA; Whiteley, M				Brown, Stacie A.; Whiteley, Marvin			Characterization of the L-Lactate Dehydrogenase from Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							HUMAN PERIODONTAL-DISEASE; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PURIFICATION; PLAQUE; GENE; EXCLUSION; TRANSPORT; SURFACES; SYSTEM	Aggregatibacter actinomycetemcomitans is a Gram-negative opportunistic pathogen and the proposed causative agent of localized aggressive periodontitis. A. actinomycetemcomitans is found exclusively in the mammalian oral cavity in the space between the gums and the teeth known as the gingival crevice. Many bacterial species reside in this environment where competition for carbon is high. A. actinomycetemcomitans utilizes a unique carbon resource partitioning system whereby the presence of L-lactate inhibits uptake of glucose, thus allowing preferential catabolism of L-lactate. Although the mechanism for this process is not fully elucidated, we previously demonstrated that high levels of intracellular pyruvate are critical for L-lactate preference. As the first step in L-lactate catabolism is conversion of L-lactate to pyruvate by lactate dehydrogenase, we proposed a model in which the A. actinomycetemcomitans L-lactate dehydrogenase, unlike homologous enzymes, is not feedback inhibited by pyruvate. This lack of feedback inhibition allows intracellular pyruvate to rise to levels sufficient to inhibit glucose uptake in other bacteria. In the present study, the A. actinomycetemcomitans L-lactate dehydrogenase was purified and shown to convert L-lactate, but not D-lactate, to pyruvate with a K(m) of approximately 150 mu M. Inhibition studies reveal that pyruvate is a poor inhibitor of L-lactate dehydrogenase activity, providing mechanistic insight into L-lactate preference in A. actinomycetemcomitans.			Brown, SA (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	mwhiteley@mail.utexas.edu			NCRR NIH HHS [5P20RR081741] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ausubel F, 1997, SHORT PROTOCOLS MOL; Barnard JP, 1999, INFECT IMMUN, V67, P6558; BERNARD N, 1991, FEBS LETT, V290, P61, DOI 10.1016/0014-5793(91)81226-X; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; FUTAI M, 1977, J BIOL CHEM, V252, P5820; FUTAI M, 1973, BIOCHEMISTRY-US, V12, P2468, DOI 10.1021/bi00737a016; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; JENSEN ME, 1983, J DENT RES, V62, P1058, DOI 10.1177/00220345830620101001; JENSEN ME, 1982, ARCH ORAL BIOL, V27, P21, DOI 10.1016/0003-9969(82)90172-8; KISTLER WA, 1971, J BACTERIOL, V108, P1224, DOI 10.1128/JB.108.3.1224-1234.1971; KLINE ES, 1965, ANN NY ACAD SCI, V119, P905, DOI 10.1111/j.1749-6632.1965.tb47451.x; KOHN LD, 1973, J BIOL CHEM, V248, P7012; MARKWELL JP, 1978, J BACTERIOL, V133, P593, DOI 10.1128/JB.133.2.593-600.1978; Mintz KP, 2000, INFECT IMMUN, V68, P6580, DOI 10.1128/IAI.68.12.6580-6586.2000; MOLINARI R, 1960, BIOCHEM J, V75, P57, DOI 10.1042/bj0750057; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Nuttall FQ, 2000, METABOLISM, V49, P1565, DOI 10.1053/meta.2000.18553; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; SCHACHTELE CF, 1982, J DENT RES, V61, P1117, DOI 10.1177/00220345820610100201; SLOTS J, 1980, INFECT IMMUN, V29, P1013; SOCRANSKY SS, 1985, J CLIN MICROBIOL, V22, P303, DOI 10.1128/JCM.22.2.303-305.1985; SOYAMA K, 1984, CLIN CHEM, V30, P293; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	27	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7864	10.1371/journal.pone.0007864	http://dx.doi.org/10.1371/journal.pone.0007864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924225	gold, Green Submitted, Green Published			2022-12-27	WOS:000271854200012
J	Crampton, SP; Wu, BB; Park, EJ; Kim, JH; Solomon, C; Waterman, ML; Hughes, CCW				Crampton, Steve P.; Wu, Beibei; Park, Edward J.; Kim, Jai-Hyun; Solomon, Candice; Waterman, Marian L.; Hughes, Christopher C. W.			Integration of the beta-Catenin-Dependent Wnt Pathway with Integrin Signaling through the Adaptor Molecule Grb2	PLOS ONE			English	Article							FOCAL-ADHESION-KINASE; C-JUN; LINKED KINASE; TARGET GENES; PROTEIN; ACTIVATION; PROLIFERATION; INVASION; CANCER; RAS	Background: The complexity of wnt signaling likely stems from two sources: multiple pathways emanating from frizzled receptors in response to wnt binding, and modulation of those pathways and target gene responsiveness by context-dependent signals downstream of growth factor and matrix receptors. Both rac1 and c-jun have recently been implicated in wnt signaling, however their upstream activators have not been identified. Methodology/Principal Findings: Here we identify the adapter protein Grb2, which is itself an integrator of multiple signaling pathways, as a modifier of beta-catenin-dependent wnt signaling. Grb2 synergizes with wnt3A, constitutively active (CA) LRP6, Dvl2 or CA-beta-catenin to drive a LEF/TCF-responsive reporter, and dominant negative (DN) Grb2 or siRNA to Grb2 block wnt3A-mediated reporter activity. MMP9 is a target of beta-catenin-dependent wnt signaling, and an MMP9 promoter reporter is also responsive to signals downstream of Grb2. Both a jnk inhibitor and DN-c-jun block transcriptional activation downstream of Dvl2 and Grb2, as does DN-rac1. Integrin ligation by collagen also synergizes with wnt signaling as does overexpression of Focal Adhesion Kinase (FAK), and this is blocked by DN-Grb2. Conclusions/Significance: These data suggest that integrin ligation and FAK activation synergize with wnt signaling through a Grb2-rac-jnk-c-jun pathway, providing a context-dependent mechanism for modulation of wnt signaling.			Crampton, SP (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, UCI Inst Immunol, Irvine, CA 92717 USA.	cchughes@uci.edu	Wu, Beibei/B-5169-2010; Wu, Beibei/B-7463-2011; Hughes, Christopher/F-7510-2010		NCI NIH HHS [CA096878, R01 CA096878, P30 CA062203, CA-62203, R01 CA108697, CA108697] Funding Source: Medline; NIAID NIH HHS [R01 AI040710, T32 AI60573, R01 AI40710, T32 AI060573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096878, R01CA108697, P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R01AI040710] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Genersch E, 2000, J CELL SCI, V113, P4319; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kim SE, 2007, CELL SIGNAL, V19, P1554, DOI 10.1016/j.cellsig.2007.02.003; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; LEE YN, 2007, CELL SIGNAL; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Penton A, 2002, GENETICS, V161, P747; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pomerance M, 1998, J BIOL CHEM, V273, P24301, DOI 10.1074/jbc.273.38.24301; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142	57	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7841	10.1371/journal.pone.0007841	http://dx.doi.org/10.1371/journal.pone.0007841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924227	Green Published, gold			2022-12-27	WOS:000271851000003
J	Frank, E; Kessler, MS; Filiou, MD; Zhang, YY; Maccarrone, G; Reckow, S; Bunck, M; Heumann, H; Turck, CW; Landgraf, R; Hambsch, B				Frank, Elisabeth; Kessler, Melanie S.; Filiou, Michaela D.; Zhang, Yaoyang; Maccarrone, Giuseppina; Reckow, Stefan; Bunck, Mirjam; Heumann, Hermann; Turck, Christoph W.; Landgraf, Rainer; Hambsch, Boris			Stable Isotope Metabolic Labeling with a Novel N-15-Enriched Bacteria Diet for Improved Proteomic Analyses of Mouse Models for Psychopathologies	PLOS ONE			English	Article							ANXIETY-RELATED BEHAVIOR; TRAIT ANXIETY; CELL-CULTURE; GLYOXALASE-I; AMINO-ACIDS; VASOPRESSIN; MICE; IDENTIFICATION; EXTREMES; PROTEINS	The identification of differentially regulated proteins in animal models of psychiatric diseases is essential for a comprehensive analysis of associated psychopathological processes. Mass spectrometry is the most relevant method for analyzing differences in protein expression of tissue and body fluid proteomes. However, standardization of sample handling and sample-to-sample variability are problematic. Stable isotope metabolic labeling of a proteome represents the gold standard for quantitative mass spectrometry analysis. The simultaneous processing of a mixture of labeled and unlabeled samples allows a sensitive and accurate comparative analysis between the respective proteomes. Here, we describe a cost-effective feeding protocol based on a newly developed N-15 bacteria diet based on Ralstonia eutropha protein, which was applied to a mouse model for trait anxiety. Tissue from N-15-labeled vs. N-14-unlabeled mice was examined by mass spectrometry and differences in the expression of glyoxalase-1 (GLO1) and histidine triad nucleotide binding protein 2 (Hint2) proteins were correlated with the animals' psychopathological behaviors for methodological validation and proof of concept, respectively. Additionally, phenotyping unraveled an antidepressant-like effect of the incorporation of the stable isotope N-15 into the proteome of highly anxious mice. This novel phenomenon is of considerable relevance to the metabolic labeling method and could provide an opportunity for the discovery of candidate proteins involved in depression-like behavior. The newly developed N-15 bacteria diet provides researchers a novel tool to discover disease-relevant protein expression differences in mouse models using quantitative mass spectrometry.			Frank, E (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	hambsch@mpipsykl.mpg.de		Zhang, Yaoyang/0000-0001-5363-9834; Filiou, Michaela/0000-0002-2991-4901				Bindschedler LV, 2008, PHYTOCHEMISTRY, V69, P1962, DOI 10.1016/j.phytochem.2008.04.007; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; DITZEN C, 2009, MOL PSYCHIAT    0113; Ditzen C, 2006, MOL CELL PROTEOMICS, V5, P1914, DOI 10.1074/mcp.M600088-MCP200; Gruhler Albrecht, 2008, V424, P101, DOI 10.1007/978-1-60327-064-9_9; Haegler K, 2009, J PROTEOMICS, V71, P601, DOI 10.1016/j.jprot.2008.10.004; HERNANDEZ M, 1981, ARCH TIERERNAHR, V31, P651, DOI 10.1080/17450398109426872; Kessler MS, 2007, EUR J NEUROSCI, V26, P2857, DOI 10.1111/j.1460-9568.2007.05917.x; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Lenglet S, 2008, ENDOCRINOLOGY, V149, P5461, DOI 10.1210/en.2008-0400; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; Nelson CJ, 2007, PROTEOMICS, V7, P1279, DOI 10.1002/pmic.200600832; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Schaff JE, 2008, PLANT J, V56, P840, DOI 10.1111/j.1365-313X.2008.03639.x; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j	21	55	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7821	10.1371/journal.pone.0007821	http://dx.doi.org/10.1371/journal.pone.0007821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915716	gold, Green Submitted, Green Published			2022-12-27	WOS:000271721900012
J	Altmann, EG; Pierrehumbert, JB; Motter, AE				Altmann, Eduardo G.; Pierrehumbert, Janet B.; Motter, Adilson E.			Beyond Word Frequency: Bursts, Lulls, and Scaling in the Temporal Distributions of Words	PLOS ONE			English	Article							KEYWORD DETECTION; HEAVY TAILS; MEMORY; LANGUAGE; POWER	Background: Zipf's discovery that word frequency distributions obey a power law established parallels between biological and physical processes, and language, laying the groundwork for a complex systems perspective on human communication. More recent research has also identified scaling regularities in the dynamics underlying the successive occurrences of events, suggesting the possibility of similar findings for language as well. Methodology/Principal Findings: By considering frequent words in USENET discussion groups and in disparate databases where the language has different levels of formality, here we show that the distributions of distances between successive occurrences of the same word display bursty deviations from a Poisson process and are well characterized by a stretched exponential (Weibull) scaling. The extent of this deviation depends strongly on semantic type - a measure of the logicality of each word - and less strongly on frequency. We develop a generative model of this behavior that fully determines the dynamics of word usage. Conclusions/Significance: Recurrence patterns of words are well described by a stretched exponential distribution of recurrence times, an empirical scaling that cannot be anticipated from Zipf's law. Because the use of words provides a uniquely precise and powerful lens on human thought and activity, our findings also have implications for other overt manifestations of collective human dynamics.			Altmann, EG (corresponding author), Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA.	motter@northwestern.edu	Altmann, Eduardo/A-3320-2009; Altmann, Eduardo G./ABD-2012-2020	Altmann, Eduardo/0000-0002-1932-3710; Altmann, Eduardo G./0000-0002-1932-3710; Pierrehumbert, Janet/0000-0002-5989-3574; Motter, Adilson E./0000-0003-1794-4828				Alvarez-Lacalle E, 2006, P NATL ACAD SCI USA, V103, P7956, DOI 10.1073/pnas.0510673103; ANDERSON JR, 1989, PSYCHOL REV, V96, P703, DOI 10.1037/0033-295X.96.4.703; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Baayen R. H., 2002, WORD FREQUENCY DISTR; Bak P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.178501; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bell A, 2009, J MEM LANG, V60, P92, DOI 10.1016/j.jml.2008.06.003; Bunde A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048701; Church K. W., 1995, NAT LANG ENG, V1, P163, DOI [DOI 10.1017/S1351324900000139, 10.1017/S1351324900000139]; CORRAL R, 2009, ARXIVPHYSSOCPH090129; Cox D.R., 1967, RENEWAL THEORY; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Heim Irene., 1983, MEANING USE INTERPRE, P164, DOI DOI 10.1515/9783110852820.164; Herrera JP, 2008, EUR PHYS J B, V63, P135, DOI 10.1140/epjb/e2008-00206-x; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hrebicek L, 2005, HANDB SPRACH KOMMUN, V27, P348; Kamp Hans, 1981, FORMAL METHODS STUDY; Katz S., 1996, Natural Language Engineering, V2, P15, DOI 10.1017/S1351324996001246; KRUSKAL W, 1987, AM STAT, V41, P6, DOI 10.2307/2684310; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lambiotte R, 2007, J INFORMETR, V1, P277, DOI 10.1016/j.joi.2007.07.001; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; McShane B, 2008, J BUS ECON STAT, V26, P369, DOI 10.1198/073500107000000278; MONTAGUE R, 1973, APPROACHES NATURAL L, P373; Montemurro MA., 2002, ADV COMPLEX SYST, V5, P7, DOI [10.1142/S0219525902000493, DOI 10.1142/S0219525902000493]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; PARTEE BH, 1992, COMPUT LINGUIST, P97, DOI DOI 10.1017/CBO9780511611803.004; Politi M, 2008, PHYSICA A, V387, P2025, DOI 10.1016/j.physa.2007.11.018; Redner S, 2001, GUIDE 1 PASSAGE PROC; Ron D, 1996, MACH LEARN, V25, P117, DOI 10.1007/BF00114008; Santhanam MS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051113; Sarkar A., 2005, P 9 C COMP NAT LANG, P48; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tanenhaus MK, 2008, PHILOS T R SOC B, V363, P1105, DOI 10.1098/rstb.2007.2162; van Benthem J., 1989, Notre Dame Journal of Formal Logic, V30, P315, DOI 10.1305/ndjfl/1093635152; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; VONFINTEL K, 1995, NELS, V25, P175; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; YANNAROS N, 1994, ANN I STAT MATH, V46, P641, DOI 10.1007/BF00773473; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	49	110	110	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A31	A37	e7678	10.1371/journal.pone.0007678	http://dx.doi.org/10.1371/journal.pone.0007678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907645	Green Submitted, Green Published, gold			2022-12-27	WOS:000271685800004
J	Rahimi, F; Murakami, K; Summers, JL; Chen, CHB; Bitan, G				Rahimi, Farid; Murakami, Kazuma; Summers, Jamie L.; Chen, Chi-Hong B.; Bitan, Gal			RNA Aptamers Generated against Oligomeric A beta 40 Recognize Common Amyloid Aptatopes with Low Specificity but High Sensitivity	PLOS ONE			English	Article							IN-VITRO SELECTION; PHOTOINDUCED CROSS-LINKING; ALZHEIMERS-DISEASE; PRION-PROTEIN; BETA-PROTEIN; ANTIBODIES RECOGNIZE; FIBRIL FORMATION; DNA APTAMERS; BINDING; MECHANISM	Aptamers are useful molecular recognition tools in research, diagnostics, and therapy. Despite promising results in other fields, aptamer use has remained scarce in amyloid research, including Alzheimer's disease (AD). AD is a progressive neurodegenerative disease believed to be caused by neurotoxic amyloid beta-protein (A beta) oligomers. A beta oligomers therefore are an attractive target for development of diagnostic and therapeutic reagents. We used covalently-stabilized oligomers of the 40-residue form of A beta (A beta 40) for aptamer selection. Despite gradually increasing the stringency of selection conditions, the selected aptamers did not recognize A beta 40 oligomers but reacted with fibrils of A beta 40, A beta 42, and several other amyloidogenic proteins. Aptamer reactivity with amyloid fibrils showed some degree of protein-sequence dependency. Significant fibril binding also was found for the naive library and could not be eliminated by counter-selection using A beta 40 fibrils, suggesting that aptamer binding to amyloid fibrils was RNA-sequence-independent. Aptamer binding depended on fibrillogenesis and showed a lag phase. Interestingly, aptamers detected fibril formation with >= 15-fold higher sensitivity than thioflavin T (ThT), revealing substantial beta-sheet and fibril formation undetected by ThT. The data suggest that under physiologic conditions, aptamers for oligomeric forms of amyloidogenic proteins cannot be selected due to high, nonspecific affinity of oligonucleotides for amyloid fibrils. Nevertheless, the high sensitivity, whereby aptamers detect b-sheet formation, suggests that they can serve as superior amyloid recognition tools.			Rahimi, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	gbitan@mednet.ucla.edu	Rahimi, Farid/E-6522-2018; Bitan, Gal/U-2204-2019; Murakami, Kazuma/GQA-7062-2022	Rahimi, Farid/0000-0002-0920-8188; Bitan, Gal/0000-0001-7046-3754; Murakami, Kazuma/0000-0003-3152-1784	NATIONAL INSTITUTE ON AGING [R21AG030709] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG030709, AG030709] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bibby DF, 2008, J VIROL METHODS, V151, P107, DOI 10.1016/j.jviromet.2008.03.013; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Bitan Gal, 2004, V299, P3; Bunka DHJ, 2007, J BIOL CHEM, V282, P34500, DOI 10.1074/jbc.M703679200; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haller AA, 1997, P NATL ACAD SCI USA, V94, P8521, DOI 10.1073/pnas.94.16.8521; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; King DJ, 2007, J MOL BIOL, V369, P1001, DOI 10.1016/j.jmb.2007.02.004; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kouassi GK, 2007, BIOTECHNOL PROGR, V23, P1239, DOI 10.1021/bp0602101; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Mannironi C, 1997, BIOCHEMISTRY-US, V36, P9726, DOI 10.1021/bi9700633; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Maury CPJ, 2009, ORIGINS LIFE EVOL B, V39, P141, DOI 10.1007/s11084-009-9165-6; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Monien BH, 2006, EXPERT REV NEUROTHER, V6, P1293, DOI 10.1586/14737175.6.9.1293; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Murakami K, 2008, PRION, V2, P73, DOI 10.4161/pri.2.2.7024; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; PIRTTILA T, 1994, J NEUROL SCI, V127, P90, DOI 10.1016/0022-510X(94)90140-6; Podesta A, 2006, BIOPHYS J, V90, P589, DOI 10.1529/biophysj.105.068833; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; RAHIMI F, 2009, J VIS EXP, V23; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Takemura K, 2006, EXP BIOL MED, V231, P204; Ulrich H, 2006, HANDB EXP PHARM, V173, P305; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	48	52	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7694	10.1371/journal.pone.0007694	http://dx.doi.org/10.1371/journal.pone.0007694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901993	gold, Green Submitted, Green Published			2022-12-27	WOS:000271658800003
J	Triana-Baltzer, GB; Gubareva, LV; Klimov, AI; Wurtman, DF; Moss, RB; Hedlund, M; Larson, JL; Belshe, RB; Fang, F				Triana-Baltzer, Gallen B.; Gubareva, Larisa V.; Klimov, Alexander I.; Wurtman, David F.; Moss, Ronald B.; Hedlund, Maria; Larson, Jeffrey L.; Belshe, Robert B.; Fang, Fang			Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein	PLOS ONE			English	Article							OSELTAMIVIR RESISTANCE; REDUCED SENSITIVITY; B VIRUSES; SUSCEPTIBILITY; HEMAGGLUTININ; TRANSMISSION; DRUG; GLYCOSYLATION; SEQUENCE; H1N1	Antiviral drug resistance for influenza therapies remains a concern due to the high prevalence of H1N1 2009 seasonal influenza isolates which display H274Y associated oseltamivir-resistance. Furthermore, the emergence of novel H1N1 raises the potential that additional reassortments can occur, resulting in drug resistant virus. Thus, additional antiviral approaches are urgently needed. DAS181 (Fludase (R)), a sialidase fusion protein, has been shown to have inhibitory activity against a large number of seasonal influenza strains and a highly pathogenic avian influenza ( HPAI) strain (H5N1). Here, we examine the in vitro activity of DAS181 against a panel of 2009 oseltamivir-resistant seasonal H1N1 clinical isolates. The activity of DAS181 against nine 2009, two 2007, and two 2004 clinical isolates of seasonal IFV H1N1 was examined using plaque number reduction assay on MDCK cells. DAS181 strongly inhibited all tested isolates. EC50 values remained constant against isolates from 2004, 2007, and 2009, suggesting that there was no change in DAS181 sensitivity over time. As expected, all 2007 and 2009 isolates were resistant to oseltamivir, consistent with the identification of the H274Y mutation in the NA gene of all these isolates. Interestingly, several of the 2007 and 2009 isolates also exhibited reduced sensitivity to zanamivir, and accompanying HA mutations near the sialic acid binding site were observed. DAS181 inhibits IFV that is resistant to NAIs. Thus, DAS181 may offer an alternative therapeutic option for seasonal or pandemic IFVs that become resistant to currently available antiviral drugs.			Triana-Baltzer, GB (corresponding author), NexBio Inc, San Diego, CA USA.	ffang@nexbio.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070281] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI070281] Funding Source: Medline; PHS HHS [HHSN266200600015C] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baum EZ, 2003, ANTIVIR RES, V59, P13, DOI 10.1016/S0166-3542(03)00011-1; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gupta RK, 2006, NEW ENGL J MED, V354, P1423; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Marinina VP, 2003, MOL BIOL+, V37, P468, DOI 10.1023/A:1024207931650; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nicholls JM, 2008, J ANTIMICROB CHEMOTH, V62, P426, DOI 10.1093/jac/dkn167; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Smee DF, 2001, ANTIVIR RES, V52, P251, DOI 10.1016/S0166-3542(01)00168-1; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Tisdale M, 2000, REV MED VIROL, V10, P45, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;45::AID-RMV265&gt;3.0.CO;2-R; TRIANABALTZER GB, 2009, PLOS ONE UNPUB; WANG ZM, 2000, ANTIVIRAL RES, V46; *WHO, 2009, SEAS INFL FACTSH; WINTER G, 1981, NATURE, V292, P72, DOI 10.1038/292072a0; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3	43	64	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2009	4	11							e7838	10.1371/journal.pone.0007838	http://dx.doi.org/10.1371/journal.pone.0007838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515ND	19893749	gold, Green Published, Green Submitted			2022-12-27	WOS:000271478000014
J	Elsayad, K; Heinze, KG				Elsayad, Kareem; Heinze, Katrin G.			Defining a Superlens Operating Regime for Imaging Fluorescent Molecules	PLOS ONE			English	Article							NEGATIVE REFRACTION; LIFETIMES; DIPOLE	It has been shown that thin metal-based films can at certain frequencies act as planar near-field lenses for certain polarization components. A desirable property of such "lenses" is that they can also enhance and focus some large transverse spatial frequency components which contain sub-diffraction limit details. Over the last decade there has been much work in optimizing designs to reduce effects (such as material losses and surface roughness) that are detrimental to image reconstruction. One design that can reduce some of these undesirable effects, and which has received a fair amount of attention recently, is the stacked metal-dielectric superlens. Here we theoretically explore the imaging ability of such a design for the specific purpose of imaging a fluorescent dye (the common bio-marker GFP) in the vicinity of the superlens surface. Our calculations take into consideration the interaction (damping) of an oscillating electric dipole with the metallic layers in the superlens. We also assume a Gaussian frequency distribution spectrum for the dipole. We treat the metallic-alloy and dielectric-alloy layers separately using an appropriate effective medium theory. The transmission properties are evaluated via Transfer matrix (T-matrix) calculations that were performed in the MatLab (TM) and MathCad (TM) environments. Our study shows that it is in principle possible to image fluorescent molecules using a simple bilayer planar superlens. We find that optimal parameters for such a superlens occur when the peak dipole emission-frequency is slightly offset from the Surface Plasmon resonance frequency of the metal-dielectric interfaces. The best resolution is obtained when the fluorescent molecules are not too close (greater than or similar to 10 nm) or too far (less than or similar to 30 nm) from the superlens surface. The realization and application of a superlens with the specified design is possible using current nanofabrication techniques. When combined with e. g. a sub-wavelength grating structure (such as in the far-field superlens design previously proposed [1]) or a fast near-field scanning probe, it could provide a means for fast fluorescent imaging with sub-diffraction limit resolution.	[Elsayad, Kareem; Heinze, Katrin G.] Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Elsayad, K (corresponding author), Res Inst Mol Pathol IMP, Vienna, Austria.	elsayad@imp.ac.at		Elsayad, Kareem/0000-0003-1642-2905	FWF; Boehringer Ingelheim	FWF(Austrian Science Fund (FWF)); Boehringer Ingelheim(Boehringer Ingelheim)	This research was funded in part by the FWF (Wittgenstein Award). Basic research at the Research Institute of Molecular Pathology ( IMP) is funded by Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; BENNER RE, 1979, OPT COMMUN, V30, P145, DOI 10.1016/0030-4018(79)90063-4; Born M., 1999, PRINCIPLES OPTICS, P461; Bratkovsky AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2040012; Cai WS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193101; CHANCE PR, 1978, ADV CHEM PHYS, V1, P37; Chuang WH, 2009, OPT EXPRESS, V17, P104, DOI 10.1364/OE.17.000104; Drexhage K.H., 1970, J LUMIN, V1-2, P693, DOI [10.1016/0022-2313(70)90082-7, DOI 10.1016/0022-2313(70)90082-7]; DUCOURTIEUX S, 2001, PHYS REV B, V64; Geddes CD, 2002, J FLUORESC, V12, P121, DOI 10.1023/A:1016875709579; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOLLAND WR, 1984, PHYS REV LETT, V52, P1041, DOI 10.1103/PhysRevLett.52.1041; Ikonen P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.073102; JACKSON JD, 1998, CLASSICAL ELECTRODYN, P410; Kastel J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011804; Kik PG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045418; Kotynski R, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/1/015001; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lakowicz JR, 2005, ANAL BIOCHEM, V337, P171, DOI 10.1016/j.ab.2004.11.026; Larkin IA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121403; Liu ZW, 2007, NANO LETT, V7, P403, DOI 10.1021/nl062635n; Logeeswaran VJ, 2007, APPL PHYS A-MATER, V87, P187, DOI 10.1007/s00339-006-3836-1; LUKOSZ W, 1981, OPT LETT, V6, P251, DOI 10.1364/OL.6.000251; MAHAN GD, 1990, MANY PARTICLE PHYSIC, P430; MAXWELLGARNETT JC, 1905, PHIL T R SOC LONDON, V203, P385; Palik E.D., 1985, HDB OPTICAL CONSTANT, V2; Palik E. D., 1985, HDB OPTICAL CONSTANT, V1; Palik ED., 1985, HDB OPTICAL CONSTANT; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pribil GK, 2004, THIN SOLID FILMS, V455, P443, DOI 10.1016/j.tsf.2003.11.243; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ramakrishna SA, 2003, J MOD OPTIC, V50, P1419, DOI 10.1080/0950034021000020824; Ruppin R, 2004, J CHEM PHYS, V121, P11358, DOI 10.1063/1.1812742; Sambale A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053828; Scalora M, 2007, OPT EXPRESS, V15, P508, DOI 10.1364/OE.15.000508; Shi LH, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045116; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Tomita S, 2008, OPT EXPRESS, V16, P9942, DOI 10.1364/OE.16.009942; TOMPKINS HG, 2005, HDB ELLIPSOMETRY, P252; Wormeester H, 2008, PHYS STATUS SOLIDI A, V205, P756, DOI 10.1002/pssa.200777740; Xie HY, 2009, SOLID STATE COMMUN, V149, P625, DOI 10.1016/j.ssc.2009.01.027; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361	43	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7963	10.1371/journal.pone.0007963	http://dx.doi.org/10.1371/journal.pone.0007963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956608	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828700002
J	Ji, JF; Werbowetski-Ogilvie, TE; Zhong, BN; Hong, SH; Bhatia, M				Ji, Junfeng; Werbowetski-Ogilvie, Tamra E.; Zhong, Bonan; Hong, Seok-Ho; Bhatia, Mickie			Pluripotent Transcription Factors Possess Distinct Roles in Normal versus Transformed Human Stem Cells	PLOS ONE			English	Article							RNA INTERFERENCE; MYELOID-LEUKEMIA; SELF-RENEWAL; NANOG; EXPRESSION; IDENTIFICATION; OCT4; DIFFERENTIATION; OCT-3/4; MAINTENANCE	Background: Cancer and normal stem cells (SCs) share proliferative properties of self-renewal and expression of key transcription factors (TFs). Despite similar TF identities, the functional role of specific TFs responsible for retaining SC state has yet to be examined in cancer. Methodology/Principal Findings: Here, we compare the role of Oct4 and Nanog, two-core pluripotent TFs, in transformed (t-hPSCs), and normal human pluripotent stem cells (hPSCs). Unlike normal SCs, self-renewal and survival of t-hPSCs were found to be independent of Oct4. In contrast, t-hPSCs exhibit hypersensitivity to reduction in Nanog and demonstrate complete loss of self-renewal coupled with apoptosis. Dual and sequential knockdown of Oct4 and Nanog revealed that sensitivity of t-hPSCs to Nanog was Oct4 dependent. Conclusions/Significance: Our study indicates a bifurcation for the role of two-core SC and cancer related TFs in self-renewal and survival processes. We suggest that the divergent roles of these TFs establish a paradigm to develop novel therapeutics towards selective destruction of aggressive tumors harboring cancer stem cells (CSCs) with similar molecular signatures.	[Ji, Junfeng; Werbowetski-Ogilvie, Tamra E.; Hong, Seok-Ho; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Ji, Junfeng] Ontario Inst Canc Res, Toronto, ON, Canada; [Zhong, Bonan] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	McMaster University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Fred Hutchinson Cancer Center	Ji, JF (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada.	mbhatia@mcmaster.ca		Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559	Canadian Institute of Health Research (CIHR); National Cancer Institute of Canada (NCIC); Ontario Institute for Cancer Research (OICR); Canadian Cancer Society (CCS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Ontario Institute for Cancer Research (OICR); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS))	This work was funded by the Canadian Institute of Health Research (CIHR), the National Cancer Institute of Canada (NCIC), Ontario Institute for Cancer Research (OICR), and the Canadian Cancer Society (CCS). A fellowship from the CCS supports T. E. W. O. and the Canada Research Chair Program provides support to M. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoei-Hansen CE, 2008, CANCER TREAT REV, V34, P348, DOI 10.1016/j.ctrv.2007.12.007; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	44	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8065	10.1371/journal.pone.0008065	http://dx.doi.org/10.1371/journal.pone.0008065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956629	Green Submitted, gold, Green Published			2022-12-27	WOS:000272828400019
J	Lambert, DM; Shepherd, LD; Huynen, L; Beans-Picon, G; Walter, GH; Millar, CD				Lambert, David M.; Shepherd, Lara D.; Huynen, Leon; Beans-Picon, Gabrielle; Walter, Gimme H.; Millar, Craig D.			The Molecular Ecology of the Extinct New Zealand Huia	PLOS ONE			English	Article							POPULATION; ASSIGNMENT; INFERENCE; SAMPLES; ERRORS	The extinct Huia (Heteralocha acutirostris) of New Zealand represents the most extreme example of beak dimorphism known in birds. We used a combination of nuclear genotyping methods, molecular sexing, and morphometric analyses of museum specimens collected in the late 19(th) and early 20(th) centuries to quantify the sexual dimorphism and population structure of this extraordinary species. We report that the classical description of Huia as having distinctive sex-linked morphologies is not universally correct. Four Huia, sexed as females had short beaks and, on this basis, were indistinguishable from males. Hence, we suggest it is likely that Huia males and females were indistinguishable as juveniles and that the well-known beak dimorphism is the result of differential beak growth rates in males and females. Furthermore, we tested the prediction that the social organisation and limited powers of flight of Huia resulted in high levels of population genetic structure. Using a suite of microsatellite DNA loci, we report high levels of genetic diversity in Huia, and we detected no significant population genetic structure. In addition, using mitochondrial hypervariable region sequences, and likely mutation rates and generation times, we estimated that the census population size of Huia was moderately high. We conclude that the social organization and limited powers of flight did not result in a highly structured population.	[Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lambert, David M.; Shepherd, Lara D.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Huynen, Leon; Beans-Picon, Gabrielle] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Walter, Gimme H.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Millar, Craig D.] Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand	Griffith University; Griffith University; Massey University; Massey University; University of Queensland; Massey University; University of Auckland	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Walter, Gimme/AAC-3635-2019; Shepherd, Lara/E-6663-2011	Walter, Gimme/0000-0003-1025-7101; Shepherd, Lara/0000-0002-7136-0017; Lambert, David/0000-0002-5821-3637	Griffith University; Marsden Fund; Allan Wilson Centre for Molecular Ecology and Evolution	Griffith University(Griffith University); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Allan Wilson Centre for Molecular Ecology and Evolution	This research was supported by Griffith University, the Marsden Fund and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Buller WL., 1888, HIST BIRDS NZ, V2; BURTON P J K, 1974, Bulletin of the British Museum (Natural History) Zoology, V27, P1; COLENSO W, 1887, T P NZ I, V19, P140; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; DOUBLE M, 2000, 176 DEP CONS; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Falush D, 2003, GENETICS, V164, P1567; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gould, 1837, SYNOPSIS BIRDS AUSTR; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GROSLER AG, 1990, POPULATION BIOL PASS, P167; GROSLER AG, 1994, J AVIAN BIOL, V25, P171; HEATHER BD, 1998, FIELD GUIDE BIRDS NZ; Hudson QJ, 2000, BIOL CONSERV, V96, P105, DOI 10.1016/S0006-3207(00)00057-4; HUDSON QJ, 1999, THESIS U WAIKATO; Hung CM, 2004, ANIM CONSERV, V7, P301, DOI 10.1017/S1367943004001453; INNES J, 1999, THREATENED SPECIES R, V30; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lack D.L., 1971, ECOLOGICAL ISOLATION; Lambert DM, 2005, CONSERV GENET, V6, P1, DOI 10.1007/s10592-004-7857-z; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Moorhouse Ron J., 1996, Notornis, V43, P19; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; PHILLIPS WJ, 1963, BOOK HUIA; POTTS T, 1885, NZ J SCI, V2, P373; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; WORTHY TH, 2002, LOST WORLD MOA	40	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8019	10.1371/journal.pone.0008019	http://dx.doi.org/10.1371/journal.pone.0008019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946368	Green Published, gold			2022-12-27	WOS:000272827800013
J	Brusko, TM; Wasserfall, CH; Hulme, MA; Cabrera, R; Schatz, D; Atkinson, MA				Brusko, Todd M.; Wasserfall, Clive H.; Hulme, Maigan A.; Cabrera, Roniel; Schatz, Desmond; Atkinson, Mark A.			Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for Immunoregulation	PLOS ONE			English	Article							SOLUBLE INTERLEUKIN-2-RECEPTOR; PROTEOLYTIC CLEAVAGE; BINDS INTERLEUKIN-2; IL-2 RECEPTOR; ALPHA-SUBUNIT; CELLS; EXPRESSION; MECHANISM; DISEASE; CANCER	Background: CD25, a component of the IL-2 receptor, is important in T cell proliferation, activation induced cell death, as well as the actions of both regulatory (Treg) and effector (Teff) T cells. Recent genome wide association studies have implicated the CD25 locus as an important region for genetic susceptibility to a number of autoimmune disorders, with serum levels of soluble CD25 receptor (sCD25) serving as a potential phenotypic marker for this association. However, the functional impact of CD25 cleavage, as well as the influence of sCD25 on immunoregulatory activities, remain largely unknown and form the basis of this effort. Methodology/Principal Findings: The generation of sCD25 by Treg (CD4(+)CD25(+)) and Teff (CD4(+)CD25(-)) cells was examined during in vitro suppression assays, efforts that demonstrated constitutive and stable surface CD25 expression on Treg throughout the period of in vitro assessment. In contrast, Teff cells increased CD25 expression during the process of in vitro suppression, with supernatant sCD25 levels correlating to the amount of cellular proliferation. Interestingly, under serum-free conditions, Tregs partially lost their characteristic anergic and suppressive properties. sCD25 supplementation at physiological concentrations to serum free in vitro suppression assays reduced Teff proliferation without specifically influencing suppression. Indeed, sCD25 production within these cultures correlated with cell death. Conclusions/Significance: These results support the notion that sCD25 functions as both a surrogate marker of T cell activation as well as an indicator of subsequent cellular death. In addition, the role of CD25 in immunomodulation is likely dependent on the local inflammatory milieu, with molecules capable of modulating surface CD25 expression playing a key role in defining immune responsiveness.	[Brusko, Todd M.; Wasserfall, Clive H.; Hulme, Maigan A.; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Brusko, Todd M.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Cabrera, Roniel] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Schatz, Desmond] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brusko, TM (corresponding author), Univ Florida, Dept Pathol, Gainesville, FL 32611 USA.	atkinson@ufl.edu	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; Brusko, Todd/0000-0003-2878-9296	The National Institutes of Health [AI42288, AI39250]; American Diabetes Association; Juvenile Diabetes Research Foundation (JDRF); Brehm Coalition for Type 1 Diabetes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039250, P01AI042288] Funding Source: NIH RePORTER	The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Brehm Coalition for Type 1 Diabetes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in part, by grants from The National Institutes of Health (AI42288 and AI39250), the American Diabetes Association, the Juvenile Diabetes Research Foundation (JDRF) (Post Doctoral Fellowship to TMB), and the Brehm Coalition for Type 1 Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Horiuchi S, 1997, IMMUNOLOGY, V91, P28, DOI 10.1046/j.1365-2567.1997.00236.x; JACQUES Y, 1987, J IMMUNOL, V139, P2308; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kobayashi H, 1999, CYTOKINE, V11, P1065, DOI 10.1006/cyto.1999.0509; LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nelson JD, 1998, ADV EXP MED BIOL, V438, P1; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Sheu BC, 2001, CANCER RES, V61, P237; Smith KA, 2006, CELL RES, V16, P11, DOI 10.1038/sj.cr.7310003; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; VanParijs L, 1997, J IMMUNOL, V158, P3738; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	35	46	49	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7980	10.1371/journal.pone.0007980	http://dx.doi.org/10.1371/journal.pone.0007980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956753	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500011
J	Ogasawara, O; Okubo, K				Ogasawara, Osamu; Okubo, Kousaku			On Theoretical Models of Gene Expression Evolution with Random Genetic Drift and Natural Selection	PLOS ONE			English	Article							MOUSE; PRESERVATION; DIVERGENCE; DISTRIBUTIONS; PROBABILITY; DISSECTION; VARIANCE; PROFILES; PRIMATES; HUMANS	Background: The relative contributions of natural selection and random genetic drift are a major source of debate in the study of gene expression evolution, which is hypothesized to serve as a bridge from molecular to phenotypic evolution. It has been suggested that the conflict between views is caused by the lack of a definite model of the neutral hypothesis, which can describe the long-run behavior of evolutionary change in mRNA abundance. Therefore previous studies have used inadequate analogies with the neutral prediction of other phenomena, such as amino acid or nucleotide sequence evolution, as the null hypothesis of their statistical inference. Methodology/Principal Findings: In this study, we introduced two novel theoretical models, one based on neutral drift and the other assuming natural selection, by focusing on a common property of the distribution of mRNA abundance among a variety of eukaryotic cells, which reflects the result of long-term evolution. Our results demonstrated that (1) our models can reproduce two independently found phenomena simultaneously: the time development of gene expression divergence and Zipf's law of the transcriptome; (2) cytological constraints can be explicitly formulated to describe long-term evolution; (3) the model assuming that natural selection optimized relative mRNA abundance was more consistent with previously published observations than the model of optimized absolute mRNA abundances. Conclusions/Significance: The models introduced in this study give a formulation of evolutionary change in the mRNA abundance of each gene as a stochastic process, on the basis of previously published observations. This model provides a foundation for interpreting observed data in studies of gene expression evolution, including identifying an adequate time scale for discriminating the effect of natural selection from that of random genetic drift of selectively neutral variations.			Ogasawara, O (corresponding author), Natl Inst Genet, Ctr Informat Biol, Shizuoka, Japan.	oogasawa@genes.nig.ac.jp	Ogasawara, Osamu/GPS-6997-2022	Ogasawara, Osamu/0000-0001-6001-3397				Aitchison J, 1996, LOG NORMAL DISTRIBUT; Araki R, 2006, STEM CELLS, V24, P2522, DOI 10.1634/stemcells.2006-0005; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Crow E. L., 1988, LOGNORMAL DISTRIBUTI; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Force A, 1999, GENETICS, V151, P1531; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Gibrat R., 1930, B STAT, V19, P469; Gibrat R., 1931, INEGALITES EC; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Haldane JBS, 1942, BIOMETRIKA, V32, P226, DOI 10.2307/2332127; Hsieh WP, 2003, GENETICS, V165, P747; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson N.L., 1970, DISTRIBUTIONS STAT C; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V31, P99; Konishi T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-5; Kuznetsov VA, 2003, SIGNAL PROCESS, V83, P889, DOI 10.1016/S0165-1684(02)00481-4; Kuznetsov VA, 2002, GENETICS, V161, P1321; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; Lemos B, 2005, EVOLUTION, V59, P126; Luscombe NM, 2002, GENOME BIOL, V3; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Mandelbrot B., 1953, COMMUN THEOR, P486; MCLAREN CE, 1994, STATISTICIAN, V43, P247, DOI 10.2307/2348342; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Ogasawara O, 2003, CR BIOL, V326, P1097, DOI 10.1016/j.crvi.2003.09.031; Ogasawara O, 2006, NUCLEIC ACIDS RES, V34, pD628, DOI 10.1093/nar/gkj137; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; OHTA T, 1993, P NATL ACAD SCI USA, V90, P10676, DOI 10.1073/pnas.90.22.10676; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sharma A, 2005, PHYSIOL GENOMICS, V21, P117, DOI 10.1152/physiolgenomics.00228.2003; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tan QH, 2005, HUM GENET, V117, P267, DOI 10.1007/s00439-005-1308-x; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	66	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7943	10.1371/journal.pone.0007943	http://dx.doi.org/10.1371/journal.pone.0007943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936214	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004800020
J	Cerezo, M; Bandelt, HJ; Martin-Guerrero, I; Ardanaz, M; Vega, A; Carracedo, A; Garcia-Orad, A; Salas, A				Cerezo, Maria; Bandelt, Hans-Juergen; Martin-Guerrero, Idoia; Ardanaz, Maite; Vega, Ana; Carracedo, Angel; Garcia-Orad, Africa; Salas, Antonio			High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SEQUENCE VARIATION; HAPLOGROUP-H; NEAR-EASTERN; MTDNA; MUTATIONS; HETEROPLASMY; POPULATION; TRANSPLANTATION; REANALYSIS; EVOLUTION	Background: Chronic Lymphocytic Leukemia (CLL) leads to progressive accumulation of lymphocytes in the blood, bone marrow, and lymphatic tissues. Previous findings have suggested that the mtDNA could play an important role in CLL. Methodology/Principal Findings: The mitochondrial DNA (mtDNA) control-region was analyzed in lymphocyte cell DNA extracts and compared with their granulocyte counterpart extract of 146 patients suffering from B-Cell CLL; B-CLL (all recruited from the Basque country). Major efforts were undertaken to rule out methodological artefacts that would render a high false positive rate for mtDNA instabilities and thus lead to erroneous interpretation of sequence instabilities. Only twenty instabilities were finally confirmed, most of them affecting the homopolymeric stretch located in the second hypervariable segment (HVS-II) around position 310, which is well known to constitute an extreme mutational hotspot of length polymorphism, as these mutations are frequently observed in the general human population. A critical revision of the findings in previous studies indicates a lack of proper methodological standards, which eventually led to an overinterpretation of the role of the mtDNA in CLL tumorigenesis. Conclusions/Significance: Our results suggest that mtDNA instability is not the primary causal factor in B-CLL. A secondary role of mtDNA mutations cannot be fully ruled out under the hypothesis that the progressive accumulation of mtDNA instabilities could finally contribute to the tumoral process. Recommendations are given that would help to minimize erroneous interpretation of sequencing results in mtDNA studies in tumorigenesis.			Cerezo, M (corresponding author), Univ Santiago Compostela, Inst Med Legal, Unidade Xenet, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/U-2029-2019; Carracedo, Angel/D-4257-2012; Martin-Guerrero, Idoia/AAF-3446-2020; Salas, Antonio/E-3977-2012; Vega, Ana/R-4758-2019	Salas, Antonio/0000-0002-2336-702X; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Martin-Guerrero, Idoia/0000-0002-0098-1908; Cerezo Fernandez, Maria/0000-0003-3073-1130; Garcia.Orad, Africa/0000-0002-5575-3080				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Anaissie EJ, 1998, ANN INTERN MED, V129, P559, DOI 10.7326/0003-4819-129-7-199810010-00010; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; BANDELT HJ, 2006, LAB SPECIFIC MUTATIO, P119; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Egeland T, 2000, FORENSIC SCI INT, V110, P47, DOI 10.1016/S0379-0738(00)00147-X; Esteve J, 2001, LEUKEMIA, V15, P445, DOI 10.1038/sj.leu.2402036; Gattermann N, 2004, LEUKEMIA, V18, P18, DOI 10.1038/sj.leu.2403209; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Grist SA, 2004, LEUKEMIA, V18, P1313, DOI 10.1038/sj.leu.2403380; Grzybowski T, 2000, ELECTROPHORESIS, V21, P548, DOI 10.1002/(SICI)1522-2683(20000201)21:3<548::AID-ELPS548>3.0.CO;2-U; Grzybowski T, 2003, ELECTROPHORESIS, V24, P1159, DOI 10.1002/elps.200390149; He L, 2003, LEUKEMIA, V17, P2487, DOI 10.1038/sj.leu.2403146; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ivanova R, 1998, INT J CANCER, V76, P495, DOI 10.1002/(SICI)1097-0215(19980518)76:4<495::AID-IJC9>3.0.CO;2-M; KIPPS TJ, 1995, CHRONIC LYMPHOCYTIC, P1017; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Linnartz B, 2004, CANCER RES, V64, P1966, DOI 10.1158/0008-5472.CAN-03-2956; Meierhofer D, 2006, LEUKEMIA, V20, P362, DOI 10.1038/sj.leu.2404070; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164; SALAS A, 2006, PLOS MED        0105; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825; Shvidel L, 1998, LEUKEMIA, V12, P1612, DOI 10.1038/sj.leu.2401140; Tully G, 2004, FORENSIC SCI INT, V140, P1, DOI 10.1016/S0379-0738(03)00181-6; VALVERDE E, 1993, INT J LEGAL MED, V105, P251, DOI 10.1007/BF01370381; van Besien K, 2001, LEUKEMIA, V15, P1317, DOI 10.1038/sj.leu.2402178; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007	56	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7902	10.1371/journal.pone.0007902	http://dx.doi.org/10.1371/journal.pone.0007902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924307	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700027
J	Cadet, JL; Mccoy, MT; Cai, NS; Krasnova, IN; Ladenheim, B; Beauvais, G; Wilson, N; Wood, W; Becker, KG; Hodges, AB				Cadet, Jean Lud; Mccoy, Michael T.; Cai, Ning Sheng; Krasnova, Irina N.; Ladenheim, Bruce; Beauvais, Genevieve; Wilson, Natascha; Wood, William, III; Becker, Kevin G.; Hodges, Amber B.			Methamphetamine Preconditioning Alters Midbrain Transcriptional Responses to Methamphetamine-Induced Injury in the Rat Striatum	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; PROTEIN-TYROSINE PHOSPHATASES; DISMUTASE TRANSGENIC MICE; MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; CEREBRAL-ISCHEMIA; HEME OXYGENASE-1; FREE-RADICALS	Methamphetamine (METH) is an illicit drug which is neurotoxic to the mammalian brain. Numerous studies have revealed significant decreases in dopamine and serotonin levels in the brains of animals exposed to moderate-to-large METH doses given within short intervals of time. In contrast, repeated injections of small nontoxic doses of the drug followed by a challenge with toxic METH doses afford significant protection against monoamine depletion. The present study was undertaken to test the possibility that repeated injections of the drug might be accompanied by transcriptional changes involved in rendering the nigrostriatal dopaminergic system refractory to METH toxicity. Our results confirm that METH preconditioning can provide significant protection against METH-induced striatal dopamine depletion. In addition, the presence and absence of METH preconditioning were associated with substantial differences in the identity of the genes whose expression was affected by a toxic METH challenge. Quantitative PCR confirmed METH-induced changes in genes of interest and identified additional genes that were differentially impacted by the toxic METH challenge in the presence of METH preconditioning. These genes include small heat shock 27 kD 27 protein 2 (HspB2), thyrotropin-releasing hormone (TRH), brain derived neurotrophic factor (BDNF), c-fos, and some encoding antioxidant proteins including CuZn superoxide dismutase (CuZnSOD), glutathione peroxidase (GPx)-1, and heme oxygenase-1 (Hmox-1). These observations are consistent, in part, with the transcriptional alterations reported in models of lethal ischemic injuries which are preceded by ischemic or pharmacological preconditioning. Our findings suggest that multiple molecular pathways might work in tandem to protect the nigrostriatal dopaminergic pathway against the deleterious effects of the toxic psychostimulant. Further analysis of the molecular and cellular pathways regulated by these genes should help to provide some insight into the neuroadaptive potentials of the brain when repeatedly exposed to drugs of abuse.			Cadet, JL (corresponding author), NIDA, Mol Neuropsychiat Res Branch, DHHS, NIH,Intramural Res Program, Baltimore, MD USA.	jcadet@intra.nida.nih.gov		Becker, Kevin/0000-0002-6794-6656	NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000494, ZIADA000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; BARDSLEY ME, 1981, BIOCHEM PHARMACOL, V30, P1543, DOI 10.1016/0006-2952(81)90379-8; Berry A, 2008, EXP GERONTOL, V43, P200, DOI 10.1016/j.exger.2007.10.016; Bigdeli MR, 2009, BRAIN RES, V1260, P47, DOI 10.1016/j.brainres.2008.12.065; Boger HA, 2007, J NEUROSCI, V27, P8816, DOI 10.1523/JNEUROSCI.1067-07.2007; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Burre J, 2007, J NEUROCHEM, V101, P1448, DOI 10.1111/j.1471-4159.2007.04453.x; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, NEUROTOX RES, V15, P252, DOI 10.1007/s12640-009-9026-0; Cadet J, 2009, MOL NEUROBIOL, V39, P50, DOI 10.1007/s12035-009-8051-6; Cadet JL, 1997, SYNAPSE, V25, P176; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Cadet JL, 2002, SYNAPSE, V44, P211, DOI 10.1002/syn.10074; CADET JL, 1994, J NEUROCHEM, V62, P380; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Calabrese EJ, 2008, AGEING RES REV, V7, P8, DOI 10.1016/j.arr.2007.07.001; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/1523086041798051; Canudas AM, 2005, MOL BRAIN RES, V134, P147, DOI 10.1016/j.molbrainres.2004.11.012; Cass WA, 1996, J NEUROSCI, V16, P8132; Cass WA, 2006, ANN NY ACAD SCI, V1074, P272, DOI 10.1196/annals.1369.024; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; DADEN AI, 1999, AM J PHYSIOL, V277, pR1196; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; Deng XL, 1999, J NEUROSCI, V19, P10107; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; DEVITO MJ, 1989, NEUROPHARMACOLOGY, V28, P1145, DOI 10.1016/0028-3908(89)90130-5; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; DOMESICK VB, 1988, ANN NY ACAD SCI, V537, P10, DOI 10.1111/j.1749-6632.1988.tb42094.x; Dong M, 2006, NEUROSCI LETT, V400, P177, DOI 10.1016/j.neulet.2006.02.063; ENGBER TM, 1985, REGUL PEPTIDES, V12, P51, DOI 10.1016/0167-0115(85)90186-7; Engele J, 1996, NEUROSCIENCE, V73, P397, DOI 10.1016/0306-4522(96)00045-0; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Friedman SD, 1998, PHARMACOL BIOCHEM BE, V61, P35, DOI 10.1016/S0091-3057(98)00066-5; Glantz L, 2005, EXP NEUROL, V192, P117, DOI 10.1016/j.expneurol.2004.11.012; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Guerra-Crespo M, 2001, EUR J NEUROSCI, V14, P483, DOI 10.1046/j.0953-816x.2001.01657.x; GUILLEMIN R, 1963, ENDOCRINOLOGY, V73, P564, DOI 10.1210/endo-73-5-564; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hirata H, 1996, BRAIN RES, V714, P95, DOI 10.1016/0006-8993(95)01502-7; Hu ZP, 2008, J NEUROSCI RES, V86, P2125, DOI 10.1002/jnr.21682; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUANG YN, 2009, TOXICOL APPL PH 0702; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jaworska-Feil L, 2001, EPILEPSY RES, V43, P67, DOI 10.1016/S0920-1211(00)00178-9; Jayanthi S, 1998, ANN NY ACAD SCI, V844, P92, DOI 10.1111/j.1749-6632.1998.tb08224.x; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Johnson-Davis KL, 2004, J PHARMACOL EXP THER, V309, P578, DOI 10.1124/jpet.103.062695; Johnson-Davis KL, 2003, EUR J PHARMACOL, V482, P151, DOI 10.1016/j.ejphar.2003.09.063; KALIVAS PW, 1987, NEUROPHARMACOLOGY, V26, P33, DOI 10.1016/0028-3908(87)90041-4; Kamath J, 2009, PHARMACOL THERAPEUT, V121, P20, DOI 10.1016/j.pharmthera.2008.09.004; Kamphuis W, 2007, MOL VIS, V13, P1892; Kim YT, 2009, J PSYCHIATR RES, V43, P1166, DOI 10.1016/j.jpsychires.2009.03.011; Koerner IP, 2007, ANESTHESIOLOGY, V106, P538, DOI 10.1097/00000542-200703000-00019; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2000, NEUROSCIENCE, V95, P113; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lee TH, 2008, BRAIN RES, V1187, P1, DOI 10.1016/j.brainres.2007.09.078; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Li QF, 2008, ACTA BIOCH BIOPH SIN, V40, P803, DOI 10.1111/j.1745-7270.2008.00461.x; Li QB, 2007, LIFE SCI, V80, P1087, DOI 10.1016/j.lfs.2006.11.043; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindvall O, 1978, Adv Biochem Psychopharmacol, V19, P1; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; OLIVER C, 1974, ENDOCRINOLOGY, V95, P540, DOI 10.1210/endo-95-2-540; Paul S, 2003, CELL MOL LIFE SCI, V60, P2465, DOI 10.1007/s00018-003-3123-7; Pizzi M, 1999, EUR J PHARMACOL, V370, P133, DOI 10.1016/S0014-2999(99)00139-9; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Reamon-Buettner SM, 2008, MUTAT RES-REV MUTAT, V659, P158, DOI 10.1016/j.mrrev.2008.01.003; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; SEIDEN LS, 1976, DRUG ALCOHOL DEPEN, V1, P215, DOI 10.1016/0376-8716(76)90030-2; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; SHREWSBURYGEE J, 1988, EXP BRAIN RES, V70, P342; Siamilis S, 2009, SPINAL CORD, V47, P453, DOI 10.1038/sc.2008.125; Simon SL, 2002, J ADDICT DIS, V21, P61; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Thomas DM, 2005, J NEUROCHEM, V92, P790, DOI 10.1111/j.1471-4159.2004.02906.x; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Truettner J, 2002, MOL BRAIN RES, V103, P106, DOI 10.1016/S0169-328X(02)00191-2; Ubieta R, 2007, BRAIN RES, V1174, P28, DOI 10.1016/j.brainres.2007.08.026; Veronesi MC, 2007, BRAIN RES, V1128, P79, DOI 10.1016/j.brainres.2006.10.047; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; WAGNER GC, 1979, DRUG ALCOHOL DEPEN, V4, P435, DOI 10.1016/0376-8716(79)90076-0; Wang L, 2008, CURR OPIN PHARMACOL, V8, P104, DOI 10.1016/j.coph.2007.09.005; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Weernink PAO, 2007, BBA-BIOMEMBRANES, V1768, P888, DOI 10.1016/j.bbamem.2006.09.012; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Yamagata T, 1999, NEUROSCI RES, V35, P9, DOI 10.1016/S0168-0102(99)00062-0; YAMAMOTO M, 1990, EUR J PHARMACOL, V181, P207, DOI 10.1016/0014-2999(90)90080-P; Ye KQ, 2008, FRONT BIOSCI-LANDMRK, V13, P540, DOI 10.2741/2699; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhou Tong, 2009, V99, P325	128	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7812	10.1371/journal.pone.0007812	http://dx.doi.org/10.1371/journal.pone.0007812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915665	gold, Green Submitted, Green Published			2022-12-27	WOS:000271721400011
J	Comas, I; Homolka, S; Niemann, S; Gagneux, S				Comas, Inaki; Homolka, Susanne; Niemann, Stefan; Gagneux, Sebastien			Genotyping of Genetically Monomorphic Bacteria: DNA Sequencing in Mycobacterium tuberculosis Highlights the Limitations of Current Methodologies	PLOS ONE			English	Article							NUMBER TANDEM-REPEATS; SINGLE-NUCLEOTIDE POLYMORPHISMS; SHORT PALINDROMIC REPEATS; VARIABLE-NUMBER; YERSINIA-PESTIS; BACILLUS-ANTHRACIS; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC INFERENCE; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD	Because genetically monomorphic bacterial pathogens harbour little DNA sequence diversity, most current genotyping techniques used to study the epidemiology of these organisms are based on mobile or repetitive genetic elements. Molecular markers commonly used in these bacteria include Clustered Regulatory Short Palindromic Repeats (CRISPR) and Variable Number Tandem Repeats (VNTR). These methods are also increasingly being applied to phylogenetic and population genetic studies. Using the Mycobacterium tuberculosis complex (MTBC) as a model, we evaluated the phylogenetic accuracy of CRISPR- and VNTR-based genotyping, which in MTBC are known as spoligotyping and Mycobacterial Interspersed Repetitive Units (MIRU)-VNTR-typing, respectively. We used as a gold standard the complete DNA sequences of 89 coding genes from a global strain collection. Our results showed that phylogenetic trees derived from these multilocus sequence data were highly congruent and statistically robust, irrespective of the phylogenetic methods used. By contrast, corresponding phylogenies inferred from spoligotyping or 15-loci-MIRU-VNTR were incongruent with respect to the sequence-based trees. Although 24-loci-MIRU-VNTR performed better, it was still unable to detect all strain lineages. The DNA sequence data showed virtually no homoplasy, but the opposite was true for spoligotyping and MIRU-VNTR, which was consistent with high rates of convergent evolution and the low statistical support obtained for phylogenetic groupings defined by these markers. Our results also revealed that the discriminatory power of the standard 24 MIRU-VNTR loci varied by strain lineage. Taken together, our findings suggest strain lineages in MTBC should be defined based on phylogenetically robust markers such as single nucleotide polymorphisms or large sequence polymorphisms, and that for epidemiological purposes, MIRU-VNTR loci should be used in a lineage-dependent manner. Our findings have implications for strain typing in other genetically monomorphic bacteria.			Comas, I (corresponding author), Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England.	gagneux@nimr.mrc.ac.uk	Comas, Iñaki/F-1185-2011; Comas, Iñaki/AAA-1155-2019; Gagneux, Sebastien/ABE-7909-2020; Niemann, Stefan/C-9327-2011	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Gagneux, Sebastien/0000-0001-7783-9048; Niemann, Stefan/0000-0002-6604-0684	MRC [MC_U117588500] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER; Medical Research Council [MC_U117588500] Funding Source: Medline; NIAID NIH HHS [AI034238, R01 AI034238] Funding Source: Medline; PHS HHS [HHSN266200700022C] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Black WC, 2007, INSECT MOL BIOL, V16, P377, DOI 10.1111/j.1365-2583.2007.00736.x; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Demangel C, 2009, NAT REV MICROBIOL, V7, P50, DOI 10.1038/nrmicro2077; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Felsenstein J., 2004, INFERRING PHYLOGENIE; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutacker MM, 2002, GENETICS, V162, P1533; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Lindstedt BA, 2004, J MICROBIOL METH, V58, P213, DOI 10.1016/j.mimet.2004.03.016; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; SUPPLY P, 2006, J CLIN MICROBIOL, V45, P691; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tamura K., 2007, MEGA4 MOL EVOLUTIONA; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Truman R, 2004, J CLIN MICROBIOL, V42, P2558, DOI 10.1128/JCM.42.6.2558-2565.2004; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	71	321	334	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7815	10.1371/journal.pone.0007815	http://dx.doi.org/10.1371/journal.pone.0007815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915672	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721400012
J	Clement, Y; Le Guisquet, AM; Venault, P; Chapouthier, G; Belzung, C				Clement, Yan; Le Guisquet, Anne-Marie; Venault, Patrice; Chapouthier, Georges; Belzung, Catherine			Pharmacological Alterations of Anxious Behaviour in Mice Depending on Both Strain and the Behavioural Situation	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; FREE-EXPLORATORY PARADIGM; ANXIETY-RELATED BEHAVIORS; GABA(A) RECEPTORS; ANIMAL-MODELS; GENETIC-BASIS; FLUMAZENIL BLOCKS; SWISS-WEBSTER; BENZODIAZEPINE; ANTAGONIST	A previous study comparing non-emotive mice from the strain C57BL/6/ByJ with ABP/Le mice showed ABP/Le to be more anxious in an open-field situation. In the present study, several compounds affecting anxiety were assayed on ABP/Le and C57BL/6/ByJ mice using three behavioural models of anxiety: the elevated plus-maze, the light-dark discrimination test and the free exploratory paradigm. The compounds used were the full benzodiazepine receptor agonist, chlordiazepoxide, and the antagonist, flumazenil, the GABA(A) antagonist, bicuculline, the full 5-HT1A agonist 8-OH-DPAT, and the mixed 5-HT1A/5-HT1B agonist, RU 24969. Results showed the effect of the compounds to be dependent on both the strain and the behavioural task. Several compounds found to be anxiolytic in ABP/Le mice had an anxiogenic effect on C57BL/6/ByJ mice. More behavioural changes were observed for ABP/Le in the elevated plus-maze, but the clearest findings for C57BL/6/ByJ mice were observed in the light-dark discrimination apparatus. These data demonstrate that anxious behaviour is a complex phenomenon which cannot be described by a single behavioural task nor by the action of a single compound.			Clement, Y (corresponding author), Univ Reims, Reims, France.	yan.clement@univ-reims.fr	Belzung, Catherine/P-6512-2016	Belzung, Catherine/0000-0001-6095-5974				Agmo A, 1999, PSYCHOBIOLOGY, V27, P105; AGMO A, 1991, N-S ARCH PHARMACOL, V344, P314; Agmo A, 1998, PHARMACOL BIOCHEM BE, V59, P239, DOI 10.1016/S0091-3057(97)00338-9; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BELZUNG C, 1987, PHARMACOL BIOCHEM BE, V28, P29, DOI 10.1016/0091-3057(87)90006-2; Belzung C, 1997, PSYCHOPHARMACOLOGY, V132, P195, DOI 10.1007/s002130050336; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Belzung C, 1998, BEHAV PHARMACOL, V9, P691, DOI 10.1097/00008877-199812000-00005; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; Belzung C, 2001, BEHAV PHARMACOL, V12, P451, DOI 10.1097/00008877-200111000-00005; BELZUNG C, 1988, PSYCHOPHARMACOLOGY, V95, P516; Belzung C, 2000, PSYCHOPHARMACOLOGY, V148, P24, DOI 10.1007/s002130050021; BELZUNG C, 1999, MOL GENETIC TECHNIQU, P738; BEUZEN A, 1995, PHYSIOL BEHAV, V58, P111, DOI 10.1016/0031-9384(95)00013-9; Blanchard RJ, 1997, NEUROSCI BIOBEHAV R, V21, P783, DOI 10.1016/S0149-7634(96)00062-0; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; Bruening S, 2006, J NEUROCHEM, V99, P892, DOI 10.1111/j.1471-4159.2006.04129.x; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CHOPIN P, 1993, PSYCHOPHARMACOLOGY, V110, P409, DOI 10.1007/BF02244646; CLEMENT Y, 1994, LIFE SCI, V55, P1725, DOI 10.1016/0024-3205(94)00341-6; Clement Y, 1998, NEUROSCI BIOBEHAV R, V22, P623, DOI 10.1016/S0149-7634(97)00058-4; Clement Y, 1997, BRAIN RES, V752, P127, DOI 10.1016/S0006-8993(96)01467-9; CLEMENT Y, 1995, BEHAV BRAIN RES, V70, P51, DOI 10.1016/0166-4328(94)00177-H; Clement Y, 1996, BRAIN RES, V709, P229, DOI 10.1016/0006-8993(95)01297-4; Clement Yan, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/35457; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Dalvi A, 1996, PSYCHOPHARMACOLOGY, V128, P380, DOI 10.1007/s002130050148; DANTZER R, 1982, EUR J PHARMACOL, V81, P655, DOI 10.1016/0014-2999(82)90355-7; DECARVALHO LP, 1983, NATURE, V301, P64, DOI 10.1038/301064a0; Dolu Nazan, 2007, J Basic Clin Physiol Pharmacol, V18, P141; EMMANOUIL DE, 1990, PSYCHOPHARMACOLOGY, V102, P95, DOI 10.1007/BF02245750; FERNANDEZGUASTI A, 1995, EUR J PHARMACOL, V281, P113, DOI 10.1016/0014-2999(95)00311-8; FERRE P, 1994, NEUROPSYCHOBIOLOGY, V29, P23, DOI 10.1159/000119058; FILE SE, 1986, J NEURAL TRANSM, V65, P103, DOI 10.1007/BF01256486; FILE SE, 1983, NEUROSCI LETT, V39, P91, DOI 10.1016/0304-3940(83)90170-2; FILE SE, 1990, PSYCHOPHARMACOLOGY, V101, P525, DOI 10.1007/BF02244232; Flint J, 1999, CURR BIOL, V9, pR326, DOI 10.1016/S0960-9822(99)80204-8; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Florio C, 1998, PSYCHOPHARMACOLOGY, V136, P311, DOI 10.1007/s002130050572; GARDNER CR, 1987, EUR J PHARMACOL, V134, P275, DOI 10.1016/0014-2999(87)90358-X; Gershenfeld HK, 1998, ACTA PSYCHIAT SCAND, V98, P56, DOI 10.1111/j.1600-0447.1998.tb05968.x; GRECKSCH G, 1983, LIFE SCI, V32, P2579, DOI 10.1016/0024-3205(83)90241-2; GRIEBEL G, 1992, NEUROREPORT, V3, P84, DOI 10.1097/00001756-199201000-00022; GRIEBEL G, 1995, BEHAV PHARMACOL, V6, P732; GRIEBEL G, 1995, PHARMACOL THERAPEUT, V65, P319, DOI 10.1016/0163-7258(95)98597-J; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; Griebel G, 1996, PROG NEURO-PSYCHOPH, V20, P185, DOI 10.1016/0278-5846(95)00305-3; HOYER D, 1994, PHARMACOL REV, V46, P157; Lau JYF, 2007, DEV PSYCHOPATHOL, V19, P1129, DOI 10.1017/S0954579407000582; LEE C, 1991, NEUROPHARMACOLOGY, V30, P1263, DOI 10.1016/0028-3908(91)90021-3; Lepicard EM, 2000, PHARMACOL BIOCHEM BE, V67, P739, DOI 10.1016/S0091-3057(00)00419-6; Lesch Klaus-Peter, 2005, Novartis Found Symp, V268, P111; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LYON MF, 1989, GENETIC VARIANTS STR, P1; MATHIS C, 1995, BEHAV GENET, V25, P557, DOI 10.1007/BF02327579; Menard J, 1999, NEUROSCI BIOBEHAV R, V23, P591, DOI 10.1016/S0149-7634(98)00056-6; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Mohler H, 1998, LIFE SCI, V62, P1611, DOI 10.1016/S0024-3205(98)00116-7; Morelli N, 2007, CEPHALALGIA, V27, P471, DOI 10.1111/j.1468-2982.2007.01294.x; Nutt D, 2006, J CLIN SLEEP MED, V2, pS7; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; PEROUTKA SJ, 1994, SYNAPSE, V18, P241, DOI 10.1002/syn.890180310; Pokk P, 1997, J PHYSIOL PHARMACOL, V48, P253; RAFFALLISEBILLE MJ, 1991, DRUG DEVELOP RES, V23, P153, DOI 10.1002/ddr.430230206; Ramboz S, 1996, BEHAV BRAIN RES, V73, P305; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P805, DOI 10.1016/0091-3057(95)00190-8; Rodgers RJ, 2002, GENES BRAIN BEHAV, V1, P242, DOI 10.1034/j.1601-183X.2002.10406.x; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rupprecht R, 2006, WORLD J BIOL PSYCHIA, V7, P231, DOI 10.1080/15622970600868525; Sanchez C, 1996, BEHAV PHARMACOL, V7, P788; SODERPALM B, 1993, EUR J PHARMACOL, V239, P69, DOI 10.1016/0014-2999(93)90977-P; SODERPALM B, 1990, EUR NEUROPSYCHOPHARM, V11, P7; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Teixeira RM, 1996, EUR J PHARMACOL, V311, P7, DOI 10.1016/0014-2999(96)00390-1; VADASZ C, 1992, BEHAV BRAIN RES, V48, P29, DOI 10.1016/S0166-4328(05)80136-6; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; Wilkinson LO, 1991, SEROTONIN RECEPTOR S, P147; Wise J, 1996, BRIT MED J, V313, P1353, DOI 10.1136/bmj.313.7069.1353	86	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A74	A81	e7745	10.1371/journal.pone.0007745	http://dx.doi.org/10.1371/journal.pone.0007745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907641	gold, Green Published, Green Submitted			2022-12-27	WOS:000271685800009
J	Ramsay, A; Cuevas, LE; Mundy, CJF; Nathanson, CM; Chirambo, P; Dacombe, R; Squire, SB; Salaniponi, FML; Munthali, S				Ramsay, Andrew; Cuevas, Luis E.; Mundy, Catherine J. F.; Nathanson, Carl-Michael; Chirambo, Petros; Dacombe, Russell; Squire, S. Bertel; Salaniponi, Felix M. L.; Munthali, Sera			New Policies, New Technologies: Modelling the Potential for Improved Smear Microscopy Services in Malawi	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SPUTUM; FLUORESCENCE; DIAGNOSIS; OPPORTUNITY; DISTRICT; QUALITY; BACILLI	Background: To quantify the likely impact of recent WHO policy recommendations regarding smear microscopy and the introduction of appropriate low-cost fluorescence microscopy on a) case detection and b) laboratory workload. Methodology/ Principal Findings: An audit of the laboratory register in an urban hospital, Lilongwe, Malawi, and the application of a simple modelling framework. The adoption of the new definition of a smear-positive case could directly increase case detection by up to 28%. Examining Ziehl-Neelsen (ZN) sputum smears for up to 10 minutes before declaring them negative has previously been shown to increase case detection (over and above that gained by the adoption of the new case definition) by 70% compared with examination times in routine practice. Three times the number of staff would be required to adequately examine the current workload of smears using ZN microscopy. Through implementing new policy recommendations and LED-based fluorescence microscopy the current laboratory staff complement could investigate the same number of patients, examining auramine-stained smears to an extent that is equivalent to a 10 minutes ZN smear examination. Conclusions/Significance: Combined implementation of the new WHO recommendations on smear microscopy and LED-based fluorescence microscopy could result in substantial increases in smear positive case-detection using existing human resources and minimal additional equipment.			Ramsay, A (corresponding author), WHO, UNICEF, UNDP, World Bank,Special Programme Res & Training Trop, CH-1211 Geneva, Switzerland.	ramsaya@who.int	Cuevas, Luis E/I-3697-2015	Cuevas, Luis E/0000-0002-6581-0587; Squire, Stephen/0000-0001-7173-9038				Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; Enarson DA, 1996, TUBERCULOSIS GUIDE L; FUJIKI A, 1998, TB MICROSCOPY; Hawken MP, 2001, INT J TUBERC LUNG D, V5, P360; Mabaera B, 2008, INT J TUBERC LUNG D, V12, P294; *MAL NAT TUB CONTR, 2008, ANN REP JUL 2007 JUN; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Mccoy D, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-16; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Mugusi F, 2006, INT J TUBERC LUNG D, V10, P663; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; Mundy CJF, 2003, T ROY SOC TROP MED H, V97, P403, DOI 10.1016/S0035-9203(03)90070-8; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, INT J TUBERC LUNG D, V13, P613; WELCAN UK, 1990, WORKLOAD MEASUREMENT; *WHO, 2009, STOP TB PARTN RET TA; *WHO, 2007, WHOHTMSTB200740; World Health Organization, 2008, STOP TB PARTN RET TA; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization   Reginal Office for Africa, 2006, AFR REG HLTH REP HLT; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU	25	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7760	10.1371/journal.pone.0007760	http://dx.doi.org/10.1371/journal.pone.0007760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901989	Green Accepted, gold, Green Published			2022-12-27	WOS:000271658800006
J	Brettschneider, J; Tumani, H; Kiechle, U; Muche, R; Richards, G; Lehmensiek, V; Ludolph, AC; Otto, M				Brettschneider, Johannes; Tumani, Hayrettin; Kiechle, Ulrike; Muche, Rainer; Richards, Gayle; Lehmensiek, Vera; Ludolph, Albert C.; Otto, Markus			IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MEMORY B-CELLS; CEREBROSPINAL-FLUID; OLIGOCLONAL BANDS; IMMUNE-RESPONSE; INTRATHECAL SYNTHESIS; OPTIC NEURITIS; MRI CRITERIA; DIAGNOSIS; PATTERNS	Background: Multiple sclerosis (MS) is characterized by a polyspecific B-cell response to neurotropic viruses such as measles, rubella and varicella zoster, with the corresponding antibodies measurable in CSF as the so-called "MRZ reaction'' (MRZR). We aimed to evaluate the relevance of MRZR to predict conversion of patients with clinically isolated syndrome (CIS) to MS, and to compare it to oligoclonal bands (OCB) and MRI. Methodology/Principal Findings: MRZR was determined in a prospective study over 2 years including 40 patients that remained CIS over follow-up (CIS-CIS) and 49 patients that developed MS (CIS-RRMS) using ELISA. Using logistic regression, a score (MRZS) balancing the predictive value of the antibody indices included in MRZR was defined (9 points measles, 8 points rubella, 1 point varicella zoster, cutpoint: sum of scores greater 10). MRZR and MRZS were significantly more frequent in CIS-RRMS as compared to CIS-CIS (p = 0.04 and p = 0.02). MRZS showed the best positive predictive value (PPV) of all parameters investigated (79%, 95%-CI: 54-94%), which could be further increased by combination with MRI (91%, 95%-CI: 59-99%). Conclusions/Significance: Our data indicate the relevance of MRZR to predict conversion to MS. It furthermore shows the importance of weighting the different antibody indices included in MRZR and suggest that patients with positive MRZR are candidates for an early begin of immunomodulatory therapy.			Brettschneider, J (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	hayrettin.tumani@uni-ulm.de	Otto, Markus/F-4304-2015	Otto, Markus/0000-0003-4273-4267				Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; FELGENHAUER K, 1992, CLIN INVESTIGATOR, V70, P28, DOI 10.1007/BF00422934; Franciotta D, 2008, J NEUROIMMUNOL, V200, P125, DOI 10.1016/j.jneuroim.2008.06.004; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Frederiksen JL, 1998, MULT SCLER, V4, P22, DOI 10.1191/135245898678909213; GREENHOUSE JB, 1995, J COMMUN DISORD, V28, P229, DOI 10.1016/0021-9924(94)00011-N; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; JARIUS S, 2008, J NEUROL SCI; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; NEWCOMBE RG, 1992, BRIT MED J, V304, P381, DOI 10.1136/bmj.304.6823.381-c; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Reiber H, 2001, CLIN CHEM LAB MED, V39, P324, DOI 10.1515/CCLM.2001.051; Robinson-Agramonte M, 2007, ACTA NEUROL SCAND, V115, P312, DOI 10.1111/j.1600-0404.2006.00755.x; SINDIC CJM, 1994, J NEUROIMMUNOL, V54, P75, DOI 10.1016/0165-5728(94)90233-X; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Thrower BW, 2007, NEUROLOGY, V68, pS12, DOI 10.1212/01.wnl.0000277704.56189.85; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2001, MULT SCLER, V7, P359, DOI 10.1191/135245801701567069; Tumani H, 1998, J NEUROL SCI, V155, P44, DOI 10.1016/S0022-510X(97)00272-4; WALSH MJ, 1986, J EXP MED, V163, P41, DOI 10.1084/jem.163.1.41; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C; Zipoli V, 2009, MULT SCLER J, V15, P472, DOI 10.1177/1352458508100502	34	85	89	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7638	10.1371/journal.pone.0007638	http://dx.doi.org/10.1371/journal.pone.0007638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890384	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700002
J	Kuper, H; Atijosan, O; Rischewski, D; Simms, V; Lavy, C				Kuper, Hannah; Atijosan, Oluwarantimi; Rischewski, Dorothea; Simms, Victoria; Lavy, Chris			A Decade Later, How Much of Rwanda's Musculoskeletal Impairment Is Caused by the War in 1994 and by Related Violence?	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; UNEXPLODED ORDNANCE; MORTALITY; TRAUMA; SUDAN; LANDMINES; INJURIES; GENOCIDE; DEATHS; HEALTH	Background: In 1994 there was a horrific genocide in Rwanda following years of tension, resulting in the murder of at least 800,000 people. Although many people were injured in addition to those killed, no attempt has been made to assess the lasting burden of physical injuries related to these events. The aim of this study was to estimate the current burden of musculoskeletal impairment (MSI) attributable to the 1994 war and related violence. Methodology/Principal Findings: A national cross-sectional survey of MSI was conducted in Rwanda. 105 clusters of 80 people were selected through probability proportionate to size sampling. Households within clusters were selected through compact segment sampling. Enumerated people answered a seven-question screening test to assess whether they might have an MSI. Those who were classed as potential cases in the screening test were examined and interviewed by a physiotherapist, using a standard protocol that recorded the site, nature, cause, and severity of the MSI. People with MSI due to trauma were asked whether this trauma occurred during the 1990-1994 war or during the episodes that preceded or followed this war. Out of 8,368 people enumerated, 6,757 were available for screening and examination (80.8%). 352 people were diagnosed with an MSI (prevalence = 5.2%, 95% CI = 4.5-5.9%). 106 cases of MSI (30.6%) were classified as resulting from trauma, based on self-report and the physiotherapist's assessment. Of these, 14 people (13.2%) reported that their trauma-related MSI occurred during the 1990-1994 war, and a further 7 (6.6%) that their trauma-related MSI occurred during the violent episodes that preceded and followed the war, giving an overall prevalence of trauma-related MSI related to the 1990-1994 war of 0.3% (95% CI = 0.2-0.4%). Conclusions/Significance: A decade on, the overall prevalence of MSI was relatively high in Rwanda but few cases appeared to be the result of the 1994 war or related violence.			Kuper, H (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	hannah.kuper@lshtm.ac.uk	Simms, Victoria/AAU-4134-2021; Simms, Victoria/C-3278-2009	Simms, Victoria/0000-0002-4897-458X				Atijosan O, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-30; Atijosan O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002851; Bilukha OO, 2007, JAMA-J AM MED ASSOC, V298, P516, DOI 10.1001/jama.298.5.516; Bilukha OO, 2006, JAMA-J AM MED ASSOC, V296, P516, DOI 10.1001/jama.296.5.516-b; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; Neugebauer R, 2009, INT J EPIDEMIOL, V38, P1033, DOI 10.1093/ije/dyn375; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Roberts B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-7; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; Verwimp P, 2004, POP STUD-J DEMOG, V58, P233, DOI 10.1080/0032472042000224422; WHO, 2001, WHO INT CLASS FUNCT	16	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7720	10.1371/journal.pone.0007720	http://dx.doi.org/10.1371/journal.pone.0007720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	515HI	19890393	Green Accepted, Green Published, gold			2022-12-27	WOS:000271459700012
J	Bohlin, J; Skjerve, E				Bohlin, Jon; Skjerve, Eystein			Examination of Genome Homogeneity in Prokaryotes Using Genomic Signatures	PLOS ONE			English	Article							DINUCLEOTIDE RELATIVE ABUNDANCE; DEPENDENT DNA-STRUCTURE; USAGE PATTERNS; CODON USAGE; EVOLUTIONARY IMPLICATIONS; BACTERIAL GENOMES; GC CONTENT; SEQUENCE; BIAS; CHROMOSOMES	Background: DNA word frequencies, normalized for genomic AT content, are remarkably stable within prokaryotic genomes and are therefore said to reflect a "genomic signature.'' The genomic signatures can be used to phylogenetically classify organisms from arbitrary sampled DNA. Genomic signatures can also be used to search for horizontally transferred DNA or DNA regions subjected to special selection forces. Thus, the stability of the genomic signature can be used as a measure of genomic homogeneity. The factors associated with the stability of the genomic signatures are not known, and this motivated us to investigate further. We analyzed the intra-genomic variance of genomic signatures based on AT content normalization (0(th) order Markov model) as well as genomic signatures normalized by smaller DNA words (1(st) and 2(nd) order Markov models) for 636 sequenced prokaryotic genomes. Regression models were fitted, with intra-genomic signature variance as the response variable, to a set of factors representing genomic properties such as genomic AT content, genome size, habitat, phylum, oxygen requirement, optimal growth temperature and oligonucleotide usage variance (OUV, a measure of oligonucleotide usage bias), measured as the variance between genomic tetranucleotide frequencies and Markov chain approximated tetranucleotide frequencies, as predictors. Principal Findings: Regression analysis revealed that OUV was the most important factor (p<0.001) determining intragenomic homogeneity as measured using genomic signatures. This means that the less random the oligonucleotide usage is in the sense of higher OUV, the more homogeneous the genome is in terms of the genomic signature. The other factors influencing variance in the genomic signature (p<0.001) were genomic AT content, phylum and oxygen requirement. Conclusions: Genomic homogeneity in prokaryotes is intimately linked to genomic GC content, oligonucleotide usage bias (OUV) and aerobiosis, while oligonucleotide usage bias (OUV) is associated with genomic GC content, aerobiosis and habitat.	[Bohlin, Jon; Skjerve, Eystein] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian University of Life Sciences	Bohlin, J (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	jon.bohlin@veths.no	Skjerve, Eystein/D-7491-2014	Skjerve, Eystein/0000-0001-9652-6952; Bohlin, Jon/0000-0002-0992-1311	Norwegian School of Veterinary Science	Norwegian School of Veterinary Science	Jon Bohlin and Eystein Skjerve are both funded by the Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TE, 2006, PLOS COMPUT BIOL, V2, P13, DOI 10.1371/journal.pcbi.0020002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baran RH, 2008, DNA RES, V15, P267, DOI 10.1093/dnares/dsn021; Bohlin J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000057; Bohlin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-104; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Collins NE, 2005, P NATL ACAD SCI USA, V102, P838, DOI 10.1073/pnas.0406633102; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Elhai J, 2001, J COMPUT BIOL, V8, P151, DOI 10.1089/106652701300312922; Ewens W.J., 2001, STAT METHODS BIOINFO; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Garcia JAL, 2008, GENOMICS, V91, P538, DOI 10.1016/j.ygeno.2008.03.001; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; JOSSE J, 1961, J BIOL CHEM, V236, P864; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kozobay-Avraham L, 2006, NUCLEIC ACIDS RES, V34, P2316, DOI 10.1093/nar/gkl230; Kulkarni OC, 2005, BIOINFORMATICS, V21, P3818, DOI 10.1093/bioinformatics/bti639; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; McEwan CEA, 1998, HEREDITAS, V128, P173, DOI 10.1111/j.1601-5223.1998.00173.x; Mitchell D, 2007, BIOCHEM BIOPH RES CO, V353, P207, DOI 10.1016/j.bbrc.2006.12.008; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Musto H, 2006, BIOCHEM BIOPH RES CO, V347, P1, DOI 10.1016/j.bbrc.2006.06.054; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 1998, J MOL BIOL, V280, P407, DOI 10.1006/jmbi.1998.1865; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PHILLIPS GJ, 1987, NUCLEIC ACIDS RES, V15, P2611, DOI 10.1093/nar/15.6.2611; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; *R DEV CT, 2007, R LANG ENV STAT COMP; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Taylor W. R, 2004, PROTEIN BIOINFORMATI; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Ussery D, 2002, COMPUT CHEM, V26, P531, DOI 10.1016/S0097-8485(02)00013-X; Vaillant C, 2006, EUR PHYS J E, V19, P263, DOI 10.1140/epje/i2005-10053-3; Willenbrock H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r114; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8113	10.1371/journal.pone.0008113	http://dx.doi.org/10.1371/journal.pone.0008113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956556	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800011
J	Lisik, W; Tejpal, N; Gong, YQ; Skelton, TS; Ganachari, M; Bremer, EG; Kloc, M; Ghobrial, RM				Lisik, Wojciech; Tejpal, Neelam; Gong, Yongquan; Skelton, T. Spencer; Ganachari, Malathesh; Bremer, Eric G.; Kloc, Malgorzata; Ghobrial, Rafik M.			Down Regulation of Genes Involved in T Cell Polarity and Motility during the Induction of Heart Allograft Tolerance by Allochimeric MHC I	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; ACTIN CYTOSKELETON; TRANSPLANTATION TOLERANCE; ADHESION MOLECULES; CHRONIC REJECTION; ACTIVATION; RHO; PATHWAY; IDENTIFICATION; POLARIZATION	Background: The allochimeric MHC class I molecule [alpha 1h1/u]-RT1. Aa that contains donor-type (Wistar Furth, WF; RT1u) epitopes displayed on recipient-type (ACI, RT1a) administered in conjunction with sub-therapeutic dose of cyclosporine (CsA) induces indefinite survival of heterotopic cardiac allografts in rat model. In vascularized transplantation models, the spleen contributes to graft rejection by generating alloantigen reactive T cells. The immune response in allograft rejection involves a cascade of molecular events leading to the formation of immunological synapses between T cells and the antigen-presenting cells. Methodology/Principal Findings: To elucidate the molecular pathways involved in the immunosuppressive function of allochimeric molecule we performed microarray and quantitative RTPCR analyses of gene expression profile of splenic T cells from untreated, CsA treated, and allochimeric molecule + subtherapeutic dose of CsA treated animals at day 1, 3 and 7 of post transplantation. Allochimeric molecule treatment caused down regulation of genes involved in actin filament polymerization (RhoA and Rac1), cell adhesion (Catna1, Vcam and CD9), vacuolar transport (RhoB, Cln8 and ATP6v1b2), and MAPK pathway (Spred1 and Dusp6) involved in tubulin cytoskeleton reorganization and interaction between actin and microtubule cytoskeleton. All these genes are involved in T cell polarity and motility, i.e., their ability to move, scan and to form functional immunological synapse with antigen presenting cells (APCs). Conclusions: These results indicate that the immunosuppressive function of allochimeric molecule may depend on the impairment of T cells' movement and scanning ability, and possibly also the formation of immunological synapse. We believe that these novel findings may have important clinical implications for organ transplantation.	[Lisik, Wojciech] Warsaw Med Univ, Dept Gen & Transplantat Surg, Warsaw, Poland; [Tejpal, Neelam; Gong, Yongquan; Skelton, T. Spencer; Ganachari, Malathesh; Kloc, Malgorzata; Ghobrial, Rafik M.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Bremer, Eric G.] Precis Biomarker Resources Inc, Evanston, IL USA	Medical University of Warsaw; The Methodist Hospital System; The Methodist Hospital - Houston	Lisik, W (corresponding author), Warsaw Med Univ, Dept Gen & Transplantat Surg, Warsaw, Poland.	mkloc@tmhs.org; RMGhobrial@tmhs.org	Ganachari, malathesha/B-3015-2011; Kloc, Malgorzata/AAF-6982-2020; Lisik, Wojciech/Q-8972-2018	Lisik, Wojciech/0000-0003-3020-3979	National Institutes of Health [RO1 AI49945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health Grant RO1 AI49945 to RM Ghobrial, and fellowship from The Department of Surgery of The Methodist Hospital to TS Skelton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson P, 1999, J IMMUNOL, V162, P2964; Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; BELMONT HM, 1994, ARTHRITIS RHEUM, V37, P376, DOI 10.1002/art.1780370311; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; BUTCHER GW, 1982, TRANSPLANTATION, V34, P161, DOI 10.1097/00007890-198210000-00001; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Chiffoleau E, 2002, J IMMUNOL, V168, P5058, DOI 10.4049/jimmunol.168.10.5058; Choi SY, 1997, J VIROL, V71, P965, DOI 10.1128/JVI.71.2.965-970.1997; Colovai A I, 1996, Int Rev Immunol, V13, P161, DOI 10.3109/08830189609061745; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; DIBARI MG, 2009, CANC IMMUNOL IMMUNOT; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; DUNN DL, 1990, CRIT CARE CLIN, V6, P955; Dustin ML, 2008, CELL, V132, P733, DOI 10.1016/j.cell.2008.02.016; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ghobrial RR, 1996, TRANSPLANTATION, V62, P1002, DOI 10.1097/00007890-199610150-00020; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; HALL BM, 1982, TRANSPLANTATION, V33, P403, DOI 10.1097/00007890-198204000-00012; HAUSMANN R, 1993, CLIN EXP IMMUNOL, V91, P183; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ise W, 2005, J IMMUNOL, V175, P829, DOI 10.4049/jimmunol.175.2.829; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Matsuo MY, 2004, MECH DEVELOP, V121, P771, DOI 10.1016/j.mod.2004.03.014; MOBLEY JL, 1994, BLOOD, V83, P1039, DOI 10.1182/blood.V83.4.1039.bloodjournal8341039; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Pais-Correia Ana Monica, 2007, Current Immunology Reviews, V3, P170; Pernis AB, 2009, AUTOIMMUN REV, V8, P199, DOI 10.1016/j.autrev.2008.07.044; Rodriguez-Fernandez Jose Luis, 2005, Curr Opin Investig Drugs, V6, P1103; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Sayegh M H, 1996, Int Rev Immunol, V13, P221, DOI 10.3109/08830189609061749; Semiletova NV, 2005, TRANSPLANTATION, V80, P1535, DOI 10.1097/01.tp.0000188952.10692.18; Semiltova N, 2003, TRANSPLANTATION, V75, P550, DOI 10.1097/01.TP.0000046942.02001.26; Singer JS, 2001, TRANSPLANTATION, V72, P1408, DOI 10.1097/00007890-200110270-00014; Tharaux PL, 2003, J IMMUNOL, V171, P96, DOI 10.4049/jimmunol.171.1.96; Toyo-oka K, 1999, INT IMMUNOL, V11, P2043, DOI 10.1093/intimm/11.12.2043; Trivedi HL, 2007, TRANSPL P, V39, P647, DOI 10.1016/j.transproceed.2007.01.047; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; VANDINTHERJANSSEN ACHM, 1991, J IMMUNOL, V147, P4207; VANTAGGIATO C, 2009, HUM MUTAT; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005	58	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8020	10.1371/journal.pone.0008020	http://dx.doi.org/10.1371/journal.pone.0008020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956540	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828800004
J	Basak, A; Khatib, AM; Mohottalage, D; Basak, S; Kolajova, M; Bag, SS; Basak, A				Basak, Ajoy; Khatib, Abdel-Majid; Mohottalage, Dayani; Basak, Sarmistha; Kolajova, Maria; Bag, Subhendu Sekhar; Basak, Amit			A Novel Enediynyl Peptide Inhibitor of Furin That Blocks Processing of proPDGF-A, B and proVEGF-C	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; POTENT INHIBITORS; PROTEIN INTERACTIONS; BERGMAN CYCLIZATION; KINETIC EVALUATION; HISTONE H1.2; AMINO-ACID; IN-VITRO; DESIGN; PC7	Background: Furin represents a crucial member of secretory mammalian subtilase, the Proprotein Convertase (PC) or Proprotein Convertase Subtilisin/Kexin (PCSK) superfamily. It has been linked to cancer, tumorgenesis, viral and bacterial pathogenesis. As a result it is considered a major target for intervention of these diseases. Methodology/Principal Findings: Herein, we report, for the first time, the synthesis and biological evaluation of a newly designed potent furin inhibitor that contains a highly reactive beta-turn inducing and radical generating "enediynyl amino acid" (Eda) moiety. "Eda" was inserted between P1 and P1' residues of hfurin(98-112) peptide, derived from the primary cleavage site of furin's own prodomain. The resulting hexadecapeptide derivative inhibited furin in vitro with IC50 similar to 40 nM when measured against the fluorogenic substrate Boc-RVRR-MCA. It also inhibited furin-mediated cleavage of a fluorogenic peptide derived from hSARS-CoV spike protein with IC50 similar to 193 nM. Additionally it also blocked furin-processing of growth factors proPDGF-A, B and VEGF-C that are linked to tumor genesis and cancer. Circular dichroism study showed that this inhibitor displayed a predominantly beta-turn structure while western blots confirmed its ability to protect furin protein from self degradation. Conclusion/Significance: These findings imply its potential as a therapeutic agent for intervention of cancer and other furin-associated diseases.	[Basak, Ajoy; Mohottalage, Dayani; Basak, Sarmistha; Kolajova, Maria] Univ Ottowa, Chron Dis Program, Dept Biochem Microbiol & Immunol, Ottawa Hosp Res Inst,Reg Prot Chem Ctr, Ottawa, ON, Canada; [Khatib, Abdel-Majid] Hosp St Louis, Inst Genet Mol, INSERM, Equipe AVENIR,UMRS940, Paris, France; [Khatib, Abdel-Majid] Univ Paris 07, Paris, France; [Bag, Subhendu Sekhar; Basak, Amit] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India; [Bag, Subhendu Sekhar] Indian Inst Technol, Dept Chem, Gauhati, Assam, India	University of Ottawa; Ottawa Hospital Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Basak, A (corresponding author), Univ Ottowa, Chron Dis Program, Dept Biochem Microbiol & Immunol, Ottawa Hosp Res Inst,Reg Prot Chem Ctr, Ottawa, ON, Canada.	abasak@ohri.ca	Bag, Subhendu Sekhar/AAF-2161-2020; KHATIB, Abdel-Majid/A-9948-2015	KHATIB, Abdel-Majid/0000-0001-6957-0384; Bag, Prof. Dr. Subhendu Sekhar/0000-0001-5232-4793	Canadian Institute for Health Research [MOP-69093, CTP 82946]; National Science and Engineering Research Council [238547-07]; Center for Catalysis Research and Innovation (U Ottawa); INCA; INSERM; La Ligue Contre le Cancer; Department of Science and Technology, Govt of India	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Center for Catalysis Research and Innovation (U Ottawa); INCA(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Department of Science and Technology, Govt of India(Department of Science & Technology (India))	This research was supported by grants from Canadian Institute for Health Research operating MOP-69093 and Team CTP 82946, National Science and Engineering Research Council (238547-07), Center for Catalysis Research and Innovation (U Ottawa) to Ajoy Basak; from INCA, INSERM and La Ligue Contre le Cancer to AM Khatib and the Department of Science and Technology, Govt of India to Amit Basak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 2005, FEBS LETT, V579, P4813, DOI 10.1016/j.febslet.2005.07.062; Basak A, 2005, BIOORGAN MED CHEM, V13, P4096, DOI 10.1016/j.bmc.2005.03.038; Basak A, 2005, BIOORG MED CHEM LETT, V15, P2061, DOI 10.1016/j.bmcl.2005.02.051; Basak A, 2003, CHEM REV, V103, P4077, DOI 10.1021/cr020069k; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; BASAK A, 1995, INT J PEPT PROT RES, V46, P228; Basak A, 2002, BIOORG MED CHEM LETT, V12, P873, DOI 10.1016/S0960-894X(02)00029-X; Basak A, 1998, TETRAHEDRON LETT, V39, P1623, DOI 10.1016/S0040-4039(97)10856-5; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Basak A., 2002, J CHEM SOC P1, V15, P1805; BASAK A, 2000, J CHEM SOC P1, V12, P1955; BASAK A, 2009, BIOCH BIOPH IN PRESS; Basak A, 2008, CURR TOP MED CHEM, V8, P435, DOI 10.2174/156802608783955746; Basak A, 2007, CHEMBIOCHEM, V8, P1029, DOI 10.1002/cbic.200700007; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bhattacharjya S, 2001, PROTEIN SCI, V10, P934, DOI 10.1110/ps.41301; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Borders D. B., 1995, ENEDIYNE ANTIBIOTICS; Choy N, 2000, ORG LETT, V2, P3761, DOI 10.1021/ol006061j; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; Dutta S, 2009, BIOORGAN MED CHEM, V17, P3900, DOI 10.1016/j.bmc.2009.04.019; Fouad FS, 2005, J ORG CHEM, V70, P9789, DOI 10.1021/jo051403q; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gredicak Matija, 2007, Acta Pharmaceutica (Zagreb), V57, P133, DOI 10.2478/v10007-007-0011-y; Han JB, 2006, FEBS J, V273, P4459, DOI 10.1111/j.1742-4658.2006.05451.x; Henrich S, 2003, NAT STRUCT BIOL, V10, P669, DOI 10.1038/nsb0803-669b; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Jones GB, 2000, ORG LETT, V2, P1863, DOI 10.1021/ol005926q; Jones GB, 2000, ORG LETT, V2, P811, DOI 10.1021/ol0055566; JONES RR, 1972, J AM CHEM SOC, V94, P660, DOI 10.1021/ja00757a071; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Komiyama T, 2005, PROTEIN PEPTIDE LETT, V12, P415, DOI 10.2174/0929866054395220; Kowalska D, 2009, MOL PHARMACOL, V75, P617, DOI 10.1124/mol.108.051334; Nielsen P. E., 2004, PSEUDOPEPTIDES DRUG; Rabah N, 2006, J BIOL CHEM, V281, P7556, DOI 10.1074/jbc.M510607200; Rholam M, 2009, CELL MOL LIFE SCI, V66, P2075, DOI 10.1007/s00018-009-0007-5; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siegfried G, 2003, CANCER RES, V63, P1458; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Wang SM, 2008, ACTA BIOCH BIOPH SIN, V40, P848, DOI 10.1111/j.1745-7270.2008.00470.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; ZEIN N, 1995, BIOCHEMISTRY-US, V34, P11591, DOI 10.1021/bi00036a035; ZEIN N, 1993, P NATL ACAD SCI USA, V90, P8009, DOI 10.1073/pnas.90.17.8009; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	60	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e7700	10.1371/journal.pone.0007700	http://dx.doi.org/10.1371/journal.pone.0007700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956642	Green Submitted, Green Published, gold			2022-12-27	WOS:000272828100002
J	Dongari-Bagtzoglou, A; Kashleva, H; Dwivedi, P; Diaz, P; Vasilakos, J				Dongari-Bagtzoglou, Anna; Kashleva, Helena; Dwivedi, Prabhat; Diaz, Patricia; Vasilakos, John			Characterization of Mucosal Candida albicans Biofilms	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; BACTERIAL BIOFILMS; HUMAN NEUTROPHILS; OTITIS-MEDIA; BETA-GLUCAN; ORAL-CAVITY; MODEL; DECTIN-1; INFECTIONS; PATHOGEN	C. albicans triggers recurrent infections of the alimentary tract mucosa that result from biofilm growth. Although the ability of C. albicans to form a biofilm on abiotic surfaces has been well documented in recent years, no information exists on biofilms that form directly on mucosal surfaces. The objectives of this study were to characterize the structure and composition of Candida biofilms forming on the oral mucosa. We found that oral Candida biofilms consist of yeast, hyphae, and commensal bacteria, with keratin dispersed in the intercellular spaces. Neutrophils migrate through the oral mucosa and form nests within the biofilm mass. The cell wall polysaccharide beta-glucan is exposed during mucosal biofilm growth and is more uniformly present on the surface of biofilm organisms invading the oral mucosa. We conclude that C. albicans forms complex mucosal biofilms consisting of both commensal bacterial flora and host components. These discoveries are important since they can prompt a shift of focus for current research in investigating the role of Candida-bacterial interactions in the pathogenesis of mucosal infections as well as the role of beta-glucan mediated signaling in the host response.	[Dongari-Bagtzoglou, Anna; Kashleva, Helena; Diaz, Patricia] Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA; [Dwivedi, Prabhat] Univ Texas Houston, Dept Microbiol, Houston, TX USA; [Vasilakos, John] Biothera, Eagan, MN USA	University of Connecticut; University of Texas System; University of Texas Health Science Center Houston	Dongari-Bagtzoglou, A (corresponding author), Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA.	adongari@uchc.edu		Vasilakos, John/0000-0002-1075-9665	National Institutes of Health/National Institute of Dental and Craniofacial Research [RO1 DE13986]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013986] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research grant RO1 DE13986 to ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; CARLSON E, 1983, INFECT IMMUN, V39, P193, DOI 10.1128/IAI.39.1.193-197.1983; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dahlen G, 2009, ORAL DIS, V15, P265, DOI 10.1111/j.1601-0825.2009.01520.x; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Grimoud Anne M, 2003, J Oral Sci, V45, P51; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; HARMSEN HJM, 1999, MICROB ECOL HEALTH D, V14, P165; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kuhn DM, 2003, J CLIN MICROBIOL, V41, P506, DOI 10.1128/JCM.41.1.506-508.2003; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Milton DK, 2001, APPL ENVIRON MICROB, V67, P5420, DOI 10.1128/AEM.67.12.5420-5424.2001; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; ODDS FC, 1988, J ANTIMICROB CHEMOTH, V22, P891, DOI 10.1093/jac/22.6.891; OKSALA E, 1990, ACTA ODONTOL SCAND, V48, P71, DOI 10.3109/00016359009012736; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tampakakis E, 2009, EUKARYOT CELL, V8, P732, DOI 10.1128/EC.00016-09; Trebesius K, 2000, MED MICROBIOL IMMUN, V188, P169, DOI 10.1007/s004300000035; TRUDEL L, 1986, CAN J MICROBIOL, V32, P673, DOI 10.1139/m86-124; TYLDESLEY WR, 1979, J ORAL PATHOL MED, V8, P53, DOI 10.1111/j.1600-0714.1979.tb01622.x; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Villar CC, 2005, INFECT IMMUN, V73, P4588, DOI 10.1128/IAI.73.8.4588-4595.2005; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Westwater C, 2007, FEMS IMMUNOL MED MIC, V51, P134, DOI 10.1111/j.1574-695X.2007.00287.x; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0	40	146	149	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7967	10.1371/journal.pone.0007967	http://dx.doi.org/10.1371/journal.pone.0007967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956771	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500004
J	Gupta, S; McGrath, B; Cavener, DR				Gupta, Sounak; McGrath, Barbara; Cavener, Douglas R.			PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; KINASE; GROWTH; TUMORIGENESIS; ANGIOGENESIS; EXPRESSION; VIABILITY; HYPOXIA; EIF2AK3; STRESS	Background: PERK eIF2 alpha kinase is required for the proliferation of the insulin-secreting beta-cells as well as insulin synthesis and secretion. In addition, PERK signaling has been found to be an important factor in determining growth and angiogenesis of specific types of tumors, and was attributed to PERK-dependent regulation of the hypoxic stress response. In this report we examine the role of PERK in regulating proliferation and angiogenesis of transformed beta-cells in the development of insulinomas. Methodology: The SV40 Large T-antigen (Tag) was genetically introduced into the insulin secreting beta-cells of Perk KO mice under the control of an inducible promoter. Tumor growth and the related parameters of cell proliferation were measured. In late stage insulinomas the degree of vascularity was determined. Principal Findings: The formation and growth of insulinomas in Perk-deficient mice was dramatically ablated with much fewer tumors, which averaged 38-fold smaller than seen in wild-type control mice. Beta-cell proliferation was ablated in Perk-deficient mice associated with reduced tumor growth. In the small number of large encapsulated insulinomas that developed in Perk-deficient mice, we found a dramatic reduction in tumor vascularity compared to similar sized insulinomas in wild-type mice. Although insulinoma growth in Perk-deficient mice was largely impaired, beta-cell mass was increased sufficiently by T-antigen induction to rescue the hypoinsulinemia and diabetes in these mice. Conclusions: We conclude that PERK has two roles in the development of beta-cell insulinomas, first to support rapid cell proliferation during the initial transition to islet hyperplasia and later to promote angiogenesis during the progression to late-stage encapsulated tumors.	[Gupta, Sounak; McGrath, Barbara; Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Gupta, Sounak; Cavener, Douglas R.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	drc9@psu.edu	Cavener, Douglas R/E-3524-2010		National Institutes of Health [R01-DK062049, R01-GM56957]; Pennsylvania Department of Health TSF; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health TSF; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (R01-DK062049 and R01-GM56957) and the Pennsylvania Department of Health TSF to D. R. C. and from the American Heart Association Fellowship to S. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkovich I, 2001, DIABETES, V50, P2260, DOI 10.2337/diabetes.50.10.2260; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Brown JM, 1998, CANCER RES, V58, P1408; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Pelengaris S, 2001, ENDOCR-RELAT CANCER, V8, P307, DOI 10.1677/erc.0.0080307; Raught B, 1996, CANCER RES, V56, P4382; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	21	43	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8008	10.1371/journal.pone.0008008	http://dx.doi.org/10.1371/journal.pone.0008008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956728	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500031
J	Yu, N; Zhao, HB				Yu, Ning; Zhao, Hong-Bo			Modulation of Outer Hair Cell Electromotility by Cochlear Supporting Cells and Gap Junctions	PLOS ONE			English	Article							GUINEA-PIG; INNER-EAR; MECHANICAL RESPONSES; VOLTAGE-DEPENDENCE; MEMBRANE; MOTILITY; CHARGE; AMPLIFICATION; CAPACITANCE; PRESTIN	Outer hair cell (OHC) or prestin-based electromotility is an active cochlear amplifier in the mammalian inner ear that can increase hearing sensitivity and frequency selectivity. In situ, Deiters supporting cells are well-coupled by gap junctions and constrain OHCs standing on the basilar membrane. Here, we report that both electrical and mechanical stimulations in Deiters cells (DCs) can modulate OHC electromotility. There was no direct electrical conductance between the DCs and the OHCs. However, depolarization in DCs reduced OHC electromotility associated nonlinear capacitance (NLC) and distortion products. Increase in the turgor pressure of DCs also shifted OHC NLC to the negative voltage direction. Destruction of the cytoskeleton in DCs or dissociation of the mechanical-coupling between DCs and OHCs abolished these effects, indicating the modulation through the cytoskeleton activation and DC-OHC mechanical coupling rather than via electric field potentials. We also found that changes in gap junctional coupling between DCs induced large membrane potential and current changes in the DCs and shifted OHC NLC. Uncoupling of gap junctions between DCs shifted NLC to the negative direction. These data indicate that DCs not only provide a physical scaffold to support OHCs but also can directly modulate OHC electromotility through the DC-OHC mechanical coupling. Our findings reveal a new mechanism of cochlear supporting cells and gap junctional coupling to modulate OHC electromotility and eventually hearing sensitivity in the inner ear.			Yu, N (corresponding author), Univ Kentucky, Med Ctr, Dept Surg Otolaryngol, Lexington, KY 40536 USA.	hzhao2@uky.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005989] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 05989, R01 DC005989] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bobbin RP, 2002, HAIR CELL MICROMECHANICS AND OTOACOUSTIC EMISSIONS, P91; Bobbin RP, 2001, NEUROREPORT, V12, P2923, DOI 10.1097/00001756-200109170-00034; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; DULON D, 1994, BIOCHEM BIOPH RES CO, V201, P1263, DOI 10.1006/bbrc.1994.1841; Flock A, 1999, J NEUROSCI, V19, P4498; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Slepecky N. B., 1996, COCHLEA, V8, P44; Yu N, 2008, PFLUG ARCH EUR J PHY, V457, P453, DOI 10.1007/s00424-008-0522-5; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686; Zhao HB, 2000, NEUROSCI LETT, V296, P105, DOI 10.1016/S0304-3940(00)01626-8; Zhao HB, 2000, J MEMBRANE BIOL, V175, P17, DOI 10.1007/s002320001051; Zhao HB, 2006, J COMP NEUROL, V499, P506, DOI 10.1002/cne.21113; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZHU Y, 2009, PURINERGIC IN PRESS	24	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7923	10.1371/journal.pone.0007923	http://dx.doi.org/10.1371/journal.pone.0007923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936276	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004800007
J	Vermeulen, N; Godefroid, J; Mermillod, M				Vermeulen, Nicolas; Godefroid, Jimmy; Mermillod, Martial			Emotional Modulation of Attention: Fear Increases but Disgust Reduces the Attentional Blink	PLOS ONE			English	Article							FACIAL EXPRESSION; NEURAL BASIS; RECOGNITION; ALCOHOLICS; FACES; EMBODIMENT; LOCUS; TASK	Background: It is well known that facial expressions represent important social cues. In humans expressing facial emotion, fear may be configured to maximize sensory exposure (e. g., increases visual input) whereas disgust can reduce sensory exposure (e. g., decreases visual input). To investigate whether such effects also extend to the attentional system, we used the "attentional blink" (AB) paradigm. Many studies have documented that the second target (T2) of a pair is typically missed when presented within a time window of about 200-500 ms from the first to-be-detected target (T1; i.e., the AB effect). It has recently been proposed that the AB effect depends on the efficiency of a gating system which facilitates the entrance of relevant input into working memory, while inhibiting irrelevant input. Following the inhibitory response on post T1 distractors, prolonged inhibition of the subsequent T2 is observed. In the present study, we hypothesized that processing facial expressions of emotion would influence this attentional gating. Fearful faces would increase but disgust faces would decrease inhibition of the second target. Methodology/Principal Findings: We showed that processing fearful versus disgust faces has different effects on these attentional processes. We found that processing fear faces impaired the detection of T2 to a greater extent than did the processing disgust faces. This finding implies emotion-specific modulation of attention. Conclusions/Significance: Based on the recent literature on attention, our finding suggests that processing fear-related stimuli exerts greater inhibitory responses on distractors relative to processing disgust-related stimuli. This finding is of particular interest for researchers examining the influence of emotional processing on attention and memory in both clinical and normal populations. For example, future research could extend upon the current study to examine whether inhibitory processes invoked by fear-related stimuli may be the mechanism underlying the enhanced learning of fear-related stimuli.			Vermeulen, N (corresponding author), Catholic Univ Louvain, Dept Psychol, B-1348 Louvain, Belgium.	Nicolas.Vermeulen@uclouvain.be		/0000-0001-8966-6148; Mermillod, Martial/0000-0003-4367-7049; Lauwereyns, Jan/0000-0003-0551-2550				Anderson AK, 2003, J NEUROSCI, V23, P5627; Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Davenport JL, 2005, MEM COGNITION, V33, P241, DOI 10.3758/BF03195313; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Keltner D, 2003, SER AFFECTIVE SCI, P415; Kornreich C, 2003, PSYCHIAT RES, V119, P251, DOI 10.1016/S0165-1781(03)00130-6; Kornreich C, 1998, ADDICT BEHAV, V23, P413, DOI 10.1016/S0306-4603(97)00040-3; Kornreich C, 2001, J STUD ALCOHOL, V62, P533, DOI 10.15288/jsa.2001.62.533; Mermillod M, 2009, COGNITION, V110, P346, DOI 10.1016/j.cognition.2008.11.009; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Nieuwenhuis S, 2005, J EXP PSYCHOL GEN, V134, P291, DOI 10.1037/0096-3445.134.3.291; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Vermeulen N, 2007, COGNITIVE SCI, V31, P183, DOI 10.1080/03640210709336990; Vermeulen N, 2009, COGNITION, V112, P467, DOI 10.1016/j.cognition.2009.06.003; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	28	44	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7924	10.1371/journal.pone.0007924	http://dx.doi.org/10.1371/journal.pone.0007924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NJ	19936235	gold, Green Published			2022-12-27	WOS:000272004600021
J	Ciota, AT; Jia, YQ; Payne, AF; Jerzak, G; Davis, LJ; Young, DS; Ehrbar, D; Kramer, LD				Ciota, Alexander T.; Jia, Yongqing; Payne, Anne F.; Jerzak, Greta; Davis, Lauren J.; Young, David S.; Ehrbar, Dylan; Kramer, Laura D.			Experimental Passage of St. Louis Encephalitis Virus In Vivo in Mosquitoes and Chickens Reveals Evolutionarily Significant Virus Characteristics	PLOS ONE			English	Article							WEST-NILE-VIRUS; PURIFYING SELECTION; INVERTEBRATE CELLS; GENETIC-VARIATION; MAMMALIAN-CELLS; MUTANT SPECTRUM; ADAPTATION; FLAVIVIRUSES; CALIFORNIA; ARBOVIRUS	St. Louis encephalitis virus (SLEV; Flaviviridae, flavivirus) was the major cause of epidemic flaviviral encephalitis in the U. S. prior to the introduction of West Nile virus (WNV) in 1999. However, outbreaks of SLEV have been significantly more limited then WNV in terms of levels of activity and geographic dispersal. One possible explanation for these variable levels of activity is that differences in the potential for each virus to adapt to its host cycle exist. The need for arboviruses to replicate in disparate hosts is thought to result in constraints on both evolution and host-specific adaptation. If cycling is the cause of genetic stability observed in nature and arboviruses lack host specialization, then sequential passage should result in both the accumulation of mutations and specialized viruses better suited for replication in that host. Previous studies suggest that WNV and SLEV differ in capacity for both genetic change and host specialization, and in the costs each accrues from specializing. In an attempt to clarify how selective pressures contribute to epidemiological patterns of WNV and SLEV, we evaluated mutant spectra size, consensus genetic change, and phenotypic changes for SLEV in vivo following 20 sequential passages via inoculation in either Culex pipiens mosquitoes or chickens. Results demonstrate that the capacity for genetic change is large for SLEV and that the size of the mutant spectrum is host-dependent using our passage methodology. Despite this, a general lack of consensus change resulted from passage in either host, a result that contrasts with the idea that constraints on evolution in nature result from host cycling alone. Results also suggest that a high level of adaptation to both hosts already exists, despite host cycling. A strain significantly more infectious in chickens did emerge from one lineage of chicken passage, yet other lineages and all mosquito passage strains did not display measurable host-specific fitness gains. In addition, increased infectivity in chickens did not decrease infectivity in mosquitoes, which further contrasts the concept of fitness trade-offs for arboviruses.			Ciota, AT (corresponding author), New York State Dept Hlth, Arbovirus Labs, Wadsworth Ctr, Slingerlands, NY USA.	ldk02@health.state.ny.us	; Ciota, Alexander/E-1634-2017	Van Slyke, Greta/0000-0003-2646-3030; Ehrbar, Dylan/0000-0001-7872-3338; Ciota, Alexander/0000-0001-6589-4728	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077669, N01AI025490] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI25490, R01 AI077669, R01-AI-077669] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0; Ciota AT, 2007, J GEN VIROL, V88, P2398, DOI 10.1099/vir.0.83061-0; Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0; Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cooper LA, 2001, GENETICS, V157, P1403; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Dupuis AP, 2003, EMERG INFECT DIS, V9, P860; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Kramer LD, 1997, AM J TROP MED HYG, V57, P222, DOI 10.4269/ajtmh.1997.57.222; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503; MARTINEZ MA, 1991, J VIROL, V65, P3954; May FJ, 2008, J GEN VIROL, V89, P1901, DOI 10.1099/vir.0.2008/000190-0; MITCHELL CJ, 1980, ST LOUIS ENCEPHALITI, P313; MONATH TP, 1996, FIELDS VIROLOGY, P961; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Presloid JB, 2008, J MOL BIOL, V382, P342, DOI 10.1016/j.jmb.2008.06.080; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; TAYLOR WP, 1975, J GEN VIROL, V28, P59, DOI 10.1099/0022-1317-28-1-59; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; Turner PE, 2000, GENETICS, V156, P1465; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Zarate S, 2004, J VIROL, V78, P12236, DOI 10.1128/JVI.78.22.12236-12242.2004	33	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7876	10.1371/journal.pone.0007876	http://dx.doi.org/10.1371/journal.pone.0007876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924238	Green Published, Green Submitted, gold			2022-12-27	WOS:000271854200021
J	Biasini, E; Tapella, L; Mantovani, S; Stravalaci, M; Gobbi, M; Harris, DA; Chiesa, R				Biasini, Emiliano; Tapella, Laura; Mantovani, Susanna; Stravalaci, Matteo; Gobbi, Marco; Harris, David A.; Chiesa, Roberto			Immunopurification of Pathological Prion Protein Aggregates	PLOS ONE			English	Article							AMYLOID FIBRILS; PRP; DISEASE; IDENTIFICATION; ACCUMULATION; PURIFICATION; EXPRESSION; FRAGMENT; BRAIN; CELLS	Prion diseases are fatal neurodegenerative disorders that can arise sporadically, be genetically inherited or acquired through infection. The key event in these diseases is misfolding of the cellular prion protein (PrPC) into a pathogenic isoform that is rich in beta-sheet structure. This conformational change may result in the formation of PrPSc, the prion isoform of PrP, which propagates itself by imprinting its aberrant conformation onto PrPC molecules. A great deal of effort has been devoted to developing protocols for purifying PrPSc for structural studies, and testing its biological properties. Most procedures rely on protease digestion, allowing efficient purification of PrP27-30, the protease-resistant core of PrPSc. However, protease treatment cannot be used to isolate abnormal forms of PrP lacking conventional protease resistance, such as those found in several genetic and atypical sporadic cases. Principal Findings: We developed a method for purifying pathological PrP molecules based on sequential centrifugation and immunoprecipitation with a monoclonal antibody selective for aggregated PrP. With this procedure we purified full-length PrPSc and mutant PrP aggregates at electrophoretic homogeneity. PrPSc purified from prion-infected mice was able to seed misfolding of PrPC in a protein misfolding cyclic amplification reaction, and mutant PrP aggregates from transgenic mice were toxic to cultured neurons. Significance: The immunopurification protocol described here isolates biologically active forms of aggregated PrP. These preparations may be useful for investigating the structural and chemico-physical properties of infectious and neurotoxic PrP aggregates.			Biasini, E (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	roberto.chiesa@marionegri.it	Chiesa, Roberto/G-1561-2017; Biasini, Emiliano/A-3147-2011; Stravalaci, Matteo/AAB-8963-2019; Gobbi, Marco/J-2638-2016	Chiesa, Roberto/0000-0002-3842-3733; Biasini, Emiliano/0000-0002-3927-6341; Stravalaci, Matteo/0000-0002-5636-4204; Gobbi, Marco/0000-0003-1014-6225; Tapella, Laura/0000-0002-8159-1628; Harris, David/0000-0002-6985-5790; Mantovani, Susanna/0000-0001-7046-6541	NINDS NIH HHS [NS052526, NS040975, R01 NS040975, R01 NS052526] Funding Source: Medline; Telethon [TCR08005] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052526, R01NS040975] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; Biasini E, 2008, J NEUROCHEM, V104, P1293, DOI 10.1111/j.1471-4159.2007.05082.x; Biasini E, 2006, PROTEOMICS, V6, P2823, DOI 10.1002/pmic.200500620; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; Bonetto V, 2002, J BIOL CHEM, V277, P31327, DOI 10.1074/jbc.M203275200; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P10600, DOI 10.1021/bi00107a032; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2004, TECHNIQUES PRION RES, P176; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Corsaro A, 2006, INT J IMMUNOPATH PH, V19, P339, DOI 10.1177/039463200601900211; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Fioriti L, 2007, J NEUROSCI, V27, P1576, DOI 10.1523/JNEUROSCI.5145-06.2007; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; GABIZON R, 1989, P NATL ACAD SCI USA, V86, P1223; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Giese A, 1998, BRAIN PATHOL, V8, P449; HEAD MW, 2009, NEUROPATHOL APPL NEU; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; MULLER WEG, 1993, EUR J PHARM-MOLEC PH, V246, P261, DOI 10.1016/0922-4106(93)90040-G; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Post K, 2000, ARCH VIROL, P265; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Raymond G. J., 2004, TECHNIQUES PRION RES, P16; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saunders GC, 2007, RES VET SCI, V83, P157, DOI 10.1016/j.rvsc.2007.01.001; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	52	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7816	10.1371/journal.pone.0007816	http://dx.doi.org/10.1371/journal.pone.0007816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19915706	gold, Green Published, Green Submitted			2022-12-27	WOS:000271721400013
J	Kong, SG; Fan, WL; Chen, HD; Hsu, ZT; Zhou, NJ; Zheng, B; Lee, HC				Kong, Sing-Guan; Fan, Wen-Lang; Chen, Hong-Da; Hsu, Zi-Ting; Zhou, Nengji; Zheng, Bo; Lee, Hoong-Chien			Inverse Symmetry in Complete Genomes and Whole-Genome Inverse Duplication	PLOS ONE			English	Article							STRAND COMPOSITIONAL ASYMMETRY; GENE DUPLICATION; NUCLEIC-ACIDS; DNA-SEQUENCES; REPLICATION; BACTERIAL; ORIGINS; SEPARATION; EVOLUTION; PATTERNS	The cause of symmetry is usually subtle, and its study often leads to a deeper understanding of the bearer of the symmetry. To gain insight into the dynamics driving the growth and evolution of genomes, we conducted a comprehensive study of textual symmetries in 786 complete chromosomes. We focused on symmetry based on our belief that, in spite of their extreme diversity, genomes must share common dynamical principles and mechanisms that drive their growth and evolution, and that the most robust footprints of such dynamics are symmetry related. We found that while complement and reverse symmetries are essentially absent in genomic sequences, inverse-complement plus reverse-symmetry is prevalent in complex patterns in most chromosomes, a vast majority of which have near maximum global inverse symmetry. We also discovered relations that can quantitatively account for the long observed but unexplained phenomenon of k-mer skews in genomes. Our results suggest segmental and whole-genome inverse duplications are important mechanisms in genome growth and evolution, probably because they are efficient means by which the genome can exploit its double-stranded structure to enrich its code-inventory.			Kong, SG (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Chungli 32054, Taiwan.	hclee@phy.ncu.edu.tw		Chen, HongDa/0000-0002-9330-5473; Sing Guan, Kong/0000-0001-8817-781X; Zhou, Nengji/0000-0002-7530-8312				Albrecht-Buehler G, 2007, GENOMICS, V90, P297, DOI 10.1016/j.ygeno.2007.05.010; Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baisnee PF, 2002, BIOINFORMATICS, V18, P1021, DOI 10.1093/bioinformatics/18.8.1021; Bell SJ, 1999, J THEOR BIOL, V197, P51, DOI 10.1006/jtbi.1998.0857; BIEBRICHER CK, 1992, EMBO J, V11, P5129, DOI 10.1002/j.1460-2075.1992.tb05620.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chang Chang-Heng, 2005, Journal of Bioinformatics and Computational Biology, V3, P587, DOI 10.1142/S0219720005001181; CHARGAFF E, 1951, FED PROC, V10, P654; Chen HD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178103; Chen TY, 2005, COMPUT PHYS COMMUN, V169, P218, DOI 10.1016/j.cpc.2005.03.050; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; DIXON L, 1988, COMMUN MATH PHYS, V119, P221, DOI 10.1007/BF01217740; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Forsdyke Donald R, 2004, Appl Bioinformatics, V3, P3; Forsdyke DR, 2002, BIOINFORMATICS, V18, P215, DOI 10.1093/bioinformatics/18.1.215; Freeman JM., 1998, SCIENCE, V279, P1827, DOI [10.1126/science.279.5358.1827a, DOI 10.1126/science.279.5358.1827a, DOI 10.1126/SCIENCE.279.5358.1827A]; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Hsieh LC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.018101; HSU ZT, 2008, THESIS NATL CENTRAL; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jose MV, 2005, PHYSICA A, V351, P477, DOI 10.1016/j.physa.2004.11.060; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kelman LM, 2004, TRENDS MICROBIOL, V12, P399, DOI 10.1016/j.tim.2004.07.001; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Messer PW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138103; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; Muller A, 2003, SCIENCE, V300, P749, DOI 10.1126/science.1084991; NUSSINOV R, 1982, J THEOR BIOL, V95, P783, DOI 10.1016/0022-5193(82)90353-8; OCHMAN H, 2000, P NATL ACAD SCI USA, V405, P209; Ohno S., 1970, EVOLUTION GENE DUPLI; Petrillo M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-170; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; Qi D, 2001, BIOINFORMATICS, V17, P557, DOI 10.1093/bioinformatics/17.6.557; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rocha EPC, 2006, GENOME RES, V16, P1537, DOI 10.1101/gr.5525106; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rocha EPC, 2002, TRENDS MICROBIOL, V10, P393, DOI 10.1016/S0966-842X(02)02420-4; RUDNER R, 1969, P NATL ACAD SCI USA, V63, P152, DOI 10.1073/pnas.63.1.152; RUDNER R, 1968, P NATL ACAD SCI USA, V60, P921, DOI 10.1073/pnas.60.3.921; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; Sanchez J, 2002, BIOCHEM BIOPH RES CO, V299, P126, DOI 10.1016/S0006-291X(02)02583-4; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; ZEE ANTHONY, 1999, FEARFUL SYMMETRY SEA; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546; RICE ANNOTATION PROJ; NAT CTR BIOTECHNOLOG; INVERSE SYMMETRY DAT	57	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2009	4	11							e7553	10.1371/journal.pone.0007553	http://dx.doi.org/10.1371/journal.pone.0007553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZM	19898631	Green Published, Green Submitted, gold			2022-12-27	WOS:000271658000001
J	Stark, K; Reinhard, W; Grassl, M; Erdmann, J; Schunkert, H; Illig, T; Hengstenberg, C				Stark, Klaus; Reinhard, Wibke; Grassl, Martina; Erdmann, Jeanette; Schunkert, Heribert; Illig, Thomas; Hengstenberg, Christian			Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; MORTALITY; SLC2A9; GENE; LOCUS	Background: Recently, a large meta-analysis including over 28,000 participants identified nine different loci with association to serum uric acid (UA) levels. Since elevated serum UA levels potentially cause gout and are a possible risk factor for coronary artery disease (CAD) and myocardial infarction (MI), we performed two large case-control association analyses with participants from the German MI Family Study. In the first study, we assessed the association of the qualitative trait gout and ten single nucleotide polymorphisms (SNP) markers that showed association to UA serum levels. In the second study, the same genetic polymorphisms were analyzed for association with CAD. Methods and Findings: A total of 683 patients suffering from gout and 1,563 healthy controls from the German MI Family Study were genotyped. Nine SNPs were identified from a recently performed genome-wide meta-analysis on serum UA levels (rs12129861, rs780094, rs734553, rs2231142, rs742132, rs1183201, rs12356193, rs17300741 and rs505802). Additionally, the marker rs6855911 was included which has been associated with gout in our cohort in a previous study. SNPs rs734553 and rs6855911, located in SLC2A9, and SNP rs2231142, known to be a missense polymorphism in ABCG2, were associated with gout (p = 5.6*10(-7), p = 1.1*10(-7), and p = 1.3*10(-3), respectively). Other SNPs in the genes PDZK1, GCKR, LRRC16A, SLC17A1-SLC17A3, SLC16A9, SLC22A11 and SLC22A12 failed the significance level. None of the ten markers were associated with risk to CAD in our study sample of 1,473 CAD cases and 1,241 CAD-free controls. Conclusion: SNP markers in SLC2A9 and ABCG2 genes were found to be strongly associated with the phenotype gout. However, not all SNP markers influencing serum UA levels were also directly associated with the clinical manifestation of gout in our study sample. In addition, none of these SNPs showed association with the risk to CAD in the German MI Family Study.			Stark, K (corresponding author), Univ Klinikum Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany.	christian.hengstenberg@klinik.uni-regensburg.de	Stark, Klaus/D-3813-2009; Hengstenberg, Christian/U-5485-2019; 王, 强/F-4212-2011; Stark, Klaus/L-7367-2013; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014	Stark, Klaus/0000-0002-7832-1942; Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231				ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Mandell Brian F, 2008, Cleve Clin J Med, V75 Suppl 5, pS5; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y	32	84	93	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7729	10.1371/journal.pone.0007729	http://dx.doi.org/10.1371/journal.pone.0007729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890391	gold, Green Published, Green Submitted			2022-12-27	WOS:000271459700015
J	Prescott, J; Lu, YN; Chang, ET; Sullivan-Halley, J; Henderson, KD; Clarke, CA; Ma, HY; Templeman, C; Deapen, D; Bernstein, L				Prescott, Jennifer; Lu, Yani; Chang, Ellen T.; Sullivan-Halley, Jane; Henderson, Katherine D.; Clarke, Christina A.; Ma, Huiyan; Templeman, Claire; Deapen, Dennis; Bernstein, Leslie			Reproductive Factors and Non-Hodgkin Lymphoma Risk in the California Teachers Study	PLOS ONE			English	Article							EXOGENOUS HORMONE USE; BREAST-CANCER; UNITED-STATES; WOMEN; PREGNANCY; EPIDEMIOLOGY; NEOPLASMS; CLASSIFICATION; PROGESTERONE; CONNECTICUT	Non-Hodgkin lymphoma (NHL) is a malignancy etiologically linked to immunomodulatory exposures and disorders. Endogenous female sex hormones may modify immune function and influence NHL risk. Few studies have examined associations between reproductive factors, which can serve as surrogates for such hormonal exposures, and NHL risk by subtype. Methodology/Principal Findings: Women in the California Teachers Study cohort provided detailed data in 1995-1996 on reproductive history. Follow-up through 2007 identified 574 women with incident B-cell NHL. Hazard rate ratios (RR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models to assess associations between reproductive factors and all B-cell NHL combined, diffuse large B-cell lymphomas, follicular lymphomas, and B-cell chronic lmphocytic leukemias/small lymphocytic lymphomas. Pregnancy was marginally associated with lower risk of B-cell NHL (RR = 0.84, 95% CI = 0.68-1.04). Much of the reduction in risk was observed after one full-term pregnancy relative to nulligravid women (RR = 0.75, 95% CI = 0.54-1.06; P for trend <0.01), particularly for diffuse large B-cell lymphomas (P for trend = 0.13), but not among women who had only incomplete pregnancies. Age at first full-term pregnancy was marginally inversely associated with B-cell NHL risk overall (P for trend = 0.08) and for diffuse large B-cell lymphomas (P for trend = 0.056). Breast feeding was not associated with B-cell NHL risk overall or by subtype. Conclusions: Full-term pregnancy and early age at first full-term pregnancy account for most of the observed reduction in B-cell NHL risk associated with gravidity. Pregnancy-related hormonal exposures, including prolonged and high-level exposure to progesterone during a full-term pregnancy may inhibit development of B-cell NHL.	[Prescott, Jennifer] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Prescott, Jennifer] Harvard Univ, Sch Med, Boston, MA USA; [Lu, Yani; Sullivan-Halley, Jane; Henderson, Katherine D.; Ma, Huiyan; Bernstein, Leslie] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Chang, Ellen T.; Clarke, Christina A.] No Calif Canc Ctr, Fremont, CA USA; [Chang, Ellen T.; Clarke, Christina A.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Templeman, Claire; Deapen, Dennis] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; City of Hope; Stanford University; University of Southern California	Prescott, J (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	LBernstein@coh.org	Chang, Ellen/E-3168-2010; Chang, Ellen/G-5700-2010		California Breast Cancer Act of 1993; National Institutes of Health [R01 CA77398]; California Breast Cancer Research Fund [97-10500]; NIH/National Institute on Aging (NIA) [5-T32-AG00037-29]; NATIONAL CANCER INSTITUTE [K05CA136967, R01CA077398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000037] Funding Source: NIH RePORTER	California Breast Cancer Act of 1993; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Fund; NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the California Breast Cancer Act of 1993, the National Institutes of Health (http://www.nih.gov/) grant R01 CA77398, and contract 97-10500 from the California Breast Cancer Research Fund (http://www.cbcrp.org/). JP was supported by NIH/National Institute on Aging (NIA) training grant 5-T32-AG00037-29. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami HO, 1997, INT J CANCER, V70, P155, DOI 10.1002/(SICI)1097-0215(19970117)70:2<155::AID-IJC3>3.0.CO;2-W; BERNSTEIN L, 1992, CANCER RES, V52, pS5510; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Cerhan JR, 2002, CANCER CAUSE CONTROL, V13, P131, DOI 10.1023/A:1014354105164; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Frisch M, 1997, INT J CANCER, V71, P127, DOI 10.1002/(SICI)1097-0215(19970328)71:1<127::AID-IJC21>3.0.CO;2-E; Frisch M, 2006, EUR J EPIDEMIOL, V21, P673, DOI 10.1007/s10654-006-9035-8; HARRIS NL, 1994, BLOOD, V84, P1361; Hennessy BT, 2004, LANCET ONCOL, V5, P341, DOI 10.1016/S1470-2045(04)01490-1; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KLEIHUES P, 2001, WHO CLASSIFICATION T; Lee JS, 2008, AM J EPIDEMIOL, V168, P278, DOI 10.1093/aje/kwn119; LINDBERG BS, 1974, ACTA OBSTET GYN SCAN, P21; MACMAHON B, 1982, INT J CANCER, V30, P427, DOI 10.1002/ijc.2910300408; MOOR RM, 1968, P ROY SOC MED, V61, P1217, DOI 10.1177/003591576806111P206; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; OLSSON H, 1990, NEOPLASMA, V37, P185; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Reynolds P, 2004, EPIDEMIOLOGY, V15, P746, DOI 10.1097/01.ede.0000134863.45834.50; ROSENBERG SA, 1982, CANCER, V49, P2112; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Tavani A, 1997, LEUKEMIA RES, V21, P885, DOI 10.1016/S0145-2126(97)00062-3; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; VIHKO R, 1984, J STEROID BIOCHEM, V20, P231, DOI 10.1016/0022-4731(84)90209-7; Zhang YW, 2004, AM J EPIDEMIOL, V160, P766, DOI 10.1093/aje/kwh278; ZHENG TZ, 1992, CANCER, V70, P840, DOI 10.1002/1097-0142(19920815)70:4&lt;840::AID-CNCR2820700420&gt;3.0.CO;2-I	32	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8135	10.1371/journal.pone.0008135	http://dx.doi.org/10.1371/journal.pone.0008135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956586	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800026
J	Sharma, A; Mohammad, F; Singh, P				Sharma, Abhay; Mohammad, Farhan; Singh, Priyanka			Gender Differences in a Drosophila Transcriptomic Model of Chronic Pentylenetetrazole Induced Behavioral Deficit	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GENE-EXPRESSION; BRAIN	A male Drosophila model of locomotor deficit induced by chronic pentylenetetrazole (PTZ), a proconvulsant used to model epileptogenesis in rodents, has recently been described. Antiepileptic drugs (AEDs) ameliorate development of this behavioral abnormality. Time-series of microarray profiling of heads of male flies treated with PTZ has shown epileptogenesis-like transcriptomic perturbation in the fly model. Gender differences are known to exist in neurological and psychiatric conditions including epileptogenesis. We describe here the effects of chronic PTZ in Drosophila females, and compare the results with the male model. As in males, chronic PTZ was found to cause a decreased climbing speed in females. In males, overrepresentation of Wnt, MAPK, TGF-beta, JAK-STAT, Cell communication, and Dorso-Ventral axis formation pathways in downregulated genes was previously described. Of these, female genes showed enrichment only for Dorso-Ventral axis formation. Surprisingly, the ribosomal pathway was uniquely overrepresented in genes downregulated in females. Gender differences thus exist in the Drosophila model. Gender neutral, the developmental pathway Dorso-Ventral axis formation may be considered as the candidate causal pathway in chronic pentylenetetrazole induced behavioral deficit. Prior evidence of developmental mechanisms in epileptogenesis may support potential usefulness of the fly model. Given this, gender specific pathways identified here may provide a lead for further understanding brain dimorphism in neuropsychiatric disorders.	[Sharma, Abhay; Mohammad, Farhan; Singh, Priyanka] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sharma, A (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi Univ Campus, Delhi, India.	abhaysharma@igib.res.in	Mohd, Farhan/E-7184-2019; Singh, Priyanka/GRF-6098-2022	Mohd, Farhan/0000-0002-2465-1508; Sharma, Abhay/0000-0003-1306-1497	Council of Scientific and Industrial Research (CSIR), Government of India [NWP0034]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The research was supported by NWP0034 grant of Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elliott RC, 2003, J NEUROSCI, V23, P2218; Lemmens EMP, 2005, EPILEPSIA, V46, P1603, DOI 10.1111/j.1528-1167.2005.00252.x; Mohammad F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-11; Nguon K, 2005, PROG BRAIN RES, V148, P343, DOI 10.1016/S0079-6123(04)48027-3; Nickel J, 2003, EPILEPSIA, V44, P1551, DOI 10.1111/j.0013-9580.2003.13603.x; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8136	10.1371/journal.pone.0008136	http://dx.doi.org/10.1371/journal.pone.0008136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956579	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828800027
J	Hu, JB; Li, JZ; Qian, XG; Denic, V; Sha, BD				Hu, Junbin; Li, Jingzhi; Qian, Xinguo; Denic, Vlad; Sha, Bingdong			The Crystal Structures of Yeast Get3 Suggest a Mechanism for Tail-Anchored Protein Membrane Insertion	PLOS ONE			English	Article							ATPASE; TRANSLOCATION; RECOGNITION	Tail-anchored (TA) proteins represent a unique class of membrane proteins that contain a single C-terminal transmembrane helix. The post-translational insertion of the yeast TA proteins into the ER membrane requires the Golgi ER trafficking (GET) complex which contains Get1, Get2 and Get3. Get3 is an ATPase that recognizes and binds the C-terminal transmembrane domain (TMD) of the TA proteins. We have determined the crystal structures of Get3 from two yeast species, S. cerevisiae and D. hansenii, respectively. These high resolution crystal structures show that Get3 contains a nucleotide-binding domain and a "finger'' domain for binding the TA protein TMD. A large hydrophobic groove on the finger domain of S. cerevisiae Get3 structure might represent the binding site for TMD of TA proteins. A hydrophobic helix from a symmetry-related Get3 molecule sits in the TMD-binding groove and mimics the TA binding scenario. Interestingly, the crystal structures of the Get3 dimers from S. cerevisiae and D. hansenii exhibit distinct conformations. The S. cerevisiae Get3 dimer structure does not contain nucleotides and maintains an "open'' conformation, while the D. hansenii Get3 dimer structure binds ADP and stays in a "closed'' conformation. We propose that the conformational changes to switch the Get3 between the open and closed conformations may facilitate the membrane insertions for TA proteins.	[Hu, Junbin; Li, Jingzhi; Qian, Xinguo; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Denic, Vlad] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	University of Alabama System; University of Alabama Birmingham; Harvard University	Hu, JB (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	bdsha@uab.edu			NIH [R01 DK56203, R01 GM65959]; Army Research Office [51894LS]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065959, R01GM080261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (R01 DK56203), NIH (R01 GM65959) and Army Research Office (51894LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hu JB, 2009, ACTA CRYSTALLOGR F, V65, P489, DOI [10.1107/S174430910901231, 10.1107/S1744309109012317]; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shi K, 2007, BIOCHEM BIOPH RES CO, V363, P626, DOI 10.1016/j.bbrc.2007.09.015; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; SULOWAY CJ, 2009, P NATL ACAD SCI US; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	25	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8061	10.1371/journal.pone.0008061	http://dx.doi.org/10.1371/journal.pone.0008061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956640	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828400015
J	Saraswathi, R; Chowdhury, RP; Williams, SM; Ghatak, P; Chatterji, D				Saraswathi, Ramachandran; Chowdhury, Rakhi Pait; Williams, Sunanda Margrett; Ghatak, Payel; Chatterji, Dipankar			The Mycobacterial MsDps2 Protein Is a Nucleoid-Forming DNA Binding Protein Regulated by Sigma Factors sigma(A) and sigma(B)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI DPS; SMEGMATIS DPS; BACTERIA; MUTANTS; PROTECTION; SURVIVAL	The Dps (DNA-binding protein from starved cells) proteins from Mycobacterium smegmatis MsDps1 and MsDps2 are both DNA-binding proteins with some differences. While MsDps1 has two oligomeric states, with one of them responsible for DNA binding, MsDps2 has only one DNA-binding oligomeric state. Both the proteins however, show iron-binding activity. The MsDps1 protein has been shown previously to be induced under conditions of starvation and osmotic stress and is regulated by the extra cellular sigma factors sigma(H) and sigma(F). We show here, that the second Dps homologue in M. smegmatis, namely MsDps2, is purified in a DNA-bound form and exhibits nucleoid-like structures under the atomic force microscope. It appears that the N-terminal sequence of Dps2 plays a role in nucleoid formation. MsDps2, unlike MsDps1, does not show elevated expression in nutritionally starved or stationary phase conditions; rather its promoter is recognized by RNA polymerase containing sigma(A) or sigma(B), under in vitro conditions. We propose that due to the nucleoid-condensing ability, the expression of MsDps2 is tightly regulated inside the cells.	[Saraswathi, Ramachandran; Chowdhury, Rakhi Pait; Williams, Sunanda Margrett; Ghatak, Payel; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Saraswathi, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in		Chatterji, Dipankar/0000-0002-9985-0632	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work is financially supported by the Department of Biotechnology and Department of Science and Technology, Government of India. R. S. and R. P. C are supported by a senior research fellowship and S. M. W. is supported by a junior research fellowship from the Council of Scientific and Industrial Research, government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Ceci P, 2005, J BIOL CHEM, V280, P34776, DOI 10.1074/jbc.M502343200; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Chowdhury RP, 2007, BIOPHYS CHEM, V128, P19, DOI 10.1016/j.bpc.2007.02.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEONG LM, 1992, ANAL BIOCHEM, V207, P317, DOI 10.1016/0003-2697(92)90018-3; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Roy S, 2007, J MOL BIOL, V370, P752, DOI 10.1016/j.jmb.2007.05.004; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8017	10.1371/journal.pone.0008017	http://dx.doi.org/10.1371/journal.pone.0008017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956571	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400003
J	Liu, P; Lu, MP; Tian, B; Li, K; Garofalo, RP; Prusak, D; Wood, TG; Brasier, AR				Liu, Ping; Lu, Muping; Tian, Bing; Li, Kui; Garofalo, Roberto P.; Prusak, Deborah; Wood, Thomas G.; Brasier, Allan R.			Expression of an IKK gamma Splice Variant Determines IRF3 and Canonical NF-kappa B Pathway Utilization in ssRNA Virus Infection	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; RIG-I; TRANSCRIPTION FACTOR; ANTIVIRAL RESPONSE; GENE-EXPRESSION; NEMO/IKK-GAMMA; INTERFERON; ACTIVATION; COMPONENT; IDENTIFICATION	Single stranded RNA (ssRNA) virus infection activates the retinoic acid inducible gene I (RIG-I)-mitochondrial antiviral signaling (MAVS) complex, a complex that coordinates the host innate immune response via the NF-kappa B and IRF3 pathways. Recent work has shown that the I kappa B kinase (IKK)gamma scaffolding protein is the final common adapter protein required by RIG-I.MAVS to activate divergent rate-limiting kinases downstream controlling the NF-kappa B and IRF3 pathways. Previously we discovered a ubiquitous IKK gamma splice-variant, IKK gamma Delta, that exhibits distinct signaling properties. Methodology/Principal Findings: We examined the regulation and function of IKK gamma splice forms in response to ssRNA virus infection, a condition that preferentially induces full length IKK gamma-WT mRNA expression. In IKK gamma Delta-expressing cells, we found increased viral translation and cytopathic effect compared to those expressing full length IKK gamma-WT. IKK gamma Delta fails to support viral-induced IRF3 activation in response to ssRNA infections; consequently type I IFN production and the induction of antiviral interferon stimulated genes (ISGs) are significantly attenuated. By contrast, ectopic RIG-I.MAVS or TNF alpha-induced canonical NF-kappa B activation is preserved in IKK gamma Delta expressing cells. Increasing relative levels of IKK gamma-WT to IKK gamma Delta (while keeping total IKK gamma constant) results in increased type I IFN expression. Conversely, overexpressing IKK gamma Delta (in a background of constant IKK gamma-WT expression) shows IKK gamma Delta functions as a dominant-negative IRF3 signaling inhibitor. IKK gamma Delta binds both IKK-alpha and beta, but not TANK and IKK epsilon, indicating that exon 5 encodes an essential TANK binding domain. Finally, IKK gamma Delta displaces IKK gamma WT from MAVS explaining its domainant negative effect. Conclusions/Significance: Relative endogenous IKK gamma Delta expression affects cellular selection of inflammatory/anti-viral pathway responses to ssRNA viral infection.	[Liu, Ping; Lu, Muping; Tian, Bing; Brasier, Allan R.] UTMB, Dept Med, Galveston, TX USA; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Garofalo, Roberto P.] UTMB, Dept Pediat, Galveston, TX USA; [Garofalo, Roberto P.; Prusak, Deborah; Wood, Thomas G.; Brasier, Allan R.] UTMB, Sealy Ctr Mol Med, Galveston, TX USA; [Wood, Thomas G.] UTMB, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Liu, P (corresponding author), UTMB, Dept Med, Galveston, TX USA.	arbrasie@utmb.edu	Wood, Thomas/GWZ-2481-2022; Wood, Thomas/B-6172-2012; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Wood, Thomas/0000-0001-8962-8571; Brasier, Allan/0000-0002-5012-4090	NHLBI Proteomics Technologies in Airway Inflammation [N01-HV-28184]; NIEHS [P30 ES06676];  [P01 AI062885];  [RO1 GM086885]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	NHLBI Proteomics Technologies in Airway Inflammation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by P01 AI062885 (to A. R. B.), RO1 GM086885 and NHLBI Proteomics Technologies in Airway Inflammation (N01-HV-28184). Core Laboratory support was from NIEHS grant P30 ES06676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; BRASIER AR, 1990, CURRENT PROTOCOLS MO; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hai T, 2006, J VIROL, V80, P4227, DOI 10.1128/JVI.80.9.4227-4241.2006; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lehtonen A, 1997, J IMMUNOL, V159, P794; Li Kui, 2009, V510, P211, DOI 10.1007/978-1-59745-394-3_16; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; OSHIUMI H, 2008, J BIOL CHEM; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Smieja J, 2008, BIOINFORMATICS, V24, P2363, DOI 10.1093/bioinformatics/btn400; TENBERG R, 1980, HYPERTENSION, V2, P4, DOI 10.1161/01.HYP.2.1.4; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; TIAN B, 2005, LANDES BIOSCIENCE; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	47	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8079	10.1371/journal.pone.0008079	http://dx.doi.org/10.1371/journal.pone.0008079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956647	Green Submitted, gold, Green Published			2022-12-27	WOS:000272828100016
J	Fowler, DW; Freedman, EA; Scannella, JB				Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.			Predatory Functional Morphology in Raptors: Interdigital Variation in Talon Size Is Related to Prey Restraint and Immobilisation Technique	PLOS ONE			English	Article							BEHAVIOR; BIRDS; PHYLOGENY; KESTRELS; ACCIPITRIDAE; FOOT; AVES	Despite the ubiquity of raptors in terrestrial ecosystems, many aspects of their predatory behaviour remain poorly understood. Surprisingly little is known about the morphology of raptor talons and how they are employed during feeding behaviour. Talon size variation among digits can be used to distinguish families of raptors and is related to different techniques of prey restraint and immobilisation. The hypertrophied talons on digits (D) I and II in Accipitridae have evolved primarily to restrain large struggling prey while they are immobilised by dismemberment. Falconidae have only modest talons on each digit and only slightly enlarged D-I and II. For immobilisation, Falconini rely more strongly on strike impact and breaking the necks of their prey, having evolved a 'tooth' on the beak to aid in doing so. Pandionidae have enlarged, highly recurved talons on each digit, an adaptation for piscivory, convergently seen to a lesser extent in fishing eagles. Strigiformes bear enlarged talons with comparatively low curvature on each digit, part of a suite of adaptations to increase constriction efficiency by maximising grip strength, indicative of specialisation on small prey. Restraint and immobilisation strategy change as prey increase in size. Small prey are restrained by containment within the foot and immobilised by constriction and beak attacks. Large prey are restrained by pinning under the bodyweight of the raptor, maintaining grip with the talons, and immobilised by dismemberment (Accipitridae), or severing the spinal cord (Falconini). Within all raptors, physical attributes of the feet trade off against each other to attain great strength, but it is the variable means by which this is achieved that distinguishes them ecologically. Our findings show that interdigital talon morphology varies consistently among raptor families, and that this is directly correlative with variation in their typical prey capture and restraint strategy.	[Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Fowler, DW (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	df9465@yahoo.co.uk	Freedman, Elizabeth/J-1752-2012	Freedman, Elizabeth/0000-0002-5763-5272; Fowler, Denver/0000-0001-9188-4371	Museum of the Rockies graduate student fund	Museum of the Rockies graduate student fund	Support for the Museum of the Rockies graduate student fund was provided by Damaris Waggoner and David Sands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANFORD WT, 1895, BIRDS, V3; BOND RICHARD M., 1942, WILSON BULL, V54, P81; BOND RICHARD M., 1936, CONDOR, V38, P72, DOI 10.2307/1363552; Csermely D, 1998, CONDOR, V100, P757, DOI 10.2307/1369762; CSERMELY D, 1989, B ZOOL, V56, P317; CSERMELY D, 1993, B ZOOL, V60, P211, DOI 10.1080/11250009309355812; Csermely D, 2003, J ETHOL, V21, P107, DOI 10.1007/s10164-002-0083-6; Csermely D, 1998, J AVIAN BIOL, V29, P10, DOI 10.2307/3677335; Csermely D, 2002, ITAL J ZOOL, V69, P239, DOI 10.1080/11250000209356466; Csermely D, 2006, ITAL J ZOOL, V73, P43, DOI 10.1080/11250000500502368; Csermely Davide, 1994, Avocetta, V18, P63; Einoder L, 2007, EMU, V107, P223, DOI 10.1071/MU06019; Einoder L, 2006, IBIS, V148, P515, DOI 10.1111/j.1474-919X.2006.00541.x; Einoder LD, 2007, AUK, V124, P773, DOI 10.1642/0004-8038(2007)124[773:AOTHMO]2.0.CO;2; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; GOSLOW GE, 1971, AUK, V88, P815, DOI 10.2307/4083840; GOSLOW GE, 1972, AUK, V89, P47, DOI 10.2307/4084059; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Griffiths CS, 2004, MOL PHYLOGENET EVOL, V32, P101, DOI 10.1016/j.ympev.2003.11.019; GRZIMEK B, 2002, BIRDS, V1; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harris T., 1984, P 2 S AFR PRED BIRDS, P195; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Newton I., 1986, SPARROWHAWK; PETERS DS, 1992, SCI SERIES NATURAL H, P29; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; RUDEBECK G, 1950, OIKOS, V2, P65, DOI 10.2307/3564663; RUDEBECK G, 1951, OIKOS, V3, P200, DOI 10.2307/3565185; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Ward AB, 2002, AUK, V119, P1052, DOI 10.1642/0004-8038(2002)119[1052:FMORHI]2.0.CO;2; [No title captured]	38	61	64	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7999	10.1371/journal.pone.0007999	http://dx.doi.org/10.1371/journal.pone.0007999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946365	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800011
J	Flores, LG; Bertolini, S; Yeh, HH; Young, D; Mukhopadhyay, U; Pal, A; Ying, YM; Volgin, A; Shavrin, A; Soghomonyan, S; Tong, W; Bornmann, W; Alauddin, MM; Logsdon, C; Gelovani, JG				Flores, Leo Garcia; Bertolini, Susanna; Yeh, Hsin Hsin; Young, Daniel; Mukhopadhyay, Uday; Pal, Ashutosh; Ying, Yunming; Volgin, Andrei; Shavrin, Aleksandr; Soghomonyan, Suren; Tong, William; Bornmann, William; Alauddin, Mian M.; Logsdon, Craig; Gelovani, Juri G.			Detection of Pancreatic Carcinomas by Imaging Lactose-Binding Protein Expression in Peritumoral Pancreas Using [F-18]Fluoroethyl-Deoxylactose PET/CT	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; DUCTAL ADENOCARCINOMA; FAMILY-HISTORY; HIGH-RISK; CANCER; HIP/PAP; HEPATOCARCINOMA; MANAGEMENT; BIOMARKER; PEPTIDE	Background: Early diagnosis of pancreatic carcinoma with highly sensitive diagnostic imaging methods could save lives of many thousands of patients, because early detection increases resectability and survival rates. Current non-invasive diagnostic imaging techniques have inadequate resolution and sensitivity for detection of small size (similar to 2-3 mm) early pancreatic carcinoma lesions. Therefore, we have assessed the efficacy of positron emission tomography and computer tomography (PET/CT) imaging with beta-O-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[F-18]fluoroethyl-D-glucopyranose ([F-18]FEDL) for detection of less than 3 mm orthotopic xenografts of L3.6pl pancreatic carcinomas in mice. [F-18]FEDL is a novel radioligand of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP), which is overexpressed in peritumoral pancreatic acinar cells. Methodology/Principal Findings: Dynamic PET/CT imaging demonstrated rapid accumulation of [F-18]FEDL in peritumoral pancreatic tissue (4.04+/-2.06%ID/g), bi-exponential blood clearance with half-lives of 1.65+/-0.50 min and 14.14+/-3.60 min, and rapid elimination from other organs and tissues, predominantly by renal clearance. Using model-independent graphical analysis of dynamic PET data, the average distribution volume ratio (DVR) for [F-18]FEDL in peritumoral pancreatic tissue was estimated as 3.57+/-0.60 and 0.94+/-0.72 in sham-operated control pancreas. Comparative analysis of quantitative autoradiographic images and densitometry of immunohistochemically stained and co-registered adjacent tissue sections demonstrated a strong linear correlation between the magnitude of [F-18]FEDL binding and HIP/PAP expression in corresponding regions (r = 0.88). The in situ analysis demonstrated that at least a 2-4 fold apparent lesion size amplification was achieved for submillimeter tumors and to nearly half a murine pancreas for tumors larger than 3 mm. Conclusion/Significance: We have demonstrated the feasibility of detection of early pancreatic tumors by non-invasive imaging with [F-18]FEDL PET/CT of tumor biomarker HIP/PAP over-expressed in peritumoral pancreatic tissue. Non-invasive non-invasive detection of early pancreatic carcinomas with [F-18]FEDL PET/CT imaging should aid the guidance of biopsies and additional imaging procedures, facilitate the resectability and improve the overall prognosis.	[Flores, Leo Garcia; Bertolini, Susanna; Yeh, Hsin Hsin; Young, Daniel; Mukhopadhyay, Uday; Pal, Ashutosh; Volgin, Andrei; Shavrin, Aleksandr; Soghomonyan, Suren; Tong, William; Alauddin, Mian M.; Gelovani, Juri G.] Univ Texas MD Anderson Canc Ctr, CABIR, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ying, Yunming; Bornmann, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Flores, LG (corresponding author), Univ Texas MD Anderson Canc Ctr, CABIR, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	jgelovani@mdanderson.org		Soghomonyan, Suren/0000-0001-5930-9051	NIH [U24 CA126577-01]; University of Texas, MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [U24CA126577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas, MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant U24 CA126577-01 (JG) and new research program development funds of Drs. Juri G. Gelovani and Mian M. Alauddin, provided by the University of Texas, MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormans G, 2001, J LABELLED COMPD RAD, V44, P417, DOI 10.1002/jlcr.471; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cerwenka H, 2001, ANTICANCER RES, V21, P1471; Chakrabarti A, 2007, CANCER BIOL THER, V6, P948, DOI 10.4161/cbt.6.6.4191; Christa L, 1999, AM J PATHOL, V155, P1525, DOI 10.1016/S0002-9440(10)65468-5; CHRISTA L, 1994, FEBS LETT, V337, P114, DOI 10.1016/0014-5793(94)80640-3; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Evans Douglas B., 1997, P1054; Fukushima N, 2005, MODERN PATHOL, V18, P779, DOI 10.1038/modpathol.3800337; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Goggins M, 2000, J SURG ONCOL, V74, P243, DOI 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C; Gold DV, 2008, CANCER RES, V68, P4819, DOI 10.1158/0008-5472.CAN-08-0232; Gold DV, 2006, J CLIN ONCOL, V24, P252, DOI 10.1200/JCO.2005.02.8282; Hervieu V, 2006, HUM PATHOL, V37, P1066, DOI 10.1016/j.humpath.2006.03.005; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Hruban RH, 2001, DIGEST DIS, V19, P76, DOI 10.1159/000050656; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Lal G, 2000, CANCER RES, V60, P409; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Motoo Y, 2001, PANCREATOLOGY, V1, P43, DOI 10.1159/000055791; Nakashima A, 2009, PANCREAS, V38, P527, DOI 10.1097/MPA.0b013e3181a16d28; *NAT CANC I N, PANCR CANC; Nishii R, 2008, EUR J NUCL MED MOL I, V35, P990, DOI 10.1007/s00259-007-0649-1; Ohuchida K, 2006, CLIN CANCER RES, V12, P2066, DOI 10.1158/1078-0432.CCR-05-1821; Pakzad F, 2006, SEMIN NUCL MED, V36, P248, DOI 10.1053/j.semnuclmed.2006.03.005; Rosty C, 2002, CANCER RES, V62, P1868; Rulyak SJ, 2003, GASTROENTEROLOGY, V124, P1292, DOI 10.1016/S0016-5085(03)00272-5; Simon MT, 2003, FASEB J, V17, P1441, DOI 10.1096/fj.02-1013com; Xie MJ, 2003, DIGEST DIS SCI, V48, P459, DOI 10.1023/A:1022520212447; Yamaguchi K, 2005, WORLD J GASTROENTERO, V11, P5199; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Yeo CJ, 1997, ANN SURG, V226, P257; YING Y, 2009, J MED CHEM IN PRESS; Yokoi K, 2005, INT J ONCOL, V27, P1361	37	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7977	10.1371/journal.pone.0007977	http://dx.doi.org/10.1371/journal.pone.0007977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956730	Green Published, gold, Green Submitted			2022-12-27	WOS:000272827500008
J	Haley, NJ; Mathiason, CK; Zabel, MD; Telling, GC; Hoover, EA				Haley, Nicholas J.; Mathiason, Candace K.; Zabel, Mark D.; Telling, Glenn C.; Hoover, Edward A.			Detection of Sub-Clinical CWD Infection in Conventional Test-Negative Deer Long after Oral Exposure to Urine and Feces from CWD plus Deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ROCKY-MOUNTAIN ELK; BOVINE SPONGIFORM ENCEPHALOPATHY; CERVUS-ELAPHUS-NELSONI; CAPTIVE MULE DEER; ODOCOILEUS-HEMIONUS; PRION PROTEIN; CYCLIC AMPLIFICATION; PRP ACCUMULATION; LYMPHOID-TISSUES	Background: Chronic wasting disease (CWD) of cervids is a prion disease distinguished by high levels of transmissibility, wherein bodily fluids and excretions are thought to play an important role. Using cervid bioassay and established CWD detection methods, we have previously identified infectious prions in saliva and blood but not urine or feces of CWD+ donors. More recently, we identified very low concentrations of CWD prions in urine of deer by cervid PrP transgenic (Tg[CerPrP]) mouse bioassay and serial protein misfolding cyclic amplification (sPMCA). This finding led us to examine further our initial cervid bioassay experiments using sPMCA. Objectives: We sought to investigate whether conventional test-negative deer, previously exposed orally to urine and feces from CWD+ sources, may be harboring low level CWD infection not evident in the 19 month observation period. We further attempted to determine the peripheral PrPCWD distribution in these animals. Methods: Various neural and lymphoid tissues from conventional test-negative deer were reanalyzed for CWD prions by sPMCA and cervid transgenic mouse bioassay in parallel with appropriate tissue-matched positive and negative controls. Results: PrPCWD was detected in the tissues of orally exposed deer by both sPMCA and Tg[CerPrP] mouse bioassay; each assay revealed very low levels of CWD prions previously undetectable by western blot, ELISA, or IHC. Serial PMCA analysis of individual tissues identified that obex alone was positive in 4 of 5 urine/feces exposed deer. PrPCWD was amplified from both lymphoid and neural tissues of positive control deer but not from identical tissues of negative control deer. Discussion: Detection of subclinical infection in deer orally exposed to urine and feces (1) suggests that a prolonged subclinical state can exist, necessitating observation periods in excess of two years to detect CWD infection, and (2) illustrates the sensitive and specific application of sPMCA in the diagnosis of low-level prion infection. Based on these results, it is possible that low doses of prions, e. g. following oral exposure to urine and saliva of CWD-infected deer, bypass significant amplification in the LRS, perhaps utilizing a neural conduit between the alimentary tract and CNS, as has been demonstrated in some other prion diseases.	[Haley, Nicholas J.; Mathiason, Candace K.; Zabel, Mark D.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Telling, Glenn C.] Univ Kentucky, Dept Mol Biol & Genet, Lexington, KY USA	Colorado State University; University of Kentucky	Haley, NJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@colostate.edu	Telling, Glenn C/G-1217-2019; Mathiason, Candace K/E-7843-2017; Mathiason, Candace/H-9769-2017	Telling, Glenn C/0000-0002-6294-1805; Mathiason, Candace K/0000-0002-5920-4556; Mathiason, Candace/0000-0002-5920-4556	NIH/NCRR [T32 R07072-03]; NIH/NIAID [NO1-AI-25491-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR Ruth L. Kirschstein Institutional T32 R07072-03 and NIH/NIAID NO1-AI-25491-02 (EAH, GCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIMI U, 2008, PMCA BANK VOLES UPDA; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; [Anonymous], Chronic Wasting Disease; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hibler CP, 2003, J VET DIAGN INVEST, V15, P311, DOI 10.1177/104063870301500402; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 2003, J VET DIAGN INVEST, V15, P320, DOI 10.1177/104063870301500403; Peters J, 2000, J VET DIAGN INVEST, V12, P579, DOI 10.1177/104063870001200618; Race BL, 2007, EMERG INFECT DIS, V13, P824, DOI 10.3201/eid1306.070186; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Spraker TR, 2004, VET REC, V155, P295, DOI 10.1136/vr.155.10.295; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Wells GAH, 2003, VET RES COMMUN, V27, P25, DOI 10.1023/B:VERC.0000014113.44151.04; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe LL, 2007, J GEN VIROL, V88, P2078, DOI 10.1099/vir.0.82342-0; MICHIGANS 1 CASE CHR; POSITIVE CASE CWD FO	49	92	94	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7990	10.1371/journal.pone.0007990	http://dx.doi.org/10.1371/journal.pone.0007990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956732	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500020
J	Mavromatis, K; Chu, K; Ivanova, N; Hooper, SD; Markowitz, VM; Kyrpides, NC				Mavromatis, Konstantinos; Chu, Ken; Ivanova, Natalia; Hooper, Sean D.; Markowitz, Victor M.; Kyrpides, Nikos C.			Gene Context Analysis in the Integrated Microbial Genomes (IMG) Data Management System	PLOS ONE			English	Article							PROTEIN FAMILIES; FUSION EVENTS	Computational methods for determining the function of genes in newly sequenced genomes have been traditionally based on sequence similarity to genes whose function has been identified experimentally. Function prediction methods can be extended using gene context analysis approaches such as examining the conservation of chromosomal gene clusters, gene fusion events and co-occurrence profiles across genomes. Context analysis is based on the observation that functionally related genes are often having similar gene context and relies on the identification of such events across phylogenetically diverse collection of genomes. We have used the data management system of the Integrated Microbial Genomes (IMG) as the framework to implement and explore the power of gene context analysis methods because it provides one of the largest available genome integrations. Visualization and search tools to facilitate gene context analysis have been developed and applied across all publicly available archaeal and bacterial genomes in IMG. These computations are now maintained as part of IMG's regular genome content update cycle. IMG is available at: http://img.jgi.doe.gov.	[Mavromatis, Konstantinos; Ivanova, Natalia; Hooper, Sean D.; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Genome Biol Program, Walnut Creek, CA USA; [Chu, Ken; Markowitz, Victor M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mavromatis, K (corresponding author), Joint Genome Inst, Dept Energy, Genome Biol Program, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]	US Department of Energy(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pD273, DOI 10.1093/nar/gkh053; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Van Dongen SM, 2000, THESIS U UTRECHT NET; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	18	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7979	10.1371/journal.pone.0007979	http://dx.doi.org/10.1371/journal.pone.0007979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956731	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827500010
J	Oliveri, M; Bonni, S; Turriziani, P; Koch, G; Lo Gerfo, E; Torriero, S; Vicario, CM; Petrosini, L; Caltagirone, C				Oliveri, Massimiliano; Bonni, Sonia; Turriziani, Patrizia; Koch, Giacomo; Lo Gerfo, Emanuele; Torriero, Sara; Vicario, Carmelo Mario; Petrosini, Laura; Caltagirone, Carlo			Motor and Linguistic Linking of Space and Time in the Cerebellum	PLOS ONE			English	Article							PREMOTOR CORTEX; MAGNETIC STIMULATION; HUNTINGTONS-DISEASE; PARIETAL CORTEX; FUTURE; FMRI; PERCEPTION; LANGUAGE; REPRESENTATION; MODULATION	Background: Recent literature documented the presence of spatial-temporal interactions in the human brain. The aim of the present study was to verify whether representation of past and future is also mapped onto spatial representations and whether the cerebellum may be a neural substrate for linking space and time in the linguistic domain. We asked whether processing of the tense of a verb is influenced by the space where response takes place and by the semantics of the verb. Principal Findings: Responses to past tense were facilitated in the left space while responses to future tense were facilitated in the right space. Repetitive transcranial magnetic stimulation (rTMS) of the right cerebellum selectively slowed down responses to future tense of action verbs; rTMS of both cerebellar hemispheres decreased accuracy of responses to past tense in the left space and to future tense in the right space for non-verbs, and to future tense in the right space for state verbs. Conclusions: The results suggest that representation of past and future is mapped onto spatial formats and that motor action could represent the link between spatial and temporal dimensions. Right cerebellar, left motor brain networks could be part of the prospective brain, whose primary function is to use past experiences to anticipate future events. Both cerebellar hemispheres could play a role in establishing the grammatical rules for verb conjugation.			Oliveri, M (corresponding author), Univ Palermo, Dipartimento Psicol, Palermo, Italy.	maxoliveri@unipa.it	Caltagirone, Carlo/B-4930-2013; Oliveri, Massimiliano/HDO-5602-2022; VICARIO, CARMELO/AAR-2521-2021; Koch, Giacomo/G-3155-2012	Lo Gerfo, Emanuele/0000-0003-1296-415X; Turriziani, Patrizia/0000-0003-4802-280X				Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Bortolini U., 1972, LESSICO FREQUENZA LI; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Frassinetti F, 2009, PSYCHOL SCI, V20, P949, DOI 10.1111/j.1467-9280.2009.02390.x; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Kemmerer D, 2005, NEUROPSYCHOLOGIA, V43, P797, DOI 10.1016/j.neuropsychologia.2004.06.025; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Lo Gerfo E, 2008, NEUROPSYCHOLOGIA, V46, P764, DOI 10.1016/j.neuropsychologia.2007.10.012; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Oliveri M, 2009, NEUROIMAGE, V46, P1173, DOI 10.1016/j.neuroimage.2009.03.042; Oliveri M, 2009, EXP BRAIN RES, V195, P489, DOI 10.1007/s00221-009-1834-1; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Schubotz RI, 2002, COGNITIVE BRAIN RES, V14, P357, DOI 10.1016/S0926-6410(02)00138-6; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Shin JC, 2003, J COGNITIVE NEUROSCI, V15, P1232, DOI 10.1162/089892903322598175; SILVERI MC, 1994, NEUROLOGY, V44, P2047, DOI 10.1212/WNL.44.11.2047; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Teichmann M, 2005, BRAIN, V128, P1155, DOI 10.1093/brain/awh472; Teichmann M, 2006, J COGNITIVE NEUROSCI, V18, P1555, DOI 10.1162/jocn.2006.18.9.1555; Theoret H, 2001, NEUROSCI LETT, V306, P29, DOI 10.1016/S0304-3940(01)01860-2; TORRIERO S, 2008, J COGNITIVE NEUROSCI, V9, P1656; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario CM, 2007, BRAIN COGNITION, V64, P68, DOI 10.1016/j.bandc.2006.12.002; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7933	10.1371/journal.pone.0007933	http://dx.doi.org/10.1371/journal.pone.0007933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NL	19936216	gold, Green Published, Green Submitted			2022-12-27	WOS:000272004800014
J	Pitteri, SJ; JeBailey, L; Faca, VM; Thorpe, JD; Silva, MA; Ireton, RC; Horton, MB; Wang, H; Pruitt, LC; Zhang, Q; Cheng, KH; Urban, N; Hanash, SM; Dinulescu, DM				Pitteri, Sharon J.; JeBailey, Lellean; Faca, Vitor M.; Thorpe, Jason D.; Silva, Melissa A.; Ireton, Renee C.; Horton, Marc B.; Wang, Hong; Pruitt, Liese C.; Zhang, Qing; Cheng, Kuang H.; Urban, Nicole; Hanash, Samir M.; Dinulescu, Daniela M.			Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; GROWTH-FACTOR-BETA; QUANTITATIVE-ANALYSIS; STATISTICAL-MODEL; CARCINOMA-CELLS; ANALYSIS-SYSTEM; MOUSE MODEL; K-RAS; EXPRESSION; SERUM	Background: The complexity of the human plasma proteome represents a substantial challenge for biomarker discovery. Proteomic analysis of genetically engineered mouse models of cancer and isolated cancer cells and cell lines provide alternative methods for identification of potential cancer markers that would be detectable in human blood using sensitive assays. The goal of this work is to evaluate the utility of an integrative strategy using these two approaches for biomarker discovery. Methodology/Principal Findings: We investigated a strategy that combined quantitative plasma proteomics of an ovarian cancer mouse model with analysis of proteins secreted or shed by human ovarian cancer cells. Of 106 plasma proteins identified with increased levels in tumor bearing mice, 58 were also secreted or shed from ovarian cancer cells. The remainder consisted primarily of host-response proteins. Of 25 proteins identified in the study that were assayed, 8 mostly secreted proteins common to mouse plasma and human cancer cells were significantly upregulated in a set of plasmas from ovarian cancer patients. Five of the eight proteins were confirmed to be upregulated in a second independent set of ovarian cancer plasmas, including in early stage disease. Conclusions/Significance: Integrated proteomic analysis of cancer mouse models and human cancer cell populations provides an effective approach to identify potential circulating protein biomarkers.			Pitteri, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	shanash@fhcrc.org; ddinulescu@rics.bwh.harvard.edu	Faça, Vitor M/A-3989-2013	Horton, Marc/0000-0002-9266-9611; FACA, VITOR MARCEL/0000-0003-3205-7944; Pitteri, Sharon/0000-0002-3119-873X	NATIONAL CANCER INSTITUTE [P50CA105009, P50CA083636, U01CA084301] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA83636, P50 CA105009, P50 CA083636, U01 CA084301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aunoble B, 2000, INT J ONCOL, V16, P567; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Bast RC., 2003, J CLIN ONCOL, V21, P200, DOI [10.1200/JCO.2003.01.068, DOI 10.1200/JCO.2003.01.068]; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bengtsson S, 2007, J PROTEOME RES, V6, P1440, DOI 10.1021/pr060593y; Bignotti E, 2007, AM J OBSTET GYNECOL, V196, P245, DOI 10.1016/j.ajog.2006.10.874; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Catasus L, 2004, HUM PATHOL, V35, P1360, DOI 10.1016/j.humpath.2004.07.019; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; Flyvbjerg A, 1997, J CLIN ENDOCR METAB, V82, P2308, DOI 10.1210/jc.82.7.2308; Fontana A, 2005, INT J CANCER, V116, P686, DOI 10.1002/ijc.20584; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; GADDUCCI A, 1995, GYNECOL ONCOL, V58, P184, DOI 10.1006/gyno.1995.1207; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gilks CB, 2005, GYNECOL ONCOL, V96, P684, DOI 10.1016/j.ygyno.2004.11.039; Gleave M, 2003, ANN NY ACAD SCI, V1002, P95, DOI 10.1196/annals.1281.020; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hellstrom I, 2003, CANCER RES, V63, P3695; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; Hirano S, 2004, EUR J GYNAECOL ONCOL, V25, P187; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jiang Xiao-Ting, 2004, Hepatobiliary Pancreat Dis Int, V3, P464; Jones MB, 2003, GYNECOL ONCOL, V88, pS136, DOI 10.1006/gyno.2002.6704; Katano K, 2002, CANCER RES, V62, P6559; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kolasa IK, 2006, GYNECOL ONCOL, V103, P692, DOI 10.1016/j.ygyno.2006.05.007; KUK C, 2008, MOL CELL PROTEOMICS; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kutteh WH, 1996, J SOC GYNECOL INVEST, V3, P216, DOI 10.1016/1071-5576(96)00013-5; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mathieu A, 2004, CANCER-AM CANCER SOC, V101, P1908, DOI 10.1002/cncr.20571; Maxwell P, 1999, CANCER LETT, V139, P121, DOI 10.1016/S0304-3835(99)00009-9; Minagawa Y, 1999, JPN J CANCER RES, V90, P1373, DOI 10.1111/j.1349-7006.1999.tb00722.x; Mourskaia AA, 2007, ANTI-CANCER AGENT ME, V7, P504, DOI 10.2174/187152007781668689; NATHAN FE, 1994, CANCER, V73, P2853, DOI 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Nishio R., 2003, International Urology and Nephrology, V35, P189, DOI 10.1023/B:UROL.0000020306.08275.49; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Pauli C, 2002, ANTICANCER RES, V22, P3093; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Pupa SM, 2007, CANCER RES, V67, P4271, DOI 10.1158/0008-5472.CAN-06-4162; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sharma S, 2007, CLIN CANCER RES, V13, P5889, DOI 10.1158/1078-0432.CCR-07-0703; Tamakoshi K, 1996, GYNECOL ONCOL, V62, P67, DOI 10.1006/gyno.1996.0191; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vallier L, 2005, STEM CELL REV, V1, P119, DOI 10.1385/SCR:1:2:119; VOLBERG T, 1995, J CELL SCI, V108, P2253; Wakefield LM, 2007, CANCER CELL, V12, P293, DOI 10.1016/j.ccr.2007.10.002; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Wang HX, 2002, ELECTROPHORESIS, V23, P3168, DOI 10.1002/1522-2683(200209)23:18<3168::AID-ELPS3168>3.0.CO;2-A; Wang WJ, 2007, ANAL CHEM, V79, P1002, DOI 10.1021/ac061613i; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016	77	52	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7916	10.1371/journal.pone.0007916	http://dx.doi.org/10.1371/journal.pone.0007916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936259	Green Submitted, gold, Green Published			2022-12-27	WOS:000272004600018
J	Vijay, S; Swaminathan, S; Vaidyanathan, P; Thomas, A; Chauhan, LS; Kumar, P; Chiddarwar, S; Thomas, B; Dewan, PK				Vijay, Sophia; Swaminathan, Soumya; Vaidyanathan, Preetish; Thomas, Aleyamma; Chauhan, L. S.; Kumar, Prahlad; Chiddarwar, Sonali; Thomas, Beena; Dewan, Puneet K.			Feasibility of Provider-Initiated HIV Testing and Counselling of Tuberculosis Patients Under the TB Control Programme in Two Districts of South India	PLOS ONE			English	Article							THAILAND; CARE	Background: Provider-initiated HIV testing and counselling (PITC) is internationally recommended for tuberculosis (TB) patients, but the feasibility, effectiveness, and impact of this policy on the TB programme in India are unknown. We evaluated PITC of TB patients across two districts in India considered to have generalized HIV epidemics, Tiruchirappalli (population 2.5 million) and Mysore (population 2.8 million). Methodology/Principal Findings: Starting June 2007, healthcare providers in both districts were instructed to ascertain HIV status for all TB patients, and refer those with unknown HIV status to the nearest Integrated Counselling and Testing Centre (ICTC)-often in the same facility-for counselling and voluntary HIV testing. All TB patients registered from June 2007 to March 2008 were followed prospectively. Field investigators assessed PITC practices and abstracted data from routine TB programme records and HIV counselling registers to determine the proportion of TB patients appropriately evaluated for HIV infection. Patient records were traced to determine the efficiency of referral links to HIV care and antiretroviral treatment (ART). Between July 2007 and March 2008, 5299 TB patients were registered in both study districts. Of the 4701 with unknown HIV status at the time of TB treatment initiation, 3368 (72%) were referred to an ICTC, and 3111 (66%) were newly tested for HIV. PITC implementation resulted in the ascertainment of HIV status for 3709/5299 (70%) of TB patients, and detected 200 cases with previously undiagnosed HIV infection. Overall, 468 (8.8%) of all registered TB patients were HIV-infected; 177 (37%) were documented to have also received any ART. Conclusions: With implementation of PITC in India, HIV status was successfully ascertained for 70% of TB patients. Previously undiagnosed HIV-infection was detected in 6.4% of those TB patients newly tested, enabling referral for life-saving anti-retroviral treatment. ART uptake, however, was poor, suggesting that PITC implementation should include measures to strengthen and support ART referral, evaluation, and initiation.			Vijay, S (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.	nti@ntiindia.org.in	chiddarwar, shital/N-5471-2015	chiddarwar, shital/0000-0001-8078-6573				[Anonymous], 2007, MANUAL ESTIMATING NA; *CENTR TB DIV, 2009, RNTCP PERF REP IND 4; Chakaya JM, 2008, INT J TUBERC LUNG D, V12, P424; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; *GOV IND MIN HLTH, 2008, HIV SENT SURV HIV ES; *GOV IND MIN HLTH, 2008, NAT FRAM JOINT TB HI; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Jerene Degu, 2007, BMC Int Health Hum Rights, V7, P4, DOI 10.1186/1472-698X-7-4; *NAT AIDS CONTR OR, 2007, ANT TREATM GUID AD A; *NAT AIDS CONTR OR, 2008, UNGASS COUNTR PROGR; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Thomas BE, 2007, INT J TUBERC LUNG D, V11, P1296; *WHO, WHOHTMTB2009411 GLOB; *WHO, 2004, INT POL COLL TB HIV; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7899	10.1371/journal.pone.0007899	http://dx.doi.org/10.1371/journal.pone.0007899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936067	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000272004600005
J	Simpson, JE; Folsom-O'Keefe, CM; Childs, JE; Simons, LE; Andreadis, TG; Diuk-Wasser, MA				Simpson, Jennifer E.; Folsom-O'Keefe, Corrine M.; Childs, James E.; Simons, Leah E.; Andreadis, Theodore G.; Diuk-Wasser, Maria A.			Avian Host-Selection by Culex pipiens in Experimental Trials	PLOS ONE			English	Article							WEST-NILE-VIRUS; BLOOD-FEEDING BEHAVIOR; NEW-YORK; ANOPHELES-ARABIENSIS; MOSQUITO SURVEILLANCE; DIPTERA-CULICIDAE; VECTOR COMPETENCE; INFECTION; ATTRACTIVENESS; PREFERENCE	Evidence from field studies suggests that Culex pipiens, the primary mosquito vector of West Nile virus (WNV) in the northeastern and north central United States, feeds preferentially on American robins (Turdus migratorius). To determine the contribution of innate preferences to observed preference patterns in the field, we conducted host preference trials with a known number of adult female C. pipiens in outdoor cages comparing the relative attractiveness of American robins with two common sympatric bird species, European starling, Sternus vulgaris and house sparrow, Passer domesticus. Host seeking C. pipiens were three times more likely to enter robin-baited traps when with the alternate host was a European starling (n = 4 trials; OR = 3.06; CI [1.42-6.46]) and almost twice more likely when the alternative was a house sparrow (n = 8 trials; OR = 1.80; CI = [1.22-2.90]). There was no difference in the probability of trap entry when two robins were offered (n = 8 trials). Logistic regression analysis determined that the age, sex and weight of the birds, the date of the trial, starting-time, temperature, humidity, wind-speed and age of the mosquitoes had no effect on the probability of a choosing a robin over an alternate bird. Findings indicate that preferential feeding by C. pipiens mosquitoes on certain avian hosts is likely to be inherent, and we discuss the implications innate host preferences may have on enzootic WNV transmission.			Simpson, JE (corresponding author), Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA.	maria.diuk@yale.edu						Anderson RA, 1997, J MED ENTOMOL, V34, P95, DOI 10.1093/jmedent/34.2.95; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Andreadis TG, 2001, EMERG INFECT DIS, V7, P670; Andreadis TG., 2005, CONN AES BULL, V996, P178; Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Darbro JM, 2006, J MED ENTOMOL, V43, P83, DOI 10.1603/0022-2585(2006)043[0083:BTFSOW]2.0.CO;2; Darbro JM, 2007, AM J TROP MED HYG, V77, P488, DOI 10.4269/ajtmh.2007.77.488; Darbro JM, 2007, BEHAV ECOL, V18, P750, DOI 10.1093/beheco/arm043; DAY JF, 1984, J MED ENTOMOL, V21, P732, DOI 10.1093/jmedent/21.6.732; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; Diatta M, 1998, T ROY SOC TROP MED H, V92, P270, DOI 10.1016/S0035-9203(98)91005-7; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; EDMAN JD, 1974, J PARASITOL, V60, P874, DOI 10.2307/3278923; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GILLIES MT, 1964, NATURE, V203, P852, DOI 10.1038/203852a0; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; HESS AD, 1968, MOSQ NEWS, V28, P386; Hodgson JC, 2001, J MED ENTOMOL, V38, P59, DOI 10.1603/0022-2585-38.1.59; KAY BH, 1979, MOSQ NEWS, V39, P68; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; LEFEVRE T, 2009, TROP MED INT HEALTH, V14, P1; Lepore TJ, 2004, J AM MOSQUITO CONTR, V20, P321; Lord CC, 2000, J AM MOSQUITO CONTR, V16, P271; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P299, DOI 10.1089/15303660160025921; Mboera LEG, 1999, ENTOMOL EXP APPL, V92, P83, DOI 10.1023/A:1003780811793; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; MUKABANA WR, 2002, MALARIA J, P1; Pates HV, 2005, ENTOMOL EXP APPL, V114, P153, DOI 10.1111/j.1570-7458.2005.00249.x; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Patrican LA, 2007, EMERG INFECT DIS, V13, P1921, DOI 10.3201/eid1312.070275; Rappole JH, 2006, VECTOR-BORNE ZOONOT, V6, P128, DOI 10.1089/vbz.2006.6.128; Reddy MR, 2007, J MED ENTOMOL, V44, P211, DOI 10.1603/0022-2585(2007)44[211:EEQAOA]2.0.CO;2; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; SCOTT TW, 1990, J MED ENTOMOL, V27, P856, DOI 10.1093/jmedent/27.5.856; Shaman J, 2007, T ROY SOC TROP MED H, V101, P469, DOI 10.1016/j.trstmh.2006.11.007; Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; Trevejo RT, 2006, J AM MOSQUITO CONTR, V22, P37, DOI 10.2987/8756-971X(2006)22[37:CAOTCB]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; White DJ, 2001, EMERG INFECT DIS, V7, P643; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	53	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7861	10.1371/journal.pone.0007861	http://dx.doi.org/10.1371/journal.pone.0007861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924251	Green Published, gold			2022-12-27	WOS:000271854200009
J	Pohl, NM; Tong, C; Fang, WF; Bi, XL; Li, TH; Yang, WC				Pohl, Nicole M.; Tong, Chang; Fang, Wenfeng; Bi, Xiuli; Li, Tianhong; Yang, Wancai			Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; PROGRESSION; HSP56	Background: It has been shown that selenium-binding protein 1 (SBP1) is significantly downregulated in different human cancers. Its regulation and function have not yet been established. Methodology and Principal Findings: We show that the SBP1 promoter is hypermethylated in colon cancer tissues and human colon cancer cells. Treatment with 59-Aza-29-deoxycytidine leads to demethylation of the SBP1 promoter and to an increase of SBP1 promoter activity, rescues SBP1 mRNA and protein expression in human colon cancer cells. Additionally, overexpression of SBP1 sensitizes colon cancer cells to H(2)O(2)-induced apoptosis, inhibits cancer cell migration in vitro and inhibits tumor growth in nude mice. Conclusion and Significance: These data demonstrate that SBP1 has tumor suppressor functions that are inhibited in colorectal cancer through epigenetic silencing.			Pohl, NM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	wyang06@uic.edu	Yang, Wancai/O-7655-2019; Yang, Wancai/G-3750-2010	Yang, Wancai/0000-0001-7437-9197; 	NATIONAL CANCER INSTITUTE [R01CA112081] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA112081, CA112081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; GUOAN C, 2004, J PATHOL, V202, P321; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Scortegagna M, 2009, CANCER RES, V69, P2638, DOI 10.1158/0008-5472.CAN-08-3643; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Yang MH, 1998, CANCER RES, V58, P3150	15	60	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7774	10.1371/journal.pone.0007774	http://dx.doi.org/10.1371/journal.pone.0007774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924303	Green Published, Green Submitted, gold			2022-12-27	WOS:000271851000001
J	Shepard, S; McCreary, M; Fedorov, A				Shepard, Samuel; McCreary, Mark; Fedorov, Alexei			The Peculiarities of Large Intron Splicing in Animals	PLOS ONE			English	Article							RNA SECONDARY STRUCTURES; GROUP-II INTRONS; SPLICEOSOMAL INTRONS; EXON; EVOLUTION; DROSOPHILA; POSITIONS; ELEMENTS; DATABASE; PUZZLES	In mammals a considerable 92% of genes contain introns, with hundreds and hundreds of these introns reaching the incredible size of over 50,000 nucleotides. These "large introns'' must be spliced out of the pre-mRNA in a timely fashion, which involves bringing together distant 59 and 39 acceptor and donor splice sites. In invertebrates, especially Drosophila, it has been shown that larger introns can be spliced efficiently through a process known as recursive splicing-a consecutive splicing from the 59-end at a series of combined donor-acceptor splice sites called RP-sites. Using a computational analysis of the genomic sequences, we show that vertebrates lack the proper enrichment of RP-sites in their large introns, and, therefore, require some other method to aid splicing. We analyzed over 15,000 non-redundant, large introns from six mammals, 1,600 from chicken and zebrafish, and 560 non-redundant large introns from five invertebrates. Our bioinformatic investigation demonstrates that, unlike the studied invertebrates, the studied vertebrate genomes contain consistently abundant amounts of direct and complementary strand interspersed repetitive elements (mainly SINEs and LINEs) that may form stems with each other in large introns. This examination showed that predicted stems are indeed abundant and stable in the large introns of mammals. We hypothesize that such stems with long loops within large introns allow intron splice sites to find each other more quickly by folding the intronic RNA upon itself at smaller intervals and, thus, reducing the distance between donor and acceptor sites.			Shepard, S (corresponding author), Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	alexei.fedorov@utoledo.edu		McCreary, Mark/0000-0002-5590-7748				Bechtel JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-284; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BOWEN R, 1998, NUCL ACID DOT PLOTS; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; Fedorov A, 2004, J MOL EVOL, V59, P718, DOI 10.1007/s00239-004-2660-5; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fedorova L, 2005, CURR GENOMICS, V6, P589, DOI 10.2174/138920205775811416; Gish W, 1996, WUBLAST 2 0MP; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; LAMBOWITZ AM, 2006, RNA WORLD, P451; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Ott S, 2003, Pac Symp Biocomput, P339; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Rogic S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-355; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Shepelev V, 2006, BRIEF BIOINFORM, V7, P178, DOI 10.1093/bib/bbl003; Smit A., REPEATMASKER OPEN 3; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008	30	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7853	10.1371/journal.pone.0007853	http://dx.doi.org/10.1371/journal.pone.0007853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924226	Green Submitted, gold, Green Published			2022-12-27	WOS:000271851000010
J	Troy, TC; Arabzadeh, A; Lariviere, NMK; Enikanolaiye, A; Turksen, K				Troy, Tammy-Claire; Arabzadeh, Azadeh; Lariviere, Nathalie M. K.; Enikanolaiye, Adebola; Turksen, Kursad			Dermatitis and Aging-Related Barrier Dysfunction in Transgenic Mice Overexpressing an Epidermal-Targeted Claudin 6 Tail Deletion Mutant	PLOS ONE			English	Article							PERMEABILITY BARRIER; CYTOPLASMIC TAIL; SKIN; DIFFERENTIATION; EXPRESSION; ABNORMALITIES; COMPLEXES; JUNCTIONS; PROTEINS	The barrier function of the skin protects the mammalian body against infection, dehydration, UV irradiation and temperature fluctuation. Barrier function is reduced with the skin's intrinsic aging process, however the molecular mechanisms involved are unknown. We previously demonstrated that Claudin (Cldn)-containing tight junctions (TJs) are essential in the development of the epidermis and that transgenic mice overexpressing Cldn6 in the suprabasal layers of the epidermis undergo a perturbed terminal differentiation program characterized in part by reduced barrier function. To dissect further the mechanisms by which Cldn6 acts during epithelial differentiation, we overexpressed a Cldn6 cytoplasmic tail deletion mutant in the suprabasal compartment of the transgenic mouse epidermis. Although there were no gross phenotypic abnormalities at birth, subtle epidermal anomalies were present that disappeared by one month of age, indicative of a robust injury response. However, with aging, epidermal changes with eventual chronic dermatitis appeared with a concomitant barrier dysfunction manifested in increased trans-epidermal water loss. Immunohistochemical analysis revealed aberrant suprabasal Cldn localization with marked down-regulation of Cldn1. Both the proliferative and terminal differentiation compartments were perturbed as evidenced by mislocalization of multiple epidermal markers. These results suggest that the normally robust injury response mechanism of the epidermis is lost in the aging Involucrin-Cldn6-C Delta 196 transgenic epidermis, and provide a model for evaluation of aging-related skin changes.			Troy, TC (corresponding author), Ottawa Hosp, Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada.	kturksen@ohri.ca	Enikanolaiye, Adebola/AAM-9443-2020		Canadian Institutes of Health Research [MOP 84464] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Arabzadeh A, 2008, J INVEST DERMATOL, V128, P237, DOI 10.1038/sj.jid.5700966; Arabzadeh A, 2006, MOL CELL BIOL, V26, P5876, DOI 10.1128/MCB.02342-05; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Barland CO, 2004, J INVEST DERMATOL, V122, P330, DOI 10.1046/j.0022-202X.2004.22203.x; Byrne C, 2004, METH MOL B, V289, P127; Cartlidge P, 2000, Semin Neonatol, V5, P273, DOI 10.1053/siny.2000.0013; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; DAVIES A, 2008, BR J COMMUNITY NURS, V13, P254; DAVIES A, 2008, BR J COMMUNITY NURS, V13, P252; Davies Ann, 2008, Br J Community Nurs, V13, P254; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Elias PM, 2002, CLIN GERIATR MED, V18, P103, DOI 10.1016/S0749-0690(03)00037-5; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Ghadially R, 1998, Am J Contact Dermat, V9, P162, DOI 10.1016/S1046-199X(98)90019-7; GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Hardman MJ, 1999, J INVEST DERMATOL, V113, P1106, DOI 10.1046/j.1523-1747.1999.00800.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; HOHL D, 1991, J BIOL CHEM, V266, P6626; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Katoh M, 2003, INT J MOL MED, V11, P683; Kligman L H, 1989, Clin Geriatr Med, V5, P235; Koval M, 2006, CELL COMMUN ADHES, V13, P127, DOI 10.1080/15419060600726209; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Mack Judith A., 2005, Birth Defects Research, V75, P314, DOI 10.1002/bdrc.20055; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; McGowan K, 1998, Subcell Biochem, V31, P173; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pouillot Anne, 2008, J Cosmet Dermatol, V7, P143, DOI 10.1111/j.1473-2165.2008.00379.x; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Ruffer C, 2004, EUR J CELL BIOL, V83, P135, DOI 10.1078/0171-9335-00366; Simard A, 2006, MECH DEVELOP, V123, P210, DOI 10.1016/j.mod.2005.12.004; Troy TC, 2007, MOL BIOTECHNOL, V36, P166, DOI 10.1007/s12033-007-0027-z; Troy TC, 2007, GENE EXPR PATTERNS, V7, P423, DOI 10.1016/j.modgep.2006.11.006; Troy TC, 2005, MECH DEVELOP, V122, P805, DOI 10.1016/j.mod.2005.03.001; Troy TC, 2005, DEV DYNAM, V232, P293, DOI 10.1002/dvdy.20223; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Turksen K, 1998, BIOCHEM CELL BIOL, V76, P889, DOI 10.1139/bcb-76-6-889; Turksen K, 2002, DEVELOPMENT, V129, P1775; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Ward Sue, 2005, Br J Community Nurs, V10, P453; Williams M L, 1998, J Investig Dermatol Symp Proc, V3, P75	53	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7814	10.1371/journal.pone.0007814	http://dx.doi.org/10.1371/journal.pone.0007814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915705	Green Submitted, Green Published, gold			2022-12-27	WOS:000271721900011
J	Li, MY; Lai, FJ; Hsu, LJ; Lo, CP; Cheng, CL; Lin, SR; Lee, MH; Chang, JY; Subhan, D; Tsai, MS; Sze, CI; Pugazhenthi, S; Chang, NS; Chen, ST				Li, Meng-Yen; Lai, Feng-Jie; Hsu, Li-Jin; Lo, Chen-Peng; Cheng, Ching-Li; Lin, Sing-Ru; Lee, Ming-Hui; Chang, Jean-Yun; Subhan, Dudekula; Tsai, Ming-Shu; Sze, Chun-I; Pugazhenthi, Subbiah; Chang, Nan-Shan; Chen, Shur-Tzu			Dramatic Co-Activation of WWOX/WOX1 with CREB and NF-kappa B in Delayed Loss of Small Dorsal Root Ganglion Neurons upon Sciatic Nerve Transection in Rats	PLOS ONE			English	Article							DOMAIN-CONTAINING OXIDOREDUCTASE; C-JUN EXPRESSION; ELEMENT-BINDING PROTEIN; TUMOR-SUPPRESSOR WWOX; TRANSCRIPTION FACTOR; IN-VIVO; TYROSINE-33 PHOSPHORYLATION; AXONAL REGENERATION; GENE-EXPRESSION; SENSORY NEURONS	Background: Tumor suppressor WOX1 (also named WWOX or FOR) is known to participate in neuronal apoptosis in vivo. Here, we investigated the functional role of WOX1 and transcription factors in the delayed loss of axotomized neurons in dorsal root ganglia (DRG) in rats. Methodology/Principal Findings: Sciatic nerve transection in rats rapidly induced JNK1 activation and upregulation of mRNA and protein expression of WOX1 in the injured DRG neurons in 30 min. Accumulation of p-WOX1, p-JNK1, p-CREB, p-c-Jun, NF-kappa B and ATF3 in the nuclei of injured neurons took place within hours or the first week of injury. At the second month, dramatic nuclear accumulation of WOX1 with CREB (>65% neurons) and NF-kappa B (40-65%) occurred essentially in small DRG neurons, followed by apoptosis at later months. WOX1 physically interacted with CREB most strongly in the nuclei as determined by FRET analysis. Immunoelectron microscopy revealed the complex formation of p-WOX1 with p-CREB and p-c-Jun in vivo. WOX1 blocked the prosurvival CREB-, CRE-, and AP-1-mediated promoter activation in vitro. In contrast, WOX1 enhanced promoter activation governed by c-Jun, Elk-1 and NF-kappa B. WOX1 directly activated NF-kappa B-regulated promoter via its WW domains. Smad4 and p53 were not involved in the delayed loss of small DRG neurons. Conclusions/Significance: Rapid activation of JNK1 and WOX1 during the acute phase of injury is critical in determining neuronal survival or death, as both proteins functionally antagonize. In the chronic phase, concurrent activation of WOX1, CREB, and NF-kappa B occurs in small neurons just prior to apoptosis. Likely in vivo interactions are: 1) WOX1 inhibits the neuroprotective CREB, which leads to eventual neuronal death, and 2) WOX1 enhances NF-kappa B promoter activation (which turns to be proapoptotic). Evidently, WOX1 is the potential target for drug intervention in mitigating symptoms associated with neuronal injury.			Li, MY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan.	changns@mail.ncku.edu.tw	Hsu, Li-Jin/G-7822-2011		BLRD VA [I01 BX001837] Funding Source: Medline	BLRD VA		Aderca I, 2008, J HEPATOL, V49, P373, DOI 10.1016/j.jhep.2008.05.015; Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Buschmann T, 1998, NEUROSCIENCE, V84, P163, DOI 10.1016/S0306-4522(97)00487-9; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chang YC, 2006, CURR OPIN NEUROL, V19, P141, DOI 10.1097/01.wco.0000218229.73678.a8; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Chuang JI, 2002, NEUROCHEM INT, V40, P169, DOI 10.1016/S0197-0186(01)00075-4; DEFELIPE C, 1994, J NEUROSCI, V14, P2911; Demir O, 2008, NEUROSCI LETT, V437, P20, DOI 10.1016/j.neulet.2008.03.064; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Gaudio E, 2006, CANCER RES, V66, P11585, DOI 10.1158/0008-5472.CAN-06-3376; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; JENKINS R, 1991, NEUROSCI LETT, V129, P107, DOI 10.1016/0304-3940(91)90731-8; Kenney AM, 1997, MOL BRAIN RES, V52, P53, DOI 10.1016/S0169-328X(97)00211-8; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lo CP, 2008, EUR J NEUROSCI, V27, P1634, DOI 10.1111/j.1460-9568.2008.06139.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qiao LY, 2005, J COMP NEUROL, V482, P142, DOI 10.1002/cne.20394; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Soares HD, 2001, EXP NEUROL, V167, P1, DOI 10.1006/exnr.2000.7558; Son SJ, 2007, EXP NEUROL, V204, P467, DOI 10.1016/j.expneurol.2006.09.020; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06	53	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7820	10.1371/journal.pone.0007820	http://dx.doi.org/10.1371/journal.pone.0007820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19918364	Green Published, Green Submitted, gold			2022-12-27	WOS:000271721400017
J	Hough, SR; Laslett, AL; Grimmond, SB; Kolle, G; Pera, MF				Hough, Shelley R.; Laslett, Andrew L.; Grimmond, Sean B.; Kolle, Gabriel; Pera, Martin F.			A Continuum of Cell States Spans Pluripotency and Lineage Commitment in Human Embryonic Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION; PRIMITIVE ENDODERM; HUMAN BLASTOCYSTS; PROGENITOR CELLS; MOUSE; DIFFERENTIATION; CULTURE; HETEROGENEITY; TRANSCRIPTOME; INHIBITOR	Background: Commitment in embryonic stem cells is often depicted as a binary choice between alternate cell states, pluripotency and specification to a particular germ layer or extraembryonic lineage. However, close examination of human ES cell cultures has revealed significant heterogeneity in the stem cell compartment. Methodology/Principal Findings: We isolated subpopulations of embryonic stem cells using surface markers, then examined their expression of pluripotency genes and lineage specific transcription factors at the single cell level, and tested their ability to regenerate colonies of stem cells. Transcript analysis of single embryonic stem cells showed that there is a gradient and a hierarchy of expression of pluripotency genes in the population. Even cells at the top of the hierarchy generally express only a subset of the stem cell genes studied. Many cells co-express pluripotency and lineage specific genes. Cells along the continuum show a progressively decreasing likelihood of self renewal as their expression of stem cell surface markers and pluripotency genes wanes. Most cells that are positive for stem cell surface markers express Oct-4, but only those towards the top of the hierarchy express the nodal receptor TDGF-1 and the growth factor GDF3. Significance: These findings on gene expression in single embryonic stem cells are in concert with recent studies of early mammalian development, which reveal molecular heterogeneity and a stochasticity of gene expression in blastomeres. Our work indicates that only a small fraction of the population resides at the top of the hierarchy, that lineage priming ( co-expression of stem cell and lineage specific genes) characterizes pluripotent stem cell populations, and that extrinsic signaling pathways are upstream of transcription factor networks that control pluripotency.			Hough, SR (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	pera@usc.edu	Laslett, Andrew L/A-9760-2011; Grimmond, Sean M/J-5304-2016; PERA, MARTIN/A-9812-2012; Grimmond, Sean/K-3246-2019	Laslett, Andrew L/0000-0003-4729-8193; Grimmond, Sean M/0000-0002-8102-7998; PERA, MARTIN/0000-0001-6239-0428; Grimmond, Sean/0000-0002-8102-7998				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hannan NRF, 2009, CLONING STEM CELLS, V11, P427, DOI 10.1089/clo.2009.0024; Hartmann CH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl740; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; KOLLE G, 2009, STEM CELLS; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310	38	109	113	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7708	10.1371/journal.pone.0007708	http://dx.doi.org/10.1371/journal.pone.0007708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890402	Green Submitted, gold, Green Published			2022-12-27	WOS:000271459700008
J	Zhou, XM; Xing, D; Tang, YH; Chen, WR				Zhou, Xiaoming; Xing, Da; Tang, Yonghong; Chen, Wei R.			PCR-Free Detection of Genetically Modified Organisms Using Magnetic Capture Technology and Fluorescence Cross-Correlation Spectroscopy	PLOS ONE			English	Article							GENOMIC DNA; QUANTITATIVE DETECTION; GENE; MAIZE; IDENTIFICATION; DIAGNOSTICS; VALIDATION; PROTEINS; KINETICS; SYSTEM	The safety of genetically modified organisms (GMOs) has attracted much attention recently. Polymerase chain reaction (PCR) amplification is a common method used in the identification of GMOs. However, a major disadvantage of PCR is the potential amplification of non-target DNA, causing false-positive identification. Thus, there remains a need for a simple, reliable and ultrasensitive method to identify and quantify GMO in crops. This report is to introduce a magnetic bead-based PCR-free method for rapid detection of GMOs using dual-color fluorescence cross-correlation spectroscopy (FCCS). The cauliflower mosaic virus 35S (CaMV35S) promoter commonly used in transgenic products was targeted. CaMV35S target was captured by a biotin-labeled nucleic acid probe and then purified using streptavidin-coated magnetic beads through biotin-streptavidin linkage. The purified target DNA fragment was hybridized with two nucleic acid probes labeled respectively by Rhodamine Green and Cy5 dyes. Finally, FCCS was used to detect and quantify the target DNA fragment through simultaneously detecting the fluorescence emissions from the two dyes. In our study, GMOs in genetically engineered soybeans and tomatoes were detected, using the magnetic bead-based PCR-free FCCS method. A detection limit of 50 pM GMOs target was achieved and PCR-free detection of GMOs from 5 mg genomic DNA with magnetic capture technology was accomplished. Also, the accuracy of GMO determination by the FCCS method is verified by spectrophotometry at 260 nm using PCR amplified target DNA fragment from GM tomato. The new method is rapid and effective as demonstrated in our experiments and can be easily extended to high-throughput and automatic screening format. We believe that the new magnetic bead-assisted FCCS detection technique will be a useful tool for PCR-free GMOs identification and other specific nucleic acids.	[Zhou, Xiaoming; Xing, Da; Tang, Yonghong] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiaoming; Xing, Da; Tang, Yonghong] S China Normal Univ, Inst Laser Life Sci, Coll Biophoton, Guangzhou, Guangdong, Peoples R China; [Chen, Wei R.] Univ Cent Oklahoma, Dept Engn & Phys, Coll Math & Sci, Edmond, OK USA	South China Normal University; South China Normal University; University of Central Oklahoma	Zhou, XM (corresponding author), S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.	xingda@scnu.edu.cn	zhou, xiaoming/J-9589-2012		Program for Changjiang Scholars and Innovative Research Team in University [IRT0829]; NSFC-Guangdong Joint Funds of China [U0931005]; National Basic Research Program of China [2010CB732602]; U.S. National Institute of Health [P20 RR016478]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NSFC-Guangdong Joint Funds of China; National Basic Research Program of China(National Basic Research Program of China); U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0829), the Key Program of NSFC-Guangdong Joint Funds of China (U0931005), the National Basic Research Program of China (2010CB732602), and by a grant from the U.S. National Institute of Health (P20 RR016478 from the INBRE Program of the National Center for Research Resources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2002, TRENDS BIOTECHNOL, V20, P215, DOI 10.1016/S0167-7799(01)01920-5; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Foldes-Papp Z, 2005, EXP MOL PATHOL, V78, P177, DOI 10.1016/j.yexmp.2005.01.005; Fujii F, 2007, CHEMBIOCHEM, V8, P2199, DOI 10.1002/cbic.200700399; Gachet E, 1998, TRENDS FOOD SCI TECH, V9, P380, DOI 10.1016/S0924-2244(99)00002-3; Hill HD, 2007, ANAL CHEM, V79, P9218, DOI 10.1021/ac701626y; Hill M, 1999, IN VITRO CELL DEV-PL, V35, P154, DOI 10.1007/s11627-999-0026-9; Hubner P, 1999, NAT BIOTECHNOL, V17, P1137, DOI 10.1038/15129; Hubner P, 2001, J AOAC INT, V84, P1855; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; James D, 2003, J AGR FOOD CHEM, V51, P5829, DOI 10.1021/jf0341159; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; KINJO M, 1995, NUCLEIC ACIDS RES, V23, P1795, DOI 10.1093/nar/23.10.1795; Korn K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng089; Liu JF, 2005, ANAL CHIM ACTA, V537, P119, DOI 10.1016/j.aca.2005.01.011; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Minunni M, 2005, J AM CHEM SOC, V127, P7966, DOI 10.1021/ja051345q; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; Nolan RL, 2003, ANAL CHEM, V75, P6236, DOI 10.1021/ac034803r; Oehlenschlager F, 1996, P NATL ACAD SCI USA, V93, P12811, DOI 10.1073/pnas.93.23.12811; Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Schwille P, 1996, BIOCHEMISTRY-US, V35, P10182, DOI 10.1021/bi960517g; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Stave JW, 1999, FOOD CONTROL, V10, P367, DOI 10.1016/S0956-7135(99)00077-8; Vaitilingom M, 1999, J AGR FOOD CHEM, V47, P5261, DOI 10.1021/jf981208v; Vollenhofer S, 1999, J AGR FOOD CHEM, V47, P5038, DOI 10.1021/jf990353l; Walter NG, 1996, P NATL ACAD SCI USA, V93, P12805, DOI 10.1073/pnas.93.23.12805; Weisshart K, 2004, CURR PHARM BIOTECHNO, V5, P135, DOI 10.2174/1389201043376913; Yan GH, 2004, J IMMUNOL METHODS, V288, P47, DOI 10.1016/j.jim.2004.02.006; Young IT, 2003, J MICROSC-OXFORD, V212, P254, DOI 10.1111/j.1365-2818.2003.01252.x; Zhou XM, 2009, ANAL CHEM, V81, P255, DOI 10.1021/ac801914b; Zhu DB, 2004, BIOCHEM BIOPH RES CO, V324, P964, DOI 10.1016/j.bbrc.2004.09.121; Zhu DB, 2008, ANAL CHEM, V80, P3566, DOI 10.1021/ac0713306; 2000, OFFICIAL J L, V6	44	7	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8074	10.1371/journal.pone.0008074	http://dx.doi.org/10.1371/journal.pone.0008074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956680	Green Published, Green Submitted, gold			2022-12-27	WOS:000272828100014
J	Hughes, LAE; van den Brandt, PA; de Bruine, AP; Wouters, KAD; Hulsmans, S; Spiertz, A; Goldbohm, RA; de Goeij, AFPM; Herman, JG; Weijenberg, MP; van Engeland, M				Hughes, Laura A. E.; van den Brandt, Piet A.; de Bruine, Adriaan P.; Wouters, Kim A. D.; Hulsmans, Sarah; Spiertz, Angela; Goldbohm, R. Alexandra; de Goeij, Anton F. P. M.; Herman, James G.; Weijenberg, Matty P.; van Engeland, Manon			Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic Mechanisms	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; SCALE PROSPECTIVE COHORT; 1944-1945 DUTCH FAMINE; NETHERLANDS COHORT; BREAST-CANCER; COLON-CANCER; ADULT DISEASE; MICROSATELLITE INSTABILITY; ENERGY RESTRICTION; FOLLOW-UP	Background: Exposure to energy restriction during childhood and adolescence is associated with a lower risk of developing colorectal cancer (CRC). Epigenetic dysregulation during this critical period of growth and development may be a mechanism to explain such observations. Within the Netherlands Cohort Study on diet and cancer, we investigated the association between early life energy restriction and risk of subsequent CRC characterized by the (promoter) CpG island methylation phenotype (CIMP). Methodology/Principal Findings: Information on diet and risk factors was collected by baseline questionnaire (n = 120,856). Three indicators of exposure were assessed: place of residence during the Hunger Winter (1944-45) and World War II years (1940-44), and father's employment status during the Economic Depression (1932-40). Methylation specific PCR (MSP) on DNA from paraffin embedded tumor tissue was performed to determine CIMP status according to the Weisenberger markers. After 7.3 years of follow-up, 603 cases and 4631 sub-cohort members were available for analysis. Cox regression was used to calculate hazard ratios (HR) and 95% confidence intervals for CIMP+ (27.7%) and CIMP- (72.3%) tumors according to the three time periods of energy restriction, adjusted for age and gender. Individuals exposed to severe famine during the Hunger Winter had a decreased risk of developing a tumor characterized by CIMP compared to those not exposed (HR 0.65, 95%CI: 0.45-0.92). Further categorizing individuals by an index of '0-1' '2-3' or '4-7' genes methylated in the promoter region suggested that exposure to the Hunger Winter was associated with the degree of promoter hypermethylation ('0-1 genes methylated' HR = 1.01, 95%CI:0.74-1.37; '2-3 genes methylated' HR = 0.83, 95% CI:0.61-1.15; '4-7 genes methylated' HR = 0.72, 95% CI: 0.49-1.04). No associations were observed with respect to the Economic Depression and WWII years. Conclusions: This is the first study indicating that exposure to a severe, transient environmental condition during adolescence and young adulthood may result in persistent epigenetic changes that later influence CRC development.	[Hughes, Laura A. E.; van den Brandt, Piet A.; Weijenberg, Matty P.] Maastricht Univ, Med Ctr, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [de Bruine, Adriaan P.; Wouters, Kim A. D.; Hulsmans, Sarah; de Goeij, Anton F. P. M.; van Engeland, Manon] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands; [Spiertz, Angela; Goldbohm, R. Alexandra] TNO Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [Herman, James G.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Maastricht University; Maastricht University; Netherlands Organization Applied Science Research; Johns Hopkins University; Johns Hopkins Medicine	Hughes, LAE (corresponding author), Maastricht Univ, Med Ctr, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	manon.van.engeland@mumc.nl	van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund	World Cancer Research Fund(World Cancer Research Fund International (WCRF))	This work was supported by the World Cancer Research Fund [2007/54 to M. P. W] (http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Burger G, 1948, MALNUTRITION STARV 1; Burger G, 1948, MALNUTRITION STARV 2; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; DENHARTOG AP, 1983, VOEDING, V44, P92; Derks S, 2004, CELL ONCOL, V26, P291; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Dirx MJM, 2001, AM J EPIDEMIOL, V154, P530, DOI 10.1093/aje/154.6.530; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; DOLS M. J. L., 1946, Voeding, V6, P193; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2004, INT J CANCER, V108, P628, DOI 10.1002/ijc.11584; Ferguson LR, 2004, ENVIRON MOL MUTAGEN, V44, P36, DOI 10.1002/em.20029; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HUGHES LAE, 2009, ENERGY RESTRICTION C; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Lumey LH, 1997, AM J EPIDEMIOL, V146, P810, DOI 10.1093/oxfordjournals.aje.a009198; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; ROSE G, 1964, BRIT J PREV SOC MED, V18, P75; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Slattery ML, 2009, MUTAT RES-FUND MOL M, V660, P12, DOI 10.1016/j.mrfmmm.2008.10.001; Stein Z., 1975, FAMINE HUM DEV DUTCH; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; VANNOORD PAH, 1991, ANN HUM BIOL, V18, P57, DOI 10.1080/03014469100001402; WACHOLDER S, 1989, BIOMETRIKA, V76, P117, DOI 10.1093/biomet/76.1.117; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Waterland RA, 2006, J PEDIATR-US, V149, pS137, DOI 10.1016/j.jpeds.2006.06.064; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799	54	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7951	10.1371/journal.pone.0007951	http://dx.doi.org/10.1371/journal.pone.0007951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956740	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827300009
J	Roy, S; Martinez, D; Platero, H; Lane, T; Werner-Washburne, M				Roy, Sushmita; Martinez, Diego; Platero, Harriett; Lane, Terran; Werner-Washburne, Margaret			Exploiting Amino Acid Composition for Predicting Protein-Protein Interactions	PLOS ONE			English	Article							NETWORK	Background: Computational prediction of protein interactions typically use protein domains as classifier features because they capture conserved information of interaction surfaces. However, approaches relying on domains as features cannot be applied to proteins without any domain information. In this paper, we explore the contribution of pure amino acid composition (AAC) for protein interaction prediction. This simple feature, which is based on normalized counts of single or pairs of amino acids, is applicable to proteins from any sequenced organism and can be used to compensate for the lack of domain information. Results: AAC performed at par with protein interaction prediction based on domains on three yeast protein interaction datasets. Similar behavior was obtained using different classifiers, indicating that our results are a function of features and not of classifiers. In addition to yeast datasets, AAC performed comparably on worm and fly datasets. Prediction of interactions for the entire yeast proteome identified a large number of novel interactions, the majority of which co-localized or participated in the same processes. Our high confidence interaction network included both well-studied and uncharacterized proteins. Proteins with known function were involved in actin assembly and cell budding. Uncharacterized proteins interacted with proteins involved in reproduction and cell budding, thus providing putative biological roles for the uncharacterized proteins. Conclusion: AAC is a simple, yet powerful feature for predicting protein interactions, and can be used alone or in conjunction with protein domains to predict new and validate existing interactions. More importantly, AAC alone performs at par with existing, but more complex, features indicating the presence of sequence-level information that is predictive of interaction, but which is not necessarily restricted to domains.			Roy, S (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	sroy@cs.unm.edu			Howard Hughes Medical Institute [56005678] Funding Source: Medline; NHGRI NIH HHS [P41 HG001315, HG01315, U41 HG001315] Funding Source: Medline; NIGMS NIH HHS [R01 GM067593, GM67593, R25 GM060201, GM60201] Funding Source: Medline; NIMH NIH HHS [1R01MH076282, R01 MH076282] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201, R01GM067593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076282] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; GASCH AP, 2000, MOL BIOL CELL, P4421; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Huang H, 2009, BIOINFORMATICS, V25, P372, DOI 10.1093/bioinformatics/btn640; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kann MG, 2007, PROTEINS, V67, P811, DOI 10.1002/prot.21347; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LANGLEY P, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P223; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu Y, 2005, BIOINFORMATICS, V21, P3279, DOI 10.1093/bioinformatics/bti492; Mahdavi MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-262; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; McCallum, 2002, MALLET MACHINE LEARN; McCallum A, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P662; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; QUEVILLON E, 2001, NUCL ACIDS RES, V33; RAGHAVACHARI B, 2008, NUCL ACIDS RES, V36; SHOEMAKER BA, 2007, PLOS COMPUT BIOL, V3, P4; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; STARK C, 2006, NUCLEIC ACIDS RES, V1, P34; SUN J, 2005, BIOINFORMATICS, V21, P16; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Werner-Washburne M, 2002, GENOME RES, V12, P1564, DOI 10.1101/gr.225402; Witten I.H., 2002, ACM SIGMOD REC, V31, P76, DOI 10.1145/507338.507355; Yu H., 2008, SCIENCE	38	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7813	10.1371/journal.pone.0007813	http://dx.doi.org/10.1371/journal.pone.0007813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936254	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004800001
J	Xiong, NA; Huang, JS; Zhang, ZT; Zhang, ZW; Xiong, J; Liu, XY; Jia, M; Wang, F; Chen, CNA; Cao, XB; Liang, ZH; Sun, SG; Lin, ZC; Wang, T				Xiong, Nian; Huang, Jinsha; Zhang, Zhentao; Zhang, Zhaowen; Xiong, Jing; Liu, Xingyuan; Jia, Min; Wang, Fang; Chen, Chunnuan; Cao, Xuebing; Liang, Zhihou; Sun, Shenggang; Lin, Zhicheng; Wang, Tao			Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; RAT MODEL; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; FOREBRAIN-BUNDLE; ANIMAL-MODELS; PC12 CELLS; DEGENERATION; GLUTATHIONE; SYSTEM	A clinically-related animal model of Parkinson's disease (PD) may enable the elucidation of the etiology of the disease and assist the development of medications. However, none of the current neurotoxin-based models recapitulates the main clinical features of the disease or the pathological hallmarks, such as dopamine (DA) neuron specificity of degeneration and Lewy body formation, which limits the use of these models in PD research. To overcome these limitations, we developed a rat model by stereotaxically (ST) infusing small doses of the mitochondrial complex-I inhibitor, rotenone, into two brain sites: the right ventral tegmental area and the substantia nigra. Four weeks after ST rotenone administration, tyrosine hydroxylase (TH) immunoreactivity in the infusion side decreased by 43.7%, in contrast to a 75.8% decrease observed in rats treated systemically with rotenone (SYS). The rotenone infusion also reduced the DA content, the glutathione and superoxide dismutase activities, and induced alpha-synuclein expression, when compared to the contralateral side. This ST model displays neither peripheral toxicity or mortality and has a high success rate. This rotenone-based ST model thus recapitulates the slow and specific loss of DA neurons and better mimics the clinical features of idiopathic PD, representing a reliable and more clinically-related model for PD research.			Xiong, NA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurol, Union Hosp, Wuhan, Hubei, Peoples R China.	wangtaowh@yahoo.cn		Zhang, Zhentao/0000-0001-6708-1472				Alam M, 2004, BEHAV BRAIN RES, V151, P117, DOI 10.1016/j.bbr.2003.08.014; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cao W, 2007, NUCL MED COMMUN, V28, P895, DOI 10.1097/MNM.0b013e3282f1ac9a; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Elbaz A, 2008, LANCET NEUROL, V7, P562, DOI 10.1016/S1474-4422(08)70118-2; Feng Yuan, 2006, Neurosci Bull, V22, P288; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; JASSOLOPEZ D, 1995, J NEUROCHEM, V64, P794; JAVOYAGID F, 1980, NEUROLOGY, V30, P1326, DOI 10.1212/WNL.30.12.1326; Lakshmana MK, 1997, ANAL BIOCHEM, V246, P166, DOI 10.1006/abio.1996.9997; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lapointe N, 2004, FASEB J, V18, P717, DOI 10.1096/fj.03-0677fje; Ma R, 2009, NEUROPHARMACOLOGY, V56, P1027, DOI 10.1016/j.neuropharm.2009.02.006; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; MAREYSEMPER I, 1995, J NEUROSCI, V15, P5912; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; Ossowska K, 2005, EUR J NEUROSCI, V22, P1294, DOI 10.1111/j.1460-9568.2005.04301.x; Ozyurt H, 2006, ASIAN J ANDROL, V8, P189, DOI 10.1111/j.1745-7262.2006.00119.x; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ravenstijn Paulien G. M., 2008, Journal of Pharmacological and Toxicological Methods, V57, P114, DOI 10.1016/j.vascn.2007.10.003; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saravanan KS, 2005, BRAIN RES, V1049, P147, DOI 10.1016/j.brainres.2005.04.051; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Saybasili H, 2001, ANTIOXID REDOX SIGN, V3, P1099, DOI 10.1089/152308601317203602; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sindhu KM, 2005, BRAIN RES, V1051, P25, DOI 10.1016/j.brainres.2005.05.051; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Tian YY, 2007, NEUROSCI LETT, V421, P239, DOI 10.1016/j.neulet.2007.05.033; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Visanji NP, 2006, NEUROPHARMACOLOGY, V51, P506, DOI 10.1016/j.neuropharm.2006.04.015; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Xu Y, 2009, J HUAZHONG U SCI-MED, V29, P156, DOI 10.1007/s11596-009-0204-3; Yazdani U, 2006, EXP NEUROL, V200, P172, DOI 10.1016/j.expneurol.2006.02.002; Yokochi M, 2009, PARKINSONISM RELAT D, V15, pS25, DOI 10.1016/S1353-8020(09)70008-2; Zhang ZT, 2009, J HUAZHONG U SCI-MED, V29, P97, DOI 10.1007/s11596-009-0121-5; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	53	78	85	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7878	10.1371/journal.pone.0007878	http://dx.doi.org/10.1371/journal.pone.0007878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924288	Green Published, gold, Green Submitted			2022-12-27	WOS:000271936700012
J	Georgel, P; Macquin, C; Bahram, S				Georgel, Philippe; Macquin, Cecile; Bahram, Seiamak			The Heterogeneous Allelic Repertoire of Human Toll-Like Receptor (TLR) Genes	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; INNATE IMMUNE-RESPONSE; CRYSTAL-STRUCTURE; CUTTING EDGE; SUSCEPTIBILITY; TOLL-LIKE-RECEPTOR-4; RECOGNITION; ASSOCIATION; MUTATIONS; RESISTANCE	Toll-Like Receptors (TLR) are critical elements of the innate arm of the vertebrate immune system. They constitute a multigenic family of receptors which collectively bind a diverse array of - exogeneous as well as endogeneous - ligands. An exponential burst of knowledge has defined their biological role in fight against infections and generation/modulation of auto-immune disorders. Hence, they could at least be conceptually recognized - despite being structurally unrelated - as innate counterparts to Major Histocompatibility Complex (MHC) molecules - equally recognizing antigenic ligands (albeit structurally more homogeneous i.e., peptides), again derived from self and/or non-self sources - preeminent this time in adaptive immunity. Our great disparities in face of infections and/or susceptibility to auto-immune diseases have provoked an intense search for genetic explanations, in part satisfied by the extraordinary MHC allelic repertoire. An equally in-depth and systematic analysis of TLR diversity is lacking despite numerous independent reports of a growing number of SNPs within these loci. The work described here aims at providing a preliminary picture of the allelic repertoire - and not purely SNPs - of all 10 human TLR coding sequences (with exception of TLR3) within a single cohort of up to 100 individuals. It appears from our work that TLR are unequally polymorphic: TLR2 (DNA alleles: 7/protein alleles: 3), 4 (4/3), 7 (6/3), 8 (9/2) and 9 (8/3) being comparatively least diverse whereas TLR1 (11/10), 5 (14/12), 6 (10/8) and 10 (15/10) show a substantial number of alleles. In addition to allelic assignment of a large number of SNPs, 10 new polymorphic positions were hereby identified. Hence this work depicts a first overview of the diversity of almost all human TLR genes, a prelude for large-scale population genetics as well as genetic association studies.			Georgel, P (corresponding author), Univ Strasbourg, Fac Med, Ctr Rech Immunol & Hematol, Lab Immunogenet Mol Humaine, Strasbourg, France.	siamak@unistra.fr	georgel, philippe/P-5676-2016; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Bahram, Seiamak/0000-0002-6928-9952				Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eid AJ, 2007, TRANSPLANTATION, V84, P511, DOI 10.1097/01.tp.0000276960.35313.bf; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lazarus R, 2004, AM J RESP CRIT CARE, V170, P594, DOI 10.1164/rccm.200404-491OC; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pirie FJ, 2005, TISSUE ANTIGENS, V66, P125, DOI 10.1111/j.1399-0039.2005.00454.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Smirnova I, 2001, GENETICS, V158, P1657; Smirnova I, 2000, GENOME BIOL, V1; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sun JL, 2005, JNCI-J NATL CANCER I, V97, P525, DOI 10.1093/jnci/dji070; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	52	38	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7803	10.1371/journal.pone.0007803	http://dx.doi.org/10.1371/journal.pone.0007803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924287	Green Published, Green Submitted, gold			2022-12-27	WOS:000271854200004
J	Brennan, C; Momota, H; Hambardzumyan, D; Ozawa, T; Tandon, A; Pedraza, A; Holland, E				Brennan, Cameron; Momota, Hiroyuki; Hambardzumyan, Dolores; Ozawa, Tatsuya; Tandon, Adesh; Pedraza, Alicia; Holland, Eric			Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations	PLOS ONE			English	Article							GROWTH FACTOR-II; MALIGNANT GLIOMAS; MOUSE MODELS; 2 DISTINCT; MULTIFORME; SURVIVAL; SUBTYPES; CLASSIFICATION; IDENTIFICATION; PROGRESSION	Background: Glioblastoma multiforme (GBM) is an umbrella designation that includes a heterogeneous group of primary brain tumors. Several classification strategies of GBM have been reported, some by clinical course and others by resemblance to cell types either in the adult or during development. From a practical and therapeutic standpoint, classifying GBMs by signal transduction pathway activation and by mutation in pathway member genes may be particularly valuable for the development of targeted therapies. Methodology/Principal Findings: We performed targeted proteomic analysis of 27 surgical glioma samples to identify patterns of coordinate activation among glioma-relevant signal transduction pathways, then compared these results with integrated analysis of genomic and expression data of 243 GBM samples from The Cancer Genome Atlas (TCGA). In the pattern of signaling, three subclasses of GBM emerge which appear to be associated with predominance of EGFR activation, PDGFR activation, or loss of the RAS regulator NF1. The EGFR signaling class has prominent Notch pathway activation measured by elevated expression of Notch ligands, cleaved Notch receptor, and downstream target Hes1. The PDGF class showed high levels of PDGFB ligand and phosphorylation of PDGFR beta and NFKB. NF1-loss was associated with lower overall MAPK and PI3K activation and relative overexpression of the mesenchymal marker YKL40. These three signaling classes appear to correspond with distinct transcriptomal subclasses of primary GBM samples from TCGA for which copy number aberration and mutation of EGFR, PDGFRA, and NF1 are signature events. Conclusions/Significance: Proteomic analysis of GBM samples revealed three patterns of expression and activation of proteins in glioma-relevant signaling pathways. These three classes are comprised of roughly equal numbers showing either EGFR activation associated with amplification and mutation of the receptor, PDGF-pathway activation that is primarily ligand-driven, or loss of NF1 expression. The associated signaling activities correlating with these sentinel alterations provide insight into glioma biology and therapeutic strategies.			Brennan, C (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA.	cbrennan@mskcc.org; hollande@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891	NCI NIH HHS [U54 CA126518, CA100688, U54 CA143798, CA126518, U24 CA126543, U01 CA141502, CA143798, R01 CA100688, U24 CA126543-01, CA141502] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA143798, U01CA141502, U54CA126518, U24CA126543, R01CA100688] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choe G, 2003, CANCER RES, V63, P2742; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Dai CK, 2005, NEOPLASIA, V7, P397, DOI 10.1593/neo.04691; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huse JT, 2009, BRAIN PATHOL, V19, P132, DOI 10.1111/j.1750-3639.2008.00234.x; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Lassman AB, 2005, CLIN CANCER RES, V11, P7841, DOI 10.1158/1078-0432.CCR-05-0421; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lyustikman Y, 2008, NEOPLASIA, V10, P501, DOI 10.1593/neo.08206; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; MEHTA MPC, 2009, PRINCIPLES PRACTICE; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Nutt CL, 2003, CANCER RES, V63, P1602; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PECH M, 1989, MOL CELL BIOL, V9, P396, DOI 10.1128/MCB.9.2.396; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; VERHAAK RGW, 2009, CANC CELL IN PRESS; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	32	382	387	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7752	10.1371/journal.pone.0007752	http://dx.doi.org/10.1371/journal.pone.0007752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915670	gold, Green Submitted, Green Published			2022-12-27	WOS:000271721900009
J	Kiefer, P; Buchhaupt, M; Christen, P; Kaup, B; Schrader, J; Vorholt, JA				Kiefer, Patrick; Buchhaupt, Markus; Christen, Philipp; Kaup, Bjoern; Schrader, Jens; Vorholt, Julia A.			Metabolite Profiling Uncovers Plasmid-Induced Cobalt Limitation under Methylotrophic Growth Conditions	PLOS ONE			English	Article							METHYLOBACTERIUM-EXTORQUENS AM1; RECOMBINANT ESCHERICHIA-COLI; ETHYLMALONYL-COA PATHWAY; MASS-SPECTROMETRY; NONMETHYLOTROPHIC CONDITIONS; TETRACYCLINE RESISTANCE; GENE-EXPRESSION; BETA-LACTAMASE; C1 COMPOUNDS; TRANSPORT	Background: The introduction and maintenance of plasmids in cells is often associated with a reduction of growth rate. The reason for this growth reduction is unclear in many cases. Methodology/Principal Findings: We observed a surprisingly large reduction in growth rate of about 50% of Methylobacterium extorquens AM1 during methylotrophic growth in the presence of a plasmid, pCM80 expressing the tetA gene, relative to the wild-type. A less pronounced growth delay during growth under non-methylotrophic growth conditions was observed; this suggested an inhibition of one-carbon metabolism rather than a general growth inhibition or metabolic burden. Metabolome analyses revealed an increase in pool sizes of ethylmalonyl-CoA and methylmalonyl-CoA of more than 6- and 35-fold, respectively, relative to wild type, suggesting a strongly reduced conversion of these central intermediates, which are essential for glyoxylate regeneration in this model methylotroph. Similar results were found for M. extorquens AM1 pCM160 which confers kanamycin resistance. These intermediates of the ethylmalonyl-CoA pathway have in common their conversion by coenzyme B-12-dependent mutases, which have cobalt as a central ligand. The one-carbon metabolism-related growth delay was restored by providing higher cobalt concentrations, by heterologous expression of isocitrate lyase as an alternative path for glyoxylate regeneration, or by identification and overproduction of proteins involved in cobalt import. Conclusions/Significance: This study demonstrates that the introduction of the plasmids leads to an apparent inhibition of the cobalt-dependent enzymes of the ethylmalonyl-CoA pathway. Possible explanations are presented and point to a limited cobalt concentration in the cell as a consequence of the antibiotic stress.			Kiefer, P (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	vorholt@micro.biol.ethz.ch	Vorholt, Julia/K-3514-2016; Kiefer, Patrick/G-5138-2010	Vorholt, Julia/0000-0002-6011-4910; Christen, Philipp/0000-0002-3139-2874; Buchhaupt, Markus/0000-0003-2720-5973				Anthony C., 1982, BIOCH METHYLOTROPHS; Bailey J E, 1993, Adv Biochem Eng Biotechnol, V48, P29; BAILEY JE, 1986, ANN NY ACAD SCI, V469, P194, DOI 10.1111/j.1749-6632.1986.tb26498.x; BIRNBAUM S, 1991, BIOTECHNOL BIOENG, V37, P736, DOI 10.1002/bit.260370808; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; CHEAH UE, 1987, PLASMID, V18, P127, DOI 10.1016/0147-619X(87)90040-0; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; DASILVA NA, 1986, BIOTECHNOL BIOENG, V28, P741, DOI 10.1002/bit.260280514; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Gonzalez-Gil G, 1999, APPL ENVIRON MICROB, V65, P1789; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; KHOSRAVI M, 1990, PLASMID, V23, P138, DOI 10.1016/0147-619X(90)90032-8; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Korotkova N, 2001, J BACTERIOL, V183, P1038, DOI 10.1128/JB.183.3.1038-1046.2001; LARGE PJ, 1963, BIOCHEM J, V87, P386, DOI 10.1042/bj0870386; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; LEADLAY PF, 1981, BIOCHEM J, V197, P413, DOI 10.1042/bj1970413; LEE SW, 1985, GENE, V39, P173, DOI 10.1016/0378-1119(85)90311-7; LEGOFFIC F, 1976, ANTIMICROB AGENTS CH, V10, P258; LEVY SB, 1978, NATURE, V276, P90, DOI 10.1038/276090a0; Marciano DC, 2007, GENETICS, V176, P2381, DOI 10.1534/genetics.106.069443; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; Mashego MR, 2004, BIOTECHNOL BIOENG, V85, P620, DOI 10.1002/bit.10907; MOYED HS, 1983, J BACTERIOL, V155, P557, DOI 10.1128/JB.155.2.557-564.1983; Nielsen J, 2005, TRENDS BIOTECHNOL, V23, P544, DOI 10.1016/j.tibtech.2005.08.005; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Ow DSW, 2006, ENZYME MICROB TECH, V39, P391, DOI 10.1016/j.enzmictec.2005.11.048; Ow DSW, 2009, BIOTECHNOL PROGR, V25, P61, DOI 10.1002/btpr.51; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; RYAN W, 1989, BIOTECHNOL BIOENG, V34, P309, DOI 10.1002/bit.260340306; Sambrook J., 2001, MOL CLONING LAB MANU; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; SEO JH, 1985, BIOTECHNOL BIOENG, V27, P156, DOI 10.1002/bit.260270209; STABLER SP, 1985, ARCH BIOCHEM BIOPHYS, V241, P252, DOI 10.1016/0003-9861(85)90381-9; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P4809	52	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7831	10.1371/journal.pone.0007831	http://dx.doi.org/10.1371/journal.pone.0007831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915676	Green Submitted, Green Published, gold			2022-12-27	WOS:000271721900020
J	Pirnay, JP; Bilocq, F; Pot, B; Cornelis, P; Zizi, M; Van Eldere, J; Deschaght, P; Vaneechoutte, M; Jennes, S; Pitt, T; De Vos, D				Pirnay, Jean-Paul; Bilocq, Florence; Pot, Bruno; Cornelis, Pierre; Zizi, Martin; Van Eldere, Johan; Deschaght, Pieter; Vaneechoutte, Mario; Jennes, Serge; Pitt, Tyrone; De Vos, Daniel			Pseudomonas aeruginosa Population Structure Revisited	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; OUTER-MEMBRANE LIPOPROTEIN; FRAGMENT-LENGTH-POLYMORPHISM; I FERRIPYOVERDINE RECEPTOR; FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; POOR CLINICAL-OUTCOMES; INTENSIVE-CARE-UNIT; MOLECULAR EPIDEMIOLOGY; EXOENZYME-S	At present there are strong indications that Pseudomonas aeruginosa exhibits an epidemic population structure; clinical isolates are indistinguishable from environmental isolates, and they do not exhibit a specific (disease) habitat selection. However, some important issues, such as the worldwide emergence of highly transmissible P. aeruginosa clones among cystic fibrosis (CF) patients and the spread and persistence of multidrug resistant (MDR) strains in hospital wards with high antibiotic pressure, remain contentious. To further investigate the population structure of P. aeruginosa, eight parameters were analyzed and combined for 328 unrelated isolates, collected over the last 125 years from 69 localities in 30 countries on five continents, from diverse clinical (human and animal) and environmental habitats. The analysed parameters were: i) O serotype, ii) Fluorescent Amplified-Fragment Length Polymorphism (FALFP) pattern, nucleotide sequences of outer membrane protein genes, iii) oprI, iv) oprL, v) oprD, vi) pyoverdine receptor gene profile (fpvA type and fpvB prevalence), and prevalence of vii) exoenzyme genes exoS and exoU and viii) group I pilin glycosyltransferase gene tfpO. These traits were combined and analysed using biological data analysis software and visualized in the form of a minimum spanning tree (MST). We revealed a network of relationships between all analyzed parameters and non-congruence between experiments. At the same time we observed several conserved clones, characterized by an almost identical data set. These observations confirm the nonclonal epidemic population structure of P. aeruginosa, a superficially clonal structure with frequent recombinations, in which occasionally highly successful epidemic clones arise. One of these clones is the renown and widespread MDR serotype O12 clone. On the other hand, we found no evidence for a widespread CF transmissible clone. All but one of the 43 analysed CF strains belonged to a ubiquitous P. aeruginosa "core lineage" and typically exhibited the exoS(+)/exoU(-) genotype and group B oprL and oprD alleles. This is to our knowledge the first report of an MST analysis conducted on a polyphasic data set.			Pirnay, JP (corresponding author), Queen Astrid Mil Hosp, Burn Ctr, Lab Mol & Cellular Technol, Brussels, Belgium.	jean-paul.pirnay@mil.be	Van Eldere, Johan/AAI-8965-2020; Vaneechoutte, Mario/A-6189-2009; Cornelis, Pierre/H-3058-2019; Pot, Bruno DF/I-6645-2012	Vaneechoutte, Mario/0000-0002-4586-203X; Pirnay, Jean-Paul/0000-0002-6863-5219				ALLEMEERSCH D, 1988, EUR J CLIN MICROBIOL, V7, P265, DOI 10.1007/BF01963099; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72; Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; AOKI K, 1926, ZBL BAKTER         1, V98, P186; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Baysse C, 1999, J BACTERIOL, V181, P3849, DOI 10.1128/JB.181.12.3849-3851.1999; Bert F, 1996, J ANTIMICROB CHEMOTH, V37, P809, DOI 10.1093/jac/37.4.809; Bingen E, 1996, J CLIN MICROBIOL, V34, P3226, DOI 10.1128/JCM.34.12.3226-3229.1996; BODILIS J, 2009, ENV MICROBIOL   0421; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Brimicombe RW, 2008, J CYST FIBROS, V7, P30, DOI 10.1016/j.jcf.2007.04.002; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Chambers D, 2005, EUR RESPIR J, V26, P651, DOI 10.1183/09031936.05.00126704; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; CORNELIS P, 1989, INFECT IMMUN, V57, P3491, DOI 10.1128/IAI.57.11.3491-3497.1989; CORNELIS P, 1989, MOL MICROBIOL, V3, P421, DOI 10.1111/j.1365-2958.1989.tb00187.x; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; de Chial M, 2003, MICROBIOL-SGM, V149, P821, DOI 10.1099/mic.0.26136-0; De Vos D, 1998, J BACTERIOL, V180, P6551, DOI 10.1128/JB.180.24.6551-6556.1998; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Denayer S, 2007, J BACTERIOL, V189, P7663, DOI 10.1128/JB.00992-07; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; DeVos D, 1997, J CLIN MICROBIOL, V35, P1295, DOI 10.1128/JCM.35.6.1295-1299.1997; Dubois V, 2001, J CLIN MICROBIOL, V39, P2072, DOI 10.1128/JCM.39.6.2072-2078.2001; ELAICHOUNI A, 1994, J CLIN MICROBIOL, V32, P666, DOI 10.1128/JCM.32.3.666-671.1994; FARMER JJ, 1982, J CLIN MICROBIOL, V16, P266, DOI 10.1128/JCM.16.2.266-270.1982; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Ferguson MW, 2001, INFECT IMMUN, V69, P2198, DOI 10.1128/IAI.69.4.2198-2210.2001; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fluge G, 2001, CLIN MICROBIOL INFEC, V7, P238, DOI 10.1046/j.1469-0691.2001.00247.x; Foght JM, 1996, MICROBIOL-UK, V142, P2333, DOI 10.1099/00221287-142-9-2333; Gallant CV, 2000, MICROBIOL-SGM, V146, P1891, DOI 10.1099/00221287-146-8-1891; Gessard C, 1882, CR ACAD SCI IV-PHYS, V94, P536; Ghysels B, 2004, MICROBIOL-SGM, V150, P1671, DOI 10.1099/mic.0.27035-0; Giammanco A, 1985, Eur J Epidemiol, V1, P104, DOI 10.1007/BF00141801; Goldberg J B, 2000, Trends Microbiol, V8, P55, DOI 10.1016/S0966-842X(99)01671-6; GRATTARD F, 1993, EUR J CLIN MICROBIOL, V12, P57, DOI 10.1007/BF01997061; HAMMAMI S, 2008, PATHOL BIOL PAR 1030; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kettner M, 1995, INFECTION, V23, P380, DOI 10.1007/BF01713571; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; KOBAYASHI I, 1994, J ANTIBIOT, V47, P72, DOI 10.7164/antibiotics.47.72; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; KUZIO J, 1983, J BACTERIOL, V155, P203, DOI 10.1128/JB.155.1.203-212.1983; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; LEGAKIS NJ, 1987, EUR J CLIN MICROBIOL, V6, P300, DOI 10.1007/BF02017618; Lewis DA, 2005, AM J RESP CELL MOL, V33, P56, DOI 10.1165/rcmb.2004-0352OC; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Lim A, 1997, MICROBIOL-SGM, V143, P1709, DOI 10.1099/00221287-143-5-1709; Lin HH, 2006, J CLIN MICROBIOL, V44, P4596, DOI 10.1128/JCM.01531-06; LIU PV, 1983, INT J SYST BACTERIOL, V33, P256, DOI 10.1099/00207713-33-2-256; Livermore DM, 2002, J ANTIMICROB CHEMOTH, V49, P289, DOI 10.1093/jac/49.2.289; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Loureiro MM, 2002, MEM I OSWALDO CRUZ, V97, P387, DOI 10.1590/S0074-02762002000300020; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McCallum SJ, 2001, LANCET, V358, P558, DOI 10.1016/S0140-6736(01)05715-4; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Mifsud AJ, 1997, J HOSP INFECT, V36, P105, DOI 10.1016/S0195-6701(97)90116-X; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; Muller-Premru M, 2000, ZBL BAKT-INT J MED M, V289, P857; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Olson JC, 1999, INFECT IMMUN, V67, P2847, DOI 10.1128/IAI.67.6.2847-2854.1999; PENKETH A, 1983, AM REV RESPIR DIS, V127, P605, DOI 10.1164/arrd.1983.127.5.605; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; PITT TL, 1986, J MED MICROBIOL, V21, P179, DOI 10.1099/00222615-21-2-179; PITT TL, 1989, EPIDEMIOL INFECT, V103, P565, DOI 10.1017/S095026880003096X; Pitt TL, 2002, THORAX, V57, P921, DOI 10.1136/thorax.57.11.921; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Riccio ML, 2005, ANTIMICROB AGENTS CH, V49, P104, DOI 10.1128/AAC.49.1.104-110.2005; RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377; RIPP S, 1994, MOL ECOL, V3, P121, DOI 10.1111/j.1365-294X.1994.tb00112.x; Rocha CL, 2003, INFECT IMMUN, V71, P5296, DOI 10.1128/IAI.71.9.5296-5305.2003; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Ruimy R, 2001, INFECT IMMUN, V69, P584, DOI 10.1128/IAI.69.1.584-588.2001; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; Shen K, 2006, INFECT IMMUN, V74, P5272, DOI 10.1128/IAI.00546-06; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Tassios PT, 1998, J CLIN MICROBIOL, V36, P897, DOI 10.1128/JCM.36.4.897-901.1998; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TRIAS J, 1990, J BIOL CHEM, V265, P15680; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; TSAKRIS A, 1992, EUR J EPIDEMIOL, V8, P865, DOI 10.1007/BF00145334; Tummler B, 2005, J BACTERIOL, V187, P3289, DOI 10.1128/JB.187.10.3289-3292.2005; Van Daele SG, 2005, EUR RESPIR J, V25, P474, DOI 10.1183/09031936.05.00050304; VANBELKUM A, 1996, ZENTRALBL BAKTERIOL, V1045, P249; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vauterin L, 2006, MOL IDENTIFICATION S, P141; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wareham DW, 2007, INT J MED MICROBIOL, V297, P227, DOI 10.1016/j.ijmm.2007.02.004; Watine J, 1999, PATHOL BIOL, V47, P457; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; ZIERDT CH, 1975, J CLIN MICROBIOL, V1, P521, DOI 10.1128/JCM.1.6.521-526.1975; 2001, PATHOL BIOL PARIS, V49, P620	119	156	161	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7740	10.1371/journal.pone.0007740	http://dx.doi.org/10.1371/journal.pone.0007740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19936230	Green Submitted, Green Published, gold			2022-12-27	WOS:000271721900005
J	Apple, JL; Wink, M; Wills, SE; Bishop, JG				Apple, Jennifer L.; Wink, Michael; Wills, Shannon E.; Bishop, John G.			Successional Change in Phosphorus Stoichiometry Explains the Inverse Relationship between Herbivory and Lupin Density on Mount St. Helens	PLOS ONE			English	Article							BOTTOM-UP FORCES; INSECT HERBIVORES; NITROGEN; PLANT; GROWTH; TERRESTRIAL; POPULATION; IMPACT; CONSEQUENCES; LEPIDOPTERA	Background: The average nitrogen-to-phosphorus ratio (N:P) of insect herbivores is less than that of leaves, suggesting that P may mediate plant-insect interactions more often than appreciated. We investigated whether succession-related heterogeneity in N and P stoichiometry influences herbivore performance on N-fixing lupin (Lupinus lepidus) colonizing primary successional volcanic surfaces, where the abundances of several specialist lepidopteran herbivores are inversely related to lupin density and are known to alter lupin colonization dynamics. We examined larval performance in response to leaf nutritional characteristics using gelechiid and pyralid leaf-tiers, and a noctuid leaf-cutter. Methodology/Principal Findings: We conducted four studies. First, growth of larvae raised on wild-collected leaves responded positively to leaf % P and negatively to leaf carbon (% C), but there was no effect of % N or quinolizidine alkaloids (QAs). Noctuid survival was also positively related to % P. Second, we raised gelechiid larvae on greenhouse-grown lupins with factorial manipulation of competitors and soil N and P. In the presence of competition, larval mass was highest at intermediate leaf N: P and high % P. Third, survival of gelechiid larvae placed on lupins in high-density patches was greater when plant competitors were removed than on controls. Fourth, surveys of field-collected leaves in 2000, 2002, and 2003 indicated that both % P and % N were generally greater in plants from low-density areas. QAs in plants from low-density areas were equal to or higher than QAs in high-density areas. Conclusions/Significance: Our results demonstrate that declines in lupin P content under competitive conditions are associated with decreased larval growth and survival sufficient to cause the observed negative relationship between herbivore abundance and host density. The results support the theoretical finding that declines in stoichiometric resource quality (caused here by succession) have the potential to cause a decrease in consumer abundance despite very dense quantities of the resource.			Apple, JL (corresponding author), SUNY Coll Geneseo, Dept Biol, Geneseo, NY 14454 USA.	bishopj@vancouver.wsu.edu	Wink, Michael/E-3803-2012	Wink, Michael/0000-0002-7875-4510				Adamski D, 2009, P ENTOMOL SOC WASH, V111, P293, DOI 10.4289/0013-8797-111.2.293; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Behmer ST, 2002, ECOLOGY, V83, P2489, DOI 10.1890/0012-9658(2002)083[2489:HFICHE]2.0.CO;2; Bishop JG, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P151, DOI 10.1007/0-387-28150-9_11; Bishop JG, 2002, ECOLOGY, V83, P191; BISHOP JG, PLONS ONE IN PRESS; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Busch JW, 1999, ECOL ENTOMOL, V24, P132, DOI 10.1046/j.1365-2311.1999.00185.x; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CAREY DB, 1994, J CHEM ECOL, V20, P849, DOI 10.1007/BF02059582; Chen Y, 2004, HORTSCIENCE, V39, P545, DOI 10.21273/HORTSCI.39.3.545; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; Crawley M.J., 2007, R BOOK; del Moral R, 2005, PLANT ECOL, V181, P203, DOI 10.1007/s11258-005-6627-4; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Fagan WF, 2005, AM NAT, V166, P669, DOI 10.1086/497621; Fagan WF, 2004, ECOL ENTOMOL, V29, P398, DOI 10.1111/j.0307-6946.2004.00616.x; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; Gill RA, 2006, OECOLOGIA, V148, P312, DOI 10.1007/s00442-006-0358-7; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Halvorson JJ, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P243, DOI 10.1007/0-387-28150-9_17; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; HUNTER MD, 1991, OECOLOGIA, V86, P62, DOI 10.1007/BF00317390; JANSSEN JAM, 1994, B ENTOMOL RES, V84, P233, DOI 10.1017/S0007485300039742; JOHNSON ND, 1989, J CHEM ECOL, V15, P2425, DOI 10.1007/BF01020373; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kyto M, 1996, OIKOS, V75, P148, DOI 10.2307/3546238; McNeill S., 1978, BIOCH ASPECTS PLANT, P77; MORRIS WF, 1989, ECOLOGY, V70, P697, DOI 10.2307/1940220; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; RAUBENHEIMER D, 1995, FUNCT ECOL, V9, P21, DOI 10.2307/2390086; RAUBENHEIMER D, 1992, ENTOMOL EXP APPL, V62, P221, DOI 10.1007/BF00353441; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Ritchie ME, 2000, ECOLOGY, V81, P1601, DOI 10.1890/0012-9658(2000)081[1601:NLATVA]2.0.CO;2; SCHADE JD, 2003, ECOL LETT, V6, P1; SKINNER RH, 1994, ENVIRON ENTOMOL, V23, P693, DOI 10.1093/ee/23.3.693; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; Strengbom J, 2005, OECOLOGIA, V143, P241, DOI 10.1007/s00442-004-1799-5; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Titus JH, 1998, PLANT ECOL, V134, P13, DOI 10.1023/A:1009765502741; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Waring Gwendolyn L., 1992, P167; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; White T. C. R., 1993, INADEQUATE ENV NITRO; WINK M, 1995, PHYTOCHEMISTRY, V38, P139, DOI 10.1016/0031-9422(95)91890-D; Wink M, 1992, INSECT PLANT INTERAC, P133; Woods HA, 2004, FUNCT ECOL, V18, P103, DOI 10.1111/j.1365-2435.2004.00823.x	57	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2009	4	11							e7807	10.1371/journal.pone.0007807	http://dx.doi.org/10.1371/journal.pone.0007807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518UW	19907662	Green Published, gold			2022-12-27	WOS:000271721400008
J	Pang, YP; Vummenthala, A; Mishra, RK; Park, JG; Wang, SH; Davis, J; Millard, CB; Schmidt, JJ				Pang, Yuan-Ping; Vummenthala, Anuradha; Mishra, Rajesh K.; Park, Jewn Giew; Wang, Shaohua; Davis, Jon; Millard, Charles B.; Schmidt, James J.			Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; NORMAL-MODE-ANALYSIS; DYNAMICS SIMULATION; ZINC-ENDOPEPTIDASE; SUBSTRATE-SPECIFICITY; PROTEOLYTIC ACTIVITY; TOXIN; IDENTIFICATION; PROTEINS; AMBER	Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism. Current treatment for post exposure of BoNTA uses antibodies that are effective in neutralizing the extracellular toxin to prevent further intoxication but generally cannot rescue already intoxicated neurons. Effective small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are desirable because such inhibitors potentially can neutralize the intracellular BoNTA and offer complementary treatment for botulism. Previously we reported a serotype-selective, small-molecule BoNTAe inhibitor with a K(i)(app) value of 3.8 +/- 0.8 mu M. This inhibitor was developed by lead identification using virtual screening followed by computer-aided optimization of a lead with an IC(50) value of 100 mu M. However, it was difficult to further improve the lead from micromolar to even high nanomolar potency due to the unusually large enzyme-substrate interface of BoNTAe. The enzyme-substrate interface area of 4,840 angstrom(2) for BoNTAe is about four times larger than the typical protein-protein interface area of 750-1,500 angstrom(2). Inhibitors must carry several functional groups to block the unusually large interface of BoNTAe, and syntheses of such inhibitors are therefore time-consuming and expensive. Herein we report the development of a serotype-selective, small-molecule, and competitive inhibitor of BoNTAe with a K(i) value of 760 +/- 170 nM using synthesis-based computer-aided molecular design (SBCAMD). This new approach accounts the practicality and efficiency of inhibitor synthesis in addition to binding affinity and selectivity. We also report a three-dimensional model of BoNTAe in complex with the new inhibitor and the dynamics of the complex predicted by multiple molecular dynamics simulations, and discuss further structural optimization to achieve better in vivo efficacy in neutralizing BoNTA than those of our early micromolar leads. This work provides new insight into structural modification of known small-molecule BoNTAe inhibitors. It also demonstrates that SBCAMD is capable of improving potency of an inhibitor lead by nearly one order of magnitude, even for BoNTAe as one of the most challenging protein targets. The results are insightful for developing effective small-molecule inhibitors of protein targets with large active sites.			Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu; james.schmidt@det.amedd.army.mil		Pang, Yuan-Ping/0000-0003-0838-2560				Ariffin A, 2004, SYNTHETIC COMMUN, V34, P4439, DOI 10.1081/SCC-200043164; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Blommaert A, 2004, BIOORGAN MED CHEM, V12, P3055, DOI 10.1016/j.bmc.2004.03.006; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; COREY EJ, 1988, CHEM SOC REV, V17, P111, DOI 10.1039/cs9881700111; Crowner BE, 2007, CLIN NEUROPHARMACOL, V30, P310, DOI 10.1097/WNF.0B013E31804B1A0D; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; El Yazal J, 2000, J PHYS CHEM B, V104, P6662, DOI 10.1021/jp994283x; El Yazal J, 1999, J PHYS CHEM B, V103, P8773, DOI 10.1021/jp991787m; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FARNIER M, 1973, B SOC CHIM FR, P351; *FDA, 2003, BOT IMM GLOB INTR HU; Frisch M J, 1999, GAUSSIAN 98 REVISION; GARRIDO DOA, 1988, J ORG CHEM, V53, P403, DOI 10.1021/jo00237a032; HASS HB, 1949, J AM CHEM SOC, V71, P1767, DOI 10.1021/ja01173a066; Ho CY, 2005, J ORG CHEM, V70, P4873, DOI 10.1021/jo050036f; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson SL, 2008, CHEM BIOL DRUG DES, V71, P131, DOI 10.1111/j.1747-0285.2007.00617.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kessler KR, 1997, NEUROTOXICOLOGY, V18, P761; Larsen JC, 2009, DRUG DEVELOP RES, V70, P266, DOI 10.1002/ddr.20304; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; MOOTOO DR, 1989, TETRAHEDRON LETT, V30, P2363, DOI 10.1016/S0040-4039(01)80399-3; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2004, BIOORGAN MED CHEM, V12, P3063, DOI 10.1016/j.bmc.2004.02.026; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; SEGEL IH, 1975, ENZYME KINETICS BEHA, V12, P109; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Smith JA, 2006, ORG BIOMOL CHEM, V4, P2477, DOI 10.1039/b604692d; Smith K, 2007, J ORG CHEM, V72, P1031, DOI 10.1021/jo062024f; SPRINGEN K, 2002, NEWSWEEK, P50; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; VASILEVSKII SF, 1980, B ACAD SCI USSR CH+, V29, P1346, DOI 10.1007/BF00950586; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001025; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Zhang Q, 2000, J ORG CHEM, V65, P7977, DOI 10.1021/jo000978e; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	64	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7730	10.1371/journal.pone.0007730	http://dx.doi.org/10.1371/journal.pone.0007730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901994	Green Published, Green Submitted, gold			2022-12-27	WOS:000271658800004
J	Holford, M; Puillandre, N; Modica, MV; Watkins, M; Collin, R; Bermingham, E; Olivera, BM				Holford, Mande; Puillandre, Nicolas; Modica, Maria Vittoria; Watkins, Maren; Collin, Rachel; Bermingham, Eldredge; Olivera, Baldomero M.			Correlating Molecular Phylogeny with Venom Apparatus Occurrence in Panamic Auger Snails (Terebridae)	PLOS ONE			English	Article							CONUS; DISCOVERY; EVOLUTION; PEPTIDE	Central to the discovery of neuroactive compounds produced by predatory marine snails of the superfamily Conoidea (cone snails, terebrids, and turrids) is identifying those species with a venom apparatus. Previous analyses of western Pacific terebrid specimens has shown that some Terebridae groups have secondarily lost their venom apparatus. In order to efficiently characterize terebrid toxins, it is essential to devise a key for identifying which species have a venom apparatus. The findings presented here integrate molecular phylogeny and the evolution of character traits to infer the presence or absence of the venom apparatus in the Terebridae. Using a combined dataset of 156 western and 33 eastern Pacific terebrid samples, a phylogenetic tree was constructed based on analyses of 16S, COI and 12S mitochondrial genes. The 33 eastern Pacific specimens analyzed represent four different species: Acus strigatus, Terebra argyosia, T. ornata, and T. cf. formosa. Anatomical analysis was congruent with molecular characters, confirming that species included in the clade Acus do not have a venom apparatus, while those in the clade Terebra do. Discovery of the association between terebrid molecular phylogeny and the occurrence of a venom apparatus provides a useful tool for effectively identifying the terebrid lineages that may be investigated for novel pharmacological active neurotoxins, enhancing conservation of this important resource, while providing supplementary information towards understanding terebrid evolutionary diversification.			Holford, M (corresponding author), City Univ New York York Coll, New York, NY USA.	mholford@york.cuny.edu	Puillandre, Nicolas/C-9208-2012; Collin, Rachel/G-2001-2010; Modica, Maria Vittoria/P-8407-2018; Collin, Rachel/Q-7100-2019	Modica, Maria Vittoria/0000-0003-2532-6763; Collin, Rachel/0000-0001-5103-4460; Holford, Mande/0000-0001-9476-2687	NIGMS NIH HHS [GM48677, P01 GM048677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRATCHER T, 1987, LIVING TEREBRAS WORL; BULAJ G, 2008, CURRENT OPINION CHEM, V12, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IMPERIAL J, 2007, J EXP ZOOL PART B, V308, P1; Imperial JS, 2003, TOXICON, V42, P391, DOI 10.1016/S0041-0101(03)00169-7; Imperial JS, 2007, P AM PHILOS SOC, V151, P185; KEEN AM, 1972, SEA SHELLS TROPICAL; KOHN AJ, 1959, ECOL MONOGR, V29, P47, DOI 10.2307/1948541; McIntosh JM, 2000, J BIOL CHEM, V275, P32391, DOI 10.1074/jbc.M003619200; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; MILLER BA, 1975, PAC SCI, V29, P227; MILLER BA, 1970, ANN REP AM MAL UNION, V1971, P72; MILLER BA, 1970, THESIS U NEW HAMPSHI; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Puillandre N, 2008, MOL PHYLOGENET EVOL, V47, P1122, DOI 10.1016/j.ympev.2007.11.007; Remigio EA, 2008, MOL ECOL, V17, P1156, DOI 10.1111/j.1365-294X.2007.03627.x; SIMON C, 1991, POLYM CHAIN REACTION, P329; TAYLOR JD, 1990, MALACOLOGIA, V32, P19; Taylor John D., 1993, Bulletin of the British Museum (Natural History) Zoology, V59, P125; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; TERRYN Y, 2008, TEREBRIDAE VANUATU S, V3	30	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7667	10.1371/journal.pone.0007667	http://dx.doi.org/10.1371/journal.pone.0007667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890382	Green Submitted, Green Published, gold			2022-12-27	WOS:000271459700003
J	Zhu, H; Bendall, AJ				Zhu, Hui; Bendall, Andrew J.			Dlx5 Is a Cell Autonomous Regulator of Chondrocyte Hypertrophy in Mice and Functionally Substitutes for Dlx6 during Endochondral Ossification	PLOS ONE			English	Article							SKELETAL DEVELOPMENT; HOMEOBOX GENES; OSTEOBLAST DIFFERENTIATION; CARTILAGE DIFFERENTIATION; CBFA1-DEFICIENT MICE; INDIAN HEDGEHOG; BONE-FORMATION; EXPRESSION; FAMILY; RUNX2	The axial and appendicular skeleton of vertebrates develops by endochondral ossification, in which skeletogenic tissue is initially cartilaginous and the differentiation of chondrocytes via the hypertrophic pathway precedes the differentiation of osteoblasts and the deposition of a definitive bone matrix. Results from both loss-of-function and misexpression studies have implicated the related homeobox genes Dlx5 and Dlx6 as partially redundant positive regulators of chondrocyte hypertrophy. However, experimental perturbations of Dlx expression have either not been cell type specific or have been done in the context of endogenous Dlx5 expression. Thus, it has not been possible to conclude whether the effects on chondrocyte differentiation are cell autonomous or whether they are mediated by Dlx expression in adjacent tissues, notably the perichondrium. To address this question we first engineered transgenic mice in which Dlx5 expression was specifically restricted to immature and differentiating chondrocytes and not the perichondrium. Col2a1-Dlx5 transgenic embryos and neonates displayed accelerated chondrocyte hypertrophy and mineralization throughout the endochondral skeleton. Furthermore, this transgene specifically rescued defects of chondrocyte differentiation characteristic of the Dlx5/ 6 null phenotype. Based on these results, we conclude that the role of Dlx5 in the hypertrophic pathway is cell autonomous. We further conclude that Dlx5 and Dlx6 are functionally equivalent in the endochondral skeleton, in that the requirement for Dlx5 and Dlx6 function during chondrocyte hypertrophy can be satisfied with Dlx5 alone.	[Zhu, Hui; Bendall, Andrew J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Zhu, H (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	abendall@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RG249773-02]; Canadian Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	This work was supported by Discovery grant RG249773-02 from the Natural Sciences and Engineering Research Council of Canada and equipment grants from NSERC, the Canadian Foundation for Innovation and the Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Bendall AJ, 2003, INT J DEV BIOL, V47, P335; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Chen XW, 1996, ANN NY ACAD SCI, V785, P38, DOI 10.1111/j.1749-6632.1996.tb56242.x; Chin HJ, 2007, DEV GROWTH DIFFER, V49, P515, DOI 10.1111/j.1440-169x.2007.00940.x; Choi KY, 2002, EXP MOL MED, V34, P426, DOI 10.1038/emm.2002.60; Cohen MM, 2000, J CRAN GENET DEV BIO, V20, P84; Crochiere ML, 2008, INT J DEV BIOL, V52, P63, DOI 10.1387/ijdb.072322mc; Crowe R, 1999, DEVELOPMENT, V126, P987; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; de la Fuente L, 2005, DEV BIOL, V282, P294, DOI 10.1016/j.ydbio.2005.03.036; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eames B. Frank, 2003, Birth Defects Research, V69, P93, DOI 10.1002/bdrc.10016; Eames BF, 2004, DEV BIOL, V274, P188, DOI 10.1016/j.ydbio.2004.07.006; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FERRARI D, 1995, MECH DEVELOP, V52, P257, DOI 10.1016/0925-4773(95)98113-O; Ferrari D, 2002, DEV BIOL, V252, P257, DOI 10.1006/dbio.2002.0862; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hsu SC, 2006, MECH DEVELOP, V123, P819, DOI 10.1016/j.mod.2006.08.005; Huang RJ, 2000, ANAT EMBRYOL, V202, P375, DOI 10.1007/s004290000131; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; ZHAO GQ, 1994, DEV BIOL, V164, P37, DOI 10.1006/dbio.1994.1178; ZHOU G, 1995, J CELL SCI, V108, P3677; Zhu H, 2006, INT J DEV BIOL, V50, P71, DOI 10.1387/ijdb.052087hz; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	57	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8097	10.1371/journal.pone.0008097	http://dx.doi.org/10.1371/journal.pone.0008097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956613	Green Submitted, gold, Green Published			2022-12-27	WOS:000272828400032
J	Dayon, A; Brizuela, L; Martin, C; Mazerolles, C; Pirot, N; Doumerc, N; Nogueira, L; Goizio, M; Teissie, J; Serre, G; Rischmann, P; Malavaud, B; Cuvillier, O				Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Mazerolles, Catherine; Pirot, Nelly; Doumerc, Nicolas; Nogueira, Leonor; Goizio, Muriel; Teissie, Justin; Serre, Guy; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier			Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival	PLOS ONE			English	Article							INDUCED NEUROENDOCRINE DIFFERENTIATION; MYELOID-LEUKEMIA CELLS; RADICAL PROSTATECTOMY; DEPRIVATION THERAPY; ADENOCARCINOMA CELL; TUMOR-GROWTH; CYCLIC-AMP; PROGRESSION; APOPTOSIS; LNCAP	Background: Sphingosine kinase-1 (SphK1) is an oncogenic lipid kinase notably involved in response to anticancer therapies in prostate cancer. Androgens regulate prostate cancer cell proliferation, and androgen deprivation therapy is the standard of care in the management of patients with advanced disease. Here, we explored the role of SphK1 in the regulation of androgen-dependent prostate cancer cell growth and survival. Methodology/Principal Findings: Short-term androgen removal induced a rapid and transient SphK1 inhibition associated with a reduced cell growth in vitro and in vivo, an event that was not observed in the hormono-insensitive PC-3 cells. Supporting the critical role of SphK1 inhibition in the rapid effect of androgen depletion, its overexpression could impair the cell growth decrease. Similarly, the addition of dihydrotestosterone (DHT) to androgen-deprived LNCaP cells re-established cell proliferation, through an androgen receptor/PI3K/Akt dependent stimulation of SphK1, and inhibition of SphK1 could markedly impede the effects of DHT. Conversely, long-term removal of androgen support in LNCaP and C4-2B cells resulted in a progressive increase in SphK1 expression and activity throughout the progression to androgen-independence state, which was characterized by the acquisition of a neuroendocrine (NE)-like cell phenotype. Importantly, inhibition of the PI3K/Akt pathway-by negatively impacting SphK1 activity-could prevent NE differentiation in both cell models, an event that could be mimicked by SphK1 inhibitors. Fascinatingly, the reversability of the NE phenotype by exposure to normal medium was linked with a pronounced inhibition of SphK1 activity. Conclusions/Significance: We report the first evidence that androgen deprivation induces a differential effect on SphK1 activity in hormone-sensitive prostate cancer cell models. These results also suggest that SphK1 activation upon chronic androgen deprivation may serve as a compensatory mechanism allowing prostate cancer cells to survive in androgen-depleted environment, giving support to its inhibition as a potential therapeutic strategy to delay/prevent the transition to androgen-independent prostate cancer.	[Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Mazerolles, Catherine; Goizio, Muriel; Teissie, Justin; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] Inst Pharmacol & Biol Struct, CNRS, Toulouse, France; [Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Pirot, Nelly; Doumerc, Nicolas; Goizio, Muriel; Teissie, Justin; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] Univ Toulouse, UPS, IPBS, Toulouse, France; [Doumerc, Nicolas; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] CHU Toulouse, Hop Rangueil, Serv Urol & Transplantat Renale, Toulouse, France; [Mazerolles, Catherine] CHU Toulouse, Hop Rangueil, Lab Anat Pathol & Histol Cytol, Toulouse, France; [Nogueira, Leonor; Serre, Guy] CHU Toulouse, Hop Purpan, Lab Biol Cellulaire & Cytol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; CHU de Toulouse	Dayon, A (corresponding author), Inst Pharmacol & Biol Struct, CNRS, Toulouse, France.	olivier.cuvillier@ipbs.fr	CUVILLIER, Olivier/B-2567-2009; Nogueira, Leonor/L-2034-2014; Teissie, Justin/AAA-5697-2019; Brizuela, Leyre/B-1175-2010; CUVILLIER, Olivier/S-1631-2019; Golzio, Muriel/F-4715-2019	CUVILLIER, Olivier/0000-0003-3346-375X; Teissie, Justin/0000-0002-7588-8062; CUVILLIER, Olivier/0000-0003-3346-375X; Golzio, Muriel/0000-0002-7470-3708	Inserm; CNRS; Fondation pour la Recherche Medicale; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by Inserm, CNRS, Fondation pour la Recherche Medicale, Association pour la Recherche sur les Tumeurs de la Prostate, and Institut National du Cancer (to OC). AD is recipient of the Ministere de l'Enseignement Superieur et de la Recherche and La Ligue Nationale Contre le Cancer. CM is recipient of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Cox ME, 1999, CANCER RES, V59, P3821; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Eto M, 2003, PROSTATE, V57, P66, DOI 10.1002/pros.10275; French KJ, 2003, CANCER RES, V63, P5962; Goodin JL, 2002, MOL CARCINOGEN, V33, P88, DOI 10.1002/mc.10025.abs; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Ismail AHR, 2002, PROSTATE, V51, P117, DOI 10.1002/pros.10066; Ito T, 2001, ONCOL REP, V8, P1221; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Jongsma J, 2000, CANCER RES, V60, P741; Kamiya N, 2003, EUR UROL, V44, P309, DOI 10.1016/S0302-2838(03)00303-8; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Lu S, 2006, INT J ONCOL, V28, P245; Machwate M, 1998, MOL PHARMACOL, V54, P70, DOI 10.1124/mol.54.1.70; Malik SN, 2002, CLIN CANCER RES, V8, P1168; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nava VE, 2000, CANCER RES, V60, P4468; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sauer L, 2009, INT J CANCER, V125, P2728, DOI 10.1002/ijc.24640; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Shi XB, 2004, PROSTATE, V60, P257, DOI 10.1002/pros.20039; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wu CY, 2006, PROSTATE, V66, P1125, DOI 10.1002/pros.20412; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yang XZ, 2005, CANCER RES, V65, P5263, DOI 10.1158/0008-5472.CAN-05-0162; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; ZINCKE H, 1994, J UROLOGY, V152, P1850, DOI 10.1016/S0022-5347(17)32399-6	55	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8048	10.1371/journal.pone.0008048	http://dx.doi.org/10.1371/journal.pone.0008048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956567	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828100008
J	Gupta, V; Gupta, RK; Khare, G; Salunke, DM; Tyagi, AK				Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Salunke, Dinakar M.; Tyagi, Anil K.			Crystal Structure of Bfr A from Mycobacterium tuberculosis: Incorporation of Selenomethionine Results in Cleavage and Demetallation of Haem	PLOS ONE			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; IRON STORAGE; AZOTOBACTER-VINELANDII; DINUCLEAR SITE; FERRITIN; FERROXIDASE; EXPRESSION; RESOLUTION; OXIDATION	Emergence of tuberculosis as a global health threat has necessitated an urgent search for new antitubercular drugs entailing determination of 3-dimensional structures of a large number of mycobacterial proteins for structure-based drug design. The essential requirement of ferritins/bacterioferritins (proteins involved in iron storage and homeostasis) for the survival of several prokaryotic pathogens makes these proteins very attractive targets for structure determination and inhibitor design. Bacterioferritins (Bfrs) differ from ferritins in that they have additional noncovalently bound haem groups. The physiological role of haem in Bfrs is not very clear but studies indicate that the haem group is involved in mediating release of iron from Bfr by facilitating reduction of the iron core. To further enhance our understanding, we have determined the crystal structure of the selenomethionyl analog of bacterioferritin A (SeMet-BfrA) from Mycobacterium tuberculosis (Mtb). Unexpectedly, electron density observed in the crystals of SeMet-BfrA analogous to haem location in bacterioferritins, shows a demetallated and degraded product of haem. This unanticipated observation is a consequence of the altered spatial electronic environment around the axial ligands of haem (in lieu of Met52 modification to SeMet52). Furthermore, the structure of Mtb SeMet-BfrA displays a possible lost protein interaction with haem propionates due to formation of a salt bridge between Arg53-Glu57, which appears to be unique to Mtb BfrA, resulting in slight modulation of haem binding pocket in this organism. The crystal structure of Mtb SeMet-BfrA provides novel leads to physiological function of haem in Bfrs. If validated as a drug target, it may also serve as a scaffold for designing specific inhibitors. In addition, this study provides evidence against the general belief that a selenium derivative of a protein represents its true physiological native structure.	[Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Tyagi, Anil K.] Univ Delhi S Campus, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Ram Lal Anand Coll, New Delhi, India; [Salunke, Dinakar M.] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, V (corresponding author), Univ Delhi S Campus, Dept Biochem, New Delhi, India.	dinakar@nii.res.in; aniltyagi@south.du.ac.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by financial grant received from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; BERNARD AR, 1995, EUR J BIOCHEM, V230, P111, DOI 10.1111/j.1432-1033.1995.tb20540.x; Bonnett R, 1973, J Chem Soc Perkin 1, V9, P881; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Cobessi D, 2002, ACTA CRYSTALLOGR D, V58, P29, DOI 10.1107/S0907444901017267; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crichton R., 2001, INORGANIC BIOCH IRON; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; GRANICK JL, 1978, J BIOL CHEM, V253, P5402; Gupta V, 2008, ACTA CRYSTALLOGR F, V64, P398, DOI 10.1107/S1744309108007240; ISHII DN, 1978, NATURE, V274, P372, DOI 10.1038/274372a0; Janowski R, 2008, PROTEIN SCI, V17, P1138, DOI 10.1110/ps.034819.108; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; MANCUSO C, 2009, CURR DRUG METAB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller CD, 2000, GENE, V247, P199, DOI 10.1016/S0378-1119(00)00095-0; O'Regan A, 2001, BRIT MED J, V323, P635, DOI 10.1136/bmj.323.7313.635b; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; PATAI S, 1986, CHEM ORGANIC SELENIU; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Powell AK, 1998, MET IONS BIOL SYST, V35, P515; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; VERCELLOTTI GM, 1994, ARTIF CELL BLOOD SUB, V22, P207, DOI 10.3109/10731199409117415; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f	51	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8028	10.1371/journal.pone.0008028	http://dx.doi.org/10.1371/journal.pone.0008028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946376	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827800016
J	Ogura, T; Tan, AJ; Tsubota, T; Nakakura, T; Shiotsuki, T				Ogura, Takehiko; Tan, Anjiang; Tsubota, Takuya; Nakakura, Takayo; Shiotsuki, Takahiro			Identification and Expression Analysis of Ras Gene in Silkworm, Bombyx mori	PLOS ONE			English	Article							KINASE SIGNALING PATHWAYS; ACTIVATED PROTEIN-KINASE; DROSOPHILA EGF RECEPTOR; GTP-BINDING PROTEINS; SMALL GTPASES; COUPLED RECEPTORS; PROTHORACIC GLAND; TYROSINE KINASES; CELL-ADHESION; FISSION YEAST	Ras proteins play important roles in development especially for cell proliferation and differentiation in various organisms. However, their functions in the most insect species are still not clear. We identified three ras cDNAs from the silk worm, Bombyx mori. These sequences corresponded to three Ras of Drosophila melanogaster, but not to three mammalian Ras (HRas, K-Ras, N-Ras). Subsequently, the expression profiles of ras were investigated by quantitative real-time PCR using whole body of individuals from the embryonic to adult stages, and various tissues of 4th and 5th instar larvae. Each of three Bombyx ras showed different expression patterns. We also showed membrane localization of their products. These results indicate that the three Bombyx Ras are functional and have different roles.	[Tan, Anjiang; Tsubota, Takuya; Nakakura, Takayo; Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Invertebrate Gene Funct Res Unit, Tsukuba, Ibaraki, Japan; [Ogura, Takehiko] Kyoto Univ, Dept Appl Life Sci, Kyoto, Japan	National Institute of Agrobiological Sciences - Japan; Kyoto University	Shiotsuki, T (corresponding author), Natl Inst Agrobiol Sci, Invertebrate Gene Funct Res Unit, Tsukuba, Ibaraki, Japan.	shiotsuk@affrc.go.jp	Ogura, Takehiko/AAV-2708-2021	Tsubota, Takuya/0000-0002-5839-4570	Ministry of Education, Culture, Sports, Science and Technology, Japan [18580057]; Ministry of Agriculture, Forestry, and Fisheries; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), grants-in-aid for Scientific Research (no. 18580057) from Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants-in-aid for the "Insect Technology Project'' from the Ministry of Agriculture, Forestry, and Fisheries to TS. TO is a recipient of Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2000, J BIOCHEM, V127, P627, DOI 10.1093/oxfordjournals.jbchem.a022650; Arellano M, 1999, MICROSC RES TECHNIQ, V47, P51, DOI 10.1002/(SICI)1097-0029(19991001)47:1<51::AID-JEMT5>3.0.CO;2-3; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; BAUMANN P, 1993, DEVELOPMENT, P65; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROCK HW, 1987, GENE, V51, P129, DOI 10.1016/0378-1119(87)90301-5; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chen GC, 2004, CURR BIOL, V14, P309, DOI 10.1016/j.cub.2004.01.056; Chubb JR, 2001, BBA-GEN SUBJECTS, V1525, P262, DOI 10.1016/S0304-4165(01)00111-8; Ciocan CM, 2005, ENVIRON SCI TECHNOL, V39, P3029, DOI 10.1021/es0400887; CLIFFORD RJ, 1989, GENETICS, V123, P771; de Gunzburg J, 1999, CELL BIOL TOXICOL, V15, P345, DOI 10.1023/A:1007645631013; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; DIAZBENJUMEA FJ, 1990, P ROY SOC B-BIOL SCI, V242, P36, DOI 10.1098/rspb.1990.0100; DIAZGUERRA M, 1989, BIOCHEM BIOPH RES CO, V162, P802, DOI 10.1016/0006-291X(89)92381-4; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hariharan IK, 2005, DEV CELL, V8, P303, DOI 10.1016/j.devcel.2005.02.006; HARVEY JJ, 1964, NATURE, V204, P1104, DOI 10.1038/2041104b0; Helmreich EJM, 2004, BIOL CHEM, V385, P1121, DOI 10.1515/BC.2004.146; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; Huang CF, 1999, J EXP ZOOL, V283, P510, DOI 10.1002/(SICI)1097-010X(19990501)283:6<510::AID-JEZ2>3.3.CO;2-4; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KIRSTEN WH, 1967, J NATL CANCER I, V39, P311; LEV Z, 1985, MOL CELL BIOL, V5, P1540, DOI 10.1128/MCB.5.6.1540; Li WX, 2005, DEV DYNAM, V232, P656, DOI 10.1002/dvdy.20295; Lowes VL, 2002, NEUROSIGNALS, V11, P5, DOI 10.1159/000057317; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; MARSHALL CJ, 1982, NATURE, V299, P171, DOI 10.1038/299171a0; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; MOZER B, 1985, MOL CELL BIOL, V5, P885, DOI 10.1128/MCB.5.4.885; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rybczynski R, 2006, MOL CELL ENDOCRINOL, V251, P78, DOI 10.1016/j.mce.2006.02.015; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SCHEJTER ED, 1985, EMBO J, V4, P407, DOI 10.1002/j.1460-2075.1985.tb03643.x; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SEGAL D, 1986, MOL CELL BIOL, V6, P2241, DOI 10.1128/MCB.6.6.2241; Sepp-Lorenzino L, 2001, PROSTATE CANCER P D, V4, P33, DOI 10.1038/sj.pcan.4500491; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SHILO BZ, 1981, P NATL ACAD SCI-BIOL, V78, P6789, DOI 10.1073/pnas.78.11.6789; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Ward RE, 2003, GENETICS, V165, P1397; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; WILLECKE K, 1984, HUM GENET, V66, P132, DOI 10.1007/BF00286587	77	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8030	10.1371/journal.pone.0008030	http://dx.doi.org/10.1371/journal.pone.0008030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946625	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827800018
J	Matthys, F; Rigouts, L; Sizaire, V; Vezhnina, N; Lecoq, M; Golubeva, V; Portaels, F; Van der Stuyft, P; Kimerling, M				Matthys, Francine; Rigouts, Leen; Sizaire, Vinciane; Vezhnina, Natalia; Lecoq, Maryvonne; Golubeva, Vera; Portaels, Francoise; Van der Stuyft, Patrick; Kimerling, Michael			Outcomes after Chemotherapy with WHO Category II Regimen in a Population with High Prevalence of Drug Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MIXED INFECTION; MDR-TB; OUTBREAK; PATTERNS; STRAINS; GEORGIA; PRISONS; RUSSIA	Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated treatment outcomes after standardized chemotherapy with the WHO recommended category II retreatment regimen in a prison with a high prevalence of drug resistant tuberculosis (TB). A cohort of 233 culture positive TB patients was followed through smear microscopy, culture, drug susceptibility testing and DNA fingerprinting at baseline, after 3 months and at the end of treatment. Overall 172 patients (74%) became culture negative, while 43 (18%) remained positive at the end of treatment. Among those 43 cases, 58% of failures were determined to be due to treatment with an inadequate drug regimen and 42% to either an initial mixed infection or re-infection while under treatment. Overall, drug resistance amplification during treatment occurred in 3.4% of the patient cohort. This study demonstrates that treatment failure is linked to initial drug resistance, that amplification of drug resistance occurs, and that mixed infection and re-infection during standard treatment contribute to treatment failure in confined settings with high prevalence of drug resistance.	[Matthys, Francine; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Rigouts, Leen; Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Sizaire, Vinciane; Lecoq, Maryvonne] Med Sans Frontieres, Brussels, Belgium; [Vezhnina, Natalia] AIDS Fdn EW, HIV TB Penal Syst Projects Cent Asian Republ, Alma Ata, Kazakhstan; [Golubeva, Vera] Lab Mycobacteriol, Mariinsk, Kemorovo, Russia; [Kimerling, Michael] Univ Alabama, Birmingham, AL USA	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Doctors Without Borders; University of Alabama System; University of Alabama Birmingham	Matthys, F (corresponding author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium.	fmatthys@itg.be			Medecins Sans Frontieres, Brussels	Medecins Sans Frontieres, Brussels	Funded by Medecins Sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; [Anonymous], 2008, 4 WHO; [Anonymous], 1998, PUBLIC HLTH SERVICE; Behr MA, 2004, AM J RESP CRIT CARE, V169, P554, DOI 10.1164/rccm.2401001; Breathnach AS, 1998, J HOSP INFECT, V39, P111, DOI 10.1016/S0195-6701(98)90324-3; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P48; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Hannan MM, 2001, J HOSP INFECT, V47, P91, DOI 10.1053/jhin.2000.0884; Heersma HF, 1998, METH MOL B, V101, P395, DOI 10.1385/0-89603-471-2:395; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Perelman MI, 2000, INT J TUBERC LUNG D, V4, P1097; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shilova MV, 2001, PHILOS T R SOC B, V356, P1069, DOI 10.1098/rstb.2001.0895; Slavuckij A, 2002, EUR J PUBLIC HEALTH, V12, P94, DOI 10.1093/eurpub/12.2.94; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, 2000, GUID EST DOTS PLUS P; *WHO GLOB TASK FOR, 2006, M WHO GLOB TASK FORC; World Health Organization, 1994, WHOTB94179	28	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7954	10.1371/journal.pone.0007954	http://dx.doi.org/10.1371/journal.pone.0007954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956770	Green Published, gold			2022-12-27	WOS:000272827300012
J	Schultsz, C; Nguyen, V; Le, TH; Do, QH; Peiris, JSM; Lim, W; Garcia, JM; Nguyen, DT; Nguyen, THL; Huynh, HT; Phan, XT; van Doorn, HR; Nguyen, VC; Farrar, J; de Jong, MD				Schultsz, Constance; Nguyen Van Dung; Le Thanh Hai; Do Quang Ha; Peiris, J. S. Malik; Lim, Wilina; Garcia, Jean-Michel; Nguyen Dac Tho; Nguyen Thi Hoang Lan; Huynh Huu Tho; Phan Xuan Thao; van Doorn, H. Rogier; Nguyen Van Vinh Chau; Farrar, Jeremy; de Jong, Menno D.			Prevalence of Antibodies against Avian Influenza A (H5N1) Virus among Cullers and Poultry Workers in Ho Chi Minh City, 2005	PLOS ONE			English	Article							LOW-FREQUENCY; INFECTION; TRANSMISSION; CAMBODIA; DUCKS; RISK; ASIA	Background: Between 2003 and 2005, highly pathogenic avian influenza A (H5N1) viruses caused large scale outbreaks in poultry in the Ho Chi Minh City area in Vietnam. We studied the prevalence of antibodies against H5N1 in poultry workers and cullers who were active in the program in Ho Chi Minh City in 2004 and 2005. Methodology/Principal Findings: Single sera from 500 poultry workers and poultry cullers exposed to infected birds were tested for antibodies to avian influenza H5N1, using microneutralization assays and hemagglutination inhibition assay with horse blood. All sera tested negative using microneutralization tests. Three samples showed a 1:80 titer in the hemagglutination inhibition assay. Conclusions/Significance: This study provides additional support for the low transmissibility of clade 1 H5N1 to humans, but limited transmission to highly exposed persons cannot be excluded given the presence of low antibody titers in some individuals.	[Schultsz, Constance; Do Quang Ha; van Doorn, H. Rogier; Nguyen Van Vinh Chau; Farrar, Jeremy; de Jong, Menno D.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Schultsz, Constance; van Doorn, H. Rogier; Farrar, Jeremy; de Jong, Menno D.] Univ Oxford, Dept Clin Med, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related & Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Nguyen Van Dung; Huynh Huu Tho; Phan Xuan Thao] Subdept Anim Hlth, Ho Chi Minh City, Vietnam; [Le Thanh Hai; Nguyen Dac Tho; Nguyen Thi Hoang Lan] Prevent Med Ctr, Ho Chi Minh City, Vietnam; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Lim, Wilina] Hong Kong Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Garcia, Jean-Michel] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Hong Kong; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Schultsz, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	van Doorn, H. Rogier/H-3080-2019; Garcia, Jean-Michel/J-7166-2013; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H. Rogier/0000-0002-9807-1821; Garcia, Jean-Michel/0000-0002-6005-9982; Van Nguyen, Dung/0000-0002-0590-0679; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust, UK; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]	Wellcome Trust, UK(Wellcome Trust); Area of Excellence Scheme of the University Grants Committee, Hong Kong	This study was supported by the Wellcome Trust, UK, and the Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2007, REC LAB PROC DET AV; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]	13	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7948	10.1371/journal.pone.0007948	http://dx.doi.org/10.1371/journal.pone.0007948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956765	Green Submitted, Green Published, gold			2022-12-27	WOS:000272827300007
J	Garcia, JM; Pepin, S; Lagarde, N; Ma, ESK; Vogel, FR; Chan, KH; Chiu, SSS; Peiris, JSM				Garcia, Jean-Michel; Pepin, Stephanie; Lagarde, Nadege; Ma, Edward S. K.; Vogel, Frederick R.; Chan, Kwok H.; Chiu, Susan S. S.; Peiris, J. S. M.			Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin	PLOS ONE			English	Article							I RANDOMIZED-TRIAL; HETEROTYPIC IMMUNITY; HEALTHY-ADULTS; INFECTION; VACCINE; SAFETY; IMMUNOGENICITY; PROTECTION; PIGS	Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies that may potentially confer protection against zoonotic infections. It is unclear whether this is mediated by antibodies to the neuraminidase (NA) or haemagglutinin (HA). We use pseudoviral particles (H5pp) coated with H5 haemagglutinin but not N1 neuraminidase to address this question. In this study, we investigate whether cross-neutralizing antibodies in persons unexposed to H5N1 is reactive to the H5 haemagglutinin. Methodology/Principal Findings: We measured H5-neutralization antibody titers pre-and post-vaccination using the H5N1 micro-neutralization test (MN) and H5pp tests in subjects given seasonal vaccines and in selected sera from European elderly volunteers in a H5N1 vaccine trial who had detectable pre-vaccination H5N1 MN antibody titers. We found detectable (titer >= 20) H5N1 neutralizing antibodies in a minority of pre-seasonal vaccine sera and evidence of a serological response to H5N1 in others after seasonal influenza vaccination. There was excellent correlation in the antibody titers between the H5N1 MN and H5pp tests. Similar correlations were found between MN and H5pp in the pre-vaccine sera from the cohort of H5N1 vaccine trial recipients. Conclusions/Significance: Heterosubtype neutralizing antibody to H5N1 in healthy volunteers unexposed to H5N1 is mediated by cross-reaction to the H5 haemagglutinin.			Garcia, JM (corresponding author), HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	jmgarcia@hku.hk; malik@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Garcia, Jean-Michel/J-7166-2013; Peiris, Joseph Sriyal Malik/C-4380-2009	Garcia, Jean-Michel/0000-0002-6005-9982; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; GARCIA JM, J CLIN VIRO IN PRESS; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hui SL, 2006, VACCINE, V24, P5371, DOI 10.1016/j.vaccine.2006.04.032; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; SLEPUSHKIN A N, 1959, Bull World Health Organ, V20, P297; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; YETTER RA, 1980, INFECT IMMUN, V29, P650; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	31	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7918	10.1371/journal.pone.0007918	http://dx.doi.org/10.1371/journal.pone.0007918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936250	Green Submitted, Green Published, gold			2022-12-27	WOS:000272004800003
J	Cironi, L; Provero, P; Riggi, N; Janiszewska, M; Suva, D; Suva, ML; Kindler, V; Stamenkovic, I				Cironi, Luisa; Provero, Paolo; Riggi, Nicola; Janiszewska, Michalina; Suva, Domizio; Suva, Mario-Luca; Kindler, Vincent; Stamenkovic, Ivan			Epigenetic Features of Human Mesenchymal Stem Cells Determine Their Permissiveness for Induction of Relevant Transcriptional Changes by SYT-SSX1	PLOS ONE			English	Article							HUMAN SYNOVIAL SARCOMA; PROTO-ONCOPROTEIN SYT; SOFT-TISSUE SARCOMAS; CTCF-BINDING SITES; FACTOR-II GENE; IN-VITRO; EPITHELIAL DIFFERENTIATION; FUSION PROTEINS; EXPRESSION; SSX	Background: A characteristic SYT-SSX fusion gene resulting from the chromosomal translocation t(X; 18)(p11; q11) is detectable in almost all synovial sarcomas, a malignant soft tissue tumor widely believed to originate from as yet unidentified pluripotent stem cells. The resulting fusion protein has no DNA binding motifs but possesses protein-protein interaction domains that are believed to mediate association with chromatin remodeling complexes. Despite recent advances in the identification of molecules that interact with SYT-SSX and with the corresponding wild type SYT and SSX proteins, the mechanisms whereby the SYT-SSX might contribute to neoplastic transformation remain unclear. Epigenetic deregulation has been suggested to be one possible mechanism. Methodology/Principal Findings: We addressed the effect of SYT/SSX expression on the transcriptome of four independent isolates of primary human bone marrow mesenchymal stem cells (hMSC). We observed transcriptional changes similar to the gene expression signature of synovial sarcoma, principally involving genes whose regulation is linked to epigenetic factors, including imprinted genes, genes with transcription start sites within a CpG island and chromatin related genes. Single population analysis revealed hMSC isolate-specific transcriptional changes involving genes that are important for biological functions of stem cells as well as genes that are considered to be molecular markers of synovial sarcoma including IGF2, EPHRINS, and BCL2. Methylation status analysis of sequences at the H19/IGF2 imprinted locus indicated that distinct epigenetic features characterize hMSC populations and condition the transcriptional effects of SYT-SSX expression. Conclusions/Significance: Our observations suggest that epigenetic features may define the cellular microenvironment in which SYT-SSX displays its functional effects.			Cironi, L (corresponding author), Univ Lausanne, Fac Biol & Med, CHU Vaudois, Inst Pathol,Div Expt Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351; Kindler, Vincent/0000-0002-5349-1857				Allander SV, 2002, AM J PATHOL, V161, P1587, DOI 10.1016/S0002-9440(10)64437-9; Antonescu CR, 2000, DIAGN MOL PATHOL, V9, P1, DOI 10.1097/00019606-200003000-00001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Barco R, 2007, MOL BIOL CELL, V18, P4003, DOI 10.1091/mbc.E07-05-0496; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BLOUSHTAINQIMRO.N, 2009, CELL CYCLE, V8; Bozzi F, 2008, TRANSL ONCOL, V1, P95, DOI 10.1593/tlo.08121; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; COLLAS P, 2008, BIOCH BIOPHYS ACTA; D'Arcy P, 2008, MOL CANCER RES, V6, P127, DOI 10.1158/1541-7786.MCR-07-0176; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; de Bruijn DRH, 2007, GENE CHROMOSOME CANC, V46, P107, DOI 10.1002/gcc.20399; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Friedrichs N, 2008, J PATHOL, V216, P428, DOI 10.1002/path.2438; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hashimoto N, 2000, CANCER LETT, V149, P31, DOI 10.1016/S0304-3835(99)00336-5; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Ito T, 2004, LAB INVEST, V84, P1484, DOI 10.1038/labinvest.3700174; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2008, CLIN ORTHOP RELAT R, V466, P2099, DOI 10.1007/s11999-008-0330-4; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; LIU ZJ, 2009, J CELL BIOCH; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Mancuso T, 2000, LAB INVEST, V80, P805, DOI 10.1038/labinvest.3780085; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2002, CANCER RES, V62, P5859; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Ponce ML, 2008, J CELL BIOCHEM, V104, P1342, DOI 10.1002/jcb.21711; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Rosa N, 2004, DIAGN MOL PATHOL, V13, P52, DOI 10.1097/00019606-200403000-00009; Sandberg AA, 2002, CANCER GENET CYTOGEN, V133, P1, DOI 10.1016/S0165-4608(01)00626-4; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Suva D, 2008, J CELL PHYSIOL, V214, P588, DOI 10.1002/jcp.21244; Suva ML, 2007, J PATHOL, V213, P117, DOI 10.1002/path.2208; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tschoep K, 2007, CRIT REV ONCOL HEMAT, V63, P111, DOI 10.1016/j.critrevonc.2007.04.001; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Xie YT, 2002, ONCOGENE, V21, P5791, DOI 10.1038/sj.onc.1205700; Xie YT, 2002, CANCER RES, V62, P3861; Zardo G, 2008, LEUKEMIA, V22, P1503, DOI 10.1038/leu.2008.141; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	70	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7904	10.1371/journal.pone.0007904	http://dx.doi.org/10.1371/journal.pone.0007904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936258	Green Published, gold, Green Submitted			2022-12-27	WOS:000272004600008
J	Giliberto, L; Matsuda, S; Vidal, R; D'Adamio, L				Giliberto, Luca; Matsuda, Shuji; Vidal, Ruben; D'Adamio, Luciano			Generation and Initial Characterization of FDD Knock In Mice	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; CEREBRAL AMYLOID ANGIOPATHY; BETA PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; PRESENILIN MUTATIONS; DANISH DEMENTIA; TALKING POINT; GENE	Background: Mutations in the integral membrane protein 2B [1], also known as BRI2 [2], a type II trans-membrane domain protein cause two autosomal dominant neurodegenerative diseases, Familial British and Danish Dementia [3]. In these conditions, accumulation of a C-terminal peptide (ABri and ADan) cleaved off from the mutated precursor protein by the pro-protein convertase furin [4], leads to amyloid deposition in the walls of blood vessels and parenchyma of the brain. Recent advances in the understanding of the generation of amyloid in Alzheimer's disease has lead to the finding that BRI2 interacts with the Amyloid Precursor Protein (APP), decreasing the efficiency of APP processing to generate A beta [5,6,7]. The interaction between the two precursors, APP and BRI2, and possibly between A beta and ABri or ADan, could be important in influencing the rate of amyloid production or the tendency of these peptides to aggregate. Methodology/Principal Findings: We have generated the first BRI2 Danish Knock-In (FDDKI) murine model of FDD, expressing the pathogenic decamer duplication in exon 6 of the BRI2 gene. FDDKI mice do not show any evident abnormal phenotype, with normal brain histology and no detectable amyloid deposition in blood vessel walls or parenchyma. Conclusions/Significance: This new murine mouse model will be important to further understand the interaction between APP and BRI2, and to provide insights into the molecular basis of FDD.			Giliberto, L (corresponding author), Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, North Shore LIJ, Manhasset, NY 11030 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	NATIONAL INSTITUTE ON AGING [R01AG021588, R01AG022024, R21AG027139] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG22024, R01 AG022024, R21 AG027139, R01 AG021588, R01 AG21588] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; MATSUDA S, 2009, MATURATION BRI2 GENE; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Pickford F, 2006, BRAIN PATHOL, V16, P80, DOI 10.1111/j.1750-3639.2006.tb00564.x; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Rostagno A, 2002, J BIOL CHEM, V277, P49782, DOI 10.1074/jbc.M206448200; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896	32	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7900	10.1371/journal.pone.0007900	http://dx.doi.org/10.1371/journal.pone.0007900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924302	Green Published, Green Submitted, gold			2022-12-27	WOS:000271936700026
J	Harries, LW; Brown, JE; Gloyn, AL				Harries, Lorna W.; Brown, James E.; Gloyn, Anna L.			Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; PANCREATIC BETA-CELLS; MUTATIONS; YOUNG; HAPLOINSUFFICIENCY; PHENOTYPES; MOUSE	Background: The HNF1A, HNF1B and HNF4A genes are part of an autoregulatory network in mammalian pancreas, liver, kidney and gut. The layout of this network appears to be similar in rodents and humans, but inactivation of HNF1A, HNF1B or HNF4A genes in animal models cause divergent phenotypes to those seen in man. We hypothesised that some differences may arise from variation in the expression profile of alternatively processed isoforms between species. Methodology/Principal Findings: We measured the expression of the major isoforms of the HNF1A, HNF1B and HNF4A genes in human and rodent pancreas, islet, liver and kidney by isoform-specific quantitative real-time PCR and compared their expression by the comparative Ct(Delta Delta Ct) method. We found major changes in the expression profiles of the HNF genes between humans and rodents. The principal difference lies in the expression of the HNF1A gene, which exists as three isoforms in man, but as a single isoform only in rodents. More subtle changes were to the balance of HNF1B and HNF4A isoforms between species; the repressor isoform HNF1B( C) comprised only 6% in human islets compared with 24-26% in rodents (p = 0.006) whereas HNF4A9 comprised 22% of HNF4A expression in human pancreas but only 11% in rodents (p = 0.001). Conclusions/Significance: The differences we note in the isoform-specific expression of the human and rodent HNF1A, HNF1B and HNF4A genes may impact on the absolute activity of these genes, and therefore on the activity of the pancreatic transcription factor network as a whole. We conclude that alterations to expression of HNF isoforms may underlie some of the phenotypic variation caused by mutations in these genes.			Harries, LW (corresponding author), Univ Exeter, Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter, Devon, England.	L.W.Harries@exeter.ac.uk	Brown, James E/A-7503-2012; Harries, Lorna/D-2241-2014	Gloyn, Anna/0000-0003-1205-1844; Harries, Lorna/0000-0001-7791-8061	Medical Research Council [G0700222(81696), G0700222] Funding Source: Medline; Wellcome Trust [WT081278MA] Funding Source: Medline; MRC [G0700222] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*APPL BIOS, 1997, US B APPL BIOS, V2, P11; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; CEREGHINI S, 1992, DEVELOPMENT, V116, P783; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Ferrer J, 2002, DIABETES, V51, P2355, DOI 10.2337/diabetes.51.8.2355; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; HUANG J, 2008, DIABETES METAB RES R; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Owen K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/beem.2001.0148; Pearson ER, 2004, DIABETES CARE, V27, P1102, DOI 10.2337/diacare.27.5.1102; Pontoglio M, 2000, EMBO REP, V1, P359, DOI 10.1093/embo-reports/kvd071; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Thomas H, 2002, BIOL CHEM, V383, P1691, DOI 10.1515/BC.2002.190; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Welters HJ, 2006, J ENDOCRINOL, V190, P171, DOI 10.1677/joe.1.06768; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	24	59	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7855	10.1371/journal.pone.0007855	http://dx.doi.org/10.1371/journal.pone.0007855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924231	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000271851000012
J	Lin, CH; Lin, C; Tanaka, H; Fero, ML; Eisenman, RN				Lin, Chin-Hsing; Lin, ChenWei; Tanaka, Hisashi; Fero, Matthew L.; Eisenman, Robert N.			Gene Regulation and Epigenetic Remodeling in Murine Embryonic Stem Cells by c-Myc	PLOS ONE			English	Article							SELF-RENEWAL; DEVELOPMENTAL REGULATORS; TRANSCRIPTIONAL NETWORK; GENOMIC TARGETS; RIBOSOMAL DNA; PLURIPOTENCY; CHROMATIN; POLYCOMB; ACTIVATION; DIFFERENTIATION	Background: The Myc oncoprotein, a transcriptional regulator involved in the etiology of many different tumor types, has been demonstrated to play an important role in the functions of embryonic stem (ES) cells. Nonetheless, it is still unclear as to whether Myc has unique target and functions in ES cells. Methodology/Principal Findings: To elucidate the role of c-Myc in murine ES cells, we mapped its genomic binding sites by chromatin-immunoprecipitation combined with DNA microarrays (ChIP-chip). In addition to previously identified targets we identified genes involved in pluripotency, early development, and chromatin modification/structure that are bound and regulated by c-Myc in murine ES cells. Myc also binds and regulates loci previously identified as Polycomb (PcG) targets, including genes that contain bivalent chromatin domains. To determine whether c-Myc influences the epigenetic state of Myc-bound genes, we assessed the patterns of trimethylation of histone H3-K4 and H3-K27 in mES cells containing normal, increased, and reduced levels of c-Myc. Our analysis reveals widespread and surprisingly diverse changes in repressive and activating histone methylation marks both proximal and distal to Myc binding sites. Furthermore, analysis of bulk chromatin from phenotypically normal c-myc null E7 embryos demonstrates a 70-80% decrease in H3-K4me3, with little change in H3-K27me3, compared to wild-type embryos indicating that Myc is required to maintain normal levels of histone methylation. Conclusions/Significance: We show that Myc induces widespread and diverse changes in histone methylation in ES cells. We postulate that these changes are indirect effects of Myc mediated by its regulation of target genes involved in chromatin remodeling. We further show that a subset of PcG-bound genes with bivalent histone methylation patterns are bound and regulated in response to altered c-Myc levels. Our data indicate that in mES cells c-Myc binds, regulates, and influences the histone modification patterns of genes involved in chromatin remodeling, pluripotency, and differentiation.			Lin, CH (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	eisenman@fhcrc.org		Tanaka, Hisashi/0000-0001-9223-4186; Fero, Matthew/0000-0002-9967-4659	NATIONAL CANCER INSTITUTE [R01CA020525] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA20525, R01 CA020525] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LIN CH, 2009, EMBO J IN PRESS; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; MEISSNER A, 2007, NAT BIOTECHNOL; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; NAKAGAWA M, 2007, NAT BIOTECHNOL; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	82	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7839	10.1371/journal.pone.0007839	http://dx.doi.org/10.1371/journal.pone.0007839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19915707	Green Submitted, Green Published, gold			2022-12-27	WOS:000271721900024
J	Fredholm, H; Eaker, S; Frisell, J; Holmberg, L; Fredriksson, I; Lindman, H				Fredholm, Hanna; Eaker, Sonja; Frisell, Jan; Holmberg, Lars; Fredriksson, Irma; Lindman, Henrik			Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment	PLOS ONE			English	Article							AGE 30 YEARS; PROGNOSTIC-FACTOR; CONSERVING THERAPY; LESS-THAN-35 YEARS; LOCAL RECURRENCE; RISK-FACTORS; STAGE-I; CARCINOMA; DIAGNOSIS; FEATURES	Background: Breast cancer is uncommon in young women and correlates with a less favourable prognosis; still it is the most frequent cancer in women under 40, accounting for 30-40% of all incident female cancer. The aim of this study was to study prognosis in young women, quantifying how much stage at diagnosis and management on the one hand, and tumour biology on the other; each contribute to the worse prognosis seen in this age group. Methodology/Principal Findings: In a registry based cohort of women aged 20-69 (n = 22 017) with a primary diagnosis of invasive breast cancer (1992-2005), women aged 20-34 (n = 471), 35-39 (n = 858) and 40-49 (n = 4789) were compared with women aged 50-69 years (n = 15 899). The cumulative 5-year relative survival ratio and the relative excess mortality (RER) were calculated. The cumulative 5-year relative survival ratio was lowest in women aged 20-34. The RER was 2.84 for women aged 20-34 and decreased with increasing age (RER 1.76 and 1.17 for women aged 35-39 and 40-49, respectively). The excess risk was, however, present only in disease stages I and II. For women aged 20-34 with stage I disease RER was 4.63, and 6.70 in the subgroup with tumour size 1-10 mm. The absolute difference in stage I between the youngest and the reference groups amounted to nearly 8%, with a 90% 5-year survival in women aged 20-34. In stages IIa and IIb, the relative excess risk was not as dramatic, but the absolute differences approached 15%. The youngest women with small tumours generally received more aggressive treatment than women in older age groups. Conclusions: After correction for stage, tumour characteristics and treatment, age remained an independent risk factor for breast cancer death in women,35 years of age. The excess risk for young women was only seen in early stages of disease and was most pronounced in women with small tumours. Young women affected by breast cancer have a high risk of dying compared to their middle-aged counterparts even if diagnosed early and receiving an intense treatment.			Fredholm, H (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	hanna.fredholm@ki.se		Fredriksson, Irma/0000-0001-7811-9317				Abe O, 2005, LANCET, V366, P2087; ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; ADAMI HO, 1985, CANCER-AM CANCER SOC, V56, P898, DOI 10.1002/1097-0142(19850815)56:4<898::AID-CNCR2820560433>3.0.CO;2-L; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Ahn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; ASPEGREN K, 1988, BRIT J SURG, V75, P807, DOI 10.1002/bjs.1800750829; BARLOW L, 2008, ACTA ONCOL, P1; BOFFETTA P, 1993, CANCER CAUSE CONTROL, V4, P209; BONNIER P, 1995, INT J CANCER, V62, P138, DOI 10.1002/ijc.2910620205; BOTTOM O, 2006, NIH PUB; Brenner H, 2004, J CLIN ONCOL, V22, P432, DOI 10.1200/JCO.2004.04.067; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.3.CO;2-T; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; FOWBLE BL, 1994, INT J RADIAT ONCOL, V30, P23, DOI 10.1016/0360-3016(94)90515-0; Fredriksson I, 2003, BRIT J SURG, V90, P1093, DOI 10.1002/bjs.4206; Gajdos C, 2000, J AM COLL SURGEONS, V190, P523, DOI 10.1016/S1072-7515(00)00257-X; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; HOST H, 1986, CANCER-AM CANCER SOC, V57, P2217, DOI 10.1002/1097-0142(19860601)57:11<2217::AID-CNCR2820571124>3.0.CO;2-T; KEMETLI L, 2008, TEMPORAL TRENDS USE, P1; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Liebens FP, 2007, EUR J CANCER, V43, P238, DOI 10.1016/j.ejca.2006.07.019; Maggard MA, 2003, J SURG RES, V113, P109, DOI 10.1016/S0022-4804(03)00179-3; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Marrett Loraine D, 2002, Chronic Dis Can, V23, P58; Maru D, 2005, CANCER-AM CANCER SOC, V103, P900, DOI 10.1002/cncr.20850; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Ries L., 2005, SEER CANC STAT REV 1; Sant M, 1998, INT J CANCER, V77, P679, DOI 10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-S; SIEGEL BM, 1990, ARCH SURG-CHICAGO, V125, P1144; Sobin, 2009, UICC TNM CLASSIFICAT; *STAT SWED, 2008, POP STAT SWED; Tabar L, 2004, CANCER-AM CANCER SOC, V101, P1745, DOI 10.1002/cncr.20582; Tai P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-130; Tataru D, 2006, J PUBLIC HEALTH, V28, P215, DOI 10.1093/pubmed/fdl011; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Vrieling C, 2003, EUR J CANCER, V39, P932, DOI 10.1016/S0959-8049(03)00123-0; Walker RA, 1996, BRIT J CANCER, V74, P1796, DOI 10.1038/bjc.1996.632; Winchester DP, 1996, CANCER-AM CANCER SOC, V78, P1838, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y; Xiong QH, 2001, CANCER, V92, P2523, DOI 10.1002/1097-0142(20011115)92:10<2523::AID-CNCR1603>3.0.CO;2-6	49	308	315	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A38	A46	e7695	10.1371/journal.pone.0007695	http://dx.doi.org/10.1371/journal.pone.0007695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19907646	Green Submitted, gold, Green Published			2022-12-27	WOS:000271685800005
J	Haghighi, HR; Read, LR; Haeryfar, SMM; Behboudi, S; Sharif, S				Haghighi, Hamid R.; Read, Leah R.; Haeryfar, S. M. Mansour; Behboudi, Shahriar; Sharif, Shayan			Identification of a Dual-Specific T Cell Epitope of the Hemagglutinin Antigen of an H5 Avian Influenza Virus in Chickens	PLOS ONE			English	Article							CYTOKINE GENE-EXPRESSION; MHC CLASS-I; MAREKS-DISEASE; A VIRUS; FOWLPOX VIRUS; INFECTION; CD4(+); PROTECTION; PEPTIDE; VACCINE	Avian influenza viruses (AIV) of the H5N1 subtype have caused morbidity and mortality in humans. Although some migratory birds constitute the natural reservoir for this virus, chickens may play a role in transmission of the virus to humans. Despite the importance of avian species in transmission of AIV H5N1 to humans, very little is known about host immune system interactions with this virus in these species. The objective of the present study was to identify putative T cell epitopes of the hemagglutinin (HA) antigen of an H5 AIV in chickens. Using an overlapping peptide library covering the HA protein, we identified a 15-mer peptide, H5(246-260), within the HA1 domain which induced activation of T cells in chickens immunized against the HA antigen of an H5 virus. Furthermore, H5(246-260) epitope was found to be presented by both major histocompatibility complex (MHC) class I and II molecules, leading to activation of CD4+ and CD8+ T cell subsets, marked by proliferation and expression of interferon (IFN)-gamma by both of these cell subsets as well as the expression of granzyme A by CD8+ T cells. This is the first report of a T cell epitope of AIV recognized by chicken T cells. Furthermore, this study extends the previous finding of the existence of dual-specific epitopes in other species to chickens. Taken together, these results elucidate some of the mechanisms of immune response to AIV in chickens and provide a platform for creation of rational vaccines against AIV in this species.			Haghighi, HR (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	shayan@uoguelph.ca		behboudi, shahriar/0000-0001-6455-4086				Abdul-Careem MF, 2006, VIRAL IMMUNOL, V19, P167, DOI 10.1089/vim.2006.19.167; Abdul-Careem MF, 2007, VACCINE, V25, P424, DOI 10.1016/j.vaccine.2006.08.006; ADAMS SC, 2009, MOL IMMUNOL; Ayaru L, 2007, J IMMUNOL, V178, P1914, DOI 10.4049/jimmunol.178.3.1914; Ben-Yedidia T, 1999, INT IMMUNOL, V11, P1043, DOI 10.1093/intimm/11.7.1043; BENNINK JR, 1988, J EXP MED, V168, P1935, DOI 10.1084/jem.168.5.1935; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Brisbin JT, 2008, DEV COMP IMMUNOL, V32, P563, DOI 10.1016/j.dci.2007.09.003; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; Falchetti R, 1996, CELL IMMUNOL, V170, P222, DOI 10.1006/cimm.1996.0155; Fomsgaard A, 1999, VACCINE, V18, P681, DOI 10.1016/S0264-410X(99)00279-0; Gelder C, 1998, INT IMMUNOL, V10, P211, DOI 10.1093/intimm/10.2.211; Homann D, 2007, VIROLOGY, V363, P113, DOI 10.1016/j.virol.2006.12.025; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Sarson AJ, 2008, VIRAL IMMUNOL, V21, P267, DOI 10.1089/vim.2007.0094; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; SHAPIRA M, 1984, P NATL ACAD SCI-BIOL, V81, P2461, DOI 10.1073/pnas.81.8.2461; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Swayne DE, 1997, AVIAN DIS, V41, P910, DOI 10.2307/1592346; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; SWEETSER MT, 1989, NATURE, V342, P180, DOI 10.1038/342180a0; TAKAHASHI H, 1990, J EXP MED, V171, P571, DOI 10.1084/jem.171.2.571; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Topham DJ, 1997, J IMMUNOL, V159, P5197; TRIPATHY DN, 1991, AVIAN DIS, V35, P186, DOI 10.2307/1591312; Ullenhag GJ, 2004, CANCER IMMUNOL IMMUN, V53, P331, DOI 10.1007/s00262-003-0441-4; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B	44	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7772	10.1371/journal.pone.0007772	http://dx.doi.org/10.1371/journal.pone.0007772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901990	Green Published, gold, Green Submitted			2022-12-27	WOS:000271658800010
J	Kumar, K; Tharad, M; Ganapathy, S; Ram, G; Narayan, A; Khan, JA; Pratap, R; Ghosh, A; Samuchiwal, SK; Kumar, S; Bhalla, K; Gupta, D; Natarajan, K; Singh, Y; Ranganathan, A				Kumar, Krishan; Tharad, Megha; Ganapathy, Swetha; Ram, Geeta; Narayan, Azeet; Khan, Jameel Ahmad; Pratap, Rana; Ghosh, Anamika; Samuchiwal, Sachin Kumar; Kumar, Sushil; Bhalla, Kuhulika; Gupta, Deepti; Natarajan, Krishnamurthy; Singh, Yogendra; Ranganathan, Anand			Phenylalanine-Rich Peptides Potently Bind ESAT6, a Virulence Determinant of Mycobacterium tuberculosis, and Concurrently Affect the Pathogen's Growth	PLOS ONE			English	Article							DE-NOVO PROTEINS; CULTURE FILTRATE; MYCOLIC ACIDS; BOVIS BCG; SECRETED PROTEIN; CFP-10; BIOSYNTHESIS; ANTIGENS; SYSTEM; ELECTROPHORESIS	Background: The secretory proteins of Mycobacterium tuberculosis (M. tuberculosis) have been known to be involved in the virulence, pathogenesis as well as proliferation of the pathogen. Among this set, many proteins have been hypothesized to play a critical role at the genesis of the onset of infection, the primary site of which is invariably the human lung. Methodology/Principal Findings: During our efforts to isolate potential binding partners of key secretory proteins of M. tuberculosis from a human lung protein library, we isolated peptides that strongly bound the virulence determinant protein Esat6. All peptides were less than fifty amino acids in length and the binding was confirmed by in vivo as well as in vitro studies. Curiously, we found all three binders to be unusually rich in phenylalanine, with one of the three peptides a short fragment of the human cytochrome c oxidase-3 (Cox-3). The most accessible of the three binders, named Hcl1, was shown also to bind to the Mycobacterium smegmatis (M. smegmatis) Esat6 homologue. Expression of hcl1 in M. tuberculosis H37Rv led to considerable reduction in growth. Microarray analysis showed that Hcl1 affects a host of key cellular pathways in M. tuberculosis. In a macrophage infection model, the sets expressing hcl1 were shown to clear off M. tuberculosis in much greater numbers than those infected macrophages wherein the M. tuberculosis was not expressing the peptide. Transmission electron microscopy studies of hcl1 expressing M. tuberculosis showed prominent expulsion of cellular material into the matrix, hinting at cell wall damage. Conclusions/Significance: While the debilitating effects of Hcl1 on M. tuberculosis are unrelated and not because of the peptide's binding to Esat6-as the latter is not an essential protein of M. tuberculosis-nonetheless, further studies with this peptide, as well as a closer inspection of the microarray data may shed important light on the suitability of such small phenylalanine-rich peptides as potential drug-like molecules against this pathogen.			Kumar, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India.	anand@icgeb.res.in	Samuchiwal, Sachin/AAL-2904-2021; Gupta, Deepti/U-1777-2019; Bhalla, Kuhulika/P-3280-2019; KUMAR, SUSHIL/T-8493-2017	Gupta, Deepti/0000-0001-7931-0017; Bhalla, Kuhulika/0000-0002-6608-2120; KUMAR, KRISHAN/0000-0003-3957-2084; Narayan, Azeet/0000-0003-1820-7934; SAMUCHIWAL, SACHIN/0000-0001-6232-5650; KUMAR, SUSHIL/0000-0001-8481-9221				ABOUZEID C, 1988, INFECT IMMUN, V56, P3046, DOI 10.1128/IAI.56.12.3046-3051.1988; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Aravinda S, 2003, J AM CHEM SOC, V125, P5308, DOI 10.1021/ja0341283; BACKLOCK JWS, 1947, BRIT MED J, V24, P707; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Lee IH, 1997, COMP BIOCHEM PHYS B, V118, P515, DOI 10.1016/S0305-0491(97)00109-0; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Miller J.H., 1972, EXPT MOL GENETICS; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; PEAKE P, 1993, INFECT IMMUN, V61, P4828, DOI 10.1128/IAI.61.11.4828-4834.1993; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Qamra R, 2005, TUBERCULOSIS, V85, P385, DOI 10.1016/j.tube.2005.08.014; Rao A, 2005, J BIOL CHEM, V280, P23605, DOI 10.1074/jbc.M503056200; Rao A, 2007, APPL ENVIRON MICROB, V73, P1320, DOI 10.1128/AEM.02461-06; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumann G, 2006, CENT EUR J BIOL, V1, P183, DOI 10.2478/s11535-006-0018-2; Schwebach JR, 2001, J CLIN MICROBIOL, V39, P769, DOI 10.1128/JCM.39.2.769-771.2001; Sonnenberg MG, 1997, INFECT IMMUN, V65, P4515, DOI 10.1128/IAI.65.11.4515-4524.1997; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; Wards BJ, 2000, TUBERCLE LUNG DIS, V80, P185, DOI 10.1054/tuld.2000.0244; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; Yew WW, 2008, AM J RESP CRIT CARE, V177, P479, DOI 10.1164/rccm.200710-1561UP; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630	43	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7615	10.1371/journal.pone.0007615	http://dx.doi.org/10.1371/journal.pone.0007615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901982	Green Submitted, Green Published, gold			2022-12-27	WOS:000271658800001
J	Hausmann, L; von Campenhausen, M; Endler, F; Singheiser, M; Wagner, H				Hausmann, Laura; von Campenhausen, Mark; Endler, Frank; Singheiser, Martin; Wagner, Hermann			Improvements of Sound Localization Abilities by the Facial Ruff of the Barn Owl (Tyto alba) as Demonstrated by Virtual Ruff Removal	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; AUDITORY SPACE; SPECTRAL CUES; EXTERNAL-EAR; HEADPHONE SIMULATION; LEVEL DIFFERENCE; HEAD; FREQUENCY; DECORRELATION; ORIENTATION	Background: When sound arrives at the eardrum it has already been filtered by the body, head, and outer ear. This process is mathematically described by the head-related transfer functions (HRTFs), which are characteristic for the spatial position of a sound source and for the individual ear. HRTFs in the barn owl (Tyto alba) are also shaped by the facial ruff, a specialization that alters interaural time differences (ITD), interaural intensity differences (ILD), and the frequency spectrum of the incoming sound to improve sound localization. Here we created novel stimuli to simulate the removal of the barn owl's ruff in a virtual acoustic environment, thus creating a situation similar to passive listening in other animals, and used these stimuli in behavioral tests. Methodology/Principal Findings: HRTFs were recorded from an owl before and after removal of the ruff feathers. Normal and ruff-removed conditions were created by filtering broadband noise with the HRTFs. Under normal virtual conditions, no differences in azimuthal head-turning behavior between individualized and non-individualized HRTFs were observed. The owls were able to respond differently to stimuli from the back than to stimuli from the front having the same ITD. By contrast, such a discrimination was not possible after the virtual removal of the ruff. Elevational head-turn angles were (slightly) smaller with non-individualized than with individualized HRTFs. The removal of the ruff resulted in a large decrease in elevational head-turning amplitudes. Conclusions/Significance: The facial ruff a) improves azimuthal sound localization by increasing the ITD range and b) improves elevational sound localization in the frontal field by introducing a shift of iso-ILD lines out of the midsagittal plane, which causes ILDs to increase with increasing stimulus elevation. The changes at the behavioral level could be related to the changes in the binaural physical parameters that occurred after the virtual removal of the ruff. These data provide new insights into the function of external hearing structures and open up the possibility to apply the results on autonomous agents, creation of virtual auditory environments for humans, or in hearing aids.			Hausmann, L (corresponding author), Rhein Westfal TH Aachen, Inst Biol 2, D-5100 Aachen, Germany.	laura@bio2.rwth-aachen.de	Wagner, Hermann/G-5454-2012	Hausmann, Laura/0000-0003-0174-7248				Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Blauert J., 1997, SPATIAL HEARING PSYC, DOI [10.7551/mitpress/6391.001.0001, DOI 10.7551/MITPRESS/6391.001.0001]; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; Calmes L, 2007, J ACOUST SOC AM, V121, P2034, DOI 10.1121/1.2709866; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Dietz M, 2009, J ACOUST SOC AM, V125, P1622, DOI 10.1121/1.3076045; Egnor SER, 2001, J COMP PHYSIOL A, V187, P589; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; GARDNER MB, 1973, J ACOUST SOC AM, V53, P400, DOI 10.1121/1.1913336; Heffner RS, 1996, HEARING RES, V99, P13, DOI 10.1016/S0378-5955(96)00074-3; Hill PA, 2000, J ACOUST SOC AM, V108, P2901, DOI 10.1121/1.1323235; Huang AY, 1996, J ACOUST SOC AM, V100, P2341, DOI 10.1121/1.417943; Hwang S, 2008, ACTA ACUST UNITED AC, V94, P965, DOI 10.3813/AAA.918113; JAY FJ, 1990, COMP PERCEPTION BASI, P351; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; Kim SM, 2005, J ACOUST SOC AM, V117, P3657, DOI 10.1121/1.1921548; King AJ, 2001, AUDIOL NEURO-OTOL, V6, P182, DOI 10.1159/000046829; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1981, SCI AM, V245, P113; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Koka K, 2008, J ACOUST SOC AM, V123, P4297, DOI 10.1121/1.2916587; Kulkarni A, 1998, NATURE, V396, P747, DOI 10.1038/25526; Langendijk EHA, 2002, J ACOUST SOC AM, V112, P1583, DOI 10.1121/1.1501901; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; May BJ, 1996, J ACOUST SOC AM, V100, P1059, DOI 10.1121/1.416292; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P637, DOI 10.1007/BF00614506; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; MUSICANT AD, 1990, J ACOUST SOC AM, V87, P757, DOI 10.1121/1.399545; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; Parsons CH, 1999, J NEUROPHYSIOL, V82, P2294, DOI 10.1152/jn.1999.82.5.2294; Phillips DP, 2008, HEARING RES, V238, P124, DOI 10.1016/j.heares.2007.09.007; Poganiatz I, 2001, J COMP PHYSIOL A, V187, P225, DOI 10.1007/s003590100193; Poganiatz I, 2001, JARO, V2, P1; Populin LC, 1998, J NEUROSCI, V18, P2147; Populin LC, 2008, EXP BRAIN RES, V190, P11, DOI 10.1007/s00221-008-1445-2; Saberi K, 2002, JARO, V3, P80, DOI 10.1007/s101620020006; Saberi K, 1999, NAT NEUROSCI, V2, P656, DOI 10.1038/10212; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; Takahashi TT, 2003, BIOL CYBERN, V89, P378, DOI 10.1007/s00422-003-0443-5; Tollin DJ, 2009, J ACOUST SOC AM, V125, P980, DOI 10.1121/1.3058630; Van Wanrooij MM, 2004, J NEUROSCI, V24, P4163, DOI 10.1523/JNEUROSCI.0048-04.2004; von Campenhausen M, 2006, J COMP PHYSIOL A, V192, P1073, DOI 10.1007/s00359-006-0139-0; WAGNER H, 1993, J NEUROSCI, V13, P371; Wagner H, 2007, J NEUROSCI, V27, P4191, DOI 10.1523/JNEUROSCI.5250-06.2007; Walker BN, 2006, HUM FACTORS, V48, P265, DOI 10.1518/001872006777724507; Wenzel E, 1988, J ACOUST SOC AM, V84, pS79, DOI [DOI 10.1121/1.2026486, 10.1121/1.2026486]; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WOTTON JM, 1995, J ACOUST SOC AM, V98, P1423, DOI 10.1121/1.413410; Zahorik P, 2006, J ACOUST SOC AM, V120, P343, DOI 10.1121/1.2208429	57	40	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7721	10.1371/journal.pone.0007721	http://dx.doi.org/10.1371/journal.pone.0007721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890389	Green Published, Green Submitted, gold			2022-12-27	WOS:000271459700013
J	Mauduit, M; Gruner, AC; Tewari, R; Depinay, N; Kayibanda, M; Chavatte, JM; Franetich, JF; Crisanti, A; Mazier, D; Snounou, G; Renia, L				Mauduit, Marjorie; Gruener, Anne Charlotte; Tewari, Rita; Depinay, Nadya; Kayibanda, Michele; Chavatte, Jean-Marc; Franetich, Jean-Francois; Crisanti, Andrea; Mazier, Dominique; Snounou, Georges; Renia, Laurent			A Role for Immune Responses against Non-CS Components in the Cross-Species Protection Induced by Immunization with Irradiated Malaria Sporozoites	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; T-CELLS RECOGNIZE; YOELII; EFFICACY; BERGHEI; PARASITES; PEPTIDE; STAGE; MICE	Immunization with irradiated Plasmodium sporozoites induces sterile immunity in rodents, monkeys and humans. The major surface component of the sporozoite the circumsporozoite protein ( CS) long considered as the antigen predominantly responsible for this immunity, thus remains the leading candidate antigen for vaccines targeting the parasite's preerythrocytic (PE) stages. However, this role for CS was questioned when we recently showed that immunization with irradiated sporozoites (IrrSpz) of a P. berghei line whose endogenous CS was replaced by that of P. falciparum still conferred sterile protection against challenge with wild type P. berghei sporozoites. In order to investigate the involvement of CS in the cross-species protection recently observed between the two rodent parasites P. berghei and P. yoelii, we adopted our gene replacement approach for the P. yoelii CS and exploited the ability to conduct reciprocal challenges. Overall, we found that immunization led to sterile immunity irrespective of the origin of the CS in the immunizing or challenge sporozoites. However, for some combinations, immune responses to CS contributed to the acquisition of protective immunity and were dependent on the immunizing IrrSpz dose. Nonetheless, when data from all the cross-species immunization/challenges were considered, the immune responses directed against non-CS parasite antigens shared by the two parasite species played a major role in the sterile protection induced by immunization with IrrSpz. This opens the perspective to develop a single vaccine formulation that could protect against multiple parasite species.			Mauduit, M (corresponding author), ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore.	renia_laurent@immunol.a-star.edu.sg	Franetich, Jean-François/GZA-9674-2022; Tewari, Rita/M-5698-2014; Renia, Laurent/E-2117-2011; Snounou, Georges/F-3352-2011; Gruner, Anne Charlotte/C-1841-2012	Renia, Laurent/0000-0003-0349-1557; Snounou, Georges/0000-0002-6133-6398; Crisanti, Andrea/0000-0002-2406-4426; Chavatte, Jean-Marc/0000-0002-0003-541X; Tewari, Rita/0000-0003-3943-1847				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Druilhe P., 1998, MALARIA PARASITE BIO; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2006, NATURE, V444, P824, DOI 10.1038/nature05409; Hulier E, 1996, MOL BIOCHEM PARASIT, V77, P127, DOI 10.1016/0166-6851(96)02584-4; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; LOPEZ JA, 1996, VACCINES COLD SPRING, V96, P255; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; MIGLIORINI P, 1993, EUR J IMMUNOL, V23, P582, DOI 10.1002/eji.1830230245; Mikolajczak SA, 2007, CURR OPIN INFECT DIS, V20, P461, DOI 10.1097/QCO.0b013e3282ef6172; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; NUSSENZWEIG RS, 1972, AM J TROP MED HYG, V21, P722, DOI 10.4269/ajtmh.1972.21.722; Preiser PR, 2002, SCIENCE, V295, P342, DOI 10.1126/science.1064938; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; RENIA L, 1993, J IMMUNOL, V150, P1471; Renia L, 2006, EXPERT REV VACCINES, V5, P473, DOI 10.1586/14760584.5.4.473; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sedegah M, 2007, PARASITE IMMUNOL, V29, P559, DOI 10.1111/j.1365-3024.2007.00976.x; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Snounou G, 2005, TRENDS PARASITOL, V21, P456, DOI 10.1016/j.pt.2005.08.002; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Tewari R, 2005, CELL MICROBIOL, V7, P699, DOI 10.1111/j.1462-5822.2005.00503.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; ZAVALA F, 1987, J EXP MED, V166, P1591, DOI 10.1084/jem.166.5.1591; ZAVALA F, 1986, J IMMUNOL METHODS, V93, P55, DOI 10.1016/0022-1759(86)90432-1	45	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7717	10.1371/journal.pone.0007717	http://dx.doi.org/10.1371/journal.pone.0007717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890387	Green Submitted, Green Published, gold			2022-12-27	WOS:000271459700010
J	Szmaragd, C; Wilson, AJ; Carpenter, S; Wood, JLN; Mellor, PS; Gubbins, S				Szmaragd, Camille; Wilson, Anthony J.; Carpenter, Simon; Wood, James L. N.; Mellor, Philip S.; Gubbins, Simon			A Modeling Framework to Describe the Transmission of Bluetongue Virus within and between Farms in Great Britain	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS SONORENSIS; SOUTHERN CALIFORNIA DAIRY; H5N1 AVIAN INFLUENZA; MOUTH EPIDEMIC; VACCINATION STRATEGIES; NORTHERN EUROPE; MIDGES DIPTERA; CASE-FATALITY; BITING RATES; 2001 FOOT	Background: Recently much attention has been given to developing national-scale micro-simulation models for livestock diseases that can be used to predict spread and assess the impact of control measures. The focus of these models has been on directly transmitted infections with little attention given to vector-borne diseases such as bluetongue, a viral disease of ruminants transmitted by Culicoides biting midges. Yet BT has emerged over the past decade as one of the most important diseases of livestock. Methodology/Principal Findings: We developed a stochastic, spatially-explicit, farm-level model to describe the spread of bluetongue virus (BTV) within and between farms. Transmission between farms was modeled by a generic kernel, which includes both animal and vector movements. Once a farm acquired infection, the within-farm dynamics were simulated based on the number of cattle and sheep kept on the farm and on local temperatures. Parameter estimates were derived from the published literature and using data from the outbreak of bluetongue in northern Europe in 2006. The model was validated using data on the spread of BTV in Great Britain during 2007. The sensitivity of model predictions to the shape of the transmission kernel was assessed. Conclusions/Significance: The model is able to replicate the dynamics of BTV in Great Britain. Although uncertainty remains over the precise shape of the transmission kernel and certain aspects of the vector, the modeling approach we develop constitutes an ideal framework in which to incorporate these aspects as more and better data become available. Moreover, the model provides a tool with which to examine scenarios for the spread and control of BTV in Great Britain.			Szmaragd, C (corresponding author), Univ Bristol, Sch Clin Vet Sci, Bristol, Avon, England.	Camille.Szmaragd@bristol.ac.uk	Carpenter, Simon T/C-2718-2013; Wood, James/A-1626-2008	Carpenter, Simon T/0000-0001-5775-045X; Wood, James/0000-0002-0258-3188; Wilson, Anthony/0000-0002-2000-2914; Gubbins, Simon/0000-0003-0538-4173	Biotechnology and Biological Sciences Research Council [IAH1320, BBS/B/00654, BBS/B/00603, BBS/E/I/00001409, BBS/E/I/00001320] Funding Source: Medline; BBSRC [BBS/E/I/00001320, BBS/E/I/00001409] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Backer JA, 2009, J R SOC INTERFACE, V6, P849, DOI 10.1098/rsif.2008.0408; Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; BIRLEY MH, 1982, J ANIM ECOL, V51, P135, DOI 10.2307/4315; BRAVERMAN Y, 1985, J MED ENTOMOL, V22, P476, DOI 10.1093/jmedent/22.5.476; Braverman Y., 2003, Israel Journal of Veterinary Medicine, V58, P46; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; *DEP ENV FOOD RUR, DECL PROT ZON SURV Z; *DEP ENV FOOD RUR, 2008, REP DISTR BLUET INF; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; *EUR FOOD STAND AU, 2007, EP AN 2006 BLUET VIR; Evans M., 1993, STAT DISTRIBUTIONS, V2nd; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; Gerbier G, 2002, PREV VET MED, V56, P33, DOI 10.1016/S0167-5877(02)00122-8; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gerry AC, 2001, J MED ENTOMOL, V38, P197, DOI 10.1603/0022-2585-38.2.197; Gerry AC, 2009, J MED ENTOMOL, V46, P615, DOI 10.1603/033.046.0329; Gloster J, 2008, VET REC, V162, P298, DOI 10.1136/vr.162.10.298; GOLDSMIT L, 1975, AUST VET J, V51, P190, DOI 10.1111/j.1751-0813.1975.tb00053.x; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2005, PREV VET MED, V67, P143, DOI 10.1016/j.prevetmed.2004.08.007; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; HARTEMINK N, 2009, EPIDEMICS IN PRESS, DOI DOI 10.1016/J.EPIDEM.2009.05.004; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Lewis MA, 2000, J MATH BIOL, V41, P387, DOI 10.1007/s002850000050; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Melville LF, 1995, ACIAR PROC, P245; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; Mullens BA, 1998, J MED ENTOMOL, V35, P245, DOI 10.1093/jmedent/35.3.245; Mullens BA, 2004, VETER ITAL SER, V40, P160; NELVILLE EM, 1979, J S AFRIC VET ASS, V49, P129; Nunamaker RA, 1997, J MED ENTOMOL, V34, P24, DOI 10.1093/jmedent/34.1.24; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Schley D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005481; Sharkey KJ, 2008, P ROY SOC B-BIOL SCI, V275, P19, DOI 10.1098/rspb.2007.1100; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Szmaragd C, 2007, VET REC, V161, P571, DOI 10.1136/vr.161.16.571-e; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; Taylor W P, 1986, Rev Sci Tech, V5, P351, DOI 10.20506/rst.5.2.256; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Truscott JE, 2009, EPIDEMIOL INFECT, V137, P775, DOI 10.1017/S0950268808001064; Truscott J, 2007, P ROY SOC B-BIOL SCI, V274, P2287, DOI 10.1098/rspb.2007.0542; *UK MET OFF, 2009, MIDAS LAND SURF STAT; Veronesi E, 2005, VACCINE, V23, P5509, DOI 10.1016/j.vaccine.2005.07.039; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x	56	84	85	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2009	4	11							e7741	10.1371/journal.pone.0007741	http://dx.doi.org/10.1371/journal.pone.0007741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515HI	19890400	Green Published, gold, Green Submitted			2022-12-27	WOS:000271459700019
J	Sareen, D; McMillan, E; Ebert, AD; Shelley, BC; Johnson, JA; Meisner, LF; Svendsen, CN				Sareen, Dhruv; McMillan, Erin; Ebert, Allison D.; Shelley, Brandon C.; Johnson, Julie A.; Meisner, Lorraine F.; Svendsen, Clive N.			Chromosome 7 and 19 Trisomy in Cultured Human Neural Progenitor Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; SPINAL-CORD-INJURY; RAT MODEL; GLIOBLASTOMA-MULTIFORME; SUBVENTRICULAR ZONE; PARKINSONS-DISEASE; DOPAMINE NEURONS; PRECURSOR CELLS; IN-VITRO	Background: Stem cell expansion and differentiation is the foundation of emerging cell therapy technologies. The potential applications of human neural progenitor cells (hNPCs) are wide ranging, but a normal cytogenetic profile is important to avoid the risk of tumor formation in clinical trials. FDA approved clinical trials are being planned and conducted for hNPC transplantation into the brain or spinal cord for various neurodegenerative disorders. Although human embryonic stem cells (hESCs) are known to show recurrent chromosomal abnormalities involving 12 and 17, no studies have revealed chromosomal abnormalities in cultured hNPCs. Therefore, we investigated frequently occurring chromosomal abnormalities in 21 independent fetal-derived hNPC lines and the possible mechanisms triggering such aberrations. Methods and Findings: While most hNPC lines were karyotypically normal, G-band karyotyping and fluorescent in situ hybridization (FISH) analyses revealed the emergence of trisomy 7 (hNPC(+7)) and trisomy 19 (hNPC(+19)), in 24% and 5% of the lines, respectively. Once detected, subsequent passaging revealed emerging dominance of trisomy hNPCs. DNA microarray and immunoblotting analyses demonstrate epidermal growth factor receptor (EGFR) overexpression in hNPC(+7) and hNPC(+19) cells. We observed greater levels of telomerase (hTERT), increased proliferation (Ki67), survival (TUNEL), and neurogenesis (beta(III)-tubulin) in hNPC(+7) and hNPC(+19), using respective immunocytochemical markers. However, the trisomy lines underwent replicative senescence after 50-60 population doublings and never showed neoplastic changes. Although hNPC(+7) and hNPC(+19) survived better after xenotransplantation into the rat striatum, they did not form malignant tumors. Finally, EGF deprivation triggered a selection of trisomy 7 cells in a diploid hNPC line. Conclusions: We report that hNPCs are susceptible to accumulation of chromosome 7 and 19 trisomy in long-term cell culture. These results suggest that micro-environmental cues are powerful factors in the selection of specific hNPC aneuploidies, with trisomy of chromosome 7 being the most common. Given that a number of stem cell based clinical trials are being conducted or planned in USA and a recent report in PLoS Medicine showing the dangers of grafting an inordinate number of cells, these data substantiate the need for careful cytogenetic evaluation of hNPCs (fetal or hESC-derived) before their use in clinical or basic science applications.			Sareen, D (corresponding author), Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, WIMR, Madison, WI 53706 USA.	cnsvendsen@wisc.edu			NINDS NIH HHS [P01NS057778, P01 NS057778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS057778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Andrews PW, 2006, NAT BIOTECHNOL, V24, P325, DOI 10.1038/nbt0306-325; Bailey KJ, 2004, AGING CELL, V3, P391, DOI 10.1111/j.1474-9728.2004.00128.x; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Briand P, 1996, CANCER RES, V56, P2039; Cesetti T, 2009, STEM CELLS, V27, P1443, DOI 10.1002/stem.74; Cui W, 2002, J BIOL CHEM, V277, P38531, DOI 10.1074/jbc.M205981200; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hoffman SMG, 1997, GENOMICS, V43, P109, DOI 10.1006/geno.1997.4792; Huhn SL, 1999, CLIN CANCER RES, V5, P1435; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keirstead HS, 2005, TRENDS NEUROSCI, V28, P677, DOI 10.1016/j.tins.2005.09.008; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; KOCH P, 2009, P NATL ACAD SCI US; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Lopez-Gines C, 2005, CLIN NEUROPATHOL, V24, P209; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McIntyre A, 2008, GENE CHROMOSOME CANC, V47, P547, DOI 10.1002/gcc.20562; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Nelson AD, 2008, STEM CELLS, V26, P348, DOI 10.1634/stemcells.2007-0299; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Ostenfeld T, 2002, J NEUROSCI RES, V69, P955, DOI 10.1002/jnr.10396; Palmer RD, 2007, BRIT J CANCER, V96, P667, DOI 10.1038/sj.bjc.6603602; Puceat M, 2007, CLIN PHARMACOL THER, V82, P337, DOI 10.1038/sj.clpt.6100298; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Rousseau E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-47; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Sugawara A, 2006, COMPARATIVE MED, V56, P31; SUH Y, 2009, MOL CELL NEUROSCI; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Svendsen CN, 2004, NAT MED, V10, P224, DOI 10.1038/nm0304-224; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Taupin P, 2006, CURR OPIN MOL THER, V8, P156; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; 2009, GERON RECEIVES FDA C; 2009, STUDY SAFETY PRELIMI	62	51	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7630	10.1371/journal.pone.0007630	http://dx.doi.org/10.1371/journal.pone.0007630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19898616	Green Submitted, Green Published, gold			2022-12-27	WOS:000271232000009
J	Zhou, HL; Luby-Phelps, K; Mickey, BE; Habib, AA; Mason, RP; Zhao, DW				Zhou, Heling; Luby-Phelps, Kate; Mickey, Bruce E.; Habib, Amyn A.; Mason, Ralph P.; Zhao, Dawen			Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice	PLOS ONE			English	Article							FLUORESCENT DEOXYGLUCOSE ANALOG; GROWTH-FACTOR RECEPTOR; IN-VIVO; BREAST-CANCER; MALIGNANT GLIOMA; COLORECTAL-CANCER; EXPRESSION; REGISTRATION; RESECTION; CONTRAST	Background: It is recognized that cancer cells exhibit highly elevated glucose metabolism compared to non-tumor cells. We have applied in vivo optical imaging to study dynamic uptake of a near-infrared dye-labeled glucose analogue, 2-deoxyglucose (2-DG) by orthotopic glioma in a mouse model. Methodology and Principal Findings: The orthotopic glioma model was established by surgically implanting U87-luc glioma cells into the right caudal nuclear area of nude mice. Intracranial tumor growth was monitored longitudinally by bioluminescence imaging and MRI. When tumor size reached >4 mm diameter, dynamic fluorescence imaging was performed after an injection of the NIR labeled 2-DG, IRDye800CW 2-DG. Real-time whole body images acquired immediately after i.v. infusion clearly visualized the near-infrared dye circulating into various internal organs sequentially. Dynamic fluorescence imaging revealed significantly higher signal intensity in the tumor side of the brain than the contralateral normal brain 24 h after injection (tumor/normal ratio, TNR = 2.8 +/- 0.7). Even stronger contrast was achieved by removing the scalp (TNR = 3.7 +/- 1.1) and skull (TNR = 4.2 +/- 1.1) of the mice. In contrast, a control dye, IRDye800CW carboxylate, showed little difference (1.1 +/- 0.2). Ex vivo fluorescence imaging performed on ultrathin cryosections (20 mu m) of tumor bearing whole brain revealed distinct tumor margins. Microscopic imaging identified cytoplasmic locations of the 2-DG dye in tumor cells. Conclusion and Significance: Our results suggest that the near-infrared dye labeled 2-DG may serve as a useful fluorescence imaging probe to noninvasively assess intracranial tumor burden in preclinical animal models.	[Zhou, Heling; Mason, Ralph P.; Zhao, Dawen] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Mickey, Bruce E.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Habib, Amyn A.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhou, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Dawen.Zhao@UTSouthwestern.edu	Mason, Ralph/C-8472-2012	Mason, Ralph/0000-0001-7517-3721; Luby-Phelps, Katherine/0000-0002-8378-1409	North and Central Texas Clinical and Translational Science Initiative (NCTCTSI); NIH CTSA [UL1 RR024982]; DOD IDEA Award [W81XWH-08-1-0583]; Southwestern Small Animal Imaging Research Program [U24 CA126608]; NIH [1S10RR024757-01]; DOE [DE-FG02-05CH11280]; NIH BTRp [P41-RR02584]; NATIONAL CANCER INSTITUTE [U24CA126608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, P41RR002584, S10RR024757] Funding Source: NIH RePORTER	North and Central Texas Clinical and Translational Science Initiative (NCTCTSI); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); DOD IDEA Award; Southwestern Small Animal Imaging Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NIH BTRp; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the North and Central Texas Clinical and Translational Science Initiative (NCTCTSI) Pilot Grant Award as part of the NIH CTSA Grant UL1 RR024982 and DOD IDEA Award W81XWH-08-1-0583 (DZ). Imaging was fulfilled by the Southwestern Small Animal Imaging Research Program (U24 CA126608), the Caliper IVIS Spectrum under NIH 1S10RR024757-01 and the CRi Maestro was provided by the Joint Program in BME through a DOE grant # DE-FG02-05CH11280. MRI experiments were performed in the Advanced Imaging Research Center, an NIH BTRP # P41-RR02584 facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barker FG, 2006, LANCET ONCOL, V7, P359, DOI 10.1016/S1470-2045(06)70669-6; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Chang SK, 2008, CLIN CANCER RES, V14, P4146, DOI 10.1158/1078-0432.CCR-07-4536; Cheng Z, 2006, BIOCONJUGATE CHEM, V17, P662, DOI 10.1021/bc050345c; Diagaradjane P, 2008, CLIN CANCER RES, V14, P731, DOI 10.1158/1078-0432.CCR-07-1958; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galie M, 2007, NEOPLASIA, V9, P900, DOI 10.1593/neo.07541; Hama Y, 2007, CANCER RES, V67, P3809, DOI 10.1158/0008-5472.CAN-06-3794; Hayashi K, 2007, CANCER RES, V67, P8223, DOI 10.1158/0008-5472.CAN-07-1237; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hsu AR, 2007, J NUCL MED, V48, P445; Hsu AR, 2006, MOL IMAGING BIOL, V8, P315, DOI 10.1007/s11307-006-0059-y; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Ke S, 2003, CANCER RES, V63, P7870; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Kremer P, 2009, NEUROSURGERY, V64, pS53, DOI 10.1227/01.NEU.0000335787.17029.67; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; McCann CM, 2009, NEUROIMAGE, V45, P360, DOI 10.1016/j.neuroimage.2008.12.022; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Parungo CP, 2004, ANN SURG ONCOL, V11, P1085, DOI 10.1245/ASO.2004.03.054; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Runnels JM, 2006, MOL IMAGING, V5, P31, DOI 10.2310/7290.2006.00004; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Serganova I, 2006, HEMATOL ONCOL CLIN N, V20, P1215, DOI 10.1016/j.hoc.2006.09.006; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Tseng J, 2004, J NUCL MED, V45, P1829; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang M, 2003, BIOCONJUGATE CHEM, V14, P709, DOI 10.1021/bc034038n; Zhang ZH, 2004, BIOSENS BIOELECTRON, V20, P643, DOI 10.1016/j.bios.2004.03.034; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zou P, 2009, MOL PHARMACEUT, V6, P428, DOI 10.1021/mp9000052	37	47	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8051	10.1371/journal.pone.0008051	http://dx.doi.org/10.1371/journal.pone.0008051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956682	gold, Green Published			2022-12-27	WOS:000272828400010
J	Li, CY; He, XH; Zhu, SS; Zhou, HP; Wang, YY; Li, Y; Yang, J; Fan, JX; Yang, JC; Wang, GB; Long, YF; Xu, JY; Tang, YS; Zhao, GH; Yang, JR; Liu, L; Sun, Y; Xie, Y; Wang, HN; Zhu, YY				Li, Chengyun; He, Xiahong; Zhu, Shusheng; Zhou, Huiping; Wang, Yunyue; Li, Yan; Yang, Jing; Fan, Jinxiang; Yang, Jincheng; Wang, Guibin; Long, Yunfu; Xu, Jiayou; Tang, Yongsheng; Zhao, Gaohui; Yang, Jianrong; Liu, Lin; Sun, Yan; Xie, Yong; Wang, Haining; Zhu, Youyong			Crop Diversity for Yield Increase	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; PRODUCTIVITY; BIODIVERSITY	Traditional farming practices suggest that cultivation of a mixture of crop species in the same field through temporal and spatial management may be advantageous in boosting yields and preventing disease, but evidence from large-scale field testing is limited. Increasing crop diversity through intercropping addresses the problem of increasing land utilization and crop productivity. In collaboration with farmers and extension personnel, we tested intercropping of tobacco, maize, sugarcane, potato, wheat and broad bean - either by relay cropping or by mixing crop species based on differences in their heights, and practiced these patterns on 15,302 hectares in ten counties in Yunnan Province, China. The results of observation plots within these areas showed that some combinations increased crop yields for the same season between 33.2 and 84.7% and reached a land equivalent ratio (LER) of between 1.31 and 1.84. This approach can be easily applied in developing countries, which is crucial in face of dwindling arable land and increasing food demand.	[Li, Chengyun; He, Xiahong; Zhu, Shusheng; Zhou, Huiping; Wang, Yunyue; Li, Yan; Yang, Jing; Liu, Lin; Sun, Yan; Xie, Yong; Wang, Haining; Zhu, Youyong] Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming, Yunnan, Peoples R China; [Fan, Jinxiang] Plant Protect Stn Honghe Prefecture, Mengzi, Yunnan, Peoples R China; [Yang, Jincheng] Agrosci Res Inst Yuxi City, Yuxi, Yunnan, Peoples R China; [Wang, Guibin] Plant Protect Stn Chuxiong Prefecture, Chuxiong, Yunnan, Peoples R China; [Long, Yunfu] Plant Protect Stn Shiping Cty, Shiping, Yunnan, Peoples R China; [Xu, Jiayou] Agrosci Res Stn Hongxi Town, Mile, Yunnan, Peoples R China; [Tang, Yongsheng] Agr Technol Extens Ctr Qujing City, Qujing, Yunnan, Peoples R China; [Zhao, Gaohui] Agr Technol Extens Ctr Zhaotong City, Zhaotong, Yunnan, Peoples R China; [Yang, Jianrong] Agr Technol Extens Ctr Lincang City, Lincang, Yunnan, Peoples R China	Yunnan Agricultural University	Li, CY (corresponding author), Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming, Yunnan, Peoples R China.	yyzhu@ynau.edu.cn	Zhou, Huiping/H-6875-2019; Zhou, Huiping/R-9888-2016; Zhou, Huiping/J-3639-2015	Zhou, Huiping/0000-0002-0050-372X; Zhou, Huiping/0000-0002-2346-6909; 	National Basic Research Program [2006CB100200]; Ministry of Science and Technology of China	National Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Basic Research Program (No. 2006CB100200) and The Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; DAI XY, 1993, J YUNNAN AGR U, V8, P143; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Fischer G, 2002, GLOBAL AGROECOLOGICA; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Leung Hei, 2003, Plant Disease, V87, P1156, DOI 10.1094/PDIS.2003.87.10.1156; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; *MIN AGR PEOPL REP, 2007, 144312007 NYT MIN AG; *MIN AGR PEOPL REP, 2007, 124812006 NYT MIN AG; Morgado LB, 2008, SCI AGR, V65, P474, DOI 10.1590/S0103-90162008000500005; *NATESC, 2006, HDB CROP PEST FOR, P225; *STAT TOB MON ADM, 1996, YCT401996 STAT TOB M; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; WALLEN V. R., 1957, CANADIAN JOUR PLANT SCI, V37, P337; Wang LiYa, 2005, Southwest China Journal of Agricultural Sciences, V18, P157; Willey R. W., 1979, Field Crop Abstracts, V32, P1; Yang H, 2000, LAND USE POLICY, V17, P73, DOI 10.1016/S0264-8377(00)00008-9; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433	23	86	121	8	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8049	10.1371/journal.pone.0008049	http://dx.doi.org/10.1371/journal.pone.0008049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956624	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828100009
J	Craddock, M; Lawson, R				Craddock, Matt; Lawson, Rebecca			Size-Sensitive Perceptual Representations Underlie Visual and Haptic Object Recognition	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; STRUCTURAL DESCRIPTIONS; 3-DIMENSIONAL OBJECTS; CONFIDENCE-INTERVALS; UNFAMILIAR OBJECTS; EXPLICIT MEMORY; DEPTH ROTATION; SHAPE; IDENTIFICATION; INVARIANCE	A variety of similarities between visual and haptic object recognition suggests that the two modalities may share common representations. However, it is unclear whether such common representations preserve low-level perceptual features or whether transfer between vision and haptics is mediated by high-level, abstract representations. Two experiments used a sequential shape-matching task to examine the effects of size changes on unimodal and crossmodal visual and haptic object recognition. Participants felt or saw 3D plastic models of familiar objects. The two objects presented on a trial were either the same size or different sizes and were the same shape or different but similar shapes. Participants were told to ignore size changes and to match on shape alone. In Experiment 1, size changes on same-shape trials impaired performance similarly for both visual-to-visual and haptic-to-haptic shape matching. In Experiment 2, size changes impaired performance on both visual-to-haptic and haptic-to-visual shape matching and there was no interaction between the cost of size changes and direction of transfer. Together the unimodal and crossmodal matching results suggest that the same, size-specific perceptual representations underlie both visual and haptic object recognition, and indicate that crossmodal memory for objects must be at least partly based on common perceptual representations.	[Craddock, Matt; Lawson, Rebecca] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Craddock, M (corresponding author), Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England.	m.craddock@liv.ac.uk	Craddock, Matt/G-2633-2010	Craddock, Matt/0000-0002-2199-3705	Engineering and Physical Sciences Research Council; Economic and Social Research Council [RES-000-27-0162]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an Engineering and Physical Sciences Research Council DTA studentship to the first author and by a Fellowship from the Economic and Social Research Council (RES-000-27-0162) to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Borghi AM, 2007, NEUROSCI LETT, V411, P17, DOI 10.1016/j.neulet.2006.10.003; Bushnell EW, 1999, J EXP PSYCHOL HUMAN, V25, P1867, DOI 10.1037/0096-1523.25.6.1867; Cooke T, 2007, NEUROPSYCHOLOGIA, V45, P484, DOI 10.1016/j.neuropsychologia.2006.02.009; Craddock M, 2008, PERCEPT PSYCHOPHYS, V70, P1350, DOI 10.3758/PP.70.7.1350; Craddock M, 2009, ATTEN PERCEPT PSYCHO, V71, P910, DOI 10.3758/APP.71.4.910; Desmarals G, 2007, MEM COGNITION, V35, P1712, DOI 10.3758/BF03193504; Easton RD, 1997, PSYCHON B REV, V4, P403, DOI 10.3758/BF03210801; FISER J, 1995, PERCEPTION, V24, P741, DOI 10.1068/p240741; Hayward WG, 2003, TRENDS COGN SCI, V7, P425, DOI 10.1016/j.tics.2003.08.004; Helbig HB, 2006, EXP BRAIN RES, V174, P221, DOI 10.1007/s00221-006-0443-5; Hummel J. E., 1996, ATTENTION PERFORM, P93; James TW, 2007, CAN J EXP PSYCHOL, V61, P219, DOI 10.1037/cjep2007023; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jarmasz J, 2009, CAN J EXP PSYCHOL, V63, P124, DOI 10.1037/a0014164; JOLICOEUR P, 1987, MEM COGNITION, V15, P531, DOI 10.3758/BF03198388; Lacey S, 2006, Q J EXP PSYCHOL, V59, P361, DOI 10.1080/17470210500173232; Lacey S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000890; Lacey S, 2009, EXP BRAIN RES, V198, P329, DOI 10.1007/s00221-009-1856-8; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lawson R, 1999, ACTA PSYCHOL, V102, P221, DOI 10.1016/S0001-6918(98)00052-3; Lawson R, 2009, J EXP PSYCHOL HUMAN, V35, P911, DOI 10.1037/a0015025; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Lederman SJ, 1996, PERCEPTION, V25, P983, DOI 10.1068/p250983; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LOOMIS JM, 1991, PERCEPTION, V20, P167, DOI 10.1068/p200167; MILLIKEN B, 1992, MEM COGNITION, V20, P83, DOI 10.3758/BF03208257; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; Peissig JJ, 2007, ANNU REV PSYCHOL, V58, P75, DOI 10.1146/annurev.psych.58.102904.190114; Reales JM, 1999, J EXP PSYCHOL LEARN, V25, P644, DOI 10.1037/0278-7393.25.3.644; REED CL, 1990, CAN J PSYCHOL, V44, P522, DOI 10.1037/h0084264; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Srinivas K, 1996, MEM COGNITION, V24, P441, DOI 10.3758/BF03200933; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Tarr MJ, 2003, TRENDS COGN SCI, V7, P23, DOI 10.1016/S1364-6613(02)00010-4; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Uttl B, 2007, SCAND J PSYCHOL, V48, P281, DOI 10.1111/j.1467-9450.2007.00571.x; Wijntjes MWA, 2008, PERCEPTION, V37, P602, DOI 10.1068/p5714; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	49	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8009	10.1371/journal.pone.0008009	http://dx.doi.org/10.1371/journal.pone.0008009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MH	19956685	gold, Green Accepted, Green Published			2022-12-27	WOS:000272827500032
J	Hu, HJ; Leppla, SH				Hu, Haijing; Leppla, Stephen H.			Anthrax Toxin Uptake by Primary Immune Cells as Determined with a Lethal Factor-beta-Lactamase Fusion Protein	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; BACILLUS-ANTHRACIS; DENDRITIC CELLS; PROTECTIVE ANTIGEN; INHALATION ANTHRAX; MELANOMA-CELLS; MACROPHAGES; RECEPTOR; SPORES; STRAIN	Background: To initiate infection, Bacillus anthracis needs to overcome the host innate immune system. Anthrax toxin, a major virulence factor of B. anthracis, impairs both the innate and adaptive immune systems and is important in the establishment of anthrax infections. Methodology/Principal Findings: To measure the ability of anthrax toxin to target immune cells, studies were performed using a fusion of the anthrax toxin lethal factor (LF) N-terminal domain (LFn, aa 1-254) with beta-lactamase (LFnBLA). This protein reports on the ability of the anthrax toxin protective antigen (PA) to mediate LF delivery into cells. Primary immune cells prepared from mouse spleens were used in conjunction with flow cytometry to assess cleavage and resulting FRET disruption of a fluorescent b-lactamase substrate, CCF2/AM. In spleen cell suspensions, the macrophages, dendritic cells, and B cells showed about 75% FRET disruption of CCF2/AM due to cleavage by the PA-delivered LFnBLA. LFnBLA delivery into CD4+ and CD8+ T cells was lower, with 40% FRET disruption. When the analyses were done on purified samples of individual cell types, similar results were obtained, with T cells again having lower LFnBLA delivery than macrophages, dendritic cells, and B cells. Relative expression levels of the toxin receptors CMG2 and TEM8 on these cells were determined by real-time PCR. Expression of CMG2 was about 1.5-fold higher in CD8+ cells than in CD4+ and B cells, and 2.5-fold higher than in macrophages. Conclusions/Significance: Anthrax toxin entry and activity differs among immune cells. Macrophages, dendritic cells, and B cells displayed higher LFnBLA activity than CD4+ and CD8+ T cells in both spleen cell suspension and the purified samples of individual cell types. Expression of anthrax toxin receptor CMG2 is higher in CD4+ and CD8+ T cells, which is not correlated to the intracellular LFnBLA activity.	[Hu, Haijing; Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hu, HJ (corresponding author), NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov			Intramural Research Program of the National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Banks DJ, 2005, CELL MICROBIOL, V7, P1173, DOI 10.1111/j.1462-5822.2005.00545.x; Bish SE, 2008, MICROBES INFECT, V10, P1182, DOI 10.1016/j.micinf.2008.06.014; Boyer AE, 2009, INFECT IMMUN, V77, P3432, DOI 10.1128/IAI.00346-09; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; CATALDI A, 1992, FEMS MICROBIOL LETT, V98, P89, DOI 10.1111/j.1574-6968.1992.tb05495.x; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Duesbery N, 1998, SCIENCE, V280, P1673; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; LEPPLA SH, 1986, BACTERIAL PROTEIN TO, P275; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Liu Shihui, 2009, V539, P175, DOI 10.1007/978-1-60327-003-8_10; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mayer-Scholl A, 2006, BERL MUNCH TIERARZTL, V119, P216; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rono B, 2006, MOL CANCER THER, V5, P89, DOI 10.1158/1535-7163.MCT-05-0163; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Ruthel G, 2004, J INFECT DIS, V189, P1313, DOI 10.1086/382656; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Tang SX, 2009, CLIN VACCINE IMMUNOL, V16, P408, DOI 10.1128/CVI.00412-08; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7946	10.1371/journal.pone.0007946	http://dx.doi.org/10.1371/journal.pone.0007946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956758	gold, Green Published, Green Submitted			2022-12-27	WOS:000272827300005
J	Parsons, KJ; Cooper, WJ; Albertson, RC				Parsons, Kevin J.; Cooper, W. James; Albertson, R. Craig			Limits of Principal Components Analysis for Producing a Common Trait Space: Implications for Inferring Selection, Contingency, and Chance in Evolution	PLOS ONE			English	Article							DEVELOPMENTAL REGULATION; ONTOGENIC DYNAMICS; SKULL MORPHOLOGY; COVARIANCE; VARIANCE	Background: Comparing patterns of divergence among separate lineages or groups has posed an especially difficult challenge for biologists. Recently a new, conceptually simple methodology called the "ordered-axis plot'' approach was introduced for the purpose of comparing patterns of diversity in a common morphospace. This technique involves a combination of principal components analysis (PCA) and linear regression. Given the common use of these statistics the potential for the widespread use of the ordered axis approach is high. However, there are a number of drawbacks to this approach, most notably that lineages with the greatest amount of variance will largely bias interpretations from analyses involving a common morphospace. Therefore, without meeting a set of a priori requirements regarding data structure the ordered-axis plot approach will likely produce misleading results. Methodology/Principal Findings: Morphological data sets from cichlid fishes endemic to Lakes Tanganyika, Malawi, and Victoria were used to statistically demonstrate how separate groups can have differing contributions to a common morphospace produced by a PCA. Through a matrix superimposition of eigenvectors (scale-free trajectories of variation identified by PCA) we show that some groups contribute more to the trajectories of variation identified in a common morphospace. Furthermore, through a set of randomization tests we show that a common morphospace model partitions variation differently than group-specific models. Finally, we demonstrate how these limitations may influence an ordered-axis plot approach by performing a comparison on data sets with known alterations in covariance structure. Using these results we provide a set of criteria that must be met before a common morphospace can be reliably used. Conclusions/Significance: Our results suggest that a common morphospace produced by PCA would not be useful for producing biologically meaningful results unless a restrictive set of criteria are met. We therefore suggest biologists be aware of the limitations of the ordered-axis plot approach before employing it on their own data, and possibly consider other, less restrictive methods for addressing the same question.	[Parsons, Kevin J.; Cooper, W. James; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Parsons, KJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	kjpars01@syr.edu		Cooper, W. James/0000-0003-4204-4266	National Institute on Aging [RO1AG031922]; National Institute of Dental and Craniofacial Research [1R21DE019223]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031922] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R. C. Albertson's laboratory is supported by grants from the National Institute on Aging (RO1AG031922) and the National Institute of Dental and Craniofacial Research (1R21DE019223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Flury B, 1988, COMMON PRINCIPAL COM; Gower J.C., 1971, MATH ARCHAEOLOGICAL, P138; Herrera CM, 2002, J EVOLUTION BIOL, V15, P108, DOI 10.1046/j.1420-9101.2002.00365.x; Manly B.F.J., 1994, MULTIVARIATE STAT PR; PERES PR, 2005, MORPHINT AVAILABLE R; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; SHEETS D, 2002, STANDARD6; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zelditch ML, 2006, EVOL DEV, V8, P46, DOI 10.1111/j.1525-142X.2006.05074.x; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x	14	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7957	10.1371/journal.pone.0007957	http://dx.doi.org/10.1371/journal.pone.0007957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956767	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000272827300014
J	Wegiel, B; Jiborn, T; Abrahamson, M; Helczynski, L; Otterbein, L; Persson, JL; Bjartell, A				Wegiel, Barbara; Jiborn, Thomas; Abrahamson, Magnus; Helczynski, Leszek; Otterbein, Leo; Persson, Jenny Liao; Bjartell, Anders			Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITORS; IN-VIVO; GROWTH-FACTOR; CATHEPSIN-B; MATRIX METALLOPROTEINASES; RADICAL PROSTATECTOMY; GENE-EXPRESSION; CYCLIN A1; ACTIVATION; PROGRESSION	Cystatin C is believed to prevent tumor progression by inhibiting the activities of a family of lysosomal cysteine proteases. However, little is known about the precise mechanism of cystatin C function in prostate cancer. In the present study, we examined the expression of cystatin C and its association with matrix metalloproteinases 2 (MMP2) and androgen receptor (AR) in a tissue microarray comparing benign and malignant specimens from 448 patients who underwent radical prostatectomy for localized prostate cancer. Cystatin C expression was significantly lower in cancer specimens than in benign tissues (p<0.001) and there was a statistically significant inverse correlation between expression of cystatin C and MMP2 (r(s)(2) = -0.056, p = 0.05). There was a clear trend that patients with decreased level of cystatin C had lower overall survival. Targeted inhibition of cystatin C using specific siRNA resulted in an increased invasiveness of PC3 cells, whereas induction of cystatin C overexpression greatly reduced invasion rate of PC3 in vitro. The effect of cystatin C on modulating the PC3 cell invasion was provoked by Erk2 inhibitor that specifically inhibited MAPK/Erk2 activity. This suggests that cystatin C may mediate tumor cell invasion by modulating the activity of MAPK/Erk cascades. Consistent with our immunohistochemical findings that patients with low expression of cystatin C and high expression of androgen receptor (AR) tend to have worse overall survival than patients with high expression of cystatin C and high AR expression, induced overexpression of AR in PC3 cells expressing cystatin C siRNA greatly enhanced the invasiveness of PC3 cells. This suggests that there may be a crosstalk between cystatin C and AR-mediated pathways. Our study uncovers a novel role for cystatin C and its associated cellular pathways in prostate cancer invasion and metastasis.	[Wegiel, Barbara; Jiborn, Thomas; Bjartell, Anders] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Clin Sci,Div Urol Canc, Malmo, Sweden; [Helczynski, Leszek] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Pathol, Malmo, Sweden; [Persson, Jenny Liao] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden; [Abrahamson, Magnus] Lund Univ, Univ Lund Hosp, Div Clin Chem & Pharmacol, Dept Lab Med, Lund, Sweden; [Wegiel, Barbara; Otterbein, Leo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wegiel, B (corresponding author), Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Clin Sci,Div Urol Canc, Malmo, Sweden.	jenny_l.persson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022	Persson, Jenny/0000-0001-7682-7678	Swedish Research Council [20760, 09915]; Swedish Cancer Society [07-0458, 02-4573]; Cancer Research Fund of Malmo, University Hospital; Faculty of Medicine, Lund University; Gunnar Nilssons Cancer Foundation; Crafoord STF; Government Health Grant (ALF); A. Oesterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Fund of Malmo, University Hospital; Faculty of Medicine, Lund University; Gunnar Nilssons Cancer Foundation; Crafoord STF; Government Health Grant (ALF); A. Oesterlund Foundation	This work was supported by grants from the Swedish Research Council (grant no. 20760 and 09915), the Swedish Cancer Society (Projects No 07-0458 and 02-4573), the Research Fund and the Cancer Research Fund of Malmo, University Hospital, the Faculty of Medicine, Lund University, Gunnar Nilssons Cancer Foundation, and the Crafoord STF, and Government Health Grant (ALF) and A. Oesterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P243, DOI 10.1289/ehp.9630; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Bonaccorsi L, 2006, MOL CELL ENDOCRINOL, V246, P157, DOI 10.1016/j.mce.2005.11.006; Buchanan G, 2001, MOL ENDOCRINOL, V15, P46, DOI 10.1210/me.15.1.46; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Coleman RE, 2002, AM J CLIN ONCOL-CANC, V25, pS32, DOI 10.1097/00000421-200212001-00006; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; DOSREIS ST, 2008, UROL ONCOL; Ebert E, 1997, ADV EXP MED BIOL, V421, P259; Ellenrieder V, 2001, CANCER RES, V61, P4222; Ervin H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-14; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Friedrich B, 1999, EUR J CANCER, V35, P138, DOI 10.1016/S0959-8049(98)00273-1; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Gohji K, 1998, INT J CANCER, V79, P96, DOI 10.1002/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F; Gupta P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004363; Ishimaru H, 2002, ACTA ONCOL, V41, P289, DOI 10.1080/02841860260088845; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jennbacken K, 2006, PROSTATE, V66, P1631, DOI 10.1002/pros.20469; Jiborn T, 2004, J ANDROL, V25, P564; Jiborn T, 2006, BJU INT, V98, P189, DOI 10.1111/j.1464-410X.2006.06345.x; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Konduri SD, 2002, ONCOGENE, V21, P8705, DOI 10.1038/sj.onc.1205949; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Kos J, 2000, INT J BIOL MARKER, V15, P84, DOI 10.1177/172460080001500116; Krishan A, 2000, CLIN CANCER RES, V6, P1922; LAH TT, 1989, CLIN EXP METASTAS, V7, P461, DOI 10.1007/BF01753666; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Moses MA, 1998, CANCER RES, V58, P1395; Nakabayashi H, 2005, HUM PATHOL, V36, P1008, DOI 10.1016/j.humpath.2005.06.021; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Oka H, 2005, INT J UROL, V12, P899, DOI 10.1111/j.1442-2042.2005.01164.x; Pucci L, 2007, CLIN CHEM, V53, P480, DOI 10.1373/clinchem.2006.076042; Reddy Michael S, 2003, Ann Periodontol, V8, P12, DOI 10.1902/annals.2003.8.1.12; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Simon C, 1999, BRIT J CANCER, V80, P1412, DOI 10.1038/sj.bjc.6690537; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Trudel D, 2003, CANCER RES, V63, P8511; Tummalapalli P, 2007, INT J ONCOL, V31, P5; Tumminello FM, 2009, MED ONCOL, V26, P10, DOI 10.1007/s12032-008-9070-2; van der Poel HG, 2005, EUR UROL, V48, P1051, DOI 10.1016/j.eururo.2005.09.006; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; VOELLER HJ, 1991, MOL ENDOCRINOL, V5, P209, DOI 10.1210/mend-5-2-209; Watts SW, 1998, J PHARMACOL EXP THER, V286, P1431; Watts SW, 1998, ANN NY ACAD SCI, V861, P162; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214	63	54	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7953	10.1371/journal.pone.0007953	http://dx.doi.org/10.1371/journal.pone.0007953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956729	Green Published, Green Submitted, gold			2022-12-27	WOS:000272827300011
J	Nascimento, EJM; Braga-Neto, U; Calzavara-Silva, CE; Gomes, ALV; Abath, FGC; Brito, CAA; Cordeiro, MT; Silva, AM; Magalhaes, C; Andrade, R; Gil, LHVG; Marques, ETA				Nascimento, Eduardo J. M.; Braga-Neto, Ulisses; Calzavara-Silva, Carlos E.; Gomes, Ana L. V.; Abath, Frederico G. C.; Brito, Carlos A. A.; Cordeiro, Marli T.; Silva, Ana M.; Magalhaes, Cecilia; Andrade, Raoni; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.			Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome	PLOS ONE			English	Article							BOLSTERED ERROR ESTIMATION; T-CELL RESPONSES; HEMORRHAGIC-FEVER; PERIPHERAL-BLOOD; VIRUS-INFECTIONS; SHOCK-SYNDROME; ELEVATED LEVELS; SEVERITY; ACTIVATION; APOPTOSIS	Background: We report the detailed development of biomarkers to predict the clinical outcome under dengue infection. Transcriptional signatures from purified peripheral blood mononuclear cells were derived from whole-genome gene-expression microarray data, validated by quantitative PCR and tested in independent samples. Methodology/Principal Findings: The study was performed on patients of a well-characterized dengue cohort from Recife, Brazil. The samples analyzed were collected prospectively from acute febrile dengue patients who evolved with different degrees of disease severity: classic dengue fever or dengue hemorrhagic fever (DHF) samples were compared with similar samples from other non-dengue febrile illnesses. The DHF samples were collected 2-3 days before the presentation of the plasma leakage symptoms. Differentially-expressed genes were selected by univariate statistical tests as well as multivariate classification techniques. The results showed that at early stages of dengue infection, the genes involved in effector mechanisms of innate immune response presented a weaker activation on patients who later developed hemorrhagic fever, whereas the genes involved in apoptosis were expressed in higher levels. Conclusions/Significance: Some of the gene expression signatures displayed estimated accuracy rates of more than 95%, indicating that expression profiling with these signatures may provide a useful means of DHF prognosis at early stages of infection.			Nascimento, EJM (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol & Terapia Expt, Recife, PE, Brazil.	marques@pitt.edu	Marques, Ernesto T. A/L-4967-2013; Calzavara-Silva, Carlos/ABF-2829-2021; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Nascimento, Eduardo/J-4590-2014; Braga-Neto, Ulisses/ABI-2677-2020; Gil, Laura Helena Vega Gonzales/AAX-5319-2021	Marques, Ernesto T. A/0000-0003-3826-9358; Calzavara-Silva, Carlos/0000-0002-1406-6401; Marques, Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080	NIAID NIH HHS [U19 AI056541, U19 AI56541] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; BRAGA UMD, 2005, EURASIP BOOK SERIES; Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Clementi M, 2006, REPROD TOXICOL, V21, P345, DOI 10.1016/j.reprotox.2005.08.006; Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Myint KS, 2006, J INFECT DIS, V194, P600, DOI 10.1086/506451; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; OPAS - Organizacao Pan-Americana de Saude, 1995, DENG DENG HEM AM GUI, V548; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pettiford JN, 2002, CLIN EXP IMMUNOL, V128, P110, DOI 10.1046/j.1365-2249.2002.01813.x; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; SCHERER CA, 2007, VACCINE; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sima C, 2005, PATTERN RECOGN, V38, P2472, DOI 10.1016/j.patcog.2005.03.026; Sima C, 2005, BIOINFORMATICS, V21, P1046, DOI 10.1093/bioinformatics/bti081; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007; Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42, DOI 10.1055/s-0037-1612941; Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; *WHO, 1999, TREATM DENG FEV DENG; Yunta M, 2003, ONCOGENE, V22, P1219, DOI 10.1038/sj.onc.1206183	49	61	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7892	10.1371/journal.pone.0007892	http://dx.doi.org/10.1371/journal.pone.0007892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936257	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000272004600001
J	Simmerman, JM; Chittaganpitch, M; Levy, J; Chantra, S; Maloney, S; Uyeki, T; Areerat, P; Thamthitiwat, S; Olsen, SJ; Fry, A; Ungchusak, K; Baggett, HC; Chunsuttiwat, S				Simmerman, James Mark; Chittaganpitch, Malinee; Levy, Jens; Chantra, Somrak; Maloney, Susan; Uyeki, Timothy; Areerat, Peera; Thamthitiwat, Somsak; Olsen, Sonja J.; Fry, Alicia; Ungchusak, Kumnuan; Baggett, Henry C.; Chunsuttiwat, Supamit			Incidence, Seasonality and Mortality Associated with Influenza Pneumonia in Thailand: 2005-2008	PLOS ONE			English	Article							RISK-FACTORS; BURDEN; CHILDREN; HOSPITALIZATIONS; COMPLICATIONS; EPIDEMIOLOGY; DEATHS; COST	Background: Data on the incidence, seasonality and mortality associated with influenza in subtropical low and middle income countries are limited. Prospective data from multiple years are needed to develop vaccine policy and treatment guidelines, and improve pandemic preparedness. Methods: During January 2005 through December 2008, we used an active, population-based surveillance system to prospectively identify hospitalized pneumonia cases with influenza confirmed by reverse transcriptase-polymerase chain reaction or cell culture in 20 hospitals in two provinces in Thailand. Age-specific incidence was calculated and extrapolated to estimate national annual influenza pneumonia hospital admissions and in-hospital deaths. Results: Influenza was identified in 1,346 (10.4%) of pneumonia patients of all ages, and 10 influenza pneumonia patients died while in the hospital. 702 (52%) influenza pneumonia patients were less than 15 years of age. The average annual incidence of influenza pneumonia was greatest in children less than 5 years of age (236 per 100,000) and in those age 75 or older (375 per 100,000). During 2005, 2006 and 2008 influenza A virus detection among pneumonia cases peaked during June through October. In 2007 a sharp increase was observed during the months of January through April. Influenza B virus infections did not demonstrate a consistent seasonal pattern. Influenza pneumonia incidence was high in 2005, a year when influenza A(H3N2) subtype virus strains predominated, low in 2006 when A(H1N1) viruses were more common, moderate in 2007 when H3N2 and influenza B co-predominated, and high again in 2008 when influenza B viruses were most common. During 2005-2008, influenza pneumonia resulted in an estimated annual average 36,413 hospital admissions and 322 in-hospital pneumonia deaths in Thailand. Conclusion: Influenza virus infection is an important cause of hospitalized pneumonia in Thailand. Young children and the elderly are most affected and in-hospital deaths are more common than previously appreciated. Influenza occurs year-round and tends to follow a bimodal seasonal pattern with substantial variability. The disease burden varies significantly from year to year. Our findings support a recent Thailand Ministry of Public Health (MOPH) decision to extend annual influenza vaccination to older adults and suggest that children should also be targeted for routine vaccination.			Simmerman, JM (corresponding author), US Ctr Dis Control Collaborat, Thailand Minist Publ Hlth, Int Emerging Infect Program, Nonthaburi, Thailand.	msimmerman@cdc.gov						Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; *ALPH RES CO LTD, 2004, THAIL FIG 2004 2005; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; *CDC, 2008, THAIL COMM SEAS FLU; *CDC, 2007, PREV CONTR INFL REC; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Clague Birgit, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P488; Coffin SE, 2007, PEDIATRICS, V119, P740, DOI 10.1542/peds.2006-2679; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; Fedson DS, 2004, PEDIATR INFECT DIS J, V23, pS74, DOI 10.1097/01.inf.0000108195.12141.cc; Gravenstein S, 2002, CLIN INFECT DIS, V35, P729, DOI 10.1086/341246; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; JORDAN HT, 2008, THAILAND INT J INFEC, V13, P355; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Kendal AP, 1982, CONCEPTS PROCEDURES; Kositanont Uraiwan, 2004, Journal of the Medical Association of Thailand, V87, P964; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; POST B, 2008, BANGKOK POST VACCINA; Prapasiri Prabda, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P706; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Stone B, 2004, J VIROL METHODS, V117, P103, DOI 10.1016/j.jviromet.2003.12.005; Suntarattiwong P, 2007, INFLUENZA OTHER RESP, V1, P177, DOI 10.1111/j.1750-2659.2007.00023.x; *THAIL MET DEP, 2005, NAT TEMP RAINF REP; *THAIL MIN STAT IN, 2007, THAI EC FACTS FIG RE; *THAIL MOPH INFL S, 2007, EP BO; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WONG CM, 2004, COMUNICABLE INFECT D, V39; Wongsurakiat Phunsup, 2003, Journal of the Medical Association of Thailand, V86, P497; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; 2008, THAILAND FIGURES	40	122	126	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A107	A114	e7776	10.1371/journal.pone.0007776	http://dx.doi.org/10.1371/journal.pone.0007776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936224	Green Published, gold			2022-12-27	WOS:000271685800012
J	Lai, YP; Lin, CC; Liao, WJ; Tang, CY; Chen, SC				Lai, Yo-Ping; Lin, Chia-Ching; Liao, Wan-Jung; Tang, Chih-Yung; Chen, Shu-Ching			CD4+ T Cell-Derived IL-2 Signals during Early Priming Advances Primary CD8(+) T Cell Responses	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; RAPID COLORIMETRIC ASSAY; IN-VIVO; B-CELL; SECONDARY EXPANSION; DENDRITIC CELLS; CUTTING EDGE; MEMORY; CD4(+); ACTIVATION	Stimulating naive CD8(+) T cells with specific antigens and costimulatory signals is insufficient to induce optimal clonal expansion and effector functions. In this study, we show that the activation and differentiation of CD8(+) T cells require IL-2 provided by activated CD4(+) T cells at the initial priming stage within 0-2.5 hours after stimulation. This critical IL-2 signal from CD4(+) cells is mediated through the IL-2R beta gamma of CD8(+) cells, which is independent of IL-2R alpha. The activation of IL-2 signaling advances the restriction point of the cell cycle, and thereby expedites the entry of antigen-stimulated CD8(+) T-cell into the S phase. Besides promoting cell proliferation, IL-2 stimulation increases the amount of IFN gamma and granzyme B produced by CD8(+) T cells. Furthermore, IL-2 at priming enhances the ability of P14 effector cells generated by antigen activation to eradicate B16.gp33 tumors in vivo. Therefore, our studies demonstrate that a full CD8(+) T-cell response is elicited by a critical temporal function of IL-2 released from CD4(+) T cells, providing mechanistic insights into the regulation of CD8(+) T cell activation and differentiation.			Lai, YP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	mdchensc@ntu.edu.tw		/0000-0002-9904-8199; Chen, Shu-Ching/0000-0001-9112-1526; TANG, CHIH-YUNG/0000-0003-1065-2865				BABCOCK SK, 1987, TRANSPLANT P, V19, P303; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Hammers HJ, 2002, J IMMUNOL METHODS, V264, P89, DOI 10.1016/S0022-1759(02)00082-0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HOFFMANN MK, 1977, J EXP MED, V146, P1640, DOI 10.1084/jem.146.6.1640; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; KAKIUCHI T, 1983, J IMMUNOL, V131, P109; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kim HP, 2005, J BIOL CHEM, V280, P34042, DOI 10.1074/jbc.M505833200; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1987, J IMMUNOL, V138, P1813; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Nakamura M, 1993, Semin Immunol, V5, P309, DOI 10.1006/smim.1993.1037; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROSENBERG AS, 1987, J EXP MED, V165, P1296, DOI 10.1084/jem.165.5.1296; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; WU Y, 1994, CURR BIOL, V4, P499, DOI 10.1016/S0960-9822(00)00110-X; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	49	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7766	10.1371/journal.pone.0007766	http://dx.doi.org/10.1371/journal.pone.0007766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19901991	Green Submitted, Green Published, gold			2022-12-27	WOS:000271658800007
J	Barott, K; Smith, J; Dinsdale, E; Hatay, M; Sandin, S; Rohwer, F				Barott, Katie; Smith, Jennifer; Dinsdale, Elizabeth; Hatay, Mark; Sandin, Stuart; Rohwer, Forest			Hyperspectral and Physiological Analyses of Coral-Algal Interactions	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF COMMUNITY; MASS MORTALITY; ORGANIC-CARBON; PHASE-SHIFTS; COMPETITION; FLUORESCENCE; REFLECTANCE; DEGRADATION; MACROALGAE	Space limitation leads to competition between benthic, sessile organisms on coral reefs. As a primary example, reef-building corals are in direct contact with each other and many different species and functional groups of algae. Here we characterize interactions between three coral genera and three algal functional groups using a combination of hyperspectral imaging and oxygen microprofiling. We also performed in situ interaction transects to quantify the relative occurrence of these interaction on coral reefs. These studies were conducted in the Southern Line Islands, home to some of the most remote and near-pristine reefs in the world. Our goal was to determine if different types of coral-coral and coral-algal interactions were characterized by unique fine-scale physiological signatures. This is the first report using hyperspectral imaging for characterization of marine benthic organisms at the micron scale and proved to be a valuable tool for discriminating among different photosynthetic organisms. Consistent patterns emerged in physiology across different types of competitive interactions. In cases where corals were in direct contact with turf or macroalgae, there was a zone of hypoxia and altered pigmentation on the coral. In contrast, interaction zones between corals and crustose coralline algae (CCA) were not hypoxic and the coral tissue was consistent across the colony. Our results suggest that at least two main characteristic coral interaction phenotypes exist: 1) hypoxia and coral tissue disruption, seen with interactions between corals and fleshy turf and/or some species of macroalgae, and 2) no hypoxia or tissue disruption, seen with interactions between corals and some species of CCA. Hyperspectral imaging in combination with oxygen profiling provided useful information on competitive interactions between benthic reef organisms, and demonstrated that some turf and fleshy macroalgae can be a constant source of stress for corals, while CCA are not.	[Barott, Katie; Dinsdale, Elizabeth; Hatay, Mark; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Smith, Jennifer; Sandin, Stuart] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Barott, K (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	katiebarott@gmail.com	Rohwer, Forest/AAC-5315-2019	dinsdale, elizabeth/0000-0002-2177-203X; Obura, David/0000-0003-2256-6649; Barott, Katie/0000-0001-7371-4870; Rohwer, Forest/0000-0003-1548-5429	San Diego State University; Gordon and Betty Moore Foundation; Canadian Institute for Advanced Research; National Geographic Society; National Science Foundation	San Diego State University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by San Diego State University, the Gordon and Betty Moore Foundation, and the Canadian Institute for Advanced Research. The Southern Line Islands expedition was organized and sponsored by the National Geographic Society. KB was supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; CHORNESKY EA, 1989, ECOLOGY, V70, P843, DOI 10.2307/1941353; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hattery D, 2002, 31ST APPLIED IMAGERY PATTERN RECOGNITION WORKSHOP, PROCEEDINGS, P124; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KAWAGUTI S, 1944, PHYSL REEF CORALS, V6; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LOGAN A, 1984, CORAL REEFS, V3, P131, DOI 10.1007/BF00301957; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Rouse Jr. J.W., 1974, MONITORING VERNAL AD; Sabins FF, 1999, ORE GEOL REV, V14, P157, DOI 10.1016/S0169-1368(99)00007-4; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SALIH A, 1997, P AUSTR COR REEF SOC, P217; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHLICHTER D, 1994, OECOLOGIA, V99, P124, DOI 10.1007/BF00317092; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; VOGEL A, 2007, J BIOMED OPT, V12; WELLINGTON GM, 1980, OECOLOGIA, V47, P340, DOI 10.1007/BF00398527; Wilkinson C., 2004, STATUS CORAL REEFS W; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	57	103	106	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8043	10.1371/journal.pone.0008043	http://dx.doi.org/10.1371/journal.pone.0008043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956632	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828100006
J	Zhang, HH; Huang, JX; Duvel, K; Boback, B; Wu, SL; Squillace, RM; Wu, CL; Manning, BD				Zhang, Hui H.; Huang, Jingxiang; Duevel, Katrin; Boback, Bernard; Wu, Shulin; Squillace, Rachel M.; Wu, Chin-Lee; Manning, Brendan D.			Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway	PLOS ONE			English	Article								Background: The signaling pathways imposing hormonal control over adipocyte differentiation are poorly understood. While insulin and Akt signaling have been found previously to be essential for adipogenesis, the relative importance of their many downstream branches have not been defined. One direct substrate that is inhibited by Akt-mediated phosphorylation is the tuberous sclerosis complex 2 (TSC2) protein, which associates with TSC1 and acts as a critical negative regulator of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through mTORC1-dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets. Methodology/Principal Findings: We find that, despite severe insulin resistance and the absence of Akt signaling, TSC2-deficient mouse embryo fibroblasts and 3T3-L1 pre-adipocytes display enhanced adipocyte differentiation that is dependent on the elevated mTORC1 activity in these cells. Activation of mTORC1 causes a robust increase in the mRNA and protein expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), which is the master transcriptional regulator of adipocyte differentiation. In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis. Finally, renal angiomyolipomas from patients with tuberous sclerosis complex contain both adipose and smooth muscle-like components with activated mTORC1 signaling and elevated PPAR gamma expression. Conclusions/Significance: This study demonstrates that activation of mTORC1 signaling is a critical step in adipocyte differentiation and identifies TSC2 as a primary target of Akt driving this process. Therefore, the TSC1-TSC2 complex regulates the differentiation of mesenchymal cell lineages, at least in part, through its control of mTORC1 activity and PPAR gamma expression.			Zhang, HH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Huang, Jingxiang/B-4515-2008; Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792; Zhang, Hua/0000-0001-9731-2737	NATIONAL CANCER INSTITUTE [R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA122617-04, R01 CA122617, CA120964, CA122617, P01 CA120964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HUANG J, 2008, MOL CELL BIOL, V28; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li XH, 2005, ACTA PHARMACOL SIN, V26, P1081, DOI 10.1111/j.1745-7254.2005.00161.x; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PEDERSEN O, 1992, J CLIN INVEST, V89, P1964, DOI 10.1172/JCI115804; Pederson T, 2000, BIOCHEM BIOPH RES CO, V276, P162, DOI 10.1006/bbrc.2000.3429; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; [王志刚 WANG Zhigang], 2008, [东北师大学报. 自然科学版, Journal of Northeast Normal University], V40, P1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	78	286	295	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6189	10.1371/journal.pone.0006189	http://dx.doi.org/10.1371/journal.pone.0006189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19915715	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300005
J	Suhr, ST; Chang, EA; Rodriguez, RM; Wang, K; Ross, PJ; Beyhan, Z; Murthy, S; Cibelli, JB				Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.			Telomere Dynamics in Human Cells Reprogrammed to Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLONING; CANCER; LENGTH	Background: Human induced pluripotent stem cells (IPSCs) have enormous potential in the development of cellular models of human disease and represent a potential source of autologous cells and tissues for therapeutic use. A question remains as to the biological age of IPSCs, in particular when isolated from older subjects. Studies of cloned animals indicate that somatic cells reprogrammed to pluripotency variably display telomere elongation, a common indicator of cell "rejuvenation.'' Methodology/Principal Findings: We examined telomere lengths in human skin fibroblasts isolated from younger and older subjects, fibroblasts converted to IPSCs, and IPSCs redifferentiated through teratoma formation and explant culture. In IPSCs analyzed at passage five (P5), telomeres were significantly elongated in 6/7 lines by >40% and approximated telomere lengths in human embryonic stem cells (hESCs). In cell lines derived from three IPSC-teratoma explants cultured to P5, two displayed telomeres shortened to lengths similar to input fibroblasts while the third line retained elongated telomeres. Conclusions/Significance: While these results reveal some heterogeneity in the reprogramming process with respect to telomere length, human somatic cells reprogrammed to pluripotency generally displayed elongated telomeres that suggest that they will not age prematurely when isolated from subjects of essentially any age.	[Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.] Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA; [Ross, Pablo J.; Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain	Michigan State University	Suhr, ST (corresponding author), Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@anr.msu.edu	Rodriguez, Ramon Maria/AAF-9376-2019; wang, kai/G-4932-2011	Rodriguez, Ramon Maria/0000-0002-6770-5123; Goissis, Marcelo/0000-0002-7382-7477; Cibelli, Jose/0000-0002-2176-3854; Perkins, Guy/0000-0002-1834-6646	Naylor Family Foundation	Naylor Family Foundation	Funding was obtained from the Naylor Family Foundation, Michigan State University Vice President for Research and Graduate Studies and The Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	216	221	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8124	10.1371/journal.pone.0008124	http://dx.doi.org/10.1371/journal.pone.0008124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956585	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800018
J	Chen, GJ; Han, GC; Feng, JN; Wang, JA; Wang, RX; Xu, RN; Shen, BF; Qian, JH; Li, Y				Chen, Guojiang; Han, Gencheng; Feng, Jiannan; Wang, Jianan; Wang, Renxi; Xu, Ruonan; Shen, Beifen; Qian, Jiahua; Li, Yan			Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells	PLOS ONE			English	Article								Background: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used. Methodology/Principal Findings: Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7-10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524-538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509-528)- or p530 (GAD530-543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570-585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice. Conclusions/Significance: These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs.			Chen, GJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	liyan62033@yahoo.com.cn	Wang, Renxi/AAM-1326-2020	Wang, Renxi/0000-0003-4130-3334; Han, George/0000-0003-3302-5098; Friedman, Adam/0000-0001-8925-1620				Arneson LS, 2000, J IMMUNOL, V165, P2059, DOI 10.4049/jimmunol.165.4.2059; ATKINSON MA, 1992, LANCET, V339, P458, DOI 10.1016/0140-6736(92)91061-C; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Dai YD, 2008, EUR J IMMUNOL, V38, P968, DOI 10.1002/eji.200737703; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Ellis TM, 1996, NAT MED, V2, P148, DOI 10.1038/nm0296-148; Fanelli F, 1998, METHODS, V14, P302, DOI 10.1006/meth.1998.0586; Fisson S, 2006, EUR J IMMUNOL, V36, P817, DOI 10.1002/eji.200535445; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geng LP, 1998, P NATL ACAD SCI USA, V95, P10055, DOI 10.1073/pnas.95.17.10055; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Ortiz AR, 1999, PROTEINS, P177; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Severe S, 2007, MOL IMMUNOL, V44, P2950, DOI 10.1016/j.molimm.2007.01.008; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Song L, 2004, GENE THER, V11, P1487, DOI 10.1038/sj.gt.3302327; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	51	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2009	4	9							e7034	10.1371/journal.pone.0007034	http://dx.doi.org/10.1371/journal.pone.0007034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FM	19759824	Green Published, Green Submitted, gold			2022-12-27	WOS:000269796100001
